>FCMOIPGL_00001 Retaining alpha-galactosidase
MPLNLATPNQIEDSSWIQPGKALWDWRVHNYKTADGFIYGVDTKSYLRFIDFAVEKNIQY
FLIDANWYTKVTKGHFEITEKLDLEKVSKYAKTKGVKLILYYDRHKGDFGDDELFSHFAS
LGMSGIKYGFMGNNVSFTSDAIQQSAKNHLLVDFHDSPVPFTGMERTFPNAITREYCHAQ
QDSRKAFTPETFVKMALVNAIQGPLDMNNGNFDLIGINKGDRLKGPKKKNTYFSTVTSEV
ARTLIIYSGLVCLPDAPESYNKKADLFEFIEKMPVGKWDESKVLSSEMGSYISTARRFEK
EWFVGSVTNEEARTLEIKLDFLEEGKTYNVTYYQDTEKTHGIENPEVYQIKKGIVKKGDV
IKAVMAPGGGHCMWIRPTIN
>FCMOIPGL_00002 Arylsulfatase
MKNIISIIAIIFLFSSCKTIEKKQEVSKKPNVLFILVDDLGYADLSIMGSKYYETPSIDN
IANTGTVFTNGYAACTVCSPSRASLMTGQYPARHGITQFEGKRNSGQAWKERKRYTKLLP
PEYRDHLDTSTTTIAEAFKEQGYATFFAGKWHLGGKAQGSLPTDHGFDVNIGGYDAGGPS
GGYFSPYKNPFLPNLPEEKGLNLSMKLANETNKFIKKNKDNQFFAYLSFYAVHGGIQTTK
EKWTKYRNKAEKMGIHENGFEMERVLPARKYQDNPVYAGLIEHVDDAISTVLKTLKELDL
DKNTIVVFTSDNGGVTSGDNYSTNQLSLRGGKGYQWEGGTRVPFFIDVPWIKQSGAKIDV
PVSGVDLYPTLLDLAGLPLKPEAHNDGVSLKPLLLGEKIDERPLYWHYPHYGNQGGEPSS
IIRKGKWKLIYYWEDLHAELYNLDTDIGERNDLANAQPERAKEMEVQLLTWLKSMNTHYA
QVDPEWDEAARKKWLENQKTNNLPGREKQRKKMLDPNWQPNKDWWGSEVKK
>FCMOIPGL_00003 hypothetical protein
MRKSAFYLLSLLVIICFGCQNQDIDIYVSPVGNNLNNGAKETPFKTIEKALENAKSIKKE
ENDKIIIHLLEGEYHLASTLKITSQLNNLSIIGVGADKVSIQGSKVIETKWKQFSDNILV
TTIDENLDFNQLYINGEKQILARYPNYDENGGYWQGSAADAIDKERIAKWKNPIGGFVHA
LHRGRWGGFHYEITGVKDNGELNLIGGHQNNRPSEMHLKYRMVENIFEELDSEKEWYFDK
KNHKLYIFKNNDLDINQAKIEVTVLKHLIEIKGTLENPVKNVSITGIKFENTSRTFMETY
EPLLRSDWTIYRGGALLLDATENMTIEDCEFTNLGGNVIFVSGYNRNTKITGNHIHDSGA
SAISFVGDASAVRSPSFDYFKSVAIEDMDTLVGPKNELYPSNSIVENNLIHRIGRVEKQV
AGVQISMAMKIHVKNNSIYDVPRAGINVSEGTWGGHIIEYNDVFNTVLETSDHGSFNSWG
RDRFWYPDREISSKLVSKNGKMPLWDAMHTTIIRNNRFRCDHGWDIDLDDGSSNYEIYNN
LCLNRGIKLREGYYRTVRNNIMVNNTFHPHVWFLNSGDVFTNNIVMKKYAGIRIKDWGKE
IDSNLFPNKAALLKAQGNHTDANSVFGNPLFINPKSGNFTVSDDSPALKIGFKNFPMDQF
GVQKRALKAIAKQPEIPTLKIESSLKEGVKTKQWSGATLKEIETIEEQSSFGTHSLEGVI
VLKIDKKSKLFKSALKKGDVIVGFANKKVKNILNFLDIFEKNSSKESVKVIIIRDQKEIE
IKLRNTFF
>FCMOIPGL_00004 hypothetical protein
MNAFVVIISMLFLGMGSSFSQSNLKLVTSSYSPIEGLDAEAGIKRGDPSDIIKVGSLYYV
WYWKVGINVRWATWYATSPDGFTWTEKAEVLPPGKEGSWDDEGCFTPGILIANNKYYLFY
SGVNNPYRTKGLEKSKTRIGIAISDSPDGPWTKFSGNPIMVPSTDITEFDSHRIDDASII
VRDGKFWLYYKGRQWGKSPRETKMGVAIANKPEGPYVKYKNNPVVKGGHEVLVWPQGKGV
ATMIGKEGPENVRKSIMYAEDGFNFKKTHNFTNKNVPLAPGGYRPEAFTDNGKGKLIEWG
LQRVMKKGIEYLERFDLKEVSDKSKK
>FCMOIPGL_00005 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MMKVFKLILFIGLYLVSSNCIAQDVLIETESFIDKGGWVVDPQFVEQMGSPYLMAHGMGN
PVSNAVTKVNFEKIGKYHVWARTKNWVPGNWDAPGQFKIAVNGKTLKRTLGVTTGWTWEY
AGKVKIKSSDVEIQLLDLTGFNGRCDAIYFSQSKKMPTEAETNLASWRKTKLGETTIPKQ
QKEYDLVITGGGLAGCAAAISAAEQGLNVALIHDRPMLGGNASEEVRVHTLGIYGKYERI
LKMIDTKHYPNGSFKAKYDQEKRDKNVKSFKNIDIFLDWRAYDAKSENNTIKYVDARNTS
TGERIRFKAPRFVDSTGDGWIGFWAGAEFSYGRESSKTYGESWDKWGELWSPEEPDDFVM
GSSVLWQNKKTNEAQVFPELAWAADVSKEHKAIAGEWYWEFSRNDLHQIHDGEEIRDHML
RAIYGSFANAKKLDKNKNYKLQWVSFLLGKRESRRLIGDHIYTFNDVKNHTKFKDAVVEE
KRAIDVHYQRNLKDDKEPDFLSEALFYKGNKYYIPYRSLYSKNITNLFMAGRNFSCSHIG
LGGPRVMLTTGQMGAAVGLAAVICKKYNSTPREVYTKHLQEYLDLIEKQQ
>FCMOIPGL_00006 hypothetical protein
MYKIFPFITIIFIFMGFQDKIKSDYKPMFFSMNDEWKDIAKDESVFQFEVKSLDAIFNSE
INYEVRLLSDSKGVPKLFFSEIETSVCADGECKLANIKVYWNLLGNYVGFGIPPEYPLTK
FEHHHFKKEDYAKLHQLLLDDNSILKRRKMSDLIDKVPIFSSNIYSDDVDAISGATKTEI
KEAVVKGGLYSCYTIWHLVHGEVKEKMEEYLKTINSDKLIHNFLSTPYKDYQMYALKQLK
KSAYKEHSNQIISIYKTSDALTKVYILKKIPEDVLSEEFVTEQFYNKFPLIDINSRTLLI
HRLKSANKNASEILSKYVDSMSKNQLKFYLNYLNDSPKFISNSCKSNLKKASKNKKYTYS
YLLKEFLKNRK
>FCMOIPGL_00007 hypothetical protein
MKKINLICILLVIFGNQFLKAQKIKTEIRPAKVWLDSNGNSINAHGGGVLFNKGVYYWYG
EHKLEGKSEAQFADGGIHCYSSTDLVNWKNEGIVLTVNYKDEKSDLAYGCILERPKVVYN
SKNKEFVAYFKLYLKGVGYDSNYVGVAVSDKPNGPFTYHHKFRGGGTNKGSGDFSMFKDD
DGILYHLAVRKPDKAFVIGKMDPDYYFPEGDYQVCKGVKVHSEAPAIIKRNGIYHMLGSG
SKGWKPNPARYHTTESILGTWTFHGNPCKGYNPVDNLGIEKTFGGQASYIILVQGKKDTY
IAMFDIWKPKNPITGRYIWLPIDFSEGEMSISWQDSWQLSTSIKK
>FCMOIPGL_00008 Arylsulfatase
MNNCKVKLKFALLLMLFSSFCSKAQNADKPNILFLVVEDTSPYLFPAYGNKTIKTPNLDY
LAKNGVIFNNAFANGPQCSPARSSLISGSYATTYGNDWHRNGHIVPQQYFFPQYLREEGY
FCVNAGKTDYNITKEVQKKYYPLVWDKMSGYLSDDKPNVSYNDADRKGKPFFAQFNNMTT
HMSRITSVSVDNREPSRINPKDVDLPSHVPDIPEMRADYALHLDGVQDADKWVGFFIDDL
KKRKLLENTIIFFFSDHGGSLPRGKAFPYETGFRSALIISAPEKWKHLLPAQQGQKSDQI
VEFVDFGPTLLNVTGAKIPEHMQGKPFMGPDAQKRTYAHSFRTNTEIHFDPSRAINDGAF
HYIKFYTPYKVHGLKQSFQWGMPSQNTWDDLYHKGECELEYKSYYEPKANEALFDSKKDP
WNMNNLADDLAYAETLQTLRKEASSHIRKTRDLGFFPKAVRDEFVSRGISLYEWVRTENY
PFNELYDLVEKASLGKVSDKEMFLKYLKHERPEFRFWATSGLTTMAYHGNLKGIPNQLLM
ACDDKWHSVAATAAEAIALAGQPEKGISMLIEQAKEGNKLSLSALEELGNRVAPFTDDIK
YLAEHGKNKDIKFLARGILINLGELPMSQLFDSKSTNKFIKTQKKRIKDWAPTLPN
>FCMOIPGL_00009 Arylsulfatase
MLTSIYTINAQEKTAETPPNIVLIYADDLGKGLLSHYGQKIIKTPHIDQLAQEGITFENA
YSGMVCAPSRASLLSGLRDCNPTNFQISKGAFYKKISNGTYTNQQIQDKLNKALTPPNKD
AVFLGEVAQKQGYATGQFGKLEWGFSTSHQQMIRHGWDEYYGYLDHVRAHGFYPPFLFRN
GEMEYIEGNTRADCGKTIENETPQKYKERWNMEGKTVYSQHLFMNNVLNFITKNKDKPFF
LYFPTQLPHGPVSIPAIHPDFANNKQLTSIEKEYASMVKMLDDNVGEIMAHLKNLGIDEN
TLVIFTSDNGHEIYYTQEGRVYKPYKNVKTGKRFDDLNNKFYSDLGGDVFNGNGGRAGLK
KSNLQGGIQAPLIARWPKKIAKGQTSNLLVANYDFVSTFADVTGYKGNFKTDGLSFYDEM
IGKGNKKEHDFVAYASFTGPTIITKEGWKLRSHLPKNAFELFYLPEDYREENDLTDKYSK
KVNFLKEEMLKACNGDFKNGVFTFNQSTISIEKK
>FCMOIPGL_00010 hypothetical protein
MIKNHLILLLTVAISFSSFSQKKIWDETEQEKAERLAWWQEARFGMFIHWGLYAQPARHE
WVKKREGISDEDYQKYFDVFNPDLFNPKEWAKKAKAAGMKYAVITTKHHEGFSMFDSDYS
DYNVTKTPYGKDILKEWVDAFRAEGLGIGFYYSLIDWHHPDFTIDSRHVIKAKNKKEYEK
LNKNRDIAVYRKYLKNQVNELLTNYGQVDLLWLDFSYPGEFGKGREDWGSVELMKMVRKL
QPKILVNDRLDLKEYAGGWDFTTPEQFKVEKWPEVDGKKVAWETCQTFSGSWGYYRDEHT
WKDNKQLLTLLIESVSKGGNVLLNVGPTARGTFDYRADEALEDMGEWMKYNSRAIYSCTE
APEGFVTPANSLLTYNPKTNRLYVHLLDYPIQNFLMKGMKGRIKYAQFLHDASEIRIGKT
HGAWGKEEMEEGDINLKLPVTKPNLEIPVIEIFLND
>FCMOIPGL_00011 NADH dehydrogenase-like protein
MNIPKVDLPRVVVVGGGFAGLNLVKKLRKLPIQLVMLNKHNYHAFQPLLYQVSTCGIEPD
SIVYPLRMFIKRQENFYFRLADVKSVDPVNKILTADIGDLSYDYLIINTGTKTNFFGNKQ
IKKYAMPMKTIPQALNLRSLILQNFEKSTIVASNEDKKFLLNFVIVGAGPTGVELAGAIA
EFRQGVLPSDFPDLDPELMQIHILEGADRVLPPMSLKSSQKATEALKKLGVKIHTNTIVT
DFDGELVKTKDGKEFKTRTLIWSAGVTGNLLNGFPETSYNSRSNRYYVDEFNKVKGYEDV
FALGDIALMQSESYPNGHPQVAQPAIQQAKLLSANFSKILKGKTNLKPFKYNDKGSMATI
GRNKAVADIWNFQFSDFIAWLIWMFIHLMSLVGFRNRLVVFLNWVYNYTSYNKASRLIIR
RFSVSSRRVRTNSEL
>FCMOIPGL_00012 hypothetical protein
MKLRQLTLLITILVFTSCSIFQKKKNEQTEIVYSDNIKYEYVGRAAENEGMHVWGSSPIK
GKDGKIHLYAAQWPTNTQPNFNGWYKDCEIGHYVGDKPEGPFKYVGVAVEDKNGLFNSPH
NPTISNIDGQYQLCFIVNENDDLKTQRIVMLVADDLNDTWRPAKGAEADGTILRQTKDSS
VWNYTARLGVSNPSLIKYKGKYYLYHKSVVRKEPKGYVYSYGLIVADNVEGPYVHNPIRV
TEEKMPLEDAYAFTMNDSVYMISRDFRGALGNRGGGLLWKSADGLSFPKENTKRAYEDLQ
HYVGKEHLKDAVSYRGKKDGHLERAQLLFENGIPTYLYLATGVQTKSGYGSSSHVFKISF
E
>FCMOIPGL_00013 hypothetical protein
MKHILGILILTLTLISCEVKKSESNFNEIPKKIDLKTFPKEGLITLGKQDLIPNTEGIIA
DIKLVLAPFEKGVYYRPFSKKLASGNRVEPIWFDRISELNSYKKEKPRFDGFKDLGSFLM
LKNASGKYLVLLPVVSNKIGNTFAIYDNEIFLRTATYGTKTEQISAPLLAYAESDNPYEA
TRKVWELAKNAEGVKGNVNWRSDKTYPEPFKYLGWCSWEHFKKDINEEIILKSISDIKKS
EIPFRWVLVDDGYLDQENWKLLSFGTDKNKFPNGWKPITSQKDDKIKWMGIWRNMQGYMQ
GISPNHTMDHLKDDIVKVKYGKSVKFMPKISEKSADAFYHEMTSVTKKAGFDIIKVDFQS
DNYFYNKGSENAIYGVHLNNTALEENCVDENLHLLNCIAQQNFNVFNQRYSSVIRGSVDY
KTTMDRTDITIVQNFTNAFWLGHLHWLDQDMFHTSFKETARLMAVSRAMSGGPIYLSDET
TNIDDTYLKPLMYKDGEIIRTLAPGVPLPQSMMKDPYFDGKAFSVIAPIENKSAVIMAVN
LNQGEKEVKASISLKDYQFAGSMIQPYQGLWNAPKEGIILYDHDAGSASILKDDYQFTLS
SRKERLFQLSPIQNGWSVIGNPDKYLSAATYDLLETNKKSLKIKMKEDGPVLLWSNGKIP
ISENFEFKKLKNGLWQGELVKPNSNSAYLILIEE
>FCMOIPGL_00014 Intracellular exo-alpha-(1->5)-L-arabinofuranosidase
MRTVLYRLYLIKMNALLVLILLLLVSCSTVNETKGQEVLEQNIEIITIDTSVRTHPVSKN
PGGVVSCWLLDSDIERPRKTSFTDAMKEMSVKYIRFPYGHLADNYLWDADNDWGNTLTPK
IATASQAPASWDWAVNQATGEFIKDMDFDEYISICNNVDAEPMVVVNILSYKYKNGPTYQ
QLKESAIEWVRYANVTKGYNVKRWALGNEVDHHSDLISQEEYKALYTDFATAMKNVDPTI
MIGPGLLGNWHASLLAHDPDNIDFICVHNYLYKYDWRNQDYEGWKNADDNLINNVEKCQN
AVNNSSIPDTEIHVTEMNSRPWKDKSDSDDIFRGLAYGEMLLNACSFEDVKATYVWNTHG
PWEGPEKNAPYNILDLDNNREPRGDVIKIINENLLDYFVKVPRVNGFIRVYASIDESNEN
LNIFLINKNDTSEVVNLETSKFNLQSNYTIKSFSGNHPEDKSPVYSEVAYNDLNDAILKV
ELAPVSFNVISVKLK
>FCMOIPGL_00015 hypothetical protein
MIKSIKNIIIFLITISCVGQETIDALLYQGDPLEKSAFLKKENPWFARYQVGESPVVGFP
GETKNEKKQRMQKWVDAKYGLFIHWGPQRAGGEYEISSEVSNAFNPVDFNAKEWVSIAKR
LGFKYIVITAKHHAGFSMFDSKLTDFNIIEKTPFKRDPIKELAIACTEENMPFGVYYSVW
DIHHPDYTKNIGSKNYVKYHEFMLGQVKELLTNYGPMISVWFDGEWVNSWTVERATEFRD
LIRAVQPNTVIANRIGQRRRGEGDHHSPENFSPYIGAQSEPWETCAKFDGSWFYNGTNKS
ESADWALYNLCYATSRGGNFLMNLGPTPEGKFLETSVEKLEKVGNWLQINRESIYGSDKG
PHYLLEWGTCTQKGNTLYYQVFDWPKNGELHIPGLKTAVKSASFLADKAHKSITTNREGN
DVVVKLPIIPPYKMANVIKIELMDTPIVDNAARALKKEIKKNQAMRQVAEGSYFLPAGFA
NIYGEKLHFYYGTGSGAQRENLKGWTEESDYVTWDLLVEKNGKYNLEITYASLVAGGAFE
LFIAGQNFKHTVKEVEYNPKAKKSPLRVDYKTFTLGEVVLKSGRYQLVIKPIEISEEAKK
LHQGLMMLRDVTLVPN
>FCMOIPGL_00016 hypothetical protein
MRNSIFIFVIFFSVQINAQFLLSYDKPASPFTKEQRQDYRKNGYMQEALPLGNGRLGAMF
SGGIAQEHIMMNEITLWMNSKRGLDSVAQSGVRIGAHKNFHKVRKAYEEENYGTGENSME
AMATKYLSSQEPLGNYAPFTDVFIATGHQPKDIRNYSRTLDIHTGVGMVNYTIGKAQYTR
EYFSSYPNDVVVVRYTSKKGKMNLTIHVSSLHKITNLEAKGNEILLQGEAAMQKDPVEFM
QRIFVDAGKARVIAQKDGSLSIKNASDVKIYVSAYTDYLPVYPTFKGRDYVADSKKTIKD
AIAVAYKKLKKSHQKDVSSLMDRCQFNLDYIPSGQTTDKLIQQGSSIELENLYFNYARYL
QISSSRTAAVPSNLQGLWNGHLKPAWNADYHTDINLAMNYWMVETANLPISFSPYVAYLK
IIAASGKHTAKESFGIEKGWSMGLNGNVFGFTAPNEHGRRMQQSGAWLCQNLFEHYAFSK
DKKYLEEIYPILKGAAEFYVTFLAPWKDGSLVVYPTWSPENAYLVKEFGKLNKQAYGASF
EQQLVLNLFTDYIEASVVLNRDEAFRKTIQETIPKLSPQKIGQYGQVQEWPEDWDSPTDH
HRHISHLIALHPGRDFSPLTTPELSNAALVTMKHRGDISTGWSTAWKTNFWARLHNGDKA
YQFYQFLTAKRTYANLFDFHPPFQIDGNFGGTAGVCEMLLQSHIRSVNNDAENIQEAAFV
AYQNNSENKKHFIPVIPQKSIANAPYILHLLPALPSAWSKGSVKGLRARGGLEVDLEWNK
DELVKATIHAKTNGLFRVYSEGKLSKLLSLKKGESMVWRSN
>FCMOIPGL_00017 hypothetical protein
MKHNIKMTCFYVSMAILTIVSVIACGNKKLNKSATKTEVSQEIKTDKKISFSYSEVKGIG
KDTVYNRRDPSDIIKVGNKYYIWYTRMDKPVRSGYWGTIWYATSEDEGHTWQEQGLALGL
GAEGTFDSHSVFTPNILAFKGKYYMYYTGVQPTPGNLKKEFEGNSTTDFTAIGVAVADSP
EGPFIRPEKNIVIAHSDVPSDFDSYRVDDASMLIKEGKIWLYYKGRCIEHGKDGPKHTQM
GVAIAENPIGPFQKYAKPLIRKGHEVLIWNHNDGVASLTSLSKSIYWAKDGLEFNSTAEN
LKKIPMAPGLYRPHLEDGNRTNEAPGWGISMRQSKGEAHLLRYEIHNMVQ
>FCMOIPGL_00018 hypothetical protein
MKNIKTIYPLAILLFVFAYANAQQNQWPTFKSYTGEYLKRVAMPVGGIGTGTVSLTGNGA
IQNWEIMSFPAKGFNAIIPKGPPSNRSAFFAINIQEEGKKAQAVLLEGPMSDRYYEGERG
AIGANHGLPRFAEATFKTAYPFGQVFLKDKDLPVAVTVGAFNPLIPGNVDDSSIPTAILS
YKVKNTSNKSITVSLAGTVQNIIGFDGTRGKTIKNINTFKDQDGLKGIHYTSNGVDKNSY
QWGTFSLATNSKEQISYRTNWIPQKWGDTTLDFWDDFTDDGLLEERPSFNADAPVGSLAV
KTVLAPGEEKDIRFFITWHFPNRPAWRNQKVNVGNFYASKYKDSWDVAKQIVTRLAALEK
GTETFVNTFLASDIPQITKEASLFNLAHLRTQLGFRTKEGHFLGWEGTADNVGRGLGTCT
HVWNYDQTTPFLFGEIAQTMRDTEFGYATTDEGLMSFRIELPLSTSAQKHGVAAADGQMG
SIMQFYREWQLSGDDAFLKKHWPMVKKALEFSWIKGGWDANKDGVMEGSQHNTMDVEYFG
PNPQMGFWYLGALKASEKMAKHLGEKSFAKTCKKLYENGSKWMDENLFNGEYYEQLIQPP
MVQENLAKGLMMGMGTKDLTTPDYQLGKGVLVDQLVGQVMAHILDFGYLAKEENIKKTNK
AVIKYNHKENMSKHANFMRSYALGDESALLMAAYPGERPDKPFPYFTEVMTGFEYTAAVS
MLYENQNEIGLKTMQDVRDRYDGKKRSPFNEAEFGNHYARSMMAWGSVLATTGFHYSAVD
QSINFTAKPGTYFWSNGYQYGKVTISDDGKSKKAVFTVLNGSVKLKSFTLNDFGTVSFRK
VKTVDENTSETFMIKNNLK
>FCMOIPGL_00019 hypothetical protein
MKRAFRVCNISIRFVGFLFLLSIGVGSFAQTTAMGKSTNNIPFQLGSLFKDHMVLQRDVP
IPVWGKATAGTTVTVKFANSKKQTIADSNGKWSVKLDALKASFDSKTMLVSSSMDKKTIK
ISDVLVGEVWICSGQSNMQFSVNGAPEVKKLIPSAKNIRSFKVKNTVALEPQDTCEGTWE
VNYPNSAVAFSFAYFLEKSANVPVGIILTAWGSSSLEAWMPKDMVETVPHFKTMMEEFDA
DDKTKNRITAILNGKKPWGKEDDIFLRRQSNILYNAMMHPLMPYACKGIVWYQGERNTQS
MHGMIKEPWFSRNSGMLKYGDVLKEWVKRYRKGWDNDDLHFLVVMLPGYGKELKTDKNIA
ANTPNAHSWAWMRESQLKVLELPHTSVANIIDLGDYKNIHPKDKLPVGKRLALLARKDVL
GEKITALGPTLKKVKIKKNTVIVRFKNAKKLKTTDGKSPTGFWLADEANRWFPAKATIKG
KRVILTSSSLENPLYVRYAFTGKPDVNLENEANLPAYPFRTDSFKP
>FCMOIPGL_00020 hypothetical protein
MKNRIVVVSIFIVTVFVMSCKNNKKEEILKTSEIVKFNTYHKDVTFMKDYTSIIELSDAS
GKSKVAIAAALQGRVMTSSAFGNEGRSYGWINKELFKSKDTLEHINVFGGEERFWLGPEG
GQYSIFFKKGDEFTLENWYTPRLIDLEHFDVEKQSTSNVVFTKKASLKNYSGFQFDMGIE
REISILSKEAISQELGIYALGNNIKAVAYQTKNTLTNLGDADWKKETGLLSIWLLGMYNH
SPNTTIMIPYISGEVSELGIPVNDTYFGKVPADRLVVKDAIIYFSGDGKYRSKIGLSPMR
AKDVAGSYDSKNGILTIVKYNKPEKVTDYVNSMWEIQDEPFAGDVINAYNDGEPSPGEKP
LGPFYELETSSSAMSLKVGESGTHIQLTCHLEGSEEDLNPIIKKVFGVNSSAIKNAFK
>FCMOIPGL_00021 Acetylxylan esterase
MKSKYIVIILLLLIGSIFTVRAQDISPDSKILYKVIDGDSLYLHVFKPKLSKKPTAAIVF
FFGGGWTGGNPKQFYQQSEYFASRGILAISAEYRIKKTHGTSPFECVEDGKSAIRWVREN
AKELNINPNKIVASGGSAGGHVALTTAVINGFENTTENLSVSSVPNAVVAYNPVSDTTEK
GYGHEKVVGRETEISPTHQVKKNMPPMLIFHGTKDKTVPFENAERFTRLMKEAGNECELV
AIKDADHGFFNGDFFRKGAGNKYFNLTAYKTDVFLKNLGFLKGKPTLSENIQKVACVGDS
NTEATYPKFLQEKLGNKYEVKNFGRGGATLLDGTNHPYFKKEEYKNSLKFTPDVVLIMFG
TNDANAKWCLDENRKTEFKGTYQEEFKSQYIKLINAYKRKNENAEIYVLTPLPIYEHKKS
RDPKVKERIEHLYDWVIPTIREVAEKENVELLDVNKLMKKAYKYTVDGVHLTEKGYEVLA
KKIAKKIK
>FCMOIPGL_00022 hypothetical protein
MKNIINSILLFVFMSSWAQKELPTLNFNLETASVSSQGDKLIVNTGKVERIWKLTNTGLI
TNAFKNRLTGEVYIENNNELNADWSYYGLIDNNTKGNLINLTASQSNDENFTSEHIEVIA
EFEYPSIETSIKYVIWAYPNATGIRTQLFIKGEAEKYIKNSDAKLREDIVFDVVLGKNKN
NYAAGEVAERYITTTILDKKSVQLHAKGLDSKKKYKLGFTWWDFEGKGIRQKVRVTSVDG
EINKEVVANVKLPDYKNSKDLFETVLVDLPSEALLDGTCRIFFDKIDGEVAKVAEVFIYE
ETQKIITITNGLAKRVDALRKASPENYSLIGYFDCGEEIQGEKMLATGRVDGLPINTEGT
TRTHIGYYNDTQHRNKRETPIIKEATFNESIETEEKVNWSNIIRVDKDGKGVLMVKESHK
CANQYGVDTGEFIVTKKGIQNTGTALFPSEINSEEYKWCWASWAIAYVGGQEGSDLALKE
FDRLRYPVDPTRDIYLQANTWGSGRNKEASQEANILVELESQADLGIDIQQIDDGWQTKN
WLLRTDWYPEGWKNVIKKSEETGVQIGLWAAAMPVTYEALKQQYDTAGFVTYKLDFARLG
NHENMDKLIGKVRKFIKYTNHKVRVNWDLTENAPRFGFFWAREYGCIYLENRKPDKPENV
VYIPYLVLRDIWHVAKYTNINKFQTSIQNVGMTNRKVSDAYLHNDPYAVAIGLVGTPLFF
QETHNYSQESRDQIKPLLATYKKYRDEMYDSYVFAIGSEPNNANWSGFQWYSLEKKSGYL
MVFRELNNKEVEQKIPLHFLKNKRLTLTNLETGVSTEKTVGNNGALNFKINNPAGYQFIK
YSYE
>FCMOIPGL_00023 hypothetical protein
MRKVILIVITIVFNLLSQQSIKAEVKLPAIVSSNMVLQRNTTIVLWGWADVGEKITIKTS
WLKDELSFNADKNGDWKIEVKTTDSKEPQFIKINSKDSDILLDNVLFGEVWLCSGQSNMY
QPLASYNGQPTYGGLMATVKSNNKNLRLFSVGKVASKTPLEKLDKFTGWQDASPESVLNF
SAVAYFFGKQLQEVLDCPVGLIHASWGGSIVQAWMSKEVLNTYKKVDLENVDLKKRAQYN
PTVLYNSMIKPLIPFTIKGALWYQGESNRSEPNDYKKLFPAMVKDWRTRWGIGEFPFYYV
QIAPYLYDNNDVFQTNDNTAFIREAQLQCLDLIPNSGIAITMDIGDEKSIHPPKKKEVAD
RLLFNALNQTYGYKTVDYAGPIYKSLEKKDGGILLSFKNAELGLYAYDGLTGFEIAGADK
VFYPATSKFVNRRKVLVKSDKVTNPVAVRYAWRNWINGTLYDTNLLPASSFRTDNWTDAT
QVKN
>FCMOIPGL_00024 hypothetical protein
MKNLIVVFFYLLTQFSYSQTAISYKDSDDEISQHDQAFYEKNTKAFVYTDKNGAKMPYRL
FLPDNYDPKKKYPIVLVFHGAGSRGNDNLKQLRPWVAGWMDVQVQKEHPSIILMPQCPKK
QQWVNVPWKEGSYRFKDIPESDPMKLAKEIFDKVVQEYSVDRKRVYVMGMSMGGYGTWNF
VMRYPKIIAAAIPICGAGDTSMAKKIKRIPIWAFHGDKDPTVPLAGSTEMIESLTRFKKH
KARLTIYKDVGHNSYELAWKNPALVDWLFSQHKN
>FCMOIPGL_00025 hypothetical protein
MNKFLVKLLLTVLLSCSINAVSQEKEISLDIHKMMKPLPKDGIFRDALYYNWGGSIIKGK
DGKYHLFYSRWKRAYTFNGWLTFSEIAHAESKTATGPWQYKETVLKGSGQGNWDEITAHN
PKIKYFEGKYYLYYIATNLGGKEFTYDDLVALSTKSLKDTDRGTLRKNQRTGVAVASSIN
GPWKRMETPIIEPSGPIANITVNPAIDQGKGGKYYLIVKGDKPNEKKFIRNQAIAISTSP
TGPFKIQPNPVIGNLDTEDVSMWFDEQQAAFYAVFHAHSYIGLMTSIDGLHWGKAKNYEI
SRKKIKLEEGGFLIPNRMERPFVYVENNEPTVLCLAIKKGDDSYTIFIPLHKSKTR
>FCMOIPGL_00026 Non-reducing end alpha-L-arabinofuranosidase BoGH43B
MKIFRFLVLLVIVFGCKGTEEKKTIHSFGDQGDGTFINPILNADYPDSDVVRHGNKYYMI
SSKKHNSPGMIILESYDMVNWRIINHVYDSISWGKEYNWDRMAGYKRGVWAGDLAFHEGT
WYCYVIDPSHGLFVTTTDDIYGQWTTPTKMISQKKVADDPSVFWDDENKEAWLVANIGRS
RTKEDKDKYLYKNAIFKMSWDGLSLEDEGTVFYKGPGAEASKIYRINDQWFIFLSEWSMT
PDGDKEDRKQIALRSKTNSIYGPYDKKVLLERGNGFERSCSQGSLNQAPDGSWWYFHQLI
QNIDAPFQGRPQCLQPVEWVNGWPIIGEDMDKDGIGEPLRRYKMPNIIAPEKLKIQTSDD
FSSSELGHQWEWNHNPRDSHWSFTERTGWLRLKASTLVPLSNYYYHKGASSFWRASNTLS
QRIMGTKAGISSAKFDVSGMTQGQRAGYARFAGVSHLIGVKMDAEGNRNLFFMDDKGTEI
DGPSIEKAIIYFKSTNSGNSASFEYSYDNKNFERFGPEFELVFGRWSGDRLGVFCWNDIE
DSGYVDIDWFEYEYE
>FCMOIPGL_00027 Arylsulfatase
MVKKHSFVGVLFFLLACFTVKAQQKKQPNILFIFADDLMFNSIGNLDNCAVKTPNLDRLM
DNGVSFTRTYNQGSYSQAVCIASRTMLVTGANLWKAATYSKSKKGDAVKKPEKYWPQYLK
EVGYDTYISGKWHVNQVNPKHIFDYAKDIRGGMASQTNLRYARSFEQDKPDTWSPYDKKL
GGFWKGGKHWSEVLADNGVAFLNQSKASEKPFFMYLAFNAPHDPRQAPKEFVDMYPLSDI
KVPENFISEYPYNEYAGAGRKLRDERLAPFPRTKYSIKVNRQEYYASISHMDAQIGRILE
ALEKSGKAEETYIIFTADHGLAVGDHGFMGKQNMYESSMRVPMIIAGPNLEKGKEVDAFV
YLQDIMPTTLELAGVKKSKEIDFNSLIPLATGKVNKSTYPVVYGAYFGTQRMYRTEDYKM
ILYPKANKVRLYDMKNDSLEKYDLAENKQQYKKVLKKLFKEYRRLQKHMNDPEDIKESFH
NFMNDVAPMPIVNKETSENSKH
>FCMOIPGL_00028 hypothetical protein
MDLTPNNIKVLNFYGDNGFVHPSKEAGLKLIEDLGIKNTWEIVSTADASIFNGKDLRSID
VIIFNNNCGNKGRILSKENQLALQKYIRNGGGFVGIHCAGAIWNEGGEFQNWYEGFIGTK
LLDHPKVQSARLVVEDSINTITKHLDKGWVVKDEWHRFSYNPRNDVKVLLSVDENSYQGA
QKMGGDHPFTWYQNYDGGRSFFTSLGHTKEIYADFNFRKLVEEGIKWAADASNNTASLPL
SEGLLLDLNADEQVLVEDGDKVSSWSNSVANKVQKFIKQDIGRKVKGSGRPQLKLNVPKL
NGHNSVVFHRQELVNHQEDAFDHLIQGSGYTWFSVMSVFKQVKGKPGVNSFFGNLRNTNL
NKQGQYEGFWAGVNIKNQVWMSSRNGLQKGTWNDDSPLLIDNDTLIKEKYYLVMGRMGAG
EGTVKMELFVNTTKALVEKSFPVNTKANPSKMVIGQERDATNHPGAESFDGEVARFLIFE
RPLSNEELKTLSDHLKNKYNIN
>FCMOIPGL_00029 hypothetical protein
MMKRPWIYIHNKLLKKFAYIILIGFTFFSCTQKKEVEEASPLKIWFNQPTTKWNQGLPIG
NGNLGAMIYGTPKKEIICLNEETIWTGGKDYNRDKKDAGKHIAAIQKLLFEEKYLEAEAM
VQDKILTNRLPSGKNTYQMLANLFVETANLDSVSNYKRELDIQKSIATTTFTSEGTNFKR
TYFSSFPDKAMVYKFTADQKGKINISSWVKRNKQTKITVSENTIEFSEHAGNGHGVKFNA
IVSFKTKGGTSEVKEGKLVISNADEVLVKVVAASNYRGDNPQEMTKNILKNIAKISYDDL
LDRHVADYKALFNRLSFKLSDSKGDEYPTDVRLQKVKEGAEDNYLTQLQYQFGRYLLISS
SRPGNLPANLQGIWVTGFKPPWNSDYHTNINVQMNYWMAEMANLAECHEPFLEYIGNLRE
MGRITAKKTYNARGFVAHHTSDPWFTTAAFGKARYGMWPMGAAWACQHLFTHYEYTEDTA
YLKKQAYPIMKEAALFFVDFMVKDPKTGLLVTGPSISPENNFLTKEGKKATLNMGPTMDR
AIVFELFRNCIKAAEILNIDKEFSDILKSKIQQMPPLKIGSDGRLMEWVEELEEAEPGHR
HISHLYALHPSNQISKSKTPELFEAAKKTLAGRLSHGGGHTGWSRAWVINFYARLLEGNK
AYENVLALQRKSTLPNLLDVHPPFQIDGNFGVVSGITEMLMQSHNDEVHILPALPTAWAS
GSIKGIVAKKGFEIDITWDLGKLKTLVIKSNLGNTLKLRYQDDVKEIETTKGEVLEFNY
>FCMOIPGL_00030 hypothetical protein
MFYRVFYFNVRLIVTFSTLCCYNGTLFVVGVLGKLHKILINYLKLTMKNFTFLLMTVLLY
VSCSNSDSDNEIINDVELNFIQFDVTLTSGGKSIGVIDNENKRISLPNISDPLEISSVNY
QYSEDVSMITPKPETRIGKWEVLEKFRLHAGEDFKEYAVEITDYQETAYTNKATISPLEK
FGRVTKYHMLDLNHNAGTLGNISNAERAFGQGEGQAKMNGLRVPLYCGDAYGGHPEEGKV
VESVYATLLKSIENAKASYYGTEPFMIFLGLKVLTNDKAEYFPDWVTTEAPTVPNPEKYA
QLIVDYIEFMHKHGHEINYVAFDKEAARMDVTDFTIAVDTLRARTARLGYVVPQVVAPEF
YKPLGESGSFDDLYNINGEDSYDVFGNHYYLNHHNQNNHSDLVYEYNLSQSDKHREAWAT
EAHWDALRCSSDYEKDREIWTSELAIGCMFDWTDLGLDLVSWWDYPLSGGNAPRHYITRA
YNEALIGSQPIRMLDHDGEEVLSREKLHSRAYIRGNEVNVFFINTVSPCKTFIPPFYEEY
PVGILDGFKIDGNISVTQWDDDDQPEGESFVIEPVEENQFLIDITTGSFTHVSFKITE
>FCMOIPGL_00031 hypothetical protein
MKKIIVSIIILSMLMISCQVKKTKNQESENKEIFQKEIQTPTAMSDHWKFIGEAVNEPGY
DVWGSSPIRDKDGNVHLFSARWSSATPFKKAWRYNSEIAHYVAKKPEGPFEFVETVRKGK
NDRSWNAVGFHNPSIKKIDNKYVLIFIANDGAKNHGASQRIGMLVSDDLNGPWTEVPNKN
NPLLSPPKDESIWCANSGLGVNNPSLIKHPNGKFLLYFKAMAGPKGTGAKVSMGVAISNT
LEGPYVIQPNPITTNNVRIEDGNAFLWRNKICLMTTDNHGILEKGGGLLWTSEDGLKFDA
EPLSGFHNYQKFYLNGVFPEGANIRYGGKNVKFERPQLLMDANNEPEYLYCPSGVALDGS
NGSNSYVLKYQK
>FCMOIPGL_00032 hypothetical protein
MKKTLLLFVTLLTVTLTNAQLVLGDTFEQGIFKYQVTTAEEAGSPNTVSLTGTVDGATIP
DALVIPATVTEGGIEYAITLIGNRAFWKATMTSLVIEGNATLDSQSFRACPNLKTVDLPL
VANIGIPPAIEGGNEIGLVFWQSTALETINMPQMENIYVGAFNGCSSLKEITFPSTVTYI
SSANQNMFKGCNNLAKVKVEYTTFIELIKIEDGNISIFNDPINNANATLSVPEGTLSTYQ
AADVWKDFNSITLGVNSPEKITLGSYPNPVVDFLHFSSNDVYSVDIYNILGARVSSQKVV
NDVDMTNLKKGVYIVKAKNDKGLNISSIKVIKQ
>FCMOIPGL_00033 hypothetical protein
MNMKQKTTFFKLALIIALFCITRHNINAQTLEAHYKFDSSITDETGNWNLTATDEDNSIT
YEMGQDGTANGAITGFDRGDLLSTVTNFPISGDASRTMTAWIKLIALTPQTAVVGGGENS
PGKKWTFGHQGAKVRAEINGKGMGVGTLEVDVWHHIAVVWDKDNSTVRIYQNGELKGSNT
TWSTNTTEAPLLIGNDYNADPKNRGFNGAMDDVRIYTGAGDDAFIKSIYDATLLSVNDNI
VKTSLNAFPNPVVDYLSFSSDKISSVEIYNILGAKVKSQKVNNKSIDMSYLSKGVYMIKC
KDANHQNIGTIKAIKE
>FCMOIPGL_00034 Arylsulfatase
MRTLFILLLCGFLVSCNTNNAVQKEQKPNVIVILIDDAGYADFGFMGSKDLETPNIDRLA
KSGVIFTDAHVSATVCAPSRAGLITGKYQQRFGFEANDTGDKSSGDIGLSDDVVTIADVF
KENGYKTMALGKWHLGKDNSDHPNQRGFDEFYGFETGSRSYFQYENPSKAKMLQHNGKRV
KFDGYLTDVLGDQSVKYIEENKDNPFFMYLAYNAVHTPMEAKKEDLEKYKNHPRQYLAAM
TWSLDENVGKLQNKLEELGIADNTIIYFLSDNGGAANNTSSGGPLKGWKGNKFEGGHRVP
FVISWPAQIKGGQTFNGLSSSLDIFTTSMAAANIEKKEGLLLDGVNLLPYLKGEKKGDPH
TQLFWRKLEEAGARVGDYKMVRLQDYGATLYNVEEDLGEMKDLQNSNTKEFNQLDKALKN
WESEMMEPLWGEPRNWMDVTYHIHQRLMENKEVLYSDPAKMKQVLNKEKKQ
>FCMOIPGL_00035 Arylsulfatase
MKYLYVLLLGGLLSCNAQNLEKSESKPNIIYINVDDLGWMDTETYGSTFYETPNINKLAE
SGLKFTNGYASAANCAPSRACLISGQNTPRHGIYTVSNSDRGNEKTRKIIPIKNTEILAD
NNITIAEMLKQEGYITGTFGKWHLGEDPKTQGFDVNVGGAKHGNPGKDGFFSPYNIKNIV
DNKKGENLTDRLTQEAISFIKEHKEKPFFLYLPYYAVHTPLSTTNALEQKYKEKGGNPFQ
NKAVYAGMIETVDRNIGLILDEIKALNLKNTLIVFTSDNGGIRAISHQDPLRAGKGSYYE
GGIRVPYIISWDGVVKPNTVSKTPITNLDFYPTFMDILNVENLNKIVDGTSILPILKGKT
INDRSLFFHFPIYLQAYNFKIDDGRDPFFRTRPGSVIIDGDWKLHQYFENNEIELYNLKT
DLGERNNLVDVHPEKVAALLKKLKSWRTEINAPIPTELNPKYEANFVPKKFKKK
>FCMOIPGL_00036 hypothetical protein
MKDKAIVLFLFLSGLLFSQSKIDPINIEIHSDKEFQTIHNFGASDAWSGQFVGKWPLEKK
EAMADLLFSTEKNADGTLKGIGLTTWRFNIGAGSAEQGEESSIKDEWRRAEGFLNNDGSY
NWNRQLGQQWFLKAAKERGVSSFIGFVNSPPVQFTKNNKAFSEDGLSSNLKRSKYSNYAL
FLKNVVTHFRDSLNLHFNYISPFNEPQWDWKNGKQEGSPWNNDELSAATKTIDSVFTSSN
LATKLEISEAGQIDYLTSIKKGKENRSNQIEVFFNPTSDLYLGNLETVSQKFAGHSYFTT
WDVSKLKRKREEIKEKLLKFPNLEYWMTEYCILENNAEIRGRGKGLTMKTALYVARLIHA
DLTIANASAWHWWLAMTPYNYKDGLIYHDKNKEDGAFVTSKLLWGLGNFSRFIRPEAKRI
KIDYKGKNSLENLEKGVLVSAYKNKDKSIVVVVVNLKETAVQLNFKNPIKQVYVTDRDSD
LELIQPNANKKDIVISAKSITTFVL
>FCMOIPGL_00037 Arylsulfatase
MSFKSIIFKCFFLSAFVLSSCKSEQKESKSSNSDKKPNIVVIYLDDLGYGDLSAYGATEL
QTPNIDALANGGIKFTNGYASSATCTPSRYALLTGVYPWRNKKARILAGSAPLIIDVAQQ
TLPKVLKKQGYQTAIVGKWHLGLGSGNVNWNGKITPGPNEVGFDSSYIMAATQDRVPTVY
IDNGHVVGLDKNDPIEVNYKKNFEGEPTAKSNPELTTMKWHHGHNNSIVNGIPRIGYMKG
GESAKWTDIDMADHFLGKAQEYVRSHKEQPFFLYYAMQQPHVPRTPHPRFVGKSGMGPRG
DVILEADWVVGEFINTLKEEGLLENTLIVFSSDNGPVLNDGYYDDAVEKLGKHDPKGGLR
GGKYSLLEAGTRVPFITYWKGTIKPAVSDAIVCQMDLLASLANLTGTSEETTDSKDILNA
FLGDAGKGRDHLLIEANSKTALRSGDWLMIPSYKGKQFNKKVNTDLGVLPKIQLYNLKED
IGQQKDLAATNPEKLAEMIQVYESLRGEKIKEIK
>FCMOIPGL_00038 Lactate utilization protein C
MGSRNQILDRIKANKPSLLSLPNINSALFHEDLDLLKEFTKKVEVVGGNVLNANSNEDIM
LQIEKIFPDTKVKFSSLENSQSFNTIDLASLQKPHDLENLDLLILESKLAVAENGAIWMS
DDEIPVRVLPFIAQHLVLVLSAKNIVPYMHQAYDQLNNFGFGVFIAGPSKTADIEQSLVI
GAHGALSLTVFLKE
>FCMOIPGL_00039 Lactate utilization protein B
MSHSKLASIFNKDEKRVDWHDKALWFVRHKRDLSVHNVKGWEELRNLGHGIKAHMLSNLD
NYLIQFEENAKKNGVEVHWAANAEEHNKIVVDILNEHKAKKIVKSKSMLTEECHLNPFLE
ENDIEVIDTDLGERIVQLAKERPSHIVLPAIHKNRHEVDELFQEHLGTKPCDGDPQYLTS
EARKHLREKFIAADAALTGVNFAVAETGGFVVCTNEGNADMGAHLAPVHIASMGVEKIIP
KQEHLGVFLRLLARSATGQPVTTYSSHFKKPQKGTKMHIVIVDNGRSEQLSRPDFRASLH
CIRCGACMNTCPIYRRSGGHSYDATIPGPIGSILSPGKDLKEYSTLPFASTLCGSCSDVC
PVKIDIHSQLYKWRQIITKETPQPFVKKQAMKAMGTIFAKPKQFEIVGKVARWSLRNLPK
SVINSKPNAWGKARDLPLGPKQSFDQWFKERENEKKN
>FCMOIPGL_00040 Lactate utilization protein A
MKVGLFIPCYINQLYPQVGIATLELLEKLNIDVGYPSGQTCCGQPMANSGYEYESDGACH
NFVDNFKDFDYIVTPSGSCAYHVKKHYNIIPQTSEVTKVRDNVYELCDFILNILKIKDVG
ASFPYKIGVHKSCHGLRGLRLGSCSEVVGKPYSYIEELLQEVTGAELMPISRTDECCGFG
GTFAVTEEAVSVKMGKDKIKDHLESGVEVITATDTSCLMHLEGLINRNNQPLKVLHIAEI
LNSNL
>FCMOIPGL_00041 L-fucose mutarotase
MTKYCFALDLKEDIKLIEEYKKYHQKIWPEITKSILDSGILNLEIYNIRNRLFMIMEVDD
SFSFEKKDEIDKNNAKVQEWETLMWKYQQELPMAKKGEKWILMEKIYQLDPQQNSK
>FCMOIPGL_00042 L-fucose-proton symporter
MAESKKIPVVSKEVLIPFIIITSLFSLWGFANDITNPMVAAFGTVMEISTAKAALVQLAF
YGGYATMAIPAALFVRKYSYKKGILLGLTLYAIGALLFFPAAKFEVFGFFLGSLYILTFG
LAFLETTANPYILSMGDQRTATQRLNLAQAFNPIGSLFGMFVASKFILVALDSDKRNEAG
ELIFNTLDEAQKAIIRTHDLAIIRNPYVILGFVVIAMLVLITVTKMPKRDTSVTYSSAAD
SFKRLFANGKYKEGVLAQMFYVAAQIMCWTFIIQYAGNLGIAKSTAQNFNIVAMSIFLGS
RFISTFLMKYINAKKLLMIFALGAMATTSGVILIEGMTGLYLLVATSAFMSLMFPTIYGI
ALNGLSEEDSALGAAGLVMAIVGGALMPILQGLMIDMDKIGPFSGVNFSFILPFICFCFI
AIYGYRTLKIYK
>FCMOIPGL_00043 Lactaldehyde dehydrogenase
MQQFNQFINGKFVKSTSTDVIEILNPCTEEVLSLMPIGSVKDAQLALEAAQASQHAWKSL
PAIQRANYLNKMADVIRENRISLAKTLAAEQAKVMGLAQVEIDVTADYFDYYAGFARRIE
GEIIQSDRSKEHIFLHKAPIGVAVGILPWNFPFFVMARKVAGSLITGNTCVINPSSIAPN
TVMAFAKLIEAIKLPAGVLNYVCGKGSIVGDALSRSPITGIISLTGSVGAGQMVMRAAAE
NITKVSLELGGKAPAIVCADANLELAVNAVVTSRITFSGQVCNCAERLYVEESIHDQFLD
MVAAKMKTLKVEDAFSDNNPDMSALVSKAQYDKVSEMVEYAKKEGAEVLIGGSRTPGFDK
GYFYQPTLITNVKQEMQIIQEEVFGPVLPVMKFSTLDEAIALANDCEFGLTSSIFSEDFN
KVMHAAEELQYGETYINREHFEAIQGFHAGWKKSGIGGADGKHGMEEYLQTKVVYAQYR
>FCMOIPGL_00044 Arabinose operon regulatory protein
MTFSKNIALGDPSSNYQNFIDLKLKLLCCRYWLLNLWDCHDMIFPFWRIYWNRNEGGELI
HLEDIYKMTPNTLYIIPPFTSFSSRFSKKHIYNDGIHVSGRHLTSDYDENDYLESSLIHF
FIHFNLGVPFDNVYPGIIEIQVTDYLRDRLEYLTERLKIENKDFKLTFNLKLQAFIKEVL
TNIGPELWKAINIDDRVLKVIRFIEANISKKLTNTEIAAIVNMAPNSFARLFKEEMHITL
HNFIQNRKIARSCELFEHTNKTIEDVAFYLGFSDRYHFSRVFKLVTGLTPGVYKSGKYT
>FCMOIPGL_00045 Rhamnulose-1-phosphate aldolase
MKTLSLPSEVEIELKKVSTVAGYLWQREWAERNAGNISMNLTSFFTKEEVQGIGTEVPFD
FPKESAGFVLYITGTGCYLRDLVDMLEEVSCILYINETATAYSIIWGGKRPNFGPTCELI
SHASIHLFNSIHHPENLAVVHTHPLELICMSHHELFDDEEELNRQIWMMCPEVKVFVPKG
IHCTPYALSSTAALAEVTMEAFKTRNVSLWEKHGATATAPDVMKAWDFLDVANKGAKLLM
MCWAAGFKPAGLSNEQLTELEQFT
>FCMOIPGL_00046 L-fucose isomerase
MSSRLIGRLPKIGIRPVIDGRELGVRESLEVQTMDMAKAAAKLIEETLRFPSGEKVECVI
ADTTIGGVADAAACADKFKREGVEVSLTVTPCWCYGTEVMDTDPLLPKAVWGFNGTERPG
AVYLAAALAGYSQKGLPAFGIYGKEVQDGGDQTIPQDVSEKIIRFAKGALAVAQMKGKSY
LSIGYSSMGIAGSMVDVNFLQDYLGVRAEFVESVELLRRMDEGIYDKEEYAKALAWTKEN
CKEGEDRNNPEAQKTRVQKDAEWEKVVKMTLICKDLMNGNPKLKEMGFGEESKGRNAIMG
GFQGQRQWTDYQPNADFTESILNSSFDWNGIRQAYTFATENDCLNAISMLFGHLLTNKAQ
LFSDVRTYWSPESVERVTGKKLTGLAENGIIHLINSGSTTLDATAQQQDADGNATMKAFW
DITKDDVQRCLDNTKWPPATVEYFRGGGFSSNFLTKAEMPLTMCRLNLIKGIGPVLQIVE
GWSVELPEDVHTILNERTDPTWPTTWFVPRTTGTGFFKDVYTVMAKWGANHGAISHGHIG
ADLISLAAMLRIPVNMHNVSEDDVFRPSAWSAFGENLEGADYRACDNYGPLYGFKE
>FCMOIPGL_00047 L-Rhamnulokinase
MKNVIAVIDIGKTNKKIFLFDENFDVCFQNATKFKEILDDDGFPCDDLESIKNWILEQIK
QVQNNSDFLLKAINFSTHGASLVYLDKQGNRIAPLYNYLKPLDIKNYTDFYQSNGGVEEF
SRITASPAYGMLNTGLQMQWMQKDKPEVWKNVASILHYPQYLSYLFTKKITADFTSVGAH
TATWNFDKMEYHPWLKAANITLPGPVNGEKAISTEINGQQVAVGSGLHDSSSSIIPILEK
EKGNDFVLLSTGTWIIAMNPFSSETLTQHQLTNNCLCFMTPKKQQVKSSMQFLGRIHEVY
LKPLSEHFNVDINKHLHLGLNEKLCKGLIAENAQIFLADGIDTNFEANENLFKYFGSYET
AYYQLIFEISKKVIAGINLITDKDKSIKNIHISGGFNKNEIFIKYLTLLKKGIVVKISEC
KNESALGAALMMKNYL
>FCMOIPGL_00049 Ribose-phosphate pyrophosphokinase
MPTNQLAPKLFACRQSTVLAENIAKEYNTTLGKVDTTYFSDGEFQPAFEESVRGRRVFII
GSTFPNADNLMEMLLMLDAAKRASARHITAVMPYFGWARQDRKDKPRVAIGAKLVANLLQ
SAGATRIMTMDLHADQIQGFFEKPVDHLYASTIFLPYIESLNLENLTIASPDMGGSKRAY
AYSKHLLSDVVICYKQRIKANVIGHMELIGDVQGKNVILVDDMIDTGGTLAHAANLMMER
GALSVRAICTHPILSGGAYEKIQNSGLTELIVSDSIPLKKETSKIKVVSCAPLFADVMHK
VQDNTSISGQFLM
>FCMOIPGL_00050 General stress protein CTC
MKSISIKGSKRESVGKVATKALRNAGMVPCVIYGGKTPIHFSAEEKAFKNLVYTPNVYTA
SIDVDGQKIAAILQDIQFHPVTDKILHVDFYQLFDDKEITMSIPVQLEGTSPGVLNGGSL
RFTNRKLRVKALPANLPDFVVANISKLKIGNKLFVTSLFNDDYTFMHPDNTVVVQVRTSR
NATVGADEDEQEEAAEATAE
>FCMOIPGL_00052 2-oxoglutarate dehydrogenase E1 component
MDKFSFLNAAHTGFIADLYDQYLINPDSVEPSWRSFFQGYDLANENYFLKDENDSVEIPL
EVRKEFLVVDLINGYRTRGHLFTKTNPVRDRRKYHPTLDIENFGLSNEDLNKEFSAGELL
GLGKTTLSKIIENLKRIYCDSIGVEYMYMRNPEKLKWWHERFNKNDNHPNYSNEAKKYIL
GKLNQAVTFESFLQTKYVGQKRFSLEGGETLIPGMSVILRDAAEIYGVKECVIGMAHRGR
LNTLVNIFKKPVRDLFSEFEGKDFEDEDIDGDVKYHLGLTLSKTYRDGNEIKMNLVPNPS
HLETVAAVAEGITRAKIDRKYNGDESKILPIIIHGDAAIAGQGIAYEVTQMAKLNGYKTG
GTIHIVVNNQIGFTTNYLDARSSTYCTDVAKVTLSPVLHVNADDTEAVCHAMEMALEFRM
KFKQDIFIDLLGYRKYGHNEGDEPRFTQPTLYKAISKHKNPKDIYAAQLLAEGSIDNSYL
NEITTEFKQMLEREFDEAKKVEKSIVREFMQSTWEGFEREDLEAMLLTDDTKYDETKLKE
IAKVVSTVPEGAKFVRKAERILAGRAKMAFESNTLDWGMAETLAYGSLMEEGYNVRISGQ
DVERGTFSHRHAILRDEVTEERINLLNTNPNNKGEMTIYNSLLSEYGVLGFDYGYAMANP
NTLTIWEAQFGDFSNGAQIMFDQYISAAEDKWKLQNGIVVLLPHGYEGQGSEHSSARIER
YLQLCAIDNMTVANCTTPSNFYHLLRRHMKRNYRKPLIVFTPKSLLRHPKAINTVQELAT
GEFQEVIDDTLNPKNVTKLVFCMGKFYYDLLEERELLEREDIALVRIEQLFPLHLEKIQK
VIDRYPNVKEYIWAQEEPRNMGAWSYMLERFELVKLSVRSRKYYAVPAAGSSTRFKKRHR
AVIDSVFSNE
>FCMOIPGL_00053 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MILEMKVPSPGESITEVEIATWLVEDGDYVEKDQPIAEVDSDKATLELPAEESGIITLKA
EEGDAVAVGAVVCLIDTSAEKPEGDAPAKTEAPKEEKKVEVKEAPKAATYATGTASPAAK
KVLAEKGITASAIKGTGKDGRITKDDAVKAVPSMGTQPAYGSRGTERKKMSMLRRKVAER
LVAVKSETAMLTTFNEVNMQPIFDLRTEYKEAFKARHGVGLGFMSFFTLAVVRALKMYPD
VNSMIDGDYQIKNDFQDISIAVSGPKGLMVPVIRNAENLSFRGVESEVKRLAIRARDGQI
TIDEMTGGTFTITNGGVFGSMLSTPILNPPQSGILGMHNIVNRPMAVNGGIVIQPIMYVA
LSYDHRIVDGRESVGFLVAVKEALENPVELLMDGNPAKALEM
>FCMOIPGL_00054 hypothetical protein
MKVTAKKNEQVANMIFGTIYPLYLNRLIKNGRTKEELNKVIEWLTGYNEDKLQALIDEKV
TYRTFFEKATLHKNINLIKGVVCGYRIEEIEDEFKLYKQCRQMEKLIDELAKGRKMDKIL
RS
>FCMOIPGL_00055 ATP-dependent DNA helicase UvrD2
MPKNPELELALQFINKTDRNIFVTGKAGTGKTTFLHQIKKESLKRMVIVAPTGVAAINAK
GVTIHSFFQMPFGPILPDQIANTNQQRKFSKTKIDIIKSLDLIIIDEISMVRADLLDGID
QVMRRYKNRNKVFGGAQVLMIGDLQQLAPVVRPNEWSLLQQHYKTVYFFSSKAYQEANVV
SIELKHIYRQKNEDFIKILNEIRTDTLSDESSKILNDQYNPTFSPTKDDGYITLTTHNKR
ANLINDSELNKLKTKSYFFDAEISGKFNENSYPNDEKLELKIGAQVLFIKNDSSSEKRYF
NGKIGIVTDISKENVTVQCANEIDEIVTEREIWDNVNYSINEATKEIKEDVIGSFKQIPL
RLAWAITIHKSQGLTFDKAIIDAEASFAHGQTYVALSRCTSLEGLVLKTPITSNAIINDR
TVSIFNEGVEENHPDEIILNESEIQFQLNLISELFDYKSFLYPITRLIDIFYKNKSSIKG
DVIDHLQTIKDDGVVALMKVSNGFKNQLKDLSKDMVLPENSSQVQERFTKAVDYFLNQTK
NNILKPLNAIEFSSDNKAVKKDFTTQFDSLQEKLLEKLFALNKMNNGFKVKEYLKVRANA
VLQKSAPKTKKKTLSIRKDPLLALKLRALRDEIRVNENVPAFQIFTQETLYAICDALPRS
EKELLKISGMGKIRVSKYGEEILEVIEQYCKENGINQQNEQKKEDKKSTKQISFELFKSG
LSIKEIAKERSLTKGTIESHLASFIPSGEVDILELVELKKYKEIIKAIEETEFKNLTELK
EKVDKSFTFMELRMVLLSMEN
>FCMOIPGL_00056 Single-stranded-DNA-specific exonuclease RecJ
MRWTLKSKPEKEKIDKLAKELQVNSTIASILCQRNIETFEEAKKYFRPSLDDIHDPFLMK
DMDLAVARIETAIANNENILVFGDYDVDGTTAVSLVSSYLKTIYPNIATYIPDRYAEGYG
VSYMGIDFAHDNDFSLIIALDCGIKAIEKVAYASEKNIDFIICDHHKPGPEIPKAVAVLN
AKREDCKYPFDELCGCGVGFKLIQALGVSRNQTIEDFVPYLDLVATAIAADIVPMNGENR
ILAFHGLNVINNNPRNGIKAIIHQIKKTELTITDVVFIIAPRINAAGRMKHGNYAVELLT
EMDLVAAIEFAAAIEIFNADRKDLDKKITSEAIIQIIDNEEENRFSTVVFQEDWHKGVIG
IVASRLIEKYYRPTLVFTKSGDKLAASARSVKGFDVYNALEACTEFIEQFGGHKYAAGLT
LLPENYENFKNKFEEVVSKTIDKELLTPEISVDAELHLSEITPKFFRIIQQMAPFGPMNM
KPTFKSTCVRDNGYGKQVGVDKTHLKLNVFQGDNQKTYNAIGFNLGDKMAFVQNDFDIVY
ALDENEWNGYKSIQLLLKDLK
>FCMOIPGL_00057 hypothetical protein
MVKNLVTTVWTQKSQFETDNPSGHKFTMFDKSQDNGDTVGFAPKALMLSSLAGCSGLDVV
SLLTKMRAEVADFKIEVTAELTDEHPKFYNKVKVDYHFTDSDLQPEKIQKAVNLSVTKYC
GVMEMFRQFADVKIEIHLHNLETN
>FCMOIPGL_00058 hypothetical protein
MIKMTKTVQFVNKIIVFLLLMLSTFLYSQTDNAPSITADGRQVFCTGNAIYIVTDFSITD
IDDTTIETFFIQISTGYQVGFDKLEVSGIHPSIRSTWSSSEGKLTLTSSVVGLEMLLTDL
ESAVKDVVFTSSTTNVVAEKFFSLSIGDANYLPSTDHFYEFVDNQSITWSDAKIAAENRT
YFGRQGYLATLTSKEEADFAGKQASGAGWIGGSDAGSPDVWKWVTGPEAGTIFWNGGVNG
SSPNFAFWNTGEPNNFDNRGEDYVHITAPGIGVSGAWNDLTNIGDDTGDYEPKGYIVEYG
IPTDSPINIVATTSIYIPQILSTTTATICESGSTIITATPSEGEILWFDASSGGTQLAKG
TSYTTANLTTSTTFYATISVDGCTTLQRTPITVTVNQIPVIIATDNDLICSGTANLKATA
SAGQVNWYESLTSTIPLFTGTNYTTPDLNVTTTYYVAAINADCNSVSRTPVTAVVDATIP
EFDVMQNTYVLCNDVGSVTLETTNQQGNYTYVWKKDGVIISGNTTSNTVSTIGDYTVSAI
SDAGCTSEEKAISVINSEIASITKNDFIIVENSNNNTIYVNNPNLGIGNYEFALDDEFGI
YRNVGFFEYISTGIHTLYIKDTLECGTQEYQFAILGYPRFFTPNEDGDNDIWKIEGYNKD
FYTVSEVYIYDRFGKLIYTIDKNSDGWNGDSNNGKAPSNDYWFKTILTDINGYSVEKTGN
FSLIRK
>FCMOIPGL_00059 8-amino-7-oxononanoate synthase
MQLDKLPNTTAFFNDVEHLYFSGTSYLGVAALPEFQEIVFKNMKNLGTSYGSSRNANLKL
NVYKRGEDFLSTFINHEDCTTVSSGTIAGQFAIATLEKIVDTFYFMPKTHPAILPKNALP
VFEENGLNSLLINQKEETICIVVDAIAALETKPFNFDFLLEISSLKKVFLLVDESHSFGI
LGENGNGISSTINIQKNIEIVTVSSLTKAFGINGGVISGTKNFIKLIRENPLFVGSSGMN
PAFLESFLDGQDLYKNQQKKLQENCTYVYENLKHLDKINISKNYPVFFINDENIADYLLT
KKIVITSFYYPTSSKKINRIVLNANHTKEQLDILIESLLSY
>FCMOIPGL_00060 L-Ala-D/L-Glu epimerase
MKIKLHSFNLELKHTFTISRESHDFQKTLIIALDSDGFSGFGEATSNPYYNSTIDKMIAV
ISNNKAFIASLSAEKPAEFWRKLQPFFKDDMFALCALDMAFNDLYARKQNKKLYEVWDLK
IDKNPMTNYTIGIDSVEKMVAKMKELPWPIYKVKLGTKDDIKIVTELRKHSDAIFRIDAN
CGWTVNQAIENSFKLKELGVEFLEQPLKADDIEGAKKLYKESALPIIADESCIVESDVEK
CVGLFHGVNVKLTKCGGLTPGKRMLEKARELGLKTMVGCMTESTIGISAIAHLLPLLDYV
DMDGSLLLKNDIATGITIHNGIISYADKNGIGASLL
>FCMOIPGL_00061 hypothetical protein
MPLVSPLNAEHDLETKKLAEFFNETLGFCPNSVLTMQRRPAISKAFINLNKAVMANEGRV
TSALKRMIAWVSSNATGCRYCQAHAIRAAERYGAEQEQLDNIWEYKTHKAFSDAERAALD
FSLAASMVPNAVDATIKKELYKYWNEGEIVEMLGVISLFGYLNRWNDSMGTTLEEDAIES
GNQFLGKHGFEVGKHNGSKY
>FCMOIPGL_00062 hypothetical protein
MNEVEDKLFNYLKVKIPKNLSFTDEIADILDISYDAAYRRIKGKTALTLKEGLLLSNHFK
FNLNDLFIDKEVDNDRVLVEKTHPILSNNALEVFFEKATVEAKNVISSKNGQIINCAKDF
PFYHSDRGALKNFRLYVFINTLSKDPEEKKVPFSKFNPSETILENYNAFLNQYKKVALIE
VWNDSTIDNILNQIQYFFEIGLTTKKETILIADGLKESLKSLQAQAKNKKRNQGSNSFTL
YHNNVISLLNTILMKSDVESTVFVPYTNLTYFKVIDKNTTNQIEAYLNGQLDFSNNLSGT
VSMERRRFFNAMNQKIDNRILKIFL
>FCMOIPGL_00063 Aminopeptidase YwaD
MFKKFIPFLFISVFFINCKDEKPLVLSSLNYTDIINQEFTGDLAFETTSFVEKYWRVVGN
TGFNKSIYKIADELEKAGFILEENATENDILTYRIEKRALKKPTWESVNAVVKIEGENEP
LLQHSTNRNMIALNSYSTPKEGIIAEVVFIDHIKKLSTMDVKGKIVFAEASPYQVYKTAI
IDGKAAGIMTYNNPDYLQPEKNTTSIQFRSIPLDSVDKPWAIALSYQAKERLKKALEKGE
TTLNVKVETNIYPSEELTIVADIKGNQHPKERLVFSAHVQEPGANDNATGVGVALEMATL
TAKFIKQKEYQPKRTLTFLWGDEIVSTRRYVQEDSIRAKEIKWGISLDMVGENTEKTGGT
FLIEKMPDPSAIWTRGNDKHTEWGGSKMSLEQMKPHYLNDFLIDKFKSQGKRANWIVSTN
PFEGGSDHVPFLRENIPSVLFWHFTDQFYHTDNDRIDKVSKTTLKNVGTTALIAAYTLLN
ADENTAKSILSDLEKAAINRLNEELKQSKIALNKGESFATQIEIISAWKDWYQKSFTTTK
DLVSDKKIISKEIEKSKKLIDSVATEIEKILKENL
>FCMOIPGL_00064 hypothetical protein
MQNLLSEIKQCKICESYLDLGANPVVTAHKNSKIAIIGQAPGIKVHKSGIPWDDASGKQL
RKWLNVSDEDFYNPENFAIIPMGFCYPGKGKTGDKPPRKECAPKWHQQIFELMPNLKMII
LIGMYAQKYYLKDKAKKTLTETVDNYPAYLPKYFVLPHPSPRNRFWLTKNPWFEKNVIPE
LQNRVAKILN
>FCMOIPGL_00065 hypothetical protein
MHFKSIIFTSYFLLTLFLSSSLTAQEKNIKVLFVGNSFTYYNNLPQVVSAMAKSQGVNID
TKHSTVSGSSLENHWKSERGTQTRIMIELEKWDYVVFNNHSLSSIYSPDKFLEYSKKFAD
LVRSKGAEPIFIMTWAYKSNPLMLPEIEKMHKKLCEQTNTNYIPGGPLFASSIKYRPDIE
LFHDDIHPSSNGTYLLGLAFYKFFTGKSVSGIPGNISTLDTNGQILYLIFMKDYDVPFLH
QLVNEFPFKTLASKTEKNLEHKTIMNIQQFKEKLKTTPAAITFAETLQVIDDNYNFTPTA
FTNGNLKNKAGENSGSCKIFAFAIQQKLTKAETLLCFAEHFRTVLNDDKGTSHQNIRNFM
KTGFEGLSIDGAPLSLKN
>FCMOIPGL_00066 hypothetical protein
MKIKMLPNWCKKVGIVVFLIGSIVSGYKGFMHGLTAECNPDSTKFDFFENLYNNPVLHFF
EVLAVIGMMLYMFSKEKVEDDYINILRLESYQFTILIGLGLTVVIYMIWGNVSLKLDYII
NLFMIFYLIIFAIKKRIY
>FCMOIPGL_00067 hypothetical protein
MKNLIKVERARHNLTQGDLATKVGVSRQTIYAIENNKFNPSVTLAIKMARFFNVTVEYLF
DIEEED
>FCMOIPGL_00068 Ribosomal RNA small subunit methyltransferase I
MSRLYLVPTPIGNLEDMTFRAIRILKEVDFILAEDTRTSGKLLKHFEISTQMHSHHMHNE
HKSVKGIVQRIQNGESCALISDAGTPAISDPGFLLTRACVENNIEVDCLPGATAFVPALV
NSGLPNDKFVFEGFLPVKKGRQTRFLLLSEEKRTMIFYESPHKLVKTLGHFVEYFGAERQ
VSVSRELTKMFEETIRGTATEVLAHYTAKPPKGEIVVIVEGKSSK
>FCMOIPGL_00069 Internalin-J
MNSPSFSVMILNKHIMKTKLFLLLAIFFGLIVKAQTTSIPDANFEHYLETHSKINLSQIS
VGDANSMGNGIDGDHLVTTANISAVTYLSVNELNISDLTGIEDFTSLTDLSCSDNNLTTL
TLPPVTSLANLIVERNNLTTINLPNTLVEILEFSCADNKITSINFNNVNYINFLYLVNNK
FTTLDFSNTNVQGLEFSDNPFLTSIDLRNGADYTEIYGFYGVNNPLLTCVFVDNVSYANA
NWKNNVDSTTNFVDSEATCNLLSTHTYVPDDNFEQALIDEGLDDVLDNYVLTNNINSITF
LDVSDKNISDLTGIEDFLELETFGCENNQLTTIDLSNNHILEFGCNNNQLTSLILNAEAR
VVDCSYNLLTALIVPSGIANLQCNNNNITSLDLSSTTELSRLNVSNNNLEFLDFRNGEND
QISSSYDYNTGYDYSFDATNNPNLTCIFVDDATFSTTNWKKVDATAHFVIDQAGCDASIT
VTTYVPNNNFEQALIDGGYDNVLDDYVLTDNIRVITDLDVSNKNISDLTGIEDFKSLVTL
SCNNNSLTSLNVTQNTSLKYLNFSFNQVSTIDVSKNIALEKLTAVQNQLTSLDVTTNTSL
KHLECWQNQITSLDVSKNTILEELYVKENALSELDVTNNIALKFLSFGGEMNTASTISSI
DISNNTQLFSLDFIYTQISELVTTNNPNLERLFIRNNKLKNLDVSQNPVLEDLVCEDNQL
RTLNVKNGNNINFYRFSAFNNSFLNCIQVDDPSWSNTNWTAINGTETFGDNCHYYQTYVP
DDNFEQTLIDLGFDTGSLDDYVSTNNINTVTDLEIINKNIADLTGLEDFDALTYLDCSYN
LLTNLSTIFNENLEVLRCDHNQLTSLDINGNVNLTQLFCGDNNLTSLDYLYYAQYLNFLS
IENNQISNIDIAGNSELLNLLVGGNNLSELEINNNTKLTVLSVSNNKLSSLNTSNNPDLF
HIFCSGNLITSIDISNNPAITRFICFNNLLSSLDMRNGNNTNISDGTFNAKSNPDLTCIY
VDDTDWSYKNWKNKDAASHFVADETACNALSVENHKINGLKILSNPIINNIKLSTTEKLN
FVLTDINGKTLKSGKLTIGNNTINVSKMAKGICFLRVTSTRNSSVKKIIIQ
>FCMOIPGL_00070 hypothetical protein
MKNLKKVLVLLLAFLLFNVSCSSDDSPNSDFCKNYIENIEEGLQDYSKAIMAQYENPSDA
NCAALKTEIQSMITTIENGKECFSDSETESYNELIAELKEALTTACD
>FCMOIPGL_00071 Transcriptional regulatory protein LiaR
MRYFFLFWCVLILSFPLFSQNKSNAVDSAFQVLKNTPNSTKKVDTLIALYKLSIKQKKIN
KRILEDALAISQRIFYIKGIGICYDRKGINARYEQDYSNSITNHKRALSYLKQTTDTLLI
VKCLNNLGVTYRKVNLEKEAFNHYFEALNLSEKIKNKRSQSIALHGIGNVFIDSEQYDKA
LYYLRKAILLEKEMNNIKGQEYGYANLGEVFTEKQVYDSAYFYIDKALEIAIKNPRKEGV
AIKYTLLGKLYQKKGDYKKSNEFYFKSIPQLEKFENTRYLSKSYLNIGINELYLHQFKEA
KRNIDIGLKKAKQINSKENILLGFKTLTDYYSKTNQFEKALNAQKQVLVFRDSIINEASL
KSFISTEISYESSKKDTKIQSLAKAKNKSEQEASSNFWLFITSVVIGVTSVLILFLLRRN
KILELDQKNTEIKNYLLQIKKLKTSHQQNPSFSKKELKEFQLSKREIEVLKHISNGLSNA
QIAEKMFVSNNTIKTHISHIYTKLDVKNRVQAVQKISA
>FCMOIPGL_00072 Aspartate--tRNA ligase
MYRSHSCGELRASHINTEVTLAGWVQKSRDKGFMVWVDLRDRYGITQLIFDEERTPKEMM
EKAKSLGREFVIQVTGTVIERESKNDKMATGAVEVLVSKLEILNASVTPPFTIEDKTDGG
EDIRMKYRYLDIRRNPVKNSLIFRHKVAMEVRKYLSDQEFIEVETPYLIKSTPEGARDFV
VPSRMNEGQFYALPQSPQTFKQLLMVGGMDKYFQIVKCFRDEDLRADRQPEFTQIDCEMA
FVEQEDILNVFEGLTRHLLKEVNNVEVEKFPRMLYDDAMRLYGNDKPDIRFGMEFGELNA
VTQHKDFGVFNSAELVVGIAVPGGNSYTRKEIDNIIKWVKRPQVGALGMIYARVNEDGSF
KSSVDKFYDQEDLAKWAEITGAKPGDLVCVLSGEKNKVRAQLSALRMELATRLGLRDPKV
FAPLWVIDFPLLELDEETGHYHAMHHPFTSPKPGQMELLDTDPGAVKANAYDLVLNGNEI
GGGSIRIHDKKMQATMLRHLGFSNEDARAQFGFLMDAFEYGAPPHGGLAFGLDRLVAILG
GQETIRDFIAFPKNNSGRDVMIDAPAFIDDDQLKELSLKLDIQS
>FCMOIPGL_00073 H(+)/Cl(-) exchange transporter ClcA
MPTTKDIYRKILKWKYRHISNKQFTNIASAIIGLLAGLGAVTLKNATHLIQHLLEGEFIK
DIHSAFYFIFPIIGLLIVILIIKYVIKKRVGHGIPSTLYAISKQKGIMPRYQMWASILTA
PITVGFGGSVGLEGPTVATGAALGSNFAQLFRLSQTTKTLLIGAAAAGAMSSIFKAPIAA
IVFAVEIFSLELTLASMIPLLLASITAVLTSYFFLGDDVLLHFDIQDKFALNDVLFYILL
GVFTALISVYFSKVYFVIADFFKKIKNPYKKLLIGGILLGLLVFLIPPLFGEGYETINNV
LRGNTLQIVENNIFNAISDNFLLIILFLLGLILFKIVATSLTFGAGGIGGIFAPTLFTGS
LTGYVFALLVNYTNFFGHKLSLINFAMVGMAGLMAGVLLAPLTAIFLIAEITGGYELFIP
LMIVSSISFMITKRYIPHNIYAAQLAKKGELVTHDKDKNVLMFLDIDTLIEKDFIPTKPK
KTLGELLKENVAKSSRNLYPVLNDKEQFLGIVLLDDVRPVMFNQTLYDKIKVLDVMTSAP
EVILTADTTEKVMQKFKESGAWNLPVIREGKYIGFISKSKLLTAYRNKLIEVTG
>FCMOIPGL_00074 hypothetical protein
MRTNSFTIKMSKKSNHELETIFQEKAKYTEEAVQAVIWELENRNLIEKTTVLYKDPEKEE
DIIVLSDSKEKVEKNESPFEELVLPILYSKKAIQGFTIFFTTIFGAVLLMQNLKIMNKPK
ARLQVLIFGISYTFGSVILLNYLPKIFFITLIFNLIGYVILVEFFWNKYLGKELEYQKKQ
VWQPLIISILITVGLVFLQFLPQILAQ
>FCMOIPGL_00075 Catabolite control protein A
MLNLSTSTISRALNDHPDISIKTKKNVKDLAKKLNYMPNIFAKGFRLHKTNIIGVIIPNI
TSYFTSTILKEILLQSEMKGYRVIISESNNDINREKEMLLTMLQFGVDGILMSLSKNTIN
VNPILNALNKKPLVLFDKVSNKVPCTQIIIDGEEAAFNAIEHLINIGKKRIAIIKEFEHS
YNSERRFQGYLRALRTHNIPIDEKLILSTDDISLKKGKRLTSQLLSLKERPDAIFSITDA
AAVGVIQTLKKFNIKIPENIAVVGFSNSLVSTIVEPNLTTTDQPGKRIGEIAVDYLIREI
QEPKDYLSSKTVEIKTNLIIRESTFLPV
>FCMOIPGL_00076 TonB-dependent receptor SusC
MKKTLLTLICIISFYAINGQTKIKGAIKDNIGEPIPGASVIIKGTTSGGSSDFDGNYNFT
TSSTGEQTLQVSYVGFKTYEKKINLNGASLTINVVLQEGGAQLDEIVLTASSTFRSQKET
PMSISSIKQKEITKLSANSQADIIRSIPGITAEGGGGETATNVFVRGLPSGGQYVFNPLQ
YDGMPLMSTFGLNSSAHDVYARPDVGFKGVEFVRGGAAVLYGAGSVAGIINYTSKTGDSN
DENLINVEWADKGRLKTDFYTGGKLGGEDSNTYYAFTGFVRKDDGPIETGMPTKGVQFRA
NIKKKFENGSFTVHGQMINDNAQFFMPLPLDGDRNRITGNDGEAVSQLLSGQLANTSFLT
AGGAYESPIEDGVSTQGGYVMADFNYNFADDLKFKSKVKYANYKHNFALYIGGNGTYNNP
LTLGDYINNVAPGNLGYDAQYQGGIGAINSNDLVVENLHVDRLRPMTDYSGEASLTKTIE
TDAGSHNITAGVYLARTEAEDVNYQYRVLSEFNNNPRLVNLSYVDASGNNVTYSEGGLYN
RIGMTSNNFLSQTKTAFYLTDEMVFDKWRFDAGIRIESTKGTFSKGNVVSSTVYDDANLS
SDLANVQFADGSFVRADVEATDWALSLAALHNLTDNVNLYANFSRGFFFPQIRGFAPVAG
IPNTNYDSEKITQFEIGAKLGTDRLSGSLAAYYVSLKDRIKITQGFVNGSLVDLTRSEQS
TSTLGLEANWSYKLTKNFDFRGTATYQDHEITKNTDKDLVTGGSSEVNVGNELARQPNFL
TSMGLHYDNSSFDGQFTLNHTGSKFTADNNNVELEAINIFRIGAGYTFSLNNDEERNENL
RIGFSVFNLFDDSGVTEGDPRNVNQAGNAQFFFGRPILPRRMFLTATFNF
>FCMOIPGL_00077 Glucosidase YgjK
MNKLEKQAIEVLNNNWTDGFSIPCANLYPFQWLWDSGFIAIGFAHFDMTKAEKEIETLLD
AQWENGFIPHIVFHTENDSYFPGANFHRSDLHPLASKKYKSTGMTQPPVTGFVLEKMYQI
SEDKEASLNYITSVIDKVYFNHEYFYNNRDPKNESLVYIYHNWESGTDNSPIWDDIWATM
NPPEYTFERRDTTHVDAAQRPSKREYDHYLHIIEIAKEHNYSDEKIAELSPFLVQDPLFN
AMLIKSNQSLIALYKLIGGNNDKIKQLEKWQEKGIESFNNKLFDEEIGAYIHYDLRNEKS
LGYLSSSSFSPLFAGIPSKERAEKMVNVMLDKFGNKDQYLCASFDPTSNRFNPKKYWRGP
VWINLNWMLFYGLKEYGFTEIAERVKQDSIDMIEKNGFYEYFDSRKEIHKDGKAGYGGNH
FSWSAALLIDMLKN
>FCMOIPGL_00078 Sodium/glucose cotransporter
MNWLDYSIVIFYIIFFLGMGFFFKENKDSKDYFLGGKSMGWFPLSLSTMATQLSAISFIS
APAFVGLKLGGGMKWLTFEFAVPLAMIFIMIVIIPPLFKSGVVSIYEFVEKRFSTSTRLI
LSIVFQISRALGTGVMVYTIAIILQAVLDIDFVYTILIISVITIIYSWQGGMKAVVWGDA
IQMIILFAGLIICLYFGWTLLQEHGGLTNGFDAERLKVIDFNLGIGEGNEYGLLPMIIGG
FFLYASYYGCDQTQAQRMLSAKDEKTIKQLLLANGLLRFPVVLIYCIMGLVIGGLIAQAP
DFLEEIAMTTQKYFPEEFATHGVKADLMIPVFIMKYLPHGLIGVLMVGILSAAMSSLSST
VNSLSAVTVEDFFNRGKKKLSNKNYMLISKGSVVFWGVICIASAFLFGGSKSAVIEIINA
IGSVFYGPVLVTFFLAFFSKKVNHIGMNAGIISAVLINLMFSKTIQELFHIDLGFNIFWI
WLNFTGVIIALVVAYTVSAFTQSIKVKRISNFNVSIKKEDFMIKEVYILIAFFIFIVVLS
YFLPTILS
>FCMOIPGL_00079 Glycerate 3-kinase
MKIVIAPDKFKNSLTGLEFCSIVKKGILEKSPEAEILNLPLADGGDGTIEVVKYYLKGKT
IDVKVNNPFFETINATYIYSKKTSTAFIEMAEASGVKLLKPVQFDCKNATTLGTGEIIVD
AINKGAKTIILGIGGSATNDCGIGMATALGYQFLDKNNQKVKPIGANLSKIKTIDATNIH
HELSNVDFKIACDVTNPLYGENGAAFVYAAQKGASTEDILLLDKGLQDFTKILNDVFSTD
VQSVKGAGAAGGMGIASKLFLNGTLEPGIQLIKNLAQFDDKIKNADWIITGEGKLDTQTM
SGKTIQGVLASAKTKKIKVAAFCGSIDLGGVNVGDFGIKYTDAVINYAKDLNDSMLNSKK
YLALMSKRFATKYL
>FCMOIPGL_00080 hypothetical protein
MSTQVYSIKHFNNTLDLFNAEKKLYSSKWFMEFGKFGSEVFNSEEKIIYYISKKFKFWKW
KMVFTIKNNDKNLIELISQNNRKTIYSIDINELTYELKIHYKKKISIFKNGHKIAEIDES
FLEPDFNEFIKLQLLDNKDLEISFLLFSCLKIGEVEQRTKTIITSQKQLEPNTEPWS
>FCMOIPGL_00081 Glycerophosphodiester phosphodiesterase, periplasmic
MKSISLFLIGLLLVSCKPSKKEIYMNPKIVIAHRGASGYLPEHTLEAKAMAHAMNADFIE
QDLVLSKDDIPIVIHDIYLDDVTDVATKFSTRKREDNRFYVIDFTFDELKTLQVTERFNP
KTGEQFYPNRFPKGKGSFKLHSFQEEIELIQGLNLSTGKNIGIYPEIKEPAFHQKEGKNL
TKIVLKVLADYGYKTKKDKCILQCFDAKELEKIRKELKSDLFLVQLIEFPEETKQLAHFA
TYADGIGPWYRQILSEKTDNKFTFTSLVSDAHKLGLKVHPYTFRADALNEFSNFNEMMQT
LLIDANVDGAFSDFPDLVVNFLKDKK
>FCMOIPGL_00082 hypothetical protein
MKLALKIMFVIFLVWMAAGLYLVNTAHEKAQIVMGLGVFYFSFLFMPFFIYYRYRDGKYK
KYILNDEKLMKAFKSQGKD
>FCMOIPGL_00083 hypothetical protein
MFSSISSSKQSKKITTVAFYNVENLFDTIDNPATNDDNFTPKGKNKWTILRYKIKVKKLG
SVISQLGMQKSKNPPAIVGLVEVENSKVVSDLVNSSYLTKQHYDFVHHDSPDERGIDVAL
LYNKTAFELLVSETYPVYLKNDNGQRDYTRDILKISGNLHGELVHILVNHWSSRREGAAE
TEHKRIIAAETLRNIIDTIQEKEMDANIIIMGDFNDDPESKSVKNHFVKDDFYNPMESLL
DKEKKGTTTYNKKWNLFDQIIFSNNFLEKEKGGLQFKHAEVFNKDWLKIHKGKLKGSPFR
TYIGKWYQGGFSDHFPVYAFLEKED
>FCMOIPGL_00084 GTPase HflX
MIDQKEAISEKVVLIGIITQQQDETKSKEYLDELDFLTLTAGGVVVKRFVQKMERPNPKT
FLGTGKLEEVRDFIQANKIGTAIFDDELSAGQLRNIEKILDCKILDRTNLILDIFAQRAQ
TSSAKTQVELAQHQYLLPRLTRLWTHLDKQKGGIGMRGPGETEIETDRRIIRDKIDVLKK
KLLTIDKQMAVQRKNRGKLVRVALVGYTNVGKSTLMNVVSKSDVFAEDKLFATLDTTVRK
VVIKNIPFLMTDTVGFIRKLPTQLVESFKSTLDEVREADLLLHVVDISHPSFEDQIASVN
AVLADIKCADKPTLMVFNKIDAYSHEIIDEDDLSTQKGKEHYSLQDWQKTWMNDYEVPSI
FISALNKDNLEDFKEKVYEEVKKVHIQRFPYSDFLYHEYNGEE
>FCMOIPGL_00085 hypothetical protein
MVENEFKYRGWLRVVLLIIPYFIFVGFFQFIGSLIIGVDFTDLEVNQTSFQYLVISFFGL
IGAFFALWIFMKFVDKEPFVKLGFQIKNRLLDFIIGIVIGLFTMSLGYLILIYLKEIIYL
KTNFNLIELLISILLFIIVAVAEETLLRGYILKNLLFSFNKYIALIVSSILFSLMHGFNQ
NVDLFALFNLFLAGILLGLSYIYTRNLWFPIAMHLSWNLFQTLFGFNVSGRDTYSLIEFE
INEPNLINGGAFGFEGSYLAIIAQIITIIGIAVYYNNKKPEQIL
>FCMOIPGL_00086 Magnesium and cobalt efflux protein CorC
MTILILYATVSIFFSFLCSILEAVLLSITPTFINLKKSEGADFAKDLETFKKDVDKPLIA
ILTINTIAHTVGAILVGVQAKVAYAEMYGTSAKTIFGIKITEDVMVGIVSTIMTILILVA
SEIIPKTIGATYWKQLANFTSKALKIMIFPLKWTGILWLLQLTTKLIGGKGHGSILSREG
FLVMTEMAEKDGVFKENESKVIRNLLGFKEIKVNDVMTPRSVLEIADESQTIQCFYNEHK
NLRFSRIPVFAENPDQITGYFLKDNLLESIINGKGEQTLASIKRDIIITERELSIPDLFD
QLIKEKEHIALVVDEYGSVSGIVSQEDVIETLLGLEIMDESDSIADLQAHARKSWEKRAK
RMGTIQDKD
>FCMOIPGL_00087 Nitrite reductase [NAD(P)H]
MKTIIVVGNGMVGYKFCEKFVSAANNKGFRIIVFGEEPRPAYDRVHLSEFFENQDAKALE
MAPAEWYAENAIDLIVDERVTDIQRGSKTIITAKNRTFNYDYLVLATGSSAFVPPIKGVE
KEGVFVYRTIEDLEGMLAYADKLRNENPNAKAAVLGGGLLGLEAGKAVMDMGLEPHIVEF
APKLMPRQLDARSSRVLQLKLESIGLNIHLSKATNQILGEDKIVGMEFGEDDVLNVDMLV
VSAGIRPRDELGKTCDLDMGVRGGIVVNNKMETSDENIYAIGEVALYNQMIYGLVAPGYD
MAAVAVDQILGNKESLMPSDIDMSTKLKLIGVDVASFGEPFMPASKGHSIIFENKTQHLY
KRINVSLDGKSLLGGILVGDASDYNMLHQIYLNGMKIPEDPAQLILPATEGGSSFGDVMD
LPDDAQVCSCENVTKGQICGVIESGEAKDLADVVSCTKAGTGCGGCKPMVKDITTATLKS
LGIEVKDSVCEHFDYNRQDLYKIIEVKGYTTFNEVLDSHGNGGHGCELCKPLVASLMATI
HADTANKEYAIQDSNDRFLANIQRNGTYSVVPRVPGGEITPDKLIALGQIAKKYDLYTKV
TGGVRIDLFGATLNQLPLIWKELIAHGFESGHAYGKSLRTVKTCVGSTWCRYGMDESVSF
GIELENRYRGIRAPHKIKGGVSGCIRECAEARGKDFGLIAVEGGWNLYLGGNGGANPRHA
ELFAEQIDNETVIKYLDRYLMFYMRTAKPLQRTAAWQERLEGGLEYLKEVIIEDKLGIVE
DLETEMETLVNKFECEWTQAVNDPEVMKRFNHFVNSDEEDDNIVFVPMRDQKMPEQWV
>FCMOIPGL_00088 Nitrite reductase (NADH) small subunit
MEQILEQYTSTKLEDVKVWFKAATVQDFPLDGGACVKYKNKQIAVFNFARLNKWYACQNV
CPHKMEMVLSRGMIGDDKGTPKVACPLHKKTFSLEDGSNLTGEDFKIATYPVKIEDEIVY
IGFSE
>FCMOIPGL_00089 hypothetical protein
MKPTRFETAIALIDKKNAEDPNTYQVAGLAYPKELLYSQRMTRKLLQFDPNASKALQIAA
RAQHICRWKIERKEYPMDRVGYLKWRETLKKIHADLTVEILQQVGFDEQFQERVKKIILK
KLIKKNEESQILEDAICLVFLDYYFDEFAAKHTDEKVIDILKKTWVKMSDKGHAAALTIP
FSDKSLALVKQAIS
>FCMOIPGL_00090 Signal transduction histidine-protein kinase/phosphatase DegS
MTKNGNSLDQRTFSKLSRLYIFALSTIAVSVIISQVLVRNHLENQESDSTVINVAGRQRM
LSQKLTKEIVSLSVSPSLENRISLKNKIKETLFLWELSHISLQKGNDSLRLPKQNSDEVK
RKFTAINPVFKTIKLASNAIVNKLEKNPVINIDDLAANIKLVTNNESSFLLKMDAIVNQY
DLEANEKVAWLRKLEFFLMALTLIILLGEFLFIFWPTAKSVKATLSELLLAEKRAKKMAF
NADLLSVAKEESVKELRALSHAMDETLLFARISPNGNLIHMGNKFSRLFRLSNFNKEILF
WDLLSINENEKILIENLINKHKKTGWQGEVKATAKNDVVIWLEMSIIPYRPTENKSELLI
IASEITDRKEAQIEVERLTEVSFEEKMSQQKIISSKIIENQEKEQNRIAKDVHDGIGQML
TGLKFNLESINLDDIEKAKIKVEHLKELTANIIKGVRTATFNLTPPELSDHGIVPAISKL
SKELGKLTGKEILLFNKTDFNQRLDSLTEINIYRITQEAINNAIKYADSSSILVSLSHSK
NMLSIVIDDDGKGFEPSKVKKVKKGDGGMGMTFMKERITYINGRLFLNSELGKGTRVTLN
IPI
>FCMOIPGL_00091 Oxygen regulatory protein NreC
MINVVLADDHVLVRDGIKALLEDQSGITVIDEASNGKEALEVIAKNKPHVLIIDIRMPEM
NGIEAVSEVKKHFSDVKTLMLSMHDSEEYVVKSIQAGADGYLLKGASKEEFLKAVIKVAS
GGKYFTGDVSSIIMNNFVNGNATNLEVSKKVSTGLPFKLTKRERQILDLVLELKNNKDIA
DELKISKRTAEVHRFNLMKKLEVKNLMELTNKVKEYQLI
>FCMOIPGL_00092 putative nitrate transporter NarT
MSTLAQEKATKLSLFNFKNVSTRTFWITSISFFMCFFAWFGIVPFMPDVVKDLGLTPDQK
WNSIILAVSGTVFARLLIGKLCDKYGPRLCYTWLLMLGAIPVILCGLVQTPTQFLVCRLF
IGFIGASFVITQVHTSLMFAPNIVGTANATSAGWGNLGGGANRLGMPLIAGAVVAFGVAD
AEAWRYSMVIAGVVCFLMGIVYFFFTQDTPKGNFKELKASGEIVTAKKDQIGFLEVLKDY
RVWILFVVYAASFGIELTVYGTMDDYLQNTFQLERVTAGNIVLSFALMNIFARTLGGFFG
DKFGKLKGLRGRVLFLSFILTIQGIMLISFSGASSIILGIVLLISFSLSVQMAEGATFSV
VPFINKKAIGSVSGIVGAGGNVGAFLAAMLLKSKSAVAEKAAIAANEGLGEEAIKAAQSV
ASSSAVSSGYLLIGFVVIATAIVSLTIKFSKEDEYSEAPEKVKEIAPELVIVK
>FCMOIPGL_00093 Nitrate reductase
MIKNEVKTTCSYCGVGCGIIVKKDINNKVFVEGDKDHPVNKGMLCSKGMNLHYVANDVSD
RILYPEMRWSRSHPRERVSWDTALDRAANVFKSIIKKHGPDSVAFYVSGQSLTEEYYIAN
KLTKGFLGTNNIDTNSRLCMSSAVVGYKKTFGEDSVPVSYEDIELADCFLITGANPAWCH
PILFRRIEKRKEENPNVKIIVIDPRRTDSANFADLHLQLTPGTDVVLYNAIARRLYKRGL
IDEDFIKKHTQGFEDYRKIILDTNLKKASKICGVSEDDIEKAAEIIGLSKGFISMWAMGL
NQSVIGTDKNTSLLNLSLITGQVGKPGSGPFSLTGQPNAMGGREVGGMANLLAVHKDLGN
EEHRREVAQFWGVEKISPKPGLTATEMFDALERGKLKAVWIACTNPLVSMPNSHQIEKAM
ANSKFVVVQEISHKSDTVKYADLVLPAAAWLEKEGTMTNSERRISYLPKEIDAPGEARPD
VEIFCDFAQRMGFRGFNYNSTAEIYDEYASMTKGTNIDVSFLNYDRLKNEGTFQWPVNEY
RHSGTPRLFEDKKFYTSSQKAIFNVPSTIENTSVKTNQDYPLILTTGRIRDQWHTMTKTG
KVSRLKTHYPKPVLEINPVDAYLNGIKDGDVTEIKSANGVVRVRAKITDAIKEGVVFLPM
HWGKVLKSNLNRANNLTNTHIDPVSKEPDFKFTSVSVSKYKKAKEKIIVAGAGAAAFRFL
QNYRDYNQVDEIHVFSKESNLFYNRVLLPEYITEELTWQQLLKIKNAELSNLDIHIHPET
LIDKIDKETKIVTDSNGETHTFDKLILATGSRAFIPKDVQIDLPGRFTMRNKSDADEFKK
YLENTGLPPEEQHVVIVGGGLLGLELAAAMKHKNVKITIVQRASRLMERQLDKISSKLLS
LDVQERGIQIYFDNEVSTVFDDDETGELTINLKSGKYITANAIVYAIGTRPNIEIAKNNG
IVCGRGVKVNQHLQSSHPDIFAIGEIAEFNNQLFGITSAAEEQAGILANFIAGDISESYK
GSVLMNILKFNDLNLCSIGEIKVPENDNSYEEIIFTDMSKRYYKKCIVKDDLLIGAVLMG
DKNEFAEFKTMIESKIEMSDKRDTLLRGSSNDVPMLGELVCSCSQVGAGNIEEAIAGGCT
NFTELCNKTGAGLGCGSCKTEVREILNNAKVKV
>FCMOIPGL_00094 Rubredoxin
MSKQLNRVIVKGGVLSPGELKYICESVESLGQKTISFGSRQDILLPKKVKKEDLSQFDKL
RVVEADEVGIENIMSSYVCADIFPSTSWLTGDRYLYILEQFRSKSTLKINITDPKQRLVP
LFTGHINFIASEHEDYWYLYIRLPGWDEIKMYPALIYSWDLDKIETTIENILKEEPETIE
TIFELVNDALDANNRTVDKPLEVPFYPFPYFEGMNKIGSDKYWLGLYWRNNKYDISFLKE
MCELCSENKIGKISITPWKSFIVKGIPRESKLIWEKFLGKRGINVRHSMLELNWHLPVSN
KDALNLKKYLVANFDQNDISTYGLTFAITNYSKASYYFTSIVVQKNKQPEMIGNFQTRDT
YNLLYAKDFDPNTRQYIMHVQDVDKVELPGLLMELSQLYFDDLGSEKEDEKGAEIKKEQI
ELEVYQCQDCFTIYDEAYGDVTQNIAAETLFSELPINYECPLCEAPKSNFEKVVLVK
>FCMOIPGL_00095 Transcriptional activator protein Anr
MALNQNIALKNTRKVINDFSCMSCTNANCLIKKNIYNLINPSFVDNKKSLRCKKGQQFII
EGAPVNGLFFILKGTVKVFRTGINGREQIVRFAKEGEIIGHRGFGTEEYYSIGAIALQDT
ILCYFSKTDLQEALLENPKFAYDMMLFYANELNRSESKVKSISQMTVRERVIDTLLYINR
KFGDLRGFLNLPLSRKEYADYAGTTEEQVIRVFSLLKKEGLIIAKGKKIGITNVQALKNE
ISEHNYYLDS
>FCMOIPGL_00096 Nitrate transport protein NrtA
MKALFKKTIYILPVAMLLFACGGKGTKKEITTEVVTASKTKQLDIEKPQLTFGFIKLTDM
APLAIAKEKGFFEDEGLFVSVEAQSNWKNVLDRVIDGQLDGSHMLAGQPIAAGAGFGRQA
KLVTPFSMDLNGNGITVSNDVWSKMKPNVPADSDGKPIHPIKADALKPVITEYKNSGKAF
KMGMVFPVSTHNYEIRYWLAAAGIHPGMYTKENVQGQIDAEVLLSVTPPPQMPATLEAGT
IFGYCVGEPWNQQAVFKGIGVPVVTNYDIWKNNPEKVFVMTEKFIEENPNTAIAVTKALI
RAGKWLDKPENRKEAVQILSMSQYVGAPVEVLANSMTGTFEFEKGDKRDMEDFNVFYKYN
ATYPFYSDGIWFLTQMRRWGQIPEAKTADWYSSTIKDIYRPDIWKKAAALLIEEGNIPAT
DIPTTDGYKPATADFIDGTTYDAKDPIGYINSFSIGNKDKK
>FCMOIPGL_00097 Bicarbonate transport system permease protein CmpB
MKASLTLGKVSNFIGLGFFTTLKDLFTGKLDKEDFKNLLRKFIVPLASILLFFLLWHLGA
KSLYNIEAEYKIEKALQDQGQAAADALTACIASGESSCQPNTLPSPSQVWDSFQSLLRDH
NIISADKAAFAEKTAALNAKRIAAGKDAIVYTGRPSFVDQIYRSLQTVFAGFLLALVIAV
PLGIFIGLSPTLKSAFNWFIQIFKPVSPVVWYLLVFMIVKTLLIGSADDSSFTISFISVG
LCSMWATLVNTAMGVSSVDKDYINVAKVLKLGTFQKIFKVVLPSSLPLIFTGLKITLSVA
WMVLIAIELLAQSPGLGLFVWEEFQNGANDSNAKIIVAMFVIGIIGFLLDRLMLTIQNWV
SFDKTDAI
>FCMOIPGL_00098 Bicarbonate transport ATP-binding protein CmpD
MAYLELNNICKTYGNDGDETEVLSNINLKIEEGEFVAIVGFTGSGKTTLVNLINGLIEPT
SGEVLFKGEPVNGTSHERGVIFQNYSLLPWLTVGQNVFMAVKEAFPKKNKAALNEIVANY
VEMVSLTPAINKRPNELSGGMRQRVAVARALAMKPEMIIMDEPLGALDALTRGNLQDEIL
NIWGKDKRTALLITNDVDEGIYMADRIIPLRPGPNATLGPEFKIDLERPRDKTEMNDNPN
FKKTRNEIIEYLMDIGNERKSVAKEEIILPDLVPKDFVNQFKFGN
>FCMOIPGL_00099 Bicarbonate transport ATP-binding protein CmpD
MITKSTTTKNVIENGLFPSSEVMLDLKNLKKVYPTPKGDYVVLEDLNLQIKKEEFVTIIG
HSGCGKTTMLSMIAGLNPISGGNISVLGKHIKGPGPDRGVIFQSPSLMPWMTSLQNVLLG
VNQVFPDATKAQRNDVAKYYLQKVGLEDSFHKKASELSQGMQQRVGIARAFAIKPKVLLL
DEPFGMLDSLTRGELQDILIEIWNKEKITAVMITHDVDEAIFLADRVVMMTSGPKAKIGD
ILDINFERPRTRKSVLEHDDYYKYRKHLIDFLEH
>FCMOIPGL_00100 hypothetical protein
MKKQYIILALMLVSCQFINAQFTLDGEFRPRTEYRNGFGNLITDGTDAGFGISTRVRLNT
SYMTDNYWFYVSLQDVMVWGENRQILPYDQNNSFAVFQAWAELKLGENTSTRIGRQVLSY
DDQRILGGLDWAQQGRNHDAALLKHVKGNFMLDFALAFNQDYSNPTGFQSVGTAYNTTGY
FSYKTMQMLYMKQKWDKITGSLLLLNNGFQEYDVNNAADGVSNLQTLGTHLNYKEGKIGL
AANAYLQTGKRQGKVDVKGAYLLGLDATYKVTSKLSLGLGVEAISGNDGGVGETGAFFPL
YGTNHKFNGFMDYFYVGNHANSIGLVDFHVSANISLNKSSSLMVKALNFRGEQALASGEK
SLGTEVDLVYKKKFKGYALVLGYSQMFASDGMYELKGIAKTAAAGTQNWAWAMLVIKPKF
LTGK
>FCMOIPGL_00101 hypothetical protein
MKKLSILLLFVFIGLSINAQTADELKKTLASKKDSIAKLQSKAKALQGKIDALPGWRKGA
FGTIGASLSGFNNWYSRTAPDASAGNIGVTINGYANLIQNDFFWRNSAAINLGWVKLDDK
TPGVTGDEDFETATDVFTISSLYGKRLNKKWAISGLAEYRTTLIDNFNDPGFLDLGVGAT
WTPTNNLVVVIHPGNYNFVFSNSGSIFESSLGAKIVADYTKKYGGLSVKSNLSMFQSYKD
GDFSNWTFTNSFGYTIWKGIGLGFELGLRKNKQEALNNALISNPAETFNTVDNKLQSYWL
FGLSYSL
>FCMOIPGL_00102 hypothetical protein
MRYCYFCIPKNKNLKNFFLLFCILFSVTFSAQKKKDKEPLPTPKWKIQGRFAFIFNQSSF
TNWVSGGENTIAGNININYDINHKHKNLNWDTRIITGYGLSHLSEKGYRKTDDRFEFNSL
LGLKSKDYWFFSFFTNFKTQYSEGYNYKTEPKTPVSNFFSPAYLSYGPGMLWKKSDNLNV
NIAPATARFTFVNDEFSGKFGVEEGKNSVFSLGFNLTGYSKFSLMENIEMENIVALYSDY
LENPQNIDLDYQSNIRFKVNKFIKMQMTFHTIIDDNSSGKIQFRQLFGMGLNYNFHEKVT
Y
>FCMOIPGL_00103 hypothetical protein
MQEEIINRVSNSKLMTFDLEEIYPEGKRVLLDIKDWLFQEIILKEKDFRKSVSEHNWSEY
KNSFVAITCSADAIIPSWAFMLVASELTPYANKVVIGDLVLLETVIYQELMEFLDLRDFA
DKPVIIKGCANKPIPNSAYSFLIAKLQPIAKSIMFGEACSTVPLYKSKK
>FCMOIPGL_00104 hypothetical protein
MTDKELEEIGDKIVRVLKTIFDPEIPVDIYELGLIYDVFVSEENNAKILMTLTSPNCPVA
ESLPREVEDKIKTLKEINDCEVEITFDPTWTQDMMSEEAKLELGML
>FCMOIPGL_00105 Cysteine desulfuration protein SufE
MTIKEIQEEIIDEFSMFDDWMERYEYIIELGKSLPIIDDKYKLDENLIKGCQSKVWLYSE
LNNNTIKFTADSDAILTKGIVALLLRVFSNQKPTDILNAETTFIDEIGLKEHLSPTRANG
LVSMVKQIKMYAIAQQSKLNN
>FCMOIPGL_00106 Bifunctional ribokinase/ribose-5-phosphate isomerase A
MSKLLAVGTVAFDAIETPFGKTDKILGGSGTFVGLAASQFGVKTGVVSVVGGDFPESYLK
MMNGKGINTDGIEIIKEGKTFFWSGIYHNDMNSRDTLITELNVLEKFEPVVPADFKDAGI
VMLGNLHPLTQASVLDQMTEKPKLVVLDTMNFWMDIALEDLHTVLKRVDVITINDEEARQ
LSGEYSLVNAAKKIHEMGPKYVVIKKGEHGALLFNDGSMFYAPALPLAEVFDPTGAGDTF
AGGFCGYLAKTEDISFENMKNAIIYGSNLASFCVEKFGTERMQELTADEVKERLQAFKDL
TQFDITLS
>FCMOIPGL_00107 Amidophosphoribosyltransferase
MSDAIKHECGIALVRLKKPLQFYKDKYGSAFYGINKMYLLMEKQHNRGQDGAGFASVKFN
VQPGTRYISRVRSNQSQPIQDIFAQINGRLNSVLEENPDKKDDVDWQEENMPYVGNLFLG
HVRYGTFGKNSIESVHPFLRQSNWRHQNLIVAGNFNMTNSKQMLEELIELGQHPKENTDT
VTVMEKIGHFLEAEVSDLYLKAKEQGFNKKDASPFIEENLSLKNILKRSSKNWDGGYAMA
GLVGHGDAFVLRDPNGIRPTYFYEDDEVVVVASERPVIQTVFNVKITDVKELERGHALII
KKSGTTSIEKVLEPKENKACSFERIYFSRGSDAGIYEERKNLGKYVFPKILTAIDSDISN
TVFSYIPNTAETSFYGMTEAAEDVLNEQKTAKILEGGKNLSAEKVTQILSERARFEKIAI
KDAKLRTFIADDSSRDDLVEHVYDITYGVVKPTDNLVIIDDSIVRGTTLKKSIIRILDRL
EPKKIVVVSSAPQIRYPDCYGIDMARIEDFIAFKAALELLKDHNKYHVVADVYQKCKNQQ
ENEDVEIVNYVKEIYSSFTTEEISAKIAEMLKTEDIKADVEVIYQTIEGLHKACPDHLGD
WYFTGDYPTPGGHRVVNQAYINFYEGNSKRAY
>FCMOIPGL_00108 Superoxide dismutase [Mn]
MAFELPELGYAYDALEPNIDARTMEIHHTKHHQGYTNNLNNAIAGTNLEGKSIEDILTNL
DMSNAAVRNNGGGFYNHSLFWTVLNPEDRGYLSGELKDAIEAAFGSKDAFIEAFSKAAAT
QFGSGWAWLCVLPGGKVEVCSTPNQDNPLMPGVTCGGTPILGLDVWEHAYYLNYQNRRPD
YINAFFKVVNWNEAEKRYAAAK
>FCMOIPGL_00109 Fructose-1,6-bisphosphatase class 1
MTAQKQTLGEFIIKNQHAFKYSSGELSSLLNSIRLAAKVVNHEVNKAGLVDIIGAAGDTN
IQGEDQQKLDVYANDKFIQTLTRRNIVCGIASEEEDSFISINSIDENHQNKYIVLIDPLD
GSSNIDVNVSVGTIFSIYRRVTPVGTPVQLEDFLQKGSEQVAAGYVVYGTSTMIVYTTGD
GVNGFTLNPAIGSFYLSHPNMEFPEDGNMYSVNEGNYLDFPLGIKKYIKYCQEEEGERPY
TSRYIGSLVSDFHRNMIKGGIYMYPKGSRNPNGKLRLLYECNPMAFLAEQANGKSSDGYT
RTMDVVPTELHQRVPFVCGSKNMVDKVEEFMREYGE
>FCMOIPGL_00110 hypothetical protein
MGFIIRQGEEKDAQSVLNLITELAVFEKEPDAVEITVDDLLKDGFSDSPKFKLFVAEEDN
VVIGIALFYERYSTWKGKTIHLEDLMVTESKRKIGAGKALYTAVLKYAFENNFKRVAWEV
IDWNTNAVNFYKSTGATYLNDWSVVQMDKENLEKYIQNN
>FCMOIPGL_00111 Bifunctional aspartokinase/homoserine dehydrogenase 1
MKIFKFGGASVKDAEGVKNVASIIKNEGAKDTLVVISAMGKITNAFEEVVDAYYNKSEEL
PSKLSFIEEYHKNIMSSLFDKEDEVYRDVDILFGELGWFLARNSSQRYNYVYDQIICFGE
LLSTRIVSGYLSKIGTENTWFDVRNYIKTDSNYRDAKVDWKLTEAIITKKVDTNKINITQ
GFVAANDTENTTTLGREGSDYTAGIFAYCLNAESVTIWKDVEGVLNADPRAFSDTTLLEQ
ISYEEAIEMAFYGASVIHPKTLQPIQKKEIPLLVRSFLNPKKAGTKVSKGTTLVPHIPCF
IVKKNQILISISALDFSFMVENNISYIFQQLHEYQLKVNLIQNSAISFSVCIDDKFNKFD
EFYNELKAQFRIDVQKEVDLFTVRHFDAKAIAVIEEKGASLLTQINKETSQIVVKTN
>FCMOIPGL_00112 hypothetical protein
MALVTSKEIAQVIGLKKFGFLGTFIGWILLKILRISAINRIYDKNKNKSDLDFLNGVLDD
FKIKFEIPEEDLKRIPKGGAFITISNHPLGGIDGILLLKLLMEKRADYKIIANFLLHKIE
PLKPYVMPVNPFEDRKDAKSSLAGVKKALLHLREGNPLGLFPAGEVSTYKDGKLNVDKPW
EEGAIKLIKKANVPVIPIYFHAKNSTLFYFLAKISDTLRTAKLPSELMSQRGKIIKVRIG
KPISVKDQNEFKDITSFYEFIRKKTYMLANPFEKAHKLISTQNIKIPKKPAKKITTQRNS
ELFVKEINALREADGRLLESKNYEVFFANAKEIPNLLHEIGRLREITFREVGEGTNKSID
LDKYDKYYYHMFLWDREANCLAGAYRMGLGKEIFKKYGINGFYIQTLFRIEPELHQMMSN
TIEMGRAFIIAEYQQKPMPLFLLWKGIVHVTLRYPEYKYLMGGVSISNQFSDFSKSLMIE
FMKSHYYDPYIAQYIYPKKEYKVKLKDADKDFVFDSTKADMQKFDKIIDEIEPGALRIPV
LIKKYVKQNARLVAFNVDPKFNNAVDGLMYIKVADIPDSTVKPVMEEFQAELERKAVEDL
LSKNK
>FCMOIPGL_00113 hypothetical protein
MKTFLKILLTALAVVVLAKILPGVTVLSYTTAIIVAIVIALLNMFVRPLLVFFTLPATIV
TLGLFLFVINAVIILLADKLVDGFEVPGFFTALLFSILLSFFRTILFSLLKENKQTNY
>FCMOIPGL_00114 Threonylcarbamoyl-AMP synthase
MSIISKDIQKAIALLSNEELVAIPTETVYGLAGNIFSEKAIKSIFETKKRPFFNPLIVHL
SSVDELETIVSEVPEKARILANAFWPGSLTLVLKKQKNIPNIITAGKDTVAVRVPNHPVT
LELLRKLPFPLAAPSANPFNQISPTKPEHVERYFKNELKLVLDGGSCKNGIESTIIGFEN
GEPIIYRLGALALEDIEAVVGKVAVKNKKEENPDAPGMLDKHYSPSTFTVLTSDITSEIK
KYPTKKIGVLAYNSSFTSDEIFTEIILSKTSNLHEAASKLYDSLHELDHLNLDIIIAEKL
PEIGLGKSMNDRLQRAAFNN
>FCMOIPGL_00115 hypothetical protein
MKKILLAFGLLFIFQNSFSQEKLGRSFFTGDVNFTLGINENYTPFNDDDETFLVPSALFF
RVGFGYEFKRKLAVGFNAGYDYHWNYAVSAFPTYGSLKYNISEADDDAFFVEARYGKMWT
PSSNYPDGNYYGLGLGVQVAGEKRWNTIIRLDFHRKGIVGFENDQLDSISFGIGFSFF
>FCMOIPGL_00116 Ribosomal large subunit pseudouridine synthase A
MKHFQYFKTDISEVQLPEKFTFPFYYEPHSLAKIAAEEIQEYLESQTDFEHNFGLKKNQT
DLPIGKMFGVLIVQNKENEIGYLAAFSGKLADKSLPEKFVPPVFNMRTEGSFYIKGELEI
DEINAQLTQLKNNEQYLTLKKSFKKLSESIAKDLENQRKKMKLSKSDRKLQKKKAISILS
DLEFKNLTKKLMQESYNDQFFYKELVEYYDDKLEKNGKEFLVFENRIAALKKERKEKSNY
LQQTLFSKYAFLNQQKELKNLLDIFNDPAIKPPAGSGECSAPKLLNYAFANDLKPISMAE
FWWGISPNSAVRKHKNYYPACQSRCKPILTHMLQGLEMDDNLLLENLSEKQELKIIYEDD
VLIVVNKPAEFLSVPGKEITDSVYSRIKEKYPTATGPLIVHRLDMSTSGILLLTKTKEAN
KILQSQFINRTVKKRYVALLDGNLTENSGKIKLPLRVDLDDRPKQLVDFVHGKNAETDWK
IIQRENGKTRVYFYPITGRTHQLRVHAAHKNGLNTPIIGDDLYGKKVNRLHLHAEFIEFF
HPSTGEKMNFTVDPEF
>FCMOIPGL_00117 K(+)/H(+) antiporter NhaP
MNLTIENILLVGSLLLLVSIFAGKTSYKFGVPTLLLFLGIGMLAGSDGIGGIRFDDPKTA
QFIGIVSLNFILFSGGLDTNWTAVKPILKEGIMLSTVGVLLTAVSLGTFVWFVTDFTIYE
SLLLGSIVSSTDAAAVFSILRSKNLALKTNLRPTLELESGSNDPMAYVLTIAFLTLVIHQ
DQSFMSIIPMFLQQMILGGIAGISFGFSSKYIINKIKLDFEGLYPVLVITLMFITFSATD
FIGGNGFLAIYICAVYLGNQDLIHKKTILKMFDGLAWLMQIVLFLTLGLLVFPSEIIPYM
GIGLLISVFLILVARPIGVFISLLFFKMRMKRRFYISWVGLRGAVPIVFATYPLLAGIDK
ANMIFNIVFFISVTSILIQGTTLSLVAKWLDVGLPETLKKLSPTDMLMAENPKAEMKELL
ITPDCFAVDKKIVELGFPKNAIIAMIKRDESYIIPNGLTIINAQDTLIVLADRPHIFDEV
YKTLKNK
>FCMOIPGL_00118 hypothetical protein
MELDYIENIDGHDQNIVRLYNFNKAEAILFRKLIKDTIIDKKQKLDLSQVDFITPRNCNL
IFGLFKSDEGILTKDNQTFFCILTLDGFINMAKLIEPFCKKESKGYQYLYDIDNPTDLLF
CPTASYDE
>FCMOIPGL_00119 DNA polymerase I
MADQKRLFLVDAYALIFRGYYAFIKNPRINSKGLDTSAIMGFMNSLLDVIKRERPDHLAV
CFDKGGSVDRVEMFEAYKANRDATPEAIKLAVPYIQEILKAMHIPIMVKDGFEADDVIGT
LSKQAEKEDYKVYMVTPDKDFAQLVSENIFMYKPRFGGGYDIWGVPEVLEKFEITDPLQV
IDFLGMMGDSADNIPGLPGVGEKTAKKFLAAYGSMENLLANTHELKGKMKEKVEAAKELG
LLSKQLATIMLDVPVVFDATDFTLDQPDTEKVTELFNELEFRNLLTNFLRTFAVENAEKV
NSVEDSSEEKPKTTSKKAPVSAEGQFDLFAAPGTGSVTKEEIISGFKTIENTNHFYQHIN
SPLSRKILLQKLMQQKSVCFDTETTGLKALEVELIGIAFSFEIGKGFYVSFPENQEETTT
ILEEFRPFFEASEIEKIGHNLKYDIKVLSNYNMPVKGILFDTMIAHYLINPDMRHNMDIL
AETYLNYQPVSITELIGKKGKNQLSMRVVPINDQTEYAVEDADITLQLKEHFTSELESGN
VTKLFKEVELPLVSVLTAMEIEGININTDFLKELSVALTDDINRLEKNIYEQAGEEFNIA
SPKQLGIVLFENMKLVDKPKKTKTGQYKTGEDILSYLAKDHQIIRDIQEYRQYKKLQSTY
VDALPNEVNPKTKRIHTEYMQAVAATGRLSSNNPNLQNIPIRTERGRQVRKAFIPRDENY
VLLAADYSQIELRIIAALSEEENMINAFKNGEDIHASTAAKVFNVPLDEVTREQRSNAKT
VNFGIIYGVSAFGLSNQTDLSRSEAKELIDTYYETYPKLKAYMSAQVDFARDNGYVETVL
NRRRYLKDINSRNAVVRSAAERNAVNAPIQGSAADIIKLAMINIYKRFEKENFKSKMLLQ
VHDELVFDAHKDELEIIKPIIKFEMENAFKMSVPLDVEIGIGENWLEAH
>FCMOIPGL_00120 hypothetical protein
MMDAIVAFFENLTSLQKFFWVVGCLSLFWILEGVYPLKKHQYNKWKHAKTNLILLLSTMI
INVVFGILTVGIFSWIDANNFGLLKMIDLPVWIEIILAIMILDFMSQYIVHYMLHKIPVM
WRFHTIHHSDTHVDVTSGTRHHPIDFIFRETFALLGIIIAGLPVSYYLMYRILTVLFTYF
SHADIQLPLWLDKTISYVFISPNTHKFHHHHVMPWTDTNFGNIFSFWDRIFGTFIYKDTK
DIVYGIDILDAEKSEDILYQLKAPFKKELKSAEYKA
>FCMOIPGL_00121 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MPRWVFPLIILLILTVVLEIYTFQALKTITKNKFLRYGFLLISIAAYTNFLVTMLTYSRS
DGQTPQFQMAVGLLLVVLVPKLVIVILLFGEDIFRSALKGISAVSSSKTEPLAGRRKFIS
QLALGLAAIPFASFIYGIVQGKYNYKVLKYQLTFKDLPEAFDGYTITQISDIHSGSFTNK
EKIQYGVDLINQQKSDLMLFTGDIVNNKADEMDNWIDVFSKLEAKEGKYSILGNHDYGDY
MDWDKPEDKVKNFQDVKDIHQKIGFDLLLDEHRYIEKDGQRIALLGVENWGKGFNQAGDL
QKASAKIKKEDFKILMSHDPSHWQEKVKNDDFNYHLTLSGHTHGLQLGIEIPGFIKWSPS
KYVYKQWAGLYEESSRFINVNRGFGYHAFPGRVGIWPEITVIELKKA
>FCMOIPGL_00122 Thioredoxin-like protein
MTKFGELIGVNIPVLIDFYADWNEVENSTDTLRDVAAALGDKAKVIKIDIKKNETLADAL
RVKGNPTFIIYKNGEMKWRQTGHQDANTLIGLVQKYF
>FCMOIPGL_00123 hypothetical protein
MTSEKFKKWNIILGWATFAIALITYTLTLEPTVSAWDCGEYISTSVKLEVGHPPGAPLFQ
MLGAFFAMFTSDVTEIAKMVNFMSALASAFTILFMFWTITNLAKKMAVKTGGITDGKYIA
ILGSSLVGSLAYTFSDSFWFSAVEGEVYAMSSFLMALLFWLGLKWENELHQPRGNKWLII
ISFVVGLSFGVHILSLLVIPAIVLLYFFKTYKTINLKTTAIATVISVIVLMFVFKFLFPF
TLKFFSASELFFINTIGLPYNSGSIIAAIILIALFYFGLNYTRKTKKVTANTLILSVLFI
MIGFSSWMMLPIRANANTTINENNPSSARELLAYYEREQYGDANVFYDTYYSNSYSREQD
AKNPTKDDKPKYEKKDGKYVIVNIYKDVLPNWSDKHKGFIPRMVNPASEKMYKAIAGIPE
KSNRRPTFAENIKFMVSYQFGYMYGRYFMWNFVGRQNDTQGNLDIFNGNWISGIDVIDEV
RLGSQQQLPADVLENKGRNTYYFLPLILGIIGLLYQIKWDKENFFTLFMFFVFTGFAIIF
YTNPKPFEPRERDYAVVGSFYIFAIWIGFGVLALFEYLQKLGPKKPIAIAITLISILAVP
SLMAFENWDDHDRSNRYTTHLNAQAYLESCDPNAIMFTIGDNDTFPLWYMQEVEGIRTDV
KLVNTSLFQTDWYIDQMKRATYKAAPIPSELTHDEYKYGTLDVAYYYHELFPSLKDSVID
LDSYMKWIRSDSPRTFYDLDDDGIPEKMLPTNKIRIPVNKENVLKYGIVAQKDADKIVPY
IDITVDRALAKNTILMLDILNNFNWERPIYFTGGSNTDSEYIWLKDYLQLDGVAFKFVPI
KTPTKIYNENGQLVRELSLFDIGRIDPEKMYKNVQKWNWRNINDGKIYLDEQTKRNAISL
RNSLMRLSSAFAIEGDTLKAIEVLDLSLEKLPIEDFDHYSLSMDYPEMYYKLGEPEKARA
AAKTLIKLFKDKLVWHSTFPSEKFDMVFDEFDMTFRYLFRGVIDQVVEFDTDEAFIMELQ
TEFNQTLQLFDHIIPSEEAK
>FCMOIPGL_00125 Threonine synthase
MTEVISFEQTDCFVSLEMTNNQQKMNYYSLHHKSPKSTFKNAVVQGLAKDRGIYFPDNIQ
QLSKDFIENISDYSNHEIAYEVIKQFVGDEIPAEKLKEIVAKTVSFDFPLVKIDDNIASL
ELFHGPTMAFKDVGAKFMAQCLEYFNKDNDDEVTVLVATSGDTGGAVANGFLGAKGVNVV
ILYPSGKVSDIQEKQLTTLGQNITALEVDGVFDDCQEMVKTAFLDEEITKTLTSANSINV
ARWLPQMFYFFFAYKELHKKHKDLIFSVPSGNFGNICAGIMAQKLGLPIKHFVASTNVND
TVPNYLVDGVYKPKPSKATISNAMDVGNPSNFIRIQELFDNDLEALKSAFSSYSFSDDET
RETMKEIYKNSGYVADPHGAVGYLGLKKHGLKENEFGVFLETAHPVKFLDVVEETLPVKV
EIPEQIKKVINNTKVAIKASTYEDLKAYLMK
>FCMOIPGL_00126 Homoserine kinase
MDYLKIFAPATVANVSCGFDSLGFAVDAIGDEMTFTKTTEKGVKITNITGANLTYNVDEN
AASAVVKKILNEANADFGIELTIHKGFSPGSGLGSSAASAAGAAFGANQLLGNIYSDLEL
TKFAMFGEEVACGTPIADNVSAAIYGGFVLVRSYSPLEIIKLPVPSELRVVAIHPQVEVK
TKDAREVLPTEIALKDAVTQWANVGGLISGLYSDNYNLISNSLVDIIVEPHRKKLIPFFD
DVKNAALKSGALGAGISGSGPTIFALCKGDEVATNVYKSIEESYKNTGIDFEMFISKVNH
EGIKIL
>FCMOIPGL_00127 Bifunctional aspartokinase/homoserine dehydrogenase 1
MKVLKFGGSSVANSENIKKVLDIVAKIAKENKVAVVVSAFGKTTNNLLAGADAALEDIVS
AKKTLDSIKELHFDTIDDLITKNIKEVKKEVTYLFDRLESIYSGVFLLQELSDKTLAKIS
SFGERLSSYIIANAAKELFDAIHGESRDLIITNNDYLNAQVNFKVTDKNIASFFEKNKHQ
VVVLGGFISSDINGETTTLGRGGSDFTAAIYAAALNADELQIWTDVSGMFTANPRVVKQA
YPISEISYEEAMELSHFGAKVLYPPTIQPALRKEIPIRIKNTFEPDNFGTLICNNPKNSN
EVKGISHIEDISLITLEGGGMIGIPGFSKRLFETLSIAKINVVFITQASSEHSICVGVYE
NDAAKAKELLDETFSIEIDKKKIKPIIVEKDLAIIAVVGESMKNYQGLSGQMFSALGRNN
VNVRAIAQGSSEKNISAVINKYDAKKALNTLHEQFFEERTKQLNLFVTGVGNVGERFLAQ
IHQQKKFLKENLKLSIKVIGIANSKKMAFDDNGIDLNNWKEALENGEPTTLDSFHKKVKE
SNHINSVFIDNTANQQVSEIYEKYLRDSISVVTCNKIACASSFDNYKTLKQVSRKYNASF
LFETNVGAGLPIIDTLKNLVNSGDRVNKIQAVLSGSLNFVFNNFNADSTFHDVVAAAQKE
GYTEPDPKIDLSGVDVARKILILARESGYKMELEEIAKNAFLPDDSLNTTNNDDFYASLT
KNEAHFQNIFKEANDKDCRLKYVAEFVDGKANVGLQHIPSDHPFYNLEGSDNIVLFFTDR
YPENPLIIKGAGAGADVTASGIFADVIRIANQ
>FCMOIPGL_00128 hypothetical protein
MSKIVTSANQQNDALFVLIKSLTKSEKRQFNLYVGRLGGNIDAKFFSLFKFLEKLKVYDE
KVIINSGIVSKQQLSNLKAHLYKQILISLRLNPAHKNIRIQLREQLDFATVLYQKGLYKQ
SLKLLEKAKHLALDNEEKNIAYEIVELEKVIETQYITRSLSNRADQLSVQAKELSLQNVL
ASKLSNLSLQLYSHLLQNGYVKNNEELEFVNTYFYGKIPRYKFNNLGFREKLWLYKSHLW
FSFLTQDFLQSYKYARKWVDLFKEDKKYINLHPVFYLKGINYLLEACFLVQKRTTFKKEL
TSFEEDVAQKNIPINTNTELLIFEYTYTNKLHLHFLEATFSEGEYLVDIINQKIENYRDR
LDNHHIVMLYYKIACLYFGMGKNELCIEYLQKIIKSKNLSSAEDLQCFARILNLIAHYEC
GLDYDLERQFLDTYKFLLKMENLQEVQKVFLTSIRDLSDIFPHEIKNEFKKIHSKLKKYE
DHPYEKRAFLYLDILSWLESKIQNKPIATIIKEKIIISKKNRNLHV
>FCMOIPGL_00129 2-isopropylmalate synthase
MMQDNKVQIFDTTLRDGEQVPGCKLDTKQKLVIAERLDLLGVNVIEAGFPVSSPGDFISV
SEIAKIVKNATVCGLTRAVENDIKVAAEALKFAKYPRIHTGIGTSDSHIKFKFNSTREQV
IERAVKAVSYSKSFVEDVEFYAEDAGRTDNEFLARVCEAVIKAGATVLNIPDTTGYCLPE
EYGAKMKYLRENVKGIDNVILSCHCHNDLGMATANSIAGVINGARQIECTINGIGERAGN
TALEEVVMVLKQHPYLNLETSINTKLLYDTSIMVRESMGMPVQPNKAIVGANAFAHSSGI
HQDGVIKNRETYEIMDPEDVGVTESAIVLTARSGRAALAYRAKKIGYELTKVQLDVAYTS
FLKLADTQKEIKNDDIHTIMKVVSKVSKITMV
>FCMOIPGL_00130 3-isopropylmalate dehydrogenase
MKLTIAVIPGDGIGPEVTAQAKKALDAVAEVYDHIFLYKEAQMGACAMESTGNPLPDATI
EICKKADAILYGAIGTLKYDNDPEAKIRPEQGLFRLRKELGLYCNVRPVKAYEKLVKNSP
LKKEVIQGADIVIYRELSGGIYFDTKELSEDGLSAFDICSYTVDQISKVAHLAFKAAQNR
KKKVTLIDKANVLETSRLWRKTVTEIAKEYTNVELDFMFVDNAALQIVLNPKQFDVILTE
NLFGDIISDEASVISGSIGLLASSSIGEKTAMFEPIHGSYPQAKGKDIANPLASILSAAM
LLEHFGLQEESDAIKRALEKSLTLGITTEDIKGKNQYSASTSKVGGFIADYILNQEDSNM
NFKNIHMGQSTII
>FCMOIPGL_00131 Dihydroxy-acid dehydratase
MELNKHSKRLTQDESQPASQAMLYAVGLTDEDMSRAQVGIASTGYDGNPCNMHLNNLAAE
VKVESKIAGLVGLGFNTIGVSDGISMGTSGMNYSLASRDIIADSIETVMNAQSYDALVSV
VGCDKNMPGAVIAMLRLNRPSIMMYGGTIASGNYKGKKLNIVSAFEALGQKMAGEIEDDE
YREIIKRAIPGAGACGGMYTANTMASAIECMGFGLPYNSSIPAENPNKLSEAERTAIAIK
NLLELDLKPLDIISKKSLENAIALVNALGGSTNAVLHFLAIAHAADIEFTLEDFQRVSDR
TPLIADLKPSGKYLMEDVHGVGGTPAIMKYLLENGYLHGDCMTVTGKTLAENLADVKAME
FEDQDVIYPKDKALKSSGNLQILFGNLAEEGAVAKISGNEGLLFEGKAVVYNGEQAANTG
IINGEVERGDVVVIRYVGPKGGPGMPEMLKPTSLIMGAGLGKSVALITDGRFSGGTHGFV
VGHITPEAQSGGTIGLLKTGDKIRISAEDNSINVLISDEELAERKSKWVAPALKHKKGIL
YKYAKTVASASKGCVTDL
>FCMOIPGL_00132 Acetolactate synthase large subunit
METQTIKNEKPATKTTERISGSEAIVRCLIEEDAKIIYGYPGGAIMPVYDELYKYQDKIH
HVLTRHEQGATHSAQGFARISGKVGVCIATSGPGATNLITGIADAQIDSTPMVCITGQVF
SHLLGSDAFQETDIVGISTPVTKWNCQVTKASDIPAAMAKAFYIAKSGRPGPVLIDITKD
AQLEEFDFSYKKCTRVRSYNPIPKTDLSSVEAAAKLINGAKKPLIVWGQGVILSEAEEHL
KAIVEKAGIPAAWTILGASAIPTSHPLNVGMVGMHGNYAPNKLTNECDVLIAIGMRFDDR
VTGTLATYAKQAKVIHFEIDPAEVDKNVKTDVAVLGDAKTSLELLLPLLNENTHPEWRKE
FADLYAVEYEKVIKDDIYPTKEGLTMGEVLHQINIQSKGNAAIVSDVGQHQMIACRYAEF
NKTKSNITSGGLGTMGFGLPAAIGAKMAAPEREVVSISGDGGYQMTIQELGTIFQQRAAV
KVVVLNNDFLGMVRQWQQLFFDKRYASTEMVNPNFVAIAEGYYIKAKKVTKREELADAVA
EMMASKEAYFLEVCVEKEGNVFPMIPTGASVSDIRLE
>FCMOIPGL_00133 Acetolactate synthase small subunit
MSTEKQLYTISVYTENNIGLLNRISAIFQRRHINIESLNISPSEIEGVSRFTIVVNMIEV
NVKKIIGQIEKQVEVIKAYYHTLDEVIYQISGLFKIKSELLFEERQIQNIIKESNARIVT
VNKEFFVLEKSGKKEEIVDLYNALSVFGIMQYTRSGLISVTKDEMKISTLLESYNN
>FCMOIPGL_00134 Ketol-acid reductoisomerase (NADP(+))
MSNYFNTLTLREKLEQLGKCRFMDASEFEDGVNALVGKRIVIVGCGAQGLNQGLNMRDSG
LDISYTLRQAAIDQKRQSFINATSNNFKVGSYEEMLPTADLVINLTPDKQHTNVVTAVMP
LMKKGATLSYSHGFNIVEEGMQIREDLTVIMVAPKSPGSEVREEYKRGFGVPTLTAVHPE
NDPEGKGWAQAKAYAVATGGNRAGVLESSFVAEVKSDLMGEQTILCGLLQTGAILSFDKM
VEEGIEPGYAAKLIQYGWETVTEALKHGGITNMMDRLSNPAKVEAFRLSEELKDIMRPLF
QKHMDDIMTGHFSATMMEDWANDDKNLLTWRAATGETAFEKQTITDQEIPEQEYFDHGTL
LVAFVRAGVELAFEAMTESGIIAASAYYESLHETPLIANTIARMKLAEMNRVISDTAEYG
CYLFDHACKPLLTDFMKTVKTDIIGKKFTDSNDVDNKELIRVNKIIRNHPVEKVGERLRT
SMTAMQVIKSA
>FCMOIPGL_00135 L-threonine dehydratase biosynthetic IlvA
MKTQETYFPSLENIKQAASNLKDVAYVTPLIQNQNLSKQFQSTVLFKREDLQVVRSYKIR
GAYNKISSLNDDEKQRGIVCASAGNHAQGVALSCKLLEIKGTIFMPSPTPNQKINQVKMF
GEEFINIIIEGDTFDDAFNSAKLECDSKNKTFIHPFNDEKVIEGQATVGLEILEQTNKKI
DYVFVPVGGGGLSSGLSTLFKELSPETKIIGVEPEGAPSMQTSIRNKKNTALETINNFVD
GAAVKKVGDLNFAICKQNLDAIITVPEGKICQTILDLYNIDAIVVEPAGALSIAALDFYA
DEIKGKNVVCVVSGSNNDITRTADIKERALLYANLKHYFIVKFPQRAGALKQFVAEILGP
NDDITHFEYTKKTNREKGVAVVGLELKSASDLEPLIHRMKENNFFGDYLNDKPDLFQFLV
>FCMOIPGL_00136 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
MKQVFEEIPDEYKIESLLHQKTYLVDGELKAWKGDTADVFSTISSTENYKPTLLGTVPNL
GEDEALEALNSAIKAYGKGQGLWPTMKVEGRIAAMEKFVVQMKTKREEIVKLLMWEIGKS
LPDSQKEFDRTVEYIYDTIEDYKQMDRDSAKFEKNSGVHAHIRRGPLGVVLCLGPYNYPL
NETFALLIPALMMGNTTIFKPAKHGVLLLSPLLEAFQSSFPAGVVNIIYGRGRTLATPIM
KTGKVDVLALIGNSKSANAIQANHPQKNRLRLVLGLEAKNPAIVLEDADLDLAINECLSG
ATSFNGQRCTALKVIYVHENIVEEFNKRFSDKVDALKFGNPWENGVQLTPLPEPGKTAYI
QELIDDAAEKGAKIINKKGGETTENYIFPAVLYPVSKDMRVYQEEQFGPVTPVLSFKNID
EPLDDMAESNYGQQVSVFGSDVKTLAPLIDTLVNLVCRVNLNSSCQRGPDVYPFTGRKDS
AVATLSVHDALRSFSIRTFVASKDTPYNNAILEELLDKKASNFISTDYIL
>FCMOIPGL_00137 Large-conductance mechanosensitive channel
MGMLKEFKDFAMKGNLIDIAVGFVMGAAFKQVVTSFTGGIVSPLIGLLFNADFKDLKYIA
KEGIADEAGKITGEVAILYGDFITNVIDFIIVAFVMFMIVKGINATKKKEEPAPEPAPAG
PSQEDLLAEIRDLLAKK
>FCMOIPGL_00138 Alanine racemase 1
MNNHVTVLEIDGKALEHNLTYFKQKLKPETKILAVVKAFGYGSDSVEIAKFLEEKVDYFA
VAFAAEGIALREAGIEAPILVLHPQVQTLQSIVDYRLEPNLYGFKVFDAFLKLADETPLM
NYPIHLKFNTGLNRLGFWHTDIPKILSDLKETNHVKVQSLFSHLAASEDLEERDFTINQI
NNFAYIAQQFYKHLSYKPMLHILNTSGVVNYAEAQFDMVRIGIGLYGFGNDEKVTSTLKN
THNLTSIITQIHLIEPGETVGYNRAFVAKKPIKSATIPVGHADGISRRLGNKKGFVIINN
QKAKIIGNVCMDMIMVDVTKIDCKEGDKVIIFNNQEMIQHIATVSETIVYETLTAISQRV
KKVLNK
>FCMOIPGL_00139 Thymidine kinase
MFLENTVNHTEQFGWIEVICGSMFSGKTEELIRRLKRAQFAKQRVEIFKPAVDTRYDEEE
VVSHNDNRIRSTPVPVSSNIRLLVNDVDVVGIDEAQFFDDEIVAVCNDLANSGIRVIVAG
LDMDFKGNPFGPMPALMATAEYVTKVHAVCTHTGNLAHFSFRKAQNDKLVMLGETQEYEP
LSRAAYYKAIKNKQNQIVSSDENKPESEDTE
>FCMOIPGL_00140 hypothetical protein
MHKKLEADLISLAHSILQMKNKENVFLLKQKSKEIYEKLSVLAFVEEYVNATPGIKETKE
ELVEKVEQAFEVKENSNVDEKDAEEFILIEEKVMYNLVDESEEEKQEIKQEVVIEEKVAP
KVEEILEQPFDELEEIIFSETKIEEPKTEEAKPEEPYINDVVMVEVNKTKTLEEELQDTF
SVDLMADLFDNAQPKSLNDKFAANIQIGLNDRIAFVKNLFNNQQEDYNRVISQLNTFKSV
KEAKEFIIKMVKPDYNWSNHEELEARFLEIIERKFS
>FCMOIPGL_00141 D-inositol 3-phosphate glycosyltransferase
MKSVLIHTHFHRRKTGVTRSIENVLPFFTDEFETYVYGTNINGVQITTSKLKSILFSDVK
TVVHCHRNNEIIRMLLFRFLGAKFTLVATRHAETVPSGLTKFLLKKADKVVTLIKSMSIN
LGIKNTIVGHGVKVNEFLPNSEKKLENILQENIVLNAGRVRKAKGQFVLLEAAKTLKEHK
NWALVIVGKVDKPAFLEELKTIAKKHEIENQVYFIDETRDIISYYQAAKIVVAPSFSEGF
SLVTAEAMSCECSVIATRNVGVHSELISDKKNGYLFNAGDSSTLENLLSKAIKNEIPHLG
KQAREEIVKNWSAKKEAQNLIALYKSK
>FCMOIPGL_00142 hypothetical protein
MKKIIFAFLIAIFTFSNVNAQKIEVKKFFGENLFYQNGEKLTMNQLKEVLKNNKETLDLI
KSAKHNYTWSSVLGFSGGALIGIPIGTAIGGGDPKWEIAGLGATLILVAIPLLNNYNKKS
KAAVDLYNVGLPTVSASFQPEFNLNFKGSSLGIVMNF
>FCMOIPGL_00143 hypothetical protein
MKHLTTILFALLITSISAQEVAFQKFYKVNKDKSTFSINLSASLAGSFLDDENDSDLMNV
IKKSSDFKVMIFDNEDNVVSKDFRKFIRKNKLKTFARIKDNGSNAELFFIEKKDYIREII
IRTNSNNDKLVLFGLKTKITKDELAEMISNSDIKISSK
>FCMOIPGL_00144 Regulatory protein Spx
MKKVYFLQTCDTCRRILKEVNTDGFERQEIKANPVTVVQLEEMHKLSGSYEALFNKRAKL
YKSKDLKNQTLTEADYRQFILDEYTFLKRPVFIFNDEIFIGNSKKVIEELKKKIG
>FCMOIPGL_00145 hypothetical protein
MKAQFDILRTSRNLVLKELEGLTLEQIHEIPTGFKNNIAWNVAHLVVTQQLLNYKLAGLD
CLCSDELIEDYKKGTLPSKTFTEEEFEEIKDLLLGLPDTLEEDYKAGIFESFKEYPTSTG
FVLTTIESAISFNNFHEGIHYGIIRSIKKIV
>FCMOIPGL_00146 Na(+)/H(+) antiporter NhaP
MDYFLIATVLIVLSALFGYINTRFLKLPNSIGLMLITILFTLAVFVLSYFDDTLLLKERE
LITSIDFKTVLLDVMLSFLLFAGALHTNFQQLKIQRKPVLIFATLGTLISTFLAGVLVFY
ALKIVNLNVDFIYCLLFGALISPTDPIAVLGIMKKVGAPKKLETKIVGESLFNDGVGVVI
FLTIYQIASGGSEISVGHIAELFLVEVVGGIVFGLVIGWITYRLLKSIDDYDTEVIITLA
AVMGGTLVAQHFHLSAPLAMVTAGLLVGTDTVRKNSMSEVTELYVDKFWELIDVLLNTIL
FVMIGMEILVLTLDTSYILAGFIVVPLLLFARYISLLIPIKLYAKKLDFVPKTNLIMTWG
GLRGGISIALALSLTQDMERDLFLVITYIIVVFSILVQGLTVGKLIKKFTLEPKS
>FCMOIPGL_00147 hypothetical protein
MKIVYRFLFLSVLLIFVTNCARTGRPDGGPKDEEAPLFVTSIPPYETVKFDKKEIRINFN
EYITLKELNSQLVISPPMENPALISPQGTPSEYIKIKILDTLQPNTTYIINFGNAIEDNN
EGNKLENFKYVFSTGTYIDSLTTSGSIVDAKLIETPKKINILLYRIDSAFNDSIVYKKKP
NYITSTLDTTVFNFTNLRKGNYLMLALQESVSDYIFNPVTEKIGFSMDTIQFPRDSIIKN
PLILFKEEQPYKFKRGKEITKGKIEFGFEGDAKNMQIKVLSKVPEDFKSVSKLEIDKDTL
NFWFTPFEADSLNFEVSNNEFSDTLTVRLRKKKIDSLVIKSSISNTLHLRDTLFFKSNNP
IVKVDTSKISLFDKDTIAIKYTTLLSKKENKIGLLFKQEPNQKYHLTVLPDAFNDIFSFK
NDTLKYNFSTKELEDYGRITLKVNNVNSKNLIVELLTGSKNFEVVQRNFIATTETIVFDL
LEPKKYTIRIIIDENKNNKWDTGSFLERRLPETILYHKEINNADLRANYFLEESFIVD
>FCMOIPGL_00148 hypothetical protein
MRLLKDLFHLFYPKLCTVCEDKLVENETSICTICRHDLPLTGFLDFKNNKVTQTFYGRIL
IEKAFSLLFYRKKGSVQKLIHDLKYKGNEEVGVFFGNWLGEILKENQEFKSIDYIIPVPL
HPKKLRERGYNQVTKFGKIISNHLNIIYLENNLVRISSTKTQTFKARFERFNNIDTKFLL
TNPSFFDNKNVLLIDDVITTGATLEACAKEFLKSKNCTLSILTMAYTE
>FCMOIPGL_00149 Ribosomal RNA small subunit methyltransferase A
MSSRIKFLKEAVKNIKTLGTVTPSSRFLSKRMLREINFSNADVIVELGPGTGAITKYILD
NLSPKAILICFEINDNFYQQLHKLEHPQLIILKASAEKIVDELKKLQIHQVNYIISSLPL
TIIPDEISSEILERSFEVLEENGNFIQYQYSLSYFRKLKNVYKESISLEFEPLNIPPAFI
YRCKKVV
>FCMOIPGL_00150 Glycine--tRNA ligase
MAKQEDQFKKVLSHAKEYGYVFQSSEIYDGLSAVYDYAQNGVELKKNIRDYWWKAMVQMH
ENIVGIDAAILMHPTTWKASGHVDAFNDPLIDNKDSKKRYRADVLIEDYCAKIEGKINKE
VIKAAKRFGDAFNKEEFLATNARVVGYQEQINTILARMGKSLSNEDLADVKLLIEELGIA
DPLTGSRNWTEVKQFNLMFGTQIGASAESSTQVYLRPETAQGIFVNFLNVQKTGRMKIPF
GIAQTGKAFRNEIVARQFIFRMREFEQMEMQFFVKPGTQKVWYEQWKETRLKWHLSLGMG
TENYRFHDHDKLAHYADAAADIEFNFPFGFKELEGIHSRTDFDLKAHEEYSGKKLQYFDH
EENKSYTPYVVETSIGLDRMFLAVFSNSLVEEELENGTTRTVLKLPAVLAPFKAAILPLV
KKDGLPEVAREIMEELKWDFNVFYDEKDAVGKRYRRQDANGTPFCITVDHDTLADKTVTI
RYRDSMEQKRVAIADLKDIIKAEVDVKTWLQKM
>FCMOIPGL_00151 hypothetical protein
MKKLVLLITLFISSFGFAQQELKLDIANTLIIKNLSFSYEQYLSDESSFGVSASFNLAKQ
SADFRYNENTMITPYYRHYFTTNEQWNFFGEGFFGINSGKKESVKNSDIYDVKYTDGALG
VAVGTKYIASGGLTIDLYGGLGRNLFGSDSPVIVPRLGLNVGWRF
>FCMOIPGL_00152 hypothetical protein
MKKITLLILLAVTTISFAQEKESIYPQDVNKKYEVKLNAFSLIVFSSLDVSYEYLLNKDS
SFGVGVFYNFNDINNDLYFPKKFSITPYYRWYFSESRYARGFFVEGFGMLNTYKDINYYY
SYYDNYGNYIENDEVYKETNFALGVSVGGKFIIKSGFTAEIYLGVGRNLFNNSSNDNDYL
ENDLITRGGISLGYRF
>FCMOIPGL_00153 Nickel and cobalt resistance protein CnrB
MKNIYILLFSITFLACGNKEKPSTTEIETVINKNEISINKAQFKGEKMEFGQLTKQTFNT
VVKASGIIDVPPENKASVSTFVGGYVTKIPLLIGDKVTKGQLIASLKNIEFVEMQQEYLE
IAEQLAYLKNEYSRQKTLFDEQISSEKNYLKAESTYKSNLATYNGLRQKLQILNINPDTV
EKGQITSTINIYSPINGFVTKVNVSNGTFVSSESELLEIVNTNHIHLELSVFEKDILKIK
KEQKILFKVPEASDTIYEAEVHLVGTTINNDRTIKVHGHIHEEEKTNFITGMFVEADIIC
DSKKEISLPKRAIIQNNDSYYALVLKGTKEDIYQFEKVELNVGLQDENYIQIKNYEVFNN
KKILTKGIFMLLNSFSEE
>FCMOIPGL_00154 Cobalt-zinc-cadmium resistance protein CzcA
MLESIIKISLKNKLIIFIFTAFIIGFGIFSLTQIPIGAVPDITNNQVQVITTSRNLSTQD
IEQFVTYPVELEMANLPGVEEIRSVSKFGLSVVTIVFNDEMGTYLPRQLIAEKIKSASEK
IPEGFGTPEMGPITTGLGEIYQYILDVKPGFEDHYSITELRTIQDWIVKRQLSGIPGVVE
VNTWGGLLKQYEVAINPNKLNAMQISVVEIFDALEKNNSIAGGGYIEKTNETFFIRGEGL
IKNLEDISNIVVKNEGTPIYVKDVAKIGFGSATRFGAITGNGEGEKVLGQIMMLKDGNSK
AIIDAVKERVSEIESTLPEGVYINAFLERSELINKTTFTVSENLILGSLIVIFVVVLLLG
DLRSGIVVASVIPLSLLFAISLMYIFGVDANLMSLGAIDFGIIIDGAVIIVEFIAFRIIT
ESDKLKSLSSEGKQEEIDKITLKSASKMMNSAIFGQLIILIVFIPILSLSGVEGKMFRPM
ALTFSFALIGAMLLCLTYVPVASSLFLKSQKQNKNNISIKLMKVLNFWYKPSIGWALAHK
KIVIGLAGLLLTTSVFLFSTMGGEFVPTLDEGDFVIQPVLKTGTSLGKTIEITTKIEQIL
LDNFPEVDQVVSRIGAAEVPTDPMSMEESDVIIKLKPKSEWISTKSKDELADKFKEALAI
IPGMEVEFTQPIEMRFNELITGVRADVAIKIFGDDLSVLANKANEVKELIKNVEGASDII
IEKVEGLPQMSVNFNRSKIARYGLNIADVNKMITMGFAGGTVGNIFEGEKRFDLVIRLDE
KNRKNLESLQHLYIDTPNGNKIPLSELATIKYTTGPAKISRDDTKRRIVIGINVRNRDLQ
SVVDDVRAIIDRKFKIPVGYKVTYGGQFENLQSAKARLTVAVPVALALIFLLLYFAFGSV
KEALLVYSAIPLSAVGGVLLLWLRDLPFSISAGVGFIALFGIAVLNGIVLIEHFKVLKEE
GIEDIEERIKRGTKERLRPVLLTASAAALGFLPMAVSTNAGAEVQRPLATVVVGGLVTAT
ILTLIVLPVLYAWFEEKKSIKMTKNSVLTILGFFFIISSSAQNKLTINETLTLAIKNNKS
LKAANLKIAESNALVGNAFNFDKTAFYYSYDENNLAVNNLPLKVFGIAQDFKFPTVYFAD
KKVQKSKVNIEETNYSLQLMQIKKAVYSNYYQLSYAKNKLKTYRFLDSLYLDFATKAKRK
FELGETNYLEMITAKSKQKQLQTSCNQALQEVVFSSEQLKAVVQINSLRILDQPLIKLKI
ETISIKNNLGLQYFDNAKNYQKALTKKEKQSLLPDISLEYFQGTNSQLNTNINGYQFGLK
IPLLFSGISSKIKASKIAQEIVIEQKAAYKIKLEGQYNTLLATLKQYEEAINYYENEGKT
LKNEIIKTANLTFKEGEIDFFQYIQSLETAKDIELTYLENLNTYNQTVININYLILNTF
>FCMOIPGL_00155 hypothetical protein
MLKHAQFHQEKYGDTFFDFLSEHYFEDQYQANNNHKEHEKLPFKHDSQTCSHLNTHFTLN
PIIFEIENDDVLEAISYFIYKESSSSFEKHAVFQPPKSA
>FCMOIPGL_00156 hypothetical protein
MLQKYTFLILLFIGFSIQSQTISTDFRKRIIEVKQDTIRLDSVPINSQKFKILDNSKNLI
ISSNYKVDFSKAILIINSKKYSKITVEYFRFPEFITKVYSPYDEKLIIENTTNNGVLYSL
TTNKKASEIKLFEGLETKGFISRGITSGNNQNAVTNSALDLEISGKLSKDVTLRANIFDT
NIPIQENGYSQNITDFDRIFIEMFSNNWRVRAGDISLKNDKSYFLTFTKQVAGLEVEANV
NDNLKIAASGAVVRGKFNRFTFTAAEGNQGPYKLYGANNESAIIMIEGSESVYINGLLIN
RGENEDYTIDYNLGEITFNTTFPVTNDMRITVEFQYSDRNYTRFITYNEVDYKSEKLNIA
GYFYSENDAKNQPIQQSLSTEQKQILANAGNNADAMFSESAFLDTYDENKILYKKVINGV
IEIFEYSNLETDELYNVTFTNVGANNGDYNLDRSIAIGNIFVFVGVNQGEYQPIVNLIAP
TKSQFFVVKSDYNPTEKMQINSEIALSNNDANLFSNINDDQNKAVAVKVGWQQILIDKKW
QLKTNINHEFVAKNFETIQRWETIEFNRDWNILTNDATKNYFQSEISLQNKKDNFVLYRF
NNLNYTDVFNGNKHELTSKLKFNNTSFFVDGSFLENTSTLEDNTFFRAKATVNQSLKKSW
IGAFINFETNSRKDLNTEEFINTSHRFKEYEGYFGIGDSTKIFAKFGFNYRNNDSIKLNE
FTEINNRKTIYLNSKLIKNKNTDLSIFANYRITKNYFTEDEKNLNSRVIFNQKLFKDFMF
LSSVYETSSGNVARQDYVYVKTEPGFGFYTWIDYNNDGIQDFNEFEIAQFQDQADYLRVP
KPNLSYIATQRAKFQQNLSINPRSWSLKTGIKKLISHFYNQSFLSVENEQERIGNSFQLN
PFNFDENSLIGLNLNFRNSLFFNKDLQKNSMTFTYGDSKIKQQYFIGNQENNIKLHQIEY
THKFADFWLIDLLGKTSKNTLETENFTNRNYEIDAKEIQPKLTFLYNTNNRFSAFYHFKN
KQNKLEDFEELNQQKFGIEYFYISKKKNQISANLNVFLNDFTGSENTPVAYQMLEGLQNG
KNYTWSLLFNQKLNSFLNLNLNYLGRKSENSKTIHTGTVQLKANF
>FCMOIPGL_00157 Methylated-DNA--protein-cysteine methyltransferase
MELKVVCYQKNNLQIQTTYYKTPIGIAEIIGDKSGIQSVAVLDENAISDKLLNLETPECL
QECVSQLEEYFTGKRIDFNLKLNPKGTSFQKKVWEELLNIPFNTTRTYLEQSKALGDVKA
IRAVASANGKNPIWIIIPCHRVIGSDGSLTGYAGGIWRKKWLLAHENPVKQQALF
>FCMOIPGL_00158 hypothetical protein
MFNTMKKYFVFIILLALTFTINSQEEYRKYWKDGKLTWDDFQAQPTQNNPTYLAYVLMYQ
TDKKVIDDVTYYGVFSDAYIDKSLSFVHHNLKDEHHLDYNQVIFNLVEIHKRKLQKRIYT
SNNIYEVNPLFSDSKSQLEREVYNFQQEGNYGIQQDVTAQWLLKTSEELATSPSFIIPDF
RKSNWTYGLYGGVDFGFYGDTYNEVFNNTIAMSLGFEFSYKKVFMGLNMNFTNSKLNTDL
IDDSFLITEGERSTIGLLNGYVGYPVYETKKFRIMPFAGYGLTFLSEAGNEDNKQETSAA
TSVFGVNFDLKNKKKVNFTPSLFDIREEGNSYFRARIFMSNSNFNPNLKGYSFNIGLYYG
IEGRLLSKK
>FCMOIPGL_00159 D-aminoacyl-tRNA deacylase
MITDTHTHLYSDQFNEDRKDMMQRAKDAGVSRFFIPAIDSTYTESMLSLEQDYPNEVFLM
MGLHPTSVKENYLEELAHVKNWIDKRNFYAIGEIGIDLYWDKSFLTQQQEAFRTQIKWAK
EKKLPIVIHCRDAFDEIFEVLESEKSDDLRGIFHCFTGTLEQAKQAISYNMKLGIGGVAT
FKNGKIDKFLNEIDLKHIVLETDSPYLAPTPFRGKRNESAFITNVIDKLVDIYGIDFNKI
AEITTQNSKNIFNV
>FCMOIPGL_00160 ATP-dependent RNA helicase RhlE
MTFKDLDLSNQLQYAIDDLRFESPTPIQEQAFSVIRSGKDVVGIAQTGTGKTFGYMLPIL
RDLKFLKTQHPRVLVLVPTRELVLQVVDEIEKLAKYLNVRVLGVYGGANINTQKQGIAQG
QDIIVATPGRLYDLALSNVLKLKTIQKLVIDEVDVMLDLGFRFQLMNIFDLLQERRQNIL
FSATMTEDVDALIDDFFKNPEKISVAVSGTPLDNIEQVSYNIPNFFTKVNLLHHFLKDRQ
TFHKVLIFVAFKRSADLLFKHLEEVFGNELCIIHSNKTQNYRIRSIRQFEEGKNRILLAT
DVMARGLDFDNVSHVINFDTPDFPENYMHRIGRTGRAEKAGKTILFSTEKEQEGKVLIEE
LMDYKIPVIELPESVEISKLLTEDERPKEDNGQSKNRTALEYVPGPAFHEKSEKNSKTNQ
GGSYRREIAKKYKKPKTRGDKNYNLRNKKK
>FCMOIPGL_00161 hypothetical protein
MHILNAQELHNLAMNIVGEKLQEMGYEFQAINSQLKRHPQFVLFKKGEPTIFVLVKASNN
LQNPHEYDVLWMETFKEHAKKQNAKVWFAGVGIANAESVESPVFKDQPYYVAFEDFLKIL
E
>FCMOIPGL_00162 hypothetical protein
MKNLKKIFFVSIFFILYACFNQVDEVTISKSGKIKLVTTIEVTAKEADKKSVQEEIDARV
KSLKKAGWKVSYKWKSKSKPYKVKFTISNTLNKLYEYQKKPEDVNPSGVYIYKKFSEKQY
VISFDLIKDANNRTINLSKKSVSLYRKYGDNKLKKFRNIESEKYYYVFLK
>FCMOIPGL_00163 Motility protein B
MKKISILLLTAILASSCVTKKKFVDLETEHELTKSELVDLKANLQKCLIDNEKESTKVFT
LLEKIKYLQEDKKTALKQVENLTVLTQSSSDNIKTVISQLSEKDKYINGIRKAMTQKDSL
NLAIKFHLTKNLTDGIQDEDIEVNVEKTVVFISISDKLLFKSGSYNVNNKAYSVLEKIAK
VINDQPAMEVMIEGHTDTTPIKRNLIQDNWDLSALRATSITRILQYKYGVKPERLIAAGR
SQYIPLAPNDSAANKAKNRRTKIIIMPKLNQFFELLEQDANN
>FCMOIPGL_00164 FAD:protein FMN transferase
MKLKFNNVLLIVLLFLIACKQESENNHHTLQGFVFGTSYKITYLDTAIDYQKSLDSLFLL
MNASTSTYIPTSEISKINNGDSTIVVDAIFSEVFTKAKRIFKETDGFFDPTVGNLVNAYG
FGPKERLNDLTDEEIKNQMQFVGLDKVNLIDGKIVKEDKKIYLDFNSIAKGFGIDLVARF
FDEKKIENYLIEIGGEIRAKGTKENNKPWLIKVVNPANASENGGYKTINLSNKSMATSGN
YRKFRVSSEGKKYVHTINPKTGYATESNLLSASVIASADCADVDAYATAFMAMGLEKTKE
FLKKHPNLEVILLFSNSEHRIDEYTTYIYK
>FCMOIPGL_00165 Demethylrebeccamycin-D-glucose O-methyltransferase
MSNKIFKKILNTIPRPWLIKFSYLVRPIIAFSLKGDKFTDPIDGKSFRKFLPYGYGKQRE
NALSPSTLSLERHRLMWLFLRDETTFFTSEEKLKTLHIAPEQCFLDIFRKQKNLDYLTSD
LESPIADVKADICNLPFEDNSFDVVFCNHVLEHIPDDTKAMQELFRVLKKGGFGIFQIPQ
DITRETTFEDDSITDKKERAKIFGQYDHVRIYGKDYFNKLRSIGFKVDEIDYTKKIAPEK
LERFCLMRNEILPVCYKE
>FCMOIPGL_00166 hypothetical protein
MTDLLYKEDTYKIIGICMEVHNQLGKGFNEVVYSDALEIEFIDNNIKYSKEQKFNISYKG
NILPHKYRADFIINDKIVLELKAIKCLTSSHVKQTLNYLAVSKLKIGLLINFGEDSLKYQ
RIIL
>FCMOIPGL_00167 Methionine aminopeptidase 1
MRESALVVSKTLGMLAKEVKPGVSTLYLDKLAEEFIREQGAIPGFLGLYDFPNTLCMSPN
AQVVHGIPNKTLLKEGDIISIDCGALKNGFYGDHAYTFAVGEIDAEIKKLLEVTKESVYV
GIREFKAGNRVGDVGYAIQKFTEDHGYGVVRELVGHGLGREMHEDPEMPNYGKRGRGKKF
VEGMVVAIEPMTNLGTQKIRQHADGWTITTFDNKPSAHFEHDVAIVNGKPELLSTFKYVN
EALGIVTDVEDEFRQ
>FCMOIPGL_00168 hypothetical protein
MKKSIIIFLIAVISACNSTKKVVETKTVETKKAEVEKVKQITREITAKKDANGYLIGVAN
KDSFKDESFKNWFNSRYNEYTTDKETVNKLKTALEGYTIKGFMSSWCGDSKRETPRFYKL
LDETGFNQNDFELITVDRSKKTPDNLQEGFNIIRVPTFIFYKEGKEVGRYVEYPRETLEK
DILKIVTNQPYKHSYDRSE
>FCMOIPGL_00169 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MILDGWGITQDPKVSAIYNAKTPFINSLYDKYPNAQLRTDGEHVGLPEGQMGNSEVGHMN
LGAGRIVYQNLARINKAVKEKTLGEEKVLLDTFKYAKENNKNVHLLGLVSNGGIHAHIDH
LKGLLDVAKENEVDNVFLHAFTDGRDCDPKSATFFINEVQEYMKESTGELASVTGRYYAM
DRDNRWERVKIAYDGVVNAIGTKTTDVLKTINENYEAGLTDEFHKPIIITNADGSPKAQI
KEGDAVIFFNYRTDRGRELTNALSQNDFPEFGMKKLDLYFTTMTLYDESFKGINVIYNNE
NIKNTLGEVLSVAGKKQIRIAETEKYPHVTFFFSGGQEEPFEGESRILRNSPKVATYDLK
PEMSAYELKDALCEDLEKGEADFVCLNFANGDMVGHTGIMEAAIKACETVDICAKEVIET
GLRNGYSILVIADHGNCETMMNPDGSPHTAHTTNPVPFILVDEEIKSINSGVLGDIAPTI
LDLMGVDQPKEMTQKSLL
>FCMOIPGL_00170 hypothetical protein
MKKLILPMLLFFFAFSTVNATNNEDDPKEVRSEITLVYNVSAFCKLIQMGDYDAVRALIK
TGEDVNQKSNGLTPLMFAARHNKAKIAKLLIDNGAKLKTKSDKGSMTALDIAKRSKAVDA
IKVIKEAL
>FCMOIPGL_00171 Phenylalanine-4-hydroxylase
MKSLTSMRFEINEITKKLPIHLHKFVVKQPYNEYTTQNQAVWRYVMRMNVDYLSKVAHKS
YLSGLKKTGISIDTIPRMEGMNRILKEIGWAAVSVDGFIPPNAFMEFQAYNVLVIASDMR
TINHIAYTPAPDIIHEAAGHAPIIANPEYAEYLRRFGEIGSKAISSAKDYEMYEAIRLLS
ILKEDPNSSEKEINEAQEKVEWLQNNMGELSEMAQIRNLHWWTVEYGLIGTLENPKIYGA
GLLSSIGESDWCMQDEVKKLPYSIEAANINFDITKPQPQLFVTPDFAYLSLVLDEFANTM
ALRTGGLNGVKKLINSENLGTVELSTGIQISGAFTKVIQYKNNKVAYLQTTGATALSNRD
KELIGHGISSHASGFGSPVGKLKGINLPIEDMSPRDLRAYGIYEGEFMTLEFESGVIVKG
KAITGTRDLRGKILIISLDECTVTYKDEILFQPEWGIYDMAIGKEVISVYAGAADVNSFE
DKSKVSDVKTHKILYSESEKELYDLYDQVKQMREANSTSEKKITEIFNQLKNKFSNDWLL
NLEIYELALQNKYALKVEILKRLEELKCNKSYTKLIENGLVLCKNK
>FCMOIPGL_00172 Thiosulfate sulfurtransferase GlpE
MGLFDLFKRKNMGEEIKEYLEKGAIILDVRTLEEWNEGHSKGAKHVVLTIIPLEIEKIKS
WNKPIIAVCRSGARSGQATQFLKQNGVDVINGGPWGNVDQFL
>FCMOIPGL_00173 hypothetical protein
MKLQTQIPLKKETRNLIDYQSKILMLGSCFSENIGDKLSYFKFQSAQNPFGILFHPKAIE
NLIADAINEKEYFFDDLIFNNETWHSFDAHSKLSSVDKNKLLSNLNSAISSTKKELKEAT
HIVITLGTSWVYRFIETDSIVANCHKIPQKKFLKELLSVDEISESLEAIIALLKTVNKNI
TVLFTVSPIRHLKDGFIENTQSKSHLISAIHNIVDNRKNSYYFPSYEIMMDELRDYRFYT
EDMIHPNKTAINYIWEKFKETWFSEETKPIMKEIDVIQKGLLHKPFHENTEQHQQFLRNL
SIKKEKIEQQFPLIKF
>FCMOIPGL_00174 3-deoxy-D-manno-octulosonic acid kinase
MTHTLEQLKSGSLIGTKRLKLACGLKQFPNEILSLSETLEILDLSDNQISELPDSISQLK
NLKIIFFERNNFTEFPTILKKLPLLNMIGFKSNHIKTVPENAFPPMLKWLILTNNEIKKI
PKSIGDCLLLQKCTIAGNQIEELPSEMSNCVNLELLRISANKLQLIPNWLFELPKLSWVA
FGGNPVSHQPKTNTNINSFDWNEFTLKEILGEGASGLISKASWKSEKEDVAIKVFKGSMT
SDGLPEDEMKISISSGSHQNLIQILGEIKNHPEKKSGLIMKLISPTYINLGNPPSLETCT
RDVYDEKTVFNEKEILKIAKSIASVCAQLHGKGINHGDLYAHNILINKTADCLFGDFGAA
SFYDVNSTLAHNIQRVETRAFGCLLEDLSSLITENEISNPFQRKWQKLIANCTSKDVNLR
LSFHQIIEELNTF
>FCMOIPGL_00175 Alanine--tRNA ligase
MKSQEIRSTFLNFFKNKGHLVVPSAPMVTKDDPTLMFVNSGMAPFKEFFLGNGKPKKNRI
TDSQKCLRVSGKHNDLEEVGYDTYHHTLFEMLGNWSFGDYFKKEAIAWAWELLTEVYKID
KDILYVTVFEGSDDADNLKMDTEAYDIWKQYIDEDRILKGNKKDNFWEMGEQGPCGPCSE
IHVDIRSAEEKATVDGRTLINEDHPHVVEIWNLVFMQFNRKANGTLEDLPNKHIDTGMGF
ERLCMVLQGVQSNYDTDVFTPIIREIEAVTDTKYGNDEKQDIATRVISDHVRAVAFSIAD
GQLPSNTGAGYVIRRILRRAVRYGFTFLDKKEPFLYRLVDVLSKKMGEAFPELRAQKQLI
ENVIREEETSFLKTLDQGLVLLDGIISSATTKEISGDKVFELYDTFGFPIDLTALILSEK
GYTLDEKGFETELQKQKNRSRAASEMTTEDWTILVDDSIEEFVGYDTLETTVKLTRYRKV
TSKKDGEMYQLVFNLTPFYAEGGGQVGDKGYLQSSQGDIVYILDTKKENNVIIHFTKNLP
KNLDDRFTASVDAKQRHRTECNHTATHLLHQALREVLGTHVEQKGSAVHSKYLRFDFSHF
SKMSVDELRDVENFVNARISGKLPLIEKRNIPMQQAIDEGAMALFGEKYGDTVRAIKFGK
SVELCGGTHVKNTSDIWHFKIKSESAVAAGIRRIEAITNDAVKDFYFENNRTLFEVKDLL
NNTKNPVKAVNTLLEENSSLKKQIEQLLKDKANNLIGDLKNQLQEINGVQFLATKIDLDQ
NGIKNLAFAIGKEHKNLFLLFASSVKKDKAMLTCYISKELANERGYDAGKVVRELGKLIH
GGGGGQNFYATAGGKNPGGIPKVLERAKDYLV
>FCMOIPGL_00176 Murein DD-endopeptidase MepM
MAKVKYYYDENTLSYRKITVKKSDSYKRVFLIFLAVIIIAFIGFVGFSQIIMSPTALAQK
RELENLKFHFELLNKRLEESSAILAQLQERDNNIYRSYFEANPITEEQRKAGFGGVNRYK
VLDGYDNSKLIKDITKEVDVLSKQMVVQSKSLDEIITLAKKKEDMLASIPAILPIKKEDL
TSVASGYKMRMHPILKIKKFHKGMDFTARIGTPIYASGNGKVTVASRSSSYGNVVYIDHG
YGYETIYAHMSKIKARRGQMVKRGDLIGYVGNTGLSVAAHLHYEVHKNGIALNPINFYYG
DLSLDEFAELQKSSEESQSFD
>FCMOIPGL_00177 HTH-type transcriptional repressor BluR
MYIDLPEKRYYKIGEVAKAFQVNASLIRFWEKEFAIIKPKKNAKGNRLFTQEDIVNFKLI
FNLVKERGFTLEGAKQKLKKNPEGIYSNHEIISRLEAVKAELQKIKNQL
>FCMOIPGL_00178 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MEVKNKIVIVTGAGSGIGKATAVLLAKFGATVIVSDINFEKAEKVVEEIVTNNGKSLPIK
ANVAVYKEVENLINKTIEEFGKLDVIVNNAGIGPSFLKTHESTLRDWERVISVNQTGVYY
CMKIALQQFLNQGHGNIVNIASLAGLKASPNNISYSASKFAVVGMTKSAAMEYATKNIRV
NAVCPGYTESALLDQLLNVKPEMNSVLKSQIPMKRFGKTLEIAEAVVWLASDNTKFITGQ
TITLDGGTSL
>FCMOIPGL_00179 hypothetical protein
MKKWLIPVIIIVVIVFGFYNWGKGFNNTAVELQEDAKTTWSNVESAYQRRNDLIGNLVKT
VQGAADFEKSTLTDVINARAKATSVNINAGDLTPENMAQFQQAQSGLTGALSKLLVSVER
YPDLKANANFLELQSQLEGTENRINVARDRFNEDVNVYNKHIKVFPNSLLAGMFNFDEMT
RYKANAGSENAPDVNFDFNNKKE
>FCMOIPGL_00180 hypothetical protein
MSKVEEFLTKEEEQEIISAIQIAEKNTSGEIRVHIEATTEKAHYDRALEVFYLLEMNNTK
DANAVLIYVAVNDKKFVVYGDKGINSVVPKDFWDTTKNVIQNHFKIGNFKQGIVDGILKA
GEELQNHFPYQTDDKNELSNEISKG
>FCMOIPGL_00181 hypothetical protein
MKKVFSSQFLVISKKVLLIFTFLISQITFSQGFEIPEKPKFQTSVYDYIDLLSVSQKQNL
EGKLVRYSDSTSTQIVVAIISSTEGENINYLAANWGEKWGIGDVEKDNGVLIVLAKDDRK
ITISTGKGVEHLLTDFQSKRIIDRVITPEFRKGDYYTGLYLGADYIFRTLNGEFKGSRQE
ESEGSDSGVIVFILIIIIFFILISRGNKNNRGGGRNNRTGSLSETIFDTILLSSLGRSGG
GFGGGFGGSSGGSSSGGFGGGGFGGGFGGGSFGGGGASGGW
>FCMOIPGL_00182 hypothetical protein
MKKILTFFTLLLFMSCQNYGQLNLLADLSNELNEVSGNEVLNNSSLIWMINDGGNKSKLY
AVSKKGKIKKEINIKSKNTDWEDLTSDKKGNIYIGNFGNNTSSRKNLRILKIDKKYLRKK
NAKVKEIEFEYEDQDKFPPKKKELFFDAEAFFYFNKNFYIFTKSRVEGEYGKTSLYKFPA
KKGKQTARLIGKFNNGNDLECWITSADISSDGTKVVLLSQKNILVFTDFKDDNFLSGKVK
KIELEHQTQKEGICFKDNNTLLITDEKAHGEGGNLYELKIDVQN
>FCMOIPGL_00183 hypothetical protein
MKKEAQKTGEIDDYLQNHYIHRSNWLRAAVLGANDGILSTASLAIGVAAASDFREPIVLA
TLAGLVAGALSMAAGEYVSVSSQTDVENADIERERIELEEMPELEMQYLADIYEKRGLKK
ETALLVAKEFTENDALAAHVRDELGINEINQANPIQAAFASGAAFTIGGLLPFLVTLFLP
LEYLEYSIYGFAIIFLIILGALAAKAGGSKIGIAVLRITFWGTVAMGITALVGHLFNVNV
V
>FCMOIPGL_00184 hypothetical protein
MTQTAVIFGSLFGFTAVIFGAFGAHLLKKKLTTDQLQSFETGVKYQMYHAIVLLILGFNL
DKNSTIDTYIINAFVIGILLFSFSIYGLVISSAKNKKIKILGPITPLGGLFLVTGWALLL
FKFIV
>FCMOIPGL_00185 hypothetical protein
MQIAENQNLELKKNDSKIDHTFYLIGDAGNSTLKKDSPALKYLKKKIKGASKNSTLLFLG
DNVYESGIPKKKKSKKYKLAKRRIEAQTDIAKKFKGNAIFIPGNHDWYHGLDGLKREEDL
VEKALGKNTFLPENGCPLTSVDISKKIVLIIVDTHWYLTNWDNHPTINDNCEIKTRNKFF
DEFEGLIKKARGKTTIIAMHHPMFTNGSHGGKYSFSSHMNPLPILGSLKNLIRKTSGLSN
TDLQNKNYNELKKRIVTLSQENDKTIFVSGHDHNLQYIVQDNIPQIISGSGSKTKATKLS
GGAKFTYGKQGFAKLDVFKDGSSQINFYTVKDNKIVYQAQVYSEDEKETFNTFPLQNITE
KKASIYTQNEITKSKLYRFLWGERYRKYFGTEVIAPTIDLDTLFGGLKPIRKGGGHQSKS
LRLKDKKGREYVMRALRKNAVQYLQAVAFKDQYIEGQFDDTATENLLSDVFTGSHPYAPF
TIGKLSDAIDLYHTNPVLYYVPKQPSLGQFNDDFGNELYMIEERTDSGHGDKASFGFSDT
LVSTDELLLNLNKNENHILDEEAYIKARLFDMLIGDWDRHEDQWRWAVFKEKNETIYRPV
PRDRDQAFSIFGDGALLNTLTTLVPALRLMRSYNEELKSPKWFNLEPYPLDMVLISMADK
KTWDKQVNFIINNITDDIIDEAFKEFPDEVKDETIQEIKRKLQGRRHNLQKISDAYFYHI
NKFQVIRGTQKDDWFEIERLQNGQTKITGYRIKNGDKDDIFHQRTYNESETKEIWIYGLD
DEDVFVVKGNGKKLIKLRLIGGQNNDKYKIKNGKKVIIYDYKTKKNTFKTKNARIKLTDD
YQTNVYDYKKLKNNQNILTPTIGFNPDDGVKIGFANTYTTYGFERNPFTAQHTLSGSYYF
ATNGFELNYSSEFANIFNRWNLGINATITSPNFAINYFGLGNNSINLEADNLEEEEYNRV
RIRKFIVGSYINWKSNLDAEIKLAVNYQTFKVENTLGRFLNSELEPNNPIFKSKEFINTE
ASYHFENTDNPAFSTMGMKTDLIMGYTTSLNNAGNFGYLIPSISFDHKLTANGQLVLATK
LKTHHTFGNSYQFYQAASIGGNDGLRGFRNQRFTGKNSFYHSTDIRLDLRQFKTSLIPLN
IGVFGGFDYGSVWGQQNTTFKNTKFNTSVGGGVFFNAANMMSGNISIFNSSDDVRLALTL
GFAF
>FCMOIPGL_00186 Purine catabolism protein PucB
MKHIAILVLAAGKSSRMNSIKQLEKINHKTLLDITLEKIKSMYSDDIYCVLGANADEIKR
KITSEKIQFIENKNFENGLSSSIISGINYFKKENLNFDGILILLADQPAIESSYLRSLVH
LFLENHDKIIASNYGNQLGVPALFPQKYFADLLLIKGDKGAKEFINQKKNEVIYPKLTTN
FFDIDTKEDLELYKNS
>FCMOIPGL_00187 putative xanthine dehydrogenase subunit A
MNHELKEIVNKAIVNQQKGLKNVLASVVFLEGSSYRKPGVRMLISEDLTSVGAVSGGCVE
KEIIHRSKSVFSDNKPKIITYDGRYKLGCEGILYILIEPFLISNEFITQFSDANSKRETI
KIESHFTKENEAFGNFGSVIIFNNKEQFQFSKFFEPKNKKDVLIFSQIVQPSFRLIIIGG
EHDAVKLCKVAATLGWEIDVITCVKDSKELKDFPGANSVNGNSAETIQFTNIEENTAIVI
MNHSYVQDLKYVIKLSKYKPKYIGILGAPNRRERLFNELFEFVPDISDEFLETIYTPAGL
HIGAQTPEEIAISIVAEILSVIRKKEPFSLRNLTGKINT
>FCMOIPGL_00188 Outer membrane protein assembly factor BamA
MKKNYKNYSLFIIICLLIYSCGIKKHIPENKRLYTGASIEIEADTTVEKIDELKTDLSSI
LSKQPNTKFLGMHLGLYYFYKNQQEKTNFLNRWLYKKFGQKPVYQSDINELENKKTLRNK
LENYGFFYSRINSEFTEKEKEAAITYQLKIPAPYKIATYKIDSMVLPIYNDVKSLTKASI
IKENMRFDLTTLKLERLRLDSELKQKGYYNFNSDFLLFEADTNRSNTKKFDLFLKLKANV
PKKATVPYKIKNINIYPNYNLNDSTEIKKNRFKDKNYLQDTVFFAPKYLDDFITLKEDEF
YNPLTSKNTARRLSSIGTYKFVNIQYKEIKNALTDSIGSLEANIFLSPLTKRAIRTELQA
VTKSNNFAGPELAVTYSNRNLFKGGETLNISTNIGYETQISNGSISGLTSLELGLKGEIV
FPRVIAPFAINKDYFDYSIPKTKTSISATYLSRSDLYTLLSGTALFGYTWNANKYITYEF
NPISVNYTRLSNTTAEFQEILDNNSYLESSFDQQFISGLTFSFTYNEMINSAKKQQLFLQ
TTLDVAGNSISLFDKKTDETNKFLGLEYAQYAKADLDFRYHYNFGNKNKQTIATRLFAGY
GYAYGNSDIVPFVKQYYSGGPYSVRAFSIRSLGPGTYNGTNTDDDSSYFDKTGNVRLEAN
LEYRFPIVSILKGAIFADAGNVWNTVSNPDFNDDEGNITDTFTSNFINELGMGAGVGLRV
DVQGFVLRFDLAAPFHDPSLEEGERWNFNIDKPVFNFAIGYPF
>FCMOIPGL_00189 hypothetical protein
MSKKTRNKKHKFLRRFLRIFLAFLFLICLLILFIRSPWGQDIVVNKAVNYVSNKTNTKIS
IDKLFLTFKGGLQLDGLYLEDTKGDTLVYSKSLEANLPLWSMIRGTSVGIDDLKWKGLRA
NIKRDDTISGYNFQFLVDAFADGETTTTVKETDKEPLNIVLGNLNLENINVVFNDEVLGI
NSHFKIGNLTASIDKVDLEKMTFNVDKIGLSDTNIKLIQQSVAKDTSTAASVSPVLSAKN
ITLKNVKTYYENSANNLIADVNISDFYTTIPEINLAENQINLSTLQLKNSDILLKTTSTN
STVAETTTNNNTAFIWPDYNIQIDEIDLDNNKIQYFVNNEKVVKNIFNPNAIALEELTLK
ASDIFLKDKKAGLQMSAFNFKEKSGFRLKKFTLNTEITDTELKVSELNINLNKSKITGFA
NANYKSISQLISSPENTRIQLGIPSFSIFLEEIFTFQPSLKQNEYISKLSKKELFGKVNI
NGVLADLNISKTNLNWGFATKMSLDGNIKNSTNPDKLQLNIANFKAKTKRNDLLQIIDEK
EFGIHLPEDIVITSSVNGSLHNISTKTTINTTQGLAKIKGNFKNEAKIKYDVIVNIENYN
VGDLLINPNFGELSVTLNSSGNGKNLQDLDAQLATNISKFQLENYVIKDLNISGNLKNSK
GKITTTYKDKNLNLDLNTLVNLDTINTKATLNLNLIGADLQALGLMQRKVKSAMELSLDF
TGNSEKYAVKSNIKNGVIVYNNQTYLLGSLAAKAFVDKDTTAVSINNKMIDLKLESNTDP
QTFSTALQRHVSSYFFKDSIVSDTIKNPVHLILKAKISQAPLLNEVFLVNLKDLDTVNMN
VDFKEKNQKLTANITAPHINFSDNKLDSLSFSMHTNKEEFNFNIGFKNITAGPLNIPKTS
IEGNKKDKDLLLNFLSSYQGNKLINVNSVITKNNNQLKFTIHQDSLLLNSNQWKIPKTNA
ILFKDNKLTFSDFKISLGNQSIEITDKISSISKDHIALNYANFKIDEIFNYLSPDKEIAT
GTLNGNFILEQPFENTGIIADLNISKLKVLKTDFGKLNIDAKSLENGKYDFNVSLKEGDV
DLDIKGDYLSENNDANLNLDLLINSFKMKALNTLSFGEIKETSGSFSGDFKITGQTSAPK
YNGNLKFTNATFNVAKLNTKFKLQNETLNIDNKGLSMSNFTILDAENNSLVLSGAIKTKS
FINPSFNLDIKAKNFRVLNATKEDNESMYGKVTFNADAKLTGDLQIPKLDTKLVVGSETD
ITYVLPSTYTNIEERDGVVAFVNRENPDAILTQQQEETATITGFDIKALLKIDKQAAVTV
IIDEETGDNFKVSGDGDFIFLMNPNGDVSLTGAYEVASGQYQLNLYNVVNRKFVLVPGSR
ISWAGDPFDAKLDIQTKYTLKTSASDLMASQISGEDASVQNKYKQVLPFNVYLNIAGELL
QPKISFNLDMPEDQQGAISGQVYDRVQQVNQQEDELNKQVFSLLVLSRFYPDSGSDGSSG
GFATIARNNLNDAVSGQLNSFSDKLLGSSGVQLDFGLNSFTDYQGDTPTDRTQLDVAAQK
KLFNDRLTVRVGSEIDIQGSSQTGEESPLIGNVSLEYRLTEDGRYSLKGFRKSEFENVID
GQTIVSGIALIFTKEFNEFQQLWDAILRSKKVEKSVNKVEKSENKK
>FCMOIPGL_00190 hypothetical protein
MNTVKLEIGNKKGLKLQAYLELPANEKPNQFAIFAHCFSCNSNFNAVKNISRSLSNHGFG
VLRFDFTGLGRSEGEFAESHFSANVEDLLAVNAFLEKNYKAPSLLVGHSLGGAAVIVAAS
KLKNIKAVATVGAPATVGHVTHLFSHGIEKIPEKGDVEVKIGGRPFKINQDFVNDFGKTD
LPKIIKDLRKPILVMHAPFDNVVGIENAHEIYHNAMHPKSFVSLDDADHLLSKPKDSIYV
GNMIGTWVERYFEPEENNMISTEGEQLVGHLNLLEDNFTTSIQTKKHSFIADEPVSVGGD
DFGPSPYDFLSAGLAACTVMTLKMYAAQKKWDLQEVFVYITYSKKHSDDLDIAVNKPTRF
DHLKKKLKFIGNLDEKQTQRLKEIAAKCPVHKTLQSDIIIETELV
>FCMOIPGL_00191 D-threo-aldose 1-dehydrogenase
MQLGLGTAALGRPQYINVRTESCDNSNLAEFRKQSFAVLEEAYNLGIRYFDTAPGYGLAE
ELVLEWLQTKNNTSIKIGTKWGYTYTANFNANATVHEVKEHSLAKLKEQWKFSKQLLPYL
KVYQIHSATLETGVLENKEVLEYLAYLKTEHHLKIGLTTTGTNQVEVIKKGLNVLVDGEP
LFNVFQVTYNFLDQSLLEILDELNLQNKSIVIKEALANGRIFSNKKYPHYAKMYATLKEL
AKQHNVGVDAISLKYCEQTVSNATVLSGASSISQLKENLKLNSFMLSSEEIETLNSFKIS
PDAYWAERKQLAWN
>FCMOIPGL_00192 hypothetical protein
MKLNIKNTFTTALPSDSNLENSRRQVENAAFSYVKPKKTSKPEVIHVSPEMADALHISDN
ALKSDFFRNIVTGNEIYPNTTPYAMCYGGHQFGNWAGQLGDGRAINLFEIEHQNKNWKVQ
LKGAGETPYSRTADGLAVLRSSIREYLCAEAMFHLNVPTTRSLSLSLSGDNVLRDVLYDG
NPAYEKGAIVSRISPSFLRFGNFEILAARKDIKNLKKLVNYTIKHHFAHLGKPCKESYIN
FFKEVSERTLKMIIDWQRVGFVHGVMNTDNMSILGLTIDYGPYGWLEGFDFGWTPNTTDR
QHKRYRYGNQPNIGLWNLYQLANTLYPIIEEVEPLNTILEQYKVDFEKQSLQMMKSKLGL
VVSDEEDVKVIQELEDNLQLVETDMTIFFRNLSNFTDEKSGLELIKEAFYDAENVSDEVK
NKWTTWFKKYTNRLALERNSSEERKTQMDLVNPKYVLRNYMSQLAIDEADKGNYALIDEL
FQLLKKPYAEQPENEKWFAKRPEWARNKVGCSMLSCSS
>FCMOIPGL_00193 Peptide methionine sulfoxide reductase MsrA
MNKNLQIATLGGGCFWCTEAVFLEVKGVEKVVSGYSGGNAPGKPTYREICSGLTGHAEVI
QVTFNADIISYQDILVIFMTTHDPTTLNRQGADKGTQYRSVIYYQDEIQQKIAEEVVKQI
QPYYDAKIVTEISALNIFYEAEEEHQNYYRQNSQQGYCSFVIAPKLTKLRKLHADKLA
>FCMOIPGL_00194 Peptide methionine sulfoxide reductase MsrB
MLTWKEIINFSVKGNPTPDKRVEKSEKEWRAQLTAEQFRITRHKGTERPHTGDLCSIYDE
GQYNCVCCNTPLFDSTIKFDSSSGWPSFTQPIKENAIKYHKDISFGMIRVEVMCNTCDAH
LGHVFPDGPEPSGLRYCINSESMILDKK
>FCMOIPGL_00195 hypothetical protein
MLGKKLQLIYFKKAFLFTKVLILFLLFSSQVHSQNVAINEVMSSNDVTLADEDGEFNDWI
EIYNYGTTAVNIGGYGLTDDASDPYQWVFPTYTLEPQEFLLIWASGKDKTIPSQPLHANF
KISSGGETIILTNSGGTEINNVPAIAIATDVSYGRQPDGTGSWEFFNTPTPKLSNTGTVN
AATEKIAINEVMSSNDATIADEDGDFNDWVELYNYGTTSVNLEGYGLSDDNGESFKWTFP
SITIDPNQYILVWASDKDISVANEPLHANFKISSGGESIFLKNPSGALVSGSPSVVLDVD
VSYGRQPDGTGDWLYFDEPTPLASNTSSGLTEIIKPPVFSHASGLFSEPFNLSLTAENEG
AVIIYTLDGSEPDINNLNGSSFQYKNDYPYDIGESFGEMLNQSYQSFSYTGPIEIRDRSN
DEDVLARKNTVSADIYIPPVKVRKATVLRAKAFLNGKGSRTRTRNYFIWPEGNPYDVPVI
SLTTFEENLFGYEKGIYTSGKTFDDWRTAEPNGNQPGNAQFSNYGQDGREWEREVHVQVF
NENLESILNQDAGIRIHGNTSRADIIKNLRIYARSEYDEDNEFELDVFDQQIPDSPVPYN
NTFKRLMLRGNGSGGQIANDMVFSRLMQPFFNGIMRIKTAVNFINGEYFGITAIRDRFDV
NHIANNFGLDSDNVSIVSCVGSCVLQDGPDDRDSNPERVLRYLFKDLKHDDLKSDVEYQK
VADILDIDSYIDHIALETFSEGDSYEIKFWRATNPVNDEFGDGKFRVYTQDFEAAMISRL
NWLEDFSGNSSSWQRNIFSNLIDNEGFKVKFINRTADLLNTAFVKERFDAIVNETFDVVA
PLLEEDRNRSPRLRFYEDGDKVKLLDWIQERPAIFRDQINELFEIDKTINLDLNVSNPNA
GYITLNTININSTTPGVNDKPYPWSGVYFDNIPVTLEANPMPGYTFSHWSGDASGNSSKI
TITPTDDLQISAIFTPDEDYSHLLYFWLFDDNITNDTPLESLNSTYSRNDLTAMMNYNSS
LSGYPFDANNADWRKASLERTNKPVAINYQTIANDNIAYAPEMMKGLQIKQPFKSGSLEN
NFELDFSTVGYEDIKISLAINSDGAANTIIAEYWNGSNWVSTNIINGTQSIVSDYELKEF
DFSNVSLADENEAFKVRFRFNGTDMTEDADKKVIFNNVAISAVDKNVLSADEFIKEKQNI
MVYPNPAKDKIKIFSNTTIKNVLVYNVLGKLVYKSEKLNNSTVDLSNFSKGIYFVKVFSD
GSSTTKRIVKE
>FCMOIPGL_00196 hypothetical protein
MNKALVLFINKFHPISLDEMNSVALMKRTDTKYVINISSLSKVLEKLSETYKVLEIKEQR
IMNYSSLYLDTKEFKFYHDHHNGIVNRTKIRQRKYVDSDLTFLEIKKKNGKGETNKFRIK
INDFETKLSDKSKKFISEITNEDYNLQTSLWNSFNRITLVNLKENERVTIDFNLTYTVDD
KEKKYSNLAVIELKQSRFDRKSLVVKVLKSIGHNPYSISKYCIGVANLYQNLKHNIFKPK
LLKINNI
>FCMOIPGL_00197 hypothetical protein
MDFFNIPLFDDDFFKLASIFLMNLFFLTLIIRWLYYSSSGRKDYLFTFYMISIIVFFLCF
TLKKYKVDIGIALGLFAIFGIIRYRTESIPIKEMTYLFVVIGVSLMNSFVNKKMSYLEII
FANSAIVFAIIIIEKVWHLKHEITKKINYEKIENIKPENYNFLISDLENRTGLVINKAII
EDVDFLKDSATVTIFYNNQVVKKLK
>FCMOIPGL_00198 hypothetical protein
MIRMTKNSFQTLFCLLLVSNVAFSQVDTSDFAIWSSVGIDYSPIKKLKIGVEESLRLKED
ATVTDEYFTEISLQYEVFKNFEIGGGVRFIKENDNVGKKQGYESHFRFNFDASYKYDIER
FTLSHRIRYQNKKELNLPVDEENVLKETIRFKTGIEYNIRKWPLDPSFSLELFSGIEEDV
QLIRDLSLDKFRVTFGTDYKFRKIGKFGVFYRYEESIIKYFKNETLHVLGLKYTYSIN
>FCMOIPGL_00199 Endoglucanase H
MSSFGKKYKRLFNVVLAIVIGYFIIYGLSAVSKSSKGPLAGFLENAGNMVKDFEHDNILG
KREKNREKKLAWFNDQRNNKFALLKTKKILFGASDDSKEGSYENIINLEDSLALTFPIIH
IYKAWGEGQTYEFPKNDVDAIVRIGSVPMITWEPWLEKFTQENFPKIKDLEQRNSHGLAS
VANGDYDSYLKEWATEAAKVGYPIYLRVGHEMNDPYRYPWGPQNNDPAEYVAAFKHVKDV
FDTVGATNIIWVWSPHLSYGKFQEYYPGTDYVDIVATGALNYGTSTSWSDWWTFEEIFGN
FYNQLAAFYKPIMIAEFGSLKPGGSRAKWFKDTFKNFNAKYPYVNAIVFFHYSSDGTITY
KNVDWYIKDDHEVTTAIKDALKEWPANIKQPSIE
>FCMOIPGL_00200 Cellulose synthase catalytic subunit [UDP-forming]
MNSKLRNDLWVFKEAKKVTSLDKAIFLGLTLAGLISMFNLMEWWFRAEHIENLPLFIILT
LFFGYGNIRIALIWINYLRIQKPKEVPVPEKDLSVAVFTTSSPGEPLSMFENTFKALKNL
NYPHTTYLLDDTGDLAFKELAEEHGVVWLDLPNIPGAKAGKINEALKITNEDFILVLDPD
HIVFPNFLDQTLGFFQDEKVGFVQVSQGYYNMYRSFTAQGAAEQTYAFYGPTQMGLFGYG
GAVAIGANCTFRRKALESIGGHAKGLSEDLNTSIRIHSKGWKSVYNPVIVSRGLVPEDFT
SFCKQQLKWARGVFEMLFDEFPKASKTLTFWQKVSYFSIGTYYLVGPMTAFFIFVPLLFF
TTKIGPASMDFTEFLILGSPIVLIATLIYAHAQRFMCDKKTEQGVQWRGMVLKYSCWPVF
TYAFYLSLINKKVPYIPTAKVAVKGFMSPFVKPLILYCIIFIFILIGVYIERRYYTPETE
LILTAEKTWAMIGFAMIAFIQFIGGIVAAYKSLNIKAENAWSNMIITSDKKIKIKE
>FCMOIPGL_00201 Beta-barrel assembly-enhancing protease
MNLKIANTFLLLLKNTCICLFFLYNLHSFSQEKPLNADNQKGNTTNTEQELLKKAKDYIT
KKEYDKAASFLSTNYQQFSENLTINWLYAQVLSLNNDKTQAEEKFKKAISIAPLNKDLQL
DYARFLYETGKIKKVESILSKFITNDSKNAEFLLMQANISFWKGDIKNSQKKIARIKEIY
PDTEITKSLTAQIDELTIYYINTNFEYHTDSQPLDFFAYHIAIGHYESRFLNPKLELSTY
NFSPEKEQAVILKISNQFYFDNLKLTANITGGIYKNLSEKVDWIGDISFIKKITKNVSLN
VGYSKNSVLSTIASTAFNLTKQDVFGEINYSNKLLLLNAGYNQQFYKNDNTIESIGAWIL
SQPIKFRNFNFQLGYSYNYTDSKDILFIYDNQGVGVYNPYFTPKEQQIHSGLFIVNYKPT
KKLSLEAKANYGFKATIRNPYPLQVTATSIEIGGFYDETFTPVELTGIINYSFSNRFNAK
ITYTNQETFFYKRENINLGLNFNI
>FCMOIPGL_00202 hypothetical protein
MKKLFFALVILSLIFTSCGGSTGEDTNNTPNAVDDSASTAINTAVNINVLTNDNFGVDGP
NTGSITIISSISNNGGSILVNKEGTTSDPTDDTIDYTPETDFEGTDTFNYTITDNSGDTS
TATVTVTVIPPTGPSLGTTFSVGELKYTITNVENKEVSVEKSTETGPSGALDLPETIEQF
DLTYSVTSIAEEGFAYSYNLTSVTIPSGITSIGNLAFYDSQGITSISIPNSVTSMGNDAF
GSCLSLKTINIPSGTTHLSDNIFASCKSLENITIPNTVTSIGKSIFYDCSSLNNVTIPDS
VKNEDMGTAVFGLCVSLTNVTFPSSFTTIPNETFYACNSLESYTIPSNITSIGSSAFYEC
SVLKEITIPATVTSIGESAFGFCVNLTKAEIPNNFTSLPDNMFYECPKLKDFTIPSAVTS
IGNAFFYGCTSLEEISLPNSITSIGDSAFGNCFSLKNFDLPSNLTTIEATVFWNCSSLTE
INIPSGVTSIESGAFGGCNSISEITIPNGVTSLPENTFYNCSSLSVINLPDNLTAIGKTA
FGLCNSLTNFSIPNTVTSISEQTFYQCTSLTDVNIPNSITSIGNSAFYNCGSLKNVTVDI
VTPLTIEANVFEYVTMSNMNLKVPSASITTYKATDVWKEFGSINAI
>FCMOIPGL_00203 hypothetical protein
MSTLLVDAEKYVFDLLNKKLPTIYVYHNLVHTQNVVEKASKLAKNLKVDEISYENLLLAA
WFHDTGFIKGVENHEDESVRILKRFLTKNNVDETRIEAISNIILATKMGFEPTNDLEKII
IDADCAHLGSKNFDNKTALLRKEWEIAENKMYTDVEWANTNLQFLTQDHRFYTDYALKNW
SKTKSKNIATLLKNQKKVKQENNKFNQKKEALEIKKNKSEVPERGVETMFRVALKNHMTL
SNIADTKANILLSVNAIIISLALSTLLPKLDNPSNHYLILPAVTFIVFTVASIVLSILAT
RPNITGGKFTKEDVANKKVNLLFFGNFHQMKLNEFEWGITEMMQDRDYLYSSLTKDLYFL
GLVLNRKYKILRITYTVFMIGIIVSVLAFAVAFKLQDSGVSL
>FCMOIPGL_00204 hypothetical protein
MKIVLPNSVSEKELPLQLNISFQKIFVLFEKYANKEFSNHPYHASAREMVNIFKNNPELI
EGFSDESLLEKHKEQINLLLEPLFPEPLLLNEIKAASVPFSFTSFKFTERFKNILKNAGE
NYELNVRNFENDDMYIMACTFILSFLYDFNVDLKRPFYFNIPDNTTGTMKYYRATFNADF
SDIKATENAPTITDKDFKELLNNFDNIELWKEKFPPNSYIFKGFGLINLFDVTAEEVLSS
IKANLLAGDTQLLPKLQNNLRDFYSIKDLKLGYSIFDNINTKICETVVKKSNSIILNNLS
EIKCDSNYFCSGILQKVFKDHETFIISDVEKYGLSTNKNPFYQNLKLLGIKSIILIPIKA
TNNGDLALLEIASPRAYDLNSVNINKLKDIIPVFEAAVKRTAEERQNILEATIQENYTSI
HSSVKWRFYQAAEQYHVDSQTNENAKLDEIIFNDVYPLFGQSDIKGSSEARNNAIKEDLI
TQLSLAINVLKDACKSEDLPIYDELMFRVAAYLSEVKKGLNAGDEILILDFLKREIYPIF
NHIKTINIKLSEQVDIYMKRIDSELGVVYEKRKEYENSVNLLNDKLAKFIDKKQIQAQEM
YPHYFERYKTDGVEYNMYIGQSITKEDSFDDIYLYNLRLWQLQTMCEMENVAFAERKNMI
ADLQVASLILVHSNSMAIKFRMDEKQFDVDGAYNIRYEIIKKRIDKANIKGTNERLTVPG
KIAIVYSQEKDALEYLKYISYLQSKNQLGKVESLVLEDLQGVAGLKALRVEVIYHKDFNA
KNTITFNDLIKEIEN
>FCMOIPGL_00205 GTPase Der
MNSIVAIVGRPNVGKSTLFNRLVQRREAIVDSVSGVTRDRHYGKSDWNGKEFSVIDTGGY
AIGSDDIFEEEIRKQVKLALDEADLIVFVVNVEDGITPMDAEVAKLLRKVKKPIFTVVNK
VDNAMREPDAVEFYNLGLGDYFTIASINGSGTGDLLDALAAEMPEPEPIDLDAEELPRFA
VVGRPNAGKSSFINALIGEDRNIVTNIAGTTRDSIDTKYNRFGFDFNLVDTAGIRKKSRV
KEDLEFYSVMRAVRSIEYSDVIILVVDATRGFEGQDQNIFWLAEKNRKGIVILINKWDLV
EKETNTMRDFEAMVRKQIEPFTDVPIIFTSALTKQRIFKAIETAVEVFQNRKIKIPTSKL
NDTMLEIVKMYPPPATKGKFVKIKYCMQLPTLTPQFAFFCNLPQYVRDPYRRFIENKLRE
IYNFSGVPITIYFRQK
>FCMOIPGL_00206 hypothetical protein
MDEKLNMLIETRNSEVFLRPRFTIDLDENRDKILQDFINEFKKEDCVFLGNIVDGHIFIS
VSKKDEHFWSPQLHLEILETSENKSLLKGLFGPKPHVWTLFMFVHFVIGVSFLGFAALLY
TNISLNESVFFPLIMIIFLPLIWVLLYFLGKIGKNTGKNQMKKLHDFMMKVINN
>FCMOIPGL_00207 GTPase Era
MTHKAGFVNIIGNPNVGKSTLMNALVGEKLSIITPKAQTTRHRILGIVNEDDFQIVFSDT
PGIIQPAYELQSSMMDFVKSALDDADVLIYMVEVGEKELKNEAFFNKIIHSEIPVILLLN
KIDKSTQDEVEEKVEYWKIKVPNADVFVISALEKFNITAVFEKIKELLPEGPPFYPKDQL
TDKPERFFVNEKIREKILMHYKKEIPYSVEVETESFIEEENIVRIRSIIMVERETQKGII
IGHKGAALKRVGAEARKDLEQFFEKKVFIELYVKVNKNWRSDKNQLKRFGYNQN
>FCMOIPGL_00209 hypothetical protein
MSWLFSKNKEYQDYYNEAYLLAVFSPKENLDRLKKKYQSMKKSASNNKKMKALMSGFMAG
LEQRNRSRLETLEKMKSKEQKQNEREL
>FCMOIPGL_00210 hypothetical protein
MFNKKNKIMTPEQEKSHILQGFNNGYMLSIYNPKILDRLLTLPHISAYKEGLEKGIATYE
KHKSLLLNSRAKLQERKAKLAKIKAQEKSIEKDEKER
>FCMOIPGL_00211 hypothetical protein
MNLDVICLETEAYYRLVQEIVEMVQEKEKVEELWCNGERAREILNIGKTSLQSLRNNQEI
IFSQPSRKTILYLVSSLYEYLEKNIANY
>FCMOIPGL_00212 hypothetical protein
MITILLFLLFISIFFPQPIKALFDTSVSIIGKILSPLATGFVKIIEVVLEKSIQIIGSIF
NGLLKIIVMVFDRIRF
>FCMOIPGL_00213 hypothetical protein
MSQRTFFDYLLNPEKVSSHGSAEFCGFWEQRKLLKPSNSGVYIANDLRLNQDSSYKNLIL
ISPTGGGKSTRFVLNQALRKWGSNVSLIFFDPSGEIRKLSETWLIKQRFEPIYLDLTNPT
NSAKHNPLLKITNKSTAKIMAESLIGVVYENSKGDQFWTQSSISILTLLILGVVLKIPVE
NRSLAFVNRLVNKMGHADEEINALMELALNEDDFDEYCSFMAGSQKVKQSIIATVKTALY
IYSEETLTTVCSESTFSFTDLRNKRTVLYLSQEEHKMPYYKGFWNLFYRQLFESLMTEST
GNAVYCFMDEFANVGAIPNFETIITTNRKKRIHLSLILQSFEQLTSVYNSKSKIIFENCN
SKLFYGGLSYESSRIVSDMLGVKTESYSAKGVFKRNQPMNRISRNLMTPEEVRTQLKDDE
CLFIHGSYKPMKLKATAFFKNRTLKNRSKL
>FCMOIPGL_00214 hypothetical protein
MLIKMLSRSLSRPNLPQLIRYINEGKTHFDNEKNFILRHNTLGKNTKEVAEDFKQNNKFI
KQGKQKRIGVQHIILSFHPKEKLFLNTEKLFGFAQKFSELMNFNSAITFGRVHFEKENIH
LHFAVSASQFGNGKSRRISKQRLKEIQIDMNRYQQKFPELKHSLLYLPELEKSKKSTLTG
IPLPEKMKETDGSIRAKKRGQKSLLENIKEKLISIAKKYPKKEDFLKSIEKEEDFSVYTR
NGKPTGIITETNKKFRFTRLLIDIENLKKEVRLYELEQLKNRDQERSIEKQ
>FCMOIPGL_00215 hypothetical protein
MNLFSMMNFQQYISHFSIKPTTLEEWKEARKSYRKYYQKEYLKTYRNNSKRIEILFSNEE
YETIKNIAKKYDEKPTTFIRKSSLAYIQSEAFLPINENIEEAKMLIRKSSNNINQLVFMS
HSQKNISEGRFSELIKQVNQLENIVNTLYVSPKINFKPIHLIPNLNAD
>FCMOIPGL_00216 hypothetical protein
MKLKNQHIKNSDLIYKARNFAFEAHAKEEQRYGEHAYSKHLSDVFLHLISMGYSEPEYLA
TALLHDVLEDCPNVTRLEIKNLFGIDVLNNVIALTKLSNGEPNYALLNKFPVAKAVKIAD
STANLGQGLLEKNSKSAKYIKRFPTYQQQLRIEGEYENLWNAMAERIIVYEALVLV
>FCMOIPGL_00217 Molybdopterin-synthase adenylyltransferase
MDYSRIIEAVDIKLLQRTHIIVVGAGGSYSLVCSLARTGIGKITVLDFDTVEASNIVRQG
YNQTDIGNYKVNALGKAVSQINPDTEYLGITKNFHDMNETELDTIFKEADLALFLTDSFK
AQSFGNILALKYMIPAIWAGFYAKSRTAEIFFSIPKYTPSCFRCCCSYRYLANKKEEIKV
SSNCNTIFHSQHLDSFIGFIALAILHKNHLKRKNDFEFASFFQEMKNEDGKINYNFIQFK
VHPLGGNKLFDNAFNNVGMNAQNFNSYWQRIEAEIPDNGYNTCPDCKGKLQQMIKEK
>FCMOIPGL_00218 hypothetical protein
METKKFKITQSAFDEIKATIGNKPAESGGLLFGSRKDFTVTRFLFDKNSINTRSSYTFNT
GYLNPIIKKWWDEEELELLGFIHSHPYGLGRLSQPDKDYFASQFKNIDVEKFLTPLVFSA
KDGGFKFIPLAYNKNGTVDTLELEIVTNSNEITKKKKKSTRKKKKINNYKSKTVIKINNT
FKVEPKTIPLKIDEIKKETEERVHKTILDSFNFSQLYQVIFTCFLIILLGFLIVLIPVFY
KYIIQQLLN
>FCMOIPGL_00219 hypothetical protein
MKFSEQITKGTLLTYQVYKYVAKNGSIFKFSYHKVGNHFEIDIHQQPSYEDRPNSSLICH
YLSSSRDATRRICITVGSEPTNLQRAKQISAEWADLTCKYIATGITIDRQVQMRN
>FCMOIPGL_00220 hypothetical protein
MKPTIEQLTSAILSNKEFFQNIKLPVPQKYGTFYQCRSYAKFCATRIFNENFKDNKSEEV
H
>FCMOIPGL_00221 hypothetical protein
MPIMRSYSRHELTSKEPVKELVLVTIIQVAIFLGFGIFCLVISS
>FCMOIPGL_00222 hypothetical protein
MDKKLNSNGIYHIKPNFHEPSEDSVNEFSGIPIPTTEASEWLNPEKLQIIHEKLNHKILN
SNNESYELHGIQGFIDFNTDAVFRVLNHSVHDMLSRRGGKGDVEFDVPQALKDNNYEKLK
DINHYIIVFQGIYNKKLIRYRNMTSEEFFKKNRLS
>FCMOIPGL_00223 hypothetical protein
MPNKAVYIEELRKRVISKTKEIGGFNKDENVFFVTPANLLIKLEEYDYDCSKGIKESYKI
LESNIKKCFKSINYKAVFEFAELIDKETKEKIKKTDLIIDSCIISSDTFQRFNKINGTKG
LDNKTFDYFSFYLGYAGWGGFQNNITIADCFMLDMDSPNIKLIFSKFDINGYKESLKSKE
KINYNKREQSDFLDIEDVEIKPPKIGDVLAAQMEEEDEEEKNTASIYMKIYEKSFLNETE
KLRVAFKENLSKGNDPFF
>FCMOIPGL_00224 hypothetical protein
MSALKIDDYLFQVLNFYFQEKEDLNIRSQKIALISGLNLSFIKNYSKCKEDYLSQLILRN
DEDISMHATIGLFLGVLCNKAKESSILSSLVQIKRIQNTILEMLNYLIVQLKTGYQTERA
PMLLKHFNDHFKWFLPDVIDDEYFSISIPFNNIKFCCYGENFYNEGVVNTKNIKIDSDLK
YIFSLTNKKIINNSKKSKGVYFYLDQLFTATLNHNKIENIGLVLKEKIISNVFNFTVELQ
KTIKSSYFSGIILMGKNKSELALNDLKNDKYINNSNKISHIIKCYNDLNRYEEAIAFSLE
NEKIEDRIDYYALIGHAYYKNSDYTKAIYYLEFTLQSKFDLLNDDNKSYVFETLGLLYYK
VGDLNKSKTLFKGYLEKDNNKSDYALYFMAFLLQKESNYKKAIELYGLLIKRKYREKKCL
YDLFECYLALNDFDNIKSTISRIGEIDDCLNDFCVFLYYKKNEDYKNMWLILEDLKIENI
EDTKILNDLGIFYNDEFGDSKMARKFFKKAYKLKPNIVVYLENIIQTYFSEMVFIASLKS
FEILEEIKPFLIELEKQYGKGDKYSLYKFQYHFYRSVYLNIDEFGIAKSYHKDKEIVATV
FGKKITGKSPININQIQNTTVEDLILQFKTGRVIFPFYSKEVLKRIGITKIESFSFTLFI
STIFKNFYNEEKIGYVNKIIDENSMISVCEYLRNDSIDKSYIGFLYLLEICFFNSNLIEG
QEFIKNNLREVSYLLDNFPSEFSFKIVEGDIPYIDLNENYLKNFKNRMKYSLNSIMR
>FCMOIPGL_00225 hypothetical protein
MKTKREFVFVQKALFSPISKSDFDIGKGALVDLELVTEALAEFLKLEYIKDSTCLSGNVL
RLFQLRKVDFINREFQE
>FCMOIPGL_00226 hypothetical protein
MKYYAYIRKSSEDKKRQIQSIPKQYKWCKTEAKRRGLKIAKFFEDSSSAHKLNRQGFKDM
IAAIEKSEEPIGVITWKISRLARNPIDEGVIKYAFMRKKITHILARDREYRENENQIIMG
VDFGQATQFSIELSKDVKEGMNKKVSSGYRPVKAPYGYVNDPVGLKGEKKIFVDDKYFKP
IQQFLKSFATGIYSVPELRKKMTEEGILARSNKPFSNSSLYLILKRRFYCGEYYWQGKLI
KGKHKPMITVEEYEKIQFLLGREQKISQSKYQNYYSGFIKCSRCKSFITGYSKTKLNRFK
GVSTYHYLKCVNKDKNCTQKPLTRAKIDSEVLLILKGLTLSESIIDFVLVKLKEVSEQEE
NQDAKKIQLLIRRNTEIENEITVLGEKLIKGIIKDDLYLKMNQKLEEELSLIQQRIKNQK
KQTELDFDKVRSLFEFTLHAQEKFQSGTFEQRKKILNLIGSNFLINGEKLSIELSLAFSI
IKKIKHLFDLENRRIELNYNRSSKGLKPVLCTDSLVWSSLRERLRTYFLENIGIESTLEN
KI
>FCMOIPGL_00227 hypothetical protein
MSTTRNISEKKLKKQLQKVLAENPNTVKACVIQEAFDYHNITDFFEDLLQNGCSSGMISS
LIYYRDTEKFFDFHYEEIMDLKTEFEESTGEVMHIPHQLKNHLAWFSFEQVAYDLADFLG
LEI
>FCMOIPGL_00228 hypothetical protein
MSLNNNIFKEISLDEEASIWKGKLPIQFDVFLNDFDEIWNLHPQDFHLVRMFGKMIPTPR
WQQAYGKNYEYSGSLNNALPIPDFLNSIHKWCKSNIDERLNGLLINWYDGEQNHYIGAHR
DDEKDIIKDSVIVTISLGEERIFRMRPWKKKGFKDLLLAKGDIIILPMSVNSKWTHEVPN
FNKYKGRRISITLRVFNN
>FCMOIPGL_00229 putative type I restriction enzymeP M protein
MTLDTQSLQPIINFIWTVADDVLINKYLENQYQDVILPMTVLRRLDLALEPTKKQVLKTH
NEFKSKMDNLSGLLTSKDHGSGLEFYNTSPYTMKMLLDDPKSIDTNLLDYLNGFSENVQD
IIQKFKFRNQLETFEETGITFSLLEKFCSPKVELSPEKISPMAMGYMFEDLIRRFNEKTN
AAAGRHFTPREIIELMTHLVYLPVKDKIKKGTFLVYDPCAGSGAMLTQSKKFATNPEGEI
KSKASFHLYGQENTGEMYAVCKSDMLLKGEDPDKIQFGSTLSKYGFDPNLKFNFMLTNPP
YGTSWKEDQKELNVGTAKKIEINDTRFNLEIKNFKGELEKKCLTTRSNDGQLMFMLHMLS
KMKDPKDGGSRIASVHNGSAIFTGSAGSGESGIRQYILENDLLECIIQLPNAMFYNTGIA
TYVWILSNNKAKERKGKVQLINASSDKFFSKMRKALGSKSNELKPNHILDIQNIYFDFEE
NEYSKIFDNEDFGYYQITTHQPAKDEKGEFIKDSKGILKSDKDLKDTENVPMKENIEDYF
AREVLPFAENSWYDKKKMKVGYEIAFNKYFYQYKPLRPLKDIAGDILALENETESLLKEI
VN
>FCMOIPGL_00230 Type-1 restriction enzyme EcoKI specificity protein
MKRYSKYKDSGIAWLREIPEQWRIESFKNILKERNEKNNPIRTKEILSLSINKGVTLYAE
KTTNLDRFKDDVSKYKLAHKGDLVLNSMNMIVGAVGVSKYFGCVSPVYYTFYGNNSDAYT
TRFYEYLFRCKVVQSVLYSLGRGLIAIDRGEGKYNTLRLKISRDDLRSMRLPLPNISEQI
ALVNYLDFKTEKIDRFIKKKKQLIVLLNEQKAAIVNKAVTKGINPNVKLKPSGIEWLGDI
PEHWETKRMKFLGDAIIGLTYSPSEMVDEGEGTLVLRSSNVQKGKLAYEDCVYVTTEIPE
KKRTRVGDILICSRNGSIKLVGKNALIDEKASNESFGAFMTVVRSPYFEYLHYYFNSASF
KAQSGMFFTSTINQLTTGVLNQIIVSIPKNIKEQNEIVSYIKEETSILDKTISTIEKEIT
LVEEYKTALIAEAVTGKIDVREFEIPNTEEPLAMVAEEAISYNKVD
>FCMOIPGL_00231 hypothetical protein
MSELEKIPNFVIFQTGKGKVNIEVYFKDDTLWLTQKLICELFEKSKSTISEHFKNIFADG
ELNENAVVREFRTTAKDGKNYTTKYYNLRAVTAIGYRVNSTRAIEFRKWATEILHEFIIK
GFAMDDERLKQMKHFGQDYFDEMLERIREIRLSERRFYQKITDIYALSADYSTDAFITKN
FFATTQNKLHWAIQGKTAAEIIYSQVDAKKIAMGLKTWKNAPDGKILKSDVSIAKNYLEK
EHLNQLQRLVTAYLDLAENRAERGIVMNMKDWTVFLDKFLELSDYPILLHKGKISALEAK
LKAESEYDVFRVEQDRNYLSDFDKLTKNLPKKKNKDE
>FCMOIPGL_00232 Type-1 restriction enzyme R protein
MSKSTNTKENGFEKHIVDYLVNNNGYVLRTSQDYNNVSCVDSELLFQFLETTQPKAVEKL
KRYHKELYQQKIIKRINDQIKLKGVIEVLRKGITDGFTDTKIRLFFDKPVSAYNTKNTAL
YQANIFSAIRQVYYSTKNRNSLDIVTFINGLPVVSFELKNELTKQNVKHAIKQYKTDRDP
NEELFRLGRMVVNFAVDTEEVWMCTQLKGDSSYFLPFNKGNKNGAGNEPNGGIKTDYLWK
EILTRDTFTNIFQNYAKLITEEKEYKDSKGKKKIKKTKKLIFPRFHQLNAVSKILEDAKE
NGAGQKYLIQHSAGSGKSNSISWLAHQLVGLHDKTGASTIFDTVIVITDRRVLDKQIREN
IKQYQQVKGVVAAITEGSKQLKSALEDGKKIIITTIQKFPHIVEEIGDLPGNNFGIIIDE
AHSSLSGQMARKLNETLAKVSDEEKLQNDLENYDETEDDEVTGEDFIRAIVKARKLLPNA
SYFAFTATPKNKTLELFGEPFEQDGKTKYAAFHLYSMKQAIEEGFIKDVLQNYTTYQSFY
ALLKKIEDDPEYDKKKAQKKLKAYVEGHDHAIKKKSILMIDHFMDKVVKKKKMGNKAKAM
MVTSSRAKAVQYKHAFDAYLKSINSPYEAIVGFSGEVDGETEASLNGFSGGNIPEEFEKD
KYKFLLVANKFQTGFDQPLLHTMYVDKKLGGVNAVQTLSRLNRSHPLKKETFVLDFANTS
EDIEKAFKPYFENTILGEATDPNKLFDLQDALDNYQVYSREQVEEFSNKILANVKVDELH
AILDESSAVFREELEEEQQADFRAKVKTYVRLYIFLSQIVDFENAYLERLYIFLNHLQNK
LVTESEPDFSQGVLDDIDMETYRLQLEATTNIAMEQGDDLQPIPTEMRGGVKDPEIDQLS
NILKTFNDRYGTEFEDADKVRKMVEDIAVDGAENIDLQNSLEHSDEQNARITSDKVAQEE
LLKYVTTNFDFYKVINDNTEAKEEFNSLFFGMVKEIWKNRNKEKVQYR
>FCMOIPGL_00233 Chromosome partition protein Smc
MDKGNHYKKCDLQIHTPRDRNWKGGPKVTEEDRDLYSRNFIKECRDAGLDAIAITDHHDM
VFYEYIKKASLEELDEEGNAIPEENRIIIFPGVELTLHSPPIQGLLIFDANFPIRLFPTI
LGALSLAQAPKTDSKTSQTVAIPSGSISSINDIYFKLDGTDGVKGRYVFLPHVKEKGHKT
LMRDGFHEAYAKMPCGAGYVDGKFENGGVGYLKVLDGTVAAYGYKSIAVIQTTDYRAEKE
IKDYDVATWIKLKEPTAEALRQACLAKESRISLTVPEIPNTFIEKIDVTNSAFLSKFDLD
FNPQLNSIIGGRGSGKSTILEYLRWALCDQTEKFGSDEAKTEIERKRNSLIEKTLKEVDG
EVRVFFNVNGTRHIIKRNPKSEEVKLKIGDEEFQSVRPSQISNLLPIQAYSQKQLSSISI
RPDELKRFIVQPIANEIEEIDKQIESASKKTRTDYLKLSSSKKIESDIKNNSLDIKSFKL
QIEELKGGLKGISEDDKKTIDRAKFYVNEKNRLDEINLEYSTVNDGISELKELVEKLNGI
SLEEGVEYENIEKFKLINDERNKYLKDLLENLTNLEKTHLNSETTIETLIKDWDILKIEF
QKEYLKAKEKTTSSQATLNGIKELEGKLEKLELIIRQKKVELSSYTVTELDFSTSLKDFI
KLQDLKINKLKESTEFFTKLSDGLIKVDFSKIINANNLSKSLISLFSGSSLNIPKARSIQ
LTEFVSNSEDSLKNWLEIILEFKLLSEFNINPESQNEYPHSPILDSLGFSIANKKKITEN
LNSNNFLDIATISLDFLPKFKYQTNNQMEDEIPFEDASAGQQATALLNVLLNQNGFPLII
DQPEDDIDNRAIEKIIKNLWNSKKHRQIIFSSHNANLVVNGDSELVICCDYNETSNQTKG
QIKHEGSIDKKEIRDEITSIMEGGERAFKLRKEKYGF
>FCMOIPGL_00234 Tyrosine recombinase XerC
MSSISATLRKKPNKQGLFPLAVRITKNRKSTFLYIGQYIEEKYWDAQNKRVKKSHSNSVR
LNNLIAKKISEANDTLLEVVAENKKASVKNIKTKITLEERSNDFFFVSEIHLENLKGRNK
FHQIKTEKGRLKVFKQFIKSDKFLLEDLTSTLLKKFQSHLLLTRKISQRTVVNYLILIRT
VYNIAITQNFVDRKFYPFGKGKIQIKIPETEKIGLNEKEILLLENIKLESAAQRHAINIW
LTSFYFAGIRIGDVLQLKWSDFVDGRLHYRMNKNQKLVALKIPEKVIPILEQYKSSQKGK
NDFVFPEMKKANMKDANDVLTKTQTATRKFNRHLKNMAKTVGIDKNLSCHLARHSFASIA
GDSINIQILQKLYRHSSITTTINYQANFVHKDFDEALDSVLNF
>FCMOIPGL_00235 hypothetical protein
MKVRFIFILLAFFSISKSNAQTLRSLLELILDNSYEKKVVEQNTIFFFDKSNGVNKIYDI
SENGKLGTKTYDKEGLNKSWDQVFTYKADSKTFAFFYDNENGTIKIYDISNSSLGVKTYN
KTGLNKDWDIIIPITENDKRYVLFYDNDKGVMKIYSLTSNGELGSKTFEKAGLHKNWYSI
QSFETANSSFITFYDKMNGVIKNYSIKNGQLGTKTYEKAELSKDWNIINTYSVKGINIIS
FFSNNGGIYKSYILTNDGEMGAKVYDNAINTSWDIILPYSISNSTYILFYDKERGLSKTY
VITKEGGLGDKIDENISLRKTWDIIAVY
>FCMOIPGL_00236 TRAP-T-associated universal stress protein TeaD
MKKKIILPTDFSKNALNAISYAIELYKEEPCEFYILHTYYLPGFSKNNLLSPEPTDKKLN
EVKKRAEKNIQKLKTHALFNNVNSKHTFYFLNEFGSFNNVLKKIIEKENIKLIIMGTRGE
TDDKNIILGSNAVITMEEVRNCPVFVIPGNVRFKHPNEIVFPTSFKADYKENELTTLIEI
SKLLKAPIRILHIKKDKEFSKEQFKNKNLLNHILASTSFTHHELYNSNLHEGIRCFSQSR
ESEMIAFFNKKHHFFGSVFSNPMVKELGNNANIPILALHDLKN
>FCMOIPGL_00237 hypothetical protein
MKNILVLTDFSKNAYCALFYAAKLFEKEPAHLIILNSFEAEVSRHSSVIDLDISQVNIDK
LFHKSEATCLAIKCKLIKELKSTKHTFKIIATSLLLTRAINEFIESENVDFVVMGSKGKT
ATERIFVGSNSFRAIQTIKKVPILIIPDEIDYKEPKKIGFASSFKRSYTNEQLVPLKEIS
KLFNSKTTIIYVYEHEKLNAKKLANLENLLEISKDENIELNWLPKRQSKADTIMEYVYKE
QLCMLTFCYYKHNFISDLFRENVVKEITYHIRNPLLILPNFN
>FCMOIPGL_00238 hypothetical protein
MKHILLPTDFSKNADNAISYAVQLYKNEVCRFYILHTDIPISSGAEDLVDSYSILTLQEI
QKEAAKQKLKKIEDQLKKKFNNANHSFIPMASFNLFISEMRRVIKENNIDLIIMGTKGAT
GAKEIFIGTNTMQTIKKLKCPVIAIPSDFKYEKPNEVLFPTNYEAIKSNKYLPLIKKICK
EHKSKLHILNVYQDIPLKEKQEKIETFLDTYFKDTHHFFHSSEKHDLIEAIEDFEIENRI
NFLIMIQNHHNFFENLLFKPIVNQMVYHTNIPFLVIPSNELIKN
>FCMOIPGL_00239 Thioredoxin-like protein
MKSSFNSIISSEVPVLVDFFADWCGPCKTLAPILKQVKETLGDKVKIVKIDVDKNTSISS
KYNVKGVPTLLLFKNGQQIWRQSGVVQKNVIIDRIKKA
>FCMOIPGL_00240 hypothetical protein
MIKKTDPHKTRVGIFVVIGTLILLVTLYFIGNRQHLFTKNIELYAVFQNVNGLQLGNNVR
YSGINIGTVSSINMINNTEIVVQMMIDTKTGAFIKKDAIASISSDGLVGSMVINIIPGKE
NLRAVISADTITSYNKVGTEDMLSTLNVTNKNAALLTSDLLKITTKILKGEGALGALITD
SLLTKDIRATLVNLKKTTNGTNKLIGTLNNKFSKINMEQSALGLLVNDTIMGNQVKQIVS
NFEQSSTTFLETTKQLEEIISGIKNSENTFNYLTKNETLPKTIDSTMIEIKEASHKLNEN
MEALKHNFFFRGYFKKQERIEKRNKKIQEKEN
>FCMOIPGL_00241 putative ribonucleotide transport ATP-binding protein mkl
MIKTKDNIQPVLEIKDLHKSFGTNHVLNGFNLKLYEGENLVVMGKSGSGKSVMIKCLVGL
LEADSGSITIKNLDILKLGRKELDVLRTEIGFLFQGSALYDSMTVRENLEFPLRRNRDKT
DATKTDEELVIEALQNVGLANTIDLMPAELSGGMQRRVALARALILKPKIILYDEPTTGL
DPITAKEIIQLMRTIQKTYKTSSLIITHDVDCARVISNRMILLVDGINYAEGTFKELSTS
EDIKIKAFFKN
>FCMOIPGL_00242 putative phospholipid ABC transporter permease protein MlaE
MSKTNSIKASTKLFFNEVGDIIYFAIRFFREVFTSPFEWKEFLRQCYQIGNRSFLLIGVT
GFILGLVFTLQSRPTLLEFGATSWMPSMVSLSIVRELGPVIFALICAGRIGSGIGAELGS
MKVTEQIDAMEVSGTNPFKYLVVTRILAATLMLPLLILMGDAIALFGSALVENLKGEVSY
LLYFNKVFDALQFSDILPATVKSFFFGFSIGLVGCYKGYNCSKGTVGVGEASNAAVVYTS
MLLFIIDFIAVFITDIFFKL
>FCMOIPGL_00243 hypothetical protein
MIEQIKIFDSNVIAIEVIDGFTKIDEKVCERIFQRKISKGFKSINILVRVDKVKISKCKV
KVFFEDIIWLSRNYNKMGRFAIVAHSDLLKALVSIDNLFFAKTSKGREERYFDVSQIEEA
FTFVIAKE
>FCMOIPGL_00244 hypothetical protein
MQVKDSNTQIKQELVNSIVHGFGIIFGIVSIPILIAFAIKSDNTIGIIGAAIYGFCFLQL
FTFSTLYHSIQHAQAKHTLEILDHISIYFLISGTYTPFLLMYMRNSFGITLLSVLWGLTA
FGIIFKIFFTGKWNILSTIIYIVMGCIMIVGGRTFFESIPSNILTMLLIGCGLYLIGVIF
YLWRKYPYNHAVWHFFVLAAAVCHYIAILLAVESN
>FCMOIPGL_00245 hypothetical protein
MKNNLFTHLYGSITILGGFFLIFSKYFTFENIKFSLGLSLITGAILALVTAFYRKRKQVE
FTYHEMHALAMMVYGASVLLFCKNIETLINFTSFLFLFYTLSEIIFCSWLFNLDRKVSYK
IIFIRLLLALIVGFGVVILEYSPEINKEINIEGFGLLFIIIGINIFLYAPVMRNKNLNKV
DN
>FCMOIPGL_00246 hypothetical protein
MKIKTIEKLILALNTCAISNTESCYLNALKKISIPLKEWEKYFKFKEYRPGRVSLFKNKR
YQLVLSCWEKGQQSPIHDIDSKEAWIHPISGQFIEERYRISKEKKGLEQVSSILMNSLSY
SYMQKSKTIYRYINSFEHRSACLHLYSKPVLERKEYDKNTGRVSIVKQLYDMQVKEYNHL
NN
>FCMOIPGL_00247 hypothetical protein
MSLLQKNIIPGNHGKVFTTNANAMHDLNVIKTQLLELSGVKDVLFNFDVFPKEFTVYTSK
LVAIEEIEKKVISTGYHAVTKDLFKI
>FCMOIPGL_00248 hypothetical protein
MKTKTLNPKTELLLGAGLNILHFESREWLEIIAFWKDEVKFFDILLKKKESSEKNNPQYE
KMLRSLDKIHKDLFDDLEGSIVEHEKLLSRILDGEKGISDNDYREKHRHIFLRMETFTSD
FKNFKKVVFEYAKGL
>FCMOIPGL_00249 hypothetical protein
MGLIIYTRKRETSDIIQNFMDFYYGLQMKYLASDLLNKGLSLEQISDALILAVKVASSSG
IGVHKHFMPIYSSINREIMKDCKLSNLGYGLVLMNASPNLPVVGDFQVNILKEFYRGRQN
TL
>FCMOIPGL_00250 hypothetical protein
MKKIYFFFLTLFICIQSYSQNQNFIIDNSFPYHVNEETLGKATIGGDTIFISSTRTNPLR
FQFTNGDINNPLVIINKGGQVKIESPNSYSWGAITFENCKYIKISGAGHPNYKYGFQLSA
DNCGLAFSDLSSDCEAEFIKISHDGFFGIMAKKNYDGNPPSPHPLFENLIIHDCFIENVS
EGMYLGETKSPGMEFKHVKIYNNIVRNTLRESIQIANMVEDVEIYNNTLLNAGLENMIYQ
TSLLQIGDNSVANVYNNILIEAPTTGIAIYGKGNSSFTNNYISSNMGMFVDNRIFTDSLT
PINIKQNYFREVRGNQIIKNYNELNYLTVQDNKYETDTIFFLNQSGNINNFTEQNNTLTS
IPEIEFTDPSSNDYSLKSTNPIEYQNMGAPGGPEYFEPEPEQIVISPEMITDLVQGSSVN
SPLFLFDEQNLNIESDEHATSNSWKPDYVMKETSYHAIIDLGKEYHISEINLHDMHNSQD
FTVEYGDESNWNTLFIDPCNTFNIWSKNETDVTTRFLRISMYTSIYAAVNEIIIYGFPVE
PEPEQIVITPNMVTDLVEGGSVNSPLFLFDEQAIDFKAGEHAISNSWKPYYTNANAPYYV
VIDLGQEYHISEINLHDMHDTHNFTVEYGDLTNWTNLFTDPLDKFQFWNKHITDISTRYL
RLVITDSPYAAVNEIIIYGYPIDEEIETEKEEETIDDEQIIVTSNMVTDLVEGGSVNSPL
FLFDEQNLDFQSGVTATSNSWKPDYAMNETSYHAVIDLGTEYHISEINLHDMNDTYNFTV
EYGDESNWNTLFVDPCDTFNTWSKNTTDISTRYLRFSMYQNVFAAINEIFIFGYPITSNS
AKSVNVEKTEKKSSNNSVFGTEKIKMYPNPVNKKLNVKFPVDMLGKSNLVIRDVIGKTFY
NKEIIISATNPNLELNNYQLPKINGIYMLSLFHESGELKTLKFIKKN
>FCMOIPGL_00251 Arabinogalactan endo-beta-1,4-galactanase
MKNLKIFFLVILIFPTFVFSQAIEIVSFSENPLEVNPLIGNNLTINYKYSSEPNSVGNHI
YIGLEILDSTNEFYASVSGITLENQSSGENIKGNVQFFIGSNNQLSANLPSGYYYQVKAV
LYKSGGWIENAWAGYWNTPTLVFQDTSNFNFSTNKISKGADISWMTEMESEGYFWKDNNG
NTKELLPLLKEYQLDAVRLRVWVNPENSGANGWCNIDDLVKKAELANALNMDIMICIHYS
DWWADPGKQNKPAAWSGLSVLELETAVSNHTTEILSALKVKNITPKWVQIGNETSNGMLW
DDGKASEGGFANYAKFVNAGSNAVKTFNNTIKTILHLSEGNDNGLFRWNIDGLLNHGLNA
NKIDIIGMSLYPDADNWKEMTDNAYANMLDLKSRYGKEVIVSEVGFNSNQPSISYQFLVY
IIEKTRQAEGLGVFYWEPIAHGDFTSYSKGAWDEDGSPSVAMDAFMDKTTLNVKDFENEN
NQLFKVYPNPTTNNITVKGLKNKITSIKIYDIKGKKIRSIKTDSITKTIDISNLKTGIYL
LKINNMHSVKFFKD
>FCMOIPGL_00252 hypothetical protein
MDKLFFSFFLLIFTANIYSQKDSLQLGDRYADDQIYAAITYAQFDSQPSGVTKSSFSYAV
STGFLKDIILNKKGSFSFALGVGYGFDFFNHDLKVSEINNSTFFDTSENISSNVFKAHNL
EFPLEIRWRTSTAKRYEFWRIYTGVKFLYNISNTFQFTENETAYKYKDVSAYRKLQYGLT
FSAGYTEFNAYLFYSLTPVFEKGTINGENIDTRVLKFGLIFYLL
>FCMOIPGL_00253 hypothetical protein
MRFYKFISVILHPIVVPTIGVMLYFLLIPNNFESKQRINILSLIFVVTYLIPLLILVIFK
RLRIIETYQTESIKERKLPLALMITLFYVLGNTLDSVINLRDLGLLFYATSLGLFIIYIL
FYFQIRASIHLLSIGIAIGFFIVLGTIYSQSFIIIIIALFLIAGLLASARLKLNAHTSKE
VYIGFFIGFLSPLSMYYIL
>FCMOIPGL_00254 RNA polymerase sigma-54 factor
MLKQSLQYKLLQKLSPQQIQLMKLIQLPTQAFEERLKQEIEENPALDTGKEESDAIDDDL
SNEFDDDEDTGNEKIEADDINIDEYLSDDEIPNYKTQANNYSADDEEKNVPYAAGTSFHQ
SLKNQLNTFIFDDEERAIAEFLVGSIDDSGYIRREVIDLVDDLAFTANVFTSEEKVVTIL
TKVVHKLDPIGVGARDLKECLIIQLKAKEKNKIRSLAIDILENSFDHFVKKHYKKLQEKY
NISEKELKEVNTEISRLNPKPGSSYAGNNKIAEQIVPDFSIKILDGELDLTLNSRNAPEM
HISKEYNNMLKGYQESTVKSKSQKDAVFFIKQKLDSAKWFIDAIKQRQQTLMVTMNSIMH
YQYEYFLTGDERKLKPMILKDIADQIKMDVSTVSRVANSKYVSTPYGTKLIKDFFSESMK
NDQGEDVSTKEIKKILETVIAEENKRKPLTDEKLAAILKEKGYPIARRTIAKYREQLDLP
VARLRKEI
>FCMOIPGL_00255 Asparagine--tRNA ligase
MTKKNVAEILKSDSVLQEVELKGWVRTFRSNRFIALNDGSTLNNIQCVIDFENTDETTLK
RITTGAAVAVKGILVESQGKGQSVEIQVSNIEILGDSNPDEYPIQPKKHSFEFLRENAHL
RVRTNTFSAVMRVRSKLSFAVHKYFQENDFNYVNTPIITGSDAEGAGEMFRVTNFEDNKA
PVTEDGKVDYSKDFFGKETNLTVSGQLEAETFAMALGKAYTFGPTFRAENSNTTRHLAEF
WMIEPEVAFMDLDGNMDLAEDFIKSVINDVLKNCEDDLAFLDKRLTQEEKSKPQAQRSEM
SLLEKLRFVVDNNFKRVSYTEAIDILRNSKPNKKKKFQFPINEWGADLQSEHERFLVEKH
FKCPVILFDYPANIKAFYMRLNDDGKTVRAMDVLFPGIGEIVGGAQREERYDVLVEKMKA
MNIDEKELWWYLDLRKYGTAVHSGFGLGFERLVQFTTGMGNIRDVIPFPRTPQNAEF
>FCMOIPGL_00256 hypothetical protein
MNIFKGQNLLEFADRFKTDEDCNKYLADIKWKDGFQCVKCGHKKAQIRKDFSRTCNICSH
QESSTSNTLFHKVKFGVRKAFFIVFEMSTSTKNLSASYVSVRFSVTEKTARLFMRKIREA
MESSGNSPMTGIVHVNEF
>FCMOIPGL_00257 Internalin-A
MKTKLFLFFTFLCLAINAQVSQAERQALIDFYNATDGDNWTNNTNWDTDINSTSDVKTWH
GVTATYIDGVYHVRDLVLTDNNLTGTLPDLSQLTELQGVSVATNKLTGNINIDLFPKKLK
SISLNENNFTGDFSDFSSFTALEKLFLIDTNFTGVISEEFFPNTLSVLFLSGNTSLEGDL
DFSSFKDLYILKVNNTKLNFLKLPRSVTTTSNRFHIKDTPNLAFVEVPYVSDFTNLEDDD
FDIGVRIVPYNQADKTAKPNILERDALKKLYQNKSYTYANTLKSGVNDTEWLEVEVIEGE
TRVTEIHTTGLGINDVLPSEIGALTELKYLHVPSSSINSIPKEINNMTKLEELYLNNNFI
TSLPNEFYSLVNLRMLNINNNQLTSIASGLGDLINLEQLYFSNTQVDLVPTTIGNLKKLE
TLEFANTKISLLPPEIGGLVELTRLVAAPNNIASIPSEFGQLTKLTYLDFANCELSNTPA
AFANLTELETLFLNDNELQVVAGLGGFTKLKFLRLHNNRLGEDNSNFNTDLPEDMSDLVL
LEELTLYNNQLTKLPVNIGNLNKLTSLKIYSNRLSSLPNSIGSLSSLVELHVEANELTSL
PTTIGGLTSLEKLYISSSSSNNKLTSLPDEIGDLSNLKELYIENMYTYQTDGTYIYHLES
LPTTMNKLTSLEVLEASNSGIGGLVDLRNLINLTRIQLHNNKIEDLKIDAPVSNFNTYSG
GTYSFNLSNNSYLTCVEVPTLEVSNWETRYASYSSIADNGIAFSDSCTGFRVPQSEREAL
VAIYKATNGGEERDTTTGVTWVGTNWSSDATELTNVGSWEGVTTEIINGQKHVTRLELGN
YKNLSGSIPKEIKDLTELTYLDLSNGSIASMATEIGDLGKLTYLSLASNSLESLPTGIGN
FTSLVELGLSGQRKDENSYTYTSTLTSLPDEIGNIASLEKLDLSSNGLTSLPSGIGNFTN
LKELRLNSQATNPVRGELIYTLTNLPDEIGSITSLEKLYLNNNVLTSLPSTINGLTSLVE
LHVEANELTSLPTTIGGLTSLEKLYISSSSSNNKLTSLPDEIGDLSNLKELYIENMYTYQ
TDGTYIYHLESLPTTMNKLTSLEVLEASNSGIGGLVDLRNLINLTRIQLHNNKIEDLKID
APVSNFNTYSGGTYSFNLSNNSYLTCVEVPTLEVSNWETRYASYSSIADNGIAFSDSCTG
FRVPQSEREALVAIYKATNGGEERDTTTGVTWVGTNWSSDATELTNVGSWEGVTTEIING
QKHVTRLELGNYKNLSGSIPKEIKDLTELTYLDLSNGSIASMATEIGDLGKLTYLSLASN
SLESLPTGIGNFTSLVELGLSGQRKDENSYTYTSTLTSLPDEIGNIASLEKLDLSSNGLT
SLPSGIGNFTNLKELRLNSQATNPVRGELIYTLTNLPDEIGSITSLEKLYLNNNVLTSLP
STINGLTSLVELHVEANELTSLPTTIGGLTSLEKLYISSSSSNNKLTSLPDEIGDLSNLK
ELYIENMYTYQTDGTYIYHLESLPTTMNKLTSLEVLEASNSGIGGLVDLRNLINLTRIQL
HNNKIEDLKIDAPVSNFNTYSGGTYSFNLSNNSYLTCVEVPTLEVSNWETRYASYSSIAD
NGIAFSDSCTGFRVPQSEREALVAIYKATNGGEERDATTGVTWVGTNWSSDATELTNVGS
WEGVTTEIINGQKHVTRLELGNYKNLSGSIPKEIKDLTELTYLDLSNGSIASIATEIGDL
GKLTYLSLASNSLESLPTGIGNFTSLVELGLSGQRKDENSYTYTSTLTSLPDEIGNIASL
EKLDLSSNGLTSLPSGIGNFTNLKELRLNSQATNPVRGELIYTLTNLPDEIGNIATLEKL
DLEYNILESLPSSITNLIVLKNLDIRHNRISGALDLSKSESLNTLEADYNNILSLKIAVS
PTIFGTNEKNPSSNRLGLKRNALGCIEVPSDELVAWQLSFYNEEGDVIDNGVVYSDNCAV
VTNNSIPDIEREALIAVYNSTNGGSWKNDLSNAYNGVTWVNDAKDNRNVGAWFGVTTAIV
NGQKHVTKVELNSNQLDGTIPSVIKNLTKLKTLKFDYNAVSEIAPEIGELSNLEQLTFNH
QYSYEKSEYVLKMIPVEINNILSLKNLSLTGIQLEGNLDFSSLVNLESLSVNSNQITGLK
IGVPPSVFDNTYVSESEYRKSFAFSSNTYLNCIAVPQNTIADWESSSFATSNPNIVWGQD
CSAYNNVPEDEMQALVDMYNNLDGANWTNSENWTGNFAKALISNPYNATKWNGITTKIVD
GGKHITDVSLSSNKLKGEIPESFSNLSKLTNVQLSSNDISGALPSSIGNLTSLETLYLNS
NKIESLPAEMTRMLKLKTIYLQNNEIMGKVPDFTEASTLERLYISSNKFQFGDFEDEFIT
YQNLKTFSYTSQEKVGEEENIDFGDGFDKTLEAVVSGTNNTYQWYKNYNPITDATNSTFE
IANATQQDAGFYYCRVTNSIVTGLTIETERVTLTFDTALSTKDEVFSNVIKLYPNPVTNV
LQIQNDSDIIINKIEIYNLLGKKIATHKNPGNSVDVIQLAKGIYIVNVFSDDAKMTKRIV
KE
>FCMOIPGL_00258 hypothetical protein
MKNKIPFKRILQQLKADLIGKDSYRGVTLTYAWLANQFGHISLGFIPSFLVYYLLNLDAL
KAALYVSAFWFLFELYNFLGPLLSKKESNSDVLFIQKKVKYIFSPKWFNVAFDTFTDVCF
FIVGSFLFAFCIYKFNNNTIIIILAVLSIYLAFATRYWYVTKMYQFYARFPFQFRLSQWD
FTINSSDKLKVENFLDLKNTGNHLLLFGSLGAGKTSLGVGILNELSIKNNSCLYVNAIKM
FNYFFKDEGDVLESHEIWNWKTVDFLMIDDINPSEPIQDELISPTKLLSFIDTLKLENKK
NREILKNKNIIWVLGNKQPLDEKNKDDWKEMLLNIGVEEQKITTINL
>FCMOIPGL_00259 hypothetical protein
MKNKFGEYTRERVSNIPFDANDPVYKEYKTRVPHFIGQAIYIYSFEKNRMLYAYGWEEML
GYKDEEITLLTIVSSTSKRHFNFSNDLNDKGLQYLKNITEDLEKYSFTLEVEKIHKNGEI
VPLLSRVGIYKSHKGTILEIIGISEKIHARKLGDIMQYAAYGPITSGFEESLNDQLFNKL
GISRKEKEALEFAAKGYAFKEIAEKLNVSQSAIEKRIIPLYKRFKVKSLPHLISFAHANH
IL
>FCMOIPGL_00260 Multidrug resistance protein MdtC
MNFWTKVAGIILRNRHLILIIIAIITGLLASQMKYMKFSYTEANLLPENDEANLEYNKFL
EIFGEEGNLVILGIKDSTVFTPKKFNAWNNLVHQFENLDEIDFTVSIADVKKLKADRNKR
KFILEPLYEKDPTTTKEVFEIKKQLFEKLPFYDNLLFNKETGTLQTAIYIKKEIINTPAR
RDFIFDKLIPTIEKFEKENNLDVRISGMPYIRTLNAQNIQDEILLFVVGALGITAIIFFF
FFRSFRATFITLLVVLIGVIWAFGFIGLFRYEITVLSALIPPLIIVIGVPNAVFLINKYQ
QEIKKHGQQAKALQRVISKIGNATLMTNITTASGFATFVFVKSNLLREFGILASVNIISI
FILALLIIPIIYSFMPLPKKKHLNHLETKWIENVVNWMEKTVKEQRISIYIASVVVIILG
IIGVYQIRVSGSLIEDMPKSTGFYKDIKFFEKEFGGIMPLEILIDTKKDKGVMKLSTLKK
MDKINETIESFPELSKPISVVNLVKYSKQAYYKGNPKYYQLPTSQEQSYIFSYTKNSNSE
AGMLKNFVDSTGRYARITTFMKDIGTDKMDIIQERLKAVINKEFPSDKFTVSVTGKALVF
IKGTNYLINNLVLSLSLAIILIALFMAWMFRSPQMILISLLPNILPLLITAGLMGFLDIP
IKPSTILVFSIAFGISVDDTIHFLAKYRQELMDSKWKVKPSVYAALRETGVSMFYTSIVL
FFGFLVFTLSSFGGTIALGGLVSITLLLAMVSNLLLLPSLLLTFEKKIANKRVFKEPSIK
IIPTKDEISEE
>FCMOIPGL_00261 Ribosome-recycling factor
MNEEIEFILDAAKEAMNNALDHLDKELRSIRASKATPAMLGTVMVDYYGSQTPLSQVANV
STPDPRTLSIQPWEKNMLQTIEKAIMLANLGFNPMNNGDVIMINVPPLTEERRINLAKQA
KAEAEHAKVGIRNARKEANNDIKKVDISDDMKKIAEDEVQQLTDTFVKNIDNKFSIKEKE
IMKV
>FCMOIPGL_00262 Uridylate kinase
MQYKRILLKLSGEALMGDRQYGIDPKRLAEYAKEIKEVVDKGVEVAIVIGGGNIFRGVAG
ASNGMDRVQGDHMGMLATVINGLALQSALEDEDVHTRLQTALEIKEVAEPYIKRKANRHL
EKGRVVIFGAGTGNPYFTTDTAAVLRAIEINADAILKGTRVDGVYNTDPEKNKDAIKFET
ITFKDVISKGLKVMDMTAFTLSEENKLPIIIFDMNEKGNLIKLVSGEKIGTIVDN
>FCMOIPGL_00263 Trigger factor
MNITKENVDALNAVVKIDIVAEDYQAKVSGLLEDYRKKADVPGFRKGHVPMGMIKKQYGK
SIMIDEVNKLLQTSLNKYLGDEKLDILGNPLPRMKEDFNWDADTFTFEFELGLAPEFDVD
LSEKNKIQQYNIVATDELIEEEVKNIQIRYGNANSLDDADEDSNLSGTFVNEEKEINKKA
TFSVKELKGDNKAKFIGAKLGDVVELGTKGLFEDDHRLQHLLDVSHDEIHDLEITVTFTI
DDITKTEPADLDQELFDKLFADGSVTNVTELKEKIKEDAEKQFLQQGDQQLLNAVTEYLV
ENTKFDLPADFLKKWLQTAGEKPLTAEEAAAEYEKSEKGLRYQLIEGKIMKDNDIKIDYK
ELIDYAKGFIRSQMAQFGNMNPEEKELEDIAGRVLQNQEEAQKLQAQLISNKLLTFFKEK
ISFKTKEVSYEDFIKEVYK
>FCMOIPGL_00264 ATP-dependent Clp protease proteolytic subunit
MDYGKEFEKYATKHHGISSTSYTKITSSLTPYIMEERQMNITQMDVFSRLMMDRIIFLGT
GINDQVANIIQAQLLFLESVDANKDISIYINSPGGGVYAGLGIYDTMQFIKPDVATICTG
MAASMGAVLMCAGAKGKRSALPHSRVMIHQPLGGAQGQASDIEITAREILKLKDELYQII
AKHSGQTIEKVHDDSDRDYWMKAEEAKVYGMIDEVLVRK
>FCMOIPGL_00265 ATP-dependent Clp protease ATP-binding subunit ClpX
MSKEENLECSFCGRKKAETDLLIAGIDAHICDKCIEQAHGIVLEEISNVKSSELSKDLIL
KKPLEIKQFLDQYIIGQVETKRAMSVAVYNHYKRLLQKDTDDEVEIEKSNIVLVGETGTG
KTLVARTIAKMLNVPFSIVDATVLTQAGYVGEDVESILSRLLQSADYDVEKAEKGIVFID
EIDKIARKGDNPSITRDVSGEGVQQALLKLLEGSVVNVPPKGGRKHPEQKFIEINTKDIL
FIAGGAFSGIDRKISKRLNRQAVGFGASLEDDKIDEENLLQYITPLDLKSFGLIPEIIGR
LPVLSYMNPLDAKTLRAILTEPKNSIIKQYTKLFLMDEVEFTIEEEALDYIVDKAIEYKL
GARGLRSLCEAIFTDAMFDLPSSDDKLFNVNKEYAETKLTNTTLKKLRAAS
>FCMOIPGL_00266 DNA primase
MISRSTIDRVFESARVEEVIGEFVQLKKAGSNFKGLSPFTDEKSPSFMVSPVKQIWKDFS
TGKGGNSVSFLMEHEHFSYPEALKWLAKKYNIEIEETEQTDEQKEQTNERESMFLVSNFA
KDYFHNLMLNTNQGKAIGLSYFKERGFTDETIKKFQLGYCLDEWSNFTNAALAKGYDLKY
LASTGLTIVKEHKQFDRFKGRVLFPIQSMSGRVLGFGGRILTADKKAAKYLNSPESDIYH
KSKILYGIYQAKKEIAKQDNCFLVEGYTDVISFNQSGIENVVASSGTALTSDQIRLVNRL
TKNITVLFDGDAAGIRASIRGIDLILEQGMNVKVVQFPDGEDPDSFAKSHTNTELKEYLE
TSAQDFINFKVSLLLKDSNNDPIKKASVIRDIVTSISKIPDGIQREVYVQECSRIMDISE
RVLFSELAQLLKKETTQKKKPTPSYNTNVDPNEPPPEYFYEQEQASMALVKKGPVASQKI
DQLSILEKEIIKILLLFGNEEVGFSEEVVTTDERGRETFSNRKYQNLVSAEIYLHLQEDE
IEFTNPLFQEIYTEMIHQLNQSEKLEIDKFVNNKNIDISTTVTSILMDEEKYQLSNWGRK
SIEVKSALEVLPKAVSDVIYNLRRILIDRLVNKFLVQGKEFTNEEKEEIMSYNSLRIRLS
EKLKRVV
>FCMOIPGL_00267 hypothetical protein
MKKILQILKIVQLFILLPFEISKGSKKRTQQRIKKIMIAANLL
>FCMOIPGL_00268 NH(3)-dependent NAD(+) synthetase
MNTEKVAEYIINWLKEYATNAKVNGFVVGVSGGIDSALTSTLCAKTGLPTLCVEMPIHQA
ASQVSRAEEHIAQLKKRFSNVSEARVDLTSTFEDFKNAVPSIENSAKLDLSLANTRARLR
MTTLYYFAGIEGLLVAGTGNKVEDFGVGFYTKYGDGGVDLSPIADLMKSEVYKLAAYLEV
PNSIQKAQPTDGLFGDSRTDEDQIGASYDELEWAMHMEDKGKTADDFSGREKDVLKIYTR
LNTINQHKMLPIPVCEIPKKFM
>FCMOIPGL_00269 hypothetical protein
MRFFFTLLMVLCLFFSCSDKNSNQIDVSKINVDFSVNRYDVDFYNTTNESLPKLKQKYPY
LFPQEFTDSIVFAKINNKDEQELFAETQKIYKNLSSEEKELTSLFKYVKYYNSDFKEPNV
VTILSNIDYDSRVIYADSLLLISLDVYLGENHKFYGDYPKYIKENNTKNHIIVDVANTII
DKQVNLSNKRDFIAKMIFEGKKMYLLDMYLPSISDREKIGYSQDKINWATRNEEQIWMYF
IDKKLLFSTDTKLNQRFLENAPFSKFYMEQDNLSPGRIGVWLGWQIVRSYMKHNNVSLQE
LLKIDESDLFNKSKYKPKK
>FCMOIPGL_00270 hypothetical protein
MAVKHNSEIKFNVGLDENKVPEEISWTAKDGGIDNEASKAIMISVWDHKQKDTLRMDLWT
KDMPVDEMKQFYHQTLVSMADAFEKATDDQKMSATMRDFCDYFAEKLELKK
>FCMOIPGL_00271 Deoxyguanosine kinase
MKIQRITYLSLGTNQGNKLENLQNAINLIADKVGDIQKVSSIYKTASWGFDSEDFFNICL
KVTTYHPPEKLISILLNIETELGRKRKESKEYSDRNIDIDILLFDDEIIFSKTLTVPHPK
MLERKFVLVPLTEIAGNTFHPIEKKQLSICLKNCKDSSKVSLINDKLKRPVPLSEKYNYI
AIEGNIGAGKTSLSNMLSDEFNAKIVLERFADNPFLPKFYKDKERYAFPLEMSFLADRYQ
QLSDDLAQLDLFKNLIVSDYYIFKSLIFAQITLQKDEYLLYRKMFDLMYKEITKPDLYVY
LYQNTDRLLQNIKKRGRDYEQNIEAAYLQKIHDGYKNFISTQQDLNVVIIDVSDIDFVNN
PEDYDFIINKIKKA
>FCMOIPGL_00272 hypothetical protein
MILTPVFIILFLLVFILLWQFVKSIDNRKWISLLLNIVFTPIVYFFLFYPLLNIFSSYHH
EKYFDSEAWKKEPKLRFEMSNQIIENQLFKGKTKTEILKSLGKSEWYGWNDSIKANSQDK
WNYNLGFKPGAFNSKQECLELIFKNDTVIKSVQYQIEKTDY
>FCMOIPGL_00273 Polyribonucleotide nucleotidyltransferase
MIPKVFREVIDLGDGRTISLETGKLAKQAHGSVVVQMGKAMLLCTVVSNYKQSDVDFLPL
TVDYREKFAAAGRYPGGFFKREARPSDGEVLTMRLVDRVLRPLFPKDYHAETQVMVQLMS
HDEDVMPDALAGLAASAAIQLSDLPFETPISEARVARVNGEFIINPNRAQLAESDIDMMI
GASADSVMMVEGEMDEISEEEMAAAIKFAHEAIKVQCAAQVNLAEAFGKKVTREYEPERE
DEELAKRINDLAYDKCYEIAKKGTSKVERTNAFAEVKEEITATFSEEELADFGGLIGKYF
NKAQKNAVRELTLAEGLRLDGRKTTDIRPIWCEVDYLPSTHGSSIFTRGETQALATVTLG
TSRDAIQIDMPSYEGEENFYLHYNFPPFCTGEARPLRGTSRREVGHGNLAQRALKGMIPA
DCPYTVRVVSEVLESNGSSSMATVCSGTMALMDAGVQLKKPVSGIAMGLISDGDRYAVLS
DILGDEDHLGDMDFKVTGTEDGITACQMDIKVKGLSYEILVNALKQARDGRLHILSKLTD
TIPAPNAEVKAHAPKMISRRIPNDMIGAFIGPGGKHIQELQKATGTTIVITEDTVTEEGI
IEILGTKPEGIEAVIAKIESMLFKPQVGSVYEVKVIKMLDFGAVVEYTEAPGNEVLLHVS
ELAWERTDNVSDVVKMGDILDVKYFGLDPRTRKEKVSRKAILPKPEGYVARPPRDDKRSG
GRDNRGGRDNRRRDDRKPREPREPRKEE
>FCMOIPGL_00274 30S ribosomal protein S15
MYLTKEVKESIFEKHGKGKNDTGTSEGQIALFTHRINHLTEHLKRNRKDFNTERSLVMLV
GKRRSLLDYLKKSDITRYRAIIQELGIRK
>FCMOIPGL_00275 hypothetical protein
MKNKTLEAKEKFGWSDKFIHDLFFATDNVVLKSKVPSIQNNSKRIIDQNPPDTCDCKFDW
GCGVVSGNCLSNEGCKLNNGDCGFFGNDDCNGSCA
>FCMOIPGL_00276 Thiol-disulfide oxidoreductase ResA
MKKFFIYSIGVVLFYLIVRFLLNGHEFIFSVFMISSFIFSFFIEKKEMIYSMSLLTLIWG
IHFFRESSIIVNIIIYFIFTPLTFYLGYYLKNKHVFYKIIYPVFLVLIGVYGFTNLWYYT
TNFNSRVNYNSPIMNFHNNEVRIDTIKNEVIVLDYWTTSCGVCFKKFPEFEKLYLKYKEN
PNVKLYAVNIPIKRDTFGSAKKMIEKYNYQFPVLYSDSDTIPKQLGFNKYPHLIILKNGK
VRYNGYPALGEDNLFVNSLDDEIELLLKE
>FCMOIPGL_00277 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MTAWFKRKDKGIQTPTEEKKDTPKGLWYKTPSGKIIDTEELKKNLYVSPEDGYHVRIGSK
EYFELFFDDNKFEELDANLTSKDPLKFEDTKKYPDRLKSVQEKTKLKDAVRTAVGKSLGK
DLVIAAMDFAFIGGSMGSVVGEKIARAIDYSIKNKIPFLMISKSGGARMMEASLSLMQLV
KTSAKLAQLAEVKIPYISLCTDPTTGGTTASYAMLGDINIAEPNALIAFAGPRVVKDTTG
KDLPEGFQKSEFVLEHGFLDAIYERKELKKQVNLYIDLIQNLPIRS
>FCMOIPGL_00278 Fructose-bisphosphate aldolase class 2
MSHNIKPGVATGKEVQAIFKLAKEKGFALPAVNVIGSDTINGVLETARDLNAPVIIQFSN
GGAQFNAGKGLSNEGEKAAIAGGIAGAKHIHELAVAYGVPVILHTDHCAKKLLPWIDGLL
DASEKHFAETGKPLYSSHMIDLSEEPIEENIEICKTYLARMAKMGMTLEIELGITGGEED
GVDNSDVDDSKLYTQPEEVAYAYEELLKVSPQFTIAAAFGNVHGVYKPGNVKLTPKILRN
SQDFITKKYGVEENHIDFVFHGGSGSTVEEIREAIGYGVIKMNIDTDLQFAFTEGIRDYM
QGKAAYLATQIGNPDGADQPNKKYYDPRKWLREGELTFKTRLKKAFEDLNNIDTL
>FCMOIPGL_00279 Outer membrane protein assembly factor BamA
MKKISFYFLLIVFLISCNSTKHVIEGEHMLNENYIFLDSVKIKGAELQKYILQKPNSRFL
GLPIGLYLHNMGDHNIPKTPTKWAKKNPKSYKTVKSIFSEKQSIAYANWFINLNNWFLDY
DEPEIINDVKISRTADNLWAYYKTQGYFNSKVTSKINKDSISKKASVAYYITKGEPTILD
TINFKIASPVLDSIYKTSGLETLLKNGDQYKDETFRHESENIVKLFRNNGIYHFTESALG
FYVDSSRTDHKTNVELLISADRLIEENDNYIEKPYKVHTIKEVNVKTDYSFTKKGEPIKD
TVLYKGIKFLSYDKLRYNPKYLAQSIFLKPNEVYKDTLSNLTRTHLKSLKNFKSTNIIYS
SVPDTDDELIMEIRLAPLEKFTLGLETELTHSNIRNIGTSAKFSITNRNTFKGAELLKMS
LLGSWFNSNNGPGWEFGADVSLEIPRLVAPFGLNKLVPKEMSPRTLFSIGSSLQKNIGLD
RQTFSFLTDYKWQFNYKKTIQLEVLNTQYVKNLNIGSFFDIYSSEFENLDEVAEVYDNVK
NTSNYPLPTDESQSIESVKFMNAVTNDSSFKTSNPDEYNTATNILNRYNIITSDFLIPVL
AFSYTYNNQTNFKDSDFSFFKIRVANSGNVLGLLSDKTNIHDKKTFLNIPLAQYFKTDIE
YKKFWDLGNSSVFGLRTFLGAIVTYDNSDIPFTKSYFAGGSNDIRAWQTYELGPGSRNTG
LEYNVGSFKFLSSLEYRFDVFSRLKGALFVDAGNIWDISGSSLVDDDSKLTGFDSVKDIA
VGSGFGARLDFSFLIVRLDIGFKTYEPYLESNKWFRNYNFSNAVYNIGINYPF
>FCMOIPGL_00280 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MSISKNQLKTITSLSQKKYRQKYKLFIAEGVKVVNELLNSSFKIDTLFATDDFKTDISSD
KIIRISDKELQKISNLKTPNKVLGLFMIPDEKPLQKNGLSIALDAINDPGNLGTIIRLCD
WFGVTQLLCSRETVDCYNQKVVQASMGSLTRISIKYVDLKMYLIETKLPIFIADMDGENV
YKSTLPKEAILVMGNEANGVSDELKTLIKNKISIPRFGETQETESLNVATATAILLSEFK
RSY
>FCMOIPGL_00281 hypothetical protein
MNKKVLLFGVFLMISNAFYAQRERVENIPTFDEKKIHYGFYLGLNQNDFKLNLRNSIFDD
ADITVEPTSGFNVGLIADLRLHKNLNLRLEPGLVSNSKNIYFNHLDTKQDSVREIGSTYL
HVPVIFKFSTDRYKNIRPYILGGISYNYNFSSNENNQDDNSSGQFRMTTHNFMYEVGLGI
DIYLYYFKFSPSIRGIFAINNEIKYDDDPDSQWTAPINYMGTRGVFLTFAFE
>FCMOIPGL_00282 Demethylmenaquinone methyltransferase
MSAEKINPYKDSQLGKKEQVTQMFDNISENYDGLNRVISLGIDVKWRKKVVEIVGKNNPK
QILDIATGTGDLALMMASLNPDKIVGLDISAGMLEVGKRKIAKVNLSEKIEMIVGDSEEM
PFDDNTFDAITVSFGVRNFAHLNKGITEIARVLKPTGVLVILETSNPTKFPFKQGYKFYT
NYILPIIGKLFSKDKVAYSYLSESANSFPFGEAFNNILQKNGFTNTKHKPVTFGVATIYT
ASK
>FCMOIPGL_00283 Fe/S biogenesis protein NfuA
MQETKITIQETTNNTILKFNSTTILINGGSYEFSNIDEAKNSPLAQELFYLPFVKKIFIT
ANFIAIQRYDIVEWIDVQEEVAEQIEAYIADGNIVVNEKTSSTKKEAIEVYAEVTPNPAV
MKFGTNKALTQTDVEYKNIDEASKSSPLAQAIFNFPFVKEVFISDNYISITKYDMVEWKE
VFAEVRTFIREYLVDGKIIIKEIPKQNTENNTAIETPIVALEGISAQISDILDEYIKPAV
AGDGGNIAFRSYNEETKVVSVVLQGACSGCPSSTATLKNGIESLLMEMLPNQISEVIALN
G
>FCMOIPGL_00284 hypothetical protein
MKRFFTIAALFATIFVSNSQSLGYEGLGIMFSQNDNNGSARFTAMSGAFGALGGDISSIN
VNPAGLSVFNNSEFSGTFNSRNSNITSTYYGNSRTTQDQFINLSNAGAVLVFDSAYSKDW
SKFAIGVNYKITKDFADSFLSEGNSNITTFSEYPLDTNTPALVYDIADGQRFNNTYTGEL
SEINIGFSSVHQNKLHLGASLNFYDLNFSQRSTLTEFNSDVNGNELDANLYQENFTAGSG
FSMNIGFIYKANQNFRFGLSYQTPTWFTELQEETNIIDNDGFFGDTEITVSEDNLIYDNT
AGGYYPFQSLIYKLKTPSKLTASAAIIFGKNGLLSLDYTNKNYKSINLSGADFSAENQSF
QDNYRNTNNFNLGTEWRFDRFSIRGGYMFEQNPDKSAIDSDNLEGYSLGAGYNFGNFKLD
FSFTDNNKTSVYNFYQGFNVNPTNLDLNNKIFTTTLTLAL
>FCMOIPGL_00285 hypothetical protein
MDTHYKGLNLKHIVLFITANLLLVSCGTYRSVYNNDGIYGDNNVTREKEQVVVLEEKKHN
DYEDNYFTKRLIELENIQDDDFFTDVDSYNSNNRYDDEAIDETLSYDANEPWGYDDNVVV
QVNLINDPYWYDYYGYNNYSLYNGWGYNNWRYRNWGIWNNNYWNYNNFYNPFYGGYNWNI
GYYNNFHYYRPGNYYGVNRNNTYGRRVTNNSYNRRGVSSNTRYSNSVSRRTNTSNTRSSS
NTSRRSSNTVSPTRRSTSTSRSSSTIKRSTTPTRRTSTSRNNTSSTRSGTTTRRTTTSSS
NNSSSTMRRSTSTSSNRGRSSSSSRSSSSSSSSRRRGN
>FCMOIPGL_00286 Proline--tRNA ligase
MSKKLTKRTEDYSKWYNELVVKADLAENSAVRGCMVIKPYGYAIWEKMQAELDRMFKETG
HENAYFPLFVPKSLFEAEEKNAEGFAKECAVVTHYRLQNDPDNLGKLRVDPEAKLEEELV
VRPTSEAIIWNTYKGWIQSYRDLPLLINQWANVVRWEMRTRLFLRTAEFLWQEGHTAHAS
KSEALFEAKQMQDVYAEFAENFMAMPVVKGAKSESERFAGADETYTIEALMQDGKALQAG
TSHFLGQNFAKAFDVKYTSKEGKQEYVWATSWGVSTRLIGGLIMTHSDDLGLVLPPKLAP
IQVAIIPIYKNDEQLDAISEKVNEIVKELRKRGISVKYDNRDTYRPGAKFAEYELKGVPV
RMAIGSRDLENNTVEIARRDTLDKQTVSQDDVVTYIDNLLVEIQHNLFNKAIEFRKEHTT
EVTTFVEFKKAIKNKGGFVSAHWDGTIETEERIKEYTKATIRCIPNDSKEEIGVCVLTGK
PSKRRVLFAKSY
>FCMOIPGL_00288 30S ribosomal protein S20
MANHKSALKRIRSNEAKRLLNKYQHKSTRNALRDLRAIEDKTEAQGKLGNVISMLDKLAK
RNIIHKNKAANLKSKLTKHVAAL
>FCMOIPGL_00289 Peptidoglycan glycosyltransferase MrdB
MRQEKNNIFAGIDWILVVLYIVLIGFGWLNIFAASKTEENNQILDFSTKYGKQILWIGLS
VPLIITILFFNSKFYEKFASVLYLISILSLILLFPFGKEINGAKSWFNFGAMSLQPSEFV
KAFTALAVAKLLSDRQYNFKLVKNQIKAFIIVFFPAFLITLQPDAGSALIYLSFFFVLNR
EGLTLNYILLGTTVIALFVLTIFFGASKMFVSLFIIISFIVAYTIYRGGKRFFRFNWYKI
LAFYLFVALFIFGTEFTYNNIFKQHHRDRFEVLLGMKVDNTNIGYNSYQSELTISSGGWF
GKGYLEGDITKGDFVPEQHTDYIFSTVGEEWGFIGSSFVIILFMLMMYRIIYLAETHTNK
FGRIYGYSLASILFFHVIVNIGMVIGLLPTVGIPLPFFSYGGSSLWGFTILLFIFIRLDA
HKNYDW
>FCMOIPGL_00290 Peptidoglycan D,D-transpeptidase MrdA
MKRSFLLYFLITLVGFVFIGRLFQLQILNKDTYDPIHNAAVKIEYDYPERGYIYDRNGKL
LVANQLSYDVMVQPNQVEPLDTLEFCNLLKIDKDDFLKRFQRAKHYASYLPSVFLKQLAK
EDFAFLQEKMHKYNGFYIQKRIIRNYPINAAANVLGYIGEVNEEKAKKSDYYQSGELEGK
DGVEKQYEDILRGRKGKKYLHRNRFNKVTGSYKEGIYDTLPENGKDLTLTLDIDLQLFAQ
KLMNGKRGGIVAIEPSSGEILALVTSPSYDPNMLVGRKRSINSTSLMDPNNPEKPTYDRG
LLAAYPPGSPFKIMNALIGLQENVINNNTTFRCFGGYRYGSRASAFMKCHCGIFNSPIHL
KTAIARSCNSYFSNTYKKIIEKNNEPKQGLDNWNRHISSFGLGNYLGYDLPAGQKGLIPD
ANYYNSRYKYAWGASTTISNAIGQGEVLTTPIQLANFTAAIANRGFFYTPHIVKKINKKT
IKNPNFTIKKQTTINKEHFTPVIEAMHEVFKTGTGRWSQVKGIEICGKTGTSENSIKMVD
GVKVQAEDHSILVAFAPKDNPKIAIAVFVENGGFGSTIAAPITSLMIEKYLNGSISDANK
YREQNMLNMSLQAVYDKQIPKPKQIASGKE
>FCMOIPGL_00291 hypothetical protein
MVSLFFSLLLLQVFVLNNILFLGYINPYIYITFVFLYPLKNNRIPFLFYSFLLGLFVDFF
SDSGGIHAFSILFIAYIRLFFVRVYFRKTETDYSFFNLNSESFGKVFNYVVTLTVIHHLI
YFSFANFSFQNLSTVILNTIFSSIFTLTLYFLGTYIFTKSK
>FCMOIPGL_00292 Cell shape-determining protein MreC
MQQLIYFFRKFKYFLFFLLLELIALTLTFNNLDFHKSKFVNSANSVTGGLYSKTSSISEY
WSLKSENKLLAEENTRLKNLLEKKISVSLIKDSTVIDSTKYQQKFTFTTAKIINNNYSKS
FNFLTIDKGENQGIEKEMAVINSRGIIGITDNNSKNYARVQSILNRNSKINARLKNSYYF
GTLGWNGEDYNIVQLSDIPRQAPLKIGDTIETGGKSTIFPEGILIGTISSINKGNSADNK
VNVTLFNDMSNLGYVQVIKNFNKLEINTLEAQNE
>FCMOIPGL_00293 Rod shape-determining protein MreB
MGFFDFMTEDIAIDLGTANTLIIHNGKVVIDSPSIVARDRTTGKIIAIGQEANLMQGKTH
ENIKTIRPLKDGVIADFQASEEMIKEFVKKIPSIKKKLFPPALRMVICIPSGITEVEKRA
VRDSAKHMNAKEIYLIYEPMAAAIGVGIDIMEPKGNMIIDIGGGTTEIAVIALGGIVCDQ
SVKVAGDLFTNDIMYYMRTQHNLHVGETTAEKIKITIGAATEDLDTPPDEMLVQGRDLLS
GKPKQVQVSYREIAKALDKSILRIEDAVMETLSKTPPELAADIYNTGIYLAGGGSMLRGL
DKRLSRKTDLPVYVTEDPLRAVVRGTGIALKELKKYKNVLMN
>FCMOIPGL_00294 Bifunctional purine biosynthesis protein PurH
MSTSKTIKSALISVFHKDGLAPIVKKLDELNVTIYSTGGTEKFIKELGINVIPVDEITSY
PSILGGRVKTLHPKVFGGILNRQDNESDIAELAEYNIPQIDLVIVDLYPFEKTVASGAPE
QDIVEKIDIGGISLIRASAKNFKDTFTVSSMDQYEEFLSILSENNGKTSIEQRKKFAAKS
FNISSHYDTAIFNYFNENEVVFKASEQNSKTLRYGENPHQKGYFFGDLDAMFDKLHGKEL
SYNNLLDVDAAVNLMNEFIGEDPTFAVLKHNNACGFAQRNTIKQAYLDALAGDPVSAFGG
VLIANKEIDLETAEEIHKLFCEVVIAPSYSDEALSTLKGKKNRVILIQKTTELPTQNVRT
ALNGLLVQDKDAITDTLKDLTYVTNTKPSESEIKDLLFASKICKHTKSNTIVFTKNNQLL
ASGTGQTSRVDALTQAIEKANNFGFDLNGAVMASDAFFPFPDCVEIAGNAGIKSVIQPGG
SIKDKLSIDYCNNNNISMVMTGTRHFKH
>FCMOIPGL_00295 Free methionine-R-sulfoxide reductase
MDTTFLLQEIDVIIASTKLSKEEKLQAICDFLESEISYYDWVGFYFKNGDKEELKLAQFT
GEPTDHVIIPFGKGICGQVAVSNKNFVVQDVTAQDNYISCGWKVKSEIVIPIFVNGENIG
QIDIDSHTANTFSAKDEHLLGCICEKLSEIL
>FCMOIPGL_00296 hypothetical protein
MKNLFAKISSFLLAFLVLFSTFSFTVEKHYCGDFLVDISFIGKTEACGMQMETVAPTKKK
NCCKDEVHKIEGQDKLQFSKIEKISFEKQQFLTAFVISYADLFVNNESKNNFYRDFSPPD
IRSDYQILYQTFLI
>FCMOIPGL_00297 Vitamin B12 transporter BtuB
MKKIIISSILLFIPVIFFSQTTLKGMIMDKNNPKDQLGVPGATLHWLNTNVSAVTNEKGW
FTIAYKNEYKKLVVNYLGYKTDTITINNLEPIHHFLTLESELEEVTINAKRKATQKSFFS
TANMFTVNADELLKAACCNLAESFETNPSIDVSFSDALTGTKQIQMLGLTSPYLLITQEN
IPSIRGASQAFGLTFTPGTWVESIQISKGAGSVVNGYESISGQINAELVKPFTDNKFFIN
GYSSLNGRLELNTHFNERVSDKWQTGVYIHGNYRGEKFDKNHDNFLDNPLANQVNVMNRW
QYTDAEKGWVSFINVRFLKDEKQTGEINFNPTLDKGTTNAWGSEIDTKRFETSAKLGYVF
PELPFQSIGIQMAYSNHQQDSYFGLNVYDIKHESLYSNVIFNSIIGDTRNKFKTGISFTH
DKFDELVNATDFSRIENDFGAFFEYAFDNLQNFSLTAGLRIDAHNLLGTFITPRLHLRYV
PWEKGVFRASVGRGKRSANIFAENQQLFASSRQINIDNVGGNIYGLNPEIAWNYGVSYLQ
RFNLFDKKGDITFDFYQTNFQNQVIVDWENPQEISFYDLNGKSIANSFQVEVNYNIAPFF
NFRTAYKYFDISTDFKSGNLQKPIQPQNRFFANLSYETVVKENNSHWKFDITFNSIGKQR
LPNTASNPVQYQLPAYSNPYQLLNSQITKVFSDKFEIYIGAENLTNVQQKNPILASNDPF
GSNFDTTIVYSPIFGRAIYTGLRFKIK
>FCMOIPGL_00298 hypothetical protein
MKKIVLVFSMIMIGFSVQSQEVKKNKNAKVSFEVDGICGMCKKRIETAALKSKGVKFAIW
SVETHQLNLIMDERKTDVATVQKNILAVGHDVLLEEDKKIEATIEAYNSVHPCCKYRDDE
IILDHKGELKKQKKQ
>FCMOIPGL_00299 60 kDa chaperonin
MAKDIKFDIEARDGLKRGVDALANAVKVTLGPKGRNVIISKSFGAPTVTKDGVSVAKEIE
LEDSLENMGAQMVKEVASKTNDLAGDGTTTATVLAQAIVKEGLKNVAAGANPMDLKRGID
KAVTAIVTDLEKQAKQVGNSSEKIKQVAAISANNDDVIGDLIATAFSKVGKEGVITVEEA
KGMETYVDVVEGMQFDRGYLSPYFVTDADKMIADLENPYILLFDKKISNLNEILPILEPV
AQSGRPLLIIAEDVDGQALATLVVNKLRGGLKIAAVKAPGFGDRRKAMLEDIAILTGGTV
ISEERGFSLENATLDLLGTAETVTIDKDNTTIINGSGDADTIKARVSQIKAQIETTTSDY
DKEKLQERLAKLAGGVAVLYVGAASEVEMKEKKDRVDDALHATRAAVEEGIVAGGGVALV
RAKKVLEKLATDNLDETTGVQIVNKAIESPLRTIVENAGGEGSVVINKVLEGKKNFGYDA
KSETYVDMLEAGIIDPKKVTRVALENAASVSGMILTTECALVDIKEDAPAGGMPPMGGGM
PGMM
>FCMOIPGL_00300 10 kDa chaperonin
MGLNIKPLADRVLVEPAPAETRTASGLIIPDNAKEKPQQGTVVAIGNGKKDEPLIVKVGD
TVLYSKYGGTDLKLEGKDYLMMRESDILAII
>FCMOIPGL_00301 Protein-export membrane protein SecG
MSYTAFLILILVVAVALILIVMVQNPKGGGLSSSFGGGGAQSLGGVQNTNNFLDRTTWTL
GIAMFALILLSNFAIPREGAGNVNLDNTLDGIESTSTPVDNTSSTTKDTVK
>FCMOIPGL_00302 hypothetical protein
MELNTNIEFIDNKRSIEQLDIAELKSVINEFPYFQSARALYLKRLKNQNSFKYNNELKIT
AAYTTDRTVLFDFITSEIFIEDQEEKVCKETKVELLTANTSDVIIKDNEIQTATASKPIE
IAKEKLEIGKPIAFTESENFSFNQWLQLSTKKPIVREDTVKQEANKKQSIIERFIENNPK
ISPLSKDKSVNVLVTQNKQDSSLMTETLAKVYLEQKKYENAIQAYRILSLKYPEKSGFFA
DQIKRVQILQKNKS
>FCMOIPGL_00303 hypothetical protein
MKKIIYISLFLINSLVFIACGAYSFTGGNTGKAKTIQIDFFPNQAQLIEPALTQRFTNDL
QDLFTRQTNLTLTSSNGDLHFSGEITGFRVTPMSGTSNQTAAQNRLTVTVNVRFENKLEP
KDDFEKTFSFYSDYGANSQLTGSVLEAALDEIIERLTQDIFNASVAKW
>FCMOIPGL_00304 Nif-specific regulatory protein
MENIQAIKQRFGIIGNDLHLDRAIEKAVRVAPTDISVLVTGESGVGKENIPKIIHSLSHR
KHAKYIAVNCGAIPEGTIDSELFGHEKGSFTGANQDRKGYFEVADGGTIFLDEVGELPLT
TQVRLLRVLENGEFIKVGSSKVLKTNVRIVAATNVNMQSAIQKEKFREDLYYRLSTVEIH
LPALRDRNEDIHLLFRKFASDFAQKYRMPSIRLDENAVAVLLNYRFPGNIRQLKNLAEQI
SVIEEERIVTAAKLQQYLPNNNGNFPTVIGSKKENDFSTERDIMYKILFDMRNDINDLKK
LTLDLMKSGNVEEVQEENHQLIEKIYGNTNSKTSKFEVLNIPQNSSEEKDYDFIETIEED
ESLSLQDKEVEMIKKSLEKNSNKRKLAAKELGISERTLYRKIKQYDL
>FCMOIPGL_00305 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MEYVEKIIDEKLQGKALVTEHKVENGKKLFIESYGCQMNMNDSEIVASILAEQGYNTTQI
LEEADLVLVNTCSIREKAETTVRKRLQKYNAVKQINKKMKVGVLGCMAERLKEKFLEQEK
IVDLVVGPDAYRDLPNLLEEIDAGRDAVNVILSKEETYGDVSPVRLNSNGVTAFVSITRG
CDNMCTFCVVPFTRGRERSRDPKSILEEIQSMVDRNFKEITLLGQNVDSFLWFGGGLKKD
FNKASEMAQATAVNFAQLLDMCATQFPKTRFRFATSNPQDISLDVIYTMAKHKNICKYLH
LPVQSGSNNMLKAMNRQHTREEYIELIDNIFRIVPEMSLSQDMIVGFCGETEEDHQDTLE
LMKYVKYDFGFMFTYSERPGTLAAKKMVDDVPFEVKKRRLQEIIDLQQEHALYRTQQHLG
KIEEFLIEGTSKKNPNEWKGRNTQNTVAVFPKGNYKLGDFVLLKVEDCTSATLKGTVIGY
SDNN
>FCMOIPGL_00306 DNA topoisomerase 1
MAKNLVIVESPAKAKTIEKFLGKEYQVESSFGHIADLPSKELGIDVDGNFSPTYIVSDDK
KAVVKKLKTLAKKAEVVWLASDEDREGEAIAWHLKEQLALKEESTKRIVFHEITKKAILK
AVDNPRDIDYNMVNAQQARRVLDRIVGYELSPVLWRKVKGGLSAGRVQSVAVRLIVERER
SILGFTAETHYKVVAEFSNKEGATFKAGIPKNFETKKGAENFLKSCINADFSIADLTKKP
AKKSPAAPFTTSTLQQEASRKLGFPVGKTMQVAQRLYEAGLITYMRTDSVNLSVDARNEA
AEEITNYYGKEYSKERVFKSKVKGAQEAHEAIRPTNMKMHTVDTEYDQNRLYDLIWKRTL
ASQMSDAQLERTNVKIENSENSKIFTANGEMIKFDGFLKVYLEGNDNEDEEQAGMLPNLK
VNESLDYTFINATQRFTSPPYRFTEASLVKQLEELGIGRPSTYAPTISTVQRRGYIEKGV
NEGVEREYQQLILSNGVVKTHTLSEKTGSDKNKLVPTDIGNIVNDFLVANFSNVLDFGFT
AKVESSFDDISEGTENWREMIKGFYQKFHDNVEDVKENAERESGERILGKHPESGKTVLV
RLGKFGPIAQIGAPEDEEKVFASLNNDQHLGTITLEEALELFLLPKTLGVYEGEEVIVSN
GRFGPYIRFGTMFVSLAKGENPMEVDMPRAEELIVAKQKADAPIYHYEDLPVQKGVGRFG
PFIKWNNMFINVSKKYDFDNLSDENIIELIEVKKQKEIDKVIHNWEDVAIRVEKARWGRY
NVIKGKIKIELPKTTEIEKLSKEEAVAMIEAKTPKKKVAKKRAPAKKKATAKKTAKKK
>FCMOIPGL_00307 Formimidoylglutamase
MSQDFLTPVKETVLAHLELQSSLCLGNKIKIYSEEEGFPELDNVKIAIFGVQEDRNSEDN
FGCGENLYFIRKKLYELFPGNWQTEIADLGNVLKGNSVTDTYYAVSEIITGLLKKNIIPI
IIGGGQDITYVNYRAYDLLEQTVNITAVDSRFDLGDLDSELTSQSYLSKIIMQEPNNLFN
YSNVGYQTYFNSQEEIQLLDNLFFDAYRLGKAKELENIEPAFRNADIVSIDIGAIRQSEA
PANNNASPNGFYGEEICAISRYAGISDKVSSFGIYEYNSQYDNNHQTANLIAQMIWYFIE
GVNFRVKDYPFSGKENYQKFTVILEDDDPLVFYKSNKTGRWWIEIRILSDNKYKRHALIP
CTYQDYKEATKQIIPERWYKAMRKM
>FCMOIPGL_00308 Serine/threonine-protein kinase pkn1
MKKAAIFALLITVFYSCGSNDRGELVGVKSNKKWFSEKPHGMALIPGGSFTMGKQDEDLI
GTLNTPTKTVTVRPYYMDETEITNNEYKAFVKWVKDSVVRTKLAYQAEFASLGATPDADG
NLPSGGIQNYKFKDTVANSTPYQKYMYENYYSFDTIQPLDWSEDIIWKTEDFPDLDYVEV
MDSLFISREEAVDGLRTFNTKYLKYKYSWFDRDNAARKGGNRKDFVQTEVLNIYPDTTVW
VKDFNYSYNDPMHQDYFYHQSYADYPVVGVTWEQANAFCNWRTKMKNDYLRTRKNATQVP
DFRLPTEAEWEYAARGGLDFATYPWGTGSTTSDRGCFLANFKPVRGNYSVDGALYTMEAK
SFNANDYGLYNMAGNVSEWTNTAYNLSSYYMASTMNPNVEDRKNKRKIIRGGSWKDVAYY
LEVASRDYEYADTARSYIGFRTVQNYIGTGNK
>FCMOIPGL_00309 hypothetical protein
MAQSKNKKKLFNIAYNIGASIVILGALFKLNHISYGWFNGSNVLAVGLIAEALIFFLSAF
DTPEDDLDWSKVYPELGEDSFSTEEKIGTEGLLSQKLDALLQEAKIDASLMTSLGNSMKN
FQGAAEGLSVASESISSTNKYNEQVSLAAVHMESLNNLYKVQVENSSKQTELNTAVVENT
ERLKMQMDSLAKNLSSLNGVYGNMLSAMSSK
>FCMOIPGL_00310 hypothetical protein
MAGGKMSARQKMINLMYLVFIAMLAMQMSREVLSAFGFMNEKLETNNISTIEKNKQAYAN
LATKASEQTEKFGKLNTQAKKIKQYSADFYSYLGELKTQMTTDLEDKKAYESMDKTTFLD
TYFFKGDNYTPKGQEFLDNINAYRTNVNATLGEGSKFEALINSRFDTNDVIDSDGKTVPW
LKYRYEGFPLIASLTNLTQMQADIKNSESEILNSLLGGKLEESLSLNNYKGIVALDKNAY
FAGEKVTGKIVLGRYDAEMVPDNVILNGKDYKKIESGQVIIDMPAGNIGNHDIKGKIAFT
QNGKVVEVPFESSYSVIPEPSNAVVSADKMNVVYRGLNNPISVSLPGVSDNNLSVSASGG
NLTGSNGKYSIKPGSGKIATINVSAKLSSGKTVNSKATFRIKDIPAAMGSVREQYGTVRM
PKSGLANSPISAGLPDFEFDLNITVKSFKIKVPGELTIIVNGTTLSAAAKKVLNKAQRGD
IINIYDIKATANGYNLKQVLPVNIELTN
>FCMOIPGL_00311 hypothetical protein
MNRNFLILFFAFLTTGFVSAQVNLLNAKSVDQIGKESIEQSVSDNDGPIPYGYVSDRDIM
WSKVVWEFVDLNQKINLPYYFPIDTTNISSDRRSLFDTLIRGIRQGQIQEAYSDSFFTSK
MTQDEINSRLVNVRTQNGYEDTYRVQSEDIGGYMLKGMWYFDKRQGEMKYRLLAIAPMGK
DVQTIGAEGIEDETLYELFWIFFPTARQTLHDSKVFNPDNATHPISYDHLLNARRFSSVI
VREENIYGNRAIEDYVRGNSLFQLLEADKIKEDIRNREIDMWNY
>FCMOIPGL_00312 Glycine oxidase
MKVDYIIVGLGLAGLAFAEELLAAKKTFIVFEDDSQTSSLVAGGVYNPVILKRFTPVWNA
KEQLAVALPFYQQLEKKLNIKFDEKFLIKKIFKSIEDQNNWFAALDKPLLSPYLDPKIDH
QKREGIIADFGCGNVREAGRIDTKKVVEVYRDYLKKEEKIQFEKFEHQQIKFRENHLEYK
DIATDRIVFCEGFGMSKNLFFNYLPLKEVKGELITIHAPDLEINFLIKSTVFILPLGNDL
YKVGATFNWRDKTSNPSEEGKAELVEKLKKVITVPYKIVEQTAGIRPTVRDRRPLVGVNP
AYNNLAILNGLGTRGVMIAPTVAKQLFNHLEKGEELDLDIDIKRFE
>FCMOIPGL_00313 hypothetical protein
MFKKGTKLYSISKGKCPKCQEGDFFKYKFTFNPSKVTKIHDHCPNCNLKYMLEPSFFYGA
MYINYGITVAISIVVFLITKLGFDLNLLQSFLSVFIALVILAPINLRLSRIIWINMFVSY
EEKK
>FCMOIPGL_00314 putative ABC transporter ATP-binding protein YheS
MGTELFSGITFKLNKGDRIGLIGKNGAGKSTLLKVLSKDIESSGTMAFDKDVKIGFLRQD
IDFVEGRTILEEAYQAFVEIKEIEALLDDINEQLVTRTDYESEGYTQLIHDLTDNTERYE
LLGGYNYQGDTEKILQGLGFQREDFDKLTDTFSGGWRMRIELAKLLLQNNDILLLDEPTN
HLDIESIIWLENFLKSYSGAIVLVSHDKMFLDNVTNRTIEISLGQIYDYKKPYSQFLLLR
GEIKEKQLQAQKNQEKEIKQKQHLINKFKAKASKASMAQSLMKQLDKVELIEVDQDDNKA
MNVRFAISKEPGKIIVEAENLSKSYGDKHVLEDVDLLIERNSKIAFVGQNGQGKSTLAKM
MVGEIPFKGNLKLGHNVELGYFAQNQSEELPPEKTVLEIMEDAATDGNRMRVRDMLGSFL
FGGDAVDKKAKVLSGGERNRLALCKLLLQPFNVLIMDEPTNHLDIASKNVLKEALKQFNG
TLIIVSHDRDFLQGLTSTVYGFKDKIIKEYLGDIDYFLDQHKIENLREAEKRTVVKAEKS
SAKIEVEQLSKEQEKDLKKLNNRLSKTETEIADLEAEIAKIDLELAKNYDEVSSRPNFFQ
KYKAKKAKVDSLMEEWEKLEAEISNFS
>FCMOIPGL_00315 D-cysteine desulfhydrase
MNFNSQIQTKNQQVFLPILEEKKVELFIKREDLIHPYISGNKFRKLKYNLEEAIKLKKKS
LLTFGGAFSNHIVATAVAGEKAGLKTFAVIRGEELGLNIAKTLEENATLRRAHESGMKFH
FVSREIYRQKSSFGFIEKMKNKWGDFYLIPEGGTNIFGVQGCEEILTSEDKKFNIICCAV
GTGGTISGLINGSRRNQKLIGFPALKGNFLSEEIKKYSTNNKKWRLQKEYTFGGYAKYDD
ELISFINSFKKETDILLDPVYTGKMIFGILDLVKKDFFEENTKILAIHTGGIQGIDGVNQ
KLKEKNKEIILL
>FCMOIPGL_00316 Autolysin
MKVKILLCCLFILMLSNCGSSKKTVKSKTKTTHKEIESKVENLPDVHGDEHIDKLEEGSK
RLNENSLEYIKKYAAIAVREMHLHSIPASITLAQGVLESGSGRSELASKSNNHFGIKCHT
DWQGKRVYHDDDEKGECFRKYKYVSSSFKDHSLFLTQRKRYAFLFTYRVTDYKKWAKGLR
KAGYATDPRYPAKLIRIIEDYKLHDFDRIKQDGFKYESNIEEGEEDNNEEVHFYTVKKGD
TLYSIARKFKVSVARLKQINNLRDNIININQVLKTE
>FCMOIPGL_00317 hypothetical protein
MKSFVLKVTTILFVFATSLGFAEHQSTKEPVKNQTIKVALLLDTSNSMDGLINQAKAQLW
EIINELSYAKYGQKKPNLEIALYEYGNSNLSSREGYIRQVLQFSNDLDEISEKLFSLTTN
GGNEFCGQVIQTSLNELSWGKNKNDLRLLFIAGNEPFTQGKVNYKDAIVNAKEKDVVINT
IFCGNYSNGISGMWKDGADLGGGDYLTINQDEKMVHIVTPFDDKIIILNKKLNNTYIYYG
NNGYSKFSSQKEQDVNAATLDEVVIVKRTVSKSSRLYDNSSWDLVDADKKQKIDYKKIEK
KKLPKELQNKSEAEIRAYVKLKGEEREEIQQKIKELDTKRRNYVAKKQQESSKKNNLNNV
LIKAIKKQAKLKNYSW
>FCMOIPGL_00318 TonB-dependent receptor SusC
MMKYKITIPKPCHENWNNMSQTQKGKFCKSCRKEVVDFTKSSALKISKKVLKEENLCGRF
KDAQLNKEIETNKKSNLKKIAASLVLVATIAVSESVFSQSKKDAVEVVNYQKGKVLIEND
SIEKFISIKGKIKDKLGDLPGVSIVLKGTEIVSQTDFDGNFLIKIPNKKRKSHILVISYL
GYKTQEIDVLSIKKPLIIQMEEDDAILGEIVITTGMIAIEKKPNIFKRIGAFFRKKDKNN
D
>FCMOIPGL_00319 Sensor histidine kinase YpdA
MTKKIYIIFILLFGVLTNVFSQVNIINQKGTDFFVRITIVDKHNIKIVKNIDIEVNGMYY
SLPDVNGRFIVKAKVGDEIRVSHPDFETVYYTLTSSEDIKIIVENYENKRSISSKLKTVS
KETDFYLGHLDSAKFYKKKDIEKSLSFIEKALKNKENTKRNAATYKLLADVYLYWKQFDL
AVYNYKLSYQINKEINTKIALANAQFLLNNFDESKQTYQELSKEKLSIYERIQIFEGLGD
VFFKTKIFETSIINYQKALQVAKDNLITPKITDLNSKIADVFAAQGKINKAETLFKNSLN
LAEKENPKRALEEEEKVADFYNSNRRFDDEIQLRKKSLIKAEENEASKRKSIEKDSITSQ
KINYKIGNAYLLKEDYKEAIPFLQKSIKGANDKEDIVVQKEATRKLSEAYVTVGDYNNAL
KSYQEYVELVDELYIKKEQEIQQVKRFSKKIADNQNRIASLEKDQELAQSKISLAYVDQK
LSEESNQRQRIIIYALFGGILLLSLLAYFMFRNNKQQKLANNLLALKSMRSQMNPHFIFN
ALNSVNSFIAVNDERNANRYLSEFSVLMRAVLENSDEDFIPLTKEIELLELYVKLEHNRF
KEKFDYQINIDKTIDLEQFSIPPMLLQPYIENAIWHGLRYRTTKGNLEISINRKDDETIL
ISIIDNGIGRKKSQELKTKNQLKQKSKGMSTIKNRITILNNMYKDRISVNVADVLENGEG
TKVALLLKKK
>FCMOIPGL_00320 Sensory transduction protein LytR
MKLKAIIVEDEQISRDILRNYIGKYCPNVQLLGEASNIDEAYKLIQKHELDLVFLDVEMP
FGNAFDLLEKVENRTFETVFVTAYDHYAIEALNNHASYYLLKPISIDELIKAVNIVTEIK
EKENQLQHQILAPKANSATGKITIPQQDGFEVLDINDIVFCKADDNYTEIHLANSKKLVS
KTLKYFEEALTEYTFARIHKSYLVNVNAITKYKKGKGGSVIVSNGKEILVSASQKGNLLS
YFK
>FCMOIPGL_00321 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MAVIKPVQGKHPQIPEDCYVAENATIVGEVSLGKECSIWFNAVLRGDVHFIKIGNKVNIQ
DGAVIHATYQKSPTTIGNNVSIGHNAIVHGCTIQDNVLVGMGSIIMDDCVVESNSIIAAG
AVVTKNTRVESGSIYAGVPAKKVKDISQELISGEIDRIANNYLKYSSWFKE
>FCMOIPGL_00322 hypothetical protein
MKKIASILILVFAFTVSTQAQKKEKRNERGPKLTVEQYTDLAVKKMTLALDLTDKQQGQI
KPIISAQAAAKKAEMQSRKENRDANKKPSADEIYEMKSKQLDNQIAFKNKMKDILNKEQF
EKFEKMAKKRKGKGKKMMKNKDAKRGKGNKRNNK
>FCMOIPGL_00323 hypothetical protein
MKKIVTILILVFAFTLTAEAQKKEGKNPVDRMLSKMTTDLNLTTEQQNKIKPLIEEQIAD
RKAMTDLRKMQGESGVKPTQEDRKKMREDRMAKEASMDAKMASILDAEQLEKYNLQKEEL
KGRRGQNRKKKDNE
>FCMOIPGL_00324 Low conductance mechanosensitive channel YnaI
MKRFIWLFAFITFYANAQDTVEVNLSSPHATIYTHLYFLQTDSYQPEKAAATILGLSEEK
AIQKAIKIKQVLDGKGLNVDFNKIPINANYKDSIGFTTFHKYILFPQRMPKIYVEKVGNN
WYYSAETVASIDQIYKDVFPWYVEKLQEVIPVSGHIKALGIELWQVLGIVLLLILVVIIF
ILAKKIAFFILRRIQHQVTHRTSNLELDKVLKKLAHPISLLISLAFIDKIFPSLQFSLEI
NTWVFLALNIAETIFWIYVLLKLVKVVMRIYEEFTERTESRLDDQLVPILNNFLKGLVLV
FGLFKVLRLFGVDTTTLVAGATIGGLAFALASQDTVKNLIGTIMIFLDKPFHIDDWIETG
EFAGTVEQVGFRSTIVRGADTSIYQIPNSKLSEIVINNKGLRLFRRYNTNLGVRYDTPPV
LIEAFVKGVREIVIAHPETRSDSYNVEFTGFGDSALLIMVNVYFKSLAWGVEQSSKHRLH
MAIVKLAKELGVEFAFPSTTVTIEQFPEKKSLDLRYNTDQEKIDATISKIVADFTAENPM
ENPN
>FCMOIPGL_00325 hypothetical protein
MIRFLIIFFRFLLLLIIAFVIFFFWASSATLDENDYAKLLEDNSIEVPVNDSVFSIVTYN
IGYLSGMTNNRPIAKPKELFDDNLATVLSETKKINPDIIAFQEIDYNASRSYKVNQQEEI
AKLGFGYRAKAINWDERYLPFPYWPISMQFGKVVSGQSIISKYPLKEHKRIVLSRVADEP
YYRDVFYLERLAQVVKVVLNEKEVVIINIHLEAFDKATREKQFEEILQIFNEYKDKYPTI
LLGDFNSSATNKTAVVQNLFANNEIGNAAFDFQNLEKTFDSKDPYERIDYIFYTKNSIEY
VSGKVLNSFGQSSDHLPVFMEFKLK
>FCMOIPGL_00326 2-hydroxy-3-oxopropionate reductase
MKKPTIGFIGLGLMGGNMVENLQNRGFKLIVMDLNKDEVAKVIARGNATEANSPKELAEN
SDIVMFCLTTSAVVEKIVYGENGILAGIKEGAVLIDFGTSIPASTIKIGKDLAEKGAGMI
DAPLGRTPAHAKDGLLNIMAAGNKETFEKVKPVLDEQGENVFYLGGAGAGHTTKLINNFM
GMTTVVAMSQAFAAAELAGVDKQQLFDIMSSGPSNSPFMKFCKHYAVDNVSDLGFSIANA
NKDLGYFVQMMNDLGTVSQIAEATSANLQTAVNADMGNGNVPEIFDYFVKLKK
>FCMOIPGL_00327 putative tRNA-dihydrouridine synthase
MNQTLLSSPLQGFTDHKFRNAFNHFFGGIDTFYAPYIRLNGKLIIKNSYKRDLLPENNTE
LEVIPQIMTNDADEFLFVTKYVQELGYKELNWNLGCPYPMVTKQGMGSGLISDFEKINSI
LHKVHNESDIIVSMKMRMGYDTPEEILDVLPILDTYPLKNIAIHARIGKQLYKGGTDLDA
FQKCLDNSKHKMYYNGDITSVAAYKKLKERFPSIDHWMIGRGLIADPFLPSMIKANTTEY
PKNRFDIFNEFHDRIFQEYDAALSGPTPIKMKMLGFWEYFSQSFSNPQKTYKKIKKAGNV
KNYAKAVEEIFKDEKSYF
>FCMOIPGL_00328 hypothetical protein
MNYTLLENKEIKPDAINCKYFTIKEELIDKVDVLIVSFFGEYPDGSLGKKHGTYISKKAI
SGIIDFNPEAIILDFRELMYNWGNSILSVFQDIEQFKNAGNEENEPNFPILIVTSEKSKK
GLLSLLTPATSNSVPDFIFEDINLAIKEAEKRGSYWLNN
>FCMOIPGL_00329 hypothetical protein
MSPFLKVFYLLSISSLFACQQNKKSVANQLPAIKEKEVVSTTNQFNNYWYSGKAELNSYE
LKQSRYGEIREGEVVLVFVTEPFSLSKQVKLDRPKNAGNDNVPVMKLNNIRKFTTGIYDY
SIVTSTFTPIDSKKYPHTLKSNTSIQEWCGHTFTQLNLKEENYHFQEFSYFEADGDTEKN
IPVALLEDELMTRIRLNKGELPLGEIDMIFSTLYSRFAYQKMKSTKAKISKTAAETTLTY
TVEYLNYDRKISITVQKEFPYRIQSWTEDNGNGLITEASLKKSINEPYWNQKSVTDEAKR
KELQLSN
>FCMOIPGL_00330 hypothetical protein
MKKSILLLILILTLNCSSTNTKKHEPELSFEEKIDLLEYNLILPFKWHPYLDIHKDIAFS
PLITSDKNSRVHILIMKIPPSEHNDISLKEIAEKGNKNLAKYLTVYGAKITTEQSKFGET
CINTYSYTLNSNKIKLEKTYFKFQEDYYCFIYASDESLFPKYYTDSKKIFESLKFKE
>FCMOIPGL_00331 hypothetical protein
MKNTILIIMLALSSIIYAQENYKIEINGETFEIKLGEDYEINVNDNLLKINVKQKDTLLY
FDEVFNFKHPKEYNVAKTDLGDGVEQLMLMTAEGSGFMIQKYSTINPTTLNELMISEVTK
ESISYGYKLTREDYERKLASGLKIKVNKATLTYNDEVNIYEIATIGKKDSGLIIMSMEMD
DLKKSQGKQLINLIWNTLDIK
>FCMOIPGL_00332 hypothetical protein
MLCVCIKAHHITNFVRNVNTQKIMKNTLILLFLISTFYSFSQNSAIKPYSDYLKKIEKKS
AKDYILQKFKNHDIVILCERDHSEFSQYELIKDVLSDAYFKNNVGNLFTEIGVLNLQPEI
TEFLKTKNLDSAFVEKKLNTFQQNATFWFIWERYNYHYLLRTIYDINNVSQNQISYFPSD
VEFDWKTVQTVEEYTREQDFEIEPRDSLLAYNIINQYKKLSSKNNKKALIILNYRHAFKI
HTTSNNGELVKNAGKYLADYFGNRAVSILSNRPIFVKKENRYVYELIHDGKWDAAFKEQD
IENIGFDFDNSVFGNDDFDLISAKNNAKYKDVFDGFVFYKSIENQHLIEFYDGLVSKDFE
QEFFRRYKIQLQYYEDSTRVKKLESKEFRETVLKKLNTTRKRKYPNFEHLIERRDTYLND
>FCMOIPGL_00333 hypothetical protein
MKIVKKILGGILAFILVIIIIVAVKFSTDRNNPYDNTIAENLIPTFKEISIDFTHQFNGT
ESLPVTASVLIDIDNDGVDELFLGGGYNQQDEIFSYKNGEFVSISKNVGLPAKENSTTLS
GASTDFDNNGFTDLILSREDGIVIYYNTNGKFTPKKLDYDLAANATPLGLTLGDVNKDGH
TDIFVANYIRKKQMVGQNNFSKNYGPQSLLLINNGDNTFKNTTIAAGLEYIHNTFMGILI
DIDNDTWLDLVIAYDTGEIRTYKNKGDGSFEMKENPSTNKYGYPMGIAVGDYNNDGLVDF
MFSNTGSTVPSFVASGNIEDKSLFNPNWIFFENKGNFVFEDVAEKTQTKDFEFSWGAVFA
DMNNDGLQELIVAENYIDFPPHKIFKLPSRFLTQKEDHTFVATEEKSGVVNPNYAITPLV
SDFNKDGYLDLVWVNIGTPVLAYINNGGDNNFVQVKLDDTAKNLGAKVEVVTSTGKKITE
DFIVGEGLTSDQSATLHFGLGKDTIKSVVVKYISGNEYTFSEAKINTLLTIPKVIISDAI
STTDLTQE
>FCMOIPGL_00334 hypothetical protein
MIVDKKKIFIAGLLGLFASIIVGAGEFLLHFSPQIIGNAENYQFFQFVSENNLITGHFLA
VFAIPFYFVGYYHIYKMLEKGNKKLASIVFGLGILAFTIGGFWMTSRAFLGTIVHLQNDI
DVNVYQKILDNYTLISESLVQFLRIIILLLSIFFSITILKGGTYYKKWMAIFNPIVLLIS
VFAIYFISPEIGKYIAPIAMNVVHFILFSLSLYQFNKIKKSSL
>FCMOIPGL_00335 Thioredoxin reductase
MNRVKLYGADWCPDCRRAKSFLSDNNISFEFVDVDLDKAATALVESINNGKRIIPTLLID
DKSYTNPNNNIIASIFGINEVGTVQLFGADWCPDCRRAKSFLTDNNINFEFIDIESEWAT
KKVEEINNGKRIIPTILIDNIPFTNPDNAKLTEVLSINTEKSHKIFDTVIIGAGAAGLTT
SIYAQRDRFDSLILEKSTVGGNAFLTEKIENYPGFESISGPKLMERMEAQATTYGAKIKT
GEDVLSISKEDEIFTIKTNTASYLSKTVVLSTGSTYRKLGITNEKELIGSGIHYCATCDG
AFYREKDIIVIGGGNSALEEGIFLAGFCKSVKIVNRSKEFSASPTYIEKLKTIKNITTYM
NQTSLEFVANEKGMFENLKVVDNETKEESSLSADGVFVFIGLIPNTKVFENVVDLNERGF
IKTKNLAETSIKGIFAAGDCREGAIAQVAAATGEGVLASYGIRNYLK
>FCMOIPGL_00336 hypothetical protein
MKWIHKYSFTNKAFLLGFLISFIGSLPLGYLNIICLQILVAQGHLAITSFILGVIAVEFF
VLKVVSFGAKWLVKQKKLLLAIDIFTILFFTSIALYFISNNDETFVLSQLEFATYPFLLG
LLLNGLNVIQWPYWSGIYIYVYRNNKLKTTKKANYLFIVGALIGTGIGMLLFAYLGQYIL
VENNIEISNYLNLVFAILFFILASIQISKLVINQNKKVKKTSNKN
>FCMOIPGL_00337 hypothetical protein
MRSLKNTIHKILNWEYWNTNVIYFPIYFYWLFLSIKARSLGFFNASNPKIINGGFALESK
KEIYDLIPTQYYPDTLFFKAHETSVNIKKALKNTSIDFPFIIKPDVGLQGLRVEKINSWQ
SLETYLQKTNYDFLVQNCINYPLEIGLFYYRMPNETEGTITGIVNKEFLIVEGNGKNTIQ
ELIEQNPRFSLQLATLKKKYGTLLNDVLPKDKKFNLMPYGNHARGSKFTDVSNKVTKKLT
ETINTICLQIPDFYFGRLDIMFNSWEDLEQGKNLSIIELNGAGSEPTHIYDPKHSIFFAW
KEIIKHYDILYKICTYNHQKGHSYLNLKQSRQLIIDNKRLTNYLKSIS
>FCMOIPGL_00338 hypothetical protein
MHIYCKENLNEIKNVLIQLTNKQYTFKSTNLFGSTIGQHVRHILEIYQSVLNGFETKVIN
YDNRARNLLIETDTNIAIAVIDEICLKLTENQQNIQMVLEGNFCKKEGKQIKIETSLLRE
LAYCLEHSIHHQALIKVGLLEVKCMNFIDDTFGLAPATIRHRKHCI
>FCMOIPGL_00339 hypothetical protein
MTIKKKALILLVLGIIITVRIGFYMFNQPARDIQATKTDISEKTTIVVNDGKISLNSKFN
LTLADYEVAFKKGKPFTNIAKTVAVSVEAHY
>FCMOIPGL_00340 hypothetical protein
MRNTLILLILISTFYSFSQNSEIKPYSDYLKKIEKKSAKDYILQKFKNHDIVILCERDHS
EFSQYELIKEVLSDAYFKNNVGNLFTEIGVINLQPEITAFLKTQNLDRAFVEKKLNTFQQ
NATFWFIWERYNYHYLLRTIYDINNTSDNQISYFPSDVEFDWKTVHTAEEYTKEQDFEIE
PRDSLLAYNIINQYNKLSSKNNKKALIILNYRHAFKIHTTSNNGELAKNAGKYLADYFGN
RAVSILSNRPIFVKKENRYVYELIHDGKWDAAFKEQGIENIGFDFDNSVFGNDDFDLISA
KNNAKYKDVFDGFLFYKTIENQHLIEFYDGLVSKDFEQEFFRRYKIQLQYYEDSTRVKKL
ESKEFRETILRELNTTRKRKYPNFEHLIDRRDTYLKD
>FCMOIPGL_00341 Inner membrane transport protein YbaT
MNKKISLKEAISIGIGGMVGGGIFAVLGLAVSLAKGGTPIAFLFAGILALITSYSYVKLS
TKYPDRGGTVKFINQGFGKTIFSGGINNLLWISYIIMLSLYASAFGSYAPNLLALTNDKI
IDSHIYASAIIVLATAINYYSIAVVGKIESYAVIIKLVILISFIFIGAYGLIGNPNISQL
AVSQWEGPIKLFAGGMVIFVAYEGFELIANAAPDIINPKKNIPKAYYYSVIFVIVLYIII
AFVTVGSLPFAKIATAQDYVLAEAAKPMLGKIGFTIITVAALISTFSAINASLYGGSKVN
YEIAEDDELPHHFLAKLWNQPIGLLITAIATLILVNILKLESISTAGSVGFLLIFGVVNL
VGYRLSKETGSNKIVPLVGFVLCIIATIILIHQQYTSNTIGAIIALVIILFCFTLEWVYK
KTEKK
>FCMOIPGL_00342 hypothetical protein
MFRLSKPTIPILQILTILCLIYSCSPKKTDYVVAVYQTSQSGDNLKLITKNQPTPTSEKI
KKVSLQVNPDLKFQEYVGFGASFTESSAWNLATIPKTLRKDVLTRLFSPTAGAGFSLTRT
HINSSDYSNKHYTYVDSGDTSLSSFSINEDMKGFTGEENDQVIGIKLITPNYDLIPMILE
AKSIKGADFNIIASPWSPPSWMKSGETSEMTNGSLLPEYYGVWAKYLSKYVSAYAEQGVD
LWGITPQNEPLHAHNARWDSNGFTAEQGRDFLRDYLGPQLVADDHLNLDDLDAGLRVLLY
DHNKSTMNNYVNTTYNDVEAAKYAWGTGFHWYANSELEENNWYQKSLDTLRTSWPNKGMI
HTESSIDIDAKDPVGQYWRESTDYAGTFVPFDTYAYDIITDLNHGVQGYIEWCMILSDKG
QPNPYDNFNSAPVLINPVTDKVIYTPLYYLLSHFSKFIRPGAHRIELIGEELEGLAYTAA
INTNGSIAVVVFNRTTTPLDLELTLKSTTHKTQIAPRALQTINITNSTTKK
>FCMOIPGL_00343 hypothetical protein
MKPNLALASILSLFLLIIGCSQPETTIIKESSATTIELKDNWYYLNGEKFFIKAIGYEIG
ARPGQHPYEDEKKDHLELMKFDLENIKKGGYNAIRTWSQFSEAQLQLVQESGLKLIMGLE
VNPEEDYSDPKFINHCKTQLENILKYAPKYDCIITYLVINEPQTDHIHKVSASSFKDLMK
MMIDMIHEQHPNIPVTLSANAMISDWMDESMYDVYAYNCYGYNEGQTATMGFRDYIKGLN
TLNGLDKPFIITEFGHSVSPKGGFGSFGSRTLQEQSEGLISNYRDLIDAGSVGMCPFYYA
DGWWKGGEKSIHNKEQPEEWFGFWGYKDVNDKYGSPRPVWFAMRDYMKGLIISPKNKTVH
TNTTIPIELYNDNSIKKVVVKNRDKIIYSKNITKEGYFSDQLTINPEGLEAMELAFEFFD
SEDNSIKNESIIILASKTAIDLPKLTIEVTPKKDLNDTKVGSIKTRIETSENFKLIGDLI
VSYNTHLGWDVGPQESVSVNDQMDKKVITSENFFTIPDNCWVVNASAGMSVRYGKFTFKI
HDQKIIYRDDWAKEISRK
>FCMOIPGL_00344 hypothetical protein
MCMYYSDIPTKKISIQFPQLCDALYRFGKIDKELAQNLLIDFKPLLIESYKNIGFRKLPS
GLNTLGKLNIDYAQSLLRELSIEDLKNRIDNILNNENNINGALGEIKKVDEKIWKTFYEY
ANA
>FCMOIPGL_00345 hypothetical protein
MTKKKILLQLFLVAFVFGFSTKANAQFWKKKKPETKKTTKPAAKPKKGDIQPYGKVVTKD
FTTDEGLFKVHQDEGTYLFEIPDSLLKREMLMVTRIAKTASGIGFGGGKTNEQVLRWEKN
NKQILLRIVSHDVVADTILPVHEAVVNSNLEPILFSFPIKAFSKDSTATVIDATALFNTD
VKPFGFPNFYRKAYQATRMDNSRSYIDRISSYPKNIEIRHVKTYFANKAPSNSDLGSITI
EMSNSMVLLPKVPMKRRYFDERVGWFTSRQTDYGLDVQKSKRVAFLDRYRLEVKDEDIAK
FKSGQLVEPKEQIVYYVDRATPEEWVPYIIQGVNDWQVAFEAAGFKNAIIAKRAPTKEED
PDYSPEDVRYSVIRYLASPIPNANGPHVSDPRSGEILESDINWYHNVMSLLHNWFFIQTA
AINPDARGNNFKTETMGELIKFVSSHELGHTLGLPHNMGSSSAIPVDSLRSASFTKKYGT
APSIMDYARFNYVAQPEDKGVALMPNIGLYDKYAISWGYRPILDKTAEEEKETLDAWILA
KAGDPIYRFGRQQGAVVDPSSQTEDLGDDAVKASTYGIKNLQRILPNLEKWTSEKGKTYD
DLATMYGQIASQFARYMGHVSSNVGGIYENYKTTDQEGAVYTHVDKKRQKESLQFVITQL
FKTPTWMLDKDIFSKVQSSGAIEDIRSLQARTLNSILSTDRMARMIENETLNGSKAYTLV
SMFSELRKGVWSEIYSRKSIDTYRRNLQKAHIERLDYLLNKVMNQTGRYGSATVNVGQSD
IKSFARGELNRLRRDVKAAASRTSDTTTRYHLEDVVARIDVALDPK
>FCMOIPGL_00346 hypothetical protein
MKTFNFYLVFSFLLIFSSCVPNADDIQNPETEDTTETPIDVLENLLIPDNFNFETERSVT
LSISDATPFVKYEIFAYSENSSSEEENISEALNNLLYSGKPFNGELNQSFSLSSVYDKVY
LLRKDGLEYTSEIITILNNQINFKSASKTTNSDKSASKTNTDSCSICTDNFFLNSDFENG
PTLPTTFIITNETNVEGWSTTATDNKIELWKSGFNGVPAQNGTYFAELNANQSSALYQRI
CTSPGAEISWSVWHRGRSKVDKAVVRIGENLATATIEATMETGTSAWVQYSGTYTVPADQ
QDTYFIFEAIGGGSVGNFIDNIVITETVAGDCTSVNNKMYYPTELTNATLAFEDLWPYSG
DYDFNDLVISYNIQTILDAENNVTQLDYNYTLESIGASYTNGFGLELEGVSPSAISNVTG
QNLTEGFIQNNANGTEQSQQNAVIIFFDNSHINVGISNTISIVFETPITTAALGTAPFNP
FLIVNKDRLKEVHLPTKATTYYPTTTTIETSGDVKDSDGDFKSPTGLPWAINITGEYRAP
KEKVLITDAYNYFATWATSGGTRKIDWFQSKNGYRVEANLKD
>FCMOIPGL_00347 S-adenosylmethionine synthase
MSYLFTSESVSEGHPDKVADQISDALIDNFLAFDKTSKVACETLVTTGQVVLAGEVKSKT
YLDVQKIARDVINKIGYTKGEYMFDGNSCGVLSAIHEQSPDINQGVDRAKPEDQGAGDQG
MMFGYATDETENYMPLALELSHRLLIELAALRRENKEITYLRPDAKSQVTIEYSDDNVPQ
RIDAIVISTQHDDFDASDDVMLAKIKKDIVEILIPRVVAKLPVHIQKLFTNDITYHINPT
GVFVIGGPHGDTGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSGAYATRHIAKNLVA
AGLCKEVLVQVSYAIGVAKPTSINVETYGTSNVDLTDGEISKIVESIFDMRPYFIEKRLK
LRTPIYSETAAYGHMGRTPEVKTVTFTNPMGETVSEEVETFTWEKLDFVEKIKEAFKL
>FCMOIPGL_00348 L-methionine gamma-lyase
MSTHKLATNALHAGHDVTQNGGTRAVPIYQTSSYVFNNSEHAANLFSLKELGFIYTRLNN
PTNQILQDRLAAVEGGIGAVVFASGTAAISTGLLTLLKAGDHIVASSSLYGGTYNLLSVT
LPRFGITTTFVDASNPDNFAEAVQDNTRAFFVESLGNPKLDVLDLEAIAVHSKAAEVPFI
VDNTVATPALLNPIKHGANIVIHSLTKYIGGQGTSLGGAIVDAGTFNWANGKFPEFTEPS
AGYHGLKYHEALGAASYTFKLILEGLRDFGGALSPTNAFNIIQGLETLPVRIQQHSKNAL
ELAKWLEEQEEVAWVNYPGLESSKYKDLADKYLPNGQSGIVTFGPKGGFEAAKTIADKTK
VFSLLANIGDTKSLIIHPSSTTHQQLDEKEQESAGVSQDLIRLSVGIENIEDLKADLKAA
FSEL
>FCMOIPGL_00349 Bifunctional aspartokinase/homoserine dehydrogenase 1
MSKLKDLLQHIKINNFTTEVGALISELNLSYQEFGQKLGSAPVVLINHALTGNSNVAGKN
GWWQDIVGENKAINTDVYTILSFNIPGNGFDEFLIDNYKDFIARDVARIFLEGLSILNID
KIFALIGGSLGGGIAWEMMVLNNKLTQHFLPIATDWKSTDWLIANCQIQEQFLVNSSNPV
HDARMHAMLCYRTPESFKERFHRSKKEDSDIFDVESWLLHHGKSLQERYQLSSYKLMNQL
LKTIDVTIGGEKSDEILDKIDANIHIIGVDSDLFFTAEENRETHKKLALTKDNVTYNEIN
SVHGHDAFLMEYDQLQKIIEPIFNKDYREKKMKVLKFGGKSLANGKGLKNAIEIIVNKYK
SGEKITIVASARGNSTNELESILQNAAAKTAYKSKFEEFKTYQLEPNSEVDFSEEFSKLE
TIFEGVSLLGDFSQKIKDEVLAQGELLSVKLVASLLEKENISANSVDARTLIITDENFGN
AQPITALSKENVISYFKNSNAINVVAGFIASNKKGETTTLGRNGSNYTAALLANYLDADE
LQNYTHVSGIYTANPDLVADAKKIEQLSYSEANELANFGATILHAKTIIPLLEKNINLRI
LNTFNKEDKGTLITSESSTKGIKSISTIDDVALLNFEGRGLLGKVGVDARIFKALSDRNI
SVSIIAQGSSERGIGLIIDAHNSEEAVAALEKEFENDFYSQDVNQISVVKNVSVISIIGQ
DLSEFHLPYNALIKNQIVPVLFNNTVTGKNVSLVVKRNELYKAVNVIHGQVFGVTKKINI
AIFGKGLVGGTLIDQIIENTQSVLERRKLQLNVFAVANSKKVLLKKDGVSKNWKENLLEK
GEENVNVNDIIDFAKEHHFENLIAVDNTASVNFVANYIPFIEAGFDLVSCNKIANTLSFD
FYKEVRSKLKEYKKQYLYETNVGAGLPLIDTIRLLHESGENITKIRGVFSGSLSYLFNTF
SAENVSFSETLQEAIDKGFTEPDPREDLGGNDVARKLLILARELELENEFDEVEIKNLIP
ENLREGSAADFLSNLELLNEEYQIIKDNQEPNHVLRYIGELSGDLSKNKGKLEVKLVSTD
KSTPLGSLKGSDAIFEIYTESYGEQPIVIQGAGAGASVTARGVFGDILRLAKHNN
>FCMOIPGL_00350 O-succinylhomoserine sulfhydrylase
MSKHFETKAIRSQTERSQFSEHSTPLYLTSSFVFDDAEDMRSSFAEEKERNLYSRFTNPN
TTEFVDKIVDMEGAEAGYAFATGMAAIFSSFAALLSAGDHIVSCRSVFGSTHGMFTNYLP
KWNIETSYFKVDEVDLVESLIKENTKVLYIETPTNPAVDILDLDRIGKIAKKHNLIFIVD
NCFATPYIQQPIKFGADLVIHSATKLIDGQGRVLGGVTVGRKDLLREIYLFARNTGPAMS
PFNAWVLSKSLETLSIRVEKHCENALKVAQFLEENENVEFVKYPFLQSHPQYEVAKNQMK
LGGNIVAFEIKGGIEAGRKFLDKIKMCSLSANLGDTRTIVTHPSSTTHGRLSEEDRLEVG
ITNGLVRVSVGLEHADDVISDLKQALGN
>FCMOIPGL_00351 Alginate lyase
MKLFFNFFTVLVLLFSFFSCSKDSSTVEESGSLSLSTLTVFSADGESKSIRVTSNLNWTA
NVDENWISITPSGGANSESILVSVDENTTNSDRSGELTVSGGSLSRVITIEQSANGDNQS
SSGLDSNKSPSENFDLSTWNLSIPVNKGDGTATTITVSQLNNKYENDAYFYTADDGGMVF
KCPVDGYKTSTGTSYTRVELREMLRGTNTSISTQGVNKNNWVFGTAPQADINAAAAFDGE
MSATLSVNHVTTTGDSSQKGRVIVGQIHANDDEPIRLYYRKLANNTLGSIYFAHEPTDGN
GSEQWHDMIGSRSSSASNPIDGIALDEKFSYTINVVGDALTVTIIREGKDDVVKTVDMKN
SGFNVSGQYMYFKAGVYNQNNSGDADDYVQATFYALEKTHTTN
>FCMOIPGL_00352 HTH-type transcriptional regulator CymR
MLSKKTKYGIKALTYLARQENKTPVSIATISKSESISLKFLESILLTLRKNGLLGSKKGK
GGGYYLLKEPSEIQMTVVMRILEGPIAMVPCVSLNFYEKCDDCPDENICAVNKLMMQFRD
SSLQIFRNTTLADLTFKKA
>FCMOIPGL_00353 hypothetical protein
MKKNVVFFLIFLISFAVFSQEENESKTKLTNFLSKSYYSINLGGIFYPFSNDNLIDGYKT
ETFSRNWFSGRLLLGHKLTGDLAVQFGTMRPASWFKYDNVNNIGYDRSVWINAWSLSLKK
DFKLHSNTTFYAEAGIANLTRFGFSINDKEIYKDAHYASLLYGFGVQHKLNDKWRLSLNG
TFLPKSTKQNQPSISQVSLGFEYHLQQLQGKKALQFANNDYFFPKNIFQVSYGTSAIGFG
VNRFFGMSLKVGNFESFGIPIFWVGEVKAKHAFSLTYQRLIFRTEKIFSLDWGTSITAFQ
SELTNENVFAFSIFPVLRFYLLRKKGFDFYTNYSIIGPTYLTKSNIDGLDSGPKITYQDT
MGFGFFFGKKRAYNFELRIMHYSNGNIFTKNDGVAVPLQFTLGKTF
>FCMOIPGL_00354 hypothetical protein
MIADQMIFSKKIESQSFEEDKTSEKPVRSIAKALSWRIVGTLDTLVVSYILTGKIALAAS
IASVDFITKLILYFFHERIWNKIKWGK
>FCMOIPGL_00355 Phosphoadenosine phosphosulfate reductase
MGKIMSLDLDKINKDLKGKSPAEIIAWAISFAKKPVITTNFRPYEVAILKAVTDVQRDIK
VIWCDTGYNTVQTYKHAEEIIEKLNLNIHLYTPKQTAAHRNVVLGVPSIEDPKHVLFTEQ
VKLEPFTRAMKEHQPDVWFTNLRKGQTAFRNSIDVVSVSKDGIIKVSPFYNSTDEQLDAY
LEEKNLPNEFTYFDPTKVESNRECGLHI
>FCMOIPGL_00356 Sulfate adenylyltransferase subunit 2
MSNKIIQVDALESEAIYIFREVVAQFEKPVLLFSGGKDSITLVRLAQKAFYPAKIPFPLM
HIDTGHNFPETIEFRDRLAKELGVELIVRNVQDNIDSGRVKEETGRYASRNMLQTETLLD
AIEEFGFDACIGGARRDEEKARAKERIFSVRDDFGQWDEKNQRPEVFDMLNGRIDLGQNV
RVFPISNWTELDVWSYIEQEDIEIPSIYFAHKRKIFVRDGMIWSADDAVVYRDKEEVVEE
RMVRFRTVGDMSCTAAVLSDAVDIAKVVEEIRDSSISERGARIDDKRSEAAMEKRKQQGY
F
>FCMOIPGL_00357 Bifunctional enzyme CysN/CysC
MKVLKIATAGSVDDGKSTLIGRILYDTKSLTDDKLEAIEEKSRQRGFDYLDFSLATDGLV
AEREQGITIDVAHIYFSTPSKSFIIADTPGHIEYTRNMVTGASTAQASIVLIDARNGVVE
QTYRHFFINNLLRIKDVVIAINKMDLVDFSEEKFNAIKGEIEYLASKSEYKGQNLTFIPL
SALQGDNVVQKSENTPWYKGETLMHHLERLEPEDINDESQTRFPVQTVIRPKTEEYHDFR
GYAGKIYGGDLAVGDEVAVLPSQTKSKIKTINFFDKEFETAKRGSSVTITLEDNVNVSRG
DMLVKTNEEPTIAKQLDATICWMDKEPLQASQKYYIKHGVNDAQAKITQLSSIIKTDFSG
KEENPSALELNQIGEIQLKLSKPLAFDSYEDNKSNGSFILINPKSNNTVGVGFIK
>FCMOIPGL_00358 Sulfite reductase [ferredoxin]
MQSFRTEIENPVVERDIIELADKIAAFNNLQIDEEKFRSLRLARGVYGQRQEGVQMIRIK
LPYGKVMSNQLRRISEVSDEYSRGRLHITTRQDIQIHYVDLNRTPELWAELERDDVTLRE
ACGNVVRNVTASETAGIDVDEPFDVSPYADALYKFFLRNPICQEMGRKFKVSFSSTDEDT
GLSYLHDLGYIAKVQDGVRGFKVMVAGGLGSQPRHAETLYEFLPSDKIIPVMEGVLRIFD
RYGERKSRAKARMKFLLKDIGLEAFRDLIEQEQNAIELKTVAIDADSYVPSTPVSVEAPK
VEIKDQTVFELWKSTNLIPQKQEGFVAVGIKVLLGDFYTDKARLLADLVDEYAAGEIRLT
LRQNIVIPFVKEDLVPYFYQELEKLDFVEAGYNKAVDITACPGTDTCNLGIASSTGISVE
LERIIAADYPQYLKNEDLVIKISGCMNACGQHNMANIGFQGMTVRTPDKLVAPALQVLLG
GGNLGNGNGTFADKVVKVPSKRGPEALRRILNDFEANANGKQFVEYYKEKGEKYFYDFLN
DLQDVSNLTQEDFIDWGESEKYVKEIGIGECAGVVIDLIATLFLESDEKIANAKEAFENK
VYSGAIYYAYQSIVNSAKASLLAENKKTNTHASIISQFDELFITSEKIDLGSSFADLIYQ
INKFAPTAEFAKKYINDANRFLQKVRAYRESETTIAQ
>FCMOIPGL_00359 Uroporphyrinogen-III C-methyltransferase
MSKKTPKLTVVGAGPGDIDLITVKAIKVLRTADVVLYDALVNEELLDYINPEAEQIFVGK
RRGCYTYQQEQINELIVERAKAFGHVVRLKGGDPFIFGRGAEEMEFVANLGVEVAVVPGI
SSSLAVAAYQNIPLTKRGSAESFWVITGTTKDHKISNDIELAAKSNATVVVLMGMSKLPQ
IVKLFQAEGKNNLPVAIIQRGTTPREKVGIGTVDTIESIVVEKELKNPAIIVLGEVVKHR
QAILDIQQQFANDLKG
>FCMOIPGL_00360 Siroheme synthase
MERNNLYPIFLKTKNLEVLIVGGGFVAEEKLTFLLKSSPDANVTMVSPFFREGTIELAKK
GCVTLVTDSYQKKYLLGRHIVVATTDIPEVNVQVWKDCRAEAKLVNVADNPPYCDFYMGG
IVTKGNVKVAISTNGKSPTTAKRLRQFFEEVIPENIDDLVKNLNEYRKTIKGDFEEKVEK
LNEFTKSLVEKK
>FCMOIPGL_00361 Ferredoxin--NADP reductase
MITTDILIIGAGPTGLFTIFEAGLLKLKCHLIDALPQPGGQCSEIYPKKPIYDIPAYPEI
LAGDLTHKLIEQTKQFEPGFTLGERAETIDKQEDGTFIVTTNKGTKHHAKIVAIAGGLGS
FEPRKPKLDNITKFEDNGVEYIIKEPEFYRDKNVVIAGGGDSALDWSIFLADVAKSVTLV
HRRNEFRGALDSVEKVQELKDAGKITLITPAEITAILGDDKVTGVTVQKKGEEPVDVETD
HFIPLFGLSPKLGPIANWGLEIEKNAIKVNNALDYQTNIPGIYAIGDVNTYPGKLKLILC
GFHEATLMCQSAYKRIFPDKKYVMKYTTVGGVEGFDGTKKEAPKAVVKAIH
>FCMOIPGL_00362 Rhodocoxin
MQDINIKITDRNGQTHEVVAPTDMAMNLMEVVRSYELAEEGTIGICGGMAMCASCQCYVN
SEHELPEMTDDEDAMLAEAFNVEDNSRLGCQIQMTPEMEGLEVTLAPEM
>FCMOIPGL_00363 Serine acetyltransferase
MKETAQIVTFKNYSMCLRDAVEVFTKQLINNLFDERHLSESGPETRLKFLKILERLSVEN
GENLWNDFENSFVSIRQKLDLDAAAAEKNDPAAKSLEEIYLAYPGFYAIAVYRLSHQLLK
LGIPVFPRIMSEFAHSKTGTDIHPGAEIGDSFFIDHATGIVIGETTIIKENVQIFQGVTL
GGIQVKKSLASTKRHPTIESGVVIYANATILGGDVVIGKNSVIGANVCIMESVPENSVVT
VQLENNIFQKRN
>FCMOIPGL_00364 Cysteine synthase B
MQTKSIIDFVGNTPLVEVQNIFKKEGVTLLLKLEGNNPGGSVKDRAAYYMISEAIKRKNI
RKGDTLVEATSGNTGIALALMAKVLGVNMVITMPENSTIERVKTMRAYGAKVILTPADKG
MEGAIDYALKLKYKKGYFRLNQFDNFDNPKAHFNTTGPEIWRDTEGEVTHFVSAMGTTGT
ITGVSDYLKQQNQNITIIGAQPKDGAKIPGIRKWSEEYMPAIFKPKKIDTVLEVGEEEAR
EMTIRLAKEEGVFAGMSSGGSVATAIKVANSIDKGVVVAIICDRGDRYLSSDIYE
>FCMOIPGL_00365 Methionine synthase
MSNIYKALQERILVLDGAMGTMLQAYKFTEEDFRGERFKDYPTPLQGNNDLLSITQPEAI
KTIHGKYFEAGADIIETNTFSGTTIAMADYQMEDLVYELNFQSAKIAKEVANEFTAKEPH
KPRFVAGSIGPTNRTASMSPDVNDPGYRAVTFNELRIAYKQQIEALVDGGVDLLLVETVF
DTLNAKAALFAIEEVKDERGIDIPTMLSGTITDASGRTLSGQTAEAFLISVSHIPLLSVG
FNCALGASLLQPHLEAIASKTDFAISAHPNAGLPNAFGEYDETAEEMGEQIEEYLKRNLI
NIIGGCCGTSPEHIKEIATIAAKYKPREFVVNE
>FCMOIPGL_00366 hypothetical protein
MVLEVAVLNIKKGLSKDFEASFKKAESIISSKKGYVSHQLKKCIEQKDKYILLVNWETIE
DHEIGFRKSDEYKEWKELLHHFYDPFPIVEHYI
>FCMOIPGL_00367 Methionine synthase
MKVKQTKYMHLSGLEPLVLNENSNFINVGERTNVAGSRKFLRLIKNEQFDEALDIARHQV
DGGAQIIDINFDDGLIDGKQAMVRFLNLIAAEPDICRVPIMIDSSKWEIIEAGLQVVQGK
CVVNSISLKEGKEKFIWEAKQIKRYGAAVIVMAFDEVGQADNYDRRIEIAKKSYDILVNE
VGFPSEDIIFDLNIFPVATGMDEHRKNAIDFIEATRWVRQNLPNVSVSGGVSNVSFSFRG
NDGVREAMHSVFLYYAIQAGMNMGIVNPALLEVYDNIPKDLLEYVEDVILDRREDATERL
LDFAETVKGSKVEKTVDLSWRENPLQDRITHALVKGIDAFIIEDIEQARQEAAAPIEVIE
GHLMIGMNVVGDLFGAGKMFLPQVVKSARVMKKAVGYLNPFIEAEKGDKQEPVGKILMAT
VKGDVHDIGKNIVSVVLACNNYEIVDLGVMVPPEKIIEMAISERVDAIGLSGLITPSLDE
MVYLAKEMQRQNFVLPLLIGGATTSKAHTAVKIDTQYTNAVVHVNDASRAVTVVGDLLNK
KTSHAYVAELKKNYDEFRTKFLKRGKEKSYISIDEARKRKYKIDWKTSEIVKPKELGIQT
LEQLSLKELVPFIDWSPFFRSWDLHGKFPDILKDDLVGEQATIMYDEAQAMIKEIIAKQL
LKPKAIFGLFEANTINDDDISVKKKGGEEFIFRTLRQQLKKREGIPNHALSDFIAPKETG
VTDYIGAFCVGIFGAQELAESYKAKEDDYNAIMAQAIADRFAEAMAEYLHKQIRTKHWGY
VADESLTNEDLIKESYNGIRPAPGYPACPDHLEKETIWDLLKVEEKIGVTLTESMAMWPG
AAVSGYYFANKEAKYFGLGKITDDQVTDYSTRKGITKEKARKWLHPILAEE
>FCMOIPGL_00368 hypothetical protein
MEFIELHLGSYIISHGFDKNNKEKMTPIVADKFGKKLIAVSRIKSLSQKYILTDYVDGRW
IYWEYKEDYEDVKKLLNR
>FCMOIPGL_00369 5,10-methylenetetrahydrofolate reductase
MKVTDHIKNANGKTLFSFEVIPPQKGKNIQDLYNNIDPLMEFNPPFIDVTTSREEYVYLD
KGNGLLDKRITRMRPGTVGICASIMHKYKVDAIPHLLCGGFTKEETEYVLVDCHYLGLDN
VMALRGDSMKDESYFKPTKGGNAFASDLVDQIANLNKGQYLHDDINVEHHSDFCIGVAGY
PEKHMEAPSLVSDLRRLKAKVDAGADYVVTQMFFDNNKYFEFVKAAKEIGINVPIIPGIK
PLAVKRHLQILPQVFKIDLPQDLIDAVYDCKDNKAVRQVGVEFAIQQSKELLAAGVPVLH
YYSMGKSDNIQAIASELF
>FCMOIPGL_00370 Thioredoxin
MALEITDANFDELVLKSDKPVLVDFWAAWCGPCRMVGPIVDEIHAEYDGKAIVGKVDVDA
NQEFAAKYGVRNIPTVLIFKNGEVVDKQVGVAPKNVYTGKIDAAL
>FCMOIPGL_00371 hypothetical protein
MIKVSEVKSVEIKNLELLAKQVVEGFITGIHKSPFHGFSVEFSEHKLYNNGESTRHIDWK
LFAKTEKLYIKKYEEETNLRCHIVIDNSASMHYPIVKKQSLDNLNKIGFSAVAAASLMEI
LKRQRDAVGLSIYADTYEYYAPEKGSERHRKMLLHQLEELLVSKSDAKTETYQYLHEIAE
KMHRRSLIFLFTDMFQTNKDDKKLFEALRHLKYNKHEVVLFHTYDEKTEFNFNFDNSPKK
FVDVETGEEINIYAENIQENYKKLAGNFFKELKNKCLQYKIDYVPVDINSGFTKVLSSYL
ISRKNIL
>FCMOIPGL_00373 hypothetical protein
MEIKKGILKAIMFVLFVFCFSTNYYSQKTGIIGVVVDDSNQPLEMVSVALLSTKESLFLS
YTTTDVKGAFHIDDIPKDSILLQLNFLGFTTYSKKIIYKKKLIDLDTIVLKEDISSLDEI
VISAVVPVQIKKDTVSFNANSFKVNYDDNIDGLLSKLPGIEIDENGSIVTQGTTVTKVMI
DGKEFFGGDPSIVMKNISADAIAKVEIIDKKSDEAELTGVSDGNKEIVINFRLKKEKKNR
GFGKLSAGVGLDNRYFGNINYNQFNTKNQLSIIGKFNNINITGSNIQGFLENADGVADDS
GDDTDGDFSNNKKSLSGFLITAVTGVHFGTEIKKKESLSGDYFYNSSENSGLSETNRISF
TSLNNFNFKSKNNFLNTSENHNLNFNYENKSSKKSSLSLRGLFYSDDRNYKLDRGGSYFN
TDEELVTENNLSSENSNLKKFGNINFNYYQRLQKKGRSFNVGFNTVITSLDRENNQNMLI
TRGLNTSSTTMQEVITFRNEDNSTQLFNLRFKYTEPLGGNHYLNTEVFADFLTGKEQTNQ
FRKTIKTTTVEDLLEINYNYFQNIMKSKISHSYNTSKLNISSALELQNLRREFGQEQEEQ
FIKEQLFFNPSIFFQYKPQRGRKYKFVYKKLIKAPRPSQTNPFVNDLNPYFIKTGNVDLK
PEKVNSFQMLLNINDLKTSLGFNAKLQYNHTKDAIIRNITIDDDFIRASSYQNNGKKEQF
KAEGSFTKKLSKLGIRLSLKNKYLYNSSNSIINFNLNTVVSEDFSTNFIIQNIRKNKVDL
KAGVYYSENNTGFSIEKDLDRKFTTQKYFGMIDFDVTKKFNFNTQLDYIFYEDNSFSIHQ
EIPVWNAAISYSLSKSNNIFKLVFIDLLDKNVDVFRRSTLNFFEETTSQSLGRYIILSYT
YKLNGIGKKKKSAKA
>FCMOIPGL_00374 Serine/threonine-protein kinase pkn1
MYHQNKSKLFNYFSLIFLAFLSLSSCKNSKTEETKTINKSEIKTPEGMVWVESKTFLQGA
KETDKFAMPREKPAHLVTVDGFYIDVTEVTNKQFAAFVDATKYVTIAERKIDWEEMKKML
PADTQKPHDSILQPGSLIFNKSVNAIADMNNYGQWWTWKIGANWKHPEGPNSTIEGKENN
PVVHIALEDALAYCKWANRRLPTESEWESAAQGKNLNTIFTWGNDATILDNNANTWQGVF
PTKNESKDGFEFISPVKSYPPNSIGLYDMAGNVWEITADLFNVNYYKDIDISQPLLNPKG
ANKSYSPSNPYQVEHVMKGGSFLCHESYCASFRISAKMGVATDSGSDHMGFRTVATNKML
ASK
>FCMOIPGL_00375 HTH-type transcriptional repressor YtrA
MKIVSLKKDSRTPKYKQIVVAIENAIVDGLLKKGDKLPSLNVIKNENSLSRDTVLTAFNE
LKNRGIIHSVVGKGYYVSTEDIDVKQKIFVLFDELNSFKEDLYNSFLLNLGDNIQVDIFF
HHFNYDVFAKLINDNIGNYSSYVIMPANLSDTENVIQNLPREKVYILDQVHKGLEEYAAI
YQNFEKDVFNGLSSGISSIVKYQKIVLLFPDEKQPEGILKGFIQFCEKYKIEHEVVASIK
GRVPEIGELYVVLDDQNLIRIIKKIKENKLVLAKDIGIISFNDNLLKEVVEDGITTISTD
FNLMGERLAQMILNNEEVKIENPSSLILRKSI
>FCMOIPGL_00376 Aldose 1-epimerase
MYKVEEISENKSSFLELKNPHNTANARISLNEGGRLQELKFKDFFLIKDQQNFDYKDSYA
SSILFPFASRIQEGKYSFEDKDYQFYLNETGKNALHGLVYNQKFELISKEENVNFCAVTI
AYKETKVIEGFPYTYNIFVTYTLFENDINLSIKIKNTDAKTFPFTLGWHPYFLSDDITKS
SLSFKSDKKIEFNENLITKKVIDHITEDEFKIEDKQLDDCFILNSDVVQFKTPTYQLEIS
TDKIENYLQLYTPKGLPLIAIEPMTGISNSFNNKIGLQVLKPNETYSITWNVKFNNN
>FCMOIPGL_00377 Galactokinase
MSAQLIKDVKAKFLKTFNTEPILIFSPGRINIIGEHTDYNGGFVFPAAVDKGIAAAIQKS
DSGSSTAIALDLDSTIKFELDKLKPSKEGSWENYVFGVVAEIQNRNKVVGDFNIIFKGNI
PGGAGMSSSAALENSVVFGLNELFDLGLTKTEMILISQKAEHNYVGVKCGIMDQYASMFG
IKNNALLLDCRTIESKPYEIDFKDHQLMLINTNVKHSLSDSAYNDRRSACESVAKILNIE
TLREASEEDLEAIIDQVTPENYQKALYVIQEIERTQKAAIAIEENDLVTLGALIYASHNG
LQNQYKVSCEELDFLVDQAKKNKNVLGARMMGGGFGGCTINLIAKTEAKSFAESASKAFK
NKFDNECSVYFIELSDGTHLVK
>FCMOIPGL_00378 Galactose-1-phosphate uridylyltransferase
MENTNLQDYSHKRFNILTGEWVLVSPHRAKRPWQGQNEEISTEKRPAYDESCYLCATNTR
INGEVNPDYKDVFVFTNDFAALQKDSPSFAVNDGLFKAQSETGICKVICFSPDHSKSLAQ
MEVADIKKVVNAWQKEYKELGGIDGINYVQIFENKGAVMGCSNPHPHGQIWSQSTLPNEV
DKKDQHQKAYFEKNKTSLLGDYLKQELEAKERIIFENDDFVVLIPFWAVWPFEAMIAPKK
AQKNILELSDSEAKDYAEAISVITQVYDKLFNTSFPYSSGIHQSPTDGEENEHWHWHMSF
YPPLLRSATVKKFMVGYEMFGSPQRDITAEIAAKRLRDLL
>FCMOIPGL_00379 hypothetical protein
MNFYGLSKNTKLCYIIAKQIAESLKILQYLKLYHFMFLTIYSKSLNLLAAISAVISL
>FCMOIPGL_00380 P-protein
MNKIIAIQGAQGSNHHKVACDFYGESVKLKECMSFDVLVDCLLDKSANLGVMALENTIAG
SIIPNYALIDNHNLHIIGEEYLNIHHHLMALEGQSLADIKEVWSHPMALLQCKEFFKKHP
HIKLVEDVDTAEVAKRIAKQNLVGIAAIAPKIAADIFKLVVIEDGIQTIKDNSTRFVIVQ
TTKPEEDENVNKASIKFQLNHKRGSLAAILNAMSDCKMNLTKIQSLPVIDTPWKYSFFVD
VTFEDYKDYQKAYSLIEIMAEDFKVLGVYKNGRK
>FCMOIPGL_00381 LL-diaminopimelate aminotransferase
MIQPAKRLDTVKEYYFSIKLREVRNLVAAGKPIINMGIGSPDLQPPAKVIEAIQGSLADA
NAHKYQSYQGLPELRMAIADFYKNKYAVDSNPENEILPLMGSKEGIMHISMAFLNEGDQV
LIPNPGYPTYTSVTNLVGAEPLFYNLSDENNWQPNFEELENQDLSNVKLMWVNYPHMPTG
TNATIETLEKLVAFGKKHQILIINDNPYSFILNDKPISILQVEGAKDIALELNSLSKTFN
MAGWRVGMVLGNAKYINEILKVKSNMDSGMFYGIQKGAIEALQLSDDWFASQNKIYEERR
NLIWQLADKLDATYNKNSTGLFVWAKIPEGKKSEEVTDAVLYENDIFITPGTIFGSQGEG
YIRFSLCVTTDVIKEAISRFLVIGN
>FCMOIPGL_00382 T-protein
MIGIGLIGGSFAIDIKKNNPDVVIHGISRKDETLNKALELKLIDKKATLDDLENADLVIV
SIPVDATVKLLPTILDKISDNGLVVDAGSTKEAICKAVEHHPKRRNFLACHPIAGTENSG
PTAAISGLYVGKTNIICEVEKTTFKLQEKALELFRAIGMRIRYMDPVSHDKHIAYVSHLS
HISAFMLGKTVIDKERNERDIFDMAGSGFASTVRLAKSSPAMWTPIFEQNKANVIESLEE
YINNLQHFKELMQQDNFSDIFNEMENTNYIKQILNGIK
>FCMOIPGL_00383 Phospho-2-dehydro-3-deoxyheptonate aldolase
MENTKELRTWLDDMKLDHPLVIAGPCSAETEEQVLKIAHELKDSDVNYFRAGIWKPRTRP
GNFEGVGALGLKWLQKVKAETGMKTCTEVANAAHVKLALEYDVDLLWIGARSTVSPFIMQ
EIAEALEGTDKIVLVKNPVNPDLALWLGGIERLYTAGIKNLGAIHRGFSTYEKTKYRNTP
EWQLAIEFQNKFPDLPLINDPSHITGNRDMVFDVCQTALDLNFDGLMIETHYDPENAWSD
AAQQVTPDSLKKIMQDLKVKKETETAVSYREPLENLRAQINVVDDQLIDLLGKRMKVADQ
IGELKKEQNVAVLQSRRWNEILGNMVMEGNSKGLSEEFILKMFKAIHQESINHQEKIINA
>FCMOIPGL_00384 Small ribosomal subunit biogenesis GTPase RsgA
MTGIVYKSTGSWYQVKSDNEEFYQCRIKGKFRIKGIKSTNPIAVGDKVVFDLEKKGGEET
GVIKKILDRDNFIVRKSVNLSKQIHIIAANIDQVFLLITIDNPPTFTAFIDRFLVSTRAY
RIDTILVFNKIDSYEIEQRAEILYLKDIYEKIGYRCIEVSSTENINVDKIKELMTGKTSM
FVGHSGVGKSTLVNAIEPTLNLKTKEISDQHNQGKHTTTFAEMFDLSFDAKIIDTPGIKG
FGIVDIDKYELGDYFPEFFEMKQHCKFNNCLHLKEPNCAVKEALETEEISWSRYKSYLQI
LNGEEESEHYRTDIWDGEEDEVD
>FCMOIPGL_00385 D-aminoacyl-tRNA deacylase
MKIVIQRVSEASVTINEIKVANIKKGLLILLGIVNEDTQEDINFLVRKIANLRIFNDENE
VMNNSLLDIAGNAIVVSQFTLQAATKKGNRPSYIKAAKPDVAIPLYENFVKSLEKELNKK
VQTGKFGADMKVALLNDGPVTIIIDSKNKE
>FCMOIPGL_00386 putative metal-dependent hydrolase YjjV
MDFIDVHTHTFSSDKNVFSIVNTYPNSLNFSQPFSMGIHPWFINIDKIEEEILLLESKLQ
DKNCVALGECGLDKLIDVDFELQKKVFKKQILLSEKYKKPLIIHCVKAYQEIIEIKKEIQ
PNQTWVLHGFNKSKQLAESFIKNGILLSFGAAIIKSKKLQEVFLEIPISTILLETDDSKL
EIQEIYQKASEIKNIHLKDLQEAIHQNLKIYL
>FCMOIPGL_00387 tRNA threonylcarbamoyladenosine dehydratase
MSWLERTELLVQKAGLEKLQKANILIVGLGGVGSFAAEFIARAGVNKITIVDGDVFDVTN
KNRQLTALDSTIGKSKAQVLARRLKDINSEIELTVLEEFLSPERAFEIVSEEFDYVLDCI
DSITPKINLIVAARRKKVKIISSMGAGGKLDATKIKIKDISQTKNCTMARTLRKRLKEHK
VDKGIKAVYSEEFQIAESLKMTDGLNFKKSFYGTISYMPAAFGLQAAAFVINEIIKK
>FCMOIPGL_00388 Protein YceI
MKKIIVSLVLVASVLTGCKSEKKEKLAVKEVVEFEATTLEKYNVDTEASVLNWKGTKPLG
AHDGVVSLKSGSLIIEEDELIDGEFVIDMNSIVNVDMKGSAGAGKIEAHLKSADFFDVAT
YPTSKFVITDVEESEDGKLDVTGNLTIKDVTKSITIPATISTEGGVTTFESKTFNVNRTD
YNVKYKSKSFFDNLKDKFIDDIMEISFVVKTKA
>FCMOIPGL_00389 hypothetical protein
MKNQKADRPCGCGNTEDPNGNCDGSHVNK
>FCMOIPGL_00390 hypothetical protein
MIKYISPTLLLLFLCTTFYSQDINYSALLIPVELKENANAVVRDNSVEITIEDVNKMTVK
KRKVVTVLNKLGDVDAVISESYDQDTKINDLSAKIYDAFGNEIKKYSKRKFEDISAVSGG
TLYSDSRVKYIDYTPVSYPYTLVFESEYETETTGFIPWFFPVNGYFVSVQKSSFTFKNPK
EIPFRKKEVNFENYTIKTTNSPSELTYVLENEKALKYENSSVHYREILPKAIFALDKFYL
KGVYGEYANWSEFGKWMNEKLLTDRDILEESTKLKIRKLVEGVEDPIERAKLVYQFMQNK
TRYISVQVGIGGWEPIAANLVDEVGYGDCKGLTNYTKALMDVADVKSYYTIVYADEKRDI
DKEFSSIQGNHIILNIPNKGNDIWLECTNQTMPFNFLGDFTEDRNVLVVTPEGGIIKRTP
AYKNEKNLQITKATINFDEAGNLKATLKRTSEGIQYDDKFGYDTFSDEELTKIYKSNVWS
YNNNLEVAEMVINNDKDSIKFTENLKINISDFATVNEKEYLFRVNVFNAINQVPKRYRKR
KLPLQIVRGYQDIDEYIIKIPKEYAVEYLPEKKEIKTQFGSYEMSISKLDENTLYYKRTI
IILAGTHPKEEYEKYRSFRRTTAKLENQRIALIKK
>FCMOIPGL_00391 hypothetical protein
MIKKIAFTLFVFTQLATFAQDYKFGKVSKEELQEKFYPLDSTADAAYLYRSRNTYYEFLQ
REGRFQIVTEIHERIKIYNKEGFNYGTKLIPFYNPEGESKESVSSIKGYTFSLLNGKVEK
TKLAKKNIFEEKRNKYRSEKKITMPSIKEGSVIEIQYTLTSPYTRTIDDLVFQYNIPVKK
LDYEVTIPEYYVFSQRTKGYHSIIPNQESKSKNLTYTIKNIGRPTGISTGAREASNTTYS
YEKFSYEILKLSFNDKNIPALKNNEPFVNNINNYRGGMEFEIKEINFTKLGGDRKFYSSD
WTDVSKEIFRSSSFGSELDKSSFYKDDLNSLSLEGKSDMLKVATIFQFVKSRVKWNGYYD
KYTYNGVKKAYKERVGNVADINLMLTSMLRFAGLDANPVLVSSRGNGIPLFPTIKGFDYV
IAAVTFKDNTYVLLDATEPYSLPNILPERALNWDGRLVKKDGNSSWINLTSEKHSLEENM
IMIKINNELVTEGYVRTKFDNLKALDFRRSYNHIKEESLITNFEENNNVEITDFKIQNKV
DLSKPIVRMIKFSSNDLIEGINGKLYIEPLLFLTKHNNPFKLEERKFPIDFTASWKELNR
VTIEIPLGYKVEKLPEVLAIALPDNMGVFKYQVSQVGNKIKAISVLQFNKPLIGAQYYKD
LKDFFDKTVSKQSEKIVLIKE
>FCMOIPGL_00392 Leucine-responsive regulatory protein
MQLDSIDKKLINLLQNDSKQTTKQLSLHLNLSITAVYERVKKLENQKVIDKYVAIINKNK
IEKSFLVFCHLKLIQHSREYVTTFEREILKLEEVSECFHVSGDFDYILKIYVKDMQEYRN
FMVSKLTAIKYIGSTHSIFAIEQVKNTTAINL
>FCMOIPGL_00393 L-methionine gamma-lyase
MSFNPADNIQDLQYYGEFGGVNPSISDSSTFTFLSAKTMFDTFEGNADGCYLYARHSTPS
NLYLGKALAAMEGTETANVSASGMGAITPVILQICGAGDHIVSSRTIYGGTYAFLKNFSP
RLGIKTTFVDITKLDIVEAAITKNTKVLYCEAVSNPLLEVADIKGLSVLAKKHNLKLVVD
NTFSPLSISPAKLGADVVCHSLTKFINGSSDTVGGVVCGTQEFINDLRNVNDGASMLLGS
TMDSLRASSILKNMRTLHIRMKQHSFNAAYLADKFQADGLITVYPGLDSHPSHNLFKSSM
NTEFGFGGMLTIDVGTLEKANELMELMQQKNIGNLAVSLGFYRTLFSAPGTSTSSEIPAD
EQKEMGLSKGLIRFSIGLDNDIERTYQMMKSCMIEVGVL
>FCMOIPGL_00394 hypothetical protein
MDSLTQIVLGAACGEAVLGKKIGNRALLFGAIGGTIPDLDVFIGRLLYGNEIQAMAFHRG
FMHSILFAILACFVFGWITYKLYNTGKRQESTTLKNWIWLFFWAIFTHPILDCFTPYGTQ
LFAPFSSYRIAFNNIAVVDPFYTIPFLICMISLMFIHRKSKKRTFWLKTGIYISSVYMIF
TVFNKFYMDAVFEKSFEKAGIKFTRFSAQPTILNNILWYAVAETDKNYHLTFYSLLDKKS
ISEKVITVKKNHDLLDMNNANLQTLTWFSNKYYNISKKEKIGTYKYVDLRYPMLNPDDAN
TSIFNFTIYNKDNEWDILPFDRSPPNKEDFNKFIERLKGV
>FCMOIPGL_00395 Na(+)/H(+) antiporter NhaC
MQDDKNLSKIKIEDQGIIVNKELSLLESLIPVVFLMSMLAYNIFFVESQEWFGAYTNQYI
LLMGGIASAVVGFYNKVSLKRMFTEIWENWKSVFVPILILFLVGALAGTWLVSGIIPAMV
YYGLQVLSPAIFLPASVIIAAIISVATGSSWTTSATVGIALVGIGSALGIPTGMIAGAVI
SGAYFGDKMSPLSDTTNLAPAMAGTDLFTHIKYMAYTTVPTLIITLIVFTILSGTIDTNG
NADISNLLTTIDHTFYISPWLFIVPGVVIAMIVMKTKPLVALAIGVILAAVFAFIFQSDV
LNGISDSNFSAISKAVLTDVQIETDNDSLSELFSSGGVEGMIWTILLIICAMVFGGIMDA
IGALAKITKELLSVATSILGLFASTVVSCLGLNVIASDQYLAIVIPGKMFKKAYQDRGLA
PENLSRTLEDSGTVTSVLIPWNTCGAYQSGVLGVSVSDYFVYAIFNYLSPIMTLTFAAFS
IKIRQLAKK
>FCMOIPGL_00396 hypothetical protein
MIDIAVVSDAIKLTEIALKSKSYWGYSDELLKSWTHDLTVSEKMIQEMIVCKFISDDKII
GFYILNQPKQKSIELEFLFVLPSFIGKGIGNQLLQHAFIKSKKLNCNRVTLLADPHAVSF
YESKGFIIIGKKESAIVGRFLPLLQKDLE
>FCMOIPGL_00397 hypothetical protein
MKNQLKHNWKLFLIASLTLGLAPFNPPHILGKIQWILGGNAFSGEHAMQAQDWFDVLLHG
SPWVLLLISIILNLFAIKAKNDQQ
>FCMOIPGL_00398 hypothetical protein
MMNKQFLFFLVLILLTATNTFSQKRMLQNEYTNLNGIDNDSIISGRTKIELSGKTKYTDY
KIFSHKGVTTYIDTTLSIKKEYKFNYLRKDNFELLEFHNQGQTFNNLGYSFNNLKQFPDI
GFTAKQFSYFEIEDIKYYEVPTPTTEILYRTGLQQGQVVDALFTLNFSKRLNVSASYKGL
RSLGAYRQSLASNGNFRGTFHYTTKENQYEIRGHFTSQDFFNEESGGLTTSSLENFISDD
PDYTTRARLDVNLDDAENQFDSNRTYLEHSYKLISSKDSINNKDFSNLKIGHIFTNESKS
YNFTQGTETTDIFGEINATEATDKNATSKITNNEINLEFNSKYVLGKFKAKANYTSYSYG
YDSILNSNSTIDKLKLKGSAISVGADWNAKIKKFQLNADASLTPGSGRLSGNYLKGEALY
KNDSLFTVKGSLLISSKSPNFNTLLHQSNYDDYNWENDFSNVNTRDLGFTFNSKWINATL
NFTNIDNYTYFDENNTPQQFENQITYLKVKANREFKFWKLALDNTLMYQNVSSGSSVFRV
PEFVTRNTFYYTDYWFKGKPMLVNMGVTFKYFTKYNENAYNPLLAEFTIQNNEEIGYPTF
DVFFNAQVRRTRLYLKVDNITSSFSDKNYFSAPNYPYRDFTVRFGLVWNWFI
>FCMOIPGL_00399 Ribonuclease HII
MLQSNFSGFTLEAGTDEAGRGCLCGPVVAAAVILPKDFTHPFLNDSKQLSEKRREELRPF
IEKNAIAFGVSFVWQDEVDKINVLQASITGMHRSIEALNITPEFIIVDGNKFKDYKEIPH
KTIVKGDAKYLSIAAASVLAKTYRDEYMAKIHQEFPMFNWVKNKGYPTKEHRNAIREFGA
NIHHRKTFRLLPEQVKLDL
>FCMOIPGL_00400 hypothetical protein
MRKNQKNYKNQPYIFRKKRKRIETLFAKFCDQFVIRRNYVKSLKRLKNRVLFKITTLAVI
Q
>FCMOIPGL_00401 Deoxyadenosine/deoxycytidine kinase
MHVAIAGNIGAGKTTLTQLLAKHYKWKPHFESVDENPYLDDFYGEMERWSFNLQVYFLNS
RFRQIVELRETGENIIQDRTIYEDAHIFAPNLHAMGLMTNRDYHNYSSLFELMENIVSPP
DLLIYLRADISTLVGQIHKRGRDYENSISIDYLSRLNERYEAWISTYTKGKLLIIDVDNL
DFVTNQEDLGYIIDRIDSQINGLF
>FCMOIPGL_00402 hypothetical protein
MKALLIMQQADFDFSFLQNLWNNIVDFLPQLLKGIVFLIFGWILIKVILFSIKKVLGFTK
IDSLPEKLNVDEIFGNSAIKIQPTKIIVTAIKWILILIFIIIASELLGLKMISEQLSNLI
AYLPKLISALLIFAIGIYIANIARKAISAMFSSLELTGGSLVGNIFFYVISIIVSVTALN
QADVKTDLITNNLSIIFASILLAFTIAFGLGSRDIIKRLLFSYYSRKNLQVGNKIKTNNL
EGVIESIDNISVVLISENKKVIIPIKEIVDNKIEVLS
>FCMOIPGL_00403 ECF RNA polymerase sigma factor SigW
MKTSSIQKLSDEDLVFKIVETNNSQLFAVLYDRFSKVVYNKCYGFSKNKEEAEDLTHDVF
IRLFVKLKTFKGNSKFSTWLYSFTYNFCVNYVQRNDHKKKERVTVVTDQVKDNDDDIEDI
EDAQLFELKSENLAKAFALIDVKEKMILLMKYQDDMTIKEISEALEIGESAVKMRLKRAK
LKVVSVYEEL
>FCMOIPGL_00404 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVDLITADEEVELAQLIKAGDQRALEKLTKANLR
FVVSVAKQYQNQGLTLPDLINEGNLGLIKAAKRFDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKMYAFLEQENERPPSPEEIAKKLDMTVNDVKESMKNSGRHV
SMDAPLIEGEDSNLYDVLNSGESPNPDRTLLHESLRIEINRALETLTPREADVVKLYFGL
GEHQPMTLEEIGETFDLTRERVRQIKEKAIRRLKHTSRSKILMTYLG
>FCMOIPGL_00405 Ribulose-phosphate 3-epimerase
MSNLIAPSILAADFANLQRDIEMVNNSEADLFHIDIMDGVFVPNISFGMPVLKAITKHAT
KPIDVHLMIVNPDQYIEIFAALGANILTVHYEACTHLHRTIQAVKAAGMKAGVALNPHTP
IAVLEDIIEDLDMVCIMSVNPGFGGQSFIENTYKKVSQLKHLIEFTESNCQIEIDGGVTN
LNANKLIEAGANVLVAGSYVFGSENSTETIADLKNIIS
>FCMOIPGL_00406 putative ATP-dependent helicase DinG 
MSKYTVVDIETTGNGYKGSKITEISIFVFDGKNIVDEFTSLVNPEQNIPAFITNLTGITN
AMVRNAPKFYEIAKKVAEITKDTIFVAHNVNFDYNIIHEEFKNLGFDFKRKKLCTVRLSR
KIIPGLSSYSLGNICTSENIPINGRHRAKGDAEATTELFRRLIERDDNFTINSFLNPKSR
QATLPPLLDKKIVDNLPEKHGVYYFKNIDKEIIYVGKANNIKQRVISHFYDKKKKEQTMC
LEIADISFTKTGSELLALLHESSEIKHIYPKFNRAQRRASEAIGLFSYEDQRGVIHLAWN
RLKLIPNPIMKFYSVAEARTYTETLCKEFELCPKYCHLQTNVASCFHYQIKECKGVCSDK
EAVEDYNIRVRRAIKSVGIGAENLVIKEKGRTKNEIGFALILNGIYQGFGYVDIYQSREL
ENPEDYQFFVEPKKDNRDIQRIITAYLKKKEAL
>FCMOIPGL_00407 Inosine-5'-monophosphate dehydrogenase
MKKIIPISEIMTTSVVTLSIDDTLEEAEKIFKEHKIKHIPIVKNKEIVGMLSYTDLLRIS
YADVSDDEKDVENFVYDIFTIQQVMTKNLYTVPPYSTVKDVAELLSQKEFHALPVVEDNE
LVGIVTTTDLINYLVKQL
>FCMOIPGL_00409 hypothetical protein
MNLQKQVMDKMKEAMKAKDTVALQALRAVKSAFLLAKTETGVQTELTEEQEIKIIQKQVK
QRKDSAAIFIKQGRQDLADPELAELAVLEQFLPEALSAEKIEEVVIATIQKLGASGMKDM
GKVMGVVSAELAGKADGKTISTLVKKVLMS
>FCMOIPGL_00410 hypothetical protein
MKSIQKILKKKKYVKIKLKKIATNHLELRAKINGVKGQFILDTGASNSCVGIDMIEYFKL
DAQVSETKAAGAGATDMETQLSENNNLKIGDWTTKNCHLVLFNLSHVNLALTQHNANEIH
GIIGADILQKGKAFIDYTNNILFLKKVKKKKK
>FCMOIPGL_00411 hypothetical protein
MMKTTRRLEAALIKLYNAYHNNRLKPEDCTACAVGNILDNHDSWKHLSDKHGSLQLSYVG
QVHQNLGRKFNGYSPQEILQIEKVFLDSCGFKTPLCHYNPKPKNHSSNEVLFNGLCKVIE
LLCAFDDIPYILDYSKLFEQENGEPVYHLETFLA
>FCMOIPGL_00412 Na(+)-translocating NADH-quinone reductase subunit F
MILAAGTTGTIIATVTAFLILTLVLVALLLFVKQKLSPSGPVTITINGEKKIEVGSGSSL
LTTLGNEKIFLPSACGGGGSCIQCECHVLEGGGEALPTEVPHFTKKELKEGIRLACQVKV
KQDMNITIPEEVFGIKKWDAVVVRNYNVASFIKEFVVEIPEDMGYKAGGYIQIEIPPCEV
KYSDMDITAHPEEHETPDKFEAEWDKFKLRPLVMKNTETVERAYSMASYPAEGREIMLNV
RIATPPFDRAKGGWMDVNPGVASSYIFNLKKGDKCVISGPYGEFFINESEAEMLYVGGGA
GMAPMRSHLYHLFRTLKTGRKVSYWYGGRSKAELFYIEHFRALEKDFPNFKFFIALSDPL
EADNWIVKKDINDEAGDGFVGFIHNCVIENYLNHHESPEDLELYFCGPPLMNNAVQKMGE
DFGLSDENIRFDDFGG
>FCMOIPGL_00413 Na(+)-translocating NADH-quinone reductase subunit E
MEHIELFFKSIFIDNMVFATFLGMCSYLAVSKKVSTAVGLGAAVIFVLAVTVPLNWLLDQ
YILKEGALVWLGPEYAEYDLSFLSFIMFIATIATMVQLVEIIVEKFSPSLYNSLGIFLPL
IAVNCAILGGSLFMQSREIPTLGLALTYGVGSGIGWFLAILAIAAIREKIRYSSVPPALR
GLGITFIITGLMAIGFMSFGGMLTGGDEEEAAKPKVEAKIEKKEIKKEAKEIVAENTNIN
Q
>FCMOIPGL_00414 Na(+)-translocating NADH-quinone reductase subunit D
MGLLSKKDAALITDPLLDNNPITIQVLGICSALAITAELKASIVMAISVMAVLAIGNVVI
SLLRNVIPSKIRIIVQLIVVATLVIIVDLVLKAFQYELSKTLSVFVGLIITNCIIMGRFE
AFALANKPWRSFLDGIGNAAGYGLILIIVGFFRELLGSGTLLGFKVLGDPIEKTGLYAIG
YENNGFMLLSPMALIVVGIIIWIQRTKNTSLIEEN
>FCMOIPGL_00415 Na(+)-translocating NADH-quinone reductase subunit C
MSKRTDSNSYTIIFAVVMVLIVGSLLAFLASSLKPNIDENKRIEKQQNILYAMGVNENEG
TSANFVSTDVAGTEFLKYIKKQIIIQGDKVTEDNKAYLIDVKKEQASAKAGNERRLPLFI
GEKDGKTFYVTPIRGKGLWDAIWGYVAMDENMVVQGAYFDHKGETPGLGANIKQRFFMDD
FIGEHLMTDSGEFKGITVKKGNNDPKNEEKTDYEVDAIAGATITGDGVTAMIKSDLKLYV
PYFKSLKK
>FCMOIPGL_00416 Na(+)-translocating NADH-quinone reductase subunit B
MGLKQNLHNLKEKYKGTKMAPAFNAIHTFLYLPNDVTHGGTHIKAADDLKRTMNTVILAL
IPCLIFGMFNAGYQHYAAIDSSLRADVLANFFTLDNLWIGIIKVLPLVIVSYGVGLGVEF
IFAIIKGHEVEEGYLVTGMLVPLIVPIDTPLWMLAVAVVFGVVIGKEVFGGTGMNILNPA
LTIRAFLFFAYPTWMSGDKVWVYQAVERAGTADAISGETILGSYAQNSEVIYSNWDKFFG
FIPGSVGETSTFLILLGAAFLIFTKIGSWRIIVSTFLGAAVMGFIFNQIVAADIITESSK
FYGLMNTVWWEHLMIGGLAFGAVYMATDPVTASQTNKGKWIYGFLIGFISIMIRVFNPAY
PEGVFLAILLLNVFAPTIDHYVIQGNVKRRLKRTKVKTA
>FCMOIPGL_00417 Na(+)-translocating NADH-quinone reductase subunit A
MSKDIRIKKGLDIKLVGIAEKNTANTSVSAVYAIKPVDFHGITPKLIAKEGAVVKAGETL
FYSKSDERILFPSPVSGKVVEIIRGARRKVLAMKIAADTTQEYKQFETKDAAKMSAEEVK
NYLFTSGCWPFIKQRPYDVIANPNQAPKAIFVSAYASAPLAADLDYTLADKQAELQAAIT
AVSKLTDGKVHVSVGANSNSSFAKLNGIELHKVSGPHPSGNVSTQIAKIDPINKGEVVWV
VSPQDLVIIGELLLTGKFNATRTVALTGSKFNKPQYVTAIAGANIADIVANNIDNNNTRI
ISGNVLSGTQVKEDGFLGYYDNQITAIPEGDDYEFFGWTKPVFNKVSTSRALTFSWLSPS
KRYNLNTNTNGEHRAFVVTGSYEEVFPLDIYPMQLLKSFMYKDLDEMEALGGYEIAPEDF
ALTEFICVSKQPHQKIIREGLDLMREELG
>FCMOIPGL_00418 Transcriptional regulatory protein DesR
MNHNISILAADDHPILLKGLRDELLNLGYNVLEGATNGAQALEIIISKKPKIAILDINMS
FLTGFEVIKKCKSESLKTKFIILTYYKEKGFVLKAKNMNISGYLLKDEPISEVHTCIQEV
LNGKFYASKTFDDVFNNEISPEIEKIKYLSPSERTIIRLIAGENTSKEIAEILSISIRTV
DKHRSNIITKLDIASTSDSLSLWVKSNKDLLENF
>FCMOIPGL_00419 Signal transduction histidine-protein kinase/phosphatase DegS
MRIEIKKLLIFFFCIFLIPFFYAQKVTEPISTTNVDFIKYNYKIGLELLLQEKFKEARVK
ISTGLEASKKLKNKNLMGFGYQYLSDCYNQQKNYQLATLNLKESLHIFTDLNIEKEIYNC
NFKLGRLYFKISEYDKSLESYFISLKIAEQNKNELQVAGNLQNIGEVYLLTPDLKTARIN
FNKALVIYKKLNNEEGIIGSLTNLGASYQKEGSRNNNEALVIKAIELFKEGLERARKDGF
KRNESIFLGNIGSSFRRLKKYDESLEYLFKALQLKIELKRFSSAAHSCNDISETYLEINN
LVKAKEYALKAVEYSKELNIHQERYASYLLSKIEYRTRNFKNAYNYLKKYHQIDDSLFSI
KKITKINDLKIKYETEKKNLKIEAQQSNIALLASKNQNKNQWLFFGGIGLLSVLLITILS
YSRNNAKKEKARQEKFSHELLQSQEDERTRIARELHDSVGQQLTLIKQKSQNLQQDEITI
LTNNALDEVRSISRGLYPALLKELGLSESIEQLINDFDEQTNLFFSMDIDAINSCFTESI
SLNFYRLIQECLTNIVKHAKAKSVTISIKREANTILTLISDNGKGFDINDGKKKYSLGLK
TISERIRIMDGNLSIDSKLGSGTSFIFSIPIKK
>FCMOIPGL_00420 hypothetical protein
MNQKIILFFIFFSTSFFAQNIKSIQLRPLQEDNYSAIMPLGTIFELSFDDLDADSKDYNY
KIEHMTHDWQKSRLLSSQYIDGFDENAIIDVTNSFNTFQNYTHYAVQIPNKNSVITKSGN
YLISVIDDYDEVVFSRKLVLYENATSVGVQVSRSRNTKNINTQQTVEFTINHPNLRINNP
SQEINVVILKNENWNEKITNLQPTFFKQNQLQYTYTNKTNFWGGNEYLNFDSKFIRNKSL
NVVKIEMKDIFHHYLYPYTYNENIKYKYNPDINGQFVIRTLNASIANTEADYAMMHFTLF
ADEPFAEKGVYVYGAFNNFEITEENRLFYNFENESYQGQILLKQGFYNYTFATVDENKNV
DTNEINGSFFQTENEYNVIVYYKAFGGLYDRVVGIGTGYFNQNK
>FCMOIPGL_00421 Autoinducer 2 sensor kinase/phosphatase LuxQ
MQSLKKRITFKVLIGYIILGLLAAISGFLILSEVKTFTQIQKQDILDRKIIVKTGTLIAN
IYKNESLARAALQFNSKSKFNEYLAENKKLVSKIDSLSLIANNNSQDFILDSIKLIIDKK
LKNIIDLKNLNSNDDSDKSINKAIKKLSAIDSLLSKTAVTDFIKNSNFIDNDTRSKLENF
AIALYEYTPKDSINKAEQKKIDSLVSISRKILKEAQDKTYNNRIYLKRKQNELIENDLTI
SRKLQELLENLEKDIILYTNNMIKSREDTFNRSKNIILFAAGISFIIIIIFSLIILNDFW
KTQRYRKQLEEANKTTKSLLKSRERLISMVSHDLRTPLSTISGFSELLQKSSQNTKDKNY
IDHIQNASTYMSKLVDDLLEFSKLENGNISIKSVPFDLKNLIDEITQITKNNVKDKPISF
IIKHDEHIKNLIISDPFRLKQILYNLIVNACKFTNKGTITVKSLITQNADKTNLEILVSD
TGIGISKDQIATIFKAFSQADNTNNTVKGFGLGLTISKKLAELLNGTLTLKSTLNVGSTF
TLKIPVKLSTKPIIPTDENKNAITLFNLTAVVVEDDVSMLQLLVDFLKQFNIKTYTFNNA
QDAIKSIDKIAYNFVLTDIQLPKMNGIHFMEILKKDKNYKNQPIIAMTGRANISKEEYLK
SGFFDVLIKPFDSNTLQDILHQFFNLNFVDFNTNTTNSEEKLTADFNLDTLKSFSNNDST
QIRNTLHIFLEDTKNNYSILKKAKQQNDIKLFKEVSHKMLSMFKQLEVKNVIPFLIAFEN
STFIDNTVFIKFEEHLNDFIKSLKNYLNS
>FCMOIPGL_00422 Transcriptional regulatory protein ZraR
MKGILLVEDDVSFSEMLKQFLKRHKYVVDVSYNIKNALQQLENKHYDLVFTDLRLPDGDG
ITLLKQIKLSNNAVPVVLMTSYAEVSTAVEAMKQGAFDYISKPFNPSEVLEVISNVLEEK
TNHTENQHKKQEKSKSKIDFVKGISNSSKVLDEYICLVAPINMSVLITGESGTGKEVVAK
TIHLKSPRSNKPFIAVDCGAIPREIASSEFFGHKKGSFTGANDDKIGHFESANGGTLFLD
EVGNLTYENQVQLLRALQERRIKPIGSSKEIEVDIRLITATNEDLLTAVEKGDFREDLYH
RLNEFSIKVPNLKDRTDDLILYADFFLNKANKQLNKSVIGFSKEVLTIFQNYQWPGNLRE
LSNVVKRATLLTKSEIIDVDVLPSELTKVKESNILSNKFSKKENEKALIISVLKEVDNNK
TQASKLLNITRKTLYNKMKEYNIN
>FCMOIPGL_00423 hypothetical protein
MKKLILTVAVTILTSSVSISAFANNNTNNNPKEVIVVVMNEEFKEIAVKELPEAVAKAFL
EKYETAAITKAYVNGSEQYKIEFTVNDTESVVYADKEGKWLKEEDVNAEKVE
>FCMOIPGL_00424 Protein ApaG
MVEQITKGIKISVKTKYNGIKYLNHRLFYAFSYFITIENKSSETVQLTTRFWEIIDSLND
TEIVEGEGVVGQTPILQPNDNYTYSSGCYLESSIGAMKGYYIMKDCNTLEEFKVFIPTFQ
LTNPVLSN
>FCMOIPGL_00425 hypothetical protein
MIVGLSISKSKFEELTKESKDDIVEVMKDDFNKGKEALSEKELDSIKKEVSDKMNSSFIP
IPEATKNQILKEIEKDVKDTTSIKIAPGNRISFGGTTRIDKFIQYQKDYPDSKIDTALDS
LGYDKNFTNRFLYTRAKAANSIVKKENREKYFGDLLSYGSISLFIFLPFFTLFLKLFYIR
RKFTYVDHLIFVFHTQTVFFMLLTMYYLISFFTDIDISNVWIFLILFLIYLFIAMRKFYQ
QGFFKTFIKFIMLNMVYIFLGSFGIIIVGLISFVFY
>FCMOIPGL_00426 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNNLNNKVILVTGSSKGIGKEVAILLAKNGAKIIVNHSNSPKEAAATVAKIVENGGKAIS
IKADVSNKDQVTQLFDKSIVEFGKIDVLINNAGTMISKKLKDATQEDFTKQFEVNVRGIF
NTLQEADSKLADNGIIINFSSSTTKLMLPTYSIYSATKAAVEQITRVFSKEIGRGISVNA
IAPGATETELFMNGKSQEFIDKLSSMNAFNRLAKPIDIAKVVLFLASDDSKWISGQVIGA
NGALV
>FCMOIPGL_00427 hypothetical protein
MCTVTYLPLGKKDFILTSNRDETPLRKTISPKTYFENEMKLTYPKDELAGGTWIGTSNKN
RLVCLLNGGFINHTRNKYYKMSRGIIVKSILSADDGITYINNFDFTDIEPFTLILVDWND
ELETYELVWDGKTKHFKKLAQEPKIWSSSTLYTDEMKQLRKDWFADWLLENEVFKQEKVL
EFHQNENLGTVETSLKMKRTFAETVSITSIKKENNKIKITYFDFLKDEVKTL
>FCMOIPGL_00428 1-pyrroline-5-carboxylate dehydrogenase
MARGFFNVPTAVNEPVKGYAPGSPEREELLATYKAMFNSNIDVPMHINGEEVRTGNTRNI
TPPHDHKHVVGQYHIAEKNHVDAAISTALAARQAWSSVSWMERASIFLKAAELLAGPYRA
KMNAATMIAQSKNVHQAEIDAACEMIDFFKFNVQYMTDIFKDQPASAPGIWNRVEYRPLE
GFVYAISPFNFTSIAANLPAAAALMGNVVVWKPSDHQAYSAQVIVDLFKEAGLPDGVINV
VYGDPVMISDTVLSSPDFSGLHFTGSTFVFKELWKQIGNNIHIYKTYPRIVGETGGKDFI
WAHNSSNPLQIATAIVRGSFEYQGQKCSAASRAYIPASLWEEVKKHVIAQTNEITMGSPE
DPSNFVNAVIHEGSFDKIASFIDAAKADKDAEIIVGGNHDKSVGYFIEPTVILAKSPTYA
TMTTELFGPVMTVFVYEDAEWEASLKLVDESTEYALTGAIFSKDRYIVEKASKALENAAG
NFYINDKPTGAVVGQQPFGGARASGTNDKAGSAQNLLRWTSVRLIKETFVTPTDYKYPFL
G
>FCMOIPGL_00429 hypothetical protein
MEYKYLMYAHLVTVVPCVFIGAYLLSVKKGTPFHKSLGKIYMSLMIITAIITLFMPADVG
PQFLNHFGYIHLFSFLTLYSVPTAIIAIKKGHVKKHKLKMIFLYVGAIIIAGGFTFTPGR
FLHNLFFGN
>FCMOIPGL_00430 hypothetical protein
MKRVFIITTIVSFCLLNVQCAKDEKNKVPNAVSLIYPTENLLCIDNSINFNWSEATDPED
DELEYNLIIATDRAMTNIVHNSTVTSLQALVSLEKQTAYYWRVDAVDIDNDQGTSSEIYA
FYTKGDAVLNYAPFTAELVSPENDSKQSATTSISLEWNAADANAGDTLTYELYFGENSTL
TLIDDSLSDKTHVVSVESGKTYSWKVNVKDQNGAKSIGQTWGFTVN
>FCMOIPGL_00431 hypothetical protein
MKNKLLFLFIVSIIVFNVDALYSQKIWTKVQQSSYLVQKKEIYQKKNFPSDYEIISLDLN
AFSSQLKSNSLNQKEIIELPNSEGGFSRFSLKETSNFEEKLQAKFPNIKSYSAQGIDDPT
AIAKISVGTDGFHAVIFSGKKETIYIDTYSKDNKDYIVYKRSSLKKEENDLNCLVDETGK
QEVFSQDFARNANDGKLRTFRLALTCSGEYAQFHLGATQQNIAVTATDEVKKAAVLSAMN
TSMTRINGVFEKDLSIKLVLVADNDEIIFLDADTDNITDGSPDTMINEVQTICDTAIGNA
NYDIGHIFSIGGDGLAGLGVVCVSGQKARGVTGRSQPVGDAYDIDFVIHELGHQFGATHT
QNNDCNRTNSTAVEPGSGSTIMGYAGICSPNVQEGNANGNSDAYFHAVSIAQMWNVIQSS
GSCGVVTNTDNNAPVADAGLDYSIPKSTPFKLKGTATDVDGLSSLTYNWEQLDNETATMP
PVSSSDEGPMFRSLPSKDSPERYMPALATVISGNTSSTWEVLPSVAREFNFSFFVRDNNA
GGGSSDRDDLKLTVTDDEAFTVTSQNTAETLNSGQTISVTWNKGTTDIAPIECKNVNIKL
SIDGGITFPITLKTNTPNDGSESIIVPDNATASARIMVEAADNIFYNVNTSPFVIVSSTP
TFLISDNSGEQSVCNTGTESISYNLDFDFINGFTEVATLSATGNPSGSTIAFSSSTIDAD
GTVTLTISNLEGKEAKSYDINVVGTSATVTQNIDLVLNVRSSTFNSLTLLTPVNDATGVS
ITETLTWEQDSNASSYDIEVALDAGFSNIISSKNVAENSFKATDLNGETQYFWRVKPKND
CGEGNFSAIFSFTTETPMYCTSTFTDEAGGTEYISNVTFGGINNDSDNDTTDGYQDFTNI
NANVLREQTKQISVTFDTGGYQDHCFVFIDWNKDYIFDADTEKYDLGSITDNVGTATFNI
TVPTDAKFGKTTMRVLIEYDDPTDGYGSGACDADHLTEWGETEDYSITIVEPVLNDDNYT
IETIHETIYGAEDGIINVTMNQDEFTYQLSLTGVGVDNNETLSSPNYSVDNLSPGDYEIC
ITAIEPDVTSCFTVTINKAEAVVDFDNITVETTSESCVDENDGIIDVAIKQSEFEYQITI
VGPSTNIDKNLTALNYSLSNLVPGDYEVCILVSEINFKQCFEVSIEESQPVSLKVASKTA
NNNYSFSINSGTAPYEVYLNEELISVSNDKEFDVEIKESGKLEVKTAKECEGLFKTSIGD
VVLRQNPIIDSIDLLLPIDVNQTYVDIIIFDVNGNQILKQSIKKEDNNLIIPFRNYAKGI
YILKLSIENSKPIKILK
>FCMOIPGL_00432 Octanoyltransferase
MNDPKYSELFIFVVEIMNRKILLLDLANKDYKETWDYQSELLQEIVDVKIHNRRNNLQET
TKNYFLFVEHPHVYTLGKSGDFSNLLLTENQLKEKGATFYKINRGGDITYHGPGQIVGYP
ILDLENFFTDIHKYLRFLEEVIILTIAEYGIKGTRSEGETGVWLDVGTPFARKICAMGIR
SSRWVTMHGFALNANVNLGYFDNIIPCGIKGKAVTSMEAELNRKVDLEEVKQKILKHFKS
LFEVEAFEAL
>FCMOIPGL_00433 hypothetical protein
MMIKKTKAEITKCILHKVANKFNSGHNVFSEDLIRFDQESYDLMKNFLLKPFGSLTQSYR
FSHHADVRLNELNNYASEVFKEESSFIEYSKNIVNHLYEQSNSAQIKTGDVIVVFIEGIE
YKDVLTEAVGVFKIENKVDFFQTYLDDNESFDVVVQKGISTKKIDKGCLILNSSDVEGTV
VFSVDNNNYDAQYWIKNFLSVKLADDYNSHTHNYLELCKEFSEEVIKPELGKHKQGDFLA
NTVDYFKEHEAVDYHDFKDEIFEDEKQKDLFEDYKKHYETLNDVLIRNNFDVSGVVLKKE
KSKLKTEIKLDTNISIKLDVDAPDAASEYLERGYDEEKKMKYYKVYFNEEK
>FCMOIPGL_00434 hypothetical protein
MIYQRRKPKMSDLEQTSLVLTSEFMSIDSETDLFRKLPTAILLK
>FCMOIPGL_00435 Response regulator MprA
MNKIKVLLAEDEASLAMIVKESLESRDFIVFDAENGEEAFEIYQKKDPDILVLDVMMPKK
DGFTLAKEIRLENKNIPILFLTAKSQTADVLEGFNNGGNDYLKKPFSMEELIIRIKSLMN
RIALKTNFDAIKIGKYSFNFTKQTLEYTSEIEQLTHREAQLLFHLFEKKNEVLDRTFILN
KLWGNDDFFNARSMDVFISKLRKKLKKDSNIQIINIRGFGYKLIC
>FCMOIPGL_00436 Signal-transduction histidine kinase senX3
MNIKKYKLLFYFITATIVATITVQFYWNYKNYEENKQRVTNEIQLSLDNAIEEYYSSIAK
NSFITIIEAINNDEVKKSISINSLDKSLYKNTTTDEKPKITINNIKITSDENTSKEKIDS
LMNSAKEFVSTFNTNLDDVKNDSVKFITQFTNHKNGYTLNKDGSKKNITFFKGKKAADSL
KVVSNLKPIFISFLDQSVAYQKIDSLIENQLKNKGINLKTSFHHLKNDTLFYQTKDSILD
PKTFSVSSKSTYAKENEKFELIYNNTTFETLKRSSLGILLSLLLSLLIISCLFYLLKIIN
QQKDLAVIKNDLISNITHEFKTPIATVSAAIEAIENFNVLADTEKTKKYLSMSSIQLKKL
HQMVEKLLETATLDSEQLLLKKETIDIVEITEKLVKKHKLLNNNKELIFSTNLQPIYVLV
DVFHFENAISNLIDNAVKYGGNHIEININSVLKSTEITIADDGNGIEKNQQEKIFDKFYR
VSKGNTHDVKGFGIGLYYCKKIIEKHNGTISLSSEKKKTIFKITIPNE
>FCMOIPGL_00437 hypothetical protein
MKKILTVLLLIASTIIYGQEEKNTFTKAESKITEIKYSLNSIKELEDIDWKELKAFFDTN
KPTDKIALSFELDLQESKNNIKSAITISGETKNIDSLIIRAKKGVLSIIKISKNYQNK
>FCMOIPGL_00438 hypothetical protein
MKTIITTLAIFIVTTISAQEFIGKAIYKTSRKSNVKFGGENSTMSEKQTKEIEARLQKMN
QKTFILQFDKSTSIYKEEVTLSVPKPSAKGVKVVSFFSGDDTESVYYKNLKEKRFANKTA
IMGKPFLVKDSLPIYEWQLSSETKNIGLYTCFKASFSKDVENITTTLVNGKLEEVKKIET
IVTTAWYTMQVPISNGPSTFYGLPGLILEINDGTKMIVCTEIIMNPSEKIKIEEPEKGKI
VNQADFDEISEKKSKEMMERFSGREGVDIGNGVNIRMIGN
>FCMOIPGL_00439 hypothetical protein
MKSLFTILFALVTITTFAQKDFQGKAIYMSKTSIDLDNFGGRDGRQVSEAQKKQFLERMK
SQLEKTFILDFDKSSSLYKEDAKLEAPTTGGGRGPRFGGFSSQGTKYKNTKDKVALEATE
FFGKKFLISDEMVQPEWELGAETKQIGNYTCYKATLLKDPNPLDFSNFRRPRNDDKDDKK
EDAEKEEVKQILVTAWYTPQIPVSNGPGEYWGLPGLILEINEGTTTILCTEIVMNPSEKA
AIEAPKKGKKITREKYSETVTKKMEELRQNFQGRGNRGGGRGRN
>FCMOIPGL_00440 hypothetical protein
MKKLLFLTIFMVTLVSSAQIKLTGVVKDSIGDPLEMANVLAINKVTKKMASYGFTDVKGN
YKLELGANGTFDVKISYVGMKTTDFVVETKSDNVIRNVTLEYDNALNGINIVSKMPVTIK
GDTIVYNADSFQNGTERKLEDVLKKLPGVEVNDSGEIEVEGKTVEKIMVDGKDFFDGDTK
LATKNIPSNAVDKIEVLRNFADVSQLSSVQNNQDRVAINIRLKEGKKNFWFGDITAGAGD
SPDDNLYLLQPKLFYYSPKYTINVIGDVNNMGEVVLDRSDIRNFSGGFRSQSPSNGTNIS
LASAGIGFLNANARNANRIETKLTALNFSYSPNPKLDLSGFLIFSSNSNGQRNINNIDYI
DIVDDPNTVEDESSVIPDDIVDSTTDQTSNTGLFKFSANYKQNVSKQFSYDLIGRFSNEY
RKDDVDSKVLSDISENERATPYKINQNFSYFYTANEKNIFALEVQHLLQDEDPFYVASLE
NDPSNNDDANNDGFDDSAETLGLDQTNFFYKLEQDRRVKSNQLDAKLDYYNILNDKSNLN
FVFGTIQSVQNFDSKFFQILDNESIYTPTPTIVGNTDPQTTNDTEYTFSDIYTGLRYRLK
SGIFTFTPGVTLHAYNVKNTQYQTEIVEDKFQKIFPELSIIAQFKQSESLRFSYKQEVNF
TDVNQLARGIVANSYGSYYYGNQDLMNAHIHNVNLNYSSFNLFNYTNVFARINYKKTIDQ
INSNVIFEPGSVVSSSTSLNSPFDNESLTASGRLGKTFGKFKTSLGANYNLSKTYQFINS
LENTNELFSQSYTASLSTNFTKAPNVSLGYSLSLSDQNNSSRPATVKGVTNAPSIGFDAY
IWNSLTVRSDFSYNEVKQDGVVANSFKIWDATLAYRKDKDAKWEYELVGSNLLATGSRST
VSTSNIAFTVNETFILPRFVSLRVRYQL
>FCMOIPGL_00441 hypothetical protein
MSLLATKSPFIATFKSLGALYLFIYFGLFLDSFYMVKITDDAQFYAIISMFIGFTIVFFK
VNKRVKEQMLTAVILAVIGEYFFSILLGMYTYRLENVPHYVPPGHALVYAAVLCFSKAKS
IILHKVKLEKVFTVFIIIYATFFLIFKNDVFGFVMTVATLLILRTKPRERLFYLTMYISV
AYLEIIGTNFLCWKWPSTAWGIFDFLPSYNPPSGISFFYFLLDLGCLWLYKKRHKIAWSR
MKNIRKIRLETNTSLN
>FCMOIPGL_00442 putative ABC transporter ATP-binding protein YxlF
MSIKVIAVSKIYKIQKALNEVSFSADKGSIIGFLGPNGAGKSTMMKILTGFIKPSSGEVF
IDDIDVLKKPLEAQKVIGYLPEHNPLYTDMYVREYLQFQASIFKISSAIDLTEKEQIETC
IEKVGLTSEAHKKINQLSKGYQQRVGLAATILHNPKVLILDEPTTGLDPNQLVEIRELIK
ELGKEKTVLFSTHIMQEVEAVCDRVIIIKKGEVLIDKKLSELKDDNKQIIEVTFDYKIEE
QFIKRLPNVVSFKNNYDNTWYITFESDEDMRPKIFDFAQENGLKILSLNTQNKNLETLFR
EVTV
>FCMOIPGL_00443 Beta-phosphoglucomutase
MILPKGFLFDFDGVIVDSFESHYSAWTSAFKELFDAEIAPFPKFNAGKSPMIIAEYFCSV
IGKEAQTEELYFLKDKHIETRFKVPKLLPGVIEFTSFLSEEKIPYGIASNATRQFLKNSI
QHLNLNFTTVFGVEDYEKPKPSPEAYITLAKALGFKNDDFKNIWIFEDSLTGTKAAKLAG
MIPIGITTQYSDKELKDAGSILVFPTLLEAYEHLTK
>FCMOIPGL_00444 L-gulono-1,4-lactone dehydrogenase
MKQNNNGVWVSWNENVTYNYKSLYTISTEQELQEVVKNSQKIRIFGNKQSSADIASGTEN
LVDIKDYNKILSYNNTEQTITVQSGIILGDLIEAVEAKGWCIPCLPDINTITIGGALATG
THGTSGKLLSEYITECNIILADGSLKKITDKDDLINAVRVSLGVLGVLSTITFKCEPIYT
LHIKEGPESDAIWLPKIKERLKKHDFLRILWIPHTDKGYVITGDKIDPNTEIKEDLGPKY
LKHRRTASKILYKYSHVFPWITAIANKLLYRGFFSSTKEHKGSLYQATVTKSRGSTLELA
EWTIGLDIFPTVFEELKSEINKWSNKSFIHIPMDVRFVHKDKSWLSYAYKKDTVTMGCVS
RNAATADTYEAFKSIENIFLKHGGKPHWAKRFKAKDAELSKVYEKWDDFKLLRRKLDPTN
KFLNPYLTELFNEKKTTNDFT
>FCMOIPGL_00445 hypothetical protein
MKNSITIIALILTVNIYSQQGKLFFETNYNTFSHSNLSDFQEEFKGDLSSIPLKTVDNFP
ANIGFTLGYEIIPSNISLFLAYNATGGKLSYSDYSGIVKIEEALNAISFGAIYYIDLSDK
KDFRIGLKAFSMYSSLSLDSYSEIQNYIEEDLVKLNSIDLGVGAQLNYEYPLSFLILKAN
FGFDLVLGGKLIFKENTETHLIDNSNNSVKTGWSGLRTGIGIIIPIN
>FCMOIPGL_00446 hypothetical protein
MRKIYSRLLLLASILLFSTCDYNFSEDYFNEIEITDPSISFVLPNFSKDETITKPKYIEY
NYSSDKNPLYYINFYIDAEFVSQNQNEKDTFFLDIENLSEGNHTLKIELTIKSNTGSLAE
LSGGEYYVAEQDFDFTVNKDAEPLIINSVELINGSIKVNFDSYELVNEIESSISPYLNIE
ADGAYNSIILSKKDIKNGYYLDTNTIGTYIEYKTLIENYYNNVYGEVNSITIPDTFNLQF
DFITEYSTKITWSKHALYNNISSIDFYLGINNLYFPLDINGGEKLLSTSFVFGVEESYSL
NFNSQNGYSSKTLYLKTHRGEKFETPESYSYRKFVYLPQSNKTYALLIENNQGYLGNNPV
KIIEFNSDTFEVINSTTITTTTNYFGDLTVDKSQNLILDLNSKSMVLDGNSLSKISEHNI
NNYSTREYGSLVRFRENTIIIDNINNYNTVKIYDVSSKKLLLSKKKDEYFGITLNGQFFS
LLDKIYKIEGEIVTEIYETSDNSSIIGFQENSLKNTIYFNTNNNEFYEYKTQSNTATKQS
IFDNLNPRYFNYLEDQNKFLVFTKDYSINTELHIIDEATQEIKSINLYNSTANIQDYFYF
NNTLISTRGFYLKNYF
>FCMOIPGL_00447 DNA polymerase III subunit alpha
MYLIFDTETTGLPKSWNAPITDTDNWPRCIQIAWQLHDEMGNMLEHNDFLIQPDNFNIPY
DAERIHGISTELAAEQGIELDKGLQLFNEALKKTKFIVGQNVEFDINIMGCEFHRLGVEN
NLTSLPLLDTCTEKTAIMCQIPGGRGGKFKLPTLTELHSHLFGVGFGEAHNATADVEATT
RCFLELIRLREFTQEQLDVDDDYFKNFSEANPKPIQVIGLKHINLKQESDKIRKRLEKLK
GTVETKSTSEGLAELKDVQFSHLHNHTQYSVLQSTMQIANIVSAAAKDNMPAVAMTDTAN
MMGAFHFVNAVLSHNKTAETPMKPIIGCEFNICEDHKNKSQKDNGYQVVLLAKNKNGYHN
LAKMSSAAFVDGFYYVPRIDKALVEKYKEDIIVLTGNLYGEVPSKILNLGEKQAEEALIW
WKEQFKDDFYIELMRHDQQDENIVNETLLKFSKKHDVKIIATNNTFYLEKEDANAHDILL
CVKDGEKQSTPIGKGRGYRYGLPNQEYYFKSTDEMKTLFADLPEAISNIQEIVDKIEIFT
LARDVLLPAFNIGDEFKDPEDEKDNGKRGENNFLKHLTFEGAKKRYGEITESIKERLDFE
LEVIEKTGYPGYFLIVEDFIRAARRMDVAVGPGRGSAAGSVVAYCLWITNIDPIKYDLLF
ERFLNPERVSMPDIDIDFDDEGRGRVMDYVIDKYGANQVAQIITYGTMAAKSSIRDTARV
LDLPLFEADRIAKLIPGIKLKNIFGDDAKSKGKVDGLRAEEKVLVEELKNMSFGTDLVSE
TINKATILEGSVRNTGIHACGVIITPGDITNYVPVSLAKDSDMYVTQFDNSVVETAGLLK
MDFLGLKTLTLIKDTVKIVKAKHDVDLDPENFPLDDIKTYELFQRGETVGVFQYESPGMQ
KHMRSLKPTVFADLIAMNALYRPGPMEYIPSFINRKHGTEDIEYDLPAMEEYLAETYGIT
VYQEQVMLLSQKLADFTKGEADVLRKAMGKKQIAVLDKMKPKFVEQASANGHDEEKLEKI
WKDWEAFASYAFNKSHSTCYAWIAYQTAYLKAHYPAEYMASVLSNNMNDIKSVSFFMEEC
KRMGLKVLGPDLNESYLKFSVNKEGAVRFGMAAVKGVGAGAVRAIIEERKNNGNYTSIFD
LAKRVDLRAANKKSFDSLIKAGAFDSFTDTHRAQYFATDEKGLTFLERAMKFGSKFQENE
NSAQVSMFGEASTVQFPEPEIPECETWGTMELLSQEKEVIGIYISAHPLDDFKNEMIFCN
ATLKDFKGDLQKLVGNNLSFAGIVTDVQHRVSKAGKGWALFTIEDYGDSYEFRVFGEEYL
RFKHFFVPNSFLFVRTTVQAGWTNKDGVTGEPRLKFIDFKLLHDIMDELCKKVTIKISLQ
EITTDAISNLENILKKSPGKQNLHFTIWDAKEKIEISLPSRNTKVNVSNELLATLDKDQI
AYKLN
>FCMOIPGL_00448 hypothetical protein
MKYTEKISNKLNELLEKNYDAEKGYLNSAENVDSPKLKIFFKNRASERSLFAKELRTEIL
SYGQIPENDGSVKGSMHRNWMSLKALFSANNEEAILEEAMRGEKASYQEYENILQEDAFA
PSTRKMLEHQKQKIQAAINIIMVEEELA
>FCMOIPGL_00449 30S ribosomal protein S16
MPVKIRLQRHGKKGKPFYWIVAADSRAKRDGKYLEKIGTYNPNINPAVIDLDVDKAVTWL
QNGAQPTDTAKAILSYKGALLKNHLAGGVRKGALTEEQAEAKFAAWLEEKSGKVAAKEEG
LTKSQADAKAKALAAEKAVNEARIEAAKPVVEEVAEEVVAEEAAPETIDDAAAKAAE
>FCMOIPGL_00450 Ribosome maturation factor RimM
MRKEDCFYLGKIVTKYSFKGEVVIKLDTDEPELYTEMESVYVEFGANLVPFFIDKSSLHK
GNQLRVQFEDVYSEEEADSILKCGVYLPLDLLPKLTGDKFYFHEVIGFTVVDSNFGEVGT
LVHINDKAAQPLFEIDSDGKEVFIPMIDDFIKKVDRENKTILVTAPDGLIELYL
>FCMOIPGL_00452 Beta-porphyranase B
MRFKNIRIIILLNVFLLILSCGHQKNVTNSNKKETTVYPFSDPENSGNWVLNADVSDEFE
DDKIDEDKWYIVGKFKDGKPFYKHPDKPNKKVWKGRAPSQFSGRNYRLENGKLILETRWE
PDFPFSDDVQKPWGKKEGQVEKFENLTTACFVGRKFFKYGYMEIKSKAADAEITSAFWAI
GNGVELDVFEQFGDHRQPNKEANGKDRELWWSIHDWARKNKVVYTEHLDYGFRVADNFHV
YGIEWNEKGLKLYVDGKYKTGATKEQVEAYALKKHNLPDGWIMTKPLSIWLDQETFPWHG
VPDSKKDLELNSPEGKKDDGVVDFEIEYVRVWQKK
>FCMOIPGL_00453 Beta-porphyranase B
MKIFKIIFIFLICFSCGNNTTIDEEIIDEIIIVDDTNDDQEEEDVVVAPNSDFPLSDQKN
EGNWILNTDISDEFDANILDEEKWQIQGKDNVYKSNFIGRAPSQFSMDNAIVEDEKLKIV
TKWEPDFDFSSNSQTVNGVVYKYENITTAAVISKKQFMYGYMEIKCKSANAQVTSSFWTT
GKNTSELDMFEMFGGHKTSDSWKKRLKLNIISWDPNNYYYQPNNKGPVYTSNIQVAENTA
DDFHVYGFDWTSEYIKIYVDGVLQANETILKSELTNKGANPEKWVTNVPYWIWFDSETFP
WLGIPNQSELQVPAEYQIEYIRVWQKS
>FCMOIPGL_00454 hypothetical protein
MKKIVLTLLLVVAFTTAYGQNKYQERQNKYFVEAAAKEFNLDEQQQKDLTEIRTTMVLAY
GESQKAFTAGDITKEEKKAKNREASKAFNNAVIKLTGKNYKELAPFFQRMRDELKGVK
>FCMOIPGL_00455 Arylsulfatase
MKLSNSIKFFTCVSALFLMSCNSSKEKVASKEKVVKNQTIEKPNILVILCDDLGYSDVGF
NGAKDIITPALDQLADNGTIFTSAYVTHPFCGPSRASLMTGLYPHKIGAQFNLPPNSGET
IKKGISVDEPFISKVLNETGYRTGIIGKWHLGSNPEFHPNVRGFDDFFGFLGGGHNYFPE
QYNAAYKKQKESGKKLIWDYLHPIEHNGKNVDETEYLTDAFSREAVRFIDDASKTKDPFF
LYLAYNAPHTPLEAKPEDEALFTHIKDKKRRTYAAMVYAVDRGVKKIVASLKESGQFDNT
LIVFMSDNGGKTTSGATNYPLKEGKGSVYEGGFRVPMFFHWPNVVPAGKKYDFNVSAIDV
YPTFARLSGAKIPEGKRLDGKNMWDNFMLNRDSHKDESIYVLRHRNGFSDVGIRNNEWKA
VKAYRQKWKLFNVNDDISEKFDLSDKYPAILKNLVTQAEIWSKSHIQPLWWHDEKTGIQW
KADKMPRFDKTFKLN
>FCMOIPGL_00456 hypothetical protein
MQELLKRLSVEKWVVPSLKIAWHFHPEFKIVYVSKSSGIRFVGNIVSQFHPRDLVLVGSL
LPHLWDTI
>FCMOIPGL_00457 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MMKLVLKNSDSVVVKKLDIYTRDVPCLDAVWHYHPEFELLYISKSNGIRFVGDSVAPFFP
GDLVLVGSYIPHLWRNDPSYYEKSSKKEVKTIVTKFTKDFLGDGFFNKTEFYEISKLLDA
CKFGLSFGKEISKTLHKDIIDLPKISSTEQHIKLLSILHKLSLVEEKDRVILSSSDMRQT
TTESSERIDTVLKYISDNYSKSIALDDISNVACMTTNSFCRFFKKMTNKSFTQFLNEIRI
RNASRILVQENIPVSEVCYIVGFNSITNFNKQFKQIMGATPKKFREAI
>FCMOIPGL_00458 Beta-porphyranase B
MKIKLHFNRNSNNFLFFLIFAFVLFYYNLSAQKLPLSDQENTGNWVLNTDISDEFEAVSL
DETQWLIQGRNDEYQSNFKGRAPSQFSTENAILEDGKLKILTKWEPNYNFNPTVDANGDS
YENITTAAVISKKQFLYGYMEIKSKAANAEITSSFWTTGPGGATGASELDMFEMFGGHKT
NDAWKKRLKLNIISWDPNNSIKQAATAAGQSVGTTHSRFIQAENNTADDFHVYGFEWTSE
YIKVYIDGVLHPNGTILKSEITNNGAEPDRWVTDVPYWVWFDSETFPWLGLPEASDLEQP
AEYQIEYIRVWQKQSGQINVTGSTNAIEGVTDGVFTVALSNGEIATEDINITFSVGGNAI
EGTDYTSIPRTVTIANGKNSAQININAIEDHIDEDQETVTITLLFSSTKTVNTTETSIQI
SDVIESTKLTAGDIAILGWQAGNGKLAFMLLKEITSATKLSISNRTWNNSQSEFTGDYSV
DDIWTWTSGAAFKTGTILMLDADGQIKQVVGNEEIIVGTTTHDYTGKVSQNSDGDFDLSA
NGEGILIFQTDPFLLPTNANSTAWVTGLNTAQGWGLGGGNSACELPTALTNGINATSVGE
KHDFGVYKGKLSGTSAELRASINNANNWAFSEDTVYKLWSFNDNSNNISGDIGVAGTLSL
SENSTFKLTVFPNPVNDYLYLNFGESQPRFEIEIFTTFGKSVKKVKENNVSTSKIDVSNL
SSGVYFLSIMSENTKQIKKIIIK
>FCMOIPGL_00459 Arylsulfatase
MNMKNILTRISVCCFALIAFNTIAQTTSGTRPNIIVILADDLGYADVGFNRDATFPVDRG
VIPTPNIDALASTGIVVKNAHVAHPFCGPSRVALLTGMMPHRIGAQYNLPNDITSTLGVP
ENETYFSSVLQNSSYNTAAFGKWHLGFKEGSYQPLDRGFDYFYGFLGGGKNYFESEYEDG
FYNRLGGANPVTNEYQDPIWRDRGYVARDEYSNAENEDYLTDLLTDEAIGYANSVAGSSD
PYFMYLSYNAPHTPLQAPEAEVAQFKLDNPNFENLIRNSTYITESTPVTKEADPAKKAEL
IEKFVQARITYATMVTNMDKNIGRLVTELKKDMTKFNNTVIIFLSDNGGYTYSKGAVNWP
LDALKGSVKEGGHKVPMFVSWPNKITSSATYNHQISSLDIYPTLVALAGETVPAGKTIDG
VNFMDKLIAGEDARPDDQILIMRPQNGFHNGGIAYDHWKIVKTANGGKWSLYDIATDPGE
ETDVRNSDPNGEEIVQDILDRAIALVVDFKDVKPAWYDNDNEDVDGDGIGDGHVHSFLWE
DGTLPGYDRLFETPLLKLEGELSKISIAKTTDATEGIVNGVFTVSLPEGVMATEDIDVTY
TISGDATDGTDYTTLSGTVTIMNGTNASEINIVATEDGLDEISESVIITLATTTFGSVES
TPAEINIFDVIEPTVLTAGDIAIVGWKAGKGKLAFMLLKDISATTKLSISNRTWSNSSNA
FTGDYSVDDIWTWSPGAAYTTGDIFILDDNGSVKQVLDNAEVVVGSTSHDYTGKTAESSD
GDFDFSVNGEGILIFQADPFVLPTDANSTAWITGINTALGWGNGGGNSRSDLPTALTNGV
NANIVGEKHDFGVYTGKLSGTPAQLRASINDVSNWSFSEDAEYNLWSFDTTSGDVSGNIG
TAGTLSLSTQNAYQLNIYPNPVSKNVTIQLNNTYKNVDIEVLSITGKLIKKINVKNMIKK
NVDISNLSSGMYVLRVKADANLSIEKIIKL
>FCMOIPGL_00460 hypothetical protein
MNKKLQKNYLFILAFLGLLSVNMNAQTHDQTFSDNASFQYYNIGYGNGTRSHDPTGGLTG
DGAFKLVRDNNNNSNFGFNDGIDASTKKVIKIRYKNETTAPNIQIKGKSTDGTTETDLGT
TIASIDSNSSDWKTLYIDMSGVAAWTNSVNNLDILVKGSVSVPASGDAVGSAFFLDEITF
LNAMPADEFSEFIPNPSFEDTTEDSNYTGNLDDGTRSFVNLADAKDGVGVLKYEYSQDQT
RTQYTFNAFQKEYSPSSFPIGTKLQVKMWVKTNRSEVTELSVRFNTRLNGANTNITETLT
TTKTDGSWEELTFDITATAEFNQMRFWFAIEYNSGAATDFNSGDILYLDKLSSGVFPVTT
AATPGTWEASGSWGGTLPDQGDSKTVDADLSINSAVVSDGPIDITTGNTLTIKAGHSLTL
NSDLDIVGSLNLEAGAQLIVKGNSTGNASFVRTLPAATSDGAATGLEGWFSMTAPFSGAA
LNTTWADAGTNNIAISADTNKRGVAWYTESSDEFTYLLANNSNATTFEAGKGYIVKQSSA
GDISFTGTINSSEDGVDVTVTKAGNGFNLLGSPYSALVNSGTFLTDTDNSGLFESSEIWV
WNDDGNTYESKPSGDNFMLAPGQAFFVQVNAGGTLNFKQSNQSIGGDTFQKSSKAEIILK
VNNGKTHRYAKVNYLNNSTLGYDNGYEGKVFEGIPNSFSVYTHLLENNESKKYQIQSLPS
SNIESMVIPVGIDVAESSEITFTLEAKNIPSGLKVFLEDRQENTFTQLDVLNSEYKVSLT
EVSNGIGRFYLHTKASALSTDNLFLNSVSIYKSDNSTLKVAGLKNGKASISVFNILGKNV
LSSSFEANGVKEISLPKLAAGVYVVQLTTVEGKLNKKIILE
>FCMOIPGL_00461 hypothetical protein
MKKQVENTQDTTQDISRKEAIKKIGNYGKYAALTALGTYMILSPQKAQAASPTPEAPGTG
F
>FCMOIPGL_00462 Arylsulfatase
MKKIITIICLAITVTSCAQKKPNIIFLFSDDAGYQDFGFQGSKVMITPNLDKLAKEGVKF
TQGYVTDATCGPSRAGLITGKYQQKFGYQEINVPNYMSPNSKFLGDDMGLPVDQKTIADY
LKTIGYKSAVYGKWHLGNADRFHPLKRGFDEFYGFRGGARSYFPYSNFNGVHHDNKMERN
FEIFEEPKKYATDAFADEAISFIEKNKNNPFFIYLAFNAVHTPMHATKEDLAKFPNLKGK
RQQVAAMTFALDRACGKVLDKLKELGLDENTIIVFSNDNGGPTDKNASLNLPLSGTKSNH
LEGGLRVPFLMKWPKKLKAGKVYDYPVSTMDLLPTFFAAGGGDVKDLEEIDGVNIVPFVN
GANKARPHKELYWKKEARAVYRENDWKLIRFADRPAELYDLTKDITEQNNLASQEPERVK
MMFKKLFAWELTQERPLWMLQQRFEKYDIDRMDRYRTPELVKKEMEQYDKSK
>FCMOIPGL_00463 Beta-porphyranase B
MKIFYKILVISFLFFGFSCAKSTSEKGDVFTSKIYPASDSENEEGWVLNEEISDEFEGTE
IDTSKWFVEGQNGDYYIWKGRAPSQYAPHNVIVENGKLILKTQWEPDYNFAKESYADGAH
KDTYGVHEGKPMPVTTAAIVSKKRFLNGYMEIKSKAPHAAMTAAFWAIGFEQELDMYEQL
AVPKIAKEGSISNKTNRTAIHDWSPPSTRPTKAFGYDETLPYITSDDFHVYGVEWGQDYL
KIYRDGKFIHSFTQDELGTDWVLNNPMEIWVDSEIFKWLGVPHKEELPATFEAEYVRVWQ
KESDNVLAKARAFYGFEGPILFEESPKPLTMVPENSEANDYQKFWLFSEGSEKYLKITEG
HYNSGVESLQFFGYGKNDSLNVDKVLIKTPKGALNLPAGDYTISMKVWLDQGRITDSIHV
SLMDPKAYLVFSGLKKIPRKEWVTIEHKISRATASTKGDGMIIEIRKEDLPETKAAKLYI
DDIEIKNIK
>FCMOIPGL_00464 Beta-porphyranase A
MKIFKNYLFISLFAMLTLTSLSCDAQKSTVNNVKIEVKTPMPFSDQQNKGGWVLNEDLSD
EFKGTEIDTVKWFVEGLNDRYYIWKGRAPSQFVAKNVIVEDDKLKLRTAWEPEYPFIKES
YADGNMGSSQYGVYKDGTPMPVTTAGVLTNKRFLYGYMEVKSKVGNAAITGAFWAIGHEQ
ELDVFELMGNPKNKGNIRADSYLATAHDWSPPAQRPTKIFNHDENLDFRTADDFHVYGAE
WGVDYLKLFIDGKLIRHFTQDQLGTSFVLNNPMEVWLDSEIFFWLGLPHKEELPVDFEIE
YMRVWQKPSDNLLAKDAAFYGFEGPILFEENPRPLTLLPESSVPDDYQKFWNINEGSAKY
LSIAYGDYYQGVNSLEFSGFSKTDSLKVEKAVAMAPEGSLKLEAGEFTISAKVWLDQGVI
ADKIHLVLQDPALEVTFLDLRKLKRREWITLESTFSRTVASGEKDAIAIEVRKEDLPKTR
AAKLYIDNIVIKKK
>FCMOIPGL_00465 Non-reducing end beta-L-arabinofuranosidase
MSTTLNLHNNAITNNAESPFVKLKSINFGDCKWDSGFWSQKVKSAEDKMLPYMGNLLCGD
IGHGLNNFKIAAGEKEGAHKGFYWHDGDFYKFMEAKMYIYGLTKNESVLKELDEYIAVIG
RAQEDDGYIHTHVQITDGVDRFENRKYHEMYNFGHLFIAGSVHFRITGQRNFLDIAVKMA
DLLYTYFMPDTKHYQRFGFNQTQIMGLVELYRTTRDAKYLKLAEKFINRRGTYEIKHDDT
TIGYPIGDMVQERTPFRESKEAVGHAVLALYYYAGAADVYAETGEKALIDALDALWENVT
GKKMYVTGAVGQAHYGASTSLDMIEEGFIDAYMMPNMTAYNETCANLCNAMFSSRMMAIK
DESRYADIIELVLYNSGLSGISIEGKDYFYSNPLRMVNNSRDYDSHADVTESPVRQPYLE
CFCCPPNLVRTICKSSGWAYNLSENGVAVVLFGGNKLDTRMLDGSPIKLSQDTEYPWKGI
VKITVDECKDTAFEIKVRIPKWAVGSAIKVNGENANVAVNRGSFAVIKRTWKAGDTIVLD
MPMEVTMVEGHNRIEEVRNQVAVKRGPIVYVIETPDLPKNTSILDVYLNGDTTLEAVYKD
DFLGGVTVVETELLIRSGKNDDMYQTITKPSFTTFKTQLVPYYAWSNRGQAEMTVFIPVV
WNK
>FCMOIPGL_00466 hypothetical protein
MKTQLLIILLFLSFSIKGQNFLELPKNIKPEDRIAFAMYTVHENIVKLTAQFYPIKNYEP
FEATLEINENGKWIQKAEASIHYPGYTALFRIENWDDTKERKYRVAHNNKAFYEGIIRKN
PIHKDNFVLAALTCNSIYPSHGGDIPKTDLVENIKKIQPDLLFFSGDQVYDHSEHYLYWL
KFGQDFGEIIRNTPTICIVDDHDVGQGNIWGNGGIKSKDRRGIDGGYYMPVEYIKEVERA
QTSHLPDAYDPTPIEQGIGVYYTDLKWGGLSFAILEDRKFKSGPGKIFKHKGKVVDAIFD
PTVNTKDFDSPKAALLGKRQLDFLEDWTTDWDNVEMKTVLSQTIFAMANNYTGKHDREIF
ADFDSNGWPQSGRNKALSVIRKSFSPMIAGDQHLGSLIKHGVDDWDDAGYSFCTPAIANY
WMRWWDPKKTGKNKAKNAPNYTGEFLDGFQNKITMHAVANPTLPEIEEGGKLSTRVAGFG
VIKYNKPNRTITFECWGRNIDITDPNSKQYAGWPVTISQFDNFNPKISYALPKLEISKEN
QVVTIRKSETQEVVSSVRIKGVSYQPKVLELGSYLIEVGEGTSVKKYYGVLSKKKNKSKL
VVKI
>FCMOIPGL_00467 hypothetical protein
MDFKKYSNSKLFLTAIIVFTLVGNSVFAQSVKFKETKKDFPRQEKNLRKWDAPVVVDLDK
DGYLDLLINDHGFGIQVQWNNKGKFAKPFDIIMGDLHGVSAGDFDNDGHIEVIMSRGGGS
GSNARNSLIFKVKGREFSVMKDFKEPLALMRGRTVKFVDLDNDGDLDLLNFAFPDGAKKG
ASENYIYKNNGLGELILQGTIPASKANGQKALITDFNNDNIMDIILYGYKNVIAYQGKGD
LTFTEVTKKIFPFEIDEVTTIGEIDYDNDGDMDLFFTRGLEFKTGETFYNKETKDLGFYT
KRGILNLDDFVSGEVLELENFQSQWPNNDTYFIGEASYDYEFKGETHSGKDISLVMSDAL
GFPENPDYKAKKGWYIGYVGNQKWRISGFLWAPATGVIHNVKNFTESQQSKGKNDILLEN
KGSKFVDVTKQANLFLEEHTMAVTIADYDNNGFKDLLVIKRGELVYDNESILYLNNGNST
FKTATNHAIITRDLGGIGMAVESLDYNKDGKVDVVIGDERAKWSLFKNQTETNNLALTVE
VKKSPKENVSPLGALVTISSCRNTQIQRVGTSASQYSLSHNTFVHFGLGTCGKNVKVTVK
YSNGETVTKTIAASSKILKIGK
>FCMOIPGL_00468 D-xylose-proton symporter
MNKHTKNAFLYAIIVAIGSFVFGLDAVLISGGFKFITQEFNLTASQVGLIGSAPGIGVLI
ALPLTAFAANKLGRKVTLQIIAIFYIVSAVGSAFAPSFLSLFWFRFLGGLAFSSVTLASM
YIGEVAPAEQRGKLVSTLQINMGIGFTAAYLINYWILQKMGSDLQWVKDLNLAETGWRWM
LGIEIIPAVLWFLLLFLIPKSPAWLIYKGRVDDAKKSLSKVYPEDKIEEQVQQMLVSVEN
SVGKNSSTISQLKEIFSSKMRVVLIIAFTLAVVQQFTGMNAVMIYAPTMFEQLGLGTDAA
FSSTIWIGVIGLVATLISLSLIDKFGRRPIVIGGLILIIISISTVSYGFKQATYQVTESA
IVKMKDIPNIKKLNAIVGKEFNSDIEFKNSLTEILGVESARDNSGVIFKETAHMNAILIL
LSILTFIAAFNFSIGPIMWVLLSEIFPISNRGVAIPLFALISSTVSALVQYLFPLEMEMF
GAATTFIIYAGIVLVGLIILYKYLLETKGLSLEEIQAKLKAN
>FCMOIPGL_00469 Arylsulfatase
MRQISKQLKLLFLGIFISIMGCTAQQERPNILFVLCDDLGYNDVGFNGSKDIITPELDKL
AKNGTIFTSAYVAHPFCGPSRASILTGRYSQEIGTAFNLHSNSSMNDADNMGIPTEETYI
SKVLQDAGYYTSAFGKWHLGSAPKFHPNKRGFDNYYGFLGGGHNYFPEKYQKEYQKQLKE
GRKEIRDYILPLENNGKNVKETEYITDALSREAIKDIKLASTNKDPFFIYLAYNAPHVPL
EAKEEDLKVFANIKDKDRRTYAAMVYAVDRGVGKIVQTLKETNQYDNTLIVFLSDNGGNF
DHGANNYPLKGTKGDAWEGGYRVPMFFHYPNKVAKGKKFDFPVSALDLYPTFAKLVNAKI
PKNKKLGGKDIMESVLNNTEPHKEDMIYCLRYRHGFSDVGARLGDWKITRVGNEPWRLTN
ITQDIGEKKNMAGRYPERLKKMVAETQKWTESFVFPLWFYSAKDEELWNDGRMPQYNETF
EVDKVAQPASKK
>FCMOIPGL_00470 hypothetical protein
MLISCKIPYQDNKKAQKLLPFSDKENFGSWIINNRVSDEFDTEIIDEEK
>FCMOIPGL_00471 hypothetical protein
MVRQRIKNLKFEKKQQNSKELLDVKNKELTTNTLQLIEKEQVIKKLSDYIKEISPDNKTK
MILKSLEKNSTSLWDSFNRRFNQLNKGFYERLQKKVPDLSRGDRKFCALIKLNFSGKEMA
YLLGISLGSVHVARHRLRKKMNLERNQNLTKFINSI
>FCMOIPGL_00472 hypothetical protein
MLSISYLKQKRTLYISLFILNILFLQCLQSQQLKTHFEESLIPIDTPSDSISFVLNKTKK
QALIKKDSTLLINTLITQSRFNRFKLNYLEAFSVAGAALFISEEYKDALLIAKANEELGV
LTYLYKQSEESESYLKKAHQLYKNLYKNKKIEVSEIYKSYYNLVLHYQRIADKENLQSYI
DSCVVLLKKMKPSPINSIFLDEKKASISEWNEKHNEALTYLKNAVNRLENSTQKSVFNYK
DKQFLLILYGRIANIYLKNKNFNEAKVYFEKFSKIDGILGETTFYRSFLYSRYAAVLKEL
NQFKLAYEYEKKSNTIGITFLNPRNEKNKGFLTIKNYYKEELTKKENN
>FCMOIPGL_00473 Choline-sulfatase
MINSMSLKTLFTVFLLCVFFNVFTQNKKPNIILIIVDDLNDYIGFLGGNDQVKTPNMNAL
AKEGTVFTNAHTNAPICAPSRASMLTGIYPHESKNFWFDKWTDNEVLKNSKSLAKFMGDN
GYKTYATGKLMHHRVKLEWNEYGVENDFGLYAFNGKKVVQHPLMPKEYSKDKNDGLFMSL
ANVPNVKATKNSPGYKGWYDVKNRKPFIYISDDNRDLMNDELSANWVVEKIKSLEKSNTD
KPFFMAVGFVKSHTPLVAPQKYFDMYPLETLKIPVIKKSDNEDTYYRTTFSWPMPWTKHY
QELEVSYKNVNNGLRAYLQAYLACVSFVDDQIGKVMNALKQSSFNKNTVVILVSDHGYNH
GEKEFLYKNNFWEESIRIPLIVRNLSIKNSKGKTISNPVSLIDIYPTIADFAKIT
>FCMOIPGL_00474 Non-reducing end beta-L-arabinofuranosidase
MNQKLKNSIIITFFSFLLIISCKENANQKLALNTRKNVDLNLDANKGIINYSNSPHVKLK
SLNIGDCEWTDGFWADKFKVAQDVMVPYMGEVLKGDVGHALNNFKIAAGLKEGKHKGFYW
HDGDFYKWMEAATYVYAINKDKKIIDELDGLIEIIGKAQQENGYLQTQTQLKNVKPFSER
KYHEMYNSGHLYIAACIYYRVTGKTNFLDIAIRHANNLYNVFQPQPAELARMGFNQVQIM
GLVELYRTTKDKRYLELAEIFINMRGKSKVKPHPSVRNNNIGDMTQERTPLRKEDEAVGH
AVLALYYYAGAADVYAETGEKALIDALDRIWGNIVEKKMFVTGACGQKHDGGSSNRDFVH
EAFTIDYEMHNANAYNETCANLCNAMFNYRMLNIKGESKHADIMELVLYNSALSGISLEG
NSYFYTNPLRRTKNHKMGGTDYPNRVGYIPCFCCPPNLVRTIAKSSSWAYSLSDNGIAVN
LYGGNKLDTKLLDNSTIKLKQETNYPWNGKIVITIDECKSDAFDVMLRIPDWSETAKISI
NGKKVNIKTEVGTFATINRNWKKGDVITLNLPMDIKLLEGNPLIEEVRNQAAIKRGPIVY
CVESPDLPKSADILDVYLPVNSNLKSIYKPKLLGGVTTISGNVKLRQDDKTGMYRVLSGI
KWRSYEAQFIPYFTWSNRGESEMSVWLPLIFDEK
>FCMOIPGL_00475 hypothetical protein
MKQLIKTILIFVLVLIFFSYAKEKNKYETEALQKIEQLEILMAKAKKNTIDVKREETLLW
FSKEFIKFANWDEANKDQVEKSFSYDRFYKKDPVKWAIELPNLERKKVIEMLGKGILQLQ
KVLDGSIVRRPTPKVDWGGIKVTDRALINKEKPVFLHDYFSKTVGIPLTNKDVYNDHLGN
MFHGGENLYEEHQDRAINPWLLNEDGSFDADRLKLLTNIPDTNIGFLYLWNSGLPDWLKT
KDSTVQVGRSLFMGLDIDNPLVRNHWGKIANKVGELTNGKKVTQLGFVLANEPHWFAEKE
YWTQKFGEMNSISIHTLNKFRKFLSNAYNNDIKALNKNWKSSFEDFNAVEIEIPISKKNQ
GKPIWYDWCRFGMARSLDWFTYIQKELRVLYPEAPTSIKMQPRYFAGNYRSHGLDFESLT
ELTSVIGDDAKAQSSRSFGAKNPESWENRYAYSWEEISFSYDFMESVSPNKIHFNSETHF
LSLSNWKDLNTPTDYVRNVFWLATLHGMDASTSWFWARDPDGSPENRLEGDLDFWDPGLG
GAYAGSANMQPQMVNEIAQVFMDMNSFSEEIMALREQRKSLRVFYSETSAINKKQHMTEL
FELYESLYFEGIPLGYATEKIIKKQNHNNWDAIVVYKTQFVTDSEFDALQDYLNYGGTII
LDNKESLSKNEYGKLRKKKLQKGKGKLIFVKSNSLEGMKKASIESIPKNLSKIKLTESNG
TAFKGCTWRVVKNKKGGYWVNILNIGKNDAKLKLSFKDGKKPIITNMLTQEKLKADFDLK
SNGVLLLKITE
>FCMOIPGL_00476 Choline-sulfatase
MKYLKPTFYSLLFLLIISCQQQEKKVSKKPNILFIGIDDLRPELGCYGSDIAVSPNLDKL
ASQGLLFENAYCQQAICGPSRASLMTGIRPETSGVFHNYIKFREVNPNVVTLSEHFKNNG
YEAVYTGKIFHHGDLDDEKSWSRKPALDSMKEVKKPVGFALKKNNEDRKKIRNEMVAKYG
AVAKYGLASGVAYESADVADNTYRDGYHTELAIATMKEMNAKSDKPFFLGLGFNKPHLNW
VAPKKYWDLYDRDKIKLSTQTESPENGATMGLHPSFELRVRSNIPKKGEIDKELAITLKH
AYLACVSYVDAQIGKMITALEKEGLRQNTIIIVWSDHGWHLGDMGIWGKATNYEIATRVP
LLIWTPDMPKGSKGKTTDALVELVDMYPTLAELAGLEIPKHVEGTSFKPLISNPEKKWKT
AAFSQFPSPALREWGGFPIRPAMRETYFGPLLKEVEGKIKKQQEDNWDRNLFENNLMGYA
MRTEQYRFIVWKDRLNKEKEPVFIELYNHKIDPKETKNIAKENPDLVGKLMKQFNKGWQG
NIPNPSI
>FCMOIPGL_00477 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MKRRDFFRKGATAAVAVGAIPMIASSCASTNDIVYDRKNDKWYHLGNGKTGTNSRKKTDA
YDVAVIGGGAAGICAAVAAARNGSKTVLIQDRPVLGGNASSEMRVHLNGVNNIKGKAERE
TGIIEEILLHNRFENEQESFPVFDHVLYDFVVRESNLTLMLNTQAVEAVMNGDKIKSAMC
WQATTETMFTINAPIFIDCSGDGLLAATSGAEYRTGREGKAEFNEKYAPDKPDGWQMGAT
LLMSSKDMGKPMKYSPPSYAIKYTHEGGHKRRKFAGFQDGIWWIEIGSDDDIIADAEKNR
HTLMAYLHGVWDYIKNSGKFPEAENLALDWVGSLPARRESRRFIGDYFLSEKDLTEHKHF
NDAVAFGGWSLDEHNPGGILDIKERPSFFHYHFKEVYQFPFRSLYSKNVSNLLFAGRNVS
QTHIALSSSRIMATCALQGQAVGTAATICNKYDVSPRVVAQKYINELQEQLLRDDVFIPK
RNANDPKDLAKKASLIFGSTTFSGDAKNLLNGISRDIYGEINHWQSEGLSAEIQLEWSNS
VNLSAVEIKCDTNVNRNIMMRKDSRNDDLYRNGIPTEMLKSLSLQGRVNGQWIELGNIEN
NKTRLIKFKFNEVKVTAIKVIMTETYGAQNVKLFEVRCYA
>FCMOIPGL_00478 hypothetical protein
MMNFIKTYVWILFPFIFLSGSLFLESPQKEIRHTILVSHPGEKTKISTTLVEVQNENGLP
IKYYTDVESVICLEKVCKVIPVRIIWNNLGEYQEYKLKEGEILEKYEDDFFESKDYIKLQ
SILSNQASPFKEVFIEDVLTVPNENDYEEVDAISGATALELDEKDTVPGAALTCYTLWHW
ANGNLVSVIKSITAKSASTKQLQDFLVDKNNAYYSLAIYELKVRREYKKSIINATIDRVL
QDDSLLKSTFEYINLAPSEIYFFIIKEVFFKGKKEQKLAAIKSLKYSSFKISKTFLDNFS
QELTSLKSFQEVTALLELIQDKNLKSVKVIENVVPLLNRDFLIARRAYWFLKNKKLLPSQ
ELLVRDFYNKNKEKL
>FCMOIPGL_00479 Arylsulfatase
MKKFKNILLIAIIAAISFWSCKGQKTVSNTTKTVVETYEKPNLIIIHTDEHNFRTLSAYQ
KLLPEEQAFVWGKGNNSKTPNIDKIADEGAIATSYYCASPVCTPSRASLVTGLYPQATGA
PKNGMHIREDIPTFATILRDQGYATSYVGKWHLAGHEKYTFDIKYKAGFEDNRYMMKGGH
APYFHIKDGKFKGINEKVAAKLPKEEVIHLTDFFTDKTLEILERDKGKPFALMLSIPDPH
TPDYAKPPYNTMYKDLQIEAPKTMAAEYTAIKPYWAGGNKPDNNEAFGKKAFKNEKNALK
QYFGMVSHIDDSVGRILQFLDDNNLTENTIIVFTSDHGDMFFEHNRRNKGVPYEGSARIP
FVIRYPNKIPAGKVLNTAYTNVDFAPTILSLMNVKTDAKFHGLDTSDDFTNNKKEITSDR
ITYFAKSGGWWVSAVNDRYKLVIDKKEKPYLFDLQKDPDELINFYYDKEYATIAKKMQTE
LFKQLNKYDESGLKMRQKYITE
>FCMOIPGL_00480 Arylsulfatase
MMKKTPLFLLYVLICFSFFAQKQKQPNILFIAIDDLNDWVSPLEGNKQAITPNMDKLTKS
GSMVFKNAITPAPICGPSRSAILSGFLPSTSGVYGNSDNMLYSDIVKENPTLPEYFSLNG
YHTLSNGKMFHKHGTKNGKTDFGEWAFDEFARARRYNNDAADKKFVTSSKAGSINGVVKP
EYKQKKAKLSWGPTKDKFEKTVDFGVADWARKQLQRDFDKPFFMSVGFIKPHLPWFVPKE
FFDLYDINKIEDILIKEDDLVDITDANGKQKFKPTAEYKWIKKHNLNKEATRAYLANVSF
VDKCLGIVMDALEKSNHADNTIVVIWGDHGWHLGEKQRYLKNTLWSEAVKPPFFVKLPGM
KETVILKRTVSLLDLYPTLINLAKLPKKENLDGHDFSNLLKNPTSEWEYPGVTVSSEGTS
VLSEQYHYIQYLSGEEELYDVIKDPNEWNNLISNSKYQKEVSALKKWIPIKRKKASKERY
GKPKNYVDADQDETIKSTRKFK
>FCMOIPGL_00481 Lambda-carrageenase
MNIKKGSYYCFSKWIQSTLTIVILFTGNIFLAQNFHTEGNGIRNAVIANVNKNKVLYFSE
LSSNVSAYTLKGKELWNYKINKPSVIFEILAEDINKDGSDDLLAVAGNGIVYCINSDGNL
LWQYTPDHKVRLSEIAVVKNDGKIQIFTGGNDGQLYELNAKGEQVSSIKIEGVIRKIESG
KFISKNKESLFLMTYNHDKFRWEFMGILDAETKQVLIETTIKKKELKDLTKIMVTDISVS
DINKNGKDEILFFGDLSWTPMFFGLDGDFNIVSRFKGDRKRDIQRYAHLKGISLQPLKDE
IIMQYGGILYRIDLKGNLIETKGKKYDQLVFSDFVLDQKSKQLIATGEVDGGNGVYFFNL
EKKNWLQTSQKLQGTMARVKDNLDKLYKQTLNFELPSYQKKSDKSWVMITKDAEDAKIKK
LHGNDIKFVIQKSPKEATDRTYLVNKIGKSALKKDKRGKYEDTRAQIIQMAKDYEAENQP
FTFWAGHGNDPFYIQIETLEEILRVAPNTCYGFVYAEMDNVKDPRVIHFVNEYLPRLAKA
IRKNNRAKLYFRYKNMFWAATSHLPLWKEMFFSGKYGDILVPASEDTSNRIQDLNLAGRI
GMRNGGYVNDFAMRLIDDNPTSWRPLTPGGQNSVSPYLRQGVMMAAYGARYGVVSTSGFV
EDPGLNILFALMKSGVLPIVEKENITSIGSWHLIKDIDPKLVHSVDTHHELKQYKKDDEN
AIFSVGQMHWAGTDIPSHDYSKIALGVDYRWLNYMPEIPNGMVPIAPVESQKELLKSNIP
FSISNGKQGFLNSEFITAKKYKSTFKNIVESGAKQLPILVKGAAWSAIKIDENHTRIILM
DPGYIEPEERNVIITFQHRKPKSVSDILSKEDLKVTKSKMNLTVPAGSLRFIDVSY
>FCMOIPGL_00482 Arylsulfatase
MKKHIIFSILFLCTIIGFSQEKPNIVFLLVDDLGFGDFGCYGAEFNETPNIDKLASQGML
FNNAYAAATVCSPSRGAILTGQYPARTHLTDWISGHKFPNAKLSVPDWNTRIEHQLTTLP
EALKEGGYTTAFFGKWHLMPSNQPDFEEHYPTNHGFDINVGGKEWGQPKGKGKYFSPFEM
PNLDDGKPGDFLTDKLTDAALQFIDTTNKKNPFLLYFSYYTVHGPIMCPPNLEEKYKEKA
INFTNSKNEYINPKRAGMVEALDNSVGRLVKKLEELGISENTIIVLTGDNGGNFDETTGG
LKGYKGFSHEGGVREPLLIKWPGKTEAGTVSNEVIIGTDFYPTFLEFANLPLRPNDHKDG
ISMLPLLNGTSKKLDRDTFYWHYPHYHRTKPYGAIRKENYKLIEFFEDGKLELYDLSIDP
YETNNLAINQPEKAIELLQNLKEWQISVGAQMMNENPNYNVKKNATKRKKKRM
>FCMOIPGL_00483 hypothetical protein
MRKAIVFLLGFVFVIQVFQAQERPNIIYILADDMGPGDVQAYNKQGEILTAK
>FCMOIPGL_00484 Arylsulfatase
MILIVFAVSKTKMVAQANSQKPNILFIMSDDHTSQAVGVYGSRLAKLNPTPTIDKLANEG
IVMTNAFSTNSICTPSRANIMTGQYSAVNGVTTLHGRLKKENQYLAIEMKKAGYETAVIG
KWHLKEKPEAFDYYKVLYKQGEYFNPHFVSREGTASFVRKAGGMTMLVEGTEEMQGHSTD
CIATSTLEWLENKRDVSKPFFMKMHFKAPHDNFEYAPRYESYLADVEIPEPENLFEQGNH
GSIATRGYNDELLPYLGTSVSARNPRRNFSKKWGSKTNPNSVEATKMAYQTYLKKYLRCV
KGVDDNVKRVVDYLKENHLLENTIIIYTGDQGFYLGEHDYIDKRWGYEEGMRMPFIVRYP
KAIKAGTRSDAIIENVDYPVMMLDYAGVEKPTYMQGKSFRTEMETGKEAKDTKQAAYYHY
WMHMSSHDNPAHIGIRTKKYKLLFFYGALEKSDTPQTPPGWELYDLEKDPSEMNNLFNNA
KYAKVVTELKSQLKALRKEYKEDDPKFECNKVIDEYWDYGPNELAKAIQISHQYRKYREK
NNSYR
>FCMOIPGL_00485 Arylsulfatase
MNSNFLRSILLIVLIGFSNLKLNAQNTKKPNVIWIITDEHNFRTLGCYRDQLEKDQAFAW
GPEAFAETPNIDSLAKNGTIFNRMYASAPVCTPSRASMFTGIYPVTLGIPNNSNKIGDGK
YLKPDVTTIADVLSAAGYYTGYSGKWHLSESRDKSGSKDKDEWWSPYPVGHPEDHYGFQD
TKFMFLGGHDKFKGIDANGNPYRAAKRPKKIGIDKYGQPLYEDEKSKNVKHTTDWLADRT
IDFIDEHKNEPFYYVVSIPDPHTPDTVREPYDTMFTDVEIQLPFTYDIAYKNKTNAAMPK
WQKPDQKTKNPEKLKKEIQQYFGMVKLIDDNVGRIIQKLKDDGIFENTIVVFSSDHGDLL
GEHGRVNKGTIHEGSAKIPFIMAQGSKGNSPLIPRGLVVNKAANNTDWMPTFLSLLNVES
PKVAGRDITPLLAKKAPSNWNDVTFSKLGFYAAITEQYKLVLANKDESWFMDIKADPNET
VNLINDAKYKQIIKKLAKDLKGYMKDNKDNNKFIKEKLDKLIAS
>FCMOIPGL_00486 hypothetical protein
MKQFKILVLIAIILQACASKIEESKTLIDFFKPMPIQKPLVSDGIWGANNVLPRDITNGL
EDSKMKNWCYWDGSIVKDDEGKYHIYASRWTQEMSHGEGWHIGTKAMHGVSENVMGPYVD
KGLVYPDWKEGLGHNIVALKTHDGKYAVISSETTRGEIFISDKPEGPFKLLGEIKVEANG
FNHGLARYDSNNKGAVKNDKVGYMSNVQILLKPNGDYLLIPRSTAPMLSKKGILGPYKIM
GDKIYKGMEGIPQEKMEDPTVWFSGGMYHMIVNQHGVDTSYHFTSSDGIHNWKSRGIAFK
KDADIFKYTNGTVNDWAIVQRMTVYVENGHPTHFLFSVIDVNKGKDRPNDNHGSKIVIVP
FDGKAFDKYMLHKIKDE
>FCMOIPGL_00487 hypothetical protein
MKQFKILVLIAIMLQACASKIEEPKTLIDFFKPMPIQKPLVSDEIWGANNVLPRDISNGL
EDPTMINSCYWDGKIVKSDDGKYHMYVCRWNQSLSHTDGWHLGSKGIHAVSDNIMGPYID
KGLLWPQWREGTGGNVIGLRMKDGRYAAVTSEITEGEVFVSNSPEGPFKLLGKIQIDSNG
FNIGLAKYQNKKQLFFGHMSNVKILLRPDGRYMLIGRSTAVMISDNGILGPYKIMSDRIY
KKYPELPQTRNEDPTIWYSGGMYHIVYNHWPTKTSHHFTSTDGIADWKYRGIAFKKEEFK
IFKYTDGTINNWQFVERPTAYVENGHVTHFMFSVIDVKKGQDRGSDNHASKIVVVPFDGV
AFDKYMQKLVKEEKK
>FCMOIPGL_00488 hypothetical protein
MIYPETPSRLLILFILCFSIKLSAQKKKTLVDFFLPMEPQKALISEGIWGDSNVIPRDTT
NGLEDATLKKWCYWDGKIIKDDEGKYHMYASRWDEKYSHSKGWHIGSKGMHAVSNNIMGP
YVDKGLLWPQWKEGIGHNVIGLRMHDGRFAAVTSELTDGEIFVSENPNGPFKLLGKIKVD
PNGFSMGLARYQNKTKPHYGHMSNVKILLRPDGRYMLIGRSTAVMISDNGILGPYKIMSD
RIYKKYPELPQTRNEDPTIWYSGGMYHIVYNHWPTKTSHHFTSEDGIADWKYRGIAFKKE
EFKIFKYTDGTINDWQFVERPTAYVENGHVTHFMFSVIDVKKGQDRGSDNHASKIVVVPF
DGVAFDKYMQKLVKEEKK
>FCMOIPGL_00489 Putative thiazole biosynthetic enzyme
MKRRDFFKKGTQGVVAASIFPIIGDISAQTSNSTNVLFKEEKALRETLKKDPIRRKTLVV
DVAVIGGGMSGISAAVSAARNGAKVVLVQDRPVLGGNASSEMRVTVNGVKNLENKHKVER
ETGIVEELLIENWHYNPQESYHVWDHVLYNYVIREKNLTLLLNTTALDVNIDENKIKSVV
CRQLTTETDFTINAPVFVDCSGDGFVAATAGAEFKQGREGKAEFNEKYAPDKPDGWVMGD
CFMMITKDMGRPVPFYAPEYAVPFDAEKAFKDKHRKIKHLKEGFWWVELGSDVDIIGERD
EIRHKLMANFYGVWNHIKNSGDFPEAANIVLDWVGSIPGRRESRRFVGDYILSEPDMLGL
RHFDDAIAFGGWSLDEHCPGGIENLNEPASYFHSRFKEVYQIPFRCLYSKNIDNLLFAGR
NVSVTHIALSSTRIIGTCSMMGQAAGTAAAMCANKGVSPRKLYQNNINDLQEQLLRDDSY
FPHRPAKDPKDKARTADLIFASSTSSGDVKNLLDGVSRDEINKIHHWQSEGLNAELQLEW
NKPQKFTSVEMKFDTNLQRLMMMHKDPAKNKGQVTAVPPELIKDFTVEARVQGNWKEVGK
KEYNITRLVKINFDEVKATAIRLKLKNTHGKENIRMFEVRCY
>FCMOIPGL_00490 Arylsulfatase
MKLNIKSIIFLLSILCTLTITSQNNTDKPNVLFIMVDDLNDWVGAFGGNKQAITPNIDAL
AANSTIFKNAYCAAPLCNPSRTSILTGYRPSTTGVYGNSEVFREEKGFENTITLPQYFEK
NGYKTAAAGKIFHSPMGKASAPKEGSDPGSFQQEKEGGLGGTFPDKKNKLKHGLDLKKYG
VKGSFLRSFDWFPVDVTLENNNDYKSADYGVNFLQESHDKPFFLACGIFRPHLPWYAPKQ
FFDMYKLEDIELPKTIKYDLDDVGKMGNNMAKKSVHQSIVDHGKWKEAVRAYLANVSFAD
ACVGHLLNGLKNSKYANNTIIVLMGDHGWHLGEKEHWSKNVLWERSAKTPLLIFDPRDGN
GKVSSSIVSLLDVYPTLVEMANLPQKNDLEGKSISSIVKKPSKEIHEFVLTSKDKGIHSL
RSKNYRYTIYSNGFEELYDHRNDPNEWANIASNSSNKEIIEKFRKELKNTLK
>FCMOIPGL_00491 hypothetical protein
MKKEILIFLICTLSCFKLFAQEEIHIVLFAGQSNMAGQGIVSNLSKQDIKRIDNISDRVL
ISTSTNSIKNVKPLSFYVSKGENKFGPELFVGLTLAEKNPNQKYLFIKKAVGGTSLYGAW
NSNWSKEKADLAEKNPEKKKMKLFSEHIKIINSNLEELKGTNYKILGLLWMQGESDTNKE
ITASSYQQNLEDLIAAYRKELDLKKLPFIIGQINVLPRKYKKGPEQVRNAMDSITRVDKF
VEIVKTSLDPKWLDYPKHSDNLHYNTEGQKKLGIEFTKKLTSLLN
>FCMOIPGL_00492 hypothetical protein
MKKNIFLLFLLMLASCKSSEITAQNDVDIQVVLLAGQSNMAGAGNFDELESNIINRIQKI
SDRVSLVFNGKLIKPLSYYDNKPSEKYNFTKRFGPELLMGLTLAENNPTKKYLLIKRSQG
GTALYGAWNPNWSSEKAQAIEKDKKQKLQLFSMHIEDIQKSLAILKSEEKTYKIIGLAWM
QGENDATLIEAARSYASNLKALILKYRTIFKEEKMPFVIGEINSRYGVKDGAKIVRNQME
SFVNKTHFTALIKTSTNQNWLDYPKHKDNVHYNTEGQVKLGTAFAFELMKMIK
>FCMOIPGL_00493 hypothetical protein
MEIFKVAIIVLSMFLVGQVSAQDDAKKEKTAKNKFKKINTDNNDFLSETEFEAFYKDKTN
KKGKAINSQFIFFGLDQDGDKKITLDEMLKGIDKELAKSKMKAFRKANKN
>FCMOIPGL_00494 hypothetical protein
MKKHYFFKYNFILALCMLLSGVIFSQDLEKEAHQKIKTLEKLITQVNKKNIDVLKEKTTI
RTAEIFLRFANWDEKNVDKNTKSFSLVNSYKKEAIKMAEDLANFERNDVNLMLDKAILEL
QAIVDKKAFRKNSPNVDWSKVTVDNDQLTFNNRPVFLADYTWKPNTKELNEFHGNQDGFF
LTPSYVIKENGTINPRKLDELQSKPDGSLGFIFMNHKGVPKWAKEKYGPNFSMREDTYTA
YDIDNPGAREIQTKLLEKVVPIMAGKKYSKLGYMLVNEPHFYTYTDAKKKKLPWASGGAS
QFTIEKFKIWLSKKHQNIATLNSIWNSNFKDFNDVKIEIPIDISLQGTPIWFDWNSFNMD
RVTDWYGFLKSEITKHDATAKVHLKIMPNLWTDNQRAHGIDLEALTDLSGIIGNDSGADH
TYTWGKPHEWQKNYAFEWRELCMGFDFMKSVSPNKINFNSELHYLSTVRSRNLYLDPNYA
RASFWLAHSYGMTASQIWYWPREENGAISKKALNDKGYAGSNIQQPRVTNEVAMTLIDLN
ANAEEIMSMQRQRKPLRIFYSKTTAINKDDHMDQLFKLYEVLNFEGTPLGFVTKDIIKKQ
DSKNWDVVLIYNTPFVTNDEIIELQNYLNSGGKIIIDTKSLLKNEYGKSIANLTSGKGEI
IKLNSTDEIKSKAISILKDKKLYPEIAVSETNSVDKKGCIWRVVKNDAGNSVLSIVNVGK
TDATLKITLKGSENITCKDIIKGINVSTTPTLKPNEVYFVEVISKK
>FCMOIPGL_00495 hypothetical protein
MKILKVVVIVFTMFIANQVSSQEVSAKTVKKFGRIDSNKDGAIDKEEMKAFYSEKKNKKG
SPVEYELMFLGLDSNDDNKISLQELNAKIDWKRAKQKMKKTNK
>FCMOIPGL_00496 hypothetical protein
MRAKNILISLFFTCFLINGQVCFGQLEQTALNKISELNTLITQAENSNIDVLKEKMTVRT
AEVFLEYANWDENNIAENTDYFLLVNIYKDTAAQMATDLPNYERSEINLMLDEAIVTLNK
LLKGEISRKPSPKIDWTNITIDGNQVIHNGKPVFLSDYTWKPAMSELTEYFGNKDGFFIS
PSHVLDASGSLNSNIINELKSKETGSFGSIFLNHKNVKDWAETTYGPDFIMREDTFTGYD
IDNPGAKIMQDFLLGGTIPFMKNKKYADLGYMLCNEPHFFTTKDVWATGPVSNYTIDKFK
IWLSEKHQTIANLNTIWNTNFSNFNDVTINMPIEGNLLGTAIWYDWNRFNMQRVTDWFTF
LHDKVQEYDADAKSHIKIIPHFWSNNEIDSGIDLEELTALTEIIGNDAKSYNSHMWGATE
PWESRYSFYWRDLSMPYDFMRSVSPNKIIYNSETHFLSTTKFRDLYLKPSYARAVYWLAN
LQGMNVSQSWFWSRREDGSIRNGSGKGYAGSNNQQPRIINEVESTYIDLNAFSEDIAAMQ
VLRKPLRIYYSKNSAINKLNHMDAVFELYESLYFEGIPIGFATQKIITEQDNSNWDAILI
YKTEFTTTSELEVLQTYLDNGGTIIKDAISLTKNEYGVAHSFTLNASNGKLLNGTTYQNI
ANQGLSIVSDNNELPVVSLFEENSLNKKGAYYRAYKNNEDENIISIINLGKENTTITLNL
TRNNNPVNITNLLTGESLSSTFLMKPDAVYLLKVEDAVLATENLNKSKLKFYPNPTSNIV
NFSSETTIKKATIYNTLGQEIKSIKGISNQLYVDLTELKKGVYFIKIDSLIGSKTISIIK
K
>FCMOIPGL_00497 Lambda-carrageenase
MKHYFLRVHVLLVTLFFFTISCSSAKTDPKKSDEAIVSIETGFTILKVKTAQKKKQSFIV
ASSYEGTLLGISYEGKILWKNTLSGFMNHDVYTRDLDNDGKDEIIAANANGTVYCLNSDG
KLLWKFNKNEVPMYAVSVIEKDNKSYIVAGGFDKNIYYISSKGKLIKEINTAKFSVEKSG
GKSGKKLPPSKVSTANFIRTITKKNGQEILVLLATNNQMNIPGSLYFFNPLEEIPFKIKT
ISADKKAKKKLRIRPLGYIKIEDVNNDGESEIILGSSAHANDLLVTTYFLNEDKFSFHKI
NKVKFGYDIAHSTIIKENGINTYLTRVGSQIHLYKPNASEKEVEKIVSTYAYNDLWKDPT
SNKIILASAQSGGSQIHIIDTNNSKWKKEFENLEPQGKIAEIIKNTKTIRKNLENYTKSE
EEKKSQSVYFMTEIVPNNLESLKNNLEEKYQNPIFLNSLHMKEVEKWDRSKVTNAKYKSS
KDRRKKYTLTSNEAVNQITKEFNNAPGIAYWAGHGNDPYMFNINTTKKVIENAKGKKTVL
IYPELEDHSENLQYLVDDLIYPLAEFSKDKNANIFLRSKHIFWLGTNYMKPWSRLMSGDF
ADVFVPSAEETTDKSMELSLAGRTGMWASGAVNSWGTRAVPDNTSFDRSRQLGYQRLPNH
FLRMLIFHTSYGSQFINNFAVDQDYLSIYWELIAKGALYVPKRNEILSFSPIHISMTSPD
EHFINEGSNVKWTTFYDEEFEKNNPFVMSRLNGSWPGAKLTKWDFSRYAAGVKERRLNFL
APYKNGLVLITPPQNGVFAQKNVSRKRLEDNLHPIYKNILKEYITDGHNYYSADGKQTFK
ADEHYKEIEKEIIDNAKKLPITVSGDVAWVVAQVSPKHLRLTIIDNGYINPEESTAVVTF
NTKKVKKITDILNKEEFKETNASTKIKIPLGGFRFIDIELEEKL
>FCMOIPGL_00498 Sodium/glucose cotransporter
MKAGFEMWDYVVFVGYAILILGVGLWVSRDKKGHQKNAEDYFLASKSLPWWAIGTSLIAA
NISAEQFIGMSGSGFALGIAIASYEWMAALTLIIVGKYFLPIFIEKGLYTIPEFVEKRFS
TNLKTILAVFWLSLYVFVNLTSVLFLGGLAIETIMGVDMLYAIIGLALFAAAYSLYGGLS
AVAWTDVIQVVFLVLGGLITTYLALNTVSGGEGMLAGFSKIWEAAPEKFHMILEKSNDNY
INLPGIWVLVGGLWVANLYYWGFNQYIIQRTLAAKSLKESQKGILLAAFLKLIIPLIVVV
PGIAAYVMVNDPSIMANLGEAGMLNVPSTEQADKAYPWLLQFLPTGLKGVAFAALAAAIV
SSLASMLNSTSTIFTMDIYKQYINKNATDKTTVNVGRISGAIALIIAVIIAPMLNGLDQV
FQYIQEFTGMLSPGILAIFLLGLFWKKTTNNAAIWGAILSFPIALALKFIPIAGLEPWMH
QMGITTLLTMLIIMVLSHLQNNGKDDPKGIEITKDLFKTTPLFNIGSIVICILLIVLYCL
FW
>FCMOIPGL_00499 Arylsulfatase
MTTKYLFIISLFSTFIISCTQEKKETVSVKKQPNIIYILADDMGIGDLGVYGQTKIHTPN
LDLLASRGMKFTQHYSGAAVCAPSRSTLMTGQHTGHTPIRGNKQLVEDKEGQVPLPKNSV
TIAEILKDAGYTTGMFGKWGLGFGEGDPNNQGFDEFYGYNDQKLAHRYYPPYLNHNQKLD
SLKGNDWTHKVTYSPDKIRDHRLQFLEDNKDKPFFAYIPLVLPHAEIISPNDSIFKMYDG
KFKETPFTADNKYTSDYGPNIVPHEYAPCDKPLATYASMITRIDAYVGEVIAKIEELGLT
ENTIIMFASDNGPSPEGGTNPDFFDSNSEFRGYKRDLYEGGIRAPFIAVWPNKIKEGSVT
DHVSTFWDVLPTLTEITNTKNPDNIDGISFLPTLLNKDTQKTHDHLYWEFNIRGGRKAIR
KGNWKGVWNNINSKGNKKGSFELYDLSKDVGETNNIAKSNPSKVKELKQIMTEARIDSNV
FPFK
>FCMOIPGL_00500 Arylsulfatase
MRIFKIFFLVTTIALFNCKSETKKEEVKVEEAKKPNIVVIYLDDLGYGDISSYGATELQT
PNIDALASGGVKFTNGYASSATCTPSRYALLTGVYPWRNKDAKILPGTAPLLISTEQQTL
PKMLKKQGYQTAVVGKWHLGLGTGIVNWNERVSPGPNEVGFDDAYIMAATQDRVPTVYIK
DGNVVGLDKNDPIEVSYKENFKGEPTAITNPEMTTMKWHHGHNNSIVNGIPRIGFMKGGD
AAKWTDTEMADHFLAKAQNYVKTHKENPFFLYYAMQQPHVPRTPHPRFVGKSGMGPRGDV
ILEADYMIGEFMKTLKEEGILENTLIVFSSDNGPVLNDGYYDDAVEKLGKHDPKGGLRGG
KYSIFEAGTRVPFITYWKGKIQPAVSDAIVSQIDLLASFANLTGTAETATDSKDILKTFL
GKSDIGRDNLVIEATGKTALRSGDWIYIPAYKGKNFREKVGIEVGNFPHEQLYNVKEDKS
QQNNLAVSNPEKLSEMKQIFGKLRGIDYTRGVKEVQFR
>FCMOIPGL_00501 hypothetical protein
MKKMKKIGIILVLIIAAFGCSENEYEAPYGDFNSFSWLTTKSTTDTDYVVALNEFIGLYD
VSNNSISHNWYLPEGTSLLNKEFSSDNLVYTEFIEAVGPVNSDEKQINVLFNTPGIKEIQ
LKNIFKDSVTEGVKQEDGNWLVEKVFTVTVFDDLKPVFQVLKGTEVVLNITETDLPNIAN
SASWKTVSVEAGEKLTYVDMTTSGEPDSRSWTFSGGDKETSSAESVDVLYNSLGDFVAGS
MNSIRKDPKPKAEVLKLIPLKIKVIPSTQPFVINGGIKEDATEVISFNVTGEIGVLTASE
KDNFTVHVENTLAGFNQNIVVKSVAINSSDATQIDITLVAPIYNSDIVKISYTSGNIQSV
DTRVLESFGPKTVAMDFQGAMNVAGYTGYEDEWGGSGNQFKKANTEGYFAQHNSNNEGGP
LYYWRDDSKAYQGKSSMKFETTADGIPALARLQGGSFSTLSPVTAGTYVPSVWVYLDGSN
TMNTIQFNFNADPTATFNFDLSTTEKGKWVRLTLPEITLGDISSGRFDLNISNTGQDDAI
VQKLWLDSFDLLIVEAR
>FCMOIPGL_00502 SusD-like protein
MKTYIAKKIFLMVMFLTLFSCDSYLEEVNPNEISTDIYWSTLDESDTNLISVYGAMLNEY
IVNARVESWRSDEGFPGSRFNDRLPNGHDVSLFAKNWYEQNIDEDTNEVQLRWDALYQVI
FRANQVIEGLNRMTDDLKSQEAWTLQMGQARFFRGLAHFYLHSTYKQGKIIIRDVNPLKP
SDFSKAASESSEVIAFFREDLEYAYNNLPGQMEPKTRVDAGAAGTILGMSYLYEGDYLLA
KDYFDDIINNKKKDYGYALVQDASIMFTKAGDFNSESILEINYSLHKAEETAFNEDDFIT
RSARYSAPRSGGGSSVLETFTASAWLIHAFSSDEMDPNDSRNTVTDRAGTVRLRKVSLRN
SAMLAVVNDEDTEYYESVSAPVLHNFNSLGKYGYFKKYTNHDITNDEQTLGLNSWQSGKN
VILNRLSGVYLMMAECLNETDDINGALFYINAIRKRWGLKVLEGADYDSKEEVRTRLQLF
EYPMELCVEGYSTRNIDLRRWGIAKARYTELSQRNFYATDYVYLNEDATGTATRTASLVR
EGISTNATDFQIEPEFLKASENYTDGYLPYPASETINNPKISN
>FCMOIPGL_00503 TonB-dependent receptor SusC
MKLKKRILHYSILSFFAILFCSFNAQAQRTTITGIVVDSADNTPLPGVSVLIKGTTRGSS
TDFDGNFSIKAKIGETLVFAYLGMQNKEVKISKTQLNVSLDSDTESLEEIIVVGYGTVKK
KELTGAVNRVVTDEIEQFITPDIGSALQGQVAGVNVTASSGEPGEAASIQIRGVTSLIGS
NTPLFVVNGIPQIGDPGLSPNEIESIDILKDAASTAVYGARGAAGVVLITTKQGKSGQMS
IDFNYTFGLQALGDEATPLMNTESQLFYEVNRNAYTSINFEPLVVRFPEWINNDNKFDDY
VLNKYAEVKNYNFSVSGGAEKITYNLVGSLYDQDGSIINSNFKRYNGRATTSYNTENWKI
DGSLAFTIEKRERSSDGLIVQAGRYRPYFPAIDPNDEYVDGSTNGGVRTPSEALNQALRR
QDKGNKDRINASLSVNRKLSESFNFVTRIGVSVTNEIRNIFKPSFTLYDLENDEDITDET
KSGVIAISSRTNKFSWDGSLNYKKKFGKHTVSATAALALEEDSFQSFDASIQGISNNNLL
VLDGGTVNQLVNSGYNPDINGTSDNYNKKTVGTIARVQYNYKGKYLLSALARYDGSSRFG
SEYRWGVFPSLSAAWNISDENFWKPMKATINNFKLRLSHGTVGNDSFADYEYASTIAPFG
DYVFDENDSGELFGTSILSYANADVKWETSISNNIGIDLSFLRNKITVTADYYNTQKRDM
LFPVTLPGSAGAYYDNLLTLNIGDMVNKGFEFATNYRGNFGKSKLKLGATFTTNSNEITK
MQDGVTITPNNNVRLVNETTQATVSFIAVGHEAGAFFLYETNGVVQTDEQLDAYKLLEGR
EDAEKGDLIYVDTNNDGKINNEDRVYKGSGLPDFEYGFNLNWSLADFDLSMNWYGTVGAE
VLNGNKAASYNYERHQDLTNMWTPNNPTSQIPIFRGDAGDHYNYSGLTDYWLENGDYLRL
KQVSLGYSLPKETATKLGLDKFRLFLTAQNALTFTKYSGYDPEVGSNNVARRGIDNSRYP
LAAIYSFGLNINF
>FCMOIPGL_00504 Alpha-1,3-galactosidase B
MENFRTNFIKTLSLTLLLLFTISCKSQIKKGEVVTFKTNIKDDATATVLKRILDANKNPI
SEIKFEKGTYHFYPDKGLEKFAYISNHCDLMVNTPFPLENFKNLTINGQGSNFIFHGVMI
PFFIENSENITVKNLSIDWSETFHSEGLIVANDEKNKTFDMQISNEYPYEIRDEQIYFIK
EYYEHSLGQSILYDPIRKAIAFNTEKYTNITNVKKNKVSNGVKKINYKYTYDERAPEYKN
IGRESKTRVEELKPGLVRINGHSKKLPPIGMILTMKGEQGFNRVSPAFRVNHTKGFNGTN
VTIFHAGGMGIIAENSSDLVLDNFNITPSKGRMVSTTADATHFVGCSGKVILKNSTFENQ
LDDALNVHGTYQKIEDILGNDKIGVRMMHHQQKGFVIGQPNETLGLVRLEDSFFSYANLT
IKNIEYINSRYQIITFNEKLPSALKIGDLIENLDGYPELLVQNCKIQNNRARGLLISNPK
TTLIENNFFSTEMEAILIPVESGHWFESGNAANVIIRNNVFQDNQHSGFNRGVIRFATDD
DNKNIAFKNIEISNNTFNQFDNLILQITNTNGLKFTGNTITNSGTFPQLYPENSAITIKA
SKNIIFKNNIYKGKSTKIIETDNEKQSTFN
>FCMOIPGL_00505 Beta-galactosidase
MKIKFKNIIKYTFLLLISFNLISCSVTNYEKKINFNQDWKFTKLNETTISDETFSKPNFD
ITSWESVNLPHTTNIEPQIVNDQWQGVAWYRKNFDVPVNPVTKKVFLELEAAMNFSKIWI
NGMLVSEHNGGYLPIKVDITKYVHKGNDNLIAIRLDNTDNKITGPKPLKRLDFNMYGGLY
RNAWLSFSDKVYISDAVLAKKVAGGGIFITFPKVSKAISKVAIKTHIINEEKEAKEIKVV
SSIFYDGKLIQEKTSNKKIIAASDVEINELFTISNANLWSPKNPNLYHLETKVFINDTEI
DAKTTRFGIREFTFDAQNQLYINGKKTFLRGVNRHQDYPFIGYALSDNAQYRDAKKIKDG
GFNYIRLSHYPQSPAFLDACDELGIVVIDAIMGWQFYNDTDAFREYCYRSASELIRRDRN
RPSVLAWEVSLNETKMPIFFMEELNKIVHAEYPGKNVYSCGWMDDVYDIYLQARQHRILH
PHELKDKPYSVSEYGDWEYYSKNAGLNQDNLPNGLRDELSSRQLRAFGEKRLLQQAFNLQ
ESHNDNLNTVAYSDSYWVMYDYNRGYHPDIESSGVMDIFRLPKFGYYFYQSQKDVNEENV
LKIATYWDKNSPLNVKVFSNAEEVKLFLNDKLIASQKPDVGKNTNKLNHPPFTFNISSFE
AGSLKAVGFINGKQVSEEVVKTPKTVTKLKIWIDESGKKPQAGVNDVLFCYIAAVDENGT
VNPYFTDEIIVTINGDAKIMNPEIIKAEAGIATALIKVGKSTDISISAKSEMLKSDNFNI
K
>FCMOIPGL_00506 Arylsulfatase
MKSIKKVVFSLCIIFTITSCKKSSEAAAQKQVKNERPNIIWIMAEDMSTDLETYGMPDVK
TPFLNKMADEGIRFDNTFVTNPICSPSRSAMMVGTHQIKTNSHNHRSNRDVPLDPQFKPF
TKLLRDAGYTTILGNHSVMKKGRKTDVNFKSKPIGNWDGKTEFGLFDKYDTFEKEDQPFF
AQIQLVVTHRGDWWNEVREKSKHPVNPKTVTLPPYLADNPAIRLDWAKYLDQIEYMDNEI
GMIFKELEDKGMADNTIVIFIGDNGRSNIRGKGYLQDTGLRIPFIIYYPKQFKGGQVRKD
VVSSTDITASIIDFAGIEVPDYMTGKPIFNKNFNREFVYGARDLWDEITEKSRAITSREW
SYIRNDMPQVPYDAQQAYLEFYRPAVHIMRQLYKEGKLNENQKPFFEPTKPKEELYNLAE
DPNQLHNLAYNSNYTDVLENLRAKTLAFDKEMAPVSNIYHPTKVPGQPFVKWFRNTQPKA
YQQMKEGVEVGYKKYSVMYKKQLKK
>FCMOIPGL_00507 Arylsulfatase
MKLFKTLFIALFLMSFCTIAQKNKQKNSIQKRPNIVFLLADDMGYGELGTYGQKEIKTPF
LDSLATVGIRFKDFYSGTSVCSPSRAVLMTGLHTGHVNIRGNKGEINGKWDRVPLKKSEK
TLGEMLQNAGYQTAMIGKWHLGLPEDTSTWAKGRGFDYAVQEQWGKDVNGKEIDERVHWV
NNNQDSIFYNYNKHKCLDEFRTNFALDYLDKKADDKPFFLYMSYRTPHAHEYFLSKTDLY
IDKLQEWPEIERRHAARITMLDAQIKRLFKKLKKSGELENTLIIFTSDNGPTNENYHSYK
FFNSSGDLKGFKRDVYEGGVRVPMFAYWKGKIKEGRTTNHQAAFYDIMPTLAEVATTNSP
NKTDGISILPELLGKENQQKHKFLYFEIQEGKGVKGFKQAIRFGNWKAVRMYDNYHTELY
DLSTDLYEKNDISNQHPELVKKANKILKRESVKNPHFPYSGGVFK
>FCMOIPGL_00508 Beta-galactosidase
MNKLHAIIVFLFVIFSQISFSQNDWENELMFEQNKLRSRVPSYSFINHSDALERNRDKAR
MQSLNGTWKFNFVEKSQNRPTDFIKKDFNDANWNDILVPSNWELQGFGQPIYTNIIYPFT
PNIKNGGKRNFNYMGPNPPQFPFIEKYRDNPVGSYYRDFTIPTEWKNLSVILHFGGISSA
FYVWVNGKKVGYSQGSRLAAEFDITEFLSKGKNRIAVQVFRWSDGSYLEDQDMWRLSGIH
REVLLLAQPKIALNDFFVRTKFDDKLENAKIEVRPHLWIKANEDNLKGYTISADLYDAEN
KKVVDKSMSCAIEDVFFERWPQRDITKFAFLETIIKNPIKWSSENPYLYTLVFDVKDPSG
KILESRSQKVGFRQVRFSKENELLINGKVTKIKGVNRHDHHPIRGKALTRKDLEDDVKLL
KKFNFNAVRTSHYPNDPYFYDLCDTYGIYVMDEANVETHHLGSYAPQQPSLAIPILSRVM
RMIDRDKNHASIISWSMGNEAGTGPAFAAAASWAKDYDSSRFIHYEGAQGDPTHPAYKEG
DEGQKMFRGPAHANPTDPKYVDVLSRMYPEIYQLKAMSESKYINRPIIMCEYAHAMGNSI
GGLGEYWDLINSKKNLIGGFIWDIKDQGLVKKDKNGKDFFAYGGDFGDYPNAGNFCINGV
FSADGKPNPHAWEVKYIHQPFNFKAVDIKNGEVLAINHLNKTNLNEYDVRWTLSENGKEI
QSGFLQNIDVRASSSSALNIPFKKVRFKDENEYWLKISVQEKQATFWAAKGYEVAKEQLL
VREKLSENNYSSTSKSKLQVIENTADVVIKTRKYRAKVSKKSGELTSFIKNGKEQILSPL
KPNFFRPPIDNDLRGASSKDFKKSRGYWEFLNEQLEIKSVKVITDKTNETRVIVKKNYKD
EVKLNLVYTFLSDGRIVVKMDLDAEESLPGLVKFGVTLGVSKDYNTTTFYGKGPNENYID
RKRGTEVDEFTFKTDDLFTNYVFPQENGNRSDVRWLQLSENRNNNLRIEGASTFGFSIWP
YSAENIQKAKHPFDLKKQDFYTLNLHLIQMSVNGTLSETLPQFVIPSGKYEFEFILN
>FCMOIPGL_00509 Arylsulfatase
MNYFVKNSIIVVSILCICTLFSCKIKDQKENNQKTNNKKPNIVLLFVDDYGWADIGYRNA
TFTTPNLDQFKKESLDFTRAYIPTPTCSPSRLSILTGKEAVRLEMSRHIPEEKDFINEDY
NVWPTDPVKRPSINYLPLEEITYAETLKDLGYYNMFIGKWHLGEGKHYPEYQGFDKTFGT
TDNGHPKSYYYPFFKDGDPKEFQKNYKTGDYLTNVLTDSAVNFIKNYDKAQPFMLSFWYY
SVHGPSVGRKDLLKKHQDAGLEGKYAHHAAMVEAMDESVGRVRNALKEKGIDDNTVIIVF
SDQGGAYTNAPLSGGKKGGNTLGEGGARVPLLISYPGVTKPNTETAIPVQSIDIYPTLVE
IASGKKYENKEIQGVSLLPILKGKTIKKRNLYFFRSYEDQYAAVISNDWKLVKYHSGKFE
LFNVTKDISEQNNLIGKGLDVENILKKDIENWEKEAVPAY
>FCMOIPGL_00510 Iota-carrageenase
MIKKNIILIFCLFLSGFIFSQNPIDRVLPADSYFYNPTINTANQLSFPNGDNSTSALQNM
INSLSASGGGILTINAGTYTLGQLDMRTGVHIRVNPNVVFKTTPQGALFQAGFDNNFANA
NNWSFQSTNGEKFTFDFSDFEPNTNIRAFQLGNTNNFKLADFIILDNYTKFNAISAGAVG
DASEPALFTKFGIIENLDTKNAHYGYGLIQFQVGQDILFRNLSGEGGVTLRLESGYSGLA
DLYVTDKTPIINNVYGRNISCTNGAHAVMLSPHTITQGIVDVRDITGISCEAAVSINFGF
LSADKGQTTPDHSEGTFSEDSVIANVFATYGTDAQVRSARLRHIPCALRNYISAEKNLDD
ESYKAPSLAPVYYLALEDYVSKNSPAGSYKIVLENVTHSGFSDEVRADGLITDGGENDFE
GCDINESPIWIKGDDKNTPNPLQTTYTALSLSVTNFIDTNDIVIYQEENTKELIIKSNLK
ANIKIYNLIGQLLKNVSKLETKISINLSDIPKNIYIIHLESDKKIITKKIIIN
>FCMOIPGL_00511 Choline-sulfatase
MKLISSQNTLKYCFLLILVVFFSCKTQQKNTLKKTKTRPNILFFIADDASMKSFGAYGDT
FINTPAIDNLAKEGLVFNNAYNCNPKCAPARASLVTGMYSWQLKEAANHWPNFPAEFKFY
PHLLMEKGYDVGFTGKGWGPGDYATKYNPAGPEFNQIKLTPPHKGISNVDYAANFEKFLA
DKTDKTGTPFCFWFGTKEPHRVYELDSWKKEGKNLDKAEIPPFYPDNKTIRGDVLDYAVE
VEWFDTHVGKAIKSLEKRGLLENTLVFISSDHGMPFPRVKGQLYEEGFHVPLIAYWKGKI
LAGRTVDDFVNFPDFAPTFMEIAGEKPDKQMTGKSFIDIIFSDKSGQIDSKRDHALLGKE
RHDLGRANEDGVNLAYPVRAIRNSKYLYAHNIKPERWPVGNPEYGFRNVDPSPTKDYLVN
LKPENNFYEMSFGKRPEEELYNILTDPHCLKNLALLPEYKDTCKKLRTQMEAELISQGDP
RTLGNGDVFDNYPYTGKAYDYINKRVIQKQKK
>FCMOIPGL_00512 Alpha-1,3-galactosidase B
MHLNPDKVEKLKNGVFRFYQKMKEFPPIGAIIAAKGDKDLNRYAPGFQTQNCKNVVYDNI
IIHHALGMGFLFERTENIKILNSGVYTRDGSDRYISSTADATHFANCKGDILIENCRIES
MLDDGTNVHGTYVKIDDIVNEYTVRIALHHFEQMGFQFADKGDEVWFIQKPSPKRGVVNE
VVKVKFINEKYSELTFKNKIPTTLSKEDILENKTWNPTFTMRGCQVTKHRARNAMIKTPL
KIVIEDNYFSSDMSSIGLRGETFKWYESGAVGEVIIKNNHFVDCAHGGTDDAVLWVSPKL
NKDFNQSEIYDSNIIFENNVIESFNSRIVWIDRLDGLIFRNNTIKQTKTSKSLFPNAPLF
DIFNSKNISISNNKVEGFVENTKINADNASKKTLNTKNNKGIN
>FCMOIPGL_00513 Alpha-1,3-galactosidase B
MILKNKLQFLVFAFLLQILHINAIEVINIKHTNKDITPIIREAISCAKEKEIKIIFEKGI
YTFLPEYAHTQFSFITNHGNGYKSIAFRFQDFNEIEIEGNGSEFIFNGRMAPFQFENCNN
IKVQNITID
>FCMOIPGL_00514 Arylsulfatase
MRKIKLLILVTLIAISFANCSKKQEETAKKINNTNKPNIILFVADDHGLDAIGAYGNPII
KTPNLDQLASEGVKFTNAYCTSASCAASRSVILSGKFGHATGSYGHVHDYHHFSTYETET
SLPIIMAESGYETARIGKYHVAPEKVYHFNQVLEADPRNTVEMAENCADILKSDKPFFLY
FCTDDPHRGHPFEPEEWDIPNNFGNKKEGYKGVETITYNPEDVLVPSFLPDTKQTREEIA
EYYQSVSRIDQGFGKLMKMLNDTGKDKNTIVIYISDNGMAFPGAKTTVHEPGIKLPCIIK
DPTKNIKNATNTAMISWVDLTPTILDMAKIEYQKENFHGTSFNSILDKSKVTGWDEIYAS
HTFHEITMYYPMRVVRSKNYKLIWNIAWRLEYPFASDLWASSTWQSIYKNDIEYFGPKKV
QNFLFRPEFELYDLEQDKNELNNLAYKSEFHKVLEDMKTKMKDFQTKTQDPWKIMWNHDA
TLQGSGVHL
>FCMOIPGL_00515 Iota-carrageenase
MCFTFLLIMNSLQLFSQIDNESNFYTSISNANYNKDLVEDFAVDNSFSTDDSSILQNAID
VIAANGGGILTIPAGNYSFGNINLKSNVHLDIHKNVFIRSFYEIPFDEKLKNYAIFKLGD
STNPIQNVTISSSSGGNFTVDLTHNNNPNVAVVNCGKVSNFIIANFNILDTYTKFSAVIF
GGDEYNGEYIFPKNGIVKNIDIKNAHYGYGTVQTQSAENILFKNLSGTGGATLRLETGFT
GLNNLQGSNLPTGVKRIGGIDKIVARNIYNTNGNSALMISPHALHNGTVDAEEIHSVSSG
FAVRIEAGFVSDKYDQDISLSDGTFEHVKVKSVTATYGENAEIKAKHFNHYPSEITPPTK
LANYLIEDETKIYVGASIATVLAETNYNCKNNVKIVLVEAPIEGTGFLYQENIIPAEFLT
TDCTALSTDEQHLNENLVEISPNPASNSIFINHLKKNKNINIYSLSGQLIKSIKTSYNSS
LKLDVSNLISGIYFIKIVSENNSITKKIIIK
>FCMOIPGL_00516 hypothetical protein
MRKEILKKGLLLTIALFAFQINAQKFTFSTGLEGWSTNYGNNGTVEHAPTEGTANDGALK
LIRATDNANFGIKPTPGVDASVKKYIKIKYKNSTTATVLRIGGKNDETTPIKTNSGGTID
INISPSLDEYVITYIDMSIYDLWKGELTDFSIAVRKNVANEASGSAFYLDEIEFLETAPA
VTYSEFIQNPSFDGPSGITHISGVKDFASRVITSTEKHDGDQSLKTTFSTDASAPYWAFS
DYVKTYTTKYPVDSDIQIKMWAKTNRTNPITISARVKLFDGGEETATKPIANVTTTNTNG
EWEELTFDIKNVEEFDGIVFWFGINYVEGEATNLLAGDIVYLDQMTANITEATLKLDNNI
LDRVSIYPNPVVYGKLNINTVNGGEISLFNILGAKVLTSKAVTKNHSLDTSNLKSGVYLL
NVVSNGKSYTQKIIIK
>FCMOIPGL_00517 Sensor histidine kinase TmoS
MIRKFNILFLLLHLSIHTIYAQESKLTFAKKITISNGLAHNGVSSVFEDSNGFLWIGTYE
GLNKYDGIKLTTYKNAIDLDILTSNRVRSISEDKNKNLLIGTDEGLTIYNTERETFFKAY
TNKDSNDEENGPIIRKILISKKNSLIYCLTEGNGVLVFDATYKLVKKIFTSTKYSSNLMF
YKALELENGNIIFSSSEGLFLYKVSSDNKIEKILSSEITASNFIVKIDATNFLSTLNNGL
AVFSLNKNNEFILKKKIFINDNFNSIKLDSKGNLWLGTLNDGILQIENFTSALKNDFKEP
FKEKRFTDNLNRLRISRIISSSNNNIWVGTFDEGLYQFNIKENPFKTYKNNEKNINKVLT
TGVNFMSKYDKNRVFIVTISGNLNLFNTKTNTFDTLPFKLPKNFKIGGVFVDSKKNIWLK
VNEIDGLYIVRNKNNTLEKITHKSLENSDGFLFRSFSEDKEGNIWIGTSNNVYKITVDKN
TIIKNIESLNSNPFFKKNKLKTIRYIYADHLKEYIWIGSGHGFFRLENKKNVALKNQIAE
KYTTNKEKKNSISSNFVTSIIRLPNEELWISTENGGICRVLENGTSLEFIPYTEKEGLSN
NAAKNILYDNEHGLWIPTNIGLNKFDLKSKQFRKFNLADGLPFEDFWFTSEKLENGVLLF
SGLNTFSYFNPQEISKSEELPNTYLSNFKVFNKLIKSGDTLNNRVLLNENISKQERIVLN
YDENVFSFELISLHFSNPKNHTIKYKLSKVNKDWIILPSNENIIRYSGLQPDKYEFTYMA
SNSLNEWSAPKKLFITITPPFWKTYWAYFGYFVLLVLFIYAIVFSITKIQSLHHKVTIEK
LELDSIKELNESKLRYFSNISHEIKTPITLITNPIETLTERYKNNLDVSEKLGLVKRQLK
KIKQLVDQVQDFRRADANMLKMHYSRFNFNKFIDQLVKDFDFLAKKDQKTFSYSSKEKNI
IVSADKDKIEKIINNLISNAFKYTRANDTINIDFRSNEKDLTITVSDSGMGIDEEDLEHV
FERFYQSQSIQKEHISGSGIGLAFTKKLVEMHYGYIKAESKINKGTTITIQLPIVKIQIE
EDEIIDEVIELPEEKEIKIDKQFIKQEILSDIKVSGDFSDTLIFYAEDNLEMRNYVSDIL
SKYFKIKVFRNGQECLDALEDEWPDIVISDVQMPVLNGLDLCISIKSNLKTSHIPVILLT
ALSNIEDHVRGIRDGADAYIKKPFNVQRLVTNVEALLINRKQLRERFQVGIPLTKENNKN
NRNDNAFLEKLYSIIEENLDNQDFDINSLSRELYLNRTHFYQKVKELTNQTPFEILKTYR
LKKAAQLLAQEKLPVNEVFLMTGFKNRHHFSKTFKKMYNVSPSKFAEEKSEEHTS
>FCMOIPGL_00518 TonB-dependent receptor SusC
MKILNLLLKKQKVNGLLLLLLLMLSFTTFAQTITVKGTVSDIEDKMPIPGVSVVVKGTQN
GVSTDFDGNYSIKAKSGDILIFSYLGMKEKAIKIKGPTLNVSMVADVQSLEEIVVIGYGT
VKKKELTGAVARVDAEALEKIVTSDLGAALQGQISGVNIVSSSTPGGSAEILIRGITSVG
DDNTPLYVVDGIIQDGDPGIPPSEIETINVLKDAASAAIYGARGATGVILITTKKGKAGT
LKIRINGTSAVQVRNAAVPLMNSTEQLYREIVTQRNTTTTLDEDYSSSTLRNPYLLQNNT
DLNDIIFNDFAQTHNYNTSISGGTEEVAYNVTMGMFKQDGLQLNSAYERFNVRSNTTYNK
EKFRAQTSVGLSLDRRDIPRSNLLSQAIVYSPLQNGLDLDDSSTLGDDGDDATRLTWVVE
SLKTKEYLKTLRGNASLNLNYDINKNFSLSGNVGITYTTARGKIDVPYQEVINSSTGNAL
TQPTNSYIEDSSNERVNIYSEVGANFKKEIQDHSLNLGVFLTAEKTTFEQFSARRTENTN
PDFNVLDSATGEQLVSSGFDYTTTRLSQIGRLQYSYKGKYNLSTSIRVDQSSIFDEDLNL
GVFPSIAFAWNISDENFWKPLKRTVNSLKLRLSRGTVGNDRATPYSYLGTVTSNINYVGD
TGSEVLLNGATQTSFVNPLLKWETSKQFNLGVDAGFFKNKLTLSAEYYTTNKEDMIFPIF
LPTSVGGGNNARIYANVGNMTNDGVELAARYRHRIGKLWFQMSSTFATNRNEITKINGDT
DSYPTNDIGLVGRAQNQSRVTYHKVGREAGAFYLWRTNGIVNTEEKLAEYQKIDSNAKMG
DVIFIDQNGDNELDDDDRVYSGSGLPKFEIGYNFASTYKNFDFSMNWYAAIGHEIMNGFN
AWAYGFGRHKDLIYQWSEANPETNIPAYRDDIRNHRNFIGYSDLWLENGSYLRLKQVTLG
YSLPDEVTKKLGIDKLRIYLSSQNPLTFTNYSGYNPEVGGNVSSRGLDKGTGPVSVQYLA
GINFNF
>FCMOIPGL_00519 SusD-like protein
MKNIFLKIVIVILTVGVITSCSDEFLDQSNPNEVDVTNYWRNLEETQAGLHATYKMLYNP
STFNIIEEMLRSDLGYPSLDRPLPASPNTFYIHTYTSTTDEVNDKWQTNYTGIFRANQVI
EALESLESEGEITEEDVADWTSQMAQARFFRGLFHYNLYTTYNKGAIIIRDKVPTSLDEY
SMPLSNAEDVLKFIREDLEFAYQNLYKNGEYPDGDISKVTAGAAGALLGDSYLNELDYTS
AMTYYNDVVNNHGYQLETDLEKMFTTAGEFNSESIFEINFTADNVDLSYGPWDGETGTNT
YALYTRGNTQKTASSPVWVAYAYKTEEKDPLDQRNYYIDPLDNTKKIRNVSLRASSMLAV
VEDVQTTYYQVPTHLVTAPPFNGVKWGGFGWWKKYSNHDIVALESDIPNGAAYSAKNVTL
LRLSGVLLNLAECKIKTGDVDGALTLINSIRKRWGLVLLGKPNGDTAYTYDKEDTDAEYT
ADELMQRFMRVEKPLEMGAEGHAARWLDFQRWKKSDNYGFGDRLKELEALTLYGVNYDYI
DENGAIKTKGNAPSVSEDSSNAVVTVDYEYDLSASNYSEDKHGYYPIPSREVESNNKID
>FCMOIPGL_00520 hypothetical protein
MKKYIIKTLLLSLLVLVGCNEKYADYTAPGEINDTSWIIGFDQNKSAENAYLINIDTYIS
FLDLSQGYIDHEWQIEEGNKFLEEGFTKNDSLPLFIKNDEITTSDEKAHVFFRKKGLNTV
RLYNTFSSPVTRETSLGTYTSKKVGDLYVVDTTFTFDVFGYIEPAFRILQDGVVKLEVSA
EDMPSLDNEAEWPVVEVKAATSLTYEDLTVEGRPNSRKWNIPDGTPATSNGESAIIKFFR
LGTYNAGTITSNRFGSFPTASAEKIIPLKVKVIQSDLPFEINGQIKEAEDEVLSFQVTGE
IEDFTGQESFFTVNVKNEGFDQNIAVSQAKRSDSDGTYIELKLSESIYNSDVITVNYSGG
SIQSTDERILADFTAPITVVPHFGNNVLPGNGWASFETPNGAINNAFAQDYFIGNVNKID
GSDTEGYYMRDTSKSYLGDASMKFESTDANPLPSINLWGFAFSKPDPIKAGTYKMSYRVW
LEEGNTLKAIRTEINKPNFLQQVWDIENTPRGSWQLITNTLVLPDDVTETNSRWAFRVHP
QLNVGVTGAQKMYIDDFSLIEIEERP
>FCMOIPGL_00521 hypothetical protein
MKKIIKFIAVFAMIFALTSCEEESNFKESEIALTPVYSITDITGTNAAFKINFYKEIDLL
TEYSTVDKLISYIPSGYVDNSTSDDYIIEATVIKERTVTVDDEETIEPYTAKYTVNASKI
TGDGTMVVLSTYQDAETSTNSYIIKVSEDQVYN
>FCMOIPGL_00522 D-galactarolactone cycloisomerase
MTIDKIEAFVLKDKLSNSFFFSQWEYSERCICLVKVTASNGQHGWGEAYGPASMVQAGIK
LLETTVLGENPLENEVIWNKMYRKTLDFSRRGVYMASVSAIDIALWDLKGKILGLPVSTL
LGGAHRKKIKPYATGLYFTNHDNFSDGFVEEAKLYVSQGFKAMKMKVGLGIKADVANVKL
IRETIGPDIALMVDSNHAYTFREAVELSNKIEKYDIGWFEEPISPEFYEQYKELRTKTTI
PIAGGECEYLRFGFNELIKNKSVDILQPDICACGGLTEAKRIAALASTNGVDLIPHTWGT
SISLHVALHFISNIESVPGRMYQPDFLMEFDQTENGLRDNLTFPKLAMKDGMLDVPNRPG
LGIDVDEEVLRKYVVYEQTKQDIIEKILK
>FCMOIPGL_00523 Glutarate-semialdehyde dehydrogenase DavD
MKTKNFGYKKLYIDGQLVDAESGEREDIICPATGEVIAQIAKAGKADAEKALLSSQKGFK
YWSKLSLSERTEWMLKLRDAILEKEDELRSAMIHEMGKTYAGSEEDILRLTEALEWYPNA
MKNLREEQIPDYEGTHTHKMISKPAGVAIAYLAWNFPLLNVGYKIGPALASGCSLIIKPS
TLSPLSTYMVGEILESINFPAGVVTILAGSSREVATPMTTSKIPAVITMIGSTQTGQRII
ADSTTSIKKLGMELGGNAPFIVFEDADFDTALDLAIGLKFGNTGQICVAANRIFVHKNIY
DKFLKAYVKRASELKIGFGTKENQDVFMGPLASRDARDRMFELIEDAVSKGAKLEYGGKI
PEGLPEGGNWFQPTIVSGIKTDMKLFREETFGPVAAVMPFDTDDEVLELANDTEFGLASY
LFTNNNKRIERFTEDLEFGEIQINGVKYAIYLPHGGFKNSGIGHDCSHLALEDYLVKKRV
TSAL
>FCMOIPGL_00524 2-keto-3-deoxy-L-rhamnonate aldolase
MAKNLLKNSLKEGETLYGPFCKIQDPAIVEIAALSGFDFVIIDMEHGPYSIESLQNMIRA
AEARGITPVVRVTENSETLILRTLDVGAKCIQVPQICTKADADRLVKSTKFYPKGERGMC
RYVRAAEYTNINAVDHFGKANNDITTIIHIEGMEGINNLEEIVRVDGIDVIFLGPYDLSQ
SCGVPGDVNNPMVVDAMKGAVETAKKYGKFVGTFTETPEKAKMWKDIGVQYISYAVDVGL
VMNTFKEITTQLKEIV
>FCMOIPGL_00525 hypothetical protein
MKKIYFTLLISFLFVASISAQTTIYNSTFDEASYDDAGVVADLNAHADWLAGHFNNASTW
VSNADADLISTGANFAYSLLSSTPITGASGDVITIRTVYRVGNDDQPFNTDETFGTAAGD
VNMFVSGLSPNNAPASSDLGQLRDGVLFKSVQTGSVELTSSGGSSFATNPSISTADKAAY
EIIFEYTLGDDAASTTKSARLTNIGSSVASTTETSTGIKQEIYDALTGSGAYFFNWALGF
YTKGNSTINALYQNSLTITKNGAVLSTKGFNNFHFSMSPNPVNDVLTINTKETLKKVEIF
NLLGKRVLSSTKNSVDVSSLSTSVYLVKISSDKGVSTKKLIKN
>FCMOIPGL_00526 Bifunctional protein HldE
MKKKVFVSGCFDMLHSGHIAFFKEASTYGDLYVGIGSDATVHELKGRHTINSEQERIYMI
NAIKYVKNAFVNSGSGMLDFKEDLENLKPDYFIVNEDGFSPAKVELCDELNIELKNLKRI
PDAGLPERSTTSLRTGGICSLPYRIDLGGTWVDQPYVSKYHPGWAITLSLEPIVEYNERC
GMSTSTRNAAKKIWPHFLPLDKPQKLAEILFKFENTPGSEMVSGAQDAIGICMPGLVRHY
YSDGYWPTKFESVHDESILGWLEEHIQMVLLWPREQGLDLLGETYINEENVKSLANASEE
VWEAIQNKDLEKFSEAFLKSFNAQVKMFPAMVNDRILKEIEKYKEKALAWKLAGAGGAGY
LILVSDKPIEGAMKIKVRRKEAL
>FCMOIPGL_00527 hypothetical protein
MKKIITILIILVTISCTTTSTTETETTPIVPKNVEIILSTDRPEFDEIVVSYHDFETNTD
LYGPRQFTYDSSGNQEPIIISLPDYSYSEIQGNAYRNNGLPYSLNAQIYINDELKFEIED
IGSAEAYATIFFDYTIIED
>FCMOIPGL_00528 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MKPFKFKEFSVHQDKTAMKIGTDGVLLGAWSSVDDYLDTILDIGAGTGIISLMLAQRSDA
MTIDAVEVDENAYEQTVENFEQSDWADRLYCYNANFQEFADEIADEEEIYDLIISNPPFY
TDDFESDNRARNKARFTSALSFEELLAGVVKILSSDGKFAVIIPFKEEENFVNLAKSKGL
FFNRVCHVQGNPTSEIKRSLMEFSFHPSEIKKEHLIIEIERHQYTKEYINLTKDFYLKM
>FCMOIPGL_00529 Lysine 6-dehydrogenase
MKNILIIGAGKSSSSLIKYLLDTSDKENLQVTIADISTENALKLINNHKNGKAITLDIFD
AQQRENEIKNSDVVISMLPARFHIEVAKDCIKFEKHLVTASYISEEMKKLDKAAKEKGLI
FMNEIGLDPGLDHMSAMQIIDRIREKKAKMLLFESFCGGLVAPESDTNLWNYKFTWNPRN
VVLAGQGGAAMFKQEGTYKYIPYHKLFRRTEFLNVHGTGKFEAYANRDSLKYRSVYGLDN
IPTMYRGTIRKVGFSRAWNIFVQLGMTDDSYTIEDSKNMSYRDFVNLFLAYSPSDSVELK
LRSYLKIDQDDIMWEKLVELDIFNPKKKIGLTNATPAKMLQKVLEDSWTLQENDKDMIVM
QHLFGYELNGEKYQIESSLVVLGENQTYTAMAKTVGLPVAIAALKILKGEIKKPGVQLPI
SKEVYEPILKELENHGVKFTERNVEYLGYNPNNVVG
>FCMOIPGL_00530 hypothetical protein
MFKNLIVTCFLGMLAIILGAFGAHALKEILTSDQLLSFETAVRYQMYHVIVLLFVNTFDG
FSIKQKNRISYIFFLGILFFSGSIYLIQLTAITAKSIWFITPLGGLFFIVGWLSMIVIFV
NKIRE
>FCMOIPGL_00531 Phosphoenolpyruvate carboxykinase (ATP)
MLGTSTKSISLNNLGIKNATIRYQLSSNELHEETIKKKQGVLSSLGAIAVNTGEFTGRSP
LDRFIVKDEITKDEVWWSKINLPFKEDKFDKLYDKVVNYLSEKEIFVRDSYACADEKYKL
NIRVVNEFPWSNMFAYNMFLRPTEEELKDFSPEWTVINAPGFMADAAIDGTRQHNFAILN
FTKKIALIGGTGYTGEIKKGIFSALNFILPMFKNTMPMHCSANVGKEGDTAIFFGLSGTG
KTTLSTDPNRSLIGDDEHGWTAENTVFNFEGGCYAKVINLSAEQEPEIYAAIKKGAILEN
VVMDKNGVVDFADTSITPNTRVSYPIYHIDNIQVPSIGKNPKNIFFLTADAFGVLPPISK
LTPAQAAYHFISGYTAKVAGTEAGVTEPVPSFSACFGAPFMPLHPTRYAEMLSKKMKDAG
VNVWLVNTGWSGGKYGVGRRMPLRYTRAMITAVLNGSLGDYTYEDYHIHSVFGVAQPRTC
PGVPTELLSPRSTWNNDEAYYKTAFQLSNAFRVNFKQFEEFANEEIRRGGPQRYAL
>FCMOIPGL_00532 Menaquinone reductase
MIKTDVCIIGAGPSGTSTSIMLSKLKIKHYIVDKATFPRDKTCGDGLILYAYKSLLALGL
LDKFVAHPKFIHSKKINLHIKNNLKLQFKESEDRNMVISYGKRIDFDCFLVNELSKEYAT
CEFGSGVKNLEETSEGIIVTLKNGKQIIAKIVVGADGIQSIVSKKLAGFSSDKKKMSTFI
SAYFSNVKMPSNNEAEIRLHYNKMPLFFYVFPLPNNEVNVTLGGNTQKILDNNINLKVEI
ESVIKNHSKVAPKFIDGKQISSWRGWGIPYHFERQKVCGSRFLLVGDAAGLANSFYKEGV
GTGMMSGIICAKKIASCLKENNFSDSFMSSYKKDLDKEFGKLLRFSEFALKVARFKSVFV
GIAKISKNIVEKRAFNIIRKRSY
>FCMOIPGL_00533 hypothetical protein
MSKSSNTVVGLLAGTVIGATLGILFAPDKGVKTRQKISDEALSVKDKLVETATDLKEKVS
STVSDKKETLDDQLEEVVSNVSHKAEDVISTLEKKLKELKEKNKKLQKS
>FCMOIPGL_00534 hypothetical protein
MSIFDNLKDSADKGTDASKQFVTKTFEHTKLKAFQVTALTLSIIVKLFIIGSLAVLGFIF
LAVSSAIALGEYFDNIAFGYLFVGLFFLIISLFLYFFRKYFDKKVITNVSKIFFD
>FCMOIPGL_00535 hypothetical protein
MKAYKSFEEINRDLKQLSLERQIALEELKMVKNDFEESLKPLSIARNVLTAIGKFGTLMF
IKKIIK
>FCMOIPGL_00536 Regulatory protein PchR
MIEIEIIADSPKDTIEQIKEAIGGKIEEHWSEFTLIIDNENAVGKIKYTPFDWGVNLLDF
DITFRKKLILKIKAHDQFNPIRFIYPSIGSLKHRFGFQNEEKNVDQFQSLIFTNKTGGYN
YINFPKNEALEINVIQIVRKHFLKKRTTKVSTLNDKLYEVFVDTDHNNRFSHFGTLNLKM
ADHIKRLKKIRGKGMLRVLKIEALVYEILSLHIQQHNRLLEGVPLPTSLAKEELKIVRKF
ASRIVKNPAKNYTLEDLSLDSGLTQAKLQDGFKFLYNRTVTEYIRHIRLESARDMLKNTD
LNISQIVYSIGFSSRSYFSKIFREKYGITPNGFKKKLLSVV
>FCMOIPGL_00537 hypothetical protein
MTYTEEVGEKLNGILEKTFDAEKGFTKAAENIENVALKNYFRAKSQERNAFGNELKTEIK
LFNQDIDKGGSIAGSAHRAWMDIKALFALDDEESMLEEAIRGEKTAVKEYEEVLQETTLP
SSTKFLLKAQKNKIENGLYNIKSLEDIK
>FCMOIPGL_00538 hypothetical protein
MLRWTITFIIIALIAGILGFGGISGAAAGIAKIIFVIFIILFILSLITGRKKV
>FCMOIPGL_00539 Putative K(+)-stimulated pyrophosphate-energized sodium pump
MESMMIYMPIAMAILGLIYMWIKKSWVLKQDAGNGKMKEISDHIYEGALAFLNAEYKLLA
IFVIIVSIALAAVSFIVPTTHILIVVAFIFGAVFSAFAGNIGMKIATKTNVRTTQAATTS
LPNALKISFGGGTVMGLGVAGLAVLGLTFFFIIFYNYFMDGAIGTFSVDKMTVVLETLAG
FSLGAESIALFARVGGGIYTKAADVGADLVGKVEAGIPEDDPRNPATIADNVGDNVGDVA
GMGADLFGSYVATVLAAMVLGNYVIKDMGGSISDAFGGIGPILLPMSIAGIGIIISIIGT
MLVKINSNDAKESKVMGALNLGNWVSIALVAIACFILCKWMLPETMKMEFFGEGLQEISS
MRVFYATLVGLVVGAVISSVTEYYTGLGKSPILKIVQQSSTGAGTNIIAGLATGMISTFP
SVLLFAGAIWASYAFAGFYGVALAASAMMATTAMQLAIDAFGPISDNAGGIAEMSEQEPI
VRERTDILDSVGNTTAATGKGFAIASAALTSLALFAAYVTFTGIDGINIFKAPVLAMLFV
GGMVPVVFSALAMNAVGKAAMEMVHEVRRQFKDIPGIMEGTGKPEYDKCVAISTKASLKE
MMLPGLLTIGFPLIIAFVPLLFGMEKLAIAEMLGGYMAGVTVSGVLWAIFQNNAGGAWDN
AKKSFEAGVMINGEMTYKGSEAHKAAVTGDTVGDPFKDTSGPSMNILIKLTCLIGLVIAP
ILGGHSVDLNHANKEEIKKEVRLEIKGDNSEMAAATITTTTTVNGKTTTDIQQIDGSVEE
IEKKANEAGKIVSVNVIKSEKKIEAHIQ
>FCMOIPGL_00540 Inorganic pyrophosphatase
MSDKKKHTFDVLIEIPKGSRNKYEYDFDLHKIRFDRMLFSSMMYPGDYGFVPETLAQDDD
PLDVLVLGHEPTFPMCVCEVKAIGVFHMTDEKGPDEKIICVPVSDPIWSNNNDISDLNPH
RLKEIEHFFKVYKDLEKKKVDVGGWGNAEEATQIFHESVKRYNESDYKKTDKFKI
>FCMOIPGL_00541 TonB-dependent receptor SusC
MKIKFPLIFILFFSISLFSQTKVSGIIIDQNNEPIPYCSIQFKNSTEGVVANEDGKFYIE
SDKTWNEIEIASIGYKTLLFKLEKKVSYNLKFVLEEQQESLNSIYIVTGKQPKKNNPAID
LLRKIWAQKRKNGLSHFKQYKYKKYQKIEFDLNTIDEELKSKKIFNGLEFIFKDIDTSNL
TGKTYLPVFLNETLSEVYGDNIKQKKKEIIIANQNTGFKNNQELTDYIENLYPDYNIYDN
YLNFFNKSFVSPLSKTGINNYNYVLADSAFIGKKWCYNIIYYPRRSNELTFKGNFWVNDS
TFAVKEINMQVPKNANINWVKDIYIEQEFNLLNDSIFVLERDYFLSDFALNKKEKSKGVY
GKRTTIYKNYEFNKPVTQEKFYEKRNYTAFSDTIYNRSKEYWNTNRLEDLNEDEKAVYKL
LDTLKTVKKFKNLSKTVATLSSGYFEIDKLNLDYGPIFSTFGFNDVEGLRVRVGGRTFKT
INDLFRLEAYTAYGFKDEEFKYGYQAKWLINKKNRFILSGGNRKDIEQIGASLTASTDVL
GRSNGSSSLISTGTNDKLTDINLTNFTAEIEPFSNFELKLAANYKTLSSASETFSLDYND
PESSNGISSKINQFESLFSVGYYPKRKLTGFGVKREISNYYYTKYFMQVTKGFKGFLDSD
FDYTKVQFSFYNLWKIGALGRLTTSLETGKTFGEVPLALLHIAPGNQTYFIFDNTFNLLD
FYEFTTDTYTSLHLEHNFNGRIFSRIPLLRKTKLRTIIGFKAFWGQLSEENRELSTTGNS
AEIPLIAPSSKPYYEYSVGVGNIFKILRVDLNYRGNYLENANARKFGITAGLRFSF
>FCMOIPGL_00542 2-oxoisovalerate dehydrogenase subunit beta
MKTVQFREAICEAMSEEMRRDESIYLMGEEVAEYNGAYKASKGMLDEFGEKRVIDTPIAE
LGFAGIAIGSAMNGNRPIVEYMTFNFSLVGIDQIINNAAKIRQMSGGQFNCPIVFRGPTG
SAGQLGATHSQAFENWFANTPGLKVIVPSNPYDAKGLLKAAIRDDDPVIFMESEQMYGDK
MEIPEGEYIIPIGVAETKREGTDVTLVSFGKIIKEAYIAAEELAKENISVEVIDLRTVRP
MDHAAIIKSVKKTNRLVVLEEAWPFGSVATEITYRIQEEAFDFLDAPVKRITTADTPAPY
SPVLLENWIPNSKDVIKAVKEVMYVK
>FCMOIPGL_00543 hypothetical protein
MKNKFLYCFFVLNILFTPFCISQENECVNCDVLPGQLDNFKAALTDSKVHYYTNGGTTKL
DLKKAEEVCDVNYFTTCNNLLVLISTGKKNDRTEIRQDKNLSLNQYSAMDFSAIYENVPS
SNSKKGVTIGQIHNDTKGVKRPLLRVEIAGGNEVRVIVTSSYLKGEGKTENNFFTSFKEK
DQLDCKIEINEADNNVTVIIKNNTTGKSEQKSYNVSKLWQEMDGEFYFKAGAYTQVDGPK
TKVSYSKFQFLY
>FCMOIPGL_00544 Electron transfer flavoprotein subunit beta
MKILVCISHVPDTTSKINFTDNDTKFDTNGVQFVINPYDEFSLTRAMWFKEKQGATVTVV
NVGNSTTEPTLRKALAIGADDAIRVNIEPTDGLAVAKQLAEVVKNGGYDLVLAGRESIDY
NGGMVPGMLAALLDYNFVNGCIGIEVEGESVKLSREIDGGTEDLSTFLPLVVAGQKGIVE
EKDLRIPNMRGIMMARKKPLNVVEPVDAESATSIVSFEKPAAKGAVKLVDADNIDELISL
LHNEAKVI
>FCMOIPGL_00545 Caffeyl-CoA reductase-Etf complex subunit CarE
MSVLVFADSAEGKFKKSAFEVVSYGKKVAEQLESNLVVLTINAQKNEDLYAYGAEKVVSV
SNDSLAVFNAKAYSSIIKQVADAQNSSVVILDSSIDGLFIAPMLAVTLNAGYASNVVALP
SSTSPFTVKRKAFSSKAFSNTVISSDKKVIGVAKNAYGIHENLVTGTIESFDASISDADL
KVKSEKIEKVSGKVTIADADIVVSAGRGLKGPENWGIIEELADVLGAATACSKPVSDLGW
RPHGEHVGQTGKPVASNLYIAIGISGAIQHLAGINASKVKVVINTDPEAPFFKAADYGIV
GDAFEVVPKLIEKLKAFKQA
>FCMOIPGL_00546 hypothetical protein
MSLILLTIKGISYSQTQSGAYALVLSEIEGTRTLPIIIGAFEAQSIAIALETEIRPPRPL
THDLFKTFADTFDIHIKEIIIHKLVDGVFFSSLICERDGKEEVIDTRTSDAIAIAVRFNA
PIYTYENILDKAGIYLKVDEEMDFENKDESTEISIEFEKAPEKDKNSFSSLTLKELNNQL
NDAVTDENYELAAKIRDEISNRS
>FCMOIPGL_00547 Putative nucleoside permease NupX
MKKLFIFLFSIVSLTLYSQEIEQNWSFSSIKKNDGKELIKTDSTDIFNLKNGKFIYSLKG
NDNLQASGNYIHQNNLLIFNFKEPKDTVRYFNIVSFDKASLVLSENDVIYNLSSKTEANI
EITQDDAVLIADDIATSEEKEDIILPSKGFSIDTLWRGMIGMLSLIIIAFLFSSNKKAIE
WKTVLLGIVFQLLIAIGVLKVGFIQKTFEWVGGLFVSVLDYTRAGSKFLFEGLVVDMDKF
GFIFAFQVLPTIIFFSALTSLLFYLGLIQKVVKVLALLLTKVLKISGAESLSVAGNIFLG
QTEAPLLIKAYLEKMNKSEMLLVMIGGMATVAGAVLAAYIGFLGGDDPVLRLQFAKHLLA
ASVMAAPGAIVISKILYPQTEEINTDVSVSQEKIGSNILDAIANGTTEGLRLAVNVGAML
LVFVAFIAMVNGILGWVGEITTLNTWMAANTSYTSFSLEAILGYIFAPLMWLIGVPAVDM
ALMGQLLGIKLAASEFIGYIQLAELKDVTNGIHLTYEKSIIMATYMLCGFANFASIGIQI
GGIGSLAPGQRKTLSEFGMKALIGGTIASLMSATIAGMIIG
>FCMOIPGL_00548 Thymidylate synthase 2
MKQYHDLVKHVLENGNVKGDRTGTGTKSVFGYQMRFDLSEGFPMVTTKKLHLKSIIYELL
WFIKGDTNIKYLQENGVKIWNSWADENGDLGPVYGHQWRNWNSDEVDQIKEVIDTLKTNP
NSRRMLVSAWNPSVLPDTSVSFSENVANNKAALPPCHAFFQFYVSDGKLSCQLYQRSADI
FLGVPFNIASYALFTMMIAQVCGYEVGDFIHTFGDAHIYNNHQEQLELQLSRDLRALPKM
KINPAIKDIEDFKFEDFELLNYNPHPHIKGAVAV
>FCMOIPGL_00549 1,4-alpha-glucan branching enzyme GlgB
MAIKKQFLKSKPVCKVTFSLAPEEAKNVAVVGSFNEWNEKATPLKKLKNGTFKGTVDLES
GNSYEFRYLVDGEYVNEQEADGVVWSDFAGADNSLLSL
>FCMOIPGL_00550 Dihydrofolate reductase
MITIIAAIAKNNALGKDNDLIWHLPADLKRFKKVTTGHHILMGRNTFESIGKPLPNRTTI
IVTRNKNYFKDGCLIANSLEDAIELAKNDAEIYVIGGAEIYKYAIENNLVDALDITLVHH
EFEADAFFPEIDTKIWKEVSREDFKADKKNNFDYSFVSYRKIN
>FCMOIPGL_00551 hypothetical protein
MKLLKQTLFLFVTAIFFWACGSSNINNKTKEKEKPVVIANDSLEYEVIIIDPGFTFFLNS
RAQPEGFYSQNYLEARNRVWVLEWNNRARNPRLFNPNIYENIVDYQSTIDYGYEVNYKLF
NYFLFAQQKYKMNLGGNFRTNRIN
>FCMOIPGL_00552 DNA-3-methyladenine glycosylase 1
MKHRCFWVTDSKLYKDYHDNEWGQPVFDDAILFEFLILETFQAGLSWITILNKRENFRMA
FDNFDYKKIATYPESKYESLLLDRGIIRNKLKIKSAITNAQLFIEIQQEFGSFSNFIWSY
VDDKPIINNFAKREEVPATTSISDKISKDLKKRGFKFVGSTVMYAYMQAVGMVNDHTTDC
FKYPN
>FCMOIPGL_00553 hypothetical protein
MFLGAYFTTGRIIFIIFFVLAFGALIIWSYKKDGKSHERYYKNTGKKVAIYGGLIIAVFI
AIRIIFGN
>FCMOIPGL_00554 hypothetical protein
MKNKIAAVTKFHTAFKLNMNNKPIANIGDDRNLLRFNLMKEENEEYLEAANNNDLVEVAD
ALGDMLYILCGTIIEHGMQDKIEEVFNEIQRSNMSKLDENGEPIYREDGKVLKGPNYFKP
NITEILEK
>FCMOIPGL_00555 hypothetical protein
MKIVLTCEHGGNEIPENQHYLFSTDQQVLHTHKGLDLGALDLFNQLKPLADFSLFSTKSR
LLIELNRSLHHKNLYSAFSKTLSTSEKKALIDSYYLVYRNKVENNIRNYIKEGNKVLHIS
VHSFTPVLNAVERNCDIGLLYDSSHKNEKKFSHQFKKELLQQNGNLNVRYNYPYLGKMDG
FTTYLRKQFPLNYIGIEIEVNQKYAKENKMNSAICEAIFNSLKKITSLKSL
>FCMOIPGL_00556 Glutamate--cysteine ligase
MGKKYHLFEVFGIELEYMLVSTDTFKVTPIVDLLLTKKNGSLTSDIENGKIAWSNELVAH
VLELKTNGPTNDVNNLSANFHENVLEINELLKEFKVQLMPTASHPLMNPDTDTQLWKHSY
SEVYALYNRIFNCKGHGWSNVQSTHINLPFFNDEEFEKLHAAVRVILPLIPGLCASSPIL
EGKNTGFKDTRLEYYKTNQKEIPEMTGKVIPENVFTKKDYHHTIFEPIQKAIKPFDTENI
LDHHFLNSRGAISRFDRNAIEIRLVDIQECPKADIAICVLIIEVLKLLVSESLVSLENQK
KRDKEALFDILNDAIKNGENSVITNIDYLNLFGLKEVTTQQNVWKHLYNLVKDAIDESHL
ETLNTILTKGTLSTRILKAINSDFSETNIKKIYTDLAICLQKNEVFNP
>FCMOIPGL_00557 Ribosomal protein S6--L-glutamate ligase
MNKYVVVNQIEKWNFSIENINIISSQEYLTDPKYSLLKKARIFNLCKDYSYQSKGYYVSL
LAEARGHLAIPTIKNIVDLKALELVRIVSEEFDDSIQNSLKNIKSREFTLSIYFGQNVAQ
KYKELSALFYKHFQVPFLRVKFNHTTKWEIQSIKAIAESEIPADHFDSVHEFANQYFSKK
RYDTPKLTKSDFDLAILVNPNDPAPPSNPKALKKFIEIAEKMNIYAEIIEPQDLSRLNSF
DALFIRQSTEVNNEAYAFARKAQQDGIAIIDYPDAILKCCNKVYMAEALNNANIATPKTI
IVHKDNRNDVLANTGLPCVLKAPDSTFSFGVKKAKTVEEYDELVTNMLKESDLIIAQEFC
PSDYDWRIGILDDVPFFACKYYMAKGHWQIYNWNAKKKDDQDGDADCLPIEKVSKKVLKM
ALKSAKLMGKGLYGIDIKVVNEVPMVIEINDNPNIDFGVEDAFYGDSVYTQILTALKNRL
D
>FCMOIPGL_00558 Branched-chain-amino-acid aminotransferase 2
MKSHIEIQRIEKSKIDSVDFNNLPFGSVFSDHMLECDYKDGAWQTPVIKPYSPISLDPSA
KIFHYGQSIFEGMKAYKDAKDKTMLFRPLDNCKRLNKSAERLVIPQIPEDIFMDGLKKLL
EVDNAWIPTNEGSSLYIRPFMFASGNGFHASPADGYKFIICTAPSGAYFAGKVKVLIEEK
YARAANGGVGFAKAGGNYAAQFYPTQLAIEKGYNQVIWTDDNSHQFIEEAGAMNIFVRIN
DTLITSPTSDRILDGITRKSILQIAEDAGIKTEVRKISVGEVVEAAKNGELKEMFGAGTA
AVISPIAGFGYQENDYDLPELENPFAAQLKKKITDIQTNKTEDPYGWRVIL
>FCMOIPGL_00559 hypothetical protein
MKNIIKFCAIALLVFASCKKETANKENDQTVKEEIIAFDSFGDKITNDAAITSNEMLAKF
NNLKVGDTLNVKFASTIKEVCSKKGCWMKLPLNDTEEAMVTFKDYGFFMPLDSKDREVII
EGKAFVKETSVAELQHYAEDAGKSKEEIAKITAPKKEFAFEANGVLMKK
>FCMOIPGL_00560 hypothetical protein
MLKMYQANLENKSLILEGKTPNAFPEEFINIHTAKLTDPSDRNASFKVFSEMYLNTFQQD
FKTEKDSLKAKHNNTIYTCIACHKTTCIGPIPKIKKLLIQ
>FCMOIPGL_00561 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MKREILITSDGSTTIHLPDWNEQYHSKHGAIQEAYHVFIKSGFELFCNSDEKIQGSISIL
EIGFGTGLNAFITFLEGIKHHKKIDYVGVEAYPVIESEVQKLNYVSELNAEKHQLIFDKM
HAVSWDEKQLISDNFKLTKRKQFFEEIEDENNHNLIYFDAFGATNQPELWTETIFLKMYN
ALKTNGVLVTYSAKGSVRRAMQTVGFTVERLEGPPGKREMLRATKK
>FCMOIPGL_00562 hypothetical protein
MEFKRKFGKQKEKKPAKGLFLIILLVIVLFLWFKAESLLSSLF
>FCMOIPGL_00563 Crossover junction endodeoxyribonuclease RuvC
MAIEKIILGIDPGTTIMGFGLIKVVGKKMEFIQMNELLLQKYDDHYLKLKLIFERTIELI
DTYNPDEIAIEAPFFGKNVQSMLKLGRAQGVAMAAGLSREIPITEYLPKKIKMAITGNGN
ASKEQVALMLKSLLNLKTLPKNLDATDGLAAAVCHFYNSGKVVGGKNYTGWASFVKQNPK
KII
>FCMOIPGL_00564 hypothetical protein
MKLKNNPLQNKSYDLALLIVKLSKKLIKENKEYILSKQILRSDTSVGANIVEANGPISKV
DFLAKMSIAYKECLETKYWYTC
>FCMOIPGL_00565 Oxygen-independent coproporphyrinogen-III oxidase-like protein YqeR
MISALIKEIEIRKDEINNSIIETIYFGGGTPSVLNVDEIKLLIDTVYRNHKVIENPEITL
EANPDDLSEEKIIELSKTPINRLSIGIQSFFEKDLKLMNRAHDSSEAKNCLSVATKYFDN
ISVDLIYGIPDCTNEEWQQNIQTALSFDVPHISSYALTVEPKTALHTLITKGKIKNVDDE
KAQEQFNILIEELENSNFVHYETSNFGKQGFFSQNNSSYWLGKPYLGIGPSAHSFDGNQR
SWNVRNNSKYINSIAENQLPIERETLSKTDCYNEYIMTGLRTVWGVSFDKIKVDFGEKYI
EYLENQSKKYIEQELLVLENRILRTTKKGKFLSDGIASDLFILN
>FCMOIPGL_00566 Kynurenine formamidase
MKATIEYNSRKIVINVSEPLDISISIDMSKGKINAWGIDDPKIEVESFDGYEVSVANGAV
VNFNSIQFNPHSHITHTECVGHITEKVHSVNQNLKHYLFLAELVTVAPEKIDGDFVISEK
QLKTALRNKKRDAIVIRTLPNLSDKKETRYFNTNPAYLSEEAAFYLVEKGIKHLLVDLPS
VDKEKDDGKLLVHNAFWGTAGKVRMDATITEFIYVPNTIEDGEYLLNLMIAPFENDATPS
KPILYKIMN
>FCMOIPGL_00567 Cobalt/magnesium transport protein CorA
MENTFLDKTTIIQYSDKNYKKSNFSSLSDIKLSDNVSETKWINTYGFDFHNEFKTVILEN
NLDDFLIKLLMENEHDTKVILLENLLFVTINVLKTEGKHLDQEKMIFIVAPNFLWSIQEK
PGDYFSWIRKRLEEQKGIVRKKKNDYLLYLIIESIIDNYQETYQKHAELRSYELNSTYIK
PTPEFTSLVEKRKQELFTFKKAAISLKNTIVKLEKVEVKGLNNKYFSEVKEQTINLISDI
DFELQELESKINLIFSIQGHRLNEVMKTLTILSVIFIPLTFLAGIYGMNFENIPELKAKN
GYYILLVVMVIITIISVWYFKRKKWF
>FCMOIPGL_00568 hypothetical protein
MNIEELRDFCIAKKGVTEHFPFDNVTLVFKVMDKMFALIGLERWEKGEQKINLKCNPEKA
EELRDKFEGIIPGFHMSKKHWNTVIINSSDVSDDLVKELINHSYSLVVSGLTKKLKEELH
NLQ
>FCMOIPGL_00569 hypothetical protein
MYNAKNSSEKRNIHLGVDFWLPENTAIHAIFNSEVVCAIYQDSHKGYGGFIILKHTFYET
EFYTLYGHLSKKSILKFSVHDKIKKGEQIGVLGNIEENGDWVPHLHFQIMLSLLDFKDDF
PGVALESEIPFWKLICPNPNYLFKLEAFQ
>FCMOIPGL_00570 Adenine deaminase
MIVQGNIVDIQDKRIYKGEVEVENGKIKEIREANHNQENYILPGFVDAHIHIESSMLVPS
EFAKIAVLHGTVATVSDPHEIANVLGVKGVDFMIENGKKVPLKFNFGAPSCVPATSFESA
GAIINSDDIQLMMENPDILYLAEMMNYPGVLFDDDEVLKKIQHAKNNNKPIDGHAPGLRG
DDVTKYISAGISTDHECFSFEEAKEKLEKGMKVIIREGSAAKNFEALIDLLPENYEKMMF
CSDDKHPDDLLLGHINQLCERAVAKGVDVFKVLQAACINPVKHYDLKVGLLQKDDFADFI
VVDNLEKFNVLETYINGEIVAKNGESFVKSVDFEILNNFNTDKKNISDFRFDSSSEKIRV
IEALDGELVTNQIEENSLIIDGNLVSNTATDVLKMTVVNRYKNDEPAIAFIKNFGLKEGA
IASSVGHDSHNIIAVGVSDEMICKAVNLIIENRGGVCAVNESEEKIVSLPVAGIMSDLPA
KEIGKSYAELDKMSKNMGSKLRAPYMSLSFMALLVIPSLKLSDKGLFDGNSFQFTSLEVD
>FCMOIPGL_00571 hypothetical protein
MSLEQDLGNRSGNKCELCASTTNLSVYDVKPSITGGGGVDGSLLACETCVTQIDNPDEVD
ANHWRCLNDSMWSEFRAVKVVAWRMLHRLKKEGWPVDLLGMMYMEDEELRFAKETGDHLS
ESEKIIHRDVNGVVLEAGDSVVLIKDLKVKGSSMVAKQGTAVRRISLDHENAKYIEGKVG
PTQIVIITDYVKKMTEKE
>FCMOIPGL_00572 hypothetical protein
MDIFLLILGFVFVILGIIGSFLPILPGPLTSWVGLLLLYFTKIIPVDYTFLGITLAIALL
IFVLDYFIPAFGTKRFGGTKYGVYGTTIGLIIGLLSPIPFGMLLGAFFGAFIGELLYDKK
DTNRALKASFGAFFGFLASATIKFSIAAIYLVLFLIKFWEFRNDFF
>FCMOIPGL_00573 hypothetical protein
MSKRLSKVEEQKRHNIVFRLLNLVTFFILFSLNAQQNADTKIETKIVNPRFDNFKGSRIV
IDQSHHNFHQMSGRFKPFSDLMISDGYQLDSIINLQELKTNDILVISNPINEKNIGNWRQ
PIYNAFSSDEIIYLKKWVKKGGKLLLIADHMPFSGAANELANAFGFDFCDGFAYINKENR
NAPDVFSMNNKRLLNSVISDGTLGSQFDNVTTFTGSSFTIPKRAIGILKFLKGDYCLTPQ
IAWQFNDDTPSIDLVNSYQGAILNFGKGKIAVFGEAAMFTAQTITNNSGTFKFGFHSEQA
PNNIEFIRNVLFWLHKD
>FCMOIPGL_00574 Penicillinase repressor
MKTQLTKAEEQIMQVLWDLQETSVKDVIDKLPEPKPAYNTVSTIIRILETKEFVGHKQVG
RGYLYYPIIDKETYSNQSLHKLMNGYFDGSFKSLVSFFVKENKMDVAELESILKEVNKVK
>FCMOIPGL_00575 hypothetical protein
MINYILQVVLFQVLFLAIYDFFLSKETFFIKNRWYLLSTPILSFLIPFIKIPRFQKAVPQ
DFIVNLPEIFLSPEKVIQKTILETTFYDSVNYIPVLFWIGVAFFSVLFLMKLVKIIKLIK
KYEVVKQQGFTLILITNQTNAFSFFNYVFLGKNVEENKREKIIQHELVHSKQKHSLDLLL
FEFLKIVMWFNPMIYFYQQRITLVHEYISDAIVAKSETKESYINNLLSNFFQVENIAFIN
QFYKQSLIKKRIIMMTKTQSKKMNQLKYLVLIPVLASMLFYVACTESEIDSSEIITTSEY
QGKIKIQDEYYFIKQNELGKTIGVNSKGQEVDILSLLPESVVDLYFEDGKLVTEFSYTYD
KKKTKELEVITDPNAITETEEVSFLKIEKAPTFPGCDSGDKDCFSKNIQKHFARKFNSGL
LKTLNLKSGRKRVFISFKIDKEGNIVDIKARAPHDKIEEEVIRVMSLLPKVVAGEHEGKA
VAVKYSIPFTLLIE
>FCMOIPGL_00576 hypothetical protein
MKNKILILLLFAIVKVEAQTSIFTVSDSLFAKGRYKLALQELDKNTPSFLSNYKKAVIYE
SIDNFKKAAEFLEKAIGFKDDDNTKLKLAKNYQRLQILGKSIKIYEEILVKDSLNLVLKY
QLGKLYLNTKVADKAVIIFKELIDNDITNANYSYYLALAYAIKKDRNRMINSFIDTFKKD
TLHIKAIANLASSFKKLNDLDSTQLFVEKGLAIDKNHINLNRLKINQLYREEKYNEVIPF
LLNLDSIDKKDTYSKSMLGRTYYNLDSLAKAKEYFKGVARMDREDFKAITYLGHIAFKEK
DFRAASFNYMKATFIGKQKRDEEYYGLASVYYEKKEPLLAIKNFEKAYSENTKNYRALFQ
LAKLTDDYYKDKKMAYKLYLKYYKYHNNRDEGMANFVKGRINDIKQEYFMKGENLED
>FCMOIPGL_00577 hypothetical protein
MDTIVDFTSVDFSPSFKICDSIIDKEEVAICFRNTMHQKIGEELQKQQLTIKDSINEIIY
VDVVINSKGEIIFDETSTSENIKKQLPQLDSLLKLSVSKLPAIHPAIKRGIPVTTKYRLP
IRILLMD
>FCMOIPGL_00578 Phytochrome-like protein cph1
MKNIQKRILKLGRVEDFEVKNSSIIFFLIGPSLFIYSYFINNYGDENVRIEGAREFFAFL
FFIASCLPFIFKKKIKFFFGWIVFLLMLLFSHYVIVLLYINKFSIQFLLGFYVFNFGAVL
LFNNRVFINIFLVTIFIHLLQKLMISNIEVMVFNAVVSSFSICFVFSFIILSGSTLFRTR
IAKLNKALHKKAKAKTLDLEKKAKDLEEKNLDLEEFAFVVSHDLKTPLRNITALSSWLKE
SAENNDKVAINTNLELIEKQITQMDLIIQGVLNYSLQNEVSSNDEKINLDLLVKDLIAVN
KTDKCLITIKKKLPVIKINKSQILQVFQNLIQNGIKYNDKEICKIEIDYTLENNFYIFSV
KDNGIGIEEKYHEKIFKLFQRLDVKTMENVGIGLSLVKKIINRNKGEIYLKSEVNIGTTF
YFTLPA
>FCMOIPGL_00579 GTPase Obg/CgtA
MTEGNFVDYIKIYASSGKGGQGSVHLHREKYITKGGPDGGDGGRGGHIILRGDKNMWTLF
HLKFKRHFRAENGGAGSKSRSSGHDAEDIYIDVPLGTIIKDADTDEVIVEITEDKKEVVL
LEGGKGGLGNWNFRSSTNQTPRYAQPGIDGIDGWFRIELKLLADVGLVGFPNAGKSTLLS
VLTSAKPKIADYAFTTLKPNLGIVEHRNHQTFVIADIPGIIEGAAEGKGLGHRFLRHIER
NSALLFLIPADSDDINKEYDILLNELKKHNPELLDKDRLLAISKTDMLDGELKAEIKATL
PKGVDAIFISSVAETGLQELKDKLWKMLN
>FCMOIPGL_00580 Adenylate kinase
MKIIKLHDLYFKPFINKEEISEIVKTLALHVKADLPKDEVPIFVGILNGCFLFAADFIRE
FKGNCEVSFVKLASYEGTSSTENIKHLVGINEDLTGRTVIILEDIIDTGNTLQEIYNIFR
NKNVKQLKIATLFFKPDVFKKELPINYIGKEIEDKFIVGYGLDYNNLGRNYPEIYQLTTQ
PKMKNIVLFGPPGAGKGTQATLLKKKYDLLHISTGDVFRFNIKNETELGKLAKSFMDQGD
LVPDEVTINMLKAEVEKNADANGFIFDGFPRTESQAIALDEFLAEKGEQINGMVALEVPE
DLLVTRLLERGKTSGRTDDTDESKIRNRFNEYNTKTAILKDFYQEQGNYYGIDGVGTIDD
ITARLSEVFDTL
>FCMOIPGL_00581 Multidrug resistance protein MexB
MQNKGLIKLFAILFGLVSLYQLSFTFLATKVEDDAVAYAATKGNDSDARQKATFERKYLD
SVANDNIIDLGVTKFTYNDVKDKEMNLGLDLRGGVNAILQVSVKEVLKSLANDSKNEVFN
KALDAADERQKSSNSTYLDLFFEEFEKIAGTTKLSDPSIFGTKALSEKISFDEENSTVKT
TLQEEINSSIGTAFEVLRSRIDKFGVTQPNIQRIGNSGRIQIELPGAKDIERVTKLITSK
AELQFWEVQTNAEVQNFFFAANDKVAELLKDDSVLETEKDSIKKDDIDALLGESTDSTKV
QKNLFTYLFPNVAQSQQQLSSVVAYASVLDTATVNNLLAKKEIRTLLPTELRYTKFLWDY
KSTKGTDGTELINLYAIKGNRNDRPTIEGDVILDASQMFDQLNKPEVSMTMNSSGTKQWA
KMTGDNIGNFVAVVLDDYVYTAPSVNQAITGGRTSISGGSMTIEEAEDIATVLKAGKLPA
AARIIQIEVVGPSLGQEAIDASFISFGIAIFLVLIWMILYYGKAGIYADIALTVNILFIF
GILASFNAVLTLPGIAGIILTIGMSVDANVIIFERIKEGLSSKKGLKQAVEEGFSIKGAL
SAIIDANITTLLTGIILYVFGTGPIKGFALTLMIGIATSLFTAVFITRILMDRAIDKGNK
LTLNTSFSKGWFENINIQYIKKRKIAYMISGTIIIAGLISIFSIGLKQGVDFKGGRSYVV
RFDQSMSATEVASTLKDAFGTAPEVKTYGNDNQLKITTVYKIDEEGQEVDEQVQNTLFTG
LKPYLGNTTYENFKPGFEKTGSGVMSYIKVEPTIADDIKTSALYAVLGSLLVVFLYILLR
FRKVSYSIGAVAAVFHDVLIVLGVFSIAYNIMPFDMEIDQSFIAAILTVVGYSLNDTVII
FDRIREFTNERRGKHNVLINDAINKTLGRTINTSLTTLLVMLSIFLFGGDSIKGFMFALI
VGIIVGTYSSIFVATPIMYDTTKKEDKDN
>FCMOIPGL_00582 Formate--tetrahydrofolate ligase
MAHLSDISIAQSKKLQHIKNIAKKLQVDEDDLEMYGKFKAKLPLYLIDEKKVQKNNLVLV
TALTPTPAGEGKTTVSIGLTEGLNKIGKQAIVVLREPSLGPVFGMKGGAAGGGYSQVVPM
EDINLHFTGDFNAVEKANNFLSALIDNNIQSKTNNLNIDPRTVLWKRVIDLNDRALRDVT
IGLGGRFNGIPRQDGFNITPASEVMAILCMASDLENLKKRLGNIFIGFTFDNKPVFARDL
KAENAMAILLKDAIKPNLVQTLEKNPAIIHGGPFANIAQGTNTIIATKMGLSLSNYVITE
AGFGADLGAEKFLNIKSKFANLNPKCVVLVMTIRALRHHGGAKKEEYNIPNLDKVIDGFK
NLERHIENIRKFNVEPVVAINSFISDTDEEVAFVIEKCANLGVEAVLSEGWAKGGVGMID
LAKVVVNVVENKASQYKPLYNWKSPVTDKIETIAKEIYGAKNVEYSKLAQLNLRRINRLG
FNDFAICMAKTQKSFSDDESLIGRPEGFTVTVREIEIAAGAEFIIPILGKMMRMPGLPEH
PASENMTIDNNSVISGLS
>FCMOIPGL_00583 ATP-dependent DNA helicase RecQ
MKKQTHTILKNVFGYDNFRPLQEEIINRTLEGKDSFVLMPTGGGKSICFQIPALVFDGIT
IVISPLISLMKDQVQALKSNGIKADFFNSSISPQEENEVINKAMNGELQLLYLSPEKLIS
VSNTWLKELNIKLVAIDEAHCVSMWGHDFRPEYTQLKIFRNSIPDVPFMALTATADKSAR
IDIQEQLGLSNSKLFISSFDRKNLSIDVRGQVQKKKKLQEIINFIKRRKNESGIIYCLSR
KNTEEVASYLKEEGHSVAFYHAGMNHEERENTQTDFINDDTKIIVATIAFGMGIDKSNVR
FVIHYNLPKNLEGYYQEIGRAGRDGLPSETILYYNMRDFVLYSQFANDGANSGMQKEKLN
RMLQFTEAKSCRRKILLSYFGEHLTENCGNCDVCENPPKDFEGTILTQKALSGIARMKEQ
DGITMLINVLRGSNNADIHEKQYFNLKTYGIGKDVSFFDWRDYIIQMANQGLIEIMYSEN
SALKISPIGWQVLKGEKKIRLTTPISAKDKKKTQKVAKTTTIDEADKDLFTELKKIRLSI
AKEESMPAYIIFNDKTLKLMASELPTTENEFLAISGVGMNKMEKYGEEFMNVIRKFKNIA
KPRKITTTQKTYNLYKEGLNPTEIAEERNLSITTIYSHLSQLYLEGKEVYLEKLVTKKVL
DNVRIAFNELERKVELKPIYEKLNEEVSYGEIRLSVTLILKNE
>FCMOIPGL_00584 Malate dehydrogenase
MKVTVVGAGAVGASCAEYIAIKDFASEVVILDIKEGFAEGKAMDLMQTASLNSFDTKITG
STNDYAKTANSDVCVITSGIPRKPGMTREELIGINAGIVKTVSSSLIEHSPNTIIIVVSN
PMDTMTYLVHKTTGLPKNRIIGMGGALDSARFKYRLAEALGAPISDVDGMVIGGHSDTGM
VPLTRLATRNSVPVSEFISDERLAQVLQDTKVGGATLTGLLGTSAWYAPGAAVSALVQAI
ACDQKKIFPCSTLLEGEYGLNDLCIGVPVVLGKNGIESIVEINLNDAEKAHMQESAAGVS
KTNGLLEL
>FCMOIPGL_00585 hypothetical protein
MKKSILIFMSIFALSFNTKAQDGFEAILLADVADSQKLLQTYFAPGMEGFLNSMNSGWYH
TAKVHKKFGFDLSVGLSASAIPSEKELFNISALALTSVTSTSATASTFGGPSNTTPMTVN
TTIDGNNVTANFDAPGGIKEDLPLNSVPAPIAQLNVGLPWKIDAMIRMVPEVNFGEDDGS
VKMLGVGIKKEITDWFGPIGKTPLHISLLAAYTTMDVDYGIPDQDFPSNNQAGIEIKNAL
TEFSLEAFTVQAIASLNFPIINVYGGIGYNNGSSNYKMEGTFKGRYETGNPIQPTIDKTL
SVPSNLDFESNGFRTTLGARLSLGFFKIFGSYTLQEYNSISAGIAFSIR
>FCMOIPGL_00586 DNA gyrase subunit B
MSEEKKHSYDASSIQALEGMEHVRMRPSMYIGDVGVRGLHHLVYEVVDNSIDEAMGGYCD
TINVTINEDNSITTKDNGRGIPVGIHQKEGVSALQVVMTKIGAGGKFDKDSYKVSGGLHG
VGVSCVNALSDHLTATVHKEGKIWQQEYAKGKTLYPVKTIGDTDFTGTIVTFLPDKSIFA
QTTEYNYETLATRMRELAYLNKGITISLTDRRETDDEGNFISETFHSDEGLPEFIKYLDS
TREQLTASVISMEGEKNGIPVEVAMVYNTSYAENLHSYVNNINTHEGGTHLSGFRRGLTS
TLKKYADESGLLKNVKFEIAGDDFREGLTAIVSVKVAEPQFEGQTKTKLGNREVTSAVSQ
AVSEMLADYLEENPNDAKIIVQKVILAATARHAARKAREMVQRKTVMSIGGLPGKLSDCS
ETDPEQCEIFLVEGDSAGGTAKQGRDRNFQAILPLRGKILNVEKAMQHKVFENEEIKNMF
TALGVSIGTEEDPRALNLSKVRYHKVVIMCDADVDGSHIATLILTFFFRYMREMVEQGYI
YIATPPLYLVKKGQKREYAWDDNQRDLIAQKLGGNVAIQRYKGLGEMNAEQLWDTTMNPE
FRTLRKVVIDSGTEADRVFSMLMGDEVPPRRDFIERNAKYANIDV
>FCMOIPGL_00587 TonB-dependent receptor SusC
MHFKFLFTLSILFSILNINAQNTGALKGTVTTEQGEPIMGASIFVKGLSMGTTSDIDGAF
SFEKMPNNTYVIQVSYIGYNTITKQVVISKLETIQNFTLKESSYMLEGVVVTSQKREQKN
KDVPIAITSYGTDFIENQGTFEYDALSDYVPGLQVQIQSVNNPGIVIRGITSDSGDSRVE
PRVSIFQDGVSISKSRGSVVELYDIERVEVLKGPQGTLFGRGAQIGAMHIIQNKAKNETS
GSAKLGYGNFNQFLATGHYNAPLVDDKLFFRAAAIYNKRDGFIENISGGDLNGKETVAFR
TSFKYLLNDNTSLDVIANWQQDTPPGTSFKSGTYAPLGGDTNPNTFADLERGEELGLDRT
VWGVTAILKHSFNDVWDLTSTTAYREFDSNEAFDADGTVAPALFFNEISIGKQFSQEFRI
NFDNDDKFRGFFGANFFYEDGSQSVPWEYDERSVAMLLLNPTFLVSNGVAVLAPSIPNDP
STFGAIAGAPLNSFNKETYTNFGENYSGDIFADASYDVTDKLSFTLGLRATLENINAAYE
VTDTEVPSVLGYLSGNYPNTLFASTNGEKIEASESFLSAVGRFAVNYAVNEEVTLFGTTS
RGRRPNVINVAATETNILSDEIVWSYEVGAKSLFLNNSLQFDVNAYVYNYSNFQTSVAKL
ENGVLTATTEDSGNASSFGFEVALQYAFSKTSSFFANYGYIDASFDDVDSDGNAQELAGN
TFRLTPENSFSAGFNINLDVNKNLSYFFRPTYTYKSKVFFEETNLPEISQDGYGLLNFRT
GLVVNKNYEINFYMTNVLDKEFIVDAGNTGGAFGIPTFIAGAPRFFGVQVKAEF
>FCMOIPGL_00588 Glycerophosphodiester phosphodiesterase
MQKTFLTFILIAFGFAIKAQEVQSIKNIESIIHDKEISNKNIKPNNQAKIIWSESYKEKQ
SPIAFVYLHGFGASSREGEPIMSQLSKKYNANVYMSRLKEHGISREDSFSKLTPDNYIET
AKEALSIGKLIGKKIILVSTSTGGSLSLKLASEDNSIAGLIMYSPFIDLKNPAFKMITTP
EGKAGFIKMNKGSKIMKQERPKEESKYWSTIYHIDGYESLIKMIVKNMTPETFSKVKIPA
FVGYYYKNEKEQDQVVSVPAILKMFDGLGTPENKKVKKAFPKTGNHVIGCDLRSKDWKSV
YNETVSFIDEVILEKEKQYSFDLQGHRGARGLSPENTIQAFDKALELGVNTLELDVVISK
DNKVVVSHEPWLNDEVTLDSKGKNITKEDAKAFNIYKNKYKKIKSYDVGSIGNPKFLEQK
KEKAYKPLLSEVITFSEAKNDQIRYNVEIKSTPTDEKNGFQPSVAEFSDLVIAQLKNAKL
PLEKITVQSFDPRVLEYIHKTYPAFTLAFLTYQNDFETNLKMLSFVPEIYSPYFILLNKE
EVKTIQNKNMKVIPWTVNKKDDMINLLKMGVDGIITDYPNIAIPLRK
>FCMOIPGL_00589 Aspartate--tRNA(Asp/Asn) ligase
MELEQLNKLLKKHDLELVIGLETHVRLNTKSKLFCSCANQEIEQPNTNICSVCTGQMGVL
PSINKEAIKKAIYFGKAVKSTFRNEVISWDRKHYEYPDNPKNIQITQFHNPVIPDGQVSC
YRNDGSQFTVTLTQVHIEEDAAKLMHEKKVSLVDFNKAGVPLIEIVTDPCIRHIEDASTY
AQYIQRIVQNLKISEANLEKGEFKSDVSVSLRKKHTYHLNPRTEIKNLNSFKFMVDALKE
EIEKQLNYFIEHKEFRPEQTTVLWDADLKQTKTMRTKEFEADYRFISEPDLPFVNIKQVV
ESIDVDVSSLPFAVESILIKGGVLPQDAKFFTADSLRSETFIAINNVIKDPSFVAKTLVN
NIGADEYANIHSIAHLTEIFQLFKEDKITSVLVQNGITSYLKDRTFDYKKYFDDNTISED
KIKDAVIKVIADNEAIANDIKAGNQGKAGILVGKVIAIIGKGASGKVIRTEILKALSHSP
LATGSHPTAKTQQLKADKEGQKGNLEEILPQIPLIIKEEYRTHKISQLSETSINEEVTLA
GWVASVRDHGELIFIDLRDSSNQIFQVRLSRETFPNLDELVKLKPETVIMVTGVVVQRKE
DDYNAGLRTGKIELETAVLEILNLSKTLPFEIKKATKSNENVRFQYKFLDHRNDDVRKAI
VNRHKVIKLLRDVLDEEEFLEIETPILTAGTDEGAREFIVPTRKQAGSFYTLPQAPQQFK
QMLMVGGFEKYFQIARCFRDEDSRGDRQPEFTQLDIEMAYASMQQIIDLNTKMFNEVVKK
IYGKKWILHPFEIITYKDAMDKYGCDRPDLRYGLQMQDITDIVKDTTFQVFSKPIDDGGI
VKCIKVSAEEQGNKRMSKGQIENLTAIAQQNGLGGLAYIIVNENDLQSPIIKFLGEEIAA
NIIKATDAQVGDIVFFSAADYATANKALDAVRQEMGRILKLINPKELRPAWVVDFPMFEK
TDEGRWTFTHNPFSMPAIYDLEKHMNNTDDEIGTIIAQQYDLILNGYEIGGGSVRAHKAE
ILEATYKNMGYNKEEMMKSVGTMYKAFQYGAPPHGGIAWGIDRLMMILEKKASIREVMAF
PKTGTSEDLLFNAPSPLSDKKVEEMNVRIIR
>FCMOIPGL_00590 Glutamyl-tRNA(Gln) amidotransferase subunit A
MKSQIHEIHQQLMNKEITCTKLVQDRLDLLKSNTHNTVNALLDTLALELATKVDAKIENG
QEIGLLEGIPFGIKDVYMLQGTLATASSDLLKNYKSSYTATAIQKLLDAGAIPLVKENCD
SFGHGSSSENTIFGAVKNALNTNLVSGGSSGGSAVNVAKDFTVFSIGGDTGGSIRQPAGY
NKIFGLKPSYGRISRFGLMAYASSTDCVGPIAKSIEDIRIVLNVMSGKDIKDQTTYQSET
ILEDNILNADEIKTVGYFKNFIESDAIDAQVKADFLASIEKIKAKGIEVKELDFFEADTL
VSTYYTLAMAETASNLSRLDGTNYGARIEGDNLKDTYSITRSENFSEETKRRIVGGNQVL
SQGFSDEIYLKGLNLRDQIADNFEKDFKEVDIILSPVTPNSPPKIGDSLKDPLAMYLSDA
YTVGFSLGQLPTLTIPQGTATGLQITAAKNNDELVLKFANFLKDTI
>FCMOIPGL_00591 hypothetical protein
MSKIMTVDILSSIKGAQPSESVNKLFESIKNANSINNNSFNNNHNNAVSLDDLRSDVVID
SPNAEKQIIIENFPKEKNGYLVVAKVIEE
>FCMOIPGL_00592 Anthranilate synthase component 1
MTHNRRMKKIQFKTISKTKMADTVTPVGLYLRFRDKYANTLLLESSDYHSKDESFSFIAI
DPVVSIKAENHHLSFSHKGVELENKEIGRDFNAIFESYSQTIDLDCPAELKSFNGLYGYT
TYDSVQYFENIDLNVKEAPSAIPLMQYSFYRFIIAINHFNDEMTLIENIEEGTESRIKEI
QSIIDAQTFNTQNFEIDGEETSNIKGEEFIEYVKKAKSHCKRGDVFQLVLSRQFQQKFKG
DEFNVYRALRSINPSPYLFYFDYGSFKLMGSSPEAQIKISAGKATINPIAGTFRRTGDMA
KDILLGKKLSADKKETAEHVMLVDLARNDLSKHADNVEVEVFKEVQYFSHVIHLVSTVSG
QLKGNPIEIVGDTFPAGTLSGAPKYKAMQLIDTYENQSRGFYGGAVGIIGLDGSVNLAIA
IRSFVSKNNVLYYQAGAGIVIHSDEEKELQEVNNKLAALKKALILAENI
>FCMOIPGL_00593 Aminodeoxychorismate/anthranilate synthase component 2
MKILILDNYDSFTYNLVHMVEKITGNFPAVFRNDEISIADVGNYDIIMLSPGPGIPDEAG
ILKEVIKTYAGIKPIFGVCLGLQAITEVFGGTIINLDEVFHGVATEMKVTDKNATIFKDV
SETFLAARYHSWAATDEGFPESIQVTARDKDGLIQAIEHKEFPISAVQFHPESILTDVGE
QLVTNFINSCPS
>FCMOIPGL_00594 Anthranilate phosphoribosyltransferase
MKQILNRLYNHERLSKSEATQILKDIAAEKYNDAHLASFMTVFMMRPITADELSGFRNAL
KELSIKVDLSDYNTIDIVGTGGDGKDTFNISTLTSFIVAGTGQKVAKHGNYSVSSQSGSS
DMLESFGYNFTNDENVLKEHLEKANICFLHAPKFHPAMKAVGPTRKALALKTFFNMLGPL
VNPSSPKNHMLGTFNMEIARLYNYILQEENINYGIIHALDGYDEISLTSGFKLFTKNGEQ
IINPEDLGQKRIQQSEIFGGTSVADAAKIFKSILDGKGTEAQNNVVLTNAAFALTIVDEN
KTFQTAFAEAKDSLFGLKAKQTLDKLVSL
>FCMOIPGL_00595 hypothetical protein
MTKKKKNIILIIPAFLIMGAAIGLQTKGVIKQTLIGLVVGVIIYFFLKYRNKKLNN
>FCMOIPGL_00596 hypothetical protein
MKKDNIIQIKSYNFAVRVVKLYKHLSQEKKEFVLSKQLLRSGTSIGANVEEAIGGQSRKD
FFAKLTIAYKEARESHYWIRLLKDTDYLSEKESESLITDIEEILKIIGSIQKTVRSTNS
>FCMOIPGL_00597 Indole-3-glycerol phosphate synthase
MTILDKIIAFKKKEIAKIKAEVPVQNLVKSPSFGRETFSLKKSLLEVGSTGIIAEYKRQS
PSKGIINDTATIADVTNGYLDANVAAQSILTDTSFFGGTMADLMEARIINQQKPILRKDF
IVDGFQIVEAKAIGADVILLIASCLTSTELKNYGNLATDLGLEVLYEVHTQEDLDKINDL
DNKIIGINNRNLKTFEVDLEHSIKLAGQIPDTCLKVSESGISDPKIITGLKEFGFQGFLI
GENFMKTENPGEACLDFINQIR
>FCMOIPGL_00598 N-(5'-phosphoribosyl)anthranilate isomerase
MKLKVCGMKYVENIQQVAELQPDYLGFIFYEKSKRNFEGIIPEFSNSIKKTGVFVNEYIE
IVISLVEEYRLDAIQLHGDETVEYVVDLKNQLTERRTLFIEENKQIKKKKNQHYISKNEV
EVIKVFGIKDEFNFDVLKPYVEVVDYFLFDTKGKERGGNGTKFDWSVLEKYPFDTPFFLS
GGIGLEDVEEVKKIMKSNLPIYALDVNSKFESKPGVKRIEELEKFKKNVITNVVK
>FCMOIPGL_00599 Tryptophan synthase beta chain
MKSKFQPDKNGYYGQFGGAFIPELLYPNVKELEDNYIQILESEEFQEEYKSLLKDYVGRP
SPLYLAKRLSEKYGAFIYLKREDLNHTGAHKVNNTIGQILVAKKLGKTKIIAETGAGQHG
VATATVCALMGLECTVFMGEKDIERQAPNVARMKMLGAKVVPALSGSKTLKDATNEAIRY
WIQNPETFYLIGSVVGPHPYPDMVARLQSVISEEIKWQLKEKTGKENPDTIIACVGGGSN
AAGAFYHYMDDKDVELIAVEAGGLGVDSGESAATSQLGEVGIIHGSKTILMQDEYGQIVE
PYSISAGLDYPGVGPLHAYLYDSKRATFMNATDKEALTAAYELTRIEGIIPALESAHALA
VLPKIKFKKDQVVVVNLSGRGDKDLSTYIKHLED
>FCMOIPGL_00600 Tryptophan synthase alpha chain
MNSIEKLFQKKDKNLLSIYFTCGYPNLNDTTKVITELEKSGVDFIEVGLPYSDPLADGPT
IQDSSQKALENGINLDLIFDQLMEVKGYNKTPLVLMGYLNQMLKYGEDKFCQKIVDCGID
TVILPDLPMIEFENHYKDLFEKYGITNVFLITPHTSEERIRKIDSYSKAFIYVVASASIT
GAKGDISNNQVAYFERIKSMNLQSNLIIGFGISDKQTFTTACNYANGTIIGSAFIKNLGN
NGIDKIDDFIKPIIS
>FCMOIPGL_00601 putative FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MKSYLYLFFSLILFTACLNDDDSNFNPETEEDIIQYINDNSLNATRTDSGLYYIINNEGT
GNYPAENSVIDVVYTGYFLDGTVFDQNDSGIINLNQVIEGLKEGFQLFREGGEGKLIIPY
ELAFGVSGNYSGSIPGGAVLIFDIKITAIYENYKAQNDAAILQYIDDNDLIATKTASGLY
YVIDDEGTGERPTSTSNVTVDYKGYFLNGTVFDESRSTGVSFGLDQVIAGWTEGITYFKE
GGEGKLLIPYYLGYGEELYNYTIPGYSVLIFDVKLISIDD
>FCMOIPGL_00602 Inner membrane protein YccS
MNFILYMVNNLIRYFKSIHFIKAFIVATAMAIPVLMSIYFFDSFDIGFSIALGAIFCAPS
DVPGSLKHKFYGILASIILTFVITLLIGYFSSSLLFIIPLLIILVFSVSYISVFGFRASL
VSLAGLISLVLAFAQQTAEVSVFEHALFIALGGFWYLFLTILTEFILPKAQADFLFVELL
EKTSEFIKIRGKLLVEVNDRSALLEENFKLQISINELQETIREVILDKRLSAGFSNRTRR
QQLIFSKIIEIYELAISNTIDYEKFDDLFKEHHEKIDEFKVLIFEISERLNHISRVILKE
EKLTFQTNFNVLLKKIQNHIEIYKVNVGLPESREGVIFLLNFKAYQEKQIRNLLDIVRVI
DNYAKNDKIRAIKDAEQFITPQDYDIKTLKENFSLKSPIFRHSLRLTLTMLIGYLIGFAI
EMQQPYWILLTIVVIMRPSYGLTKDRIKNRVLGTLVGAAVGIGIVFLTKNAIIYGIIATL
SLIIGFSLVKQNYRNAAAFITLYVISMYALIHPNILMVIEFRVFDTLTGSLLAFVGNYFF
WPVWEAKSIKEFFTNSIEGFLEFLKEINILYHEKGEVSTAYLLVRKEAFVKVANLNAAYQ
RLVQEPKSKQENIATIYELITICNTYLSSLSSLGMYIRTNETGKVPKEFEVFVKHILFNL
EKAIDKLNNKESTISLDSKELEIANKNYEDYFQDLSIQRDKEIEKGLPISKEMRMKLHET
QLVSEQIRWLFNLSESLVKTVKKI
>FCMOIPGL_00603 N-substituted formamide deformylase
MKNIFILFILSLLMVSCQKEKADLIVINSNTYLVNEKFEHAEAFAIKDGKFIAVGTSKEI
QEKYKSDSIIDVKNQTIVPGLIDAHCHFFRLGLQQQKVDLTGTNSYDEVLAKLVDFQKEK
NSTFITGRGWDQNDWDVKEFPTKEKLDQLFPTIPVAVGRVDGHALLVNQAAIDLSEITAD
TKVSGGEIILKDGKMTGILIDAAMDFIKFPEISKQEAIQGLLDAQKISFSYGLTTVDDAG
LDRNTIELIDELQKENKLKIRVYAMVSGDKQEQIDYYIKKGITKTDRLNVRSFKVYGDGA
LGSRGAAMRKPYSDRENHFGALIYAPERYQEIAKQIAASEFQMNTHAIGDSSNTWMLKTY
KEALKNQENRRWRIEHAQIISSKDFSSFDNILPSVQPTHATSDMYWAEDRIGKDRMKGAY
AYKNLLNKYGKIALGTDFPVEQVNPFLTFYSATYRKDSNNFPEDGFQMENSLSREETLKG
MTIWAAFSNFEEEEKGSIEVGKFADFVILSQDIMTVDSDQIIKTTAVSTFVNGEKVY
>FCMOIPGL_00604 hypothetical protein
MTLLLLILRIIFGAFFCYAGFMHFKKPKFFNGFIPDFLPKLTVNYVFGAIEFILGISLFF
NPTIKNGALGIFILMTLFLPIHIWDLLKEKPAIGSKKLAIIRIPLQFLLMYLSYLIYINS
>FCMOIPGL_00605 Bacterial leucyl aminopeptidase
MKKLILLFASVICLFSCTQKIEKTINSDALSSEEKIDSTNIKTLFNSALTEGKSYEWLRD
LTQNIGPRLSGSEGAAKSVIWGEKIMKEVGLDSVWLQPVMVPHWVRGEKEIATYTTNGVQ
KNVPICALGFSVATPASGVLAEVIEVKSLEEAKALGNKMEGKIVFFNRPFDDTLINTFRA
YGGCVDQRVQGAEVCGEFGAKGVIVRSMTNAIDDFPHTGVMMYGDLPVEKYIPTAAISSR
GANILSADLKENPSLQFYFKQSCETLPDAPSFNVVGEIRGSETPENIVVVGGHLDSWDLG
EGAHDDGTGIVQSLEVAYLFKKNNIKPKNTLRVVFFMNEENGTRGAKEYAELAKLNKEKH
IGGLESDAGGHTPRGFSIDANTVNTKLLQSWKKLLSPYGLHDLDKGGSGADIGPLKDENV
TLVGYRPDSQRYFDYHHTSSDTFDKVNKRELELGSASMASIIYLMDKYLYSNTPVKP
>FCMOIPGL_00606 hypothetical protein
MLVYYLTIGLQVFCMYHAYKNRSNYYWYLIIFLLPLIGCLIYLFTQVINKRDISTITEEI
TTIINPTKKIKDLKKELEFSNTFQNKVNLANAYHESKDYLNAILYYEKALEGNFKDDPYT
TNKLLHCYFKTANFDKVIAYANKIDINKEFKDSLYFYGLALEKTGRLDEAEIQLKKVDKR
YSNYPERLELSKFLIRRNKKEEAKEILSDITSEITAMNSKNRKKYNSILSEVQKLLNQQ
>FCMOIPGL_00607 hypothetical protein
MKKGFFIFLSLFGILTISAQKKSTEKENTVKIDTVKTEVVEVETKYNPKIADATKIKKNP
TLKLLDKSKKKKLNYNIFSAPVASTFIPKTGVVKGVDVGVKERIYDNYIAAGFGNYTSPY
LEASINSSTRFENEFGFYTKYAASLADIDNTVLDSNFSNFLASAFYKKEERYFDWKVSLN
SERNQYNWYGLPNSNFTQNTVDLINEKQTYNYFNIVGEVDFLDAYLDKSSISIGYFSDAF
NSNEILVNINTHLELPLDMIYNQLDNLDIKAGLELLNGKFEKNYTTENELKYSIFTVKLN
PEYKTTFSGFSLKIGAKIFGSFDTENSVNNFLVYPDLHIQKPIIEEYLNIYGGVSGDLKT
NTYKEFSEENPYLSPTLFITQTSEKYNAFIGLNGNFNNDISFNISASLKAEDDKPLFLRN
NSKSDGTNTSLNGVDLKGYEYGNSYNVVYDDIKTTSIFAEIEYDFTKRMTFATNIQFDDF
SMTNQAKAWNLPTFQTSFIAKYKTNKWYATSNIFYINERQDLIYSATYPSSTSGFQTLSS
YVDVNLNGGYHFNDKFSVFLKLNNVLNNNYQRFANFDVQGFQALGGVTYKFDF
>FCMOIPGL_00608 Lipopolysaccharide assembly protein B
MKLRFVKKHFLSVCCFLAVFTVYSQQTIVDANVITDFNNALELYNNKAYAAAQKVFEKIQ
VNAVKSSSLKADASYYDAMCAVKLNQTDADQKVLDFVDENPTSNKKNKAFFNVANYYFAN
KKASYALKWYTKVNVDLLSKENQKELNFKMGYSLLVTNNLELAKNKFLPLINDAKYGNDA
RYYYGFISYKLEDYGLAESTLKEIADNKSYKAEISYYLLDISFKSGKFERCIIVGTELLK
TSKRKEASEISKIVGESYFNLGRYQEAIPYLKAYKGQKGKWTNTDYYQLGYVFYVQNDYV
NAINYFNKIIDEKNAVSQNAYYHLAECYLNIDKKTEALNAFKTASEMTFNPKIQEDAALN
YAKLSYEAGNPFQNISDVLQDYLKKYPNSSSYNEINELVVSSFIHQQDYKGALDYLKKKN
SVENTALTTEVSLYRGIQLFNDNKYKESLSYFAKGKESKNEEIYQKALYWEAETLFRLKN
YEEAVTKFVSAKRFIKSNNEEFSLIDYNIGYSYFKLKEYNKAINAFKQFLADDIADKSIN
DDALVRLGDSYFATRNYADAINSYQIVVRNLGTDADYAEYQIGMSHGFRNESEAKIKALT
SVVNNFKSSSLKDDALFQLANTYIKIKNNEKAHQAYERLLQNHPKSSFLSKALVRQGLLY
YGDNQNKKALEKFKLTVQKFPNTSDAIQAVNNAKNIYLDEDNLDEYVAWVKKLNFINVSD
DDLDNSTFLIAERKYFEGKNNKDIIVTLNKYLEKYPKGAHNLKANYYLADILFKDNQLDK
AIANYKVVLKAGTSEYSEDTLAKLSQIYLEKEDFEDALPLLERLEQEAYIVENVQFAQSN
LMKGYYETEAYKKAISYAKKVLSIDKDKNSLIEDAKTIIARSSFKIDDFDTAQEYYNSVE
KNATGELKAETLYYNSFFKNQQENYEASNKVIQELIADYSAYKYWGVKSYVIMGKNYYSL
KDAYQATFILENVIKNFSQYKDIVDEAQIELTKIKENEAKTNNSIIPKN
>FCMOIPGL_00609 Cell division ATP-binding protein FtsE
MEKPVLHLENADIYQRDNLVLSKVNLTINKGDFYYLIGKTGSGKSSLMKTFYGDLRLQSG
SGKIVDFDLKNLKDKEIPFLRRKIGIVFQDFKLLSDRTVFGNLEFVLKATGWKNKDEIKQ
KINEVLEKVGMQSQYYKNTFELSGGEQQRIAIARALLNDPELILADEPTGNLDPKTSLEV
MHLLNEIHKSGKTILMATHDYQLIVKFKHKTLKIEGGELFEVSRQSDSE
>FCMOIPGL_00610 hypothetical protein
MISVLIPTYNYNAYNLVAEIHRQFIKSNIKFEIICLDDGSYSKENILNEKINTLSYSKFE
ILQDNIGRSAIRNLLAKKANFNWLLFLDADVIPVKSDFITTYFKQISKKNNVFCGGIAYE
NHTKNKKYLRYKYGKKHEEVALEERIKEPLKYFFTGNFFIAKKVFEKVKFEEKLLEYGKE
DLLFSVSLLEKKLSINHIKNEVFHLGIDDNKIFIAKTKKAMDNLVFLGKEGFLENEKQRL
LAFVDLLTRLKLNYLLIKLYPFFERKAEKLSSVRYLNLLKVSYICFLKRKENPQK
>FCMOIPGL_00611 hypothetical protein
MKKIIVTVTNDLSTDQRVDKVCTTLFNDGYKVLLVGRKLKNSVPISRDYETKRIKLFFNQ
GFLFYAEFNFRIFFVLLFSKKNILLSNDLDSLVANYAVSVLQNKKLVYDSHELFPEIPEL
VHRPFVKNFWSSLEKLLLPKLKNTYTVCKSISDFYNNRYATNFKVVRNLPTFKKIEKSKL
PFSTDGKKIIIYQGAINIGRGLELMIDAMEYLDDYLLIIVGNGDIISDLRERSENKSTEN
KVHFLGKLLPNELQKITPLADIGLSLEEDLGLNYRYALPNKIFDYIQAEIPILVSDLPEM
KQIVLDYKVGEIIKSRSPKGLANQIQTMLKVDYYKSIKKAKQELTWDHEKTILLNIFKNL
K
>FCMOIPGL_00613 hypothetical protein
MKFGIIKERKNPPDRRVVFSPEKLQEFKEKYPKATIKVESSDIRVFSDAAYKAGGLEVTE
NMSDCDVLFGVKEVPIDALIPNKKYFFFSHTIKKQPYNRQLLKAILDKNIELFDHETIVK
ENGLRLIGFGRYAGIVGVYNGFRAIGKSKETFNLPKAETLENQQELISELNKINIENIKI
LLTGNGKVAYGAKEMLDAMKIKEVSVNDYVTKTFNEPVYCLADVLDYNKRKDGKIIDNFD
FYDHPEQYESNFMQFAKVTDFFIAGHFYGNGAPYLFTREDAKSVDFKIKFVADISCDVDG
PVASTLRASTIADPFYGYNPQTELEVDFKDKNAIVVMAVDNLPCELPQDASEGFGEMFLQ
NVIPAFFNDDKDGVLERAKMTENGKLTARFSYLQDYLDGKE
>FCMOIPGL_00614 hypothetical protein
MTEDKQFLIDLAKMKMPFGKYKGKFLIDLPEHYIVWYKNKGFPHGKLGKQMELVYELQLN
GLEDIVREIRNKF
>FCMOIPGL_00615 hypothetical protein
MEKQDNFQLNFSLKGYSSIQIGVYFLLAAFSIKKILEGFLIDGNPMSLLSTEIIEYLVLG
IIFLTILFSTLTLFYKGRRKARKLEYKLWNSKTKKNFKLFSFSFTLIYLVLFYLTTHHFA
DYLTPTFLFLYGISLLFLKIKKSKNLFVLSGISLLLTMICVLIPNYWYSSIYILGVAHVI
YGIIIKG
>FCMOIPGL_00616 hypothetical protein
MKPAEEYILNQPEPFKTILLHLQILIENTFPEVDLKFKWKIPFYYLNDRPFCYLNPSKKK
GYVDVVFWVSAHLTKYNEFLISDNRKVVKSLRYYKLEDINEKVLLSVLEEAHQLKEKGFY
KRS
>FCMOIPGL_00617 hypothetical protein
MLCILELACNNKIQYFREMNKIFFILLICSFSIQSQNLKKVDLIISKYQSISSVEQLAEK
INYDFKTDKEKVRAIFSWITLNIKYDQISTQTNLIKAPEIIMYFNEDDLERRTQLAKDEI
VYKTIKSKRAVCNGIALTFQKLCNLLSIENELIKGFARTLTNEINYIPKSKNHVWNAVKI
NKNWIFIDATFGLATHNSKPDYFYFDIKKEELNLTHYPSKFKWVKYFNQKSLKSFCYQPL
FMSAYFNNEIKLMEPQIGEIKTRNRKILFKFKNIDSTTEVLYKFEDYNEIKKPQIIYKNS
IAHFMIDNPKRNTNLYIYFNGISALAYKIRE
>FCMOIPGL_00618 hypothetical protein
MMKQLILIFLFFSLSTFSQNFKKVDAVVINYPRFSKVEDLANQIEKDFSSDADKSRAAFF
WLAKNIRYNLREFYNPTKRNYSFSYKSEEEKTEKIKSHIDNIVSETFRNQTGVCEEYAQS
FKKICDLLKIEAEVIKGNARTSSDEIGKISNTSNHAWNAVKIDKKWIILDATWAAGYENN
GKWIRSFNDYFYDIPVNKIFKTHYPEDTIWNIRFGRMSVQEFYNQPIYSNTFLTLNTDLI
SPTSGIINLKASEDIVLKFKNLDKNLLVFYTLKGMKNPLKPIITSEKNTTTLTIKNPKIN
TDLVLFINKEDALHFRISMQ
>FCMOIPGL_00619 2-dehydro-3-deoxyphosphooctonate aldolase
MILSEIPNIKYTNENNFFLLSGPCAIEGEEMALRIAEKVVTITDKLKIPYIFKGSFKKAN
RSRIDSFTGIGDEKALKILRKVSETFGVPTVTDIHEISDAQKAAEYVDVLQIPAFLVRQT
DLVVAAAETGKVVNLKKGQFMSPGAMKHAVQKVKDAGSNKAWITDRGTMFGYQDMIVDFR
GIPEMRAFAPTILDVTHSLQQPNQVAGVTGGRPDMIETIARAGIVNNVDGLFIETHFDPA
NAKSDGANMLHLDNLEGLLSNLVAIRKTINNL
>FCMOIPGL_00620 Aminopeptidase YwaD
MNRIVITLIVSVFLISCNSAKNVNKSENKSAKTEKTESAFFIDSVTVKKHLYTLASDEME
GRKTGTQGIEKAAKYIENEFKRIGLTTFEDLETYRQTFNFTPRNSKEEISTANIIGVLEG
KSKKDEYVIISAHYDHLGNEGKGDDKIYNGANDDASGVTGVLALAEYFKQVGNERTIVFA
AFTGEEMGLIGSTEFGKGIDASVFVAGINLEMIGKVPSFGPNTAWLTGFERSDFGKIIQK
NLMGTGYQLFPDPYKNFNLFFRSDNASLARLGVPSHTFSTTPIDVDKDYHKVSDEAETLN
MTVITQTIQAVAKGTESIINGKDIPTRVVLEEK
>FCMOIPGL_00621 hypothetical protein
MKNLKYLFLFLLMSCSSSKVMTDYDNAINFSDFKTYSFYEDVGGGLNELDVKRVIFAINF
ELNQRGFKETESPDFYINVTSKTSESSNNNSIGIGVGGGGRNSGFGISGGIPIGAKKLNE
ELVIEFVNAKTNQIIWEGALNSKIKENRNPEEKELQYTEVVKKILNHYPPNNEN
>FCMOIPGL_00622 hypothetical protein
MAYNAFLADRIAQFFIEKRVSFYEKKMFGGTCFMVNEKMCVVVLRDEIMARIHPEVYEES
LKKEGCKEMNFTGRSMKGYVFLTDDAYDLDVDLQYWLQLALDFNPLAKASKKRKSSKN
>FCMOIPGL_00623 hypothetical protein
MKKTLLVFGLFLATTLSINAQDIADNSIGLRLGGNDGFGSEVTYQRKLEDNNRLEINLGL
RDSFNDVKLTGLYEWVWSLENQFNWYAGAGAGIYDANKTSIFASGVVGVEYNFDIENDIP
LLISLDYRPEIGITGSLDGLNSDFGLSVRYQF
>FCMOIPGL_00624 TonB-dependent receptor SusC
MIFLFSTTLNAQNNFEDLWLKVQKLEVDGLPKSALKIVEEIYTKADAENNSQQIIKTLFY
KSKFALTLEEDAQLKVINNFKKHIAKSTFPTKNVLENVLANLYWQYFNENRYKFYNRTKT
TNKVNTDDFRTWDLDTLFEEIHTYFNASLDNADQLQEIAISTFSDILQINIDSKIYRPTL
FDFLANNTLQFYKSSETSITSPAYKFLVDDVSFLGDVKTFSNLKITSKDSLSLQLNALKI
YQKIIAFHLKENNKNALAEIDIQRMNFVNQHATFEDSENILLKSLIASEEKFKTHEASAL
YAFEIASIYKNKASYSSSENNKNRFKNKEAIAICDAVIKKFSKSFGAEKCAILKAQIEQK
TLSIEGERFIPIDKNSRLLITYTNVEKLFFTAYKIDKKKLKLFNKLYKLEDKKTFFSKLE
KVTNWQHQLRNEHDYLQHTTEVIVPKFESGMYLILASESDDLTEKSIYGTTQIQVTNLTL
IENNFDNTYNYQIVDRNTGKPIKKAAIHLKNTSNNEDYFINKKLTTDKNGFASFKSKDQY
RNVDITVKTKNDFANFGSHYFYTYDRNNYENTNKEITIKPFIFTDRSIYRPGQTVYFKAI
VLKKQGEKSEVFTNEFVEITLNDVNNQVVKTLDLKLNEFGSVAGEFVIPNNGLTGEFTIE
VDESLEEDSSEYFEYDYNNSATISVEEYKRPKFATDFKPVTESFKINDSVTVIGFAKAFS
GANITDAKVVYRVHRKVQYPSWYYWRRPNSSSSSQEITHGESITDASGIFSVKFKAIPDE
SVDIEGLPIFTYEITADVTDINGETHSATTTVKIGYHSLIASISMDDEIDKNEKETILKI
DTKNLNDEFVAAKGTVKIYKLQSPKSPQRKRSWSAPDYQDISENTFRTLFPHEPFTDDES
DEKNWKKGALIFSENFDTSTSKELILKDIDNWISGKYIVVLESKDKFNQAVKDEKRITLF
SSKEKEVADNKLLTINFNKLYYKVGDEVEIQIGSAAKDMTIVLQIEKNYKLIDTKIIKLN
NCVKTIKFPIKKEDIGGFAVKYHFVKSNYFESENFNFDINEAPKNIEIITNIFRDKLQPG
QDETWSFTIKNDKNDAVAAEVLASMYDASLDEFKSHNWQFNPITPKPSYYSYSTSNANKS
FDNTYFNIRNIARNYYGFPSIGNDSYKWFGFSLNNNRWINQQYLRETKRNINSTRTVFDG
TITGFVSDENGNSLPGVNVQIKGTTFGTQTDFDGNYTIKIKTDDVLTFNYLGFKSQEISV
RKQTNIDIKLEEDASNLDEVVVMAYGIKRTSAQVTISNQVVRAEEMTMDGAENLAAALTG
KVSGLNVSQKNNDKELTITLRGMRSFPKDDKFLYIVDGKPMPHEQVLKLDPTTIADVSVL
KGANAAALYGVEATNGAIIITTKPSQEKLENQLSQVKARKNFNETAFFFPQLKTDKDGKV
SFNFTIPEALTRWKLQLLAHTSELKSATKTLTTVTQKELMVVPNAPRFLREKDTITLSAK
ITNLTNNQLSGIAKLLLTDAISGKEIDTELQNTNATKNFTVDKDGNTNVSWNLSIPETVQ
AVQYKIVAKAGDFSDGEQNVLPVLSNRILVTETMSMWVRSNETKTFTLDKLKNSTSSTLK
NHKLTLEMTSNPVWYAIQSLPYLMEYPYECAEQTFSRFYANTLASFVANSNPKIQEVFNS
WKTSDALLSNLEKNEELKSLIIQETPWLRDAQSETEQKKRIALLFDLTKMKNEQEKAINK
LQDIQMNSGGFPWFKGGRYESTYITQHIATGFGHLQKLGVSDFNTSTKKMIEKSVHFLDK
EFLDQYLKLLERASEIKEISKTKKEGEIAYKDYLEKNNLNYFTIQYLYMRSFYKDISLDE
KTKNAVAYFQNQSATYWNEYNLYAKGQIALSLFRNDEKVVANKILKSLKENAIYSDELGM
YWKTNTAGYYFYQAPIETQALMIETFSEIENDTETIDNLKIWLLKNKQTNRWKTTKATTE
AVYALLLNGSDWISVTEMVDIKVGDKTINPAEMENVKVEAGTGYFKTSWNTDEIKSEMAT
VTINKKGNGIAWGGLYWQYFEDLDKITSAETPLKINKKLFLKVNSDTGKELKEITENSSI
KIGDLITVRIELRSDRDMEFIHMKDMRASGVEPINVLSQYKYQDNLGYYESTKDAATNFF
FDRIPKGVYVFEYDVRVNNAGNFSNGITTIQSMYAPEFSSHSKGIRLKISE
>FCMOIPGL_00625 UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase
MNIHFIAIGGSAMHNLAIALHQKGYQVSGSDDTIHNPSKSRLEKYGLLPKEFGWFPEKIS
SDLDVIILGMHAKKDNPELLKAQELGLKIYSYPEFLYEQSKDKTRVVIGGSHGKTTITSM
ILHVLNYHEKEVDYMVGAQLEGFETMVHLTEENDFIVLEGDEYLSSPIDMRPKFHLYKPN
IALLSGVAWDHINVFPTFENYVEQFKIFTDSMVNGGSMVYNMEDENVKDLVESSENHIKK
YPYKTPEYFIENGITYLETAEGNLPLEIFGKHNLQNLAGAKWICQHMGIDEDDFYEAIES
FGGASKRLEKIVENNSTVIFKDFAHSPSKVEATTKAVKEQYAERTVLACLELHTYSSLNA
EFLAEYKGALNAADKAVVFYSPHAVKIKQLEEVTAQQIANAFERDDLIIYTNPAEFKEFL
FSQNLEKTAVVLMSSGNYGGLDFEEVKKLV
>FCMOIPGL_00626 hypothetical protein
MTYKETLFFIGKCLTINHEQHNKILVETELKSGNIDWNSVVKVSTGHFVFPALYCNLKRA
EFLDYVPQDLVDYMIHITDLNRERNQQIIDQAKELNELLLSHNITPIFLKGTGNLLEGLY
EDIAERMVGDIDFIISKKNYPPAIKILANFGYKKVHKTDYDFPQFKHYPRLNKKNNIAAV
EIHKELLTEKYANEFNFNLIEKDTQNINNTTLISFKNQLALTIIAKQINDHGFLYIDIAL
RNAYDVFLLSKKTDALVAFNNLTKLKKPLNCFLASCFVIFNKPNSLKFLEDKNTKSYIKL
LNTFLNDDILRKEHQKKISKKIIINHRLFMTYKSIVNKEHRIWFMNTMTDKKWLRKKMVE
FGLKKPKPTS
>FCMOIPGL_00627 hypothetical protein
MKKTTTLYKVIDDKTITWFENNNEYVVLENTTADILKRLHKGIAVKEIATVLSKKLDVPL
DKTIDLILELDKKFFTKEKSKTSEIGNDFRELKKPKDFEFIKYYKINDIIFKISFLSEKE
LSLVHPKFAHLVIDEATEFENEFEVFINHNYIFLYVNNTFIGSWSSKNVHYFQGKFSMEL
IQQIHQKEENEWLGVFHASAISNSKKSMLFLGDSGNGKSTSLALLQANGFTCLADDFVPV
DAKKQEVYSFPAAISIKKNSLETLLPIYPELGTSAEYNFTRLNKIVRYLKPNNDDFFAHL
PCNDLVFIKYEKDAELSCKEISKIDAFQQLIPDSWLSPKKENAQIFLDWFEGLKCYQLTY
SDNKKMIASVTKLFDNDL
>FCMOIPGL_00628 hypothetical protein
MKNNIENKQEEITRKDAIKKIGNYGKYAALTALGTYLILSPQKAQAASIEAPGTGF
>FCMOIPGL_00629 hypothetical protein
MKQKNLLKIAMLFVFAIISNFSYCQGTETFTGITGNVSSYLSRSWTGDDGSTWTATNARV
SEDINGDAITLNDDKSDTYVQSGTISGGIGDITISTQRKFSGGSSVLSVFINDVKVGTVP
VETAITTTTISNINVSGDIVIKLWNDTGGSSSGGADRVGIDDVVWTAFTGIITPTVTFDT
ETSSVNEADIDVVTTGIPVTLTNYAAGVTITPTVNGASTADPADYTIDLTPIVFGADETK
NIPLTIHHDDDFINGTIIIDFTVTDGTADLGTSQHTVTITDDEVAPSIGFDTATSSETET
DTTFNVLIPVTVSDYSGTQIDVSIAASGTADVADYTLNTASLTFTADGSQNVSLDINDDA
DSDIETVILTITETSTVTGLVISQDTHTVTIIDNDIAPGISLPYTIDFTSVDPFSNDWTA
QNIAGTSTWAYTNGTGVSMNAYTDSCTAEDWLISPAFNLDTAANEILSYDFSQQYGSTAI
EIYYSNDYIGTGDPNTATWTLIESVAAQSSTGTIVEISSENLTTLQGVAGTNVYIAFKYD
TNADCSNWIVENFTLETASLTPNVTFDAETTSVNETDVDVVTTGIPVTFTNYNTDVTITP
TVNGSSTADPSDYTIILTPLTFSANETLSIPLTIHDDADFIDETIIIDFTVTTGTADLGT
SQHTVTITDDEVAPSIGFDAATSTESETDATFNVLIPVTVSDYSGTQIDVSIAASGTADV
ADYTLNTASLTFTADGSKNVSLDINDDADTDNETVILTITETSTVTGLVISQATHTVTIA
DNETPNYFVEDFTNSNATGGYNDNSFLGNNNITWTYVESRDENGDANGAGIVGNALMLRN
SGSKVTSSTITGGIGDFSVKLYKGFTSSGDRQVELFINSVSKGTSIAFDDADDKDAYTFA
VDDINVTGDIIIELRNITGKQIIVDDITWSPYSPTTITWDGSDSSDWATAANWDTNTVPT
SADNVIIPDVATAPIIGTSTGAEANDLTITETDGVTISSGGSLIVSGTSSGNVTYNRTLA
YDADKTKAWYLVSSPVNGEIMTDMISNNTFATSGANIGFAPYDNSQADSNDRWSYFGSGA
TDALVNGKGYTAKLGAAGDLSFTGTLNTGDVAIGLTQGSNNFNLIGNPYASYINSGTFLT
TNTDELVQEEIYIWNQGTGQYDTQISGDSFKIAPGQGFFVEAKTTNDVTFTTALQSNEAS
DTFQKSATRPEVQLFMNNGDASRYLKVYYIDGTTTGFDNGYDGKLFGGVPQPFALYSHLV
SDSKGENFQIQSLPNSDLETMVIPVGIIADAGKEITFTAQALNLPSELKVFLEDREANSY
TRLDEANANYKVTLDEALNGVGRFFLHTSAKSTLNIEAVSLDNISIYNTNNSNLRIVGLS
QGKANIKLFNILGKQVLNTTFTSNGVQDISLPNLATGIYIVQLETEAGKLNKKITLE
>FCMOIPGL_00630 Trk system potassium uptake protein TrkH
MGSLNLKIIYRFLGITAILNGLFMFVAYPFSYFNDEKAGDGILISGIITVLIGVLLYFLN
KPQSTSIHKKEGYLIVTSGWLILSFTGMLPYLFSGAIPSITDAFFETISGYSTTGSSILT
DIESMPKGILFWRSVTHWIGGMGIIVLTIAILPLLGIGGMQLFMAEAPGPSADKLHPRIT
DTAKRLYLIYVSLTFAEFFLLKLAGMTWFDAINHAMATLSTGGFSTKNSSVAFYNNLPFA
QYIIIFFMLIAGSNFVLIYFALKGKIKKVFQSEEFRYYLFGVLGVSAVVAILIIFFQDPN
LQTTIAHPKVYGEAESAIRHSLFMVTSVVTTTGFVSADFTTWCFFATAIFFALFFTGGSA
GSTSGGVKVVRHIIMLKNSFLEFKKALHPNAIIPVRYDGKSVSQTIVFNILSFFIIYMLI
FILASVILTLLGLDFLSALGATASSLGNIGPGLGSVSPVDSFAHLSSSAKWFCSFLMLIG
RLELFTVLILFTPFFWRKN
>FCMOIPGL_00631 Trk system potassium uptake protein TrkA
MKIIIAGAGDVGFHLAKLLSYESQDTYIIDFDGDRLNYINNHLDVITQKGDATSIKLLKE
IGIDSADLLIAVTESQNTNFTISVIGKSLGAKKTIARIDNPEFLNECEVDFTKFGVDFMI
SPQELAANEIKMLLNQSSFNDTVAFESGLFNVLGTALTYNSPLIDLTVKEAKEKFSNVDF
ITIAIKRENVSQTIIPRGDTTYKLDDQVYFSVPNYSMKDLYPLLGKKQFNIKNVMILGGS
SIGEKTARNLCEDNFRVKLIEKNKEKAEVLAETLTHTLVINGDGRDLELLEEENIRETDA
FIAVTANSETNIMSCLVAKSKGVKKTIALVENMDYIDISQTIGIQSLINKKLIAASNIFK
HIRKGEILELANLHNIDAEVFEFEVKINSKVTKEPIKDLRFPREAVFGGVIREGKALMSF
GNMQIQTGDKVIVFCLPEAISTVERFFN
>FCMOIPGL_00632 Beta-barrel assembly-enhancing protease
MKLKYVNSPVFLKVCNFLVLFLLFASFFSCDKKPEYKEIETSKSVFLSGELIPDSHFLGD
KKCKECHQNEFKKWEGSHHDKAMQIADSVTVLADFNNHTFTSQGVTSNFFKKGEDFYVNT
DGPDGKNHDYKIVYTFGITPLQQYIVQFPDGHYQCLRTAWDSVKNKWFDLYPDFKVVHSE
WLHWSRGGLNWNNMCSDCHSTNVRKNYEQETHSYNTKFALINVSCEACHGPGKEHVTAEE
NLGEKYVANGSFQMTSDTAPKELVDECARCHMRREQFSEAFNFEGTMLDHYYPQLLEERL
YQADGQILDEDYVYGSFVQSKMYQNNVTCTNCHDAHSLKLKFDGNKLCAQCHVAENYDTP
KHHFHPQNTESSKCINCHMPGRYYMGNDFRRDHSFRVPRPDLSVKYGTPNACTGCHKDKD
DVWAAKNFTKLFGEVDSVHFSDKLAPGITMQPGAHEGLIDLMHDKQQPEIVRASATKALS
NYNIPSSIQEYLNLLKDESALVRGASVDVLSTINTKDYTSYFLPLLNDPKRTIRIKAFFG
LAVMDESEIPEFYKESYQKVKKEFFTNLKTNADFVGSRIKKGDYYNKKGNIVEAIKNYEN
ALAIDNINNQIRINLATLYYNNKQYEKAEKAFKTVIEQEPEYGPVYYSLALMYGELNRVD
DAIAQLKTAIKVMPDNIRFYYNLGLLYDKNQDLKNAEKTIVAGLKIDPNNESLLYALAYI
YSKSSQKEKAKNIVLRLIQLYPNNQQYRSFLNSL
>FCMOIPGL_00633 hypothetical protein
MEKLTIKSWALDDRPREKLIAKGKNALSDAELIAILIGSGNRKESAVALSKRILQAADSN
INALAKLSVEKLMTFNGIGEAKAITIITALELGKRRQLEIALEKLKITCSKDGFNIMQPI
IGDLEHEEFWVLFLNNSNKVLAKNQISKGGLTATIVDVRLLFKQALELTSVAMIVCHNHP
SGKLQPSTADKQLTQKIKQAGTTLDIKLLDHLIITEKAYFSFADEGLL
>FCMOIPGL_00634 hypothetical protein
MILVYTHKLTPRVRYIFKHIITRTLLIPVSFTTRIEEFVAHSGPKLTYTKAPLGNEFFIK
SNDLLFEQGVNDLEISVQKWDDVPCFFTTNKKALIPFDIFAASFYLITRYEEYLPHVKDI
HGRFTAEQSLAFKHQFLEKPIVDIWAYKFLNILKERFPDYTYTQRAYNYISTIDIDNAFA
YKHKSLIRTVGGFFNDLFKFKLLEVWNRFTVVWGLKKDPFDTFDKILRLRKEYNVKTIFF
FLIGDYSTFDTNVSASKMKYKLLIKEMVDYARVGLHPSYFTMQNAVLLKKEKERLEAITN
MPVSRSRQHYLRFSLPETYQNLIDLEIEEDYSMGYASNVGFRASTCTPFYFYDLDFEIQT
PLKVFPFALMDTTLNDYMKLTPKQSLGRIRDLKNEVKAVNGTFITLFHNENLSDYLRWKG
WKRLYESMLKIATS
>FCMOIPGL_00635 hypothetical protein
MINYIKRKDLDIAKFDTCIENSVQSRISAFSWYLDIVADNWDVLVLDDYKAVMPVTWRKK
VGIKYVYPPLWLLELGVFSLDESLDIQPFLAILYSKFKFVELRLNTTNQFLNSDCLLPKQ
FQYLDLKIGYEAILKGYNRNRKREIVKANKHHLIENWTDNPEKLIAIFKENIAERVKGIS
DKDYTNLLNLMNLSIEKGVGELLTIYDENNKLLAAAFFLKHKNKVTQLVCASDISNRKNG
VHTFFNDRAIFKYQSHFDIYNFGGSSMENIANYYLSFGSKTEKYQQIKYNNLPFFIKLLK
P
>FCMOIPGL_00636 Maltose O-acetyltransferase
MFKKIDFLFFGWIINWLYPKYYRPKYSYQRYYILFFHYLIPQKLFRLNPKVKWPVHFTSK
VLAPENIQKGILCDPGDNYNNYIQANNGIIFGSNIELGPGVSIISSNHKSDNLREHTKGK
PITIGNNVWIGANSTVLPEVSIGDNVIIGANSLVNKDIPSNSIAVGNPCKVIKQKESYTE
DLSAIIFNKKLPKKFDEFLNSKASTTL
>FCMOIPGL_00637 hypothetical protein
MNITLKHNKGFKWYKNDSLFFKGYFYINAIFYEKENAVNYLSSVRTTSDFKELLKNINGV
FTLLFSDKNKVFIASDITRSFPIFYTFQNNKLFLSDDIFYLKDTFNLDTFDALSEIEFKA
CNHTHGKKTLLTNVFQVQASEYLIIKNDEIIESNFFYSYAIKKESSDPYTTLKKKAIDAF
ENTIKRFINSLNNRTVVIPLSGGFDSRFIAVMLKKYNYKNVFCYTYGRKDSFEIENSKNT
AEALNFKWIFIEYNSQIIDGFLETSAFKEYAHFAGKLSSMPNLQEYFAVNYLKENNLIAE
DSIFIPGYAGDLLGGSQFLKVIPENLNHTDIADLIIEQKFTNYPLSASNKKIFKRQVKKQ
LTHIDDNYVEKIPSSVFEDFDLKEKIAKYIFNSANFYTYFGFEHRFPFWDKELLDFFKKV
PVKNKLMKTFFDAILINEYFKKYNVYFESELQPSEKNINIQKVKNKIKPFLPTFIKQQFL
EKNDWVNYKPLTDKMLKSLNLNKLKVEKSSKEYNEIITQWYLYFSKNKIK
>FCMOIPGL_00638 hypothetical protein
MQLFSFLKKEFVKNVLTLITGSALSQVVIYASILILTRLFSTELFGIYTLFSSATLILKP
LATLQYEFAIVLPKRDKDAINLAAFSFIILAIYCLLLLIIIFFFNESIANFFNITKLANF
IYLLPLSVFLFASVSIFDYWNNRTSMFKNISKGLLAKSATMSSAQLATGFSSFNSLGLIP
GMLLGQCMQLLFLIKASAKTMQKLIKNLSLKRMFFLAKRYKDIPVFNTIINLTNNLSNEL
PVLLITKYFGLASSGIYGLAIKFMRAPVGIFQQSINQVFFNKASKIYNEKGDLHDLVIKT
AKHLLFISSFLFIPLFVISFFLDIIFGENWADVGLYSRIIIPWLFFAFLSNPITPLILIL
NKQKTMVIYDSFLLIFRFLALFLGYYFYDNIVISLILFSGVGMLFNILIFIYLLKTSKEK
KIAYS
>FCMOIPGL_00639 Putative HAD-hydrolase YfnB
MKQIQHVFFDLDHTLWDFEKNSDLTFRKVFDKQNITLDLNSFLEVYKPLNLEYWKLYREE
KVTKEELRYGRLKKTFDAVSYSISDALIDVIAIEYIEFLPDFNHLFEHTFEILDYLKGKY
QLHIITNGFEEVQTKKMQSSNILQYFNAVITSESVGVKKPNPKVFEYALESTKALKENSI
MIGDNIEADIEGAINVGMHAIHFNSEGLEINSNNFRSIKCLLEIKQYL
>FCMOIPGL_00640 hypothetical protein
MKPPIKISVLFCIFLLTSCYESLDFNQLDDQVSKPVFTSAITYFTFVPAQFFDSNGNQKL
FISDITNFYGFQNSYIKENLVKIDFNAEIKNEFDREVTLQVEFLNRNNAVVYSFTPIIVK
KENLNYIYYKEIEIVSNPTILETEKVRITARLENTGSSLNANDTREFEFKSSVTIYIESS
I
>FCMOIPGL_00641 hypothetical protein
MLMLSVVRITAQNKQVLYDFAELPQTLLLNPAAETNYKFHFGVPLLSGISLDYGSSGAVL
TDVFAKDNIDVNDKISTMLNRLTDRDFVKFNSQIEVFNGGFRVDDNTYISFGFYEEIDAI
SYVPKDVITLINEGNSSYLNKNFSASQLLYKLDVLGVIHAGVSKKINEQLTVGGRFKIYS
SALNIESTNNTGTFTTVLGNNNIYKQYLSNININAKTSGLVVDDEYIEDPNAYLKNTFLG
GNLGIGFDFGITYHINSQLEFSASILDLGFVNHTKNVKNTTAKGDFVFEGIEFEYDPNSS
TNYWGQLDKNFTEQIPTDENEESYISWRPAKFNAALKYSFGERRSKYCYDNTYKDFYTDA
LGVQLYSVFRPLSPQVALTGFYQKSITNKIHTKFTYTIDDFSYANIGAGFSAQFSRVNFY
GMVDNILEFDNLSSANSLSLQLGINVIFN
>FCMOIPGL_00642 hypothetical protein
MIKKITFLLVLFITSSLFSQQINLDKYQYIIVPVQFDFVKKTDQYQTSSLTKFLLKKKGF
KVFLSNETLPNELNNNRCLALFASVKDDSSMFTIKNTIEIKDCYGILLYSSEVGKSKNKD
YKKGYQEAIRKAYETMTDFEYSYNPASNNVKNVERKEAVIVDKVKTISPIIDTPSDVKIE
TLKEKTTVSSTTLDVLYAQATSNGFQLVNTTPKVVFVLLKTNVKDIFIINEKNGILYKLG
DNWVAEFYENNQLITKEYQIKF
>FCMOIPGL_00643 Replication-associated recombination protein A
MNEPLAERIRPKTLDDYISQQHLVGKNGVLTKLIKQGIIPSLILWGPPGIGKTTLANIIA
TESKRPFYTLSAISSGVKDVREVIEKAKKSGGLFTTKNPILFIDEIHRFSKSQQDSLLGA
VEKGWVTLIGATTENPSFEVIPALLSRCQVYILNSFDKDDLVALLHRAIEKDTFLSTKKI
TLKETDALLQVSSGDARKLLNIFELLVSADDEIEITNKLVLEKVQKNAARYDKTGEQHYD
IISAFIKSIRGSDPNGAVYWLARMIEGGEDVKFIARRLLISASEDIGNANPTALILANNT
FQAVSVIGNPESRIILSQCAVYLANSPKSNASYLAINNALGLVQKTGDLSIPLHLRNAPT
KLMKDLDYGKNYKYSHDYPNNFVEQEFLPDEISGTKLYEPGNNARENQFKETLKNRWKNR
YDY
>FCMOIPGL_00644 hypothetical protein
MKDAQKLNSSRLFLVVPIVYVVSIWVIYWIEIQFNLNFNKFGVYPRTLEGFRGIFLTHFI
HSDTGHLFNNSIPLFVLLCSLFYFYKEVAYKVLLIGGFLTGFLTWMIARDSYHIGASGIV
YLLFSFVFFSGIIRKHYRLVALSLIIIFLYGSMIWYVLPIKDGMSWEGHLSGFLIGFVFA
IIYRKKGIVKEEHQFIETEFDLLFDEDGNFSPPNIEELEKIEEKRIEIAEE
>FCMOIPGL_00645 Putative TrmH family tRNA/rRNA methyltransferase
MKENTTIFGIRAIIEAIESDATINKIYLQKGLRGNLFYILDKIIKEKKITTSLVPVEKLD
RLSKNNNHQGAVAQISPIDFYDLERLIEDTIESDKIPLFLVLDQLSDVRNFGAIIRTAEC
TGVNGIIIQKNGSAPVNAETVKTSAGAAFKVPICKVDHIKDALYLLQASDIKTVAATEKT
EDLIYDIDFNQPIAIVMGSEDKGVNPSVLKMVNYKAKLPLLGEIASLNVSVACGAFLYES
VRQRINKL
>FCMOIPGL_00646 hypothetical protein
MNKILKTGISLLLFTPLFLSCETVEDVVLPRNDKSTVDISTTAVTVTEGESSTITITTGT
PTSKPMQFKLLQTGGNAVEGVDYEFAAYSAGDYGPIGGEVVIAAHESTGSVEIIALTDFE
ADNKTATFELESMAAMIGVVGTTKEVTVTVANATDDQLTMQLEWDNGVEDDHLCDADFDA
YLDTFEAYMFTGNCPEFVDHFVDGSSLVSGVLSDGTHNIVVDYWDDNGVAAGIDFPMKLS
VGKKGKFLAVIDLEGLYTTDSPISNGGAGGENVVGKIVVSGGLYSIYDASNTLVYQE
>FCMOIPGL_00647 hypothetical protein
MKKIKLILFSAIISSFFFTSCTELGSNDLSGSDLTNGGSAPTIVGWAQATVSESYFSDIG
TLNNNYPIDVLGTSDGSPTQSDISLTISVDPETTAIEGGEYSLPSTTVTIPAGSSFAGVP
IDLNTGGFNLTQPTLLVLNVSTSVNGVVVSEASKQMRITFVGCKSTLDASTYDVTITRRN
TGSVTTRTGITLTALDVNYFESPYVGHWPLSPGVRFTDICGDLFITSHDLADTYSNQVTG
AAGANGLAGTVDSNGNFTLTYSVSPAETWGIYDAVYTKN
>FCMOIPGL_00648 hypothetical protein
MKLINKYILTLFVLTSIFSCSDYLDVNTSPNDPTADVVGPELILPAAQNGSYSAKAGTQN
RFGLTLMNQWAGDVTNFTGGNVDEYRFNVTATFYGGIWNNAYLASDKLQAVINIDSPENV
YFTAIAKVLKAQTMQYVVDIYGDAPYSEAFQRGENYQPAYDAASDIYKSLFIELTEAITL
IDGAGLEAVNPGSSDVMLGGDMDMWKKFANTLRLKLLVRASSSSDGDVQSWVSSSWGAVK
SLPFLGVGENITTNPGYTNGNGQQNYFWEIYGFSTDGNQTNTNRFIVGSQYFIEYLKASS
AVSPVGAFDGRIAAFFNTASGSGGDYQGVIQGADDPVDENIGLSYIGAGLLADPSQDGLY
FSAAESLFLQAEAALNGNISGSAQTFFENGISSSFAYYGLDATTYLTGISGISGIGWSAS
DNLEAIIRQKWTALHGIDGAEIFIEHNRTGFPDAPLPTLATQAHRPYRLLYPTSELNGNT
ANVPAVAASAIFAPAIFYQK
>FCMOIPGL_00649 TonB-dependent receptor SusC
MKTKFNGILTLLLAFVVQISFAQQKTISGTVSDKSGSLPGVSILVKGTNVGTESDFDGKY
SIKAKAGDVLVFRYLGYKMVQKTVGSSNSINVAMEEDSSVLDEIVVTAFGIKRKPDELTT
SNQVVKAEELTKAGAQNLAAALTGKVSGLDVRQVSSGVNQDFTITLRGMRSFSANNEALV
VIDGVPSTAALFFALDPDIIENVNVLKGANGAALYGPRGSNGVVIVNTKKGGNGSEKGYT
INIKTSSEFESYAYLPERQTRYGQGWASAGLFQHFVYENGAWGPEFDGSSIPVGLPLEDG
TFRYSPYETLGSDNIGEFFQTGNTQNYSASISGGNLEDGYANFSVSHLNREFIIEDDTQK
RTTISLRAGKQLGKFSLEGNIQYVTFRTQNAGTSLYGDLLHTATNIDLSQFSDGNNATHW
NGYFDSPYWNRKNIRTFSLSDRINASVNLGYKVNDNINIRSTTSLYSSTGSGYNYNNGYV
DPTSVSDLSGFTRTITSSYGSNTSSYIRLYSDLIANFDYQLTEDFNLNANLGATVNQTTT
TNNGQSGTNLTIPGLYNIQNVINTNPATDSKTISRQQAIFADVTLGYKDYLFLNATARND
WLSTLNGQNFFYPSAGVSFIPTKAFESLTDNDVIDRIKLSYSFVQVGNANAVSAYDTNNL
YSQASGTFYGTYPFGTANAFLPSASITDPNLKPEFTNSHEFGLTAEFLKRKIRFDVSGYI
GSTTDQISEISTSYASGLTSNTINIGAADTKGIEIDLGLTPIDTENWTLLLNASYAASRM
EVTKVSDQSDEVQVAGGTVGIFAEVGEQFPIIKGSDYVYDPEGHVVVDTNGDPLVSEELQ
ILGKTTPDYILNFNGSLRYKDFTLSVTADYRTGHSFYSGTKSQLAWSGYLVESAENGRNG
FIFPNSVIETSPGVYTTNTSVVTGGPDDSAFLNYYSGRYSDIARNFVLDATALKVREISL
SYTMPKAYLDGTGVSGLSVTAVARNPFTILSAENRGYADPEASNQGGNGVGLSTVGNYPN
TRTFGLNLNLTF
>FCMOIPGL_00650 hypothetical protein
MNKKITHYIYVLFFIFFSSDFIAQKINLKITSKSNIDNLILEEVDFKKTHNNTTSINSEV
NKVSNYLKNIGYFTNTIDSIITIKNKQIAYFSLNEKTKNARIRINNNINLLQTKYKIENK
IISIPIKKIKALLLEISNSLEKQGRSFSKVQLKNIYIKDKILFGETEILSSEKRNINKLI
VKGYKEFPNSYLKNHFNLKLNSVFNQKKIKDISNSTKSIQFIKEIKPPEILFTKDSTILY
LYLKKIQNNSFDGIISFTSKENGKVVFNGNINLKLHNILNTGEKFELFWNSIGGERQEFK
ILTEIPYIFNSTITPEISFSIYKQDSTFLNTNFNSKIKYSITRKLKIGLSYNTETSSELE
QPNYINNINNFTNNFIGFQLSYTKPKFDLFYNNKFSLEINPSIGKRKSKNNTSNQYKLRA
TTSYIFDINYRNSIYIKNDTGLLNSDTYLNNELFRIGGANSIRGYNEQSIFTKSYTFFNL
EYRFLTTEKSYLYSITDIGKIKENNNKLLSFGLGYKFINNSSFFNIGAAISKDQTDQILL
KNTKIIIDWSIYF
>FCMOIPGL_00651 30S ribosomal protein S12
MPTIQQLVRKGRTKITKKSKSAALSSCPQRRGVCTRVYTTTPKKPNSAMRKVARVRLTNG
NEINAYIPGEGHNLQEHSIVLVRGGRVKDLPGVKYHVVRGALDTAGVEGRTQRRSKYGAK
RPKK
>FCMOIPGL_00652 30S ribosomal protein S7
MRKRAAKKRVLLPDPKFNDQLVTRFVNNLMWSGKKSVAFKVFYDALDIVEERKGEGEEKS
ALEIWKDGLSNVMPHVEVRSRRVGGATFQIPMQIRPDRKVSMAIKWMILYTRKRNEKTMA
QRLAAEILAAAKEEGAAVKKRTDTHKMAEANKAFSHFRF
>FCMOIPGL_00653 Elongation factor G
MARDLKFTRNIGIAAHIDAGKTTTTERVLYYTGVSHKIGEVHDGAATMDWMEQEQERGIT
ITSAATTCEWQFPLENAKPTPETKGYHFNIIDTPGHVDFTVEVNRSLRVLDGLVFLFSAV
DGVEPQSETNWRLADNYKVPRIGFVNKMDRQGSDFLNVCQQVKDMLKSNAVPIVLNIGDE
DDFRGIIDLVKNRAIVWHDETQGATFDVIEIPEDMKAEARKYRALLIEEVASYDENLLEK
FMEDEDSITEEEVHKALRAAVMDMAIIPMICGSAFKNKGVQFLLDAVCRYLPSPMDKEGI
VGVNPDTEEKELRKPSVDEPFAALAFKIATDPFVGRLAFFRAYSGRLDAGSYVLNNRSGK
KERISRIYQMHANKQNAIDYIEAGDIGAAVGFKSIKTGDTLSAEKFPIVLESMDFPDPVI
GIAVEPKTKADVDKLGIGLSKLAEEDPTFTVRSDEASGQTIISGMGELHLDVIVDRLRRE
FKVEVNQGQPQVEYKEAITASADHREVYKKQSGGRGKFADIVFTLEPADEGVQGLVFESV
IKGGNVPKEFVPSIEKGFKEAMKNGPLAGYEMDSMKVTLKDGSFHAVDSDQLSFELAAKL
GFKAAAKAAKAKIMEPLMKLEVLTPEENMGDIVGDLNRRRGQVNDMSDRNGAKVVKALVP
LSEMFGYVTALRTMSSGRATSTMEFSHYAETPSNVSEEVIAKSKG
>FCMOIPGL_00654 30S ribosomal protein S10
MSQKIRIKLKSYDYNLVDKSAEKIVKTVKSTGAVVNGPIPLPTHKKIFTVLRSPHVNKKS
REQFQLASYKRLLDIYSSSSKTIDALMKLELPSGVEVEIKV
>FCMOIPGL_00655 50S ribosomal protein L3
MSGLIGRKIGMTSLFDENGKNIPCTVIEAGPCVVTQVRTEEVDGYSALQLGFDDKKSKSS
NKALDGHFKKAGTTAKKKVVEFQGFEGEFKLGDSVTVEHFTEGEFVDVSGVSKGKGFQGV
VKRHGFGGVGQATHGQHNRLRAPGSIGAASYPARVFKGMRMAGRMGGDKVKVQNLRVLKV
VAEKNLLVVKGAVPGHKNAFVTIQR
>FCMOIPGL_00656 50S ribosomal protein L4
MEVAVLDITGKDTGRKVELSSDVFGIAPNDHAIYLDVKQYLANQRQGTHKSKERAEITGS
TRKIKKQKGTGTARAGSIKSGVFRGGGRMFGPRPRSYSFKLNKNLKRLARKSALSIQTND
NNLMIIEDFNFEDPKTKNFVSVLKSLELDTKKSLFVLGNENTNVYLSSRNIKNSKVINVS
EINTYGVLNANKVVITEGSLEEINTNLSK
>FCMOIPGL_00657 50S ribosomal protein L23
MSILIKPIITEKATNDSELFNRYSFVVDKKANKLEIKNAVESAYGVSISSVKTLNYPIQR
NTKFTKKGLVTGIKSGYKKAIVQLAEGESIDFYNNL
>FCMOIPGL_00658 50S ribosomal protein L2
MSVRKLKPITPGQRFRVVNGFDTITTDKPEKSLLAPKKRSGGRNSQGRMTTRNIGGGHKQ
RYRIIDFKRDKSGVPATVKTIEYDPNRTAFIALLNYADGEKRYVIAQNGLNVGQEIISGS
GVSPEIGNSMPLSEIPLGTTISCIELHPGKGAVMARSAGSFAQLMARDGKYATVKLPSGE
TRLILLTCTAVIGVVSNSDHQLLVSGKAGRRRWLGRRPRVNAVRMNPVDHPMGGGEGRAS
GGHPRSRNGIPAKGFKTRSKTKASNKYIIERRKK
>FCMOIPGL_00659 30S ribosomal protein S19
MARSLKKGPYVHYKLEKKVLANVEAGNKTVIKTWSRASMITPDFVGQTIAVHNGRQFVPV
YVTENMVGHKLGEFSPTRSFRGHAGAKNKGKK
>FCMOIPGL_00660 50S ribosomal protein L22
MGVRKKNMADQLKADRKQRAFAKLTNCPTSPRKMRLVADQVRGVEVEKALQILKFSPKEA
SINLEKLLLSAIANWQAKNEDESIEDAKLFVKSIYVDSAGMLKRLRPAPQGRAHRIRKRS
NHVTLELGSKNLSN
>FCMOIPGL_00661 30S ribosomal protein S3
MGQKTNPIGNRLGIIRGWESNWYGGNDYGDKIAEDYKIREYVNARLSKASVSRVIIERTL
KLVTVTITTARPGIIIGKGGQEVDKLKEELKKITGKEVQINIFEIKRPELDAKLVAVSVA
RQIENRISYKRATKMAIQATMRMNAEGIKIQISGRLNGAEMARSEHYKEGRIPLSTFRAD
IDYALVEAHTQYGRLGVKVWIMKGEVYGKRELSPLVGLSKKQSSGKGGDRSKRQQPRRRK
>FCMOIPGL_00662 50S ribosomal protein L16
MLQPKRVKYRKVQKGKGNMSGLSGRGSQLSNGMFGIKSIDQNLLTSRQIEAARIAATRHM
KREGQLWIKIFPDKPITKKPLEVRMGKGKGAPDHFVAVIKPGRILFEIGGVPLNVAKEAL
RLAAQKLPVKTKFVIARDFDINA
>FCMOIPGL_00663 50S ribosomal protein L29
MKQSEIKELSIADLKEKLGALQKNYTDLKMAHAITPLENPLQLRGLRRTVARIATELTKR
ELQ
>FCMOIPGL_00664 30S ribosomal protein S17
MEKRNLRKERIGVVSSSKMEKSIVVSETKRVKHPMYGKFVLKTKKYVAHDEKNDCNEGDT
VRIMETRPMSKSKRWRLVEILERAK
>FCMOIPGL_00665 50S ribosomal protein L14
MLQTESRLKVADNTGAKEVLVIRVLGGTRKRYASIGDKIVVAVKSATPNGTVKKGQVSRA
VVVRTKKEVRRKDGSYIRFDDNACVLLNPTEEMRGTRVFGPVARELREKQFMKIVSLAPE
VL
>FCMOIPGL_00666 50S ribosomal protein L24
MKKFKIKSGDTVKVIAGDHKGSEGKVLQIIKDKDRVLVEGVNLVSKHTKPSAQNPQGGIV
KKEASLHISNLMLVQDGVAVRVGYQVDGDTKTRISKKTKK
>FCMOIPGL_00667 50S ribosomal protein L5
MSYVPRLKAEYKERVIKALTEEFSYKNVMQVPKLEKIVVSKGVGAAIADKKLIDYALEEV
TKITGQKAISTMSKKDVASFKLRKGMPIGVKVTLRGDKMYEFLDRLVTASLPRVRDFNGI
KANGFDGRGNYNLGITEQIIYPEINIDQVKKINGMDITFVTSANTDKEAKSLLGELGLPF
KKN
>FCMOIPGL_00668 Alternate 30S ribosomal protein S14
MAKESMKARERKRAKTVAKYAEKRKALKEAGDYEALQKLPKNASPIRMHNRCKLTGRPKG
YMRQFGISRVTFREMANQGLIPGVKKASW
>FCMOIPGL_00669 30S ribosomal protein S8
MYTDPIADFLTRVRNAIAAGHRVVEVPASNLKKEMTKILFDQGYILSYQFNNDKVQGTIK
IALKYDRETKESVIRKIQRISTPGLRKYVGSTEMPRVLNGLGIAIVSTSKGVMTNKKARQ
ENVGGEVLCYVY
>FCMOIPGL_00670 50S ribosomal protein L6
MSRIGKNPVSISQGVDVNIVDSVITVKGKLGELSQTISDGIKLTIEDGIITFDRASESKD
HKAQHGLMRALVSNMIEGVSKGWTKDLELVGVGYRASSQGQKLDLALGYSHNIVLELAPE
VKVETISEKGKNPIIKLSSFDKQLVGQIAAKIRSFRAPEPYKGKGVKFVGELLRRKAGKS
A
>FCMOIPGL_00671 50S ribosomal protein L18
MALSKLQRRARIKRRIRKIISGTATKPRLSVYRSNKEIYAQLVDDVNGVTLASVSSRDKG
IKADTKVEAAGSVGKAIAEKASKVGVETVSFDRNGYLYHGRVKVLAEAARESGLKF
>FCMOIPGL_00672 30S ribosomal protein S5
MQGYKNVERVKPSGLELVDRLVGVQRVTKVTKGGRAFGFSAIVVVGDGNGVVGHGLGKSK
DVSSAIAKAIEDAKKNLVRIPILEATLPHEQKGKFGGAKVFLKPASHGTGVIAGGAVRHV
LESVGIHDVLSKSQGSSNPHNVVKATFDALLQLRSAASIAKQRGISLEKVFNG
>FCMOIPGL_00673 50S ribosomal protein L30
MAKIKVTQVKSQIGRLQSQKRTLEALGLRRMNQTVVHEATPSIVGMVNTVKHLVSFEEIK
>FCMOIPGL_00674 50S ribosomal protein L15
MSLHNLTPAEGSVKKGKRIARGEGSGHGGTSTRGHKGQKSRSGYSRKIGFEGGQMPLQRR
VPKFGFTNINRKEYQGINLDKLQSLVDDGKITDTVNLDILVAIGLASKNDLVKILGGGEL
KAKLNITVHKFTATAKAAIEAAGGEVVTL
>FCMOIPGL_00675 Protein translocase subunit SecY
MMNFINRLKDIFSIEELKNKILLTIGLIAVYRFMASVPLPGIDPLQLAALKESTSGGLLG
LLNAFTGGAFARASVMALGIMPYISASIVVQLMGIAVPYLQKLQKDGESGRKKITQITRW
LTIVITLVQAPTYITAIKTQFGLGPEAFLVSGATFWISSIIILTAGTIFAMWLGERITDK
GVGNGISLLITVGIIANFPAAFLQEFVAKTTNAGAGGLMMVLIEIIIWFVVILLTVLLVT
AVRKIAVQYARRTVAGSVQNVAGSRDYIPLKLNAAGVMPIIFAQAIMFLPVALAQRFPFM
ASLQDMHGLGYNVIFALLIIIFSYFYTAITIPTNKMAEDLKRSGGFIPGIRPGKDTADKL
DSVLSRITFPGSLFLAALSILPTIVIQFGVQQSWAMFYGGTSLIIMVGVAIDTLQQINSY
LLNRHYDGLMKTGNSNRKSNK
>FCMOIPGL_00676 Translation initiation factor IF-1
MAKQSAIQQDGTITEALSNAMFRVELENGHIVTAHISGKMRMHYIKLLPGDKVKLEMSPY
DLSKARITYRY
>FCMOIPGL_00677 50S ribosomal protein L36 2
MKVRASVKKRSADCKIVRRKGRLYVINKQNPRFKQRQG
>FCMOIPGL_00678 30S ribosomal protein S13
MARIAGIDIPKNKRGVIALTYIFGVGSSRAKEVLAKAEVDESIKVQDWTDDQIAAIREQV
GSFTIEGELRSEIQINIKRLMDIGCQRGIRHRLGLPLRGQRTKNNSRTRKGKRKTVANKK
K
>FCMOIPGL_00679 30S ribosomal protein S11
MAKASSKKRKVIIDAIGEAHVTASFNNIIISLTNKKGDVISWSSAGKMGFRGSKKNTPYA
AQLAAEDCANVAKEAGLRKVKVYVKGPGNGRESAIRSIHNAGIEVSEIIDVTPIPHNGCR
PPKRRRV
>FCMOIPGL_00680 30S ribosomal protein S4
MARYTGPKTKIARKFGEAIFGEDKNFEKRNYPPGQHGNARRRGKKSEYATQLMEKQKAKY
TYGILERQFSNLFKKAQAASGITGEILLQLCESRLDNVVYRMGVSNSRSGARQLVSHRHI
TVNGEIVNIPSYSLQEGDVVAVREKSKSLVAIENALASNSNVFEWLTWNGDTKTGTFVKV
PERLQIPENIKEQLIVELYSK
>FCMOIPGL_00681 DNA-directed RNA polymerase subunit alpha
MAILNFQKPDKVIMIESTDFSGRFEFRPLEPGFGLTIGNALRRVLLSSLEGFAITSLRVD
GVEHEFSTVSGVVEDVTEIILNLKQVRFKKQIDDTDRETVSISVSGQEQFTAGDLQKFIS
GFQVLNPDLVICNMDKSVKLNAEITIEKGRGFVPAEENKKASAPIGTIFTDSIYTPIKNV
KYAIENYRVEQKTDYEKLVFDIDTDGSINPKEALTEAAKILIHHFMLFSDERITLEADEI
AQTETYDEESLHMRQLLKTRLIDMDLSVRALNCLKAAEVDTLGDLVSFNKSDLMKFRNFG
KKSLTELEELVIVKGLNFGMDLTKYKLDRD
>FCMOIPGL_00682 50S ribosomal protein L17
MRHGKKFNHLGRKTAHRKAMLANMTCSLIEHKRINTTVAKAKALRLFAEPLITKSKSDTT
HNRRIVFSYLRDKFAVTELFKEISVKVADRPGGYLRIIKLGNRQGDNAPMAMIEFVDYNE
IYNPKGTKAKKTTRRGRSKKADNAQVEGSASTEEKSEE
>FCMOIPGL_00683 Carbamoyl-phosphate synthase small chain
MKYQTRKKALVLLADGTIFYGKSVGIEGTSTGEICFNTGMTGYQEIFTDPSYFGQLMVAT
NAHIGNYGVNINEVESDSIKISGLICRNFSFIHSRVDSEENLLDWFTKHNLVAISDVDTR
ALVAYIRDNGAMNAIISTDVDNIDSLKKQLSEVPSMEGLELASKVSTKEPYYVGDKNSDI
KISALDIGIKKNILRNLAKRGVYIKVFPFNSSFEDLSAFNPDGYFISNGPGDPQPLIEAQ
QVAEEIINRDLPLFGICLGHQVIALANGISTYKMHNGHRGINHPVKNLLTGKGEITSQNH
GFAINREEAEANENIEITHVHLNDHTVAGIRMKNKNVFSVQYHPEASPGPHDSEYLFDQF
IANIEKTKKISS
>FCMOIPGL_00684 Enolase
MSIIISVHARQIFDSRGNPTVEVDVTTDNGSLGRAAVPSGASTGEHEAVELRDGGKDYMG
KGVLKAVKNVNEIIAEELLGVSVFEQNAIDKLMIDLDGTPNKSKLGANAILGVSLAVAKA
AAIELGMPLYRYVGGVSANTLPLPMMNIINGGSHSDAPIAFQEFMIMPVLAETFSEALKM
GSEIFHNLKKVLHDRGLSTAVGDEGGFAPTLDGTEDAIETIALAVKNAGYVFGEQVKIAL
DCASAEFYVDGKYDYTKFEGDKGVIRTSKEQADYLAELSAKYPIISIEDGMDENDWEGTK
YLTELIGDKVQLVGDDLFVTNVERLSRGIENGIANSILIKVNQIGSLTETIAAVNMAKNA
GYTTVMSHRSGETEDNTIADLAVALNCGQIKTGSASRSDRMAKYNQLLRIEEELGTTAYF
PKENAFNL
>FCMOIPGL_00685 Citrate synthase 1
MSDIAKLQIGDNSYEFPLVKGTENEVAIDIKKLRVVTNGIITIDPGFKNTGSCESAITFL
DGEKGILRYRGYPIEELAEKADFLEVSYALIFGNLPTKQELDKFHADIKEHSLVDDDVRK
ILEAFPKAAHPMGVLASLTSALTAFNPSSVNTASKEDMYHAIVRILAKFPVLVGWTMRKS
KGLHLNYGKKSLGYVENILYLMFKQPNEEYVMNPIIKDALDKLLILHGDHEQNCSTSTVR
IAGSSHVGLFASLSTGISALWGPLHGGANQAVLEMLEAIQADGGDTKKYMAKAKDKNDPF
RLMGFGHRVYKNFDPRAKIIKKAADEVLNDLGVDDPILKIAKGLEQEALNEPYFVERKLY
PNVDFYSGIIYRAMGIPTDMFTVMFALGRLPGWIAQWREMRLNKEPIGRPRQIYIGETER
HFVELDKR
>FCMOIPGL_00686 Arginine deiminase
MLQLNIQNETSKLRSVILGTAKSNGPVPRVEDCYDPKSIQHVLAGTYPKEEDMILEMEAV
AKVFEKYNVQVFRPTIIQNYNQIFSRDIAFVIEDKLIKANILPDREEEYLAIKHVLDQIK
EENIIHLPEECHVEGGDVMPWNDYIFVGTYSGEDYADYITARTNTDAVIALQELFPDKIV
KSFELRKSNTDPKENALHLDCCFQPIGKNKAILHKNGFLIEREYEWLLNYFGKENVFEIS
KEEMYSMNSNVFSISEKVVISEQNFTRLNTWLRNNDFIVEEVSYTEIAKQEGLLRCSTLP
LIRD
>FCMOIPGL_00687 hypothetical protein
MIRPINFRMNEQTAVNNYYQKSLKDLLPATINSKAQKEFDTFVEKLRSFGVEVIVVSDNK
EFDTPDSIFPNNWVSFHDDATAAIYPMFAENRRLERREDVFLELEKKGFLIENIVDYTAA
EEEQVFLEGTGSMSLDRENKKAYCALSPRADEDLFIEFCEDFEYTPVIFTSYQTVENRRE
AIYHTNVMMCITETFAVICLSSIDDKSERKNVLKNLKEDKKLVIDITEEQVANFAGNMLQ
VKGANDELFLVMSQAAHDCLTQSQKSQINRYCKIISSSLATIEACGGGSARCMMAEVFLP
RN
>FCMOIPGL_00688 Protease PrsW
MHLLFLAVAPVMVIILYIYFKDKFEKEPIHFLFKNFLLGAFVSVLITFVLSIITGFLFDL
TNDNSILNQFIKAFIVVALVEEFSKYIIVRYYAQPNKEFNEPFDGIVYAVMVSMGFAALE
NVLFVYKHGIETGITRAFTAVPAHATFAILLGYYMGKAKFSKNKRKLNLIGLLVAIIFHG
AYDFFLFINFIPGTVIGALSSLLVGIVLSRKAIKIHQKNSNFNV
>FCMOIPGL_00689 hypothetical protein
MKIKTPYLFLLIFLNSFLIQSQITEFKEKFEIPAVAKETSGLLFLNGKIITHNDSGDNAY
LYELDSLTGVLNRRITITNATNVDWEDLADDETYIYISDSGNNKGTRTDLKIYRVLKSDL
KKSNTVSAETISFSYEDQTSFDGSDTHNFDAEALVVYENNFLIFTKNRGDLKTNVYKFPI
TLGNHTAVKVSSANIVGLITGATVQNSNFLLCGINANAIPFLVHISANRSPGDDIFKSGF
SKYTLTNELGVGNQVEGITSFDYGRFYISREAVNEDIISLKQKLFEFRDYRSLLLSIEKN
TLENLNIYPNPTSGNITIRSEKEIQTISIYNTLGKKIKEFNANQKEINISNFSKGIYLLK
IKFDDKKNVIRKIIKH
>FCMOIPGL_00690 Alkaline phosphatase PhoV
MKKHILFLTFFTILISGCKVQEVKQETTSAKPKLVVGIVIDQMRYDYLRRFSNRYSDDGF
KRLLNNGFSLENAHYNYIPTYTAVGHTSIYTGTTPSNHGIISNNWYDKFLKKSIYCVDDS
NYKTIGNESSTGKKSPVRMQTTTVTDQLHLAQNMNGKTIGIAIKDRSAILPAGHTANGAY
WFDGGKNGEWVSSSFYMENLPKWVLDFNKSGKADSYLKTPWNTLYDINTYTNSIVDDNIF
EGKFTGETTTSFPHDIPNLKEKNGGFNIIKAIPAGNSFTADFTKAAIIGENLGKSNYTDF
LAVSFSSTDYVGHQFGPASKEIEDTYLRLDKDLADLLSFLDQQVGQNNYTVFLTADHAAV
DVPSYLQSLKIPAHYLSFSKFKKAALEITKKYFNSIELIENISNYQIFLDKDKIESLGLD
KNVVAEKLVEEVINFDGIYKAVSAKTMQTSNFTSGILNSLQNGYNQKFSGDVLLIPYPAT
LTGGRTGTSHGSGYSYDTHIPVIFYGNGIKKGVSKKSYEIIDIAPTISNLLQIEAPNSST
GKIIDEALK
>FCMOIPGL_00691 putative phospholipid ABC transporter permease protein MlaE
MNYIEHTGKYFMMLVQVFKKPQRKKVFYEALFKEIEELGLKSLGIIMFISFFIGGVIALQ
TALNLDNPFVPDSLIGFAAKRSIILEFAPTFCSIILAGKVGSYITSSIGAMRVTEQIDAL
EVMGINSLNYLVLPKILATVLFYPFLIILAMILGIFGGWLTGLLSGLFSGVDYVIGLQTE
FKPFLIVYSMIKTLIFAFLIASVPSYHGYYVKGGSIAVGKASTKAVVWTTILIVIANYIL
TQMLLT
>FCMOIPGL_00692 putative ribonucleotide transport ATP-binding protein mkl
MIEVKDLYKGFGDVEVLKGISTTFEAGKTSLIIGQSGSGKTVFLKCLIGLHTPEKGTISF
DGRINTQFTIEEKRQWRQEIGMVFQGSALFDSQTVEENVMFPLKMFTDNTYSEMLDRVNF
ALNRVNLPNSNKKLPSELSGGMQKRVAIARAIVMNPKYLFCDEPNSGLDPQTAIVIDKLI
QEITDEYNITTVINTHDMNSVMEIGEKIIFLKNGNKAWEGSSEEIFKTNNEAVVDFVYSS
NLFKKVREAYLNEKK
>FCMOIPGL_00694 hypothetical protein
METEKKDENIDVIEQSKNDVKSDAKGLFLSIKEFLIELLDFRHDTDHEATINAIKADIPF
KGATAWILIFAVFVASIGLNANSTAVVIGAMLISPLMGPILGIGMSFAINDINTLKKSFV
NLGTMIVLSLLASFLFFYFFPLSEDNSELLGRVSPDVRDVLIAFFGGLALMVARTKKGTI
ASVIFGVAIATALMPPLCTAGYGLAKGNLTYFTGAMYLFTINTIFIALATFLVLKLLSFP
MHKYANAAKRKRYAIIATIVGVAVMIPAIFTFINVFNKSKIDSQIGGFIKNEIKNNNSLQ
LIDWDPDYQKKELYLNFLSEVTDATINDLNNELLNKQLYPNLNDFKLRIKGSDTKSYDLI
TTAYKEKREELLESKKIIVDLQSQIVDLQATISSLNNRIEQDALNKHQNIVAFSRIAKDT
KIRYSDVEKISFANVLSSKDFIKIDTIPTATIKWNYRLTDSIIRPKERELRTWLQKEMEL
DTLFIKRER
>FCMOIPGL_00695 Protein SprT
MSLEYQKHIPPKAIPFVQFLIDEHSFDLFIVNQRATKHGDFRKLPNGRFQITVNNNLNKY
QFLLTLVHEIAHHVTHQKFGRVQPHGIEWKTVFQHLMLPFINPDIYPKEILPYLANYLKN
PKASTDADVNLSLALKGFSADSGKHFIFDIPFGNLFVFKNTIYKRGNKRRTRYECMEMHS
KKVYLFNQNVEVKIYKP
>FCMOIPGL_00696 Gluconate 5-dehydrogenase
MKNVVITGTSRGIGFELAKLFAKKGHQVLAISRNTKPLETVNHKNISLLSVDISNNSDVK
KVTDFIQKNWKQVDILINNAGKLINKPFTDLTSDDFLEVYKVNVFGVAEITKNLIPFLQK
GSHVVTISSMGGIQGSMKFPGLAAYSSAKGAVITLSELLAEEYKEQQIAFNVLALGAVQT
EMLEEAFPDYKAPLSAEEMANYIFDFSLTGNKFYNGRVLQVSTTTP
>FCMOIPGL_00697 hypothetical protein
MKKFRLPRKIKKKLSGLWLYPKDEKGNSLMAHPKTSQEDYTAVKQGLVHNILDRKNSRKR
SIEFHQKIDVEISISDELLKKYVDDYFREDVRIASYQTLINAKNNLHTIKYYFNFINAYQ
LNKKDGSYSNIPALAVEQAQKLLKKKYIRKNNK
>FCMOIPGL_00698 hypothetical protein
MRYFLSFLICVALISMSSCRKDFSTIPSFGSLEFSKDTVFLDTVFTNIGSATYNLKVYNK
GKNAITIPKIALENGTSSNYRLNVDGIPGKEFNDIDILAKDSIFVFIETTIDVNNTVNPL
YTDRILFDNGTNEQDVDLVTLVQDANFIYPGRDALTMKIDSLTIDGEPTTLKGRFLTDTE
LTFTNTKPTVIYGYAAVAANKTLTINAGAKVHFHDNSGLIIDDKATLKVNGTLAEKVIFE
GDRLENSFSQTPGQWGTIWMRAGSKDNEIYHAQIKNGIIGILIDSIGATSTPTLKLQNTE
IYNHSTYGILARETNIEAHNVVIGSAGEASFAATIGGTYNFTHSTFANFWNNGIRQLPAV
LINNFFTYQDDSGQDIIETRDLHAANFTNCIFDGNNNIEFVIDKVDGGGIFNYNISNCMI
QFNDTSNSFEDNTELDFTNSFYQNIILNGYTNFRNSQNEDFIIGLDSDAINKAKTSTFNV
DILGVDRTTNPDIGAYQHITFEE
>FCMOIPGL_00699 hypothetical protein
MKKLAVLISFLTFLLVTSCNDDYKFTLDVVKKTTLNSSITITLKEKNDKPVDNVQFFVDG
VEISADGNSVTINTSDFGVGKHAVSTLAFFPGKTKKTNNSFEVLADKAPAIYTFKIINSF
PHDTKAYTQGLEYHNGFLYETTGQRGESSLRKVEISTGKVLQKINLDKQYFGEGMTILNN
KIYWLTWQAKKGFVYDLATFKQEKEFAFNKSKEGWGLTNNGTELIKSDGTNKIWFLNPTT
FKEKHAIQVYTNKYALDNLNELELIDGKIYANKYQQNAIVIIDVKTGAVLGVANLSDLKT
EMEKTQTLVPEDEVLNGIAFDKENNRLFVTGKHWGKLFEIELIKK
>FCMOIPGL_00700 50S ribosomal protein L31 type B
MKKGIHPENYRMVAFKDMSNDDVFLTRSTVDTKETLDVDGVEYPLVKLEISRTSHPFYTG
KSKLIDAAGRIDKFKNKYAKFKK
>FCMOIPGL_00701 Glutamate synthase [NADPH] large chain
MRNTILSIFIGITILSGVLVYFIPQTGTIILLSIACFLTVIAIYDSLQTKHSLLRAFPVI
ARLRWFFEDERDKIQQYFIEDNLNGTPINREKRSIVYQRSKLSKETVPFGTQHNVYAKGY
EFVKHSLFPKDHHYIKGERVVFGSDKCTQKYDASIINISAMSFGSLSKNAIMALNQGAKM
GKFAHNTGEGGISPYHLQGGDVIFQVGTGYFGAGKHDINGKRIFDDAIFKANAIRPEVKM
IEIKFSQGAKPGHGGILPAVKNTPEIAEIRAVVSGTQVDSPPSHSAFSNYEEMILFIQKV
RDLSEGKPVGIKFCVGDNDEIEAMIKAFADANNYPDFISVDGGEGGTGAAPMEFTNYIGT
PLVEGLVFVNKLLVKYKLKNQVKIIASGKAIDAFDIVKILALGADAIGMARSFMLSLGCI
QARECNLDSCPVGVATQDEDLVKALVVEKKNLRVKNYHNETIKSVKEVVASMGVDSIADL
KPNQVFRRRKDEEIVSLENIYYKK
>FCMOIPGL_00702 putative oxidoreductase CzcO
MNFFDIVIIGGGPIGIACGLEAQKKGLSYVILEKGPIVNSLYNYPVNMQFFSSSEKLEID
EIPFISKEAKPRRSEALEYYRRIATSNKLNIKLFEKVTSVAKIENEFTVISDKNSYKSKN
IVIATGFYDIPNLLQVPGEDLPKVSHYYNDPHFYAGQKLAVIGASNSSVDAALECYRKGA
EVTLIIRGTEVGQRVKYWVRPDIINRIEEGSIKVFYNATVKEISEENITINTENGIEKIQ
NDFVLALTGYKPNFTFLNQIGVELSKDEKKIPSYSCETMETNIKGVYLAGVICGGMETHK
WFIENSRIHAKMIVHDILNKK
>FCMOIPGL_00703 hypothetical protein
MYATIYLNHFYEYFEKIASLKPEMKSSFKEAILVLITKNNKNQREDPKNLN
>FCMOIPGL_00704 hypothetical protein
MKKLILVALLIVSAITVGQEKKEKQNIKKGTWVFGGDLNFSSGGNDYTDPSISDTDYTGF
GITAKTGYVFTKNNLELGLGLGFSTSKNASGDYENKTNSYKIAPYVKKYLPVNDIFSFFL
QGEVAFSNYNIEENYNNSTDIESNSLFIGVRPGFVYFVTKKLALNANIGALGYNTNTYKT
DNVTQSKNNSFSFNLSSSDLLFGFCYFL
>FCMOIPGL_00705 Glycogen phosphorylase
MEHIYSKWHHPYKPAAKYKKKVAYFSMEFGIDQAFNIYSGGLGFLAGSHMRSGFELKQNM
IGIGMLWKYGYYDQARNEDQTLKTEFNEKHFDFLEYTGIEVTIKLHDNPNVKVRAYVLKP
EVFGTVPMYFLSTDVDGNDHLSRTITNHLYDQNPVTRVSQSIVLGIAGAKVVEALGGAET
YHLNEGHALPAFYYLRDKGVTKDQMVFTTHTPEKAGNEERDARHLNRCGFFGRTLSEEEL
HKEMVNGGMINYTISALRMARKANGVSKLHAIVANDMWKDYDGICEIIPITNAQNQKFWQ
DNVIKESWKKRDAVVYKNKKTQLKKELFDEVYKQTGKQFDPNVLTIVWARRFAGYKRADL
LLHDYNRFKELIHNEKYPVQIIWAGKPYPFDYGAIDTFNHLVHQSKQEANLAVLIGYEID
LSRKLKCGSDVWLNTPRITREASGTSGMTAAMNGSVNVSTDDGWIPEFKKDEENCFVLPA
LDYKLPTYEQDKLDTDNLYNILENKVLPTYYDAPKNWQKIVFKAMDDVIPEFTTQRMADD
YYKKLF
>FCMOIPGL_00706 hypothetical protein
MISKPIPSFVQFILLLFVNFLLLSCNSKPKSSKITDQKLTIKAKSTSDFKISLAQWSLHR
AFKDGSLDPMDFPKIAASYGIYSIELVNSFYLKKVNDKTYWKTFKQRCDENKVSVGIIMC
DRLGNLRNPNVKERIKTVENHYAWIDIAKYLGAHSIRVNATGKGNADEVALNAIDGLNKL
SKYASEKDINIIVENHGGNSSNGKWLASIIKQVDKKNVGTLPDFGNFCLKRDSDKNCLSE
YDRYKGISELTPFAKGISAKSYDFDKKGNETKIDFLRMMKIVKNSGYKGYIGIEYEGNSL
SEPEGIIATKTLLEMVFTELE
>FCMOIPGL_00707 hypothetical protein
MLKLKIILSLITIISLNSCTSNTAKKNNKWVYLFNGKDLNGWVTKINHHKLGDNFANTFR
VVNGAIQINYNEYSEFNERFGHLYYEKPFSSYHLKFEYRFTDQWMEDAPHNTYRNSGIMI
HSQNPNSILKDQNWPISIEYQILAERKEKESRPTGNMCSPGTEVFFKGEMEPKHCISSSS
KTYKWNQWISGEVIVYKDSLIQHIVENHKVLEYTKPQIGGKIVKGYDKHVKIDGKPLKEG
FIALQAEGQGIEFREIKIKNLN
>FCMOIPGL_00708 Succinate-acetate/proton symporter SatP
MSTIKLGNPAVVGLSGFGLTTLLLQFHNLGWCGLGPIVAMAFIFGGLAQLIAGFMEQKTG
NNFGFAAFSTYGAFWIGLGIIWLLNYFKVYTSSTTDVGFYLVGFTLLTLIFWIGSLFIHA
AMSITFTTLALGFILLDLAHFGFPEVTTLAAIVLIICAFSAWYMMASIVINDVAGREILK
TGKPWIKKTSKLL
>FCMOIPGL_00709 hypothetical protein
MHNSKIIKEIAQNLTCGEDSYYNYKTEELVTIPNASIGFDEEEFQEIFKDDLEKIAKHKA
DFIKIEVLESFQSYKLMELFIDQLPEIELKQILKNVIQKKKSFQRFKHHIDASTFRESWF
EFQQNELEKIVAKELENAIRLKKL
>FCMOIPGL_00710 ATP-dependent DNA helicase PcrA
MVAIEQIKKHIIENKSYVLEAGAGSGKTYTLIQTINHVLATKGESIKLNNQKIVCITYTN
VAKNEIIERLENNPLVIVSTIHEFLWDCIKRFNKQLITELDVLNEFMIANSKKPEKYKTG
LKDRIKTDVKYDDSGYRDFEQGSIHHDDVITLSLQMFKNYSTLTQILGQKYPYIFIDEYQ
DTASETVDAIVNYLLERNKTKLLIGFYGDSYQKIYDEGVGSLQTYIDSNKLELVTKDDNY
RSSENVVNLLNNIRDNIIQKIPESKESLKGSVQFINCINAPKQLKEKVADYKERIAPKKD
SDYNSVVSSLEKNGWDFSELGDDKILIIANSKVAERAGFLNLYKIYTKRYTLGAKEALLK
RENIFSSYFMGSIDKKTSKERETGIEHLVSFWEDKNYNRVIKYLKQQGSFSSLTNHSDKK
EIESKLKELITLRKTGTVQDVFDFCQENKLSLPSRKLQKFIEKLNIDITTITDEDEKKRA
TKNKVFYDSFMLINYNEIICAFKHIQEQTSYSTKHGTKGEEYRNVLVVIDDTSWIAKYNF
EKFFNDTDDKEDRKLRTKNLFYVSCSRAKENLVVLALSQMGDSAMNKITEWFGVENIQTE
>FCMOIPGL_00711 DNA replication and repair protein RecF
MKIKKIEVTNFRLLEKIICTLEDDITLIVGKNNTGKTSFFEAIKLATSTDGKFIFEDFSQ
STYAVFKSSFNKYLESKKEGITEENQEELEKQLLAEIPKIKINFEIEYNKDNNESLVELS
EFITDLEDSRNDATICISFEPKNTLKVFHSFENREDKSIDIIKYLQQNIKFLYDTVCYAI
DKESDYKRKIEDSFKTKIQKVMLFENIKAMRILDDINGDSNNALSLGFSNYYKQRDKTSN
QDVKDLEDKLKTVSGELKIKYEKVLESIMSKLGRFGAKTRISIPTITIDSKFDSEKVIKN
NIQYLYLQNEVNLPESYNGLGYSNLIYMILELESFIEKFKNSKEEKFSNFLVILIEEPEA
HMHPQMQQVFISQVSEVLKDAKNDTGIQIQVIITTHSSHILSESGIETELGFNRIRYFNR
LETESGGYKITNQDFNNLKIKDDKRTFRFLRQYLTLHKSDLFFADKVILVEGTTERMLLP
QMIKKSAESLCNEYVSILEVGGAYAHSFREMLEFINVRTLIITDIDSSNKKDGKCPVEQG
EYTKNYTLIRWLPQKELISELTSCKTEYKIQENIRVAYQTKENGFNARSFEDAFINTNKE
FFLTGHPIEKEKNIKDEFAYLRNKNIDLSKKIPDKFSSKQKTEFTFDIMSFNEKEYGEWK
VPEYINEGLIWLAKKD
>FCMOIPGL_00712 hypothetical protein
MDFLQSLLENYNIPILSAFILGLMTAISPCPLATNITATAFISKNISSKRKVLLSGLLYS
LGRGFSYTTIGLILYFGASKFHIARFFNQNGEKFLGPLLIIIGLIMLNVIKLNFLGKLNF
QEKLSEKFKGKGLLGSFLIGIVFALAFCPYSGALFFGMLIPMTIASADGLYLPIVFAFGT
GLLVLLFTYLLAFTAGKVGVFYNRITKIEKVMRTIAAVVFILTGLYYVFIFLGIIK
>FCMOIPGL_00713 hypothetical protein
MKKFKFLTVLVISLVLNSCNNQPKNKTASVDESVSKIEVFDFHSTHRCMTCNAIEANTKY
TLNTFFADELKNNKITFQVINVDEKKNEKIAEKFEASGTSLILNVIKNGKETQINLTEFA
FMEGNDQEAFSKELKSKIDMELKAL
>FCMOIPGL_00714 Putative two-component membrane permease complex subunit SMU_747c
MFDWIQNIADWFVYDILNLTKGQHLAEALNFFIYDTTKILILLFVIIFFMGIVNSYFPID
KVKNYLSRNKLYGLEYLMASLFGVVTPFCSCSSVPLFIGFVRGGIPLGVTFAFLITSPLV
NEVAIGLFVGLFGLQTTIIYVISGILLGTISGVILQKLKLERYLTPWVKEVLANAQKDQD
TFIAEKQTLKQRLPIIWDEVLKILKGIIPYVLIGIAIGGLMHGYIPEGFFEQYMDKDNLF
AVPIATILAVPMYSNASGILPVVQVLVAKGIPLGTAIAFMMGVVGLSLPEAMLLKKVMTL
KLIAIFFGVVTLCIIISGYLFNLLL
>FCMOIPGL_00715 hypothetical protein
MNYQIKASSISNKDAVIHIKESNINFGTTSKTAEVLPNPAELFLGSFAACMLKNVERFSI
MMKFTYSKTTLEVNATRLENPPRMDNIFYDLKIYSNDKKLNIDLLKKNIEKFGTIYNTIK
LSCAISGTINQFENV
>FCMOIPGL_00716 hypothetical protein
MSKVIKVLGTGCPKCQSMTAVVKDVVSENNIDATIEKVEDIMEIMKFNVMSTPALVIDDV
ITIKGRIPSKEEVLALLN
>FCMOIPGL_00717 putative HTH-type transcriptional regulator YgaV
MYRKFAIDNMKRNLEPITYKENTEALAKYAKALAHPTRIAILKHLENQSCCFTGDLVEVF
PLAQSTISQHLKELKNAGLIQGELKPPKIKYCINKENWSIAKSLFQQFFD
>FCMOIPGL_00718 hypothetical protein
MDFYLAIISFLAAFIFSLGGVGAAIILIPIMDAFGIPISVAKPVGLFYNTISLAGASANN
IKNNRLDFKLGIPLIIFSFIFASVGAYLSQYIPSRIVLIMFVGFLLFSSCMFLFFKKKDE
TIFREDIPYFPLALIGAFAGLLSGILGIGGGGIISPLLLVMGFNPKKITTLTAFVVPFSS
LSGFLTYWSIGSVDWKLIAITAIAGILGATIGTSIMQKKLNPKTVKKILAIILIIIAIKM
GVKII
>FCMOIPGL_00719 hypothetical protein
MKFNLLLVLFFVGLISCNSNKKNKENLKSENSNKKEIVVHKKVTSTIKVQSKGYKLMQQK
CYICHFETPNPSKRDQMIAPPMLRVQEHYKPTYTNKEEFIKAIMAFTKNPSEEKTLMPGA
VKKFNLMPKLPYDDAELQLIAETIYDYEFGKAPKMKMMASVLQLNNGKKWVLKKESILLI
NTIIKKTSNFKSTKIEAYNKLGKDVFNDAKTIMLDDSYQDELFNQIHIFFAGIENNMHTL
MSTTSISEANKELTELNQQLKGFHNYFE
>FCMOIPGL_00720 Arsenical-resistance protein Acr3
MASKKLSFLDRNLTLWIFVAMAIGVGLGYFIPTFPTIINSFNSGTTNIPIAIGLILMMYP
PLAKVNYALLPKVFRNTKILSISLILNWIIGPVLMFVLAITFLRDYPEYMVGLILIGLAR
CIAMVLVWNDLAEGSSEYGAGLVALNSIFQVFAYSFYAWLFITILPPYFGFEGAIVDISI
STIAESVAIYLGIPFLMGILSRLILVKIKGEEWYTKKYIPTISPITLIALLFTIVIMFSL
KGELIVEIPMDVLIIAVPLLIYFTVMFIIGFFFTKATGAEYDKTAAVAFTAAGNNFELAI
AVAIAVFGLNSGQAFTGVIGPLVEVPALILLVRVSFWLKKKYYS
>FCMOIPGL_00721 Protein ArsC
MITTQPTLFLEIENLIKNLKPESISDDRKEILKPLTEFIQAKVSNDQEIRINFICTHNSR
RSHLSQVWAQTMANYFNIKNVFCYSGGTEATALFPMVAETLKNSGFEIKTLSEGKNPVYS
IKYAENEHPIIGFSKKLDDGFNPKSKFAAIMTCSQADGGCPFIAGAEKRIPITFEDPKAF
DNTPQQAEKYNERSLQIATELFYIFSQINS
>FCMOIPGL_00722 HTH-type transcriptional repressor CzrA
MGLAKTEMFTDLQNEIALFAKVFGHPARVAILQQLFKIDACYCGDLVNEIGLAQPTISQH
LKELKNLGLIKGNVEGTSVCYCINTENWTKMKETMLQFLNQDISIKGDCC
>FCMOIPGL_00723 Glycine dehydrogenase (decarboxylating)
MNTNSFQLRHIGPNKKEQEKMLSAIKVDSLNQLINETVPEKIRLKEELNLDPAMSEYEYL
AHIKELSEKNKVFKSYIGLGYHEAIVPSVIQRNILENPGWYTAYTPYQAEIAQGRLEALL
NYQTMICDLTGMELANASLLDESTAAAEAMALLFDVRERSQKKNNVNKFFVSDEILPQTL
SVLQTRSIPIGIELVVGNHEEFNFSDEFFGAILQYPGKYGQVFDYADFVAKANEKNIKVA
VAADILSLVRLKAPAEFGVDVVVGTTQRFGIPLGYGGPHAGYFATKDTYKRSIPGRIIGV
TKDKNGNRALRMALQTREQHIKREKATSNICTAQVLLAVMAGMYAVYHGKDGLKFIADYV
HTNTKTLAIILEDLGFKQLNTSYFDTILVEVEAAKLKKVAEANNINFNYVDENHVSISIN
ETAGIKEIKAIVHCFEQAFNVKSGDLPLPIKVLPENLLRNTPFLENEVFNTYQSETEMMR
YIKKLERKDLALNHSMISLGSCTMKLNAASEMLPLSNPQWGNIHPFVPLNQAEGYQEVLK
KLEHQLNIITGFSATSLQPNSGAQGEFTGLMVIRAYHESRGDSHRNICLIPASAHGTNPA
SAVMAGMKVVVTKTDERGNIDFEDLKEKAEIHSKNLAALMVTYPSTHGVFETGIKDITNV
IHENGGQVYMDGANMNAQVGLTNPATIGADVCHLNLHKTFAIPHGGGGPGVGPICVAPQL
APFLPTNPVVKTGGENAITAISAAPWGSALVCLISYGYITMLGFRGLKNATKMAILNANY
IKERLNEFYPTLYTGEKGRAAHEMIIDCRGFKNNGIEVVDIAKRLMDYGFHAPTVSFPVG
GTMMIEPTESESMAELDRFCDAMISIRKEIDEATKEDENNPLKNAPHTQEMLTADEWTLP
YSRKQAAFPLDYIADNKFWPTVRRVDDAFGDRNLICSCSPIEDYM
>FCMOIPGL_00724 hypothetical protein
MKVLKTILNFYINASIHVALAVYAFVRITEIYFKLSYNENLDYFIFYGTITGYNFVKYAG
VAKLHHKRLTKGLKIIQIFSLGCFFAMCYYGHLIDFKTLLLSVPFTLLTVLYAVPFLSGF
DKNLREISYLKIIVVAFVWAGFTVLIPVFDAEKEFSLSVVFTIIQRFLIVLVLILPFDIR
DMKFDAISLQTIPKKIGVEQTKKLGLTLLVFSLVLEFMSSTEITTKSPFMMFFFLLTIFL
MRAKIKQPKYYSSFWVESLPIVWWLILLGFHNF
>FCMOIPGL_00725 D-3-phosphoglycerate dehydrogenase
MITTKRNYIFDFDSTLTRVEALDVLAEITLKDNPNKDKIIQEIIDITNLGIDGEISFTES
LERRIKLLNANEADLANLVNALKKQVSKSIESNKEFFENYADDIYVISCGFKEFIDPIVA
QYNIPSERVFANTFEFANDGKIIGFDANNPLSQHNGKIKCLKDMELEGEIQVIGDGYSDY
VTRKAGVADKFFAYTENVSRVKTTENADFIAPNLDEFLYVNKLPRNISYPKNRIKILLLE
NVHPDAFTKLSTDGFSVETVSKSLSEDELIEKIKDVHVLGIRSKTNVTQKVVDAADKLMV
VSAFCIGTKQIDLEACKEKGVVVFNAPYSNTRSVVELAIGEIIMLMRSVFQRSTEIHNGQ
WNKTAEGSREVRGKKLGIVGYGNIGKQLSILAEGLGMDVYYYDVEDTLGLGNATKVDKLE
DLLALSDVVTLHIDDNAANKNFIGEKEISQMKDGAYLVNLARGFVVDIPALVTALKSKKL
AGAAIDVYPEEPAKNGEFFSDLQGLPNVILTPHVGGSTEEAQRDIADFVPSKIMAYINSG
NTVDAVNFPNIRLPRQIKSHRFLHIHKNVPGVMAKINKILAKYELNISGQYLSTDPKVGY
VITDLDKEYNKEVIEKLRNVEGTIKFRVLY
>FCMOIPGL_00726 Dipeptidyl-peptidase 6
MKILKYFSFLVLIALFSCKNNSEIIPELENIHAKLKSEFAPDKRVELFDINFKLKDNQLI
LEGETTSKKAFSILLDSLKKRELEFANNVRVLPDSAVGIKTFAVARNSVINIRSNPKHSA
ELGTQGLLGMALKVLDKKGDFYRIQTPDNYISWVDKGGIQLMNKEEIDTWNQTKKVLFTK
NFGYVFTDKKNETNIISDITLGGLLQYISEDNQFYEVKYPDNRTGFIKKEEAVIYDSWLE
NLGSSKENIEVVAKNFTGFPYLWGGTSSKGMDCSGFTKMVYLMNGFIIPRDASQQINAGK
IVDDQLNFKDLQKGDLLFFGTKATSEKKQRVVHVGIWLGNDKMEFIHSSGNVHLSSMDAS
QPNYDEFNKNRYLGSKRYLGIKDKMIIDLKESIKL
>FCMOIPGL_00727 Kynureninase
MFYIWDKSFLLSMNYQNTLAFAQQQDKEDRLSYLRNRFHIPKDKNGNDWLYFTGNSLGLQ
PKSTKEYINQELEDWANLGVEGHFEAKNPWLHYHEYLTDKMAKIVGAKPVEVVVMNTLTT
NLHLLMVSFYRPTKTKYKIVIESDAFPSDRYAVQSQLKFHGFSEDDVIEWKPRKGEELLN
IDDLEKIVATQGDEIALLLIGGVNYYTGQYLDLKKIAEIGHSKNCVVGIDLAHGAGNIQP
NLHDSNVDFAAWCTYKYLNSGPGSLAGLFVHEKHSKNKDLPRFAGWWNHNKSTRFNMRMP
FDVMEGAEGWQLSNPPILSMAAIKASLDLFDEIGMDVLREKSEKLTGYFEFLINEIGADS
IKIITPKNPKERGCQLSIQVKNADKSLHQKLTEKNIITDWREPDVIRCAPTPMYNSFEDV
YKMVTILKDLL
>FCMOIPGL_00728 hypothetical protein
MRKNILIILLTLQSLVTFSQNKYLSDFNYFWETIQMEYAYFDVKQTNWQKVKEVYSKRLN
SIKEDWEFTYLIELMKHELYDAHFTLNKNLAFSFRLIPNDVDAFVSIKNNKYYIKDIRQN
YTITNFNLKIGDEIVKMNGVNFADIVQLNLPKSIESPDHKVKEYFANLIFAGRHDKPRKI
KVLRNGKFIILKLPKPNLKKYNSTLLDYKLLPENIGYIRINNSLGNNNVIKQFPKIVDSL
QNSKAIIIDLRNTANGGNTDVAKSIMGKFVKEEMPYQIHERVGLEREFGIKRKYIELLSP
LKNPYTKPVYVLVSRWTGSVGEAIAQGFSNMNNVTVVGTTMAKLLGAIKCKQLQNSGIRF
CYPFEKLYNVNGLPREYFKPDFTTNSYKETYLKALELIDEQTR
>FCMOIPGL_00729 Kynurenine 3-monooxygenase
MNKQDKILIIGAGLCGSLLALRLAQKGYKIELYESRPDLRKVDISAGRSINLALSDRGLK
ALRLCGMEEKAKEISIPMYGRLMHDKEGNTFTSNYSGREGEYINSISRGDLNAILLDEAE
KHENVNIHFNSGCESVDIENTIAHFKDYKSKRKFFVKADVIFGADGAGSALRKSYISERK
FLFSYSQNYLNHGYKELEIPADNSGNHQISKSHLHIWPRGDFMLIALPNLDGSFTVTLFL
SYNEGEYNFENLTNTEKINEFFEKEFPDALALIPNIKKEFSHNPTGALGTVKCSPWSYLN
KTLLIGDAAHAIVPFYGQGMNASFEDVFVFDEILNQELSDWKSVFKAYEKARKKDTDAIA
DLAIDNFYEMRDHVANPLFKEKRKIEMDLEKMFPNQYFSKYSLVTFNENIGYNEAMKRGR
AQDKALLNLIADDEVHTHLNMTREELRTILDKVIHETDKILEEDKIAGL
>FCMOIPGL_00730 hypothetical protein
MNTYIILLRGINVSGKNKIPMADLRDLLNSLGFQKVKTYIQSGNIILESSKTKSVTCEMI
NVGIKDKFGFDVPVIARTILEWEKAINNYPFSKQNEKIVAFTFLDKASEITEIEIKNVGE
DEYKINGDVVYLNCPSTFAKTKISNNLLEKKLQVIATTRNLRTTLKLLELAKDLTGF
>FCMOIPGL_00731 hypothetical protein
MKYEVLESNNYYHIFNQGNNGENIFIEDINYLYFFVLTKKYIHPIASILSCRLFKKYFYF
LIQIKDVVAISTFLENTIKKN
>FCMOIPGL_00732 hypothetical protein
MIKIFRNIRHNLLNEGKNVKYFKYAIGEIFLVVIGILIALQINNWNENRKSDAIRKNYYA
QILQDLGKDYIFLRGNISWLNANITLYKKYQEDFAKQKSVKDLIIRSGKLNYYFKYIKFN
VNTIETLQNTGDIKLIPTEIRNKLIDLKRLQDIQVNTASGNYDSFMKEFMNATKLGFMPN
VFDKLIKSNQSNQLYKDLKVEDNFSKIALIINSAYSLKDITEQEQLKSSTLMLASINNLF
NLINEELGNPYANIESVTNSLLKLETLIESGKTIDEIIAVIKKQDKNAPVYDISESYINA
LGYWYINTAKNNKDALKIFKLNTELYPKAWNTYDSYGECLLLLGDTENGIKAYKKSLELN
PKNQSALKVLSKLKVDN
>FCMOIPGL_00733 Methylmalonate semialdehyde dehydrogenase [acylating]
MKIQNYINGEFENSILGNYIDNYNPSNDEAYCKIPNSTKEDVEK
>FCMOIPGL_00734 hypothetical protein
MNKEIKEKIIQVCNDKITKKGENVGLSFYAFFKNKNDNPKLLMEVAKWWIETHQLDHFEK
ATKIKQMILNSK
>FCMOIPGL_00735 3-hydroxyanthranilate 3,4-dioxygenase
MSNLVQPLNFKKWIDENRHLLKPPVGNKQVWKNGEYIVMVVGGPNNRKDYHYNETPEFFY
QVEGDMILKIIDDKGKMMDVEINEGDIYLLPAKVPHSPQRKANTVGLVIEYPRSKKMLDA
LEWYCEKCGNQLYREEFKLDNIETDMPIIFDNFYSDIKKCTCDKCGEIMEAPKKVSN
>FCMOIPGL_00736 hypothetical protein
MKRKLRINGHSHLLPYPEEIPQFMKEKEIFWVDNERKHMLQKGWKRPVTDSSFFLDEKLL
WMEKNKIDHAVVLNLSQLYGNGLRLEEMKKALRFQNDFNAKVQHNHPSKFTCGFVIHPGF
IYGALDEMKRCVEELGLKVLCLPTHFMDSIGQWRCVFDEENDRIFELANKYKLAIEIHPY
DGDKMIKLENTNWRFHLIWMLAQCGDAYHFYTLNGMQERYPNIRTCFAHGGQLAQMNLGR
RIQGFDGRPDLFEGKIHPRKAVGHKNIFFDTLVHDTDSLGLMFKRQGTKQVLMGLDDPYP
LGEMESDKQSSYPGKILDLAVEKGIISNDEKDQIWKDNVLQWLFGDDEKAKQNLIDKILS
>FCMOIPGL_00737 hypothetical protein
MKKFTIIIAIFIATGISAQTNYQTGMQKAFGLWEKGNTTEASQLFERIASVEKDNWLPSY
YAATLEILGSFGLKDEAVLKAKLTKAQEFLDTAKSISKNNPEIIITQALLNLGYIAFDGQ
KYGMTLSGANNQLYAQALAISPNNPRVILGNAEWNMGSARFFGKSTKPYCDEIKRAIELG
KKEEIDIEFYPKFMLERAESVLKLCQG
>FCMOIPGL_00738 hypothetical protein
MKKLLLITAFIFIGFSSTSAQENHTITLDFKGMKSNNGNLYVALYNKEDSFLKNPIKATI
LKIENKKASVILKDIPSGIYAVSAFHDANNNKKMDTNFIGIPKEPIGISNDAKGFMGPPK
YKDAKFEVSKDTELTIIVK
>FCMOIPGL_00739 TonB-dependent receptor SusC
MKRILFIFFTICQFSLIAQNTISGKVTNNKNEPIIGANIYLDGTYDGTSTNDKGEFSFST
SEKGTQTLVISFISFETYIKTADVSSLKNLKIKLRDDVNSLDAVVINAGTFEAGEKAKVT
VLKPLDIVTTASALGDFVGALQTLPGTTTVAEDGRLFVRGGEAEETQIFIDGVRVFTPFT
PSTNNIPSRGRYSPFLFKGISFSTGGYSAEYGQALSSVLLLNTIDKPVQEKTDLAFMTVG
LGLGNTQIWKKSSFSINTSYVNLSPYLEAFPDRNTWNKPFQSLNGEMVFRHEFKDESLLK
LYGAYSYTDFDVIQEDINYANGFRFAMQNRNLYFNTSYKNKFGNNWKFETGISFTNDNSK
LKIIDDNVNSNQNSAHFKFKLKKLFSNRFKLNFGSEYFISDYNENYTPINASKFEYGFSN
NIFASFIETDIFFSKNLATKIGVRAENTGLLNEFTLSPRASISYKSSKNSQFSFAYGQFY
QNPKSNYLKFYNNFKSENTSHFIANYQATKQGQIFRIEAYYKDYNNLVKYNETQPTFNST
FNNNGNGYAKGIDVFWRQNGKIKNTDYWVSYSYLDTKRNYRNYTTSATPNFAAKHNLSLV
TKHWIEDWKSQVGFSYNFASGRNYTNPNKPGFLNNKTKNYNSLSLNWAYLINQQKILYFS
VNNALGTKNVFGYNYKNTPDNNGNFDRQAIIPNADRFFFVGFFWTISDNKKTNQLNNL
>FCMOIPGL_00740 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MNSDKIAKENIARLNTAITFIEGNLSKKLSLEIISEKAYFSPFHFHRLFKLVVGETLHNF
INRKRIEKSAAYLLHQKEKNITQIAEAVGFGDLSAFSKSFKKFYGISPNKFKEESPKKYS
KISKNESKIGKVIVTFEQYICNINNALKWLQMNAKTEIKKTPRLDLAYIAHKGKMEAIGS
IYNKLVKWATPKGLINEQTRMVTIYHDSPKITDPNNLRMSACIVLNDPIDLDEEVNLKIL
SPTKCIVSRLEIAPFEFQQAWESSFAFMVENGYKKSEIDPFEIYYNNAAEHKENKFIVDL
CIPIL
>FCMOIPGL_00741 hypothetical protein
MKKLLLYYFIFSIITGAFIYFSSHLNIQLPRFVRHYVNDFLIIPIILFISLQVLKWSKND
TNYTLSIWVILYLCLMYSVLFEFIFPEYLARYTKDFIDIILYFASGLIFYYLQKTKNEF
>FCMOIPGL_00742 hypothetical protein
MKAKTIKCPNCGTLNTGKKYCTNCNKSLTQEILLQEKLEKIKQQEINKVIYKRENPNFIE
RLKKHSFFLYRIFGWILYSGFVVVSAIGAGLAWFIAMVAAG
>FCMOIPGL_00743 NADH dehydrogenase
MNIPQSSFPRIVIIGGGFAGLAAARGLEKQELQVVLIDKHNYHTFQPLLYQVATGGLEPD
SIAFPLRKRFNDVENFYFRLADVEKINPETNSIETSIGNLEYDELIIATGSTTNFFGNTN
IQKFTMEMKSIPQSLNIRSLILENFEEALLTSNMDERNALMNFVIVGGGPTGVELAGALA
EMKKGILPKDYPDLDIRQMQINLIQSSDCLLKGMSAKASEKAEDFLINLGVNVWKNLRVL
DYDGKTVTTNSEDSFVAETVIWAAGVKGELIDGLATECVIERAARIKVDEFNKVINYKNV
YAIGDVACMSSEKNPYGHPMMAQPAIQQGKLVAKNILAKLFNKEQKAFVYNDKGSMATIG
RNKAVVDLPKWKFQGVFAWFVWMFVHLFSLIGFRNKAIVFLNWVYNYIRFDRETRLIIRP
YKKKNKYSFKE
>FCMOIPGL_00744 hypothetical protein
MKNFNKNNFFKHTFCEFTQIENFEFPENTNYKSKSDSMYFYTDEGVYRKSNHWGRVANCR
WKLISTENYKNQNIVIAFAKWSDFYPINSSEKIFFIDVDFDSKSAKLQPKIENSTNFLFT
FSEAQKRIKQINHLFKDDKWAKYFNGNLNDIRFKIISDFMNSDKILQEIKREFN
>FCMOIPGL_00745 hypothetical protein
MKNFKKTQLVSVTKLVVLAITMVFASCSSNNEDDVIKEQSITAANFESHTSYSDNGYTNI
QFGDVTNNSFVPIIKVENYNDAYNYSIVIKGDYLENEYKVALTFDEVNNSGDTILKFDNA
EFDAVPDTYQAYVLEEDSNTEVIINNRPNQGERTYYVYDADHSEYLYNLTFKTSRTDFTR
PTAIYKNEDIYVGFSQGFSQDLKLEMVVYDTDLNALGRVDIHNVNTSYTNKFYGTDLTFI
TESGNYIFQVEGTPLATSSSNTIKKSTYKTMTVNIN
>FCMOIPGL_00746 Internalin-J
MKTKLILFLVTFVAMVANAQQTVGTIFTVGGFKYQITVAGSANASSVREVAVIDYLDVNN
FTPTIPSTVFSGTTYNVTSIGEEAFRSNSLTSVSIPTSIISIGEDAFLFNSLTSVSIPNS
VTSIGQSAFSYNPLTNITIPASVTAIGAYAFNYNSSLVSVVSESTNPSFLLSGVFDNNNS
IDLTIPVGLEQTYIDANWVGFNTINTIDYTFTQNDIVYQILDITNNDIVATYDYIGTSTT
ISIPATVTNSGSTYNVTTIGDASFDYNSLTDVTIPASVTTIRAAAFKNNSLTSITIPESV
TTIGASAFENNYYLTDVTSKSTTPATLLSFTFSNNNIDTDLTIPENTTTAYTTAGWVGFK
SVTEVASLCTVNIPDANFKAYLVGNSLINTNGDTEIQCSEATAFTGSIVAISLNISDLTG
IEAFTALTSIDCRDNQLTSINLPSSTALTELKCGENQITSLDVSANTALTNLSCHTNQLT
SLDVSSNTALTELDFDTNPITSIDVSANTALVRLAISRTQLTSIDVSTNTALEDFFATDC
QLTSLDVSAQPNLVLLWCNENQLTSLNIANGNNGNMTSFYATDNTALTCIEVDAAIVGTS
PTDWYKDTTATYSASCTTCTVNIPDTKFKTYLVGNAAINTNGDTEIQCSEASAFTGTIDV
SSLTINYLTGIEAFINITELNCNYNNYISSIDVSTNTALTSLACNGNVITSLDVSNNTAL
TYLDCANNLIPSLDVSANTALTTLACNGNLLTSLDVSQNTLLINLWCHINQLTSLDVTNN
INLEFLTLYINQLTSLDVSNNMALEQIQCFNNQLTSLDVSNNTVLEQLHCSNNQLTSLDL
SNNTALTRLSCAINQLTSLNVANGNNSNIVNASFYAGTNPNLTCVTVDDVAYSDANWTNI
DAQTSFSTNCGALSTDNFSLNTVSIYPNPTTSVLNIKMDSNLKRATIYSVLGTKVLETSS
KNITTSNLNKGIYLIKIETEDGAVSSKRFMKE
>FCMOIPGL_00747 hypothetical protein
MKKMKQIILAIVLLVATVTQAQKSFFDNISEDDIYNVYIKMSKAGNGTYKAEERGTPVKF
KKEYLPTGEGYKFSTILQEGPKKGETDFTVDISDKKIECKGYPYESVISGEDWGYRYYYV
SIGDYVFSLKGVSTKFATFKGINAVYIKAGKPEKADTEKKTKKKNSFFSKMKALKNQALG
SAGVFGSEYKEFKNKNMDKIITDYLVAMKAKQEGRTAAQKQSDTNVANLTKNKMAKEKAA
KDASYAEAKKYNDSVKATPEWKDLERRKRQNEANYQSRQKADFVTLRNTSGSAIYVARSG
SKNRGTKISTGGSVKWSCGQDAYIQVNNTTTNTKVYSKNSGCGNTITVR
>FCMOIPGL_00748 Sensor histidine kinase TodS
MKKKYESIIALGTKDSFSNSLNKRIRLLNTYCLVWGHVILLFLSLDVIVGLVLETISQNT
ITLDFFDFNMFLTHLYILILLILILFLNKRFLFKPGRFVFITTVIIANLYASLIISPGSY
IEYYFLLISPIAITLYQKKITSYLFLAIGFLCFLTPYYIYIVYPPDYVDKLIILETACIF
VVIHLLVNYFKANNLKYEKLLALERDKVLSDKIILEKQEAELRELNEFKSHFFVNLSHEI
RTPLTLIQGYTNQLSFKDSDTENKQKATIIKEQCQQMQDIINSIMDLSKMESDQFQLISE
PVDINSFLEKHFTDFQSLFAKKNIDFVFNNNTLKTTILVDEKLFSKAITNLLSNALKFTP
ANGHVSMNTAFTDEGLKIDVIDSGTGIHIEEKEAIFNRFYQVKNDITKSQGSGIGLAFTK
SIVNAHHFKIAVKSSFGEGCCFTISIPKTFVNSTVNQSSTKILDTLDNIEVATTNIKKQS
KTISINKKQKILVVDDHVQMRVYLKKVLQNYDVTEAENGKEALHILQNNSFDLILTDYMM
PVMDGEALVKQLKKQQNKTPIIVLTARTDQQGKLSMLRLGIDGYLYKPFMEEELLINIKN
SISLYKNVIEFDKGKSPEVLKSLNEYADKFNTKITSYINQNINSPLLTVDTISEYMKVSR
STLNRKVKSILGQTVNQLIQEARLEKARNLRSEDPFASKKQIAEAVGITNSTYLFDKLKE
RYGT
>FCMOIPGL_00749 Chaperone protein DnaK
MSKIIGIDLGTTNSCVSVMEGNEPVVIPNAEGKRTTPSIVAFVEGGERKIGDPAKRQAVT
NPTKTVSSIKRFMGNKFSESSNEIKRVPYKVVKGDNDTPRVDIDGRLYTPQEISAMVLQK
MKKTAEDYLGTDVSAAVITVPAYFNDAQRQATKEAGEIAGLKVERIINEPTAAALAYGMD
KAHDDKKIVVFDFGGGTHDVSILELGDGVFEVLATDGDTHLGGDDVDAKIIDWLAAEFKA
DENMDLTTDPMALQRLKEAAEKAKIELSSSAQTEINLPYITATASGPKHLVRTLTKAKFE
QLIDDLIKRTIEPCKTALKNADLSTSEIDEIILVGGSTRIPAIQEAVEKFFGKAPSKGVN
PDEVVSLGAAIQGGVLTGDVKDVLLLDVTPLSLGIETMGNVFTKLIDANTTIPTKKSQVF
STAVDNQPSVEIHVLQGERAMAADNNTIGRFHLDGLPPAQRGVPQIEVTFDIDANGIIKV
SALDKGTNKSHEIRIEASSGLSEEEIEKMRQDAEANADADKAAKETAEKVNGADSMIFQT
EKQLKEFGDKLSDDKKGPIEAALVELKAAHESKDLAQIDAAMEKINEAWKVASEEMYAAE
QAAGGADAGAQQGQPEAGADQGDNVEDVDFEEVK
>FCMOIPGL_00750 hypothetical protein
MSKFDEKVAQYSKFMDDKGLEYNAELLKAVTKGLGPSIYKRDAETVSGSDAKELETVKKN
FLMKKLGLEDGPKLDEAIAKVVEAIGKSERSKYRAVVYYMLAVEFGKESVYGM
>FCMOIPGL_00751 L-serine dehydratase 1
MSQFISVFDMLKIGVGPSSSHTLGPWRAAEAWIRKIKNNQLFDSIDAVKVDLYGSLSLTG
KGHATDLAILLGLSEADPEYIPIEDIAIIVERINTQEEIYFKGGKKLPFPKNSIKFNRDF
LPFHANGMTFRGFQNDVEISTETYFSIGGGFIVQENDTLEKEIEITEKNFPYPINRAIEL
EEYCEKENLLISEIVYKNELELRTSEEIDFELNRIWDTMLECMYLGCHTEGKLPGGLNVK
RRAFDLHNKLIKDTTYKNPKEWITAIRSTEVKFREILKWVSCFALSVNEVNAALGRVVTA
PTNGSAGVIPAVLMYYLVIENHEADFSHIKRFLLVAGEIGSIFKKNATISAAMGGCQAEI
GVSSAMAAAALTELLGGSPAQCLSAAEIAMEHHLGLTCDPIAGLVQVPCIERNSMGAIKA
IHAAEIALETNPKEALVPLDKVIDTMWETAKDMNKNYKETSEGGLAVTVRIVDC
>FCMOIPGL_00752 hypothetical protein
MKIIISPAKSLDFESKVATSLHTQPRFLEKSEKLNKKLKTLSKKKLSELMKISDDLAALN
YDRNQTWQTPFTTKNSKQAIYAFTGAVFQGIDVNSLDEKKLPILQENLRILSGLYGILKP
LDLIQPYRLEMGTKLKVGRTENLYKFWDDTVAKSLNDELKDDELLVNLASLEYFKVIPKK
VLKVPMITPVFKDFKNGEYKTIMTYAKIARGLMVRYIIDNNVKTIEDLKGFNVDKYRFSE
EMSSGNELVFTR
>FCMOIPGL_00753 ECF RNA polymerase sigma factor SigW
MNKDAELVKKLKDATQKDSAFSELLDVYQERLYWHIRKIVATHENADDVLQNTFIRIYKS
IQNFQEKSSLHTWMYRIAYNESIRFLEKNNKKRADNIDEVSESHLAILFEDAYFDGDEIK
KKLHKIIEGFKEKQKQIFKMKYFDDLSFRQISEILEVSESTLKSSYYSSVKTIEEKIFL
>FCMOIPGL_00754 hypothetical protein
MGKSIENNNNKNFLKQGFKGNISKHHKKYLGTEIPKGYFTKSKLSILDKIKEESNREEPK
KQIVFWMKPQFKYMIAASLVFLFALTVWLQNSANNDANFELLVFSDDVLLESLLIEDSEI
DDFTEATLFNEIVIKAELSEQKLDNLIFNNLILEDSLLDNYIDDELLKTIIL
>FCMOIPGL_00755 hypothetical protein
MKTSISRERIFKSSILFLTISAFVLSALLFTSCSDSETSENELAISDTALVEKIESASKV
TVAIASLPVETASAFSGDLADSYIESAEFAAGLGYKVAIATDNQSREEVTSDVYFSLQGK
QLADSNEKRTKRRSKCFEFVFPIDFIMPDDSSITLNSKDDWTLIRTWYEENPGATERPEL
VYPVDVTIEDGTVQTLIDSSDLDAIKDSCKKGKSKRKCFKLVLPVSFTMPDATVIDITER
SDYKLLKEWCKANPDATEKKSLNFPVDIEYRDGTTATVNDQTEYDAAKDAC
>FCMOIPGL_00756 hypothetical protein
MKLKNIIFTLAFFSLMLFNTKVFAQESSFNLIQKELTKQQRDLLQQEKEVMKTNREAFKA
SLTKEQLAILKDKTISKSEIRKRLVATFSIDQKKMVSDQQISLRKTRENFRSTLTNEQRK
MLKERIDKIRNSKDRGELKDGSRINNTKNERKKRN
>FCMOIPGL_00757 hypothetical protein
MRRLFQGLKNRFKVFGLLLISMATSFCSYAQEENLDDLDSLIDELFFNDQQFLDELIESD
FSFNFLYTSVSYNSNTFFSGRDSGTDQFNIIPQVSYYHSSGFNASISGIYYQNFEPSWDF
TSVSLGYFNSFGKKKNLLYNLGYTKYFYSDGYDDFTNSLDISLGIRNKKRTLGTTVSASY
IFGKDNSYQIITSTFANFTLTRAANFALRFRPSINFIIAKQTLAIKNIVFYNGQSVLQTL
NDNVFDLLNTQLNFPISLTTNSWDFELGYNLNLPRATATESDLPTTGFFNLSVGYMFDLN
K
>FCMOIPGL_00758 putative HTH-type transcriptional regulator
MGLTKSEIFTEEQNKIAAIAKVLGHPARIAILEFLIKLKSCVCGDLVKDIGLAQPTISQH
LKELKKVGIIKGTIDGTSVCYCIDQENWDKIKNILGKFLNKNSTESCC
>FCMOIPGL_00759 Arylsulfatase
MYSNKLVRKYKLSITCILFVIITINVSCRTTVLSTVTNIETEESKPNILFILTDDAGYHD
YGFQGSKDFKTPQIDRLAASGIFCTNGYVSASVCGPSRAGILTGRYQQRFGFFMNPNDSQ
NLPKDETTIADALKENGYKTGIIGKWHMGFEENFHPNDRGFDYFYGFLSGNRSYFPLPKK
MNKKRRYKDNLRHNDSILPEASMDFYTTDLFTDKAMEFMADSQKSKKPFFLYLSYNAIHG
PLNALPEDIAVYKDLKDPVRRITGGMTASLDRSFGKLLDYLETNGLRENTLVVWVNDNGG
QGKKMHTNNWPLKGFKGAETEGGIRVPFLLSMPNILPENKRYDLPVISLDLMPTFIKLAG
GNPSANPKPLNGVNLMPYLKGENTNSPHEILFWQRNDAAVRKGDWKLIDYVTKNELHLYN
LKKDIGEKINLIDKYPEIAKELKKELSKWQNQNAPRMK
>FCMOIPGL_00760 hypothetical protein
MKLSEIKNHLKGLEKIAFQLPNGELVPSHFHVTEVGKITKDFIDCGGKVRSENVINFQLW
EENDYDHRLHPEKLIGIIELSEKIFKFDDLEIEVEYQGKQTIGKYNLDFDGTNFLLTSKI
TACLAKDACGIPQEKPKLEFSEAQGSCCNPGSGCC
>FCMOIPGL_00761 hypothetical protein
MKEMWESRYSAEDYAYGIEPNTFFKETLEKYKLEGTILLPAEGEGRNAVFAAKKGLNVLA
FDISEEGKKKALKLAAKQNVTINYKVGDFFNLDIVNHKYESVALIFAHFPVSILSKYHKK
IGDLIKPNGLVILEGFSKNHLKLSEKNPSLGGPKNIEVLFSKESIQNDFPDFEILLLEES
NVNLSEGKFHNGESSVIRFIGRKKEK
>FCMOIPGL_00762 Ribosomal large subunit pseudouridine synthase D
MQENQSQDIENDDLYEHYRFTASEGQEPLRVDKFLMNFVEGATRNKIQQAAKAGNVLVND
IAVKSNHKVKPNDIVRVVLAYPPAENLLVAEDIPLDIVYEDDTVIVVNKPAGMVVHPGHG
NYSGTLVNGLIYHIENLPSNSNERPGLVHRIDKDTSGLLVVAKTEFAMANLSRQFFDRTT
ERLYYALVWGNIEEDEGRIEGNIGRSLKNRLQMSVFPDGDFGKHAVTHFKVLERLTYVTL
VQCKLETGRTHQIRAHFKHIGHTLFNDERYGGDDILKGTTFTKYKQFVQNCFKVLPRQAL
HAKTLGFTHPKTGEFMQFNSDIPQDIVDCLEKWRTYSENSKHEFE
>FCMOIPGL_00763 hypothetical protein
MSILKFLKSKTFFKQIAFAIIGLVIFVFFLKFWLGVTTNHDQKIQVPDLHKLTITEAERT
LKELNLDFIVIDSASYNPTYPKKSVIEQNPEEGDFVKEKRKIYLTLNPSKYRDITIPDLN
GRTKRQAISELQAIGFIVGTDFTYVNDIGKDVVRGLRHKDKIINANDKLPKNSIIELVLG
DGERN
>FCMOIPGL_00764 D-alanine--D-alanine ligase
MKKNIAIVMGGFSSEVNISLKSGNVVFKHLDRKKYTPYRVHILKEKWVALDDESKEYPID
KNNFSFVIDSKSVTFDCVFNAIHGNPGENGELLAYFNLVGLKHTSAPYYQMALTFNKRDT
LSVVKEYGIKTATSVYLNKGDVINTDKIIAKVGLPCFIKPNNAGSSYGISKAYNKEEILK
GIEVAYKEDSEILIESFLDGREVSVGVIQYKGAIKVLPITEIVTENDFFDYEAKYEGKSH
EITPAQISSEEKIKIEAIAEKVYKVLNMSGFSRSEYILVNGEPHFLEMNTVPGLTEASIL
PQQAQVAGISLSELFENAIESACE
>FCMOIPGL_00765 Phosphopantetheine adenylyltransferase
MKRAIFPGSFDPITLGHFDIIERGVKLFDELIIAIGINADKNYMFTLEERKKFIEDCFKD
EPKIKVLTYQGLTVNFCEEQNANFILRGLRNPADFEFEKAIAHTNRKLSEVETVFLLTSS
GKSFISSSIVRDVIRNKGDYTGLVPESVIVK
>FCMOIPGL_00766 hypothetical protein
MKNILKQIFFFSFFFLMISCDNSSKENTDFTTLFEKSNGTETPEYKDVITYYKKLSEAYN
QISLFSFGQTDSGEPLHLAVYNSEGIFNVDEIKNSLKNRILINNGIHPGESDGIDASMML
LRDIVQNDSLQEKYKNSIICVIPVYNIGGSLNRNSHSRANQNGPKEYGFRGNARNYDLNR
DFIKQDTKNAAAFAAIFHAVNPDVFVDNHVSNGADYQYAITHLFTQHNKLGGNLGMFLQN
EMQSQIEESLEKKDIIITPYVNVWGTTPEAGFSQFFDSPRYSTGYTTLFNTLGLMVETHM
LKPYKIRVEQTYELLFSVFDVTEEKSKKIKELRLNASDKILAKKTYPIQFKVDKEAYRDL
SFKGYEGEIIDSKVTNGKRLFYDRNKPFEKVVKYYDEFVATKEITIPKAYILQQGWHNVI
DRLKNNHIEFTRFKKDTIITVEVNHIKDFKTSKTPYEGHYLHSKTTVTSTLAKINFKKGD
IYIDTNQNGVRYLIETLEAAATDSFFNWNFFDTVLQKKEGYSAYVFEDVAAQILAEKPAI
KKAFENKLTSDEDFAKNPRMQLDFIYKNSPYYEDAHLRLPVFKIF
>FCMOIPGL_00767 hypothetical protein
MKSFLCSVFLIILVSCNNTSEVAKKDLKEIAKEIMISAKNCALITVDSLGVAHARTMDPF
LPEEDFTVWLGTNSKSLKVRQIKQNKLVTLYYFDAKNVSYVTLQGVAHIVNTQKEKEKFW
KNEWENFYKNKATDYMLIKFIPNKATIISEKYNILGDSISWETPIIKF
>FCMOIPGL_00768 6-phosphogluconolactonase
MNKIAIVFLMLISTLLITGCKAIQKENYSFYVGTYTKTTSKGIYKYAISSEGELKKIALV
AETINPTFLAKSKDNKTLFAVGETNENGSGFVKSFKIENDSLLLISKEESGGAGPCFVAL
NDDNYIVTANYGGGNVGLLKTDTSGKLSSLLNVQQHFGKGSTNRQKAPHAHSAWFYPTKN
ELISVDLGTNQLWFSTIDKEKNELVLTNQKTLKMAEGAGPRHLTFHPNNKWMYVLNELNN
TVSLVKEKDKNYFIASSVSLLPADFKSYSKAADIHITKDGKFLYASNRGHESIVIYKVNQ
KDGTLKTIGFQDVLGKSPRNFSLSPNEEFLVVANQDTDNIISFKRNAKTGLLTFVSEIAA
PMPVCILF
>FCMOIPGL_00769 Isoquinoline 1-oxidoreductase subunit alpha
MSKNLTINGKVYTVDVQDDMPLLWAIRDIVGLTGTKFGCGAGECGSCSVIIDGALTKSCS
MPVSYGVGKEIFTIEGSSENLEYLREAWNDGNVPQCGFCQSGQLMAATSLLDKIENPTDE
DIDLAMSNNICRCGTYSRIKKAIHKAVALKNESL
>FCMOIPGL_00770 Membrane-bound aldehyde dehydrogenase [pyrroloquinoline-quinone]
MSNIQQINRRDFVKLFGLATGGLLLGCNISSGKKDFIPHTNGTLAPNLFVQIQKDGTVIL
IASRSEMGQGIRTSLASAIADELEADWKYITVKQATGDAKYGNQNTDGSRSVRTLLAPMR
KMGAVAKAMLVTAAAKKWKVAETDCIAKNHFIINTKNNDKIFFGDLVDDAVKVTIPDEET
IKLKKVADFKFIGKTLKSVDLKDFTNGTATYGNDVRIPDMKFAAIARCPVTFGTVKSFDS
TDAEKTPGVEKVFQLDRMEPPTGKFYGALGGVAVIANNTWAAFQGKLNLDIEWNYGKNHS
FDSEKFKEILTKRVKEKGKSVPGNSGDVDDAFEIAEKTIEATYYVPFLAHTPMEVPNATA
WYQKNKIEVWAPLQDPQTARAELAYFFEVPLESITINVTFLGGGFGRKSKSDFVVEAVAL
SKEIKAPVQVVWTREDDIQNSYYHATSTQYLKGSLDKNGQVTGWLQRVAFPSIGSTFKPL
SEYAGGFELNQGFTNNPYNLANFSLENAKAEANLRIGWMRSVVHIHSGFGNNSFVDELAF
VAKKDPIKFHLDLIGEDRVIEGRSEFPYDSKRMKAVLKNTAKISNWGKELPENHGLGVAI
HYSFYSYVATIVEVSVVNEKVKVENVWTTIDCGLALNKDNIKNQLEGAAIFGMSLALYGK
ISVKEGAVEQQNFFDYQMTRMKDAPKIHVDIIDAMDKHPTGVGEPGVPVMAPAICNAIFN
ATGKRVRSLPLSDFGMV
>FCMOIPGL_00771 hypothetical protein
MQAVTTGTVDLETISNVISNECSLHSVDVQAVLIALGKKLDFYLQEGNIVDLGAVGKFKM
GFQCTAEEDPKLLSPKRNIKKYHVNYQPSVKLKRVLKKGITTYKEGSRSI
>FCMOIPGL_00772 hypothetical protein
MSTKYKATMTDTGYFVTITIVGWVDVFTRLKQRYIIINALNYCQKEKGLEIYAYCIMPSH
VHMLCKANEGYLLSNIMRDFKKFTSKKIIDTIINYPESRREWLLDFFKNACKHLNRKQTY
KVWQDGYHAEICNSNTFIKQKLNYIHNNPVIDKIVANPEDYMFSSARNYADLDSELDVVV
LNVF
>FCMOIPGL_00773 CTP pyrophosphohydrolase
MNKIINVTCAIISFKDKTLAVQRSETMKLPLKWEFAGGKIEVGESEIDCIKREILEELNI
QIEVKERLTSVVHQYPNFKIKLIPFIAEYIKGELKLREHSDFVLANKKEMLNLDWAEADV
PILKEYMKL
>FCMOIPGL_00774 Putative DNA repair helicase RadD
MNKGIYEELITQLINDKLNEIDKDKFFLKKNLIDKEEASGILSKHLSKTVKQAFDLIKGQ
NKVEEQIKIANKIIKLLKQELKKQDFDEDLVHVEGEILKAVFSKTDAHFSNLDLHLKEIT
PYTTLTQSELFTGGNGGLSLESELKKEILSSDKINLLVSFIKFKGIIILEKELREFTERG
GELNVITTTYIGATDYKAVQLLAKLPNTKVKISYNTSNERLHAKAYLFYRNTGFHTAYIG
SSNFSRSALTDGLEWNLKVTTKEVSHIIDKFQKTFDAYWQSNDFELFNDSIHKEKLQDAL
KQSKFSKPYENTTAFFDIKPFPYQKEVLEKLEVERTVHKRFRNLVVAATGTGKTVISAFD
YKRFKQNNESSKLLFLAHRKEILQKSHSTFQGVLKNNNIGELWVDGQVPDNFECVFASVQ
TVNNQIENVNISADYYDYIIIDECHHQKAKSYRSIINYFKPKILLGLTATPERMDGGDIL
EDFDNKIAAEIRLPEAMNKKLLCPFQYFGITDSIDLSNVKWVKGRYVASELTDVYTVNDR
RVREIIDALDKYTKDVNDVRALGYCVSMEHAKYMSEKFTLAGLKADFLTSNNSKDRVHIR
KKLEKKEINYLFVVDIFNEGIDIPEIDTLLFLRPTESLTIFLQQLGRGLRLFEEKDCLTV
LDFVGNSRPEYNFESKFRALIGKTNTTVVKEVEDNFPHLPLGCSIVLEKKTKETILKNIS
AATSLNKNKLIQRIQQFQHDTDLSLTIGNFSAFYNIPLQSIYKRNSWKRLCQLAGKINDF
DSKNEKPIISAISNKWLSTNSLSYFTFILKIAKQNFAINISEFNSNEKTMLLMLHYDVWQ
KEGGFDSLEESIKAIGLNTILVEEITEVLEVLIENIDFKELPIELPYQQPLKLHSRYTRD
QILVAFKFSSFEKKSSNREGTAENKDLNTEVLFINLIKTEENFSPTTMYNDYAVTESLFH
WQTQNPARPDLGKGLSYINHKKTKKRILLFVREKAINEFGKSLGFIFIGEGNLKDHRGSK
PMSINWELQEPMPHYLWKDAAKLSIG
>FCMOIPGL_00775 hypothetical protein
MKEETNTLYAIYKNGIHLGNEKGININDAIRKYLIASLYEDFLEDKEFASLYSGKESIKK
IHFL
>FCMOIPGL_00776 Bicarbonate transporter BicA
MTEFIRKIIPNAKDDVLAGITVSLAMIPEVVAFAFVAQISPIVALFGAFVVGIISASFGG
RPGLISGAAGAVAVIFVHMIQEGHAKGLLFDNPVENMGYFYLLAAVVLMGIIQVFAGVFK
LGRFVRLIPHPVMMGFVNGLAIVIFMAQLGMFKENKKDFFGQNMRKTESKELVYNVSNNQ
VKDLKSNTLLFTIDGKSVKNSNTNEEVFLVSDGQVFDAKTKKVVFNASDEGFYTVKDSGV
VKTTMQGNTLYVMIGLVLLTMFIVWGLPKLTTKIPAALTAILIVTLISIFSGLGSINVGD
FIRDGGGAGLNGIAELSKNLNVVELWSNLPFNLDTLKFIAPYAFLAASVGLIETLMTMNL
VDELTESRGNGNKECIAQGAGNIVSGAFGGTGGCGMIGQTVININAGGRGRLSGIMMALT
LLTFILFADKYIEQVPIAALVGVMFMMVIETFAWSSFRILKKIPRSDAFVLIIVSAVTVF
FDLAIAVFVGVIVSALVFAWESAKKIRARKRFREDGTKVYEIWGPLFFGSIATFNEKFDI
KNDPEKVEIDFVEARVSDHSAIEAIYALVEKYQAAGKTITLKHLSEDCKLLLYKSSPVFT
DIIIDDIDDPRYHLAANPEKFPKPLKEYKF
>FCMOIPGL_00777 Diadenosine hexaphosphate hydrolase
MYKVFINDKPIIITSSLKKENIFPVYNFKNILFDEVLNKLKNDDIKGIKLISSDIETDWL
IFLKNMKVIPAAGGLVLNQKKEVLFIYRNNFWDLPKGKIEKGESIETAGIREVEEECSIF
NLSIKKKLITTYHIYFYKGIKLKETHWFLMTSDFDKPLVPQTEEGITEVCFKNEKEIDEA
LKNTFANIKLVYDAYKKA
>FCMOIPGL_00778 Orotate phosphoribosyltransferase
MILNKDNAKKTAKHLLQIKAIKLSPNDPFQWASGWKSPIYCDNRITLSFPPVRIFLKEEL
AKIVELQYGKPDVIAGVATGAIAIGVLVAQELGLPFVYVRPEPKSHGRKNQIEGYLERGQ
NVVVIEDLISTGNSSLNAVKAIKEAGGVVKGMVAIFTYGFQIAEDNFKENNIRITTLSNY
ENLLEQALDSKYISLKELDTLKEWKGNPSQWKQEKVDNYEY
>FCMOIPGL_00779 hypothetical protein
MNISGTKVVVKKSQKETFEFLSELKNFEQLMPESIQKFEVEGDSFIFGLKGMPEIRLILK
ESTEFSNITLGAASSKLSFELVAIIDEINESSSEVQLDFNGEFNMMMAMMVKKPLTSFID
TLTDNLGKV
>FCMOIPGL_00780 Bifunctional ligase/repressor BirA
MGQNSTLKNFTVVVTNNQEKGRGQVENKWISKPFKNLTFSVFTKDFDLEIKDQKYLNFAI
SLAIFNTLSNYKTPNLSIKWPNDILSANKKICGILIENNIKGTKITSSIIGIGLNVNQEK
FADSLKNATSLKNSTNSKYDYDLDDLLLEIIENLKNTIHLLSLKKYQELETGYLNVLYKK
NIPSMFKDRNDVLFMGKIIGISLYGNLQVELEDEIVKEFGLKEISFA
>FCMOIPGL_00781 Ribosomal silencing factor RsfS
MAKKQASADDLISLIIKGIDDVKGENILLLDLREIENTVCDYFIVCSGSSNTQVNAISGS
VQKVVSKALKDKPWHIEGQGNSEWILMDYVNVVVHVFQKHVRDFYDIESLWGDAKITEIN
PV
>FCMOIPGL_00782 ATP-dependent zinc metalloprotease FtsH
MSDSNKENKSNLPKFKFNSYWIYGAIFIIIIAVQFFSSGDLASKSISKNKFEEILKDNDI
KEIVVVNKDIAQIYLTTEALKKEKHSKQTTTTFYRPGSPVYEYNFGDLRTFEENVASIKK
ENNLIVDVDNKESTSIFDAILGFLPFIILIAVWLFFMRRMSGAGGGAGGGGQIFSIGKSK
AKLFDKDTKVKTTFENVAGLEGAKEEVQEIVDFLKNPDKYTSLGGKIPKGALLVGPPGTG
KTLLAKAVAGEADVPFFSLSGSDFVEMFVGVGASRVRDLFKQAQQKSPSIIFIDEIDAIG
RARGKNSMTGGNDERENTLNQLLTEMDGFGTDTNVIVLAATNRADVLDSALMRAGRFDRQ
IYVDLPNINERKEIFEVHIKPLKLAEDVKIGFLAQQTPGFSGADIANMCNEAALIAARNG
KKAIHHQDFLDAVDRIVGGLEKKNKVITPKEKQVIAFHEAGHATVSWMLEHAAPLVKVTI
VPRGQSLGAAWYLPAERMIVQTEQMLDEMCATMGGRAAEKVMFDKISTGALSDLEKVTKQ
ARAMITVYGLNDEVGNITYYDSSGNDAFVKPYSEETGRKIDKEISKMIENQYQRAIKLLE
DNKEKLTTLAELLLEKEVIFKDDLQEIFGKRLFDEIEEAEVDATKQELEKPTVDKISEE
>FCMOIPGL_00783 hypothetical protein
MNFFKKLFNIQETEDKEIQEQEINLSLDESFVHNFVEKGGKFLYCLNKEEVIDNFKKVLS
ENSWDEVYLLNDKLASLFNKNEVKILNKFNDNTPILTPCEHLIADSGDILFSSNQLKSTK
LGDFSDNFIVYATTSQLVKDTGQGLTGIKTNNKEQIPTNISPIKNYVINKNDDNFLNYGN
SNSKNLYLLLLEDL
>FCMOIPGL_00784 Phosphatidate cytidylyltransferase
MRHLLKRSFSGIIYVLLFLFAILFSRESYIVLTTIFGFLCIWEFNKMVDLKNYASYIFYA
FVLFLMLQRQESYATVLVLSITLLSSLFLIYQLFAKKQITFSNDRAKLGVTIRYIIFSIC
FLVLLPFHKNTFHPYLMISILSIIWINDSFAFFIGKNFGANKLFPSVSPKKTIEGFLGGL
TFSLIAALFISKFNLEFSMINWLVIGVIVSVVGTIGDLVESKFKRQAKIKDSGNIMPGHG
GILDRLDSLLFAAPFVYLYINFII
>FCMOIPGL_00785 Phosphatidylserine decarboxylase proenzyme
MIRFHKEGYKIISITFIIAISVILLADYFIDITWLLKTIQVIMLGFVVIVLQFFRNPARH
TKLDENQIIAPVDGKVVVIEEVEEPEFFKDKRLQISIFMSPINVHVTRYAMSGIIKYSKY
HPGKYLVAWHPKASTENERTTVVVENKTFGNVLYRQIAGALAKRIVNYAKVGDKVVQGTD
AGFIKFGSRVDVYLPIGTKVNVKLGDKVKGGVQVIAEK
>FCMOIPGL_00786 hypothetical protein
MVSKLSQKNNIDLDTEYKAAFDKISKLKEAVAPDIMLKFYAYYKQANFGNKFSFNNGSDL
RTGFKFNAWMQLNGMTTEEAKREYIELAKEF
>FCMOIPGL_00787 hypothetical protein
MKKIFIISFLVIATAFNFTACKSDTKKEESKTEEIESTTKSESTFSVTNAKNEINFTAYK
TSEKVAVGGQFKEINIIAGGEGNSVKEAINNTEFSIPVSSLFTKDTSRDFKVKKFFFGMM
EDTQLLSGKLMITDDANGTAEIKMNGVSKNVPFTYTIVDKTFNMKATMHINNWNASKALE
ALNKACFDLHKGADGVSKTWNDVALDITTTF
>FCMOIPGL_00788 Epimerase family protein
MAKVIITGGTGLVGKRLSKLLIDKNHQVVILSRSPKNKNEFKWDISTNYIDEKALLNADY
IIHLAGAGIADKRWTTERKQIIIDSRVNSANLLFDKINELSIALKGFISASGVGYYGAIT
SNKIYTETDKPGNDFLSEVCQKWENAAHHFLAKDIPVTIFRTGIVLSDKGGALDKMKTPI
ISPLGSGKQFLPWIHIDDLCEMYIKAVEDNLTGIYNAVAPEHQTNTSFSKILAKSIKRPF
LPIAVPDFLLKLIFGKMAIILLEGSKVSAKKIEKNGYSFRFKTLKKALNNL
>FCMOIPGL_00789 hypothetical protein
MLRYIKAMLIFIFDAFKAVFLSSMKNNSKRKGFVFKTYEAENQSPFEKLFEIFKELITHT
SGDFDEAIDWLRSLDKEYKLTDENYTIDDFIEDLKKKGYIKEEIKGDGTGGTKITPKTER
AIRQQALNHIFGKIKRSGAGNHKSKSPGIGDEHTGDFRNYQFGDALDKVSMTESIRNAQI
NNGIDNFNLTESDLVVEETLHKSQMSTVLMIDISHSMILYGEDRITPAKKVAMALAELIT
TRYPKDTLDIIVFGNDAWAIKIKDLPYLQVGPYHTNTVAGLQLAMDLLRRKRNTNKQIFM
ITDGKPSCLRLPDGQYYKNSNGLDKYIVNKCYAMAQQARKLHIPITTFMIAQDPYLMQFV
RAFTKANQGKAFYTGLKGLGEMIFEDYETNRKKRIR
>FCMOIPGL_00790 hypothetical protein
MNLENIKTLGELKKSGYESKSIKDELRENLISKMMNKETVFKGVHGYENTVIPELERAIL
SRHNINLLGLRGQAKTRLARLMVNLLDEYIPVVTGSEINDDPFNPISRYALELIKEKGDE
TPIFWLHRSERFAEKLATPDVTVADIIGDVDPIKAANLKLSYADDRVIHFGMIPRANRCI
FVINELPDLQARIQVALFNILQEGDIQIRGFKLRLPLDMQFVFTANPEDYTNRGSIVTPL
KDRIGSQILTHYPEDIETAKTITQQEANKVNAQKEFIEVPELAKDLLEQIVFEARESEYI
DAKSGVSARLSISAFENLLSTAERRALISGDDKTMIRLNDFDGIIPAITGKVELVYEGEQ
EGAQVVAETLIKNAIKTLFPSYFPEIKKLERQDAESPYDDIISWFFNADEDFELLDEYSE
EQYKTELDKVKPLDDFVKKYQPNITKEESYFIKEFVLWALVEFKKLSKYRFAEGTQFKDP
YGNFISGL
>FCMOIPGL_00791 HTH-type transcriptional activator Btr
MKVYSEITPLRDANIFVIQNHINARFDYPIHLHPEFELNLVMNCSGRRIIGDSVNDFHKT
DLVLLGPNLYHKWERTDDKNSIAKVITVQFDKNLLSNNILNKNSLKPIKNLLENSFRGLC
FYEQTKKDLIIQLHDLFNLKGFDATIKFLSILNNLAKSESYNYIAGAGFSSDLELSKNQK
IHKTYDYITANYKSNNLSVKKIAEINNMSESAFSHFFKKRANKNFTEFVIDFRITQVIKL
LQETNKTIREICYECGFNNISNFNRIFKKKMNVTPKSYRNKIQRISNLKNAGFNEEHNIN
KYTL
>FCMOIPGL_00792 TonB-dependent receptor SusC
MKKNKKQVITRSCLLLFFVLQTVFMASAQEVKREVSGKVIDETGMPLIGANILVKERNIG
TITDFDGFFKLSITKDAKELQISMLGYKTQNVLLVDKLEFEIVLKEDINQLSEIVLIGYG
GAKKKEDLTGAVGTISGKDFKDQPVTRVEHTLSGRTAGVQVKSNSGAPGGNLSIRIRGSN
SIKGNNQPLVVVDGVIGANFQLVNPNDIESIQILKDASSTAIYGSRGANGVVIIATKSGK
NKKPSISFNTFHSMSFLPKKIDYLNAAEFAELYNSYDRDLNFIPGVYAAPFSAADIAIYE
QEGGTDWQDELFRQAFSSNYQISVAGGADKVKYYLSGEYLNQEGIVINSDFKRYNLRSKV
DVELNDKMDLTLNMGWSKLKGVNNEDVGHQLGAIGRLPQWSPIEPIWDVEGVLYNNTPQY
GAVSGNPVGLQYANISHNETSIFQPSAKFSYEIIEGLKANLFGSYENTNTTVYNLENNHI
LDPSPDVVSRASINNIGRERGQVNFILDYSKEIGEHKLQATGIYESGSYIEKGNFNGANG
LNDVTLGWNNLALSESQTSSSYYYDEYYNSLALRVNYSFLERYLVTATVRRDGVSKFQGN
NRYSTFPSFALAWNLGKEEFIQNFDVFSNLKLRASWGESGSHAIGSYATLPYFIQNGESN
YHPNGSGTQTYVGLGVGAPGNENLKWETTAQYDLGIEIGLFNNKLNFEADYYNKDTNDLL
VDVTLADYIGGESILKNIGTINNQGFEFSVNSKPIINDFFSWDVSANISVNRNTVVDLGG
DELVLASTLYADSTTPITAIKVDEPLGSFYGYNFLGVWKSNEVTEAATFGNKPGDAKYED
VNGDGQIDSEDLKIIGNAQPDFTFGFSNTLNFGDVNFSFIITGQKGGKIFNGVYQKSIGL
FGQNRAFTSPEWYNRWRVNHEDTDVPAFSSTSQNFPNSNRWLQDASYLRVQNITLSYDFK
KEFISKLNLSEFQFYINAENIFTWTNYTGYSPDISSAGRSTGGGSTTDVDQNIDTGAYPV
PRTFTIGLKAKF
>FCMOIPGL_00793 SusD-like protein
MLKTIKQLLVFAILVALLGCANNLEEEPRGKVNDPESIYKQYANLEATVMAMYAGIRGDA
NWSRGFATSAYMTTMFGADDLTTQIGGNKGEFREFDSFNKSANNGAMMNLWRGCYNAILN
ANEVIEYGYLTIGDQEEIDNLIGQAYFVRAFSYFYLVRSWGRIPLYTSAKTLPTDIGLSN
VEDVYAVIIDDLLQAENLLPTIQSLLGLPSQGAAKALLSEVYLTQAGWPLNVQASYKLAA
DKAKEVIDNKGVYGYDLLPDFASLWLRSYDNSSESIFSLQYDNSDGANAFHISGKASMPE
GEENGWDDFFVELNFFNEFPDGPRKDATFRTSFLTSDGVTVHYTNSATKHPYYAKFRDGA
VDETNPSTATFFNNAAYMLIRYAEVLLIYAEAQSRADGSPSSSAYDALNQVRVRAGLIPL
SGLGTDEFIEAVIDEKGWELAGEGQRWYDLIRTEKVAEVNNKRSSEEQVKIIGSTGTDNY
YAPIPESEILLNPNLGN
>FCMOIPGL_00794 1,4-beta-mannosyl-N-acetylglucosamine phosphorylase
MLEIKRHPQNPIVIPGEQEIRKVVTFNPGAIYDNNKFYLYDRAAITLSPFRTTIGILESD
NGVDFKPLQDEPVFTSEKLGFPEGSVQDPRVVKIDGKYYMNYAFQPYGFNCYPTGEGVPF
YDVSNYPKWKEEVYPMITRSGIAVSDDGINFEQLCYTSPKEIDDRDHILFPEKIKDKFAL
LRRPIEFVGDEYGTDRPGIWICFSDDLFEWSKPVLIARSEEQWEGKKIGAAANPIKTSKG
WLVMYHGVDKGSVYKVGALLLDLEDPTKVIARTKNYIMEPEEYYEKVGLIIPNVVFPTSL
VEKDGLLYIYYGACDTSICLATVKTEELVNHILDPNS
>FCMOIPGL_00795 hypothetical protein
MISKIKGEFLHFKTMPHGMRVLLITNMIYSMVLPIIEVFVSAYIMRSQNDPSLVLKYQLA
VFTGIPITFIVNGYLLNRIRVAHLYSLGMLLSGVSMFIMMFLDNLDLTAIIISGFLMGLS
YGFFWSNRDFLALETTNDENRNYYYGLETFFYTISAIIIPALVGALFFYTNEFNWFGGGE
VISYRLLTVLVFVLTITSTVIIHRGKFQNPKLKKFIYFKFDNLWNKLLVLSALKGLAQGY
LVTVPAILILKLVGNEETLSTVLSFSGIIAAVTLYLLGRFTKPNHRIYIFAIAYIIFFIG
AFIHAYLFSALGVIIFILSKVLYQPLHDISYFPIQLRVIDVLSEKENKSEFSYILNHEFG
LYIGRIVGIGLFLMLAAFASDTIALRYSLIIIGIVQLLSIPLAKHIIKKTK
>FCMOIPGL_00796 hypothetical protein
MSLKIINPKVRLVLILLIVTLFSCENEDGERRYDPGANDLPNSGITLPLNETFEVGKPST
VNQKVYMHYLPWFSEGVEGNHWENGTVNEPLIGYYSSQSWATHLYHILLSAAVGIDGAVI
NVRTDYDQTSFKKFVESIERIDAIYPEFKYDIAVSYDDQDATPASAIAEFTDLRDDIIPN
TNHYLYKDGEPVIFIWNYDGYLTSQDYRDVANLVFTDNIPLLLKNELDLGAIPGQFVMNS
IYPWVQGWADDGSAWGEGYMNWFYNTQIDFKLNNKVEFVTGAVWPGFDDRNTSWGQGRWI
DRRNGGTYDDTWALINDTHPGEIDWVILETWNDFNEGSELEPIAGSGNYQYMDLTANHIA
TYKGVSTLIDSEKWMYGAPIRIYEAAKLIEDGDRDYNVYYPVLEESIKHYLKTNGQKAYE
LAEEIISGS
>FCMOIPGL_00797 hypothetical protein
MKNFIIGLCFCLFLFQCVDSNKSKITKSSLPKNKTKVIAHYMGWYSDKNSQNKKLRHWEH
GYANTPIIGAYNSKSKATLVYHSLLAWSSGLDAIAINVKDKYDYETMEELFNTIDELQSI
SKGKFNLKYLISYDDQGFDLQEPLDTTFVKVKDFKEHIIKRKNYLFHKNNPLFFSFDYPK
KFLTAKSFRTVIDSVFKENKPYLIWNTFGEGEEVQTYVNAFYPWVQPGGEWDTEGLNWGK
GYLNYFYDQVNKFETKYSFVVGGVWAGFDDRKNTSWGGNRLISRQNGKVYDDTWNFIHNY
KGKLPMDYVVLETWNDWNEGTEIEPSLEYGYQYLTKTVKHINKLKGTSIKENSLKFELAK
EIHDAIQKNNDTISEILKESIELFCKKSYKQVQEKLK
>FCMOIPGL_00798 hypothetical protein
MRKIYFIYVLFALICNTAFAQFKDGGINYEIVSNITMTAQVGSNNELTGDIVIPETVTDG
TNTYTVVSLKGWAFAQGEAAVSSITSISLPNTVASISNDAFANNTLLTSVSLGEGLTYIG
VGAFYKAGLKSISIPNSVTTIDNVAFFANIALEEINFGSSLTSVGSQAFAYCNPLSSVSS
SAITPPSLNANSFEGLVLANINLSVPSESVSTYSSSSNWQGFNIGVLNTNVFEKEYLITV
YPNPVFKELRINIPQNIVLKSIKIYDIKGRLILVEDSNKIDVQNLSKGQYFTLIETNKGK
SIKRFIKS
>FCMOIPGL_00799 hypothetical protein
MCQNSKIISSVKNGELAVCYGCKNYALTFNNVYFQFDKNQLLEFRKYIANIDVNYWQNYY
ASTTKKRKIPVTTLHQNLILIFSLEEIEDLKKLLLLKKTSDNDFISLEQINYAFILN
>FCMOIPGL_00800 Bifunctional cytochrome P450/NADPH--P450 reductase 1
MTISIWRYSHLTLAISSVLFIIIASITGIILAFEPISEKLNPYNIVSIDAVSVSETLSVL
NEKYDEIITLEIDENNFVSANVVLKDGKSDTFYINPKTGEKISEILEKKPIFEFATNLHR
SLFLKSTGRFIIGFVSFLLFLISATGVILIAKRQGGFSKFFSKIIKEDFNQYYHIIIGRY
TLIPIVIITITGVYLSLEKFSLLPKDTSSHQNITQKKNASNINLADFEFFKSTKLDEVKK
IEFPFSKDEEDYFFVKLANKEVAIQQFTGQIVSQKKEPLVAFGSYYSLLLHTGKGSILWS
IVLLLACFAILFFVFSGFSMSLKRKKNKFEIKNKFHKDEVEFIILVGSETGSTFNFANAF
YNALLIAGKSVYLSDLNQYTTYEKAENIIIFAATYGEGEAPVNATKFIKLIEKTYQKRIL
KLSVIGFGSKSYKEYCKFAILVQASLQLHQKFVPILPLFKINNQSFVDFENWLKEWSSFY
KLNLLINQEDLDKKNFKEQIFTVINKPEINIDDTFLIELKPSKKIKFESGDLLSITPKGE
TRSRLYSIAKIDNTILLSIKKHEFGLCSNNLNNLNKKDIVVANIQKNENFHFPKKAKGVI
LIANGTGIAPFLGMINEKKSKGKVHLFWGGRTKKSLEIYKNYINTSLENKALTSFNAAFS
QEQKEKFYVQDLLKNHSDLIANTLKSGGEILICGSLSMQKGVTELLSNITENSLKKSLKA
FKENYQIKTDCY
>FCMOIPGL_00801 hypothetical protein
MKTKKTILITSAFLILISTLFSFKKFSESSPYKCMIQMKNYTGEGAYVVVSLLNPKGEYE
KTLYVQGDDDEWYFDITEWWTFQGKKRADIDAITGATISGGQRTISVIRIDNDKLNKGYK
IRFETAVEDQEYHKDDVEFDLTSENVKSKIEGKGFIRYVRMMPQ
>FCMOIPGL_00802 Phosphocholine transferase AnkX
MLLISFSVSAQKNNIFHDRSFWKTNPSITIIDQKIDEGNDLTALNINAFDGTMYAILEKT
DNKTIKYLLSKKGNGVNKLTHDGRTYIFWAAYKGNVEIMKHLIAKGAQTDVIDTHGNTYM
NFAASTGQLKKEVYEYAFKVGADITKEKNHDDANALLLIASHLKDDKLVDYFISKGATLN
DKDINDNGLFEYAAKGGNIQFLKILLNREVNKGKNAMIFAANGSRRSQNKLETYLFLEKN
GIKPNIVDANNRNPLHYIARNNKDLASFKYFINKGVSINLQDKDGNSPFINAASNNSLEI
VTFLSKYVKDINLKNKNGVSALTNSVNRNSVDVIEFLLKNKADINTIDKEGNTLSYYLIR
NFSTKKPEVFEQKLILLEKNGLVINQLQNKGNTLLHIATSENNLALLQRLSSFNIDVNTK
NEDGLSALQIAVMKAKNTEIIKYLISIGADINVKTDYDETLFDLASENELLKKQDINFLK
>FCMOIPGL_00803 hypothetical protein
MNKLLFSCLLLLVSISINAQSKKSKDKNAIKEMCGCFEVTFNFSETFNYSDDATYKPSKT
KVDKGLEWAGLVEDENNKISIQHLLQVGNPAKPMIIKHWRQDWLFQNRDFYMFNGNNNWT
FEQKDKKEVKKQWTQKVYQVDDSPRYEGSGTWVHVDGKSYWESETTAPLPRREYTKRSDY
NITLRGNRHEITNYGWVHDQDNSKIIREADKEDILLAKEKGYNTYIRVADSKCKAAADWW
KANSKKWQLVRNKWDEVFSRNTNLTLETKVDNKPLYKHLFSDEITEEKEMNKVIESFVKK
>FCMOIPGL_00804 Colicin I receptor
MIKNKVYICRKLLRMFLNKGIIIVLTLFAVASFCQEKKKDSARITVLDEVVVTGQYNPAS
IKKSVHNVTVIKREQIESQAANNLADLLNFNLNLTIIPSSQTGKSTISFFGLDSQYFNIL
ADNIPIVSDNGLGNNIDLTQINLEDIERIEIVEGAMGVEYGANAVSGVINIITKKNIDTK
WRINTSIQEETISNEYALFNKGRHIQTFNVANNINKNWFARIGVNRNDFKGFYNEKQGGN
YYKNDGLRGFDWLPKQQFSTTGLLQYQRENFKLFYKFEYFNELLNYYDASVRANINTQAQ
TSNPSATDKIFTTNRFVNNINLSGKLNTGAVYNASFSFQEQKRNLNEFNLFILSKERSNE
TDEVYQSSKVFFSKGSINNFVKSDFFNIQLGYETRFISGFDTQASGDVTQQDKTQSQDNY
AVYGSSEFTISDAFLVRHGIRYEYNSLFKSKILASISARYLMKKGFELRANIGTSYRTPN
FEELYYYFVDSNHDLRGNENLNPENGFTSFINLKKYSYLDDYSVLNTIKISYLNVADKID
LAIVNPTPLQYQYINIDAYKLWGISSENSIKKDNWTFNFGATLQGISRILNNEVNAENNY
LYSFQLNTRASYNIKKWQTTVTLLLKHNGSQQDYIASETDADGNSIFSKSTTSAYNWLDA
SIKKSFFKNKIQATLGGRNLFDVTNVNVSNSGAGGTHASNNNSLLLGYGRSYYLKLLYNL
NF
>FCMOIPGL_00805 hypothetical protein
MTNKFLTFILCSAVFSFTSCSSDDSPIEPIKVVIEGASISPEVGGPNEPNQVYIDLSTNT
TNAVKRDSWDLGFYAGSEYRVTLNGSLYMAAGQLSETDIDVVISTSAEVQELQPKVAVGT
FDAANTTYVDSPDGTITATAIAEISATDANNKVYLLNLGDEIGTETPATGSVDISDDSRG
WKKIRILKSGNDYVLQYADLDATTHKEITISKSATHSFTFFSFNTESEVIVAPEKTKWDL
NFTVFTNEISGYGSYGYSDYVTNNTKAEVKVYMIDTDVDAFTYDSFSLLDVNNTNFTNDQ
RSIGSSWRNGGGPGSLPSLKENVFYIVKDTDGNLYKLKFLALTNADGERGHPEFVYSLLQ
>FCMOIPGL_00806 hypothetical protein
MKEIEVFYFKNDIEWRNWLSKNHEFSKGVYLIFYKIENKEESMRWEEAVKVALCFGWIDA
TVKSLGDGKRRQYFCPRKQKSVWSAVNKKHIKNLIADNLMHQKGLEIIEIAKQNGSWFAL
DVVEKGIIPNDLQAEFNKNKTAFINFKNFAPSYRKSYLYWIHQAKRETTRKNRIIEIIRL
CNANIKTRNN
>FCMOIPGL_00807 Mannosylfructose-phosphate phosphatase
MTLKSLITENRIKLLSFDIDNTLIDFHTYKSNFKKIWEKYQDQNEVILTYNTGRLIDDVL
HLIEKGVLPEPDYIISGVGTHIYNFKKGAVEKEFNDVLDDGWNLESVENIVQRIEHPISD
QPSKFQHSYKRSYFFHDASTELIESIEQDFVDADMDVNIVYSGNKFLDVLPKWANKGNAL
QWLLRMLGLKSNQVLVAGDSGNDSAMFDLKDVFGIVVANAHDELYIYTKHKKVYHTEKEK
GDGIIEGLIFYEILPEEALEDTKIDHSDDFFIKKEIESIAHEDTDEKIALIKEGYLKAIE
ALKKNITPLGFSACSIKDNIPNGTDENYHSVWARDGAITVIGSLSLIDDEEIHQCQRQTL
ITLLENISRNGQIPANVRLKDQEPDYSGVGGICSIDSGIWVVIAFYEYVNVTKDIKFLRK
YIGDIKETMRWLGAHDSNNDALLEIPEAGDWTDLFGRSYNILYDEILWYRSNVCFGRMLE
MLGSHEEAGEYIRWSQVIKKEIVQNFWPSTQQKLFQSVSFAEKQFTLGDTSYLIAQTTPF
DFSWRCDVLGNVLAFLHGTIDAEKAHQTFRFMLGVGANDPFPVANVYPVVSPGDPDWKPY
YTVNLLNLPNHYHNGGIWPFVGGFWVKFVNKLGFRDVAIAELHKLALINKEGISEEWEFT
EWAHGVTGKPMGKAYQAWSAAQYISAYNDLKITKTKK
>FCMOIPGL_00808 Mannosylfructose-phosphate synthase
MKSILMISLHGYVGAHAELGKPDTGGQVVYVLELAERFSRLGKRVDLVTRQFEDQPEYDE
VNENYNVWRIPFGGKKFIRKEDMHDHLKKFVTNTLAAIKKENKKYDVVYSHYWDAGWAGQ
KIAEELGICHVHTPHSLGWWKQHSMGSDMDEKEMEKTYRFKERIRKEYFVYQMCNYVIAT
TLPQVELLIEQYDVLSKNCSMIPPGIDENRFFPVPSKENDKIRLKYDIKPTDILALGRMA
HNKGYDLLINALPTVFNLCPEARLVACIGGDSQQDKDGIEKLKELASELGVMDKIKWKTY
IEDEDLANVYRSASVFAMPSRYEPFGMVAIEAMACGTPSVITVHGGLCDLIDFGNQGLFA
DPHRPAEFGAMMAMPLLYPKLRNEMSVEGARFARRNFGWTGIAKRMLSIFSSSINQQTME
SNIY
>FCMOIPGL_00809 Fructokinase
MSKIVCFGEVLWDVFPTHKKIGGAPLNVAIRLKSFKNDVAMISAIGKDEFGNLILDYLQE
HQINKEYIQVLNDFETGSVTVKLNDKGAASYKIEHPKAWDKIQFTKSASDVVQQSDAFVF
GSLITRDEVSKNTLYQLLEFANYKVFDVNLRKPFYDKIVLVELMQKADFIKFNDEELYEI
AAFLGSKFNNLEQNMHFISEKTKTKHICVTKGEHGAVLLYDNKLFYNSGYKIKVADTVGS
GDSFLGSLISKLINGKNPQKSIDFACAVGALVAQNEGANPVISEKEILDFSCL
>FCMOIPGL_00810 Toxin ParE1
MADYKLSNLAKEDLIRIHRYGIEKFGTNQADKYFDSFFENFDTITKNPFSFESVDYIKIG
YRRCVCGSDSIYYKINDNIVEIMAIIGKQDLIKIL
>FCMOIPGL_00811 hypothetical protein
MARQSISFTQPNDEWLKKQVDKKEYSTKSELVNDLIRQARKQQRQIDWISAKLEKAENSG
FTNLSKEQILAESKSLI
>FCMOIPGL_00812 hypothetical protein
MHNYIEKDFIGVIGNRPVYKILRADITKLPFKANKRTLLIGDGIHTPFLIVKDALKAMYH
FILETPIFNFKELDFPGDLGLTDKEILTYIVFKHDTNGHFIYHNFTPQNTNTFIQLCKSN
LLKTPYNENNELDFNNWLHINIGAFVWFNCKELIDFITFSSYDYFDENYLDNVAITNSTN
NIIGLKDRINSFKDLFLENKRELNYNTFKSIDDDFLYTEMLAGNNWDLDNVYSYYKEREQ
TNSKRDTEL
>FCMOIPGL_00813 hypothetical protein
MTEIFTTKKLEKIINKKIENNDLIVESILGNWNATIIYIAKKKCLLFVNSETFFSVIIPR
FSMKDIDKIDELFINCFYNQLLFEKINIDFKTISSILGKISFHPTNNNKKVIGVLNYNVE
KINYFKYDYPILNSSIIRKMTHKLNITPFKQLGWKLPCETMVAKLNIESEKVN
>FCMOIPGL_00814 hypothetical protein
MKNDYKDNKFKELLDKLQQESWQLELLISGFAIFGLFSALEPLERMGQEASASESYTKTF
FVVAAISCIVLIVNLIIHVVLRGLWIGAIGLRYVSGEIDYEALNYKKRFTNHLKKKVGSF
DKYIGSLENYCSILFAVTFLYLFYIISFFIIFLVIFIAGSFFIESGIFPEIFGMFLLGIF
AIFFLFLSLFVFIDFITQGYLKKVEWTSFLYFPLYKIFSVITLSFLYRPLVYNFLDNKFG
RRLLFILFPVYLLTFYVTTLHNVRSNFVNNQSYSTINYANNNNYLNSLTKNENINKAAIQ
SKIIEKPFLQVFIPFRKKMEDIIINQNLDLKSENDKRGYSSSLFSSNTSNTSKDSLQSKY
LAAFKKAYLLKIDSLQIQSDFIITEINNQLGFETVFPIHTIKEGKHSLNISRFIASKKTK
KIENEAVIEIPFFYYK
>FCMOIPGL_00815 Spermidine/spermine N(1)-acetyltransferase
MFKIVKATLKDAQILSVIGKTAFLTAHGHSAPQTDIDNYVDNNLTENNFLKELEDTNNIY
YLIFSDDTIAGYSKIVLNTENENIDAKNITLLSRIYLLKEFYGLNLGKELFNFNVKVSKE
NNQKGIWLAVWVENKRAIKFYEKAGFVKVGKFDFKISETHYNPNHIMYLDF
>FCMOIPGL_00816 hypothetical protein
MKWRSNRTSQNVDDRRGMSSGSSGGGGLNPMLISLLLKLVTSKKGLIIIAIVFGVMYFTG
NNPLQFLSGNSTNQIQNTNYEGTAKENELAAFSNRVLVSTEDVWNQILPNYKEPTLVLFT
NSVSSACGSASSATGPFYCPGDEKLYIDLSFFEEMATKLNAPGDFAQAYVIAHEVGHHIQ
NLMGTTDKMQQIRGKVSQKEYNQFSVKLELQADFLAGVWAYHAKNKDLILDEGDLEEALK
AAFEIGDDRLQKKSSGSVVPDSFTHGTSAQRMRWFKKGFETGDLSQGDTFNTKSL
>FCMOIPGL_00817 ATP-dependent RNA helicase RhlE
MQFSDFPFHKSILKAIAQERYHRPTLVQQKAIPIVLDKKNVIVSAQTGTGKTAAFALPII
QLLSNKPVIENEVKKIKSLIVTPTRELAIQILENFKSYSKYTNLKTTAVFGGVSLEPQKE
ELANGIDILIATPGRLIDLQMQGNIDLSGIEIFVLDEADLMLDMGFITDINKIEKLCPKK
KQTLLFSATIPEKIDELAKSIVKNAVKIEINPEETTAKNIGQLLYYLPKKNKTDLCLLLL
RTTINGRILIFRRTKLGVDKLEQSLLKNEYKVTSIHGDKTQGVRNKAIEDFKTKKATILI
ATDVAARGIDISNVDAIINFDIPNVPETYVHRIGRTGRAGKSGIAFSFCSPDENSYIKSI
EALIEKPIKIITDHPYIINKPKHKKLQPNTVSKNKKGRKSDASKKNKKRWY
>FCMOIPGL_00818 putative oxidoreductase
MQLTNKTVLITGGASGIGKIMVRLALERKAKIIIWDINQIGIDNTITEFKNLGEIAGFVV
DVSNPTQIKETAQKVKQKIGFVDVIINNAGIIVGKYFHEHSNNEIDKTMAINANAPMYIT
NAFLSDMLQKNTGHICNIASSGGLISNPKMSVYVASKWSLIGWSDSLRIEMKQLKKNIKV
TTIMPYYINTGMFDGVKSSKIKILEPETASLTIIKAIEKNKKMVTIPGYLYRFVKIGQAT
MSINFFDWFAGSALEIYKTMDAFTGRKKQQ
>FCMOIPGL_00819 hypothetical protein
MIIDVHTHLNNYHEDRVTSINESLDLLSKTMKENNVDYSLVLSSYKVNEHRPSTKQIVEA
VKGYKNIGIVAGISYLHYNYKDVIEISQYLKEGHIKGLKFYPGYEPFYPNDIRFKLMYEM
AIEYDVPVMFHSGDTYAPTGKVKYSHPLHIDDLAVDYPDLKIVICHVGNPWIKDCMEVVY
KNKNVFADISGLVLGDFNEKFERYMKKEIEEMITYAGDPKYLLYGTDWPISNMKSYLKFM
NQLDLAEDKKELILWKNATELFKIDVNDLK
>FCMOIPGL_00820 hypothetical protein
MFFANAENASDDKTNVSSFIITNMYKKKKNTRLEKTRRPIYWLKRKLLLIITAFMLGISN
SINDEDTSIFGNQHNIEQQDKMD
>FCMOIPGL_00821 hypothetical protein
MQLKHLFVFLLVFLHSVAESTFYAQESTSNYYQYSKIIQKKKFNYKNTKHVVLKKDVLSS
ADFLALFFPSIYLKSAFQKQIKLTLKLQKQLYQNIALLHKQHIFLINKIIASNSISNLYI
A
>FCMOIPGL_00822 Chaperone protein HtpG
MAKGNINVSVENIFPLIKKFLYSDHEIFLRELISNGTDATTKLKHLISIGEAKTELGDAK
IEISIDKEAKTLTIKDQGLGMTMDEVEKYINQIAFSGAEEFLEKYKDDKNETGVIGHFGL
GFYSAFMVAEKVEIFTKSFKDEPAAHWTCDGSPEYSLVENDKSDRGTEIVLHIAEDSTEF
LTEEKISALLNKYNRFNQVPIKFGTKKVNDPDFTPQTTTDKDGKETTEPHKQIEVDNIIN
NTNPAWTKAPADLTDEDYENFYRELYPMQFEESLFHIHLNVDYPFNLTGILFFPKLSSSM
DMQKDKIQLYQNQVYVTDNVEGIVPDFLQMLKGVIDSPDIPLNVSRSYLQADGAVKKISG
YITKKVADKLTSLFKNNREDFEKKWNDIKVIIEYGMLSEDKFFDKAKKFALYPTVADTYF
TFDELIEKTKENQTDKDGNHVILYTSNKEAQHSYIKDATAKGYEVLVLDSPIISHLMQKL
EGGDAKVKFTRVDADFIDNLIKKDDAIISKLSEEETAKLKPIIEGAVNSKTYTVQLEAMD
SAASPFLITVPEFMRRMKEMQASGGGGMMGMGNFPDMYNLVVNTNSPLVSEILNSKDEAA
QKALISQAFDLAKLSQNLLHGEELTNFIKRSYELFK
>FCMOIPGL_00823 Aldehyde dehydrogenase
METIKDELNIEAITAIFNTQKEHQFVVANQTIKERKRKLKALKKAVEITYRAAIKEALYK
DMGKPKAEVDLTEIYPVTSEIKHTLRHLNSWTEKQRVGTPIAFIGSSSYYKYEPKGVCLI
ISPWNFPVNLTLAPLVSAIAAGNTVIIKPSEMTPHISKVMKELIATIFNENEVTLIEGAV
QTATDLLSLPFNHIFFTGSPVIGKVVMTAAAKHLTSVTLELGGKSPTIIDETATIKTAAK
RIAWGKFVNAGQVCIAPDYIYVHKSKQEELVNEFKKVLAKFYNNNANQSENYTCIVNESH
KGRVTSMINNAKENGAIVSYGGKVDEKSNAIEPTILTNVKMNTKVMQEEIFGPILPIIPY
DNINEVIDTINSKEKPLALYVYSNKSKNIEYILNNTRAGGSCVNNNAVHFFNNNLPFGGS
NNSGIGKSHGFFGFQEFSNARGVLKQTIPGALEILMPPYTNFKEKLINLTIKWF
>FCMOIPGL_00824 3-oxoacyl-[acyl-carrier-protein] synthase 3
MYNSKITGLGYYVPDNIVTNNDLKEFMETSDEWIQERTGIKERRWIDPKTGDTTAVMGAK
AARIAIDRASLTKDDIDFIVFATLSPDMYFPGGGVQVQDLLDMPTIGALDVRNQCSGFIY
AMSVADQFIKTGMYKNILVIGAENHSGGLEKSTRGRNVSVIFGDGAGAAILSRSEEKGKG
ILSTHLHSEGKHAKELVLEGPSTQRWVPEILAANNPDDVSYFPYMNGQFVFKHAITRFSE
AIVEGLEANNLEKEDIDMLIPHQANLRIAQFIQRKFKLSDDKMYNNIMKYGNTTAASVII
ALTEAWELGKIKDNDLVVLAAFGSGFTWGSVIIRW
>FCMOIPGL_00825 hypothetical protein
MKNVTLVLGASANPNRYSNIAIKRLLDKELPVVALGKKKGKVLNVNIADKRQDYKNIDTV
TLYLNPKRQEEYYNYILDLQPRRVIFNPGAENDEFVKLLEEHKIEPVIACTLVMISINEY
>FCMOIPGL_00826 Virulence factors putative positive transcription regulator BvgA
MKKFKINSIYNEIFETYPNVEIEEHIKKLIELDYYYPYNSTFYCITNTVHQNFEYISKNF
TACTGLSIDKMMTGGMDYYWSLFHPEDIKLWLNSLTDLMVFTMTELNDEQRKRMSYTWNY
RIKNADNKYVNIIQNTTPLQFDSSNKPIIGMAHYTVLDGHLKMDICATAKYLNNKNEYET
LFYKNQSTSNLLNIITNRERDVVRLLITNKTSEEISNNLHISKHTVNTHRKNILKKLNIE
STFELMKYFKNNQNLI
>FCMOIPGL_00827 Ribonuclease Z
MSINLTILGCHSATPRANAFPTSQYLEINNQHFLIDCGEGTQRQMRKYKVGFSKINHIFI
SHLHGDHFYGLVGLLATYGILSREKELHVYGPKGIKKVTLLQLKISQSHAKYPIIFHELT
SKESELIFEDDKVSVRTIPLNHRVYTNGYLFTEKEKPRKLNMLNISGYPEIDKADYLNIK
AGKDVVLSTGEIVTNKELTIAPTKPLSFAFCSDTYYKPDIIPIIKNTDLLYHEATFLSDR
EDLAKKTKHSTSEQAAQIAKDANVKQLIIGHYSGRYKDISLFQKEAKEIFENTKLAEPGK
IFNM
>FCMOIPGL_00828 hypothetical protein
MIKKLLFILFLSLTTIGFSQHKSVEKLSAAPNPFTENTKISFKAANNATIIFSVINVLGK
TVYKENIKVTTGNNSFTFKKGNLLSGIYIYKLQDKETIISKRFVIK
>FCMOIPGL_00829 hypothetical protein
MIIEKKENYTLITSDENSFLDFYTTFLKKEKDFNEVHLVLQISNEIKTTKEEISLFLNNI
KKKNSKSFVIVYNNVDIDDLPEDLNIVPTLTEAEDVLEMEAIERELGF
>FCMOIPGL_00830 Aspartate carbamoyltransferase
MDQLSVEHLLGIKYLKKTDIDLIFKTADHFKEVINRPIKKVPSLRDITIANLFFENSTRT
KLSFELAQKRLSADVINFSASQSSVKKGETLIDTVNNILSMKVDIVVMRHGNVGAGVFLS
KHVNAKIINAGDGTHEHPTQALLDSYSIREKLGTVKGKKIVIVGDILHSRVALSNIFALQ
LQGAQVKVCGPTTLIPKYITSLGVEVETNLKKALEWCDVANVLRVQHERMDIKYFPSTRE
YTQLFGINKDILDNLGKKIVIMHPGPINRGVEITSEVADSDQSIILNQVENGVAVRMAVI
YLLAQQIKR
>FCMOIPGL_00831 Bifunctional protein pyrR
MSKKTLLNSKDIEIILHRLACELIENHNDFSNTVLIGVQPRGTYLANRLATLLKNEYGIK
DLKLGLLDITFYRDDFRRRDSPLAATSTKIDFLIENKKVVIIDDVLFSGRSIRAALTAIQ
SFGRPESIELLVLIDRRFSRHLPIQPNYKGRQVDAINEEKVLVSWKETHKKDAVYIEQK
>FCMOIPGL_00832 Beta-barrel assembly-enhancing protease
MSLTKFESMLKTNNIFFFDLVEFEEIIVHYLEAGKLSLAKKAVKLGLEQHPESVYLKLLH
VEIYIFENELDKASTLLEKIELLDPNNEEVFIQKSIINSKSGEHNEAIVNLEKALIFTDD
KVDVLSLIGMEYLYLENYENARLSFEKCIEVNFEDYSSLYNIVYCFDMEQKHEESIVFIE
KYLNNNPYCEVAWHQLGLQNFILKNFKKALSSFDYAVLIDESFIGGYIEKAKTLEELERY
QEAIENYLITFELDDPTAYAYLRVGECYEKIQKFDAAISYYKKAVHEDPLLDKGWLLLTN
IYYNDDNYQKASYYISKALKIDEDNLLYWRKYSDIKLKLNFYEEAVTGFENCLALNDNTF
KVYIGLVDVLSFLGEFEKAIKVLERAQKIYKNIAEIEYRFAGIFFILNNEKYGFHHLIKA
FKQDYDHHVILKEIYPTVFENEKVQKLIKNYKKATE
>FCMOIPGL_00833 HTH-type transcriptional repressor Bm3R1
MARKIDEDKIARIKQATMQTIVEKGIEATTIAMIAKKANVSGGYLYRIYTGKQDLINELY
HDKVDSLYKELETLLILNKTSVKPLIKSFIKNRITYFLKEPNASKFFYQLLHNENFFASE
EIRHKSADLIKNIKLIGIRAGEISKNTSVYQLHYHILVYAVDYINFTRKNIFGEQEVTID
DVDKLTDNILKILK
>FCMOIPGL_00834 Cobalt-zinc-cadmium resistance protein CzcC
MEINLKFKAMKLSRIHVKLFLFLCFITTFTNAQNITLKQAYDLMLSKNGEAKASSFEVKA
MEEEHKATKGLRLPTVSVSGTYMHLDKDIAVDLNDQRNMVGGLLSITDPASVLGDWDFTL
QEKNLGFATANVSMPIYAGGKINAANKASEIKLSLSETKHKIKEDELTVQLINYFFKLKL
AQEAVKLRKEVYDVILLHNNQANKFFENGIIPEVETLNAKVALSNAKRELLAAQKDVDLA
TTAVQNLIGVDSINGFTSKFNKPTIVKPLQDFTNEMLTENEQLKIIDKNHELAKVGVKVE
NSEYFPKVGVSGKYIVWKDNLPLVDTKWFVGVGVEWELFNGFQREHKIKASKYKISQVEE
FDKQARLNLTTYTEKLYNTMQKELEQYESLNSDEALANKLKFMRTRAFEEGTGTSLEVVD
ATLKLSEIKIHKIKALYEYNIAYGELMVLTGKTATFLNQN
>FCMOIPGL_00835 Multidrug resistance protein MdtN
MRNPKFIKSLIGIVILSIIVLTSVWLLTKPKSVILQGRIEVKEIYLSAKIPTRINSFEVK
EGESVKKGQLLATLLSPEILAKEQQALALKDAANAQKNKAQNGARLEEIRAAKSVYEKAS
AAANVMNKTYKRMENLFKDGVISEQQRDEIFAKKEVALKDQEAALSMYQMAKKGARNEDI
EAASALVKQADGALIELEGYKNERNIIAPIDAEVLNFLPEEGELIGAGYPVVHLVDLSNS
YAILNIKETSLFNFKKGEVFKAIIPALNNKEVEFKIYYIAALGDYATWNATKASGDFDVR
TFEIKAMPVKKELALRPGMSILIDYSQFNE
>FCMOIPGL_00836 hypothetical protein
MKPSFRIAKREIALLFNSKSSFILAIILPFVSILFFNSLLSKGVARDLPVAVVDLDHTAT
SRNVIAQLDAAPEIKIGFFPLNQQKGEELIRLGKAYGVITIPQNFEADLKSGKQVNIINQ
YNSNLLLAGGLEYKAFRKVIGTISAGINIEKQRKRGVSTEQALVNYQPIKTNSHVLSNPY
TNYSYYLNTGFLTMFFQLFVMLTTIYCFGADLKYSKGNKLLSITNGSLSAIILGKVLPYT
VWFLFVGIITLLSMYVWQDFPFSGSKITVLFGLLLLILANQSFALFFISISGSFREALTI
GSGFGAVSLSFSGITFPIFGMPIVLQWLSQVFPFTHFFELLLDQSQRGFPAFYSLKAIII
LVVLSITPITLSWIKLKRLFLKGRFNHNI
>FCMOIPGL_00837 hypothetical protein
MKNLYKLFYKGIISFKNTFKTEWNSIKSDKAVVSTFLSVTLIILVVYTYIYSNQIIKEVP
VAIVNQDGTRMSRDYIAMLNATQGTKTISSFTDLEAAKVAYYSRKVQGVILVPKYFEKNI
RSGKQTTITTFSDAANMLFYKRVLGDVSTVNGYFSAGISIKKEMAKGVSFDKAQKDYTPI
KAISTSLFNTSSGYATYLIPMLTALIIQLVLLMGIGLLSGSRRETVSTHIKFPRLLHKGG
VLSVLLAKACLYTLIYMVIIPIQIGIVYTIFGIPVRSSLFTIYVFIIPYIFSVVFLGISI
SSFFKRREDSIVFLVLLSIPSLMLSGLSFPEEGFSEFYKYVSEIIPSTSGMNGFVKLTQM
EASFLDVLKEWNHLWFLTGIYFVIAAISLKIRARKEVVLKNV
>FCMOIPGL_00838 hypothetical protein
MSRKIKDYVVIGLKGMAMGAADVVPGVSGGTIAFISGIYEELLGSISNVNLDLFKTLKKD
GFKVAWKQLNGNFLLSLFVGIFISIISLAKAIKYLLENEPILLWSFFFGLVLASIIYIAK
QISNWNVISFIVLILGAFLAYYITTLNPLVTENSSLLFMFFAGAIAICAMILPGISGAFI
LVLLGAYKPILTAVNDRDLKTVAAVGLGAIVGLLTFSKILKWLFAHYKNYTLAALTGFII
GSLNKIWPWKETLTWRINSHGVEVPFNQQSVSPFSFDGDAQLLFSIVLAVVGFSLILIME
KLAVNKQ
>FCMOIPGL_00839 hypothetical protein
MQKERTFKQKLNLFLKGLLMGVANKVPGVSGGTVSFVLGFYEELIFSFKRVNIIALKFLL
NARFKSFIQYTNAQFVSLIMFGSVFSYFSASLILDYLLEHYELYVWSWFFGMIIGSIYYI
GKDYGQWTRKNFIFLVLGVTLGLGISFLTPAKENDNLWFVFVCGIIGVSGMTLPGLSGSF
ILILLGNYVLLLVDSVNVLLHVFTSILSGDFKVLTDPVKIRYLKIIAVFTSGSAFGLISI
SHVLGYVLKRWNKIVNAIIIGFITGSLGIVWPWKDKIYATNNGAFLFDQEGNKVIENYQR
YIPEMYSIDTLIAIFFIFFGVGLILAIDYYERRKQ
>FCMOIPGL_00840 Shikimate dehydrogenase (NADP(+))
MKEENSKIFGLLGKNISYSFSRGYFTEKFEKLNITNYKYVNFDIQQIKDFSSIIDNKKSL
GGINVTIPYKEEVIPFLDKLDETAKNIGAVNTIKFTKRGNLKGYNSDVVGFENSIKPLLK
KHHKRALILGTGGASKAIAYALKKNNIKFKFVSRNPEGKKEISYDSLTEETLKKYTVIIN
CTPLGTFPAIEKCPNIPYQFISEKHLLFDLIYNPEVSTFLSKGKEKGATIKNGFEMLQLQ
AEESWRIWNE
>FCMOIPGL_00841 hypothetical protein
MLDENEKNELEASEKVNKIISKPEQKVGEVKAIKVDEANEAVDEIEKSVAESAENDDSKE
DESPVVNYDTFSLEELVLSLKKTLADNPVQKIKSQVEAIKSAFNLKFGKTLAEKKAAFLA
EGGNSIDFQFSSPIKSDYNQLLSDYKKERDVFYKNLENKLNDNFVKREQVIENLKNLIEE
ADTSTMYKKFKEIQDTWRSIGAVPKSHYNDTWKTYHHHVERFYDLLHLSNDFRDLEFKHN
LEKKLKIIEKAEALSQENDINFAFKELQDLHKQWKEDVGPVAKEMREEVWQKFSAATKNI
HDKRHDYYKEMRSKYDEIIEKKQVAINAINSYDTSKNKSHNDWQKSINEIEKLRQIYFDA
GKLPYSKSEEVWQKFKKATKKFNAAKNIFYKQEKNDQQENLEKKIALIEFAESIKDSEDW
EMATNAMKKVQSDWKKIGHVPRKFSDDIWKRFKAACNHYFDRFHEQKNAVSKEEQAVVDI
KKEFLDTLKTTEVTTKDAVLEAINSWRDLGRLPREMRHLDGKFNKQIDKMLESLSLDKNE
VSMLKFTNVVDSFLAANDVRKLDSEHIFIRKKIDEVFKEIQQLENNLGFFSNVDDNNPLL
VNVKNRVEAHKDELAIWNEKLTYLKSLDY
>FCMOIPGL_00842 hypothetical protein
MAKKKEVSVEEKLRALYDLQLIDSRIDEIRNVRGELPLEVEDLEDEVAGLNTRISNLSKD
LANLETDINNKKLAIDESKSLMKKYDEQQKKVRNNREFDSLSKEIEYQDLEIQLAEKRIS
EYRAKIAQKNEVIDATKEKMAKQEKHLGHKKSELNAILKETEKEEKLLSEKSVEFSDSID
NHLLSAYKRIRTKVKNGLAVVAIERGASGGSYFTIPPQVQLEIANRKKITIDEHSGRILV
DAALAEEEKEKIDQLFA
>FCMOIPGL_00843 GTP cyclohydrolase 1 type 2 
MIIKEITNYIEKLAPLNYAEDFDNVGLLVGNYSTNVTGVLVTLDTLEETVDEAIAKKCNL
IVSFHPIIFGGLKKLNGNNYVERVVLKAIKNNIAIYATHTALDNSKNGVSAKMCEVLGLQ
NTRILIPKKGIIKKLTTYVPIKNEDALKTALFDAGAGNIGNYDNCSFTVLGDGTFKGNES
SNPIIGEKGKIHTEKEAKISVVYESKNEKAILKALQENHPYEEVAYEIVTTENVHQNIGM
GMIGELPLEMDEKEFLFYLKKTMKTDCVRHSNFINKKIKKVAVLGGSGSFAISNAKKAGA
DAYVSADFKYHEFFTAENCILLADIGHYESEQFTKNLLVDYLTKKFSNFAVILSEKSTNP
IYYI
>FCMOIPGL_00844 Tetraacyldisaccharide 4'-kinase
MKLVRFLLFPFAILYDLITTIRNIFFDVGIFKSTSFKIPVIVVGNLSVGGTGKTPQIEYL
IRLLKNTYNVSVLSRGYKRKTKGFVLVNKNHSANDVGDEPLQYFKKYTAINVAVDENRVE
GINNLISKKLPEVILLDDAYQHRKVKGSFYVLLTKFDDLFTDDYLLPTGNLRESRAGAKR
CDIIVVTKCPSNINDSQKDAIKLKLQKYNKEVFFTTISYADRISGSEEISLNTLKDFEVL
LITGIANPKPLLEFLRTKNINFMHLKYGDHHEFSSKEIVEIKQKFNRINSDKKLILTTEK
DYTRISNKIKALSFLEIETTFIENKNKFDALIKAHIQQNRC
>FCMOIPGL_00845 Disulfide bond reductase DsbH
MRKIFFVFSICLFTSHVNFGQDVVSSDEEIIKSNEITLNWMPNYKEALKKSKKEKKPVLI
YFTGSDWCGPCKVLDKKLFHTEKFKALADKNLILLEVDIPRRLDIISPDKMVENKSIQKK
YKVKAFPTLMFVNHRGKKIAEKKGYILSEYYYPFFQSEIDNY
>FCMOIPGL_00846 Outer membrane protein A
MTLEKKMCHIKNKLKINKKQNRFIMKKILLGGAFLLLATSSFAQALTLPENPEPGKCYVM
CKTPEVWKNEEVTIEIEPAYKKIITHPAEYKTITESVLVKEAVKTLEIVPAVWETKAVSY
VAKEDANKLSVINATFSKDSETIETKAASANWQMSDKKPDCQSDDPNDCRYWCYKPVAAK
YVTVPLTKLKSDATTASSSVPGFEKSYTRRVVVQPETTRTVEIPAVYGTIKKIVLVKDAW
KEEVTVAAKYKTVSKEVLVSKGGLSSWKEVECELVDNTPLPINWNLNSATLTPEAKRIID
ERLLPILKSGVAVALESHTDARGTKESNQDLSDRRAKAVTNYLISRGINSSQLTGSGYGE
SKLLNRCSDGVVCSEAEHAQNRRTTFRVINQQ
>FCMOIPGL_00847 Outer membrane protein A
MKKILFSFAFLMFSAVVFGQDLPENPEPGKCYVRCKTPDIWKNETVSVAVSPAYKTIITH
PAEYRTIEEKVLTKEAGEEILLVPAVWGTQEVTYYEKEDGSKLEVQEATFNQGFETVEIK
AASATWAMSEKMPDCESNDPNDCRYWCYQPLPAEFKTMPVEKLKTDASVVKTPVTGVKKT
YKRKVMVNKPTTTIVQTKPEYKTISKTVLVKDAWSEETIQPAVYRSITKQILVKKGGLTS
WKSVDCKLVNNTPLPINWDFSSAVLNDGAKAIIDARLLPILNDGVAVFIESHTDMRGTKS
DNQELSDNRAKAVTDYLISKGINRSQLYAKGFGETKLLNKCSDGVVCSEAEHSVNRRTTF
RVVNQK
>FCMOIPGL_00848 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MLEIKKYGAIDIGSNAIRLLVSNVIVAKGKEPQFKKSALVRVPIRLGADAFVGGIISEQN
TTRMIDAMEAFKLLMKVHNVERYKACATSAMREAQNGIEIADKILKQTGVKIDIIGGKEE
AAIISSTDLNQLIQGNNSYLYVDVGGGSTEFTIFSDGKIVNSKSFKMGTVRLLNNKKSVN
KEIFSNVEKWIKKNTHGLKNLSLIGSGGNINKLFKMSGRQEGKPISFIYLNAQYQFLKQM
SYQDRISELSLNPDRADVIIPATKIYISAMKWSGATKIYVPKIGLSDGIIKSLYYNKL
>FCMOIPGL_00849 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MKTLYIVRHAKSSWEYEGIEDIDRPLKKRGIKDAHLMSKVLSKLIPRPDVFISSSANRAL
HTAVIFCENFEYPLSNLKIRRQLYSFSDGYLVKTVKALDDGFSSAIIFSHDHGINTFVNK
FGHKPIAHVPTCGIVGIQFEEKHWKNLKKGKTILTEFPKNHK
>FCMOIPGL_00850 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MQKDLSNYRKSYEKQELLESNCPENPLQLFQTWFLNADNSDSVDESNAMTISTIGLDGFP
KNRVVLLKKYTWEGFIFYTNYDSEKGKSIAKNNHICLSFFWPALEQQIIIKGKAEILSEN
LSDGYFESRPDGSKLGAWASNQSTVVSSRKELDENLVSFEKKFEGKEITRPKNWGGYLVK
PFSIEFWQGRPNRMHDRIRYNLEKDFSWKIERLSP
>FCMOIPGL_00851 hypothetical protein
MKKIFFLCIILSSTTILSQFKITGYFNAEIGLTYKFSKNIQSELRISDNLGMEFNTELSL
LYTLLAKDNYNMNLGTGISTFPFHSKNIDFIESYFIPAQIEITPFKEVRNFGFLFETSYH
FSDIENSSGVRNSIGIRYIFN
>FCMOIPGL_00852 Serine-aspartate repeat-containing protein F
MSYANKTTLFLVIFFISLVPLSYGNIFLDNFENENALSTEKITSSTNFYDSYQSNWKNLE
KQKSGYLWNNTKPTTKVSFASVKSTILDDKQSYITANGYSSAKSKEKISYKSNQSKSSTT
SADVCYPETSLTITEDSGWGISRSTLNNSGVPSFCMDITKDAPNTGNVYNTTLTPDPDIS
FNNSNYTHAEIRELVQRTVSILTHPNYAPNTLPSNEMSNFYKSIQATIWKWTNNTNVSTS
YSWTASNGSTYNANNIKTWVLNGTLSPANVFWLVPTNSHKQPEVLLNQTSKPAPVITNVT
ICSDETYQWSVNGVTYNGSAGNTTITVEGDSSVDGNGAATCAADQTLNITVSPEPTPIVT
DITICSDEDYVWAFNSVTYNGSAGTQTVFVEGANCAADQTLNITVNPEPTPVVTDVTICS
DEEYVWAFNSVTYNGSAGTQTVFVEGANCVADQTLNITVTPEPTPIVTDVTICSDEDYTW
AFNSETYNGSAGTQTVFVEGVNCAADQTLNITVTPEPTPIVTDVTICSDEDYTWAFNSVT
YNGSAGTQTVFVEGANCAADQTLNITVSPEPTPIVTDVTICSDEDYTWAFNSVTYNGSAG
TQTVFVEGANCAADQTLNITVTPEPTPIVTDVTICSDEDYTWAFNSVTYNGSAGTQTVFV
EGANCAADQTLNITVSPEPTPIVTDVTICSDEDYTWAFNSVTYNGSAGTQTVFVEGVNCA
ADQTLNITVTPEPTPIVTDVTICSDEEYVWAFNSVTYNGSAGTQTVFVEGVNCAADQTLN
ITVSPEPTPVVTDVTICSDEDYVWAFNSVTYNGSAGTQTVFVEGVNCAADQTLNITVSPE
PTPIVTDVTICSDEDYTWAFNSITYNGSAGTQTVFVEGVNCAADQTLNITVSPEPTPIVT
DVTICSDEEYTWAFNSITYNGSAGTQTVFVEGVNCAADQTLNITVSPEPTPIVTDVTICS
DEDYTWAFNSVTYNGSAGTQTVFVEGVNCAADQILNITVNPEPTPIVTDVTICSDEDYVW
AFNSVTYNGSAGTQTVFVEGVNCAADQTLNITVSPEPTPIVTDVTICSDEDYVWAFNSVT
YNGSAGTQTVFVEGVNCAADQILNITVNPEPTPIVTDVTICSDEDYVWAFNSVTYNGSAG
TQTVFVEGANCAADQTLNITVSPEPTPIVTDVTICSDEDYVWAFNSVTYNGSAGTQTVFV
EGANCAADQTLNITVTPEPTPIVTDVTICSDEDYTWAFNSVTYNGSAGTQTVFVEGVNCA
ADQTLNITVSPEPTPIVTDVTICSDEDYVWAFNSVTYNGSAGTQTVFVEGVNCAADQTLN
ITVTPEPTPIVTDVTICSDEDYTWAFNSVTYNGSAGTQTVFVEGANCAADQTLNITVSPE
PTPIVTDVTICSDEDYVWAFNSVTYNGSAGTQTVFVEGANCAADQTLNITVTPEPTPIVT
DVTICSDEDYTWAFNSVTYNGSAGTQTVFVEGVNCAADQTLNITVSPEPTPIVTDVTICS
DEDYVWAFNSVTYNGSAGTQTVFVEGVNCAADQTLNITVTPEPTPIVTDVTICSDEDYTW
AFNSVTYNGSAGTQTVFVEGANCAADQTLNITVSPEPTPIVTDVTICSDEDYVWAFNSVT
YNGSAGTQTVFVEGVNCAADQTLNITVTPEPTPIVTDVTICSDEDYTWAFNSVTYNGSAG
TQTVFVEGANCAADQTLNITVSPEPTPIVTDVTICSDEDYVWAFNSVTYNGSAGTQTVFV
EGANCAADQILNITVSPEPTPIDTDVTINSNETYLWPVNGITYDGADGDQSVLIEGINCA
ADQILTLTVVCITADNTTTTTSITEDETKTLTSSPNGGTWAIVSGDGTINGNIYTPDDIN
VNTDVTIRYTIAGTSGCSATTDDVTFTVTPSLLLGSIGDQVWYDTDGDGIRDPGEYRLEG
ATVTLDPGTPGNPSDDLTTTTDVNGNYLFTNLPAGNYTVTVDISTVTGGLPPGKALADLI
PTFDADGVGTPNTSSLTLASGENNLDQDFAYVAPSGGTSGGNSGGVESESLGDAISKIYV
GRKKNSMPTEFVKSNENLYNKSKMKSAQPYQGKGQTMLDMFPTELIAGNVANVTSPTDIL
DYTVADEILSVDFSINGETKGVVLGIKTSDKIYNHTKASCDRLRGAEILNIQKVQLEGYN
FLMQGIKQRNDIVEYAISFAVAKNNNDTNYTIQTNWYVNNYTKFNDVYNFQVWSTKPADT
QKMVKDILENLQSFIPMNQTEVQKVPETYASKIYRDKGELIVNLRSTEVGNTADISMVEL
YSETANNIKHRYNTLDTEIQQALRLDIADGYEYEGLIEVENEVEDAFYHADGNWGLDYDK
NYTEILNYFVWNNFDRTYEDDEYSINRNVEVKATSEYDYLTVYKSLLPGTISADYSEYKY
LSFTAKGSGLMELGLIKSSVENWKEQYRIMVDLSEEEQTYYVPFEYFSSTGTTAKITADD
LTTITFTFLPVEANTKELDLFISDVKFTKTAVEEQTIAKIETFENNFMAYPNPSKGNVNV
LLFSEVDTQATVTLFDVTGKEIFVSDVQLTTGKNEIDFNLKVKPGVLFLKVNSKQTDYGT
SKIIFR
>FCMOIPGL_00853 Serine-aspartate repeat-containing protein F
MRKITFLLTAVLLFANTVFSQSPTSPAQGFNVFVENNATLKTNESEGGVAIGGDLTIKGN
YNVNIHNVGTFSTNGTLIGLLVGGKIDYNSSSSGNISVNSNRYVKIGDGTGSTVWYQDQN
GAYSNIRITDGNNYNSSSKIQLQTNAQNLGVSATNNPVIEGSLIDFASAFQTMRASSTGI
SQNTNNAQLTNPNGQTISNTNLPNQVKINLQNGINYLNITGTDLNNVDVFTYNNQPSASK
VLVINVDAAGTFNWDVWNQAGVGFQNAPYIFYNFYNTTQLNINGNSTVEGTVFAPFADID
KSVNQSNIEGQVIGKSIIHAGGQMHYALFDTTLTAPVVCSTADNTTSTTSITENQTKTLS
GNPTGGTWSIVSGGGTINGNIYTPANINTNTDVTIKYTIAADGSCAATSSDVTFTVTPVC
SIVADNTTSTADITEGETKTLSGNPTGGTWSIVSGGGTINGNVYTPANINSNTDVTIKYT
IAADGSCAATSSDVTFTVTPVCNIVADNTTSTADITEDQTKTLSGNPTGGTWSIVSGGGT
LNGNIYTPANINSNTDVTIKYTIAADGSCAATSSDVTFTVTPVCSIVADNTTSTASITEG
QTKTLSGNPTGGTWSIVSGGGSLNGNVYTPANINSNTDVTIKYTIAADGSCAATSSDVTF
TVTPVCSIVADNTTSTADITEGETKTLSGNPTGGTWSIVSGGGTINGNIYTPANINSNTD
VTIKYTIAADGSCAATSSDVTFTVTPVCSIVADNTTSTASITEDQTKTLSGNPTGGTWSI
VSGGGTLNGNVYTPANINSNTDVTIKYTIAADGSCAATSSDVTFTVTPVCSIVADNTTST
TSITENETKTLSGNPTGGTWSIVSGGGSINGNIYTPANINSNTDVTIKYTIAADGSCAAT
TSDVTFTVTPVCSIVADNTTSTTSITENQTKTLSGNPTGGTWSIVSGGGSINGNVYTPAN
INSNTDVTIKYTIAADGSCAATSSDVTFTVTPVCSIVADNTTSTADITEGETKTLSGNPT
GGTWSIVSGGGTINGNVYTPANINSNTDVTIKYTIVADGSCAATSSDVTFTVTPTILVGS
IGDQVWYDTDGDGIKDASENGLEGATVTLDPGTPGNPTDDITTITDANGNYLFNNLPAGN
YTVTVDISTVTSALPSGKTIADLIPTFDADGVGTPNTSSLTLASGENNLDQDFAYVAPSG
GTSGGNSGGVESESLGDAISKIYVGRKKNSMPTEFVKSNENLYNKTKMKAAQPYQGKGQT
MLDMFPTELTAGNIANVTSPTDILDYTVADEVLSVDFSLNGETKGVVLGIKTSDKIYNHT
KASCDRLRGAEILNIQKVQLEGYNFLMQGIKQRNGVVEYAISFAVAKNNNDTNYTIQTNW
YVNNYTKFNDVYNFQVWSTKPADTQKMVTDILENLQSFIPMNQTEIQKVPETYASKIYRD
KGELVVNLRSTEVGNTADISMVELYSETANNIKHRYNTLDTEIQQALRLDIADGYEYEGL
IEVENEVEDAFYHADGNWGLDYDKNYTEILNYFVWNNFDRTYEDDEYSINRNVEVKATSE
YDYLTVYKSLLPGTISADYSEYKYLSFTAKGSGLMELGLIKSSVENWKEQYRIMVDLSEE
EQTYYIPFEYFSSTGTTAKITADDLTTITFTFLPVEANTKELDLFISDVKFTKTAVEEQT
IAKTETFENNFMAYPNPSKGNVNVLLFSEVDTQATVTLFDVTGKEIFVSDVQLTTGKNEI
DFNLKVKPGVLFLKVNSKQTDYGTSKIIFR
>FCMOIPGL_00854 Pesticidal crystal protein Cry22Aa
MKTFKTILITVFTLLFAQIAIANNTNNAVKNDNKVLPTSTTVIDPCDAVASGNLDSDNDG
ISDICDLDDDNDGILDCDENNLNATSSLSSLFSIAGTASFMNSNEIELTPDLQTQAGSAM
SYGKIDFNYDFNFSIEINLGTKDIGADGIAIVFHNDPDGINTVGITGQGIGAWHIKNGIS
IEFDTYQNQDDITNDHTQIKKTSTWAGLTTMTDLGNIEDGNWYPIDFSWDASSKTLSYSF
NGNVIANYTDDLVSNIFNNESKVHFGFTASTGGQRNSQKIRLINDLCSYPFVLDTDNDNI
PNHLDTDSDNDGCPDALEGGSNFTVTTNNNQLTGGVDANGVPLVASTVGQTIGSSLNNNI
VSSICDVPYSPISPTQGFNVFVQKDLTVKTDETKGTVAVGENLTIKGDYRIGSDTCGDFT
TNGSSTTTKIGLLVNGNVNYPLNTTINTTDEDCDCGDPTIIHNGSFESNNTVTTWKQFDQ
NNVDGWRTTSTDEKIEIWKSGFLGKASQNGGFHAEINATQRAALYQVICAEPGSVLTWSV
WHRGRDGVDVADVKIGSTVASATTKAVMKTGKNAWKQYTGTYTVPAGDNKAYFVFQAISS
KPNNNLSYGNLLDNFEVTKTVTGTCPTGTTNPNGILTVVDPSYYTKIGNTNGNASWYFDE
LNAPANIRITPDANYNSSSRIQLSTNSTALNVSSSNNPIFESNLIDFTSAFETMKSSSTS
MSNCSSNITLTDNSNQPINNTNLPSTVKINLQNGANYLNINGSDLNNVTTFTFNQPPSAT
QYLIINVDASGTFNWDVWNQLNIGLNESYYILYNFYNTTELNILGANEIKGTLFSPLADI
NKTVNKADIYGQVIGKSFNHDGGVIHCVKFIPTIKSCTTSSVAPTADFSLNVDPQCLVGN
EYQFTNNSNTGGTIQPTNPITYIWNFGDGSTSTEMNPTKTYVNSGTYTVILTATNTSGSN
TTTKQIEVLANTDPIITETTKNSSNGSVTKELTLTNSTEFSEFYWELASEGSNLFQDQAT
VSFTFTQAGTYNVTVTAIKNGCSSMSTIAITISSNEVTTGNSGGLESESLGDAVTKRYVN
RKKKSEPTIFVKSDDIIYNKTKLKSAQPYQGKGQTILDMFPTELIAGNVSHVTSPTDILD
YTIADEVLSVDFSIDGNTKGVVLGVKTSDKVYNHTKASCDRLKGAEILSVQAVKLDGYNF
LMQGIKQRNGVIEYAISFATAKNNNDTNYTIQTNWYVNNYTKFNDVYNFQVWSTNPTDTQ
KLVTDILANLKSYIPVIQTETQKVPKTYAAKIDREKSNLLITLRSIKKAQNIEITMEEIY
SETANNLKHRYNPVNSETEQILKIDIADGYEYDGLVKVDGEIQDAFYHADGNWGLDFDSK
YTEITEYFVSNDFDREYNDDELAINRNIKIKAVSEYDYLGIYKSLLPGNIPADYTAYKYL
SFTAKGSGLMELGLVKSSIENWKAQYRIMVDLSEEEQTYYVPFDAFTSIGTSENITADDL
TTLTFTFLPVEANTKELDLTISDVKFTKTAVEEQTIAKIETFENNFMAYPNPSQGNVNVL
LYSKVDTNATVSLYDVTGKEIYTAPVELLNGKNEISFNVKVKPGMLFLKVNSKQTNYGTS
KIIFR
>FCMOIPGL_00855 Sodium/glucose cotransporter
MQPIHIILLIVAYFSVLILISFITGKSANNKTFFKANNSSPWYLVAFGMIGASLSGVTFI
SVPGWVEAQSMSYMQMVLGYVVGYAVIGLVLLPLYYRLNLTSIYSYLQDRFGNYSYKTGA
SFFLLSRVIGSAFRLFLVANVLQLLLFDEYGIPFWATVTITILLIWLYTFKGGIKTIVWT
DTLQTLFMLIAVGVCIYTISNELHISNIFSYVADNKLSKTFFFDDVNAGNYFWKQFLAGA
FISIVMTGLDQDMMQKNLTCRNLKDAQKNMFWFTIVLVIVNFFFLALGILLTDYAQKNGI
DAHKDELFPIIATKGTLGLATAIFFLLGLIAAAYSSADSALTALTTSFSIDILEIDKKKK
EADQEKIRKKIHILFSFILIGTILIFKYFIADASVIAKIFTFANYTYGPLLGLYAFGLFT
KLKIKDKAVPFICITSPFLTYLVSYLCLHYLNFDFGFALLILNGLITFIALSIFKLKKAE
A
>FCMOIPGL_00856 Recombination protein RecR
MDFSSKILENAVNEVSRLPGIGKRTALRLVLHLLKQPKENTKYLSEALLHLRNDVKNCEK
CFNISDTVLCDICSSPKRNPEIVCVVEDIRDVMAIESTSQFNGLYHVLGGKISPIEGIGP
QNLEIDSLIEKVSSGEIKELIFALSSTMEGDTTNFYIYKQIEKFEITTSTIARGIAVGDE
LEFADEVTLGRSIINRIPFEQSIRS
>FCMOIPGL_00857 hypothetical protein
MPFQSGLSLFINELQTLKLNLKLMDFLYIKALHIIFVVTWFAGLFYIIRLFIYHIEAEKK
PEPAKEILQTQYKLMSKRLWYIITWPSAILASIFGIWMLVKNPYYLEMPWMHVKLTFILA
LYFYHYSCHRIYSQLQNNIIKYSAFKLRIWNEVATIILFAVVFLVTLKSAINWIWGVVGI
ILFGVLLMLGIKLYKKIREKNSWEKAEKEVLDRE
>FCMOIPGL_00858 Ferrochelatase
MKGILLNNLGSPDSTETKDVKKYLGEFLMDERVIDIPYWKRWLLINGIILKTRPKKSGAA
YKKIWWKEGSPLVVISERFTKKLIKKVDIPVALAMRYGSMTMENGIKELADKGVTEIFLA
PMYPHYAMSSYETVVTKAEEIIAEKYPNIKLDTLPPFYNEPDYIKAMSNNIANHLKGFDY
DHILFSYHGIPERHILKSDVTKSHCKIDGSCCERNSVAHHTCYRHQCFETTKEIAKTLQL
KKGTYSNSFQSRLLKDPWLKPYTDFELEKFPSEGKKKLAVITPAFVADCLETLEEIAMEG
KDEFLKFGGTDYKHIPCMNDNDDWVDVVVKWINDWKNK
>FCMOIPGL_00859 tRNA (guanosine(18)-2'-O)-methyltransferase
MIQLTHNDIENKQQQFPITIVCDAIRTPENIGMCFRISENFGIQKIYFHESSPSLENRKV
INTARNTINQIEHDYYTDFTTVINKLKAEGNTIIGIEITDKSINIQDFNFKNHEKIVLLL
GSERNGIENINLVDYTISIPMFGRNSSMNVIHSLAITLYEVTNQLAVSS
>FCMOIPGL_00860 Regulatory protein PchR
MIENVGESSFEEINLEKGFYILHFQNESNEIQCFEREINSTFIQIHFCLRGNSKFLFNNG
AYSFDVLDNRSILLYNPQRILPINLEIQPKTTLISLLISIEKFHALFSKESGYIPFLSSE
NSNKKYYDDKEIKTTESIVLQQIINSNINSSIRELYVKGKVYELLSLHFQKDETADGEYC
PFLVDEENVLKIRRAKEIIISRMAEPPSLQELANEIGLNIKKLKEGFKQIYGDTVFSFLL
DYKMEHARRLLESNQFNVNEVGTQIGYSTASHFIAAFKKKFGTTPKKYVMGLNQ
>FCMOIPGL_00861 Glutamyl-tRNA reductase
MLEDRQEHFYNIGVSYKKADAKTRGKFSLSKENQIALLELSKEKGYTGVFILSTCNRTEI
SGFAERPCQLIELLCEFSEGTIQEFSQVSNVYKDNDAIKHLFRIGTGLESQILGDYEIVG
QLKQSLKLAKSVKTTNAYLERLINSVLQASKRIKNETKLSSGTTSVSYAAVQYIIKNLPD
YNSKNILVFGLGKMGKHTCKNLAEYTQNKSVCLINRTEEKAAEFVKEHASIRKSTIGNLS
EEIKKADVLIVSTGSDKPTITKKHISENKELLILDLSMPENVSKEVADFKGVSLVNVDEL
SKITDETLTIRLQEVPLAESIIVSHKKEFKRWLNHRSFTPTIAALKVSLENIKNDEINFQ
KKKIDNFDENQAEILTSRIIQKITTQFVKHLKDDETSVSESIQIINKVFHHK
>FCMOIPGL_00862 Porphobilinogen deaminase
MQKIIRIGTRDSKLALWQANKVRKELEALGYQSVIVPIKSTGDLIQDKPLYELGITGVFT
KNLDIAMLNGEIDVAVHSLKDVPTVLPEGIIQIAVLKRANYTDLLVLKDTEEFFGQPNGV
IATGSLRRKAQWLNRYPTHKVEDLRGNVITRLDKLHNSETWNGAVFAAAGLERLGIRDKG
AIPLTWMIPAPAQGTIMVACLENDDYVKDACEQINHYETKVCVGIEREFLRLLEGGCTAP
IGALAYIDEKTQEVNFKGILLKKDGSRKITVNQNVKLGSHKFLAKDCADYVINRGGKELM
LEDNEVSKKLQHIYSTKKLSKAQKEILSPEIGVQDSDFIKIRFNRIPPKVMKSEIENVVI
TSQNGVEAILNSFTKDEIKFKSIYCVGRRTKKLIENRIGKVAHVTKNAKKLGEYLSKELI
NKEVTYFCSNLRLDILPAYLQLHNIVVNEVEAYKTMLSPVEIDKEVPGVLFYSPSGIESY
LEKNSTDKVAFCIGETTAKEARKHFEKVEVAHLPSVESALELVNSYFTK
>FCMOIPGL_00863 Delta-aminolevulinic acid dehydratase
MFRTRRLRKSEGIRRLVRETKLSVDDFIYPLFIEEGENIETEIVSMPGIKRFSLDRISKE
LDEVVSLNIPAVLLFGIPSNKDDEGTETWNDNGIMQQAIRFIKKNYPSLYVITDVCFCEY
TSHGHCGIIHDNDVDNDATLVNIAKQTISHAKAGVDMVAPSGMMDGTIDMMRQALDNSGF
VNLPIMGYSVKYSSAFYGPFRDAADSAPTFGDRRTYQMDPANRDEGMREATFDDQEGADI
LMVKPALSYLDIIRDLKNNFDRPIACYNVSGEYAMVKAAAEKGWIDGEKVMMESLLSMKR
AGADIIITYFAKEAAKVLLKK
>FCMOIPGL_00864 Glutamate-1-semialdehyde 2,1-aminomutase
MKFKKSEKLYKKGLKNLVGAVNSPVRAFSSVGGNPLFIKKAKGTKITDVDGNKYIDLVLS
YGPMILGHRHKKVQKAVEKALKNGYSFGASTENEIKLAKIVCDAFPGMDKVRFVNSGTEA
VLSGIRLARAFTGKDKIIKFAGCYHGHQDALLVAAGSGLATLSLPGSKGVPEGAVKNTLI
ANYNDLESVKKHFKEYKDIAAVIIEPIAGNMGVVLPEDNFLVELKKYLESKGALLIADEV
MTGFRSKFGGAQELLGVQADITCLGKVIGGGFPVGAYGARNEIMEMVAPLGGMYQAGTLS
GNPIAMAAGIATLTELKKQNPYEHFEEIASILEVLLLESAKKHKIGLVVNRFGSMINPFF
LKGEVTNFVEAQLSDTKKFAVFFWEMINNGVFLPPSQFEAWFLSSALTDKDIKKIATAID
KAMLAVSKM
>FCMOIPGL_00865 Uroporphyrinogen decarboxylase
MIKNDLFLRALKGETVDRPPVWMMRQAGRYLPEFQEIKKKYDFFTRCQTPELASEITVQP
IRRYGMDAAILFSDILVIPQAMNIEVEMKPNFGPYLPNPIRTQKDLDRVIVPDVHETLGY
VMEAIKATKEKLNDEVPLIGFAGSPWTILCYCVQGQGSKNFDKAKELCFTNPVVAHSLLQ
KITDTTIAYLKAKVEAGVDAVQVFDSWGGMLSPVDYQEFSWQYIQQIIDALKDETPVIAF
GKGCWFALDKMAKSGASALGVDWTCSPRNARYLSGGQITLQGNFDPTRLFSPPKVIKKMV
HEMINEFGKDKLVVNLGHGILPNIPLENAKAFIDAVKEYKN
>FCMOIPGL_00866 Sulfate transporter CysZ
MIKNIILGIKEYAGALSLISKLKLWKYFIIPVLISIVTAILIGVEAYVLSDNIGSYIAKA
WVWDSGKETFTSISNFIGGLIVVIIGLIVYKHIIMALSAPFMSAVSEKIEHHFYGNVKHL
HRKTSFTEQLIRGIRINLRNLLKELLITFPILLLKFIPIINIFSTILLFLVQAYYAGFGN
MDYTLERHLDYKKSVDFVGKNKGYAIGNGIVFMLCLLIPIIGIIIVLPLSVTAASTKTLS
LLHSKHE
>FCMOIPGL_00867 Oxygen-dependent coproporphyrinogen-III oxidase
MKNKFYKYIENLQNTITSKLEEVDGLAKFEEDIWERKEGGGGRTRVIENGNVFEKGGVNI
SAVYGDLPEVLRNQFKVKEGNFFACGLSLVLHPKNPFVPTVHANWRYFEMYDEAGNIVNQ
WFGGGQDLTPYYLFDEDATHFHTVCKSACDKHHPAFYPKFKKTCDEYFWNSHRNEARGIG
GLFFDYQKKTEEFSIEDRFNFVTEVGNSFLESYVPIVEKRKEIGFTKEHKDWQEIRRGRY
VEFNLVHDRGTLFGLKTNGRIESILMSLPPIVQWKYNHHPEKNSEEERLTQILKSPKEWI
>FCMOIPGL_00868 hypothetical protein
MYYKFILIFFLFFVLKANSQNLDSIFISKKEILKSIKTDDKKLQFLFECGNYFYSKNVSK
SEYFLREALLLCKDKNAIIEGDVLHKLGFIEKNKGNLSTSLRYFNRAKDIFEKTNDTERY
ASIFFDIGYLYRYKNQMNKEFEFYKKGLELSVGQDELILGKGYLHLGNYYTRLQKLDSSI
YYYDKALEVFKKLNRDDRVYNVYNNIANTYYKQGEYNKIINIRTLVLKFAKKESNQLLVS
VNYHNIAAAYSKMKEYNKALKYLDSAIMVAKKENFKLRLSKSYGSIAKINYAMKNYRESY
IYYQKYKIYSDSIYESQLSNTIVEAEIENKLKIEKKNLEIINQKQAFDKKLYLIIIIVFF
LLSIPLVILLYRNSENKNKIIEANLEKEKIKKEVLLQKFKRSEIEIKNLVADNSMRLEFL
KQLLSQLKKQRKSINSIDVKNYIKDLSFKIQQQITTDSKLTVLKQRINSINDGFDNMLIS
HYKDLTKTEREVCALLRLNLSVKEIASIRNSSSDAIKVTRYRIRKKMNVPKSQKLEIFIQ
NLSV
>FCMOIPGL_00869 Reverse gyrase
MNLEQNELNSPLSNLNFIFTWRPYQEKVLKNFDKFIKDNHFHVIAPPGSGKTILGLELIK
RIGKKTLILTPTITVRNQWENRLQTFFTHNNSFTDFSFDIRKPKTLTFSTYQSLNSLYKS
FENKNEYFNFFEEHNIDVLALDEAHHLKKEWWTCLYELKKQYHKTIVALTATPPYDSSNT
EIKKYFSLCGEVDDEIMVPDLIKENNLCPHQDLVYLSEPLDYEINFIVNYRIKIANFIDA
LLVDTHFITFLKQHRFYQQTENNIDEIYQNIEYFSAILIFLNQVSEHINQEKLSVLGFNK
NETIEFPKVTNNWIEILLQNLLVTDRINLFNKEGYLHELEKKLRKISAYKQNKVNLTGNK
TIYKSLSSSPSKLNSICEIVLHEQINLKANLHCVILSDYIRKEYLNACNTEIDAINKLGI
LPIFHKLRKCIPHKNTIGVLTGSLVIIHESILYLLQEKEPLSMYSGTPLSSQNEFLIINS
KSSKNQIVNSITELFESGDIKILIGTKSLLGEGWDAPSINSLILASVVGSFVTSNQMRGR
AIRMHIKKPNKVGIIWHLACVDLSEKSGGKDLEILSRRFTAFLGITYSEKVVITNGFGRL
QIPAKLNSDTIKTYNQHNFKKAKNRNQIKNNWNKAVSIGKSITQEILLLNQEKDKPATKT
KIFYQDIVKYLSIEVIIGISYFLPNFIFKNLNIILNKGIVTFFFSLLSAFAFAFGYKIFT
ITKLYIRYGFIYKKIHKMALTILDTLITIKLITTDKNEILISTEKLSNGNISCNIQGANK
LESQLFTNALDEILKPIENSKYLIVKTNWYRKKLNIYNFFAIPEIFSNNKKEALLFQENW
LKHLGKSKLIYTRNKIGRRILLKARLSYIYNIDKKITKKNVIWK
>FCMOIPGL_00870 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MARFELKLPKMGESVAEATITSWLKEVGDTIELDEAIVEIATDKVDSEVPSEVEGTLIEI
LYQKDAIISVGETIAIIETETSGETPIATQPKAEVPKEVEEIENAIEKAVNVVSTPIAKT
SHSGKFYSPLVRNIAQTEGISMKELETISGTGKDERVTKEDILSYIENKVKSPQNIVEQA
SEITKVEAPKQVEKVVAKATPVSVNGEDEIIEMSRMGKLVAKHMVNSVLTSAHVQSFIEI
DVTNIVKWREKVKDAFFKREGEKLTYTPILMQAVATTIKKYPLINIAVDGENIIKKKNIN
LGMAAALPDGNLIVPVIKNADQLSLVGITKAINDLAVRARNNALKPDEIQGGTYTVTNVG
SFGSVMGTPIINQPQVAILALGAIRKVPAVIETLEGDFIGIRQKMFVSHSYDHRVVNGAL
GGMFIKTLKEILEAWDVNQDF
>FCMOIPGL_00871 hypothetical protein
MKKLLVLFLVVSSTISFAQESVLLRLNYNKGDVYNAQMTMSQEMGTMMSMGMNIDMNMKI
IDVTDDTNTSEMSFTKMTMDMLQAGNVMSFDSTKSDDELDEAGKMVKAQMSPMLAAVLTA
KGNNLGEVIEMKAEPNVPGMDDFANQSNVIYPKEAVKVGSTWTYQKNQKGMILDFVYTVK
SILKDKVELDITGKSSGMATGDITGTMNIDKESGVPLSSVIDMKLSMQGQDLISKVTMTM
TKL
>FCMOIPGL_00872 hypothetical protein
MKNLEDKLKNPVWYSLNETHKKYLIEFDGVQFYRPNVNIFGAFFDEEKTAKALNEYSKIA
NKFFLVSENQVPIIDANHVILEKKINGCQMVFDHLIDIEITENIVLLSKEYIDEIYELIW
LVMPGFYQKGGFEMGKYYGIFKDNKLVSITGQRMQTDDFIEVSGVVTHPEYTKKGYAKQL
VTYTTKEILKERKLPILHTNKGNPAIALYKKLGYKLTRDMNWWLFSRK
>FCMOIPGL_00873 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MATIINMPRLSDTMEEGVVAKWLKNVGDKIEEGDILAEIETDKATMEFESFHEGTLLYIG
IQEGETSPVDTLLAIIGEEGEDISAFVKGNSPSEETETKAEVKEEVVAETSNSDAVEIPK
GVQVIMMPRLSDTMTDGTVATWLKKVGDKVEEGDILAEIETDKATMEFECFYEGTILFIG
VQEGETVPVDSLLTIIGPEGTDVSAIVANGGNVSSSEPSEKATPSEKKEEKKVETVAEPV
ATTNTSTNNSGGRIFASPLAKKIASDKGINLADINGSGENGRIIKKDVENYTPTAQPTQA
AASNAAPAVSFVAAGEEKSEEVKNSQMRKAIAKSLGNSKFTAPDFSLNIEVDMDNAMASR
KTINAIPDTKVSFNDMVVKACAMALKKHPQVNTSWTDTNTVYHSHIHVGVAVAVDDGLLV
PVIKHTDALSLTQIGAGVRDLAGKARNKKLAPTEMQGSTFTVSNLGMFGIENFTSIINQP
NSAILSVGAIVQKPVVKDGQIVVGNTMNLTLTCDHRTVDGAVGAQFLQTLKTFIENPVTM
LA
>FCMOIPGL_00874 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKKITKQTYLDWYKDMLFWRKFEDKLASVYIQQKVRGFLHLYNGQEAILAGALHAMDLSK
DKMITAYRNHVQPIGMGEDPKRVMAELYGKATGTSKGMGGSMHIFSKEFRFYGGHGIVGG
QIPLGAGLAFADKYKGNDAVTLTCFGDGAARQGSLHEAFNMAMLWKLPVIFIVENNGYAM
GTSVNRTANHEDIWKLGLGYEMPCGPVDAMNPIKVAEAVDEAIQRARRGDGPTFLEMKTY
RYRGHSMSDAQHYRTKNEVEEYKKIDPITQVLDVIKENNYATDEEVDAINKEVKRMVKEC
EKFAEDSPYPEPKQMYDMVYEQEDYPFIS
>FCMOIPGL_00875 hypothetical protein
MKSFLNVLLLIFCFFLSTTTLVAQLDNNNDSKEKGKIKAIILNNSKEATKPKALDLDGSD
GFKKVYDEENKKLKEKQKKSDLKNKGILTQEKINEQNFLKSFKKINGQYSIPKIDQDLGS
FRTDSKSVNIICRDFQYPDGDRITIFVNDIPVIHNIELKSSYQKFNIPLEIGINKIAFTA
LNQGSSGPNTAAFKVFNDTGTLISSNEWNLATDAKATIVIAKDK
>FCMOIPGL_00876 D-alanyl-D-alanine dipeptidase
MKNLLFLLTVIISFTLYAQKLPEGFVYLSDVDATIKSELRYFSNNNFIGKKIDGYYANCV
IVTKETADALQKIQSTLAKKGLSLKIFDAYRPQQAVNHFVKWAKVLNDTLMKQQFYPKVH
KSALFNSGYIASRSGHTRGSTVDLTIVDAKTGKELDMGSPFDFFGVESHPFYKNISENQK
ENRFYLRKIMLANNFKPYDNEWWHFTLRNEPFPKTYFNFPIKD
>FCMOIPGL_00877 hypothetical protein
MEELTLTTPALLFSAISLIMLAYTNRFLAYAAVIRSLHSEYLESKDASLLRQIKNLKLRL
SLTKWMQIFGISSLLFCVLSMFIIYINYHRVAEFVFGFALILLIVSLALLIKEIHISNEA
LKHHIADIEEHLENKN
>FCMOIPGL_00878 hypothetical protein
MENRFNISVLIDGDNAQPKLIKEIIEEVSKYGKATIRRIYGDWTSQQMNSWKATINQHSI
TPIQKFSYTTGKNSTDGALIIDAMDILHGKSTEGFCIVSSDSDYTGLAKRIREEGLFVMG
IGEKKTPTAFVKSCEVFTFTENLKNDEEEDEKNTIETDNTKKKAVKKAKSITSNIRLSKE
DWKTIMKAFDISLNEEDKAHISTLGLNIRKIDPSFDPRSYGFKNLTKLFENIDKFEVIKN
EVNGLNHPLLKMK
>FCMOIPGL_00879 hypothetical protein
MKIKFLYIILSTLLFSCNNEKEISSVNPENWTKRTADISTKDSLENGKSYLSIYSQIYSM
SEHKTHNLTAMASLRNTSDVDSIYITKAVYYDTHGKVVRTYFDYPIYLAPMETTEIIIDE
VDVSGGTGSNFIFEWKIPKNCPEPLFEGIMSSTIGQQGLSFTTHAKRIK
>FCMOIPGL_00880 hypothetical protein
MNSFLTPFRESIILKTLFAIALFLYSLMTSAQVDKNSDLFKTLKSKDSILFASSFNNCDI
EKFEPIIAENFEFYHDLGGVQNKEEFIAVIKNNLCTNLGMNQRSLVDTSLEVFEMKNNNK
LYGAIQKGKHTFQQKIDGKMKTVGIADFTHLWILENNQWKLKRVLSYNHQPLTE
>FCMOIPGL_00881 hypothetical protein
MKSTTTKFLTLLFTITLFTSCNINMFNRVNGNKNVVTEDRTTKEAFTTIKVSSGLDLFIS
QGSKNKIIVEADENLQEIIITEVKNGELKIYSEKNIWRAKARKIYVTVKNLETLTATSGA
EVYAKESLKVNNLRISATSGAEINISVNANTVETNATSGADIEISGISNKYITNATSGAS
IDAYELKSKNVIAKVTSGADINLFVSEKLDAKATSGGDIDFKGNPKKVDKKSTSGGSISA
E
>FCMOIPGL_00882 hypothetical protein
MNKTININLGGFFFHIDEVAYQKLRRYLESISKSLSDDPQGKNEIIADIEARISELLSEK
ITDARQVVNESDIDDIIKIMGQPEDYAEAEESYNESTYSYTRNNASGKKLFRDGDDKFLG
GVASGIAHYFDIDTIWVRLGLLALFFGAGFGVLIYIILWILLPEAKTTAEKLQMEGEPVN
IDNIEKKIREEFNNVSENVTVFANKASEKIKDGANEFSDKMSKTFSGKTKKNNGLQDLFE
TLGKIILAIFKVIGKFIGVIIIFVSAAVILSLIIGGFSVGSLEWLNVDGQLLQYPPFFYD
ATLPKWLLVLSAFFLIGIPFLILFILGLRILSSNVRKLSKPASLTLLGIWIVALLAMIFT
GLEYGTSYANYGQSTEKNTLNIVKNDTLRIKMINDDTIYYRHNLRRNSSQEEVEIDGTMM
TYSNYIKVDVKRSSSNESYVIIQKESRGKNKSNASKNAQNIKYKYEVVDNTIVLDAYFLS
EYKNMWKDEEINITIYVTENAYVYFDNSTKHFLNDVDNETDIYDKEMVNHHFLITESTLK
CTDCIEEIEDKKEVLEEQANEKVDEKLVKKHELTV
>FCMOIPGL_00883 hypothetical protein
MKIENTKAQMRKGVLEFCILSILKNGDAYTSEILSSLKSAEMIVVEGTIYPLLTRLKNAG
LLTYRWEESTSGPPRKYYVLTENGGMFLKELDKTWHNLVNSVHQVTSKKATTNE
>FCMOIPGL_00884 hypothetical protein
MKKNNENTNAFLIHISAFAGFIFPFGNIITPLIAWQTLKDRSTFLDEQGKEAVNFNISYT
LYVFLLTLTFIPFAFGSIFRNNHHLWNNNHFNFNLNFDNLFGFISFGTITTFIYIIGIAL
VIIASKKAREGENYKYPFTIKFIK
>FCMOIPGL_00885 hypothetical protein
MFFKLPLGWWSGMRVLSLTNTTAVVNIKYKWMNQNPFKSMFWAAQGMAAEMSTGVLVMQE
IEKSNRKVSMLVTHQEGDFFKKAKGKIVFTCSGGNQIREAIEKSIKTGEGEVVDLISEGI
NEDGVVVSNFKFQWSLKVK
>FCMOIPGL_00886 hypothetical protein
MKYLSPQIEALSKQFEITKSLARTNVSCGIFQECDYNEERPKLYEKRNEIYKK
>FCMOIPGL_00887 hypothetical protein
MYQDKLPRNSSNSSNRLNAHEIDYKIFGEEMQFVEIELDPQEGVVAEAGTFMMMDDNIKM
NTILGDGSNQDKGLLGKIFSAGKRILTGESLFMTVFTNDGVGKKQISFASPYPGKIIPID
LTEFGGKFICQKDAFLCAAKGVSIGIEFSKKLGRGLFGGEGFIMQKMEGDGLGFIHAGGT
MAKKVLKPGEVLKVDTGCIVGFTQDVNYDIEFVGGIKNTIFGGEGMFFATLRGPGTVYVQ
SLPFSRLAGRVLAMAPKTGNGSRGEGSVLGGIGDLLDGDNRF
>FCMOIPGL_00888 putative transcriptional regulatory protein
MGRAFEFRKARKMKRWSAMAKTFTRIGKDIVMAVKEGGPNPDSNSRLRAVMQNAKAANMP
KDNVERAIKKATDKDTADYKEVLFEGYAPHGVAILLETATDNNNRTVANVRAAFNKCDGN
LGTSGSVAFMFDHTCNFTVKKEDITMNMEELELELIDFEVEEVFDDEEGVIIYAPFEQFG
AIQSYFEENNIEILSSGFERIPTTTVKLNDDQKADVEKLLEKLEEDDDVNSVYHSMEE
>FCMOIPGL_00889 hypothetical protein
MKKITFLLFTIVTTAFFGQEKLTSSLSEYFNGEKWVSSNKATFTYDNDNNFTEEVEFYWD
SSTSKWIKSYASKYVYNDDNRVISETYENYDATGNIDGEQYKTINTYNSSGDLSQILNQK
SVNSNWVDEGKFELSYTDNRLSSALGYEWNGATWIFGDDSSRITLTYNANGKVYISKSDS
WDGTNWIDSDRTVYTYDANNRIIVEDGQTWDGTNWETDYKSEYTYDANGNAITEKDYYLD
DDVLVEGDLETITFDTSKLISSYLHPFKDRTGIDYIFSANGIVNKILARSSTNYRTTYNY
GDATANVNNFSLANFTIYPNPATSVLNIDDSNFTIKNVEVYNVLGKKIVTSSINQLNIEN
LVNGVYLVKVQDDKGNIATKRFVKN
>FCMOIPGL_00890 Acetate kinase
MNILVLNAGSSSLKYQVIEMPSQIVECVGLVERIGMEDAIFTHEKNGEKYSETLPIKNHE
VGLQKIAKTLLDSKIGVINSVDEIEAVGHRVVHGGSKFSKTVIINDEIKDKIRDLFDLAP
LHNPANLTGIEIAETIFTSAKQIAIFDTAFHQTMPKEAYQYAIPNSFLEDHKVRAYGFHG
TSHKYVSEKAMEYLGEKSKKIITIHLGNGCSMSAVKDGKSIETSMGFSPTNGLIMGTRAG
DIDQAVIFLLMKKLNKSADEVNNILQKESGMLGLTGFSDLREIEEAAEKGNEKCQNALQL
AAYRIKKFIGSYTAILNGLDAIVFTAGIGENSDLMRELACKNLYFLGIDLDKNKNKIRSK
EIREIQSNESKVKILIIPTNEELEIAKQSYNLLK
>FCMOIPGL_00891 Phosphate acetyltransferase
MSKSIYITTIEPNSGKSLMSLGILRMMLNQSSKVGYFRPIINKDKNSLYDDHTYTAINFF
NLDIKYEDCYAFEQSEVVELLSEGKKDKVIHDIIKKHKSLEAQYDYVLVEGTDFSGEGGF
TELDVNLMIAKNLGIPVLIVGAGNDKKKKDFINTMQLSYNSFIQKEVDVIGVIANKIEVD
EIGYIKTELRKVIPNEVHIDVVPKVHFLANPTVKEVVESLNGRVLFGEQFLDNSIGSYST
GAMQLRNYLTRIKENTLVVTPGDRADIILGAIQANSSSNYPRIAGIILTGSLIPEDSILK
LIEGIQSSVPIISVEGGTFGITNKIGAVKSKIYASNSKKILLALDTFDTYINVESLSSIL
SKFNSDKLTPSMFQYNLLQKAKSSRKHIVLPEGNDERIMEAAARLQLLNIVDLTLLGDRR
EIQNKADQLGLQIDLDKINILNPENSIHNNDFAKTLYEARKHKGLTETTAMDLTRDVSYY
GTLMILNGLADGMVSGAVHTTMHTIKPALQIIKTKPGVSVVSSVFFMCLSDRVSVMGDCA
VNPNPNAEQLAEIAISSAQSAEAFGIEARVAMLSYSSGSSGKGEEVEKVRKATEIAKKLN
PDLLIEGPIQYDAAVDMSVAKTKMPDSKVAGQASVLIFPDLNTGNNTYKAIQRETGALAI
GPMLQGLNKPVNDLSRGCTVDDIFNTVLLTAIQANQE
>FCMOIPGL_00892 putative propionyl-CoA carboxylase beta chain 5
MDINFNKNEDYNKLLVSDLRKRFAKVKLGGGQKRIDKHHLNGKMTARERIDYLLDSNSKS
IEIGAFAGDEMYAEHGGCPSGGVVVKIGYIKNKQCIVVANDATVKAGAWFPITGKKNLRA
QEISIENKLPIIYLVDSAGVYLPLQDEIFPDKEHFGRIFRNNAIMSSMGITQISAVMGSC
VAGGAYLPIMSDEALIVDKTASIFLAGSYLVKAAIGETIDNETLGGATTHCEISGVTDYK
AKDDKDALDKIKFIIDKIGDYDKAGFSKTESFPPKENENDIFGILPKERNAQYDMLEIIK
RLVDNSEFEQYKEGYGQTILTGYSRIDGWAVGIVANQRKLVKTKKGEMQFGGVIYNDSAD
KATRFIANCNQKKIPLVFLQDVTGFMVGSRSEHGGIIKDGAKMVNAVSNSVVPKFTIIIG
NSYGAGNYAMCGKAYDPRLIVAWPSAELAVMSGNSAAKVLLQIETASLKKRGEEITPEKE
AELFDKIKSRYDKQISPYYAAARIWTDAVINPLDTRTWISMGIEAANHAPIEKKFNMGIL
QV
>FCMOIPGL_00893 HTH-type transcriptional regulator RamB
MMIEDEYIRLIFGLKLKQIRTEKNLSLFGLSKLSGLSKSYLNEIEKGKKYPKPDKILLLS
ESLEVPYDHFVSLKLDKNLAPIGDILQSKILKEIPLELFGIKENNLIDIIANAPAKVNAF
ISTIIKISQNYNLTRESFFLASLRSYQEAHNNYFEDIENDVEKFAKSYHLDVSKRITSIQ
LEEILIEEFSYTIDDKELSKYENLGEIRNIYIPKNKTLLIDKNISEAQKTFIYAKELAYN
YLKIEDRLYTFPWVKFENFDQVLNNFIASYFAGALIISRKSLTEKLTDFFALEDWKPLKL
HQLIKHYNCSQETFYQRLTNILPKYFNIKNLFFLRFTHKENSPEYKLSKELHITQQQSPH
ANRNNEHYCRRWVSIKTIQDLEKSNKKRATFGIQISSYENQKNEYLVLSSATPDPFKKDI
NRSVSLGLLLSPHLKKKLAFLKENTFHKNLVGVTCETCSVKNCTERIAEPTRLEKQHLHS
EIAKTVDNIINSYS
>FCMOIPGL_00894 Malate synthase A
MKENTIAKEISFNGFKIDEYQDVLTSEAQLFLLELHDKFNQRRLKLLEERKVEQAYFDAG
NFPSFPKETKSVRESNWVCAPLPEDLLDRRVEITGPVDRKMVINALNSGAKTFMVDFEDS
NSPNIHNNLQGQINLRDAINKTISFHDDKKNKTYQLGENTASLIVRPRGLHLDEKHFMVD
GEKMSGSLVDFGLYFFHNIKALQAQNSATYFYLPKLEHYLEARLWNDIFVFAQDYLNVPQ
STIKATVLVETITASFQLDEIIYELKNHMAGLNCGRWDYIFSYIKKFRNHKDFMVPNRDQ
ITMKTPFMKAYSLLVIQKCHKRNVHAMGGMAAQIPIKNDEMANQLAFKKVIADKEQEVKN
GHDGTWVAHPGLVSVAMAVFNENMKTKNQIHKSRSDVKVSEADLVEIPKGTITEEGIRKN
INVGILYIESWLRGNGAAAIYNLMEDAATAEISRTQVWLWLRNGIIINNGETFNTKNYEK
FKHQEIEKIKNYVGQSGFDTGKFKEAIQLFDELVLTENFEEFLTLKAYDQI
>FCMOIPGL_00895 Isocitrate lyase
MKNLSENSYSSALDTVRNLKQKYGNSWNAINSESAARMVSQNRFKTGLDIAKYTASIMRK
DMAEYDADSANYTQSLGCWHGFVAQQNMIAVKKHHKTTSKRYLYLSGWMVAALRSEFGPL
PDQSMHEKTAVSSLIEEIYDFLRQADAIELNDLFRRLERGEDVQNEIDNFDSHIVPIIAD
IDAGFGNEEATYLLAKKMIQAGACAIQIENQVSDAKQCGHQDGKVTVPHEDFIAKLNAIR
YAFLELGVEEGIIVARTDSEGAGLTQKLPVSQESGDLASQYLAFVEAEEIAINEAKEDDV
LLKRDGKLVRPVRLANGLYKFKEGSNVDRVVLDCITSLQNGADLLWIETPTPNVKQIAHM
VNRVKQIVPNAKLVYNNSPSFNWTLNFRQQTYEEMLAEGENMTAYDQNNLMDQQYDASEL
GYRADRKIKTFQIDGAREAGIFHHLITLPTYHTTALHMNDLTEGYFGEEGMLAYVKGVQR
QEIRKGVACVKHQRMAGSDLGDDHKTFFAGDKALKASGENNTSNQFETVEESKEMRNEIG
KVA
>FCMOIPGL_00896 hypothetical protein
MLKKSFFYSILFLISFFTFQNTNAQLSKTHYLPPITSDDPIENQYIYISTPKNNNVNFTI
TPIGRPSSEEIKGTVSNSKPYTTTSSRVGDQLFQESNNTATIITTKGYIIEADDVIYVSI
RMVSSSTFQAAAIVSKGNSALGTDFRMGGFWSPSPKGGFLNFISVMATEDDTNITFDDFS
AGISINNYSGSLPFTKNLNRGESFIVSVSSDAGGDPNDLIGTLIHSEKPIVVNSGSATGS
FYEGSNNRDYGIDQIVDASKIGTEYIFVRGDGEDEWENVLIVAHENNTEIKVGGTVVKTI
NTGEFHVIEGGYYNANGNMYIETSKPAFAYQGVGFGDDAANQGLFFVPPLNCESKGNVDN
ISSIDEIGSNNFGGGVTIVTNTGATVSINGLPTSSFSSTGPSSVNGNPDYVTYKITGLTG
NVSVESSEELYCAYFNRNGAATSGSFYSGFPSAPEINFNTTVSSLGNCIPNITLQAANTE
LFDGGIKWYYYNETTLTWEERSTNSSYKPIASEPGRYKLVGIIDCTGATFESIEIPVSIC
PDDFDGDLIIDNLDVDLDNDGILNCDESFGNAALNLSDINNPEIIFADNTKTSSITTPIF
TITEPTNSFTGNTEGDFVSVINPATDSKLKYEINFNQKINFKFTQNKAFDHKVVAGEFFI
LKIGPNSKNITLLDPDDQLLIDTNFDGEFEDGITNISASEIWYKYKSNTTGAASTFEFLA
NQVDQIDFKHQSSGIAATSTFNGNIQLTCFSLDSDGDGIENMFDLDSDNDGIPDISEASS
PQIILSNLDVNQDGLDDIFNGIITNIDTDNDGIPNYLDVDSDNDGIFDLAEAGHNLVDTN
NDGIIDDANATSVGINGLINNLETTADNAILNYTITDTDSDTILNFLELDSDDDACFDTK
EAGFTDANSDGIIDASPFQVDTNGKVLNITNGYTTPNLDYITSAPIVITKFEDEIFCEAS
TDTITIETTADSFQWWVSIDGTTWNIISDDAIYSESSTNSLKLTNIPLTYNNNKYRVVLN
RTGNACTITSDIITLTVNPKPIVTAIVELKQCDDDLDRISTINLTEAEISISSNYKNETF
TYFATEAHAIAGTPEITDKLRYPVNQNGEAWVRTISTEGCYNISKINLEVEASADVIYNK
EFPAVCDDFLQTDGTNGALNNDTDGITNFNFSDAESEILFFFPAILRPDLEVSYYESKDD
RTAVINKITDISNYRNIGFPSNITRQTIYFKITNKNNNNCNGTGELYLKTNSVPTAKTVD
DLELCDDINDGDATNGIVQSFNLESQTATILGTQNPADFTVTYHDSAANANSGNDPLSSP
FTNSVRDLQTIYVRVTNNSTGCFTDHTTFNLIVNPLPIANFVGDLEVCDDNTDGSARNGF
SDTINLESQTAGILGTQDPSLFTVTYHRSLAEAQNGNSPLVSPYTNLTPYRETIYVRVYN
ADAQCANGISNFDVIVNPEPTFETISNLSECDNNDDFDDANNIIQTIDLDGKIPEILGAS
QDPDDFNVTFHSSKANATSGDLPISSPYENSSATETIYVRIQNKKTGCINDDAFFDVIVN
PLPDFTVTTPQILCLNNLPLNIFVENQKGTYEYVWKYQNGDTVSTEDNVNISVAGTYTVT
ATTTNGTFCSRTETIVINESNIATLENSFITIIDESNNIGSESNLSIAINTIDNDLGPGD
YQFAIENTDENTRIPFAGFQDDPLFENLEGGIYKIIVNDKNGCSPDTTLLVSVIQFPKFF
TPNADGDNDTWIVRGANKTFYPNSSINIFNRYGKLVAQLPIDGQGWDGTYGGKTLSSDDY
WFNVTLIPADITKPAINKKGHFSLIRK
>FCMOIPGL_00897 hypothetical protein
MSDDFDLLETNSAEKTEKVDVNWGKAVDTMKSKLAQEDDPQQRQKILNATLDDVVHMAEK
DRTTLLDAIKDLTDYQDEVGIMFEKFSALNPTEQKVIDDAQKELERARIELEDAQNKPDT
WWNNLWGRKSKIKKEEVEFAEAEKIRAGADNKAKAMFQQRIESADIQTLLSELSYKSQAA
VSRLKNREVEIKEVEEKLKDAIVEASKNHTKALEKKKEIEDKLEEQYALLKQSRQELDEI
ADKQSTEYSEAIGKVTTLEQKVEELEGLKNAYTTLAASKDSFVHKHNLTIKVLTSLRSNL
QTHRAKLKSDTEERLKYYDGYVVALKARTDQEFAAILEHLGVKTDEHIGATLASMHSASA
RARQEMMDNIPVHEKVMKGVYSTYAEALQEIREKDGDIQKNFADRYGIDMKEIFEDFYKA
DKETPVLEDNSTTEAPKKEVSDDDMLS
>FCMOIPGL_00898 hypothetical protein
MATFTSSLPDALLEKLSTLAKELKLPKNRLIENALELYLEQIEKASYIKSYQQAATDKDI
LVVAEEGMQDYFNTVNNADSK
>FCMOIPGL_00899 Endoribonuclease MazF
MKQGEIWELYLNPTEGSEQSGRRPAVIISGNMLNKYLQVVIVCPLTTSVKNYKGNLIIKP
NAKNGLTKISEVLTFHVRSVSKTRFDKKLGEIPLKDVEVIKKTLNDILKY
>FCMOIPGL_00900 hypothetical protein
MITTPLDSAVLNTKEQYVFYHKMVDFVLKEIIVRIQQEQLCSQQEVVFFKQYSDLLLYSI
EAMRIKYMYDEEDNMKVDLTDSGFPNYLEFRYLYNDLELRKQYLDKLVDTSILKEQFLDT
LLRKKQPIKKTELFKASSIIYYTSVERQFIFNRFVQGKILDAPKDANYDYVTSWSFYDVS
HNRPFICFMYFNYDGNNAIKDKEKIYQTLKESADREMSLDTMAYNIDRKLTGIQPKHIKR
IDLGPLHNVFAKDENQITHAILSGISSKTVSLESYAVSLTIDEVFSGDTFTEGGFFSKQT
MQKWSDVIKQKYLFAPHRIIQLLHNQIPRSLDNLAKEPIQMADLKVK
>FCMOIPGL_00901 hypothetical protein
MEHNSTFPIKQNELDMLRDEATDYIKTVQWEQGNKAKSREKDAKDDSILLYLSRANNGSN
VEITSVSKTILALKKRLLPDSIAIPVHLNQTLFAVQEGLTLGIWIKDSYYDASGLSSLNE
RKSGLNSSQKREFESKLQTATAFQLFATAYKILHDLKPSASDDLSVMKQKFAGIPEVSFL
SPLKGIACALFYFDKYLGHPEIIKSDKDVIDFTVVYFEALIDEIQLRKSSLEYTETIVDR
TYKLENSDFAISGWENVFQGTAKSVEFNKIQFEQIVGNKDAKHFARRLTERMLSYDFEAQ
KNPFQELGGFMPVFMGYGIPGTGKSMLIAAIATRLKEHCDHLDIPFLFHPMPDTLISTFQ
GGSAEKMVEWMKPMQDPTKIIFAPIDDAENNLQERTAQGVSAGVKEVIGVFLRYTEGAYA
VNYGNSSVGLFTNLPEMLDKAVISRIQGRFKIDGARTEHDFLDQDYIWWKKFEKTMPGFV
NMQNPKKYDFLKDQGLTKSMGEILNAIEKPSEARVLEAYDKASQNHKTNEHSFFASLYKE
IQNIFPFFSSRDVRNIQSAISLRLTDFDLEQDWFVNPEIYFKKDYQTKFNMLQELMKANM
KGLDFSEIRRQEVVRYLDNVATIADTDFKRKVDARVNQLNIDLEARKSFENGN
>FCMOIPGL_00902 GDP-mannose pyrophosphatase NudK
MEIKKKINNVSSTLKSNGWGKLEDINFDYTFESGTSKNLTFEIYGKSDGIAILLFNPKTN
KVILSKQFRVPVYVHGFSDGFSIEVVGGAIDKDESPEHAAIRETEEEVGYKIDKVKRIST
VFLSPGIVNEKVHLFIGEYADENKTENGGGVLAEDEEIEVLETEFSDALKMIATEEIIDA
RTIMLLQYLQINKLLK
>FCMOIPGL_00903 hypothetical protein
MSGFEEFDNYQAKFEKASIGRRIVASVIDFIIYYFVCVFLALVLDNSSESIFSFHLEGFS
ALVAFLIGFFLWPVSEGIWGQTIGKRFMDIKVVSKDYTDVNMGQAFGRFVLGFIDCSFIS
GIIATIINKDNQRIGDMAAGTFVINSKYKE
>FCMOIPGL_00904 hypothetical protein
MQKLIKANLYRSELIPISGKLVERYNKCLVKLGFTKTKLTSFSIDGIGWSPEIAEEKSEV
FYLNNGEANPHAIIITPLQKGLPIYNPFHSFDVELMKLVFRTHQQKIQNITRDSALCIDF
DQSIDVFYEPLDVLKYQDVEIKFHLIDNLHKAKEEQLKLIETFHKDNNFIDENLHQKLLK
SAKKYGDLRERDISLESIIYTSDSFYTKAFGGVYLLRNFIKPILVFENQEAYKEAINDTT
YDVLMFHITQPELVTQLRDHVIIECDLTKEVTSKRYERIKKFIFGEALKETQHPVNDILK
DKMLFKSYLNKVDIKTRKKVMSVERYLEKKQINPDIKIKDIVDEEFYFSLHKPHSSLRPN
HQDLIWKLLINIAPKDVLFWYWYDKENFYANFKNWEESKKDWVVETISNNF
>FCMOIPGL_00905 hypothetical protein
MTLELIVFITSILFGVVIYWRESQGNGMYRFFNKIMNSKELQMKLTDKKGFVYQQSFLLR
LVFVTSLFLIVIVITRFLIPIDLATISLFASMIFGTLIGTYIANFIFKSSEVIEEQSESF
EVKLDEVLEKGKDFIDDLQIKDAKEEVAIKKETPKTDKKSARERLKDKGFLK
>FCMOIPGL_00906 hypothetical protein
MIKTYWNKGSKQKKRVIIFSIILLALLFFLRDDYQPVLLFIRKFIFIILLCFTVLFFGLR
KFRKSVGAGKRIGILLLLTMFFTLIYFVGFHYNMYDYMKTYNVYNNLNRYEIVELPLTQN
ERIQPLRNIFSMANESVGETKDVSLPHLVRVDGKNQWTMAIQPTEKYVWQGIKDNTEEVF
SVSSTTPFPRFSSENRIPVTFSIGESLKFSRNTYNAVVQRLNPWMLFNYEPSDTYYMKND
KGAWVEVVSLIKWKGFFFPYPTFGGVMVIDNGEHDFKDYLERITIGKGTYISPEEMKNFA
YLTRQNTLAEKVSRLQAESLKFLAGFSDPLPWNMKSAVKIPIAPKDQNAQPYVTDFDFSD
TKTDAYSGLYHWFGLEPVGDERTSLSYSVFIPADGTNKFYYYDHASKKQGYAGVSAMPLK
VKESKKEYDWNSNTPVEFRPYIKNIAGRKRMFFLGTVSTISNNNPEQFDGSATPDLALVD
SEYRDVVWINAKKPSTWNEELYNQLNEAWRTSEGANVYFEKEKTILEKNQQILDSIKLIS
KQEKSVKEIQRLQQQIDSIKFNQ
>FCMOIPGL_00907 hypothetical protein
MKTYKNIYFISTGLLSLLLLFSAGMYFFNHEEVAKMFTRFGYSTDIIYPYAVAKIVGVIA
LWYTGNNTVKLFAYLGFFIAFTLAIIAHLTIKDGEQTAAIVAMVLLIASYFSDKKIRYEE
G
>FCMOIPGL_00908 hypothetical protein
MKKVKNSEVILSNKNYLAEAKTRNHFLTIDEPVASGGDDNGPTPVEYLLTAVGGCVSITL
RMYAERKGWNVGKITVNVFQKEEQTSEGIKKWLEEDISFENEITEDQKKRLLVIAGKCPV
AKMVKGETEIVSSIQ
>FCMOIPGL_00909 Chromate reductase
MKKILAFAGSTSSTSINKKLATFAAENLQNTSFDVIDLRDFTAPIFSEDEEKNGFPEDVK
KFTSILDNYDGFILSLAEHNGSYAAAFKNIFDWSSRIEGKIFRDKPVLLMATSPGGMGGK
FVLAAAEQRFPRQGAKELITFSLPSFYDNFKDDKIVNEDLLSLLVEQVKQFENFVNL
>FCMOIPGL_00910 hypothetical protein
MKIVLYGKQGHAYTVAFKNFLNSTDVPYTYKDISKDAAAREHSKELYKGVAKFPTLFVDD
KVYLTPTTEEFNKIMQDLRLRA
>FCMOIPGL_00911 HTH-type transcriptional regulator MhqR
MGDISKDINSKFDSNKVKALINIKYTSNWLNSKENEFFKPYGISPQQFNILRILRGAKDK
IKVQIVKDRMIERAPNATRLMDKLCDKNLIERERCEADRRVVYVRITNQGLELLSTIDDN
KNISFLDNLSDEEAATLSNLLDKIR
>FCMOIPGL_00912 Putative quercetin 2,3-dioxygenase
MKTLKTIQHKVASPLVNMGPIKLRQPLPTEGIENVDPFLLLHHYGPYAISEFNNPFDLGP
HPHRGFEPITLLFKGEQLHRDSLGNEIIVKAGDVQWTTAGRGIIHAEGPTKEFVKKGGDL
EGIQLWLNLPAKDKMIPPNYQHLEEKQIPKIFSDDKKAQLNIIAGNQNKESGLIKTQTEV
NVFTVNTEEGGKLEIEIPENHQSLIYLLEGEVLVNASEVLKKGENQMITFNQDGNTIKFE
AKKQSTLLILSGVPINEKVTQYGPYVMNTQTEILEAMRDYQQGKMGYLY
>FCMOIPGL_00913 hypothetical protein
MIKSKIEIHDKFSVVINVTYDTIFKKKRSKYTTITYLFFADTLNINSKTYPATKFYNDVR
LFLKYDAPKYTLNDINIEEDSLFKKLINNTEKFIKDESVKNNTHYKEQVKMFAATLSSLI
SKEIDSLIRKKEVSPDDITSFLEKIDSILLKFRSHVVFTVKESTIKEKNKNAIFYADEHI
SNVVELQLMKLFIYLQNNKFKSLILNKVVNLINSEQNYKKQKGYDSPKDKNINPEELLFK
RNQLKKYIDSVFFLKQDIRKDGAVFEQTLLALAAGLAMIFSTGIAFYYQQVYGNFTLPFF
IALVVGYMLKDRIKGFFGSLFMSKSNNLFYNYKINITNSLGKRVGSIKEVFSFAPYKKLN
EKIKKYRQIDLIVKSDSESLNEHVIQYKKKIEIYPEKFGNDLPDEKIIGLTDSTRLNFHR
FIQYMDNPKKEYILIKKGEVYNKIANKIYHINIIQKYYTEEGIEFNRYRVIMNRNGIRRI
EKISL
>FCMOIPGL_00914 Sodium-dependent dicarboxylate transporter SdcS
MSALQQNGFDVLDMKNYRMEKLPKREKSKFERVLMIIGAPLAIISFILILYVLKIPFLDN
LDTSALSSSAKSNFKEIGLQNFIFSNKAMLAIFVASLILWVTEAIPNYLTSLILIITLVL
TKVLPEDVAYAQLGHKVMWLNIMSFVLASMLVATGVAKRFALWFIIKFGKSASSVILSFL
VINLVLSLFISATTAKAAILLPVFMVVAAIYGASNGNQNNVGRNVLLQNLFQNNMGASSF
LTGSGANLLAASLIAGAIGSDIFFSQWMIASFPVALGLMLIAWIIGTKIIFPIKKEDQKP
SIPGGMDSLKKDLKDLGKVSFNEIKSIIIFVSILTLWVTDKWHGISPTAVAFVGAIVALM
PKIGIVSWNDVDIPWHLLLFSAGAYTLGAAFKVTDLPSISVNATFDALGFGAETPFWILY
VVLTAAMIFSALFMQSKTMRAMIFIPIAIGIATRFNYPIMSLAFPVALLIEHVYTLPFNS
KPALLLYSTNQYSMTDAFKFGFTMQIIAWITSILMAMTYFKWLGITPNGLGLF
>FCMOIPGL_00915 Inorganic triphosphatase
MKNREIERKFVVKNDDFKKESFSQTKIVQGFLSTVPERTVRIRIKGDKGFITIKGIGDKS
GASRFEWEKEISVEDAKDLLKISEPGVIDKTRFNVKSGTHTFEVDEFYGENKGLTVAEIE
LNSEDEDFKKPSWLGKEVTGDVKYYNSMLMKNPYKNW
>FCMOIPGL_00916 hypothetical protein
MATSEMKIGEISKPRFEFRTFGQNFDNSSKRMARLSVPIPEKVWERKSEEIYILSKTNDI
NNTKIRDGKMDIKTYIQTVDGLEQWNPLMKSEFPISKEVLENDVFPAFKVEMPSLTKNTY
TLKEFLAMIDAHKDLQSVKVKKQRFGYMVNNTLCEVGNVLINGAKVVTINSESTELEDIK
KTIVDCQLEGCENINYLQVIKRIIGWINKPLAN
>FCMOIPGL_00917 hypothetical protein
MKNYNYILYSLLFVLFSATSCVEDAVYEGDLPDVATSTIKLNEIMSTGSPDWIELYNEGT
TSVDLSGFKLTDTSQEWIIDNLTIESGSYVTFDCDDSNVSNVSTNFKISSGGEEITLYNA
SGELIDQITTPDMASQIGLTYGREIDGGEIWTVQSASKGVANSNVNNPPVLIAEPLTEFT
EVYEVTASDANGIASVKLVYLVNGGVQSIEMALVDGEYKTSVPTSKVGDLVSYYVVATDI
TGMTSYYPEDGSNSPAEFLVEGGLKELTFEGAKAGYREEVTFTASPYYPEQVSEIRLYYL
LPGQLQDDVNDDKTKVELTKNGDIFTGVIPAQNTDDVIRYYLRVEYIDDTKTYYPKEEKN
TDDIVISDFNHDLGTTWPSYTVEAITYDAVVETTINSTQGPLTSITFPTNPVPETDINLV
LAYTSTETINEARVYFAVGDSPVYIKANKVSGEDDASFTQTGVTINLKDVLSDASESLSQ
TGAKVSFYIRIATDTAEYYYSNTGAMSLDNTPGGGTTDESDAFKADPSLWNVYNVQ
>FCMOIPGL_00918 Porin P
MKNKLYILLVAMMLLSIGSFAQNNDEVVTLNQYGQEVEAVELNTEARNSILTFESKDKNY
KFWFDNRVYFDGGMFFDKDAYNPIGNGVTIRRARVAMKVIMHKNWYGEIDFDFSGSATEI
KDAYIKYTTDAGDLNIKAGHFRESFSMETTTTSRYVNFIERSLMSKFAPSRQLGFQANYI
KDTYLLSGGVHFNNQGSFEEVEWSQDANKDYGTDEGYSFTGRAVFRPILDADKVIHIGVA
ASYRTPKTDLEVPNSYRFSTRSISNVNRKKYLDTDDILNVENNTIYNVELAGAYKNMMFQ
SEYIGNDISRTNGLSNVNLNGFYAQAGILLSGGKYNYNKNEGEFTQVSLGSKKGELEAAF
RFDYIDLNDQNAEIYGGSANAYTLGLNYHFNYNVKFMLDYSYLDHDRYANGKGKLFVGSD
INGDLTKDPTKVVDAEGKGGDDYGQLQFRIELDF
>FCMOIPGL_00919 2,4-dienoyl-CoA reductase [NADPH]
MKYKHIFEPLDLGFTTLKNRILMGSMHTGLEEEKNGIDRIAAYYAERARGGVGLIVTGGI
APNIQGWTGPFAARMSTEKHAKHHQKITEAVHKEGGKICMQILHSGRYGYHPFSVAPSKI
KSPITPFKPFKLKESGIKRTIRDFVNCAELSKLAGYDGVEIMGSEGYLINEFIVKRTNKR
TDSWGGEYKNRMRFPIELVKQTRKAVGKEFIIIYRLSMLDLVENGSSWEEVVQLGKEIEK
AGATIINTGIGWHEARIPTIATSVPRAAFSWVTKKMKEEISIPLVTSNRINMPETAEKIL
SEGDADMVSMARPFLADPEWVNKAEAEKADEINTCIGCNQACLDHVFERKVASCLVNPRA
CHETELNYNQTENKKKIAVIGAGPAGLAAATIAAKRGHIVTLFDADKKIGGQFNIAKQIP
GKEEFYETLRYFNKQIKLHNVTVKLNTRVSTDDLLKSDFDEIVIATGIKPRELKIEGIEN
KKVLSYIDVLKLKKPVGKRVAVIGAGGIGFDVSEYLAHEGESTSLNIDAWLKEWGIDKTL
KARSGIEGVKAEVHPSPREIFMFKRSKGKFGGNLGKTTGWIHRSTLKKKKVQFIGEVSYT
KIDDKGLHYTQNEEAKILEVDTIVICAGQTPLKDLYQPLLDAGKNVHVVGGADFASELDA
KRAINQGARLAAEL
>FCMOIPGL_00920 hypothetical protein
MKRILVVLIAFASTAFFAQPPGGGNGGGRRSQGQESDQNEEQKVKKFSASDVAGVFYYDI
EEVIKKLKIKDENNQYLVSKALKDYNFKIKEISFLNSKKFSDFDLAVNSVVQGNDREASL
EMRKKVGEIIGPIKDEIHENEKQLNDTLEKLLSEKQQKKWLKYQKKKKESLQPKKSDNEN
RERARSNSRGTRRQ
>FCMOIPGL_00921 hypothetical protein
MGMNKNAVLGWATLLMLIMGVILILLGAYRYNDVAGWGFATVGIGFFCIAWVFNALKGRM
>FCMOIPGL_00922 Energy-dependent translational throttle protein EttA
MSDDKKVIFSMNKLSKTYQSTGKQVLKDIYLSFFYGAKIGILGLNGSGKSTLLKIIAGVE
KNFQGDVTFVPGYKVGYLEQEPQLDPEKTVIEVVKEGVAETVAILDEYNKINDMFGLEEV
YSDADKMEKLMNQQAELQDKIDAANAWELDTKLEIAMDALRTPDADKKIGVLSGGEKRRV
ALCRLLLQEPEILLLDEPTNHLDAESVHWLEHHLAQYKGTVIAVTHDRYFLDNVAGWILE
LDRGEGIPWKGNYSSWLDQKSQRMAQESKMASKRQKTLERELDWVRQGAKGRQTKQKARL
KNYDKLMSQDQKQVDEKLEIYIPNGPRLGTNVIDAKGVSKAFGDKLLYENLEFNLPQAGI
VGIIGPNGAGKTTIFKMIMGEETPDAGSFNVGETAKIAYVDQAHSDINPEKTIWENFSDG
QDLVMMGGKQVNSRAYLSRFNFSGSEQNKKVNTLSGGERNRLHLAMTLKEEGNVLLLDEP
TNDLDVNTLRALEEGLENFAGCAVVISHDRWFLDRVCTHILAFEGDSQIYFFEGSFSDYE
ENKKKRLGGDLMPKRLKYKKLIR
>FCMOIPGL_00923 RNA polymerase sigma factor CnrH
MKSFLEDFTLAKNIKKDDEKAFRTLFDRYYKKLLNYANTFTGDLQEAEDIVQQVFITLWT
NRKKIDTKKSIKSFLYKITYNSYIDIYRKQKHKESFFDEIKERALRDRISDNDEIIEQRI
LKLKVAIDSLPKRSKEILQMNKFEGLKYKEIANQLNISVKTVEAHMHTAFKKIRETFKSD
DLFLFMLSKIFR
>FCMOIPGL_00924 hypothetical protein
MESLRLWLKKEKNQNTFEQYIKAFYDIDTAMNKPDLDAAYKKIKLSIDSKKKSKLRVLPV
WSRYAAAAVVVFIFSYIYVFDNKEQPVEVLNTFVTTVESGVDKATLTLDDGSNIILEEGK
AYSNNTVASNGEEIIYKKEQETIINLDDKVETIKTEPKIVYNYLTTPRGGEFQVMLADGT
HVWLNSQTKLKYPTSFKKGVSRQVELVYGEAYFDVSSSKNHNGATFKVISNLQEVEVFGT
EFNIKAYKDEASVYTTLAEGKVAVSNFAFNENLKVGQQSIISKSTGEITIKTVNIYNETA
WKSGVFSFKNKSLKEIMKVLSRWYDVDIVFENKELETIKFNGVLSKKMTLEEILSPIKRN
SNLNYIVNDTKIILK
>FCMOIPGL_00925 TonB-dependent receptor SusC
MKINFTQEWLKKQTQNFIMRTVFLLFCSTVFSFTSIDVISQNAEIKINQDKTVTVDQIFD
IIQAQTDYTFIYRSDMFIDLPRVELKKGVVKAKKLLLKAIPRRYYNFELFKDNTIVIERN
TISRKVDVSGKIIDVNNNPLSDVNVIVKDLNLGTFTNKNGEFLMTIPHENFKLTVSLLGY
KTVEIDLSLESNLSNIKITLKEDLLGLDEVVVTAKKTVSREGTSTYKIGSQAMKQVQAMN
LGDVLSLIPGNKIEQTNLTSTKQANLRSAVSSDVNSFGTAIIIDGAAISTDANMQTKNSS
TLDGGKAVVGGGVDLRSITLANVESVEIITGIASPKYGNLSSGGILVKSKVGKSPYIVSA
NVSSTNYQASVAKGYELNKFGVLNTDLSYAYSSGSPTERKLFYQSFNLGLRWKLPVFKDV
QWNHFTSLRIGHSDDGNRHEPEEVFKNEADVKSTSFQATLSGDFRSSFLGKVSYNFSGSV
VNQHSFYDTYVINGPFPIIESIESATYATTYSANAFNQTRDIKGKPINLNGRIDASQNAS
FKSFDFNFETGLQYSFDDNTGSGRVATGNIAHTQDIAGSRSATFEKIPASKTFSAYHQTI
IKRSGDASKQQLNLGLRYDNMLERYNLLSPRMSFSSKHNNFTARGAWGVSYKAPAMVQLY
PGRAYIDYINFQYYAENPEERLAIVTTYVYQPTNEHLKPNYSDLKEIGFDWSPSFMNFNF
TYFKKDMRRGISTTDELLLLPKAVYEVVDAPIGVQPTVELTGEVNNIPRTVKVMNNNYYV
LTNGVEATISPEKIKATNTQFNFRYSYLESVVTNTGFDIDKSNYVVGDNSVRYGVYDNSV
RKSIRSFGTLTLIQHIPSLRFVLTLSAELNFKESSQYTRTNIYPFAYYDIDGTYIEIPEE
NRMNPEFDDLKKDANSYISDSTPFYSNFNLQIRKETKQGHSFSFYANNAPWNNPTYEFLG
SRRTLNNKISVGFNLTLLIK
>FCMOIPGL_00926 hypothetical protein
MKKTILKQLGLTKLIALFLLISVTISCDNEDDIPNLGNLEIQVTLASGLSDISLTDIDVT
ITQTIDNSTLTMNTDANGLAIFSDIPVGTYTAVIAHSTDDYTLSGTANNIIIAKQETVAT
TLEVDAVNQDGGLVLKEIYTSGSGFVTLFKDSFIEIFNNSSETLYADGMYIANLFGDSGA
TGSVSVYSVLTDENYVYTDVMSQIPGTGTDYPVAAGKSIVIALNAINYKEASANPDGELD
NTDATLEHYSIDWLEAQGRAGNSFFEFDNPAVPNMTNTYMFEGTNFFRLSTPGSIVLVSS
DATFDASSIVDYTKPGSTTTYKIMKISIENVVDGVEILDNSAAADFKRMPSSIDGGFTYL
TADRAVSYTGISNRRKIDEVATARFGRTILLDTNNSTIDFEAIDFPDKYGYNE
>FCMOIPGL_00927 hypothetical protein
MNNKINHVTIKRVFLTFSLLFIVLNSFSQTARTLNSLSVIERDFQFEMFENRYFQIPSLI
NQSNLTKFSYGEGKYLYAEGKLRHPQEYKKQNGLYLKTASLAPLENTNWTFYGGLEYLNT
RIEDVENNLTYGISEYNSPYYFFQKTTGLWNHQNYNFEISAANKLNSKLSLGGYLNYDTN
FYFRKTDTRNELTALKINGKLSASYQFNKKHLLSLAVSTEFFKTDSELGNKFPENNTELT
ANYYLNTGLGSYIKNIDNGFQTKRVIPQIQLYWLLKQNNWDLSVESATKYGVERWIDKNI
VRLDENEELTKYSFLNQQFNVVFNQYHKNRLVSINLNAQYLKGKGKVWQEVGTYYAKNFN
ATNYNFKTEATVLFYKKLLNKVSLGVNYFNVEQLDLNYAYQFDYQFLEPKIAVGLHKVVS
TKWALFTNISGLYHHVLDIQNNPYAANNIYVDWIGNSVADYVGTSSFNLNTKLGFDVKLK
NENKLECSVTGDYWKATNLSNETVNYISKSDDYLSLVVGLKLYF
>FCMOIPGL_00928 putative zinc protease
MKSLFKIVIFFIPLFICAQKMNNVHLEEYDLANGLHVILHKDVNEPNVIVGTKYHVGSKN
EEVGKTGYAHFYEHLLFHGTKNIPQGKFEKIILDAGGYCNAYTSYDVTYYYQLLPAHEFK
LGLWAESERMLHPVITPEGINREREIVKEEKRMRYDNKPLGNSYFEMMSKMFSDETYGHN
MIGSMNDLNVASKEDFDAFLKTYYIPNNACLVVSGNIDIKETKKWIKLYFKDIPKGKKIK
RPKNFDRISGLEKHTERTVKGLKNESILIGYPLMSQSNSDASTMQIISAILSGDRDYSYF
ENHLNIEKDTIIKRINASADFWEKIGTLRITATVKNKNSESYLQEKIEEQLTLLKNEPVN
PVLLQQVKKQFEAIYVDYFYHAETFADKVTSFYHLYNKTSDIKNLIENINKVTSKDIQRV
AKKYLDKKNQVVIVYHPE
>FCMOIPGL_00929 hypothetical protein
MKNIYILIFAICCSFKTFAQVDRSMPPEADEPAKLNVGKLIPIQLENGLRVYLAPVKDFP
KFTISVNIELPGYDEETRLAEKKILNSAYSNKLSEKYPNGEIDSIAKYYGAMLNASMNGG
TIKGMKQDIDLLLDVYADALLHPVITDKYIQKRREEQVEKDRKKTTKVNTRKKEFSVEKI
IDSLLFGSEEKVAKTKKTVKANYKGLTISDIEKFKNDRIVSNNSLIVVVGDFTEKECKKL
MTHYFGAWKPGEPYVKNSPITKKTSIIKRRKIVVVDAPNAVQSKISFRWHLGDAYTYFND
DLKLQVLNEIFGASQLSYLYKNLREDKGLCYFIRSSVGASAVGGSGSVSTSVRNDQTAYA
IENIILEMLRLRNGKVSASDLKIAKNSLIGSYTRSLNAIAPIPYITFAMQKDLYHLSDDY
LQSKVEKYYEVNVDDIMAMSQKYIDPFKTVISIKGKVSELKGTLEKFGDVMYFDQKGNKI
E
>FCMOIPGL_00930 Release factor glutamine methyltransferase
MNKKPLHPFMTVSLYREEFSTKLSDIYPKTEIDSFFFILMDEFLNLKRINITLQPDFRIP
YDIFILLQNALERLKNEEPIQYIIGNTEFYGFPFLVDENTLIPRPETEELVEWILLEVEK
LESLKVGKPLNILDIGTGTGCIPISLAKNLPTAIISAIDVSSDALKIAKKNADLNNVEIE
FIETDILKTNSLSKQFDIIISNPPYVRELEKVEIQNNVLQNEPHLALFVSDENPLIFYDK
IADLAKKQLTKNGLLFFEINQYLGNETVKMLEKKGFKNIELRKDLFGNNRMIKAINS
>FCMOIPGL_00931 hypothetical protein
MSSTDFIIREIIHQDNAQVAKVIRDVLIEFGVPKVGTAYEDKATDLMFENFQKPTSTYYV
IEHNNKIVGGAGIAQLDNFDGKTCELQKMYFLPISRGKGLGKKLISCCLKKAKDLGFENC
YLETLPYMEAARALYKKNGFVNLDKPIGNTGHYSCNVWMIKTL
>FCMOIPGL_00932 hypothetical protein
MKKALYFLGLFLFLYSCSVKKPPVFVKVDDVQVLSFSSDTIRLKANVYFKNPNDVSGKIS
TDDILIFVNNVEVAQVFSDEFKVPSRRDFSIPLTANISTKRILSSDKNGVLGGLINSFLT
KKVNVRITGKLDYVVFGYKKEFIVDKTEEIKIKF
>FCMOIPGL_00933 Riboflavin biosynthesis protein RibD
MHIIKNEFYIKRCLQIAKNGIGSARPNPSVGAVIVYQNKIIGEGFTSNYGGNHAEVNAVN
SVKDKALLKEATIYVTLEPCSHFGKTPPCADLLVKHKFKNVVIGCVDSNSLVAGKGIERL
KNAGINVIVGVLEAECKEHHKRFFTVQEKKRPFIILKWAETTNGFIAPLKRNLQAPVWIS
NNYSQQLVHKFRSEEHAILVGTNTVIADNPKLNVRSWFGNNPIRVVLDKNLRIPKEMNVF
DGSVKTIVITEKENCHCEQCEAICFETIDFSKNVAKQIVAVLQKHQIQSVIIEGGTQTLQ
TFIDANLWDEAKVFTGESSFKNGIKAPVFSAQITSETRIKNDILKIYEND
>FCMOIPGL_00934 D-ribitol-5-phosphate phosphatase
MIKNIIFDFGDIFINLDKPATYRKMAALGVTEITEEMIGVYHQYEKGLMTTANFINFYHD
KFGIEKADLVNAWNAILLDFPKKRLDFLKELSASKKYRLFLLSNTNELHINWVKNSLGEV
FYNEFKNCFEQFYLSHEINFRKPDKEIYEFVLNTNNLVADETLFVDDLKENTDSASTLGI
KVWNLIPEKEEVTSLFDKI
>FCMOIPGL_00935 hypothetical protein
MIYLFLSVLFSTGLFVVFKYFGIYKVDVLKAIFVNYIIALTLGFTLAERSFSIVEVPKQP
WFFGAVLLGALFVSIFFIMAKTAHINGISVASVAGKMSVVIPVFFGVFLYRESVTFLKVL
GIIIALVAVYLASVKEEKTAHKKAGLLFPVLLFLGSGIIDTTLKFVQFSYVEKEDVSIFS
GSLFACAAFFGLIILLIKTIKKKESFGVKNIIAGVILGVPNYFSIVFLIKALQTEGFESS
TLFTINNVGIVIVSTLVGILVFKEQFSLKNKIGVLLAVLGIVIVALA
>FCMOIPGL_00936 IMPACT family member YigZ
METDSYKTILKPSEETLFKVKGSKFFGYAFPVLNEDNVKQFLEELKKKHHSARHFCYAYQ
IGVENIKYRANDDGEPNNSAGLPIYGQIQSFEVTNVLIVSVRYFGGTKLGVGGLISAYKT
SAQITLEASNIQEKTIDVYYQLNFQYDLMNAVQRIIKEKNIEIIKQKLEVACEYVISIRK
KEAEAIFTIFDNLYKVEIKELET
>FCMOIPGL_00937 Acyl-CoA thioesterase YbgC
MKKSSTKTRVRYSETDQMGVVYHGNYAQYFELGRTEWLRKLGVTYKAMETSGIMLPVISL
TCNFIKSAIYDDLLTIETFLKKKPMVKIEFEYKITNQNNELICTGSSVLAFMNMKTMKPA
RCPDYLLTSLGF
>FCMOIPGL_00938 Chromosomal replication initiator protein DnaA
MSFTAESVWTDCLSFIKDNIKPQAYKTWFEPIKPVKLSGEALTIQVPSKFFYEWLEEHYI
KLLRVALVRQLGNEAKLIYDVKMENNYSSNRPQIVKIPSSNRDPLKPQKVTVPLDSSSKR
ELRNPFIIPGLQKVKIESQLNANYSFANFIEGDSNRLARSAGMAVANKPGGTSFNPLLIY
GGVGLGKTHLSHAIGVDIKDKYPDKTVLYISSEKFTQQFIDSVKSNTRNDFIHFYQMIDV
LIIDDVQFLSGKAGTQDVFFHIFNHLHQNGKQVILTSDKAPVDMQDIEQRLLSRFKWGLS
AELQSPDYETRISILQNKLYRDGVEMPVDIIEYIAKNIKSNVRELEGVLISMIAQASFNR
KEFSIELAKQIVDKFVKNTKKEVSIDYIQKEVSKYFDMDVATLQSKTRKRHIVQARQLAM
YFAKRLTKTSLASIGNQIGQRDHATVLHACKTVDNLTETDKQFRKYVDDLTKKLTF
>FCMOIPGL_00939 Low molecular weight protein-tyrosine-phosphatase YfkJ
MINVLMVCLGNICRSPLAEGILVSKVDNKIVFVDSAGTGAYHIGNLPDVRSIKVAKKYGI
DITNQRARKFSVKDFDSFDYIYVMDESNYQNILMLARNTADENKVHLILNETHPTKNLSV
PDPYHGGNQGFENVYKMLDEACEIIANKLSS
>FCMOIPGL_00940 Ribosomal RNA small subunit methyltransferase I
MIGKLYLIPTTLGDTEPLEVMPLSVKNVIDQLDYFIVENEKSARRFIKKITPEKKQSSLH
IMSLDKYAEEIETLTYLDVCQKGISVGLLSEAGVPAIADPGASMVKLAHQKNIQVVPLVG
PSSILMAMMGSGMNGQNFAFNGYLPIDKGARKNAIKDLEKLSKDKNQSQIFIETPYRNEK
MFTELKDTLAPITHLCIAADITLPSEYIKTMMVKDWKRQKPDLHKKPAIFIIQK
>FCMOIPGL_00941 hypothetical protein
MVIKKFLYLSSSIVVLATTTSLTTLEEDKPVSYPKYLEYNIPYLQKNFVAFKQAVAFKES
QGRYTVVNTLGYLGKYQFGRTTLERLNIYNTRDFLLNPELQEQAFIALCKVNKWILRKDI
KRSVGKVINGITITESGILAAAHLSGAGNVKNYLRSNGKDCFSDAYGTTIKSYLKKFGGY
DVSNIEADKNAKA
>FCMOIPGL_00942 Endolytic murein transglycosylase
MGKKFTYTAIITVLLIGGIIGYNYYQKIFGKAITKETVLFVYSTDSLVNIKDKIAEYSKH
PSTFLLVAAKKNFSKPKSGRYILKEGMSNNDLVNMLRIGNQTALNVSFNNQDTLEKFAGR
IAEQLEIDSLSILNSFTDAKFLSENKLTPKSVLQICIPNSYQIYWNVSADGFRDKLLLEY
NRFWNSSRLEKAKALKMSKEEVITLASIVQKETAKNSERPIVAGLYLNRLKYGWPLQADP
TIIYSIREQKGQDFAVKRVLTADLEINSPYNTYKNIGLPPTLISMPDISSIDAVLNATKH
KYMYMCASIDKIGYHTFAKTLTQHNNNAAKYHIWLNKQGVNR
>FCMOIPGL_00943 Spermidine N(1)-acetyltransferase
MNTLIGEKINLRALEPEDLEFLYQIENNESFWEVSHTQTPFSKYILKQYLENAHLDIYES
KQLRLLIEDKSTKKQIGMIDLFDFNPQHKRAGIGILIHPDFQKKGFASEALSLLINYSFT
YLQLHQLFATITTDNDKSLTLFKKHNFVKIGIKKDWILSEGKFKDEVLFQLIKE
>FCMOIPGL_00944 Diaminopimelate epimerase
MNLTFYKYQGTGNDFVMIDNRTKIFPKENTDIISHLADRHFGVGADGIILIENDENFDFK
MIYFNADGSETFCGNGGRCAVAFAKYLEIIDSETTFIAFDGEHFATINNRIISLKMINVD
EIKVNENSVFAYTGTQHHVELVDDLNEYPVFENGKKIRYSYENPGSNVNFVQQINDSTFR
VRTYEKGVEDETLACGTGVTAVAIAMHKTNKTNSNLISLPVEGGVLEVSFTEENSIYKNV
FLKGPAKFVFKGSLEI
>FCMOIPGL_00945 Periplasmic pH-dependent serine endoprotease DegQ
MKKFFGLLGMAILGGAITLGGYKMLFKDNVVIERNVPEKMQTVQTNYTPTIDGHSTAVAA
SAIDFTIAAEKSLNAVVHVKNTAIRTQSNPLDIFFGNGNGTRKYEQVGTGSGVIISSDGY
IVTNNHVVDSANEIDITLNNKKTYSAKLIGTDKENDIALLKIDTEMDLPFVPFADSDAIK
VGEWVLAVGNPYNLTSTVTAGIVSAKGRDLEGNSAIDSFIQTDAAVNPGNSGGALVNTRG
ELVGINTAISSKTGSFVGYSFAVPSNIAKKVIDDLLEFGAVQEAVIGIRFSPVDNDKIEG
VKIMAVEKGQGAAKAGLKENDIIVKVNNIDITKFSELRGQLTAKRPGETVNITVDRSGEL
LTKTVKLSKKEKQYISKSFNWELKNLSKEELKRNNIKYGVKIIETGDRDSKNSLKNFIIT
KINDEEVETAEEAVKLLESVAKSRYSIVLEMVNTEGEKEMLRFR
>FCMOIPGL_00946 Glyceraldehyde-3-phosphate dehydrogenase-like protein
MLTNLDYEKEVAIQAITRRATIKFINIVNDLWYDKSIELVLFRNPLVDKRASEVLNLINY
AKEFVNKPITIIDALNIAKAIQKIDLPSSKLDIGKLAYECHLNPKGCEDKVAFVQKQLKN
ATEFKDITPKDVVLYGFGRIGRLLARELMTKMGKGSQLRLRAIVTRGEITQAVLDKRASL
LSVDSVHGDFLGTVETDIEHKALIINGTTVFMITANNPEEIDYTAYNINNALIIDNTGAF
RDNEALSRHLKSKGASKVLITAPAKGVPNIVHGVNHKQYNSDNIDIFSAASCTTNAITPI
LKVLEDNFGIKKGHLETIHAYTNDQNLVDNMHNKSRRGRAAALNMVITETGAGAAVSKAI
PALSGKLTSNAIRVPVPNGSLAILNLQLRVPVSAEAINSIIKKYALEGDLVEQIKYSLDP
ELVSSDVIGTTAPSIFDSTATITDKETIVVYVWYDNEYGYSHQVMRLAKHIAKVRRFTYY
>FCMOIPGL_00947 hypothetical protein
MKYGIKIHKISTVDALSDAWTIEDFKELLKRFDFANDEVNDFKELQDLLFMAIADREPSE
AATIVLDYRLSDNLNAGQIDSLSYEMLVDKISEEYPVISLHKELFSINQLLNKAFKGKFP
NTKATIVDFEITPKGNADTNITKEIVLKSITQNLDSHNLIKRLFGKQLSAEEKFEEANDV
IWELQKNDNQYKLITSDYWMGKNEFLSDKFEANIAFFDEE
>FCMOIPGL_00948 DNA ligase
MTIQEKINLLREELNNHNYNYYVLDNATISDFDFDIKLKELEKLEEENPVFFDSNSPTQR
VGGAITKNFETVTHLNRMYSLDNSYSKEDLLDWEKRIQKMLGTSEIEYSCELKFDGASIN
LTYENGQFIKAVTRGDGFQGDDVSTNIRTIKSIPLSVNSDFVRNFEMRGEIILPLDGFIK
MNEERVENGEEEYRNPRNTASGSLKLQDSAEVAKRPLDCLLYQVVTSERKYKTHFESLEN
ARKVGFKVPETIALAKSIDEVFDFINNWDLKRHELPYETDGVVVKVNNLQQQEELGYTAK
APRWAIAYKFKAEQVATILNEITYQVGRTGAITPVANLEPVQLAGTTVKRASLHNADQIE
KLDIRVGDTVFVEKGGEIIPKIIAVDLSKRPENSEPTIYATNCPECNTPLVRTEGDAKHY
CPNEFGCAPQITGRIQHFISRKAMDIDGLGGETVDLLRKEGLIENYADLYDLKVEQVIPL
ERMAEKSAQNMIEGIEKSKNIPFEKVLFALGIRFVGETVAKKLAKHFKSIDKLMTATFEE
LINVDEIGDRIAQSIIDFSNDLGNIQLINRLKAAGVQLEVSAESLENQTNKLDGQVFVVS
GVFHQMSRNELKKAIEDNGGKVSSSISKKTNFIIAGDNMGPSKLTKAQDLGIAIISEQDF
IDKIN
>FCMOIPGL_00949 hypothetical protein
MICSFSVLAQKREIDSLPKSLEDYVFVKPGDTLTVQLNEFSILPKPKFKSKEDIRYYLWF
RKKVMKAYPFAKLASERLDTLNSRLENIQSKSKKRKYTLLIQKYIEGEFTEQIKKMTRTE
GRILIKLIHRQTGKTAFNNIKGLRSGWKAFWYNSTANIFKLSLKDEYHPESVNEDFLIED
ILQRAFQDGVLKKQETKLNFDFQTAIIERKAEVNVEKYKEMFAKQRKKKKKPKKVK
>FCMOIPGL_00955 hypothetical protein
MKFYYWFLLIFLFPLSIQSQVGGENVYQFLNLSSSARQIALGGEVLTLIDDVNQPIWNPS
VINDDMDNFMIERLLDGL
>FCMOIPGL_00956 putative acyl-CoA thioester hydrolase
MSETKKEFKHISESQVTITQLMLPSHSNFSGKIHGGHILNLMDQIAFACASKHSGNYCVT
ASVNKVDFLNPIEVGELVTLKASINFTGRTSMVVGLQVESENIRTGEKKHCNSSYFTMVA
KDENGKSTPIPGIILTTKDEIRRFSRSIIRQSEGRNRSSRFSSEVFKTEDYLHLFEGSNS
KITLFEQN
>FCMOIPGL_00957 hypothetical protein
MNYILFDGDVRKSLLPFTYTKPVADLRVGILTIREKWENYLGSTTTTVTEEYLEEKYPMV
ELEQNILINASFCPTKSLVEKIKNLSENEAIFKGEDVIAFFTSDSQEEVNFEEYKQIEFD
EELLQIKNTWDIFSLNNVAIQQDFDLITEGRTSQPIPEGTRFLNKENIFIEEGAEITFAT
LNATNGPIYVGKDAVIMEGCVVRGALAMCEHSVLKMGAKVYGATTLGPYCKVGGEISNSV
LFGYSSKGHEGYLGNSVLGEWCNLGADTNNSNLKNNYAEVKLWNYETGRFTKTGLQFCGL
MMGDHSKCGINTMFNTGTVIGVSANIYGSGFPRNFVPSFSWGGASGFTEYKTDKVFEVAE
IVMKRRNINFNQVEQRILENVFEETKKYRNY
>FCMOIPGL_00958 Lipoyl synthase
MAIESVILPTEKQKKPKWLRVKLPVGKKYTELRTLVDKYKLNTICTSGSCPNMGECWGEG
TATFMILGNICTRSCGFCGVKTGRPETVEWDEPEKVARSIKLMSIKHAVITSVDRDDLKD
GGSIIWAETVEAIRRANPTTTLETLIPDFQGNTTQIDRIIEVHPEVVSHNMETVRRLTRE
VRIQAKYDRSLGVLKYLKEKGMRTKTGLMLGLGETEEEVIQTMKDLQGVNLDILTIGQYL
QPTKKHLPVNDFITPEQFKKYETIGLEMGFMYVESGALVRSSYKAHKHAV
>FCMOIPGL_00959 ECF RNA polymerase sigma factor SigW
MEINDKKLEQNISKAKEGNQAAFRYLLETFWPVVYNYQLKRTKSENDSEDITIQTFSKAF
DKIHTFDENYVFKTWLIAISKNVHIDLLRKKNTSISIETTKEQEEKVYLVVDENPTPEDK
IIGEQNLAKLLKDIKKLKPKYQEVIQLRYFQELSYKEISKQINEPMSNVKVKLLRAKKLL
AEIIKRN
>FCMOIPGL_00960 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MILSVIFYAFVVCAVIQLTYLFTFSSFLFKPKRSRKTKIEIPVSVIILVKNQSEKLLKLI
PLILEQSYETFEIVIINNASSDDTNDIIELFSKKHTNIKVVQVENNEAFWASKKYALTLG
IKASKYDHLLFTNANCNPVSKDWISEMSKKFTSKKEIILGYRKYKKEKSIFNIFVRFDNL
LTAIKCFGFAKMNSPFMAFEGNYAYDKPTFFKVNGFINHMKINFAEADLFIKDASQKENT
TFCISESSFTEKDTPKSFSKWFSDKKDTAFIRKKYMFKHRFLLNTFAFTKILFYILATIL
FFTYPYQITLSIVLFYCLVYYIIIGISAKKLKEPQIIFFLPFLEIGLLLIQITIFISNLN
SKPSHWK
>FCMOIPGL_00961 hypothetical protein
MKLLLLTLGLLLLAVAGIAIKIWAKKDGKFAGTCASQNPALNKSGESCGFCGKTPDKFDT
CSEPQHN
>FCMOIPGL_00962 Small-conductance mechanosensitive channel
METTTESLKNFYNSISSGLGDWGLQLIGAIAALVIGLWIIRMIMKGISKMFEKTKLDETL
QPFLLTTIGFLLKLLLIVSISGIVGFPVASFAALLAGVGLGIGAAFNGSLGHIASGIMLL
IFKPFRVGDLIKTNGAFGFVKEISVFVTVIETFQNETEIIPNSSITSNKITNLTKIGNLR
IDMPFAIRYGSDIAKAKQIVLDVLKNDKYILQEGALAPRVAVNNLGVNSVELLALPYVNC
ENYWEVYWDTRQEIVEALGKANYEAPLPQRVVTMTK
>FCMOIPGL_00963 ECF RNA polymerase sigma-E factor
MEEKSFIKDLRAGKQTAYSQLLDDYQQKVFGTCISFVPNREDAEDIAQEVFLEVFKSISS
FKGDSKLSTWIYRIATNKSLEFIRKKNTKKRFAFMQTIMGNEIPIDKTSYFTEFDHPGIL
LENKEKSATIFKAIHTLPENQRVIFTLAKIDGKSYQEIVEITGKSLSSVESILFRAKKGL
QVKLENFYKNDKS
>FCMOIPGL_00964 hypothetical protein
MKNKEHINQQVEATFNTLDAIEEVKVNHFFKHKVLQQLKNQKEEKTSLFAWFTPQFQMAT
LAFVLLLNASAILYAFSSQKNTSNSSLESFAQEYSLQSETTSLLN
>FCMOIPGL_00965 hypothetical protein
MKTKLLPILLILLIVLNGVLIFMLINKPHQNLGAQQERNFLIEELQFSDNQKDQFINLDN
AHKENMMSFENEIRRNKDILFNSFSNETINFDSLSTVIGSIQAKKEIEVFRFFKSVRKIC
NKEQQEKFDKIINKAIRGSNQGQSQGPPPREGGMPPPPPR
>FCMOIPGL_00966 hypothetical protein
MKNQFIKKATLLSILFIGLVSCSSESLTDTDTTATDDTVVTELHAAFAQFNTEATDIYLS
SGGTKVTIETTGLPNHESVYWGSSSSLYKDEPDVSTTPSLMTSNNNATTITVDATPNLTG
SSVSTELNTIGIAVSGASIFNDQEGNGALSSAAGSLDWTGAHIGPGVYHYHLEPKAFSND
DDNLVGILLDGVFLYGRKCNTTGTYPEDLDTSGGHITTTQYTGGVEEYHYHIINELYSTT
GSYIAFAGPYKGY
>FCMOIPGL_00967 hypothetical protein
MKTVKLFLLIFIIGCNTTTNNNDVESDQSEKIVIDAANIVHKDSLVLNGNEGNWYYKNKL
YNGFAVKYYSNDSLKEKTGFFNGKKQGVYKVWFENGVLKLETHYNQNVLVDSYKAWWMNG
VLALESTYKNGEKQGVERQWFPDGSLSKERNLLNGKENGLQRAWLQNGKIYVNYEAKNGR
TFGMSRATLCYQLKNEKVEENKTK
>FCMOIPGL_00968 SCO1 protein 
MKKLKKIKQNSFLLLGILLFLSCKKVKTDDVTSRVDALPYYNEASFTPKWIDVKSDELKT
FHKIPDFSLTNQYGKNITQKTFENKIYVTDFFFTTCPGICPMMTKNMTLVQEAFKDDTNV
LMLSHSVTPSIDSVLQLKKYAIEKGVGKNWHLVTGDKKEIYDLGRKFYFVEEDLGEPKGI
DDFLHTENFVLIDTNKHIRGIYNGLNKNSVAQLIADIKTLKEE
>FCMOIPGL_00969 hypothetical protein
MKRSTIIIASLLTIATLTISCKSTADAKEERTERSGQRKGGERPNLETIFTEMDANKDGK
ISKSEAKGPLSQSFSKIDTNDDGFISKEELKNAPKPERNERPRN
>FCMOIPGL_00970 Inner spore coat protein H
MFSALIVTSFLSCSSDDISDVDAAAEEEEIVVDIDDTDFEATDWTTETHSKDADPNFDEV
FEDNAVKRLDIVITESNWQSMLSDMTSMYGAFGSRRGSFSNDDEDPIFVPSEVFYNGKEW
YKVGVRFKGNSSLVSSWSSGILKLSFKLDFDEFEDDYPQIENQRFYGFKKLSLKNNYNDK
SNLREKVAADIFRNAGLAVSHTAFYTVYVDNGNGPQYFGLYTLVEEVDDTVLDDQFSDDN
GNLYKPDGDAASFANGTFDEDEYVKKNNEDEADFTDVQNLLTILHDGSRTSDAETWRTNL
ETVFDTDVFIKYLAVNTVIQNWDTYGRMTHNYFLYNNPATSKLNWIPWDNNEALQTGNQG
GSLALNFSGLSSSQWPLIGYLYQDDVYKAKYDAYVEEVINGAFNETTIQALYTNYASLVE
EYATSEVSGYTFLNSSSDFQSAVSTLKAHATSRKSVVTSYLN
>FCMOIPGL_00971 hypothetical protein
MQRNIEKLIAEFLPISLEEMNSVALMKRTDTKFVINKTQLVLMLENLNSDYKVLEIKSDR
IMTYSSLYFDTIENKFYNDHHNGKVNRTKIRQRKYVESNLCFLEIKQKNGKGETNKSRIR
VNDFELDLTNTSLDFITSTTDKEYNLKPSLWNGFNRITLVNLKEKERVTLDLNLSYKMNE
VEKNFKNLVIVELKQERFNRKSEIVKALKALRQNPYSISKYCIGMISLYKDLKYNIFKKK
LIKINNIIAQ
>FCMOIPGL_00972 hypothetical protein
MEFLDIPLFDQDFFKMMFRFTLNFIFLTLIIRFIYYPNSKRKDYVFTYYLISIIVFFLCF
TLKKYEMDIGMALGLFAIFGIIRYRTNPVDIKEMTYLFVVIGVSIINSLANKKMSYAEIL
SANAIIVVVLVFIEKYWALKQVVSKTIVYENIENIKPENYNLLKNDLENRTGITINSISV
GNVDFLKDVATLTIYYYENKQINI
>FCMOIPGL_00973 hypothetical protein
MKSNKTNQLFLKLVLLNIVLFTSVNLAQSEGETDWASWSTIGVEYKLNKKWSFGLEEQFR
LKENFSETDNFFTQLNADYQLFNNFKLGAGIRYIRENDNTGNIQGYEDHFRFQFDAAYKH
KINNFNLGYRLRYQNKNELGVSADEGDYVNQNIRFKTSVEYNFNNWSLDPKFSAEIFNRF
QEGEENGFNKYRLTLGTDYKIKNIGKVGLFYRFEKELNVDFPDTKNILGLSFIYNIKN
>FCMOIPGL_00974 Arylsulfatase
MKNKFLLSTLLLSIVISFTGFSQKKKQPNVLFIAVDDLRADLGTYGSDVVISPNIDKLAS
EGIQFNKAYVQQSICGPSRASILTGSRPETINVIDLFQDFRANRPSIVTLPQHFKENGYE
TVYLGKVFHGKYNDQELSWSRKPTIVKLNDNIPETSGGYALAESQLMYLKNKIALEAKYG
EKLIRENWLDKGPALESADVPDETYEDGHNTLSAIATLNEMVKKDDKPWFLALGFKKPHL
DWIAPKKYWDLYDETKIPIATNVNPPKDGAAMGLSESLELRVSADIPKTGEFSVELQQKL
RHGYYACISYIDAQVGKMIQALKDSGEYENTIIVFWSDHGFNLGEMGYWGKATNYEIATR
VPFIISAPGITDKTKGQKSDALVELLDLYPTLCDLAGLDKPSNLEGKSLLKNLKKPKTKS
QKPAFSLFPTPALREWAARPFTPPFRTTFFKPLIVKIENKIKAQMGEKWDKKTFEQFVMG
YAMRTDDYRIVIWKDRRKPKETPLFIELYDHRTNSDESVNVAAQNPELVKRLVNQFNKIY
>FCMOIPGL_00975 UDP-N-acetylenolpyruvoylglucosamine reductase
MNIQQNKSLKNYNTFGISVNAKRFISIDSVYQLQQLLKVEKDLFLISGGSNMLLTKDIKE
LVVHINIKGISIDKENENEVFITVNAGESWHEFVVWCVENNYGGIENLSLIPGNVGTCPI
QNIGAYGVEVKDTITKVEALEIETGKLVSFSNDECNFGYRNSIFKNEVKGKYIITSVSFK
LTKNKHQLNTSYGAIDVELASKEIEKPTLKNISDAVITIRKSKLPDPKKIGNSGSFFKNP
VVSKKQFLKIKEANSKVPFYEIKPLGDSKGDVEYKIPAGWLIEQAGFKGKRFGNYGVHEK
QALVLVNYGNATGLEIYQLAEKIKQTILQKFGISLEIEVNIIL
>FCMOIPGL_00976 Aspartate aminotransferase
MPTISKKGIQMPESPIRKLVPYAEDAKKRGTKVFHLNIGQPDIKTPQVALDAVKNNNITT
LSYARSEGSEEYRTKLANYYKNHNINVNVNNIVITTGGSEALLFSIGSITDPGDEIIIPE
PFYANYNGFSTASGVTVVPVISSIDNNFALPKIEDFEKLITKKTKAILICNPGNPTGYLY
SKEEIEKLKQIVLKHDLYLIADEVYREFTYDGLQHTSILSIEGLEQNAIVIDSVSKRYSM
CGARIGCIVSRNEEFIKTAIKFAQARLSPPTYALIASEAALETPQSYFDEVIEEYVERRN
TLITELKKIEGIKVANPKGAFYCVVELPVIDSDDFAQWLLEEFSDNNETVMVAPASGFYS
TAGEGKKQIRIAYVLNKKDLIRSVEILAKALKQYNS
>FCMOIPGL_00977 hypothetical protein
MIVIPLVINGKELSFILDSGVTRTILFNISQNDSIGLNDVEKFSLQGLGEGKPVGALLSR
KNNIKIKNIASNNETIYVLLNDYFDLSSKMGITIHGIIGYNILRNFVVKINYKSKKIDFY
NPKSYAYKKCRKCEVFPLEFYQKKPYINTKVQIDTISNVLTDVKLLIDSGGSDAIWLFEN
SKKEIKTPIRFFNDILGEGLSGHIYGNRSRIPKIKLGDFEIENPTVSFLDTISTKNARRF
KERNGSIGGGILKRFIVWFDYPSKKITFKKNGSFTKGFNYNMTGLDVIYNGKQLVEEQVL
KPYSNNNEYNLNNSINYISSFSYKFKSSFKIKSILKNSPAEKAGLLKDDIILKINGTPAH
HLNLNKIIFKFQEKDNKKIKIIVNRNGEELKFEFRLEKKI
>FCMOIPGL_00978 hypothetical protein
MKSLTSILVLFLISFSINAQEFKFEKETINYGKINKGADGERIFTFTNIGDQPIIIKRIQ
SSCGCTVPKKPEKPIMPGEKGEIKVSYDTKRVGGFSKSITIFSNATEAIKVLRIKGIISN
GVSLEKEKSMLSNSEI
>FCMOIPGL_00979 Valine--tRNA ligase
MPTIYQKGYQSMTIPSKYDAKQVEDKWYDYWMKNNYFHSTPDEREPYTIVIPPPNVTGVL
HMGHMLNNTIQDVLIRRARLLGKNACWVPGTDHASIATEAKVVAKLKEQGIKKSDLTREE
FLQHAFDWKDEYGGIILEQLKKLGASCDWERTAFTMDPEMSESVIKVFVDLYNKGLIYRG
YRMVNWDPEAKTTLSDEEVIHEERQGNLYYLEYKIEGSTDTLTIATTRPETIFGDTAICI
NPNDERFTHLKGKKAIVPLCGRIIPIIEDEYVDLEFGTGCLKVTPAHDENDKNLGDKHKL
EVIDIFNDDASLNSFGLHYQGKDRFVVRKEIAKELEEKGILVKTEVHTNKVGTSERTKAV
IEPRLSDQWFLKMKDLAQPAIDAVLGEDAEINLYPKKFENTYRHWMENVRDWNISRQLWW
GQQIPAFFYGDGKEDFVVAENIDDALVLAKEKTGKSNLQTSDLKQDEDALDTWFSSWLWP
MSVFDGIRNPENEEIKYYYPTNDLVTGPDILFFWVARMIVAGYEYKDEKPFQNVYLTGLV
RDKQRRKMSKSLGNSPDALKLIDDYGADGVRVGLLLSSAAGNDLMFDEDLCQQGKGFANK
IWNAFRLIKGWEVDASLPQPETAKIGLTWYEAKFQKTLAEIEDHFSKYRLSDALMAIYKL
INDDFSSWLLEIVKPAYQQPIDKKTFDAIIEVLENNLKVLHPFMPFLTEEIWQYIADRTT
EEALVIAKYPEIKEFDTQIIADFEFATDIVSGIRTIRKDKNISFKDAVELFVVDAEKSSK
EFDAVIQKLTNTEAINYVSEKVEGASFRVKSNEYFIPISIENIDVEAEIKKLETELKRAE
GFLFGINKKLSNERFVSNAPEKVLALERKKEADTIAKIETIKSSLSSLQ
>FCMOIPGL_00980 Nucleoside triphosphate pyrophosphohydrolase
MNSRKEQLAAFNRLLDIMDDLREKCPWDKKQTLESLRHLTIEETYELADAILDNDLQEIK
KELGDVLLHIVFYSKIGSEKKAFDIADVANAISDKLIHRHPHIYGDVVVKNEEDVKRNWE
QLKLKEGKKSVLEGVPKSLPAVVKASRIQEKVKGVGFDWEKPEQVWAKVQEELTELNEEV
KAGNKENTEKEFGDVLFSMINYARFIGVNPENALEKTNKKFINRFQYLEQEAKKEGKELS
EMSLVEMDIYWEKSKEFFK
>FCMOIPGL_00981 hypothetical protein
MEFNKIISVNGKPGLYQVVSQSKNAIIVESLTDKKRLAINSTQNVSLLENIAIYTYEEDV
PLLTIFQSMFEKTEGKEAISHKESGKKLAAFFAEILPNYDEERVYASNIKKVIQWYNLLV
VSGMDFSKTEETTTVEDTEKE
>FCMOIPGL_00982 Peptide deformylase
MILPIIAYGDPVLRKVGTEIDKDYPKLETLIANMKETMYNASGVGLAAPQIGLAIRLFII
DASPFAEDEDLSDEDRATLKTFNRVFINAQIVKEEGEEWSFNEGCLSIPDVREDVSRQPK
ITIEYQDEDFNTHTEVLEGLAARVFQHEYDHIEGILFTDKLSTLRKRLLKKRLENISKGK
VNADYRMRFPNLKKGK
>FCMOIPGL_00983 Putative pre-16S rRNA nuclease
MGRILAIDFGKKRTGIAVTDELQIIASGLTTVNTDEIFAFLKEYISKEKVELFIVGKPKQ
MNNTDSESEALILPFLEKLSKEIPQIKVKRVDERFTSKMAFQTMIDGGLKKNQRKNKALV
DEISATIILQSYLYNKN
>FCMOIPGL_00984 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MEKIRKIIESAWENRELLKEQNTIDTIRKVIDLLDKGELRVAQPIEGGWQVNEWVKKAVV
LYFPIQKMETLEAGIFEYHDKMPLKTDYAAQGVRVVPGASARKGSYLSPGTILMPSYVNI
GAYVDEGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQAAPVIIEDGAFIGSRCIV
VEGVRVEKEAVLGANVVLTMSTKIIDVTGDTPIEMKGVVPARSVVIPGSYTKKFAAGEYN
VPCALIIGKRKESTNKKTSLNDALREYDVAV
>FCMOIPGL_00985 hypothetical protein
MTKITAIIPTLNEEIHIEEAIKSVSFADEIIIIDSFSTDNTVTLSEKYNVKIIKRKFDDF
SSQKNFAIEQAKHPWIYILDADERVTLAVEKEILEAVKNPNECVGFYVRRTFYFCDKRVD
YSGFQRDKVIRLFLKDHCRYSGHVHEKITTTGKLGFFKNKIDHFSYRNYDHYISKMNHYA
AIRAKELHKRGDKVNIYHVMIKPSARFFIHYFIRLGFLDGFAGFLVAKTQAYGVLTRYIK
LWLLNRKIN
>FCMOIPGL_00986 Capsular polysaccharide phosphotransferase cps12A
MQNNENLVVDAVIAWVDGNDPKHRQKMENYIENKSSINSKAVRMRFDQVNEIEYSVKSIL
KYAKFVRNIYIVTDNQTPDFLKDKEKAQKEYPTVFVVDHKTIFEGFYHYLPTFNCFPIES
LLYKIPNLSEHFLYLNDDFFLLREAKVSDFFIDGKPIIRGFWTNFYENIWYKKLQKQLYK
FLGKESKENIWGFKKGQQNIAKILGFKKYVRLDHTIAPLRVSTYDNYYKKYPEILELNVK
HRFRHPEQYTNQSLANHLEIQNNTYVLKNDFQLVYFQNYKKPFWWIKSKLKRANKDQDKL
FLCMQSLDQCPDDKLKYIKNWLQNKYD
>FCMOIPGL_00987 Lipoteichoic acid synthase 1
MYKKIPNYIKYIFTNIFFLFVFNILFRVIFYVFFVNLDDITKSEIQKALFLGIRFDLKLA
ILTFFPLAIIVLITNYRFFEKTVYKKIATIYLILSYLILTLFYIFDLGYYEYLGIRLDAS
SLRFLGNLKISSQVLAESYPVYKGLFALLILGFIIYKFAGFLYNSFIKITIKNTKKIKTI
HFIVTFLLLSFGIYNSVNHYPLRWSEAFFSKKNTVNQFALNPVLYFFDSFKFRSEGVDIE
KFKTYYPVIAKHLNLPKDTINFAKKVTFKDHYKEKPNVVYVMLESTGTATLSNYGNPLNS
SPKIDSIIKKSLSFSKFYVHKPGTAGSVFASITGLPDIEDVKTASRNPMIIDQRIIFDQY
KDYEKLYFIGGSANWANIRGVFQSNIKDLIIYEEGGFEEENRADVWGIDDYDLFKESDKK
LKQLHKKGKPFVAYIQTATNHMPFTVPDKKESYTPILESEITEETVLKGGFRSLDQLNAM
RYLDFNVARFLERAKEAGYYDNTIFVFFGDHRGGMKKLNFLDNNEDDLGIQVHHVPFFIN
APKYIKPQVVDKYAKLIDIFPTATSLAKVDYTNYTLGRDLLDSTTVNTAAFVYIQSKGEK
AVGLIKDGYYYEKTNISKKASLFSLDVNKIKDIKLEKPAITTKMDSLLSAYYHTTKYLYF
NNKKVTKPVVNIK
>FCMOIPGL_00988 O-antigen biosynthesis glycosyltransferase WbnK
MIIVKIIGGLGGQMFQYAYAKNLEQRGYKVKIDISKSKRFKLHGGYQLNKFKIDLKTTTN
VSNFQSELGLRKFLKEKSLLFNETFLNIPKNEYVKGRFQTEKYFKEIRAILLEQFVIKEK
HSNSTVAFSEEIKSKENSCSLHVRRGDFISDRKTNSIHGTCGLHYYSEAIKLINKKYSNT
HFYVFSDDLNWAKQSIKIENVTYIDHEVIPHEDMHLMSLCKHNITANSSFSWWGAWLNTN
KDKTVIAPKTWFTESENEVACESWIKL
>FCMOIPGL_00989 Multifunctional CCA protein
MKYTEAVSSEIFSVISNASKQLGIKSYVIGGFVRDYFLKRGTAKDIDVVAIGSGIKLAEK
VAKLLPNKPKVQVFKTYGTAMLRYKDIEIEFVGARKESYSEESRNPEVSEGTLQDDQNRR
DFTINALAISLNEEKFGELLDPFNGIEDLKNKIIKTPLDPDITYSDDPLRMMRAIRFATQ
LNFKIEQDSLLSISKNANRLKIITRERIVDELNKIISSAKPSIGFLLLEKTGLLPQILPE
LVALKGVEEVEGQKHKDNFYHTLEVVDNIAQNTNDVWLRWAALLHDIGKAPTKKFSKKVG
WTFHAHEFVGSKMVYKLFKKLKMPLNNKMKFVQKMVLLSSRPIVLASEVTDSAVRRLVFD
AGDDINSLMTLCEADITTKNPKKFKRYHQNFELVRAKIIEVEEKDKVRNFQPPVTGEEIM
KAFSLKPCREIGQIKEAIKEAILDGKIPNEHEASYQFMIEKGLSLGLKQS
>FCMOIPGL_00990 hypothetical protein
MNANLETWHTVIFNQDRTKLLEILADDVVFHSPVVHTPQKGKQLTFMYLSAAFVVFFNDT
FKYVREVVNETETLLEFEVEIDGILVNGIDMISWNDEGKITSFKVMLRPLKALNLIHAKM
GEMLLKYQNKK
>FCMOIPGL_00991 2-oxoglutarate carboxylase small subunit
MKIKKVLVANRGEIAIRIFRACSEISVKTVGIFTYEDRYSLHRYKADESYQIGEDNQPLK
PYLDINAIIKVALENNVDAIHPGYGFLSENAEFAQKCEDNNIIFVGPKVSVLKSLGDKIA
AKKVAIENDIPIIRSNQKPLESLEIALFEANIIGYPLMLKAASGGGGRGMRVIREEEELK
KAYGESKREALNAFGDDTVFLEKFVENPKHIEIQIVADNYGNTVHLFERDCSVQRRYQKV
IEFAPSYGLKEETKNDLYNYAITICKAVNYNNIGTVEFLVDDDGSIYFIEVNPRIQVEHT
VTEVVTNIDLVKTQLFIAGGYKLSDQQIKIANQKSIKINGYALQCRITTEDPQNDFKPDF
GTISTYRSASGFGIRLDAGSVYQGVKISPFFDSMLVKVTANSRTLDGASRKIRRALSEFR
IRGVKTNMPFLDNILKHDTFKKGAITVNFIKSNPDLFIFKAPRNRANKVITYLADITVNG
NPDVKKFDATKTFIKPRIPKFDADARFPKGTKDLLTELGPDKFSQWLKNEKKIHYTDTTM
RDAHQSLLATRMRTFDMLKVAEGYVKNNPDIFSMEVWGGATFDVCLRFLQENPWERLQLL
RAKMPNVLLQMLIRGSNGVGYKAYSDNLIGKFVEQSWENGVDLFRVFDSLNWMKSIAPCI
EHVRTKTQGLAEGSICYTGDILDVKNTKYNLKYYVDLAKEIESSGAHILGIKDMAGLLKP
YAASELVGALKAELNIPVHLHTHDTSSIQSATYLKAIEAGVDVVDVALGGLSGLTSQPNF
NSIVEMMKFHERENPININSLNVYSNYWETVREYYYPFESGLKSGSGEVFQHEIPGGQYS
NLKPQAQSLGLEDRFHEITKMYAEVNTLFGNIVKVTPSSKVVGDMAQYLVSNNLTVTDVL
ERGDTISFPQSVASFFKGELGQPVNGFPKKLQKLILKDQIPFTDRPNAHIPPTDFDKEYA
EFRKIFENDLGRKIDFTDFLSYKLYPKVFTDAYNNHLKYDNLTNLPTKNFFYGMEIGEEI
TVDIDKGKTLLVTLDYVGKPNSEGMVTVHFKVNGQGRIVQVKDNSIKVETVSNVKVDKSD
ATQIGAPLQGLLSTILVKNGEDIVKNQPLFIIEAMKMETTITANENGTINKIVLKAGTMV
NADDLIIKLK
>FCMOIPGL_00992 Lipid A export ATP-binding/permease protein MsbA
MNHFKDILRYEKKYRKFTLLNIIFNIFYAIFNVLSVLAFIPVLGILFGTDKKVVTKPTYE
GFTRIGGFLKDSFYHFISEKIENEGQINTLFFICLLALSMFFLKNLFRYLASYVITFLRT
GIVKDIRDKLYNKIVELPISYFTEKRKGDIIARMTSDVQEVEISILTSIETIVREPLTVV
IAISIMLFMSLKLTLFVFILLPVSGFIISSISKKLKAKSIKAQKETGTFLSFIEETLTGL
RVIKGFNSEKIIERKFNTSTETFRSLMTSVFHRQTLASPMSEFLGSATIIAILWYGGTEV
LSNTSSLQPDEFMGYIVLFYTVLNPIKLITTSYYNIQKGEASAERIMQILNTENSIKDKP
NAFIKKDFKNEICFNNISFKYKNDYVLKDFSLTIKKGQTVALVGQSGSGKSTLANLITRF
YDVNKGSISIDGIEIKDITKKSLRGLMGIVTQESILFNDTVKNNIKLGTENASEEQIKEA
SEIANAYEFIKDLPLKFNTNIGDSGNSLSGGQKQRLSIARAVLKNPPIMILDEATSALDT
ESEQLVQVALEKMMQNRTSLVIAHRLSTIQKADIIAVMKKGKIVEQGRHEELLAKKGEYF
KLVSMQSF
>FCMOIPGL_00993 Phosphoglucomutase
MEDILNKAKQWLTSTFDAETQSEIQDIINNNPSDLADRFYKNMEFGTGGMRGVMGAGTNR
INKYTLGRATQGLSNYLIENVKKEELKVVIAFDCRHNSKKFAKVVADVLSANNIKVFLFE
DLRPTPELSYAVRHLGCDAGIVLTASHNPPEYNGYKVYWADGGQIVPPHDGGIIAKVNDL
DFSEIKFDANESLIEVIGKDVDRDFIEASVKNGSLSDRINRDNLKIVFTSLHGTSIVSVP
DALAKAGYTDIHIVEEQRVPNGDFPTVKSPNPEEPEALKMATDLANKINADIVIGTDPDC
DRLGVAVRDLDGNMKLLNGNQTMVVMTNFLIKKWNDEGEINGKQFVGSTIVSTELVNKVA
ETYNVETKVGLTGFKWIAKMVRDFPELDFIGGGEESFGYMVGDFVRDKDAVTATLLACEV
AAYAKQHGSSFYEELLNIYVKNSFYKEHLISITKKGMDGAAEIQQMLSDMRNNPLTEIDG
EKVESLSDYDASTKKNIITGEVTEIDLPKSNVLIYQTANGTRIAARPSGTEPKIKFYFSV
NTPLDAIENAKTVEAELDAKIQRIIKEMKLN
>FCMOIPGL_00994 Dodecaprenyl-phosphate galacturonate synthase
MDISVVIPLLNEDESLIELHDWIAKVMQSNRYLYEIIFIDDGCKDNSWNVIEQLSAKNKN
VKGIRFQKNYGKSQALDAGFQLAKGNVVITMDADLQDNPEEIPDLYNLIIDEDFDLISGW
KKKRYDNIITKNIPSKLFNAAARKTSGLKLHDFNCGLKAYKNEVIKTVKVSGEMHRYIPV
LAKNEGFTKIGEQVVKHQARKYGVTKFGIDRFINGFLDLITISFLSKFGKRPMHIFGLWG
TFMFLFGTTSAFYIGAYKLYKLYNGSKTILVTDNPWFYIALTSMILGTLLFLAGFIGELI
IKTKSDEKHYTIKEKLNF
>FCMOIPGL_00995 hypothetical protein
MENQTNSKSIILNYGLILGVISILPGLIKYAMGGNYLENDWISSVLSLVLTVAFIVLGIK
KFKSENEGFLSWGQGVKVGLGIVLISMIISIVYLLLFTNFIEPDFKNKVIESSIVKWEDA
GMSSDQIEMSTKMTKDYFELSLYGSIVVMSLFLGFVISAITAAIMKKTEEDTY
>FCMOIPGL_00996 putative oxidoreductase
MSKVILVTGASSGIGKSIATFLQEKGYKVFGTSRNPKNAENFSFELIALDVLKVETIESA
VAYIIKKQGRLDVLINNAGMGITGPIEDTPTDEMRAVFNTNLFGAVDVMKAVLPQMRTQK
SGMILNVTSIAGYMGLPYRGLYSATKGALELVTEAISMEVKNFGIKVINVAPGDFATNIA
AGRYHTPVFENSAYKENYQANLDLMNAHVKGGMNPLEMAKTVYKIINTENPKIHYKVGGF
MEKFSIVLKRVLPDKMYQKILMNHYKL
>FCMOIPGL_00997 hypothetical protein
MKFYRYIITLFFISTLFSCDETILITGIEGEIICDVSEIEVSASDNIVIADDESPVFWQG
TYTDNSVKISYTKNAGTDGETETLAFVFNKKDGCLQIDRCYKYYYGSVADISAVTEMQVF
EFKMKDWEIDKKFTGQLVYKDHHDKQTYTINFWVEFTEENYEVEDTNYTYFSDCFDNQLP
IDIDLNKDGITDYSIISEEKFDLGNVPNFAYNNIKLISVDESINEIHSPKKSSIPYTVIF
EPPFTSEDTKKYDANKFDSEEVKNSLDVFYEFAAPYESYNFFLQNNLTYKKELSNNKDDY
YIVKMAIDENSYYGWIKIEFSATECYIAVVDTYLESIPNKHISVD
>FCMOIPGL_00998 Transaldolase
MKFFIDTANLEQIKEAQALGILDGVTTNPSLMAKEGITGEANIINHYKAICELVDGDVSA
EVIATDFDGMVKEGEALAALNPQIVVKLPMIKDGVKACKYFSSKGIKTNVTLVFSAGQAL
LAAKAGATYVSPFIGRLDDISTDGMNLIEEIRLIYDNYGFETEILAASVRHTMHIINCAK
LGADVMTGPLSAIEGLLKHPLTDSGLAKFLEDYKKGN
>FCMOIPGL_00999 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MRKINNINGFSSKPAFSADEMGELKGAFPQKPLAQMVISACHQFHIDTVVISPGSRNAPL
TIGFSNHTEIETLSVVDERCAAFFALGIAQQTKKPVAIVCTSGSALLNYYPAIAEAFYSN
IPLVVISADRPKHLIDIGDGQTIRQENVFENHILFSANLVENEKFKTRNSQLIGEALQIA
TSQKGPVHINVPFDEPLYETVAELQEFHFPHISLSSLDNSHINYDNFSKIWNAAEKKMIL
VGVNYPDEGLHKLIDFYADDKSVLILTETTSNLYHKNAVNSIDQLIFSLEESQLQDLKPE
ILITFGGMIVSKKIKQFLRKQQPKHHWNIDERKAVNTFFCLSEFIQTKPVDFFSNFNKLI
LKKESNYQQKWLQLRDEKRVKHQQYLSKTVHSDFKVFEQILESIPKNSQLQISNSAIIRY
AQLFTIDKTNTIFCNRGTSGIDGSTSTAIGAAFANKNQTVFITGDISFFYDSNALWNTNI
PSNFRIILINNSGGGIFKILPGPKLTNALSFFETPHCLTAEHLCKMYEFEYQKAFSSESV
TEELKGFYKTSEKPKILEIFTPSAENDLILTAYFKYIQ
>FCMOIPGL_01000 Conserved virulence factor B
MDIQEHDDFEEVEMNLKEGDKVQLIIETETNLGYTVLINEEFDGLLFRSEVFQELEENME
VVGYIKNIREDGKIDVSLRPQGFRNVINSDVEKVLVKLKNSREGFLLLTDKSSPDSIRFH
MKMSKKAFKKAVGNLYKQKLILIKEDRIELL
>FCMOIPGL_01001 hypothetical protein
MIKKSLTLLFILFCFCGYSQKIIQKNLESTFLDSDRSISIYIPEGYEKDSIKNYPLAIVL
DEDYMFDIYVGNSILFSKKDKAPKQIVVGVSMKDTKGADVSFNRNTGELTASAQNFYTFI
RDEVLFYMESTYRTSPFITLVGQGYSANLISHFLQEDTAFINSFICINPSFSDFIGGELQ
SYNLPKFGREDNTFYFYTNNSTSFSPEKQNKINQVQKGLSTLGIKNFNVNNDVITTSSSI
SAMSEAIPRALTKVFEVYSGITKEEYDKYIKELAPLDAISYLENKYLEIEFLFGTNLGIR
ESDIYAIENIIIEKENGDRLRDFGKMILKIFPSSPLGDYYIGKYYETGKMIKKAIRQYKI
GYGKMDPSDPNADAYYENILRLGGQ
>FCMOIPGL_01002 1,4-dihydroxy-2-naphthoyl-CoA synthase
MIQPEWKTVKEYEDITYKKCNGVARIAFNRPNVRNAFRPKTTKELYDAFYDAGEDVNIGV
VLLSAEGPSTKDGVYSFCSGGDQKARGHQGYVGEDGYHRLNILEVQRLIRFMPKAVIAVV
PGWAVGGGHSLHVVCDLTLASKEHAIFKQTDADVTSFDGGYGSAYLAKMVGQKKAREIFF
LGRNYSAQEAYEMGMVNAVIPHDELESTAYEWAQEILAKSPTSIKMLKFAMNLTDDGMVG
QQVFAGEATRLAYMTEEAKEGRDAFLEKRKPNFPKRWIP
>FCMOIPGL_01003 Formyltetrahydrofolate deformylase
MKSQVVSFLIKCPDQKGLVAKITSFFYEKGFNIVSSQQYVNAIENTYFMRIRLNADGTTL
SKSELESSFLELATPLKIDWSVNYDDKKQNVAIMVSHTSHNLYDLLERSKEGRLACNVKM
IISNHDKLRYIAEMFNVPFHYLPVTKETKLAQESQVIDLLDANEIDLIIMARYMQILSSD
FINHYPEKIINIHHSFLPAFQGANPYKKAYERGVKLIGATAHYATEDLDEGPIIEQDVKP
VTHESTPTTLKRIGADIEKLVLARAVKNHLNHQIIVSGNRAIVFPEAGE
>FCMOIPGL_01004 Fumarylpyruvate hydrolase
MKIICIGRNYAKHIEELANERPENPVVFLKPDSAILPRKNPFFIPPFSDDVHYEVEVLVK
INKVGKHIDAKFAHKYYDEIGLGIDFTARDVQAKCKEKGLPWEKAKAFDGSAVVGEFYPK
EEFDLDNLKFQLFKNDEIVQDGNTNAMLWKTDELIAYVSQYFTLKKGDIIFTGTPAGVGR
VVENDTLKGVIEGKEAFNIRVK
>FCMOIPGL_01005 hypothetical protein
MAIKLLSYIFLFYVGFYFYRLAENHNKYKWLCGFLGIASFFLGSILYLLYIRFFTEIIIN
EFEITNLSFKSSIAGFVFVVFLFKILNFIWSKKKKLKNEVDKIGED
>FCMOIPGL_01006 hypothetical protein
MLGLILIYWLGKKFYKLAEEYNKSQWGYAILGIVVYYAVSIIFATVILIIIESFSNTLND
YILGLIAMPFGLLGCYLLYKYLEKTWEHKNPINDSLIDQIGKTEI
>FCMOIPGL_01007 Putative competence-damage inducible protein
MKAEIITIGDEILIGQIVDTNSQFIGIELNKIGVSVYQITSIQDDKQHILNALKEAQERV
DIVILTGGLGPTKDDITKKTIAEYFNDDKLIEYPEVIAHIKEMFKKLDHPFNEVQRYQAQ
LPSKATLLKNNFGTAPGMWFYENNTVFISLPGVPYEMKGLITNEVLPRIQKQFKLPFIIH
KTIMTYGAGESMIAERIENFENNLPSYIKLAYLPSFGKVRLRLSAKGDTKEILEKELNEK
VAEVYALIPEIITGLDDNGTIEKRIGELLAEKGKTISTAESLTGGKIASTIVSVPGASTY
YKGSIVAYSSEVKNSLLNVSKETIEKYSVVSKEVALAMAKGAKQKLKTNYAIAVTGNAGP
TTDLTDKSVGVVFIALATDTGVYVEEFNFGQPRERVIEKTVNKSLEMLLKEILKN
>FCMOIPGL_01008 50S ribosomal protein L28
MSRVCELTGKKAMVGNNVSHAMNRTKRTFDANLMTKRFYIPEEDKWITLKISASALKNIN
KKGISAVIKEAKANGFLTK
>FCMOIPGL_01009 50S ribosomal protein L33 2
MAKKGNRVQVILECTEHKASGERGTSRYITTKNKKNTPDRMEIKKFNPILKKMTVHKEIK
>FCMOIPGL_01010 hypothetical protein
MAKKTVASLQTSSKRLTKAIKMVKSPKSGAYTFVETIIIPEKVNEFLAKK
>FCMOIPGL_01011 Signal recognition particle receptor FtsY
MSFFKKIFSKEKKETLDKGLEKSKESFFGKLSKAVAGKSKVDDDVLDNLEEILVASDVGV
NTTLKIITRIEERVAKDKYVGTDELNRILREEIAGLLSETNVGNETDFTIPANKKPYVIM
VVGVNGVGKTTTIGKLASQFKKQGLKVVLGAADTFRAAAIDQLQVWADRTNVPIIRQEMG
SDPASVAFDTLTSAVTQNADVVIIDTAGRLHNKVNLMNELTKIKRVMQKVVADAPHDVLL
VLDGSTGQNAFEQAKQFTLATEVTSLAVTKLDGTAKGGVVIGISDQFKIPVKYIGVGEGI
DDLQVFNKHEFVDSFFK
>FCMOIPGL_01012 hypothetical protein
MNSTKIYSLLLLFFFTFSFCSKKDIEEEIIEEPQTAEIYFPSITTNIWETILPEELNWNL
TKIEDLKTFLSEKNTKSFMVLYNGKIVMEEYFNNHTATSNWYRASAGKTLTSTVSGIAQD
ENLLHINDKVSDYLGTGWTSATLDKENLITCKNLLSMTSGLDDSLGDAVSPDNLKYVADA
GTRWAYHNVYVKMQDVVANASNTTWSNYFNTKLRDKIDMNGVWTDVGSLSVYWSTTRSMA
RFGLLISANGKWENTQIVSESFLNEATNTSQNINTSYGYYWWLNGKPNYHLPQSQYQFNG
ELIPNAPADMLCALGKNDQKIYVVPSKKLIIIRMGEAAEDSNFALSNFDNELWEKMNDVI
E
>FCMOIPGL_01013 Ribosomal protein S12 methylthiotransferase RimO
MRTKTIKKNKINVVTLGCSKNIYDSEVLMGQLKANGKEVVHEDENDDGNIVVINTCGFIG
KAKEESIDTILHYAKRKEAGEIDKVFVSGCLSERYKPDLESEIPNVDQYFGTHDLPNLLK
VLEADYKHELIGERLTTTPKHYAYLKIAEGCDRPCSFCAIPLMRGKHVSTPIEDIVTEAT
KLAEKGIKEVMLIAQDLTYYGLDIYKKRALADLLEALAKVDGIEWIRMHYAFPTGFPMDV
LDVMKREPKVCNYLDIPLQHINTELLKSMKRGTTHEKTTALIHKFRETVPEMGIRTTLIV
GYPGETEEMFQELKDWVEEMRFERLGVFEYSHEENTGAYVLEDDVPADVKFKRVNEIMET
QSQISWELNQEKIGKTFRCLFDRKDGEFFYGRTEYDSPDVDNDVVVDAKEHYIKIGEFID
IKIHDAGDYDLHGTPVVKQEKPVSLNQKRK
>FCMOIPGL_01014 hypothetical protein
MKKTYFNWSSGKDSALALYKVLQDSDYNVDLLVTTVNKNFDRVSMHGLRNELLSKQAASI
GINLKTIEFPADVTMDLYSEIMKKAMDSLVEQEYSHTIFGDIFLEDLKAYRDTKLAEVNI
KGVYPLWKKDTKEILQEFLDLGFKAITVCVNAKLLGEEFVGRIIDEQFIKDLPENVDVCG
ENGEFHTFVFDGPIFKKPIDFTVGEKTLRSYTLHDDDDDNCYQAKKEGANHDTSFWYCDL
T
>FCMOIPGL_01015 Phosphomannomutase/phosphoglucomutase
MTLIKSISGIRGTIGGKTADNLTPIDAVKFASAYGAFIKSRNPNKEKITVVIGRDARISG
KMISSLVANTLVGLGINVVDLGLSTTPTVEVAVPLENADGGIILTASHNPKQWNALKLLN
EKGEFLNGEEGEQILALAESEDFEFAEVDDLGSYKKNKKYLKKHIKEVLNLDLVDVKAIK
KAKFKVVVDGVNSTGGIFIPALLKKLGVECVELYCTPNGEFPHNPEPLKEHLTAISELVV
KEKADLGIVVDPDVDRLALVSEDGSMFGEEYTLVACADYVLGRLKGGNTVSNLSSSRALR
DVTEKHGGTYTASAVGEVNVVIKMKETNTVIGGEGNGGIIYPASHYGRDSLVGVALFLSH
LAHQKVSCKTLRDSYPSYFMSKNKIQLTPEINVDEILETMASTYKNEDVNTIDGVKIDFA
DEWIHLRKSNTEPIIRIYTEAKSQQAADDLAVRFIKEIKAIIA
>FCMOIPGL_01016 hypothetical protein
MKTKAIIVSFLLMSVFSFSQEEKSEKITNKGKFFVYWGWNRANYSNSDIHFTGNNYDFTL
HDVTAHDRQTPFSFNDYLNPGRITIPQNNYRIGYFLKENYTISIGVDHMKYVMDAGQTVK
IDGEINSGTTFDKIYNNDDIELLEGFLKLEHTDGLNYVNVEFRRFDDISHLFGLNHKNFQ
VNLTEGFGTGILYPRSDVTLLGQDRHDEFHLAGWGASAVVGLNLTFFKYFFIQSDLKLGY
INLPDVRTTISTDDKATQSFTFFERTILFGGRFNIF
>FCMOIPGL_01017 putative cysteine desulfurase
MNLEQFFSQFRQQTIGVNQTFTSPYGEQKIIYADWTASGRLYRSIEEKICNELGPFVANT
HTETSTTGAAMTLAYHEARNIIKRHVNANSNDVLITTGSGMTGVVNKFQRILGLKVSESL
KNYTTIPEGLKPIVFVSHMEHHSNQTSWLETIADVEVVPCNEEGLVCLESFEKCIQKHEN
RIIKIASITACSNVTGIKTDYHKVAKLIHEYNGLCFVDFACCAPYVDINMHPEIEEEYLD
AIFFSPHKFLGGPGSAGVLIFNKKLYKNTVPDNPGGGTVSYTNPWGQHDYFDDVETREDG
GTPGFLQTIKIALAIQLKNKMGVENIKKREDEINKVMFATLENLSDVKILAPNHKERLSI
FSFYFEKYHFNLVVKLLNDRFGIQTRGGCSCAGTYGHFLLNVDQATSNRIKDEILHGCNT
QKPGWIRLSLHPTVTNAELDFICNSLQELSENIENWSQDYSYDSIKNDYAHKSVEPIEKE
LVKSWFSV
>FCMOIPGL_01018 Lipid A biosynthesis lauroyltransferase
MQFLAFAITYPFIWLLSRLPMRILYAFSDFFYFLIYYVIGYRKKVVLENLKLAFPKKSEE
ERIKIAKGFFKHLTDLIMESVKAFSISDKEISKRYTYKNPELVNNFVQQGRSIALVAAHQ
ANWEWSISLPLVLEGNILGAYTRLGNSYFEKVVRNSREKFGILGYKTSETVRGMQKNFSE
KMQGSYVLLSDQSPQVHKTFYWNEFFGVNVPIHTGAEMLSKRFNLVVINYITRKVKRGYY
ETEFQLITASPKEFEDYEITDKYISLTEKNINQQPELYLWSHKRFKHRNKFEEWKKIKAS
KQKTNS
>FCMOIPGL_01019 Rhomboid protease GluP
MMQGSNPIVLVIIIANVLFSMKGFDDYSFLDKYKFQVGRVLGKEKIRMLSSGFLHVDWMH
LGFNMYALYMFGGFVTNFLGTISFLIIYFGSLLAGSLYTLHYHKDEPYYSAVGASGAVSG
IVYSSILLFPDMQLLLFFAIPIPGYVFAVGYLLYSIYGMKKQVGNIGHAAHLGGTIGGFI
LTLILNPILFTTNSQLVIMLAIPIILLLLFGDKLKNL
>FCMOIPGL_01021 hypothetical protein
MKKLIAFISICFFCILSFSAQEKKGGKEKIIALKISYLTEQLNLTPAEAQKFWPIYNAYS
EEQHDLRNKQRNELKKALKNSDEIEALNESDAEKLITLKLTIDKKLYESQKDFINDVKQV
ISYKKIIKLHVAEMEFGRKLMSKYRHKKN
>FCMOIPGL_01022 hypothetical protein
MEREIKNNVNYISKKTGKKTGFSTPTDYFNNLEDVIATKISEENLNKEIGFKVPDTYFNN
LEDTILAKVSSEKETKIISFKDRLLKMIPYAAAASIVLFIGLNSFVFNTDKELTLDSLTD
TEIEYWLDANTLNTNDISIVLEDDLLDENDFYFTTLNDETIEDYINSIDNIALLNEIN
>FCMOIPGL_01023 ECF RNA polymerase sigma-E factor
MTEEITFIAELKNGKTKEKAFRVLITQYKERLYWHIRKIVISHDDADDVLQNTFIKIFKN
IDKFNEQSKLYSWMYRIATNEAITFINKRAKDRSVDISDYQHQLASTLESDVYFSGDEIK
VILQKAIATLPQKQQLVFNMKYFDELKYNEISEILETSVGALKASYFHAVKKIENYIKSE
TN
>FCMOIPGL_01024 hypothetical protein
MAISLRGDQEISSVPTIKSKALRINLNRDIYGTFAEIGAGQETARNFFRSGAASGTIAKA
MSAYDKDFSDAIYGMEEDKRYVTQPRLHTMLRHEIDLIEDRLSRQKHPEKLFFSYANTVT
TIDFARQFKGHGWVGIRFQLDPLEGYNEIVLHLRFKETDARLQQETLGALGVNLIYGAFY
LNDSPKELIKSFYDNLGNHQIEIDMVNFSGPRFMYVDNRLMSLQLLKNGMTNAVMFGADG
NNLLPAQVLYKKNILALRGSFRPVTKVNMDMFELSKKMFLEDNKVEEKKTQIIFEITLSN
LTEEGKINERDFLDRAELLCSLGQNVMITNFQQYFKLVEYFSEFTKERMALAMGVFNLIQ
IFDEKYYRDLSGGILEAFGKLFYRDLKVYMYPYKDPETGEYINSDNLKVHPRMKELYKYF
KHNGKLADIKDFNKEHLEIFSRTVLKMIMDGEKGWEDMLPAGIADTIKQKRLFGYSRARA
TRK
>FCMOIPGL_01025 Phosphoribosyl 1,2-cyclic phosphate phosphodiesterase
MKKDKKLLQITFLGTGTSQGIPMIASNDPVCLSKDQKDKRLRSSIMISWNEVSYVIDCGP
DFRQQMLRENVQLINGVLFTHEHSDHTAGIDDLRPFCYKIGEMPIYLSEKTLQSLEQRFD
YIFSKENRYPGAPSVQSNIVNKIPFILDDVQVIPIHVMHGNLPVLAYRIQDFAYLTDVKS
ILKSEKEKLKNLDVLVVNALRHEEHPTHFNLQDALDFVKEIKPKKTYFTHISHKLGFHSK
VSETLPKNVYLAYDGLKISV
>FCMOIPGL_01026 hypothetical protein
MGKNPQQDNEVEIKNQQVDSRIAAVRDLIFGENIQQYNTEFADVYDKLKALENQTRSNLA
ESVIQLENKLSDLESLMDHKFQDLNEDLDKRLADLDDEKADRKKLGKALEKIALMLQE
>FCMOIPGL_01027 hypothetical protein
MEKTTVDNKDNRFELLKELLLADDRKDFNLLKEEYLEREKFKIKVDPVVDEKIEDLKENF
PKYFGDTITETIKVQIRDSQDEVVEALYPIMGKLVKKFIIAEITKLTESINETINDKFSI
SQIIKRLFKGKRTDADDVLQEVFEPIIEEVFVINKDSGLLAGNYSRGNIADKDMVSGMLT
AIKSFAKDSFSQEGQDIEDIKFENFQLSIQNFKTIYIATATSGVISPEFEDELLDDINNL
AEVILRDRTYLVDEVRLNKVIKKYLIKNE
>FCMOIPGL_01028 hypothetical protein
MIAKKVLLVGNFGVGKTSLIRRFVLNEFSEEYISTIGVRVSSKIIQIDKEEIKLLIWDVA
GTSDDEKVPKAYFLGASAAMFVFDLSREETYKSIKNQVEVVKQLSGLKNITVVGNKKDLV
SVDEIEQLKKSISISVDLITSAKDNENVEDAFKELAKQTLN
>FCMOIPGL_01029 Autoinducer 2 sensor kinase/phosphatase LuxQ
MAISKIEHFFIELRTNHIGILTDIISGKFAINEFEVNQSIYSGCPFLEGTLEALIINDPF
LIEGMIIVSDEKEYNVDVELLKTEKEVSVLVHNRTNVYKYAAQLNQNRNDLFFLKRELHE
KNIELDRLRKIADKANEEKSRFLAMMSHEVRNPLNVILGYTELINEEEVSKNVKEHLKYL
TISGKNLKVIVDDILDLSRVEAGKLQLSNTPVNLTLLVEQLRNNYKSSHRDLDISLEFSC
SKKLPKFVFGDDVRLLQILTNLINNSIKFTQKGAVTTQVNVISSDKKNVKISFKVTDTGR
GMTESQAATVFEEYQQNELNDNRVHKGAGLGLAIVKRLVSAMNGTISVSSKIDVGTVFQV
DIPFQIDDSIIVNENLEEVLDKNYINGSKILVADDNFLNRTIVAHILNKEKANLTLVKDG
IEALSELQKEKFNLVLLDINMPNLSGTSLVKQKETYREFNSETPILALTGNSSVEDVKGY
LKIGFKGVIPKPFTSTQFVEILNNNLKN
>FCMOIPGL_01030 hypothetical protein
MNLETIKYLAYEKELPQAGKHIIGQTRNNNIIVYQAFNLNISKWAIENQKFGGSHYKFSR
MSWIKPNFLWMMYRAGWAKKEHQQKILAIEISKSNFEVLLEEAVHSDFKEEIYVTKENWK
SQLAKSKVRLQWDPDHGPDGEKLERRAIQIGIKGDLLEKFGKEWIISIEDITAFAHEQKT
ILDSKKRENLHVIKEQPIIIENKNIIDKLQLSKL
>FCMOIPGL_01031 Carboxylesterase 2
MSLDYISREPKIKTENPPLLILLHGYGSNKEDLFSFAEELPDELLIISAQAPYEMGYGGY
AWFSINMDSAKGKFYDIDEAKQSVDKIAIFIDEIKEKYKTNPDKTFLLGFSQGASLSYAI
SFLYPNKVQNVIALSGFIVTEMLPKSISKDITTKYYSSHGSVDQVIPVEWARKSKPFLDK
LGLENVYSEYPVGHGVAPQNFYSFKTWIEENL
>FCMOIPGL_01032 hypothetical protein
MENYTVKEGKTAAIISYFTILGTIIAFFMNSNKKNSFTSFHIRQMIGIFLLSMINKYIIY
DFLGNTVGYVVFLFIVVLWVIGFIGVLKGEEKLVPFVGQQFQTWFQNI
>FCMOIPGL_01033 Dihydroorotase
MSTLLKNATIIDANSPYHNQKKDILISDGKLEKIANSIPQKDNYTVIDLENLHVSSGWFD
TSVSLGEPGFEERETIKHGLQVAAKSGFTSIAVNANTDPVIDSKSDVEFLISKAFNSPTK
LYPIAALTKESKGVEISEMYDMQQSGAIAFGDYNKPIENDNLMKIALLYAQNFDGLVLSF
PKNNSIAGDGIANEGINSTKLGLKGNPALAEHIQIARDLFLLEYTGGKLHIPTISTAKSM
NLIKEAKKKGLKVTCSASVHHLTLTDYELHSFDSNFKTNPPLRTKDDVKALQKGVETGVI
DIITSDHNPIDIEHKKVEFSEAKEGTIGLESAFGAVNSILDLEDLINCFTTKPKTIFGIE
NHSIQEGNIADITLFNPETETIFTHKNILSTSKNSAFINKKLKGEVYGIFANNQLTLNK
>FCMOIPGL_01034 hypothetical protein
MQFKNPEVLYFLALLIIPILVHLFQLQKFVKVPFTNVAFLQKLVQETRKSSRIKKWLILC
ARLLLFSAIIFAFSQPYLSQKNTTQDQHTFIYLDNSLSTNTEGEKGNLLQISAQEIIENA
SKKDIYSLQTNDHFYKNIPYSELKNELLKVKNTSKKLAFSNILLKISNTKENKTNTSHKN
ILISDFQNNYNYKFTNVTPTFSAIKLEASTKNNISIDSVFISNRNTNNFTVNVVIKNQGK
EKNNVPIAIFNGTKLISKQSYSIKKDSKEIVPFVIQNQADFLGKIHTTFSDTFSFDNTFY
FSLNSTKKINILSIGNEANFLSKIYTEDEFNFTQTSLQNVNYNSIQKQQLIILNELEKIP
ETLSKSILDFCNKGGNIVIIPNENSEIKTYNNFLEKISSSKISSKISDTLKITTINYEHP
LFKNVFQNKVSNFQYPNTQSHFPIVSKNSSKIVSFENNSSFISQIKNTNNNKIYLFSSAI
NKNNSNFLNSPLIVPVFYNFGKMSFQQSKLYYYLDDENKIDIETSLDKDEILNISNLESS
FIPEQQTSQNKVSIFTKEQPYNTGFYYILRKKDTIQTLAFNTPKEESLLNFINLNSLEEN
NSKISFSTSISDVFNDLNKNNKVHWLWKWFLSLAIVSLLLEILILKFYKP
>FCMOIPGL_01035 hypothetical protein
MSFRCTFWQCGKKIKTALRTQNDWKALSELDKNLRKLDKKDPVKYDFALFGLGVFEKF
>FCMOIPGL_01036 hypothetical protein
MVRDDKTGVDFGIWQSHNPANLSCPLDVHSGNVARKLKLL
>FCMOIPGL_01037 hypothetical protein
MKKSELKEFLDEKVILYNNPKFIESDPIQIPHQFSKKEDIEIAAFLTATISWGNRTMIIK
NAFKMMELLDNSPHDFVLNHKEKDLEAFQNFVHRTFNYIDFKQFIKSLQNIYQNHG
>FCMOIPGL_01038 hypothetical protein
MKKLTLFLLIIITLTSCATILNGKKTVVKISADKESKIVFEKDTISINKKEIIIYPNRSK
KPLKIIVLKDSLSQDFYFNRKLSSLFALNVLNNYGIGILVDLTNNKRFTYRHNLHFITDT
ISNKILLSNKKVTVLPKNSFLLYTSPLQFLDLFSIPMFTLGTEYFIKNNISLSAEFGYKI
KNATSSYEHTSYLKDNAFTYRFETKLYNVINLTNNVHLNEYVSLEFRKIKSQYNDYIDYT
EINNSDIENYITDDFGTKKDVTIINLKYGLLVPLGERFYFDFYSGFGIRIKKFNHINLEY
NKSIHHINFSDSLSLFDFREFKSYDKKSFLNYSLGFKFGIKL
>FCMOIPGL_01039 Lipoprotein-releasing system ATP-binding protein LolD
MITTKNIHKYYGEVQVLKGLDLHIKKGEIVAIVGPSGAGKTTLLQILGTLDKPLKEQDFE
LSINNISLKDLSDKELSNFRNNQIGFIFQFHQLLPEFSALENVCIPAFIGKKSKKEAETR
AKELLEFLGLSHRIHHKPNELSGGEQQRVAVARALINNPSVILADEPSGNLDSESAKNLH
ELFFKLRDEFGQTFVLVTHNEELANMADRKLTMIDGKII
>FCMOIPGL_01040 hypothetical protein
MIKKLVLLVLVAAFSIKISAQNNQNRKKIKATRVTKTPKIDGILNDDAWKNAEIMTDFVE
LRPDNGKIVSDEYQTVVKVMYDDDAIYISGQMNDPDPAGIPKEFAVRDNFSIADFLLVTI
NPNDDGQNPFEFLVQVTGNQGDAKVSNGNEDFNWSAVWESAVSTDDKGWNVEMKIPYRAL
RFANRPIQSWGFNFHRRLEKLNAQHTWTHIDNSVGRWTQYDGLIEDFKDIKPPTRLNFYP
YASATTTSYEGKTDSDWSVGMDIKYGLTDNFTLDATLIPDFSQVGFDDVELNLGPFEQQF
TEQRQFFTEGTELFSIGNLFYSRRIGGSPIDQFNVSESLAADEEIIDYPGKVNMLNAVKI
SGRTKGGLGIGFFNAITETTNATIKNNSTGETREEVINPFTNYNILVLDQQFNQNSTISL
INTNVTRDGGFRDANVTALDWHLETKDSKYNADGSVRMSNISDDIYNPNTGYTFDNSFGY
NSGHWNWEIGYNFENKDFNPNDFGILFSNNQQTIYNSAGWRTLQSTKRFNYTYFNFYQQL
NFQHYSGTYTGYNAGFGYDAQTKSRFSYGANLNYGTEEKDFFEPRQGSTSGIYFLQPENK
NVNFYISTNSQKKLELNVDGYYTGYSNNPKTGYGFSFAPRYRFTNQLSLRYNLNFNKTNS
DQGYVDKVDTNIIFGMRDRKSYTNTISGSYSFSTKSSLSLSFRHYWSSAKYNNYYNLNSD
GELDINNSYTGDNVNFNSWNLDLNYIWQFAPGSQLIAFYRNSIFNSDTNSNLNFKDNLDN
LFDQSQSHTFSVRFVYFIDYNKIKNIF
>FCMOIPGL_01041 Succinate--CoA ligase [ADP-forming] subunit beta
MNLHEYQGKEILSSFGVRIQRGIVASNAKEAVEAAKQLTEETGTGWHVVKAQVHAGGRGK
GGGVKLAKNLADVERISDEIIGMMLITPQTSAEGKKVNQVLICEDVYYPGASEPDEYYIS
VLLNRATGKNMIMYSTEGGMDIETVAEETPHLIFTEEIDPLLGIMPFQARKIAFNLGLSG
AAFKEMTKFVTNLYRAYIGSDSSMFEINPVLKTSDDKIMAVDAKVSLDENALFRHKDYAA
MRDLREENPIEVEAKAAGLNYVDLDGNVGCMVNGAGLAMGTMDLIKESGGEPANFLDVGG
TADAARVETAFGIILKDPAVKAILVNIFGGIVRCDRVAQGVVDAYVSMGDKINVPIICRL
QGTNAKEAKELIDNSGMEIISATEFQEAADKVQEVLEAS
>FCMOIPGL_01042 Pyrroline-5-carboxylate reductase
MKILVIGAGNMGLTYAQGMSKSRLLKKKNIMVLDNSVEKQEALNEISHFDAFKELEDCVP
KADIIFIAVKPYHAENLFKALKPYTKPGQVIVSIMAGVHIENIKKYSGLTKIVRAMPNLP
AQIGKGLTSYVTSEEVSRIEKLTVESLLDTTGKSMEVSNEKLIDASTGISGSGPAYVFYF
MQSMMEAALKMGFSKNDSTVLVSQTFIGAVELFNQSNLSPNSWMEKVASKGGTTRAALDS
MQDNNVNELIKEAAFAAFNRAIELGKEN
>FCMOIPGL_01043 Cysteine synthase
MKFNSIIETIGNTPTVKLSKLFPNANVWIKLEKSNPGGSIKDRIALAMIEDAEQKKLITK
DTEIIEPTSGNTGIGLAMIAAIKGYKLTLVMPESMSVERRALMTAYGANIVLTPKELGLG
GTIAKANEMVAKNKNAWMPSQFTNPANPAIHRKTTALEVINDFPEGLDYLITGVGTGGHI
TGMTEVLKEKYPSLKVFAVEPNDSAVISGDKSGPHPLQGIGPGFIPETFNIKIIDGAIRI
TKEEAFSEVKNIAKSEGILVGISTGASLAAVRKQLQTLKGDETILTINYDTGERYISIEG
LLS
>FCMOIPGL_01044 UvrABC system protein B
MEFKLESKFSPTGDQPEAIKQLKEGVLSGEKFQTLLGVTGSGKTFTVANLVKEVNKPTLV
LAHNKTLAAQLYSEFKQFFPKNAVEYFVSYYDYYQPEAYIPVTGTYIEKDLSINDDIERL
RIRATSSLLSGRRDVLIVASVSCLYGIGNPVEFKKNVIPIEVNQQIARTKFLHQLVQSLY
SRTEVEIKSGTFKVKGDVVTIYPSYGDYGYRVHFFGDEIEEIESFDLENNTVIESFNELT
IYPANLFVTSPDVLQNAIHQIQEDMMKQVDYFKEIGKHLEAKRLKERTEFDLEMIRELGY
CSGIENYSRYLDGRQPGTRPFCLLDYFPDDYLMVIDESHVTVPQTHAMYGGDRSRKENLV
EYGFRLPAAMDNRPLKFDEFEAIQNQTIFVSATPADYELQKTEGVFVEQIIRPTGLLDPI
IEIRPSLNQIDDLIEEIQIRVEKDERTLVTTLTKRMAEELTKYLARVDIRCRYIHSDVDT
LERVEIMQDLRKGLFDVLIGVNLLREGLDLPEVSLVAILDADKEGFLRSHRSITQTVGRA
ARNVNGLAILYADKMTNSMQKTIDETERRREKQIAYNTKNNITPTQINKKIDDTLSRSAV
SSYHYDNAKQIAAEQDLQYLPKEEIEKRIRDKRKQMEAAAKDLDFIVAAKLRDEITTLKE
SL
>FCMOIPGL_01045 hypothetical protein
MRKILLFLPLIFTLNIFSQKEANFWYFGANAALDFNSGQPVPVDGSLLNTVEGCSSFSNA
DGELLFYVGAPSPTTNNLTIWNRNNEPMQNGVSIQGDASSSQAALTIPAPGNPNLYYLFV
VGAASSGNQGFWYYTIDMTKNNNLGDVVSGPRDLSDGLIDFWSEKVTAVRGKNCNEYWVI
SLVSNTFYSYKVNSSGVDYNNPIKSNISNFFNNDSRGYLKVSPNGTKIVAANMSAGSFLL
DFNDETGIVSNIKKLNVDGDGYGVEFSRNSERVYISTGQVSNSIENLFQFDLTQPSIDAI
NDSRYLVHSYNNARGALQLGPDGKIYWTSNGSERINVIKNPNELGANCDYSHRSVLITTP
GSGVTASQGLPPFISSLLLPVKVTETSSGNSINDEILQLCTGQNKEITSEKIVGSEITYE
WSFIKDTNSTIISTEPNLQLTNINLEDTGNYTLTVKLKDECDNFTQYTASFQIEVFESLT
ANKPNDINFCDSDNDGFNEFDLETTINSQVLNGQNALISNISYYNSFENAIDLVNPITLP
YKNPTAFSKETIYVRIHNNQAINTCFEITNFELNVYGEPIIQDPTEYRVCDNTSIGTDTD
GIVNDFILSNKNSEILGSLDPTKYSISYHTTLNGAQTSSLIDVIDKTTNYTNIKANSQPI
FVRVENNSSSTCFNASKSFNLEISPLPIINSKVELKQCDNDTDGFSNFNLYQAATSISTD
YQNESFTFYPTLADANAGSNAYSIDETTTFRNRTQNTDTVWARAKTSFGCYRISEVLLTV
STTGIPETFQYSFTECDDFLDSDGNYTISNSDTDGITNFDFSSVNEEVIKLFPIGQQITI
TYYRNESDALAEKDPIINTSKYRNIGYSTTQKIFIRVDSDLNNDCLGLGPHITLNVDTVP
KANSVQNLEECDNIKDGSTSNGIVQNFNLESQTATILGTQNPADFTVTYHDSAANANSGN
DPLSSPFTNSVRDLQTIYVRVTNNSTSCFTDHITFNLIVNPLPIANFVDDLNVCDNDIDN
SARNGFSSSIDLESQTSGILGTQDPKIYSVTYHNSLAEAQNGNSPLVSPYTNLTPYRETI
YVRVYNADAQCANGISNFDVIVNPEPTFETISNLSECDNNDDFDDANNIIQTIDLDGKIP
EILGASQDPDDFNVTFHSSKANATSGNLPISSPYENSSATETIYVRIQNKKTGCINDDAF
FDVIVNPLPDFTVTTPQILCLNNLPLNIFVENQKGTYEYVWKYQNGDTVSTEDNVNISVA
GTYTVTATTTNGTFCSRTETIVINESNIATLENSFITIIDESNNIGSESNLSIAINTIDN
DLGPGDYQFAIENTDENTRIPFAGFQDDPLFENLEGGIYKIIVNDKNGCSPDTTLLVSVI
QFPKFFTPNADGDNDTWIVRGVNKTFYPTSSINIFNRFGKLVAQLPIDSQSWDGTYGGKT
LSSDDYWFNVTLIPADTTKPTINKKGHFSLIRK
>FCMOIPGL_01046 hypothetical protein
MFRLLTIEFHKLKYNKASKVLSIIYFGLLTSIALIAAIKFEFGDFKLHLAEAGIFNFPYI
WHFNTYIAAILKFFLLLVIVSMMSNEYSYKTLKQNLIDGLSKKEFILSKFYTVITFALIS
TIFVFVVSLVLGLVYSDYNELAIIFSDLDYLLAFFIKLVGFFSFGLFLGILVKRSAFAVG
AMFIWLIAESMFKGYLYWVFKDAENTGDKVDGVMQFLPLESMTNLIKEPFSRLGAVRSAA
NTMGETFTKSYAVEFSTILIVSFWTFIFIYLSYALLKKRDL
>FCMOIPGL_01047 putative ABC transporter ATP-binding protein YxlF
METILSLKNLDKKYGKVHAVNNLSFDIQKGNVYGILGPNGSGKSTTLGIILNVVNRTSGE
FSWFKGQLSTHEALKKVGAIIERPNFYPYMTATQNLALICKIKGISTEKIDEKLATVNLF
ERRHSKFSTFSLGMKQRLAIASALLNDPEILILDEPTNGLDPQGIHEIRQIIKSIAANGT
TILLASHLLDEVEKVCSHVVVIRKGIKLYSGRVDEMTASNGLFELKVDEKEDELIKLLEN
HEAIGKITKDHETLITTLNNNISSAEINAYLFKNGVVLSHLVKRKPSLEQQFLDLTNNN
>FCMOIPGL_01048 hypothetical protein
MYKIRIILDTKEDVIRTILVDESINLEDLHTTIAASFGFEGHEMASFYRTDDEWNQGEEI
PLFNMAEAGEEISMQTCFVDEVLPQENSKLIYVYDFLKMWTFYVDVVEISSEKNENLPQT
ILSFGEMPEKEPKKEFVAEKLEDEFGDEDIDDFDDYDFNEY
>FCMOIPGL_01049 1,4-dihydroxy-2-naphthoyl-CoA hydrolase
MDKIKTLEILNNLNKNTLMETLNIEFVDVGTDYVTAKMPVNSKVHQPYGILHGGATAALA
ETVGSCASALFVDTKTKIVKGIELSINHVKSKKEGFVFGIAKPIHQGKTTHLWEIKIIDE
EDNLISICKLTNIILDKK
>FCMOIPGL_01050 Isochorismate synthase EntC
MKIFNNITAFYKEAKPFVVYRKPNSFTISGFFMRDETLFFTDNFAESGFVFAPFDSEQKA
ILFPFKKSEFITEKLSLDTFITDEKTFSADEASKENHIKLVEKTIKEIKKNDFKKVVISR
TEEVEISDFNLLEIYQKLLQNYSNAFAYVWFHPKVGLWLGATPETLLNIENSVFTTMSLA
GTQVYENTENVVWKNKELEEQQLVTDFIKNQLTDISSNLKIDKTETVKAGSLLHLKTKVT
GVLNEKSNLKTLVRALHPTPAVCGLPREKAKKFILENEYYKRSFYTGFLGELNIENSTVN
IQNSSLFVNLRCMNINKNKASLFIGGGITKDSNATKEWEETVSKSNVMKRVL
>FCMOIPGL_01051 hypothetical protein
MAERVEQEEIFSQVLRAGRRTYFFDVRATKADDYYLTVTESKKFTHDDGTFHYQKHKIYL
YKEDFTDFHQMLSKATDYILNEKGNEVISERHQKDFKKEETTEQTKSTDSFTDISFDDI
>FCMOIPGL_01052 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MKALQYLNKYFSKYKWRFLIGILITVLSKIIALKVPKLVGNSLNIVEDYLKGTTTDLDIV
KHELFINILLIIGVAFFSGFLTFLMRQTIIVTSRLIEFDLKNEIYQQYQKLSLNFYKNNR
TGDLMNRISEDVTKVRMYVGPSVMYTTNMIVLFAVCFAEMVKIDLKLTLYTLLPFPLLSF
SVFFLSKIIHKRSTIVQQNLSKLTTFTQELFSGIDVVKSYGIEKSMTKDFDKISNDNKEK
NIHLEKANALFFPSIVLLIGISNIIVVYVGGLQYINGTIKSGTILEFLLYVNYLTWPVAI
VGWVTSMIQQADASQARINEFLNQVPEIKNENDSHTDIYGKITFKDVTFTYDDTDITALK
NINFTVNPGETLAILGKTGSGKSTIIELITRLYDTQKGIILLDDKPIKEANLYDVRRQIG
FVPQDPFLFSDTIENNIKFGKEDATEQEIIEAAKNAVVHDNIIDFANGYKTILGERGVTL
SGGQKQRVSIARAIIKNPKILIFDDCLSAVDTETEEKILSNLEKVSKNKTTLIISHRVSS
AKNADKIIVLDAGKIIQQGTHNQLITVSGYYKDLYDQQLLEKEM
>FCMOIPGL_01053 N utilization substance protein B 
MINRRHIRVKVMQSVYAMQQSNNDDIIREDKFLKHSILKMFDLYVLNIQLLVEVQKLAAK
RIALSKKKILVTKEELNPNTKFLDNKVINAIAESISVESYIEMNNLNNWELDSEYVKIIL
DELQKSDLYNKYLNTKESSFKLDKAFVVDFFKEIIAPNEKLAEYYEDKMISWVDDIPFVN
TWVVKSLSKFKEIGIFVVGSLYKDKDDEDFVSALFKKTVLKQQTYEQDITDKTPNWETDR
IADIDMILIKMAITEFISFPSIPTRVTINEYIEIAKDYSTEKSSYFINGVLDKISKEFIN
NKRIVKIGRGLL
>FCMOIPGL_01054 hypothetical protein
MRKITILLAFVLSASFFTACKNADNAAKKINKENVDNAKSRDLEIKKGVASISFDKSEFD
FGTVNEGDIVETVFKVTNTGKTDLVITNAQATCGCTIPVWPKGAIKPGETGDVQVKFNTN
GKPNRQQKTVTLTTNTEAGREMLTIKGMVTPKSK
>FCMOIPGL_01055 hypothetical protein
MFSTIGLQFDTGSLASMLPFVAMIGVLYFFMIRPQMNRQKKEKAFQAEIKKGTKVVTSSG
IHGKIVEINNTDNTVTIETGAGKIKFERSAISMELSKKYLAPAIK
>FCMOIPGL_01056 hypothetical protein
MKTTQKIPKTFIGFLIASFFIWLLITFSKEYSTVITCPVNYINIQQDKLLQETPIKQIDI
AVKSSGFKLLRSKIYNKTINLESSVLQRKKGSKYYLLVKNQFTKIQKQLKSGIQLQEILQ
DTIYLNLGLLKSKKVVLKPDLDIKYQIGYALLGDIKVVPDSIVISGPEDQLKKITSLNLK
KITLNDLKENFSEEVQIVEQTKGKNLKFSTAKATVSGNVERFTEGRLKIPFITKNLPDHI
NLTTLSDNVEVVFIVALSNFTKVSEASFTVECDFEISEKNNLSYLIPKVTTKPDFIKSFK
IVPTKIDFLIQK
>FCMOIPGL_01057 Dephospho-CoA kinase
MIVGLTGGIGSGKTTVANLFFKFKNVAIYIADVEAKKLMNSSEVIKEKLIKEFGDQAFVN
QKLNRKYISEIVFNDAKRLATLNAIVHPEVKKHFKDFVNKNLDKTYIIYENAILFESKSN
LFCNFIITVYADISTKIKRVTLRDTSTKEEVLSRMKNQWKDDKKLLQSNYIICNENLDDS
KKQVNYIHNILTEKYRYL
>FCMOIPGL_01058 Sensor protein kinase WalK
MGKKMFVLIVVLMSFSLIGIIAVQLYWINNAVESKKEQFKNDVQKSLGSVTEKINEKERS
LFDKKFEGILESAVLANKAQIKSLFFQEIDTTNHQKISFGSTILEENIEIPTEFLSNDSV
IFKRVTGKKDFFQSKLIKGPDNLFSATDEKSYSYTKRLTNIEKSQFSEWFKDYNRINPIH
KRLSNRELNETIKEELKKRNIDLDFKYGVYGRDGLAINLKSGYYTINKKDSYSFPLFFDS
NDEPEYLLYITFPTKNDHILSGLSNILLLSLFFIFIIIVAFSSSLYQLLQQKKISEIKTD
FINNMTHEFKTPIATINLALDSIRNPKILNDEEKVLRYVQMIRDENKRMHTQVENVLRIS
RLEKNQLELSKDIVDVHEIIEDAISHVSLLINNKNGIVETHFEAITTEISGNEFHLTNVI
VNMLENAIKYSSEKSPKIDVYTESTNKFFIFKIKDNGIGMTKSVQKLVFDKFYREQKGNI
HDVKGHGLGLAYVKEIVEKHHGTVFVESEKGEGSIFTVKLPLI
>FCMOIPGL_01059 Response regulator MprA
MGSKKILLVEDDPNFGTVLKDYLALNDYNVTHAKDGIEGLIMFKNSDYDLCILDVMMPRK
DGFSLAQDIRVTNKEVPIIFLTAKTLKEDVLKGYAVGADDYLNKPFDSEVLLHKIKAILQ
RKDSDQSKESEEFEFNIGSLFFNSKLRHLSDGKDGEPVKLSPKESKLLRMLAIHKNDLMP
RELALTKIWRDDNYFTSRSMDVYIAKLRKYLKADENVEILNIHGEGFRLVDKT
>FCMOIPGL_01060 Threonylcarbamoyl-AMP synthase
MAEFVKLYNDNPNQRQIDKVVKILKKGGLIIYPTDTVYGLGCDITNTKALEKIAQMKGIK
LDKANFSFVCNDLSHLSDYVKQIDSPTFKLLKRALPGPYTFILPGSNNLPKSFKNKKTVG
IRIPDNNIARALVTSLGNPIVSTSIRDDDDVLEYTTDPELIFEKWNHLVDVVIDGGYGDN
YASTIIDLTDDYPEVIREGKGSLDIL
>FCMOIPGL_01061 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MKTAIVILNWNGKKLLEQFLPSIVKFSSDEAEIYVADNASDDDSISYIKNAFPSVKIVKN
IENGGYAQGYNDALKKIDADIYCLINSDVEVTQNWLSPILDVFKSDENTAIIQPKILDFK
DKTKFEYAGAAGGFIDLYGYPYCRGRVFNDLEKDSNQYNDISEIFWASGACLFIRSKIYC
KLNGFDEDYFAHQEEIDLCWRTQNIGYKVKYVGSSTVYHVGGATLQETNPQKTFLNFRNS
LLNVVKNVPKKWFLFVVFSRLLLDGIAGIKFILELRPIHTWAIVKAHFSFYKNFFKFLKK
RKVLQKKSDYNLHTSIVWQYFVMGRKKFTDLK
>FCMOIPGL_01062 hypothetical protein
MVLTPEEWVRQHYVSFLIEEKNYPTSLIALEKQLTINNRKKRTDILVFNTDGNPEIIVEC
KAPSIKITQDTFDQIARYNLKLKANFLIVTNGLEHFYCKMDFENETYIFLKEIPDYK
>FCMOIPGL_01063 hypothetical protein
MNEIRNIVSDIKNGNLKPIYFLMGDEPYYIDKISDYIEENVLDEAEKGFNQQIMYGRDAS
VEDIVSSAKRYPMMAERQVLIIKEAQDLSRSIEKLLSYAENPQPTTVLVINYKYKKLDKR
KKLHKAIVKSGLIYESKKLYENQVSDWIRRVLSGKKYQIEPKASQMLVEFLGTDLSKISN
ELDKLMIILPKETIIDDKHIEDNIGISKDFNNFELRKAVGEKNVLKSNRIINYFSENPKN
NPTVMTISLLNSFFTQLLLFHGLKDKSKNSVARALGVNPYFVDEYFLAGRNYPMRKVAQV
IAFLRDADVKSKGVGANLTQEDILKELLFKILH
>FCMOIPGL_01064 hypothetical protein
MKNIFTKEVVDEIVKRINNLSPNTQANWGKMSVSQMLAHCCVTYEMVYTDKHPKPNAFVK
MMLKMFVKKTVVSDKTYSKNSRTAPQFIISDEREFEKEKKRLIDFINKTQKLGEKYFDGK
ESHSFGKLTITEWNNSFYKHLDHHLTQFKV
>FCMOIPGL_01065 hypothetical protein
MKKYFSNKTIEDYNLKNSFIDIYQKAVIAICFLVSLTVMLGWFLDIRFLLSILPESATMK
FNTALIFFIAGINLVILRANNKSFKKVYNFLAVTTIIIGVITFIEYFDISSFKFDNVFVE
DNYSLENPGRMSPATALCSILLGLGFLGNSSKIKIIKKLSEDTVLFVALISLIALVSYFL
MIPLEKRTYFFQSMAFHTSIVFFIISILLILNNNSLYIINLAKGKSESNKFFRKLLPKII
YFPIALGSVLLVAINLDLVNSTFGISSFILILIFINIIYISHISKNYDVSNIKENVSKNT
NKKDLQ
>FCMOIPGL_01066 Nitrogen fixation regulatory protein
MNSPQTLVKMNHIKKTANKLIIISCVFFSLAVIISWFTKSEEILYFFTSGATMKFNTALI
FLLLGINLFIFDKKEEIYKSLYKLFSTITILLGLFTLVEYGGFTFFEIDNLFIKDSFSKV
NPGRMSPATAICSILIGISFLTCKTNNDLLIQFGKSTKVLVTIISFISIISYILIIPSEN
KSFIFRTMAIHTSVLFFAISLLLMFKRENSIFNSLFFDKSIGSNIFRKSLPLIILIPAVI
ANAILLAINQKWLSIDFGLVTFTIILTPICIIYLSKLSINLNLIDTKRQLLENNLKLKNK
NLVEFNEALDYTAIFSITNIDGKIKYANDSFCEISKYSREELIGSSHTLLNSGYHDNNFF
KNLWQTIISGKIWTGDIKNKSKDGSFYTVNTTIIPIKNSSGNISDFLEINNKFTISS
>FCMOIPGL_01067 Long-chain-fatty-acid--CoA ligase FadD15
MPTEITRLFDFPNYQLETYNLKKALSTKYNGKWKSISSQEYVDKSNQFSRGLLKLGIKPN
DKIAIISTSNRTEWNICDIGVLQTGAQTVPIYPTISKEDYEYVLNHSESIYCFVSDVTIL
EKLNQIKSKTKLIKVFTFDDIKGENSWNEILTLGEDTSNQNEVEERKNAVKTDDLATLIY
TSGTTGRPKGVMLSHKNIVSNVISSTKRVPLEYGNSKALSFLPVCHIFERMILYLYQYCG
VDIYYAESIEKLSENAQEIKPEVMTAVPRLYEKIYDKIVLKGEDLKGIKRNLFFWALNLG
LKYEPYGANGWWYEKQLSIARKLIFTKWQAALGGQLKLMVSGSAALQPRLTRVFAAAGMP
IMEGYGLTETSPVISVNDVNNGGFRVGTVGKVIEGVEVIIADSGEILVKGPNVMQGYYKD
PEKTATALKNGYFYTGDKGELDKDGFLKITGRTKEMFKTSGGKYVIPPLLEGDLKQSLFI
EQVMVIGENEKMPAAIIQPNFEFIREWIHHKNYTIGTSNEEIVTSDIVIKRIQQEVDKYN
KNFGKWEQIKRFELTADEWTIESGHLTPTMKMKRVIILKIYENLYNKIYR
>FCMOIPGL_01068 hypothetical protein
MKNKITFIFFLFLATTFSFAQKTIEATNILKDIKAGKSVSYKNATIVGVLDLTYMDDAMK
KLPNKKKSSWWSSGNSSNEIKKIIDVKVSFINCTFKNDVLAYIPDEDSGYTFTASFEEDV
IFKNCNFERKAMFKYSRFERNTDFSGTSFNDDSTFKYAKFDNSINFSNTKFDEIATFKYA
NFSKNVSFADADFKDSAIFKYTKFNNGVSFKNTNFKEDLNIKYMKVSGDFNITNMKVSYE
IDSKYTKINGKSFDKYLLETR
>FCMOIPGL_01069 hypothetical protein
MEFITLDSHTKNPLIDYFYQFKITEKDLPFETLILPVGSSNIAYNFCEEDILFTHKKNKS
FYNKLTLIGQFYGSYEILINKVNYNVGFDLKPTSLYKIIDKDVSFVTNKQKQLKDFHFEL
YEKLNPLFLKYKDDITKLIESINNEFDQLTLSKDKNIEHIDKAIAIIIKNEGIIKVTDLL
KEVPFSQKSLEIQFKKIIGVTPGKYIRQYRFMNLMRKYVSKQIEIRDLIFQSNYYDKSHF
EKDFKLFMNQSSKKFFHEDYPLLRKILKES
>FCMOIPGL_01070 hypothetical protein
MKLKLIVLLIFSITINSNLKAQKTIKLSKDFDKVIVSPHIEAVFKKGNEPSIVIEDINVP
DEKFNYELEKGTLQVYLKGAKTYTKNKKVVIRNSEMKVPLYKGRVVKLIITYVDVNTFSL
RGEEKITFQTPLNQDQCKLLIYGKSEVTINKIKVDKLTVSIYGDSFLKMDNGNINKQKIT
AYGASKVMASDVITEETKLTAYGDGTFTFNVSKKIKVTSYGEATVLYKGDASLKKGIVIG
ESTIRKVQ
>FCMOIPGL_01071 hypothetical protein
MKIPEKYKFIVELGKALHTYGIPSYKIQSYLTEVAKTQGITGSFMDSPTWINYVFYEDEN
SYNYIECIPPGSLNLGALSRIAELTNKVIDYKIDNEQINEELNIIHAKTKLTNHYQLTLA
YAFSAGSFSILIGTNWISFAFSLLLGAFIYLLVYLSSKSKYLVNVFESLSALIVTIICCL
LTLIFPNFNLGLTILASIIIFIPGLAITTALEEITSKNLVSGGAKLFDSIILLFKQFFGV
LLGLALMTSLIDIDLTYHVSEMPKWTIFFAVPVLSITLLPIFQVRKKDMIFGVLTGVIAF
FMTVLLSGYGVLVSTFIGTLTVVGVSRLFGFISKTPKTVFLIQGIVMLVPGSKSFMGLSN
SFFNPNTTTGSGNLFEQVAFILMGIIGGLLFAGTFRERSPKKYKLETKK
>FCMOIPGL_01072 Phosphoribosylformylglycinamidine synthase
MIHFFGNKSSKVYAVQTTKELTAETIAKLTWLFANQPKIEETSIDAFFVGPRAAMITPWS
TNAVEITQNMGISNIIRIEEFTTVSEDFSDFDPMISEKFNGLHQDSFTIEIQPEAILEIE
DIAAYNNQEGLSLSDEEVEYLEGVATKLGRKLTDSEVFGFSQVNSEHCRHKIFGGTFIID
GEEQPTSLFNMIKETSKQCPNDIVSAYKDNVAFVKGPKVEQFAPKTADKPDFYQTQDFES
VISLKAETHNFPTTVEPFNGAATGSGGEIRDRLAGGKGSLPLAGTAVYMTSYSRLEASID
AVKNTRYWENKFEARDWLYQTPMDILIKASNGASDFGNKFGQPLITGSVLTFEHEENSSV
SDSSARKLGYDKVIMQAGGIGYGKADQALKDTPKEGDKIVILGGENYRIGMGGAAVSSAD
TGEFASGIELNAVQRSNPEMQKRAANAVRGMVESDENFIVSIHDHGAGGHLNCLSELVED
TGGKIDLDALPVGDPTLSAKEIIGNESQERMGLVIADKHLETLHKIADRERSPIYDVGVV
TGDDRFTFESKSTGVKPMDLALEDMFGSSPKTVLTDKTVIRKYKNPRYKTKNLEIYLKQV
LQLEAVACKDWLTNKVDRCVGGKVAKQQCVGPLQIPLNNVGVMALDFKGKEGVATSIGHS
PISALISPEAGSRNAITESLTNIIWAPLKDNLKSVSLSANWMWPCKNEGEDARLYKAVKA
VSEFSIGLGINVPTGKDSLSMKQKYTDGEVIAPGTVIISAAGNCNAITKVVEPLLQVDGG
NIYYINISQDEFKLGGSSFNQTLNAIGNEAPDVTNVNYVKTVFNTIQDLITADKITAGHD
VASGGLITTLLEMCFADVNLGADFDISSLHEEDSIKVLFAENSGIVFQADASVETILSEN
NIEFFNIGSANNSGTVTIKNNEDNFSFDVTEMRDVWYRTSFLLDLKQTANNLAQDRFDNF
KNQPLTYKFPENFTGKLPVIGKEKPKAAIIREKGSNSEREMANAMYLAGFDVKDVHMTDL
ISGRETLEDIQFIGAVGGFSNSDVLGSAKGWAGAFKYNEKANTALKNFFKREDTLSVGIC
NGAQLWMELDLINPEHKVHGKLGHNDSMKHESSFTSVKIQENNSVMLSSLAGTELGVWIS
HGEGKFNLPESEENYNIVAKYGYAGYPNNPNGSNFNTAMLCDPSGRHLVTMPHIERSTFQ
WNWANYPANRKDEVTPWLEAFVNAKNWLTK
>FCMOIPGL_01073 Extracellular ribonuclease
MKKTLFLFTLFISLFVSAQEQYYNGLDWTKSGLDLKDELATKTINAHTNILSYGWDAIKA
TDVNPENSSEVLLIYGYSASGTTARTRGINENGGGSNEWNREHTYAKSLGNPNLGTSGPG
ADTHHLRASDVSFNSQRGSLKFADGTGNAGSVSGGWYPGDEWKGDIARMMMYMYIRYGDR
CTPNGVGIGNNANAGDDMIDLFLEWNAEDPVSDFERQRNTYHDSNANFAQGNRNPFIDNA
YLATRIWGGTPAADTWGIFTSNDSEAPTAPTNVSLSNITTSTINVSWTASTDNEEVSKYE
IYANDILKGETANTNYTLTDLNSNTLYAVTVLAKDVANNESAKSSVVNATTLTDTTAPSV
PTNITITNQTGTSFKVNWSASTDDSAVTGYDIYVNGTLNSSNIANTSYTVTGLTISTTYS
VTVLAKDSANNMSAQSAAINATTTDGSNNVVELFFSEYVEGALNNKALEIVNLTDNPIDL
SEYSIKKQSNGAGSWINELPLSGTINVNDVFVVIHFEADNATLVNEADLVAPEGSNWGAP
INFNGNDPVGLFKNGVLIDIIGEYNQTAKNLENMTLRRKLIITKANTTFTITEWDQFASE
TYDGIGIYNAATANTNTSDFDTFKMYPNPVENKLYFNTTKDVKVSVYTVLGKLVQSSEIT
STKKNIDVSNLSSGIYIIKIDNGNQFITKKLMKN
>FCMOIPGL_01074 Extracellular ribonuclease
MIKKLLLLIAITTCSLTFSQEQYYFNVDLTLTGLQLKDELATKIIATHTRVLDYTSNNGP
DVWDACKATDENTSNTDEVVLFYGWEEGRDQDDTNDRTRDKDLQDAGGGDAFVWNREHVF
PKSLANPVLDTDIPGPSTDAHHLRAADRIRNSTRNNRKYGRGSGNSDFSSIDFFNGLSGP
NTAAWYPGDEWKGDAARMIMYMYVRYGDVCLPSAVGVGSSEFTPDDMIDLFLTWNAEDPV
SDIEIARNNYHEDTRNYAAQGNRNPFIDNPYLATRIWGGTTAEDRWGLYSGSDTEAPTTP
TNVTLSNINLTSIDISWTASTDNVQVSGYNVYVNDVLTAQTSNTSTTINNLNTNTTYSFT
VTARDIINNISEASTAVNGTTLQDTEAPTTPTNIVISNTSDSSFKVSWSASTDNNAVAGY
EVYIDGNLIASTTDLFYTVTGLNTSTTYAVEVLAKDIDNNKSSKSATVNTTTTDGSSNGV
TELFISEYVEPNTAAGGNNKVIEIVNLSSATISLAGYSIQKQSNGGSWVNDFKLDTGDVT
SIIPNDVFVITHADASNEILLAERDLVGPPNNDTNNFGSPFNFNGNDPVGLFKNGVLIDI
IGEEGNSSDHIKDKTYRRKSNISVPNSTFTLSEWDALDITYDGIGSHTSTLSTQTNVFQS
FKMFPNPANGNNVYFSVTEDAIISVYNVLGKLIQSTEVTKSKNNIDISNLSKGVYLLKIN
SGKQFITKKLIKN
>FCMOIPGL_01075 Ribosomal RNA small subunit methyltransferase B
MRLHRNLTFAVIDSIRDIFNEGVYADKAVEKALKRDKRWGARDRKFVAETIYDIVRWNRL
YAEIAEVKAPYDRDNIWRLFSVWCILRGIKLPDWNQIGDVPERRIKGRFAELSRTRKYRE
SIPDWMDELCLSELGEEVWTKEIAALNEQAKVILRTNTLNISREALQKKLQAEDVITELV
PNHPDALVLPERANVFKTEAFHNGLFEVQDASSQLVAAYLDVKPGMKVVDTCAGAGGKTL
HLSALMENKGQIIAMDIYESKLRKLKVRAKRNKAHNIDMRVIDSTKPIKKLHGKADRVLI
DAPCSGLGVIRRNPDSKWKLQPEFIENIKKVQQDVLQQYSKMVKPGGKMVYATCSILPSE
NQEQVKNFLTSESGKDFTFVSDKKVLAHISGFDGFYMALLEKK
>FCMOIPGL_01076 ATP-dependent DNA helicase RecG
MNLNYPITYIKGVSVQRAALLYTELGIKTCNDLLNFFPFRYIDKTAFYAIKELQPNSSEV
QIVGKITSIKSVAQKRGSRLVATFQDATGSMELVWFKGQKWIKDALKPNEPYVVYGKLNH
YNGSFSIPHPEMELVTEYKKKLQTKMQPVYPSTEKLTNSGVSNKMIRTYIQNLLQQFFDV
IQESLSKEIIDDFKLMHKRDAYLNVHFPKSQENLAKAEFRLKFEELFFIQLQLLRKKLIN
KTKIKGFIFENVSDYFNEFYTHHLPFDLTNAQKRVLREIRKDVGSGAHMNRLLQGDVGSG
KTIVALLTMLLAIDNGFQATIMAPTEILATQHYHAISEMLKDMDLNVDLLTGSVRAKKRR
EIHANLEDGTLHILIGTHALLEDKVQFQNLGIAIIDEQHRFGVKQRSQLWKKGGRSPSQQ
GDEIRNRYETARPSVYKLMKELQKNRKQQTTPAEQILWEQLKTKQLEFKFRRQHIVDEFI
VDFICISKCLIIEVDGKYHNTKEQQEADDLRTNILQDLGFKVIRFTNEEVIGNIENVLNK
ISKELKDVPQEEENKSKNSLPSGGLGWASLPPHILVMTATPIPRTLAMSVYGDLDISVID
ELPPGRKEIKTVHRFDSNRLAVFKFMRDEIEKGRQVYIVYPLIEESEAMDYKDLMDGYES
VSRDFPSPKYQISIVHGKMKPADKEFEMQRFVNGETQIMVATTVIEVGVNVPNASVMIIE
SSERFGLSQLHQLRGRVGRGADQSYCILLSSYKLSEEGKTRLKTMVETSDGFKIAEVDLK
LRGPGNLMGTQQSGVLNLKIADVVKDSKILVNARNTAIAVLQEDSNLSKPENANIKKTYV
EVSKNSKIWSEIS
>FCMOIPGL_01077 Quaternary ammonium compound-resistance protein SugE
MNWIILIIAGLFEVAFATCLGKAKESTGTEATYWYVGFLICLSISMVLLLKATEELPIGT
AYAVWTGIGAIGTVLLGIFIFEEPATFWRLFFISTLIISIIGLKIVSH
>FCMOIPGL_01078 ECF RNA polymerase sigma factor SigW
MQLYNLYCKAMFLVAFRYVKDRFMAEDVMQDAFIKAFKNIHNYNNEVAFGAWLKRIVINQ
SIDELKKNKLELVSINEEVIVKSVEDDWNIDCDISIDRIVEVINGLKEKYRLVLTLYLLE
GYDHNEISKILNITSNTSRTHLLRGKNLLKEELKNTSYAARY
>FCMOIPGL_01079 hypothetical protein
MQQDIRKLLKDYKAENIELPLNHSSKFQDLLEKEMHQHTSKKKNFKWLSVVASVMLIICL
ATKFYPTKKIDAPVKNESKEISLGSISPEFETIETYYNNSISLKISELEMTDQNKEIIDG
YLLKIGELTKEYKSLTKELNTNGVNDSIIDALISNLQLRLQLLKRLQKQLKRVKNLNTKQ
NESQIL
>FCMOIPGL_01080 hypothetical protein
MNHKYYKSVITLFALCFLGTTFAQKFDKKITENFKVNKDVEVVINTSNAAINVTTWKKNE
VQVQAFLEVEGLSKEAAEKYFKNENFEALGNSGKVKISLGNNSSNLRNDFLIFNDMDFTL
PDIQMPDFDSIVLPEVNFDFDFDFDFENILEDLDDLDENMEKNGKYSFDWNDGVEKISIK
SKKEWEAFKKSKKYQELKDKMSIEKEKLRKNFAESKEKMKIGLEKAKLKYEKIDKAEIKR
SLAKAKKQIMEMKLNHSSNSGNITFNGKKIIIKKRLEIKVPENATFNLNTRHCKVKLPNT
KAFGKVSYGNFNANNLNGGKLTIDYSKVLINNLNKSNLFLNNVTDAKITSVTNTTLSNNS
SSLKIMNVNENVKIIDRFGELTIENIKPKYETFKLTLDNSEAKLNLSVANSKLKLSASNI
IIPEKTTTNKKVSIFNGFVNTIDNDTFIIEGKNSKLTIIRDIL
>FCMOIPGL_01081 Cysteine--tRNA ligase
MELYKENKLKVYNSLSKQKEDFKTITDGYVGMYVCGPTVYSNAHLGNVRTFMFFDVVYRY
LLHLGYKVRYVRNITDAGHLENDADEGEDKIALKARLEQIEPMEVVQRYTVDFHDVLKNY
NFLPPSIEPTATGHIVEQIEMIKEIIDKGFGYEVNGSVYFDVHEYNKKENYGILSGRKVE
DLLNNTRTLDGQSDKKNPQDFALWKKADEKHIMRWPSPWSDGFPGWHLECSVMSTKYLGE
SFDIHGGGMDLKFPHHECEIAQSKTCSGVKPVNYWMHTNMLSLNGQRMSKSTGNFILPNE
ILSGENNVLPKAFSASVVRFFNMQANYRSILDFSGEALEASEKGHAKLMEAINFLDKIEA
AKTSTFDVQKWKTACYAAMNDDFNTPMLIAHLFDAVKVINQIKEQKASLTADDLSELKTT
INAFVFDVLGLMNENSQDNSEKIKGVVELLIKLRKEARENKDWALSDQIRDELIALGIQL
KDGKEGTTFSIN
>FCMOIPGL_01082 Putative membrane protein insertion efficiency factor
MKKILSFPFILLVRFYQAAISPYTPSTCRYSPTCSHYTIEALQKHGLFSGGWLALKRIFS
CHPWGGSGYDPVPEKLE
>FCMOIPGL_01083 Prolipoprotein diacylglyceryl transferase
MSFLAIEWNPSLGIDLGFFVVRWYSLMFVTAFLLGLHLMKKIYIKDEIPVEKLDTLFMYT
FISMLIGMRLGDVFFYSWDYYQNHLLEIIIPFKQVNGTWKFTGFTGFASHGAAISIIITM
YFYAKKHLNKPWLFILDRLAIMVALAGFFIRMGNFFNSEIYGKETGSNFGVIFKANGEDF
ARHPTQLYEAFSYLALFFVLWYLYWKTDKKQQIGYLFGLFMVVLWSLRFVIEFLKVEQTE
GREDAFFNLLNTGQVLSIPLILIGLWLMFKKTKKAA
>FCMOIPGL_01084 hypothetical protein
MVDVQKNKKSSIGLIEKLKQRWNIESNWSIIAILLVFSINGSFAAWVAKPITSFFGLSLE
TVSPFIFWPLRILLIFPIYQLTLPIVGWLFGQFRFFWAFEKKFLSRLGLGFLFKESN
>FCMOIPGL_01085 hypothetical protein
MNKKYKKLILSIVLDAIGFITIIPVDVVWAPISGYIMSKMYKGNKGKIAGVISFLEEIIP
GIDVIPTFTIMWVYTYLINKEDKNNQEETIIDV
>FCMOIPGL_01086 putative Nudix hydrolase NudL
MNFKNFTQKIEELKRKELGGLEAQFKLAPKLRLRYDKDKIAAKKPRKAAVLVLFYPNEEN
ETCFLLTQRASYKGTHSAQISFPGGKIEKTDKNLEQTALRETLEEVGVLPSSVEIIRELT
DVYIPPSNFLATPFLGFVSERPKFILNHEVAVEIEALVSDLLDDATLSSVILDTSYMKKI
EVPCFKINNHIVWGATGMMLSEIKELLK
>FCMOIPGL_01087 hypothetical protein
MPLFKRNPFGHYLFLKKWLIRILGIVSHGRYRKFNDLHIEGSEIIRNLPDKNVLFISNHQ
TYFADVAAMFHVFNAALKGRDDTIKNIGYIWDPKLNVYFVAAGETMRAGLLPKIFAYAGS
VSIDRTWRSKGKDINRRVKNSDISNIGKAIKDGWVITFPQGTTTPFKPIRRGTAHIIKTF
KPVVVPIVIDGFRRSFDKKGLRIKRKNVLQTMVIKEPLEIDYENEEVADIITKIEYAIEQ
HPSFLKVLSVKELEELQNEEEELNEQRKFWRS
>FCMOIPGL_01088 hypothetical protein
MLNIIGMFYFPFRKYFKNELIEFLSILIKKYNNTKGLKLKY
>FCMOIPGL_01089 hypothetical protein
MKKISLLVFSLFFVVAASLAQEKKEAKETQQGHTDQNKFRQMKDVLATPNDQHTASGAPG
HQYTQQKVDYVMDIRLEESTNKIYGDEKITYHNNSKDNLDYLWIQLDQNMRADDSKTPLA
SSNAASAFLTPDKFKSSFMKEGKGFGFNIEKVESNGKPLSHFINSTMMRINLPKALAPGE
TFKFSIKWNYKINDINKDGGRSGLESFPDGNNNYTIAQFFPRLCVYDNVQGWQNMQFWGR
SEFALEFGDYEVNLTVPADHIVDATGVLQNEKDVLTKEQRNRWAKARKSYKDPVIIVTQK
EAEIAEKGRSTKTKTWKFKAEQVRDFAFATSRKYIWDAMATNINGKTVMAVSLYPKEGNP
LWEEHSTRAVAHTLVEYSKLTFDYPYPKAISVHSERQGMEYPMICFNFGRPDEDGTYSDR
TKKGMLGVIIHEVGHNFFPMIVNSDERQWTWMDEGLNSFVEILAELTYDPELFATNPANE
ITRYMGGSQDNISPIMSQGDYVKQFGPNAYSKPAAGLYMLRQTIMGPELFDHAFRTYSKR
WMFKHPTPEDFFRTMEDASSMDLDWFFRGWFYTTDVTDLGIKEVKPLYLTDKPSERVAKL
KEQYKQYFEGLGDLVYITDKKEDANPKAMENHADGKEVPSFIYSVEFEKPGGLVMPIIVE
LTYADGTTEKQTFPAQIWMRNDTSVKRVFASTQEITKITVDPDLETADVNTTNNSWPKKE
SDKFDQFKEKVKN
>FCMOIPGL_01090 hypothetical protein
MKKIGILLLSFVFVANTFAQKRQVQQGHTNQNKFKQLKDEFSTPNDQRTASGAPGKNYTQ
QKVDYVMDIVLDDEKQKITGAETITYHNNSTDDLAYLWLQLDQNMRAADSKSPDIQTDNV
PTKISKARFDKNFSDETFDGGFKIMSVTNINGSNLSYTINQTMMRINLPKPLVAGATFKF
NVKWWYNINNHRTDGGRSGFEHFDDGNNNYVIAQFYPRLCVYDNVEGWQNDQFWGRSEFA
LEFGDFTVNITTPEDHMLGATGILKNESDVLTKKEQKRLATARKTFDNPVVIRTQEEAEK
IEKGHSKKTKTWKFFAENVRDYAFATSRKFIWDAMAVDINGKTVMAYSLYSKEANPLYGD
HSTRAVAQTLKTYSKYTFDYPYHKAISVDGQMGMEYPQICFNPGRPAADGTYSDRTKYRM
IGVTIHEVGHNFFPMIVNSDERQWTWMDEGLNSYMQMLAMMDYEEGYPLGRGLPKNIVRY
MSGDQSKISPIMSKGDNVHSFGNNAYGKPATALWILRETIMGKELFDHAFRTYSQRWMFK
HPSPEDFFRTMEDASGVDLDWFWRGWFYTTDVTDIGLKNVKKFYSTQNDNIVEFTEDTSE
GLGFSNKHKKYHYEITYNKPGGLVMPIIVEFTYKDGTKERKTYPAQIWRLNDNEITKVFS
SSKEIENIAIDPDLETADVDISNNNWPQEKADKFDKFKNKIKG
>FCMOIPGL_01091 hypothetical protein
MKLNKTFLLLLIIPLLSFSAHKYYLSLTQINYKPEAKSVQIIINVFMDDIETALNKDYSI
DLRLDTKKELKDNDVYFKKYLKEKLKFKIDGVAKEFIFIGKEYESDLVYFYLEIENINEL
KTIEVTNKLLIEHFPQQQNLTKCKLGKKHKSVLLTKQENSAKFSY
>FCMOIPGL_01092 hypothetical protein
MIKKILFTSLFFISFINSFSQEKNKIISGKVSDSLGIVKNANIINLNTRQGTFSSDDGLF
RIFVSEGDSLKISSIQHIPKIIFITKKIIQQKNIQVLLKSNIYTLNEFELKRHNLSGRLG
IDTKVVPINKKDSLLGEVMDFSNINFKEKDLTIDANTRAKPPVNDVDPISRLAGAGAKAV
IPFKYSERFKALRKELELKKAFPNKILSELGDKFFFDELKIPVERYFHFLEYCNPLGIEN
LHKEGKILELIKILRTESVPYHEIIKND
>FCMOIPGL_01093 hypothetical protein
MKNQLIPIFLFFVVITYSQEKRKIISGKIILNTAIVSDVHIINKNTKQGTITRDDNWFEI
PVSIGDSLQFTHVNLKEKHIVITKEIFKNRTLEVELEEKTYSLNEITLEKPKSIFYEDPE
IIPPKTVNAETLKLPYANTKAKKDLSVFKFRSGGVVSLDNLINSLNGNNKRKKELKKITL
EDNALEKIRKYFTDDFFITDLQIKKEHINPFLNYCYKKNIITYFNRSENITVTEILMNES
KTFSQKISTDTLIVSKK
>FCMOIPGL_01094 Peptidase E
MIASTSTIHGSGYLEYLMPTLAVFFADVKSLLFIPYARPSGISYNEYTKIAQKAFEKIEI
DVKGIHEFKNSKEAIQKAEAIFTGGGNTFELVNQLYKNDVITTLKQVLENGTPYLGTSAG
SNICGVNMMNTNDMPIVYPPSFTTLGMIPFNINAHYLDPIKDSTHMGETRETRIKEFHVF
NKTTVLGLREGSWLEVLGDIISLKGNYTARLFQKNENAKELEIGVLNIK
>FCMOIPGL_01095 hypothetical protein
MKKLSLFNKLVYIVNSLIATLLLLSFLLPYISPKTIPVFAILSLFVPFLIIINFVFVLYW
LLQFKKQLLLSLIILVIGWLFITPFFKMTEHNSSLNDDVKVMSYNVRMFNHWQWIDDENI
SKKINAFITEKSPDILLFQEYYSLEKQQFNYPYKYIKTKNKKDKIGLAIYSKFPIINSGS
LNLEHTSNNIIFADVLRKKDTIRVYNLHLQSLELNTKMENFGQANPEKLVARLKERFKQQ
AEQTEIFLAHEKGFKGKKIVAGDFNNTCYSWVYNQIAKNKKDTFVEAGIGFGKTYNYWFP
MRIDFILTDENATVNKFTSFSEKNSDHFPIIAKINW
>FCMOIPGL_01096 hypothetical protein
MSFIDNLKNRYSNGNIVDKLIYINIAIFVLTLVISTLQGLYKGDINWLVEWFSLDDDYSS
LLKKPWSIITYGFLHADFLHILMNLIVLHFIGNLFVEYFTQKQLLSFYILGTFFGGLLFI
FSQNYFPLFEGQSSLLVGASAGISAIFIGIATYMPNYQLKLRFIGFVKLWHLAAIWIALD
VIALVGDNAGGHFAHLGGSLFGFLYVTKASNKEINLFNGILSIFKTKRKPLKTVYKSPKK
TTSTTKNTDLTQQQIDAILDKISKSGYDTLTKKEKEFLFRQGKK
>FCMOIPGL_01097 Rhomboid protease AarA
MNNITDAIKHLIIINVIVFVAPQLLQLDFTNILALHFPMNEHFGIWQYVTHMFMHGSFAH
ILFNMYGLWAFGTPLEKMWGKKKFIFFYFSAGLGAGIIYTLVNYYQFNNLYELFINAGLN
HSEILSILKSGTTNDTRVITAITQEQFNEITSLFNTPAVGASGAIYGVLVAFGLYFKDAK
LALIFFPVPIAAKYFIPVMILGDLFFGMTKYSVGNVAHFAHIGGALIGFLIAWYWKKNQF
KVY
>FCMOIPGL_01098 DNA mismatch repair protein MutL
MSDIIQLLPDHVANQIAAGEVVQRPASVVKELLENAIDAGASSITLLLKDAGKTLIQVID
NGKGMSATDARMCFERHATSKIQKAEDLFNLCTKGFRGEALASIAAIAHVELKTKQENEE
LGTSIKIEGSKIVSQDFVSTSKGTSIAVKNLFYNIPARRNFLKSDTVETRHIIDEFQRVA
LAHPTISFLMHHNNNEVYHLKGGNLRKRIVAVFGAKMNEKLVPINEQTDILTIEGFVAKP
EFSKRKRGEQFFFVNDRFIKSSYLNHAVVNAFDGLLEYGAHPSYFLYLTVPASTIDINIH
PTKTEIKFDNEKALYAMLRATVKHSLGQYNVAPVLDFNRDSNLDTSYDLNKNAVKTSVPK
ITVDPDFNPFKETKTTQKENQTPYKREQKTQSWESLYTSTAFSDEGNQSELFEHQQESKT
QKTFQIQRKYVMSLIKSGVVLIHQSLAHQRILYEEFLESITVKEANSQQLLFPVKISFSS
AEIEMIYTIKNELENAGFSFDEFTKDSVTIKGIPVSVTESKITIILEELLNDIDLEVPDA
SFSHFDVMAKSFAKTLCIKTGAQLSEKEQESLVNNLFSCKEPTVSPFGKATFKTLTLNEI
DNLFNS
>FCMOIPGL_01099 hypothetical protein
MGFLKRTNKKFDYQPRYYKGEGSPYKIEHKLDQFRTTTGKNKGLKSKFSTALNELKNAEK
GSNNTVIYIVLVLVMIFLYIIDFDISIFYSK
>FCMOIPGL_01100 hypothetical protein
MNKKLICLSLLFLLQFLATSCDPCSCGPIKTYERINKKLNIKSWDTSGFQNRETTEPVSK
NSFGISIFIESELKQIAFTKSKINISSLGFSSAYACSCPPDKYINNTPVISIQILATNSL
NSEVIDVTDNFSTYDNFGKQIAIKEYLENKEISNNYEYYSDDYFQLDMTKSDNIPDTTIF
TIKIFLQSGEELIEKTQEINFK
>FCMOIPGL_01101 6,7-dimethyl-8-ribityllumazine synthase
MATTNLSVYDKATIPNANNFRFGIVVSEWNPEITQNLKKGAIETLLDCGATNENIISWDV
PGSFELVYGCKKMIQSQKVDAIIAIGNVIQGETKHFDFVCEGVTQGIVDLNIKHDVPVIF
CVLTDNTKQQSLDRSGGKLGNKGTECAVAAIKMAALKNLGKKADSIGF
>FCMOIPGL_01102 hypothetical protein
MATYKKKGFKAKDKKEQNQIDDAKFETAEVFHSLEETATKSEQWIEKNSQPLFYTLIGIV
VLFLAFLGYNKYIIEPNELEASNELAFPRKHFDEAATAGSGIDSLLNLGLEGADGKYGFI
DIADSYSGTDAGNLANYYAGVSYLQMKQYDKGIEYLSKFNSDDEMLGPVSLGAIGDAFSD
INQPEDALDYYEKAANKKANDFTTPLFLYKAAQTAMSLKEYSKAVDLFTQIKEDYAKSDQ
GKDIDKYINAAKYAE
>FCMOIPGL_01103 DNA replication and repair protein RecF
MYLQKISLVNFKNIESQSFDFQQKINCFVGDNGVGKTNVLDAIYYLSFAKSYFNSVAIQN
IKHNEPFFMIEGEYILNDRTEKIVCSLKRGQKKVLKRNGKNYDKFSEHIGQIPLVIISPA
DRDLVTEGSDTRRKFIDGVISQQNKTYLQDLIAYNKVLSQRNALLKYFAANRTFDALNLS
VYNEQLANFGTKIHEIRKEFLEKFIPIFNEKYQVISGDKESVNLKYKSQLEDFTMLENLQ
KSLEKDKVLQYTSSGIHRDDLSFEIEEYPIKKFGSQGQQKSYLIALKLAQFEFIKQQSKI
IPILLFDDIFDKLDENRVSQLIDLVNNDEFGQIFITDTHQERTENIVKQSNKPYKIFKL
>FCMOIPGL_01104 hypothetical protein
MAKRENDSFSIQDLMQSFIKENNLSKGMQKIKVEETWCKMMGPGVETHTTSVKLQNKTLI
IQLNSSVLREELSYGKDKIIKMMNEELGDEVITKLMLV
>FCMOIPGL_01105 Nucleoside diphosphate kinase
MATNRTFTMLKPDAVENGHTGAILEKMNAAGFRIVALKKTQMTKADAETFYAVHNERPFF
GELVEFMTRGPIVAAILEKENAVEDFRTLIGATNPADAAEGTIRKLYATSMGENAVHGSD
SDENAAIEGNFHFSGRDQF
>FCMOIPGL_01106 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MILKGFEELKTFLEKPKNIVIVGHRNPDGDAMGSTLALKLYLDKKGHSCTVVVPNEYPDF
LHWLPSSDTTYRFDWQNTQSQRAINNSDIIFLLDFNALHRVGSDMQKTLEKYPNDFAMID
HHQQPDDVKYMYSDVEICSTCQMVYQFIEMNADLALIDADIATCIYTGIMTDTGSFRFRS
TTSTTHRIIANLIDKGAKNDRIHNNVYDANSYNRLLLLGKALSNLQILPTYNTAYITLTS
EEKKRFDFQKGDTEGVVNYALSLKGIVFAAIFIEDEEQGIIKISFRSKGEFSVNQFARNY
FHGGGHDNAAGGKSNDSMENTIIKFTSLLPKYKSELETSYEE
>FCMOIPGL_01107 hypothetical protein
MFCFSCSKIEPRKPINSKPSTTLYNETIKEAISLNKIEDDKILQLIKNDSTKVYLQSSQG
FWYTYIHKIEENLPTPKNGDEVIFEYEIRNLSDSLIYSKKDLGIKSYVVDKEDFISGLQK
GIKLMKIGETITFVLPSYSAFGITGDGNKIGINQSIISTVTLTNIK
>FCMOIPGL_01108 FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase
MRILKSLVVVVAIASLTSCTGQKADVKSLETEIDSASYALGMDMALKVKANFSEANTDLF
LQGYRNGMDSTNLLIADKDLNNFLRDFFQKQQVAKQKEMQEKAAKEAEVKFADVKKAGED
FLAVNKTKEGVITTDSGLQYIVLKEGKGDLVLPTSKIKIHYHGTTIDDQVFDSSVDRKQP
YESNANQFIPGFNEALALMNTGAKYRVFIPQELAYGVQQRGELIKPFSALIFEIELLEII
KK
>FCMOIPGL_01109 putative peptidyl-prolyl cis-trans isomerase
MKNGIYIFLAFVLLSSCTSEKYKNLNDGLYAEIQTNKGDIFLELYADDAPMTVANFVSLA
EGTNNRVSDSFKGKKYFDGLTFHRVVENFIIQGGDPTATGTGTAGYRFGDEFTKDKDGRL
LHAHDDAGILSMANGGPESNGSQFFITHKAIPHLDGKHTVFGKTTIDNLQLNTLKKQIKD
SVKLKKAIDSLRMVVVNNIQQADTMLTVKIIRLGEKATSFDAAKVFDDELIKYAESKKER
EQNEIDADIARYSRYLEDKAVFLAEMGESKAVKTESGLRILMLKKNPKGEKVVDHKPIKT
NFTLYIADGTKIQSTEETGEPFVFQLNDADKPMITGFEEGVATLRAGEKARLFIPYYIGF
GEAKYGPFPAKSDLVFEVEILEIGK
>FCMOIPGL_01110 hypothetical protein
MVNNLLDSLIQKDKELLIFLNNLGSEQWDSFWLIITNQFSWTPLFLFMFYLIFKTFGWKK
GGFVIVSLIVLVAFSDQFVNLIKNSVERLRPNNDPEINHLLRHLKNPQSFSFISGHATTS
TFFSVFMILLLRENYKYIYLILFFPLFFAYSRLYLGVHYPLDISLGILTGILLANGYYFL
FKKIDKKLFT
>FCMOIPGL_01111 Phenylalanine--tRNA ligase beta subunit
MKISYNWLQQFLQINWEPTITGELLTDLGLEVEGIETKESIKGSLKGIVVGKVLTCIQHP
NADRLKITTVDLGDGNPLQIVCGAPNVAAGQKVPVATIGTTLYDEKGEGFKIKKGKIRGE
ESHGMICAEDELGLGKGHDGILVLDENIKEGTTAAEVFKIETDYVFEIGLTPNRSDAMSH
FGVARDLRAGLIQKGNKLELISPSVSDFHVDERTLRFDIEVEDKELIPRYCGIAITDITV
KDSPKWMQNRLKAIGITPKNNIVDITNYVLHELGQPLHAFDAQKVKGNKIIVKTLEEGTK
FTTLDAVERTLSADDIMICDGDSNPLCIGGVFGGLNSGVTENTTSIFLESAYFNPVSIRK
TAKRHALNTDASFRFERGIDISSTEYALKRAALLIEKYAGGKLASDVSDFYPVKVEDFQV
FFSYENAYRLIGQEIPKDTIKNILASLEIKINSETESGLGLTIPSYRTDVQREADIIEEI
LRVYGYNNIEFSHKLNTSISFDSNKVTKIENVVANQLSSLGFNETMANSLTKASYTDLSD
NLNDEANVVMLNPLSTDLGVMRQSLLFSGLESVSYNLNRKNNSLKFYEFGKTYHKYNDKY
QEDKHLTLFITGNRTKESWKTTTTTSDFFYVKGIITAVLNRLGINNLKTTPTKSDIFSEG
ITLSLGKIKLVDFGVVKRSLLKEFGIKQEVLFADFNWENVLKLSTKRNTKVIELSKFPSV
KRDLALLIDSKTEFKQVYNLAFQSEKSLLKEVDLFDVYEGDKLPDGKKSYAVSFVLQDEK
KTLEDKQIDKIMQKLQQTFEKNLEAVLR
>FCMOIPGL_01112 Dihydroorotate dehydrogenase (quinone)
MYKLIIRPIFFLFDPEKIHYFTFYLIKFLCKIPFVSNIFRSLYQINDKKLERTLFGLSFK
NPVGLAAGFDKNAVLYNELANFGFGFIEIGTVTPKGQVGNPKKRLFRLKDDQGIINRMGF
NNEGLQTAIQQLKKNKGKVIIGGNIGKNTQTLPENYTADYLECLKGLHPYVDYFVLNVSC
PNVGSHAKLNDKDYLVELISACQKLNSELSKTSQSKLKPILLKIAPDLNNQQLDEIIELV
AETKIDGVIASNTSTNRDNLKVSKERLAAIGNGGVSGQPIKDQSTKVIKYLADNSNKSFP
IIGVGGIHSEKDALEKIEVGADLVQIYTGFIYEGPGLVKRINKAILTNG
>FCMOIPGL_01113 Homoserine/homoserine lactone efflux protein
MTETLLSFAIATAILAISPGPDNIFVLTQSIVNGKKFGLATVFGLISGCLVHTTLLAFGV
SAIIKESENLFFSIKLFGAIYLLYLAFKVYKSDASILLSEENVEKKTTLQLFKQGFIMNV
LNPKVSIFFLAFFPGFLFSDSISTVIQFYVLGLLFMLVSLVIFSTIAILAGVISEKIKEN
KNIGLYLKWIQIIVFVLIAVFILI
>FCMOIPGL_01114 Multidrug resistance protein NorM
MKIVQYTSEFKYNLKLAAPVMLGMLGHTFVSFIDNIMVGQLGTAELAAVSLGNSFMFIAM
SIGIGFSTAITPLIAEADSSDNLQQARATYKSGLFLCTTLGIVLFLGVFFSKPLMYLMKQ
PKEVVELAIPYLDLVAFSLIPLVIFQAIKQFSDGMSMTRYPMYATLLSNVINVVLNYLLI
FGKFGFPEMGIVGAAYGTLVSRLVMVIYLWLLLRYKKRSAQIVKNIKFFVLDILTIKKIV
NLGSLSAMQMLFEVAIFTAAVWLSGTLGKNPQAANQIALNLSSMTFMVATGLSVAAMVRV
GNQKGLQSYKELRRIAFSIFLLGVLLAMFFALLFFIFHKNLPHMYVDLKDVTNYMDNMEV
VSIAANLLIAAAFFQISDSIQVVFLGALRGLQDVKVPTILTFISYWVVGFPVSYFLGSEE
MYGSFGIWLGLLAGLTTASILLFIRFNSLTLKLIKEKEITNEM
>FCMOIPGL_01115 hypothetical protein
MNLPKFLLADNSNFPDDIFVLHTEFPRFIINLKDDEIEWFEDLTGENEEDIATELADLMD
KAGAFYDEEMKEYDE
>FCMOIPGL_01116 hypothetical protein
MEVRFYNISKTKEDSSVVIKVIKKNHINFKFDMVF
>FCMOIPGL_01117 Phosphoenolpyruvate carboxylase
MEKETLEREGLQKIRTDFNYLISIFREMLQSLGEDKMAAMLPFENNQPLLSNEKVSDEKV
AQAIGICFELLNSVEENAATQFRRKTETQFGLENIRGSWGETLNLWKTSGIEEQEIIALL
PKIKVMPVFTAHPSEAKRLTVLDIHRELYILLVKNENPLWSISERNVIRQEIKSLLERWW
RTGEIYLQKPRLDDERSNVMHYFENVLPQALRLTDQRLLDAWKYMGFSPENLERPEQFPK
IEFGSWVGGDRDGHPYVTPEFSASTLKLHREAALKIMKKELLLLAKELSFSEYLNAIPSD
FLTSLKTSAEKLGKAGQKALDRNPSEPLRQFINLLIVRLENTLNESFNLDKDCYFYRPES
LAIELQKLRNLLIKLGANQINLKCLFPVERSLECFGFHLAKLDIRQNSEYHEKAITQILT
ASGFADADYASWTEEKRLDFINQELLSNRPFLVSGTKCGTEADNVLGYFKEIKTFVDLHG
SDGIGSLIVSMTRSLSDLLLVYLFLREVGLKDANLPVVPLLETIDDLIAGPDILESFLTH
PTVQEIRKNKEDLVQEVMLGYSDSNKDGGILTSRWTIYKAEENLTEVGDKLGIKLCFFHG
RGGTISRGGGKVHRFLESMPNGSVSGHIKMTVQGETIADQFANRLNACYNLEMMISGTAR
QAMISSNKVKNQKLYDIMDRLVEMSRKNYRSLLDHPNFIKFYSEATPIDVLEQSKIGSRP
ARRTGQRSLNDLRSIPWVFSWNQSRFNLTGWFGTGAALAEFEEQFPEDFEYLKTVAKEWL
FLKYDLIEIETNLLNSDTDIMKSFADLVHDSDVKTELMNLILSDYERCLKQIESLLSASA
EKRRISKLENNKLRKEALDILHFIQIESLTKWRQNKEGDPKEDSQLLLMLLLLVNALSGG
LKGTG
>FCMOIPGL_01118 Alcohol dehydrogenase 2
MLQNRRIYLPPLSLIGPGALNDLGEELKSLPYKKALFVTDQILVKIGVAQKVIEVMKASN
IEIVLYDDVQPNPTTKNVNKGLKLLQENNCDFILTLGGGSPQDCGKAIGILATNGGKIGD
YEGINLSKHKSLPIVAINTTAGTASEVTINYVITDEKRHIKMVMVDKNCLVSIAVNDPKL
MLGKPAALTAATGMDALTHAIETYVTKGAFGWSDALALEAIKLISQSLEIAVVDGQNLEA
RSKMAWGQFIAGQAFSNAGLGYVHSMAHQLGGMYDMPHGVANAILLPHVEQFNIPACAHK
LKKVARAMGVGVLEMSDTQGANAAISAIKALSKSVGIPSGLKELGVKEEDFEEMAKNALA
DVCTGGNPREVTLEDTIAIYKAAM
>FCMOIPGL_01119 Aminopeptidase S
MKKILYVASALAFIACGSSKNAPKEDANVDQAAKYAATITAKDLGTHLFIYASDEFEGRN
TGEPGQKKAVEYLKNYYVSKEIPAAEGSDDYFQKVPSEWLNKNSRRGKFNDSENVVAFIK
GTEKPDEIVVISAHLDHEGIKNGKIYNGADDDGSGTVALLEIAEAFKMAADAGKGPKRSI
LFLHVTGEEKGLLGSKYYTENPLFPIANTVCDLNIDMVGRIDDRHKEDPNYVYLIGSDKL
STELHNISEEVNKKYTNINLDYKYNDENDPNRYYYRSDHYNFAQYNVPIIFYFNGTHADY
HKHTDTPDKINYELLENRTRLVFYTAWEVANRETRIIADKAEIKKEEKDK
>FCMOIPGL_01120 Fe(3+) dicitrate transport ATP-binding protein FecE
MVLTERLPESQLTVFELVTFGRQPYTNWIDKLSKADLKKINWAIDETEINHLKNKRFYEL
SDGQLQRVLIARALAQDTEIIILDEPTAHLDLHHTIKIFSLLKNLVEKTSKTIIMSSHEV
NFSIKFADEIILFSDDKIMYGSPSELIEKNSFDNLFPKEIVNFNRNLQQFIINKK
>FCMOIPGL_01121 Hemin transport system permease protein HmuU
MENKSYTKHFIYLSVLLVVLFFVNVSLGSVSIQFKDIFKILLGGIPEKESWQIILLNFRL
PKAITAVLVGSGLSICGLLMQTLFRNPLAGPFVLGISSGASLGVALLILGSSVFGGFLLN
ASISNWSLPIASSLGAFLVLSAVIIAANKVKNTMSILIIGLMFGSLTSAIISVLAYFSEA
AQIQQYLFWSFGSLGNLSWNEISIFAIIYLIGITGTIFVIKPLNSFLLGENYAKSLGINI
KRSRNIILLITSILTGVITAFSGPIAFVGLAVPHISRMLFTTSNHKILIPSSAIIGAIVL
LICDSIAQLPTSEFTLPINAITSLFGAPIVIWLLMRKKRIFV
>FCMOIPGL_01122 Non-canonical purine NTP pyrophosphatase
MKLVFATNNLNKLAEVQKMLPASIELLSLKDINCFDEVDETELTLEGNAKLKANYITEKF
GFNCFADDTGLEVESLDGKPGVFSARFAGEPSNSEKNMKKLLSELEHKTNRKAQFRTAIC
LNIDKNQFIFEGICNGEILEKKHGEKGFGYDPIFKPEGYSVSFAEMSSEEKNKISHRGIA
IQKLVAFLKKYNK
>FCMOIPGL_01123 Coenzyme A disulfide reductase
MKYIIIGGVAGGATTAARLRRIDENAEIIMLEKGPHISYANCGLPYYIGGVIKDRNKLLV
QTPESFNARFNIDIRIYSEVISINSDEKSVSVKKIETDETYTETYDKLILSPGASPIKPP
IPGINSPNIFTLRNVQDTDKIKAFVDDEHPRTAVVVGAGFIGLEMAENLHLIGVKVTVVE
AASQVMNMMDSEIAAPLHQHFKEKNVGLFLEDAVKEFVPNGDLIDVHLSSERVISADFVI
LSIGVKPDTFLAKTAGIKIGDAGGIWVDEYLQTSKKDIYAVGDAIEFPHPITGKPSLAFL
AGPANKQGRILADNMVYGHKRKYTGSIGTAIAKVFDLTAGITGLTHRGLKALGIKHESTI
VNAGSHAGYYPGAMQMIMKISFDPVNGKLLGGQIVGYKGIDKRLDLLATTIKNGGTIYDL
QEIEHAYAPPFSSAKDPVNQAGFNAENIIRGLFKPLSPFQFKKRSIKDSFVLDVRTAEEY
ALNSIDGALHLNVDDIRNHLNKIPKDKKVMIYCAAGLRGYVAARILRQHGYDDVYNLSGG
LKVYKQAMAEQSNPIFFKNEVKIKNVEETIIPITVKKIEVDACGLQCPGPILKLKENIDN
LSDGDQMEVIATDPGFFGDVESWCKVTGNKLVTRENNAGEIKAVIEKQKKEVFQGLQAPL
DHKTIVVFSDDLDKALASFVIANGAASMGKRVTMFFTFWGLNVIKNANKPKVKKDTMGNM
FSKMMPGHAGELSLSNMNMGGMGRLMMKWRMKDKHVDALETMIQVAQESGINMIACQMSM
DIMGVDKEELLEGVHIGGVANYLEEAEQSNLNLFI
>FCMOIPGL_01124 hypothetical protein
MLESFLFLFTGIIGFITLALMLRHYKSNPFCNFFLVLIFSIVSIRYLIHGSYYLGLQTFL
QPDSGLYSLLYLTIVPASYLYYNHLTLQEKGYKLKDLKHIIFIVFLYFINSIEALDNSFI
FYFGPITNFFFIAIFILFYLLLIFNLLSKKIWFRKNHDLNKEHFKLIKNWTIIFFVINVL
NSLMVLISLYTEFHKGLAVSGKSMAIFSLIFWLFIFFKILISPEILYGLPILNKTLLKFS
DLLSEKKEIISITGNNWVLETSTIKSTQDQKLQENISTDIESYIIEVDKLSTEKLVFRNQ
KTSQSDIAEKLGVPTSHIVYLFKYHSKISFSEYRMNSRIQDAISLIEKGFLNTETFESLA
YKTGFSSYNPFFIAFKKITTFSPQDYLKHKNTT
>FCMOIPGL_01125 Ribosomal RNA large subunit methyltransferase H
MKIKLLAIGKTDNKQLIKLIEEYQNRLKHYIKFELEIIPDIKNVKNLSEVQQKEKEGELI
LSKLQNTDELILLDDKGKHYTSIEFSKYLQKKMNSGLKQLVLVIGGPYGFSDAVYNKSTG
KISLSKMTFSHQMIRLFIVEQLYRGFTILKNEPYHHE
>FCMOIPGL_01126 Nicotinate-nucleotide pyrophosphorylase [carboxylating]
MISEEQFNNELDLIIKNAIREDIGDGDHTSLSCIPSDAKGKAKLLVKDDGIIAGVEFAKQ
VFSYVDKDLQVETFINDGQKVKYGDIVFHVSGKSQSILMAERLVLNAMQRMSAIATKTAF
FADLLKGTKTKVLDTRKTTPGIRALEKWAVKIGGGENHRFALYDMVMIKDNHIDFAGGIT
AAITKTKKYLADNNIDIKIIVEARSLEEIKEILSNKGVYRILIDNFNYEDTKKAVALIGD
TCLTESSGGINEDTIRKYAECDVDFISSGALTHSVYNMDLSLKAL
>FCMOIPGL_01127 Pentapeptide repeat protein MfpA
MDDYFDNEEFIKIDFTKTKINKGEYDNCTFINCNFEGIHASNIQFVECEFLDCNFSNTII
NNTAFKDVNFINCKLLGVKFNECDPFLLQFSFKDCQLNFSSFYQLKIPNTKFSKCNLQEV
DFTETILTSSTLDDCDVREAIFENTNLEKSDFRTAFNFNINPEKNKLKGAKFSKENIAGL
LSAYRIVIE
>FCMOIPGL_01128 hypothetical protein
MTKEIEKNLSKIPVVNLLVKFGKQIKVPGLEGMSLYDVLEMYSIGIIRGALTSRAGGIAF
SFFMAIFPFMLFILTLIPYIPIDGFQEGLFSFIKDVLPPQTFEAVDSVLIDITKNQYGGL
LSFGFLGSIFLMTNGINAIFGGFEYSYHVNDNRNIFKAYFISLAVSLVISLFLIITITLV
ILYQVALTKMNDKGWLNTEDLYLFNLGKYLLFLIMIFTTVSLLFRFGTKQVKQIKFFSAG
AILTTILSLCTFYLFGIYVVKFAQYNQLYGSIGTLLILMLFVWLNAIILLLGFELNASLF
MLKQINKTDSTQ
>FCMOIPGL_01129 Histidine--tRNA ligase
MKPSIPKGTRDFSPTEVANRTYIMNTIKTSFETFGFQPIETPSFENSSTLMGKYGEEGDR
LIFKILNSGDYFSSIDFKVNSLFPSILYHYIESIKSGSIEYLQINNLKKQLKSTNKDNSL
QLPNDELLIILLSSLDKNSDLILSFDDEDLEKNKDYIKDVILKTFYEELIQKAKNISEKA
LRYDLTVPFARYVVQHQNEITFPFKRYQVQPVWRADRPQKGRFREFFQCDADVVGSKSLW
QEVEFVQLYDSVFGKLGLSETTIKINNRKILSGIAEVIGAQDKLIDFTVALDKLDKIGKD
GVVKEMLSKGITEDAIEKVQPLFNFTGSNLEKLASLESMLQTSEEGKNGVEELRFVINAI
EELGLASANLEVDVTLARGLNYYTGAIFEVSAPKGVKMGSIGGGGRYDDLTGIFGLKDVS
GVGISFGLDRIYLVLEELGLFKSVDLPKPKVIFLNFDASTDVLKMKALKSLRENNIKSEF
YPDLGESNKAQKRQWKYVTNREIEFVVSEVENDVFTLKNMISGEQTNCSLSELVEKLN
>FCMOIPGL_01130 GTP cyclohydrolase 1
MFELNSKMNDERIEEIGENHIGTSAKTPLRADAFDISDEEKIERIQESVKDILNTLGMDL
TDDSLQGTPKRVAKAFVNELFMGLNPKNMPKASTFENNYNYGEMLVEKNIVVYSTCEHHL
LPIIGRAHVAYISDGKVIGLSKMNRIVEYFSKRPQVQERLTMQVVQAMQEALGTQDVACV
IDAKHLCVNSRGIKDIESSTVTAEFGGKFKEKETKREFLEYLKMNTKFE
>FCMOIPGL_01131 Chitodextrinase
MYKTKLTKLLFLVFITFSFSNFAQTVQAGNGSYTKTFPGTDVAGRNGYPSGAPQLTGNAA
GKPVPTNDWWSKLLKEDHADNLFNYPMTLKTTNNGLIVTYIPSGVIGDSAPIEVKLSGLS
TTKTTVSDYSDWTVTMNWKDANHELKTTAGIGMPFLYFEKDADDIVEIKVNSGTATINNE
MLIIENATSGADFVFYAPSGSSWVNSGSTFTSTLNGKDYWSMIMLPQNTSNVTTSAQEFK
KYAYVFPTNSETSWVYNETSSKVTTTFNVTTDVKEGTETDMLLGLLPHQWNNLSAISATP
NEATYSSVRGALKMLKGNTFSVENTFKGILPTLPYLANYSEGFSAAALDSKIAQIENDGL
ATWTDSYNEGQVMNRLIQTARIADQTGNIAARDKMIATVKERLEDWLSFESGEKAFLFYY
NTEYSTLIGYPAGHGQDSNINDHHFHWGYFIHAAAFMEQFQPGWMNQWGEMINLLVRDAA
SSDRNDDTFPFLRNFSPYAGHSWANGFASFPQGNDQESTSESMQFASSLIHWGTISNNKE
IRDLGIYIYTTEQTAIEEYWFDVYERNFSSSQQYSLVSRIWGNSYDNGTFWTSDIAASYG
IEMYPIHAGSFYLGHNQTYAQKLWDEISQNTGVLNQENNDNLWHDTYWKYLSMINPQEAV
NLYNAYPDRNLKFGISDAQTYHWLHSANALGVVDATITADYPIAMVFKQNGETTYVAHNY
TNSEIIVSFSDGFQLTVPARQMITNKDVLIYGVISSDFNQAYANGSVNLSVATTGSGITK
VEFYDGTTLIGTKTDAPYNFKAENLVLGVHGMYAKVYENTNFNVTNIVQIQVGEQVPFLD
TAFTIPGSIEAGNYDKFEGGVGQNISYVDVSQNNEGDFRTDEYVDAAMDNTEGNTVGWIS
AGEWLEYSIDVQTSGKYNVDVRFASGNSNGGGPFYFEIDGKKISSDINLTYTSDWSSWQT
KTVNDIEFTKGKHILRAVFVNGEFNLAKMDFTYAAPLDYMPPVANAGNNVVVISPETTAT
LDGSLSNDPEDETITFLWEQIYGPSIINFNDTTLESPSISNLEKGIYKCKLTVSDGTYSA
NSFVLVIVQDNANASPTISITSPSNNNSFSVGTAINITTSAADLDGTITKVEFYDGNTKI
GEDTTAPFSFNWTNATVGAHEIKAIAIDNEAAQTTSLSINITVNEVKECTETSNDAQQGS
FSTGYTATFETIGTSVKITFELLDTDRVGVVAYLWKESPFGETQMESVSGLKFTKTIGGL
TQGETISYGCKFAFAGGLAVTKYINYKVGDSCGSLNTTDVNLNDEIIVYPNPVKNTLFIK
SNSVDISKIEIYSTLGSMVKKATNNFNSIQVEDLSKGLYLVKIYTDKTAITKKFIKN
>FCMOIPGL_01132 hypothetical protein
MKKFSLIICLLLISSFGYSQSKKMLKFKKEYTTLEYLVKTKTDSLNYLTTQKINKLSYKA
KTELSELEEKYGSSNLKIMLYHNKYNKEVSKVNSKYEIEIAETQGEHQLAMSKIQFKFET
EVAKLQLKYEIY
>FCMOIPGL_01133 Protein translocase subunit SecA
MSILDSVIKLFVGDKQQKDLKILQPIVEAVRKFETEISKLSHDELRAKTQEFKDKIKAAT
KEFDSKITTLEDEAKNADIDRQEDIYSEIDTLKDEAYKVSEETLLQIMPEAFAVIKETEK
RFKENEEIEVTATPFDRELSAERDNVTLEGDKAFWANSWDAAGKPVTWDMVPYDVQLIGG
SVLHQGKIAEMMTGEGKTLVSTLPVYLNALTGNGVHLVTVNDYLAKRDKAWMGPIFEFHG
LSTDCIDYHQPNSDARRKAYNADITYGTNNEFGFDYLRDNMASSKDDLVQRPPNYAIIDE
VDSVLIDDARTPLIISGPVPQGDRHEFNDLKPLVADLVALQSKHLIGVLAEAKKLIADGN
TKDGGFLLLRVYRGLPKNKALIKFLSQEGNKQILQKTENYYMADNNKLMPEIDEDLLFVV
EEKNNQIDLTDKGIALLSEKTENDNFFVLPDIGVKIGQIDTADTTSEEKAAQKEELYKDF
SIKSERIHTMNQLLKAYTVFEKDVEYVVMDNKVMIVDEQTGRIMDGRRYSDGLHQAIEAK
ENVKIEDATQTFATVTLQNYFRMYRKLSGMTGTAVTEAGELWEIYKLDVVEIPTNKPIQR
DDKEDLVYKTAREKYNAVIEDIVKLVEQNRPVLVGTTSVEISELLGRMLQMRKIPHNILN
AKLHKREADVVAEAGKPGIVTIATNMAGRGTDIKLTDEVKKAGGLAIIGTERHDSRRVDR
QLRGRAGRQGDVGSTQFYVALDDNLMRLFGSDRIAKMMDRMGLKEGEVIQHSMITKSIER
AQKKVEENNFGIRKRLLEYDDIMNAQRSFVYKRRRNALDGKRLQVDIANMIYDTCESIIN
SNKPVKDFQNFEFELIRFSSTTSPFTKEEFEKLSEKELTDKLYDVVSAHYKSKIERNAVL
AFPVIKDVFENEGDRYERIVVPFTDGTKSLQVVTNLKEAYESEGKSLVTDFEKNITLAII
DENWKDHLRQMDELKHSVQNASYEQKDPLLVYKFEAFELFKKTVDEINKEVLSFLFKGEL
PEQNRDQISEARSQKRERLNTSKADVQNSTEQAIQNSKKQPQEPVETIVRDQPKIGRNEK
VTIKNVMSGEQKEVKFKQAIPLIEKGEWVLVNN
>FCMOIPGL_01134 hypothetical protein
MYWTLELASYLADAPWPATKDELIDYAIRTGSPLEVVENLQDMEDEGDAYDSIVEIWPDY
PTEDDYLWNEDEY
>FCMOIPGL_01135 Cob(I)yrinic acid a,c-diamide adenosyltransferase
MKIYTKTGDAGTTALFGGTRVKKYNLRIESYGTVDELNSYVGLIKDQEINSAIKETLLII
QNELFTLGSMLATPPEKETLKNGKERLNIPKVDENSILFLENEIDKMETELPQMTHFILP
GGHQAVSFCHIARCVCRRAERLSVELNDQETLNIDILKYLNRLSDFLFVLARKLSKDLLV
EEIKWIPEKK
>FCMOIPGL_01136 hypothetical protein
MFYKTISRLKFLLRATNQHGVHSPFVYDFVTKGLYKKENKVLDFKEYSALKKLSKKEKKV
FSKIVSYFKIDEIYSDFKTFSSNSDNNFKILFINLIGKIKISELNTLNSKHIIVVHGIYQ
QKETTLKWRKIIKNKKATVSIDLYYFGLIFFRKEQVKEHFNIRV
>FCMOIPGL_01137 Imidazolonepropionase
MTKLFTNIKELIQVREASVQKVSGTKMNILPTLKNAFLLIENNIIKDFGLMDEIPNFSAD
EIIDCAGKMILPTWCDSHTHIVFAGNREQEFVDRIKGLSYEEIANKGGGILNSAKKLQAT
SEEELYQQSAKRLNEVIALGTGAIEIKSGYGLTLDSELKMLRVIKKLKENYNIPIKATFL
GAHAIPTEFKHNKEGYINLIIDEMLPKISSENLADFVDVFCEVGYFSVDDTDRILSAAKK
YNLISKVHVNQFNSIGGIAISTKHNALSVDHLEVLSDDDLAQLKASETMPVALPSCSFFL
GIPFTPARKIIDANLPLALATDYNPGSTPSGNMNFVVATACIKMKMTPEEAINAATINSA
FAMNLSNKVGSITKGKLANFFITKEIPSYGFIPYSFGSNLIDEVYINGNKF
>FCMOIPGL_01138 hypothetical protein
MVTNIHKSIEMIPENEYASYYKQYIQLIENNNKSIIENLIDSQKEFDAVLRNVPSKKQNF
AYAEGKWTLKELIQHIIDTERVFNYRALCFARNDQTSLPGFDQDLFANNCNANTRDYEDL
LDEMSVLRKSTILLFKSFSDEVFLRIGVGSGNKMSVRALGYLYSGHQIHHLNIIKERYL
>FCMOIPGL_01139 Putative glutamate--cysteine ligase 2
MKFTLGIEEEYQVIDPVTRELISHDQQIVINASQVLNDQVKAEMHEAVVEVGTNICYDIK
DAREQITHLRKSISTFANDLGFKIGAAGTHPFSKWETQLITPNPRYDEIITELQDAARSN
LIFGLHVHVGIEDKNMAMHIVNAMRYFLPHLYALSTNSPFWEGRNTGFKSYRSKVFDKFP
RTGIPGVFDNYTQYENYVNLLMKTKCIDNPKKIWWDIRIHPVFPTIEVRICDVPLTIDET
VCIAALIQALAAKLYKLRTQNLNFMIYHRALINENKWRAGRYGIDGKMIDFGLEKEMETK
FLMREVVEFVDDVLDELGSRKEVEYVFEILKNGTGADRQLKVFEETKDLKKVVDFITERT
ILGL
>FCMOIPGL_01140 hypothetical protein
MKREKLKLAILDMNNDEPNQGLRCIKEIADFFSSEVDITVFNVRAKQEIPDISFDIYISS
GGPGSPLEEENWRKPYLYLMQQLWDHNIKSLGSKKHVFFICYSFQVMCNYFGLGEIKLRK
STSFGALPIHKTKKGLKDPILDGLNDPFYAVDSRDWQLIQPNLKVFKERGASILSLEKIR
THIKLERAIMAVRFSDEFIGTQFHPEADPISMKVYFSLEETKQKIIKNFGETKYNQLMDT
IDDPDKIIMTYNTVLPKFITTAIRNIKQPIHS
>FCMOIPGL_01141 hypothetical protein
MIDKNRSLYNEQFTEEKYQNFLQEITNEFKCVPKFRVSETPVFIPKDLKVKLIDACTEIM
AVINQPNFKELTNGAFFDKNTIVPNEDDNAKFLQLDFGICKDENGNLVPKLIELQGFPSI
YFFQELLGRKYRKHFKNAIPENYSQFVNGITNQENLELLRQEIVGDTNAKQVILLEIEPE
KQATAIDFYATAAKLDIKVLCISKLIKKGKALFYLDDEGKEIKILKIYNRIIFDELFQRD
DLKREFNFLDEVDIEWIGHPNWFYRISKYTMPLLKGEFVPKSYYLNALKTIPEDLENYVL
KPLYSFAGAGVQIHVTRKMIDEITNTSNYLLQEKVVYAPIIKTMDEPAKCEIRMMMLHNS
KTNKTEIVNNLIRLTKGEMVGVKYNKDKTWVGASTGFYEN
>FCMOIPGL_01142 Virginiamycin B lyase
MKKIYFLTTLFLLTNINLIAQTIDVITQLSSPNAIEIDGDNLYIAEFDGNKISKINITNS
SPVAVDVVTNLNGPSGIILIGNYLYIAELNGNKISKIDITNNSSTAIDVVTELNRPVQIL
LNGNDLYIAELGGGKISKIDITDSSPTAIDIITDLNRPQGMILNGNDLYIANSGDHKISK
INITDSSPTAIDVITELSSPTGLALNENDLYIAEFNGNKISRISITESNPTIKEIVNELI
GPTGLIINGNEMYINEFTGNKISKIDLATLSIDNFSLFNNLKASPNPTNNFLQISGLTKI
ENYKIYNILGAEIKKGSIYENQKIDVKNLIGGIYFLKLENGSSIRFIKE
>FCMOIPGL_01143 hypothetical protein
MRYYDYFIDGLNLLLDYIITNYLVIIGFILFVLGIKLFLKITERKKLDSNSENVINEIRT
LDNYWMYCLFSIILGAYLIIKNV
>FCMOIPGL_01144 Guanine deaminase
MNNHEEFMSEAVKAALKGMSNNEGGPFGCIVVKDGKIIGSGNNKVTSTNDPTAHAEVTAI
RDACKNLESFQLDGCIIYTSCEPCPMCLGAIYWARPDKVYYGSNQKDAADIGFDDEFIYN
EIPLPYEKRSIPFEQIGREIALEPFIKWSEKQDKIEY
>FCMOIPGL_01145 Fumarate hydratase class II
MTKYRIEKDTMGQVNVPADKYWGAQTERSRNNFKIGPESSMPIEIIYGFAYLKKAAAYTN
CELGVLTSEKRDLIAQVCDEILEGKLDDQFPLVIWQTGSGTQSNMNANEVIANRAQELAG
KIIGEGEKVIQPNDDVNKSQSSNDTFPTGMHIAAYKKIVETTIPGITQLRDTLKAKSEAF
KDVVKIGRTHLMDATPLTLGQEFSGYVAQLNFGLKALNNTLEHLSQLALGGTAVGTGMNT
PAGYDVLVAKYIAQFTGLPFVTAENKFEALAAHDALVETHGALKQIAVSLNKIANDIRMM
ASGPRSGIGEIIIPANEPGSSIMPGKVNPTQCEAMTMVAAQVIGNDVAVTIGGAQGHYEL
NVFKPVMASNVLQSAQLIGDVCKSFDVNCAAGIEPNHARITELVNNSLMLVTALNTKIGY
YKAAEIANTAHANGTTLKEEAVRLGYVTPEQYDEWVKPEEMIGALK
>FCMOIPGL_01146 hypothetical protein
MLDFSEFSGLVLFMFIFTAGFWLLIFLLTFVVPYWIGGTIWENMKLKKEARKAAEGK
>FCMOIPGL_01147 Vitamin B12 transporter BtuB
MIKKITLLFCCLFSATLLFSQKPIKPNTVTLKGTVIDAKTNQPLEYATIVLKNLQTEKVT
GGITDEKGSFSVQTPKGTYDISIEYISFKTKRNLAQEITENKNYGIIKLEEDESSLDEIV
VIAEKSSVDIRLDKKIYNVGKDMTVKGGNAADVLNNVPSVDVDAEGAISLRGSENVRILI
DGKPSALVGLSGADALKQLPSDAIERIEVITSPSARYDSEGTAGILNIILRKGNATGFNG
SVSATVGDPKNYQTSVNLNLRSEKINLFSNFGYSDNTSPGVYNSNITYLKDAVIDSTRIE
NRDNNNNRKSFNANIGLEYFLNKKSSVTGTIFVRDSDGRDISTNNISSFDVLGNNLNNST
RIQNESEIDKTLQFSLNYTNNFNDKGHKLTVDLQHSTNKENQSAIITDVYPETNTTDELS
LDNLLQADYVLPIGENSQFELGYRGSFEDLTSDYLVNAPNLDPRYDPSNNLEFKQNVNAF
YTQFGSKINKFSYLLGVRAEMTNIDINLVNTSESYTKNYTNFFPTVNFGYEMTEDQSFTL
GYSRRLRRPRSYYLNPFESRESETVIFKGNVDLDPTYTNSFDLGYLNRWGKLTLNSSIYY
QHSTNDIERVNSQEIRIINGKETNVLVRQPINLASEDRAGFEFTANYNASNKVKLSGSFN
FFQFETNGDYTYNVTDPITNDVTNIIQNFDAKNNSWFTRFDAKITLPWDIQSQTGIFYRG
ARNEAQSDVDGILSVNLAFSKEILNDKGTLVLNVSDLFNSRKYNVTGYAPSRENPTNITD
QTFQRRVRQVSLNFSYRFNQKKAPEKRGSGEREEGGGDEF
>FCMOIPGL_01148 Arsenate reductase
MDKTEKFSPLGERGLQIYHNPRCSKSRQGVEVLENSGKEFKIIKYLDAIPSEKELTEIIK
LLNISPIDLVRKNEKIWKENYKGKELSDKEIILAMIQNPKLIERPIIINNNKAVIGRPSE
NILTII
>FCMOIPGL_01149 Peptide chain release factor RF2
MITQDQLKDIATRIEKLKSYLEIDKKLIEIANDEEKTVNPDFWNDPKAAEVLMKELRFKK
KWVEDYRKAITLNEDVNVLYEFYKEGEVDEAEIEEQFEKVSTFLEDIEFKNMLSDEGDSL
SATIQITAGAGGTESCDWVEMLFRMYTMWAEKQGFKLKTLNYQAGDTVGIKTVTVEIEGD
YAFGWLKGENGVHRLVRISPFDSNAKRHTTFGSVYVFPVADDSIEIDVNPADIEIVTARS
SGAGGQNVNKVETKVQLTHKPTGIQIQCSNSRSQHDNRATAMKMLKSQLYEIELQKQQAA
RDDIEANKLKNEWGSQIRNYVMHPYKLVKDVRTAHETGNVDAVMDGNINPFLKAYLMLNG
QKKSPS
>FCMOIPGL_01150 hypothetical protein
MKNKLLFLLFITISFNGFSQFFTEKTGKNLQKGISKYEGYFTFYYDDISDKIFLQIENLD
ADFLYVNSLSEGIGSNDIGLDRGQLGDGVVVHFKKAGNKILLIQPNQDYRAITKNSEEIK
SVKEAFAKSVLHGFVIKQEKKGMYLVDATDFFMRDAHGVASKLARNNQGNYSLDKSKSAF
NIERTKAFPKNVEFDIMLTFKGSPKGYNIRSVTPNASLVTVHQHHSFVELPDNKYKPRKF
DTRSGSYGMSYLDYATPVNESITKRFIYRHRLEKKNPNEAISEAKEPIIYYLDRGTPEPI
RSALLDGGRWWNQAFEAIGYKDAFQMKLLPEGADPLDIRYNMVQWVHRSTRGWSYGGSIS
DPRTGEIIKGHVSLGSLRIRQDFLIAQALQAPYKNNATDDDFALQMALARIRQLSAHEIG
HTLGFAHNFAASTVNRSSVMDYPHPKFTLKDDKIDFSDAYDTKIGAWDKVIVAYSYQEFK
DAENEDEQLNKILINAYESGLKYLSDADARSQGSASISAHLWDNGNNIYDELNNLLKIRK
IAIDNFSTDNIKSNEPYSVLEDVFVPLYFLHRFQTEAAVKIIGGLEYSYAVKGGNQTVVK
RVSGAIERKALEAVLKTINVDEIAIPKEKLALFPPRAFGYGRTRESFKSELGVEFDAFSA
VETASEMTLGLLLNSQRASRLIAHKSLDKTQLGLEELIDELILKSIRKSYKDSYYQELQN
VINNQVLQQLFDLASNQNQYKQVNAIVFFKLDEIKSIIQNKKSKGTQKIYNITMLKKIED
FIKNPTSFKKTEALKIPDGSPIGNDY
>FCMOIPGL_01151 L-allo-threonine aldolase
MIIDLISDTVTRPTKGMLDAMINAKVGDDVFKMDPTVNKLQEKAAAMFGMEDALFFPSGT
MANQTAIKLHTQPGDLVICDKYAHIYNYESGGVAFNSGVTCKLVDGERGMFTANQIEEMA
AVQPEIYLPYTKLICIENTTNKGGGACWDYEEIKKIQKVAKKNNLGFHLDGARLFNALVA
KNETPKQYGALFDTISICLSKGLGAPIGSLLLGSKKDIKQALRLRKLLGGGMRQIGFLAA
AGIYALDNHVERLAEDHKKAKEIGEVLAAVSYVTKVEPIETNIVIFYVDKKIGDSKFIKK
MEAKNILLTPMGEGKIRIVTHLDYTNKMHTILLKELKNMSF
>FCMOIPGL_01152 hypothetical protein
MDLLDKYKEAWTNQPEDANKYSAKEIYNLAHSKSSSIVKWIFIIGILEFVLWSGLNFFMP
EDFYKIYKDLNLMTFINIFTVIHYLIIAAFLSLFYRNYKRISLVDDTKKLIKSILGIRKS
VKYYVVYNLAIVFLISIIVNITMFSDTDTLMKTMNPENLTMDINHVLTITIIGQVIALVI
ILVFLWLFYKLLYGILLSKLYKNYKELAKLDN
>FCMOIPGL_01153 ECF RNA polymerase sigma-E factor
MQKDLETKFLSDFEQNQNIAHKICRLYTTNNDAHKDLFQEITIQLWKNYPKFRGDSKFST
WMYRVALNTAISLYRKSTRTVKTQDISDFSYKIKATTYDDTEEKQLASLHKAIHQLNDIE
KALIFLYLEDKPYKEIAVTLGISSVNARVKMNRAKEKLKNILNP
>FCMOIPGL_01154 HTH-type transcriptional repressor CarH
MLNTKRIKLNKIKEEFTIKDLENISGIKAHTIRIWEKRYNLLEPKRTKTNIRFYNSDDLT
KLLNIALLNNNNFKISKIAEMSDEDIVLKSRELAFESATNDEAINNFKIAMFQFDKILFN
NSYNTLLHKKTFREIFKEVFLPFLNQIGLLWQTETLLPAHEHFISNLISQKIQLNTEKLQ
YNINDTNKMYVLFLPENEIHELGLLYLNYELVLRGFHTVYLGQSLPLNNLNYFFKNNKEI
CFITSLTIQPYDDKIEDYFNEINDLMSNSKNKFIATGRKVNNVSHLKLNTNIQLYNSILD
LLKVL
>FCMOIPGL_01155 Dehydrosqualene desaturase
MKKNIHIIGSGFSALAASCYLAKEGYDVTVLEKNDTLGGRARQYKKDGFTFDIGPSWYWM
PDVFERFFADFGKKPSDYYILDKLNPGYEVYFGENDSVKISSELKEIYDLFEKEEKGSAK
YLKEFLNSAKSNYDTAIKDLVYQPGVSPLELVNTTTIARVSQFFSTIRKQVRKNIESSRL
IKILEFPVLFLGAKPNNTPAFYNFMNYADFGLGTWHPRGGMYKVIEAMVSLSESLGVKFK
TNSNVEKIITDSSNNVIGLKVNGEEIKTNLVLSGADYHHTETLLDDNVKQYSEKYWDKKT
FAPSSLLFYVGFDKKIENVSHHTLFFDTDFDAHAKEIYDNPQWPTDPLFYANFTSITDKT
SAPEGKEAGFFLIPLAPGIEDTEELREEYFHKIMDRFEKLTNQEVKKYVLFKKSFCVNDF
KSEYNSYKGNAYGMANTLLQTAFLRPKIKSSKVKNLYFTGQLTVPGPGVPPALISGKIAS
ELIFKNQQ
>FCMOIPGL_01156 All-trans-phytoene synthase
MKELFDSVSNDCSKLVTKKYSTSFSLAVNMLSPKIRTDIYNIYGFVRFADEIVDTFHEYN
KELLMEHFERDYYLSKEHGISLNPILNSFQQTVNRYKIPDEMVQAFLKSMKADLFKTEYQ
TKEEYDAYIYGSADVVGLMCLKVFVDGDDKRFEELKDAAMRLGSAFQKVNFLRDLKDDFE
VLNRSYFPNVDLGKLDATSKQLIIDEIEADFDYAYKNGILKLPVEAKFGVYMAYRYYRRL
LKKLNKVPSEKIMDTRIRISDPMKINLLARSYVKYKLNII
>FCMOIPGL_01157 hypothetical protein
MMYIFITLGVFLLMEGVTWCTHKFVMHGFGWYLHEDHHQPKYQGVFEKNDAFFVVFATPS
ILLFYFGTYTSHTYLFFIGLGILFYGIAYFLVHDVLIHQRFKWFKHTNNRYLKGLRKAHK
IHHKHLGKEEGECFGMLFVPFKYFKKPKI
>FCMOIPGL_01158 hypothetical protein
MFLYLLLNLGSISIPLLYSFEKKMRFIKHWKAVFLSLIIVSIFFLIWDAIFTANGVWGFN
PDYHLNFLLFGMPIDEWMFFICIPYASIFIHYSLEYFKPNLLISEKITKLITAFFILILL
PVIFMNTDKAYTLVNYSFLVFVLLMGFFFGIKHLQRFYISFLIILVPFFIVNGVLTGTGI
DEPVVWYNNAENLGIRLLTIPIEDIGYAFTMIFGNVLLIEKFKK
>FCMOIPGL_01159 Calcium-transporting ATPase 1
MSVNNFNIKGLNNDQVIAARKKYGKNSLDYKKENNFLDAIKTLAKEPMVLLLLAASLIYF
ISGRTDDAIFLASAIILVSIISLFQDSRSRNALQKLKKLSQPHCKVIRNGKIVEIKSEDL
VVGDRLIVEEGTSITADGIIVHSNDFSVNESTLTGESMSVFKDKDKKDNLIFRGTTVTSG
LAIATITNIGNETKLGEIGKSLGSIKEEKTPLELQITNFVKTMVIAGTIVFLVVWAINYF
HSHDLLDSLLKALTLAMSILPEEIPVAFTTFMAIGAWRLMKMGIVVKQMKTVETLGSATV
ICTDKTGTITENKMSLAKVFSLNSDRIVSPKEANEDEKILITLAMWASEPIPFDAMEISL
HQVYQDFQEQDERPNFKLIHEYPLGGKPPMMTHIFENNSGKRIIATKGAPEALIAVSNLT
NVEKDKIKNEIQTITSQGYRVLGVGQSDFKGTDFPKTQQEFKFNFKGIVAFYDPPKKNIN
KVFEDFYKAGISVKIITGDNAATTTAIAEQVAFKGFEHSITGDELMQLSEKELEESVMTT
NIFTRMFPEAKLRIINALKAKNQIVAMTGDGVNDGPALKAAHIGIAMGKKGTEIAKQAAS
LILVDDDLSKMVTAIAMGRKIYTNLKKAIQYVISIHIPIILTVFIPLALGWIYPNILSPV
HIIFLEIIMGPTCSIIFENEPMEKNTMSQKPRPFTTTFFNWNELTTSIIQGLVITIGTLF
VYQYAVYMLYDEALTRTMVFTVLITANIFLTLVNRSFYYSIFTTLKYKNNLVLLIISITI
IITGLLLFVPSLTTFFEFKKLNFSQLVICIGIGFVSVIWYEFVKIKTRLKSNKI
>FCMOIPGL_01160 hypothetical protein
MKREYHKWYSQHLEKEMELLIFGYAGTKVLFFPPRMGRFFDYENWEIISALKQKIINGEL
QVFCVDSVDLESFYNSFKDPGYRIYRHIQYENYVIEEVLPLANLINSNKNVVSAGCSLGA
YHAVNIAFRHPDLFTKVVGMSGRYDLTKSSGDFKDLLNGFHNDFVYFNMPNQYLKNLKDS
DLISEITKLDIIAIGKEDSFLESNLKLSDILKEKGVPYNLYIWNEEAHRARYWRKMVEIY
F
>FCMOIPGL_01161 hypothetical protein
MFWFHPDLERLENQIQELEYDPKLIFYGSSTFTSWKELTTIFRKHNPVNLGFGGSTLAAC
AWFFDRVFENIKEIDAIIIYAGDNDLADGRHPEEVILFLENLLLKIRTKYGNIKCTFISI
KPSIARSYLLKSIHYTNHKIKQLLYNDDDCYFVNIYDLLLDKKGNPDGKYFEEDGLHFNS
LGYQLLTKALKKHPEIFPKKILHKMF
>FCMOIPGL_01162 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKYIRILLLSFTLVLMACDHPFEFSVYEANVKSGQRNTTEKNLKLLEDITINTKEFKFAF
ISDVHFFYDQLRTVIEDINKRDDIKFVIFGGDIADQALLREYEIFYDMMEDLKKPYLTVI
GNHDYNNNGEIIYKKMFGDYNYSFDFNNNKFVLFDDIVWESEKELDFDWLTSQLKGNESY
NQVFVITHIPPYGDQFDDELREKYRSIMSEYKVPLSIHGHTHSFNYEQGEVSYLTAPAVK
AKAYNIVSVEDKGFSVELIEL
>FCMOIPGL_01163 hypothetical protein
MKIRKIFTLPILLLFFNNSFAQEAVSVKEKSWYVPDYVKAQFAGNIGLVSVGAGYQLFNR
VLYTELLYGFVPKFASRADNIHLITIKNTFPIYRKEIGKNLTITPIAGFATTLDIGTNTF
TTLPSKYPDGYYVPTAVHFTLFGGALVHKDFKKPKLFKGVDFYLEFGTVETYLWYALTLK
EVSVLDVFSADIGVNFYF
>FCMOIPGL_01164 hypothetical protein
MITKIEHVNITVPDIDAAVSFLQIIAPDFKIKKDEKPINDKRWMHIGNDEFYFALQEAPI
ATHPIKPNQTYINYGFNHIGLVVNNIDKIEKKLIKSGYQKGIDTPKETFRKRIYYFDNAG
FEWELVEYLSEKNEDKYLYE
>FCMOIPGL_01165 Argininosuccinate lyase
MKLWDKGFSIDKQIELFTVGNDREIDMHIAKYDVQASLAHAIMLESIGIITADELKDLKS
GLEELASDIENGTFIIEASFEDVHSKIEWELTNKLGEVGKKIHTARSRNDQVLVALQLYY
KENLSIINDKTKTLFDTLLGLAETHKESLLPGYTHLQVAMPSSFGLWFSAYAELLIDDVY
MLNAVAKVVDQNPLGSAAGYGSSFPIDRELTTKELNFATLKYNVVAAQLSRGKSERSIAS
ALGGLCNTMSRFAMDVCLYMSQNFGFITFPDELTTGSSIMPHKKNPDVFELIRGKCNKIQ
ALHTEMVMITNNLPTGYHRDFQLLKENIINAFEDVKDILDIFNYSIQQVIVKDIDLNDEK
YQYLFTVDSINNLVVEGMSFREAYQKIGGQVQAGTYKPDLGKQHTHVGSIHNLSLDKIAE
KYPK
>FCMOIPGL_01166 Acetylornithine deacetylase
MNIEKLTENAISLLKNLIETQSFSQEEENTAKLIEGWFIENEIPFKRTKNNIWATNKYFD
ESKPTMLLNSHHDTVHPNTAYTNDPLKAIVEDGKLYGLGSNDAGGCLVSLIATFTNFYAQ
ENLKYNLVIVASAEEENSGPNGLNSMLPIIPHIDVAIVGEPTLMNLAVAEKGLVVFDAVI
EGTPSHAAHPNNNNSIYNSIEVLQWFKDFKFEKPSVALGDVKMTVTQINAGKQHNVVPAH
TNLVVDVRVNDAYSNQEIATILQEQSPCTKITPRSLRLNSSSISTDHDLVKAGIAMGRET
YGSPTLSDQSVLSCQSLKLGPGDSTRSHSANEFIYLAEIEEGIKIYVELLNRVIV
>FCMOIPGL_01167 Acetylglutamate kinase
MEKLSIIKIGGNIIEDETSLNDFLKLFSNLEGHKILVHGGGKRATHIASKLGIESKMVNG
RRITDAETLEVITMVYGGLVNKNVVAKLQALNIDAIGLTGADINSIKSEKRPVKEVDFGF
VGDVKEIAHNSIDKLIKADFTPVFCAITHNGNGQLLNTNADTIASTIAVGMSEIYETSIY
FCFELNGVLRDFNDKNSVVKVINSKTYQKLLVDKIITDGMIPKLDNCFDALNNGVSRVNI
GNTSMLTKENDNFTTITL
>FCMOIPGL_01168 N-acetylornithine carbamoyltransferase
MKNYTSINDIEHLDDWIQEAKEIKRNPLSNNHLGKNKTLGMLFFNSSLRTRLSTQKAALN
LGMNPIVMNVSGDAWGIEFGDGTIMNGTTAEHIKEAAQVVSQYCDIIAVRAFPTLTDKEL
DESEQVLKSFVQFASVPIVSMESATGHPLQALTDAITISENATKKRPKVVLSWAPHVKAL
PHAVANSFVQAMQKMDVEFVIANPEGYNLNSEITKNTPIYNNQEQAFKDADFVYTKNWSS
YNEYGKILNTDPNWMITKEKIGDAKFMHCLPVRRNVVVEDAVLDSDSSLVIEQANNRTFA
AQIVLKKILENN
>FCMOIPGL_01169 Glutamate 5-kinase
MQKKKRILLKIGSNTLTKETDNISRGKIEDLANQIAKLKDTCEFVIVSSGAIAVAKQFVK
LESKHEEVFVKQALASIGQPHLIRIYQEIFREYGLLTSQCLLSYSDFERDQSKINIVNTI
NVLVQNNYIPIINENDTVATDEIQFGDNDKLAALTATLLEVDLLIIATNTFGIYTKESIK
NNEPKTILEVHNLNELLNEVVNSKSTHGSGGMQSKIEAAALAKKANIETWIVNGLEDNFI
ANAFKNQVPFTKIK
>FCMOIPGL_01170 Gamma-glutamyl phosphate reductase
MNTLLSIETRNAVLLTMAVLLEQERATIININKKDLEAYKGDDISMFDRLKVDDSKVDEM
IKAAKHLASQEDPVGLVRFSFKHDNGMQVYNKTASFGTVLIIYESRPDVTVEAAGIAFKS
GNKILLKGGKESLNSNLKIVELWHQALKQHYAATDWVEYLQFNRTETQAFLEKPTQKVDL
IVPRGGERLIAFVKQHATCPVIISGRGNNFVYVSKEADLDIAIAVILNGKSKISACNAVD
KVLIDQNLPNKNKFISTLISKLNEAKIQVLGDETISKSHQLEQISSNEVWYEEFLDYKIV
IGEIESNSAAITMINTYSGGHSSVIITKNEAEAKLFMENVDTAAVYHNASTRFTDGGQLG
LGGELAISTDKLHQRGPIGLQHLVTNKWYVHGNGQVRS
>FCMOIPGL_01171 Acetylornithine aminotransferase
MPLFNVYPLYDVTPVKAKGVYVYDENKIEYLDLYGGHAVISIGHSHPKYVEAISKQVSKL
GFYSNAIQNPLQVKLANKLETISGCKDYELFLCNSGAEANENALKLASFKTGKSRVIAFK
NGFHGRTSAAVAATDNKNIIAPINAQQKVTILDLNDIEAVKTELEKGDVCAVIVEFIQGV
GGLDEATKEFFEEVDVLCKANNTFFIADEVQSGYGRSGKFFAFQHYNVTPDVISIAKGMG
NGFPIGGILIHPCIEAKFGMLGTTFGGNHLACAAGLSVIKVIEEEKLIDNVNEMSCYFIK
IAKTIPQIKNIKGKGLMLGLEFDFEVGDLRKKLIYEYHIFTGGAMNKNLLRILPPLTIKK
EHIDQFFEALVDALDE
>FCMOIPGL_01172 Pyrroline-5-carboxylate reductase
MKVAIIGAGSLGQSISKGLLKNKVVSSLYLTKRNTNSIKDFNDFNEVILTSDNTEAIKNS
DILIFAVQPRHLETILTSVKPLLHKNHVLISVITGFSIAKIEAIVGENHFIIRSMPNTAA
SVGQSMTCLSPNTKGKEKVELAQTIFNSLGVSLEIPEEQLQAATVICASGIAFWMRLIRA
TTQGAIQLGFEADVAHKLAMQTCFGAASLLKESGRHPEAEIDRVTTPGGCTIEGLNEMEH
QGLSSSLIKGINKSFDKINQIKN
>FCMOIPGL_01173 N-acetyl-gamma-glutamyl-phosphate reductase
MKNLEIGIIGGAGYTAGELIRLLLNHPETNINFVYSTSNAGNKLYKVHQDLIGDTEINFT
SEINADVDVLFLCLGHGNSTAFLAKNSFSDTTKIIDLSNDFRLLADKNFDGKDFVYGLPE
LDKEIIKTAKYIANPGCFATALQLAILPLAANGLLQNDVHINAVTGATGAGTSLSETTHF
TWRDNNFSHYKAFNHQHLGEINQTVHQLQPNFNSKINFMPNRGDFSRGIFATTYTKFDGT
LEEAKKMYKTYYKDAAFTFVSDESIFMKQVVNTNKCLVQLEKHGNKLLITSTIDNLLKGA
SGQAIQNMNLMYGFKETLGLNLKANYF
>FCMOIPGL_01174 Argininosuccinate synthase
MKKLVIAYSGGLDTSYCAVSLSKEYEVHAVSVNTGGFTTEEIKHIESNAYKMGVSTYKNI
DAVSTFYNKVVKYLIFGNVLKNSTYPLSVSAERIIQAIEIVEYAKSIGAEYIAHGSTGAG
NDQVRFDMIFQTLAPGINIITPIRDQKLTRQEEIEYLKSEGIDMPWEKSKYSVNKGLWGT
SVGGVETLKSELPLPNEAYPSQLEKEGEEKVTLTFKNGEFVALNGEENKPEINIENLNNI
ASKFAIGRDIHVGDTIVGTKGRVGFEAAAALITVKAHHLLEKHTLTKWQLQHKEYLSSFY
GMHLHEGQYLDPVMRDTEAFLQSSQKMVSGNVVVSLKPYHFSLDGIISDHDLMSSAFSTY
GEENKAWTADDAKGFIKILGNQNKIYQQVNK
>FCMOIPGL_01175 hypothetical protein
MEIVIANKSHTVYADIICKTIEDAAQVRGTGIAKRKPEYVATKMENGNAVIALDGDKFAG
FCYIEKWGHGKFVANSGLIVHPDYRNIGLAKLIKQVIFNHSRTKFPDAKVFSITTGLAVM
KLNTELGYKPVTFSELTDDQSFWDGCKTCRNYDVLTRTERKMCLCTGMLYDPNNKITEDP
KEVKENVFKRLKHIKQSLFLKKEKK
>FCMOIPGL_01176 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MFDLKKIISANQTKETDNYTIKKEGISSLKLMERTSLSFVNAIHKNIYNYSKIVVICGVG
NNGGDGFAITRILQAKGYLAEAILIKTANNLSLDCKTNFNKLEEVTIIKSEDDLFDFNKF
DIIIDAIFGSGLTRKVEGLAAKTIKSINEVKKHVFSVDIPSGLYCNQLPDSDFIVKSDLT
ISFQRPKLSFFFQESNQYIKNWKVINIGLDEDFIQKLPTNNFVLDSTISKSVKKREKHSH
KGTFGHALIIAGSYGKIGAAVLASQACLKAGSGLLTTYIPNCGYNILQISTPEAMCLTDK
KKKYISELPDISSYNSIGIGPGIGKKDATKEVLKQLFESTKVPLVIDADALNIISENREL
LNILPKNAVLTPHPKEFERFVGTWKTTIECFEKQKQLAKEHECIVVLKGANTCICNPEGT
LFFNISGNPGMATGGSGDTLTGIITGLLAQGYPPIKAALIGVYFHGKAGDYADEQKGENA
LIASDIINYLKIETE
>FCMOIPGL_01177 hypothetical protein
MKFLVAIIVTAVLFFSNKITAQENVSITATVVNVTSDEGKVSFALFDKENFRIKSLQSVL
SEIKEGKSMVSFTDIPSGEYAIICFHDKNENNKMDFATNGMPLENYGASNNVMNFGPPKY
EDAKFVVADKNVSLEIRF
>FCMOIPGL_01178 Sensor histidine kinase YpdA
MTSSNSSFLNVIKKDAIVCTKLTVVLGVFFIIVNQQFSVVGMAYVFLISGMYSFVLGLGN
GVINEYLNTKWDWVKETNKRVWGGIIATVLYTVSAVLVIHFIQYILLFGHDINNFFKGEL
VWIHLITIIFSLGVAAFFHARGFMVNWKLAMTQETTKQEIVAKTETAKFESLKSQIDPHF
LFNSLNVLTSLIGENPAQAEKFTTKLSKIYRYVLEQRNKDLITLTEELKFAKTYMELLGM
RFEDAVKFNIPDAVSNPDLKIVPLSLQLLLENAVKHNVVSSSKPLTIHIYEKDDYLIIEN
NINPKEAIGKSTKVGLQNIADRYGLITPKGVKIENNNKTFKVSLPLLIKMENSMYQDNLE
NSKYVKAVERVEKLKEFYQNLASYCLVIPFLIFINLRFSPGFHWFWFPIFGWGMGLIFHF
LEVNNYNIFLGSNWEERKIKEMMDKENKHKNYR
>FCMOIPGL_01179 hypothetical protein
MEPNFTEEQRYILAKKRVEKISKFYKHLAVYIVVNIFLSAIFIVGDINDGDTFNEAVFNY
HNYKIWLFWGIGIVFQALNTFGLTLFMNKDWEQKKIKEYMNDKKI
>FCMOIPGL_01180 hypothetical protein
MEANNVQQERYLRAQKKVKAIKGFYTHLTIYCIVIPIIIYVNLTFEPHFHWFWFSTLGWG
TGLFFHWLGVFGFNLLGFGKDWEDKKIKEFMNENK
>FCMOIPGL_01181 hypothetical protein
MESDFRQEQSYLRAKKRVKAIKGFYVHLIVYVLVNIFISAIIIFGLMQNNYSFSDAITNF
GVVSTWLFWGIGMFFHWLGVFGFKSFGLGKDWEERKIKEMMDKDNKFTKNF
>FCMOIPGL_01182 hypothetical protein
MENLTEKKMIRAKQKVEDIKKFYKHLVSYILVNLFLTFVWSFSFKLFGDFIVSNQFDEDG
FKYIPFWLIWGIFLVFDALKTFDILNFHGKDWEEIKIEEFMKEEK
>FCMOIPGL_01183 Sensory transduction protein LytR
MNVLIIEDEKPAARRLSRMLAALDIEAKQMLHSVEESLNWLQNNEHPDLIFLDIQLSDGL
SFEIFEEIEVKSAIIFTTAYDEYALKAFKLNSVDYLLKPLDEDELKVAVDKFKENQPKQS
DVQVNIDDIRKLLINPVDRKFKKRLSIKVGQHIKIIPIDDIECFFSENKSTYIHTLEKRN
HLLDNSLENWEEQLNPEHFFRVNRTFIVHINAIKDIISYTNSRLKLILNSYSETEIIVSR
ERVKDFKSWID
>FCMOIPGL_01184 hypothetical protein
MTLLEAQKDMRNSYFGGAPGAFVSGFVWLASGITALINTQKISVLVFFFGGMIIHPLGMA
LCKALKRSGKHKKENPLANLALESTILLFIGLFIAYSILQIQANWFFSIMILIIGARYLI
FNSLYGNKIYWIFGAVLILAGVLGILFSKYFYLIVIVGGIIEIIFSLIIFYLEKKTK
>FCMOIPGL_01185 Mannosylglucosyl-3-phosphoglycerate phosphatase
MKNRFIFLLTILLLITGCSKNEQIKIVTSEEKNLTIFFINDQHGQLDNFSKIKHIIDLEK
QETNVLTVCSGDIFSGNPVVDNHPQKGFPMIDLMNRVGFDVSVLGNHEFDYGELILTDRM
SQANFDWVCANVDMSNSSIPDPFEYKTLSVEDIKVTFLGLVETNGSDTQTIPSTHPWRVQ
NLSFERPESVITQYADIKSKEDSDVYIALTHLGFNTDSQIAEQYPYFDLIIGGHSHQEIN
TTINNIPIFQSGANLNNLGKIELTIKDKTVQEINYELIDLNAYSKYDADLKAIIDDYNDL
PYLNEIIGFSHLYHYKSQVGCFYTDALKGAMNVDVTFQNTGGVRSTLNEGDITNREIFEI
SPFNNGTVIYEMTVAEIKNFLKGAGSGFYFSGINIEQNGNYIEIKDLNNNTIPDATILTI
GTNDYIPAVYEDYFPANGKVQLLTAAETILSYLNNYNDQVNYPNCNHYFRYQ
>FCMOIPGL_01186 hypothetical protein
MKKVIIFLVVVSFMNCSNNDNDSENEVAINLVTGINLVDTFGSKTGELGNPNKFNNNNFV
FYPNPSVDLLNIKSVEKISKIWITSANSSKKYLQTDFNSILNSDLYIEDEIESNAKLKFI
DLNSSEIKIDLISLEIGYYRVFVKINESIYWENIFVGVNNAEIDDLINYWK
>FCMOIPGL_01187 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MNIYKQIEAEIKAASNIVITAHKSADGDSVGSSLGLLYFIEKLGKKAMVCHPDKAPDFLD
WLDTSAIILMDENPEEVTSEMQKADLIFSLDYNATNRVGPEMQVLLEEATCKKIMIDHHL
NPDEFPTITVSETTASSTSQLIVDLIEQSGHLELLDEKIGTPLYLGILTDTGSFRFNSVK
PRTHEVLAKILAAGVEHHLIHEKLSDNNTETRLRLQGYAMSEKLEILYDHNVAIISLSKE
ELAKYQYKKGDTDSLANLVLSIKGMKAAIVFTERDGIMKISFRSKGAENAVNFLAKEHFN
GGGHANASGGMSDLTVDETLEKLKGLIPEYFPKG
>FCMOIPGL_01188 hypothetical protein
MAKKKAFALRINEDMMKAVEKWAADEFRSTNGQIEWMLMQALKDAKREPKKKDE
>FCMOIPGL_01189 Putative aminoacrylate hydrolase RutD
MIRVITYLIVSIFGILVSFGQIKSEEITIKNDAIELPGTLTFSEENAPLIIWVHGSGVVD
RNGNQPNYIQQFREAVNKENIAFFSFDKRTANKNNSKYLKDTKFTDFALDIDVIVNHFKK
DKRFTKITLIGHSQGSLIAMLASKNIDKYISLAGAGETIDKTIVKQIGKNNPTLGEAAQQ
QFDTLKAKGKIETVNPFLISIFAKQNQEFLYEWMQINPTEEIKKITIPTLIINGDKDLQV
KIEDAENLKNAKPNAELVIIKNMNHVLKNIEKEEDNLASYYSANFPLSEKLITTIVEFVK
K
>FCMOIPGL_01190 hypothetical protein
MKVFKEEQRFTQSWLIIILIIALIGPLCFGIYGIVQQIFLKKPFGDQPMSDTGLLVFTFV
MLCFSILIFLFKLTTKIDEIGIHYQFYPIHFSLKTIKWSEIKAARVRTYLPLSEFGGWGF
RSGFFGNKGKGKALNISGDIGIQLEFKNGNKLLIGTLKEAEAKSVLETYQNKII
>FCMOIPGL_01191 hypothetical protein
MKEYKVVQPKLSFRNRLQSMEDNLNQYAREGWNVINIAPNWSNIVLEREKNR
>FCMOIPGL_01192 hypothetical protein
MKSEKIIKPANGYLMLLVVLVLFFGGIATSFIKENPIFLPASIIGFIGFFGFILVNPNTS
KVILLFGKYVGTIKDNGLYWANPLFRKKSISLRASNFDSERLKVNDKLGNPIMISTILVW
RVTDTYKAAFDVDNYENFVRVQTDAAVRKLASMYPYDNFADEGHDEDITLRSSVNEVSEA
LEKEIDERLSIAGIEVLEARIGYLAYAQEIASAMLKRQQATAIVAARHKIVQGAVEMVEM
ALNELNKKQIVELDEERKAAMVSNLLVILCGDKEASPVVNAGTLSH
>FCMOIPGL_01193 hypothetical protein
MKIKLLLLIPFLFFMKSSSDDAYFWGKNGHRVTGKIAEKYLTRRTKKRVDKILKGHSLAF
VSTFADEIKSDRKYSKYYPLHYVNMDLDQTYEQAEKNPQGDLVTGINESIAILKDKNSTD
EEQNFHLKMLIHYIGDLHQPMHIGQKEDKGGNTIQVQWFGNGANLHSVWDSKMIDDWEMS
YVELAENADDLSKKQIEAIEKGTIIDWVNEVHAITKEVYNSVKVGENLRYKYSYNHFATV
RTQLQRGGIRLAKVLNDIYN
>FCMOIPGL_01194 Thiol-disulfide oxidoreductase ResA
MIKKTIFIFLFSVGFVSCKKEVVKETNTQKVAEVILVKTYNYSELKPFLEKKDDKIYVIN
FWATWCAPCVKELPFFEKIKQKYADKNVEVLLVSLDFPKQVEKKLIPFIKKHKIQSEVVL
LDDVNEDVWIKAIDENWSGALPATIIYNKNNRKFYEQSFDYETLESELLTFIN
>FCMOIPGL_01195 Thiol-disulfide oxidoreductase ResA
MKTIKTALILSVFAFITVAFTVKTDAGYKVGDIIEDFKLKNIDGKSVSLSDYKEAKGYII
IFTCNTCPFSVANEDRINDLDAKYKSKGFPVIAINPNDPKASRGDGFEDMKIRASEKGFT
FPYLFDEGQKVYPKFGASKTPHVFIVSKKEMTVEYIGAIDDSSRNPDAVTEKYVENAVDA
LLLGKKIEKTETRAIGCSIKSGKKS
>FCMOIPGL_01196 hypothetical protein
MYRVIYSFIFFLVTNLTFSQELPPINIFSAENYGAANQNWAITQASNKFIYVANNEGLLE
YNGASWQLYPTPNETIMRSVKSFKDKIYTGFYMDFGFWKKNDFGLLEFNSIVKEHDIKML
EDEQIWEIFELDGWMIFKSLERIYLYNIKKNTVKIIKSESRIHKLSIVDEIIYFQENDRG
VFRIENGIAKLVSDDPVLKNNRIVDFFVKDDKLLILTQKEGFFFLEGKVLIPWKIPADQF
LSDKTIYSASHLKNGNFALGSISSGLVYLRENGELDYHITQTLGLGNNTVLSVFEDIDNN
IWLGLDSGINSINFKSPFKLFVKKNNFWGTIYASIVYKDYLYIGTNQGLYYREKDSDNAF
SFVTNTQGQVWNLQIINNTLFCSHDFGTYIINNNKAELIKGVVGTWGLEKINETTLLQGN
YEGLYILTKEGSSWKLRNKIAGFSNSSRYFILTDKNKIFVNHEYKGVFKLEIDKDFRTVL
KISKDKSVEKGIHSSLIKYNKDIFYSSKKGVYKYEAAKDQFILDSIYSKLLPKDVFLSAK
LLYDKPTNKLWSFTKEDIRYFTPGKLSNKPKLEIIPIKGSVHKGATGFENILYLNDKKYL
IGTYDGYLVVDLNNVIQPKDFLVSINRIYNNELDKPQNKISLLKKTAFKSSENNFEFFYS
VTNFNKTSSVNYQYQLVGFNEKWSKLSNSNSLLFENLPPGNYTFKVRALVDQKVSENVAK
YAFEIDKPWHLGSFMVIVYVLLFIYLGYITNVLHRKYYRNQREKLLEKAQKELELQELEN
SQKIIKLNNEKLRNDIEGKNRELATSTMSIIRKNEFLSSIKTELVSGGKDSLNKVVKIID
KNLNNTDDWKMFQEAFNNADKKFLDKIKTKHPELTPNDLRLCAYLRLNLSSKEIAPLLNI
SPRSVEVKRYRLRKKMNLPHDENLTSYIIEV
>FCMOIPGL_01197 TonB-dependent receptor SusC
MRKKGSLLLFMFISFWATAQTLNVKGVVKDAATGDALPGVSIIIKGTTTGTQTDFDGLYS
LSKVAKGSVLVFNYLGYKKKEVIVNEETINASLEESAESLDEIVVVGYGSQRKELVSGAF
SSISSEKIAEANPTRIEEALKGSAAGVQVTANSGSPGASLNIRIRGVTTNGDNSPLVIVD
GVNIGSDLSIIDPNDIEKMDIIKDASSAIYGVQAANGVILITTKGGKLNRKTKFSLNSYI
SFQEASNKLDLMNASEYAIYVNETEVADGNQIPFTNISSYGVGTDWQDALFTTSPIVSHT
LGATGGSDKVTYGFSASYFNQEGIIAPEKSNFNRFTLKNNLGIDLTDKLKLNTFLLYTNI
KNRSINESGRGSTLYYALNASPLTSIYDGTDGTGPSGGFSYIADNQGSEIVNPLALIDNT
NNVTRTNRFTGKVELVYNVLENLKATSRYNFNYSDVVNRQYFPISYYGAGKVVNSVNLEG
GAFDLDRNDNGTTDVFSTVYENNQNYYDFTFENFIDYNFSIEDKHNFNVLAGTSLRSEQF
YGAYATGFLTVSADRDNWSNAYLFNTQSFIYDEALDVDGNIDSDNTLRQNNNASTGVLED
RWYSFFGRIQYDYESRYLFSAMLRRDASTRFGPDNRFGYFPSVSAGWVINKEEYFNVKAI
DRLKLRASWGITGNDKIGSYRYLGFLQGTNGSEASYSFGNNLYYGNAIGALANPDLQWET
NKQLNLGFDVSLFSNKLDVTFDYYKKRTENLLLVADVSGLVGASAPGSSAPVVNAGTIEN
KGFDVSINFNHEISEDLKFSLGVNATTVKNKAIEVNNAAGFFSGGLFDLAQTTSRFQTGL
PIGVFYGLKTDGIFQNQAEITAHATQSGAKPGDIRFVDVDGDGVVEFGSSDDQTVIGNPI
PDVTLGANLNINYKNFDFATSIYASIGNDVARSYERFLTYSNKPTLYLDRWVGEGTSNTV
PRATTTSTANTLFSDFYVEDGSYLRIQNVQVGYSLPAGVLEKLNMDKLRVYFAVNNLYTF
TKYSGYNPDVSNSSPLGAGVDLGQYPQTRTFTTGVNLSF
>FCMOIPGL_01198 SusD-like protein
MQNKITKIITLLVLAFSFNACDDYLDITKEGEQSSENFFNSQQDYEDALIGVYDLLGTNY
LNHILGEIASDNAYCGGERPDDVTDWQQIDDMIHTPDNEALRNVWKWMYAGISRANYIVE
FQDKVDFSRKPELLAENLFLRSYYYFELVKFFGDVPLFTENRVSVADSQSAERTAKADVY
AKIEADLTAAIPNLPWVQTQPGRATKGAALALLGKIYLFDKKYDEAATEFQKVISSGQYQ
LVADYSTIFLNNNENNSESVFEIQYSIGVEGASYDFLEGSEGNVAAGFMSPRFTGDRTNW
APYDDGNTFSTPVQALVDLYVAGDSRLNPTIFNMSDFVAANPAVTFDTRNEYTGYYNHKY
MVYQESNLGDTRITHGNNYRAIRYSDVLLMAAEANLLASAQKNNPQDLLDEVRDRAFGDS
DHRVTANLDNILLERRLELAGEGHRFFDQVRTGKTITISGFKTEKNELFPIPRIEIELAG
NRWCQNKGYATSTCSTN
>FCMOIPGL_01199 hypothetical protein
MKIINKITKVFIIILMIYACTDDDNLSFLDNIPAPSNVSAVFNITQDNTGVVTIMPVAEG
ATVFDIYFGDGTVEPETINQGNAIEHTYLEGTYQVKVVASNIKGDTVEITEELMVSFKAP
ENLVVSIENDAAISKQVNVTATADFATVYEFYSGEDGVTQPVVTSNIGEAVSYVYANPGI
YAIKVVAKGGAVDTTEYAADFEVTEILAPIISASIPSTREDEDVISIFSDKYTDIADTDF
NPNWSQSTLYNVYDLNGDKMIQYSNLNYQGIDIGSEIDASSMEMLHIDIWTTDATSIDIF
PLPNGVQPEDERFVTKTLVADQWNSFDIPMSEFTSQGLSVDKLKQFKFVGSGTIFIDNLY
FYKQGSGVIFDDGLLTNGDFENGSDSWLIGVDDSTSAPVVTEGGNTYYSVDVTAAGNSYD
VNTSQKVEIIQGNTYTLTFDAWSNVNRGIIAGIGLSKDPWTNKSETVNITTSKTTYSLTL
SAAEFGATDARVIFDLGAEIGIVNIDNVSLIIGTGNIVVNGDFENGSDSWLIGVDTSTSA
PVVTEGGNTYYSVNVTAAGNAYDVNASQILEIIQGNTYTLTFDAWSDVNRGIFAGIGLSK
DPWTNTVETVNITSTRTTYTLTLTATEFGAADARIIFDLGAEIGMVNIDDVSLSSN
>FCMOIPGL_01200 Beta-glucanase
MKKIKNIYIVLFSLITVFYSCQENKYEVGEIVVPSNLAISLEVVGQDASNPNGDGTGFVV
FTATSDDVINYQFDFGDGKKDVEPTGVITHRYTEVGVNSYTVIVNATGTGGLSTSTTIDV
TIFSSFSDVEAGNFLTGSASEEDFGSSKKWYWQADKDVHVGLGPVTDDYGNGEFAYEAWW
NGIKAWDTEKSCMYDNEFVFTRTANGITFEQTVGPAFVPGTYADVLGVTGDTCQDETVAT
SMFGVKTVTMVPSESKAATEGTYNNEPYRGTTFEISDGGFMGWLVGSSTYDIISISNDEL
IVRIIQDGDGFAWYHKFTSTKPVEGAVSYTYNDLVWEDDFNTDGAPDAANWTYDLGAGGW
GNGEAQTYTNELENAKVENGSLIITAKADGSGGYTSARLKSEGLYDFTYGRVEVRAKLPT
AQGTWPAIWMLGSNFSTVGWPKSGEIDIMEMTGQDKNTTLATCHWFDEASQTKADYGTTT
AITNVDSEFHLYTLEWTDTAIKMYVDGVSFYELTNNSDLPFNDDFFLILNVAMGGTLGGD
IDAGFTEDIMEIDYVKVYQ
>FCMOIPGL_01201 hypothetical protein
MKSTFIAFFIILITLSSCAQKNNVAVVSNDQGVKLKVNGKDFFINGMNWDYFPIGANFEY
SLWNQSEDFIEKALESEMSLLQKMGVNTIRVYSGIPPKWITHIYKHYGIYTMLNHSFGRY
GNTINNQWIPVTDYRNPETQKGLLSEVTNMAKAYKDTPGLLLFLLGNENNYGLFWAGSET
EDFPDDENQKREMGEKRGRPMYKLFNEAAKLIKEIDNNHPIAVCNGDLLFADMFADECKD
VDIFGTNMYRGKSFGDAFVRVKKEINKPILFTEFGADAFNAKTNAEDQKMQAYFMIENWK
EIYLNAANLGKANNSIGGFTFQFSDGWWKYGQTKNLEIHDNNASWSSPGYHFDFTEGSQN
MNEEWFGICAKETPDQEGFYVLKPRVAYYAIQEIHQLNPYKKGLTKEFISNYFKNIQAKH
TGLIKE
>FCMOIPGL_01202 hypothetical protein
MSKTVSYKDNVNSNPNTAITGELVTLENESYYKISNSHTMRPFFMTIVSDSNHWMFISSN
GGLTAGRKNAEYAIFPYYTDDKITELAETTGCKTIFKIAKNNKTVLWEPFSERQAGLYHI
TRNVYKNEYGNKVIFEEINHDLNLTFKYQWNSSDQFGFVRKASLINNTDENLDISILDGF
QDIIPYGVGSDIQGIRSNLVDAYKKCELEAEVGLGIYALSAIIVDKAEPSEALKANLVWS
LGLENPTYLLSSLQVNNFRRGLQLQQEVDMKAEKGAYLINADIHLPSNSEKKWLQVANVN
QTVADVTRISELIKTNDNLEELLQNNIEAGTKNLINLVAASDGLQLSNDPLINTRHFSNT
LFNIMRGGIFDDNYTIEKDDFTTYLSKANKPLFAAKKESLANLPEKFTLTFIKNLAENDA
DKDFKRLCLEYLPLKFSRRHGDPSRPWNKFSINTKSEIDGSKILDYEGNWRDIFQNWETL
AHSYPQFIESMIHKFLNATTFEGYNPYRVTKGGFDWEVIEEHDPWSYIGYWGDHQIIYLL
KFLEFIEKHYPSKLAELFNDDIFVYANVPYIIKPYADILKNPKDTIDFDHQLNAKIDEKR
AEIGADGALISNKNNKVHKVNLIEKLLVTVLAKVSNFIPEGGIWLNTQRPEWNDANNALV
GNGVSMVTLNYLRRFINFFEGIVANADVSEVQISDELATLFAEIVETLENNEAILSRKVT
DKERKTVLDGLGNPASEYRTTIYKNGFSSNKTTISKSALAHFLEITKSYLEHSIRANKRS
DNMYHAYNLMTIENDEEVSISYLSEMLEGQVAALSSGYLSPKEALDLLDGLKASALFRPD
QYSYILYPNKDLPRFTQKNNISANQVESSKLLQQLIADNNIEIIEKDVLGNCHFNGNFNN
ANSVKAALANLSEEYSSLISEDENTVLSIFEDIFDHKSFTGRSGTFFGYEGLGSIYWHMV
SKLLVAVQENCLLAVKLGESEKVIGRLLDHYYEISAGIGVHKSPELYGAFPTDAYSHTPA
NKGAQQPGMTGQVKEDLLSRFGELGVFVKEGKVVFNPRLLKVSEFLNDAKAFTYINVNSE
KAALDIAKNQLAFTYCQVPIIYNLSDKNTIDVIFNDDKKVVFDGLELDKETSTKMFDRSN
EINHIKVSIVK
>FCMOIPGL_01203 Beta-glucosidase BoGH3B
MKISYFIYLICSFLLIGFSCTKEIKISKEDVIEQKVDSLLKLMTLEEKIGQMSQIRHFDQ
AADSLITSNFIGSIIHTQGPNPGKTALEWQNRFYELQKKALSTRLGIPLLFAVDAVHGQN
TFDGATIFPHNIGLGATRNEKLVEEIARITAIESQATGFNWVFSPCVAIPFNEKWGRVYE
AFSESTSLTEKLTKAAVNGLQGNLENSKTVLATAKHFIGDGATDFGREGGNTSLSVKEIE
TYLLPPYKVAVQENVGAIMASFNTISGISMHAHKALITDTLKVGMNFKGIVVSDWQGYSR
FGKNDIINAGVDMVMAVDGNVIGYQKGLKEGIENKAVSIVRIDDAVRRILRQKFRLGLFK
NPFPDTTLANKVGVKEHRKVAKQAVRESLVLLKNKEKILPLSKETKKIVVVGEHANSGGL
QSGGWTINWQGTKENYKGATTILDGIKKLSKGEVLYDSTATKNHLDVDVAIIVVGETPYA
EFFGDIGHESNQLRLTLSEEHQKYIKNYQENGVKTIVVLVSGRPLVVTNQIKKVDAFVAA
WLPGSEGDGIAEVLFGDYNFLGKLPHSWPKSEEDYKGEYGPNFWDNSIETLFPFGFGLNY
>FCMOIPGL_01204 hypothetical protein
MPMKSFINIKISILMLVLFFGCNSKKENKTADKQEIKTNMTAAQILGNPDYLAISYGGYR
QKSRENQPTIAQLKEDLKLMFAMGIRIIRTYNVQPELPHAANVLEAIHQLKQEDSSFEMY
VMLGAWIDCLNAWTDKEPNHEVESEQNEGEIERAVALTNKYPDIVKIIAVGNEAMVNWAT
SYYVQPSVILKYVNYLQNLKKQGKLDKDLWITSSDDFASWGGGDSSYRVADLENLIKAVD
YVSMHTYAYHNSHYNPNFWKVPDNEQHLSEKEKIDNAMLRALEFAKMQYKNVSDYVKSID
ATKTIHIGETGWATVSSGHYGVNGSRATDEYKQGLYYKHLRNWTNKAGISCFYFEAFDEQ
WKDAQNPLGSENHFGLFTLKGEAKYPIWSLVDQGIFKDLKRGGNPITKTFNGNKEELMKT
VLVPNTEYQR
>FCMOIPGL_01205 hypothetical protein
MKKTTYFLYTLLSFMILSCQNNQDKLNVEVYETSASGNNLTKLEGFSSDENQKETIKVKL
LPTKKRQTITGFGGAFTESSAYLLNRLSKEKRDTIIQAYFSTEGANYSLTRTHMNSCDFS
ISQYSYSPVADDVNLEHFSVKEDKDDLIPMIKDALKASTDGFKIFASPWTAVPWMKDNNK
WVGGKLLPNYYDTWALFFSKYVDAYKAEGIDIWGFTVENEPLGNGNNWESMHYSPDEMTN
FVQNHLGPKLEADGHQVKILGYDQNREHLKEWIDSQYKNEATSKYFDGTAIHWYASTYEI
FPEELQYAHQKAPNKYLIQTEACVDSQVPVWQDDAWYWQKEATDWGWDWAPEKDKYLHPK
YAPVNRYARDIIGCLNNYVDGWVDWNMVLDTKGGPNWFKNWCIAPVIVDPQTDEVYFTPL
YYTLAHFSKFIRPEAKVIELENTDKDLLITAAENLDGTIAVVVFNEKETPKSIKLSLGEK
NIKIAIQGQAIQTIVVKN
>FCMOIPGL_01206 putative symporter YjmB
MSDKILIKGKVAMGQKIAFGIGMFANQMFPAILGIFMVVLVQDLGFPGWMWSLIYFFPRI
FDSITDPIMGFISDNTKSKWGRRRQYVLIGGIIMGIAYIFMWQLFKENSLQFNFWYFFIW
SIVFYLGLTFFSVPYVAMGYEMSDDFHERTSIMAIAQWIGQWAWVIAPWFWVIMYDPDWF
PSAEVAVRELSIWVAIPCAICAIVPALFIKSKSTLNENYEPLNSSNIGNSLVKIYDSFKE
AFKIKVFRKLCGATFLIYNAFNTVAALTFFVIVYKLFNGDAAESGIWVSLFGCLGALGTT
FLVIPIITKMSKIWGKKKAFLIAQGISIIGYIMLWFLFVPGKPWMYIIALPFFSFGIGSL
FTIMMSMTADVIDIDELNTGKRREGIFGAIYWWMVKVGFAIAGALSGAIIAVVGFNPDLP
TINQQSAVNGLHTFFCFFPVLGTVLAMYIMWDYDIDEKRANEIRLELEKRKELKNN
>FCMOIPGL_01207 hypothetical protein
MSYRKENHISFEKVKVNFSKNIGVEFSQYSKEDIVKLWRETLDSGMHGICFSIYADSQKP
GDFISEEQIERRINILKPYTKWIRSFSCTEGHEHIAKIAKKHGIKTLVGAWLSDDLEKNE
EEIEGLIQLAKKGFVDIAAVGNEVLYRKELTEEELLVYINRVKEEISNIEVGYVDAYYEF
SKRPAITAACDVILSNCYPFWEGCNIEYSLNHMQEMYEQAKKTAKGKRIIITETGWPSKG
SSLEGAHSNAENAMKYFINSQVWAEVDNIEMFYFSSFDESWKVGDEGDVGAYWGLWDKYG
NLKF
>FCMOIPGL_01208 hypothetical protein
MKKITLLIAFLITSIGFAQQQQYHLDFEEGTPSGIAANWFTFDNNPAPAEIIDNPDLDGV
NATASKVMKVVVGPGNAFYAGVNNAWETSKFGTWKIDKSLASNLTLSIDVNKNYVGTVGI
KMGTNSAGTSFQITDQNVNNNVVDQWQTLTWDLSAIEDGLLSDISQIVIFVDWTQDKADR
AEGSTIYIDNIKFNAEKLTDAPAVPVAGTATLPLDFENATTWVDFDGGEVTTVENPHNNA
DNNSANVGKMIKNADKTWGGSSIALASGMDFANNDTFTMKVYSPRVGAKVLLKVENSSDA
NTFFEKEVVTTVANSWETLTFDYAAISKTNIYDKLVLIFDNGTEGDGSANFTFYIDDIAL
SSSGVVVPSVALPLDFESATTWADFDGGVVTTVTNPHNNANNSSANVGKMVKSAGQTWGG
SSLVLSSGMDFANNDIFTMKVYSPRVGAKVLLKVENSGNSGTFFEKEVPTTMANAWETLT
FDYAAISKTNIYDKFVLIFDNGTEGDGSANFTFYIDDIALTSSGVVVPTVALPLDFESTT
IWGDFDGGVVTTVTNPHNNANNSSANVGKMVKSAGQVWGGSSLNLSSPMDFANNDTFTMK
VFSPRVGAKVLLKVEDSGNGATFFEKEVATTIANEWETLTFDYAAINKANTYDKFVIIFD
NGTEGDGSANFTFYIDDVTLFNSATASVVDNDLLNIKMYPNPTTNTLNISAVNTIKNAQI
YNVLGKKVKSLDINKNSESIDVSNLASGIYLIKYQVSNAVGTAKFIKE
>FCMOIPGL_01209 hypothetical protein
MKKITAILALSIILFACSSKKEGNMIVQGQIKGLKKGTLYLQKMADTLIVSVDSIALNGS
DKFILTDNVESPVMYYLTFDGNTTDKRILFFGEQGVITINDKVEKFGFNPKITGSKNQKV
LDKYHLVSKRFQNERLEFIKKDFYAKKADDKELIKKLEEDYNKLVRRRVLYTTNFAITNA
DFEAAPYIALTEMYDASLKMLDTVNASLTPKVKSSEYGKRFQEYLDNIKSDKE
>FCMOIPGL_01210 hypothetical protein
MSEPIFTNDAIVFGVLMISLGFVFYTENLKTGFWPKFYKIVPGLFMAYFIPAIFTTFRII
SPEWETKNIAGEVVKNSSQLYYVASRFLLPAALVLMTLSIDLKAIFNLGSKALIMFFTGT
VGIIIGGPIAILLISIFSPETVGGSDFDAVWRGLSTLAGSWIGGGANQTAMLEIYKYNPA
KYGGMVIVDIVVANIWMAILLIGIGKKEKINKWLKADNSAIEELKEKVIKFTKKVKRNPT
LTDLMVMLAIAFGTVGFGHFAAGYLGSFFSDIVASMSSQTWRNIFSFLDSEFFWLISIST
IVAIVLSFTKARNYEGAGASKLGSVFIYILVATIGMKMDLNQAFENPGLMVIGLVWMTIH
AVLLILVAKIIRAPYFFLAVGSQANVGGAASAPIVAQAFHPSLATVGVLLAVFGYAIGTV
GAIACTILMELSSTL
>FCMOIPGL_01211 hypothetical protein
MRKICVLLCVSLFCYKIQAQNSAENKLGTWYMYNGSHKLSKNIKLKTSAHFRYYELASEY
QQEIYRTGLNYNLTKKVNITGGVVYSITDTSYKSNLPDLYEYRFYQDVNLKDNWNKIQVN
HRVRLAQRFKRKNFEDEVKHRIRYGLFLKYPLSQKWETYAFSEIFIKFAAKAFSQNRTGA
GFIRGINENLKLKLGYFYTKFSNSSLHRLQLGIILNTNHIKNNL
>FCMOIPGL_01212 Xyloglucanase
MKKLLTIFFLSATSLLFSQEFSMDLVKNMKPRNIGPGGMSGRVTAIDVVHSNPEIMYVGT
ASGGIWKSTSGGIKWEPIFEKELTASIGAVAIQQSNPSVIWAGTGEGNPRNSLNGGFGIY
KSLDAGKTWKSMGLEKTRHIHRVVIDPTNPNIVYVGAIGSPWGEHQERGVYKTIDGGKTW
KQILFTNAKAGAADLIMDPKNPNKLIATMWEHKRDPWFFKSGGTGSGLYITHDGGENWKQ
ITEKEGFPKGELGRIGVAIAPNNTDVIYALVEAKKNALYKSEDGGFKWKKINDKSDIGNR
PFYYSEIYVDPQNENRVYSVFTYINVSEDGGKNFKQLMPAYGVDNGVHPDHHAWWIHPKN
GKFMIDGNDGGLNITKDGGKSWRFIGNIPVAQFYHINVDNEFPYNVYGGMQDNGSWRGPA
YVWKVQGIRNSYWQEISFGDGFDVVPDKDDSRYGWSMSQQGSVSRYDYITGNNYGVQPTH
PDANIQLRFNWNAAINIDPFDNATLYFGSQFVHKSTDKGLTWSVISPDLSTNNPEKLKQS
ESGGLTLDATGAENHCTILVIEPSVLEKDMLWAATDDGQVHITKNGGETWTNVAKNIKGL
PENSWITQIKASNKNKGEALLIANDYRRFNYTPYAYRTKNYGKTWERIVDENDVQSYALC
IIEDPENENLLFLGTDDGLYISINAGEKWTKWTEGFPTVPVKDLVIHPRENDLVIGTFGR
AAWILDDIRPLRAIANGNVISKNLALFVPPTAHQVAIQQPTGSRFGADALYQGENRKGGA
IISYYINIPQIEKKEEKSADENDKNSADKSDKTENSIKNDSIKLEVFDGQRLIRTLKFKT
PKENGVHKTTWYFREKGVNRASRSIRESKNEPRGVAVKPGTYHLKMTLGNNISEQDINVK
FDPRLQISEEAINQKYEASKELESYQEKIAAIVKQLVESKNTTETIKSQLSKEDKKKYEL
EIKSSTEIIKKINNLIDIYLGKIDKRQGITRNKEVTINQRLRTASRYVSSRFGKQTATET
QLVHQFKEAFTKAVKETNSFFNSDWLTYKSSVEKIQISLFKEIKTFK
>FCMOIPGL_01213 hypothetical protein
MSQQEEFFEFINDGYATKGDYIELGAAMLGEETVTNAIVKIPLKTLNRHGLIAGATGTGK
TKTLQVLAETLSDKGIPVLLMDIKGDLSGLAQPSPGHPKIDERHAKIGFPFEAKKFPIEV
LSISEQNGTRMRATVSEFGPVLLSRILDLSEVQQGIVAIIFKYCDDNKLPLLDIKDFKKV
LQFITDEGKEEIKKEYGRISSSSTGAILRKIIEIEQQGGDLFFGEKSFDVEDLTRIDENG
RGIISVLRLTDIQDKPKLFSTFMMQLLAEVYETFPEQGDSGRPELVIFIDEAHLVFEEAS
KALLNQIESIVKLIRSKGIGLYFVTQNPNDVPEDVLAQLGLKIQHALRAFTAKDRKAIKL
AAENYPSSEFYDTKEVLTQLGIGEAFVSVLNEKGIPTPLARTMLRAPMSRMDVLTDSELT
TVINNSKLIHKYNQELDRESAYEMLNSKIEKINLAEEKAIKAEADEKERKRNQKSSSRSY
TRKSTRINPIVKVLTSATFIRAVFGILKKVIK
>FCMOIPGL_01214 hypothetical protein
MNKKNFLPLIAIVFLLLIISCNKGDDFKIEKGKVGKISTLTTINDLETIFKNDSIVKNLS
EGALGDDYFQDDDEYLIFEKGGNLLLTITPKEQLDSTSTIKSIEIHDTRFKTENGISLSS
NFSEINANNILRPESTLQSVTLFLDELNATITIDKEELGIKDFITKKISLEQIPDLAKIK
SFIVWFN
>FCMOIPGL_01215 hypothetical protein
MKEFSILHQKETILRPNSEFERRIIFQYYLDNDIKIDKKEREILLECVAVEAENIGIIGC
LLKDKTHINTLRLAIGAKNKSNVKLANLSKIYLENLSIETADNYYALEKDFSTFTKVEVD
VESIYNMIYY
>FCMOIPGL_01216 hypothetical protein
MDKKYTIQNKPFVVPTTDCKLIEEHFGNATDKNSQISIAHMIAPPKWKEPFQTPAFDEYT
YIIKGKKQFIIDDEIVVLEAGQSIKIEKNIRVQYSNPFDDECEYLAVCLPAFSIDLVNRE
DE
>FCMOIPGL_01217 hypothetical protein
MSDTIPSKKIRQVFVLLIILLFAILIFLEMIPYLLGVFGAITMYVLLRKWMAFLVRKKWH
PDLAAGMLMFLSFICILLPVSGIIFMLGNKIGQVVNNSEKVEEAIKNFAVTFENKYGYDL
SSNINVSEISKWLASNLDNFAGSTFNTFIALGLMYFMLYYMLTNRNKLKDSLLEYIPIDD
KNLKIIGKEAVAMVRSNAVGIPLVAIAQGLIALIGLLIFDIKDPFFWFIIVTIGSMIPFV
GTLIGIIPVFVLTISSGNEFTAWGILIYGLLVVGSTDNIIRLFVLRKLDNVHPLITLIGV
IVGVPLFGFIGLIFGPLLISLFLIIMRIYKKEFGV
>FCMOIPGL_01218 Bifunctional protein FolD protein
MILLDGKKTSADIKEEIALEVRELKDKGNKTPHLAAVIVGNDGASITYVNAKVKACERVG
FESSLIRLSEQTTEEELLNEIAILNIDNDIDGFIVQLPLPKHIDEQKIIMAINPDKDVDG
FHPTNVGKMALNLPTFISATPFGILELLDRYNVETSGKHVVVLGRSHIVGSPMSILLSQK
RKVGNATVTMCHSRTQNLKSFTLQADIIIAAIGIPEFLKADMVKDNVTIIDVGITRLADS
SKKNGFRLVGDVAFNEVSEKAAFITPVPGGVGPMTIAMLLKNTLLARNRKS
>FCMOIPGL_01219 hypothetical protein
MSKEITNNLAFENIKKLLFIFLGVCIFFVSNTNGMFWDNVLFASKMGNHLYYNSIFNWTI
PDQFDPGHPPFLGFLLAISWKILGHKLWVGHFLMMPFTIGVFYQLFKFISYFVENQKNQI
LAFLLIIADPTLSTQFVIVNPEVIIVFFFLLSLNGILFKNKKTKFIGLFFLSIVSFRSML
LFGGLFLFDIFNTYLLEKKNLKKILNLKFLLFYFLSALPGFVFVCWRLLTKGWLQTHPDS
PWAGLWGFADLKTFLKNCFFLVHRYADFGRVFIFIFLAIICIFFGKKIITSTKNKQLLLL
AIASVFFIVVISLISTNTFGHRYFIVSYIAFTLLAYTILQQYYKSKKILFSLLFLGLISG
NLWVYPRELSQGWDASLAHIPYHSLRIKAINYLNKENIDIDKVASFFPNLTTLDNIDLRG
DQRAFSKFNTKNKYIFYSNVFNLTDKEYEILDTNYNILKEFNKNNITVIIYILKEK
>FCMOIPGL_01220 Signal recognition particle protein
MFNNLSDKLDKALHTLKGHGKITEVNVAETLKEVRRALLDADVNFKIAKEFTKKVQTQAI
GQDVLTTLNPGQLMVKLVKDQLTELMGGETVGVNLGGSPTVILMSGLQGSGKTTFSGKLA
NYLKTKKSKQVLLVGCDVYRPAAINQLQVVGEQIDVDVYAEVGNNNPVEISLNAIKHAKA
KGKNVVIIDTAGRLAVDDAMMTEISNIHKAVNPQETLFVVDSMTGQDAVNTAKAFNDILN
FNGVVLTKLDGDTRGGAALSIKSVVDKPIKFIGTGEKMDAIDVFHPDRMADRILGMGDVI
SLVERAQDQYDEEEARKLQKKIAKNQFGFDDFLSQIQQIKKMGSMKDLVGMIPGAGKAMK
DVDIDDDAFKGIEAIIHSMTPSERSTPTTINASRKKRIAKGSGTSIQEVNQLMKQFNQMS
KMMKMMQGGGGKKMMQMMQGMK
>FCMOIPGL_01221 hypothetical protein
MKKIITKPHLFFFGLAFVFILLGLYKKDITLDIAVYSTYFEFHADFWCYLSAIFFCLIGL
NYFSLIWAKKTPKVWLTILHIFLQTISLIPFIYGIFSLNSDEKLTQINSFYFIDLDLAIA
ISFIIFLCSIFIHLISFFTSLFLKTK
>FCMOIPGL_01222 hypothetical protein
MKTIIKKPHIFFFSLIPLFIIFAIIKKGGIIDITINNTFFAVKIHYWCYFSAVFTALIGI
NYYMLYWAKKRTVHILSLFHILFQFAALIPFTFCIFFLNTKVVFTKSSIDFYYILSISYI
LFTISICLHILNFILTILRKTS
>FCMOIPGL_01223 hypothetical protein
MTRLQIQQKKLQYKTVHISEKNLDTLVLPHPLMGKMTVREIIMWTAYHTEHHTKTLQNLY
>FCMOIPGL_01224 hypothetical protein
MDKVEIANLLEEKHQQLFSWLENQPIENWEIGPETKWSTSQHIEHLVNSLQLLNNALSYP
RFILKYKFGTCNRAPRDYETVAKNYQQKLLENLEKARVLIKS
>FCMOIPGL_01225 hypothetical protein
MKKIKFPSAQTVLLLIAAFVALLTWCVPSGQYDRLAYNKDDNSFIKTSQEGSIILEASQK
TLDDLEVKIPLEKFTSGAIYKAISIPGTYQKLEAKPQGFIEFILAPLKGIIAVADIIILV
LFIGGLVAIVNFTGAFEAGISRLSNVLKGKEYILIIVVTTLIALGGTTFGLAEETIAFYP
ILIPIFIAAKYDAIVALACIYIGSSIGTMVSTINPFSTIIASNSAGINWTTGIEGRVVML
LIGLIICILYIIRYAQKVKKDPSKSIIFDQKESIEKRFSYQDSLEKINFTFRLKLVLTIF
ILCFIIMVYGVSNLDWWFLEMTGVFFVGALLIGFICRINETVFVDTFIKGANELLSVAFI
IGLARGVTILMEDGLISDTLLFYASSFTEGMNKGLFINSMLFVYSGLSFFIPSSSGMAVL
TMPILSPLADTVSLGREHIVNTYLLGMGLFNFINPTGLILASLAIVKIGYDKWLKFVIPL
VLILTLVSMIFLTISVYI
>FCMOIPGL_01226 Peptide methionine sulfoxide reductase MsrB
MKKLASILVLFLMISCVGNAQNSSKEKKIYKIVKTDIEWKELLSPLQYNVLREAGTERAF
SSDLNNNHKKGTYVCAACKTALYKSDHKYDSGSGWPSFDRAIKGNVELDIDYKIGYARTE
LKCTTCGGHLGHSFDDGPRKTTGKRHCINGAALEFVPEK
>FCMOIPGL_01227 Beta-barrel assembly-enhancing protease
MKKIIVLIVAVFLFSECSTVPITGRKRVNLVSDAQVLPASFAQYQGFLEENKLSSNSKMT
NQVKEVGKNISAAVDRFMRANNMTSEADSYKWEFNLVEDATVNAWCMPGGKVVFYTGIMP
ICANDNGVAAVMGHEVAHAFAKHGQERMTNSYGQQIGGLLVALGTSNKSAESQQMWNTAF
GVGSGLGMLKFSRVHEQEADRLGLVFMIMAGYDGTEAAEVWVRMSANSGGSSQPEILSTH
PSNESRIQDLRSYLPTAKKYAAEYNVKGNLLMKN
>FCMOIPGL_01228 hypothetical protein
MLKIGDKKLINGWAFYDWANSVYSLVISTAVFPLYYSAVTDGKTVIFLGTEWNHPDSLYS
YALSFSFLVVAFISPILSGIADYTGSKKKFMKFFCWLGGLSVASLYFFDGIDTVWIGIVF
TILASIGFWASLVFYNAYLPEVAHPEQQDRASAKGFIYGYAGSVILLIINLIMIQKPDWF
GIDASLASRISFLLVGIWWIGFAQITFKRLPNDIYNKKPEEDYIWRGFKELKIVAKEVMN
YPTLKRFLISFFLLSIGVQTIILMAAIFGSSELGLPAINLIITILLVQIVAIIGAFVFSR
LSEKWGNIKALKVTILIWMVVCFAAFMLDKKQENVAFYFYGLGVLLGFVQGAIQSLTRST
YSKLLPETEDHATYFSFYDVTEKIAIVLGTFVYGFLYSITDSMQWSVLCMAVFFLASFII
LSSLKKTKYVQ
>FCMOIPGL_01229 putative TonB-dependent receptor
MKTFIKLLLLVAVFSANAQNSISGKITDNNNNPLSEVGIYAQEIHKGTTTNEDGTYVIKN
IPNGKLKITFTYLGYKSVTKTIVITSKNEILNIQLEDSSFEMDEIIISTPFNKLQSDNVM
KVERLSAESIKKMGATTLAEGITNIAGVSQISTGSSIGKPVIRGLSGNRVLVYTQGIRLE
NQQFGGEHGLGINDAGISSVEVIKGPASLLYGSDALGGVLYLNPERFASENQKEINFSQK
YFSNTLGSNTSVGLKTSKENWKFLARGTYASHSDYTIPTDERVTNTRFNEKDFKTGIAYS
KNKFTSEIRYNFNNSQLGLTEGIADQSTSKSLLEPYQVIDNHILSAHNHIFFGNSKLDID
LGYTFNDRQEFEEHEEHDDGEEDEEHEEHEEAALRMKLKTYSYNAKYHFPKTGNFEILSG
VQGLHQTNTNFGEEILIPNAIINDFGIFTTANYAWNKSTLQAGIRFDNRNISTESHEVAH
EDEIHVFNAIDKSFNSFTTSLGFKTSFTDFFTTRINLATGFRAPNLAELTSNGVHHGTNR
FEEGNNNLSNEKNTQIDVSLEYKTEHFEFFANGFYNHLNDYIFLNPTGEIEDENPVYTYV
QENAKLYGGEFGFHLHPHPIDWLHLESTFETVTGKQSSGDYLPLIPANTWKNTFRTEFNI
KNWLQKGYTSLSLQSTFNQNNVSVFETETPSYNLVNLGFGGDVVLGKTTFTTSISVNNLF
DKEYINHLSRLKADGILNQGRNIVVGVNFVL
>FCMOIPGL_01230 hypothetical protein
MVKKLISTFFLFVLIAPLSIQILHVLENHEHTSCTSKVENHIHKQSFNCKELHKHLTFFT
FDFTSNFDVIPTHFYTSIFILNPQIDKEIYQSIKSTRGPPSFTV
>FCMOIPGL_01231 hypothetical protein
MEIFLHADTWVALVTLTFLEIILGIDNIIFISITANKLPKNQVRKATLLGLALAMVTRIL
LLFSISYLIALKDPFFEIDLGWFKTALTGQSIILFLGGLFLLYKSTKEIRQKVENTNEEH
VLKTPKVISFKSVIIQIILIDIVFSFDSILTAVGMTNGIHGALLIMIIAVIISIVIMMIF
SNPISNFVNNNPTIQMLALAFLILIGFMLITEAAHLSHTEIFNKTVGAIPKGYLYFAIAF
SLGVEMLNLKMRKK
>FCMOIPGL_01232 hypothetical protein
MKKLVFILVGILALTSCKSEFEDNSDRFKLGVFEIPAGKGFVKETIIRKDSIQISKHGDH
VDTLSIKWKNNFFYTLKYINPKNDLQEDPMFVQINKIHKDSYDFTVKIGFSKFSKKATVY
KVK
>FCMOIPGL_01233 Adenylosuccinate lyase
MELSQLNAISPIDGRYRNKISKLADYFSEEALIKYRVRVEIEYFIALCEIPLPQLADFNN
DLFADLRKIYTDFTTEDAQKIKDIESITNHDVKAVEYFIKEKFDALGLQKHKEFIHFGLT
SQDINNTAVPLSIKEAMNDVYVPHYFELLEKLQELVIEWKDISMLARTHGQPASPTRLGK
EIEVFVVRLKEQFNLLNDIPSAAKFGGATGNYNAHKVAYPTIDWKEFGSKFVQEKLGLYH
SFPTTQIEHYDHLAALFDTLKRINTIILDLDRDFWTYVSTDYFKQKIKAGEVGSSAMPHK
VNPIDFENSEGNLGLANAIFEHLSAKLPVSRLQRDLTDSTVLRNVGVPFGHTIIAFTSTL
KGLNKLLLNKQKFEDDLENNWAVVAEAIQTILRREAYPNPYEALKGLTRTNAKINQKSIA
DFIDTLEVSSEIKAELKAITPSNYTGI
>FCMOIPGL_01234 hypothetical protein
MSIFFVTEQLNNMENPKRENRERVANIVLADQKLFKDLVTITFDVENKVSIKAAWILEWI
CNHHQLNWILPHLKEFSTKISNLKFDSAIRPCAKICELLANAYFAKNDNEIKNQLTTKHI
DSIVETGFDWLITPQKIAVRAYTMNTLYFFGLQKDWIHPELKHLIETKIIHESKGCKARG
KYILQMIEKHENSAS
>FCMOIPGL_01235 hypothetical protein
MLNIKRLIAVFAFIACFFTNEKISAQKINQFNENKQRTGTWIKYYSDDKIRYTGQFENGK
EVGVFKFYDISSSKYPVIIKTYSKESQNVLVEFYTIKGKLQSKGYFKDKNRIGNWTYFFS
DGKIMSEEVYKEGKLDGKLVNYYPNGKETEITFYVNGLKNGLSQKYSSDGILIEEITFKN
GKPNGQAKYFELNGNLKEAGTYLKGKRVGEWEYYLDGEVANKKDIENNKKYKKNENDEK
>FCMOIPGL_01236 tRNA-specific 2-thiouridylase MnmA
MKRVVVGLSGGVDSSVTAHLLKEQGYEVIGLFMKNWHDDSVTISNECPWLEDSNDAMIVA
EKLEIPFQVVDLSEQYKERIVDYMFDEYEKGRTPNPDILCNREIKFDVFMDIALKLGADY
VATGHYCRKSEEIIEGKPVYKLLAGKDNNKDQSYFLCQLSQEQLTKALFPIGELTKPEVR
EIAKKADLITAEKKDSQGLCFIGKVRLPEFLQQKLQPKEGVIVTIPSDFEQYTKAAPEFE
NKEAELKYYSTKFAYKKEDGKVVGKHQGAHYFTKGQRKGLNVGGTKEGLYVIETDVVENV
IYAGEGKSHKGLYRNVLFVDNEEIHWIREDLILKSAETMQVDARIRYRQPLEKATLYKVE
SGLYVEFQNKQSAIQEGQFVAWYKNEELLGSGVIS
>FCMOIPGL_01237 Subtilisin NAT
MKKLLLFLCVASFFSTFSQTEDAWLYLKDKPNSATFLQNPLQMLSQRSLDRRIIQNISLD
VKDVPIDENYYNQLKNEGNITVLGKSKWLNAIHVQGTVSQINGLLSNFTFIESIEFANKS
LNPGAKKRVKSVTPNHQNKFSNTTTDFIYGNAENQIKMLKGDFLHEQNFTGEGMQIAIID
AGFPNVNTLSAFQRIRDNNQILGGYNFADRNTDIYTRDSHGTHVLSTIAGYVENQFVGTA
PDAKFYLFISEIAETETVLEETLWVEAAERADSLGVNVINTSLGYTTYDNPDHSHSYADM
DGKTTFISRGAEIGASRGIILVNAAGNEGGDSWKYIGAPADAVSVFSIGAVNSSENIVYF
SSFGPTADNRIKPDVLAKGQSAAVINYSSGNISTSNGTSFSSPIMTGVVACFWQAFPNKT
NFEIMDLIRKSADKYNNPTDQYGYGVPDFETAYNQVLSTNDFSNSTISIYPNPVKNSFSF
SFEGTSVENLSIQIFNILGEKVLEKSKLISNTVDISNLEAGFYMLKIQMENQQKTVKLIK
Q
>FCMOIPGL_01238 Nitronate monooxygenase
MTNKITKLFKIQYPIIQGGMVWVSGWRLASAVSNAGGLGLIGSGSMYPEVLREHIQKCKK
ATDKPFGVNVPMLYPDIEKIMDIIIEEGVKIVFTSAGNPKTWTSFLKDKGITVVHVVSSV
KFALKAESAGVDAVVCEGFEAGGHNGREETTTFTLIPMVNDQVNIPVIAAGGIASGKGML
AAMVLGAHGVQIGSRFAATLESSAHQNFKNTIVNVKDGDTQLTLKELAPVRLVKNQFYNK
VQELYQQNPSTEQLKELLGKGRAKKGMFEGDLENGELEIGQIAGLIHEIKPVKDVFDEIL
EEFSSIKALLTST
>FCMOIPGL_01239 Cold shock-like protein CspC
MNKGTVKFFNESKGFGFITEEGNNKEHFVHVSGLIDEIRENDEVEFDLQDGRKGLNAVNV
RVL
>FCMOIPGL_01240 Cold shock-like protein CspC
MNKGTVKFFNESKGFGFITEEGSNKEHFVHVSGLIDEIRENDEVEFDLQDGRKGLNAVNV
RVL
>FCMOIPGL_01241 hypothetical protein
MIIDARKRANIKVGLFVEIVLKPHQRTGELTQGIVAKILTKSVTHPYGIKVQLESGLVGR
VKNIIE
>FCMOIPGL_01242 Membrane-bound lytic murein transglycosylase D
MSNTYKIISILSVISVTFLCVNAINKTESDAINDPKIGTHLSYKIQALKLPDNLNLAGEQ
VPLEIADVKERMERELLVNTYWQSNGLLLLKRANKYFPIIEPLLAKYGLPDDFKYLALAE
SGFTDETSSVGAAGIWHFMRTTGKEYGLEINNNVDERYHIEKSTKVAAEYLKKAKERFGT
WTLAAASYNAGMYGVSRRMEEQQVNSYYDALLPDETERYIFRIIALKEILSNPEKYGFVF
DKEDLYSLPKTYTIKVDTAITNIATFAKGFGLNYKEFKIHNPWLRENKLNNKSRKLYEIK
IPVK
>FCMOIPGL_01243 hypothetical protein
MSKTHIYFMPGLGVGPDIFKQLNLSKEFELHYLKWKKPLYQEETLTNYAMRMLEDIKHEN
PVLIGVSFGGIIVQEISKFIDTRKIIIISSVKSKNEFPKKFKFANLSNLYKLFPTNIITN
FEKYSKFFIGKKLKKKAANYKRYLTVKDKTYLQWSIYNVLNWQQEIPTKNILHIHGTKDK
VFPIKYIHNCEQIIGGDHAMIMTKAKKISEIINTYLK
>FCMOIPGL_01244 hypothetical protein
MLFETERLKVRELIFDDIHVFHKMQTNPKVMQFADGEIKNFDKNVEELKELIKRYSIKNN
DFWIYAVV
>FCMOIPGL_01245 hypothetical protein
MIVDNLNPPYYAVIFTTIVTDNLEGYTKTAEKMETLAKKQKGYLGIESARSEVGITVSYW
QTLSDIIAWKNNIEHTEARNLGREKWYKKYQLRICKVEREYGFH
>FCMOIPGL_01246 Riboflavin biosynthesis protein RibBA
MKTQILQNKTQLNTIEEAINDIRNGKVIIVVDDENRENEGDFLAAAEKVSPEMINFMATH
GRGLICAPLTEKRCKELELVMMVNNNTDPMETGFTVSVDLRGKGVTTGISASDRALTVKA
LIDKDTKPFDLGRPGHIFPLRAKEGGVLRRTGHTEAAIDFARLAGLKPAGVIVEIMNEDG
TMARLPQLLKVAKKFDIKIVSIEDLVAYRMEHDSLIEKKDDFDIETRFGKFRLRAYQQTT
NNQVHIALTKGSWTNDEGVLTRINSTLVNNDILGTLTNNADKKLDQMFNVINEAEKGAIL
FINQQNESKNLLNRLSVLKESQKNGELKAPAIGMDQRDFGIGAQILHDLNISKLKLITNT
QQTKRVGMIGYGLEIVDYITY
>FCMOIPGL_01247 hypothetical protein
MLLLRFMKILDKYILKSFFKPFIATFLIVLFVLVMQALWQAFENIAGKGISLIFILKFLY
YTTLMIIPQALPIGVLLSSIMALGNLGENYEFAAAKSAGISLHRLVRPLGILAILLSIVN
FLFLNNVYPYAVYEQINLKNNIKKKQPAMALIPGSFNADLPGYQIKFDEKYGEDKNLLKN
VLIYDLKSNRGNQKVITAKSGKIVTEEGSRYMTFILYDGNYYEEHVKSARTSIKRKKMAA
SNATFKEYEFNIDIGGISSVVDTTKSKGYPMMYTLKEIKDTIPRLKEKYYDALDNRAKNI
FISTQANDLYKYPDSLKKKNLDSKTLQNFKDKEKITILNSAIAKTNRVVSSLNNNNLTIK
WNRKILNFYDTEYYNRFAFSLSCIILFFIGAPLGSIIRKGGFGLPMILAIAVYVIYFFAN
TFGKNLAEESTITSFLGSWISAIIMTPVAILLTRRATKDKGIFNLNSFLQPITNFFKKII
PNKGTKI
>FCMOIPGL_01248 hypothetical protein
MKKFTTLLLSLFITTITFSQNSKEAKSLLDEVSTKMGAYQNMFIGFSQTLSNKDAGIMEG
DEPPIRGEIYLQGEKYSLKYLGNDFIYDGKKLYIINNDEKEISITDGDLDGDDGFIYPSK
LLTFYKEGYNFKMGKLLDMNGRKIQFVTLNPIDSNSDIVKVELGIDAKTMHIYKLIQTGS
NKSKTTFTITKFKNNQSLSETFFKFDKKKYLSQNYIID
>FCMOIPGL_01249 DNA translocase SpoIIIE
MAKKKISTNKATAQKGEKSSIFSYLKTRQAKTLLSIFLMLFAVFLCIAFISFFFNWQDDQ
STLNYLTDKTVKSKNLLGKIGANLSNFFIYEGFGLSAFIIAYQVFLTGFHILIRNKFSKI
IISWNWGLLCMLWISVALGFLNSKFALLSGVVGFEINNYLQTFIGKTGLIIILIFTLITY
IIIRYKVSFDAYIEKIKEKKLKREAENLETESVEKPSEKTTAKAILNTDETTSETISLSK
NKKSNFEISSEKLQPTIQKHSSITSEENDEIILKVEKDSEVNIEETVKELAIDIEETEEE
ESSTENLSDKILKDFGEFDPTLELSNFKFPTFNLLKQYNDSISVDPQELEANKDRIVETL
KNYKIGIAEIKATVGPTITLYEIVPEAGIRISKIKNLEDDIALSLSALGIRIIAPIPGKG
TIGIEVPNKRSTIVSMHSVISSKKFQESHMELPIALGKTISNETFVIDLAKMPHLLMAGA
TGQGKSVGLNAVLTSLLYKKHPAEVKFILVDPKKVELTLFNKIERHYLAKLPDMEEAIIT
DTTKVVHTLNSLCIEMDNRYDMLKSAMVRNIKEYNVKFKQRKLNPNDGHHFLPYIVLVID
EFADLIMTAGKEVETPIARLAQLARAIGIHLIVATQRPSVNVITGIIKANFPARIAFRVT
SKIDSRTILDSGGADQLIGRGDLLYTAGNEINRIQCAFVDTPEVEKITDFIGSQKAYTEA
YLLPEYVDDESGTSIDIDISDRDKLFKEAAEIIVTAQQGSASLLQRKLKLGYNRAGRLID
QLEAAGIVGGFEGSKARQVLVPDFVALEQLLENEKNL
>FCMOIPGL_01250 Undecaprenol kinase
MKNPNDSYIRGRIRSLKYAFKGFYILITTEDSIKAQLFFALIATILGFYFNISATEWCLQ
LIVIGLVLVAEAANTAIEELADFVHPEFHVKIGLVKDIAAGIPTFAALISLIVAGFIYVP
KILLLF
>FCMOIPGL_01251 Thiol peroxidase
MANITLKGNAINTIGNLPKTGSKAPDFKLTAVDLSTKTLKDFTGKKVILNIFPSVDTGTC
AASVRAFNKKASELENTVVLCVSRDLPFAQARFCGAEGIENVIMLSDFATGSFGKDYELE
IANGPLAHLNSRAIVIIDENENVVYTEQVPEIVDEPDYDAALKAI
>FCMOIPGL_01252 hypothetical protein
MSTSKKILPIIVISQFCCTSLWFAGNGVMSNLATTFQLQENALALLTSAVQFGFIAGTLV
FALFTIADRFSPSKVFFISAFLGALFNIGFILEKQTLFSLICLRFLTGFFLAGIYPVGMK
IATDYYQKGLGRSLGFLVGALVLGTALPHLLKDLLISFSWKSVLITTSSLALFGGLLMLV
FVKNGPFRKPSTTLDVSVCFKVFKNVNFRKAAFGYFGHMWELYTFWAFVPVLLMTYQNLH
PQNTFNISLLSFIIIAIGSISCVFGGYISQKFGVKKTAFSFLFLSFICCIIAPILFLIPN
KYIFIAFLIFWGMVVIADSPLFSTLIAQNTPSKDKGTALTIVNSIGFLITIISIQIISSL
LNFTNSNLVFSVLAIGPFFGLIGLKNKTI
>FCMOIPGL_01253 Hydroxymethylglutaryl-CoA lyase YngG
MKKVKVIECPRDAMQGIKSHFISTEKKALYINSLLKVGFDTIDFGSFVSPKAIPQMRDTA
AVLSKLDLSKTQSKLLAIIANVRGAEDASQFEEIDYLGYPFSISENFQMRNTHKTIAESI
EALDETLNIADKSKKEVVAYLSMGFGNPYGDPWNVDIVGNWTEKLSKMGVKILSLSDTIG
SSTPDVISYLFSNLIPKYPAIEFGAHLHTTPDKWFEKVDAAYKAGCNRFDGAIMGFGGCP
MAKDELTGNMPTEKLLSYFTAEKADTNIKPMSFESAYNKALEVFI
>FCMOIPGL_01254 Mannosylglucosyl-3-phosphoglycerate phosphatase
MKHLKSFLYLLSFTLLFSCKKDDDKIDFTFLQINDVYEIAPIQGGEFGGLARVATVHQEL
LKENKNTMLFLAGDFLNPSLLGTIKVDGERVRGKQMVEVLNEMDVDLVAFGNHEFDISQK
DLQKRLNESNFPWISANVKLKTKNKSIPFYKEKEGKQIPLKETFVKEFTDEDGTKIKVGF
ISVCIPSNPVDYVEYGNMFVKARASYAAIKDSVDVVFGLTHVKLTNDKRIAKLIPDLPLI
MGGHEHTNSYDKIGNVIISKADANAKTAYIHRISFDKKTKKTIVTSELKEINTTIKSDEK
VDLVVKKWQNILKSEIKVVVENPEKIIYATKIPLDGRDTQVRSEQTNLGTIITKSMSFAF
DDKVDCAIVNGGSIRIDDELLGNINAVDIFRVLPYGGAIFKVEIKGRLLKRVLDYGILAA
GTGAYLQRFNAEKVGEKWMIKNKELNINKIYTVAFSDYLLQGFDIPFLSSENKEVLSIYK
PKNNELAFDIRKAVVEYLKGNQ
>FCMOIPGL_01255 ATP-dependent RNA helicase DeaD
MSTFKELGLKEPIIKALTDLGYENPTVIQEKAVPQIISSTSDLKAFAQTGTGKTAAFSLP
ILELLDTSSNNVQAIILSPTRELAVQIGNNIKDFSKYLKGVNVTTVYGGSSMEEQIRSLK
RGSQIVVGTPGRTVDLINRRALKLGNVKWLVLDEADEMLNMGFKDELDKVLEATPDTKQT
LLFSATFPREVESIARNYMTKPVEITSGEKNSGSDNVSHEYYAVTERTRYPALKRIADLN
PDIYAIIFCRTRRETQEVADNLIKDGYSADSLHGDLSQAQRDSVMGKFRKKSIQILVATD
VAARGLDVNELTHVINHKLPDQIENYTHRSGRTGRAGNTGISIVLVNGKEKGKLRAIERI
IQKKFVEGKVPSGKEICQNQLMNLIDKVNNIEVNETQINEFLPSIYDKLKDLDREELIKK
FVSLEFNTMLAYYENAKDLNNLSRENSRSRETADNMTRFFINIGRKDSLNPGKLIGLIND
QNIGDKIEIGAIDILDTFSFFEIDKNYEEKTLEVFAANQPDFGGRSVNIEITKKDRSGGG
GRRGGKKPFGKKDGGFGRRRSSEASSDRGRKRSSRSSDRPDRGSADRKTGGFGRRRRER
>FCMOIPGL_01256 hypothetical protein
MTKRLFSFLPMLLLVVISSCESNKKEKITYFGGKIINPKSNSVVLYSMDKVIDTFYLNKQ
NKFLGKLKNANEGLYYFFHGDENQYIYLEPEDSLMLRLNTWDFDESLVFAGEGAERNNIL
IDCFLENEKDKKAFYNYNKLDPKNFKKKVDYLTKQKLKTYDNYLEHHTEETEGFKQFLKV
ALTFPVYEQIEKYPIIYAKYSDSGDFPELDKSFFDYRNSIQINKDSLMYYPPYFQYIRTY
LYNKTYALGHPSVKSNYSAKFTLDLLKVIDKNIKSEVSKNVFLKQTVISHFYNKSSCNIN
EKPFNKFFELSTNEEDKNQIQKIVNDSKAVKKNNTLPDFNVINYSNTEIPISKIIKNKNV
LLFFWSPEYYTENYITSRIKYLSKKYPKVSFIQIKIDGTKNDNIKKNTLSNQFYINNKSD
ANLFLTSKMPRCILVNKQGKVTNGYASFSSFNINPYLKALSEN
>FCMOIPGL_01257 putative ABC transporter ATP-binding protein YbiT
MLSVSNLSVQFGKRVLFDEVSTKFLQGNCYGIIGANGAGKSTFLKIISGKQEPTSGQVHL
EKGKRMSVLSQDHYAFDEFPVLETVVMGNKELFKIKKEIDALYADYTDENAEKIGELQIK
FEEMNGWNADSDAAAMLSNLGISEDLHYTLMKDLDGKQKVRVLISQALFGNPDVLIMDEP
TNDLDFETIAWLENFIANFDNCVIVVSHDRHFLDAVCTHISDIDFGKINNYSGNYTFWYE
SSQLAAKQRAQQNKKAEDKKKELEDFIRRFSANVAKSKQATSRKKMIDKLNVEDIKPSSR
RYPAIIFERDREAGDQILNVEGLSREFEGEKLFNNVHINLNKGDKVAVISKNSRAISAFY
QIITDNEKADDGKFSWGVTTTQSYLPLDNSSFFQNGELNLVDWLRQYAQTEEEREEVYLR
GFLGKMIFSGEEALKKSNVLSGGEKVRCMLSRMMMKRANILILDEPTNHLDLESIQSLNN
SLINFKGTVLFSTHDHEFAQTVANRVIELTPKGVIDRYSTFDDYLSDPKIKELRDSMYS
>FCMOIPGL_01258 Hydrogen peroxide-inducible genes activator
MTITQLKYVLSVAEYQNFTVAAEHSFVTQPTLSMQIQKLEDELGVKVFNRSKKPIELTEV
GKKIVEQAKVIVDESNRILDIVHQQKGFIGGEFKIGIIPTIMPTLLPMFLNNFTKKYPKV
KLIIEELTTEDIIRRLTDGHIDAAIAATPLENESIKERPLYYEPFVGLVPQNHRLYKNKM
ITSDELEMEDILLLEDGHCFKDSVLNLCRTHKIDNKKGFQLESGSFDTLIKLSKEGLGMT
LLPYLHTLDLNDVDKSHLREFTNPPPAREVSLIYHKSQLKMQLIEALKKTIDGVIRGAIS
FSDVKIISPLQNK
>FCMOIPGL_01259 DNA protection during starvation protein
MNKSILGLDKKDTANLVTELNGLLSNFQIYYQNLRGLHWNIKGKNFFQLHVKFEEFYTDS
QVKIDEIAERILTLQGKPLHTFEDYLANSSVAVGKNISNDVEGVELVVNSLSELLKIERT
ILGISDEADDEGTNSMMSDFIAEQEKTIWMLNSWLGK
>FCMOIPGL_01260 hypothetical protein
MRKSHTILIILFVFTTTYSQEKKKSTLKPSKIGFLYNYGTNENLIFDDVDYTYSTNTFKA
QAFYKLGNWKNLNFELIVQPQVQFLDHQLINEQFVLPSEENYLEKRAEFTKAKTMNLYGI
EFGIAVKKQLTEKLNFQGTISLGFNYIDTRTERIAKGFTFIENFSVGFSHQTFTNSFIYL
GTNFGHVSNLNFQQPNNGYNILGLEIGYSYALN
>FCMOIPGL_01261 putative 3-hydroxybutyryl-CoA dehydrogenase
MKNIAVIGAGTMGNGIAHTFAQFNYKVQLIDISDAALKKGMATITKNLDRMVAKEKISEA
DKAQTLTNISTFTSIKEGVKNTSLVVEAATENAVLKAKIFKELDEVCDAETILATNTSSI
SITQIAAVTKRPEKVIGMHFMNPVPIMKLVEIIRGYNTSDDVMNFTVDLSKKINKIPVEV
NDYPGFVANRILMPMINESIETLYNGVAGVAEIDTVMMLGMAHPMGPLQLADFIGLDVCL
SILNVMYEGFKNPKYAPCPLLVNMVNAGKLGVKSGEGFYDYSENRKAEKAAKMFS
>FCMOIPGL_01262 scyllo-inositol 2-dehydrogenase (NAD(+))
MLKVGVLGAGHLGKIHLRLLEQSKRYNLIGFYDQDTVNAEKVATEFGYKLFNSIDDLIDA
AEVVDIVTPTLSHFECAKKAIEKGCHIFIEKPIAKTVLEAEAIKTLASQFHVKGQVGHVE
RFNPAFIAAKDMIVNPMFIETHRLAEFNPRGTDVPVVLDLMIHDIDIILSVVKSKVKNVH
ASGISVISDTPDIANARIEFENGCVANLTASRISMKNMRKSRFFQKDAYISVDMLEKKAE
IVRMKDVPENPDDYAMILQNAEGVKKQIYFDNPEVTNNNAILDELETFADAILNNTEPIV
SLRNGAEALRIAQMVIDSY
>FCMOIPGL_01263 Protein-L-isoaspartate O-methyltransferase
MKDTQKHQGLRNQLATVLKAKGITDKNVLNAVKKIPRHSFIDSSFESHAYQDKAFPIAAD
QTISQPYTVAFQSQTLEIKAGDKVLEIGTGSGYQTAVLLELNAIVYSIERQHELFKKTSL
FLPKLGYKPKKFIFGDGYKGLPEQAPFDKIIVTAGAPYVPNPLLAQLKIGGKLLIPVGNE
TQIMTLFIRKSAKEFEKHELGDFAFVPMLEERN
>FCMOIPGL_01264 putative ABC transporter ATP-binding protein YlmA
MEKIHFAIKNENLSTNSNLVDRFLNNTHSLPNLKNKKGFLFSVSVLEKFIEKEARYNTKT
LTFKENRSIRSFSSGEQKKALLNYLFEQKPDFLILDSPFESLDVKAVADLKEKLIKLSSE
IILIQIFNRKEELLPVITHILEVENNEITSSNPIEKHTFQENNFDFKGTIPKPITFYKNI
SNQLISLQNVSVNYDENCILNNINWTINKNEFWQLIGPNGSGKTTILSMIYGNNVKAYGQ
DIYLFGKKKGSGESVWEIKEKIGYFSPSILELFQRRTTVNEMIISGFFDSIGLYKSPSNL
QIQLAEQWIKLLDLETKKETPFTNLTTATQRLVLIARSMIKHPPLLILDEPLINLNNQET
SIIVALINKIAKESDTTILFVSHRSVDNLKPNYTYKLTPTKSGSLGKVEE
>FCMOIPGL_01265 hypothetical protein
MKKIILTVLLITISVSINAQTIFGKWNSRNDDTGKIDSVVEVYEENGKAYAKIIEIKNPD
RKNAVCDLCEGKNKDKPILGLNILTGLEEDGDEWSGGKILDPRNGKVYKCYIKLEGANKL
KIRGFIGFALIGKTSYWERAE
>FCMOIPGL_01266 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MEISYKQLLPNINTLIFDVDGVLTNGMVTIMPDGELIRHMNIKDGYALKTAVDKGLNICI
ISGGNNEGVRTRLANLGIKDIYLGAHDKIEQYNELVKKYDLKPENVLYMGDDIPDFPVMK
LVGLSCCPNDAAAEIQKISKYISYKKGGEGCVRDIIEQVLKVQGKWDNNFNAKYD
>FCMOIPGL_01267 hypothetical protein
MISVLLVGKGNVATHLYDAFLNVDAVKVTQISSRELDKIPQADVTIIAVSDDAITEVSSK
ITNNFVVHTSGSVSINDLKNNTRKGVFYMLQTFSKDKNVDFSKVPFCLESESKEDYKLLE
TLAKSIGKKIYSINSEQRKTLHVAAVFVNNFTNHMYKIGNDICIENNVPFEILQPLIKET
ASKIEYLSPEKAQTGPAVRNDKRTIKNHLNLLDINQQEIYKILTKSIQNGN
>FCMOIPGL_01268 Cystathionine gamma-synthase
MDKNKKLGVNSICVHVGEVKDEQFKGAISPIYMSTSYAFDGVDVKRYPRYLNTPNQEMLC
KKIAALEHTEDALIFSSGMAAISNAMLAFLKKGDHVIIQQVIYGGTYNFVVTEFEKYGIE
YSFTESDKAADFKALIKKNTKILYIETPSNPLLGITDMRAIADTAKEKNIITMIDNTFAS
PINQNPIDFGIDIILHSATKYMGGHSDISAGAVAASKEHIELIWKTAINFGGNLSDQTVW
LLERSLKTMNLRVKEQTKNAQIMAEYFENNADIDRVYYPGLKSHPQYEIAKKQMKGFGAM
LSFELKEGIDAMKFQNSLQLIKPSMSLAGVESTTVSPTQTTHALLSEEERLERGIKDGLI
RFSVGIEETDDLIVDIEQAIKKAKN
>FCMOIPGL_01269 hypothetical protein
MKKTLLTFLLFISFTNFNAQTKAERNFGSWYYIYGTHKISTNWSILTGFEEHNYQTLKNY
NLVLYTVTANYKLSKKFTTTLGYMYLDIDKTFDEDIDPNTIENRHYEQISYKFSLLNLPF
DHRVRVEHRHLNTLGNNSLIHRVRYRLRTKISLNNTFYLTASNESFLNFKGNLYAENRFY
SALGIKASKNIALEIGYLGHYISDLHLDRLQFGIFFNTDLRKKAKI
>FCMOIPGL_01270 Phosphoenolpyruvate carboxykinase (ATP)
METNRNMETYGLKNVTVNWNLPTEELQKITIEKGMGRETKNGTLAINTGKFTGRSPQDRF
IVKDDYTADKVWWGKTNKPVSQENFDKLKANVTNYLSNKELYAKDGYVCADPTYRTNVRT
VAEYPWSISFVFNMFLRPTEEELANFDEDWLVLCAPGYVCDDPKAYGIRQGNFSIINFTD
KIALIGGSGYTGEIKKGIFSALNLVLPVEKNVLPMHCSANVGEDGDTAIFFGLSGTGKTT
LSADPTRKLIGDDEHGWTADNTIFNFEGGCYAKVIDLSEEKEPDIFRAIKPGALLENVVF
KEDGEVDYMDGSITQNTRVSYPIYNIDNIAVPSYANNPKNIFFLTADAFGVLPPVSKLTP
GQAAYHFISGYTAKVAGTEAGITEPVPSFSACFGEPFMPLHPTKYAEMLSKKMTEAGVNV
WLINTGWSGGPYGTGSRIKLKYTRAMIGEILKGSLDNIEFEQHPIFGLFMPKYCPNVPTE
MLNPMNTWLNKSAYISKAIHLAHFFHLNFEKFANEASDHIIEGGPLIDEHHQLDHM
>FCMOIPGL_01271 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MKLDILAFGAHPDDVELGCGATIAKEISLGKKVGIVDLTRGELGTRGSAELRDVEAANAA
NILGVSVRENLRFADGFFVNDKKHQLEIIKMIRKYQPEIVLCNAIDDRHIDHPKASSLVS
DACFLSGLIKVETEIDGKLQEKWRPKQVYHYIQWKNIEPDFVINVTGFMDVKEKSVLAYS
SQFYDPKSNEPETPITSKNFTDSINYRARDLGRLIGVDYAEGFTTERYVAIENFSKLI
>FCMOIPGL_01273 Sensory transduction protein LytR
MKKLTSIVVDDIPVALEMLCSDIEKYHPEIEIIGKAASVIQAAKLLQKKQPDILFLDIML
GDGTGFDILEIVPNLQSKIIFVTASDAFAIKAFKFAAIDYILKPYSNDDLTNAIEKAKKQ
IQPNKEQLDVLQEAINNPYSANQKISLHTSEKIIVVQLSEIIRCKSDNNYTTFYLENNQK
ILVSKTLKYFADMLKENGFLRVHQSHLINIKYIKEFIKSDGGYLMLKDKSNIPVSIRKRN
EVIEALNNFN
>FCMOIPGL_01274 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKRRKFIKKTIYGTLGASFLGGIYSWQVEPYWLEFVEKKMPIKNLPENLIGKTLIQISDI
HVGNKFNYQYIIDSFKKAQKLNPDFVVYTGDFVSYDTNEQFAQLKEVFKYSVTGKLGTAG
VLGNHDYGHDWVQQNVANKITSIVQSAGVKILSNAEFNFNGLNIIGLDDFWGLNFNPKKI
MDKYNSENANLVLCHNPDVCDLDVWNNYKGWILAGHTHGGQVKPPFLNPLILPVKNKKYN
AGEINLNDGRTLYINRALGCLIPVRFNVRPEITVFKLEKLS
>FCMOIPGL_01275 Sensor histidine kinase YpdA
MFYKKNLLVFFLLAFVNMFAQQNNLQLFTVDDGLPSNIIFDIHQDKTGYLWIATEKGLVK
FDGDDFTQINKQKTTNLTTKNNTIYAGLENGLLIKEHSKEVFLASKKVLKTFIFNDIIFV
GTEEGVYKIYKNHIETIKINTEINKSSINDIIFVYNAFYVATNKGLWKLNRLENPSKIEK
INNNYIISLANFQNEIIVATLKNGIKTINANAIEKTISFQENITSVKKLKNEIWVTSNKN
GIEIFTLPSFSFKQKINKYNSLKTDEINTVFKDNQNTIWIATNKGLYQLKNDNYNNSNNK
KPVIYFENLLVNNRKVDSLLNSKIAINFSPSENNISIYFKTVDLINPKKIKYRYQLIDGF
SAWSTNNSVQFANLNAGRYTFKIQSKIDKEESKIKSFSFKIDAPFYKKTTYILAAIALLL
FIAYLILDFYIRNLNKKNKEKIDTLKLENHLLSLEQKALQLQMNPHFIFNVLNGIKALGN
SGKTTELNTTISQFSVLLRSILNNSRKEEISLKEEIESLKNYIELEQKMSSKTFEYKIIT
NLNNIDAEEILIPTMLVQPFIENAIKHGFQANTKGIITISFDVKYHFLNCSIIDNGIGID
QSKKGKSNSNHNSLALKVSKERITHISNKSSFTINEIVENSMIKGTKVWFKIPLKTDF
>FCMOIPGL_01276 hypothetical protein
MKKVFKKLGIVAAIILTSSVFINCDRTTKIAKNESETAIVYDHINSNVKEEIITRKPLVF
ITGFDIDDETFYNNARTYFTEKDFEIVEDQYSLEEIINWLNQNESENPYGEIHIVNKSNP
YKGMTLETVVKGEKITAESLRKNITKGTLPILKESVNANSKIIFHANGLGENIELMNTFK
DAFCSDELPSVIASSYFSVFGGEFTEHYLAKPFYVFYPTANSPGKVDLSKEIARKYREEK
NIDWYDALNNKNERYVGDAYSTQFSIPIKFELDYHNSDDEMPTFSNQQEIIDFIQQKESL
YAEFVKLNIPLEKFRWTTKVKNSLFTIYGKTTGLIVLKPLIKPYGALEHVKPDTNNKRLY
AMN
>FCMOIPGL_01277 UvrABC system protein A
MKTDLSTINPKENIIIKGAKLHNLKNIDVVIPRNKLVVITGLSGSGKSSLAFDTLYAEGQ
RRYVESLSSYARQFLGKLNKPKVDYIKGIAPAIAIEQKVNSTNPRSTVGTSTEIYDYIKL
LYARIGKTYSPISNQEVKKDTVSDVVNFIKKFADKTKLLLLAPIIIDESRDLKTLLQVLE
QQGYARLKWNEKVYRIGDFPIDDYKNEALYLVVDRIVTKDDEDFYNRLADAIQTAFFEGK
GVCFIENLADNKVSEFSNKFDLDGMSFLEPNTHLFSFNNPYGACPTCEGYGNVIGIDEDL
VIPNTGLSIMEDCIFPFKTPSYIHYKEELISVAYQFDIPIHKPWFQLTDKQKELVWNGNK
SFNGIHHFFSVLEEKSYKIQNRVMLSRYRGKTKCTTCNGKRLRKEANYVKINEKTISDLV
TLPLDELAVFFKNIKLNKYEEKIAKRLLTEINNRLLFLTDVGLSYLTINRTSNTLSGGES
QRINLATSLGSSLVGSMYILDEPSIGLHPKDTERLIKVLKDLRNLGNTVIVVEHDEDIMR
EADYIIDIGPEAGTYGGHVVAEGNFDKILKSESLTAKYLNEDLKIEVPKKRRTSKNSIQI
IGAREHNLQNIDVTFPLNGLTVITGVSGSGKSTLIKNILYPSMQKKLNGFGDKIGQHTEI
KGDFENIKNVEFIDQNPIGRSSRSNPVTYIKAYDDIRALFSNQKLAKIRNYKPKHFSFNV
EGGRCEVCKGDGIVTIEMQFMADVHLECDACNGKRFKKEVLEVKFDGKSIDDILKLTIDD
AVEFFSENLVTKIAKKLKPLQDVGLGYVQLGQSSSTLSGGEAQRIKLASFLVKGITKDKA
LFIFDEPTTGLHFHDIKKLLASFNALINKGHSIIVIEHNIELIKCADYIIDLGLEGGKKG
GNLIFQGTPEDLAKNKTSFTAKYLAEKL
>FCMOIPGL_01278 RNA polymerase sigma factor CarQ
MMRIQKETDSSLIKGYINGNEAFLEVLIKRHQHRLYSFIFSKIKDKDLTEDIFQDTFIKV
IKTLKKGNYNEEGKFLPWVMRIAHNLVIDYFRKNNRMPKFKNTDDFDIFSVLGDNNLNAE
KQLIQDQIFEDVRDLIKGLPEEQKEVLVMRMYKDMSFKEISENTGVSINTALGRMRYALI
NMRKLIENNKIILVNQ
>FCMOIPGL_01279 hypothetical protein
MMQIYSKKSSDFQMQPKQETVQFLIDFSKSLTFVKTKSKGLIELNLN
>FCMOIPGL_01280 hypothetical protein
MALQYRITKRNNSIQNNTPQYILQAISKGTIDLDKLSVDISNECSLHQVDVQAVLIALGI
KMNFYLQDGYAIDMGDVGKFKMGLQGVAASTPEELSPKKNIKKFSINYQPSIKLKRMLKA
GVKVFKEGSRHL
>FCMOIPGL_01281 hypothetical protein
MDVVLPLDVSCKRTFKALNSTYIYTKLLIYTASLYKTIHTRGVYYFFGLTLVSRLLFLTF
ISLSFLGKIAKND
>FCMOIPGL_01282 hypothetical protein
MNKNNISESDTCANFIDPKLSESQWESIHIVREY
>FCMOIPGL_01283 putative sugar epimerase YhfK
MENILVAGANGTTGKKIVNLLESSQYFNPVAMVRKKEQEKQFLERNIQTVLADLEGDVSH
TVHNIDKVIFAASSGAKKVKEVDENGAKKLIAAAEKQNIKKFVMLSSMGADNPKEAENLQ
EYLEAKHNADEFLKQSNLTYSIVRPGSLTNDKGSGKIELKHKLNKQGEISRDDVAQTLVR
VLHDTAEVDDTFEIIKGDTLIGKAIPQ
>FCMOIPGL_01284 Endonuclease III
MTKQEKVQFVIDTLQEKYPEIPIPLDHKDPYTLLVAVLLSAQCTDVRVNKITPLLFAKAD
NPFDMVKMSVEEIKEIIRPCGLSPMKSKGIYGLSKILIDKYNGQVPQSFEGLEELPAVGH
KTASVVMSQAFGVPAFPVDTHILRLMFRWNLSNGKSVAQTEKDAKRLFPKELWNDLHLQI
IWYGREYSPARGWDLEKDIITKTIGRKSVLSDYNKAKK
>FCMOIPGL_01285 Putative peroxiredoxin bcp
MTSLKIGDKAPQFEAKDQAGNTIKLADYAGKKLVLFFYPKASTPGCTNEACDLRDNYQSF
LAKGYDVLGVSADSAKRQQNFINKNELPFPLLADEDKAVIEAFNVWGPKKFMGKEYDGIH
RTTFVIDENGVIKDIISKVKTKAHAAQILD
>FCMOIPGL_01286 Transcriptional regulatory protein DesR
MIKKPLKIIIADDNHFFCDALKDSLNIHVELNVTNTFTTLKELIKFTNYNNLDVLILDIN
FNGESSLDFIDQIKKENKGFKIIALTTMNNNFIKEKAINNGVDFFVGKDGNLENFKEIIL
NCFVNKTIKKNKTSSKITIDNYTFTKRKLEILQALYIHSDKKEKELSAILNITESSLKSH
KRELFEITNTKSTPELIKFGIKKSLIIS
>FCMOIPGL_01287 Sensor histidine kinase LiaS
MKLKLFTFLFLFTSLIFSQENSLSVYTGLKTFYTNEKEPHTITDIINKYKEGQFYKEENQ
KIYKKLNHKILWHNFSIKPCKTNTGDKYFTISNTYLPYGKIYLKKGNKIDSLYRVSNNKF
FPHKNIFYRNPVWKIPLDSILPTDVFLKVKNSSGRTRMALYLETENEFLKRIETEYFYFG
LFISFLISMTLILIFFAVLKKEYAVLFYAFYIITVLFEFLAGKGLGVQYFWSNSPFFINN
IRSFSQTVGVFCIGFFYMKFYKLKASQTISKGIFKWGTFLTIPIILLYIYKYYFGGLVNL
YLVVWTVLKIIIFIWVLNHLYLTIKKQLPIYLVIAFILPILAVINGQIMNPEVHHKLAVK
LSGPNIYYITLSLEILLFTRYIFGSVIDTQRKYFKLKKVSDELKYNFQNKTFKIQQQERN
KLVNNVHDTFGGYLEALKLRLLQKSENTPEKIQEILDAFYTDYRYLLNSLYAPKINSENF
ISNLIEFCEKLDKLTNQKIYYDFNIHHLDLEQEKCVHLYRIISELTTNAIKYSEASEINI
LMNQKTDQFVILKVLDNGIGFNPKNLLKTGFGLNSVKDRVEQINGSLEIISNKNGTIFKI
EIPIND
>FCMOIPGL_01288 DNA-binding transcriptional activator EvgA
MEIIKLYENFQFEEAYSNKITERKKLPITSVKDFLFFFNISLEDFPKLMQFSEELEKEKQ
FILKHKTKFDSLTFKEKQVFKLVVNGKKSNEIAQKLFVETTTISTHRKHIKQKLNLESIF
DWYRYAKAFKLIEF
>FCMOIPGL_01289 Internalin-J
MKTKLFFLGIFFLSFNFMAQTIAIPDTNFEQALIDLGWDSNGLNGNILISEAQAIDSLNI
QDPENNTLLPNVSAKIKSLQGIEAMGNLVSLESGVNEISSVDLSQNLALTNLFLNDNQLT
SIDVSNNTALERFGVMRNQLTTIDVSMLTNLQELFLHGNQLTNIDITNNTALWKLYAYDN
LLTSLDVTQNTLLEMLRLENNYELQPNNQISTLDLSNNINLKDLRFSNNPINAIDISNNV
NLEFITFYGVGLSNIDVSKNTKLKRIYAGYNSNLTSIDVSNNLDLEWLTIINNNFASIDV
SNNTKLQYLVMDTNSLSAIDVTNNPELYWLSFENNAISTIDISNNSSLTNLYLNGNDLTS
LDVSNNLLLGQGDPQYTSVVSLYDNPNLACIQIDATQNTTNWAKDDTATYSTNCGGENTI
VTIPDTNFEQALIDLGWDSNGLNGNILISEAQAIDSLNIQDPLNNTLLPNVTEKIKNLEG
IEAMVNLVSLESGVNEISSVDLSQNLALTNLFLNDNQLTSIDVSNNTALERFGVMRNQIT
TIDVSMLTSLQELFLHGNQLTNIDITNNTALWKLYAYDNLLTSLDVTQNTLLEMLRLENN
YELQPNNQISTLDLSNNINLKDLRFSNNPINAIDISKNVNLEFITFYGVGLSNIDVSKNT
KLKRIYAGYNSNLTSIDVSNNLDLEWLTIINNNFASIDVSNNTKLQYLVMDTNSLSAIDV
TNNPELYWLSFENNAISTIDISNNSSLTNLYLNGNDLTSLDVSNNLLLGQGDPQYTSVVS
LYDNPNLACIQIDATQNTTNWAKDDTATYSTNCEGENTIVTIPDTNFEQALIDLGWDSNG
LNGNILISEAQAIDSLNIQDPENNTLLPNVSAKIKSLQGIEAMPNLVSLESGNNELTSVD
LSQNLVLTNLFLNDNQLTSIDVSNNTALERFGVMRNQITTIDVSMLVNLVDLFVHENQIT
SLDVTNNTELNWLFTSNNQLSAINLSHNTKLKRIDIYWNYLTTIDVSMLADLEDLRVGSN
QLTQLDISNNSSVYNLSCDNNQLDVLNVKNGNNSNFTYFSANNNANLACIQVDDVSFSTA
NWELIDATATFNTDCNIPATVSIPDYNMKTALVADTTINTNEDTEIQVSEAEAVTGTITL
EALDIDNLTGIAAFKNITGLNVSENNLKTVDLSNNTKLSYLSIYTNQLTALDITFLTSLE
FLYAGSNQITEIDVTNNLFLKRLWLNINNISAIDISKNSDLEELELDWNYNLSAIDFSNN
LKLYRIHLWKTAISTIDVSQLVDLQRLYVSETNLKTIDISNNIKLYDFRSTDNPEIPTYD
FSNNIALNRIDLSNSGVSDVDVSNNINLTQLLLGQNNLTTVDISKNTLLQEVYLNNNKLE
NIDISKNTNVTKLFLNDNVLERAYLKNGNNTAIVEFDIANNANLTCIAVDDATFSTNNWT
SIDTSVNFNTDCSAEWEVYTEDENFETALLTAAGLDFNNDGVITYEEAQAFTGDLDLSGK
NITDVTGLEAFSNAASINISGNSITDISSLLDNTSVVVTSKSTGEKRSIKRDNSQGIKKL
NVANNLIIDIDISKVSSLTELIVSNNKLESLNLNNNSNVTLLKFDATGNSDLTCIQVDDV
NASNTNVNWKKDATASYSTDCSKSALSINEFLKENISVYPNPAITNIQVSLANSLELKSI
EIYNAIGKKVIKSKNYLIDIKALSQGIYFVRVITDKGFINQKLIKN
>FCMOIPGL_01290 hypothetical protein
MKNLIKLFILMLFVAPQFLSAQSITNVKTLLIENEYGNARLKVTPNTYDMTATKPTKLSG
VYGLLVCYTYKGVKKALHQDLTYDFAKKGEKELFLGMSATKANIVINSALFYRRDLTAKK
DYPKKTDCF
>FCMOIPGL_01291 hypothetical protein
MKNILFFLLLIPSFLVAQKTTILKGTVRNNLNEPIEKVTIKYGNTGDVTDKNGNYSIRIP
FNEEITIIFSHVSYRTFTKIITANSRNAIRYSPTLSLKTEQLKEIIVKDIRKKVEGLTTI
DAKKAKNIIGPNAGVENVLMTLPGVSNNNELSTQYNVRGGNFDENLVYVNGIEIYRPFLI
RSGQQEGLSFINSNMVQNINFSAGGFQAKYGDKLSSVLDITYRKPTETATTIDASLLGAS
VTFEGNFLNKKLSTITGVRYRDNSLFVNSKQIETNFRPKFTDIQTFLSYEFSEKLSLNFL
GNFSLNNYNYQPISRSTRFGTVAEPLELNVFYSGQEQDKYLTLFGALSAEYEVNDNFTLT
TTASRYNTQEEEHFDIAAAYSLGEVDANIGSESFGEVDFSQGIGSQLNHARNDLDALISN
IQVRGTIKNGETQWNFGAKYQKEDIKDRIREWEIIDSLGFSIRPPYHSSNNQPYEPFEGE
ITPYQNIRKDNSVAINRVSGFVQFNQRSFWNDHEVFYNVGIRAQNWSVTGNGIQSKNQTI
ISPRAQFAIKPNWEKDMLFRISGGLYAQPPSYRELRNFDGDINVDVKAQKSIHYVAGMDY
SFQMWERPFKLTTELYYKDLSDVNAYSVDNVRIRYRADNVTTAYATGIDIRLNGEFVPGS
DSWVSLGYLKTEENIDNQGYIARPSDQRIKFGILFQDYVPNLPDLKAYLNLVYNTGVPGG
APSYADVYQFQQRLRDYKRADLGVSYIFVDANKQFSTGWLSKFKELTAGLELFNMFDIQN
SITNTWVRDVYSKTQFGIPNYMTGRVLNFKVGMSF
>FCMOIPGL_01292 hypothetical protein
MLFSFLLLPFLCTSQEKYPQNYFNNPLEIPILLSGSFGELRSNHFHAGLDIKTKGREGLK
VLAAAEGYVSRIKVQQFGYGKAIYITHPNGFTTVYGHLSKFADEIEDYVKSIQYKTENYE
TGNLYFKENEFPVKKGEIIALSGDTGGSGGPHLHFEIRDTASENVINPLLFGIKVDDTIA
PTFLNLKVVALNANTRINQQRKSFQIPIKNIGKGKYVANRISASGVIGFGVNVIDRFNNS
YNKNGIFSLEMLVNGKRFYYHYVETFSFAESKFLNLLIDYKHYKKYKKKYQKTYKETASK
LSTYKNLINNGKIDIKEGLNYNVEIIAKDFEGNLSSIKIPVAGKESNALFTEQKDTTAYK
IIAKNFNKFKNKNVTVAFPKKTFYEDIYLDFKVDKGIAKIHTPTIPLDKNYTLTFNVSDY
SNDQKEHLYIANVEYPKYPRYQYTRKKDSTFFTTTKTLGNYTLLSDKQKPRIKLLYFKDK
QWISNFKTLKVKISDVGSGIKNYRATIDDEWILMEFNHKKNILTYNFSDKKLVGSKHIFK
IVVSDNVGNTNELSATFFKKQIN
>FCMOIPGL_01293 hypothetical protein
MSNTLEAIHLLEDKLKILLSNYEFLKNENEILLQSNTELQHQILESKQHLIAQKKDFDLL
KIAKTIEGSSTNTKDTKLKINTLIREIDKCIIQLQE
>FCMOIPGL_01294 hypothetical protein
MDKLKINIVIAGRTYPLSVNNTKEEEGMRKAANAINNLISMYEQNYAVSDKQDVLAMSAL
QFASKLEMISLNKNDTNEEEIKKLNELTNLVSKHLK
>FCMOIPGL_01295 Ribonuclease Y
MDGMILPIIVGVFIGIAVGFLIFKTIEKSKGKKILDATRSEAASILKEAKIDAEAIKKDK
ILQAKEKFIELKSEHEKVILSREKKISDVEKRIRDRESKVASEVDKNKRLNQSLERKEKD
FDFKLDFLEKKEEDLDKMHKRHVDMLEQISGLSAAEAKVELVASLKEVAKSEAMAFIQTS
VEEAKLTAEQEARKIILGTIQRVGVEQAVENCVSVFNLESDDVKGRIIGREGRNIRALEA
ATGVEIIVDDTPEAIILSCFDPVRREIARLSMHKLVTDGRIHPARIEEIVKKTENQITQE
IIEVGKRTVIELGIHGLHPELIKTVGRMKYRSSYGQNLLQHSREVANLCGIMASEMGLNA
KLAKRAGLLHDIGKVPETESELPHALLGMQWAEKYGEKDEVCNAIGAHHDEIEMKSLLSP
IVQVCDAISGARPGARRQVLDSYIQRLKDLEEIAFGFSGVQKAYAIQAGRELRVMVESGK
VSDTKASELSFSISQKIQNDMTYPGQVKVTVIRETRAVNVAK
>FCMOIPGL_01296 TonB-dependent receptor SusC
MKHKFLSKFLILMSFFLSTIAFSQQVLSGKIIDETGSPLPGATVNVKNSDKWATSDFDGN
FKIEFKEEKNIIRVEFLGYQSKDIVIGNKNNITITMLPEVNSLSEVIVTALGIKRSQKKV
GYATQKVEASTIKEIVAPNAAGLITGKVAGLTVSNPTGLFQAPSFTLRGKTPLVVVDGIP
VSTDFYDISPDDIVDITVLKGTSASALYGYRGGNGAIQITTSRGQKSNGLEITVSHNTMV
SAGFTVFPETQTEYGNGSNGQYEFWDGQDGGISDGDMIWGPKFEPGVEIAQWNSPIKDNV
TGEVTPWWGDVSGTKYDDKSRYSRVPIAWEYHNNLKDFLRTGVINTTSFSVANSSKNGSY
RLSGNYKSHTDRVPNASLKTAGLTFNSSTKLSDKLTLDSKLAYNKVYSPNYPRHGYGPKN
HMYTILIWMGDDVNGKELNEHRYIPGQEGYRQANFNYAWYNNVYFAANELNQKYDSNVLN
GQLKLNYKVTDDFSIQAMGSAVMKDRFEDRESPKSYLNYGDPRDGDYKTWNTNSVDVDYN
LLATYNKEISNKLSFSANVGASSEYHKYQQEYNATDGIIVPELYSLNNTKGNIKGSTNFS
ERSVNSLYGMLELDFDSKLFLTFTGRTDKHSTLPTDNNSLFYPSVSLSSMISDWFQLPES
INYLKAFGSWAQVKRSLSAYQINSYYDNAGTYDGSPELSYSGSLVNPDIEGSLTTNVELG
LSAGFLNNRIGLDFAYYNAVDENSIIDLPISLGSGFSSRKENAHQFTTNGFEVSVRATPI
KNTDFRWDVLANWSKKVQRLTRLDEDAEQYNSLRLNDRTDAYYATVWEKSADGKLILDAN
TGMPTKNPYKQNIGNKNPDFRFGLENNFKYKGFSLKVGIDGVWGGLMRSLTVEKMWWGGK
HPNSTLYRDAEYANGIGTVYVPTGVNVIGGSVQRDLNGNVTSDTRTYATHTSPVSWQAWS
QNYPYRAQVTEEESEIFANVFDRSYLKLRTVSLSYDLTKIANIKGVKQLNASFNGYNLFI
LKKADIIDPDFGDDDNLQDPSTRYLGLGLTFKF
>FCMOIPGL_01297 hypothetical protein
MMVIVVFSCEDLDINENPNKVSETHPSLLLTNITTSAFQVKGTGAMYASRMIVQTDGEST
SQFYKWDRASFDAYNSLRQVTKMMEEADRIKDDSYKGIGYFFRAYYFYDLALTFGDVPYI
DALKGETEDLYQPKYSTQEEVFTGILKELEMANSLLDGTDIITGDPIFNGDVSKWKKLVN
SFRLKVLLTLSKKEGSSSLNIKNEFAAIYNSQPIIATPEEGARLEFVDVVDSRYTEFNSS
GYGSGLYMASTFIDMLVEREDKRLFAIAGQTKNAKEAGLAINDFSSYAGGNPVIPYNDVN
LLAAAGKVSKVNERYTADPTAEAHNLLSFSELQFILAEASVKGWIPATNAQIFYENGIKA
NFQFYNTYAKGYEAYYTQAEAVNYIAGSKVNFLNATTDAEKLELILTQKYLTSFLQGGWR
MYFDHLRTGYPVFPLGVGTAPTRWIYPLDEYNNNSVNVTEAIARQFGGSNDGIRELTWWL
K
>FCMOIPGL_01298 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MQDAEPTSIKIMWQTDFDEESIVYWGTKKNRLKNKVIGTSFDINFTEKRVHEVAITGLTR
FTTYFYKVQTGKAVSKVYQFKTPPFAGESKKINLVAMSDMQNDWQYPTKFKEVVEEGILP
YFDKNFEGNISDNLAMVVIPGDLVVTGTTFNQWEEHFFKQSEKLFSQVPVYPVPGNHERN
SDYFFKYFSLPKNGSPEYAEHWWFKDYANTRIIGLDSNDGYRDIKQQLIWLKELLAKTAK
NDTIDFVFAQLHHPHKSELWIPGEEDFSGKVVKLLENFTKESNKPSLHFFGHTHGYSRGQ
SKEHKHLWVNVASAGGAIDNWGEFEGRDYDEFTVTQDEYGFVLATINPDKENPSFTLKRI
SRGNNIEFRNNELRDSITVFKKTIQPNTPVLVDFGKEPQPIYKVVLKANSFKSDKKDAFH
GASNWQVSTTKDFSKIIYNSWKQHENWYYKENRQKDDDLSDEILDRKLNNYTTYYVRVRY
RDQFLNWSNWSVVRAFKTIK
>FCMOIPGL_01299 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MKNIKLISVLFLLIISACSSEEKKKQEIEHAASKVFVITLDGLRWQELFSGADSLLIANK
EYVNDTLALKNLFWKYKATERREILFPFIWSEVAVMGQIHGNRWQGSKMNLTNGMHFSYP
GYNEILTGKADDKRINSNSKIPNPNITILEIAEKNDAYKGKVAAFGSWDVFPSIINEERS
GLYVNAGFREAKGANLSDKELFLNELQAETPSPWGGVRLDVFTHHYALETIKKKHPKLVF
ISYGETDDFAHDGEYDAYLKSANRTDEYIKKLWYFTQQDSFYKGKTTFIITTDHGRGTEP
LKSWKHHGNSIKNTDQVWVIAFGQHVEPQGEIVSEEQIFTNQVAASVAKILDIEIRTDSI
GKPFSFVK
>FCMOIPGL_01300 Response regulator rcp1
MFFYIFIMPKRNKILLIDDNYATNFYHNIIINNLDTSNEVDYCTDGIDALNYLSNKGKYK
ANDSYPRPDIIFLDLNMPKMNGIEFLEVYKNLSKEQKGEKLIVMLTISLNEKEKTKIKLF
QDVIDIENKPITEEYLSKIITT
>FCMOIPGL_01301 hypothetical protein
MIKSTIKILLIEDNAADAVLIERQIKKIVTSPQIKCIDLYNDFITTLKNFKPDIILCDYR
LKGYSGSDVLEYMNTNLSFYIPLVFVTGAIKDEELAANSILSGASGYILKNNMNSLHEKL
LPHFKKIESLKNNHLIDQDLKLKIEQLQNYINGVKNDNTINIESFNEMKKAFDKLKYLIN
>FCMOIPGL_01302 Phytochrome-like protein cph1
MEKKELLKENKILKAKLAFIEEKLRNIENENEKQIDIKNAEFDDFVYIISHDLNEPIRTI
NSFVEIIKEEYHDSNDKKLGTYFYFIEDAIKRLNTKMKSLLDFSRLGKNQTLELTDINET
IDSIKIELSDLIKKNNASIVYSDLPIVNCYSSEIKQVLLNLILNSIKFKQPKNSLLIEIS
CISKPSFWEFCVKDNGIGINDNEHFEIFQMFNKLDITNSEKSNGTGLAFCKKIIEIHKGT
IWVKSTLDLGVEFHFTISK
>FCMOIPGL_01303 HTH-type transcriptional activator Btr
MSNKTHIINSIKNLHNLFGFKKPIHPLLSIISENDLHAFKNRLGEKFILNFYSISLKDQN
CEAHFGRKNYNFDKGEIIFSAPNQTLTLSKTTNLNNNQGWILFFHPDLVRNTSLDKKIEN
YKFFTYDIDKALLLSDTEKLIITNCIELIKNEIAGSTDNYSKPVVVSTLDLLLNFCARFY
ERQYKTKSIHTNNIVTQVSSILKDNYDSGLFIKQGIPTVENIAEIIGITPNYLGDVLKKE
TGKNAKDFINSYIIDKAKTLLLNDNITISKLAFDLGFNYPHYFSRLFKAKTGLTPNQYRQ
NH
>FCMOIPGL_01304 Phytochrome-like protein cph1
MKKEKKELSAPNKTKKNLDTVVNKEMFVVGIGASAGGLDALQEFFEHIPVNTGMSFCVVQ
HLSPNFKSLMNELLSKYSRMTISTVEDGEKIKPNHIYLNPNNASLKVENNSFKYVPKESR
TALNLPIDMFFHSLAKEYQDKAIGVILSGTGTDGSRGIRTLKEVGGTIMVQSPLSAQFDG
MPNTAISTGLAEYIGTPSELAVELTKFPNKPSFIREVDGGSVTEVETIFNDILDLLFKFS
GQRFKDYKNNTLVRRLEKRMGILNFSKISEYYSFLQKDDKEKQLLINDFFIGVTSFFRDK
EAFNLIKTEIIPKIFKNKEPHETIRVWSAACSTGEEAYSLAILMDEYITKNKLQNDYKIF
ATDADMRAIEIASIGEFILNSANDIPSNYIEKYFFRNGDNYLINKKIREKIVFSKHNLIA
DPPFIKMDLISCRNLLIYFSTKAQQKSLQHFKFSLNLDGYLFLGSSETLGEIQTDFATIS
AKYKVYNIVNKSRTITDFTFDNNMRKIESKRSRLHISSLVSSKRVEDNENFYNQHLVNVF
SPKCIFIDKDYNILYVKGDLKEILHISQGVAQLNLMKMLDDKLAAMVRNGVRRINEENKK
VMFSDIKNLLDDKTKALNLVFSKVETTNNSEIYLIVLNEAENVENFTNDAVKYNQFELDE
FSKQRIEDLEYELKTKNAELQFIVEELETSNEELQASNEELMASNEELQGTNEELQSVNE
ELYTVNTELQFKNKELTIASDDINNLLKSTEIGTLFLDDKLKIRKITPHIKKHFALESSD
IGRYIGSFKHILPTYDEQNFIEELKNAIKNNKKTEAKVKDIEGNTYLKSIIPYINSNNKV
DGVVINYVDITNLTKAEDELLQISNDYKNLSSELELIINNIPALVFYKDDKNNYVRVNNA
LSEIHDSTSKDLVGKNLSDLLPAEEAIEYWEEDLEIIKSGKSKFNIFQSIINNNKKQYLS
TNKILIKNNNKNFILGVSSDITLLRKNQDELLLTLEKLKISNNELSQFAYVASHDLQEPL
NTIIGFISLLHKEFNEAENKKASQYINIALEATERMKSLIKGVLEYSRIGKDKVVSKIDT
RDIIQEVLIDLDNLIKEKKAVINIGSLPKQIKGYKTEIRILLQNLISNGLKFVEEGKAPN
INITGEETKDSYNFSIKDSGIGIEEKHTIEIFEIFKRLHSNKDYNGTGIGLAHCKKIIEI
HNGTINVISTPNLGSSFNFSISKKLD
>FCMOIPGL_01305 Autoinducer 1 sensor kinase/phosphatase LuxN
MHKLKTILLVDDDDATNYLHEIHLNNLNVAGNILKVHNGKQALDLLFSGKLLIPDLIILD
INMPIINGWVFLEEYSKLRDSETSKIIMVTASINPLDETKGKTHPYVLDFIGKPLNENKF
IKILNLMKN
>FCMOIPGL_01306 Oxygen regulatory protein NreC
MKKNNLDLFTEIFDTHKEYCGTVVETHVQKLKELDAYLPRMQSFFIVTNTSTKMYPFVSK
NFEYTLGLDRKKMAKLGATYWFSHFHPDDLPIWMRVLEDLMLFTMTEISKKDRPKLCYSW
NFRIKNKNGEYLNTFEHLTPVFFDDSGKPIIGVAHLCIVGGGEQRPIIATVKKLNDKNEY
ETLFYKNYSQKLLSVSLTNREKDVVRLLALNKTSAEIAKKLFISTHTVNVHRKNILGKLN
FDSTIQLVQYCLVNQLF
>FCMOIPGL_01307 hypothetical protein
MYKKQFPTGSWFGVKELALPAFMIEIELEVYKPE
>FCMOIPGL_01308 Acetylornithine aminotransferase
MKSDFFKYQAQTSPYPLAIEISHAKGSYIYDIHGKKYLDFVAGVSANSLGHNHPKVSEAI
KNQVDTYTHVMVYGEFIQQPQVDLCKVLASTLPENLSSVYITNSGTEATEGALKLAKRVT
NRSEIIAAKNSYHGNTQGSMSVSGVEKQNSAFRPLVPGIKFIEFNNEIDIAKITHKTAAV
ILETIQGGAGFIEPKNGYLTKVKQRCIEVGALLILDEIQTGIGRTGTFWGFENYNVTPDI
IITGKGLGGGMPIGTFIASYEHMSLLQDNPKLGHISTFAGHPVIAAAANATVKEILEKNL
VSESLRKEKIIRKHLQHPAIKEIRGKGLMLAAMVDSAELASKIILKCLDKGLILFFLLFE
GKAMRITPPLTISDEELAKGCAIIIETIEEFV
>FCMOIPGL_01309 LPS-assembly protein LptD
MKRFFFLLLLIITSISYSQEKRKIVYKAEIQEADEEKFPGASILIGNVKMNHEGIDLTCQ
KALYYKKENFFKAIGNVFIKQGDTITQTSDYADYDANSKQALSWGNVVLKDPTMTLTTDT
LHFDRINQKLYYQSFATIKDTTNTLKSKRGNYYLENKKFIATTRVTIENPEHFLESDHLD
YYTESGYTYLWGPSTITNTKNQNKIYSEKGFYDTKTDISHFVKNAKLYLKERTVEGDSLY
YDKRKGFASATKNIKVIDTVQNFITKGNYAEIFEQKDSLFIIKKAVAISIIEKDSMFIHG
DTLLVTGKPEKRIIRTYHNVKIFKSDLQGKCDSIHTNQETGLTKMYRNPVIWSDKNQITG
DTIYLKSNVDTEKLDSLKVFNNSFIISKDSLSVDDFNQIKGRNMFGKFEENKLKTLLVKG
NAESVYYNRNEETDIIETITKEISSNIEFTFEDGIVASIKYLKATEGKTYPPSMLPEDVK
KLKDFIWRESEQPKKMEDIFIIDSDEKKAPIKKESLKKSKAILDERTFLKEKLKKGKNLR
SSIKKQ
>FCMOIPGL_01310 Iron-sulfur cluster repair protein ScdA
MENIKNNTVAGFVVNNIHTANIFKKYGIDFCFDGKISIEEACIKNDVNYKQLENELNDLD
IKTNFLNDFNKWGLDFLMIFIIHIHHRYVKMNIPILKKYGEKAVKNQGKDYTELSEINKL
IIKFSNELIIHMEKEETIVFPFIKRLFKANKEHSTISLSNFNSLNHPIKMMEEYHDKAGD
ILKKISKLSNKYKIPEDASLAYKELYKKLQEFEDNLKNHVHLENNILFPKAKKLVLEVVK
>FCMOIPGL_01311 L-2,4-diaminobutyrate decarboxylase
MKPFFDLSVEEMKSYGYNIVDIIVTHFENIESKKPVTKASRKEMDTIFLQEAPEKGMPAD
EVLNFVMENVIPNSNISSHPKAFSFVPGPSNFISAMSDSLATGFNIFSGGWIVSPSAAEL
EIVTLNWLLKMFNFPVTKGGGIFTSGGSMANLTALVTARRIKCGDDFSDAIIYLSDQAHS
SNIKAIRVLGFKKEQIRIIPTDLEFKLSINKLKNEIAKDRLKGKKPFCIIASAGTTNTGT
VDPLDVLADICEKEDLWFHIDGAYGGAAILSEKGSKVLQGIERADSLTVDPHKWFFQPYE
IGCLLVKDASWLSNTFSEKPEYLRDIEGNESEINFYDYGIQLTRRFRALKFYMSIKTYGL
ETFKEAISYNIDLAEKTEDILRQSKNWEVVSPATLAIINFRYNPLDLNLYDKKLDKLNQE
ISSRVVASKEAFLVTTILQNQIVIRMCLINPNTTLDHIKDTLDQCDQFANEVLAEWKK
>FCMOIPGL_01312 hypothetical protein
MIKNKIYSFISLFYFLIAASLGILLRLFPVTNVEATYKYIVHTHSHIALLGWVYIALTTL
IFHLFIQKEARKKYLILFLATQITILGMLLSFPITGYALYSIIFSTLFLICTYWFYAFFR
KHTTFVKNTFSYKFVNVSLLFLVISSIGPWALGIIMNTLGNTTHLYKNAIYFYLHFQYNG
WLIFCLLGLFIFFLEKHEISINKKAFSLFYKLMILSCCFTLFLSFLWIKPSIFIYILAFL
GAVLQLIALIKLQQIINNLKADLSKRINPFIYRLLQFIYILFVFKIVLQLLTSIPFFAEL
VSQIIDFVIGYLHLTFLGIVSLSLFVFFKEFGLLKLSKFWLRMYLTGFILSEILIFYKGF
CNWQQFSIINNYYTILVSVSALIPVAILGICIQNMKTIFSTQQELH
>FCMOIPGL_01313 Copper-containing nitrite reductase
MKKSFFIKLLTKNKLTMKLLKTICVLCVASILFYSCKKDEKKEIAIKDSATIYIKGTMEA
ELTSPPFVPAPVGDRTAKKLLVKMEILEKEGEMTDGVKYVYWTFGGSVPGSFIRTRVGDE
VEFTLSNHPDNKLPHNIDMHAVTGPGGGAESSFVAPGHEKTFSFKALNPGLYVYHCATAP
VGMHIANGMYGLILVEPAGGLPKVDKEYYIMQGDFYTKGATDEKGLQAFDMTKAIKEDAD
YVVFNGKVGALTGDNAITANVGETVRLFVGNGGPNLTSSFHVIGEIFDKVHVEGGDLINE
NVQTTSIPSGGAAIVEFKVEVPGTFIIVDHAIFRAFNKGALGMLKVSGEENKKLYSGVKQ
EGIYHPEGGTIQTMPENDQKEVVVNTKEKPLAQKIADGKQLYMTTCFACHQAEGQGIPNA
FPPLAKSDYLNADVKRAVGIVLNGKTGEITVNGNKYNSVMTKQTLSEEEVADVLTYVYNS
WGNNKTNVSISTVKEVKNGK
>FCMOIPGL_01314 Serine/threonine-protein kinase pkn1
MKTILRLIICILFFYSTNASCQSKMVKIKGGKYIPLYGRDSMKVSINDFSMDVFPVTNKE
YLAFVKKNPKWQKSKTIKLFADESYLRDWKSDTLLNVNQKLNSPITNISWFAAKDYCECM
GKRLPTVDEWEYVAMADKKMPDARKLKTYNEFILGWYEKPKSFNQTIGSTFKNYWNVYDL
HGLVWEWTSDFNSVLISGESRKDVDADANLFCGSAAINATDLMNYAAFMRYAIRGSLKAK
YTMKNLGFRCVKDN
>FCMOIPGL_01315 SCO1 protein 
MKLIKYLLLLTVTTTLLSSCNKSTAKETEMSTVSYQCPMKCEGDKVYVEKGSCPVCKMDL
RLVSKSTKVKSDKISDESIFNLTSKWNTEEGKTITLKDLKGKTLVVVMIYTTCKAACPRL
AADMRNIEAKISEDYKNDVNYILVSIDPKTDTPEKLKKFAIENYMDEDQWTFLQGTESGV
REFANVLAVKYKEISPIDFSHSNIISVFNPQGEIVHQQEGLGVDNKETITKIIETINKD
>FCMOIPGL_01316 Iron-sulfur cluster repair protein YtfE
MNITKENTVAEVVTYNIKTADVFKKHGIDFCCGGGISIEKACKKHNVSFEEMEKELLNVN
NPTSNAYNYDSWKLDFLVDHIENIHHNYVTENTPIVLQYAAKVAKVHGHHYTEVIEINKL
FNEVAQELAAHLKKEELILFPFIKQLVKADKEGIKVKTPHFGTVNNPIAMMEEEHESAGD
ILKEIKKLSDNYTPPNGACNTFKALYAKLDEFEQDLHQHIHLENNILFPKAIALEKKNNL
>FCMOIPGL_01317 hypothetical protein
MKNAHSFHIPVMGIGFTIDSPLKVAQYGIDSVISLVDDILIEKMRKVYSEKFEIPYKEIT
DKAEDFRAKRITSYLNLLQEQTEEKFHQLKNITSEKSKALKEYIHLLPEYSTLKKDFVKL
TEEGIDFTKLKDWAHKNLTSGSIDVNIMTKIDKGNYLNKELLPIEYNDAHAALRGYANSK
LASSLVLSAGMNPRLYSYISNFNDFFPDENGYIKKKIILKVSDYRSALIQGKFLAKKGLW
VSEYRIESGLNCGGHAFATDGFLLGPVLNEFKENKAVLQNEIQSILIDALKETNKIVPKN
NLVLKITTQGGVGTEEEHSFLLDHYQLDSVGWGSPFLLVPEATSVDDKTMELLSNSKEKD
LYLSNSSPLGVPFNTLRGNTKDIHRQELIDKGRPGTSCPNKFIALNNEFKESGLCTASRE
YQHLKLKEIDSLEISSEEKQKQVDKVTEKSCICVGLGTSTLILNKVSTKKTGDGVSVCPG
PNMAYYDKVMSLQNITDHIYGRDNMISRIDRPNVFIKELSLYITHLHDKVEELKSNFDKK
QLRSLTKFKKNLEAGINYYNELFLNQKQAFITHKEALLSALQLEQNKLNLISIEIENL
>FCMOIPGL_01318 Adenylosuccinate synthetase
MAVDLLLGLQWGDEGKGKIVDVLTRNYDIIARFQGGPNAGHTLIFDGFKHVLHTIPSGIF
HKTALNVVGNGVVIDPVIFKKELENLDKHNIDYTSKLLISRKAHLILPTHRLLDAASETS
KGKAKIGSTLKGIGPTYMDKTGRNGMRVGDLELENWKEKYDALTAKHIKMLEFFDVQVEY
DLKELEAEFIKGIDKLKTLPFIDSEEFLNQAIKDKKTILAEGAQGSLLDIDFGTYPFVTS
SNTTAAGACTGLGVAPNKIGDVFGIFKAYTTRVGSGPFPTELFDNDGETMASVGHEFGAT
TGRPRRCGWLDLVALKYAVDVNGVTQLMMMKGDVLSGFDTLKVCTSYNYKGKEISHFPYN
IEPENVSVNYTEFKGWDEDLTEMTSADQLPKNLLDYVAFIEKETGVPVKIVSVGPDRKQT
INR
>FCMOIPGL_01319 Ferric uptake regulation protein
MINPLDNQEVVKKVFTAYLQEHKHRKTPERYAILQEIYDAKEHFDIESLYIKMKNKNYRV
SRATLYNTIDLLLDCNLVRKHQFDGQSMARYEKSYFDKNHDHVIFTDTGEVKEFCDPRIQ
IIKKTIEEIFDIDIHNHSLYFYGTKKNKE
>FCMOIPGL_01320 GTP pyrophosphokinase
MDYTATVEEENKEIANRYKDLLKGTYEVLSKEDKELIRKAFDLAVEAHSSQRRKTGEPYI
YHPIAVAKIVAMEIGLGATSIASALLHDVVEDTKYTVEDIEQMFGTTIARIVSGLTKISR
LNKEKNASIQAENFRKMLLTLYDDVRVILIKIADRLHNMQTMDAMPDDKQVKIASETLYI
YAPLAHRLGLYNIKTELEDLGLKYTEPDVYNEIENKIKESKQDQQKYLQRFTDTLKSGLD
KENFSYEIKGRFKSIYSIRKKMRTQNVTFDEVYDKYAIRIIYYPSSNDDKFDAWKIYTIV
TDYFKPNPTRLRDWISQPKSTGYEALHITVVGPDAEWVEVQIRSERMNEIAEKGYAAHFK
YKQGDQKESGLENWLNKLKETLESQSLNAVDFVEDFKLNLYSKEIYVFTPKGDLKSLPKD
ASALDFAFSIHTDVGLKCRGAKVNGKLVPLSHILKSGDQIEVITSSANKPNSRWLDFVIT
ARAKTKIRAALKDDEKQVAEEGKAVLMRKLRHLKINFDDKVINELVAYFKLRTSFDLFYR
FGNGAIDNTQLKAFVAQRNGAIVNFFKSKLRRSNSAKDIPEATDEVSPKYDALVFGKEEE
KLDYKLSKCCNPIAGDKVFGFVTINDGIKVHKKNCPNAISLQSNYAYRIMSAKWIDSTKQ
DFKAILHIAGLDNQGIVNNVTRIISNNMSVFINSINITGDEGFFDGKISLSVKNSAQLNK
LIKKIQKVEGVKKVERVNTL
>FCMOIPGL_01321 Protease HtpX
MHPTTLFYILIAIIVISFIVDKILDTLNAKHFDDKIPEKLADVYNETEYKKSQTYKKTNA
KFSNLTSTFSIISTLVFFFIDGFKYVDNFARSFTDNPILVALIFFGVIMFGSDILTTPFS
YYKTFVIEEKFGFNKSSKKTFWLDKLKGGIMSIILGGGILALIIWFYQIAGDFFWIYAWA
LVAIFSLFMNMFYAKLIVPLFNKQKPLEDGELKSAIEKYAQKVGFTLNNIFVIDGSKRST
KANAYFSGFGSQKRITLFDTLINNLETDEIVAVLAHEVGHYKRKHIIFNLVSTILLTGFT
LFILSLFINSSILSEALAVSIPSFHIGLIAFGILYSPISEITGLFMNYFSRVFEYQADNF
AKETFAAKPLITSLKKLSKNSLSNLTPHKAYVFMHYSHPTLLERIENLEK
>FCMOIPGL_01322 hypothetical protein
MRRYIENFTSNLNGIDFKTLENSKHSVYGLSEDLNLTYVNPEWMNFAKENGINNNILKKF
PLGEPIVNAFLGEWVKNFYTEKFMEVLKTGKPWHHEYECSSVDHFREFHQDTYPLKNGKG
LIISNSLTIHLPMSKTGRKAFKAQDKRYVDATGFVTQCSNCRCTQRVMEPEIWDWVPEWV
NKIPKNCSHSICPICFDYFWKI
>FCMOIPGL_01323 Polyphosphate glucokinase
MKVLGIDIGGTGIKAAVVDTKTGELLSERHRIETPKPATPEAVAKVVKEMVRHFKWKKAV
GCSFPTTIVKGKCIHTGNLSEKWLNVKVDKLFRKECKLPFYVSNDADLAGLAEVSLGAGK
KEKGVVIVITIGTGIGSGLFYDGKLIPNLEIGKMLHSDGNIIERFTADSVRKKEGLTLKN
WALRFDLLLEYARIVFSPSLIILGGGISKRFDGFKEYLTTDVKVKVAEFRNNAGIIGAAM
YASKKVKK
>FCMOIPGL_01324 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MKEITSIQNAYIKNLLKVQEKARERRKQSLFIIEGKREISLAITANYKFDTVLFFPDLIS
ENEILNLFNENINRIEISKDVYQKLAYRDSTEGIIAVTKTKDFSLKNIHFKNEKPLILIT
ESIEKPGNIGAILRTADAANVDAVFIADAKSDLYNSNIIRSSIGCVFTNQIAVGSSEEII
TFLQEKNINIFAATLQNSNEYHKENYTNATAIVVGTEATGLSEIWRENATQNINIPMQGK
IDSMNVSVAAAIVVFEAKRQRNFKI
>FCMOIPGL_01325 hypothetical protein
MKKNGYRLLVFTIAAVMMSFKINTTEILKKEELIKIDVNSNSYQNGWSTWKTTDCFRGLD
LRVKKKPKSNYSEKHEWLVQFRNRYNNKIYFSYEIVPYSEKQNIRNSQRTTNRVDLKGNT
TEKSTHYKYLREANTVYVHVNKVRFSNDYGKGYSDCDN
>FCMOIPGL_01326 Imidazolonepropionase
MFFFLVGNILAQQTPADKQTTDYSIEGATAHLGNGQVIENSLIMFSQGKIVFVGNANVKI
ARRGTIINAKGKHVYPGFIAANSTLGLVEIDAVKASDDEDEIGTNNPHIRSLIAYNAESK
IVESMRPNGVLMAQITPRGGIISGTSSIVQLDAWNWEDAAIKTDDAIHMEWPGSFTRGRW
WLGEDPALKVDGNYSKKIENIKTYFTKAKNYLAGEKMKKNLPYEATKGLFNGSQKLFIHV
NGQREITDAITISKELGIDNIVIVHGNEADKISDLLVKNNVPVILDRPHRNPNREDNAYD
YTYTIAKVLTDKGVLVSLGMEGQMERMNTRNLPFYAGTFAAYGLDKEVALKLLTSNTAKI
LGIDDFVGTLEVGKDATLFISEGDALDMRTNILSEAFIQGRKISLETHQTELWKRYSNKY
KTK
>FCMOIPGL_01327 Adenine deaminase
MKRLLFLLFFLSLSVSNAQDYFPTDEGVKTTESTTFAFTNAKIYVTPTEVIKNGSLLIKD
GKVISIGKSVKIPKGTKTTDLEGKTIYPSFIDIFSDFGIAKPQRQSRSSRSAQYEPEREG
YYWNDHIRPETNSLDDFKFDAKKAKSFIDAGFGVVNTHVQDGIIRGSGLLVALNPNSTNA
YRVLDTKSAQYLSFSKSNKSRQAYPSSLMGAMALLRQVYNDADWYAKGNMKNKDLALEAL
NSNKDLIQIFETNNLLDALRADKVGDEFGIQYTILGSGEEFERINDIKATNANFIIPINF
SNAYDVSDPLLTQHISLRDMRKWNQEPSNLSVLSKNNVNFALTTYKLKDIKSFHKNLQKA
IKYGFDKEKALAALTTIPAEIIGNNSIGNLKTGSYANFIITSGDVFDAKTTIFENWVQGD
KNIINDMNIKDITGEYMLYVNNTNYDLSITGKGSKQTGSIKLGDKKLKSKFSFKDEWVSI
TLNNDDNFTRLLGKVINDANLIQGDAFDAEGKKSTWSASKKVKGKDDKKSKGKSDKNADE
KEILVLPVSYPNIGFGNFSQPKTTTLLIKNVTVWTSENEGILENTDVLLKDGKIYKIGKG
LSSRGATEIDGTGKHLTAGIIDEHSHIAASSINEGAQNSSAEVTIEDVIDPNDINIYRNI
SGGTTTSQILHGSANPIGGRSAIIKLKWGENAENMIYDNSPKFIKFALGENVKQSRSSNG
TRFPQTRMGVEQMFTDYFTRAQEYEVLKKSGKPYRKDAEMETLVEIINGERFISCHSYVQ
SEINMLMKVAEKFNFNINTFTHILEGYKLADKMVEHGVGGSTFSDWWAYKYEVNDAIPYN
AAIMHNAGVTVAINSDDREMSRRLNQEAAKTVKYGGVSELEAWKMVTINPAKLLHIDERV
GSIKVGKDADVVLWSNHPMSIYTKVEKTIIDGKVYFDINEDHKKREAISQERSKLITMML
KEKLGGGKTQAPKKRVDRNFHCDTLEELKN
>FCMOIPGL_01328 hypothetical protein
MKWNKTHIILAILLPIQVFLMQIVANNPAFIERYYSNGIYPIISSFFRIILGWIPFSFGD
LLIAFGIFFLIRFLYRLIKTRFRNFIPKTLHFTAILSVIYFCFYLFWGLNYYREPLSKNL
KYHQKKYTTEQLLKVTEHIIVKLNYYQQKITKNDTLLVKNPYSQKEMYKMAVSGYDNLSE
DFPQLKYQFPSVKSSLMSLIQTYNGTAGYLNPLTGEAQVNDRIPKTGYPTTTCHEMAHQI
GFAAENEANFVGFLAANYNDDVYFKYASYRMAFGYCLSEIKKRDQEVYTAILKKVNKGIL
KDFNASYQFWLQYKNPFEPLVKKGYNAYLKANKQAKGVQSYNYVVDLIISYFEASNEV
>FCMOIPGL_01329 Replicative DNA helicase
MEKTNPIAGTKIDKARIISLEKGKIPPQAVELEEAVLGAMMIDKKGIDDVIDVLSADAFY
DQKHQEIYAAIYELFQNSEPIDLLTVSNLLKKNGKLDFVGGDFFLIRLTQKVASSAHIEF
HARIILQKFIQRKLISISSEIIENAYDESSDVFELLDDAEAKLFEVTQGNLKKSSEDAGS
LVKQALAKIQEIGNQEGMSGLQTGFTKLDALTSGWQPSDLVIIAARPGMGKTAFVISMAK
NMAIDFNHGVAVFSLEMSSVQLITRMISSETGLTSEKLRKGNLEPHEWEQLNVKVKRLSD
APIFIDDTPSLSVFDLRAKARRLVSQHNVRILVIDYLQLMTAGGKAGGNREQEISMISRN
LKALAKELSVPVIALSQLSRAVETRGGSKRPLLSDLRESGAIEQDADIVSFIFRPEYYGM
TEWDDDEHTPCEGQGEFIVAKHRNGGLDNIRLKFTGHLAKFSDLEESFSSEFQSSMNADI
SQDHRIEPGDAFGDDDIDDMPF
>FCMOIPGL_01330 hypothetical protein
MEIFFGTIVLLIYLSIFLFGYKKDYQRNPKEFLKTIIGMPVSFILSLFGGNFLDKKIKKW
TKK
>FCMOIPGL_01331 hypothetical protein
MLRKLFILNLFLFISNSIWASFIYVPMSHDNQKNHLKAYGIVYFSLEAGLKSKWLLNYDG
GAFLIENNKAVENECKIRGVSYQIISDAKSQLILEEISSPSSNQDAVTLEKAPKIAVYSP
KDKMPWDDAVTMVLTYAEIPFDVIYDKEVLEDKLLIYEWLHLHHEDFTGQYGKFYGAYRT
TPWYIEAKLASEKKAKELGFAKVSEEKLAVAKKIRDYVIGGGFMFAMCSATDSFDIALSA
EGVDIAEAMFDGDASEPNYQSKINYNKTFAFKDFELVRSPITYEFSTIDMTRKRKIPKTS
DYFSLLEFSAKWDPVPTMLTQNHTTLVKGFMGQTTSFDRNTVKTNVLVLGENKTNREARY
IHGTKGKGMFTFYGGHDPEDYTHRVGDPKTELDLHPTSPGYRLILNNVLFPAAKKKKQKT
>FCMOIPGL_01332 Transketolase
MPTTQKLQDFTQQVRRDILRMVHAVSSGHPGGSLGCAEFITCLYQEVMEYSTDFDMDGKN
EDLFFLSNGHISPVFYSVLAHSGFFPVSELASFRLLDSRLQGHPTTHEGLPGVRIASGSL
GQGLSVSLGAAQAKKLNGDDKIVYTLLGDGELQEGQNWEAIMYASAKKVDNIIATIDLNG
KQIDGSTDQVLPMGSIRAKFEAFGWDVLDVEKGNDIDVILAGLAKAKSLTGKGKPVCILL
HTEMGNGVDFMMHTHAWHGKAPSDEQLENALAQNPATLGDY
>FCMOIPGL_01333 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIGIVCYPTFGGSGVVATELGMALADKGHEVHFITYNQPVRLDYLSHKLHFHRVLIEEY
PLFQYQPYELALSSKMVEVVEKHQLEVLHVHYAIPHAYAAYMAKQMLLEKGIDVKVVTTL
HGTDITLVGSHPTYKTAVEFSINNSDVVTAVSNNLKETTNQLFNIKKNIEVIYNFIDVDK
YDKEEHQECKRSALAEPHERILTHISNFRPVKRVEDVVKVFYEVQKEIPSKLLMIGEGPE
RIKASTLAKQLKIKDKVFFLGNSTEVAKILCYTDVFLLPSQTESFGFAALEAMAAKTAII
STNTGGLPEVNIHGKTGFLSNLGDTEDMAKNAIQILKDGASLEFFKQNAKEHAKKFSIQN
ILPVYEDIYKSCYKSKV
>FCMOIPGL_01334 hypothetical protein
MAGILDILSSDLGKSIISGVAGSTGNDSSKTSSVLTMALPVLMKAMERNSSTQEGAEGLM
GALSSKHDGSILDNLGGLFSGGVDESVKEDGAGILNHILGSKQKGVEQVIGQKSGLDAGS
VANILKVAAPLLMGVLGKQKKEQNISNSGDLTGLLGGLLGGSESKNEQNFLEQMLDSDGD
GSVIDDVAGMFLGGDKKETDGIGGMLGGFFGK
>FCMOIPGL_01335 Proton/glutamate-aspartate symporter
MRNLALHWKILIGMVTGILFGLGMLNIDGGAVFVSNWINPFGNIFVKLLKLIAVPLIIAS
LVKGISDLKDISKFKNIGLRTISIYIGTTVIAITIGLLLVNIVQPGDGISEETINKLTDT
YATSGGVQAKIQEASKQINSGPLQFLEDMVPDNALKAMSENTSMLQVIFFTIFLGISMLL
IGEKKSKPLKEFFDSLNEVVLKMVDLIMLFAPYAVFALLSNVVVSSDDPDLLVALFKYAL
TVVGGLLILVAFYMFLVSIFTKKNPLWFLKQLSPAQLLAFSTSSSAATLPVTMERVEEHI
GVDPEVASFVLPVGATINMDGTSLYQAVAAVFIAQALNFDLTFADQLTIVLTALLASIGS
AAVPGAGMVMLVIVLESIGFPADKLAIGLALIFAVDRPLDMCRTVINITGDATVSTLVAK
SVGKLHDNPIPKNWDDNYDEVK
>FCMOIPGL_01336 3-mercaptopyruvate sulfurtransferase
MILKIKNPIVSVDWLFKNLNNENLIIFDATIAKVTAKKEAVSSDKKLQLKGGLFFDIQKS
FSEKNAPFPNTVLSAKKFEEKVQELGVNVNSCIVVYDDLGIYSSPRVWWMFQLMGFTNIA
VLNGGFPAWELKKYPTEKTVRRQIKKGNFIANYQSEKIKFTADVLYAIESESILIADARS
KGRFLATEPEPRSDIKGGRIPNSVSLPYSEIVEYNLLKSEEDLKTVFNSLNPKNKDLIFS
CGSGITASVLALGAEIAGVKNHAVYDGSWTEWGSTKGLPIEK
>FCMOIPGL_01337 hypothetical protein
MGKLDWTRKEFEAYVLLYAAHCNFFESKEEQDYIFSKVDKKTFHRIHTEVVVDSDETNLD
KIQQYLSENNLHQEEKEALIRDIKNVFFADGSVDVIEKNVFSILKKIIN
>FCMOIPGL_01338 2-deoxyglucose-6-phosphate phosphatase
MKLPKEIKCVIFDMDGVIIDSEEIHKKAYYETFVSIGVHVSDELYKTLTGSSTINAFQKL
VTHFNLDLIPEELVIDKRKRYVNFFENDPTLHLVKGVEDLIKHCYNKGLTLVLASSSAMV
NINRVFNRFNLNQYFTAKISGADLTKSKPNPEIFEKAAILGKTAKENCIVIEDSDNGVKA
ANDAHIFVVGFKNPMADNQTLENADFIINNFKRLRKLI
>FCMOIPGL_01339 hypothetical protein
MKKIRFDKDFKIKLPIIVLSIFIFIGILSYQITTSNFYIISTIIGFLTIIIAVFSIIGLY
NAIKKIRNPTTVKKVFYVLIMAIFICTILYIIVENIMAVMKITI
>FCMOIPGL_01340 hypothetical protein
MVDIPKNKKIILFDGVCNLCNNSVLKVIKHDKKNLFVFAALQSKSGQEIISYLKIDISKM
DSIILYEPGVAYYIKSTAALKIMKYFGGFWFLTQIFGLLPEKIRDYFYDYIAKNRYNWFG
KKESCMIPTPELKAKFIN
>FCMOIPGL_01341 putative ABC transporter ATP-binding protein YknY
MIRIEKMHKSYPIGKDSLHVLKGIDLHIKEGEFVSIMGSSGSGKSTLLNIVGLLDIHDEG
NYYLNGELIKDLNEKKAAILRNKFLGFVFQSFNLISYKTALENVALPLYYKGISRKERLD
IALDYLDKVGLKEWANHLPNELSGGQKQRVAIARALVTKPKVVLADEPTGALDSTTTDSV
MDLLQDINDEGMTVFVITHEEEVAEQTKRIVRLKDGLIISDELTNVGKTV
>FCMOIPGL_01342 Macrolide export ATP-binding/permease protein MacB
MFDLDRWREIFQSINKNRLRSVMSGFTVSFAILLFTLLFGVVSGLSNSFTSAFADDAQNS
MFVRVWKTSKPYKGLQTGRRIQLKNADYNYVKETYENKIQYQSARIYKNFTIKYKNEAST
YSVRAVNPDHQFLEKTIIDEGRYLNERDLKEKSKVLVIGRLIKKDLFGERPALGKRVNVN
GSSFLVIGIFSDEGGDNEERMAYMPVSTSQMMYGNNDYISQINLGYNPNLSLDAAIAFGN
KMERDLREKLNIHPDDQSALSVRNMAEANKGIGMFMGVLYAIVILVGSGTLVAGIIGISN
IMIFVIKERTKEFGIRKALGATPASIVGMVVQESVLITTIAGYLGLSLGTYILSLIGNSL
EEKYFIKDPSVSPGIVIGATIVLILSGLIAGYVPAKRAANIKPIEALRAD
>FCMOIPGL_01343 Macrolide export ATP-binding/permease protein MacB
MNFLFEADTWQEIYGSIRKNKMRTAITIIGVLWGIFLLVVLLGAARGMENGFNKLFGNFA
TNSVFVWTQSTDKPFKGFQEGRRFTLTMNDIDVLKSEYSDEIKLLAPRNQTNNLIIKDFK
SGDFQVSGDYPILDQIQKKQLLYGRFLNQNDILSIAKVAVISEDMYKQLFDIGEFPIGQL
IKINSINYNVIGVYKPSNTINFDGDCAYIPFTTFRKVYNTANKVDWMMITANEGTNIEQM
ERDVLLTLKGLHKVHPEDERAFGSVNLGKEIGKITGFLVGMQFLTWFVGIATLIAGVFAI
GNILLITVKERTKEIGIRRALGATPKNIRQQIILESVFLTTIAGMLGIIFGGLVLYIIDT
AFGQGPDAALINPTVNIPIILIAFATLIVLGTLIGLIPAHMATVVKPIEALREE
>FCMOIPGL_01344 Macrolide export protein MacA
MSKRSKIILIIIAVLFIAALIWFGKKNSKNIVEYETETPFRTTIVKKTVATGKVTPLEEI
EIKPQITGIIDKIMLLEGAKVKKGDLIATVRVVPNEQSLISAKGRVDNIKISLNNAKVSY
DRNKNLFEKGVISRAEFETIEVTYKQAIQDLKNAQNDYQIIKKGSSGSGASANTNIIAQM
SGTILEIPVKEGDQVIQSNNFNAGTTIASIADMSKMIFEGKVDESEVGKLISGSDIDVSI
GAIEGVKFPAKLNFIAPKGTEEGGAVQFKIKADVSLDAKYFIRAGYSANADIVLEKKDSV
LSIKEALLKFDKKTEEPYVEVLVSEGVFENKTLKLGTSDGVNVEVLEGVTKDDKIKIWNK
ASNDDDKKVD
>FCMOIPGL_01345 Inner membrane protein CreD
MEQQQPNKFLQKIKTSITSRMVMIGVLSFILMIPLMYIEGLIEERSYHQKNVVNEISKQW
GNEVAVYGPILKIPYKIYKEKVITNEKTKQVTTELIENIKYGYFFPDKLDINSNINPEQK
KRGIYSTAVFNSNISISGEFKTIDFSKIEVNRENILWNKCKIIFKTTNVKGISTNLSIKI
NNKDYSLSSADFKKARNKDFYTLETNFLSFKELKKTEEKVLFSLGFKVKGSKDVRFIPIG
KETKAQIVSSWKTANFMGEFLPYNPDKINKNGFNAKWKVLDINRPFSQEHFDGLPHLNEF
DFGVNFKIPVDEYQKSLRSAKYGFLVISLTFLIFFLIQTISKINMHPFQYLMIGLALLMF
YTLLVSISEHSNFLKAYTIASISVIGLITFYSKSILKNIKFMILIFLSLTILYTFIFIII
QLESYALLVGSIGLFIILAAIMLISRKIDWSIN
>FCMOIPGL_01346 hypothetical protein
MHQKTKIIQKRYEGFLQTNCLWKGNSIYKLNQFEIEQVSSKINIEIDEKLRLGKYIERFV
SYQLEQEKSIKIISENIQIQKEKITLGELDCIILKDNKPIHLEIIYKFYLHDNAVGETEI
EHFIGPNRKDSLVEKLTKLSEKQLPLLYSNECVHYLKSINLNVDEIEQEVYFKAQLFVPF
LEENIILEELNQDCIVGFYINKKELEQFKDSKFFIPNKKDWLIIPHQNVDWLNFNQFKEK
STEYLEREFSPFCWMKFFNGEIKKFFLVWW
>FCMOIPGL_01347 hypothetical protein
MQFQKSTFNFLKDLEKNNNRDWFTEHKPTFTEIQNHVKEVFAEIQVNLEKHDEIEKMKIY
RIYRDVRFSKDKTPYNPRFAVSFSRLGKELRGGYFLQIKSGETFLGGGFWQPEKEDLFRI
RKEIEQDATEIREILSDKNYLKYFGGKFDGEELKSAPRGFDKEHADIDLLRKKGFIAIRN
FTDQEVLSENFLEELDKSFKALRPFFNLFSDILTTNLNGESLV
>FCMOIPGL_01348 Multidrug export protein MepA
MAQIVSELGTEKISKLLIKQAVPATIGILVMSLNMIVDTIFVGQWVGVLAIAAITVVLPI
AFLISSIGMGIGIGGSSIISRALGAKDTEKAFLTFGNQVSLTVILAILFVILGSVFSVPI
LNLFGAKGDILPIASKYFSVVIYGVPFLAFAMMGNPTIRAEGKPKFAMYAMMIPAVLNVV
LDVVFIKFFNWGMWGAGLATSISFASSGLYILYFFLSSKSQLKIIPKNFKLDPKILREIV
ELGGVSIVRQGAISILMIVLNYSLFTYGGEISISIFGIINRVMMFSLSPVLGVSQGFLPV
AGFNIGAEKNERVKETIKKAIWFGSILGTIIFIGIVILKEEIIWIFTDDITLLDKTPNAM
LVVFLVTPIVTMQLIGSAYFQAAGKALPALFLTLLKQGIFLIPLAYILPKFYGINGIWWS
FPIADILSTIITVWILKREVDKNLN
>FCMOIPGL_01349 hypothetical protein
MFVKIDKMKNIFEVKFTVSSEDIDDLNHVNNVVYVKWMDEVAFHHWAFLTKNYPLPEYIW
VVARHEIDYKGQAVLGDEIIAKTWVGETKGFTSERLIEFYKDSILVAKSKTVWAMLDAKT
YKPTRIRENVLKVLQPNK
>FCMOIPGL_01350 DEAD-box ATP-dependent RNA helicase CshE
MSTFSALGIRKEYIQSLKELGISTPSEIQEKTIPILLQSETDFIGLAQTGTGKTAAFGLP
VLHKINANEGNIQALILSPTRELVQQIKKQLFKFTKYNEEKIFIEAVFGGEKIDRQIGNL
KRTTHVVVATPGRLIDLIERGSIDISHVKTVILDEADEMLSMGFKQDLNRILKFTTESNR
KTWLFSATMPEEIKKIIKTYMDANAPRVEINRNSLVNANIRHQFVKTTIKDKPADIITYL
LKREASRGIIFCRTKAGAQNLAHHLVEEGFSAAALEGDMQQKERDKVMRAFKNESLQYLI
STDVSARGIDVSGLEFVIHHQLPEQLEYYTHRSGRTARAGKTGTSLVFILPYELERIHEI
QKELNIKFTEVTV
>FCMOIPGL_01351 hypothetical protein
MELIYVLDILGTFAFAISGALVASDKKFDLFGVLIIAFVTAVGGGMLRDVLMNAHPINWI
GDLNYLWTILAAVILTFLFKSKIAPLSKTMFLFDTIGIGVFTLLGLKKGLLFNLHPVVAL
IMGMISAVFGGVLRDVLTNKIPLIFQKEIYASACLAGGITYLILNSFGVKENIIFVIAAF
VIVIIRVIAVRFQLQLPKIKDDLFTKT
>FCMOIPGL_01352 putative enoyl-CoA hydratase 1
MKPLVFENFKEFRLMLGKQLPSGNWYIVNQQMINDFANATLDKQWIHVDEKRAAKESPFK
STVAHGFMSVSMISKLLEESFSIKSVKMGLNYGLNKVRFPNPVPVNSELRMHTVVKEIED
LANNGIKVTFSCTIEIKGQEKPACVAEFLAALYE
>FCMOIPGL_01353 hypothetical protein
MTSNTNKPNRLFWIIGVIALIWNSMGIDGYINQVYQTKRFKTMYTEEQLEIIFNLPSYVT
AAFAIAVFSSVIASILFLLRKKLAKTFFLIGLIAVSVQTFYNVFLNPGKEMYRTVEYSML
ILIPLFALFLYWYTKKCADDGILN
>FCMOIPGL_01354 hypothetical protein
MSKESICERERNHLEKMNKFQLGHQYKKVGYSIAIGTFVIMIARKYFEDSEWIRPILHGV
LLIGLLIISLSKEKLEDEFIDSLRSQSYRLAFIMAIVYSLTQPLINYAVAFLFNQNEEMK
SFDYFQVLFFMLIVQLLFFWQLKRMNK
>FCMOIPGL_01355 hypothetical protein
MKNTLKVQRAILDLTQDDLAKKIGVSRQTINSIEKNRYVPSTVLALKLSTVFKIPINDFF
VLEETD
>FCMOIPGL_01356 hypothetical protein
MIKLMKKSVLFLLLLMSFQLFSQEKANSVLTLSEFLGYVKTYHPIVKQANLIINNSEAKL
LKARGAFDPKIEIDFDKKQFKEKEYYNKLNGAFKIPTYYGLEFKANFENNDGYYLNPEST
VPTDGLYAAGVSASILKGLLINERMASLKQAKLFLNQAKEDQQILVNEILYNASLSYFKW
LKTYNEKVVYQDFLENAEIRFKGTKKAFLEGDKAAIDTIEAGITLNERMLNLEKSRIKLV
KSSLELSTFLWLNNNTPIELQEHIIPDENTLNSIDTTFNIALFNNADFDINNHPKVKSLR
YKIESLQVDKNLKTNNLLPKLDVQYNFLTQKPRELNSLNVDNYKAGINFKLPLFLRKERG
DLKLSKIKLQETKYENEVAKISIKNKIDALQQELSSFVTQSNYLANIVKDYNTLLNAEER
KFFLGESSLFLVNYRESKLIETKLKAIVLENSFFEAKANLFKAAVISISEE
>FCMOIPGL_01357 hypothetical protein
MLNISNNRVNKKVDLKQFKSGQKIFDKEYYKSFNKFLLAFAILGFIVLFLPWTQNITGKG
LVTTLTPEQRPQTIQSQIPGRIEQWFVKEGDHVKKGDTILRISEIKSDYFDTKLIERTTD
QINAKTSSVDSYQLKVAALNRQISALSDERKLKLEQSENKLLQSKLKVKSDSIDYEAAKT
NILIAEKQFKRTKTLQDEGLKAVKDVEEKRLKLQETQAKLISQENKLLASKNEVLNAKIA
ISSVKANYTDKISKAESDKFTAESSGFDAKAQVSKLENSNSNYKVRNSLLYITAPQNGYI
NKAIKGGIGGTFKEGEDLVGIMPEKYDLAVETFVRPIDLPLLHINEKVRVQFDGWPAIVF
SGWPNASYGTYGAKVIAIERFISDNGKYRILLAPDDDGITWPEVRVGSGAKTIALLEDVP
IWFELWRQINSFPPNYYQPENNKSVKSDSKKK
>FCMOIPGL_01358 Toxin RTX-I translocation ATP-binding protein
MAKNQLTPWQRFIELLKLEKRDIFQIFYYAIFGGIVALSLPLGIQSIINLIQGAQISTSW
IILVIIVTIGVLFSGALQLMQLRIIESIQQRIFTRASFEFSYRFPKIKMNELRDYYPPEL
ANRFFDTLTIQKGLSKLLIDVPTALLQIIFALILLSFYHPFFIIFGILLLMLIYIVFKFT
AQRGLETSLMESKIKYKVAHWIQEVARTVVSFKISGNTNLAMSKNDNLVNKYLEARENHF
RILILQFMQMISFKVIVTASLLLIGGALVLNQEMNIGQFVAAEIIILLVIQSVEKLIIGL
ESFYDVLTSIEKLGQVVDKKLESQKGERPIFKNGLTVELDAVSYGVENKEKHIIKNLSLT
IKPQSRILIMGESGAGKSSLLRLISGVIEPISGNIYVNNLSLKSLHLNHYRSQLGLSLSE
ESPFEGSIRDNLVFGNKSIKDEIIFNALEVVGLTQFLKEQSKGLETILYPEGKQMSYTIA
KKIILARAIIKQPKIMILEDPLDQFNLEETVKIIGYLTDPKQPWALIVVSSKKSWRTKCN
QIITLEKGEIKSIN
>FCMOIPGL_01359 hypothetical protein
MKDLLSVLKISVPDKIFIKDPETSNLGQRIIEQSIILINEIGFENFTFKKLGTKIGSNES
SIYRYFESKHKLLLYLSSWYWAWIEYQLVIETFSISNDLEKLKTAILIVTRTIKVDSKFS
HINEPLLYRIIVNESFKSYLTKEVDIENKEGYFEIYKRLIARLEQMIIAVKPDYKYGLSL
ASTILEGSLHQHFLFEHFPSITSCKNEETPTNFFIHLVTKILK
>FCMOIPGL_01360 Cold shock protein CspC
MAKSQQTFSKSEKEKKRLKKRLDKQKKMEARKAEKEENGTSGIQFAYVDHNGNLTDTPPD
PDLKVEYELEDIQISVTKKEDLPEEDPVRKGKVSFFDSSKGFGFIIDTENNEKYFTHISG
IIDEITENDKVSFELEKGMRGLNAVKVKKI
>FCMOIPGL_01361 HTH-type transcriptional activator RhaR
MDNKIDTYNKIADYKDVKIEKFDVNKRYTKPHKHNKYLEIVYFIKGSGYHHVDLKSYKIK
PSTIFFIKRDEVHHWEITTKPKGYVIIIKEVFLEKTLDKFINYQLLKLQQKSKIKATKND
VSLKALFKALTWEKQQQVINKEAIEGGLKALLSKLVDYANIEKVETTNLVLQFADCLSQA
LKNNVQFYADKLNTTPQNLNVICRKEYNKSASDIIADHIIKEIKRRLLYTNETISDIAYS
LEFNDASNFTKYFKRYTGETPKQFKIKNKTS
>FCMOIPGL_01362 hypothetical protein
MNLKKNVFLLLAFIVSQFTVAQISGKIVDSGDNYPLEYASVALYQTNNKALVTGVVTNFE
GLFSFTDVKPGNYYIEASFIGYQVKTITSIVINKKGEKKDIGTLTLVLGSGNQLNEVVVK
SEKSAVIHKIDRQVFDTKKYQSTVGGNAVDVVKNLPSVTVDGLGEISVRGSKGFSVLING
KPTQGDASAILAQLPANAIESIELITAPSAKYDPEGKGGILNIITKKGAINGTFAQVNVR
GGFPAIEDYDTKVASKRYGIDATINKRTDNWNLSFGASYQRNDKSGRREGDMFIVNQAEN
KTTFLPSDGERSFDEVTYNGRFNVDYTPNKSDSYSLGLFAGKRTKERLADIVYYDNHSIS
PIGGSTRDYTFAYYNHNLRIRKGDFALGSFDYAHKFNNESKISTSVLYEYTFLGGPTEND
NLGHPDNNIVYQKEYNTNDNPLYGARFNLDYLWKPFSFGTLETGYQYRDLDHTGKFVYER
DGVQVDEFSSDVSLKRSIHAGYAQITGSKSKWDYAAGLRLEAMDRTYKEALQSETTENVY
DYDFVKLFPSASLQYKIDDKTNIKTAYSKRVERTTTFMMNSFAEREHSEVFEQGDNTLLP
EFIDLVELGITKKLKGGNSIYATAYFRHVNNVINRVNTLAYEANGAVIDSIINRVYSNVG
KSKSIGLEVGATIKPTSNWSNSIGANVYNYVIDGILNFKHRDGVERNYDIDSKSTIYSFN
VNSTYNFWKNASLQFTFNYLSDRNTAMGEDSRFYSPNLTFIKKFMDDKLTATLQWQNIDM
GLLNTNEQRISTSRPDQFYTTTNYVYEVDMVSLNLSYTFNAAKNKSKFIDSEFGKREF
>FCMOIPGL_01363 3-dehydroquinate synthase
MKTIQAVTYPVHFQKDSYQELSKLIDAKNYSTIFILVDENTFEHCYPKFIPNLTTDKRIE
VIEIESGEINKNLETCIGVWNAITELGGDRKSILITLGGGVITDLGGFVASCFKRGIDFV
NIPTTLLSMVDASVGGKTGVDLGVLKNQIGLFTNPQMVIVDTDYLTTVTDREIKSGTAEI
IKYGITYDVKLFNEIKNNKNLNINDLIFRSVEIKNEVVLQDPKEKNLRKILNFGHTLGHA
IESFYLESEDKETLTHGEAIAIGMVCECYISSKLLGFPSDKVSDVKEVILSIYNKTTLLK
EDFTAIMDLLKHDKKNVNGQVNFVLLNDFEDYKLDCKVSEELIIESMEFYNL
>FCMOIPGL_01364 Bifunctional protein PutA
MKLFDNTEVAFALKSDSQLERAYFLFRMIQNQPMVRIGSAVTNFALKAHLPIEGLIRSTV
FDHFCGGVTEEDCLPIIDNMYNNGSVHSVLDYSVEGKDKEISFDGALEKILKIINFCEEK
KGIPFAVFKPSGFGRFALYQKISEGKKLNSDEQEEWNRVVGRFHKVCKVALQKDVPLLID
AEESWMQKAADELIDELMETYNKEKAIVFNTLQMYRHDRMDYLKSLHLKAKEKGFYIGIK
VVRGAYMEKERERAEEKGYPSPICENKNATDINYDAAIRYLMEHPKMALFAGTHNEDSSY
LVMDLAKKYNIKENDNRLWFGQLFGMSDHISYNLASKGYNVAKYLPFGPVRDVMPYLIRR
AEENTSVAGQTSRELNLLKTERKRRKL
>FCMOIPGL_01365 hypothetical protein
MTSVEEIKILLIKNKNSLLLELRQSKEAMSLIKKSTHTKLTSEEKTKIKIHLLDICKTIP
ALAVFLLPGGTFLLPILIKLIPDILPSAFRDDVPVDKK
>FCMOIPGL_01366 GTP-binding protein TypA/BipA
MQPIRNIAIIAHVDHGKTTLVDKIIDQAKILDERKERTDLLLDNNDLERERGITILSKNV
SVNYKNTKINVIDTPGHADFGGEVERVLKMADGVLLLVDAFEGPMPQTRFVLGKALELGL
TPIVVVNKVDKENCTPDIVHEKVFDLMFALEATEEQLDFTTVYGSAKNNWMSTDWKNQTE
DIVPLLDAVLESIPETKYNEGTPQMQITSLDFSKFTGRIAIGRVFRGDLEVGKDYMLCKA
DGSTKKVRIKELHVFEGMGKVQVEKVPCGDICAITGLEGFEIGDTVADLENPEALPRTEI
DQPTMSMLFTINNSPFFGKEGKFVTSRHLRDRLFKELEKNLALKVETTDSEDKFNVFGRG
VLHLSVLIETMRREGYELQVGRPQVIIKEIDGKKHEPMETLSIDVPEDMASKAINLVSLR
KGDMLVMEPKGDLQHLEFSIPSRGLIGLRNKILTATGGTAIINHRFSEYGPYKGDFTEEV
KGAIVSSAAGKATAYALNRLQDRGVFFIDINQEIYVGQVIGENSKSDDMAVNLIKGKQLT
NMRKSGTDDAMKIAPKVDFSLEENMEYIKADEYLEVTPESLRMRKIVFKG
>FCMOIPGL_01367 hypothetical protein
MFQFLINIFYKSSSFKLGLFYLCTMSDFKVFFDILQENLLNDEFVKLTLSKPMRKSEGLL
NVYVRLFKVEGKEVFELKYRHSEENTFKQFSLDALTVELEKLLLETFRTATLFTLSQDLI
VLVSKKKLVSYRDNAPSFKNKLPEIPMQS
>FCMOIPGL_01368 hypothetical protein
MNAIFTDASFQNIVNVANKYGISTNAVTDLTYCLMNSNGTMAQFNIPELGGGGQWMQGGM
TMVGDMFNNNLKYLVDGLCTDLSNLIQQGAIQYKPLPKTANGQGGFAGNWWGNLGFPNST
GSQNDTSYAIFNGIHRLAIQQNGKVTIFDTLDHNIGGVGQQQGGNYSVSFTSQYGNVDLG
SLPIVSGGNEPQQPAPVQNNEIQNNVVETPVAPIAQDPIQPAESNNNVNNSAFEEDIFGK
IEKLAGLKDKGILSTEEFENKKIDLLNRL
>FCMOIPGL_01369 hypothetical protein
MNYKTKILSYFFLVCFLSYFKVISAQKRKVKDINVQLKELQSKKTLNAKDSLKYAHFYLY
QFIDLHKKKISHQNISSLDKGISFCPKSQQGDSLKAVFYNKKAYLKNELGYAMKSYKSIL
NSLNLLENIDNPNAGSIMGAYLLLSNQNAYFGNFEKAKQYMRLAENIYNKNKNYIDSNTF
LLNNNYHRLKVIAKYRKIYMLWKLSENSKDSISIIKAMESLESMHKQPDFHKEERIYYST
ALNHIGDWFISHTPDSLVSSKNISTGLNYLFKALYLTEEKNYPGLPWAIKYNIAKGFTKG
NQLNKADSTMSVLFRGITKNDDRIPFFLAQKALIKAKKKQKDSALFYFDKSIQNIHSGKN
SLANNYKNFIPSKSYNHTRLLLRINEELTNYYPKDTVVQKKNVIIYYLALKQFENSYLDI
HFNEQQNKQLRKIIYGVLKNKKTGYFNTNLNQKLILNKFEIFRNKLEWKKFYQNRYTNTL
PKLDSLKQRNIQLASLYNKAKTSNNLFKRDSIQLLIAKHESYKKKQFPQLELLSDFNFSV
KELQKKLTKNDLILKYIYLENEMAIYQISKSNFKVNLVPWTDTEENILVSFISKIKKKKL
KDKLGNELSAILIPNINANITRLIINPDGVLFNLPFEILKVNDKFITELYSTYYTSNLGL
INYKLENKSASENIHIYVPNYSNSKTKSKVRNKPNILKGASIEAKNISKLFPSKLFNDDD
LTKVEFIKTASSAKILHLAMHADINKTYPELSRLLFSNNLDNEEDHLYLEELYGLSLNAE
LAILSACNTGNGKIKNGNLESFQRAFTFAGVPATVVSLWEVPDSSTEKIMVLFYKNLKKG
QTKSEALKNAKLSFRTKNASNKLSAPYFWAGFVVYGNDNAIISSFPIFTTIILTTVLIIF
IIILIKIRKKHTTIISKKL
>FCMOIPGL_01370 hypothetical protein
MENKEFDKNLKKAITLQKRKELKSYIQSVENSIAKPKKYNWLLVASIALLIGLSSFYLFN
SKSLSNNELYNLHFTPYENVIEPIVRDKVNKSKKAFAFSLYEQGKYLKAIESFNKLTEKD
SIEANTLLFFKANAYLQLEEFKKSEILFHKILINDNKEWKNESLWYLALISLKQDKKDAA
ITFLDKLQRQQKLNFKTEEIKIILNNIK
>FCMOIPGL_01371 hypothetical protein
MREQQTLLLLKQADKNALKMVYTENRTPFINFARTLGISDDDILDVYQDAIIVLQEKALK
GEIDHLKCTIKTYLFGIGKYMLYEKTRKNNKKIKDFSLEKEDYNYKEISNKFLDDEPNQF
QLLLQKAFTTLGKKCKEVLTLFYYRGYTIDEITDALNYDNKNVVKSQKSRCLKQLKEKIK
TETHGK
>FCMOIPGL_01372 hypothetical protein
MILKTNLKILITFFVLSAGFTTPVNGQLWKKLKKKVQTKIEQNIEKKVDKETDKVIDKTL
EGKKEKEDITQTSNIDNSIKSYGTASINHSTLYGTFRVDDVTKTKVNKEGEKVSIIGYWR
TSDVDVFDGYKLIINKVENIDNLKNKTFKIPEEATLKLAYNALLQGTYSYERDEVRAHQN
MNVINGTVSVTFNKDKNFAINFSGNVKLHDYKNTNSLEQNIPSILKGTVTTTSPEYTITK
PTKVKKSNTNDFSDEEKTQRFKEALPTVDIPSTFNFNKRIEVKMTDERGETQNLSFLIGS
YPDIYGISVKTKEMQGQEMLVVNTPKSSTIFMSMAGMKIKKTTSLEQIGSQIGVEDKLPE
DGDFDYRKTGETKMIIGYLCEEFKVDYEYTNQIGSTSFWVSKDFPIQNKSLPMLGMKMNN
PNLSGFVLEINTTNKDENFKMEIVNISDKSVKINTNEYKKMGF
>FCMOIPGL_01373 hypothetical protein
MRKILIFTLIISLFTSCLGDKKSAVGTNFNDTSFENKKFKTKVVYADLAQPCSYVVKKDL
AQQYNVSVEEVLMMEGNSQNKICTIRVKLSDDEYNYLVGSIRFYEEKDNLEDGSSWVESW
QLQKGISKSGEWIPNLGKAALWIAKKRELRIKFKDYTMALNVPGAAFNKQEKALNRDYKK
IALTIVKDIEILN
>FCMOIPGL_01374 Internalin-J
MKIKLLYTLFLITSFTYSQRTYMPDDVFEAHMIRLGYDNVLDDYVSTNAINQIKTLNLGG
DIVDPTGIEDFIALEKLVLDHNKIKTIDVSKNTKLEYLDLGSNELTSINVSTLINLETLY
LGGNMLTSINISQNNELIKLGLSANKLKSINLEYNKKLERLALSENLFTSIDVSSNTKLT
YLYANDNKDLYSLNMSNLKYNEISSLSNIRNCPNLYCVTVTDVAAAFDKFKVEQQRDSHT
GFSLNCTETTSIPDANFEQYLINLGYDSGEIDGKVITGNLSAINSLNIKSKGISNLSGIE
DFINLVELNAANNQISTIDLSKNLLLENLFIANNQLQTIDLSNNLQLKNIDVGENDLSNL
DVHLLVDLVTLYCDQNQLTVINLFSNKELLVLIANENQLKTVDIRENDNLFLIDVENNLL
ESLTIKNGSNTKITTFKAKGNLNLTCIEVDDISFSNTNWTDKDTVANYSTNCAPANNDCV
NAIPLIFGQQTYGDVINGNTNNDAICAEGTVLADVWYSIIVNDSGKLSFQGTGFGGLLKF
AVYNSCTSTQPVACGETISLSNLIVGTKLYVKVWLETNSPKNVKNLSESGTFIFTAEDTS
VLSAKDYLIDKDGLNVFPNPSLSSNFISIESNNSMSNIELYSTNGQKIISKRIKNLSNID
LDISKVSTGVYILKVKADNQIISKKIVIK
>FCMOIPGL_01375 hypothetical protein
MDFLCIGTIFIHLITQKKLKYSNFISPVINSK
>FCMOIPGL_01376 Nuclease SbcCD subunit C
MKILKIELQNINSLKSDTPVVINFENEQFRDVGLYAITGSTGAGKTTILDAITIALYHNV
PRFNGTKGTLLDVISHGAHEAFSRITFKNNTTVYEAFWGIRIADKKGKTYKNPKEEVSLK
NLTTDTILAAQKRNLINEIISVTQLDYNQFLRSVLLAQGEFASFLTAKGPEKGKLLEQIT
GEQIYKKIGQGILDRKSEEEKKLREIEAKINADDILTEDAKTDLKKQDLTLDTDILKTEK
EIKRTQLITDWYVQYKDLATASETLNENTKKLDAFIEKHKPELDLLILNEKAEPFKELIQ
NFNRTEKETFVKKKQLIEIEKELNILKPQIENLEEINKKETNEIANSEKEFSSWLPKFDA
VTKLDSELKSEVSSQQKSKEKVAELKQQLDALKVEKQKLLKALSATETKIKIDNTYVSEN
KFLNDVALEISDWTTGLTTLKGHKEALNTTTSSFVEKKSILNQTAESLKTNTDLLLKKTT
DVTKIEKEISKINSAIEKNNLADLLIKKDRLLVLETNWKQYKTLAEQYKKTTEIRTNLIE
NKKSHTLDLEVINKQLATLKKDIEAQEKAVSDANKILDLEKSVAKYETDRKYLVKGKPCG
LCGSKVHPFTEHVKEINISKSELELNNRREKLLTLIHSKTTLDKNEVQLNTNIDSLTKQI
NTLTSEINSIETNAKQLNISCELSTISKIEVELNLLSKQLQELNKNVASAQKLQVDKNNL
SKDIEVQKKEVQSLQTTVATLNEKNKNAKTEIEKHQKTIENLSKVCADLETDFKTKLSKH
NYKLPSTENTQIFIREIEEHISIFNKTQKNLDTLKAEIKVIETKLENHKKQLETLSKTES
DVLKNLTTSRTKYLELTTQRTAILPIEISVESKRNSLQNLKNKIVEKANLTKINLQKLLD
KKNQQETLKVDNIATQKELKDKLNTFTSTLNLQLIDSGFASKEAVESALLSVEDKLKFTN
NKKRINENQLKIKTLKEENLKAIENLKKSKNFETSESESKQILIDLKTKKDALLTAKGKI
VEAFRKDKEIQDRNLVVYKKIEVQTEICTVWKELFKIIGNSKDAFNVYVQRLTLKHLLDL
ANVHLYQLNKRYSLKMEDNYKPKEELNFNLIDHYQTDQARLVDTSSGGEKFIISLALALG
LSDLASKNVKIESLFIDEGFGTLDGNTLETVISTLETLQSQGKIIGIISHVENLKERIPT
QIQITKKSNGISSVAII
>FCMOIPGL_01377 Nuclease SbcCD subunit D
MKVLHTADWHLGHRLHEQSQFEEQSLFLSWTETYIVDQKIDVLLISGDVFDTGSPSNQSL
EMYYSFLVKLIGTTCKSIIITGGNHDSPGTLNAPKHILGALNIKVVGKATEDIKDEVFEI
EINNEKIIIAAVPYLRDGDIRRAVAGETFDELTDKYKTALINHYVSAAEHCKLKNTSNAP
VVAMGHLFATGGTISDSEQNIYVGTLGHIGAEDFPSYFDYIALGHLHRPQIIGENNKVRY
SGSPNILSFSEINYDKKVIVLSVENNKITAINDAIIPKFREFYKLTGNLQECINAFPNIT
SNAYNLKPWVEIALKEDHTVNTDNLKSEAAKYPFEILKIGLKNQRKIKGIEELLENTKSI
KELLPTEVFKLKCEEMDYDLEKRPEVWDAFNEILQSVKNQ
>FCMOIPGL_01378 hypothetical protein
MKKHSLKILTISLFLVGFSACKSNTTSKKNIVQDKVTIAVNSDNFLTGGLAEPITIVSRT
LSDGSTADCYKIVATSTPTDHNMGPWCPTNIADDASAGGIWLEDGKVYDVDGEFVKNLST
FYKDESWMLYDSETGEITKTTTKQECEEAANPNVGEEYKNYCVECLPSYVADVTHTYYIP
VTPKKAATPYSFSRGGRGGRPGGPPPTGHERPEGGERPPRPEGGGRPENSSAMPSSRGLA
FNGVVFDAPAPTDNILSAYTLAPFDDAGGHINLAAGYHYHAATGVSKKITQTDNHAAMIG
YAFDGYGIFENADANGNEYTDLDTSRGHYDDIRGYHYHVDKAGNNNFINGLRGEYAQ
>FCMOIPGL_01379 hypothetical protein
MFHKKKYNNFYFIFLLMSNTLFAHQPDASNIIISKTDNGQVILQITSSLTAFQQEVNFIN
GEGYYKTPEEFRNLVIKHFKNRFSLIINKNDTIKFKNPKVFLGHETKLVAEIIGLPEAIK
NIQIKNTIFKDIYLSQSMVIFLLSQFPTSKYSLNVDNKYQINLSLKDGNWEKVIAKKTSS
YLKYAGYFASLLVLLAMFFVFRKKNKLN
>FCMOIPGL_01380 hypothetical protein
MPTKIIDINEATIKNYVEKLRPEDLEIRKQVDIGYAYRANVVSLYEIRPNWQDSKKIEKI
EFARIKHFKTKKIWKLYWMQANGKWILYKPFSESTHLSKIIEAIKNDKHGSFFG
>FCMOIPGL_01381 Haloacetate dehalogenase H-2
MKKSNLTRPKVLFFDVNETLLDLTLMKKQIGDALGGKEDLLSLWFTTMLQYSLVVSASGQ
YKPFGDIGAASLQMIAANNDIVISDEEARNIVVKSMQNLPPHPEVKDALTLLKKKGYILV
ALTNSNKESLKNKFKNVGLTNYFDDLLSIESVGKFKPFTDVYNWAANRMNVKPEDCMLIA
AHGWDVAGALWAGWRAAFVSRTKQQTFPLAPKTEINETDLLRVAEILINYS
>FCMOIPGL_01382 Putative peroxiredoxin bcp
MSSNNNGELDVLLDKVRKSGAAKFTDEKKQIYADGITSVANSGVLDSALKVGDKAKNFTL
KNALNESVTLYNELKNGPVVLTWYRGGWCPYCNITLHALQEKLQEFKQEGATLLALTPEL
PDNSLNTSEKNNLEFTVLSDLGNNIGKEYGVVYSLTDDVASIYNAGFGLNKVNGDASNEL
PLAATYIIDKNGIITYAFLDADYTQRAEPLEIISALQQLK
>FCMOIPGL_01383 hypothetical protein
MADKLKIDIVSDVVCPWCTIGYKRLEKAIHELGVADQIDIEWQPFELNPNMPAAGQNLNE
HITEKYGSTVAQQKQSKQIMTEAGAELGFKFDYFDEMRIVNTFDAHILLEYAKDFGKQTK
LKMTLTKAFFSDRKDVTKKAVLKEALLEVGLNADEALAKLNNDYAQIKVREEQNYWKNMG
VNSVPTIVFNRKSAITGAQPVATFKQVLSELIKEQQTV
>FCMOIPGL_01384 hypothetical protein
MIKVSVMYPNSKDIQFNTDYYTNKHLPMVSKLVGNALKDLELDLGIASRIHGEKAPYVAI
AHLKFDSIGAFKESFSPHAKTFAEDLKNYSNVQGVFQISELKTF
>FCMOIPGL_01385 hypothetical protein
MTTLKIHNIESAPEESKSLLENSQKAYGMIPGLHGVLAGSPQILQAYQTLHELFTQSSFN
EEELTVVWQAINVEHACHYCVPAHTGIAHMMKVDAAITEALRNETPLTDSKLEALRTMTL
SVVRNRGNVSQEDLNAFYAAGYEEKHVLDIILGLSQKTISNYTNHIANTPVDAAFSKFAW
TKK
>FCMOIPGL_01386 HTH-type transcriptional repressor ComR
MARKKKYNEDEVIEKAMLLFWKNGYETTSMQMLEQEMGINKFSIYASFGNKHGVFLESLK
HYKLKVNTVLEKFKKGTNGIADIKQFFYDSVSSNFKSDHIKGCFVTNTYNEFSEKEDKCI
KEQMNLFMDNLKSIIIEKLQMDTTKDKQTITKQANYLLLAKNGLAAAARVNTKEEIEDYI
ELIFKNL
>FCMOIPGL_01387 tRNA 2-thiocytidine biosynthesis protein TtcA
MENVKQVTKKLQRSVAEAIQQYRMIAEGDKIMVCLSGGKDSYALLNMMLYFKKVAPISFD
IIAVNLDQKQPGFPEEVLPTYLTNLGVDFKIIEKNTYKIVMDKTPEGKTTCSLCSRLRRG
TLYEAAKDLGCNKLALGHHKNDILETFFLNFFFSGKLETMPPKFKNDAGDLVVLRPLALC
NESDIETYASFMNFPIIPCNLCGSQENLQRKKVKQMITDWETEFPNRNAIMMNALQNVFP
SHLLDKNLYDFENLESKIS
>FCMOIPGL_01388 ATP phosphoribosyltransferase
MSNLRIAVQKSGRLNEDSMKLLKDIGISIDNGKDQLKAAARDFPVEVFYLRNGDIPQYLK
DGVVDAAIIGENVLIEKGSDIEFVERLGFSKCKVSIAVPKDSEANSLKDLDGKRIATSYP
ETVKKFLKEQNINADLHIINGSVEIAPNIGLADGICDIVSSGSTLFKNGLKEIEVLLKSE
AVLAVSSKITEERRAILQKIQFRIQSVLKGRNSKYVLLNAPNEKLEAILKVLPGMRSPTV
LPLAEKGWSSVHTVISKNEFWEIIEDLKAKGAEGILVCPIEKMVL
>FCMOIPGL_01389 Histidinol dehydrogenase
MKIINNPLKKDWIQILQRPTKTVDDIENTVNQIFDDVQKNGDKAVDKYTALFDGVSLENK
LVSSDEIQEAIALISNDLKNAINLAKENITQFHKAQKTNKVFVETTNGVECWQEKRPIQK
VGLYIPGGTAPLFSTVLMLAIPAQIAGCKEIVLCSPPNKEGKIHPAILYAANLCGVTKII
KVGGIQAIAGYTFGTEIIPQVYKIFGPGNQFVTVAKQLSTKHGVAIDMPAGPSELLVVAD
DSANASYVASDLLSQAEHGADSQVILVSTSKELINEVEKEIKMQLAVLPRVEIAEKAIVN
SKSIFVENDEIALELINEYGPEHFIVCTKNNDFYVDNIENAGSVFIGNYTPESAGDYASG
TNHTLPTNGFSKSYSGVNLDSFTKSITFQKITKEGIQTIGNAIELMAAAEGLDAHKNAVS
IRLKDLK
>FCMOIPGL_01390 Histidinol-phosphate aminotransferase
MSPRAQSRGFMMKTNFNLENLLRENIKSLKPYSSARDEYKDVTITEMIFLDANENPFENG
VNRYPDPQQNNVKDLLSEIKGVSKENILLGNGSDEILDLIYRAFCEPNKDNVITLPPTYG
MYGVLANLNAIENRKILLNNNFQPNVNKILETVDVNSKILFLCSPNNPSGNSFTNDIVEE
LLIKFNGLVVLDEAYIDFSDKESWLKKIEKFPNLVITQTLSKAFGLAGIRLGICYASKEI
IKVLNNIKPPYNINELTQQRAIVRLQKIGEVKNEISQLISERNRLKKELECCVNYIEKVY
NSDANFLLIKVDDATKRYKQLIEYGVVIRNRTNEPLCNNCLRISVGICEENQKLLRALKK
IQ
>FCMOIPGL_01391 Histidine biosynthesis bifunctional protein HisB
MKKVLFIDRDGTLVLEPPVDYQLDSLEKLEYYPKVFRYMARIAEELDYELVMVTNQDGLG
TDSFPEDTFWPAQNKVISAFEKEGVVFSDVYIDKTFPHENAETRKPRTGLLTKYFSEDYD
LENSFVLGDRITDMELAKNLGAKGIFLSEDPELGADEIETSKQEILNCIALTSTDWKAIY
EFLKLEDRVSEITRNTNETKIYIKLNLDGSGKNDISTGVKFFDHMLDQIGRHGAMDLTVK
VDGDLEVDEHHTIEDTMIALGELFHKALGNKLGIERYGFCLPMDDCLAQAAVDFGGRPWL
VWDADFKREMIGDMPTEMFLHLFKSFTDGAKCNLNIKAEGDNEHHKIEGIFKAFAKAMKM
AVKRDANKMFLPSTKGVL
>FCMOIPGL_01392 Imidazole glycerol phosphate synthase subunit HisH
MSLDKEILKYNSESSSPSGKLEGASVVIIDYGAGNIKSIQFAFKRLGVDAVLSNNIYEIK
AADKVIFPGVGEASSAMKMLQESGLDKVIPTLTQPVLGICLGMQLMCNSSEEGNTKGLGI
FDVAVKKFSNAVKVPQMGWNVIYNLKSDLFTGIKEKEFMYLVHSFYAESCEDAIATTDYE
FEYASALKKDNFYGVQFHPEKSGVEGAKILQNFLNL
>FCMOIPGL_01393 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
MRIIPAIDIIDGKCVRLTKGDYDTKKIYNVNPLEVAKEFEAAGIEYLHVVDLDGAKASEI
INYKVLEQIASKTNLKIDFGGGLKSDNDLEIAFNSGANQITGGSIAVKNPKIFENWIAKY
GSEKIILGADFYPDNNGGKIATNGWQEESSLELIPFIADYQQKGIQYVICTDISKDGMLQ
GPSFDIYNQILSDVKSLKLIASGGISAFDEIPKLAENGCEGVIIGKAIYENKISLKQLEQ
FILTK
>FCMOIPGL_01394 Imidazole glycerol phosphate synthase subunit HisF
MLTKRIIPCLDIKNGRTVKGVNFVNLIDAGDPVVLAKQYAELGADELVFLDISATLEGRK
TMIEMVHQVAEQVNIPFTVGGGISSVDNVNELLKWGADKVSINSSAVKRPDLVNELAEKF
GSQCVVVAIDAKQIDREWFVHLAGGTIPTDIKLFEWAKEVEERGAGEILFTSMNHDGTKA
GFANEALAHLSEILNIPIIASGGAGTIQHFADTFTKGKADAALAASVFHFGEIPILELKQ
ELKKQHIPVRI
>FCMOIPGL_01395 Phosphoribosyl-AMP cyclohydrolase
MVYSYWTKNEEPTTKIMNIDFNKNNDGLVPAIIQDATTKNVLMLGYMNEEAFKKTQETKL
VTFFSRTKNRLWTKGEESGNVLNLIDIKLDCDNDTLLVSVNPNGPTCHKGTDTCWGEVNK
QNYGFFSTLEDVITERVANKDTKKSYVASLFAKGINKVAQKVGEEAVETVIEAMDNNDEL
FLYESADLMFHYLMLLQAKGFTLKDIEAELKGRHK
>FCMOIPGL_01396 hypothetical protein
MKNLIKFLTVLLVSVFTLSAQNKPQEIVIIGTMHTVPKIVKNSYKPMLKFAKKYKPEAIY
VESPMANDSISWQYLKNGWSKGYQKFYKLSDSLQKNFDYNDSKFNATINKDFSKMTNNDL
DYLIKSFIYKRDNGNYELYSYLKKYGVNGAKKPTRHEDGDLTYKLALFMNHKKVINIDDQ
QTNKEYHNAWNKCSKEGVKNGNNSANSKLYKKNYNNAIFPAIFRGLGKHTNKRKSLQQLH
DMASFSYVVKDTKGCKEGRKYFDERNMRIAKNISKEVIKSKKDRNIVIIGAAHIIGLEKE
FKENYPNFKVILMKDY
>FCMOIPGL_01397 hypothetical protein
MNKKYPFDPLVKHHLIIAFGLALWIFVFLYFTNPLDVSEFNESEKLIYLPLYGLLGAFCY
SLFLPIQHFIYQKNNKNWFVKSEILFFLIFILISTIIARAFYLYVIVLGEPNPYTLWYYL
KTVLFPAFTTILPIIIFGRFALGKYHNKQTKAKKIEIKGEGNYEGLRLFFNDIICIQSSD
NYIEVFYLSGNELKKNLIRNKLSVIADEFPELLRTHRSYLINPYHFLQWKTEKSKLFVLL
FHHVEVPVSRTYQNNVKTILNSTTE
>FCMOIPGL_01398 putative inner membrane transporter YedA
MKNSKALVVIAFVAIYVIWGSTYLFNKIAVTELPPFFLASIRFLTAGFLIMLIAKSLKKS
LIITKKQLLNTVISGFLFLVYGNGVFVWALKYVDSGFAALLAATQPLFVLLLMRLIDQKK
MQKKSVIGIVLGFFGMYLLVSQSEITISEESLLGIFMMFSCVLSWSYGSVFVSKADLPKN
FFVSTGYQMIMAGFLLIIASLGFDEEWIKPTLWSFKVQASLLFLIVFGGIFAFTSFNYLL
KIVSPEKVSTSAYVNPVIALFLGWYFLDEEFTTQSIVASVVLLTGVYFITSRKRQ
>FCMOIPGL_01399 hypothetical protein
MKDTNKLPLFSTYEFNPKLYDELFSQNNEVREIYKTLYDLFSSYSVEEYDRLNAQAKASF
FNLGITFQVYGEKEVKEQIFPFDLFPRIINNKEWRTIEKGVLQRSKALNLFLWDLYHDQK
IIKQGIVPADLIKSSVNFLPQMVGVNPPEGIYNHISGTDLIKHSDGNYYVLEDNIRCPSG
VSYVVGNRNAVKHTLFGVFNQYNAHTVVDYGSKLLETMESVKPKGVDAPVCVIITPGVYN
SAYYEHSFLAKQMGVVLVEGRDLFVENDFVYMRTIYGPEKVDVIYRRVDDLFIDPLVFKK
DSMLGVPGLFAAYTKGNVTLINAPGTGVADDKAVYTYMPQIIKYYLDEEPILNNVHTYHC
SRKDDLKYVLENIDKLVIKPVDESGGYGISIGNKLTKEEIETVKKTILEEPRKYIAQPIL
SLSTHPTYIEENESFESRHVDLRTFTLLGKDIDFVLKGGLTRVALKKGNLIVNSSQGGGS
KDTWVLKK
>FCMOIPGL_01400 hypothetical protein
MLARVANNLFWMGRYIERTEHLARFLSVNYFTSLDAPDELSRSRQFVLRSTMYMSANEIM
DSDMILDEEEVLYNVGLNPDKPYSILNAFTNAHENARSSRDLISTELFECINKISHTIKG
YPADKFVKSGLHDFTSLAIQSASEVRSKIESTLLHDEVYAIIMLGVYIERALQVSRIINS
KLSDAAAAKVIHGDEIDGSYQWATLLKCVSTYDMMRRSYKKTPVRTSTLEFLILSSKCPR
SIKNCLIQIDKYINIISINKYVENDSAAFLIGKMKAEFDYKLIEDIDESLEVFTGDLIDH
LILIADKLESNYFNISDVVASTKQLQKQVQR
>FCMOIPGL_01401 Protein-glutamine gamma-glutamyltransferase
MIFDLWHKTKYSYENGASFCHNITTLKPRSFKGQELLEYKLEISPTPTDISERLDFFGNT
VTRFSIQQNHKELIVIARSKVSRDYNLQIENDNALEGKKITIEKALQLLKEVNTETIEAR
QFVLFSPLISDFSEDIKEYAAKSFKPERSLFEASHELMERIFTDFDFDPEFTTIATPLKE
VLKEKKGVCQDFAQIAIACVRSMGLPARYVSGYIETLPPPGKEKLIGTDASHAWFSVFIP
TYGWIDFDPTNNQIPKNQHIVVAYGRDYYDVPPLKGVIYSTGKSEMDVAVDLRPAKSYQT
QNSGQSQSQT
>FCMOIPGL_01402 hypothetical protein
MEIDTKSMIHDYFKNKSKYDELLTSKMDIKSDWNELLDNLLKIGPKKLASKQADINWLLA
ENGVTYNVYNDPKGLNRPWSLNVVPFLIHQKEWNLVEKGIQQRSEILNLILKDLYGKREL
LKNGIIPPEVIYAHRGFLRSCDQIEYKTEKQLLIHAVDLARGPDGRMWVVNDRTQAPSGM
GYALENRFSISKTIPEIFENINVKQPSTFFNDFNQLLLNVAPSNVENPKVVILTPGPLNE
TYFEHSYLSSFLGYPLVKGNDLVVRHGKVWLKSLKGLKQVDVILRRVDDSFMDPLELRED
SYLGVAGLLEAVRLQNVAIVNPIGSGVLENPALIPFMENICKYFLNEKLILPQIASWWCG
QEKERKHVLENLASYVVKRIDRSHRESIYFCEFLNKEELKELTDEILENPTNFVAQEKIS
FSTAPNFVNEQLEPRKILCRSFSIAKKDTYSVMPGGLVRVAAEREELFVSNQRGGTSKDL
WVISDDSQNYLQNYSWNKMNTNQSLSINDVPSYTAENLFWSGRYLGRTLFTARYLRMVLN
QMTHVQYNTDRKSESESLKILFQSITNITSTFPGFTGENEEEALKNPLKEIIAVALDEQK
IGSFAQSLQSFNFSYYSLRNLWSRDMWRVFDGIQKQLKKVKEEKNYSMNSLSVFFDKMIT
RLIAFMALTEESILVRHGLLLYFLGLQIEQASMTIEKFRSLIIVNYDEELEYEILESLLT
SHESLNIYRYSYSSYLSIKNVIKLLLLDTEYSRSLMYQIKRIKKDIYKLPNTNSKTELTQ
CQENIEAVLLKIQSLNIEEMLEIDTNSNMRKKLDTLLSDLSDLLHTTSLSISDTYFNHSQ
QQKQLVDRKISN
>FCMOIPGL_01403 hypothetical protein
MALKIVISHKTTYKYDRKVSLSPHIFRLRPAPHSRTPIESYSIKITPENQFFNWQQDPFG
NYVARLVFPDKTDEMSIDVEIIADLKTINPFDFFIEEYAEEYPFKYTETTKKELQPYLEI
TDKGKLLEAFLKTLDYTPRKTIYFLIDINQKIYEFLNYNIRMDPGVQTCEETLSQKNGSC
RDYAWLFVQTLRHLGFGARFVSGYLVQLKSDEKSLDGPSGPEEDFTDLHAWAEVYLPGAG
WIGFDATSGLLAGEGHIPLACTPSFESAAPVSGMTDKCETEFFFENKVTRIFESPRVTKP
YVEEQWNEIYKLGNKVEKQLQKRDVRLTMGGEPTFVSIDDLESPEWNTAADGPHKRKLGA
DLAKRLYDKFGNGAVLHHAQGKWYPGEPLPRWQIEICWRKDGRPIWYDRKYLSSYAENTF
VPQNTDKLFLETLSKYLRVSTEHIMPAFEDPFYYLWEQGNLPIDINPETDKDSSLARKKL
HDIYENGTSNPVGYLLPLNKTEGKWFTSEWTFRRQHIFLTAGNSPMGLRLPLNSLMSKPE
HEIFPVYEPDMFSKKKRLPSFKNIVKERHQQFLDHGLEHNMPNYFVRTAICAEIREDKLY
LFLPPLESAETFLDLIAAIELTARELNIPVIMEGYDPPKDNRLESLKITPDPGVIEVNVH
PVTNWEDLCKNTFTFYEQAKLSRLGTEKFMLDGKHTGTGGGNHVTLGGTSPKDSPLLRKP
SLLRSLLTFWQHHPGLTYLFSGSFVGPTSQAPRIDEARLENLYELEIAFSQIPKGEEVPF
WLTDRLFRHLLTDLTGNTHRAEFCIDKLYSPDSSTGRLGILELRGFDMPPHPQMSLVQML
LVRTLVAWFWKKPYEHNLVRWGTELHDKFLIEHYVREDIKDIVEQLNRAGYAFKEDWFNP
FFEFRFPLHGMVEINNIHLELRAGIEPWNVLGEEMTGGGTARYVDSSLERLQVKVTDFNE
DRFVLSCNGVKVQLKSTGVKGQYVAGVRYKAWDPYSALHPTIPVDTPLVFDIVDTWNKRS
IGGCTYFVAHPGGRSYEEYPVNSYEAESRRINRFWEFGHTQGEIDPVENINPNTESTNRT
VEENTSSKRFKFKELPVNFEFPYTLDLRKK
>FCMOIPGL_01404 hypothetical protein
MNQTHLTNNQITVLKALENQHLTSFQILQKVENISLILVLYNVMDELEDMGILKSYTKKK
KKFHYTC
>FCMOIPGL_01405 Metallothiol transferase FosB
MNISHIEHLGIAVENLEESIKYYEEVLGLKCYSVEEVADQKVKTAFFMVGSTKIELLEST
YPDGPIGKFIAKKGQGIHHIAFAVDSATKALKQAEERGVTLIDKVSRKGAEGLNIGFLHP
KSTLGVLTELCSKQE
>FCMOIPGL_01406 Propionyl-CoA carboxylase beta chain
MANQDKINELIEKRAQAKMGGGEKRIDSQHAKGKLTARERIDILLDEDSFEEFDMFVTHR
TKSFGLDKQVYLSDGVVTGHGTIDGRIVYVFAQDFTVFGGSLSETYALKICKIMDMAMKI
GVPVIGLNDSGGARIQEGVRSLAGYAEIFQRNIMASGVIPQISSILGPCAGGAVYSPALT
DFTIMTDQTSYMFVTGPKVVQSVTGEVVTTEQLGGANIHSTKSGVSHFLAENDEENLLLV
RKLISYLPSNNLEEPPTISTSDPIDRLDDILNEIIPENPNQPYDIVDVISTIVDNAEFTE
VHRNYARNIVVGFARFNGRSVGIVANQPKYYAGVLDSEASRKAARFVRFCDAFNIPIVTL
VDVPGFLPGTGQEYAGIILHGAKLLFAYGEATVPKVTITLRKSYGGAHDVMSCKQLRGDL
NYAWPTAEIAVMGAKGAVEVLEGSNIRKIEGAEEKQDYIDKKEEEYTTKFANPYVAAKYG
FIDDVIEPRNTRFRIIRGLELLSNKKEVNPPKKHSNIPL
>FCMOIPGL_01407 hypothetical protein
MIHTMLAIDQISEGYVILLTGLIIVFSALLTLSLFFKFGLPVMLYVYKIITKGSDKKIKD
ISVKNDEKFTGEIAAAISVAVHLYLHEQHDNENAVLTIKQARKLYSPWSSKIYGIQNRL
>FCMOIPGL_01408 Glutaconyl-CoA decarboxylase subunit gamma
MKNFKFKINENSYSVKIVSHESDTIDIEVNGTSYAVKMKEEIKKAKTPTLVRSASKRPAE
PLKVSPSSSSSSSNIKVIAPIPGTVLSIDVKVGDEVKLGDRLLVLEAMKMENNIASEKAG
TVKAVHVNVGQQVLQSELLIELG
>FCMOIPGL_01409 Glutaconyl-CoA decarboxylase subunit beta
MKKLLLIFGVLSLLIFMRPVFGLNTASANTATISSIVQTEEVEGEGFVHEAFNGIKQFYN
YTGFANATSGNLLMILIGIIFIYLGIKFDYEPLLLIPIGTGVILGNIPFVAGNQTGIYEA
GSVLNYLYFGVVKGIYPPLIFLGIGAMTDFSSLIANPKLMLLGAAAQIGVFATFLGALYL
GFSLPEAGAIGIIGGADGPTAIFLSSKLANGINILPDGTTVKNLIGPIAIAAYSYMALVP
VIQPPIMRLLTSKKERIIRMKPPRAVTQKEKMIFPIVALLLTTFISPSSLPLLGMLFFGN
LLKESGRTERLADTARTKLIDIVTILLGVTVGASTQADIFITKDSMLIFGLGAISFVIAT
IGGLLFAKFMNLFLKGNDKINPLIGAAGVSAVPDSARVVHAEGIKADPHNYLLMHAMAPN
VAGVIGSAIAAGIILSFLG
>FCMOIPGL_01410 Propionyl-CoA:succinate CoA transferase
MKIPNKMTAQEAVKLIKSNDRVLIQGGSATPQALINAMVARAPELKNVELVHLHTEGACG
YTAPELRESFHTNAFFIGGNIRKMIGDTADYIPIFLSDIPSLFREGYMDLDVVMVNVSPP
DKHGFCSLGVSVDIIISGIEQGKKVIAQINPQMPRTFGDAQIHIKHFDACVEISEEIYEM
KFVEPSEIEKAIGKNIAGIIDDGSTLQMGIGGIPNAVLTFLHNHKNLGVHTEMFSEGVVD
LVEKGIVNGSQKKVNPYKIVSGFAMGTRRLYDFMDDNPEIEMLDIAYVNDTSVIRKNPKV
TAINSAIEVDLTGQICADSIGTRMFSGVGGQMDFMRGAALSEGGKPICAITSTTAKGVSK
ITPMLKLGAGVVTTRAHARFVATEYGIAELFGKNLKQRAQALRNVAHPDHREELDKAIFE
RFGSSLMTK
>FCMOIPGL_01411 putative methylmalonyl-CoA mutase small subunit
MSNKNKALFSDFPPVSTEQWMERVTADLKGADFDKKLVWNNLTGINFQPCYTIENKITKL
KNTGENSQSLVNYRSIIVTTAENGNQLAVKAVEEGINGIIFQLKENVSVASLLSGIDLNT
TTVSFEIEADAVAFTKDLVSYAKDSNLKGFINTGIISNYLTSGSFDENQVEVTAELVKLT
SSFPNFKVITISGTEYLDSGANQVQEIAYTLNSLVFLTEKLKEKGVEVQAIFDNLNFKLA
IGLEYFVEIGKFRAFNNLLAEVAAKYGVIEFSNTITAKTSIWSKSITDAETNLLRCTTEA
MSAILGNVDGILIDAYDKEFKNPSDFSSRIAGNITTILREESYFGKVSNPVDGSYYIEEV
SSKIANKALELFKAIEADGGFYANFENETIQKQIAEIRLKKLKLISQRRTPMVGINKYPN
LMESVDANLLSKGASDNLKVLTPRRASLEIEAMRRVTEELVAETNVRPIVQLASYGNLNM
RKARAAFAYDFIGVSGFDVHQEESFTSAQNAAEVSAKSDSHIVVICSSDQDYDETALDFI
KVFRAINTDKVLLLAGAPKNMDELTEAGLDGVVNMRIDVLVTLSNIQKKVQKTLKS
>FCMOIPGL_01412 Methylmalonyl-CoA mutase large subunit
MKPDFSDIKINSAVKQTVATSENKEVWNTPEGIPVKKQFVKEDISEAEHLGYAAGVPPFL
RGPYSAMYAMRPWTIRQYAGFSTAEESNAFYRRNLAAGQKGLSVAFDLATHRGYDSDHPR
VTGDVGKAGVAIDSILDMEILFDQIPLDKMSVSMTMNGAVLPIMAFYIAAARKQGVPLNQ
LSGTIQNDILKEFMVRNTYIYPPAPSMKIIGDIFDYTTKNMPKFNSISISGYHMQEAGAT
ADIELAYTLADGMEYIRTGLKSGLKIDEFAPRLSFFWAVGMNHFMEIAKMRAARMLWAKI
IKSFNPKNPKSMALRTHSQTSGWSLSEQDPFNNVARTCIEAMAATLGGTQSLHTNALDEA
IALPTDFSARIARNTQIFIQDETQMTKSVDPWAGSYYVEYLTQEIAKKAWKLIEEVEELG
GMAKAIETGVPKLRIEEASARKQARLDSGQDILVGVNKFQTEEKSNIEILEVDNTVVRDS
QIARLNKMKAERDSDLVASNLKALEDCAGTGKGNLLELAVEAAENFATLGEISDALEVHF
GRHKADTKLISGVYGKEVNNDDTFAKAQKMTDKFAEIEGRRPRVMIAKMGQDGHDRGAKV
VASSFADLGFDVDMGGLFQTPEEVAKQAVENDVHFVGASSLAAGHKTLIPQLIGELEKLG
RPDIMVFAGGVIPAQDYDYLFERKVAAVFGPGTVISESAITIMEKYLEQE
>FCMOIPGL_01413 hypothetical protein
MTFDNYFDKQFELRYFEMNKLGFATPTIILGLLEETAAEHCFSINYSLFDLFKKNIGWIL
VSGVFQMDRYPNYKEIITIRTWLSKYTSITGYRENIIYDENQNIIGKAKGLWVFFDIEKR
KPIPIFNQIKEKWSCFINESISSDIKKKINSIDFADYLKQFRVNRYDTDMNKHVNNIRYL
QWVIESIPENISENYYLHKIDGRFIAEAQYGDTVLSLTKKLETENSFAHTIKIEGNNKVC
ATAKTLWKKY
>FCMOIPGL_01414 putative GTPase
MKNYKPKNRLTSQAYIDGILSGNRVILSRAITIIESNLESDKILAKEIVQEILPNSGNSI
RIGITGVPGVGKSTFIEVFGMYLVKKGHKVAILSIDPSSQRSRGSILGDKTRMEDLANLQ
EAYIRPSASGDTLGGVSNKTGETMLLCEAAGYDVILIETVGVGQSETAVHGMTDFFLLLM
LAGAGDELQGIKKGIMEMADMVVINKADGENITMSKMAKIQYQNALHIFPQSESGWSPVV
STASAIKNIGISNVWNEILKFKTLVDENGYFLKNRNHQQIKWMYNNINEELKQLFYGSKN
IKSELTNLEKDIVGAKISPVKASQQIIEQFKRSFE
>FCMOIPGL_01415 hypothetical protein
MTVVIFVIILWYGGLFFQSFFLHRYAAHQVFTMSKTMEKITFILTWIFQGSSYLSAYGYG
IMHRMHHAYTDTEKDPHSPSHDPNMFAMMWKTKNIYQDINTQRIEIDERFTKNVPQWKTF
DAFAGSRFSRILFIAGYIAFFAFFTTAWWQWLLLPITFLMAPIHGVIINWFGHIYGYVNF
KMKNTSKNLFRFDFLMMGEGYHNNHHKHASNANFGVKWHEIDITYLIIRILDFLGLINLK
PIKVKS
>FCMOIPGL_01416 hypothetical protein
MYLCTNKLVELDLQQIKAHLDQIATISNVDWDFFNSKLQRRVIKKKAVFLKLNEIENHIS
FIESGVVRLFIPKEDPEKEITFGFSFKNQFISAYDSFLTQKPSAYQLQALTETTILSITY
ADLQEVYKKTQIGNLIGRLTAERLFLIKSKREQNLLNLSAEERYLKLFKERPELLKIIPL
KYISSYIGVTAQALSRIRKRI
>FCMOIPGL_01417 ATP-dependent RNA helicase DbpA
MSKSFSELGVHKKLQDSLAKLDISIPTDIQAKTIPVVLNQKEDLVVLAKTGTGKTAAFGL
PLLQLVDLENPQIQSLILAPTRELGHQIYDNLVSYATEIPEISIASICGGIPIKPQIERL
KSTTHIIVATPGRLVDLVKRGVINIKEIKYFVLDEADEMVTILKEEVDAIIKEIPKSRRT
LLFTATMPGTIKQLVQNYMAKHVVHIEADMKTLGHQGIDHQYVVVEPIEKLEVLMHFLSS
KEGKRGIIFCKTKAAVNKLAKNLAINKFSSGAIHGSLTQGIRDRIMGQFRDGNINILVAT
DLAARGIDVKEIEYVVNYHLPDTYEAYVHRSGRTARAGAKGLSLSIIQKEELEEIPEFEE
DLGLIFKAYKKADSQSIEENNGLLWAKKIFKTKPNHDVSQDFKSQIKTIFHHLTKEELVD
KILANYLVQTASAKIKPEVSKRRKKK
>FCMOIPGL_01418 ATP-dependent RNA helicase DbpA
MANEIKNQEEILAKLNITALNKMQKEAVFVIESTINTILLSPTGTGKTVAFLLPLIASLD
PDIHEVQALILVPSRELAIQIEQVIRTMGSGYKVNAVYGGRSMAKDKIELKHIPAILIGT
PGRISDHFANDRFSKDYIKTLVLDEFDKSLEVGFEYEMRGIINQLPTLSKRVLTSATQGV
DVPDFVKLDKPTIINYLKEKRTSQLAIKTVISPNHNKLNTLLDLIKHIGNEPGIVFCNLK
DSIEKVSAFLDKHKISHACFSGGMEQKDRERSLIKFRNGTCQLLIATDLAARGIDIVEMK
YIIHFELPKHEEEFIHRNGRTARVNEKGTAYILKWEKETTPDFIKNTKGENIAKKAKLEP
QYWETLFISGGRKDKISKGDIAGLFIKQGGLTKDQLGTIELKPDCAFVAIPLEFADSLVE
KLNNTRLKKKKVRVTFL
>FCMOIPGL_01419 hypothetical protein
MEYLNNIKGQITKVSKIRIIKAPQTSFDI
>FCMOIPGL_01420 hypothetical protein
MKYRYILILITFISCKTEINKKQSQSNKNIQNQTIFINGISK
>FCMOIPGL_01421 hypothetical protein
MKLTLILFFSFLTAVGQNVKGVVLDKENLKPLKNVNIYLNKDKTGTVSNEKGEFNLKIIS
KINPIDSIRFSIIGYEPKKYTLSKLKELNNIVHLSKKTENLNEITIVNKRKLKRTISYKK
LSPLKNGVYNFGATLVDNKLYIIGGDETYFDDNARKALSESSSLEEFIKNTKYNSIWENY
SDKLQVYDIENDTWQMLELKFRKRAYHNIVFVNNYIYILGGKTLSTNRKREYLDDKIEVL
NLETKQIILDNTNPHQAVNFTAFPYQDNIIVMGGSIKQNRNGQKTYTDQSHIYNTTNGYW
YKLPKMTKPKEVKGIIINNKIYLIGGFNKVPLSLIESYNIITGKWNNEGNLFYGIENPAL
THYGSIIYIYNDNKIITYNINTKILNEFRIDLNLKNSEIYYYKDKLYILGGLIEEEFEKS
PSSKLYSIDLNEFTNTRIINTKNN
>FCMOIPGL_01422 Putative aminoacrylate hydrolase RutD
MVCLHKEKPSTAKLASNMKKILIIILLFISVLTFCQEKFNNEKEIENIQNYKVEEISKII
DNNITISGTLLTPKFKFDNVIVIISGTGKISQKAHNYLTEYMLKNNIGVFRFDKRGVGKS
TGEYNDQAKVYTNDFLEIFSELKKSQTLENKKIGFLGHSLGGIVSLKVIEKQILPNFLIQ
WSAPIGKPRDLLKYQINNGIRNYDNLIIGKTANDKIKTLDYIFDLIDKNPNKTAWEIWKT
AKKESKKHGINKKSFSNYLMPHKLEEARIDNTKTLENINFPTLVIIGKEDILVNPKQSKT
KLDEIGNSNIEFKEMDKLNHFMTKKGTNERTNEIYNVNLNFKEYLVNWINNLKK
>FCMOIPGL_01423 hypothetical protein
MNLKEHYSKLYKESIKNICVGKYRIDNLIDSKGDKRFGITLLVRPSNDVKEKIEKLILEL
KKTEPNQYYYPNSDIHITVMSIISCYDGFNIENIELSKYIELIKKCLPTKKNIEVNFKGL
TASTSCIMVQGFLNNNLLNEIRDNLRFEFKKSELEQSLDKRYSIETAHSTIVRFRNQLNK
KESFLKIIEDYVDFDFGTFEITKIELVYNDWYQRKKLVKKLYEFEI
>FCMOIPGL_01424 hypothetical protein
MKKVTGIIILMFIGINLNAQSCKQYGNNYFGCGVPTNEFEYMRATSVNGGSQMQSNWCWA
ACIQMTLNYHGLYVSQVDVVRKIYGFSNSNRPANERQILNALSGWAADNRGRFSSINAYG
GYTSVQEIISGLSKKWPLIVGLSNSNGGIGHAYVMTGIYYSNRYDNFGNVIGIIPDKVVL
RDPWPLNDSRQEMSWNEFQRRAFMGVKVWVNRM
>FCMOIPGL_01425 hypothetical protein
MKKYILFTLLLLVAFNTNSQSKNDWPHIPGFDPTLHTTLTNRSTLIGVLGLAALSYSLEE
FVFKNHENINFYSARAGMNNEYAFGLKNVWHQNIGIEHRVASWFSVSAEFNIQEWQDKTP
LINGNQKFGLGVGLMTYYRWYLFGKKKISPFIEYGTGIFTGFKKFPYNGTNFTFNNSTLL
GLEYTLINNSKIRLSYGNFNQTNYNLSGSNPAYNGNGFSIGYSLKMK
>FCMOIPGL_01426 hypothetical protein
MKTFYFLITIILICSCKPIEIEDFSGDSDITVMSFNLRYDEPADEENQWENRKESCLTML
NEVKPTVFGIQEGLHNQVSYLDNNLQNYSYVGVGRDDGHSGGEYAAIFYDTTTVELLNNG
DFWLSETPEYPSLGWDANNIRICTWGKFRDIDKDKEFYLFNTHFDHKGKTAQGESSKLIV
QKIEEITESDLPVFITGDFNMLIGNSRLEPIRNNYFSAQRFAERSDDNKSYNAFGLGIIS
RNIDFIFYNRSKAVSYKTLVKNYGVSYISDHYPIITHFKFQ
>FCMOIPGL_01427 hypothetical protein
MLKNILTPITTLLIIFSCNTVKQNYSTLSKSEFLVIHTKNENDGQTITLRNNHNKIYTTT
ISIPNRNWVELKKGNIISMEIKDSIEMNPTLLNSKNIKIISKKYLKENIISSISTTKTSY
NLGEVIELEMDTKNFGEEKFTFLPWKTPIENSFTGEFMDIIYDSKKIEYSGIMVKRMPPT
KNDYITLKPNESISGKINLLDGYKFNKKGIYSIQFNGVNDKLPASNLILIEIK
>FCMOIPGL_01428 hypothetical protein
MTFKEYLIKKYNKETYDLFLENFETKRYSKEHIITNYEEVEKYCYFIEKGIIEAEISNNK
NEFLIDILFEGEICTSFISFYNGLPSDILLRCTSDTILTKIPLHFIKSSKNPLIINFLQN
ESMRYTMKRIQREKDFFILSTKERYLKILKNNQELINRIPLYKLAKYLKVSPERLSRIRK
EIS
>FCMOIPGL_01429 hypothetical protein
MELLKLATEWAKAEVFSTRFFILFAIIFLIASIGFCQLGKTDLAKAYIIPTLVAGILLLI
IGSGLNYTNVQRVKQFEKDFNGDASAFYQSEIERSESTLKEYKVVFKVIPILIIIAALLI
LFVNTPTWRAISITIIAMLIVILLVDGTAHSRIESYHKELKLVDIENEIKNNYTQQR
>FCMOIPGL_01430 HTH-type transcriptional activator Btr
MEHFKTLASYLDYLKLPRPEHPMLSIFNSNGEGYLPCPRESSPPITNDCYSISLKKYVEG
DLNYGRTKYDFTNGALIFIAPRQILQWDNSVVFEQKGFSINFHEDFIKGTDLAQQIKKYG
FFSYSVNEALHLSPKEEKQIESIVANIEIEYQNNQDVFSKEIIISQLNTLLKYANRFYER
QFLNRIEISNNLLEQFNKHLTEYFESGQLQEKGIPSIEHIAGKMYISQRYLSDTLKKETG
KTTTEHLHLHLIDEAKNILLQPNKSISEVAYELGFEYPPYFSRLFKKKEGISPTEYREKY
KLN
>FCMOIPGL_01431 Fatty acyl-CoA reductase
MNTNQFGKKGWTPDRIGDLCGKTFVITGTTSGTGFEAAKILLSKGAKVVMLNRNQNKAED
TIKTLKQELGNQIDVLAIKMDLAEQASVKKAAEEVLKIIPQIDALICNAAIAQVPKQKLT
TDGWESQMGTNYYGNFTLQALLFPLIEKSKGRIVTVGSLGYDMGIKTIKFDDLNWDKDYT
PNNAYSQSKLAQIMTIYELQDRLNKAGKSDVKAYACHPGSSRTNLINTSGSFMMKFIFNL
MKLSPLTQSAEKGAYPKLMCATESNLDQSCFYGPTGRSNWTGPVGAHKIEPHAKDKVVAK
KLWELTEKETGVKWNF
>FCMOIPGL_01432 Spermidine/spermine N(1)-acetyltransferase
MEIRKVSIQDIENLKEIAKRTFIETYSLVNSKENMTNYLENKFSTEELKTELNDINSEFY
FSEFEGKIIGYLKVNIRQSQSVIKDKNALEIERIYVLKEFYGKKVGQNLYKKAIKLAKEK
NAEFVWLSVWEKNPRAIRFYEKNGFVPFDKHIFKLGNDEQSDILMKLELNKEKQ
>FCMOIPGL_01433 Apolipoprotein N-acyltransferase
MLETRNKAYTKTLWAIKTNHIQEMKICIAQTKSQKGKAKENIQNHLRIIELGVKSNTDLI
IFPELSITNYEPNLAKELTTEIENSIFNLFQELSNNNDVTIGIGMPTKANDGIKISMLIF
QPNEKRVVYSKQMLHSDELPYFVCGNDQVILNIKEKKIAIGICFETLQSEHFLNANKEGA
DIYIASVAKPKGGIEKAYKHFPKIAREFSTPILMSNCIGNCHNFISVGQSAVWNKNGKLI
EHLDSENQGILIYDTETELVKIDQSKIEKGQLFDLEKIFQIYLNGKIDLENNGIYQWTDN
YPSISIIENDLKKDVLYTLKSNEKIIGAINISEEQETEYKLIKWEFNNSKVLVIHRLVID
PKYQKKGYAQKLMDFAENFAKENNYSSIRLDAYSQNLEVIEFYKKRNYFIRGNVNFPERE
YPFHCMEKDIITVYNNLYN
>FCMOIPGL_01434 hypothetical protein
MPFLKTMKTMKIKYLFKVAFLLIFTITFNSCSSDEKPMNPLDDRVFTTNDDTDFFINFDG
TVNLIISGTFQNNANFGNEINRGFVYGTSSTPLVSANNTSNVSGSSSAATGYIEGLTSNQ
TYYIRGYFEYDDGTFFYGNEIQASTNIDASANRDLTLAIESDAFLIQTNFITVTLNINDI
MKEIPVEFGVEYSVNSDFTNSSTNEVEGFNGVHNKGVILTTSYSVVAEPLTFGTQYFFRP
YAKYADNTVTNGGISTASFTTN
>FCMOIPGL_01435 hypothetical protein
MKTYCIFFFLIVVKYSALAQEYSSYKQPFQLNLYSETLNDSVSLEITLPKGIKNNTDAEY
PIIYLLDKQNQNNYKYNLNTIDYLTSLLWMPEAIVVGITFPWKKRNKWTNPNISGGKADD
FIIFLEKELNNELKKNYSISNFNLLIGHSRTAIFSSYALSKSPDFFNGAIANSVSNFDFG
DKQQQAQFEFFLNKIPSIPHKYFYYFSVGEQSYGDLHETAVDTLNSYLISKDLPKNLEWR
YYKYKVTHNLTPGLTASRALSEIFKDYGRRIDICFNLAKASKNKVPWNGFQELYSSLSSE
LGFKILPSELFYNSIASEYYNDYDNIYGTKKLNFTLEVLVKAIEKYPKDFSYFSWIGEIY
MTQKDYEKGLLFLNKSIELINNDKSISKSDRISYIEEIEALKN
>FCMOIPGL_01436 Ribonuclease BN
MTKHLALLLFFLGTQLFAQENNNHLSATIIGSGSPKFNTERCGPSVLITYKNTQILVDMG
NGTQANLNKINSKIKDIDGLLFTHHHLDHNEEFAPIFIQSLLGGNKTIIAGPKQTTSLID
NTIENYREDIDYRLSKSGRSLTDVKSNFTAKNLTGNTIFYIGEIKITYTPVNHTIATLAY
RFDVENESIVISGDLTYSESLPILAKNADYLIMDSGGAIEVGSKRNVIKNNNNRNNSRAK
EKAHVNLAESSQMAKEANVKNLVLTHFNFTNVDEEATSAEIRKNYNGTILYGEDLMSITL
NQNIITNKHSNLKNSSALVNTGVQNYYSNTKKNSKPTVAQLNKQPKKNKKSQQTEQRETK
PSNYISQYANVPEGGVVTSGELPDLNAFSANGNSLKIKELSKGKYTVLAMGCLTCPEFHK
AYTGIEALNVDYAPKDVQFFFVYKSLRHPELDGYVEAQNISERLLMVKEVKKKLGTKVPW
IVDAMDDNIRIALNSGSQSVYLISPEGKIVKGWGKLKEQELRQMLSDKVGAASTLTTIKD
LDLPVIKRYEKRLNEETNTTIYRPEGLNILSIVPKKPEDTYYVKLRAEADRNLIETGNGK
LALGFFPDPILDAHWNNLTPPMKYVLELPEGVTASPQEASAEKGPGDSDTEPRQFWVDIK
GASPADQIELTLHYYGCTSNMCMALTHKYTINITPEDNGSRTFGFNKGKHNNNNNNNNNS
QKAKNSGPSFERMLANMDTNHDGKVSKSEAKGKLKENFNKRDKNKDGYITEDELARRNR
>FCMOIPGL_01437 hypothetical protein
MKKAFLLSTLFFSIQIIFSQINKDIHELNSIDKLLTEQVKEIIDTNIGKKKTVFLGEAVH
HSGSDFLGKTEFIKYLVTKHGYKDIAFESDFFALLFDHDKHNLYTMWSKSKQCKELFEFL
KENSVTIWGFDNKIHSRYSYQNFTKKLSEILKKDGIELNTEFTRLIKLIIKNQHNSRKEL
SQKEVDYLKNYIQKLQTNEKIKTNKVWNQILNSIESAIKLYTVKDNYSDKHRIKIRDKQM
AKNLDFLVKTNPSKKFIVWLANGHMSKSNNGLMKGQTMGYQFRKLNPNSSYHIAFGSIRL
PERKEKNIIKARKKSKNILSLLPSLESNYFLDSKKIISNNIELKNKIFNDMYIFNLPNNK
TKLLNHFDALVFIAFGEEVKYEK
>FCMOIPGL_01438 hypothetical protein
MKNQTKKKILTLISFICLIIPFIIYSLWIYVCNLGTTQAERVSIFKNYFPDFLDGRWSTT
IVSIIFSISAVIISSINLKHLNGIWKLINIVLLILSSLLLFLNLFSMM
>FCMOIPGL_01439 hypothetical protein
MKIIITRIFIVGLIISNLNAQESKENNGVFVNFEQFKLNRPCPLESIDLKKRSELFLSVD
DIESECKFKKVNKLIAISFENEIYYNMRFNVEFLTKNKFSKLLVKGKYCAFKVDESYPKN
IQGQAGFNTGGLIGAIILGVNGKNKIYYLDTSKGYKTKVLTKNRLKEILSQEKELLDAFN
KEKDVSAELYLNYLEKLNKKVENR
>FCMOIPGL_01440 hypothetical protein
MTKIIAENLLQLIIVFPIILITLKNRKSETFEILMAFIIFFLINQISLVLPMVYPKLRIS
NWNSNWNWVGKIYAIFGAIAFLLIYRKYPLKDYFLTFKQESKFLKKGILIITSLLIIKTV
LMFFAPTKILNWETLFFQFSMPGINEEIAYRGIMLGLLAKILKSKNLILNTPVWITAILF
GLEHGLSLSTELIITFNIQPFLITMIYGLIWGWITIKSGSILLALISHNLGNGTGNIIRM
R
>FCMOIPGL_01441 Thiol-disulfide oxidoreductase ResA
MKKITLITIMNFLIISCGKQKENKITSENFFKAGTIQFTGKVKNFKLTDDRTLFISQYNV
LTGEDEVSSIKINKDGKFEKIIPIYSPHEITLKYKNKRTILLVNYLDSLNFIFDVKNKTI
ISGKGSNRNNLLQQYIESSYKIKNNYFDAIFGKEFELLLKEHSKTKRKLDSITDMIFLDK
KPDSLLDIWIKTDKKTLKTYGFINYALKNEPFPTHFLSEKKIINDSDLNNINSYYNKSFT
IDVFNLYIGAIVKGNRENFNKMRTLFKKGSYEEATNLLADSIFKKYKNLGKDIVLYREFK
QMTQKDLIRDDPNIDLLKRQFLKKIKNEFIKTNILNESFKSNSAQKEKSTINNSDNVLAD
LIKKHEGKTLYVDISATWCGPCIAEFPYSVNLHESLKNENIVFVYLFAKSNQDTWKKLST
KYKLKGENLIISDNQYNLLLSEYGINTGFPQYFIVDKNKEIKKNIKRPSTTGMKEYLLKI
L
>FCMOIPGL_01442 18 kDa heat shock protein
MFNLNFLIMSNLVSVPKNGSLANSNSNQNFPNLSSWLDDIFNRDLPSVFTSNFNTGITLP
KVNIKETADAFIVEMAVPGLKKSDFQIDLDNQLLSISTETKEESEHKEENYTRREFGYSS
FKRTFNLPESVNDEKINANYEDGILNILLPKKEEAKQKPARSIKIS
>FCMOIPGL_01443 hypothetical protein
MKKYILLFIVSLLTVSCKGQENETKKDEKEKNQTNIVEEPKGNWKVDKEFDENGNLIRYD
SIYSWSSNNNFDNLSLSDKDSLMQSFKSRFFSNYSVFENQGFENVFSQDSLFSKHFFNDD
FFGSNFGKDFMDIDKLRQQMISRQKKFLEKYQSEFIKPEDEN
>FCMOIPGL_01444 hypothetical protein
MKKPLILLFLVLFFSNSIFSQDMPEKLAKKICKCLEKEQIKTIEEMNPCFEKVLIDNMKE
IYKAYKIKSIEELDFDKLGLEIGDKLMNECDYALEKLTPEENKFEKDFVPEKNLDCSNLK
NGEFFYLDFNTSTKTKDTTFVTIKDNMFLERMNNGRTYAMLDIKWKNDCEFELIFKDSND
PIKSVMSKPGEKYRYQAVSSTSNSYILKFFLEKKEFKIEFFKAK
>FCMOIPGL_01445 hypothetical protein
MIELDYTNENQIVDFVNRTNFFSIPLDKLYQIFDSKRPIAIGIKQFKK
>FCMOIPGL_01446 hypothetical protein
MTTNLDSLYFQKGTEDLEGIRQARNYTPQNYINSINNYPKFWNSVRKNTLKTEVYVPELN
ESIEKMRKTNNQQLKK
>FCMOIPGL_01447 hypothetical protein
MKKLTLLIITIIFFNCKTENQSQVDYADSLSNYLTKNEIKLLNRGCELFEKEILKINEKN
NVGNSYKEYVESFKEYPRKISESKNINKYLIVLKKSELYNKIWTENKLNENFLDCLIEKS
QKPKVKELLNGYKEIIDIALIVVSESLNKSLTEKEYDSKTMKIFIGIEFYYGLKINQIE
>FCMOIPGL_01448 HTH-type transcriptional regulator CynR
MVNLEWYRTFKEIYENGTLTKASIALYASQPGVSVHLNALEAYVGKKLFERTSRKMIPTE
DGKFLYEYIIESLKKLEIAEQHFKKTTQEKNPSLNVGMCSEMFQLIIEPEIPKLDFDLVA
RFGAHTDLIRDLNNGILDLVITPKKQHEKKSLVEYIPFSKERIVLIAGNKTNVTKIQKHI
ESNNLSKLEAELLQNIWYSSSNEMEHFRRFWFENFNKKPAFKPNYILPNITSIIRCLNNG
NGLALVPDFLCQEQILTNKIKLVWEGKVKTENTLYFASRTDLKYKKELDTIKDIFTSKMK
>FCMOIPGL_01449 Modulator of drug activity B
MKNIFIINGSHPFAHSGGRFNETLFNKTISYFDTHEGFEVKFTQVGENYNVKEEVEKFKW
ADIVIYHTPIWWFQIPFGFKKYIDEVFTEGHQNGIYASDGRSRKNPNINYGTGGLMRGKK
YILTTSWNAPKTAFTLENEFFNQKSVDEGAMFGFHRMNAFTGMELLATHHFHDMEKNADV
PFELNNYSVFLNDLMINL
>FCMOIPGL_01450 hypothetical protein
MKHIKLLFTLIVLTLLTSCASSKINKTLKQGNIVQEDFKTTIPFEYRKGLIILKVTIENE
KYDFILDTGASNVLSKELAEKLNVKSLGSENVTDIHKTSQLLNYTKIDDIEIGGLNFKNT
IAAISDFNSGELACLNADGFIGSNLMRFAVWDFDFKNQIITITDNEQKLNIPKDAIESKM
FIGTAVSQPSIISYINGDKALNNMIDLGNNSTSHLSYLDFLKQKKSKKITKYISGSGYSG
IGMYGKGKKKNEFSAKIDEIKIGDHIIKNKVMRVKDGKTNLGILFFKNYRLILNWEERNV
KMVLQESTSNNTELNHFGFNPNFNENKVFVDFIYNDTEASKVLQFGDQILQINNIDFTNI
TDNNKCDYFNDGIIPKGTDEITIIILRNEEELEFQLKKVRLL
>FCMOIPGL_01451 hypothetical protein
MKKTILLIILYFLSLDLSFSQEKISNKDLKFYKELIKEFKKNSINKDSINWVLFEKKVLE
KSKISKDSAIIEALSLNGESHSRYFKKDTKSSLHGKFKSKKIFQDFEKTGYIKIDYFTPS
KTSLKETITKARKYINKRIEAIKLQDQKELNCWIIDLRNNGGGDMWPMIISLTPFFNNGI
LGYTVKKEKENIWRKENSKIYYKNINKTKKYLEKPFDYKLKNNNIKIAVLINNRTASSAE
ATAIALTNNENVKFFGTKTFGYTTNNTSIEMKNGDFLILTTGFWKNYNGKKFKDGIIPDF
ESCNEKELKESLKNWIKK
>FCMOIPGL_01452 hypothetical protein
MKNLKGNILFFIIIFISINVFSQKKFKVKTEEKYETKNQYYLVDEKENILQKLDTSKYYI
FLEENSLKYFAVFGIKGENGWSAIDSNENILFQVYNSVNGEPSPDSLIENKIRIINENNK
IGFANEKGEIIINHQFEIVTSFRKNRAIFGNKCKKVYWKKEKHENGCNHYSIECSEHGYI
NEKGKILISGNYTFEEIMKELNWKNE
>FCMOIPGL_01453 hypothetical protein
MEKDITNWQNLWKEEKSTPLDFGKLVTHLNKIEKKGKLERIILLVAVPITIIVLATLLPI
LSNIYYLISILIIGFGMIMILIQSYRSKYSLISNDAELNNHKYIKNLIHKLKQRMLTTSK
YMWFYTFLLVLGINIGYIDVLQKFNVSITLRIIIHVVFTVFMICVMYYSIEKRKKENNKG
ILPLIDFLENLN
>FCMOIPGL_01454 ECF RNA polymerase sigma factor SigW
MKNKEQKFKQVYEQSKDKVYRLCLGFMGNKTDADDLFQEVLIKVWNNLDTFRNESNIDTW
IYRITTNTALLTLNRKTKLNKKEIAYQPNIPHYEIENLNATDKEQEVKKLYKSISLLKEI
DRIIIGLLLENCSYDDISNITGLKTSNVGVRINRIKKILRKKLK
>FCMOIPGL_01455 Pimeloyl-[acyl-carrier protein] methyl ester esterase
MKKLAILFVIFCYQTTTYSQSEKYSFNIEIKGQGKPIILIPGLASSGKVWEETTDTLEKN
FECHILTLAGFANQSAISLENGYLPIIENEIIKYVQDELNEKPILIGHSLGGFLSLSIAS
SQPKLLKKIIIVDSYPFMSAAHNPNATVENVIPQAKMMKEMMLSTSDSQFIQQQKMTMPT
MITDSTNIQLANKWSIQSDRNTMAQAMFELMTTDLRDGIEKVKIPILVFGSWYGAKDYGI
TKETVEANYKNQFSKAANCEIIVAETAKHFIMWDEPKWFINSVEAFINYEE
>FCMOIPGL_01456 Thiol-disulfide oxidoreductase ResA
MKRILLVLLLAINVLVYSQIPKEAFELTNSLPDLWEKENPEEAIKSSEKLNEIFQPFFID
RLHHSLAQTILRNKGKGNETVFLNELYKKDKISIKKIIEPIYLWNKSFKINRSDKADSLL
KTYYAKLSDSTNYNSKIELYGLLIVKEFEDKEIGSSKLKDKILSKIVLNLSLNPLINNPA
KGNRRIKEERAYYRFLLAYNYNLLFEKNKTEESIKNASKYSPDQTDLQNKSGYFYDAYLL
VNDLKNINYKKKYINFLSKNGKQEIALDMLLEETYIQATNENLKNLKGFYNQIVKNKTFK
TIWSNYLNSKMLEVPKIKVEFKEEILDLSKKRDSWVYIDIWGTWCAPCIKELPEFDKVAK
EYNKKLDSKIKFYSFSYNSKKLEEFMNKNNYTFPVSEINKQITQLFKVSAYPTKILISPD
NKYLKIPFGVNWKEFIKNYTLID
>FCMOIPGL_01457 hypothetical protein
MGYKLDNHIRTSLCTDALAMAIKNRKYTNQKLIHHSNRGFQYCNPKYTEFAESNGIKMSM
TEQYYPYENAVA
>FCMOIPGL_01458 hypothetical protein
MRRIKIVSIIIVLSIICFNSAFAQNKLSIPGFGDIPLTKDGNLYSLNFGKLGKFGFAGSV
DPLSLTASIGMDDLKTFPGAKAMGALGLRDIEMNVKQKALEIAANFDDKIKDDLVNELRK
IEQLKPIIETIFNTLEIRESHASLIYNTDGSLGGELDFNIIVFGKKLRIPKIKGKVDIDT
ITSQLVSIIKKEAISLLANLDELVKGAEKIAKMASSEADKLIADAKVASKHTHSKGECDK
KCCPKHAKKLSGPIIEGSFDAVRKFYFDVFPTIGKIHGATPKETRQMRSSLIKEDWDALF
TKIDEKWAKILKDRTYVRFYIMPSSAANGGNIYRSKVKEYKKKDLDYRKTVWERMMTNTA
TGKEEAKIKGTKIPAGTYYIKSANTGNANNGYFDISYNREKKKWKMKGQRLQIWTKDNSG
AKKYRFHKNKYLSYYIITPASDSKFALDCYGGKSSKKTAIHLWSTHKAGSQQFYLEHKGN
GKFAIIPKRNHNMCLALVDNKNADKGNKVHLWTYSDMPSKHWYLINVKTNKKYIPKQ
>FCMOIPGL_01459 hypothetical protein
MILGVFLGVMASEWSTNKRLKKDQEKLLFGLKVELSSNLEYISDRKVEIYEFAIRINQLV
KENGQNPSFFIVPFKEKPFAARIPGFPGLGKSALNRAMFEAAIYSNLFPDLNIELIKQLS
VSYSIQHNFLDSRAKIERKLEYIDSETTYREVMDIMYEYLDEFYKTHERLESEYQKTIEL
IENSLN
>FCMOIPGL_01460 Molecular chaperone Hsp31 and glyoxalase 3
MKKLILIITIVMITNISLSAQNKKILFVLSAADTLELNKGQKLRQTGVFLNEFYLAYKSV
SENGYTVEFATPNGNVATIDEESTNDKYWKEVLEIKNEALEFITKDNSFNSPITLENAIE
NQGNYVGIIIPGGQGLMIDLIEDKNIPILLKLFAKENKPTGLICHAPSLILTIPAEENPY
IGYKVNSVSPFEEFVIEKFIMKGKPKNRKIAKQLRKLGLIYRSGLPKANFAIKDRNLITS
QNPFSSSTFNTLYLEALTEYLETKK
>FCMOIPGL_01461 2-iminobutanoate/2-iminopropanoate deaminase
MIEKIMSFTILLVLFSCTESKNVNTLNNNSMAQEKNSFINPKGLFNPKYNGFSHIVKVPK
GKEMYYFSGQWASNIEGKLVSEDFEEQVRQTVSNVKIALETAGLSLDDVVKQTVYIVDFT
LEKKQILIDVASKEWRVKNFPASTIVPLPLLATAPNCLIEIEIIAAK
>FCMOIPGL_01462 hypothetical protein
MKDLYNFLNAISPIKEKTWNEIKTLFTEHSLKKGEYFLQEGEVAKNFGFLKQGVVRAFYR
NNEGVEYNKHFFTKNNMIGGYSSLVSQLPSTINQQALTDCNLLIGNYKKLTDLLDKYQDL
ERLLRKIAEHYFVDKEKREVEIVLLEANKRYAIFQREYPQLEQLIPQYHIASYLGITPTQ
LSRNRAKNSKN
>FCMOIPGL_01463 hypothetical protein
MKQNLLVGLLLIFTPNAFSQDSKFSLEVNYPITIDQNFLGEDSYGIIDLGLKYRFVELNP
LKLGISINGGVLVDNSNQNNSPQDFLVTTYIIQPKIFAEFNIQSIENFHPFIGLGYTFMN
FQLSGSNNGMDVSDESDKLSGFGLNFGIAYDISRKIFMQAQYDFTKLNVDDVPDIKFNTN
VNLLKLGIGFRI
>FCMOIPGL_01464 hypothetical protein
MKTLSIKRFPTNSIINKKGEIINSNSSLKPSNIETINILKELTK
>FCMOIPGL_01465 hypothetical protein
MKNPLDYELLRKKRAELKAEKFLNFKDSLYGLQENYINKLLLNKTLSKPFLNWLEAEKLY
AYPSSFSFFNLHKFKKNTTQTDIKDLSNINLKTDYSKYNLFDLPTVKSEYLINGNISDNL
SQNIFGYYMFSNQAEIAKLPVDKRFNFILLQIKKENIDRPFLTQILFIEFVSTYLNKKNT
NVYENNLDLINDVLDNSIFKDSLLAKYKKIKKNIIIPIKE
>FCMOIPGL_01466 hypothetical protein
MKNTFLITILIFTLFGCDKKVEDSKQNIITSDITNFWKAYDKITSTQDSILQYKYLDSLY
LKNGTVGLKGIRQARNYTPQDYINSINNYPKFWNSVRKNTLKTEMYVSELGEGIEKMRKI
YPELKAARIYFTIGALRTNGTTIDSLVLIGSELAMSDKNTIASEFQGDLGKGRRKYFDSK
PIDNLVLLNIHEYVHTQQNEQVDNLLSYTLREGIAEFVSVIAMEVPSATPAINYGKQNDK
VKKKFEEEVFYGNNIHHWLWSDFPNEFKTRDLGYYIGYAIAEINYNKAKDKQSAIKEMIE
LDYTNETQIEDFVNRTNFFSKPLDKLYQIFENKRPTVVKVKQFKNKAQNVSPKTKEITIE
FSQSLNGHNTSVDFGNLGQDAFPKGTLNGRYWGKDNTSWTIPVKLEPNKKYQIFITNNFR
TEEGVPLKPFLIEFKTSK
>FCMOIPGL_01467 hypothetical protein
MKRTLIALMILASSNLFAQSSPQKLIDTFFATYEKDAGKAVKDLYATNKWTERIKDDIDK
IIGTVNGFTESYMGKYYGQELITTKKFAESFVLYSYLVKYDRQPIRFIFKFYKPNDEWVL
YSYALDDSLDDEIQEAAKLYYLNLDKE
>FCMOIPGL_01468 hypothetical protein
MYSQDVNNDLLGNRWVSFRKEPKKGEVLHIWKLAIPEDDNETLHEERDAFRKMDENEIVY
QLNLFSTIENGNIMEQEAILFEVSSSYEDRKTISGIELKNLIAEWKILELK
>FCMOIPGL_01469 hypothetical protein
MLESLIFMILSFIGIVGLIISIIILLVGLIKKSKKLKMTGLIFLIIPIFCYGLIQFWYKI
VIPNSNDRISNEFVGVYSTHKVKSKKFLKRNGLFDKERFLILKEDGTYEFDSIPGVDLWK
RGKWQTGGIDGAFDFYNNKGDLIERGMPFGSGDNCGLEFDFYPNPKDYKKRENLTLIKTN
D
>FCMOIPGL_01470 hypothetical protein
MGKTDFFYDTTRLIFEKVISEKNSDFYLPSLNLASFADGEYAEEFMVYLELIINTDKKKF
CKSLSRIKYKNRNPIKYYSELNKCE
>FCMOIPGL_01471 hypothetical protein
MTFKAYIHKIIKIETSNTQVIFLSGLFLMIIGLVFSYIYNEIFHTDSGKGILASIMMIGM
LTILFTYFYQYYDFEKIKNLKKGFIELEKDELIINYSEKIKYEELTDFDLSINAYYNEKI
NLGHRNPTEKRSLGISNSLTITHKSKTRTFNFKLESKSHQNVLERNIYNLVIHDKLRNID
GKKSIKLIPEQYKGFEEYREYVEKQLKEKKINCTEGLLLMGYKSFDEAQELKKKYCG
>FCMOIPGL_01472 hypothetical protein
MVLDYRKKVGMRTGGIKLYDELKSDFIKQNIKMGRDKFYDFLRLHNLLVPKLKNYVTTTD
SNHQFRKYKNLIKDQVPNRPEQLWVTDITYIKTENGHNYLAIVTDAYSKQIMGYKLDNNM
KTSLCIEALAMAIKNRKYPNEKLIHHSDRGFQYCNPKYTAFAEENGMIMSMTEQYDPYEN
AIAERINRTLKYEYGLRNCIKNTAIAQEITKQAVDIYNNLRKHFSLDLRNPADVHLNPNI
KYKSYRKNKVNLPELKI
>FCMOIPGL_01473 hypothetical protein
MKTQNEHCRKKTYEKVTLELKLLVVDQIQNGQISTNFASKKYDIPRTTIGYWIKKYSTLV
QQNTGMSKINEIKKLKERIEALEFIKDFQQDIIADMEIITGVDLSKKSLPKTLVKEIELK
KKNRLKESGSINVLGLVNKPSTKDVKNKKSNK
>FCMOIPGL_01474 hypothetical protein
MNINLNKIERIKNYLVFKYSGICGIGSIGNSDVVKILENSKKEIESEKGIQGIIYDFNDL
RYEFGNKFSELLSFDKQNKKLFVRIIPNKSDLNNWKSLQVNCSQNRNIELFQTNIKNAIN
SINSEMNNSNKEITLKEYNLFCKYGSELLWVSDKLRFKRPKDTNKETDEMFILLEKLDQY
LEIISLGTYNSELIEQYKNEIVLLKGKVSKEVFEIIRGKYKTPHNTV
>FCMOIPGL_01475 hypothetical protein
MKKRQINPIDLLIDNLSVNFAKINDFEKLQESEEGQRLFDLIVKSTSEMESFQTLFLNYY
IPAANRSIADSWTHISKSKYKSLLNISKQDLKDNLYETIRLGYVGLFHKYESYLKDLVAA
TNFLFAELREENNLLTLEKYCKKEYNIDIYKSHYQFDITKRVSYICNCVKHKDSFPVKEP
IHPDFKHSDRNKKIEIEKEIFKIDIERMKIHCQSLQSQLFSMGFKQYLELEFETILESVK
PELKESLETKEKILLAKKNFELVLSDFRK
>FCMOIPGL_01476 hypothetical protein
MKKLLITEPDFKDKPIEWVSWNIKTTGNSMQTALTILRQKQILSSF
>FCMOIPGL_01477 hypothetical protein
MKLYHGSYTEIEKVNKNTGMYFTNDIEIARDYALGLDDCGNYNEETFIYEIEIPENSNII
LMDDWMDFDSIGYVDYKNAPEFASAEEMEGYFFVKNPENFIFKLIENFKNEL
>FCMOIPGL_01478 hypothetical protein
MAYIYLNKETNEARIFGSITSLSNVTGIKPDNLYTTFSRKGLKEFENDLYRIIKTKIERA
>FCMOIPGL_01479 hypothetical protein
MKKDENDYVIYDARMMENEKFLTTQEATEHFKVSRSTLYRLRKKLLIPVSKIGSRPIYPL
LLLNTTFSKRAVQSIIQQKPTDK
>FCMOIPGL_01480 hypothetical protein
MATFEKGILGGFSGKVGNVVGSKWRGKNVMRSLPQRGKYTPTEKQEQQRAKFKTVIGFLS
PITEVLNLYFGNTIGDKSRFNIATSYHLKNAVKSTPLGMVMDYEKVLISKGDLRGIDGGT
IATGAGQTLTFGWQDNSGQGKATATDAFMIVIYVPDLHMYYTNLSVATREATTATVTLPN
YMASFEVEVWASFNKPGTNFAATSTYLGPVTIL
>FCMOIPGL_01481 hypothetical protein
MNSFIKKALCMLLVLYAGSYLKAQNNSTKIIGVLIEDATSLAIPYATVVLHDKTSKKIIV
GTTSNDKGAFSITTTHNNFYLEISFMGFKTKTITTFNFINKKADLGNIILTTDKQALDEV
VVTGEVSKTVFKLDKRVFNVGADISSTGASALEVLNNVPSVNVNIEGEISLRGSTGVQIL
INGKPSVLADESSNALGTITADMIESIEVITNPSAKYEASGTAGILNIILKKEEKKGWNG
AVSLNTGTPDNHSIGLSLNRRTESFNLFAQLGAGYRSIPKKSEAINTDLVNNEVIFSNGT
ESRDETFYNLTLGTDYYINDLNVITLSGNFAYEVEEQPSETNFSYFDATNSLISSWVRNE
ITDATNPKYTYELNYKKEFKNNEEHTLLFSALGRFFGKDQSSEFTNTTISGTDSNSEQET
ETNFKQANYTFKIDYTNPISNIYTLETGAQYVINDVGNDYEVRDVSNGVFVVDEDLTNDF
EYNQKVLGVYVTGAYEKEKWGIKAGLRVEHTNLTTLLTNTNEANEQNFTNIFPTLHSSYK
VAEDFSLQAGYSKRIYRPGLRDLNPFFNIRNNFNIRVGNPNLQPEFTDSYELTSIYKIGK
ASLSSSFYHQYTTDMVQQVSTYVDNVTISTPENIGTDSAFGFETNGKYRPNNWLTITGNV
NFNYFDRKGSYETQIFDFSGSQWSSKLGSKIGLPADIDLELTGNYQSGYKTVQGSITGFV
FLDVGVRKKIFKGKAIVNLGVRDLFESRNFEQFVSQTTFETYSFTQRGRFVTLGISYGFG
KGEAMTYSGGRRR
>FCMOIPGL_01482 hypothetical protein
MAGYVYILQCSDGTYYTGSTRNLEKRLAAHQSKKGANYTKTRLPVTVVFQELFLNIADAF
YYEKKIQKWSHAKKKALIKNNWKLLPILSECKNDTHFKNKE
>FCMOIPGL_01483 Sensor histidine kinase YpdA
MHKNIKINIFSHLLVWLVLFSIPYILSYGQEQDVNRIIAHFWVPLVFYAIVFYLNYFILI
DRFLFLKKIIPFIIINIIVIAFFITTKELIENFYFEELFKKTPKVEGEGPPLKMFIYFQM
ISYMAPLLFSIAIKSTKKLVKTEAERKEAANFKLKSELEHLRYQLQPHFFFNSLNNIYAL
VDLSPEQAKKSVHSLSKLMRYMLYETNVELISLTKEIDFMKKYIDLMKLRVSDKTVINYN
FPTEESGIKIAPLLFISLIENAFKHGVSASKESTIDIVITCKDKTVLFTIENNNFPKKTD
DKSGSGIGIPNIKKRLELLYPNKNSFNTFVKDNRFTAILEIKTN
>FCMOIPGL_01484 Transcriptional regulatory protein YehT
MSNMKITCVIVDDEPMALNLVESYVEKTPFLELKKKCSSAIEALEFIKTTSVDLLFLDIQ
MPDLTGIEFSKMLPKETRVIFTTAFDQYALEGFKVEALDYLLKPFDYSEFLVAANKASTW
FELVKRKKQPIISEEKEFLFVKSEYKQLRIKLADVLYFESLKDYIKIWIKDNPKAILTLM
SLKTLEEELPETQFMRVHRSFIVSLKNVEVIERSQIIINKQRITVSDQYKPKFLAFVNNN
SLNS
>FCMOIPGL_01485 Sporulation thiol-disulfide oxidoreductase A
MYKSILITICVLFLGFTTKSNLVVEQETEKNKDILVLNFKTLEPLLYTESKEIQIVNFWA
MWCAPCVKELPILEAYQKKHPNVKITLVSLDFPEDIETKLKPFLKKKGITSKVVLLDDPD
ANSWIDKVNPKWSGSIPFTIIFNNKKRTYHERMFESMEDLENEIKKIN
>FCMOIPGL_01486 Thiol-disulfide oxidoreductase ResA
MKKPNLIFATIILISSLFITNTVNAQDHERKGPPPNGDRKGPPGGGHSPEQTKTLAEIGG
YQIGEVATDFKLKNVDKKMFSLSDIKKAKGYIVVFTCNECPFAKMYEDRLIELHNKYAPK
GYAVVAINPNVSEDNKKENFESMQKRAKEKKFPFVYLADEKHEVFPKYGAVRTPHVFLLD
SERKVQYIGTIDDNARSAEAVKVKYLENAIDALIKGKKPAVNFTKAIGCPVKAI
>FCMOIPGL_01487 hypothetical protein
MKKVIVLLVLTTSLFSCNSLSIFEPTSLNEATSLLKSLNSDSTLQEVTSIFNLLDINRDS
SISTTEAIGLVEENFSILDADKSESLNIKELHGLVKLVK
>FCMOIPGL_01488 hypothetical protein
MKLFLKTYGIAALLLVSFTAQTTAQSRRSTNNKVVVKKTVSRRIPSTRVTYKKKQRKVVA
VRNLPNRTVVRNNGQNYYYANNRFYTQSRGRYIVIAPKIGFRIKVLPTNYRKIRFNNRNY
YTANGVFYIQINNEYEVVDPEIGTIVYELPEDYEKVVIDNQTYYEYANIIYEKIQVDGTR
AYEVIGIVEMK
>FCMOIPGL_01489 2-deoxyglucose-6-phosphate phosphatase
MASNTFIFDMDGVIIDSEPFWRQAQIDILSNYNITITIDDCIKYTMGKRIDDVALTWCQL
YSLKISPKLLAQEIISAVANLISQKGNAKIGLYELLDFLKENNFNIALATSSSLAIIEAV
FKRLSIAHYFDVVCSADEEVYGKPHPAVYLRVVKKLGVKTRDCFILEDSVTGLIAAKAAA
IKTFVIPEDTTDPRFSLADHIFNSMFDVIDYLK
>FCMOIPGL_01490 hypothetical protein
MNTKKIPNLSVDCVVFGYDTDTKSLNVLLLNRYLESKSSNAILVNDFVLTGYHVYENETL
DESASRVLKELTGLTNLYKKQFKAFGDPNRLMDEKDSLWIENQEFNQRTVTIAYYFLLKT
DAVAIENNKHKAQWFAINELPKLGFDHEQIILEAYEDLKIKCLQDPIIFELLPDKFTINE
VQDVYQSILDIEIDNRNFRRKLINKKYIVPLDEKQVGVSKKPAQLYMFSKDIYDKMFQKN
YLISI
>FCMOIPGL_01491 hypothetical protein
MKRVHQNSKQNALVTFKKNINSILLIAILVASFQNLQAQQQDTAKEYQAFNISGHLKNMH
LWHGFMVHSGALFATSLEYNSKNTKFTFGVWGGASFAGNDVWNETTKKYVNANYKEFSIY
TSYRFSDNFFMEAVSHNNYTGVEERGDQLHYWSYDKTQGYNFVDIGFGYKLDKNTSVYLA
TIIGGGSGDYEVQTDGSLKDSYTNYLEVKRKVWEKENAKLSLFVGGAWSFITDKTFYTES
AGNVINVGAALNKNIKIANFKLPVEVTAMWNPEKEITVLQLDITLF
>FCMOIPGL_01492 hypothetical protein
METSNQFKQFESLEEDQLPIAKNKLHNWGHFAGLYAAEHVAATEFVIGATFVALGATTKD
IILGLLIGNVLAVLSWTFITSPIAVDTRLSLYTYLNKIAGDSMTKLYNWANVIIFTVISA
AMITVSSTAVRFAFNIPAQLDWYPTNLWFVMIVLCVGAVVVSIAIYGFTAVSKFSAICAP
WLFVMFISGAFILLPALSLDVLGETLPSSWGEFINLGDQSIWTGVNSDGEPGIGLLEVIG
FAWAANSITHFGLIDMALFRFAKKKSYGLTTSTGMMFGHFIAWISAGIMGAGAAVIIGKS
IVELDPGDVAYYALGWSGFVIVIVAGWTTAVANLYRAGLAAQAIFTKTSRKKTTIIVGLI
TMVVACFPFVFSQMLPLLTYAGLLVVPVGSIVFAEHQIFPKIGYTRYFARYRKLTFSTPA
IASWALGLAFGFGLNILNIMSFYYLFIPTWIFTILVYTFLAGKYGAKDKYPEEEKAESER
NNNIKKFQEEKAEKEVVLIKDTSVFTKVLKVISLIVLVITLVLACIVLFGSETEIIYKEN
REIFYTYAFVCTVIYFATSIWALKRGNSLNK
>FCMOIPGL_01493 Polyol:NADP oxidoreductase
MENTIKLNQQNLAVIAKKVSCPTYNRSNIKTGIIHVGIGGFHRAHEAFYTDQLLHDESVT
EWGICGIALLDFDAKIYNTLKEQDGLYTLIIKELDGKLTKRVIGSIVDYLYAPENPLKVI
EKMASVDTKIITLTITEGGYNYNEATKAFDFTNPLIHHDLENPEAPKTIFGYLTAALKLR
KERGLAGFTLQSCDNIQGNGHMAKNMLLSYVEKAAPELVTWIAKNVSFPNAMVDRITPAT
SPSDITNLLETSGIEDAWPVVCEPFKQWVIEDDFIAGRPAWEKVGAQFVEDVVPFEKMKL
SLLNAGHSVLGILGDLIGYATIDESVHNPEIKKFLKNYMNIEVTPTLAGLEGVNLNAYKD
SLLERFGNIYIKDQIDRICSESSAKFPIFILPTVNKQLENNGSVDFAAFVIAAWAIYSLG
SNEKGQPLLIKDAMKTILNEKALAAKENPAAFLEIASIFGNLKDNEAFVKAYTSAYNNIV
TNGIEKCVIAMNNSVLK
>FCMOIPGL_01494 Fructokinase
MKNIVCFGEVLWDVFPTHKKIGGAPLNVALRLKSLDNNVAIITKVGNDIPGTEIKDFIKE
RGVQIENVQIDEKLNTGEVAVLLDDKGSATYTINFPRAWDAIQLTKSAAKIVKESDAFIF
GSLVARDHTSRNTLYELLKLAKYKIFDINLRAPHYSLDVLHYLMNEADFIKFNDEEIFEI
AKSLDAKTSTLIETIQFIAAITNTKSICVTKGSKGAILYYQNTFYENAGYKVDVADTVGA
GDSFLAALTDRLLKGVSPQESIDFACAMGAIVTSREGANPEITKQDIEKFITFE
>FCMOIPGL_01495 hypothetical protein
MKRLIVLVTAICISSFTYGQFQVSVSTGYSVGSAGMKLGETMSTTETENTYGSYGEGLNF
QLRGTYFFNNKFGLDLGLGYLNGSDQTVSEVSVPGTEVDAIARARAFGASASVVYKFNKN
VYGRFGALVKVGGKTEAVVYNQATLPDATATALGLPSGSYTETNYVEDYHGHLPLGFVAA
LGYTYELNENFSLFVEGEYYGISLKRKDSKIQEFNTDVFLPDGTVAMSGLYTLDNLPAGT
YQETTYVDTLSNTETDASKKLSQKVPYSSFGINFGLIYKFKNSSSK
>FCMOIPGL_01496 hypothetical protein
MYQNYKIITITKKYVFLFFIFCIYNFSAQSVRINEVVSSNDAYLDEDGDTSDWLELHNFG
TQQISLKDWYLSDDVNDLTKWIFPDITIAPNEYMLLWASSKNRTTVSVPRTLINKGDQFK
YLIPSSEPSSNWKNLDFNDSSWATGVSGFGYNDGDDTTIIPVGTQSIYLRKAFTIDNLTK
ISSILLDIDYDDAFVAYINGTEIARANIVGTPPAYNSGTITDREAEIYSGGKPERFTVAD
FATILVEGENILTIQAHNISSSSSDFTIIPFLSAVFSTQSNLGITPPAILNLSENNKLHT
NFKISSTSETLTLSNDSGTIVHQLTAENLAKNTSIGTSIISGEIVSYIDTTPGYENSRQE
YVGSVQNEVLFSHQEGLLESAISLVLSGNFDNELILYTIDGSSPTENSLLYTDPIQISTN
TTVRARLFLENYIPSDVATKTFVMNASSSTFTDSNLPIVIIATEDNVAIQDASRVFGTMK
IIQRPNGARNYVSDANNEDFIDYSGTINIEIRGSSSQYLPKKPYGFSTLTADRFENDNVK
LLGMPKENDWILNSFAFDDSMMRDYISYEMARRMGQYAVNLKYCEVIVNGEYMGLYALSE
KIKIDGDRVDIAKLDIDDNTLPKLSGGYLLQTDRPTVEDPQAWYNNGAGYIIEKPNSEDV
TTQQASYIENVFRSFDQNASNSSITDGYPSIIDVPSFVDYMIMAEVSSNADAYALSTFYH
KDRSGKLRAGPVWDYNLTYGNDLFNTFDVYYDRSLTNVWQFQYSNTGSYIWRSLFYNTTF
KCYLAKRFNEVTSTGASLDYNYIANLIDTTANLISEALVRENEKWNTINNFPSEVQNLKS
WLQQRISWMKSNLGQFSNCSNITTPSLVISKINYHPQETTTFPESDDLEFIEIQNTGNTN
VVLTGIYLLKLGVSYQFRKFSTLLAGKSIYLASNAATFEAKYGFAPFDTFTRNLPNSSHN
LVLADAFGNVIDQVQYTDKAPWPETADGNGFYLELINPLSDNSLASNWKANTEDVLNTTF
NLPTDIFTVYPNPANEKLTINASQTIEKIAIFNVLGQQIKTIKVNLQSTEIQIPALKKGM
YVLSVQFIDGTRISTKFFKE
>FCMOIPGL_01497 Limonene 1,2-monooxygenase
MKAKPTLYSVLDLALVSKNNSLQQTYINVLELAQNAEAFGYTRYWLAEHHNSPNIGSSAT
SILVGYVAAGTQTIRIGSGGIMLPNHSPLIIAEQFGTLATLYPNRIDLGLGRAPGTDRET
AQAIRSDFMQAAQSFPKEVDKIQRYFSADNSSSKVRATVAEGVEVPIYILGSSTDSAHLA
AKKGLPYAFASHFATTYLKDALAIYRKEFKSSKELQKPYVMAGVNIIVADTDEEAQSLST
SLIRMIVGIFTGKRDKVQPPIPMNDELREVMQNPQVHQMLKYSFIGSKATVKAKVKEFIA
ETDVDELIAVTNIYDGKARVHSYKLFAEIMKELNL
>FCMOIPGL_01498 hypothetical protein
MKKALVLITLFIFNLANSQVHKEYFDNGKLKEIGKYKKGEQEGVWKYYYQNGQLESKTTY
VNGDKIGSYEAYLQNGSPTRKGNYKKVKEVGAFGSYYTSKPSGIWYYWEYHSNGKLYYKK
IIDEDTGFDIGKYECYYENGELQEKGKFVNNKKDGEWYFNIDFERNHLLKRLHPVEGKYK
IIYKKGEPINFKYVNSQFDPIEDNELYELGFKNNCNKKIQVAVRYVNLDGNWKTYGFYTL
NPKEEFTLGKTKNSVYYLYALSIDGKDKWKGIFKKFFRGKHYDFKKVMIYDGYGKYTKVL
NCN
>FCMOIPGL_01499 hypothetical protein
MKLYKKATLLASMLALFLFVSCNSEDEPIQDSEFTIEITNFEASYDKVQIDWSFEKGDDV
HIQKIYVIRTTTDQNGFVDTKIIATLPATQFSYIDTDIPYFAEISYKVTPLYVVTDAFIE
SEFYDYISLDSEIKTYDRNIVFFNEVPFQVKKDPLDDHIFHLIDRLDIAALKKYDFNDNT
VIKNADLSENYTHNVVFKVIDNLIYIGDDTGKFRLINKSTYEIEKEFMVAIDGKLKSFAV
DGDRIYYHDNDVLKLYNLSTEVSLNLNLAYLPSKFMETITGNQILFESTKVAEISSTNCP
DNTNCNPNILYSYDAVAGEELHHDPYIFSFNKDKTKFITSYFGDVVNLSNLTKEASLKEI
TGENYFQAVFDNEGKIYATVQGKKMIHVFNADYELIDTIETKLYPLFPLLTSEGLKVIGS
YTSVQYSGYLYGLEFNFNDSNGKCAIEVF
>FCMOIPGL_01500 hypothetical protein
MDNLITFSITVFTGFFAITNPISNMTVFISLTQGIGKKTKREINKKSNLIAFVIVTVFIL
LGKYIFELFNISIPAFKITGGILIFFIGFEMLQSKQSNMKNIKNVNIDEDIAVSPLAIPI
LAGPGTIVTAMNFVSNAAPLQIFLVILIFGSMSLLTYFTFRLSDLIVKTVGNNVISVIGK
IMGLIIAIIGTGMIIQGIKITFDLLS
>FCMOIPGL_01501 Arabinose operon regulatory protein
MQVLEAYKPFEIQEIELTEWKQRPVKNNFFELVLIKEGEGSQCINYNDYSYTKNSMFLLP
PLKCHSFTIEKPTRFVFLKFTDSFFKNVNRITIDRNEWFKEAAYILSNYNQLPGDIIKNE
IDRNHLNSLVTMILQESRNYGEESVNLVTSLMTSILEILIRNIKKSSYFEIPKNNSDDRI
TKMLTYINENIDKTELLKVENLADVFMMSSTYVSEFFKKQVKMSLREYIIKAKLKLVEIR
LLNSDFTLTQIADELGFTDVSHLSKTFKRYTGTSIREFKNNGEYMLLKRGSCTPRRI
>FCMOIPGL_01502 Oxygen-insensitive NAD(P)H nitroreductase
MNLKEILNWRYTTKEYDTTKKISEANMAEVKNLLRMSPSSVNLQPWHFIVAETAEGKARI
AKGTQGFFSFNEPKVTNAYAVVLFCVKTDADDAYYQHIADTEDKNGRFPNEDIKNGFLGA
VKAFAGIHKYDLKDQQHWMEKQVYLNIGSFLLGVAGLGIDATPMEGIDVKALDEEFGLRE
KGYTSLVAVSLGYRAESDFNSTEKTPKSRLPESEIFTEI
>FCMOIPGL_01503 hypothetical protein
MKKNIIIALAIFASIYINAQTPSTDSVKTVNEVVTEDNVEWGWLNPLRGDKSPAAGKLWG
DRTKNEPAGFLVKFNKGFSSPPHIHNITYRGVVIKGLLHNDDEQAEKQWLPAGSYWQQPA
GEAHITAADSQENMAFLDIQEGPYLVQPISEAFDNRERPINIDQSNMVWLNANDIKWIAG
KSNVETAFLWGSHEKNQLRATLLKLPAGFSGKIKNLSPSFRAVVISGGITHQFSKKGVVN
RLNAPSYFGAEKNATSIISAKKETVLYIRSNGEFKVK
>FCMOIPGL_01504 hypothetical protein
MLVSLVVLVVVLIVIYFLFVGFYPSFGGDISKEKQTEFMKSPQFHNRKFENTHPVNMDMS
FSETLTMAKKFFFTKVEDGRPKNDIVVQKIDATNIANYASSTRFVWFGHSSFLLQMNHKN
ILIDPMFSDVPAPHSLLGGKRFSAELPIEVQKLPKIDAVILSHDHYDHLDYESILKLKDK
VGIFYAPLGVGVHLEAWGVSTENIIELDWWQETTLADLKFVCTPAKHFSGRKFSNRQSTL
WSSWVIQSATENIFFSGDSGYDSHFSAIGKKYGPFDFAMMECGQYNEMWPEIHMFPEETA
QAAVDVKAKKMMPIHWGAFKLAMHSWKDPAERVTKKAKELNLPLITPKIGEAFLLKAEVV
HNQDWWK
>FCMOIPGL_01505 hypothetical protein
MGVIRKTKSVEALLNEFKNNSVAISAKMLIDQLDTKFNKTTIYRVLDKLEDDGVLHSFLG
KEGLKWYAKCNGCSTNNHNDFHPHFQCLECGKVDCLDVTVTLPKISNRKIEVSQLLIQGK
CEKCLT
>FCMOIPGL_01506 hypothetical protein
MIITKQKSDSIGAIASTLCLIHCAATPLLFIVQAGASACCNTTPVWWKSIDYFFLVISFF
AIYRSTETTTNNWMKPSLWFSWILLFVVIINEKIALLSIPESAIYIPAIALIILHTYNRK
YCQCKTDKCCTHES
>FCMOIPGL_01507 GTP cyclohydrolase 1
MNHKKQIEIVGDNHFSSSIKTPLRADAFDKTDDEKIENIQHHFKRIMEEMGLDLTDDSLS
GTPYRVAKMYVKELFYGLNPVNKPKLSTFENKYGYKKMLVEQNITIDSACEHHFLPITGY
ANVAYVPKDKVIGLSKINRLVDYYARRPQVQERLVLQILNDLQSILETKDVIVSVTTKHL
CVSSRGIKDQSSFTTTLEYGGCFEDNENRNDFLKIIGQEKI
>FCMOIPGL_01508 hypothetical protein
MKITGLHALTHSDDKEHVIYCAICDTAITHNLTPTITPDFSYFEIKSINFYVQKEVAINN
CDIVYNNTILRELFSRPPPFLV
>FCMOIPGL_01509 putative TonB-dependent receptor
MFKNLLSIWLYFSLCAIAFGQDSYQIKGSVINASTLHPIEGVNIIGKNLYAISSNTGNFV
IDNVIKGSSYTFTISHLGFDSQTVTIKVKSPIEFMPIYLIETATVLEEIKVIGKSKRRKI
KELPIVAQSVSKEFLNNNRENSLMQTLSKIPGVSTINIGSGQSKPVIRGLGFNRVAVVQN
GIKHEAQQWGNDHGLEIDQQGIEQIQIIKGPASLLYGSDAIAGVVDIQPNKIPSPNSFSG
EVNILGESNNDLLGISTGIVSRKAKWFYRSRLTYRDYGDYKVPTDKINYENYVFSLHNNN
LRNTAGKEADASFSVGFISDKITSETVFSNVNAKNGFFANAHGLEVRTSSIDYDTSNRDI
DLPFHKVNHFKITNNTSIKTENHKLYFDFGYQNNHREEHSEAVPHGYMPKPPSTKERLFK
KNTYSFNMRDAFKPNNHNNMVVGLNIEYQDNSIGGWGFLIPEYNRFTAGVFGYDQYKINH
NLHLLAGLRYDYGMIDTKAYKDWFPSTINNNDNSTSYVYLQRSKDKVLNFGNLSASLGLS
YIYKNTTYKVNVGRSFRMPLANELASDGVNYHMYRYERGNLDLDPEISYQLDVDIDHSTK
SFSIGVSPFINIFQNYIYLNPTANYYETLQIYEYTQAKVFRIGGEFRANTNISKNLQLDA
SVEYVYSKQTSGPKEGFTLPFSPPLSGVISANYKLKNILFFKKPKLVADYRITASQNEIV
PPEEITDGYQVLNMSYLAQMDVFKKHLPVEMRLKLNNVFDTKYYNHTSFYRLIDVPEAGR
NLSLSLTIPF
>FCMOIPGL_01510 hypothetical protein
MKTKIMKTNFKFLAIIAFIALSIQSCTNDDDPLEFAAPVISEFEYGKGSEHTTDQIAYKG
SDIHLEAVINAEAIVSSITLAIHAHDLALGDDEVEWEFEQVFTDAKYLAINPTFHEHVDV
PSNIPAGEYHVELTVTDELGNSTEVEGHIQILDVITLSDISIDSEVVRGKDFHAEFMIDA
VNGIHSISVDAHAHGLTVADGEVEWDYEEEFLGTYHEQTSVEFHEHIDVPATAPAGEYHI
IFTVEDEDGNTKEYETHIDVTA
>FCMOIPGL_01511 hypothetical protein
MKITLKFLYFLSFILIFTACSSESSIYKDQEKPTIDINYAEGFPQGCTSLKKGETYYFRA
MVTDNKELAAYSIDIHHNFDHHTHDDQVTECDLGEVKDAVNPFIFIENYTIEDGLNNYEI
NVAITIPDDIDTGDYHCAYSVTDATGWQARTSVDIKIIE
>FCMOIPGL_01512 Mannosylglucosyl-3-phosphoglycerate phosphatase
MKLSHFICCLILLISCKEANNHLTKISAKNIGIDSMLVSSKSIENMIAPYKEELTADMQE
VLSYSTVSFTLNATNRQSNLGNLLADLCMEVATPIFKKKTNTNIDFSMFNSGGIRSTIPI
GNITKQHAFKLMPFDNELVVVTLTGDKINELVAYFIKNKEAHPLSKNINLTISDEEYSLK
INGETFDKNKTYSVLTTDYLQGGGDKMNFFKNPVKLTFLDYKMRDAIIDYFQKVDTLQSA
IDNRVKLN
>FCMOIPGL_01513 Trifunctional nucleotide phosphoesterase protein YfkN
MKRRDFIKRTGAVSALALVGGFTLPSFMAKKQKHITILHTNDTHSQIEPFKANDTQFPNK
GGVARRATLIHQIRKENENTLLLDAGDIFQGTPYFNYFGGELEFKLMSTLKYDVATIGNH
DFDNSIEGLYKQLPNAKFDFVSANYDFKNTVLDTHVKPYKILNKDGIKIGIFGLGIELEG
LVGKKMYKETGYLNPIEITQDITHQLKNIEKCNLIICLSHLGYYYKNNPTKVSDLTLAKA
TKDIDLIIGGHTHTFLPKPTIVKNAEGKNMLVNQVGAYGVNLGRIDFYFDEDNEKSSKGT
TILV
>FCMOIPGL_01514 HTH-type transcriptional activator RhaR
MNLFSDINNYFLNSLDPANDYFNSFYIRRMDASKNHIVLDKKFSSPHKRDFFEIAVLERN
TKKIQIGNQTLPDMNNSLAIVSPFQVINYSDFPPNDDKGYILYFNASIFTKLNQSYGLQN
EFPFFKIHTMPIYQLSDSDFNAILSLSEELYTESRSSKLHHFEIVKSLLLVLLYKVKRST
QDNKGIVAMNRFDAIMYKFEQEILSSNNQFLSVKEYASKMHISPIYLTECVKKATGKSAQ
KIIIDYKILYAKTLLHQMDKSIADVAYGLGFNEVANFNQFFKRNLGLTATQFRNREA
>FCMOIPGL_01515 Multidrug export protein MepA
MSNQNNIFNKLFLFLKEKKESIVSKTRNDNKKYSLKHDSILKLLIVFVGPAVLGMLINAL
YNFVDRIFVGQFVGVDGLSAVTMVFPVTLFQFGFVLLFGSGSGVLIAKYLGESKPEKAEN
ILGNAIAGLMVIMLVFTSTGLLFYKPMLELFGASGVLLNLSAEYLLVIILGFPLSFFLAL
EFTCRAEGNPKFPAKLVVLSCIINVCLDYVFMKIFKLGIRGAALATVIAQATNVLLLMRY
YMRGNSVVKLVWKKIRIQKHFIFPIVMVGFAPFLMDLAISFQNIFVNNLLIQSSGVNGVA
AMGILFGVNVFFMMIALGTGDAMQPIVSFNFGAKRYDRASKTLELALKIVGVVAIVGVII
IEVFPTQITSVFIDTNQNQEVIHISKIALRIFAISIPFYAIQIIITRYFQALQKNKKATF
LALLRPILLFIPITYLLNSYFGLLGIWASFPVSDGASAIISLFLVKKDEMKKVSLLNSND
SVLENMSNL
>FCMOIPGL_01516 hypothetical protein
MKTQYLKVASFCAALSLIGCNTSKHKKANTNLNKVHFVLTDTGQDKFYDNEGNQIDEPSK
EDAFYGQDAQFKGIESSYQDNGDGTVTDLNTGLMWQKTPDFKRHNFYDAFNYVENLEIGG
YTDWRMPTIKELYSLLNSNGELYPQDLEKSQPYLNTDYFDFEYDKRMPFAGQYWSSTKYV
KGPLQNIKMEGAFGFNFADGHIKAYETGLYFDGSKGVHDPGNNVRAVRGKENVYGVNNFV
DNKNGTITDKATGLMWQKADNGKTYNWAEALQVAKNRKIAGYEDWRVPNTKELQSIVDYD
KKTFPAIDENFFECTEDSWFWSSTTQGDFKYTACYVAFGKAYSKDNSSATEYYDWHGAGA
QRSDPKSGKIEDYLLESVNAADSLRIKNYVRLVRDFN
>FCMOIPGL_01517 Carbohydrate-binding domain-containing protein
MKNVALKNKVSSLGLFSLLFLIIAIFTGCSSDENEESLVVSLSEDVVITDTNTSGTAEGD
TDNTGADEGDLVENATFANTIQIVFSNTSATITNPVPDNVVITQDGAEVTINSTISEVAY
EISGTTSDGMLKIYSDKKLKLSLKDLSITNADGPAINIQTSKTIFVVLEGTNNLTDASSY
SNIPDDEDAKAAFFSEGQLVFSGTGALNVKGNYKHGIASDDYIRVISGTITVSADTDGIH
TNDYIIVDGGTLNLTADSDGMDCEEGYIIINDGTFTINTGDDGIAASYDIDEEDEPDDTI
TPNVTINGGTFEINSSAGEGIESKAIMTINDGTININAYDDSINANGILYINGGNIYAYT
TLNDAIDSNAGITITGGTTIAITTRTDEPDGSFDCDDDTFKITGGTILGLGLNTSFPTAS
ASTQNSVIFDGVSANQLLNIQSEDGTEALTFEVPYTVNTIIYANAKLETGETYYIYTGGS
VSNGTETNGLYSAGTYTGGSNTGDYFTINSTVTQIGGDMGPTGEGGGRR
>FCMOIPGL_01519 putative type I restriction enzymeP M protein
MSENQLQLQQTLWNIANDLRGNMDADDFRDYILGFIFYKYLSKKMSLHANYILQPDHLTY
NEVLGNEQEEILLQEIKFSSLDALGYFLHPSELFDELAKRGNSGGVHKFILEDLQKVLTN
IEQSTMGSESEDDFGNLFEDLDLTSSKLGKTEEAKNELIVKVLVHLQGIDFDLENDENDV
LGDAYEYLIGQFASGAGKKAGEFYTPQQVSKILAKLVTTNKERLKSVYDPTCGSGSLLLR
VAKEVKEVGAFFGQESNPTTYNLCRMNMIMHDVHYKKFDIYNEDTLVNPSPKHRDQRFEA
IVANPPFSAKWNPDSIISDERFSPYGKMAPKSKADFAFVQHMIYQLDDTGTMACVLPHGV
LFRGAAEGHIRKYLIEDKNQLDAVIGLPSNIFYGTSIPTCILVLKKNRPTTDILFVDASN
DFEKVKTQNVLTDNHLSNIIETYRTRQTKDKYSYVASLAEVQENDYNLNIPRYVDTFEEE
EAIDLFNVSSDLKALEKDMATTDQTIANFCKELNIETPF
>FCMOIPGL_01520 hypothetical protein
MTKENNKQIASCLAMTEGNVIANGVKQSANKKEIASARLLRTSQQELRNDETNKNASLRD
FSSKQSLSLVPKLRFKEFEGEWIKTTLGDLFTFKNGLNSDKEKYGTGIKFINVLDIIGES
VITYDSIFGKVEITDKELEKNEVIYGDVLFQRSSETREEVGQANVYVDKNKSAVFGGFVI
RGRKKVDYNPYFINYLLKTSSARKEITTKSGGSTRYNVGQDSLSEVLIKLTNLKEQQKIA
TFLTAVDTKLQQLNKKKELLANYKKGVMQQLFSQQLRFKPTPSLRGTKQSLDNNKKFPDW
EEKRLGEVCIKIQDGNYGASYPKTNEFIEIGIPFLTSKALGTGGSIISNKIDFIPIKKHQ
ELKKAHLMLNDVLFTNRGANVGAIAFVDTTISHGNIGPQLTLLRVDMNIIESTFLYHSMN
SFKVRKQVRSQDSGSAMNFFGIGATSKFKISLPSLKEQQKIATYLSAIDTKIENVQTQID
KTQAFKKGLLQQMFV
>FCMOIPGL_01521 hypothetical protein
MKPGFVYILTNKNNTTLYIGVTANLEQRIKQHKAKIDKKSFTARYNLDKLVYFESFQMIG
DAIAREKQLKAGNRARKIALIESINPEWEELYYE
>FCMOIPGL_01522 Type-1 restriction enzyme R protein
MSKQSELQLENNLIKQLVGLGYQNVTVLDGDALVANLKHQLEQFNNCVFSDKEFEKILNH
LEKGNVFEKSKTLRGRFQFENDKGEATYIRFFNSEVWTDNLFQVTNQITQEGTYKNRYDV
TILINGLPLVQIELKRRGLEIKEAFNQINRYQKHSFWSNRGLFQYVQLFIISNGVNTKYL
ANNELQSVKQTFFWSDVHNKNIKELPDFTNAFLNPNHLGLMIAKYIVRNETHKILMVLRP
YQYYAVEKLVAQVETTTDNAYIWHTTGSGKTLTSFKASQIIMDLPQVDKVLFVVDRKDLD
YQTMNEFNSFKKDSVDVTKNTHNLVKQLASDSKLVLTTIQKLNNAISKEHYKKQLADLKS
KRVVLIFDECHRSQFGETHKLITDYFTNSQLFGFTGTPIFADNASKNNLGKRTTKDLFGK
CLHKYVITDAIEDGNVLKFGIEYIGRYKKKSNTLLDIDVEDIDKTEVFKDEKRLEKIADY
IIKYHSTKTDNKHFSALFAVSNIKSLIKYYDIFKAKKIAGEHNLRIATIFSYGANEANED
AQDYLPDDELDVAAESELSYKSSHSREKLDEYIVDYNKMYNTGFSTKDSKLFEEYYKDIS
KRLKEREKKNFNDAKDRLDIVIVVNMMLTGFDAKKVNTLYVDKNLKQHGLIQAFSRTNRI
LGENKSQGNIVCFRNLKKDTDEAITLFSNKEANETIIMPPYEDIATKFDETLKALLTIAP
THKSVDNLVGEEQKLQFVQAFRRLLRAKNVLESYVDFDWQNLDIDEQTFENYKSEYLDIK
DFVDEQRRTHKTSILNDVDFELELIHRDEINIVYILQLLSKIKVKDKTEAQKQKKAIIDL
LGGNVKLRSKRELIEKFIEENLPHITDADSITDEFENYWKEEKVKALSKICEDEHLDQKQ
FNALIQSYTYNGQEPIRQDIFKCLDNRPSILKAREIGDRILTKMKTFIDVFITGMVG
>FCMOIPGL_01523 hypothetical protein
MKTLQIKTAQNVNIKFTVATVFQRLFAFSIDNLLKFAYFYFAFKFFGFSSLDTSLNGDGW
TIKAIEVLFLVPITFYSLYTEILMDGQTIGKRLLKLKVINVDGFKPSITDYIMRWFLRIV
DFNLFLLLFVYVASLGLNEHTGLLVVLFLFGKMVGFFLILFTNKSQRFGDVIANTIVIYL
KDDVQFSETILEDIKENYVPTYANVIKLSDNDMRIIKETYKTAAKHNDYKTLIKLRSKIL
EVTGIKSVHNSDLEFIDTVLKDYNYYTQSM
>FCMOIPGL_01524 hypothetical protein
MREVAFIKQNKEKWLEFELSFSNKEKKSPDDVANLHIKIMNDLVYAQTYYPKSKVTSYLN
KLAKTSFHKVYDSKRSDQNVFMSFFLHKVPLLSYKYRKYFYISFIFFFICFFIGLLSTFN
DESFARQILGNTYVDQTLENIESGDAMAIYKSGSNWGTFIGIYDNNQRVGLSMFLSGLFL
GIGTGFYIVYNAIMVAVFQAFFYQYNSLFDSLKGIWIHGTYEIFGMIIEAAAGYIIGASI
LFPGTLKRFQSFKIGMRDAFYIFISTIPFTLMAAFLEGYITRYSNTMPTIFCFAIIVFSL
ITISYYYLVLPFVVAKKHGLR
>FCMOIPGL_01525 hypothetical protein
MTFFVHAQEDLNTIVVEKADTIVYTKNTDISKERTFSSNLKDKYSDEDFQYKENVPEKKD
NSAPFDLGFIQGLVFFMSNIFPYVLGGIIIFIILKIVLGFDYQFWKTNNVSKRKKEQLIY
EDEDIHDVDLATLLQQAIDNQNFRLAIRYYYLTTLKGLSTKKMIAYHKDKTNSEYLFEIE
NTALRSQFSYISYVYSYVWYGEFPIDAQNFKAAQQKYQSFLNQIL
>FCMOIPGL_01526 hypothetical protein
MILQLTSCKETNWDENFREKEKSPFGTYIVYNEADKLFKNQEIVYLKENLYDFLIDKNNI
DKNKLSNYICIKSNTNKLTDDGVSYLLGFVYSGNTAFLALNYFSDELREQLAFKTNNLDK
DVYGVENLKELKGEFHLENESFDNQTFTFDRNIRRNYVVSYNEKTTIVLGTTKIDGEKIP
NFIKIYHGFGEIYIHTNPIVFTNYYLLKDKENYVENVFSYLPENTVYWDPQIKKSNYADS
SDDDNKSIFKFFLQHKTLTWFLFVSFGGVLLFMLFNARRKQRAIPIINPLDNTTVAFTQT
ISSLYLKEDDHKNLADKKIAYFLEKVRTKYLLNTNNLNKEFIQHLAAKSGNKIENTNYLI
NTIITLHKRSECSKEELLVLHKMIETFFNKQAHGTTK
>FCMOIPGL_01527 hypothetical protein
MEQPNNETNSEHLSFENRIDLAELQESVFKIKQQLQKVIVGQKEMMDLLLVSLLANGHVL
IEGVPGVAKTITAKLLSRTINVGFSRIQFTPDLMPSDILGTSVFNVQTSQFEFKQGPIFS
SMILIDEINRAPAKTQAALFEVMEEKQVTIDGFTYKMLEPFIVLATQNPIEQEGTYRLPE
AQLDRFLFKVVVEYPSADEELEIIIREQALENTTKDSKIETIIDGFKIVEFRALVKQIKI
EENLLKYIANIVVNTRTNSFLYLGASPRASIAILSASKAFAAIEGRDFVTPEDIKRATIP
VLQHRVIVTPEREMEGLTSKQIIEQIIEAVEIPR
>FCMOIPGL_01528 hypothetical protein
MTRFTIKQLNIYTIKQTLKHFYNTLFLNNRFFYALATIAILFVVGFFAPIFFEVSKVLLF
VLTILTFVDVFLLYKTKNAIQIERYLPERLSNGDENKITLQLTNNYPFVAHLSLIEELPY
QFQKRDFFFHQQLKQRQEKTIHYNLTPKERGVYFFGNVNVYASSRLQLATKKYILGEEKE
LKCYPSFLKLRDFNIQAFNNSTISYGTKKVRRIGHSLEFEQIKEYVSGDDVRTLNWKASA
KRNQLMVNQYVEEKSQSVYAIIDKGRAMQMQFNGLSLLDYAVNTTLAISNIILRKQDKAG
MLSFSTKLEDWVVAERRSSQMSLISEALHNIKTNFSESDFSTLYAVVKRKITHRSLLILF
SNFETIDALNRQLPYLRALAKNHLVLVVFFKNTELDILTNAKAETIQEVYDTIIAEKFMY
EKKQIVNELKKYGIQSVLTKPADLTGNTINKYLELKTRGLF
>FCMOIPGL_01529 Inner membrane protein YhaI
MKWYFKAFYQYFNFSGRARRKEFWVFFLTNIFIYWILTNLYRFTDADLTNVPYIFLAIIL
IPSIAVLLRRLHDSGKNGWNILFVFIPILGWFWLLILLILLGEPKLNKWGPYPKGITEN
>FCMOIPGL_01530 Inner membrane protein YhaI
MNWYLKVINQYFDFSGRARRKEYWMFILFNVLISWTFSILDFAFATFYFTIASYIYSLIV
FIPSLAVLLRRLHDMGKSGWYFFLLFFPIIGWIWLLVLLCMDSEPGVNKWGENPKGFGND
NVINQIGVE
>FCMOIPGL_01531 Bicyclomycin resistance protein
MSLVALAIDALLPAVADISKSIHITNPKNNQLFITMIFLGLGFGQLISGPFSDSFGRKPI
IYVGFIVFALASLICVFATSLEMMIVGRLLQGIGLSAPRTISIAMVRDRFSGNYMAKVMS
FITVIFILVPVVAPAIGKLMLDLYGWKSIFYSQLIFGFFTMIWVWKRQPETLKLENRKKF
KFTLFMEGAKEFLKHKYAVIFTIFSGFITGSFMVYLSASQQIFEEQYNLKEEFPFIFAGL
AISIGLATFLNGKLVVKLGMFKLVSVFTVLFTVVPLFYILFFSGETNPSIYILIPFFSLQ
FFSIGFLFGNTRALAMEPIGHIAGIGAAINGFFSTIMAVPIATFIGSFISVRALPLFIGF
FVCGSIALLLIVYLKFSEKKLKLALKTN
>FCMOIPGL_01532 tRNA pseudouridine synthase C
MSLEIIFEDDYLLCVNKPNNVLVHHAFHSRNVADEDSLLQIIENEKGLKVYPIHRLDRKT
SGIILMAKKKDFISKFQELFTNDEIQKTYYGVVRGFSPDTKTIDTPVKGRDANVHKDALT
YLKTLEKITLNIPVKPYDSSRYSLVELKPKTGRMHQLRVHTNKISHPLIGDAKYGDKNHD
VMFDENFGWKNLFLHAGKLEFTHPFSSKTLTLKASFTEDWISLFKVFSWKNPLA
>FCMOIPGL_01533 hypothetical protein
MEHFFQCPYCWEEISMLLEANVHQQIYIEDCEVCCNPIEITATFNQNELIGFDAQSIEQ
>FCMOIPGL_01534 Putative NADP-dependent oxidoreductase YfmJ
MNNKQIIFKKRPSGVPDAATWQLETNQIPELEEGEILIQQHYISLDPAMRGWLNDSKSYI
PPVEIDAVMRAGSIGKVIKNNGNPDFEIGDCVTSWGGVQQYVITDGEGWYKVDTRLAPMP
MYIGTLGMPGMTAYFGITEVGKIKEGDIVLVSGAAGAVGSIVGQIAKIKGCTVIGIAGGK
EKCNYLINELGFDEAIDYKSENIYSALKKKCPKGIDVYFDNVGGLILDAALSKLRMHARV
VICGAISQYNNKSKISGPSNYLSLLVTRSTMQGMVVMDYANEYSKAAKQMAIWIKEGKLK
SKEDIYEGIENFYETYNRLFSGDKKGKLILKVIED
>FCMOIPGL_01535 2-oxoisovalerate dehydrogenase subunit beta
MNHLLKYNSSHKLKNSKLLSLYKKMLKPRLIEEKMLILLRQGKISKWFSGIGQEAISIGV
TDALEKNEYILPMHRNLGVFTSRDITLHRLFSQWQGKMNGFTKGRDRSFHFGTQEYNIVG
MISHLGPQLGVANGVALANKLKKNNKICAVFTGEGGTSEGDFHEALNVASVWSLPVLFCV
ENNGYGLSTPTQEQFNCKDIADKGIGYGIESCIIEGNNILEVYTKVSEIAKSVREKPRPI
LIEFKTFRIRGHEEASGTKYVPQDLMDFWAVKDPLENYQAYLKKQGILTEEIEVLYKSEI
VHEINEHLKIAFDEEKIIPNVETELNDVYKSFEYQEEKPSENKKIIRFVDAITDGLKESM
HKHVDLVIMGQDIAEYGGAFKITDGFLEIFGKERVRNTPICESIIISTAYGLSINGVKSV
VEMQFADFVSSGFNPIVNLLAKSHYRWSQNADVVVRMPCGAGVGAGPFHSQTNEAWFTKT
PGLKVVYPAFPQDAKGLLISAINDPNPVLFFEHKGLYRSVYQDVSEGYFTTEIGKAALLK
EGNHLSIISYGAAVHWVLEALEIMSEITADVIDLRTLQPLDVETIYTSVKKTGKAIIVQE
DSMFGGIASDISALINENCFEFLDAPVKRVASLETPIPFQTDLEAQYLGKSLVTKAIQDL
HNY
>FCMOIPGL_01536 Regulatory protein AsnC
MKKFTLDEIDHQILDVLIENARTPFTDIAKQLLVSAGTIHVRVKKMEDEGIIQGSTLSLN
YEKMGYSFIAHVGVFLEKTSMTQAVIENLRKIENVTVAYVTAGKYNIFCKVRAKGTNDAK
DIIYKIDDIPGVNRTETMIALEESINDKKRMMHAIFKEL
>FCMOIPGL_01537 hypothetical protein
MQILSSVVVKKIFKDQKEISLSGKWITFKNIEKLFLKHQDAFEITQLGFSEQQRPIYKLK
IGFGKKRILLWSQMHGNESTGTKALFDLFNCFSNCNNQELKTILEECTLVFVPMLNPDGS
QAYTRVNANNIDLNRDAVDRVAKESNLLRNLLEEFNPQFCFNLHDQRTIFGVEGTKNPAT
ISFLAPSEEITRALTKGRIETMDVIVAMNSLLQNIIPNFVGRYTDEFYPTATGDNFQKLG
YNTILIESGHYPNDYQREFSREFTFYSILQGLFHVATATKFNSFEPYFLIPNNDKIFYDV
IHRYSNSEKDVAFQFKDEIIDKKFVSKLEKIQENDLKTKIGHNEIVFEGKFD
>FCMOIPGL_01538 hypothetical protein
MINSLEFTTRIKKVMEFHDLSASLFADKIGVQRSSISHILSGRNKPSLDFVLKITSEFKD
VDIHWLLNGIGSFPKNEKTVTQTSTPTLFANNSNDGKRIQRIVVFYADGTFEEYQK
>FCMOIPGL_01539 hypothetical protein
MNKIDIRTVNVTQYLQPLREGGSLPAIVKADDGFLYVLKFRGAGQGKKALISEFIGGELA
RAIGLNVPELVFMNLDDSFSKTEPDEEIQDLLKFSVGLNLGLHFLSSSITYDPLVSDVDS
LTASKVVILDSLISNIDRTAKNTNLLNWNKELWVIDNGASLYFHHHWETWENHLSRTFPL
IKDHVLLPKATSLQEALSEIKKIINTDVIKEIVANIPEDWLESEGDFLNADEMRAAYISF
LNAKLSMIDTLVKEAEDAR
>FCMOIPGL_01540 hypothetical protein
MQDKVTFEYAIIRFVPKVEREEFFNIGVLLFSKRKKFLGIKFEINPNKLKVFASEIELET
LNNYLNAWKLICEGKAAGGKIGELEISDRFRWLAACRSTIIQSSKTHPGLCENPEKELQD
IFEKYVL
>FCMOIPGL_01541 hypothetical protein
MAKRKTPFSFQVRIIHRYLGYFLSGIMFVYALSGIIMIYRDTDFLKTEVITEQKLETNLT
ANQVKPIFKKRAKVIKKEGDIIYFNNGTYNQTTGIASVKKQELPFILDRMEHLHKANTNS
PLYFLNIFFGVSLLFFVLSAFWMYTPKMPVFKKGMYFAAGGIVLTLILLFI
>FCMOIPGL_01542 hypothetical protein
MSINTLLITPPFTQLNTAYPATAYIKGFLDSKNVKTEQLDLSIELFTAVFTKEFIDAIFK
QAAMLGNKELPLVWKQKEEYINKVDAVMNYLRVQEVTAAYQIVHKDFLPHGHRRIKLDKD
LTTEFGKLGILDKAKHIATLFVEELGDFINVNVDEFFSFTRYAEQIGRAASSFDELDECL
QFETTLIEDEMLYLLDEKLQQKNINLVCFTIPFPGNLFSALRCAQFIKQNYPNIKIGFGG
GYCNTELRRLSDTRIFNFVDFITLDDGEGPLLRITEFLDGKIGEEQLERTYICKNDTVIY
QNKLPNTIFHHKNLPAPSYVGLPTEKYLSFLDVMNPMHRMWSDGKWNKLTISHGCYWKKC
SFCDVNLDYISNYQNTTSDDLVDKIEKIISETGITGFHFVDEAAPPKMLRALANKLIERK
VYITWWTNIRFEKTFDAELCALLSKSGCIAVTGGLEVASDRLLDKMKKGVDIGQVARVTK
AFANENIMTHAYLMFGFPTETAQETIDSLEVVRQLFQNNCIQSAFWHQFACTSHSPVGKN
PDEFQINIIGPEFKGFAENDLYHEDPTGAEHHLYSEGLNLALNNYLNHKGFEIPIHEYFN
FKVPRVTLKSNLIKEYLDK
>FCMOIPGL_01543 hypothetical protein
MAREFHLGHFLQEYHFEKAALLLKEQLKQTSPLYNNLDYTLYKQSYINAINVSKFYANFI
KRDSLYYIENHFNHPAFYTILDVFFFKNKLIY
>FCMOIPGL_01544 3,4-dihydroxy-2-butanone 4-phosphate synthase
MIFTELETLQTIDKDSQERLEKALIHLQNGNGIILTDDKDRENEGDLIFSAHNMTIKQMA
LMIRKCSGIVCLCLTNEKADLLNLPYMVKENTSSFQTPFTISIEAKEGVTTGVSAKDRLR
TIKVAANKNAKSNDLAKPGHIFPLRAKNNGVLERKGHTEGSVDLMKLADLKPEAVLCELM
NDDGTMAKTDTISQFANEHNLIVLSIQDIIHYRKFVRDYK
>FCMOIPGL_01545 hypothetical protein
MTNYIELTNFIKKNINIEDDDLKIVLSYFKTIKKKKHEILLSNGKNSQVSYFVKKGCLRL
FYLDEEGKDVTRYIAFENQFATELVSFITKQPAQETIQVIENSELLYITHEDFRHLMKTI
PKWKDFYSIYLEKAYVNNSKRLISFTTLDASERYKQLFKINPNIVKRLPNKIVASYINIS
QETLSRIKSKI
>FCMOIPGL_01546 Putative peroxiredoxin bcp
MKTLREQTDAKIAAGRNAKPDFMKGVDDIIEKAKAFEEGKNACKVGEKAPNFELPNPDGK
LISLDTLLNNGPLVVTFYRGDWCPYCNLQLRALQARLSEIHDLGATLVAISPQVPDGSLT
KSEISEMDFTVLSDQDAKVATQFGVAWEVPEFLAEHMRVDRNLDLEKINNGNGNVLPIPA
TFIVGKDGTVKWNYVNVDYRTRSEPEEIIEALKKLS
>FCMOIPGL_01547 hypothetical protein
MKFKIITLFITTLLAVNFQVSAQETTDTLLKNAQEIAKKEGKSIFIKFEASWCGWCHKMT
KDMKSEKTKEFFEDNYIMVPVVVNEAKGKEHLENPGSTALLKQYKGDKAGLPFWVILDSD
LKIITDSFDANGQNLGGPASVEEVKEFINKIKKSAKKVTQKDVDNITNQFVTQ
>FCMOIPGL_01548 Protein MtfA
MLYLIAITALLIVLIVSLLPKKKAKEISFKKVDIPAHWHQLLEDNILFYKKLTSDEQQLF
RTKIFHFLNTKNIEAVHFKLEELDSLLVAASAVIPVFRFPTWNYSNLTTVLIYPDYFDDD
LQFNSKISDRTIGGLVGSGRFENQMILSRKALHHGFSNKTDKGNTAIHEFIHLLDKEDGV
IDGIPAALLDKQYIIPYLQLVHKEMEAINKDTSDIRNYGGTSEIEFLAVAGEYFFERPKL
FKRKHPELYKMLDACFMKS
>FCMOIPGL_01549 Aminopeptidase N
MKFQKFIIFIFILFSFLSSAQNATYKSEREKIHDLVHTKLKVDFNFDNKTMNGEAWITAK
PHFYNTNTITLDAKAMLIHQVSMNNAALKYTYDDGLNLIISLAKTYQKDEEFTIYIKYTA
QPEKVYQKGSAAITGAKGLYFINADGSDKNKPTQIWTQGETESSSCWFPTIDAPNQKTSE
EIYITVPNKYVTLSNGELISQIKKGNNRTDYWKFDQKHAPYLFFMGIGEYEIIKDSYKNI
PVNYYVEKEFAPYAKDIFGLTPEMIGFFSDKLGVEYPWNKYSQIVGRDYVSGAMENTTAV
MHGEQAYQKPGQLIDENVQENTIAHELFHHWFGDLVTAESWSNLTLNESFANYSEYLWRE
YKYGKVEAEMHLFEDVDAYLNGLSESKDLVRFNYDDKEDMFDLVSYNKGGAILHMLRTYL
GDEAFFLGLKEYLNTYKYQAAEVHQLRLIFEKITGKDLNWFFNQWYFGSGHPNIEISYDY
NTLRKTVTVNVVQLQADTFKFPFAIDVFEGGKRTRHSVFVESKDASFSFPYTKQPNLIQV
NADGSLVCEIHENKVLSDYIFQLKNADNYAHRREAFLEVAKKQDDKDAFNAVVEALDDKA
YKIRVLALKQIDLINKFSKKDVILKIMNISNTDTKTLVQAEAINTLGKLTDPELKSIFEK
GLQSKSYSVLGKALVSLYYVDKPAAIAKSKELPDEVRKILATPLTKIFIEENDESELPFV
AKSVLSGMFLTGDDATKVLFQKAFKQISETNNSEAIRNLVDDMVEKGKQYKSFNFDKVVI
NLMRDMVKEQQKVNKSNKEKNIEIIKTAMAKLL
>FCMOIPGL_01550 hypothetical protein
MKIKNSLFLYLFIFLISCESNETVEIEKIPTATITSYSILDNNNIFIQTKTDLEFSDPQS
NFLEEHGVYWYKNTGSKGKINLGSLQENQFIADISQGLLKDSIYKTYPYIKFQNKYFYGD
TLTFKSNFTSMVKIDKVFPLNGFINDTITFEGKNFCAEDFSNTILLGTFSQLHIISESDT
LIKAVVPSYLRESELSLTLKTCNTTTQIKDKFTINEPIIDSISSGEKFIGDVLTIYGENI
HTSISEVWLENIKTELVYNNNSVDSVSIKVPKKLSVGKVALKMKVLDRIIEKPNYFETTT
PYIESLLPQSVGFLDTLTIKGNYFIQKNSNLKVYVGNSLQKIVALKKGEIKILIDRYFND
TNPKVKLEFTDFTIEKPVQILPPTIEGFNKEIYHLNETDFTIKTESFLDDDIEIGGRPKT
FGVKSEIDILGNVNLSLISWLNINFYSWNYNLTTPGSLEIKITTPFGEDSKLVKIHKPEI
ISVNKEEFKYNDHIILTGNNFAYRSFTKVFIDDEEVPFQANSAYTLNNSKIEFPLNINTT
AGKHKLYVITAGQKSNEIEYSIKKTEVFSLSSNSGTRRDLYEITGKNLQKLDITADDFYV
FQISEEDEKVTFMLPYFNKLKPSFKITASSGDQKFDLGTFNGIEPFDFYEQVYEDDVPYY
KTHISFSDEENWFFCNNKGVYKFSFIKNKWELFDNNPPPFGTPIFGEKAYISLENGIAKY
PIGSKVYLYDTNTKIWSEAALTNISVKNGVIVGDYLYGIQYNTNDFYKVNLLDNSVEKIN
KPSDLNILYENITYGDDKIFINPFQGSGYYYDIKTNNWVNMGRPRDFYGTYNNVSLKYYN
GSLYFSGGYTDGGVEHRLYEYNISTNSWSEKNPMLQKLMNHVTYIKDDTMYFSLGIGQYY
YINPYVQVYDIKNDPH
>FCMOIPGL_01551 hypothetical protein
MKKLTTLFSVVFLVLFASSCKNEKSLQSYLVDTSGKEGFFTGDLPVGSMLTAKADVSEEV
KETMKSIKKINVAFLKKTEDNTAAYETEKATLKNIFTNKDYKSLGAVKAKGMNVKVYYTG
NTDSLDEVIAFGYSPELGVGVARLLGDNMNPSKVIEMLNSVKMDEDNIKNFGKIFTGK
>FCMOIPGL_01552 hypothetical protein
MLIAFIVTPIVTNAQSFFDTLEDTEGVDMVVVTKDAFELISKFKNVEIEDNEGMKVFQMI
QELKEFKMFSTDKASVADKMESMVNSAIKTQNLTQLMRIKEDDSRIKIYVKSTKNKDYVS
EVLMFIKGLSKKTNQASEAVIVSLTGNIDINKMSELADTFVKEGNNK
>FCMOIPGL_01553 hypothetical protein
MELANIEKLVEKYLNAETTLQEETTLKNYFKEGSVAPHLQEYAYMFNYFAAIKAETYTKT
IELEPKKSNKRRNYKWLSVAASIVLLFSVFIGKQEYERYQALKQFDQISKGLRLLSTNLK
KGEKAVATLYTYEDTVKKILK
>FCMOIPGL_01554 ECF RNA polymerase sigma factor SigW
MNQSDFLKVVLPFKDKVFRLAKRLLVSTEEAEDATQELIFKLWRSKEKIADYNNVEAFAM
TMTKNYCFDRLKSKQASNLTLVHSNYKEKDTSLDKQMEYQDSVNQVHLLIEKLPEQQKII
IQLRDIEEYDFDEICKMVDMKPTAVRVALSRARKTIREELIKKHNYGVS
>FCMOIPGL_01555 hypothetical protein
MNTYFTINKTLIICILSIVTLFSSCEKEKAYSIETTINDDINYFIWEGLNNYYLWQKDVP
NLSDDKFSNLNDLYINFKGYSSPEAVFESLLNRPEDRFSWIVNDYVALENSFQGINLSNG
MEFGLVEYKNNSNKIFGYVRYVIENSDAATNGISRGMIFNYINDSQLTYDNYEALLFSNT
TNYTVGFANYNDGNPIFNNNTISLSKVELQENPVAIIKVFTEGSNKIGYLLYNQFASNYD
GQLNAVFANLKSENITELIIDLRYNGGGSVSTATYLGSMVTGQFNGELYSQEVWNDKVMK
KYSSDGFLNNFTNKIRNTDENGTVILEESINSLHLNKVYFITSYSTASASELVINSLSSY
IDVELVGKTTRGKQVGSITIYDSDNSQRNGSNLNPNHTYAMQPLVLEISNKDNQNYPEGI
IPGKTLSGIELGEDYNNLGVLGERSDPLLNKTIEYITTDSKTSTKTKNLFEFNEFFNSKL
ATPAKDNMFINLNK
>FCMOIPGL_01556 hypothetical protein
MKKALVISGGGSKGAFAGGVAQYLMKKENRDYDLFIGTSTGSLMVSHLALGKLDELKQLY
TNVNQKTIFSNNPFKIKKVAGEKVISIRHLNTLWNFLNGRKTFGESKNLRSLIKKKITKE
MYEEIRKSNKEVVVTVSNLTANQIEYKSSNDCAYEDFADWIWGSCNYVPFMSLLEKDHCQ
YADGGFGSLVPIREAILRGATEIDAIILETEVSHFNKIPSKNPFTLLFDVLEFMLVHVER
HNITIGKLAANNKNVKLNLYYTPTVLTTNSLVFDEKLMRKWWKSGFKYAKSKREELMSEF
RPDVLTDQEIEEGVDNVEKLVL
>FCMOIPGL_01557 Ycf48-like protein
MKKITLLILTFTLIVSCYEKYIPRNIENIKIQEFKMDNTSIRAIVAIDANTMHYAGSKAD
VGFTSDAGKSWSTKHITYQDSIIPHFRSLAKNGDAFFALSIANPALLYKISKEKTELVYT
ENHEKVFYDALQFFDDGLHGIAVGDPTEDCASVILTADRGNSWSKISCDNLPEFADDEAF
FAASNTNIKTIGSTVWIASGGKKTRILKSDDFGKTWQIFETPIIQGNGPQGIYSIDFSDK
NNGIIIGGDYSKPTENKANKAITKDGGKTWTLVADNQNPNYKSCVQYVPNTNGQEIFAVG
KTGVSFSNDAGNTWVEVSKDDYYAIQFVDKNTAWLSGNQKIGKLILE
>FCMOIPGL_01558 hypothetical protein
MSIYLYKSIKPVSKISYSILLIASLLFLSCSKQSEISKDFNCETSAYKNLEKVEDVKNLF
SIDLPKDWKINLYQDEVQSSIFAADTTKQLTESVLLDVTFIRNKINFDDAFILQQEQENL
TKGLIKIKSKEITLLEKPSIYIIYKGKKGNFMYETCHTFIKINAQSFILAKTEIYGDSLV
NERLCNSFSLIENIKIHQ
>FCMOIPGL_01559 Peptidase T
MIDKQHITTRFIKYVTIDTESDPNNPAFPSTKKQWDLAKILEKELKQIGLQDVELDENCY
IMATLPSNLNYEVPTIGFVAHIDTSPDFTGKNVNPQIIENYDGKDIVLNKEKNIILSPDY
FEDLLQYKGQTIITTDGTTLLGADDKAGVTEIVTAMEYLIKNPEIKHGKIRICFTPDEEV
GKGAHLFDVEKFGAKWAYTMDGSQIGELEYENFNAASAKITITGKIVHPGYAKGKMINSI
LIANEFISSLPVTEVPEKTTDYEGFFHLHDITGNVEETVLEYIIRDHDFDLFEERKYLMQ
RIAFDFNERLQQDLVKVEIKNQYFNMKEKVTPVMYIVDIVEEVMKEIGITPLIKPIRGGT
DGSQLSYKGLPCPNIFAGGHNFHGRFEYVPVESMIKATEVIVGIAQKVANKYKS
>FCMOIPGL_01560 hypothetical protein
MKAIAKFILYTILGWKLENDFPKDIKKYVVIAAPHTSWVDFPIAILSRMASGVMINFIGK
NSLFKGPFGFFFRALGGTPVDRSQSNNLVDAIIDIFNSKDEFRLGLSPEGTRKKVDAWKT
GFYYIAKGANVPIVMATLDFEKKQVKISEPYYTTDDKEKDFKVFYAFYHNVKGKNPDQF
>FCMOIPGL_01561 hypothetical protein
MNELIIYLLIALVFSFVGFFIGKLLTKLNLEKEKTFIEKEKSTLEERVALLQQSKDMVED
NYIELQKELKNNQQEKENLITVNTRQESENKNLQLKLDEHKSEVEKLQQKFTNDFEVLAN
KILEEKSNKFTEQNKENLKIILNPLQEKIKVFEDKVDQTHKESIDYHAALRQQIIGLKEM
NLQMSKETINLTKALKGDNKTQGNWGELVLERVLEKSGLEKDREYYVQQSFTNEDGKRIL
PDIVIHLPDNKKMIVDSKVSLTAYEQYVNEDDETLKAQFLKEHVASLKRHVDQLSEKKYE
DIYKIASPDFVLLFIPIEPAFAVAINADTHLYNEAFEKNIVIVTPTTLLATLRTIDSMWT
NEKQQKNAIEIARQAGALYDKFQSLLTDLVTIGKRIDDSKKEYSNAMNKLFDGRGNLINS
VEKLKKMGAKAKKAIPENIIKRAKEIE
>FCMOIPGL_01562 hypothetical protein
MKKDDKNLYDKDVITGGVTKNVVGEQTIQTHKTKVLKNNEHEVLIGEDIEDVKKVKEEFE
SLQRKILNKLMK
>FCMOIPGL_01563 hypothetical protein
MKTKKLRGHKRIFKNIENWKNSSLKLDLKDLEEYQRNYEKVWVRPFSDTSISGKPIPVPK
RKSRKLILESLLAIFNSWETQLKTLDKPYYLAIWLYEPNIAYSQVVCAIDGFLNFYDITF
YRPENQKKMPTQNYGNLKTELDTFNWLYAKDDNYFTSEDLKMTEDEYYTIEEYYNFQKWY
KRKLKQKLRTYTDKDGKITYYIPKDTVWIGTRRG
>FCMOIPGL_01564 hypothetical protein
MLYIKFAIKSQEKFIAFKEVYNHMCAVRKPGYQEEEKTIDWETATDEEIDHFMDEDKPKI
ELFNQLFPVYAQEFLRNYFSYDKSKSILVRADILSFFNYLEYGFEVDLDALEKQKENEVI
VKFSTGNYPYGGMERFLMTLKAFELNPIECFDGYNVYLFQWTSDYEHDAIILSEKTKEYI
TSLQQK
>FCMOIPGL_01565 hypothetical protein
MQTRDYDDYIYVSSTLGFRKVNDDGNEVFVNKETDGYCNLYADSISVSYLHSMNDAQINA
IHFFEENHEYIFEVLMAHFSKRYQNPKLELGFRDVNILDENENEICFTEYAFIDAKKNKI
KIKMHQLKLIN
>FCMOIPGL_01566 hypothetical protein
MKNLRIVFITMLSLYSFFANAQQKGTGLVVPTDQEFRKLFKVQSGYIQDGQKIYDLTLTK
YGDENATSFDLRDYNGVTSVKDQGTCGSCWAFAAVATIESSHALINKEKLDLSEQSFVNC
VNDSNGCSGGWYDFAFNWLLENDAEVALEGQTPYETVQKSCALSEGKSNVKLANYNFISG
NPSTVEIKNLLVKHGAMSVALDANTFEFQNYNSGVIKTMNTFPTHAVTLIGWDDDKEAWL
IKNSWGVNWGLNGYAWVGYNTSGLTAFSWADVTKNDFLPEPNNDTDLVEIDFVHALGSLQ
VHQELYVKIDDEDPKIFGMNKKGVKYHNRVFATKGKHKFEIITTSIIKKENKKSLIFGYS
SANVNVKKNKTYKLVYKERLKESNIFKLTLEEDDIKVD
>FCMOIPGL_01567 hypothetical protein
MKKIFLIVCLISISLQSCKLIENYKATEGYKVNEEFKIELEKEGDGGYQWSYIPIPEVEQ
INTSKKIIKSEGKLLVSYNKVFTFKALKPGTYNLEFHFLRSFEKLDSIPEDFKKIIKVNI
KK
>FCMOIPGL_01568 hypothetical protein
MEKKTFIKGASQPSKKNTIKFKGVTKKQIELLKAKRLPFAAALGLIAGIGSQYAFLSATG
KIVEKEDVDTDETDAETEETFDFEVPTDIEFSDAVKEDMSFAEAFKTAREDTDGSGFFNW
HGNTYHTLNKEEWDALSDEEKQEFYDKIKEHSDFDNTDYSKNDTDETDVIIDEDETDENN
ENEDETIDEEIIDEISYDDIVFNDDNDIIDSNSELEEFVTLDEIGETVDIIEGLNDGDAT
EEAEGIEGGVTYEETEIEETNIEDSSFEETDFEDSSYEESDNDDTSGDDIDYDDDYLDII
F
>FCMOIPGL_01569 hypothetical protein
MAGYKCKKCNTNNTVLQEWIELGISRVVTCKFCGHKMNLNLKPRSVQNNPGTQVSENGQG
FNHFMENEPGTNVVGINKKSKSKFKLQILKSNGSASNLAVKNPKENYTIFIGRNPEGASG
NFNAEKDVSWILDDDYLSRAHCSIKVQKQQNKVQFIIEDLKSTNGTLVNKTKLENEDQIL
LHLGDEVEVGDTVFTLTQA
>FCMOIPGL_01570 hypothetical protein
MITIEIEVPKKPDTEFLADENFVSLDLEEIENTLITDEITLEDLEIDTAQITIDEFEDDD
FEEDFNELNPLDEIDLDFDEIFE
>FCMOIPGL_01571 hypothetical protein
MKAFTIGRNENNDYKIDNNTVSGNHAELQIANDFKTFTLKDLNSTNGTSVNGQNIISKRI
DEKQRIQLGTFSLDVEDFFKKVQAYILKNRTEFSTEFHQLKEIELKYKNEKQNVNKYFKL
KSALLKGSITIGLMVLVYNNAYVKSIEGIRIYLMLGIGTIGGLISTASISDKKVKEKLED
LYIDFSEKFHCPKCKFDMTSKSWRFWKSKKKCPKCKCNWVK
>FCMOIPGL_01572 hypothetical protein
MKQINTIQCLNFSNIEDASFLEENASLLSVSSKLSFFYLKEDSLDNRILLRKLINTNENE
HFVVVSTNKEVAFLAWKANVLAFMHYQKELSVGFHEFRNRFKKYPPIKEEIKEKLKINFK
GGFELVDITSICFCVGSGNYTYIYLENGTRKCISYPLNVLENRIKEVSFLNRIGKSFIVN
INRIKKVQSQHIVFKGATEIELKLGEIYIKRVKQNLLWY
>FCMOIPGL_01573 Serine/threonine-protein kinase PrkC
MTQQEFRKRYEFDLKTDTIGGGSFGTVYKAYDTVLDIEVAIKVSEVKIVGDKEFSLLEEF
KAIENLKKHKNIANYEEVYRFESFPAIYDYGIMQYYALGNLSHYLKNNEVSLEKRDSITK
DILEGIAFLHQHKVVHRDLKPSNILVVDRRGKIIPKITDFGLSKQAEGDGKASRFTNSFA
GGTLQYSSPEQLKGLPLKLNTDLWSFGAIAYEILTGKTLFEADNQGTASAEWQNTITQKI
LHTDVSKELEKLPVKWKKVVTACLEKDVNKRIQNASTLFSILNDDENVQKENFEEKETIV
KPKKSYKEKESTSKNNNDATRIKGKEKTVINKEKEPINKEPIENRKSKNLLVYVISIVFI
LAIALFFWKPWEKNIETKDLQTYTAFKNKAANAYKVDSLDLALKYYKEVDSFMNGLNIKA
AKQLLLKEGIIDSINSLNKIIKNQLELAIKKENDAWDVAKKTNTIDTYNRYLNEYPNGVF
SETAKSLVLDLRKKQLTPNQIKKQVITAIKQGIEKRESNRTIAQKFLKLQSKLTIYKLLN
AVYKVNNTNGIEYDFLELLDNVANSSNNFLEIKDYYKNNMLSRKRLSQIVPFLLNDINSK
IVSNTQFDKESFNLLSADVSIVDCIAETELKFNTGRYDNRFIDNQNSQRSIFNFLRMINE
AILSSNKSKSAIKKDISVGIKKVNNEIYYLVKSMNMDAQTRELFNSNTLSNGNYKLVKDS
FKSSLNSAISSANGFYRFRYLRSGEIKLDDI
>FCMOIPGL_01574 Serine/threonine-protein kinase PrkC
MTQQEFRKRYEFDLKTDNIGGGSFGTVYKAYDNALDREVAIKVSEVKIVGDKEFSLLEEF
KAIENLSAHQNIANYEEVFRFESFPTVFDYGIMQYYSLGNLSHYLKNNEVSIAKREKITK
GVLEGIAFLHQHNVVHRDLKPSNILVVDRRGEIIPKITDFGLSKQAEGDGKASRFTNSFA
GGTLQYSSPEQLKGLPLKLNTDLWSFGAIAYEILTGKTLFEADSQGTATAEWQNEITQKI
LHKDLSEELQGLPGNWQKVVMVCLERDLTKRVQNTDELFLLLDDKKTIITSNVNSVFPKQ
INKDTETISRNNDATIIKGSENLHQDKQQEEEQVNIKSFKPKDYSTNKPKKKNFKFIKTA
IAFVLLICIPLGYFANKSYKENKIWASAKQINTKESYQDYLDNTASIENLEEVKQNLDWI
KAIESNTVLGFQKFEKDYPKSNFILKLDSLMKSLSWSIKLEKNKNGSGKWTENHMLPDEP
KVFNLKNDNILISRNTNSNGNNNIELKFINKYGEMVWTKSFGTSKKDLVYNALTIDKDKT
AIIAYNYFSLKGVYKPQKDLWIMLLDKQGDLIWETKFSKDNLGDVSVKTNDKNNIIVSGS
FRKHDSEIGNDWLIVLDSKGSKLIDKAFSDTNFRGMWHEFLPLDSNYLLYWNNGLDLKTP
KGIIKKLDYNGQVIWEKTLGNYIIKSASIKRDSILVNQSRGFSNGVIKDSVVDYYLDFDG
NILGKKSKPLEYYAWGNPEKVKRLTYHKYSIVKLEANKLKNTTSISLNSLDNKLLFEQEL
KGRSELIYEKGKNNYLTLSGDDSSYNSIKDATLFSINRKGKILYDENIKNCVILSFRDYN
SDESQSTFFYRYDNEDNLILEKRDRFGFKYETKE
>FCMOIPGL_01575 Secretory immunoglobulin A-binding protein EsiB
MTQQEFRNRYEFDLKTDTIGGGSFGTVYKAYDTVLDIEVAIKVSEVKIVGDKEFSLLEEF
KAIENLKKHQNIANYEEVFRFESFPTVFDYGIMQYYSLGNLSHYLKNNEVSIAKREKITK
GVLEGIAFLHQHNVVHRDLKPSNVLVVDRKGEIIPKITDFGLSKQAEGDGKASRFTNSFA
GGTLQYSSPEQLKGMPLKLNTDLWSFGAIAYEILTGKTLFEADSQGTASAEWQNTITQKI
LHADINEELQNLPSKWQKVVRLCLERDVNKRVQNTVILFKILNADESVINSNELQNKNVQ
KSVESNNEATIIKGNKELKKDVEKTKETSQSPALSKNDATIIKGNKKEEKVVEKPKPYTN
QKVTKLKKEESKWMLPAVASVVILIASTIGYFMFSSKDIKVQDAKLSIFKEGNFYGYKQE
NKIIIPAKYKSAALFVNDSAIVSIKDSSFYINKKENWLGTYLKDTISLTKGEDYYYGFNG
VKQHYTEALKWFLKAAKNKSVDAQNYLGYMYHFGKGVPINYEEAQKWYFKAVEQGSASAQ
SNLGSMYQYGRGFNISYKKALIWYRKSAEQGFAIAQNNLAFMYQYGYGVSIDYKEAMMWY
QRAANQDELFAQINIGRMYASGSGVEKNKKEAEKWYLKAAKLGNEKASWYFNRYGYKSNK
KKWDVYFDKLKRLRIKNRIKNMFESGEGISRKDINEIYLYY
>FCMOIPGL_01576 Secretory immunoglobulin A-binding protein EsiB
MTQQEFKERYEFSIKTDKIGGGSFGTVYKAYDNSLDREVAIKISEVKFVGDKEFSLLEEF
KAIENIPVNKFIANYEEVFRYESFNGIYDYGIMQYYPLGNLSNYLKNNNLNLEKRESLVV
GILNGISFLHKHKVVHRDLKPSNILVVDRRGELIPKITDFGLSKQAEGDGKASRFTNSFA
GGTLQYSSPEQLKGLPLKLNTDLWSFGAIAYEILTGKTLFEADVKGTATAEWQNEITQKI
LHKDVSEQLNMVSERWQRVIKACLERDLTKRIKTSDELFTILNNEKIEENIALAAPIANN
DATIIKSKEPEKVISTKKIEEPKKEAAPKQKIIQKTQPIPKKEKPKWMIPTIAAAVIGIL
GVAGYSMIKPEEIKPLNTNYQIYEKDGLFGYKVDDKIVIPAKYSLARSFINGVANVDTKD
SSFFIDKTGFWIPNPTIAIKDSISEQVEKPIKKETIKESETIEKKEIIQPVKKEEVKKPI
NKITIDYKIIPKSELSSWIKKGNNLQNTIDAANAGNGVAQRRLGRINAFIYDNIDKKIYW
YKKAVLNGDAIAQSNLGVSYHYGENGLRQDYKEAVKLYQKASDQGYRGGQHNLAVMYRDG
LGVEKNIDKALYWFKKAGNQDYLISQTSVGEILYYGRYGAKKDYTEALNWYKKAAYLNDV
NSQYTIAFMYDNGQGTTFNWKEAFKWYTKAVNQGHTISKRKVGEFYFFGVGGVSKNITKA
KQLFREAANKGDKKAKSYLTVIDDYKNQNTYLITPSKYGNTLKASSATIDELAKGDQPET
ISKYSNSWSYSFDYTLGQSSNVQIWPAASAFNKERYDDEVDYSSYSSSERYTKDGTKKVS
VGFKDGGGYRGIGYMYVRAGFNSPSEVLEVKVPMMACWKPRDEY
>FCMOIPGL_01577 Serine/threonine phosphatase stp
MNYKSYTHIGKKKVNEDYLTCSKNSFIVCDGVGGEVRGEIASKEVATLILKRLENTQDDL
SKEKIYDAIINAQEKLNNYIKEKEDLVGMATTLAAIFISENGFYSTHIGDSRVYIVRPSN
NTFWHTWDHSLVGNLVKNGEISREAGRKHPMNNQIFKAIKANFKDKVTEPEIHFITDIRK
GDLIFICSDGVSEAFSDVALLELLADETKDLTEKIAIIEKKCSEDSIDNNTAFLCEVEKK
DIPNTTIIPLEWSSIDSLHENDSLETVSLEDNQEEEIEKPKKKKWFRF
>FCMOIPGL_01578 hypothetical protein
MSKLNTKYSRRDFTKLSAIGLASIPLFSFQNVVDKSFSSTNDELNVSLFSKHLQFLDYND
MSAAAVDMGFDGLDLTVRPKGHVLPENVKDDLPKAVEAMKKHGLKPKMMSTNVWDVHNSV
QKSVLETASSLGFTNYRTDWLKYPEDTSIVESQTLFGKQAKELEILNEKLGLIGGYQNNS
GMNVGAPIWDLLPIIEATNGNYFGSQYDIRHAVIEGGECWELGLRRIKPYINSIVIKDVK
WGIVDGKWQPINVPVGEGMVDFNRYFSLLKKYKINVPVSLHVEYDLGGAEKGNQKITIDK
KEVFSRIKKDLEFLKQAWKNAE
>FCMOIPGL_01579 ATP-dependent RNA helicase RhlE
MPFKKLHSDIKEMFEYLEITTPTPFQKASIPVIKSGANIFCTAPEGSGKTTTLILTTLQK
LKCEEVGTAPRAIVLVENREKASEIYEAFLKYVRHHPLRLYLCDEKLHIDVIKSEVFEGV
DILIATPKTLNKLFLLEGINTTQLQIFSMDDAAFLEQKVAHNTMMLLTQSIHKCQFVMYS
EKMHPSLKRYESYFMQHARVISTK
>FCMOIPGL_01580 Thiamine-phosphate synthase
MTIPKLQYISQGNTPEEHLENIQKACSAGAEIVELHLQNVSEKKHLKLAEEAREITSHFQ
TRLLIYNDYKIAKTVKADGVHIDQNTISNTKARIHLYTWQIIGGSANTLKDCEKLITNQV
DYIHLGPFRSAETKENMPTVLGLNGFTVIIEALKTETPIIGVGEITTKDVKDILATGISG
VAVSDEITRNFDSIKLFHQLLNASSIAEQRHTF
>FCMOIPGL_01581 Miniconductance mechanosensitive channel YbdG
MKIEHLLYDYLVTTGTSVVIAKYLNMIALLFGLFIITYLIDFLIRKIIVQLFSKFATKTK
TNFDNLLVQNKAPRNIAHIIPLIIVLELLPIVFVDFSYFENIIQKGLEVFTIILVLWIVR
SLLHTLKDYFKTLPSLKDKPIDSYIQVFMIFSWVVGVLSAFAILTGIEFIQFITTLGAAS
AVVILIFKDTILGFVASIQVSINDMVRIGDWITFEKYDTDGDVIEINLATVKVQNFDKTI
TTIPTYALISDSFKNWRGMADSGGRRIKRALNIKLESVHYLTNDEVHNLKEIQLISAYLE
TRQSDIKNYNTNNNINKELLLNGRNLTNLGVFRKYIETYVENHSGINKDMIIMVRQLAPT
PQGIPIEIYAFSSDKRWKNYEYIMADIFDHVIAAVPYFNLEIFELPSNSSFRDAKIT
>FCMOIPGL_01582 hypothetical protein
MWMYLGLLAALFLGLHNLCKKHAVQGNEVFPVLLGTISSGFLFVATFYVLAIFYPDDALE
NGYNFQQISWQIHGFIFIKSAIMAASWILAYQALKHLPITIVTPIRSAGPFFTFIGAIVI
YKESPNVYQWIGFFFIIFSVILYSRIGKQEGINFKRNKWIFAIIGATFLGASSGLYDKFL
IQNLSLNPQTLQFWFCLYTILILLIILTITWFPYAEKRKAFKFRWSIIAVGVLLQAADYF
YFKALQDPDALIMLLSAIKRSQILIAVVVGGLVFKEKNKRKKLIPLVGIMIGVFLILYS
>FCMOIPGL_01583 putative HTH-type transcriptional regulator
MAKLQKSIDKRNALVKATIELVNNNGFHATPMSKIAKMANVSPATIYLYFENKQDLLNQT
YIEVKAAYTEYAFETYDETMPVEAGFKLIWKRIADFKLNECENAMFLAQCDNTPIIDETS
RQEGIKHLQPLLDLWERGKKEGIIKPISDYLLYAYAINPLSFLMMTQNRGAFILDKTHIE
EAYEAAWSSIKI
>FCMOIPGL_01584 hypothetical protein
MNKTAIILGATGLTGNLLLQKLINDDNYTSIKLFSRKKIEGLPLKVEQFIGNIIDLESFK
SDFTADEVFCCIGTTLKKTPNKEVYRSIDYGIPTKAAKLSKENNIETFMVISALGASSKS
ALFYNKLKGEMEDSVLSFGIKNTYILQPSYIQGDRTENRPLERLYDVIFPIVNIFLIGNL
KKYKIIKATTIADAMQNLASIKPTIKRIESDQIKEYAIHK
>FCMOIPGL_01585 Putative NAD(P)H nitroreductase
MELLDKLNWRYAAKAMNGKKVSEDKIERILEAARLAPTSSGLQPFEIIVIKNQAIKEEIK
PVAWNQSVITDCSHLLVFAAWDTYTEDRINHMFDLTNEIRGFKNEGWENYRQMLLGMYPQ
RDSEENFNHAAKQAYIAFAEALTAAAFEEVDTTPLEGFDANAVDKILGLREKGLRSAVML
PVGYRKEDADWLVNLVKVRKPMEELVTIIE
>FCMOIPGL_01586 Alcohol dehydrogenase YqhD
MNNFEFKNPTKIIFGKDSIKKLENEIPKDAKVLLLYGGGSIKKNGIYNQVKNALAKVDIV
EFGGIPANPEYALLMDALKVIKDEKITYLLAVGGGSVIDGTKFLSAAALYEGDSPWDILT
KNIRTEKGMPFGTVLTLPATGSEMNSGAVITRKETKEKLAMGGPGLFPEFSILDPQVISS
IPERQLANGLMDSFTHVLEQYMTYPIGALLQDRFAESILQTIIEVAPKVLKDPTDYNAAS
NFMWSCTMALNGLIQKGVPSDWAVHAMGHELTALFGIDHARTLAVITPSHYKFNFEAKKE
KLAQYGERVWNITDGNTDEKAHAAIEKTVDFFHELGIDTKLSDYTKDYEGTAEKIAKRFT
DRGWLGLGEHQNLSPDKVEKIVKMAY
>FCMOIPGL_01587 Molecular chaperone Hsp31 and glyoxalase 3
MKILFVVTSHDKLGDTGKKTGFWVEEFANPYYTLLDKGATITIATPKGGIAPIDPSSDSP
DAATADTERFNKDADAQAKIANTYKLSDMNPDNFDAVFYPGGHGPLWDLANDKTSIALIE
KFNSQQKPIAFVCHAPVALKGVKNTDGKYLVKGKKVTGFSNLEETQVGLTEIVPILVEDM
LIEAGAFYSNADAWAPYAIQDGNLITGQNPASSQLVAEKLLASLN
>FCMOIPGL_01588 hypothetical protein
MKTYKFNKPIIVLTFVLLILNLQSCKGQKKDSKAIEKKVNNYVQIATGQTVTYDNDGEVL
TNLQPNDSLYGQDATYLKGKKMSFKKNEDGTVLDLNSGLMWQEIPTTEGFDWKGAKEYTE
NLELGGYDDWRMPTAKELYSISDFSEGWPYLDTTYFSLVNNEHVDKSEQYWTSNKYVGHT
EEGKYAAVFGVNHATGHIKAYAGEEPKDRKDRKGPPPGNQKPQGAKGENSNENRPPPPGQ
GKGTRPIGNPMLKHVRAVRGAIYGTNQFIDNGDKTITDKASGLMWSKDDSKKGLDWKSAL
YYAEHSELAGYSDWRLPNVKELQGIVDYDYAPGAKDSNFDSAAIDPIFSTSEITNENNVK
DYPYFWTSTSARFQKGKPYYYAWYVSFGRAVNNEGLDFHGAGAVRFDTKHENGPASEGGE
RYNNYVRLVRNVE
>FCMOIPGL_01589 Macrolide export ATP-binding/permease protein MacB
MRLLNLLKIAFKAIVLNKTRTLLTMLGIIIGVASVIAMLAIGEGSKESIRTTISSMGSNM
ITIRPGADDRGPARGSGGNVQTLILKDYEKIKEEANLLSYITPVVNSGGQVINGSNNWPS
TIYGVNPEYLNIKVVGLQSGSMFTDAEVKSASKVVLIGQTVVDNVFPDGQEPIGQMIRFN
NIPFKVIGVLEEKGENTFGQDQDDVVIAPYTTVQKRILAIDYLNQIMASAVSEDDAPEAV
TQVTEILRSQHKLMDNEDDDFTVRSMEELISTFSSTSEMLTVLLVAVAGISLLIGGIGIM
NIMYVSVKERTREIGLRMAVGAKGSDILMQFLIEAILISITGGILGVILGLSATVFIEKF
LNWPTSVALYSIIISFVVCAVTGIFFGWYPARKASALDPITALRYE
>FCMOIPGL_01590 putative ABC transporter ATP-binding protein YknY
MTKEIIKIEDLKREFIMGTETVHALRGISFNIKEGEFVTIMGSSGSGKSTLLNILGCLDQ
PTSGTYEIDGVKVKDLSRNDLATIRNEKIGFIFQSYNLLARTSAIENVELPLIYNSKVST
EERRKRAIEALEMVGLGDRMDHTPAQLSGGQQQRVAIARSLVNNPVMILADEATGNLDTR
TSYEIMSLFQELNKKGITITFVTHEPDIATFSNRTIVLKDGHLIKDYKNENIQSAAKELA
KLPKQED
>FCMOIPGL_01591 Macrolide export protein MacA
MKNNRTIIISSILILVLAIAAYFFFKNDDAIIIEAKTITAKKSNVTTMVTATGTIEPINQ
VDVGTQVSGVVEKIYVDYNSVVKAGQLIAELDKTNLKAFKTQAQASYDNAVTQRNYMKTI
YERQKSLYDNQVISKSDFDEATYNYKTAKGTVTQRLSDLQTANTNLGYANIYSPIDGVIL
SRDIDEGQTVAASYSTPTLFTIAQDLKEMQVEADVDEADIGTVKEGQRVEFTVDAYIGET
FNGVVTQVRLDPTVTSNVVTYTVVIKADNEDLKLKPGLTATISVYTLELKNVLSAEAKAI
NFKPEAEILSTYNLHHNLPETTFNNSSKNKTLWVLGKDKSITEKIVTLGASDGVNVQILS
GVNEGDKLVYSLKGVSKSEGKPGGAAGSGESPFMPKPPGSKK
>FCMOIPGL_01592 Outer membrane protein TolC
MKLFLIIASFFILQLSFAQETANTTQKIWSLQDCIDYALENNITIKDAILNKNIAEIDYS
TSKSSKLPNLFGSASQSFSNGNTIDPITSSYVTEQIHSTNVGINTSMTLFQGNQINNQIK
QNKILFDQSIFEEEVAKNNIVLNILETYLQTLYSKESIVIAQNNLIASEAEVLRAKSRLD
AGTIALSDYTEAQSQAATNKYNVISAKNDYQQYIIVLKQLLELSPIDEMEVESVDENLDL
LNIELNKVEVYKNALGYLPEIQSSSLNVDANKKQLEIAKGGFLPTLALSGSLGSGYTSIS
DNTFSDQFDVNFNQKLGLSLTIPIFNRNQTKAAVKTANINIEKAEIQKQTTEKEVYKKVE
TAYQNAMSAQEQVIAAEASKEAAKDSYQLAQKKYELGDLSTTDLVISQNTYTNAQQNYLQ
AKYLNILYHQLLQFYQGNKIKL
>FCMOIPGL_01593 Neutral endopeptidase
MKNTVYFLLLIATFISCNSLDNTSKSKIDFEGISENIKPGDNFFEHVNKVWLDSVVIADD
QVGVGSYSFLNIPQKKLLENILIEVSAENHKKGSIEQMVGDFYTSGMDTININKRGFEPL
KATFNKIDEINSVASLMVFVANEMSLGTQSIISMYVSSDNENSNVNMLHFGQSGLGLPDR
DYYFKSDEATVAIQDAYKKYISTLFTLSDENEAESKAAIVYEIEKKLAVSHKTRIERRDI
KANFNKINVIELSKNEPNIGWATLLKQLNLKADSIDIEQPNYYKELNSMLVSIPISNWKI
YLKANTLSIYANILSKPFQNASFEYTKVLYGQDTQNTRAQLMVKKVDRQLGFALGQLYVK
RYFNEDAKQRVLDLVNNLQKAFENRINQLDWMSDATKKQAKEKLYTITKKIGYPDVWRTY
NANIEKDAYFENVVALNKNAYQYNIAKLNNPPNRDEWGTTPATVTAYYNPPLNEIVFPAG
ILQFPYFDITADDAVNYGGIGMVIGHELTHAFDDQGAQFDKDGNVKNWWTDEDYTKFKAK
TQLMIDRYNSFTVLDSLKIKGALTVGENTADNGGIAIAYDAFKLTEQGKSDTKIQGFTPD
QRFFLSIARIWRVKTRDAYLANYIKTNPHSPPIWRVNGPLMNFDPFYDAFNVQPGEKNYK
TDAERIKIW
>FCMOIPGL_01594 Phytochrome-like protein cph1
MRFISCFILLFFLQYSFAFKLIEEKTNIIDLRDTQINDDSEIYLDTNWEFYWNDLIIPGN
FNNYKPFKIVTLKDWTEFNLPKTDRSPSFGYATYRLNFRINKNRPHVSLYIPSAYSSSRI
WINGHFFSEMGHVGKTRSKTIHRRFSQIIPLNTDENNFEIVIQVANYYHNKGGLDKPLIL
GASNHLHDLKSKRIMADMIFIGCLGFIGVFFLFFYLIYWNKDKAILYFAILCISLSYISL
SDRYAPFTVIFDSISFILLTKFEYITLFLAGASGSLFFNNIFYNFIYRAYSKIIVFSFLA
LVILIFSLSPPHFTKLLIPFLILMIINLIYVTLVVIKAIIAKRLESILLLLSIILGSIIF
YIHVFFFLGENGNAIIYVNFGYILVFLLLSMLLMKRFSDSFQELEHSKEIALQQKKEIST
QSNQLSRANLELEENLKLLENYNAELDDFNHIVSHDLKTPLVSVHALVSFIEEDLKTTLH
ADTKNHINLLKDVVARMDALINGLLEYSKVAKGNKQKEWFKLNDLLHKVIGVVDNQQKNT
IHLPDEDLEIYANKIELNHVFQNLLSNSIKYNDKKHTIIHISVVKQNNEYIFSVSDNGPG
IDPKYHNKIFKMFSQLDVNEDVKSTGIGLAIVKKIISENYGIISIESEKGMGIKMNFSWR
IK
>FCMOIPGL_01595 Putative pyridoxal phosphate-dependent acyltransferase
MTKDLFERIKEDKGPLGKWAKQAEGYYVFPKLEGPISNRMSFNGKKVITWSINDYLGLAS
HPEVLKVDGAAATEHGMAYPMGARMMSGHTKYHEQLEKECAEFVEKDAAYLVNFGYQGMV
SAIDALVSKNDIIVYDMDTHACIIDGVRLHAGKRFVYRHNDMESFEKNIKRAKKMAEQTG
GGILVISEGVFGMRGEQGRLKEIISFKKEYNFRLLVDDAHGFGTLGKDGKGTGVEQGVQD
EIDVYFATFAKSMAGIGAFFAGDKDVIQYLQYNMRSQMFAKSLPMAMVKGALKRLDMLRT
MPELKEKLWQNTNALQSGLRNAGFDLGTTQTCITPVYLKGDIPEAMAMVNDLRENHGVFC
SIVVYPVIPKGLIILRLIPTTTHTQEDIDLTIKAFSAIRELLENGTYKKIAASMM
>FCMOIPGL_01596 Putative cystathionine beta-synthase
MTRNQGITENILKLVGETPLVKLNNITKDLKGSYFAKLEAFNPGHSAKDRIALHIIEDAE
KKGIVKKGFTIIETTSGNTGFSLAMISIVKGYRCILAVSDKSSVDKIDMLRSMGAEVHIC
PANVAPDDPRSYYEVAKRIHKETKRSVYINQYFNELNIEAHYRSTGPEIWKQTEGKITHL
VVASGTGGTISGTGKYLKEQNPNIKILGVDAVGSVLKKYHETGKLDPKEIKPYKIEGLGK
NLIPTATDFDVIDVYEKVTDKEAAFTSREIVKSEGIFPGYTSGAVLQAARQYADSGMFDD
ESFVVLIFPDHGSRYMNKIYNDSWMKKQGFL
>FCMOIPGL_01597 Dipeptidyl aminopeptidase BI
MRKICVTTILISLIFATACKNDTKDMKSTDAQFPIADKQPTKLEKHGDIRIDNYFWMRLS
DAQKNAIVKDEQTQKVVDYLEAENAYFDKVTDYTKKFKENLFQEMKGRIKEDDSSVPYKD
NGYYYITRYEIGKQYPIYSRKKDNLEAPEKVLFDVNELAKGFEYFKLGGLNISPDNKLAV
FATDTVSRRQYFLRIKNLETGEIYKDIIDNTSGGSVWANDNKTIFYTKKNPETLRSEKIF
RHVLGTPASEDVEIYHEEDDTFGTYVTKTKSDEYIIIGSHSTHSSEAQFLDANNPTGKFK
LIQAREKELEYDISQYKEHFYILTNKDGATNFKLMKTPISKPTKENWVDVIPHREETLLE
DFSIFKEYLILEERTNGLNKIRIKRWDNKEDYYLPFNEETYSAGVFGNPEFDTDILRYAY
NSFTTPSSVIDFNMKDQSKDIKKEQEVLGGKFHKENYESKRVWATARDGKKVAVSLVHHK
NTKLNENTPLLQYAYGSYGHTVSDSFSTTRLSLLDRGFVFALAHIRGSQYLGREWYEDGK
MFHKKNTFTDFVDCSKYLIDNGYTSSKHLYAMGGSAGGLLMGAVVNMNPELYNGVIAAVP
FVDVVSTMLDDSIPLTTGEYDEWGNPNNKDSYEYIKSYSPYDQVGHHAYPNMLIITGFHD
SQVQYWEPAKWIAKLRELKTDTNLLMLHTNMDSGHGGASGRFEALKETAEEFTFLLALEN
KLEL
>FCMOIPGL_01598 Nucleoid-associated protein
MFGDLSGMMNKLKEAQKEVEITKSRLDSVLVDETSADKKIKVTLTANREIKSISIDETLL
GDKEELEDFLIITLNKAIEKASKINEAEMAVAAKKGMPNIPGMDMFK
>FCMOIPGL_01599 hypothetical protein
MSLEDYMLPCLNKKLFGIDCLGCGFQRSLLSVIKGDFTAAFNLYPAIFTILIMAFFLLLH
LKFKFKNGKKIIIILAIVNVLIIVISYYIKMKPLFNL
>FCMOIPGL_01600 hypothetical protein
MEKQTLPNATVSLVLGIFSLLTCICYGVLGLPLGIAAFVLGNKALKVYQNNPENYASSGN
ASAGKILGIIGIILNLIFILLIVWVISKIGWENLQNEEVMQERMMEIFGQ
>FCMOIPGL_01601 hypothetical protein
MNKEIKKNSLVKRVLKWLVAVFLILIIALVAIPFLFKDKIVEMVSTTINENINATVTFKD
TELSFFKNFPLASLTVKDVVVANKAPFIGDTLFSTKEVSVSMSITELFKDKEEALELKSF
SSKNGQINIIFNTESIGNYDIALKNETAEETGSESDSFSLNIQDYEFENMSFMYLDRSSN
MKMKLDSIYHYGKGNFAEEILDLDTKTTAKLSFDYENTNYFNNVAISLNAVLGIDLKNSK
YTFKENTGYINQLPLEFNGFIQMLDETQVYDITFKTPTSDFKNLLALLPKQYSGDLNAIK
TAGNFDLNGVVKGVLSETTIPAFDISFASKDAMFKYNDLPKSVQKINIDTRVINKTGNIK
DTYINLNKLTFKIDTDVFAANGNIKDITTNPKINLTAKGTINLANIGKVYPAPIEQELAG
ILNADITTNFDMNSVDKGNYENIKNAGQVKVNDFKYDGKDVAKPFYINKTAITFNTNSIK
LNEFDAKTGDSDISITGNLDNFYGFIFKDQTLKGNFSLNSNTFKVSDFLATDTSTTATVD
KKEETEKIKIPAFLDCKFNATATTVVYDNINLKNVSGTIYIKDETVNLENLKTEVFGGNI
GFTGNVSTKGDTYSFSMDLNLKELNIADSFGTLDMLKAIAPIAKTIDGKMNSTINVSGNL
SDDFTPNLKTISGDLFGKLLNPTLNSSNSKALSLLSEKVSFLNTDKLNLDGINAYLSFEN
GTVTVKPIPLKYQDIGIEIGGKHGFDNTMNYDIKFDVPVKYLGTEVTNLIAKLSSKDAEK
ITSIPVNASLNGSFSSPSFTTNIKDATANLVKNLVEQQKQNLINSGKDKLLNLVGGDTKK
DSTSTSTKDKLINIITGDKKDTTKTNNEDKVKNVINGLFKKKNN
>FCMOIPGL_01602 hypothetical protein
MIGNPITQLEQLTINTEAKSFLKETAKWAFFLSIIGFIGIAFLVVLAIFSGVIFSAIPQA
KEVPFDLGLAMTIVYLLFAVLYFFPVYYLMQFSNKMKKALATKDDTILADAFKVLKSHYK
FIGVFTIIILSLYAMLIVVSVVTGSLL
>FCMOIPGL_01603 Ornithine aminotransferase 2
MAVLDKLTSQEAIELENKYGAHNYHPLPVVLSRGEGVYVWDVEGKKYYDFLSAYSAVNQG
HCHPKIVDAMIHQAKTLTLTSRAFYNDMLGKYEKFATEYFGFDKILPMNTGAEAVETALK
ICRKWAYEVKGIPENKAEIIVCENNFHGRTTTIISFSNDPVARKNFGPYTKGFVKIEYDN
LQALQEALESSNNIAGFLVEPIQGEAGVYVPSENYLSEAKKMCEEYNVLFIADEVQTGIA
RTGKLLAVDHENVKPDVLILGKALSGGAYPVSAVLANDHIMNVIRPGNHGSTFGGNPIAA
AVAMAALEVINDENLAENAEKLGVIFREELTAFAETNSLVKSVRGKGLLNAILINDTENS
STAWDICIKLRDNGLLAKPTHGNIIRFAPPLVMTEAQLRDCVAIIKKTITEFKK
>FCMOIPGL_01604 Cytochrome c-552
MKKVIFSLAFIVCVSFLIVSFTEKKEILNTIPQSSIDKGKRLFKKNACTGCHQEKTKVIG
PSVKDIATKYKTEKGDLIAFLKGKNKPIVDKDPGQIAIMNASLGITKNMKAVDLKALYDY
IMSIK
>FCMOIPGL_01605 hypothetical protein
MKSIFKYLLILLSTTFFAQNKASLDSLLVKGVKAMNNKEYSLSLELLTKANSIAEEKHWY
KQQFLAINNIGANYYSMLDYGEALNNYLDAYTIALKHLDENEEMIVLNNIAILYSKENEF
KKAEEYFGKAYKLALENNLETKKGLYSINLGIVTNQQNKLDVALNYLENGKKIFKNKPSL
LILAETAIVDNYYKRKEFEKAKVLATKILPNLKGISYSEERISILILLSNIYKESRKLSL
ATSYAKAALEASLNSENRISAFNQLAEVYKASNIIDKAIEAKDSVIALTNSLNKIKNGHL
FETNKVKFEIANYKQELKKNQEKQKEDRFLFYGLLTILLLIICLITWALRNSSIKNKQRK
ILDDRSKEIIQLELQKKKSDNLVLEKQLYAKEAFSLLEQERLKNEIEKRNQKLAAKALQV
SARNELLKEVINSLSSQTEVSKNVFLSRKVTELKNLLKSDTEWESFLTHFEQVNHTFISK
LKKQHPKLTANDIRYISYLYMNLTNKEIASLFNITIEASRKRKERISSKMELKYNLDLYT
YISSI
>FCMOIPGL_01606 hypothetical protein
MKIKITLLLFILCLTFQSVFGQLEVDGSDEFGRIFNVTYDATIPNKVYAVTLGNHIIVSE
DNGKNWQVLYSLIYYGASIKDMKLSSDGKSLTFSAHLPNTEVNAVMVYEISSASIIKTYP
LPNQKDLGYLVSYDFYDNDMDVLIVATKFPVGFETEGKTFYTADGGANWEMIYYTNDNDF
VFINKVAISPNNPDKIFLTRGNGKLEVDGGLFISDDAGRNFTEKLPGIVLDPIAFDPSND
ETIFLGTGISFGGNEENLYKSVDNGNTFDIISIRWTTSTLNNITVIEFNENNPSQIIVLE
ENEIAISEDGGNTFENTVYPDDNTDSYYYGLNASYNPQNNQEVIISSNYIPLFSSEGGQT
VSKIYSPYFTSTGSTAIFKNETNTNLYYGVQKGHIHRDLNSGKETAYNILPLNNFSSGGE
SQTLVDQIIPNRIYSFSSSFFGSALYVSNDNGATKNQLLSLFKNKFTAQATFPNHTETIF
AAFAGYEASETVLKKIDFTDINKVEQIDIKLPTLNFIYGIIIDNTGKITLSIGNEVYSSI
DEGETWENNSKGLDELDESDIIFDLKQDPKNNDFLALATSKGIFISEDNGENWVKKTKDL
VNKVEFSSETSGAIIASTYNSLYTKFTLYYSVDYGANWETINNEQLLGIQAYSSAFHFEK
DTITAYIGSSDLGLLKYIIDLSSLSVLDPINSTSLITIFPNPFQNVLNIKLNNSKVIYAS
IYSLTGKKVLEFKNKESINVSGLAAGIYSLRIKDNNNTIFFKRIIKQ
>FCMOIPGL_01607 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MPRRERNKFVKKNQVLELRIEDYAFGGKGIARIKSDEGSFVIFVPNTLPGQLVKAQISKS
SKKYAEAKLIDVLEPSENEVEVPFQDIPGAPYIQLPIELQHQYKKESTLSLFKRIGKVEN
IEDLFDELVVSPNVFHYRNKMEYGFSAIGYDRINKTDKDEFTLGFKRRGVWWMGDNLEKD
SGLFDKQMEDNLKNIRHYCLETGLEPWHGPKKTGFFRYFVVRKSYKTNELLFNLVTTSPE
LPNFDLKKFANYLVELFGNRVAGLLHTINDETGDRTIATSGSINLVYGKDKIVEELLGLN
FEISMKSFFQTNPKCAEKLYSKVVEYVLEDKSKVDNTVVMDLFCGTGTIGQIVASRSENA
KIVGVDIVASAIKDAQKNAKRNNIEGLQFYAADVGKFLVAHPEYKDKIKTIILDPARAGI
APKTLQKIINLNADRMVYVSCNPATQARDTELLAEAGYQIKKISLVDQFPHTSHIETVVL
FER
>FCMOIPGL_01608 hypothetical protein
MKSIKKTILLFTLLTLYNCSELNSALSNVNRGMGGKCRVYIAENYLYDSSSDKWLSGKYY
TKDRDGNDIDYKEDSWISSCGKYYANKGVFSTYYRTSPYSNGKYKFVVSCSSWY
>FCMOIPGL_01609 Putative pterin-4-alpha-carbinolamine dehydratase
MKKLTEFEIELKLESLPDWEYYDEALHTDLEFGSFKDCMSAMNRIAFECEALNHHPEWTN
VYNTLDITLKTHDAQGVTELDFALAEAINKIVEVE
>FCMOIPGL_01610 hypothetical protein
MKKIIPILILITIIFSTCEKDDFCVKNPITPNLVLRFYDETNQETLKTAKLLSVWAEGKD
TIDDYTSITTDSIAIPLNSLTTETIYHLKINEEDGAKADNLYTTFTINYTPEDVYVSRSC
GYKVIFNDVTFSSDNTNWIKEFTPETLTIIEDQNSAHVQIFH
>FCMOIPGL_01611 hypothetical protein
MYKYFISIFFLFVLVDGFSQNPRKPEKPKSEIKEPKKDTIVYKSAYGFRLGMDISKPILS
SISSSYSGFEVVGDYRISKRFFVAAELGYEEETTDEDYTNSTVKGSYARLGINYNAYENW
LDMNNEIFVGFRYGFSLFDQTLNSYTPNVNSTYFPADLIDTPVTASSLNAHWTEFLFGLK
VETFNNLFVSASISYKVMMSTKEPENFKTLYAPGFNTIYETSTGFGFNYTISYLIPFKKK
>FCMOIPGL_01612 hypothetical protein
MNKIPSVNLADFLSDDKTRKQKFIDEIGHAYENIGFVALKGHFLNTELVESLYSEIKNFF
ELPTDIKEKYEIPGIGGQRGYVSFGKESAKGKKEGDLKEFWHFGQYVDKTSKYADEYPAN
VIVEELPKFNEVGKETYQMLEKTAKYVLRSLALHLGLEETYFDNYIKNGNSILRPIHYPP
IKTEPKGAERAAAHGDINLITLLMGAQGKGLQVQNHKGDWIDAVAEEDELMINVGDMLSR
HSNNKLKSTIHRVTNPPKEMWGTSRYSIPFFMHPISDMKLNVLENCIDENNPKQFSDITA
GEFLDERLRELGLKK
>FCMOIPGL_01613 hypothetical protein
MNFKDQLKNLFPEHIESEEPVVEKSTIWLQDDPIICKYEKRKGKPITILEGYTGATKDFK
MLAKEIKTKLSVGGSFKDDKIIIQGDFRDKIMTMLKNKGFNVKRVGG
>FCMOIPGL_01614 hypothetical protein
MGASILHITNGDITTNYLKKLKFSGEFITWREMLSEGKTTSDIGSENFWKTRFDFLKSSY
NISKKKFIDYTLKEYRNLCSQKEQDEIVLWFEHDLFCQINMLAVISWLKRYRKGHQITLV
SSGKVKGSNKLLGLSQLNKKEILQHFKNRVTLNQDDIEYADYIWQLYCSDSPLRLETVYK
FNPMSPFQHLASAIEAHLQRFPSIENGLNKIENTILKTAEKNNLTSKKELVHQLINDQEV
YGFGDLQYEYSIKTLDKLFSSFNPVKLSKKGKEVLDNQINFYGQLRNDISYLGGSKKYSF
LFHNETNKLLQITS
>FCMOIPGL_01615 Uridine phosphorylase
MSIKQSELILNPDGSIYHLNLRPENIATTIIFVGDQDRVDKISKHFDTIEFTTQKREFKT
TTGTYKNKQFTVISTGIGPDNIDIVLNELDALVNIDLKTREPKEKLTKLNIVRIGTSGSL
QADIPVDSFVIGSHGLDLNGLLHSYLIDEISNPDIEKAFVSHTNWSDKKSYPVIIKNSKE
LETKITSEKTYTGITATAGGFYGPQGRVLRLAIQDAELNHKIDSFNFNGHRITNLEMETS
AIYGLSKLLGHNACSINAIIANRANGTFSKNPGKVIADLIIYTLEKLIQ
>FCMOIPGL_01616 hypothetical protein
MTNLKVGGVPEHFNYPWYITLKNKEYNKHNINLRWQDFPGGTGQMCKALRNGDVDIAIVL
TEGIIKDIADGNPSKIVQTFVKSPLIWGIHVGSKSKFNKIEDLENATIAISRFGSGSHLM
AIVNAYNQNWDIQKLKFKVVGNLQGGIDALTNGDAEYFMWEHFTTKPLVDNGTFRRIDDC
PTPWPCFVVAVRNEVLENNFEEVKKVLDIINAETKDFKKIDNLDEILAERYEQKIDDIQK
WLKITEWNAGKTITKNLITRIQNKMVKFNVIEKKKNSGEFIKNMYI
>FCMOIPGL_01617 hypothetical protein
MKKAVFIVVCILGISCLSSCRSTSQSCGLADNETNQITLQQVDLT
>FCMOIPGL_01618 Uracil-DNA glycosylase
MQVKIADTWKNILQPQFEKPYFKELIDFVKSEYQKHTCYPQENDIFAAFDFCAFDDLKVV
IIGQDPYHGENQANGLCFSVKDEIKHPPSLVNIFKEISTDLNQEIPQSGNLEEWAKQGVL
LLNATLTVRAHEAGSHQKKGWETFTDAVIKKISDEKENIVFLLWGKFAESKTKLINIEKH
TIFTAPHPSPLGAWRGWFGSKHFSKTNKFLKSIGKKEINW
>FCMOIPGL_01619 Endonuclease MutS2
MRTNISDKTLQDLEFSTVLQHISEFCLSGLGKEKVLEIKPIHNKKVLIKELHLVDEYVTS
FTSENRVPNHNFDNITESVKRLAIENSFIETDAFLKIATTSLTVNELIKFFKKFQIQFPT
FFELSQKIEFTTFIDDEIKKIIDISGEVKNNASSDLKQIRKDINNVRGKIGASFTSALTK
AISAGHLDDIKETVVDNQRVLAVSAMHRRKVAGSLLGASKSGNIVYIAPQATLSYSREYQ
NLIYEEKQEIVKILRALATTIRPFVYLLKEYITFLIHTDAIGAKAKYALEMNAILPKISK
EKKIFFKNAYHPILWKKNKKQKIDTVAQTIELNEKQQIIVISGPNAGGKSITLKTIGLLQ
IMLQSGILIPVDERSQTYIFGTVLTDIGDNQSIENQLSTYSYRLKNMRNFLRKCNENTLF
LIDEFGTGSDPELGGALAEIFLEEFYHNKAFGIITTHYSNLKVLENELENVTNANMQFDE
RTLEPLYKLFVGQAGSSFTFEVAQKNGIPFNIINKAKKRVETEKVRLDKTISNLQKERNR
LQKNSDNLEKQKTKGQRHLDNLQEKEQKIQDKLAGFQELYDSNQKMLSLGRKMNELINKY
FQTNNKKELTSNFNKWVTDEKVKHLKKNPQKPKTKAQKQKAKVVEKKQQEIIKTIEKEVL
EKVVEVRKEKKIEAIKIAKEKSEYNYKVNDRVRIIDSNSVGTIDKIDRKKVTINYGFFTT
KTSVDKLELVEKAKK
>FCMOIPGL_01620 hypothetical protein
MRNLKTFAAILAITLATTFSTTASKKKPSEITKEIRTEIVSMLGSELYLELDEASSAEIS
FIINNENEIVIVSVDSKINELKSIIKHKLNYKKVIVKGAKKGEIYIMPLKINTK
>FCMOIPGL_01621 hypothetical protein
MKKVLNLAFAFTIATFFVACSDDENTLATTGDLTVDLTGLEELGSDFVYEGWLIVNENPV
STGTFTSVSFPQTYTVGINDLQTASKFVLSIEPAGETGEAALEPAATKILEGDFSGNSAN
VSSTGIVGDFSTSWGKYILATPTDADDTNEASGIWFLDNSETATVAGLSLPTLTDGWKYE
GWVVLNGTPVSTGTFSAVDLADDNAAISPYKGTTGNGPSYPGEDYLMGSAAGVNFPTDLK
GATVVISVEPSPDNSAAPFTLKPLAHVVPADAMNHTVISMGAGPLAVLSGSVSR
>FCMOIPGL_01622 Global nitrogen regulator
MTNLWFFDNVNLFNLLCPHKFKDYKKYHSFHAYKKSDYIYFEEDAASKVYLIEKGKVKLG
YYNEDGTEIVKAILTKGELFGEKAILGQELRNEFAQSVDVSTSICPIGVETMHDLMRDNK
TFSLKIYKFLGLRFKKLERRLQLILFKDTRTRFLEFTKELCEEYGKDCEKTGDKVIEHPY
TQKDIASLIGTSRSNLNVLMNELKEENIINFNRKEIRLLQKII
>FCMOIPGL_01623 Aconitate hydratase A
MAFDIEMIKQVYASMSERVDAARKITGKPLTLAEKILYSHLWDVTPEKAYVRGKDYVDFA
PDRIALQDATAQMALLQFMQAGKSKVAVPTTTHCDHLIQAKNGASSDLQTALNTSNEVFN
FLESVSNKYGLGFWKPGAGIIHQVVLENYAFPGGMMIGTDSHTVNAGGLGMVAIGVGGAD
AVDVMAGMAWELKFPKLIGVKLTGKLSGWTAPKDVILKVAGIVSAKGGTGAIVEYFGPGA
TSMSCTGKGTICNMGAEIGATTSTFGYDESMERYLRATDRSDVADEANKVKEYLTGDAEV
YANPEQYFDEVIEIDLSELGPLLNGPFTPDLSTKAGSDMTEIANKNSWPLKVEWGLIGSC
TNSSYEDLSRASSIAQQAIDKGLGIKAKFGINPGSEKVRYTTERDGILETFKALGATIFT
NACGPCIGQWARYEDPKNAPKNSIIHSFNRNFAKRADGNPNTHAFVASPELVAAVTIAGR
LDFNPMKDKLINKNGEEVMLDEPTGWELPPKGFEVKDDGYLAPEEDGSGVLIKVNETSDR
LQLLDPFTPIGSDISGAKLLIKAHGKCTTDHISMAGPWLRYRGHLDNISNNCLIGAVNAF
GMKTNFVKNQLTDEFGGVPDTARAYKAAGVKSIVVGDHNYGEGSSREHAAMEPRHLGVVA
VLVKSFARIHETNLKKQGMLGLTFDNEADYDLIQEDDTFNFIDLNEFAPGKPLTIEAVHA
DGTKDLIIANHTYNQGQIEWYNEGSALNLIKKQNA
>FCMOIPGL_01624 Aconitate hydratase B
MSMYQDYLKQIEDRKVQGLHPQPIDGAELLSEIIAQIKDLENQYREESLNFFIYNVLPGT
TSAAGVKAKFLKEIILGESIVKEITPSFAFEQLSHMKGGPSVEVLLDLALGDDAAIAKEA
AEVLKTQVFLYEADTARLEKAYKNGSEIAKELIESYAKAEFFTKLPEIDEEIKIVTFVAG
IGDISTDLLSPGGDAHSRSDRELHGQCLFEHNKEQQKELLELQKQHPDKRVMLIAEKGTM
GVGSSRMSGVNNVALWTGVKSSPYVPFINIAPIIAGTNGISPIFLTTVGVTGGIGIDLKN
WVKVKDAEGNTVRDEAGDPVLEEAYSVATGTVLTVNTKEKKLYNGDVELMDISASLTPQK
AEFIKAKGSYAVVFGKKLQTFASKVLGIDVVPVYAPSKEISIEGQGLTAVEKIFNKNAVG
TTPGKVLHAGSDVRVEVNIVGSQDTTGLMTSQELEMMAATVISPIVDGAYQSGCHTASVW
DNKSKANIPRLMKFMNDFGLITARDPENKYKPMTDVIHKVLNDITIDDWAIIIGGDSHTR
MSKGVAFGADSGTVALALATGEASMPIPQSVKVTFKGNMASYMDFRDVVHATQQQMLTQF
GGDNVFQGRIIEVHIGTLTADQAFTFTDWTAEMKAKASICISEDATLIESLEIAKGRIQI
MIDKGMDNHLNVLQGLIAIADKRIAEIKSGEKPALTPDANAKYAAEVVIDLDLIEEPMIA
DPDVNNADVSKRYTHDIIRQLSYYGGTKQVDLGFVGSCMVHKGDMKILAQMLKNVEAEYG
KVEFKAPLVVAPPTYNIVDELKAEGDWDVLVKYSGFEFDDSAPKAVARTGYENMLYLERP
GCNLCMGNQEKAEPGDTVMATSTRLFQGRVVKDSGEKKGESLLSSTPVVVLSTILGRTPN
LTEYKVAVKGINLTQFTPPHKLLVRA
>FCMOIPGL_01625 Chaperone protein DnaJ
MAKQDFYEVLGISKSASQAEIKKGYRKMAIKYHPDKNPDDKTAEENFKKAAEAYEVLSDE
NKKARYDQYGHAAFDGPQGGGGFGGGGMNMDDIFSQFGDIFGGGAGGFGGGFGGFGGGGQ
RQARVKGSNMRIRVKLTLEEIAKGVEKKVKVRRKVQADGVKYKTCTTCNGSGQVMRVTNT
ILGRMQTATTCSTCSGSGEIISSKPSNADAQGLIVKEETVSINIPAGVTEGVQLKVGGKG
NDAPGNNSISGDLLVLIEEVPHETLKREGTNIHYDLYINFSEAVLGTSKEVDTVTGKVKI
KIDAGTQSGKILRLKGKGLPSIERYGTGDFLIHTNVWTPQELNKEQKAFFDKMSDNENFT
PNPNKSDKSFFEKVKDMFS
>FCMOIPGL_01626 Protein GrpE
MSQKENIKEEELNNEQENAQVDENQEIEAEVVKEEPTTEELVQAEKDKFLRLFAEFENYK
KRTSRERIELFKTAGQELMTSLLPIVDDFERALAHIEDDKEAEELRKGVLLIYQKFYNTL
EQKGLSKVETKEGDVFDAEIHEAITQIPAPSPDLKGKVIDCVENGYKLGDKIIRYPKVVI
GQ
>FCMOIPGL_01627 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MASFKIEGGHKLSGTITPQGAKNEVLQILCAVLLTPEKVVINNVPDIIDVNKLIFILGEL
GVKIEKLSRNSYSFQADEVNLEYLESKDFKKDGSSLRGSIMIVGPLLARFGKGYIPRPGG
DKIGRRRLDTHFEGFIRLGAKFRYNREEHFYGVEADELIGTKMLLDEASVTGTANILMAS
VMATGTTEIYNAACEPYIQQLCKMLNSMGAKISGVGSNLLIIEGVKYLGGCEHKVLPDMI
EIGSWIGVAVMTQSELTIKDVSWENLGQIPNVFRKLGIKFEKRNDDIYIPAQKSYEIQNY
IDGSVLTVADAPWPGFTPDLLSIVLVIATQANGTVLIHQKMFESRLFFVDKLIDMGAKII
LCDPHRATVIGLNHKSNLKATKMTSPDIRAGISLLIAALSAKGTSIINNIEQIDRGYENI
EARLKSIGAKIQRIED
>FCMOIPGL_01628 hypothetical protein
MTFDLEYNSERPLMIIPEYGRHVQKLVNHCVALKTIEERNEMAKAIVDVMGNLQPHLRDV
PDFKHKLWDQLYIMSDFKLDVKSPYPQPSKEELQEKPEPLAYPKSASKYRYYGKNIQTMI
NVALSWEEGEMKEALVFSIANHMKKCYLNWNKDTVDDAVIFKHLFDLSDGKLDLRNSNEE
LSETKNLLKKRNSQGQNSSKNNYKKPHNNQHKNRKR
>FCMOIPGL_01629 ATP-dependent DNA helicase PcrA
MNTYLNTLNEAQKQAVIQKDGPMIIIAGAGSGKTRVLTYRIAHLMQQGVDSFNILSLTFT
NKAAKEMKARIAGVVGASEAKNLWMGTFHSVFARILRSEADKLGFPSNFTIYDSQDSVRL
ITAIIKEMNLDKERYKAKQILGRISSFKNSLITVRAYFNNSDLQEADLHASRPKVGDIYK
EYVDRCFKSGAMDFDDLLLRTNELLARFPDVLAKYQDRFRYIMVDEYQDTNHSQYIIVRS
LADKFGNICVVGDDSQSIYSFRGANIQNILNFQKDYPDVKTFKLEQNYRSTKNIVNAANS
VIERNKTKLDKEVWTSNDDGDSINVMRTISDGEEGRFVAQSIWENQMNHQLSSDDFCVLY
RTNSQSRAIEDALRKKGIDYKIYGGISFYQRKEIKDILSYLRILINPNDEEAFKRIINYP
ARGIGATTIDKLTIAANHYKKSIFEIIKYINKIDISINSGTKNKLQNFMNMMLRLQIESQ
TKNAFEIAETVVKETKLIKDLEKDGTPESVSKVENVQELLNGIKDFITDKIEQGEDASLT
TFLEDVALATDFDAKTDDDKPTVSLMTIHQSKGLEYMYVYIVGLEENLFPSAMSMNTRSE
LEEERRLFYVALTRAEKVAYLTYAQTRYRWGKLVDAEPSRFLEEIDDQYLNYITPKSTNP
TINNFIDKSIFDDAPKGIRFQKPIQRKKMERDLVKKKEIVIPKNMKKVSQTSAKANLFDG
KVVVGNIVEHNRFGTGEVLSLEGNGPNKKAEIKFGTVGKKKLLLQFAKLRVIG
>FCMOIPGL_01630 hypothetical protein
MTSILTGDIINSRKNDELFWMKTLKGTLDTFGESPKYWQIYRGDSFQLEIENCENAFYAA
LKLKSHLKSSENIDVRIGIGIGKKEFNVDKITESNGEAFINSGYAFDNYLKKQTIAIKTP
WQEVDEELNIEFDLALLTMDSWTKNSAEVFKLSLESKNRTQKEIAEILGITQGSVSERYK
RSGFESIMKLEKRFRKLIIQNKNE
>FCMOIPGL_01631 hypothetical protein
MILFLKFLLAHILGDFVFQSEKWVKNKEEMKVKSVKLYVHIAVHAFLLLLILQFNLKEYW
LGFLLIITSHYIIDVLKLYLQKKKTKRIWFFVDQILHLLTLFLISTLYTDFSISIENFFT
DKLLLLFIFILLASSVSAIIIKIIITQWNPEKKTENDDSLAKAGRYIGILERLFVFIFVI
TNHWEAIGFLLAAKSVFRFGDLTSSKDRKLTEYILIGTLLSFGFAILLGVLYLYVLNAL
>FCMOIPGL_01632 hypothetical protein
MEDKLLESIAYILPATVTGIVAYYMFNRFLNNQNSEKKLELLAQNKKESLPIKLQAYERM
LLFCERINPVKMLLRIKPLTDKTDDYLQLLIANIEQEFEHNLVQQIYLSNNTWLSIVAAK
NAITNKLKQVAENSNSANELRENVLMEYTKTLPQTETAISFIKNEVKKLLK
>FCMOIPGL_01633 hypothetical protein
MKITKSIFKLFLISLVFTSCSNNEEEFPEISGNYKDGVIVSAEGSFGNKDGSISYVNENL
NRLATNFMYTGVNEAQLGGLIQSMAFSDDEALIVLNDVNTIVVVDRITFEKKYEITSGLD
NPRYIAIVDDKAYVTNWGPDTFNTNDDYLAVINLTTGTLEASTISLSYGVEQIVANNNKL
YVTHTGAWSSNNIVSVVDLSAGNAVTEIEVNDNPDDIIVDNSGNLIVLCEGNTLYNADWS
VAGITTSSISFINTSTNTVTNKIEFADQEKASLLSYENGTIYYYKGADSTVYSINESATT
LATSGINTGSIYGMSVKDNKLFTTSYSFTALSKLMVTDLSTKEAIYTSPVGLGASKIYFN
>FCMOIPGL_01634 Vitamin B12 transporter BtuB
MKRGVLFTVFFIITHTVLSQNDSIRNILKEIVVVTKIEEANKVIGQKKIELGSIQIIKNP
INFTNLLRFNSPISFRDYGNGGVSTARFRGTSASNTAVLWNGISINAMGSGQTDFNSLSA
SISDEIIVNSGGGSVDYGSGAIGGTVHLNDNLSFKKHKDFNLFSSYGSFNTTSNFFKAHI
GTGKWAVKFAATLNYSDNDYTFIDTRYKNNDGSFLKNENGVYKNYGVNFSVGYKFSNKNK
LYFYTTGYYGDRLFSDGLPNPSAGSERNEDFNQRNLLKWTSSFSNFTQTLNVAYLTQEYR
YYDDKNASDFVFGKSKNYNFNYNLKYRFSNYFKVLTSFIYDENIGTTNDILSKKRTFFAA
LAKVTYKPTEKLTTAVSFRKESNSDFEVPLLVSVAAEQELSNSLLLKANLSTNYRIPTFN
ELYWPVVGNLDLIPEESVQGELGATFKKKNLKITSSLFYIHLKNKILWLPTVFSNLWRPK
NVGDVTHSGVETAIKLSKKINKHSFNFSTNYTFTMAKNKETDTFLPYAPKHLLNFNFEYD
YKKMSFFMQHLYQSKVYTNEINLDFYSLESLNVTNFGSDLKVFENKKNTIKIGFKVNNIF
NNVYYFSNLRPMPGRNYNINLNYKF
>FCMOIPGL_01635 hypothetical protein
MKTQNEHCRKKTYEKVTLELKLLVVDQIQNGQISTNFASKKYDIPRTTIGYWIKKYSTLV
QQNTGMSKINEIKKLKERIEALEFIKDFQQDIIADMEIITGVDLSKKSLPKTLVKEIELK
KKNRLKESGSMNVLGLVNKPSTKDVKSKKSNK
>FCMOIPGL_01636 hypothetical protein
MVLDYRKKVGMRTGGIKLYDELKSDFIKQNIKMGRDKFYDFLRLHNLLVPKLKNYVTTTD
SNHQFRKYKNLIKDQVPNRPEQLWVTDITYIKTENGHNYLAIVTDAYSKQIMGYKLDNNM
KTSLCTEALAMAIKNRKYPNEKLIHHSDRGFQYCNPKYTAFAEENGMIMSMTEQYDPYEN
AIAERINRTLKYEYGLRNCIKNTAIAQEITKQAVDIYNNLRKHFSLDLRNPADVHLNPNI
KYKSYRKNKVNLPELKI
>FCMOIPGL_01637 Bifunctional adenosylcobalamin biosynthesis protein CobP
MIHYISGGERSGKSSYAQKMAENISKTPIYLATSRIWDEDFRARVDKHISDRDDCWTTLE
EEKNISAVIADKSTVVVDCVTLWLTNFYVDTKYDIQESLKLAKQEIEKLVEIDANIIIIS
NEIGMGLHATTESGRKFTELQGWVNQFIAKKANKATFMVSGLPLKLK
>FCMOIPGL_01638 Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase
MTSTIKPLCKEIQIALQKKIDFKTKPLGSLGLLETIAIKIGSIQNTLTPKIIEPTIVVFA
GDHGITKTKGVSPYPQEVTQQMVFNFLNGGAAINVFCKQNNINLKIVDAGVNADFDQNND
LISLKIAKGTKDFSLGKAMTTAQCNLALEKGKEIVNTLFHKNCNTIGFGEMGIGNTSSAA
LLMSYFTSINIENCVGKGTGLDDKGLQQKKTILKEVYEKHIKNIDSPTEALATFGGFEIV
MMAGAILEAAALKMTILIDGFIVTSALLAANAIDKNVLDYCIFTHSSGEQGHQKILDYLN
VKPVLNLGLRLGEGTGAAIALPIIESATLFLNEMATFESANISEA
>FCMOIPGL_01639 Adenosylcobinamide-GDP ribazoletransferase
MKKEVHYFLTAILFFTRIPCPKWVGHSSEMLNKSNRYFSLVGILIGFIAAFIYYLATFIF
TVEIAIFLSMISSIWATGAFHEDGFADTCDGFGGGWTKEKILTIMKDSRLGTFGVIGLFS
ILILKFSATQALSLSTINIPLLIISGHAISRFIATILLYTHPYVRDIDSSKIKPTTTQMS
KKSLSISFFFGVLPLFFFQNYWVFLCLLPLLITYWYLARFFKKWIGGQTGDCAGALQQVA
EVVFYLFLLVLWKFY
>FCMOIPGL_01640 Putative phosphoserine phosphatase 2
MEILLIRHTTPKIAKGICYGQSDIDVTDTFLKEIKPILQAVDVKDTETVFYSSPLKRCKK
LAKKLSTNVLFDDRLKELNFGDWELQNWKDINKKELDYWMNNFVKVSATNGESYLDLHAR
TTNFLLEIAKQGHKKVVIITHAGVIRSLFSFINKTPLEKSFDLKLQYAQVLKIKY
>FCMOIPGL_01641 hypothetical protein
MKYFLSLLIISSFFISCQKKRAFQTKNKSVKSTVKYAKGFDIITTGNQKKLIIKKPYQNA
KETFMYILGNKTNVAKNELKVPIKNIVVTSTTHISMLEQIGAENYLIGFPQTKFISSEKT
RKRIEEGSIIELGSEQTMNTERLIELAPDLVIGFGLNGNNKTYETIERNGIPVLYNGDWL
EETPLGRAEWIKFFGVLFNKEKEADSIFNVIEANYLDVKKTALKTKKIPTIISGNLFKDV
WYMPAGKSFIATYFKDANTNYLWKDTAGNGSLPLSIESVLEKGQNADFWVGCGLFENKED
MLRSNQYYNSFTSFKKNKVFTYATKKGATGGLIYFEKSPTRPDLMLKDIIKITNPDLLPN
YNLTFFEKMY
>FCMOIPGL_01642 hypothetical protein
MKKLHPKSNIDELCYPFIYEDSSLCDYEIETDQLTRSVAWAIDELSTLIINYPKSEELKK
LEKELNWLLPLCYHLNGSIRGKLAITENDHKQLLVHYRNMKLLVEDAISGFVLPGGKSPV
GILNQCSSLSKKAIRLMVIIHNNEQKEVADILPKFANLLCNYFFTATILINKVTGFKETP
FVSKSY
>FCMOIPGL_01643 GMP reductase
MRIENELKLGFKDVMIRPKRSTLKSRSQVTLEREFKFLHSTITWAGIPIMAANMDTVGTF
EMAKALAKHKLFTAIHKHYSIEEWRNFASSSSENILKNIAVSTGTGKEDSEKVKQILTEF
PQINFICVDVANGYSEHFVKFVQKMRKNHPNKVIIAGNVVTGEMVEELLLAGADIIKVGI
GPGSVCTTRVKTGVGYPQLSAIIECADAAHGMGGQIISDGGCKIPGDIAKAFGGSADFVM
LGGMLAGHEESGGDLIEKNGEKFKAFYGMSSETAMNKHVGGVANYRASEGKTVEVSYRGN
VDKTVIDILGGLRSTCTYVGASKLKELTKRTTFIRVQEQENKIYN
>FCMOIPGL_01644 hypothetical protein
MKNLKITLLFLFLIISFSCKKEVKNVAKKTPIESTIKYAKGFDIVNENGVKKLIIKTAYQ
NSDEVFEYIIKNNTDKNESTKNTIFTPIQKIVVTSTTHIPMVELLNEETSIIGFPYSKYV
SSEKTRQLIDDGKIAEIGKESSLNTEILLDLQPELIVGYSVSSADKSLTTLEKAGVNVIY
NGDWLEETPLGRAEWIKFFGVLFDKEKQADSIFKVIESNYQIAKNIALKSTKKPTILSGA
IMSKDIWNLPGGESFVAQFLKDANLTYLWQESEGRGSLSLSFESVFDKGKNAEFWIAPGY
FSSKEQLLNSNKVYTEFDAFKNDLIYTPSNKKGKTGGIIYYELAPTRPDLVLKDIIKITN
PELLPNYELTFFERMQ
>FCMOIPGL_01645 hypothetical protein
MKFKLIIIFLFFVGTTFSQSEVYYFKDSESKLTYKNIEKEEFQVLEKRVLEKYSKATFWF
KIPANQSDLDYIFRINNVIIKDAHAYQNYQEVKKLKNQRFVSYKFSRQSPLYVKVNAKFN
SYFPIELKTEEATLYKDKIELLIDGFYYGIAFLVVLFCIVYFYFFKDNSFLYYSFLLVSL
TFSFLVTDGIFKFFNLGDKAIEFLILLNYLFLAYSSSKFANSFLLLDIYYPKIKKYTHII
IVSIILFVNLYLVYSKNAIFIIINILTFILLLTYWFMGVLLFKKDLHTKLFTFGYVILLF
SGIDFFVLKNLGISFFESSSANLKIGGFAQILILSFAIMSREKKLRRHNYYIKNEIINFN
KVSKKPNLIDAERASIEETLNNLSVRERVIYDQIIEGKLNREIADEIKISSNTVKFHTIN
IYEKLNLEKTE
>FCMOIPGL_01646 Putative HTH-type transcriptional regulator YhjB
MKYIVVTFILFFHAIVFSQKDVYFYKDVESTLTLENVKDQEFLVLENQILEKHSQATYWF
KIPAYNTNLNYIFRIPYDRFNTANVYQNSKSIEKLTNRRYLSYRFSRDNDVYIQVIPKLH
SYIPVEFGSEEIMSLREKNNLLLNGFYYGFAILIIIYNLFYYFLFKDNSFLYYSLFLSNI
CFGIFTMDGMLNYYNINEGLNDFLMCLNYVLLAYFSSKFSDNFLFLDIFFPKLKRYSYGI
GIIILFLAVFYVTTKNYYFLFFLNILVFLLLFINWFCAVLLFNKNVYTKILAIAYVIILF
SAIDFFILKFLGISLIDINAVTIKIGAFLEMIILSIAVLYRMKILKDENIHIRNEIIKYS
LQLKNLTSINDKTNININILSFREREVFDLICAKKSNKEISSEINISINTVKFHVKNIYE
KLNVKSRQEVFILKNSFKK
>FCMOIPGL_01647 Aspartate racemase
MKKIGLIGGITPESTILYYRILNQLNAASLGKSHSAEVVINSFDFGKIAKLQKENRWDLL
DEMMADAGKSLENAGASCILICANTMHLCINAVRNAVKIPVIHIADATSKEIIKKRLKKV
ALLGTKYTMEKIFFTDVLKSFGIEAIIPNLEERNIIHNIIYDELASGIINKTSKEKYIKI
IERLIKNGAEGVILGCTEIPLLIQQENVFVPVFDTTKIHATAAFNFSTKYLQQQQQQQQQ
>FCMOIPGL_01648 DNA gyrase subunit A
MSEEINENEHEEELTNEGEQLDSPQEETITKVTGMYKEWFLDYASYVILERAVPSLEDGL
KPVQRRIMHSMKDLDDGRYNKVANIVGHTMQYHPHGDASIADAMVQIGQKELLIDMQGNW
GNILTGDRAAASRYIEARLSKFALEVVFNPKTTEWKLSYDGRRKEPIDLPVKFPLLLAQG
AEGIAVGLSTKILPHNFNELIDASIKYLKGRSFKIVPDFLTGGIADFSHYNDGKRGGKVR
VRAKISQLDKKTLIISEIPFSTTTTSLIDSILKANDKGKIKIKKIEDNTAAEVEILVHLP
PNVSPDKSIDALYAFTNCETSISPLACTIEDNKPVFVGVSDMLKHSTDLTVDLLKQELEI
QLNELEEQWHFSSLERIFIENRIYRDIEEEETWEGVIDAIDKGLQPHIKHLKRAVTVDDI
TRLTEIRIKKISKFDIDKAKQFIESLEDKIAVVKNHLANLIDFAIDYFKRLKESYGKGKE
RKTEIRIFDDIVASKVAMNNAKLYVNREEGFIGTSLKRDEFVTDCSDIDDVIIFRKDGVM
MVTKIDSKTFVGKDIIYVAIFKKKDRRTVYNFIYRDGNRGASYMKRFNVLSVTRDKEYDL
TNGSKGSIVHYFTANPNGEAEVVTVNLRAVGSVKKLKWDIDFADLGVKGRAVRGNRITKY
TIKSIDFKSEGVSTLKPRKIWFDDTVQRLNVDERGELLGEFKAEDKLLIITQSGKAKAVK
PDLAMHFEDDMIVLEKWKPNKPISAIYFDGEKERYYIKRFLIETTEKEEIFISEHPKSHL
EIIATDYRPIAEVQFSKRSLENEEVNLEEFIAVKGIKALGNQFTTDKIKQVNLLEPLPFE
EPEEEKIEEVEVVDEEVLEDKLPIEIPETKKPVLEELSADEKAKIALQKSIARKKAEQKK
IDDENQTKLF
>FCMOIPGL_01649 hypothetical protein
MKEEENLIIPDEIISNKIYLIRNQKVMLDRDLSELYQVETKQLKRQVRRNIERFPEDFMF
ELTEKENENLRSQIGTSSWGGSRYVPMVFTEQGVAMLSSVLKSDRAIAVNIKIIRIFTKM
RDLLSDNLSLRLEIEQIKKKMNNHDKNIELVFSYLDELVERKEEKKERTQIGYKKD
>FCMOIPGL_01650 Type 2 topoisomerase subunit B
MSKETKYTEDNIRSLDWKEHIRMRPGMYIGKLGDGSSADDGIYILVKEVLDNSIDEYVMG
AGKTIEISIHGNKVTVRDFGRGIPLGKVVDVVSKMNTGGKYDSKAFKKSVGLNGVGTKAV
NALSDFFRVESTREGKSASAEFSQGNLINQDFLEETSRRKGTKVSFIPDESIFKKYKFRN
EYVSKMLKYYVYLNPGLTIIFNGEKYFSEHGLKDLLEDNNNVDDMLYPIIHLKGDDIEVA
ITHSKTQYSEEYYSFVNGQHTTQGGTHQAAFRETIVKTVRDFYGKSFEASDVRKSIISAI
AIKVMEPVFESQTKTKLGSTEMGGNLPTVRTFINDFLKTKLDNYLHRNADVADSLLKKIV
QAERERKELSGIRKLAKDRAKKASLHNKKLRDCRVHLADIKHENYLDTTLFITEGDSASG
SITKSRNVNTQAVFSLKGKPLNSYGLSKKIVYENEEFNLLQAALNIEDGLEDLRYNNIVI
ATDADVDGMHIRLLLITFFLQFFPELIKEGHLFILETPLFRVRNKKQTFYCYSDEEKREA
IEKLRGKPEITRFKGLGEISPNEFVHFIGNDIRLDPVMLDKEMSIEQMLQFYMGKNTPDR
QKFIIENLKVELDYVEEEV
>FCMOIPGL_01651 Diaminopimelate decarboxylase
MERTQLLELAHKYGSPLYVYDTDKIESQYNRLTDAFSSVKNLKLNYAVKALSNINILKFF
KNLGAGLDTVSIQEVQLCLTTGIDPKKIIYTPNGVSLTEIEEVAKLGVQINIDNLSILEI
FGQKHPEIPVCVRINPHIMAGGNSKISVGHIDSKFGISIHQVPHIKRVVENTGMNINGIH
MHTGSDILDIDTFIRATEILFDVAKQFENIDFIDFGSGFKVPYKEGDISTDIEQLGLQLS
ERFNDFCVEYGKEITLMFEPGKFLVSEAGSFLAKVNVVKQTTSTVFAHVDSGFNHLVRPM
MYNSYHHITNISNPEGRDRYYSVVGYICETDTFASNRRIAEISEEDVLCFHNAGAYCFSM
ASNYNSRYLPAEVMVYNGKDYLIRKRQTLKDILNNQEVIDFSKENKTSKDQKIEA
>FCMOIPGL_01652 Fumarylpyruvate hydrolase
MKILGIGSNYVTDIKDIEEKKKGKKFIFSKPESSLAVNCDVVYPSAITNQLIYEVELVVK
IGKEGKNISKEEANSYISEIAVGIDYTATDILKDARETKHPWDFAKGFDGAAPISSFKPV
SDYNLGDIDFELKINGQEKQKSNTAYMINDFADIIVFISKYMTLQPGDLIFTGTPALGKG
EIFKGDKLQCYVNGELLLDFKMI
>FCMOIPGL_01653 Inner spore coat protein H
MKKITHILMLFLITSTALSQDLYDINTIQKIEIVFAETNWDALLDAEKAGDNNYTEATSV
TINGTVFNSVGVKYKGNSSYDRNYAKNPFHIELDTYVDQDYQGYTDIKLSNGFSDPSFVR
ETIAYNIVNQYMDAPEANYANVYVNGTLIGLYTNTESISKKFVNKHFYSKDNAFFSCSPP
DGAGPTSSVLPSLEYLGTNSASYEDGYEIKSDDDEDLTVAVAHWNDLIELTNILNNDISN
IENVIDVDMAIWMLALDNVLVNLDSYIGEFKQNYYLYKSDNNQFKPVMWDLNMSFGTFSM
TGESSSGGGPGGPGGGPGGGPGGSSSGTLNSTTDKAELDYLLHTDDDSFPLFSKLMEVPK
YKRMYLAHYKTILTENISNSNYLTLANDYQTIITTSVTADTNKFYTNAQFSGNINTDYSV
GNNTAPGLTNLMSARSTYLLAQSDFTNTQPTISNIASSKDTPTIGDQITLTTTVINTNTD
AVYLGYRSDNTLPFTKVLMYDDGAHNDGVSGDNVYGATITVDTDYTQYYVYAENDNIGAF
SPAKAAYEFYTINATYTTLNVGDLVINEILASNDSGETDEEGEFEDWVELYNTTSSTLSL
DNLYLSDDEDDKLIYQFPTGTLLAPNSYLIVWCDKDEEQGDFHADFKLSAGGESVILSYA
DGTVLENITFGDQTTDMAYARSPNGTGDFVIQTPTFGIDNDTVLSTETIVSDLNVHFYPN
PIQSTLNIESVTSIQSLKVSSILGQVFYNKENLNTTKTEVDFSSLSKGVYFITINKSKIV
KIIKQ
>FCMOIPGL_01654 hypothetical protein
MKKITQLLMLFLITFSAFSQDSYKIESSISTIKAGELVINEIMASNTKTASDQDGEFDDW
IELYNNSNQTLSLDNLYLSDDSTNLTAWQFPAGLTIEAGDYLIVWCDKDDEQSGLHADIK
FSLGGESAILSYGDDNSIIENITFGVQQDDMSYARNPNGTGDFVIQSPTFESNNNSGQEG
EEYDKIAEGDLVINEIMASNTLTVTDQDGEYDDWLELYNNSTKTLSLDNLYLSDDFSALT
TWRFPSGLTISPGSYLTVWCDKDDTQAGLHADIKFSSNGENAILSYGDADSIIESVSFGE
QIDDKSYARRPNGTGDFVIQSATFESNNNSGVIVDDEEEEFDKIIAGELVINEIMASNET
TVTDQDGEYEDWIELYNNSSKTLSLDNLFLTDDSTVLTTWKFPTGITIEAGGYLIVWCDK
DDTQAGLHADIKFSLTGESAILSYGDEDSIIENVTFGLQQTDMGYARVPNGTGNFQIQSP
TYNANNGNNLSVNDKENSLNFNFYPNPVKSILNIESSTNQIESLKVSSILGQVIFNNQNI
NTTKTTVDLSSYSKGIYLVTINNLEVIKVIKE
>FCMOIPGL_01655 hypothetical protein
MKIRLSKIEDIPKIMQIIEDAKTYLASQNIDQWQNGYPNSAQVESDILKEESYVVINNEN
KIIATSMFTTNPEPTYKTIDGNWLIDETKTYGVIHRMAIKKEFRKFGLATFLFDEFHLQL
LEKNIKSLKIDTHEDNLGMQSLIKKLGYKYCGIIYTNYNAKRLAFEKIIS
>FCMOIPGL_01656 30S ribosomal protein S1
MQLLSYIIEKTQLSSKSIENTISLLNKEATIPFISRYRKEMTGNLDEIQIGEIVKYKEIF
EALEKRKKAILKALEEQGVLTDELTQKVKSTKDLIALEDLYLPFKKKRKTKAETARLQGL
EPLAKMIMSQRVNNLEHTASKFTSNEVETIQIALEGARFIIAEWINERTDIRTNIRRELE
RFATISSKVIKTKIEDEKAQKFKDYFEWNEALKNIPSHRLLAILRAEKEGFIRVKIEIDS
EKAIQKMEDRIIRTQNECTSQIQIATKDAYKRLLFPSLSNEALSLAKEKADENAITVFSK
NLKQLLLVSPLGEKRVLAIDPGFRSGCKIVCLNAQGDLEHNETIYPHAPQNNLIEAIKKI
SFLADAHKIDAIAIGNGTASRETEQFVKKIQFKNPVDIFVVSEAGASIYSASKIARDEFP
NFDVTVRGAISIGRRLQDPLAELVKIDAKSIGVGQYQHDVDQSKLKKSLDTVVESCVNTI
GININTASESLLSYVSGIGPKIAQNIIIYRNESGSFTSRTAIKKVPSLGAKAFEQAAGFL
RIKNAKNPLDDSAVHPENYALVDKIAKDNKKNVSDFIGNKELLNKIQLKNYISKTVGLPT
LEDIIKELEKPGLDPRAKAKVFSFDATIKTIDDLRIGQLLPGIVNNITNFGCFVNIGIKE
SGLIHVSNLSDTFVKDVNAIVSLQQQIIAKVIEVDVVRKRIQLALVK
>FCMOIPGL_01657 hypothetical protein
MKEEKNKTNRKLTPLTFKEKISFFLFPFGYGSDLFPIKDINDSELERFKKYGFDKKIEDA
IVAKKLGIIFYLLIPLILLLSTS
>FCMOIPGL_01658 DNA topoisomerase 3
MKVCIAEKPSVAREIANILGANTKRDGFYEGNGYAVTYTFGHLCTLLEPKDYKPHWKSWD
LNNLPMLPERFDTKVTGDSGIKKQFNIVKSLFEKATVVINCGDAGTEGELIQRWVINQCN
YKGEVKRLWISSLTEEAIKEGFNNLKPSEKYDNLYYAGYSRAIGDWLLGLNATRLYTVKF
GGFKQVLSVGRVQTPTLAMLVNRYLEIQNFKPEPYWELQTTYRNTLFNYEDGRFVKEEDG
KILADKVKQSNFEIVSVIKKKGKDYAPKLFDLTGLQVYCNNKFSFSADETLKIVQKLYEM
KVVTYPRVDTTFLPNDVYPKVAGILSKLTNYSQLTQPLLEKKIKKSKRVFDDKKVTDHHA
IIPTGIEAHLQYNQQQVYDIITRRFIAVFYPDSDVSNTSVIGKADKVTFKTTGKEILTKG
WRVAFETQESKIKKELNEAQTLPSFVKGEKGPHEPSFLQKETKPPRNFTEASLLRAMETA
GKQVDDDEMRELMKENGIGRPSTRASIIETLFRRKYIERKKKLVLPTQTGIDLINIIDNE
LLKSAELTGRWEKRLKEIERGEFNAGTFINNMKKMVDELVYEVRSNTSRKRISSNTTVSS
NAVENSSKSNPKAKTKKQVAGKTCPKCKKGHILKGTSAFGCSEYKNNCDFKIPFEIYGKK
VSENQIIRLLDKGCTTNLKGFVLEDKKVEGLIRFDNDFNLKLEPKEKTVTSSPVEKSSDK
ISCPKCKKGTVLRGKTAYGCSNHKIGCDFRFSFDDIKKMANGKPLTKELVLKIISN
>FCMOIPGL_01659 Long-chain-fatty-acid--CoA ligase FadD15
MNYKHLLKVIKDNTSRFTTKEAIFYKEKTSQSWKGISWNSFYFQIQQVSKALINLGIREQ
DNIGVFAQNMPEWIIADLGIMGVRAVTIPIYATNSKKEVEYVINDAEISILFVGDQEEFN
KVENISEENKYLKLIVVLTKTVDIKNHKNAVYFDDFIDAEYPKSIETELKKRYFESDLND
LASIIYTSGTTGEPKGVMLDQSNFASSLKAHEAELDVDENDVSLSFLPLSHIYERSWVFF
CLQQGIQVYFNQDPKKIADVLKEVKPTLMCTVPRIFEKIFTAIQEKRKEASPTKMKLASW
ALGIGNKYHNKFHRLDKKVPLILELKYKIADKLVLSKLRDVFGGNIKFMPCGGAPLGPDL
VSFFHSFALNVKCGYGLTETTATVTLFGNQFFEFNSAGKTITGSEIKIGNNNEVLVKGPG
VMKGYYKKPEATSEVFENGWFKTGDAGKIDKLGNLVITDRIKDLMKTSGGKYIAPQKLET
AFVSDSFIEQIAVIGDQQKYVTALAVPSFENIKKYAEDHKISFKDIEDLISNIQIKEMFE
KRFEELQKEFSKFEQIKKFTLLSKEFSIEAGEITATLKLKRKVILEKYKALIDKMYAD
>FCMOIPGL_01660 hypothetical protein
MDFTNPLVYGVPCFLGLILLELTYSKHHKKEKNKEIYKWKDLAASLTMGIGSAILAPLTK
TIAAIVLFNFVYEIFNPIVEGIRTNIMGYESFGYAWYTWIICQLLDDFSYYWFHRQNHNV
RFLWAAHIVHHSSDNFNLGTAVRNGWFTIFYKPFFYMWIPAIGFPPEMVVVCLGIEALWQ
FQLHSVYVPKLGIIEKVFNTHTMHQVHHAQNLEYMDKNHGGFLNIFDKIFGTWKELDENI
DIKYGVTHPPNSYNPIIILTHEYKDIWNDMKKSKNWYHKFMYAFAAPGWSHDGSTLTIKQ
LRKTLKNNE
>FCMOIPGL_01661 DNA-binding protein
MSKEQPNNPLHGIKLATMLEELFLEYGWEELGNITNINAFKNNPTYKSSLKFLRTTPWAR
GKVENLYLKTMIK
>FCMOIPGL_01662 Xaa-Pro aminopeptidase
MKYLKILLITCLTFVLNGFSQTPTDYLTKDFHKNRREILRAKMPTNSIIVVFANPVRNRA
NDVDYVFHQDPNFYYLTGYREPNAVLVMFSDNQTDKNGNLFNEILYVQKRDKRAEQWNGK
RLGVEGAIRELGFKTAMNAEDFVKLNIDFKKFDKVFIEKFNDDYRDLSGSADIFNLVKDF
KIKAGYDPNIYLSRVKEYVYNNIANTPIESSANVIQIINQVEGRFEEIKDDKLIKEYKTA
NTDVLKKDIKQKITLALKPKTNIDITFLTSNLATMREVKTAEELKLLTKAVRISAIGQIE
VMKAMKPHMSETELQGIHEFVYKKYGAEYEGYPSIVGAGNNGCILHYIENNKTKIGNDLV
LMDLGAEYRGYTADVTRTIPASGKFTTAQKEIYDLVYEAQEAGITLYKIGTNMQAPNLAA
IKVINEGLFKLGIIKSADEKHPYLPHGTSHHIGLDVHDPGNYGNFEENMVVTMEPGIYIP
DGSNCDKKYWGIGIRIEDDILITKNGPVNLSEEAPRTSEEIEKMMAKKSVLDDFVLPNLD
>FCMOIPGL_01663 Aminomethyltransferase
MKNIALHSIHEKLGAKMVSFAGFNMPVQYEGVTAEHLTVRDAVGVFDVSHMGEFLVSGEN
ALALIQKVTSNDASKLAIGDAQYSCFPNENNGIVDDLICYKIKENQYLLVVNASNIEKDW
NWISKYNEEFKADLKDLSEDYSLLAIQGPKAVEAMQSLTSLDLAEIPFYKFKVGDFAGIE
NVIISATGYTGSGGFEIYCKNSEVVQIWNKVFEAGASFGIKPIGLAARDTLRLEMGYCLY
GNDIDDTTSPIEAGLGWITKFTKDFVNADALAKQKEHKPERKLVAFELDERGIPRHGYDI
VDGNGNIIGNVTSGTMSPSLQKGIGLGYVPTLFSKLGSKIYIQVRKKAIPASIVKLPFYK
G
>FCMOIPGL_01664 putative HTH-type transcriptional regulator YybR
MHIRTFCANLFVTLVLKQKKMKKSYCPIDTFINTIKGKRKCTIILHLFQGDKRYGELVKL
LPDISERMMTKQLKELTEDGLITRTVFAEVPPRVDYSLTALGKEIHPTLKSMFRGGLLFE
KSIIRVEN
>FCMOIPGL_01665 putative acrylyl-CoA reductase AcuI
MKSTYKAFRIEEHEGNFTSSIKQVPFTPLVKGELLIKVHYSSLNYKDALSASGNKGVTRN
FPHTPGIDAVGIIVSSESNKFKIDENVIVTSYDLGMNTDGGFAQFVKVPEDWVVKLPQNL
SMKEAMIIGTAGLTAGISVLRLSELVKPEDGSIIVSGASGGVGSLSISILNKLGYKTVAI
TGKETEIDFLKSLGADEIIMRKDFEEMDKKPLLKPIYAGAIDTVGGVILENIIKSVKPMG
TITCCGNVASPKLDLTVFPFILRGITLIGIDSQNYPMIYREKVWDKLSTDYKTAKLTETC
TEINLDELKEKINLMLAGKLKGRTVIKMDI
>FCMOIPGL_01666 hypothetical protein
MQTTKLSNESILPLTCSRSGSCCFGKAVMLNPWELLCFSKEKKITPREFRDLYCEFGGIQ
LLFDGKPDKKGQKACSQYIDNFGCSVHEGRPLACRLYPLGRKIQFDKAHYIYEGETFPCL
TDCAEVLDLPKLSVGKYLQGQEAEPFEKAQDEYLIIMQNIADIAFELLLDTGLSASGDTK
TLPLWREIGNELPEILAERIGKEWIDLLMIPEITNEIENPITFAHKHNDLLLLKAQEKFG
SIQTLQEVHDASVLIMAVALHLARGLGANPKEIAEHFIEIAKSHGAQE
>FCMOIPGL_01667 hypothetical protein
MKNNISIEDQYKRTSLFEKENVNYLVHVLKRFNTVPKVNNINIITSSSTPDLFKIEPNKS
ILIGTLYLKNPVLALVYLRYGIEWQLWYKALNGEKHATALCNIAALEVTRIFYKLLTKND
KEKLENLDYFLIDLIKNEEGLNADSLLKHEGLEAIHGINSVNEVFKKSWKPIIDNLAKPT
EYLLMSGGDLRLNIDEIDLLNKYGCRPFPRPEAFTFASSTATSVSNFAFDKSDKTRSILI
KESLKNGFKNTAIDFSESLKNSIKSIFKLNNGCEIIFSPSGTDSSLQVAAITQIVTDKDI
THVLVASDETGSGVPAALKGCHFENNTALNYPAKKGEKIEGFRDIDLIKIPFRDENGQLK
STPQLDTEVYNAISKMNELGRHIVLHVMDHSKLGYQSPSENMLENLNTLEDLSLQVIVDA
AQLRLDPLDIQNYLQKGYIVSITGSKYFTGPPYSGALIFPESVSKLVKSVKNILPEGLNK
YYNHSDWPVSWFCSKDLSDGFNYGSNMRWKAAIVEMERYYKTPILYRNMGIEMFCNFVND
SINEASFLAPLSGDEINENLYEAKEFGIRNIRTIFPFFILNDKEVLSVDCVKKLYVLLNT
DISNQFEGSSLEIIRLAAQKCHIGQAVNVMFDNDTQSAVLRISLGARVISESWVNRDISL
YFRNIEAQMSEITVIIKKIELILTNPQILN
>FCMOIPGL_01668 hypothetical protein
MKLTVLTENCAGSGFLAEHGLSYLIENEKEKFLFDTGATDVFLINAQKLGIDIQQEVETV
VLSHGHWDHGNGLEYISNKTLITHPNVFMKRYRQKEDVNIGLKLSKKEIEKKFTLILSKR
PYYLSDNIIFLGEIPKVNDFEAKETTFSDKLGQPDIVKDDSAIVVIQNNEIIVITGCSHA
GVCNIIEYACKVTKIKNVKAVIGGFHLKQNNLQTQETIKYLKEKNIKKIYPSHCTQFPAL
VAFNEVFHIEQVKTGMILNF
>FCMOIPGL_01669 Acyl-CoA thioester hydrolase YbgC
MITDVFQLRPRYGEVDKMGYVYHANYVTYCHQSRNELLRKLGLDEVILEEHNIMLPVISF
DIKYKKPAHFDELITIKTTIKEMPKVRFSFEFEIRNEQNILLNKSKSTVVFVDIDSRLPK
NIPTFIEKILITKFKTNVV
>FCMOIPGL_01670 GTP cyclohydrolase-2
MSDKNISILQGERVQLPTKYGHFELIPFQEKESGLEHMALIKGYFKANETVLTRIHSACA
TGDLFGSLRCDCGDQLIEAMNLIEKNGSGIIVYLQQEGRGIGLMNKMKAYKLQELGMNTI
EANVHLGFAADERDYQIGTEILSKLSIQKVNLLTNNPEKIIGLEENGIQVIDRTPLIIPS
NSFNKNYLDTKEKQMGHQLSKEKQVNNCYDN
>FCMOIPGL_01671 hypothetical protein
MKKIAIPITKDNKIENHFGRCKFYEIYSFSDKNEIIDLQLLESDGKCGCKSNIINTLTNE
GVTFMLSGNIGDSAMHKLNNAGIGVIRGCKGNSADVILEFVEGKITDNGISCVKHHHNHT
KGHAHACNH
>FCMOIPGL_01672 hypothetical protein
MPNFDHKGPEGLGPKTGMQLGKCRKTKTDNNEDPINRPFKKGRRNNNNKTKITTSNFLK
>FCMOIPGL_01673 hypothetical protein
MPRPKKKRKVDHPPKMLGFKPFGIRFCDTEHIVMQFEEYETVKLVIYDKLSQDAAAEKME
VSRPTLTRIYNSALKKIGKAFVEGKSILIKGGDFEFEKDWYKCKTCFKLVDGVKDDAICG
DCPSDEKNELENLNE
>FCMOIPGL_01674 hypothetical protein
MKKTFTITLLGILLFVSCQKQVKKEVVTNETEKKVLITNFTEKIEIAHKKAEFLKHEAIQ
FDAFIEFGGNEIFNANVTISTNSDIAKITYKNGDEIYVNKENIFVSPSLKDNKGVRFHAY
TWGYFFLYPYKLSDKGTKWNYDFKTKETTNNFDVAKLTFEANIGDAPDDWYIVYTNKNTH
LLEHVAYIVTAGKTKEAAEKDPHAIKYEDYKMIEEIPFATNWGYYGWNIESGLSDKIGNA
KITNIHFVEGFRKDFSIPENYIKK
>FCMOIPGL_01675 hypothetical protein
MDQFFLVLSLLLIILSLLPFIKNQHWIFRVPEFLKIQLFTLKITAIIGLFVFAKKDTWFW
LVIVFLVILIIYHAYLLANFIKLKPKQHKLVKTLKEIKVISANIYQFNKEFERFKNLIRK
EKPDIFVTIESNKDWEFELRDLENNYPYNEKITLENTYGMHLYAKIPILKITTHYFVADD
LPSIEALFKTESGEEFVVFCVHPPPPSPTEENTSKERDGDLMCIAKRVKEIKKPTLVIGD
FNTVAWSRISKLFQKNSELIDGRTGRGILATYHAKYWLFRAPLDLVFHSSTIFLKELKVL
EYIGSDHFPICCIFCINTSNFNQEKQVKTITTEEEKETFSLIKKGKKEDSNNRNT
>FCMOIPGL_01676 hypothetical protein
MWLRVSCKLAFNIELSTPFVLMLRPRSGEEQWIERDEFKIAPNVPITEFTDHYGNLCQRL
VAPKGNFSIHTTSDVKTSEFVDVDFDAPFVEIKNLPNDILCYLLPSRYCESDRFNELANA
ITANVNPGYSQVFAIEEWLRTNISYIPGSSEYPISAIEVNYKLSGVCRDLAHLGIALCRS
LSIPARMVVGYLHNLYPMDMHAWFEAFVGGRWYTFDATQTGIKGGYVSVGYGLDAADVAI
FNQFGPVAHSLQQSVSVIQIKN
>FCMOIPGL_01677 hypothetical protein
MKKILLFTAFSFLLIACSSIKNTQEAINNGNYDFAINTALENLKKNKAKKGNQPYVFMIQ
EAFAKATAKDLDRISFLKKDQNPENIETIYGIYNNLKNRQEAIKPLLPLRILENGNEAEF
NFHNYDDEIIANKNQLSDYLYLKARKLFDANNKFDYRTAFDDLEYIEKINPNFKDVRNLI
NIAHERGLDYVIVSMKNETQKVITKRLEEDLLNFDTYGLNDLWTVYHGYKNPKIKYDFGL
ELNLRDIQISPEQVREKQIIKQKEVKDGFKYLLDKDGNQVLDQEGNKIKVDKMIKVRCEL
YQFTQFKSSKVIGQVKYVDLNTRQIIETYPIESSFSFQHIYAKFKGDKRALEDSFLDQIA
LKVVLFPTNEQMIYDSGQDLKERLKSIITRNNFRN
>FCMOIPGL_01678 Ribosome-binding ATPase YchF
MKAGIVGLPNVGKSTLFNCLSNAKAQSANFPFCTIEPNLGVVNVPDERIKKLEELVKPER
VQTATVEIVDIAGLVKGASKGEGLGNQFLANIRETDAILHVLRCFDNDNIIHVDSSIDPI
RDKETIDIELQLKDLETVQKRLERVKRTAKTGNKEAQIELVILLKVEETLLQGISVRAIE
FSEKEMELVKSLQFITAKPVLYVCNVDEASAVSGNSYVDKVKEAVKDENAEVIVLAVGTE
ADITELDDYEERQMFLADMGLEEAGVARLVRSAYKLLNLQTYFTAGVKEVRAWTIPIGST
APQAAGVIHTDFEKGFIRAETIAYEDFVAFGSEAKAKEAGKMRVEGKEYIVKDGDIMHFR
FNV
>FCMOIPGL_01679 hypothetical protein
MPKKLLYFTVLFIHILEMNSQTISGKIYNINSLEPIEKAAIITNLKSGTNSDEYGNYSLN
LNNVTTITFSCLGFQSKTISKNELIKRNYIVKLIENINQLKEFQLNIAKISLDSLLIKTT
RNMKENYLSSPVKQDVYAIENQKLDFKKLEFELNSSSILNRKKRKLAEKDLIKFADNLKK
RKPTFGTEFKSTILSNKFYSEKIKKDVDSYQVKEVQGFQKINIGNGISIKNIAEKLQNVV
LKHLSTKFTYKVKSGLFKVEDSLSLAETTKIADSLAKDNTFSDYNQTYPLSNIKRKGLFF
NVSSENNFLDQKYYKHKLEENELLGVNKYYVISFKPKKSKSKYAGKIYIDSSNFFIKKIE
YAYANGKRGEHLNLKFLFGIKFSENEHNVTLFYEKNENNKVYISYLKENNTNYAYIDRPI
KFIENSSDKNKVKFNIKIEINVNEERETLVNNITDYESDNLKKKTKEELKAAYKKRTPFM
TKEEYNTTDWKNRFLIKQYLEQYK
>FCMOIPGL_01680 Ferredoxin
MAIIITDECINCGACEPECPNTAIYEGADDWKYSDGTSLKGNVVLPNGKSANADEDQEPV
SDEIYYIVPDKCTECKGFHDEPQCAAVCPVDCCIPDDEHVETDEVLLEKQSFMHGE
>FCMOIPGL_01681 hypothetical protein
MITIQNRITAFAKLGDFLSQFSTDNIIKRDDIEHNEIFFDGFLHQIKIAQENNSWFTKDN
VLFTLNSWSKSLTNSNLTTFTNSINLDIKSPKKVAIIMAGNIPLVGFHDFLSVLISGHSV
VVKQSSSDKHLLPFLAKYLEYVEADFKGKITFTEEKLSDFDAVIATGSNNTARYFEYYFK
NKPSIIRKSRNSVAVITGKETEEDFVKLSDDIFQYFGLGCRNVSKLFVPKGFDFDAFFTG
MYAKKDIINNAKYANNYDYNKAVYLMSLFDLLENGFLMIKEDESYSSPIATVFYEYYDNE
IDLKIKLYEDREKIQCIVAKDFIENEVEFGQTQHPNLTDFADGVNTLDFLSTI
>FCMOIPGL_01682 Phosphoserine aminotransferase
MKKHNFSAGPCILPEEVLKKASEAIINFNDDNLSLIEISHRSKSFVDVMEKARSLSLELL
GLENKGYKALFLQGGASLEFLMVAYNLLNKKAAYLNTGTWANKAQKEAKAFGETVEVASS
KDKNFSYIPKGYSIPEDADYFHCTSNNTVAGTQIKAFPETNVSLVCDMSSDIFSRQLDFE
KFDLIYAGAQKNMGPAGTTLVIIKEEILGKVERHIPSMLDYQIHINSDSMFNTPSVFAVY
VSMLTLQWLKDLGGIPFIEEVNNKKAALLYNEIDRNPLFKGVVEKEDRSNMNATFVLTDE
NLKETFDKMWTDAGISGINGHRSVGGYRASMYNALPLYSVQALVDVMQELERTQK
>FCMOIPGL_01683 Hydroxypyruvate reductase
MKILANDGISKSGKDALEKGGFEVLTVKVAQNQLENYINEHNIDAILVRSATQVRQELIE
ACPSLKLIGRGGVGLDNIDVEYAEDNGLFVINTPAASSSSVAELVFSHLFGMVRFLHSSN
REMPLEGDSRFKELKKAYSQGTELRGKTLGIIGFGKIGQEVAKIAIGIGMNVLATDDEIL
SAPIILEFFNGQKTTFTIDTVDKEDVLKESDFITLHTPAQEDYIISASEIKKMKDGVGII
NTARGGILHEVDLVSAIENGKVQYAALDVFETEPNPAVQLLMNPEISLTPHIGAATKEAQ
ERIGLELAKQIIELLEN
>FCMOIPGL_01684 hypothetical protein
MIKENLIKIKESIPENVTLVAVSKTKPIEDLQEAYNAGQRIFGENKIQEMVDKYDALPKD
IKWHMIGHLQSNKVKYMAHFVDLIHGVDKFKTLVEINKQAKKHNRVINCLLQAKIAKEDT
KFGFSFDEIETVLSTEKIAELQNINVVGFMGMATFTEDEVQVSEEFLSLKNFFDKLKAKN
KFLKVLSMGMSGDYQLAIKNGSNMIRVGSSIFGNRNYNQ
>FCMOIPGL_01685 putative ATP-dependent helicase DinG 
MYAILDIETTGGKFNEEGVTEIAIYKFDGHTIVDQFISLVNPEKEIQAFVVKLTGINNKM
LVNAPKFYEVAKRIIEITEGCILVAHNTSFDYRILKTEYERLGFDFKRNTLCTVELSQQL
ILDQPSYSLGKLTRSLGIPMTERHRASGDALATVQLFKLLLEKDTEKTIIQESIKYFDRR
LEKERLQTLIDTIPNVVGVFYIHDSKGKVIYIGKGKNIKAEINKLFLKITRRAVKIQERA
TSVSFDKTGNELFTRLKYYIELEKLAPKFNFKKKFKMTLNNFNNDNFVIIDKGREVEENA
IILIENNIVYGYGYTNLAIQENDLSILESVLTKIENKEISKTIIKNYLNKNSVQKIVRF
>FCMOIPGL_01686 hypothetical protein
MGQTTLDELKMTIYDKDSTATAVVLYEHANIYIDVNNDYNTRTDFYFRIKILDKTAFDLA
NISIHLFKKKRLLDVKARTYNLTEIGTIEKIALSEDKIYTKDASENWTTKNFTLPNIKVG
SVIEYSYSIISPYLGIDDWLFQSDIPKIKSEFDAAILGNYKYKIRITGYLKLDKDDVSVK
KKCIYIQGLGEGDCAIYSYGIDDIPAFEEEDYMLSKKNYLSRLSFDLETYTSSRGVIENY
TTTWKEADKKLKKIFLNNQTSKKSFFKKNIPEEILNIKDDLEKAKSIYTFIQNRFTWNEE
YWNDQDEKIKQAFNDKSGSAGEINLSLYNSLKVAKINANLIILSTRNNGIPTTLFPVIFD
FNYVIVKTVINGVDYYLDATNKYLPFGQIPERCLNGKARLIDYSGESNWVELKPKMSSLK
NITAILNLNEDGFLDGELKIRSLGYEASKKREKINLLTEDSYLEAFEGDNSDVEVEDYKV
NFKDELEKPLQEFFKIKMFLDNELANKIRINPFFFDRLKRNPFKLKERNYPVDFGYPRKN
NFALSITIPDNYKITKIPESVAFSLPNNGGLFVLRSKVVKNKITLYVRMSINKQIYSTDE
YFALKDFFNQIISAEKSVIILEKKI
>FCMOIPGL_01687 ECF RNA polymerase sigma factor SigK
MHTLAVDTTMNQEQLILQFQKKDVKAYEKLYNLYCDSISGVVNSIVKNDNVAQEITQDVF
IKAWNKADTYSAKKGRFFTWLLNIARNSAIDYTRSKKFKQSKQNLNADFFVDILETSSSL
DSLTNTIGLTDFVKKLGDTCKAVIQLLYFKGFTQKEASEELEIPLGTIKTKNRTCIGELR
TMLDT
>FCMOIPGL_01688 hypothetical protein
MDSKEYIASGILELYVAGSLSEKENQEVYEAMQKYPEVLAEVESIENAIVQLTAFAKKDS
TYSFNDIKNQLKVDEHKVIPISKPKSNWGLYTGWAAAFIFGSTLILSVLQNNKLKNQLAS
EKELLEAQIDSASTNLAAAEKLIEIFRDKDIISVSLAGQTVSPTSYAKVYWNKKTNSIYL
DAKGLPEPPKGKVYQVWSLTLDPLSPTSLGTLDSFTADTNKIFTIYNANKSEAFGITLEP
TGGSLSPTLEQLYTLGAVSS
>FCMOIPGL_01689 Vitamin B12 transporter BtuB
MMKHKLTILIVFTFCLNSFGQELKGRILNSFNEPLENVYVVNTTSNSHTHTNENGSFTIE
NTTLNNFIQVSILGFEKKTIQVKEQDIKNDITIILKTKIFQLEELVLRKEINALQTISRV
DLQLNPVNNSQEILRKVPGLFIGQHAGGGKAEQIFLRGFDIDHGTDITLSVDGMPINMVS
HAHGQGYSDLHFVIPETIQKIDFGKGPYYANQGDFNTAGYVDFSTKTSINKNLISVGYGD
FNSLRTVGMFNLLENSKKEDAYVAVEYIETDGPFESPQNFNRLNLFAKYNTFLNGKDKLT
LTASHLTSSWDASGQIPEREVENGNISRFGAIDDTEGGFTSRTNVNVQLHKTLSDESIFK
ANIFYSKYDFELFSNFTFFLEDAVNGDQIRQFEDRDIFGMNAKIISTKKYGSVEAKYTKG
FGLRYDLVADNQLSHTKNRNELLDRIQFGDVKQTNLYAFFNSEFEIGKFKISPAVRVDYF
KFLYNDNLNTSYETLSKTKAIVNPKLNFLYTQNDNLQWFLKSGIGFHSNDARVVLQQNAD
KILPRAYGADFGNIWKPTKNLVLNTAAWYLLSEEEFVYVGDAGIVEPSGKSERFGLDLGI
RYQLTDHIYFDTDATITKARSLENISGEDYIPLAPNFTMAGGLSFSNLGNFSGGFRYRYL
ADRAANEDNSIIAEGYFVSDLNINYNINKDLTLGVAFENIFDVDWNETQFATESRLQNET
DSVEEIHFTPGTPFFAKATISYEF
>FCMOIPGL_01690 Lipopolysaccharide assembly protein B
MKYIQLILVIVVFSFATSCNKNETKQITNTKDYQAYLQVDENSSLETVNEELSFWNNKLE
KTPNQYPYYLKLASANSQIFQLTGDINQLKEAEKNLFSANKKTNFNNAGYLRSLAKNYIS
QHRFKEALELLTKAEYNGESLQQTRYMLVDVYLELGNLEKVEKYLSKIKNFKDFDYLIRV
SKYNDDIGNLDKAIEYLESALKIAKASNNQSLLQWNYTNLADYYGHAGRIQDSYTAYLKA
LAINKNNSYAKKGIAWIVYSHERNPEEALRILDAVTKENATPDYHLLKAEIASFMGDFSK
KETETKLYLAKVVDTKYGAMYAKYNVLLFADDKTSTTKALEIAKQEVAQRPTAQSYDLLA
WCYFKNGNSKKAIQVSEKYVIGKTFEPEALLHCAYILKANNKLLEAKKLKEELLKSIYEL
GPLTENDVQNI
>FCMOIPGL_01691 hypothetical protein
MKIYKIKYLAIAFLSLIVVSCNNNDDDGMIEITSDFSGTFVQKDQMGRPAVNTVFVSSAS
KDDFNVTIPSEQGAMFQSMFETNLTGLSPAYSNADDKNALGLDAATFTGLLATDVLNVSL
DGTTTFYDGTNVLTGRALADDVITVELLLIFGGEDFTENAAFSDDHVDANDKPFLTSFPY
LAAAW
>FCMOIPGL_01692 hypothetical protein
MKKSKILTGTIFLAIIGLITIAADHIDAPATSGTNADISDFYAFEAENTNNLVFVANVQG
LLSPTATANASFDENVLVEFNIDTNDDKVEDLVIQAIPKDGKMYFFGPFSPSSTGLNSTI
NEMATKNEVAISGYGASAIIENNNEMKFFAGPRDDPFFMDFAQYGAIIGGTASGFNNPGA
DTFAGTNVLSIVVEVPKSLIGGSGTINTWVESKVKQ
>FCMOIPGL_01693 Cyclic nucleotide-gated potassium channel
MEKSSTKSNWKEKLHEIIYEADTKEGKLFDVILLIAIIASILLVMLESVESFDKEYHLFL
NIFEWIITILFSIEYILRIITIKKPLKYIFSFYGIIDLLSTLPKYLSFFLIGSHHLAALR
ALRLLRIFRILKVTRYIGASNRLLIALKASRVKISVFLYFVVILCIILGTIMYMVEGAEN
GFTSIPRSVYWAIVTLTTVGYGDIAPQTPFGQLLASIVMILGYGIIAIPTGIVISEMPKT
PDNKVNTNTKACPSCGAESHKDGAEFCYNCGSKLN
>FCMOIPGL_01694 tRNA dimethylallyltransferase
MTSNNYLITIVGPTAIGKTALSIKLANYFNADIISCDSRQFYKEMTIGTAVPETDELAAA
THHFIQNRSIFEDYNVGSFERDALSKLDELFQKNSVQIMVGGSGLYVDAVLKGLDYFPEV
DPKIREELTKQLHEKGIETLQEKLKELDLETYNSIAIDNPHRIMRALEICIGAKIPYSTF
KNKPKTPRNFTSIKIGLNANREIIYNRINLRVDIMLANGLLEEAKNLYVNKNLNALQTVG
YRELFSFFEGEFTQEFAVSEIKKNTRRFAKRQLTWFKKDEDTLWFDYQTNINDIINKISD
KINAI
>FCMOIPGL_01695 Outer membrane p25
MKSKITVLFIAFISTLSIAQTKVGTINSDYIISIMPEGKIVVEKTQEYGAKLDSSFAIKA
KEYQDKVDDFRKNEAEYGELMKKTLVKEITLMEQDLQKYQDNGNKLMQLKQNELMRPLYK
KLNDAISFIAKENNYTQILTTTGNQFAFIDDKFDITQLVMDKLGVKAPEPEVQE
>FCMOIPGL_01696 hypothetical protein
MVLLGSFLRQFTNNFISSFKSKKRTFSEFTYLKEDSNIEIPIS
>FCMOIPGL_01697 Peptide methionine sulfoxide reductase MsrA 1
MKIIKSVFAISAVLLLISCLGFSKKETISTSTYIPSDKIKVAYFASGCFWCVEAIFESVV
GVEEAVSGYAGGFTKNPTYQTIGTGKTGHAETVAVYYNPKKVSFETLVTVFFGSHDPTTV
NGQKPDYGTQYRSIAFYETNDEKAIIEKAISKLNKEVYHGKIATEVTKISAFYEAEEYHQ
NFEKRNPNQGYVKAVSIPRLNRFKKKFPELLKKE
>FCMOIPGL_01698 DNA polymerase III subunit tau
MEHFIVSARKYRPQNFEDVVGQQAITNTLDNAIKNNHLAQALLFTGPRGVGKTSCARILA
KKINQQGLEIAEDEDFAFNIFELDAASNNSVDDIRSLTDQVRIPPQTGKYKVYIIDEVHM
LSQSAFNAFLKTLEEPPAHAIFILATTEKHKIIPTILSRCQIFDFKRIGVLDAKNYLKVI
CEKENITAEDDALHIIAQKADGAMRDALSIFDRVVSFSGKNLTREAVTENLNVLDYDSYF
NMTDLMLTNKIPDVLNAFNTILGKGFEGHHFINGLASHFRDLLVAKDKVTIDLLEVGDAA
KKKYLEQATKASIPFLMQSINKANDCDLNYRASKNQRLLVELTLMQIASITFDGEKKKPA
NYIIPATFFQALSPAVKEIAKPVKKTPVLQTKKVEQPKTEVKKSFLKSVSKRTSSLSLKS
IHQKKEEKKSTIEENFDNHPKDPFTEKELQQFWIDYVKLLQKKGENSMASIVATDIPKLK
ENFKITFTVPNKLMQDQFKKGRPKLLNFLREKTNNYGISILVKLNESVEKKFAYTPLEKF
NKLKEKNPLLEKLRQTFELDM
>FCMOIPGL_01699 DNA mismatch repair protein MutS
MNYILGVLFILVVIFLINNYLKKKKLKKYRKQLFENWGNKTKKEYYNFFVIGKYFNNNSH
KNKAYHILSEKNNIDFDIDAVFKFIDRTSSKIGQQYLYFKLRTIGSISDLLEFNKLTTTF
LKDKELSISCQLEISKLNNNNSYYFEELINDKQLDKPKHLWLVKGLTITAISSIILLFFY
PIFSLLLVPVFSANLFFHYKNKHSVAYYLNGVNELSKALKVSQKLVKSNKIVAHFKDISF
IDKIKSIQLKTEFIAFEKNVSDEYLFFFWFAAEMIKILFNVEYLMFYSFLEAITRERKNI
EKLFLFIGKIDAAISTASLKASNLKICTPTFNETNELNVKEIYHPLIENCISNNLNLSNK
SMLLTGSNMSGKTTFIRTIAVNSILAQTLHICFADVYSAPYYKVFSSIRITDDLLDDTSY
YLQEVLNVKELINAADDNNPCLFVLDEIFKGTNTVERISGGKSILSYLNKKQHTVFVSTH
DIELTELLQKDDYNLFHFSEQIENNELFFDHKIKKGKLKTRNAIKILELYKYPSEIIKDA
KKIESTYFS
>FCMOIPGL_01700 K(+)/H(+) antiporter NhaP2
MLELAGIIILGILAQWVAWKFKIPAILPLILIGLLVGPIAAEFLSEDGTKWIEPIWNGEK
GLFPGDGLYYFVSLAISVILFEGGLTLKRDEIKNVGPVITKLITLGSAITFFGAGIVAHY
IFELGWELSFLFAGLIIVTGPTVITPILRNIPLKRDVSTVLKWEGILIDPIGALVAVLVF
EFISVGGDGGFTKTALIEFGKILLFGTTFGFTFAHALAYAINKKLIPHYLLNVASLSTVL
LVFVESEVFAHESGLLAVVVMGMVLGNGKLNNIKELLYFKESLSILLISILFILLAANIN
INDLMLLYTWKTAALFAIVVFVIRPLAVFMSTINSNLKFNEKLFISWVGPRGIVAAGIAS
LFGSKLLKAGVEGAEYITPLVFMIVLGTVLLNATTARLFAKLIGVFLKISNGILIVGASK
PSRLIAKFLTDKGKRVVLIDSNKKFIEQALNDGLEAINKNIYDDNLTDNIELNDVGYLIA
LTGNDSVNNHVLSSFSKDFGEHGTYKIASSMEAQKATLEQRGSFFTPNDDFINLSEAYRE
NPHINEIKISTEDEYSKILDLLALEEKSIPLFIQKDKGLYLIAEFEKMEESKEKCVLYYL
GKKLIFQEK
>FCMOIPGL_01701 hypothetical protein
MQNIHKILIGIAFSPNLKPNIFEAVRLANMFDAELVGVHVGTKSDQKKTDLKALLSEAEP
LNNTFKTIWKEGNPVDVILETCALENINLLILGALQKENLLKYYVGSIARKITRKAPCSV
LLLIKPSLKRIPCNHIVVNGLKDERTEETIKTAFFFAKSLQCAKITIVEEVSQNELQVKV
SDDKTLRKATITKERLKTREDQRVKTILKDINCNDITIKTQSIFGKRGYSIGHYAKVKRA
DLLVMNAPNKLGLLDRIFPHDLEYILSQLPTDLLIVK
>FCMOIPGL_01702 C4-dicarboxylic acid transporter DauA
MPKKNTFKLFLNDIPKNIFSGFVVSLIALPLGLGLALASGAPPISGIIAAIVGGIVTSIF
GGSYVTITGPGNGLVVVVLAAITTLGEGDMHQGFLYTLAAIVISGIIMIFLGFLRMGSLG
DFFPASAIQGMLAAIGIGIFAKQIHVMFGNLDAKGSIVELLIQIPEGIINLIKTDNSSMF
FAGLVGIGSLLIMIFYGKIRNRYFQLIPAPMWIVVLTVGMYYYYDLVSTSPYPIDKSLLI
GLPNDILSNFAFPDFGKVFHANFINAVISITLIASIESLLSIKAVDKLDPLKRRSNVNKD
IRALGLATVISGFLGGLNVVAVIARSSVNVNNEGTNRSANFFHATFLVAFILLFASELRK
IPLPALAAILVFTGYKLASPDNIKKVFSIGSEQLIIFLVTLFTTILTSLITGIIVGILIT
FIIHVIINKNIFLFIKNVLKPNVLMFKEDEKYYVSVQNFSSFLNYTKLKKKLDQIPEYEE
AIIDFSFCDFVDHSVMENMSNYIASFNRKGGHFEVIGLDDSKSRSSHPFALRKSLPKQVI
PKEVFFTKRQKNIQLISDSMRWQYSAFSKQEMEELPTFGYFKTRNIDKVSNVLSNGDSTI
FDVHFTEGEMIAKQVIKTTMLHIHPVEPVPNFTLDREGIFEYIMEFAGYKDIDIKNHPDF
SKRFYLAGKNEEKIRAFFTDELILFFESNKQYHISATEKGILIFGNERLASVKEIKALAY
FGMGLQKII
>FCMOIPGL_01703 hypothetical protein
MLGLQFETETSWAEIAKDNLQQILTDHAFLEQKAASNAVSIIINYSEETELVKEMSNIAI
EEMQHFKMVHLLMVKRGMVLGREQKNDYAIRLQKFFNKTKDRTDALIQRLLVAALIEARS
CERFKVFSENMEDEELSKFYNNLMVSEANHYTTFLQFARQYQDREIVDKKWNALLNFEAQ
MMRERGNVAKIHG
>FCMOIPGL_01704 hypothetical protein
MDFLAKIGEVLLIVFFVYLWNKFIVTTLIKKVTGFHKKYNSKNINKQPVKFAVDNELNII
KYTQYFYWFGCLLISIEILFN
>FCMOIPGL_01705 hypothetical protein
MFSKEEAVKLRKEFWTSFGKSFPRKWLLYNTKIKGFSFKFVADKKKAMVCLDIEHPDEIA
SELLYDQMISLKVLLETEIPNVIFNDAYELESGKIVKRIYVPLDDKFSIHNKNTWRNCYE
FYVDIMPKFELFFYEYEDFINQAI
>FCMOIPGL_01706 hypothetical protein
MFLSSLQNYNQYKVCLCSNRIHFNSNTFSNRIFFKFVFVTKQVNLRLISTQLKIKMKEDK
QLLVITHLSQLLDFVTGIGGFIVPLVLWLTKKDEIFGMDEHGKAILNFRISMFIYLLICI
PLVFLLGLGILGFIAIGIFYLIFPIINAIKVSNNEAPNYPFSIKFLK
>FCMOIPGL_01707 DNA protection during starvation protein
MNYLNIDKDKMLPIVTELNVLLADYQVYYQKLRNFHWNVLGKNFFELHNQFEDMYNDTKI
KIDEIAERIVTLKYHPISKLSDYIEASNLVESSPLLSDIEMVDILKKDQKIILKQLSIVI
ENANEAKDEGTIDLIGAYIRELEKSSWMLNAWSKNTNEVLDNSFVK
>FCMOIPGL_01708 Small-conductance mechanosensitive channel
MDKIIDKLETWKELFIKNIPNIAIALVVIFIAYYASRAINTFITKNLGKRIKQESVRNLV
SRVASAFIFLTGLYIAMTVLKFDDTLKAIISAAGVSGIVIGLALQGTLSNTISGVVLSFR
ENLNIGNWVETNGFSGEVIDINLNYFVIREADNNTVIIPNKTILENPFKNYSLTTKMRIS
ITCGVTYDADLEKVETLTKKIITSNFNQDKLEKNVEFYYTEFGDSSINFLCRFWVDSKNA
LEKLKAKSDAIIKIKQAFDKESITIPFPMRTLEFLPNQNLNINK
>FCMOIPGL_01709 tRNA modification GTPase MnmE
MYFCSMIKNDTIIALATPSGVGAISVIRLSGDKAIDIVDAFFKSIKKEKSLKNQKSHTIH
LGHIINKGLIVDEVLVSVFKNPKSYTGENVVEISCHGSSFIQQEIIQLFLQNGCRMADNG
EFTMRAFLNGKMDLSQAEAVADVIASNSAASHQMAIQQMRGGITNELKELRSQLLDFAAL
IELELDFSGEDVEFADRTKFKELVSKITFILKRLIDSFSFGNAMKNGIPVAIIGEPNVGK
STLLNTLLNEEKAIVSDIAGTTRDAIEDEMIIDGVAFRFIDTAGIRETEDVVESIGIKKA
YEKADNAQLIIFLIDSNKYAYAREEFLEEIETIKTRFPNKRLLVIANKIDTLSCHDSSIL
QSEIENLILLSAKNKTGIDELKNELTSLVNIGALSNNETIVTNSRHFEALNNALIAITSV
QEGIDLEIGTDLFSIDIRECLRHLGAITGDYDVDKDILGHIFGNFCIGK
>FCMOIPGL_01710 hypothetical protein
MTTQDLIGNFSIIGSNQDADENTYKGTLSLTLDKNERVIAKWVINKTQHQFGSGFFKNNI
LVINFNYKGFENKTYKGVVVYKCINKNILEGFWSEELGNPTYLGSENCFRITDKNPLLN
>FCMOIPGL_01711 hypothetical protein
MKKSILLIVFLSINFIAFSQEHEHEKENFKHFRISPVLSHTYIPMATNDGDKTVIVPSIG
LDIEYWINEKFGFGFHNDLELETFEIEKEEEIFIEKEFPVVLTFDALWKFHKEWVFVFGA
GVEFEKNENLFIVRTGLEYEIEFGNNWDVSPTVLYDHRANNFDTWSIGIGIGKRF
>FCMOIPGL_01712 Chondroitinase-B
MILKKILLSLIILSQLSIFSQDNKVLVSNISEYKAAIKKAIPGTKIILKNGIWKDAKLDA
FGNGTKEKPITIQAETAGKVILSGNSSIDIYGTYIIVSGFWFKEGNPTEKSIVNFKKNDT
QFANNCRFTHNTISYYNPEDASVNSHWVDLWGKNNRVDHNNFTGKTNDGTTVVVWLKGEE
HIENNHSIDHNFFGPRPDLGKNGGETIRIGTSENSMKSSKTIVENNTFKNCDGEIEIISN
KSGDNIFRDNLFIESKGALTLRHGDNALVENNIFIGNNVSNTGGIRIINQGHIIRNNLMI
GLTGNNFRGPIVVMNGVPNSPLNRYRQVKNVNIQNNTLINCGSIEFAAGKDDERSLPPTN
TIFANNLITNTNGIKILNSSDDISGITLKNNIVDSSVDVDENQFTKQTIDWNLLQSLPMP
SSKNQFLISNFKNDKSPKVDITESEKNPFVVGAFNLDNAKLPKALKVKTGPYWNPIIETP
KVIVKAVTIEVEPGVETLAKALKKATPLTTLQLKDGLYYFDKTQKIKSNITIKGTKETVL
KVSDNLEKELTYFFRVEENATLNLKNITFDGSNDTQVKYAIVSPDKEQGGLYKLFIDGCT
FKNFTNKNGGSIYKAYNGTLADTISIKNSSFLNSYRGLNLSYEKENFKYNAKTIIIHNSI
FKDIEEFAINYTKVDPLLLEQNGSLHITNSIFSRVSNSEKGYVIKVKSIPSVIIKNSVFE
NSYNIINPIKLSDKGSIIENCLVYSCGKIIAKKNAEEKNILYKNPKWDDKNNFIPSKKSD
LLKENNKIETIGLIFSDK
>FCMOIPGL_01713 Riboflavin transporter
MKQNKAIFYMIFSVMAFSLMNAVVKYLNVFNVYQIVFFRSIGTLAFTIPLIIKYKIPVLG
THKKLLALRGIAGVISLTCFFQSLNYLAIGTAVSLRYTSPIFGAIFALIFLKEKIKLMQW
FLFIIAFVGVLIIKGFGVEVNSIGLLFVFCSAISLGFIFIIIRKIGDKENPLVIINYFMV
MAFVFGGIMSINHWRNPTLNEWLLLLSLGVFGYVGQLYMTKALQLHETNVIAPLKYLEVI
FMIIIGASWFGEKYNLWTLLGIFLILLGLIYNIYLKRKKDKAA
>FCMOIPGL_01714 KHG/KDPG aldolase
MAQFTRLEVAQVMKDTGMVPLFYHKDLEISKKVITACYNGGARLLEFTARGDFAHEVFGE
LVKYVTKELPEMVMGVGSVTDAAAASRFMSLGANFIVTPVLREDIAIVCNRRKVLWSPGC
GTLTEIARAEELGCEIVKLFPGDIYGPQFVKGIKGPQPWTSIMPTGGVSPTKENLEGWFG
AGVTCVGMGSQLMAKDANGNFDYAKIESLTKGAIEIIKGLKK
>FCMOIPGL_01715 Pyrophosphate--fructose 6-phosphate 1-phosphotransferase
MKKSIAIMCGGGPAPGINTVISTLAKTFLKDGYEVIGVHHGYKGLLSNDPSLVFFNFHRA
DRIFSLGGSTLIMSRFKPKDSDFKADFFKKYNVNLLVTIGGDDTASTANRLTKYVNSQDL
DVKHVHVPKTIDNDLPLPDRNPTFGFHTAKDEGVRIGNTVYEDARTSENWFVVAAMGRSA
GHLAFGIASACHYQMMIIPEMFNKTKITFEKIINMIVSSIVKCKIQGIEYGVALVSEGVF
HFMEEDEIINSGINFTYDDHGHPELGNVSKSHIFNYLLQVKLKELGLDIKSRPVELGYEL
RCCKPIAFDLTLCTLLGIGVKKLFDQGVSGCIVSANSRGDIMPLYLKDFEDNEGKIPPRL
VNINSDMAQLFINNLFYIKEKDYEDSKKYLPNPEAYDFKKILNWE
>FCMOIPGL_01716 2-dehydro-3-deoxygluconokinase
MSRVVTFGEIMLRLAPEGFLRFSQANSFDVVYGGGESNVAVSLANYGISTDFVTRLPKND
IGECAMMEMRKRGVNVDKIVWGGERLGIYFLETGAVSRGSKVVYDRAHSAMSTIQPGMID
WDEVFKGVEWFHWTGITPAISQSSADVCLEAVQAASRLGVTISTDLNYRAKLWNYGGDRE
AIMTELTSYCDVILGNEEDAEMHFGIKPTGAAVQTAGHDVKAEAFLNVCQQMMEKFPRAK
KVITTLRGSISASHNTWAGVLYDGTKMLETRQYQITDIVDRVGGGDSFMGGLIYGLLTYP
DNDQNALDFAVAASCLKHTIKGDANLATVAEVNKLMGGDASGRVAR
>FCMOIPGL_01717 HTH-type transcriptional regulator DegA
MFKRLSKDIKILINKKKTTIKDIANVLNISAAAVSKALHNDPRISDKTKKAVKQVAKNLN
YQPNHLASALRSGKSNLVGVIVPKTNSNFFSSVIENIEQVLNKEGYNIIITQSKESFKKE
CDSIDTLLFTQVDGIIASMANETTNLEHFEKVKSNEIPLILFDRGENDLNVDYIGIDDYN
SSHLIVEHLVEQGCKRIAHIGGYKRTRIFNNRIKGYVDALNKFNLPLDDELLIESSLTIE
DGRDKMEQLLALKNRPDAVYVAGDYAALGAQQVLLENNVKIPDEIALVGFGNEPFTALLT
PSISSINQHSEIIGKKAAEAFLVHAKKSSFKQSLNKIILNAELIIRDSSNKKNQ
>FCMOIPGL_01718 Serine hydroxymethyltransferase
MQLDNQIFDLIEEEKERQLNGLELIASENFVSDQVMRAQGSILTNKYAEGYPGKRYYGGC
EVVDVIEQIAIDRAKELFGAAYVNVQPHSGSQANTAVYAACLKPGDTVLGFDLSHGGHLT
HGSPVNFSGKLYNPVFYGVDKETGRIDYNHLEQQAKEHKPKLIIAGASAYSRDIDFEKFR
EIADSVGAILMADISHPAGLIAKGILNDPLPHCHIVTTTTHKTLRGPRGGMIMIGKDFEN
PFGETLKSGKPKMMSTLINSAVFPGNQGGPLEHVIAAKAIAFGEALTDEFLEYQIQVKEN
AAAMAKEFVARGYNIISGGTDNHCMLIDLRNKNISGKDAEIALGKADITVNKNMVPFDDK
SPFITSGIRIGTAAITTRGLKVEDMVAVVNFIDEAIINAANEIALENIAERVAEMMSTRR
LFVM
>FCMOIPGL_01719 hypothetical protein
MIITANNPNRKSWLKVKEDSDFPIQNIPFGVFITRDDIITIGSRIGDFAIDLGAFHQLGY
FEGIPLTDDIFLQDNLNDFIADGRKTWRLVRNRIAEIFDVKNGSLRDNAVHKEKIIFRMD
EVEMLLPVAVGDYTDFYSSKEHATNVGSLFRDPENALLPNWLHVPVGYHGRSSSIVPSGT
KIRRPYGQTKPLEGSNVPEFGPTKLLDFELEMAFITTDANVLGDRIPIEETEEYIFGLVQ
FNDWSARDIQAWEYVPLGPFLGKNFASTISPWIVTLDALEPFRVESPKQVYEPLPYLKQK
GKGSYDIHLQVGIKPENGVETVVSKSNFKYMYWTMAQQLAHHTVNGCPVESGDIMGSGTI
SGPTKDSYGSMLELTWKGENPIKLKDGSTRKFINDNDTVIMRAYCKNSKVRIGFGECVGT
ILPAK
>FCMOIPGL_01720 (R)-stereoselective amidase
MKMIKNIENIELHYLTLDDYKELKEAMIQVYASMPDSYWRENQIKSLIDKFPEGQVVIKI
NGDLAGCALSIILDYDKFDDDHTYEDITGNFTFNTHDSDGDVLYGIDVFIKKEYRGLRLG
RRLYDYRKELAEKLNLRGIAFGGRIPNYHKYAATLSPKEYIEKVKRKEIHDPVLNFQISN
DFHPSKILKGYLEGDGNSGEFAVLLEWDNIYYQKKSKKAATKKTVVRLGLIQWQMRLYKD
LEELMEQAEFFVDSVSAYRADFALFPEFFNAPLMADYNHLPESQAIRELAKYTPKIVQKF
SELAISYNINIITGSMPEIKDELLYNVGYICKRDGTKERYEKLHVTPDEAKVWGMQGGNQ
LKTFDTDCGKIGVLICYDSEFPELSRLLADEGMDILFVPFLTDTQTGYSRVRHCAQARAI
ENECYVAIAGSVGNLPKVNNMDIQYAQSMVFTPCDFSFPANGIKAEATTNTEMILIADVD
LDMLKDLNKFGSVRNLNDRRKDIFELKKK
>FCMOIPGL_01721 hypothetical protein
MKRVIVEYAKLTTDILDMLIEKYPDGYDYSDVISFKNAKGETVKAIEVRTEETIYLVKIS
DRLEQTMEDYAEDEDSFDDTDDLDLDDLEDDDDK
>FCMOIPGL_01722 Deoxyhypusine synthase-like protein
MTTNQKPITNFIEKYFLHFNAAALVDAAKGYEDQLKKGSKMLVSLAGAMSTAELGKIFAE
FIRKDKVQIISCTGANLEEDVMNLVAHSHYKRVPNYRDLTPQDEWDLLEKGLNRVTDTCI
PEEEAFRRIQEHIVKIWKDAEAKGERYLPHEYMYKLLLSGVLEQYYEIDLKDSWMYAAAE
KNLPIICPGWEDSTMGNIFASYVMKGELKASTMKSGIEYMTFLADWYTDNSKDGIGFFQI
GGGIAGDFPICVVPMLYQDMERTDTPFWSYFCQISDSTTSYGSYSGAVPNEKITWGKLDI
NTPKFIIESDATIVAPLIFAYLLEM
>FCMOIPGL_01723 N(1)-aminopropylagmatine ureohydrolase
MNTSKNYAGISPEYGDLATSKIVIIPVPYDGTSTWQKGADKGPEAFLDASDNMELYDIET
DSEVYKEGIFLAETVTENSSPEAMVDAVHKITKKYINKNKFVALFGGEHSISIGTVRAFN
ECFNNLTVLQIDAHADLRKEYLGSKYNHACAMFEANQNTNLVQVGIRSMDISEKRVMNTD
KVFFAHDMVVNEDWMDDVVDQLTNNVFITFDLDAIDPSLLPATGTPEPGGLFYYETLEFL
KRVFAEKNVVGFDMVELCPNEDDKSSDFVAAKLFYKMLSYKFASKDDTYDNGDDIDDSNN
PFGKLSKFKNDEDDY
>FCMOIPGL_01724 Biosynthetic arginine decarboxylase
MNTKYIDLIQQTFYFPQEEFKTENNKLFWHGINLMELTAKYGAPLKFTYLPKISENINKA
KGWFQKSMDKHNYKGKYFYSYCTKSSHFKHILNEALKNDIHIETSSAFDIDIVNNLKKEG
KIKDSTYVICNGFKRDQYIKNIGGLINSGHKNCIPIIDNYEEIDLLLLETKEKFNVGIRI
ASEEEPKFEFYTSRLGIGYKNIVSFYEREIADNEQVDLKMLHFFINTGIKDNAYYWNELM
KCLNVYINLKKVCPTLDSLNIGGGFPIKNSLGFDYDYQYMIDEIINQIKQACDEAEVEVP
HIFTEFGSFTVGESGAAIYEVLYQKKQNDRERWNMINSSFITTLPDSWAINKRFVMLPIN
KWNHKYERVLLGGLTCDSDDYYNSEQHINGIYLPVYEKDKPLYIGFFNTGAYQESVGGFG
GLQHCLIPHPKHLIIDRDENGNLITKIFKEQQKSSELLSILGY
>FCMOIPGL_01725 Putative DNA repair helicase RadD
MAEISTSKKIIGKELYGYQQDALEEIFQRFKDAPQDYHLLYQLPTGGGKTVIFSEIVRRY
IKTYKKKVLVLTHRIELSKQTSKMLNEFGVKNKIINSTAILDDQDNFNCFVAMVETLKNR
LNDDKVDISDVGLVIVDEAHYNSFTKIFKFFDESFILGVTATPLSSNTKLPMYENYQELF
VGESIQHLIDNEYLASANMYSYNVGLTSLEVGANGDYTVKSSEDLYTNTDMLSKLVSAYE
ETAKGKKTLIFNNGINTSIQVFHAFKKAGYPIAHLDNTNTKKEREFILKWFHKTPNAILT
SVSILTTGFDEPSIEAIILNRATKSLTLYYQMIGRGSRIYGDKNTFEVVDLGNNFHRFGA
WGADLDWQKMFRAPDYYLDAILSDEDIESTFRYELPADVKKEFAKSTDTYFDMKKVYIDT
IKAGESSKRVLEKSIEHHAIMCIENSEDVFDALILAKMLGEEIDDRINRYAKCISKSTHN
FVTWLKDDYRKKLNAFLRSNFDEIFEEIYGYPPED
>FCMOIPGL_01726 hypothetical protein
MSIFNKIFGESSSSESSSKSNLKINWIPLNDVSQLKEIKEESKTTSVFIFKHSTRCGISS
MVIKRFEKLFTEEHEHLKVYYLDLLNYRNISDEVGYTFQVMHQSPQLLVIKNEISVFDAS
HYDITNINLARFI
>FCMOIPGL_01727 Chaperone protein ClpB 1
MNFNNYTTKSQETIQMAQQIAQGFGHNQIENEHLFKALTQVDENVLPFLLKKLNINIDVV
AQILDKQLESLPKVSGAELMLSREASKTLTEAAVIAKKMKDDYVSIEHLILAIFKSKSNI
AQVLKDQGVTEKHLKAAIEELRKGENVTSQSQEETYNSLNKYAKNLNQLAEEGKLDPVIG
RDEEIRRLLQILSRRTKNNPILVGEPGTGKTAIAEGLAHRIVDGDVPENLKNKLIFSLDM
GALIAGAKYKGEFEERLKAVIKEVTNSDGDIVLFIDEIHTLVGAGGGQGAMDAANILKPA
LARGELRAIGATTLDEYQKYFEKDKALERRFQKVIVNEPDTESAISILRGIKEKYETHHK
VRIKDEAIIGAVELSQRYITNRFLPDKAIDLMDEAMAKLRMEINSKPEELDVLDRKIMQL
EIEIEAIKREKDETKLKSLRSDLANLKEERNEMNAKWKSEKDIVDNIQNAKAAIEDYKIE
AEKAEREGDYGKVAEIRYGKIQKAQEDLEGFQKVLHENQSEKSLIKEEVTYEDIAEVVAK
WTGIPVTKMIQSDREKLLRLESQLHKRVVGQGEAIIAVSDAVRRSRAGLQNPNKPVGSFL
FLGTTGVGKTELAKALAEYLFDDENAMTRIDMSEYQEKHSVSRLIGAPPGYVGYDEGGQL
TEAVRRRPYSVVLLDEIEKAHPDTFNILLQVLDEGRLTDNKGRIADFKNTIIIMTSNIGS
QIIQEKFSDPKADLESVTELAKIEVLALLKQSVRPEFLNRIDDVIMFTPLSKNDIFEIVR
LQIEQLKKMIGKQDITLDATDEAITYLAKKGYQPEFGARPVKRVIQKEVLNQLSKEILSG
KVTTDSIILLDAFDDQLVFRNQSEFVEN
>FCMOIPGL_01728 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MKKYLLVLFVVLISCNSNSKKEETDTATTTYFLIRHAEKDRTDASNKDPNLNPEGLERAE
KWAKYFQNIDLDAVYSTNYNRTQQTAKPTADSKKLAIINYNPSNMYDSIFQKNTSGKTTL
VVGHSNTTPAFVNKILDQKKYKDIDDNDNSSLFIITINKNGKTSKIEKVN
>FCMOIPGL_01729 hypothetical protein
MRYLFILLFTLLSAVHSSEKKLTAQQIIDKTITASGADKIANSQIRFKFRDKNYAAVRRN
GNFKLFRTYKNKFSEIEEDLVSNNGYSKFLNGHKLPELENSKAKSNENAVNSVHYFSVLP
YGLNDEAVRKKLLPSATIKGKEYYKIEVTFSENGGGEDFEDVFIYWIGKKDFLIDYLAYA
YHTNGGGKRFRVLKEQCSINGIRFVDYHNYKPENTSIALIDTDKAFENNQLKKISEIVLE
DIEVKILE
>FCMOIPGL_01730 SsrA-binding protein
MTVQKKINIQNKKARFEYEILDKYVAGIQLTGTEIKSIRLSQARITESFCEFNDRGELFI
VNMYIQEYMFGHHFNHKPKSERRLLMNKRELRSLKKDVEAKGNTIVPLRLFLNDRGLAKL
EIALAKGKQTHDKREVIKDRDNKRDLSRIKKNFNG
>FCMOIPGL_01731 Septum formation protein Maf
MLKEKLKNYHIILASGSPRRQQFFKDLDIDFDIQLKEVDEIYPHKLKGSEITDYLADLKS
KAFTNLSENDILITSDTIVWLENKALGKPKDTQDAFNMLRALSGKKHEVITSISIKNKHF
QKIINDTTFVTFKEISDEEINYYIKNYSPLDKAGAYGIQEWIGFIAISNIEGSYFNVVGL
PVHKLYEELMKL
>FCMOIPGL_01732 1-deoxy-D-xylulose-5-phosphate synthase
MKKYTYTEKKDTRSGFGDGLTELGRTNPNVVALCADLIGSLKMDQFIKENPERFFQIGIA
EANMIGIAAGLTIGGKIPFTGTFANFSTGRVYDQIRQSVAYSGKNVKICASHAGVTLGED
GATHQILEDIGLMKMLPGMTVINPCDYNQTKAATIAIADFDGPVYLRFGRPKVPVFMPTD
EEFVIGKGIQLTEGTDVTIVATGHLVWESLQAAEQLEAEGISVDVINIHTIKPLDEEIIL
KSIAKTGCIVTAEEHNKLGGLGESVARTLALNNPTPQEFVATNDTFGESGTPEQLMAKYG
LDAAAVVKAVKKVISRK
>FCMOIPGL_01733 hypothetical protein
MKKIILIMFLTFAISETTNAQIDFGIKGGVNYNNNGDATFSTAGNDIIDGAESKSGYHAG
IWFRGKLPIIGLYLRPEIVYTQIKSEYLYKSLSTDYDFKKLDVPVLLGKKVLGFGNIFIG
PSFQYILEDEFKFSTLSTDDFDKFSVGLQMGFGVEFGSLGIDVRWERGLSNTEANFVDSN
TNVNIDNRTNQIIFGVSIKL
>FCMOIPGL_01734 Peptidyl-prolyl cis-trans isomerase Mip
MTKIKNILALIILATIVYACDESSSVYVDNFDYEGQALIDSDTLVKFLSNHYYDVTEDEV
KLLVSGKTALIEDENLEQYDVVDNEIDYTFYYYTNRVGSPTVEKGYPTVMDSVLVKYEGK
RIVNTDSISASFDKNNGLWLTLNSVIRGWTYGIPKFKGGDNITDNGPITYENGGKGILFL
PSGLAYGPSGTTSILGSECLMFKIELYDFIKDTDHDNDGVASFFEDPDGDGDPRNDDTDL
DGSPNYADADDDGDGILTINEDANSDGNPANDFSDPDNSTLADYLNSLIKVSN
>FCMOIPGL_01735 Heat shock protein 15
MRIDKYLWCIRVFKTRSIATAACKKGQVKIENKSIKPSKEVFGNELILVRKNQINYQIKV
LDLPESRVGAKIVDLYKKDVTPKEEFEKTELLKYSKDYYRKKGTGRPTKKDRRDIEGYQE
DTEENL
>FCMOIPGL_01736 Bifunctional protein PyrR
MTTEKNIILNTLKVNQKIKRIAYQIYESNSNEKEVIIAGIVGNGYLFAEKLVEILKEISS
LKVTICLVKINKKKPLAPITTTLTVADYKNKSLVLVDDVLNSGTTLIYGVKHFLEVPLKR
FKTAVLVNRNHKKYPVKADFKGVSLSTSIKEHVHIDFTDKEINVYLI
>FCMOIPGL_01737 Shikimate kinase
MKIILLGYMASGKSSIGKMLSKNLSLSFIDLDDYIIDQEKMSISEIFKEKGEIYFRLIEN
RYLKQILSKKEDFILSLGGGTPCYANNMEEINKNDTMSIYLQGNVPTMVKRLIKKKSKRP
LIASLDDDQIPEFVAKHLFERRFFYEQAKKIIKIDDKSKKKVAKELVEFLN
>FCMOIPGL_01740 TonB-dependent receptor SusC
MCLFISLSAFSQKDSTLTILKGQIIHAETKRALSAAHVLNLNAVLGTITDDKGFFKLSAK
ANDTILVSYLGFSSIKLKITNDLLKGNELEIALHEKPEEIKEVIIKSTQLIGVLEVDVKM
VPKDKFTRIHINGLPQTYEVGKPQSRNYSSPIAALFQPVDFLYSLFGKKPKQLKKLQKLK
KEDDLRKMLAGNFDREVIMEYLEMDRQELTDLITDCNYSEYFIKKASDLQMIEAVLDCYE
NHKALKKGKIERNKLPVKN
>FCMOIPGL_01741 hypothetical protein
MELKFPKGGIFIVVVIVAVIILFSKSTITIGPGEGGVIFESLGNGVNTEKTYSEGFHIVA
PWNRMIVRKVRQQSISDEMNVLSVNGLEVKVNGTIWYEPEFKNLGLLIKTKGEDYERELL
DPAINAAARSVVGRYTPEQLYSSKRDVIEQEILDEIKIVLKDQYLLVTRVLVEDVKLPTT
IRTAIETKLKQEQESLEYEFRIAKAEKEAKRQKIDAEGKAVANKILSESLTDKILQEKGI
GATLELSKSTNSKVIIIGSGKSGMPIILGNQ
>FCMOIPGL_01742 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MGYHHHHHENSSTENIKIAFFLNLFFTIIEFIGGIYTNSLAITSDAIHDLGDSLSLGMAW
YFQKISNKKATKNYSYGYKRFSLLGAIINSIILLVGSVIIIFNAIPRIINPEESDAKGMM
WFAILGIIVNGAAVLKLQKGTSINERVVSLHMLEDVLGWVSVLIASIVMQFWNVPILDPI
LSLLIALYILSNVFNNGQESIRIILQGTPIAISVDKIKTKILENKEVKSIHDCHLWTMDG
EYNILTVHLLMFDKSISWQKADEVKKEIRKVLHDDFYLEHITLEMDVSEDCEYIDCV
>FCMOIPGL_01743 hypothetical protein
MRFHTRKWVKPEDLNPNGTLFGGKLLQFIDEEVAIYAIIQLETARTVTKYMSEIDFKSSA
KQGDIIEIGIDVVKFGRTSITLTCNVRNKLTRKTIIDVDRIVMVSLDENGHPKEHGKTEI
EFVKDRLNED
>FCMOIPGL_01744 hypothetical protein
MQIATILYTILALLLSLSIAFFQYYYKVKNKPKVTNLLFVLKTLSLFLLILLLINPTIEN
TVIENEKPILAVLADNSKSVPFFKEDKNVKGIIATIKNNNDLKNKFSVKQFTFGKDLQVL
DSFSFSENETNIEAAITGIDELYKEKIAPIILITDGNQTIGSDYEFLNTKQPIYPIVIGD
TTKYVDVKITQLNVNKYSYIKNKFPVEVILNYEGNENVTTQFSIFNEGKTVFRKDVTFSS
DKKSATITANLTSTKEGLQYYTASIRKINNEKNTKNNSKNFSVEVIDEQTKVLILTSVLH
PDIGALKKSIESNKQRTVDVFLIDKFKNNLYDYQLVILYQLNNKFNHFISDLKQNNSNYL
LISGSNTDWNFINKQQLGFTKNAINQTENYGAIYNDGFLTFLQEDIGFSNFPPLKDKFGE
VVISKEHQTLLYQNINGVVTKQSLLATFDINNQKSAVLFGEGIWKWRAASFLNTNSFEEF
DKFTGSLVQFLASNKKRNRLEINAESLYPANSTINISAFYTDKNYQFDARAALEISITNT
ETKEVSKIPFSLIHNSYQVEIENLTSGDYTYKVEVLNQKINKYGRFKITDYQIEEQFTNA
NVNKLQQLATKTGGKLFYKNQVDDLSKELLTNESFYTVQKSSVKQQNLIDWKWFLGIVIC
LLSIEWFIRKYHGKI
>FCMOIPGL_01745 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLLENKSAIITGATRGIGRGIAVEFAKQGANVAFTYSSSVDAANALEEELKSYGVSAKG
YQSNAANFDAAQELAKEVLKEFGAIDILVNNAGITKDNLLMRISEDDFDKVIEVNLKSVF
NLTKAVIRPMMKQRAGSIINMSSVVGLKGNAGQTNYAASKAGIVGFSKSVALELGSRNIR
SNVIAPGFIETEMTDKLDEATVQSWRDGIPLKRGGTPEDIANACVFLASDMSSYITGQTL
SVDGGMLT
>FCMOIPGL_01746 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVLVNKESKIIVQGFTGSEGTFHAGQMIDYGTNVVGGVTPGKGGQEHLGKPVFNTVADA
VEKVGADTSIIFVPPAFAADAIMEAADAGIKVIICITEGIPTADMVKVKAYIANKDTRLV
GPNCPGVITPDEAKVGIMPGFIFKKGRVGIVSKSGTLTYEAADQVVKQGFGITTAIGIGG
DPIIGTTTKEAVELLMNDPETEAIVMIGEIGGNLEAEAAQWIKADGNRKPVVGFIAGQTA
PAGRTMGHAGAIVGGADDTAQAKMKILAENGIHVVSSPAKIGEMVAKVLK
>FCMOIPGL_01747 UDP-3-O-acylglucosamine N-acyltransferase
MNFSRTQTLEEIAQIINCEFIGDASFAIKGINEIHVVEKGDIVFVDHPKYYDKALNSAAT
IILINKKVDCPEGKALLISDDPFRDFNKITKHFNPFIASKVSISESAIIGEGTVIQPNVF
VGNNVSIGKNCVIHPNVTIYDETIIGNNVTIHANTVLGADAFYYKKRPEGYDKLISGGRV
VLEDNVDLGASCTIDKGVSGDTTIKKGTKIDNQVHVGHDTVIGEKCLIASQTGIAGCVII
EDEVTIWGQVGTNSGITIGKGAIILGQTGVTKSVVGGKSYFGTPIEESREKLKQLAGLKR
LLKEK
>FCMOIPGL_01748 Elongation factor P
MASTSDIRNGLCIRYNNDIYKIIEFLHVKPGKGPAFVRTKLKSVTNGKVVDNTFPAGRKI
DDVRVETHKFQFLYHDGEFYHFMNEADYTQIRLLEAALDNPGLMKEGEIVTIIINSEDNM
PLSVEMPQSVILEVTHTEPGVKGNTATNATKPATVETGASVNVPLFINEGDKIKVETTKG
TYQERIKE
>FCMOIPGL_01749 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MNQPLAYVHPQAKIARNVVIEPFTTIHNNVIIGSGTWIGSNVTIMEGARIGKNCRIFPGS
VISAIPQDLKFDDEETTVEIGDNVTIRECVTINRGTKDRMKTVVGDNCLIMAYCHIAHDC
LVGNNCIFSNNTTLAGHVTIGDNVVLAGMVAVHQFASVGKHAFVTGGSLVRKDVPPYVKA
AREPLSYVGINSVGLRRRGYTTEKIREIQNIYRILFQKNYNYTQGIDIIEAEMEATPERD
EIIQFIKDSHRGIMKGYFNVN
>FCMOIPGL_01750 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MSNKQKTIKSEITLSGVGLHTGNTVSMTLKPAPVKNGFTFVRVDLEGSPIIEAKAEYVVN
TQRGTNLEKNGVQIQTSEHVLAAAVGLDIDNLIIEINASEPPIMDGSSKYFVEALEKAGI
EEQDADIEEYIVKEIISYKDEVTGSEIILMPSDEYQVTTMVDFGTKILGTQNATLDKISD
FKKEIADARTFSFLHEIEMLLEHDLIKGGDLNNAIVYVDKELSENTMLKLKKAFKKDNIA
VKPNGILDNLTLHWANEAARHKLLDVIGDLALVGTRIRGKVIANKPGHLINTQFAKKLAK
IIKTEKRNYVPTYDLNLPPLLDIHQIMDILPHRPPFLLVDRVIELSDRHVVGMKNVTMNE
GFFVGHFPGSPVMPGVLIVEAMAQCGGILVLSTVPDPENYLTYFMKMNNVKFKQKVLPGD
TVIFKADLITPIRRGICHMQAYAYANGKLVAEAELMAQISKIK
>FCMOIPGL_01751 UDP-3-O-acylglucosamine N-acyltransferase
MKFTAQQIADILEGEVVGNPDEEVSKLSKIEEGEKGSLTFLSNPKYHPFLYTTDASIAIV
NKNITLEKEISTTLIKVENAYKSFSKLLEFYNEVKNNKLGRENPHFISDSAKIGKNEYIG
AFAYIGENVSIGDNVKIYPNCYIGDNTIIGNNCVLFAGVKIYSETQIGNHCKIHSGCIIG
SDGFGFAPNEAGEYKAIPQIGNVIIEDYVDIGSASTIDRATLGSTIIRQGVKLDNQIQIA
HNVEVGKNTVIAAQTGIAGSTKIGENCMIGGQVGFAGHLTIGNNVKIQGQSGIAKNLKDG
DKVQGTPAMNYSDYSKSYVYFRNLPKIATAINKMEKELNTQNQ
>FCMOIPGL_01752 hypothetical protein
MKKKTANKLKILNDPIYGFIQIPNSLIFDIIEHPYFQRLRRIAQMGFSNLVYPGANHTRF
HHALGCIHLMQKAVRVLRFKQIEISEEEENGLCMAILLHDIGHGAFSHALEHSIVSGISH
EEISLKFMKKLNEEFDGKLSLAIEIFEGKYHRKFLYQLISSQLDIDRLDYLKRDSFYTGV
TEGNISSDRLIVMMNVKNEELVIEQKGIYSVEKFLIARRLMYWQVYLHKTGLVAENMLVN
VLKRAKELADKGEVLFASSALKYFLYNKINQDNFTDETLEMFSKLDDYDVLSAIKEWTNH
DDKILSLLSKMIVDRKLLRIELKMDVFSEEVINKKRRKFSKRLGLSEVEINYFVFSQEIR
NQAYNTEKPILILNKRGKLKDIAKASDQLNIQALTKPVVKHFICYPK
>FCMOIPGL_01753 Transcriptional regulatory protein SrrA
MSSIQILWVDDEIELLKPHILFLELKNYKVTTCTNGADAIDLVGENNFDIVFLDENMPGL
TGLDTLAEIKQKQANLPVVMITKSEEEYIMEEAIGSKIADYLIKPVNPSQILLTLKKNLD
HSRLVSEKTTSNYQQEFRKISMDLAMVNSYEEWIDLYKKLIHWELELENISDPGMLGILE
SQKQEANNQFFKFIKKNYEDFLTSNDKPTFSHTLFKDYVVPELSKDQGVLWVVIDNLRYD
QYRILEPLINNHYKKDEEYSYFSILPTATQYARNAIFSGLMPSEMEKRHPNFWKNDTDEG
GMNMYEDEFLSAQIKRLSLNIKHEYYKITSLKSGKELADNFNGTKQNDLTTVVYNFVDML
SHSKTEMEVIKELAGDDKAYRSLTLSWFKNSPLFEIIQKAQNLGQKLIITTDHGTINCKN
PTKVIGDKNISSNLRYKTGRSLSYEEKDVYAVRNPKDIFLPTIAMNSPFIFAKEDLFFAY
PNNFNHFVKYYKNTYQHGGVSLEEVIIPCAVYSPK
>FCMOIPGL_01754 hypothetical protein
MENKKDISRKEAIKKIGNYSKYAALTAIGTYLILSPKKAQASSATTGLDGLGGNW
>FCMOIPGL_01755 hypothetical protein
MKTKISIFSLLLLFGFNFSAQETERFNWVINNASSTSISKSKSITEDTNKDIISFGSFKS
DVDIDPSSNELKFISKGESDIYLQKLDSNGNLIWGKSFGGLGSDIPYSVKTDSNNNIYIV
GYFSSTVDFDSSNEIYNLTSNGDKDIFVVKVDSEGNFIWAKSFGGLGFDAASALKIDSND
NLYISGWFEEIVVFDNNDLNGTATSLASSRNGFLLKLNKNGGYIYSKTFGSLNFSTISAI
DLHENNIYLVSTFNKDLDADPSNNTVTLDAGDSLNGAIIKLDIDGNFIWAESIGGNEGYD
QAVNVKVDSDENIIITGTIDSSTDFDFSSNQFNLGSSAGYPDAFMLKIDKDANFLWAKTF
SATSAIFHLSVDLDKDDNIYSIGYFYGSATFESQNFPDRGAGETTFIKKIDKEGNIVWIE
NYKADNTATRGEDILISSDNKKILSTGSFAGSVDFDSSSNQEIITSGSSLNNNGFLLSLL
IESNEEDNVDNKDEFITKWKTTAANESITIPTTGTGYNYTVDWGDGTIENNFTGDATHTY
TVAGDYEVSIIGDFPRIYFYYNNQNQDKIIDIVQWGSNEWSSMELAFFDCTNLNISATDS
PNLSNATNLYGMFQGCSTFNANINHWDVSSIENMPRMFYQTVSFDKPLNNWDVSNVTNIS
SMFSGSNFNQPLDNWNVGKVILMNRVFANNIVFNQNINNWNVNTVVNMISLFEKAESFNQ
PLDLWEINNVTNMNAMFDNSGMSVINYDKTLKGWSALSSLKPNINLGAFNINYCNSETER
TKLINDYNWTFVSDSKDCSTIDSPVSINGMWNDPANWASGVVPTSTDNVVIPTGTTLQIS
DDISEINSLENEGTIVINPTYSLKSNSNMVNNGTIIMNSDNDDSSVLFVVGTSTGEVKYS
RGGLKANLWSLVTPPVSGQKIKEFATNIDNDIRKNETVSPIRYAISYYDDKEPSGSKWKY
FTESIDSEETFTAGESYGLSRATDGSVTFTGTLTTNNSVMTLKPGEWNAIGNPFTTYYPA
NKNGASSFINDNYDILDDEFKGLYIWDSAQNKYVVVSEVDIQNRSITPGQGFFIKVKAGE
NTIEFKEAKRSLKPTTGDNTFSKEVHKYIKLLANNGSYTVTTDVKFLSNATKGFDVGLDI
GNFSASSFDLYTHLVDESTTNNYTIQSLPLENKEEVIIPISVLSNKSEVYLSSLHENLPE
NIILLLEDRENDAFTDITNKENDYKISFNDQQNIQKTLYLHISYSSALSVVDSAIDKIQI
YSANKNLYVKGLMDSADLEMYNVLGQSVFKLNLTKDQEINLPMNLKEGVYTIKLSSENNI
VTKKIVIK
>FCMOIPGL_01756 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MFYGQMGVGKTTLIKEICKQLGVLNSISSPTFSLVNEYQTSKKDKVFHFDFYRITDEEEA
LDMEIEEYLYNNDWCLIECPENIENLLPLDASEIHLSLLDDGERNIQLK
>FCMOIPGL_01757 hypothetical protein
MPKSNISIILLFYVSITWSQEFISSNLPIIIITTDKDPNTNNPIPIIDKEKVMATMKIIY
RPDNSRNYLDDQNNPDFINYNGKIGIEFRGSTSQSLPKKPYSIETRKEDGSNNNVKILGL
PKENDWVLNSLAYDKTLLRDFITYELAREMGNYASRGKYCEVIINDEYKGLYIVAEKIKI
DSDRINIVELDTIDNSIPSITGGYFIKTDKTTGDDSIAWQYINRLNKKVDFIFGNPEPTD
ITFKQSAYIKSIFDDLSTTTANQNGLIKDGYPSLIDLPSFIDFIILNELTSNVDAYKFST
FFHKDRAGKLRAGPIWDFNFSFGNDNRSGTDIWQFDNGNNIGPDFWKDLFDNPTFNCYLR
KRWNGLIKIGEPLEYIKIEEKINSLVALLSEAKNRENQRWGTLSGYELEISNLKLWLQKR
YIWLNENLGNITDCSFPELPNLVISEINYHPKAIDDTDDNDLEFIAIVNNSNIKVNLTGF
YFRALGISYQFPDNKYIDSGQKIYLANNIEVFENNYGFPAFGEYTRNLSNKSQQLLLTDA
YGSVIDEVTYTDDNPWKKEADGDGFFLILNNLNDDNSLAANWNAIPQTTLKLNNTNFNTS
IYPNPIENLVVIENNRTNIIQLTLYNLQGKKIISVDNNSHKVELRIENLPKSIYLMKIIL
DNKQLIYHKIIKE
>FCMOIPGL_01758 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MNKNYSLENLKEIAKEIIASAKNKTLLFYGQMGVGKTTLIKEICKQLGVLDTISSPTFSL
VNEYQTSKKDKVFHFDFYRITDEEEALDMGIEEYLYNNDWCLIEWPENIENLLPLEAVEI
HLSILEDGGRNIQLK
>FCMOIPGL_01759 Alanine dehydrogenase
MSQFSPFSKEELLPQEEMLEIKRQKGELFIGLPKETYLGEKRVCLTPDAVTALISHGHRV
VIETGAGDGANYTDKEYSDAGAKITYDVEEAFKCKYCIKSCATNRR
>FCMOIPGL_01760 Alanine dehydrogenase
MSGVNKGNGLLFGNICGVPPSSVVIFGAGTVGEYAARTALGLGARVKVFDNSITKLRKLQ
HSLNAPIYTSTVQPKSITKALMRCDVAIGAIRGKNRSPIIATETMIEQMKEGAIIVDVSI
DRGGCFETSNVTTHSTPTFVKHGVIHYCVPNIPARYARTATLSISNIFTPYLLNIAEEGG
FENAAIYDKSLRNGMYFYHGILTNKTVADWFDLPFRDINLLIL
>FCMOIPGL_01761 hypothetical protein
MQLLKRIGYFLIGVSISSIGVYFFWQKKKATFDYGMDARTLKTIRIKKRLFSDDAKQVML
NSYIDSIKISTILLNGDVDFGKSKPRQKPCAEYYITGSRELEYVSLYISRCDSTATIEKI
IID
>FCMOIPGL_01762 hypothetical protein
MKNSKVDEYISKKENWRKELELLRSVFSDLPVDETIKWGAPTYVFNNKNIVGLAAFKEYC
GLWFFQGALLNDKHKVFINAQEGKTKAMLQWRFYNLEEINAALIKTYVLEAIENIKLGKE
IKVDRSKKEIIIPDELNNKFSEKEELKSKFENFTNSKQREFCEYISSAKRENTKQTRLKK
IIPLILNGTGLYDKYKNC
>FCMOIPGL_01763 tRNA (guanosine(18)-2'-O)-methyltransferase
MFVTMIDKKLLIYLESYLTDKRKALFKKVISERTQHFTVVLEDISQPHNASAVLRTCDIF
GVQELHTVENKYINRVSKYVAKGSQKWITTKRYKSDGNNTKVCFDNLRNQGYQIIATSPH
DNSCFLQDFDISKKTAFVFGEETEGVSDFTKENADGFLKIPMVGFTESLNISVAAAIILQ
DVTTKLRNSNLDWQLSEEEKEILYLNWIKESIKNVDKIEENYLNNNV
>FCMOIPGL_01764 NAD-dependent protein deacylase
MKKLVVLTGAGISAESGIETFRDADGLWEGHDVMEVATPEGFKANPKLVLDFYNARRNQL
LEVQPNKAHYNLVDLENDFDVEIITQNVDDLHERAGSTKVTHLHGELLKVRSSVDESIIL
DWKKDLFLGDLCIKKSQLRPHIVWFGEMVPMLEKAIEITEKADILVIIGTSMQVYPAASL
INYVKLNTPIYFIDPKPSVSKNNFNKLTIITDLASLGTDKLKKILIKE
>FCMOIPGL_01765 hypothetical protein
MRKMLIILVSVVITILNINSYGDLDASIIEKAKINKLEKKEKDVLKKSINWGFGSTLFKL
IHFAEIMFISEVSRKKISH
>FCMOIPGL_01766 Transcriptional regulatory protein YpdB
MNCIIIDDEQMARVIVRTLCNEIKSLDILEEFTNAIEAIKFLNENDVDLIFLDIHMPNFS
GLDFIKTLKDPPKIIFTTSDPKFAIEAFEYDFIVDYLLKPIEFPRFEKAVKKAEKLQLRQ
TQISNTKEVSPKNDFYVNIDRRLIKIDLSTIYLIEAKGDYINIKTEEKNYVVHSTLKKIE
EKLPDTLFLKVHRSYIINVKKIIDIEDNSVLIKKDVVPVSRSNRPELMKRLDLL
>FCMOIPGL_01767 hypothetical protein
MEKPNLIYIDKLARGDESIKKTLIDVIKSEFPGEKEEYYQSLKNKDFRKIEDNVHRIKHK
FSILGLEKSYKMANEFEHNLREQVLNLKEEKDFDKILIAISKYLKTI
>FCMOIPGL_01768 Phytochrome-like protein cph1
MNPLLKRQIRKYLPKNLQSNKDMQDFLDAINKSYNTSGEQFTMLQRAASISSEELFNSNK
QLREESESQKEIIEKLNSVINTLKFYNLKGDNNLEGQDSLELVDFIEIQTKEIIEINKLK
DKLVLDLERQNQELNEYAHMVSHDLKSPLQSIDALTVWIKDDFSDVLGESGSEVVDLIRE
NVEKMDTLIQGILEYSTIGKTKMALYDIDLNLLIEDVLVTIDNPNDVDVLVTSDLPRIKG
DQHRLELLFYNLINNAVKFNDKKSKGFVEIRFEDKNKYWQFSITDNGKGIEQKYFDKIFI
AFQKLENDYKSTGIGLSIVKKIIETYQGEIWLKSIPNIETTFYFTIKK
>FCMOIPGL_01769 hypothetical protein
MKTVQLKKRGTNKFKYLSKQCTLKKPLVLVFGNRYMLQEKNIYNEIRDIFEDGEIIFGST
SGDITSESVDDESITITAIEFERSSFIIKTANVLNSNVEINSFKSGKELIEQLPKEGLKY
VFVVSDGSFTNGSQLTKGMNAATDDNLIITGALCGDAARFETTLCSYNENPKEGKIVAIG
FYGETLEVSFATKGGWIPFGPERIVTKSKDNILFELDGKPALDLYKTYLGEKSKELPGAA
LLYPMKVKSKHEKKSIVRTILNINEEENSMILAGDIFENSKVQLMMTNVDSIVNAAELGA
AQALELRKSKPELAILISCIGRKLVLDQRVEEEIEEVMEVVGKDTTISGFYSYGEIAPFN
GEMNCHLHNQTMAITLISE
>FCMOIPGL_01770 hypothetical protein
MKGIVFTEFLDLVEDKFGLEMVDTIISQSNLTSEGIYTTIGTYSFSEMLSLLKNLSINTK
ISIDNLLLVYGEHFFAVLKNSYPDIIESYKEPIDMISSIENHIHIEVRKIYPDADLPTFI
VEEKNVNSLTLIYKSSRAMHYFGLGLMNKTFEHFNSEAIIKLEKIKEVGTEVRFNIQKKA
I
>FCMOIPGL_01771 Response regulator rcp1
MEKSLKILLVEDNLIEIMKMKRTLSLLKLNHIMYEAKNGEEALNFLDNRSNIPDIILLDL
NMPKINGIEFLRILKANDDLKHIPTIILTTSSNQKDLLECYRTGMSGYILKPLKYEDYVK
KIEIVLSYWSVNELIKS
>FCMOIPGL_01772 hypothetical protein
MKYRQLTKEQFESLNEEFARFLATQSIDVKEWNQIKKEKPTVADDEMNVFSDVVWDDVLS
KTNYVEHFSKTSANLFKCEAKEMHRIAIKINTDINLLEQAGFEWLLKNPLDSSVEIFKGS
KAYNLERNLEIFDLIEKGSNISKGEIFEYFNGLIS
>FCMOIPGL_01773 50S ribosomal protein L9
MELILRQDVENLGFTDDIVVVKNGYARNFLIPTGKAVLATSSAKKVLAENLKQRAYKEAK
LIEDANAIAETIKGYEIKIASKVGSGDKLFGSVNNIDLAAALVKAGTELDKKFIKVVGGS
VKRLGKYEASVRLHRAVVTDITFEVVSE
>FCMOIPGL_01774 30S ribosomal protein S18
MASIEQQAKGGKSADVRYLTPLDIDTKKEAKYCRFKKKDIKYIDYKDADFLMYLVNEQGK
ILPRRLTGTSLKYQRKVAQAIKRARHLALMPYVGDMLK
>FCMOIPGL_01775 30S ribosomal protein S6
MNHYETVFILNPVLSDTQIKETVQKFEDYLVSKGAEMISKEDWGLKKLAYPIQKKKSGFY
HLLEYKVAGEEISAFELEFRRDDSVMRYLSVKLDKHAAAWAKVRTERVKSTKK
>FCMOIPGL_01776 hypothetical protein
MQIPDIPNLIHYAIPFFALTVIIEVILTIKVKLEDYDFKDASTSLLMGFGNVLLGIITKA
IVLTAFLFLYKYRFFTISVTLWTWVILLFAEDFMYYWFHRISHESRLFWASHVVHHSSKK
YNLSTALRQTWSGGFYTFIFWIPLILVGFHPIMVMAQMSISLIYQYWIHTELIKKMPKWF
EAIFNTPSHHRVHHATNPQYLDRNHAGIFIIWDKLFGTFEPEIEKPVYGLVSNINTYNPL
KIAFIEWYNMLTDFFNSKTSIFNKFKYLIKPPGWKHDGTSILSTDLRKEWEEKNK
>FCMOIPGL_01777 Alanine dehydrogenase
MKIGIPKEIKNNESRVGMTPAGVFELTKKNHTVFVQATAGEGSGFFDKHYQEVGAIILPT
IEDIYSQSDMIVKVKEPIAEEYPLIKENQIVFTYFHFASSEPLTKAMIQSKSICIAYETV
EDNEGTLPLLTPMSEVAGRMAVQQGAKYLEKPIKGRGILLGGVPGVAPGKVLVLGAGVVG
VQAAKMAAGLGAHVTIMDINMKRLRYVNDVLPNHVITAFSSEYSIRQLIKTHDLIIGGVL
VKGGKAPKLITRDMLKEMRPGTVVVDVAVDQGGCFETTKATTHEHPTYIIDDVVHYCVAN
MPGAVPYTSTIALTNVTLSYILKIANLGWEKACEFDKSLSKGLNIVKGEIVYKELEGIFD
>FCMOIPGL_01778 hypothetical protein
MKRILLILVLLCTTMAQSQEKTFEKEVIKISKRIEIITNQQKDSLKSKIIDIDKKLEKGE
ITKVTSETLKQEVAAYHARRIEILVGEQERLLQLLVQDKTNGKIATSEENETITGEDDDN
TFSIGNKIFKLNITEGDLEERNNKRKERWKEKNKKQRSTTTQFVFAMGVNNVLNNDKFSS
LNDSEYKFWQSHFYELGWTWKTRLTREPSQLYFKYGFSFLWNNLRLEDNRIHVKNGDVTE
IETYENKLSDSRLRHVQMNFPMHLEWDLSKNKIYDDGRVRDRTNNAVRLGVGGFFGFKLG
TRQYLEYNDANGVEVEEVQFDNFNMNTVNYGLSAYLGYKSTSFYVKYDLNPLFKNTKTRN
ISLGLRLDLN
>FCMOIPGL_01779 hypothetical protein
METNNIDKNIKEKFENRTFEPSASAWERLSTQLDEQPKQKKKGWFFYIGVAASILLLISV
VFFNKNVETKPSEIIVDNPIDTTIIDNKINKIINVIPVEKALVKVDEIEEDQKINKDVIA
KSYKEMHPKKKNIIAKTDDQISITNVDENPSEKSASAIKKVDLQQNPNSRIKINSEDLLY
AVTHTPEEVKTYYAKYNLNRDDVLKTIKSELKKSNIKVNPETILAEVERTIDDEDFQNNF
MKSLKNKISDIATVIASRNN
>FCMOIPGL_01780 ECF RNA polymerase sigma factor SigE
MKIISLHNNQTSLIKKAIANNREAQQQLFEKHSPKMLGVCRQYVKDLHHAEDLLLQGFLK
VFTNLHKFKNEGSFEGWIRRIMVNTCLSYLRKKNLVDLSDEDYVFNDAATESLENTSVED
IQKLIDKLPDGYKMVFNLFAIEGYKHSEIAEQLGISESTSKSQLFKARKLLQENYYKMNK
TINGDK
>FCMOIPGL_01781 hypothetical protein
MNYSFLLDNNIYREIVKYGNEIVFENFNSDIKNHRIIKNIPVENIIYSLTPFTIMEALGI
TIPYPKIILPLELKSPKKYNEAFIFINDEAKKYFSNLSLIKPKELLKKVKQQKKFTSLKA
KKTEQIFIENPLKTKEFYDYFLESLVFDYTCKYEFPREVQKRIFSEYLLPTFFLNNHTIS
RFSKFRIIKRLWDNSYTGLKKSPVFPKGYFEEINNSMKLKGNQDFLDCEIIHFACVGDCV
ESKHNPVFVFTQDDKKTIINRIIVYKSMIKTILNDLSEDNYKINKPIINNWEQGMIIFCN
SDGSIKESIDVSDIKTIN
>FCMOIPGL_01782 putative malate:quinone oxidoreductase 1
MRFKKEYDLICVGGGIMSATLALITKLLKPEMNILIVERLKNVAQESSAAWNNAGTGHSA
LCELNYCPEENGKVSIKKAIDICTQYETSKQFWSYLTEKGLIENPNEFISTVKHHSWVLG
KENADYLEERFKTLKEHFMFDSIEFTREIDKMKEWFPLIANDRTEDEIMAASRIDRGTEM
NYGSLTEKLFHILKTKFNTPVHCNMEVLDIDPDTDLDWTVEIKNLKTKKVHQLDAEHVFI
GAGGGSLLLLQKVEIDEKEGYGGFPVSGEWLVCTNEDIIKQHDAKVYSKAGLGDPPMSTP
HLDTRYIDGKRQLMFGPFAGFSPKFLKEGSNLDLFKSIQFDNIPSMLGAFWHNLPLTKYL
VEQVMMSKEDRMDSLRKFVKNANSDDWEVVKAGQRVQIIKKDEFEGGKLQFGTEVISSKD
GSITCLLGASPGASTATSIMLEVIEKAFPELINSKKGKQLLKEIVPFYKSKVTKELFDKE
LEKSKISLGL
>FCMOIPGL_01783 Primosomal protein N'
MTMHFIDVILPIPIQKTFTYSVTEDEFNFLQKGMRVAVSFGKTKMYTGLVFNIHQTAPVL
YEAKEIHQILDEKPIVNELQLKHWQWIANYYMCSLGDVYRASLPSAFLLESETIIYKNEA
FLEESILADEEFLIFEALQHQSQLTIHQVADILGKKKVMPIVNELIKKSAIYIKEEIYEQ
YKPKLVKYIRLNANYFDDDSLGKLLEELSRAKKQREAVLTFFQLSTSKKPIKAKDLETKA
QVSQSILKSLVDKNIFEFYHIQTDRIQFKGDTNDLKVLNEHQQKALVEIKETFKEKDVTL
LHGITSSGKTEVYTKLIQDILDEGKQVLFLLPEIALTTQIITRLQFYFGDQISVFHSKYS
MNERVEVWNNVSENKTKAQIILGARSSIFLPFSNLGLIVVDEEHETSYKQFEPSPRYNAR
DSAIVLAKIHRAKLLLGSATPSLESYFNAQQKKYGFVELNRRHGNVQLPKIELIDVKEKH
RKKEMNGHFSDRLLKLIQEALDLKEQVILFQNRRGFSPVVECKTCGVSPQCPNCDVTLTF
HKFRNELRCHYCNYQRAMPNSCGACGSNTLDTKGFGTEQIELELKELFPDFKIGRMDLDT
TRGKFGYQKIIGAFEAREIDVLVGTQMLSKGLDFENVSLVGIINADSMLNFPDFRAHERA
YDMMVQVSGRAGRSKKQGNVAIQTYNPYHQILQQVSTTNYTEMYKEQLQERWQYKYPPYY
RLIKITLKHKDYNKVDSGVNWLFKSLHNSFGENVLGPTAPAVSRIRNQYIKNIVIKIPPK
QSLVNTKNHVSKIRNSFEAVKDFRPIRFIIDVDAY
>FCMOIPGL_01784 hypothetical protein
MEQIKELIDYYLTFKNVYLVKNTLVKIVSLTTKDNYA
>FCMOIPGL_01785 Haloalkane dehalogenase 3
MTADNWKSRGKFYTIADKKIFVVDEGSSLQTIVILHGYPTSSFDYSRILPELSKHYRVII
HDHLGFGFSDKPKSYTYSLIDQADFALQLWHKMGLKEVTILAHDYGASVAKEILARKNHN
LIPLKIKRILLCNSSMRLEYLHLRNMDKLLKDKKLGRYIARLTNYGFKKIKDKFKNKNLN
PEIHTNYDINKVWDQLDTSEGKNEIHLLSNFINERYTFWHRWTEALKESEIPIKIVWEKS
DPVAIKEIAIVLATENINENLEWIENERHFSILENPTNWLNLVFNINKSKI
>FCMOIPGL_01786 Haloalkane dehalogenase
MDSLNDNAIVMTSSEWEKKGNLIPVFDKEIFTIDIGTHKKTLVILHGYLTSSYDYYKVLP
ELSKHYRVVLLDFIGFGFSEKLDKQYFTIIDQTDYVLELCRLLDLTNITIFAHDYGTEIA
QEIIARQNYSLINTPIENYIFCNSNMPIYHSYFLDYHKSLKQQVAKKLIAMVASFGIYKK
TIKGVFCDDSKIADEELREMWYQLELNKGRDVINFADNYVRERNIFWNRWIAALKENKVP
LKLVLGRKDVINTVEKLEPLTEKFDGNNIHWIEKCGHYPMLENPKEWIEAVLKA
>FCMOIPGL_01787 Ribosomal RNA large subunit methyltransferase L
MLNCSFNSLFQCIFAVNFTSMNKDFKMVATTMFGLESILAEELKNLGAKDVQESIRSVSF
KGDEGFMYKANIALRTAIRILKPIKVTKIYDEEDLYDTVKKIKWEKYLDIDGTFAIGAVS
NSKNLPNHSHYIALKSKDAIADYFRDNFGKRPDVDLDYPDLKIHIHINKDLLTISLDSSG
DSLHKRGYRTATNIAPINEVLAAGMILLSGYRGDENFIDPMCGSGTILIEAAMIANNIPA
NINRKRFGFESWKDYDEDLYFTIQDSLLKKIRSSHFKIMGFDKAPSAIVKANANIKEANL
DEFIGVHHVNFFNSTKEVFGKTTILFNPPYGERLNVDTQEFYKKIGDTLKHNYPDSTAWF
ITSDIPALKHVGLRTSKRIDLRNGDLDCKFVRYDLYEGSRKFKKNNNNFCSKEE
>FCMOIPGL_01788 Ubiquinone biosynthesis O-methyltransferase
MKKKDWFTDWFNTPYYHVLYKERNYKEAQLFMKNITTFLALPKITHILDLPCGKGRHSVF
LNSLGYKVTGGDLSENSIEYAKQFENDTLNFSVHDMRKPFKNRYNAVFNLFTSFGYFEDD
DEDILILQNIKNGLKKDGVFVFDFLNATFVKNTLVTKETKIVDDITFNITREIKNNFIIK
NISFFADEENHKYIERVKYLDIEKMKKYFEKVGFTITAIFGDYNLSNFNAQTSNRLILVA
K
>FCMOIPGL_01789 hypothetical protein
MNYILLVLSVLIGSLLVFIIKPSNKIVRLLLAFSGAYLLSVTVLHLLPEVYTINSNHKSI
GIFILIGILLQSVLESFSKGAEHGHIHIHTDGKKFPALLFVSLCLHAFSEGLPIHNSDSN
LLWAIVVHKIPIAIVLTTFLINTKYTKKTVFGFLFFFGLMSPLGVLVGDKIPFFTTYGSE
ITALIIGVFLHISTIILFESSENHKFNLQKFTAILLGILLTIFTL
>FCMOIPGL_01790 hypothetical protein
MKKTNFKNLDPKEYACIHNKIGKRTYLNRPSEPEEQEILYRLYSPRVQLLDNIKNGNSYI
SIEYLSAGSKKISNIKCEFKDNILSIIIDINALNNNGNDKNTMSHIVFNVSETCKDLITK
EDSIDKITVLLQNNNKLKAESLTENLLIIKGTTTITDPYEEYPPFAPTSISLGEYPIEEE
EK
>FCMOIPGL_01791 Signal transduction histidine-protein kinase/phosphatase DegS
MKYNILLFLLLFSGKAIFSQVLPENKNLYDSISKHIRQRNFSKIKSFLNNNKKKFNKNDK
YLIIDINDFYYHYLKKNYDNCYIVLNRIEKYKDKLNYENLNQYFTSKGYLFKAENKIDSA
TIYFTKSLSFFEKDKIKYSSELANIYQGLATIYRLSNNTSKELKYLNDYLEIAKKTGNEY
KISSAYNSLGVYYDKNNNPKNSLENFKKSLNYKQRNISRNTTLQNIGSIYLKYFNNVDSA
FYYNQKAINEYTSKRNLAFIHYDLSLIASRKNNLNQENKELQTSLKYIKLDPFPELEIKL
YKDLSENNKKLKNYKESLRFLEKYDSLNNVVKNQSLIEKVEEIEIKYQSEKKEKENLQLK
IEKEKTNNFLIASLLFIFLSSIITVLIFKNSNKKRKVAEQQKELETQKNLTLLKEQEITT
INAMVDGQEKERKQIAEDLHDNLGSVLATLKLHFEKLKINCEKNLIDPEILFNKTENLID
EAYIKVRSIAHAKNSGVIANQGLLVAIKLMADKISSADNIKIDVIDFGLNKRLKNSLEIT
VFRIIQELITNIIKHAEAKNATINISLYDKNLNIIIEDDGKGFNFKKGNLKKGMGINSIE
TRVAHLEGTFEIDSTLGKGSSIIINIPIS
>FCMOIPGL_01792 Oxygen regulatory protein NreC
MITIIMAEDHQMLIDGVQSFFEYSDEISFIATANNGEDLVKLVDLKKPKLVLTDIRMPRV
DGIEATKIIKKKHPYIYVLAMTMFDQPDAIKQMLDAGATGYILKNSGIKMLSKAIQTVAN
GETFFDPNVAFNFMNNYIDDNVTIGKTDKIVLSNREKEILTLIANGNTSKNIAEILFIAK
STVDTHRKNMIRKLDLKSGSELVKYAIDKKYKF
>FCMOIPGL_01793 ATP-dependent DNA helicase RecQ
MDLHSPLKKFFGFNKFKGLQEQVIKSIVNNENTFVIMPTGGGKSLCYQLPALMAEGTAIV
VSPLIALMKNQVDAIRGISEHNGVAHVLNSSLNKTEVAQVKEDITNGITKLLYVAPESLI
KEEYVAFLRNQKISFVAIDEAHCISEWGHDFRPEYRNLKHIIKAIDSVPVICLTATATEK
VQEDILKTLGITDANRFKASFNRANLFYEVRPKTKEVEKDIIRFVKQREGKSGIIYCLSR
KKVEEVAQILQVNGIKAVPYHAGLDAKTRVKHQDMFLMEDCDVVVATIAFGMGIDKPDVR
FVIHHDIPKSLESYYQETGRAGRDDGEGYCLAFYAYKDIEKLEKFMSSKPVAEQEIGHAL
LQEVVGYAETSMNRRKYLLHYFGEEFDDVNGEGADMDDNSRNPKKKHEAKEDVVKLLSVV
KNTLQQYKSKEVVNTLIGKENALLTSHKTHLQPFFGIGKDKSAAYWMALLRQILVVNFIK
KEIEQYGVIKLNKVGEDYLENPTSFMMTEDHSYTETGDNLIITNSKSSGGAADEKLIKLL
KDLRKRVASKQGVPPFAVFQDPSLDDMALKYPMSLEELSKVHGVGEGKSRKFGKEFVKLI
TTYVDENDILRPDDLIVKSTGVNSGLKLYIIQNTDRKLPLEDIAKSKGLEMNELIKEMEV
IIFSGTKLNIDYALDDLLDEDQQEEIHDYFMEASTDKIQVALDEFDGDYDEEELRLMRIK
FINEVAN
>FCMOIPGL_01794 Arabinose 5-phosphate isomerase KdsD
MKDKPNIIANAKKTILAESKAIANLANFIDSAFENAVKYIYKSKGRVIVTGIGKSANIAT
KIVATFNSTGTPAVFMHAADAIHGDLGNVLKDDVVICISKSGNTPEIKVLVPLIKNYGNK
IIAITGNTDSFLGKNADFPLNTFVEKEACPNNLAPTTSTTAQLVMGDALAVCLLELKGFT
SKDFAKYHPGGALGKRLYLKVSDLTTNNELPKVLENDSIAKVIIEISEKRLGVTAVLKDD
KIVGIITDGDIRRMLSKTTEISNFKAKDIMGKNPKSIHKDAMAIEALDALENNSITQILV
KDDNNNYVGVVHLHDLIKEGIF
>FCMOIPGL_01795 Sec-independent protein translocase protein TatCy
MAETQKEMSFLGHLEELRWHLVRGVSAIFILAIVFFIFAEEVYNNFLLAHIQPDFITYQL
FCDFFNFFGMDSEFCHINFADKKLQSIEVTSQLMNSIWSSLILGFIASFPYILWEFWRFV
SPGLTKSEINKSRGFIFIASFLFFIGVVFSFYVIAPISVQFLYNYQISDAIVNSFTLESH
IGLITNMLLGVSILFELPVLIYFLTKIGLITPEFLKKYRKHALVIVLIAAAIITPPDVAS
QVIVAIPILILYEISIKVSRRVIKNQQKNAN
>FCMOIPGL_01796 hypothetical protein
MPTKVQEFNEYRQKMNDKILASDNKIVKRIFNLDTNAFSEGHLPVKTKELLGLVASAVLR
CDDCIAYHLETAHKNGVTKAEMMETMSIATLVGGTIVIPHLRRAVEYWEALENE
>FCMOIPGL_01797 Lipopolysaccharide export system ATP-binding protein LptB
MILRAEKIEKIYGSRKVVQDISLEVKQGEIIGLLGPNGAGKTTSFYMIVGMIKPNFGRIF
LNDEDITNDAMYKRAQKGIGYLAQEASVFRKLSVEENILSVLQFTNLSKKEQKIELESLI
EEFNIGHVRKNRGDLLSGGERRRTEIARCLASNPNFILLDEPFAGVDPIAVEDIQSIVAQ
LKNKNIGILITDHDVQATLAITDKTYLMYNGSILKEGTPEELAADEMVRKVYLGKDFELK
KKKFFTP
>FCMOIPGL_01798 hypothetical protein
MFKSIRTFIGAKNFETSKNFYKDVGFIETILSDNLSYFKIDEKLGFYLQKAFVKDWIDNS
MLFLEVEDLESYFNIIKEKNLIEKYTKVKLSKIVYNDWGKEFFLHDPSGILWHFGNFKE
>FCMOIPGL_01799 Phytochrome-like protein cph1
MKSAKIPHNEKERLAVLKEYSILDTLPEEEYDAITKIASGICNTQIALVSIVDKDRQWFK
SAHGVNATETPRDIAFCAHSILNPDELFIINDATKDDRFFDNPLTINEPNVVFYAGAPLN
STEGYPLGTLCVIDNKPKVLTENQKESLVLLSKQVVRLLELRKKNKELEASNLKVKKLNE
QLNNFAFRLTHDLKSPINGVHFLLNVLKEDHLALFKNTEAEEHLSLISDRILYIDDLINE
ILNYSKVTSENIIYENFNIKILLDTIINNIDFENKITLEANNLDLEIFSSKIGLLQVFQN
LISNSRKFCDEEKSIISVNFKEDADKYYFTYEDNGPGIEEKYWDKVFALFETLGSSKNTN
NTGIGLATVKAIIKRLGGKINLKKRADEKKGVCFYFYIYKKKTN
>FCMOIPGL_01800 hypothetical protein
MLILAVEKLFYMAVGEKIPNYITLGNLFSGTVAAIFAVEGDFKTAGIFVLVGIIFDFFDG
FVARLLNVSGELGKQLDSLADMVTSGVVPGIIMFKLIQNNLIADNLFEEKTAQILDVQLI
GLILTLAACYRLARFNLDTRQTESFIGLPTPAMCLFVVSLPLIQMETDIEFVKDLISNNY
FLIALTWFLSFLMNVEMHLFSLKFKDYSFKNNYVKYAFLLASVLLMFTLNFLAVPLIIIL
YIILSVVKKRFL
>FCMOIPGL_01801 Multifunctional-autoprocessing repeats-in-toxin
MPVFSSDFLPTIPFRNGYFNTTFRPLFMKDKATYTRKRVSTWDHDFFDLDFTFVGSKTIV
VLIHGLEGSSNSKYMASNVNHLKNKGIDTVCFNLRGCSGEDNLLLSTYHSGKTEDVDFVV
NYLLENYKYKNIIIAGFSLGGNLTLKYIGEKGENISPIIKGAIAVSVPIDIGSAEIEMDK
FKNKLYMEMFFKTMKNKILEKSYKFPEYKLDQDKLSKATKFKHLEHLYTVPVFGFKNPED
YWEKASSKQYLSNIKKPTLLINAKDDSFLSRDCYPYEEAENSNFFFFEETKYGGHCGFMT
SFKPNENKWLEFRIERFIKENIQLDIL
>FCMOIPGL_01802 hypothetical protein
MKYKIVLFLVAFPLFLKAQSFRNYSNEFLNIGVDAAALGMSKAVVATTNNVNAIYWNPAG
LVGIKDYQGSLMYASYFAGISNYNHAAFAMPIDKISAIGISVIRFGVDDILNTTELIDSE
GNIDFNRISLFSAADYAFNFAYARNLIFKDVKIGVNAKIVRRIIGEFATSWGFGFDAGLQ
FERNNWKFGLMARDITTTYNSWIINEDEFNKIKDAIPGQNQELPETTEITKPKIQLGVAK
DFRIGRLFNLQTEADLNIRFEQTNDIFSSEVGSIDPAIGFQLDYDQLVYLRLGVGNFQYI
TEYDNSKSLSTQPNFGVGFNYRGVQVDYALTNIGSVGNALYSNIFSITFDYSFFR
>FCMOIPGL_01803 hypothetical protein
MKKKYLLLLFLFAFIKPYNSQVNLSVYSEVSIVTAGPGSELYEAFGHSAIRIKDPVLQLD
VIYNYGMFDFDAPNFYSNFTKGNMIYMLASYDFKYFLASYKRDKRWVKQQVLNLTSQERQ
KFFMYLENNALPENRNYNYDPYFNNCATKLKDITISILGDKVVLIDENIEKNLSFRQLMN
KEIPWNSWGNFGINLALGSKLDQKATSEQYMYLPKYVYTIFKDSKLFVRNQPENLIKRED
ILLDFEEQKPKISFFNPFLIFSIFSLIGLFITFSDFKKKKISKWLDFTILSTTGILGVLI
IFLWFFTDHSTAPNNFNFLWAFAPNLIIAFIMLKENQQKRIKYYFIFLTFLLFTIPILWI
LEVQLFPVAVIPLLVLLFFRYLFLSKTLK
>FCMOIPGL_01804 Glutamate formimidoyltransferase
MNKQLIECVPNISEGKDINKINAIANVVKTVEGVKLLDIDPGKATNRTVITFVGEPKNVI
EAAFRLIKKASELIDMSKQKGEHPRFGATDVCPLVPIANISMEETAKHAHQLGKRVGEEL
GISGYYYENAATTSERKNLATVRSGEYEGLKEKLSKPNWKPDFGPSAYNQQIISSGVTAI
SARDFLIAYNINLNSTSTRRANAIAFDIRENGRVKLVNGKKVLDKNGNPERIPGKLKAVK
GIGWFIEEYGIAQISYNLTNITITSMHEAFYETDLAATKRGLRVTGSELVGLVPLQAMLD
TADFYLKKQERSLGISESEKIKIAIKSLGLDDLKPFHPQERIIEYVMNSNADKKLIDLTI
TNFAEETASESMAPGGGSIAAYVGTLGVSLGTMVANLSANKQGWDKKWEYFSDWAVKGQK
YKNELLFLVDEDTNAFNKIIDGFRMPKTNPEEIEARKQAIEDATKYATEIPFKVMQTAYN
SIEVMLEMMKTGIQNSLSDAGVGILCAKTAVTGAYFNVRINAKDIKDRKFAEEIIAKAED
IYQKTIVLENEMMKIINAKI
>FCMOIPGL_01805 Mycothiol acetyltransferase
MELENLEIIAYQPEFANDFYSLNVEWLEKYFYVEPYDEKVLRNPQKYVLDPGGFIFFAKY
NNEIVGVVSIINQKNFFELSKMAVLPKYQGLKIGLQLMNFCIEFAKNQQWKSITLYSHRK
LVPAINLYKKIGFKEIPVEENSHYERSDIKMLLNL
>FCMOIPGL_01806 3-dehydroquinate dehydratase
MKLIIINGPNLNLLGKREPEIYGSKTFEEFFKELQLKFKEVELHYYQSNIEGEIIDKLHE
IGFNYDGVILNAGAYTHTSVAIADAISGITTPVIEVHISNVHKRETFRHHSFLSPVCKGV
ILGFGLKSYELAIQSFL
>FCMOIPGL_01807 hypothetical protein
MKKLLLAAFVAIIGVSSIHAQEGVLNGGLNVGIPTGDTNDFYGLTLGAELNYMFPVAEGF
TLGPSVQYSHFFGKDHDFGGITFETEDASFLPISGAARFNVSEKFVVGANVGYAIGLSND
YDGGFYYRPVVGYKVGERTQLNMSYSGISNEGVDLNSVNLGFMFGI
>FCMOIPGL_01808 Tyrosine recombinase XerD
MKWQNAIRDYRLYLKIERGLSKNTIDSYTRDLDKLILFLAENEISFTPISIDNNTIQQFN
YEVAKKVNPRSQARIISGLRSFFDYLVFEDYRETNPTDLIEAPKIGRKLPDTLSEEEINE
LISAVDLSHPQGERNRTILETLYSCGLRVSELITLKISDLFFNEGFIKVTGKGNKERFVP
IHYNAQKYITIYINEIRIHLKPAKSFEDTLFLNRRGKGLTRQMIFTILKDLAVKINLNKK
ISPHTLRHSFATHLLKNGADLRAIQLMLGHESITTTEVYVHLDTSYLKEIVETYHPRKST
F
>FCMOIPGL_01809 Inosine-5'-monophosphate dehydrogenase
MIAHNNKILGEGLTYDDVLLVPAFSKVLPREVSIQTKFTRNITINVPIVSAAMDTVTESA
LAIAIAREGGIGVLHKNMTIEQQAQEVRKVKRAESGMILDPVTLPLTAVVSDAKQNMREH
GIGGIPIVDKDGILQGIVTNRDLRFEHNNARPIVEVMTSENLVTADVGTSLSDAEKILQN
YKIEKLLIVDKDYKLKGLITFRDITKVTQKPIANKDTFGRLRVAAALGVTGDAVERAEAL
VNAGVDAVVVDTAHGHTEGVVNVLKAIKEKFPNLDVVVGNIATPEAAQFLVAAGADAIKV
GIGPGSICTTRVVAGVGFPQFSAVLEVAEAIKGSGVPVIADGGIRYTGDIPKAIAAGADT
VMLGSLLAGTKESPGETIIYEGRKFKSYRGMGSIEAMKKGSKDRYFQDVEDDIKKLVPEG
IVGRVPYKGELFESIHQFIGGLRAGMGYCGAKDIETLKENGKFIRITASGINESHPHDVA
ITKESPNYSRR
>FCMOIPGL_01810 Iron-regulated protein A
MNLKLSKLIFAIGITTILSCTSESEPIPEITIEKSSVLDNYATIVFANYSDAKTDAESLQ
TAINVFVTTPTEANFTAAKDAWLNARESYGQTEAFRFASGPIDDTDGPEGLLNAWPLDEN
YVDYVVGEANSGIINNLVDYPTIDKATLESLNEVGSETNISVGYHAIEFLLWGQDTTVPS
EKLAGQRPYTDFVDGGTADNQDRRRDYLAACADLLIDHLQLMITEWQVGGAYRTTFLALD
EDTAIKNILTALATLSKSELGGERIFVAYDNQDQEDEHSCFSDNTHRDIRLNLAGIANVY
RGSYGSISGDSLEDLISETNPTLAAEITAQLVAAENAIDATATPFDFAISDTSERPFVLA
SVNALQDLGDKFVEGGSALGISISSQLPD
>FCMOIPGL_01811 hypothetical protein
MISCSNNEEIYIPLVAEENEAFSGGETTIFDVSVNAFGFQAPNLVGDNSLFFFTGNSLFN
QNWVTAPASTTARDGLGPFFNARACSTCHFKDGRGKAPESIGDLNHGLLLRLSIPGTDLN
GGNKPDPIYGGQLQDQSVTNTTTEASFSISYSDKIVNYSDGTSVTLRNPEYIINDLAYGN
LASNLQVSPRVAQQMVGLGLLEAVTENTLLSFADEFDTDNDGVSGRPNYVWNIETQSTTI
GRFGWKANQPTIKQQISAAFAGDLGITSTLFPDENCPEGVDCSSFANGGSPEISDENIGK
VTLYSSTLAVPGRRDYDEINILEGKKLFIDSKCTSCHIAKMTTGSHEIPALENQTIRPYT
DLLLHDMGVDLADNTPDFKATGTEWRTPPLWGIGLIETVNGHTNLLHDGRARTIEEAILW
HGGEAENSKNIFVNLTSEERTKIIDFIKTL
>FCMOIPGL_01812 Iron-regulated protein A
MKSQIRKKLFFILPLSILASLLIFISCNTDGITESEYQIQYTRTAQLENVYENEILVLSN
EFIQQTSLLETSIQEFKTTPTLVNLTKTQASWLATLKVWKQLELYNLGAVENSFIHFEIN
RWPTNSETINEHINGTETINEAFIASKGSSAKGISALEYLLFSSEENQEILNSFTTELNF
ERRLDYLLSLSNNLKTKANALLSLWENDKSDFISSVENGISGSQNQLTNAMITLIEEVII
SKLGNPLGNNTGGIINLDDLEASRSITSLVIIQEHLNALKRCYNGDFLENEINWGYDNYL
GLIERDDLDLSIIEAFNNCQTKIDAIHNPLTIELINNPENVENLQDAFRDLLVLIKVDMS
NAIGTTVTINDNDGD
>FCMOIPGL_01813 hypothetical protein
MGIKKITSYLLKETSILPLAIFRMAFGFLMCFSMFRFIFNGWIEKCYTNPEFHFTYQFFD
WIQPLDVNEMYIVVIICALSALLIGLGFLYRIATILFFISFTYLELIEKSWYLNHYYFVS
LVAFLLILVPANKNYSVETKIFKNLKLNYVHNWTILIFKLQLCVVYLFGGIAKIKSDWLL
NAQPLKIWLKAKTDVPLIGWLFEYDITPYLFSWSGMLYDLTIPFLLFIRKTRPIAYIFVV
VFHVLTYVLFNIGMFPWLMIFGSLVFITHQEWNTILGYLGKKINLEEDKKENNSFKTNKI
VLAFLAAFFAFQFLFPLRYHLLTNNVLWTENGLRFAWHVMIMEKNGFAEFTVFDKKTSKR
WVEYPKNHLTTTQEKQMSFQPDMIWQYAQFLKDKYAKKGITDVAIFVDSRVSLNGRVSQK
FINPKKDLLEIKDVDAIYKAVLKLN
>FCMOIPGL_01814 hypothetical protein
MVLKGLIFQFPKEIKLLIVAFVCTLSIGFYSGISFVRSTTNANPTGIEHRYLGNEEDESA
TKMMFKKSEGEIMTTVHSHILSLSVIFFIISLLLSTTDISQKLKLFLMIEPFFSLIFTFG
GIYLLWKDLYFMKYVIMISGFFMTATYTASIFIILKQALKKTN
>FCMOIPGL_01815 hypothetical protein
MLVSFSLPDKLLKKVNKEIKSVFDIKDFQLKLVKIEDSINDKLPKKIGNDNLFKIESNSK
LIGYAFVDKSPSKTDEFDYLILLDKNLIIAKTKVLVYREDYGGEIGSKRWLNQFTGKSSA
DKLKYRKDIIPISGATISALSMTKAVNSFLLDLNILHINKVL
>FCMOIPGL_01816 hypothetical protein
MKRLLTFAIAIVSTISIAAQNNQKDSINNPKNQINGAQRILNGNINTKGVSVGGYGELIY
NKVSDNNAVLDVKRLVLFFGYKFDERTQFITEVEFEHVNELFVEQAFLQYSLNDNVNLRA
GLMLIPMGIVNEYHEPTTFNGVERPSMDNAIVPTTWREMGIGVSGRYNEASLRYQAYIFN
GFKSVESNEAGTITAGLIGGRAGLRGGKQKGIQSTFNNANFATKIDYYGLPGLRLGLSGY
LGRTQSPADVEDLSGADVGISMIGLDARYAYQRFTARGQFVHASLSDTNAYNIATGSDLG
SALQGYYVEAAYNLLPQTKRQQLFGFVRYEDYDTHASVEGNLTKNNSFDRHEWTFGLSYQ
IASGAVIKGDYQLKDNAVIGGATINQLNFGIGVWF
>FCMOIPGL_01817 Diacetyl reductase [(S)-acetoin forming]
MSKLENKIAVITGATGGIGFAVAKRLGKDGYTVILNGIEDEAGAERVKELTAEGITAEYY
GFDVTKDEEVTANITKIGEKYGKIDVLVNNAGGLGGRSRFEEMTTEFYRFVMALNLDSAF
FASRAAIPFLKKSDNASIINYTSNAGWNAGGPGAGIYGTSKAGVHAITRALAKDLAEYGI
RVNAVSPGTIDTPFHAQIKATKPEVFASWANNIMLGRLGQPEDVAGVVSFLASKDAAFIT
AETIQVGGGQALGI
>FCMOIPGL_01818 Hexuronate transporter
MKVKGLRWFIIGLIFLATVINYIDRSALAIMWGSSDQPNSISGSLDLTKSDYGLILNIFM
VFYALGQLFSGKLFDKVGTRIGYVISIGVWGLSSFLHSTVQGIVGLTFFRSTLGISEAGN
WPGGVKSNAEWFPIKERAIAQGLFNAGASIGSVIAPPFIATLFVAFGWRTTFMVVGSFGL
LWIIPWLLINKAGPKKHPWITPEEQKYISEGQSKADQNATADTKGKSLKEILSYKESWAI
VVGRFFLEPIWWLFVGWMPLYLADVYGFNVKEVGMFAWVPYVGAALGSIAGGYVSGQIIS
KTNSIDKGRKFTILIGGVIMFLGLVATVLFGDSPERFVAIVFFVLFGFQFAIGNVQTLPS
DLFSGKSVGSLAGLAGMVGVFSVILMNFLVPIIQDKFSYTPIFVAIAAFVPLGLGAIYYF
AREIKSVEE
>FCMOIPGL_01819 HTH-type transcriptional regulator LutR
MKLETLTKSDSSSIQKDIISKIRDLINFKNLEPGDKLPSERMLSDKFEVSRSAVREAIQK
LEFYGLLKSIPQSGTFVADIGIVALNGMIGDILRLEVPEFKALVETRILLELKTARLAAI
RRTDEDLVQIKEALEAYNTKVLNGEDAVQEDLLFHLAIAKACGNSTMNTFMLIITPGIIN
NFKKHHVCDAGLSKRGIEDHKAIYDAIKDQNPQLAKQKMKEHFKELYQYCYNIE
>FCMOIPGL_01820 hypothetical protein
MKNNIKFKRRVSLHILSAFVLIGFISLSSCVDALEYDLAEAGSKEDLNPPAASFKETVTS
DYLTYTFANTSSSATDYLWDFGYDGDGDGVSDSSTELDAEYTYPYEGSFTISLTVSDKLG
ATDTYSVDIEVVEPEIPVSITPDIINGDFTDKFDGWKFDSFSGGTTSPFNSSSDGSWLNY
DGTDNGSKTAGAKWTSSTSTGPATSKTRYAYQAITVTPNVLYTIEYEYAIKTDNSDRDGG
DRVVVEILDGHFSTGAEGVASSDAGALVQSVGNVANGKGNFETNKVSFTSNGSGLISILI
YAITNDELYVDNVKVYPLN
>FCMOIPGL_01821 SusD-like protein
MKFRIYIAIMLIGGLVTSCSDFLEPDPSSAITSENYYTTTAELQAAVIGAYDAIQGINSY
DKLENHGIQYEFYVTEMRSGNTSTKIPDSDDASDAGQFESFNVLATNGFVKNYYNSYFQV
IYRANVVLENLGNVEGDTSAIEAEAKFIRAYAYFNLVRLFGDLPFIDRVISPTEKEIQFT
RVDKSLIYDLIVSDLTTAISGLDNTYKTRGSKAAAQGLLAKVYLTLDTPNYTEAQSLCES
IINSNEFDLEPSFYDVFYTELNDEILFAVGFESVSDSQNYSAQFMNAVGQSSGLNYATDD
LVTSLNDFGGNRTEYSFRKDPVHLTSDRYQCAKYFPDGDNGGSNGVFTGNPELAGNDWVV
LRYSDILLLHVEAIMAGSEETSSSSAITSFQKVRARAGITDAVSKITLDELLLERRVELA
FENHRLFDLIRLGKAESVLSAYSTANGYGYTSTDLLLPIPQNEINLSDGVMSQNPGYN
>FCMOIPGL_01822 TonB-dependent receptor SusC
MKLKFRLTLLFVMLVNICFYAQGTTTITGVVSSKSDNTPLPGVTIRVLNTTRGIQTDFDG
IYSIKVSVGEVLEFSYLGYASKKVIVANQKTIDVVLEESASQLDEIVVIGYGTQKKSHLT
GAISKVKNDDLDQIAASRVDDALVGQVSGVNIQATDGEAGAAPTITIRGVGSMAGDSTPL
IVVDGVIVDSDFLGSLNMNDVDSFEILKDAASASIYGSKGSNGIIMITMKSGLEGKTRIN
YSTYTGIKTARKSDAYGYTTQGWANQQMATNGEVSIYTQAQLQTGTDRSWQDVFFDGGTI
TSHSLSFRGGSESTKFAASLNYSDDGGVLLGDNYTKHGVRLKVDNKINKNFSIGASFSPT
MTNRKRFSESIYNVARHQPWLPIYHTEETLQHVDFSNAAFADLQVGDYARQSHFTIFDLD
GDGLINDELNNIGNSNNSNPYARVTERNRGDKKFKLFGSVYGKYKIMDGLNFKTTISGSI
QDTKRTDYLGTLAKEQVSDAYMVETSQKEQYYIFDNFLSYNKEIGKHSLGVTLGNSIETR
DYFFSTIKGIGYTNDVVQQITNATEIILDDTDGFEWQKRGVSFVSRFNYAYNDKYLVSLS
MRRDGSSIFGSDYKYGNFPAASFGWNIDKEDFLKDANFISKLKIRASYGVTGNDRLNTGS
VNPDAQGSSSVLSTGDILTDYYPHLSLLQSTTYAYAGSVTAGFSPLNIANPDLKWERLIE
INPGIDFGFFNNRISGSVDWYQRNSDQLLLNNPISATTGFTSALVNLGKVRNQGFEFELR
TKNIRKENFSWRSTFIATTNKNTLVDFADSDGQIVADGTPSVQAEWINSEGLPISSYYGY
VVEEEVPVEYRDRPYRHVGAEFGLVKVKDLNGDGVLDGEDRTVLGNPYPELIWSLTNDFT
IGNVDVSFMFQGSHGAEVRNLGDHYLFSHNNNQTLSDLAIADGYDGTFLVNKYFTNSVVQ
NASYIALRNVNIGYNLPEDVVEKLGVSKLRIYATGSNLLYITADDYTGWNPEAIDKSGPT
TYGFQKGGSPVYSTISLGLNLDL
>FCMOIPGL_01823 hypothetical protein
MKRVSEKYVIAKDIKWEELGGGVSRKFLGYDNQIMMVSVKFEEGALGAPHQHFHTQATYC
VSGKFEFEIDGVKQIVEAGDGVYIEPNLLHSAVCLEAGQLIDTFSPVREDFLTGNGPSYF
GDKE
>FCMOIPGL_01824 Exo-oligoalginate lyase
MKIFYRLFLMILIFVSCSDKQDKETEIVSETKHPNLILTNKSVAEIKLQLGTIPVFDETL
KLAKEAVDLEIEKGIDVPIPKDMAGGYTHTQHKLNYATMQKAGVLFQLLGDEKYAIYIRD
MLLTYAKMFPTLPLHPQTRSYSRGKLFWQCLNDSNWLVFTSQAYDCIYSWLPKEQSDYLN
KTLFRPYADFLSIETPQFFNRVHNHSTWGNVAVGMIGLVMDDEELVNRALYGLKKENLDL
KAKDNDGGFIFDKDGKAGFLANLDSPFSPDGFYTEGPYYQRYAMYPFLIFAEALQNKKPE
LKIFEYKNGVLIKAVDALLNLTDDNGEFFPLNDGQKGMSHYTSSLVSAVDIAFYYGSQNP
ELLSIAQKQNEVQLDASGLMVAIGLKENKEKPFIKKSMELTDGSKGDEGGIGILRYQKED
EKLALVLKYTGQGLSHGHYDKLSFSFYENGDEVLQDYGLARFVNVEQKNGGGYLKENKTF
AKQSIAHNTIVQNETSHFNYDFGTGSAHHSEKYIFDASNPNFQIVSAKEANAYPGTEIHR
TMIMVVDESLEKPFVIDINKIQSNKNNNYDLPYYYFGQIISTNFDYNTPKTLSILGKKNG
YNHIWNEGSGIANQESIQFTWLDNRRFYTITSATDKKDEIIFARIGANDPEFNLRKDPSI
IIRKKGVKNTVYASIIESHGTYDPVKEVANNAYSNFSKIEILKDDANYTAIKIQFKEGKE
KILILSNIDNSIDKKHSVSINSKDYTFTGSYYYN
>FCMOIPGL_01825 hypothetical protein
MKKTLLIIALFSAFLGYSQTFDNIPTGSGYYINKLIPSPSGSDLTNEYIEIRGAANAVVP
SDLYLISIEGDGNSSSRGKVSEAIQLGDGTLTFGANGMLVVITNYTDTDDNSLTESPYKS
VISSDATVIEIALTGTDVTSSSSSAVVTKTPDIGYDGNLIDATATYMLISAPSNPKGVRI
DGSSNSDDANGVINDTGDHTSWVLYDSVGYGDDDDVDASENGEFLYGQIVYVQDNASFSS
KHFITTSATIVDFATTSDANYILRQGTKTGFTADDWIVSANGSDSSVPNWVFSTSSSKVY
PDEFLGWEGIKDVYGLLNPTAASLSVNDVFSSKISVYPNPATSFVKISTSEKITGVEMYN
LIGKKVLNVSSLSNEGVDVSNLSKGVYVLKVTSNNLVGTRKVIIE
>FCMOIPGL_01826 Chondroitinase-B
MKKSFLIISLILLFVSCNEKVTSSILVSNESELNDAIKNAKPGDDIVLKNGTYKDLEIKF
YGEGTEENPITLSAETAGEVFIEGVSNLEIGGKYLSVKGLFFRNGYTPTKNVIAFRTTEE
KVANYCSVTNCVILDFNQLQRDKDDLWVQLFGTHNKLANCYIAGKTNGGPTVRVDLKGNQ
SIRNYHQIVNNHFGPRPRKGGARGETIQLGSSFTSMSPSNTTIANNLFEECNGEVEIISS
KTNFNLIKNNVFYKSEGSVVTRHGNYATIDGNYFIGDGVNKQFGGIRIVNTGHWIINNYF
YNIIGENFRSPLAVMNGIPKSPLNRYNQVTDVVVAYNTYVNCKSPWQFGVGTNIAQAAVL
PKSEIRSARALRSVVANNIIYNKEGDKNPIIEHDKADGVKFKNNIINNQSVAFSNPERIK
EAKFELTKVSDNIYIPNLTSDFDIYNGFGFDTITEDLFGNSRANSNSIGATIKGELNDPK
ILDKTKYGTDWYSNVVEAREPKIYTVKKASELQDKINAATNGDIIDLGFGVFTVDESLVI
NKTITIQSSGDGKAQIVFSGKENTPLFELNPKGKLTIKQVILEGNKSNYAFASLKENMSN
HFGLAVEGCEISNFDYVLKAYKQTFSEEVTFEGTSISNCENGIELSEETNDRGDYNTEYL
TIENCNFKNVKQNVIDYYRGGYDESTIGGNLLVSNSIFTNCGSDEKNKMLLNHRGIVNVN
ITKNVFKNNKVDYVSILWGAKNNVESENTLINSGKIKTEENLVMKLMY
>FCMOIPGL_01827 hypothetical protein
MNSGVIIVFSNNEKEISNFNTEYLSNINASKICFVNNASSDNTLNLLKDIQFKSEKNISI
LDIKLNKGLKAAIKYGARLLLSESEFDFIVYLKPNMLDSLPSLTTFLKNFQENKQDYTSL
PTRSSRNVLFDVFSIQEIMKKKSVA
>FCMOIPGL_01828 Transcriptional regulatory protein YpdB
MKCIIVDDEKMARVIIQTLANEIKDLHIIEEFSNAIQAMKFLNENKVDLIFLDIHMPDFN
GLDFIKSLKNPPKIILTTSDSKFALEAFEYDFIIDYLLKPIELSRFQKAISKAEKKNIQV
ASPVSKVKDVSNDFYVNIDRRLIKIDLPSIYLVEAKGDYIHIKTDDKKYVVHSTLKKIEE
KLPDSLFLKIHRSYIINIKKIIDIEDNSVLIKKEVIPVSRSKRPELMKRLDLL
>FCMOIPGL_01829 Phytochrome-like protein cph1
MNQDKIEILERALDRQKKARKQAEKILEEKSLALFNASQELNKANIKLAALLAEKTSQLK
GVFENINDSYVVIDLEGEVLKMNDVAEKFFGYNTSEKLNAAKLVYSEDYQYAINSFSILI
DKGYFTNYTARIITKNNDIKWVNINGSIIYDNLKKPIAVQGIIRDITAEREKRLIVDMIN
NIMKSILGKENIYEIAWEISSSIATYLDTNDCVIYLVNEATKSLEQITAYHSKAIPNKPV
LNKVVIPFGKGIVGSVAQTGISEIVVNTNNDERYILDGVRRLSEITVPIISEGKVIAVID
AEHKKENFFIKEQLNTIENIASLVSLQLKSAINIRERKKTESINAELLNKLKKSNEELHE
YAHIVSHDLKSPLRSFAALTSWIKTDNIEAFDEASLQNFKDIDITLETMENLITDILQYS
SLEATVSEEEIVDLDSLVKNLIHVLYVPDSISINILNTLPKVKGDKTKFQQLFQNLIGNA
IKFNNKEKGIINIDVEDHNSFYKFSISDNGIGIQNRHFENIFKIFQSLKKEKNSSGIGLS
IVKKIVDIYKGEVWVESEIDKGSTFYFTIKK
>FCMOIPGL_01830 hypothetical protein
MKGIVFTEFLDLVEDKFGIEMVDEIILNSTLESEGVYTSIGTYSFSEMLQLLKNLSDKSG
ISIDNLLLIYGEHFFSVIERSYPGLLDTYKDPMEMLSSIENHIHVEVRKIYPDAELPTFL
IEEKSEKRLIMNYKSSRAMHHFGLGLMNKTFEYFNSTAEIIIEKIKEDGTEVRFIVNKN
>FCMOIPGL_01831 Response regulator rcp1
MLQKKVKILLIENDEMEIFKFKRALSSKFSDFTIIFANNGKEALSILENCFPDIILLDLN
MPDINGFDFLTNVKNLSQIKHIPIIVLTTSNNINDIKKCYKLGIAGYLLKSLNDEDYLIK
INKIMKYWSVNDFIRK
>FCMOIPGL_01832 hypothetical protein
MFLSAILFGLLGSFHCIGMCGPIAFMLPVDREKPVKKFFQILSYHLGRLFTYSLIGLLFG
FLGKGFYFFGFQQQLSIIVGVSMILVVLFPKIFQKLSFSKKISKIIFKIKNSLGNELKKK
GNDTFFTIGFLNGFLPCGLVYMAIFGALATSNEFAGALYMFLFGLGTIPLMTAVVYLGSF
AKGNLRKNIQKAIPIMVIFIGSLFILRGLGLGIPFVSPLEPILNTAGDTVNGCH
>FCMOIPGL_01833 hypothetical protein
MKFNWGTGIVIAIVAFIGFILFFVVKMSTDNSYSYDLVTEKYYQQELGFQDEINAEKNAL
ELKEKVTIQRSEGGLKIEFPADFSPKEIKGKVFLYRPSNKQLDFEIPISISKTYLLVPEK
RLLDGRWNINIAFKYNNKEYLIKEEIQY
>FCMOIPGL_01834 Putative electron transport protein YccM
METPKNEQFRDSIGTIDKSGKRSWVYPKKPSGKFYKYRSYVSYFLLIFLLSAPFIKVNGN
QFLLFNVLERKFNIFGFPFWPQDFHLLVISMIIGVVFIILFTVVFGRIFCGWICPQTIFL
EMVFRKIEYWIDGDRGKQIRLDKQPWNAEKIRKRLLKWFIFFVISFIIANVFLAYLIGGD
TLISYITGNPLDNISTLISLLIFTGVFYFIFAWFREQVCIIACPYGRLQGVLLDNKTINV
AYDYKRGEREEGRSKFKKNEDREALGKGDCIDCKQCVVVCPTNIDIRNGTQLECVNCTAC
IDECDHMMESVGLPKGLIRYASEDNIAKKEPFKLNARVKGYSAVLFILVGILIGMLFLRN
DVEATILRLPGQLYQHKENNIISNVYTYKVINKTTKDIDDVSYKLLSHKGTIKLVSNHDF
TVPKQGLAEGTLFIELNASALKSDKEKIEIGVYSGDKLIETTITNFLGPRSYK
>FCMOIPGL_01835 Cbb3-type cytochrome c oxidase subunit CcoP2
MKKYFQSTIYIIFVIVTFLALAKSFMVYENPFDIYENPLVWIALIGFVLVVVLKEMVNII
AISKATELQNEKLGIVPEDSNAWIKKLLQSWTKSKDIDSEEEIILDHNYDGIQELDNTLP
PWWVYMFYASIVFAVVYLVRFHVLDGDNQIVEYNKAVAEAKASLDKYKATATDLITAESV
TLLTDAKDLARGKAIFKLNCASCHIADGGGSIGPNLTDEFWILGGGIKNVFTTISNGGRD
GKGMIAWNKTLKAADMQKVASYVLSLQGTTPANPKAPQGDKWVAE
>FCMOIPGL_01836 hypothetical protein
MLKFIKGHMESITGIEIYPLISLIIFFTFFMVLFWWVFTAKKEYINTVSNLPLDN
>FCMOIPGL_01837 Cbb3-type cytochrome c oxidase subunit CcoN1
MEMQQFYYDNKIVKKFIYATLFWGIVGFTVGLMLAFMFLFPYYTEGISWLSFGRLRPLHT
NAVIFAFVGNAIFAGVYYSLQRLLKARMASNFLSNFNFWGWQLIIVAAAITLPLGYSSSK
EYAELEWPIDIAIALVWVAFGVNMIWTILQRRQRHLYVAIWFYLATFVTVAVLHIFNSLE
LPVTMFKSYSVYAGVQDALVQWWYGHNAVAFFLTTPFLGLMYYFVPKAANRPVYSYRLSI
VHFWSLIFIYIWAGPHHLLYSALPEWAQNLGVAFSIMLLAPSWGGMINGLLTLRGAWDKV
RTDPVLKFMVVAITGYGMATFEGPMLSLKNVNAIAHFSDWIIAHVHVGALAWNGFLTFGM
LYWMIPKMFKTKLYSVALANVHFWIGTLGIIMYTLPMYVAGFVQASMWKQFNPDGSLTYG
NFLETVHEIIPMYWMRAIGGSLYILGAFVMLYNVIRTIKAGSKVEDELAEAAALTKVSSY
RTKGEGWHTWLERKPIKLTIYATIAILIGGAVQIIPTLLIKSNIPTISSVKPYTPLELEG
RDIYIREGCVGCHSQMIRPFRSEVERYGEYSKAGEYVYDHPFLWGSKRTGPDLHRLGAKY
SDSWHLNHMYDPQSTSPGSIMPSYKWLITDELYKGDIESKMKAMVTLGVPYSDEEIANAQ
EHMLAQGTKIEENLHSDPDFAKNYEADKKYAKENGEEFIEMKNREIVAVIAYLQRLGTDI
KVKDEQKITKN
>FCMOIPGL_01838 hypothetical protein
MSVIYLLLTISILVAILFFIAFIYSVKTGQFDDSYTPSVRMLFDDELIKDKKEKPTKD
>FCMOIPGL_01839 hypothetical protein
MKNVYQTPSSYTELEDTNDYNDLSQLTDSKINFLDICSIVILFISAGFLFESIIF
>FCMOIPGL_01840 hypothetical protein
MNNTYQNPNGYSEFEDSSDYNDLSKLSDSKINFLDICSIVILFISAGFLLESIIF
>FCMOIPGL_01841 Oxygen-independent coproporphyrinogen III oxidase
MKSLVQKYNIPGPRYTSYPTVPFWDNETFTKEKWIETFKQSFIESNSKEGISLYIHLPFC
ESLCTFCACHKHITKRHEVEEDYIETVLKEWKLYINLVDEKPIVKELHLGGGTPTFFSKE
NLKYLIDGLFENAIKHPESEFSFEGHPSNTTKEQLQTLFDVGFTRVSFGVQDYNEKVQQA
IHRIQPFEEVKNVTNWAREIGYTSVSHDLIFGLPFQTKENVLYTIKKTKELQPDRISFYS
YAHVPWVKGVGQRGFNEKDLPKNEEKRELYEIGKELFFELGYEEIGMDHFALKTDSLYKA
TISKTLHRNFMGYTSNKTQLMIGLGMSAISDSWYGFAQNVKTVKEYQKIVNSGEIPVFRG
HILSEEDQIIRKHILNIMCNFSTSWDDKSTKIKNIESHLSLLQEMQNDGLVIIKENSLSV
PDSARAYVRNICMAFDKKLQKKQPETKLFSMTI
>FCMOIPGL_01842 Purine nucleoside phosphorylase DeoD-type
MSVHIGAKKGEIAETVLLPGDPMRAKWIADTFLKDIFQYNDVRGMYGFTGTYKGKRISVQ
GTGMGIPSTLIYAHELINDYGVKNLIRVGSAGSYQKEVKIRDIVLAMAASTNSGLNTIRF
NGADYAPTASFKLFQKAIEVAKEKNIEVKAGGILSSDEFYADDFDSYKKWADYGVLCVEM
ETSGLYTVAAKHNVNALSILTISDSLVTKERTTSEEREQTFKEMIEIALELS
>FCMOIPGL_01843 putative copper-importing P-type ATPase A
MEICIGKRVNMKTTHCYHCGDSCDDTIIKVGDKSFCCNGCKTVYEIFSENDLTCYYDFQD
NPGAIPTEIIGKYDFLDNKEIIEKLLDFNDGNTQIATFYIPHIHCSSCIWVLENLHKLNA
KINTSQVDFPNKKVRITFNAETISLKEIVLLLSSIGYEPYISLEDYETGKKKVDRSLIYK
LGIAGFAFGNVMFLSFPEYFEVSEFWLEQYKFIFRWLMFFFSLPVVFYAGNDYFISAYKG
LRSRILNIDVPIALGISVLFIRSTVEIIFDLGTGFFDSLTGLVFFLLLGRFFQQKTYNFL
SFERDYKSYFPIAVTRITSNQKEENIQIYDVEKGDRLLIRNQELIPVDGILINGNAQIDY
SFVTGEAVPVAKKSGDKLFAGGKQLSGVIEMEVLASVSQSYLTQLWSNDVFAKDKSSSFK
TLTDKISKNFTIFVLSVAFLSTAYWLYFDSSKALNVFTAVLIIACPCAIALAAPFALGNL
LRIFGKKKFYLKNATVIEQLASINSIIFDKTGTLTTNKENTVSYVGKTLNKQEKRILKSS
LRASNHPLSRSLYNTFPELETLTVSNYNEIIGKGIEVDYKGEKLKLGSATFVKKDEDIFS
FDTSVHVSFNDDYKGKFIFKNSYRKGVSSLFNSLKNEYDLAIVSGDNEGEKEFLQENLPK
ETKLIFNQKPEDKLEVVASFQKENKKVAMIGDGLNDAGALAKSDVGISLSEDINVFSPAC
DAILDASQFNKIDDFLKASKKGIKVIKQSFLLSLCYNIIGLYFAVKGDLMPVIAAILMPL
SSISIVIFTTILTNLIGKKIK
>FCMOIPGL_01844 Transcriptional activator protein Anr
MSKCEQCIVRKFNSLKELTKDELIRITACKSSKNIKKGDVIFKEGDHLNGIFCIKDGVCK
VSKMSDNGRNQIINLIQKGNILGERSLISDQTSNLTAIALSDMSVCFIPKEEIIRDLENN
PNFTLDLLKTMANSLKNADNLVVGMAQKSVKQRLADTLLLLQKKFSTNSKGAINIQLSRE
DIANIIGTATESAIRLLSELKKKKIIGFVGKDITILDDKELEKIAQGF
>FCMOIPGL_01845 hypothetical protein
MKQLIIFILIIIAGLIGYGKYNQYKRYNSPQINYKTDKKLDISYHNQDLVLRYYEAVENL
DSFTMLQWSANNIDVRTPEDDDDATKNAVNTYAKKLAKVNYYEMILENSLQLKEKGLSNN
EIKFIEENGIDLASYKKEVNFKIIKNLFDPKVNLYKGEKNAIIFEVQKRLNDLGSNIKID
GVYRTETLEAIKNFEEKNNLLADGFIDELTLELMFK
>FCMOIPGL_01846 2-succinylbenzoate--CoA ligase
MNLEQNKFHKDFKLNGFSFTSVDEILMYTKSFSDEIYSFLESWFSVDDRITVQTSGSTGR
PKPILLKKEFVINSAIATGNYFDLQKNTTALLCLPTAYIAGKLMLIRAITLGWHLDVVAP
NSYPLEKVDKEYDFSAMVPLQLENSIAKISKIKKLIVGGGVVSKELERKIQNVSTAVFAT
YGMTETITHIAVKKLNNIDLIPDFYQTLPNVTIYKDERNCLVIDAPKVSEELIFTNDVVQ
LISDTQFEWLGRFDNVINSGGIKLHPEKIEEKLSEIIINRFFVTGIADEKLGEKLVLIVE
LENSKIFNYQSFLSEEIKKTASLSKFEIPKEIYFIANFLETETKKIQRKKTLDLIAGR
>FCMOIPGL_01847 hypothetical protein
MNYIQQAFKGNNEWYHWVLTIILVFIGWQVLGAIPLTLVAYFHSADLAEFAAAGADNFMT
LDINKNLFLFLMLFMFAVGLVFLIIGVKYIHKRTITSLVTSRKKIDWKRFWFAFLIWGTL
VVVFTILGILLTPEHYTFNFNAKPFFILVAISVVFIPLQTSLEELLFRGYFMQGLGVLAK
NRWVPLLITSVCFGLLHGANPEVQKLGMITMVFYIGTGFFYGITTLMDEGTELALGLHAV
NNMLAAFLVTTDWMVFQTDALFIDSSEPSVTWEMFIPVFVLYPLILWLFSKKYGWNNWLE
KLTGKIVKPVNLKENYRVLDELGTE
>FCMOIPGL_01848 L-Ala-D/L-Glu epimerase
MIKATYKKYILNFKNPSGTSRGILKTKETWFIILEKNGKKGIGETGLFRGLSIDDVSNYE
EKLIWVCANINLGLEKLVSVVVEFPSIQFGLEQAFLSLKSKSEFELFPSKFTKGKEAIAI
NGLIWMGAQQFMKNQIKEKLKMGFSCIKMKIGAIDFDAEIELLKSIRKEFSSKEIELRVD
ANGAFNPKNALEKLQRLSALEIHSIEQPIKQGQVQEMAELCAKTPLPIALDEELIGVFTS
EEKQELLATIKPQFIILKPSLIGGFGGSKEWINFAAQNKCDWWITSALESNIGLNAIAQF
TYTLQSNLPQGLGTGGLFTNNFESPLEVKNGTLTYNPTLNWNFNLT
>FCMOIPGL_01849 hypothetical protein
MKTIKIILGIITTIVVIFLATGLLVKETNYSTQVSINKPVEEVFEAFSTSENIKNWIPEI
KSFEVINENIGKTGSSYKIIIENQGQEIVMTQKVIAYVKNEKVTLFFDAENMLKRDDYIF
EEKNGITTITSNSSCQSESYLMACMFPYFKGTFKEQDQTYLNNFKAFVEK
>FCMOIPGL_01850 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MDVKSFIKAARLRTLPLSISGIIVGSYLGNNDLLLTEIFVRPPIWFTPIFWLAILTTIGF
QVLSNFANDYGDGIKGSDKNRTGEARMVSSGAITPKQMKSAMIITTIITLIIALLLIYVA
FGSDNFGYSILFLGLGIASIAAAIKYTVGNSAYGYSGFGDVFVFIFFGLLSVVGSYFLYT
KNINFKIFLPAISIGLLSTAVLNLNNLRDQLEDKKNNKNTLVVKLGNEKAKKYHYFLIFT
ALITALVYVFLDFESVYQLIFLVAFIPLIKNVKTVAQNNIPAELDSELKKVALSTFLFAI
LFGIGQIF
>FCMOIPGL_01851 hypothetical protein
MNNSFDFSNFSRQSSKGILVIYLNLIYKVIRVTWILLFFVVKDFNKISSIKLTYIYLSIA
GVLIFLLIRAYLIYKNFQFKTENDHFILKQGILKKTNTSIPFYRIQNINFKQNIIQQIIG
VFEVSIETAGSKDTEIAIKALPLSKAEALKEIVSKSSNFDTKTSIDTDKKPLVKIGIKEL
FKVSLTENHLQNLMLFLALIIGFFQQIEQVVDSLGRTEALDGFISESTDALSTSFFLITI
LLFLLTVIALMSSFVKIFLVHFNLTAYLKEDAFEINQGLFTKKSIVLKKQKVQNITISTN
PLKRLIGISFITFKQAVSGELNKKKEKLIRIVGCKKEQIEIIKTSLFDVTELENGEKKYP
DKYYKRRIFLFTFLFAIILYVGLYLVFLKVEILYSAILVFPLLTFLVLKKVKKRFYKITD
SMLLVGSGLLETHLTYLEIFKVQNIKMKQNIFQKRSNVADIMLQTASGKINIPCIRFEDA
IKIYNHTLYKVETSKTSWM
>FCMOIPGL_01852 hypothetical protein
MFENETVSNYPSISEIIFKSIDLKYLKVILLNVLLLFTAILIGLFSADYFNLFEEINSYV
YLFYIAFVVVFILVNLFMFVGFKKRKYAVREKDISYKSGIFLRKLTTVPFSRIQHIEVDE
GLFSRFFKLASLSVFTAGDSSDDLVIKGISKQTALEIKEFISTKINE
>FCMOIPGL_01853 hypothetical protein
MKYFYTFIFGFLFLISCGKNEIKKETFKTEDPIVLDTIKETVLEVEEIKKVPEIYFTVQI
AALKNNDIVLKNIENIQTFEEDNLTKYRLGQFETYEEARNFRASILNRYDDAFVQALKNG
VPISIKEALK
>FCMOIPGL_01854 Lactate utilization protein A
MIVPTMADMMAQGKQPEVLFWVGAAGSYDDRAKKISRAFVKILHQANVDFAVLGTEESST
GDAAKRAGNEFLFQMQAMMNIEVLNGYEVKKIVTCDPHSFNTLKNEYPGLGGKYEVFHHT
QFIQNLISEGRLKIDDTTLKGKRVTFHDPCYLGRGNDVYESPRDLIKRLGVNLSEMKRHK
STALCCGAGGAQMFKDAEKGDKEINVLRTEDALETKPQIIATGCPYCNTMMTDGIKFKEK
ETEVVVKDIAELIAEANNL
>FCMOIPGL_01855 Lactate utilization protein B
MEYLPNLFFALALIAGIGFFVINIRKLSRNINLGKDIDRSDKKPERLKNMMKIALGQSKM
VRRPLSGFLHIIVYVGFIIINIEVLEIIIDGLFGTHRIFQGVLGDSFYGFLIGFFEVLAA
LVFIAVVIFWLRRNVAQIKRFLSKEMKGWPKKDGNYILYFEMVLMSLFLVMNATDSAFQT
AGIGNTISQFIAPFFDGFSPDALHTIERTCWWIHILGILVFLNYLYYSKHLHILLAFPNT
YFANLNPKGQFTNLESVTNEVKLMMDPDADPYATPEEGTEEAVPEKFGASDVTDLNWVQL
LNAYTCTECGRCTSACPANLTGKELSPRKIMMDTRDRLEEVGRNMDANKGVFVDDGKQLL
NDYISPEELWACTSCNACVEECPVNIDPLSIIIDMRRYLVMEESAAPQELNMMMTNIENN
GAPWQYNQQDRLNWANEE
>FCMOIPGL_01856 hypothetical protein
MSKELKTGIVLIIVIIAFIWGYNFLKGQDLFQPNNRYYKVEYNNIGGLTKASLVTLNGLK
VGKVDEINLNESPEKRGHLIVQFSMHNDFKFSKNSVVKIYSPNPLSGSNLAIIPSYTGED
AVSGDFLKGEIESSLFTSIGERLDPIQSKLEKVIVSADTLFHRVNNVLDKKTSESLRNSV
QELELTIVDFRTTLGSVNSLMNESSADFKETLKNTKSITANLSKVTDTLANSNIGEIMKK
AEMTLSSVNSLLDGMDKGKGTFGKLVNDETLYNNLATMSKELEELLKEMKLNPKRFVHFS
LFGKKAKPYNEENNKVNKTTQ
>FCMOIPGL_01857 N-acetylmuramoyl-L-alanine amidase AmiA
MIILQMHKFNILLKKLFYVIFFITFLSTSSTIVFAQKNYTIVLDAGHGGKDPGNLGRKGS
GYKEKNIALNVALLVGKELQKQKDIKVIFTRNKDVFIDLWKRGDIANTAKADLFVSIHCD
SHTSNAYGAGTFVLGLRGNKKNLEIAKRENAVILLEDNYKEKYAGFDPNSAESVIGLSLL
QEENLDKSLEIASIIQKNFTSKLKRLDRKVKQDNFQVLRETIMPSVLVELGFLTNKKEGR
FLNSSSGQKQMAKSIAEAIESYVDHLKLNTVTASVNEIKTDVTSKNDIEFKVQIASGRNL
ISTKSYNFKGLREVQRVEVGNYYKYYYGITSQYKEVLKSLKTAKQKGYTSAFVVAFKNGE
KISVKEANKME
>FCMOIPGL_01858 LPS-assembly protein LptD
MDSLKPKETIEDMITHIAKDYTIQNAKEKTVTLYNEANITYTDIDLKAGIIVIDYKKNTL
FAKGIKDSTGYVQRPVFKQGNEESEQDSMIYNFKTKRALIYGLKTKQGEMFTYGEKTKRV
NDSTVYIRNIRFTTSDKKVPDYYIATDKAKLVPGKKIIVGVSNLVLADVPTPLFLPFAYF
PMTETSVSGFLIPSFDTGSSDRGIGFQNGGYYFAMSDYADLTVLGDVYSNGTWGARVTSN
YKKRYRFNGTFSFNYENIITGIRGFDDYSKANNFNIRWSHNQDAKASPNSRFTASVNLGS
SSFFKESLNQYNVSQSQNNTFNSSINYSKTFVDTPFNMAITASHQQNTNTESITMTLPSV
SLNMNRLYPFAGKDGIKKTPIQKLGFNYNMLGQYLINTTDDEFFTSKMFETARAGMQHKT
STNTNIKAFKYFTLSPSANYEETWQFDYINKEYDVTDNVVVTDTLRGFKTYREYNMGVSL
STNIYGTFNFTKGRLKAIRHTFRPSISYSYRPDFKDKYIKEVQQSALATDLLEYTVFDQG
IYGAPSSGLSNSIGISLNNVLEAKVAPKDPDSDEEDEKITLLNNLNFSSSYNIAADSLRW
STVSFSAGTRLFKDKLALNFNGSLDPYQVNDDGVRIDKFNPNIFRLTNANLTANYSISSK
DLSKNEKDNPNDNKNGNGANNPTDTMGANIDPTNPQGRRENSQQNKTSKTELYQSTIPWS
INLVYSANYSNNGVDPGSIGIHTLGFSGNLELSPKWKVGYSSGYDVKNGAFSFSRFNFTR
DLDSWQFNFNWVPFGSVSSYTFFIGVKSSTLSDLKWDKNKPPDRTLF
>FCMOIPGL_01859 2-iminobutanoate/2-iminopropanoate deaminase
MKKIITTTKAPAPIGPYNQAILSGNTLYTSGQIAINPETGELVLESIQAETTQVMNNMKE
VLAAADMTFENVIKTSIFISNMNQFTEINKVYGSYFNEETAPARETVEVANLPKFVNVEI
SMIAVK
>FCMOIPGL_01860 Methylglyoxal synthase
MEIAIIAHDGMKAEMVQFLNENKEALLQKKITLVSTGTTGSKAEKAGFKVTKFLSGPIGG
DAQIAARVAEGKCNMVLFFRDPHAKHPHEPDIIMLLRICDVHNVPLATNPATANLLIKAI
>FCMOIPGL_01861 Glyceraldehyde-3-phosphate dehydrogenase A
MIKIGINGFGRIGRLAFRSTVNRKDVQVVGINDLLDVDYLAYMLKYDSVHGAFDGTVDVK
DGKLVVNGNEIRITAERNPADLKWDEIGAEYVIESTGFFLTEETAGKHLEAGAKKVVLSA
PSKDHTPMFVMGVNNTELKADQKIFSNASCTTNCLSPIAKVLNDNWGISEGLMTTVHAAT
ATQKTVDGPSMKDWRGGRSAIGNVIPSSTGAAKAVGKVIPALNGKLTGMAFRVPTMDVSV
VDLTVKLEKPATYAEICAAMKAASESDTMKGVLGYTEDMVVSQDFVGDTRTSIFDAKAGI
ALNDNFVKVVSWYDNEMGYSTKIVDLIEYAASL
>FCMOIPGL_01862 ATP-dependent 6-phosphofructokinase 1
MEKIKKIGVMTSGGDSPGMNAAIRAVVRTCAFNKIECAGIYRGYEGMIEGDFIELDARSV
KGIINKGGTFLKSARSKGFRTKEGRQTAYDQLKKANIDALVVIGGDGSFTGALLFNQEFG
FPVMGIPGTIDNDIAGTSHTLGYDTALNNAVEVIDKIRDTASSHNRLFFIEVMGRDVGHI
ALNVGIGAGAEEILIPEEDLGLERLLESLNRSKQTGKSSSIVIVAEGDKTGKNVFELKDY
VNEHLPEYDVRVSVLGHMQRGGSPSCFDRVLASRMGVKAVESLLKGKSNLMVGLISDRIT
VTPLERAIKGQSKINKELIRVSDIMSI
>FCMOIPGL_01863 hypothetical protein
MLLSIPALQTKLGSYVTNTINEDFGTNLSIEKVDFSLLGSVKLKGVQIRDHHKDTLIFAK
NVTTSILNAKRILDNEVNLKNVSLDGVDFIMKTYKGEESDNMSIFIDAFDSGKPSDSLNP
FILRTSNVYVNDLNFTLINANNLDSISYAVKNVGGNLQKLSIVGPDFSSNIRGLYFVDKN
GLEVSNLTTDFSYSRTAMHFRKTTLETKNTSIKADIDFNYDRKDLVNFNDKVKIKAKFNE
SKVAIQDVKNFYNELSGNDILDFSGNFDGTINIFDLKNLKLYSREGIKVIGDLTFVNTVS
QERGFVFEGNLKNLTATYQELKNILPNVLGNNLPSEFHKLGEFALKGYVRVTPDQIQAEI
DVNSQIGSAISDLQITNIDNIDYAGYEGVIQLNEFNIGTFFNDPLFGTVSLKGKVKGSGF
KLDNINTAFNGSVSKIEFKGYPYKNIVANGQYQNNKFDGDITISDENFKMNFNGLADLSS
EVRKFDFKTNIAYLNLKKTNLFVRDSIALLKGIIELDIEGNTFDDIVGEAIFKDVFYTNQ
KQEFRFEEFKVLSSVKDSIKRIDVESKDIANGYLTGKFIFSEVSKVAQNALGSIYTNYKP
YKVTPNQFLDFNFTVYNQIVNVFFPEISIDDNTKIKGKIESTKNLLKLTLSSLRIDAYGN
ELKDILLRTDNQNPLYNSHITASEVNTKYYNISKLNLLNLTQNDTLFFKSEFNGGVNKNE
NFNLDFYYTINEASKSVLGFEKSTFVFKDTAWDINPNETNTDKITFDLKNDEFNFSQFEL
VSGSQKINFNGNLSGDSEKVLLADFTKVKLQSFMPEIDSLSLKGRVSGNLDFVQKGNVYS
PEAVLVIKDFQVNKFKQGDLAINIKGDNSYKKYNVDLSIDNEKVKSIAAIGSVDFSNLRP
IIDLEVFLEDYVLDAFSPLGQDVISSLRGSISGNFYLSGFLGNPDMDGTLYLKNAGLRIP
YLNVDYDFEGESTISLLQQSFILDDIKLLDTKYKTRGKLLGNISHQNFDKWFLDLEIDTR
NLVVLDTKNTEEAVYYGTAFMDGNAIIYGLTDQLTIEVNAKTKAGTKFVVPLKDIVTVDN
FKLIHFKSDETKLEDRQRKLAQEAIKGLSLNIDIEVTKDAEAQVVIDETSGSQLTGRGAG
NLQIRINTRGKFDMFGDYTIDNGVYDFKYGGFISKPFLIQKGGTVSWSGSPYDANLDVTA
IYKAKANPAVLLENFSSSRKEEIDLVTRITGGLFSSKQELDIQLTNVDPTIASELEFVLN
DNNINEKTTQFISLLAFGTFRNPDKANFDVNNTLTNTATSAISAAFSSLLNSPDSKFQLG
VDYQQGDSGNDIEALNIDNQVDLSVSTQVSDRVIINGKVGVPVGTQSESSVIGEVKVEIL
LNKQGNLRGTIFNRQNEIQYSTEEEGYTQGVGLSYQVNFNTLSNLFSRSRLNKKLKKESK
KIIKKDTLKIKKTEFINFEGN
>FCMOIPGL_01864 tRNA N6-adenosine threonylcarbamoyltransferase
MNKPVYILGIESSCDDTSASVICNAKVLSNVVANQEVHSKYGGVVPELASRAHQQNIVPV
VQQALEQANITKKQLSAIAFTKGPGLMGSLLVGTSFAKSLALGLQIPLIDVNHMQAHILA
HFIDDDKSKNPTFPFICLTISGGHTQIVKVSNYFDMEILGETIDDAVGEAYDKSAKILGL
PYPGGPLIDKYAQLGNEKAFKFTKPKVGDLEFSFSGLKTGILYFIQKQVRINPNFIQENL
NDICASIQFTIAEILMDKLKKAVNLTDIKQIAIAGGVSANSEIRKRLQLAEKHFGWTTYV
PKFEYTTDNAAMIAISGYLKYLNNNYADVSVTAKARLKVTE
>FCMOIPGL_01865 Lipoteichoic acid synthase 2
MLKIESNINYQKDFNSVKYFKNRLLFNVYYFLFWIVYFIFARIFFLAYYFDKTQELDTNT
ILKTFLYGIQLDISFSAYLSFIPFLLIIFSTFINPKIIIKFIKYYTITVLIFINLMLMID
AGLYQAWGVRLDTSLLPYLNTPQLMISSASTLQLVLGVLAWCIITYVFIKIYNKIHQKNN
EKLNFGSWLEIPVFLLITAALIIPVRGGFQTIPVNQSNVYFSDNMYANHASVNFIWNFFN
TLTHETNGKNPYKYFDDETAIKIINKAKNKLLLADTDSILNTSRPNVILILWESLTAKVV
GSLEGEPTVTPNLNKLSKEGLLFTNFYANGDRTDKGIPAILSGYYPMPVKRIMRMPNKTR
SLPMLPHKMIDLGYKTSFYYGGDLNFGNMNTYLRNAGITDFIDGSEFDKKDWNSKWGAYD
DVFMKRFAKDLSTKQKEPFFKIALTLTSHEPYEIKGKYVFGNDTEDNKFRSAHHYTDQVI
GDFIAFAKQQDWYKNTLIVIMADHGHASPKHEGPYSSPKKFKIPMLWLGGAVNKNIKEIN
TIASQVDFPFTLLDLLKADNKDFIFSKNIFNSSDDQFAHYTFNKGFGTLTKNGLFLYDYT
SKKPILETGTNTKKLDSLGKAITQNTYTDFLNRK
>FCMOIPGL_01866 2-dehydro-3-deoxygluconokinase
MPKKLVTFGEVMMRLSPPGYSMFSQATSFELVYGGGEANVAISCGYLGMKAAHFTRFPDN
ALGKAATQFLRKHWLSTEHIVYGDNMLGKYFLEKGASYRSSEVIYEREGSAFSLIKPSMV
NWEKVLTGADWFHWTGITPAISDGAAMCCLEAIKTANKMGIKVSGDINSRNNMWKYGKTM
QEVMPQLVENCDIVISSTRGIYEMFGLGKLGGKFKVSAKELMEKFPRIQKVVGKNRTSIS
ASHQQILGKMWNGKKYIKTETLDITHVIDRVGTGDAFASGLIYGLLHYDNDVQALNFAAA
ACALKHTVPGDVNMVSMEDVVSLMEGNTSGSIKR
>FCMOIPGL_01867 Glucan 1,4-alpha-glucosidase SusB
MKNCIYSFLLLFVITFVSCDVPSSEIASPDQNIAVKFHLSEKGEFFYTINYKEKNVIDTS
YVGFEFTNTAPLHKGFIAQVKKPKEVDEIWEMPWGEQLNVENHYNEVSIALQEKTDLKRK
LNIVFRVHNDGVGFRYEFPEQDNLKEVLISEENTEFNLTEDYKTFWIPGDWDIYEHLYST
TKLSEIDTRNYKVNSALAQTNIPENAVNTPVTLVGKNGIHLSFHEAALVDYSGMTLKVDT
DKLSFKSSLVGSNNTDYKVKRTLPFKTPWRTIQITDNAPDLIASKLILNLNEPNKLGDVS
WFTPMKYTGVWWEMHLGKSSWDYGMEMVDGKWTDTGKSHGKHGATTENVKRFIDFSAKNN
IGGVLVEGWNTGWERWIGFDDREGVFDFVTPYPDYNLEEVTAYAKEKGVEIIMHHETSAA
TETYEKQQDAAYALMQKYGMHAVKSGYVGKILPKGEFHHGQYMVNQYNNAAIKAAKYQVA
VNAHEPIKATGLRRTYPNIISREGLRGQEFNAWSPDGGNPPEHLSIVAFTRMLAGPIDFT
PGIFNIKFDEYKKDNQVNTTLAHQLALYVVIYSPVQMAADLVEHYEANPKPLEFIKDVGV
DWSETKVLNGEVGDYVTIARKERKTNNWFLGSITDENARDLEVDFSFLDDNTTYEAKVYK
DGKSAHFNENPLDIEFETLRITKKSKLKVHLAEGGGLAISVKKKWNN
>FCMOIPGL_01868 Periplasmic alpha-amylase
MKNIIFIISLMVLISCQEKSSTKTIVKMETKEFVWEAANIYFLLTDRFNNGDTTNDVNFG
RTKETGKLRGFEGGDLKGITQKIKEGYFTDLGINAIWMTPIVEQIHGSTDEGTGNSYGFH
GYWTKDWTKIDPNFGTKEDLKELVAVAHKNGIRILLDAVINHTGPVTDKDPVWPSDWVRT
GPQCAYNNYENTITCTLVKNLPDIKTESNENVALPPQLIEKWKAEGRYEQEFKELDDFFA
RTGHPRAPRFYIMKWLTDYITEFGIDGYRVDTVKHTEEFVWQEFKQECDFAFAEYKKNNA
EKVVDNDDFYLVGEVYNYAISHGKAFDFGNKTVNYFDKAFNSLINFEIKWNAKQMAEEAV
FEKYDSILQNDLKGYGVLNYMTSHDDGQPFDKERKMPFKTATMLFLTPGTAQVYYGDESA
RPLIIEGTVGDATLRSFMNWDAINTDVETQKIMKHWQKLGQFRVNHTAVGAGKHQLISDE
NGLVFSRIRNADKIVAGINLSKGKKEIDVASVFENGAVLNDFYSNQEVNVVDGKVTVNSE
FDIVLLELK
>FCMOIPGL_01869 Alpha-amylase
MKKIHPYSLAVILSIIIGCTSEKVSEKKMKNPSVKKKAVVYQVFTRLFGNTNTTNKPWGT
IEENGVGKFNDFTDKALSEIKDLGVTHIWYTGVPHHDVIRDYTEFGISNDDPDVVKGRAG
SPYAVKDYYNVNPDLAVNVENRLEEFEALIARSHKNGLKVIIDIVPNHVARNYKSVSNPE
GVVDFGADDDTSVVYDVDNNFYYNPNKEFQVPDFLNNYKPLGGENHPLSDGMFDENPSKW
TGNGSRSVKPNFYDWYETVKVNYGISPEGKKDFAELPQSFENEDYKKHFEFWQDKKIPDS
WIKFRDIALYWLDKGVDGFRFDMAEMVPVEFWSFMNSSIKMKNSDAFLLAEVYQPHLYRD
YIKKGKMDYLYDKVQLYDTIKNIMQGRGSTDNIAKIQDDLKDIEHNMLHFLENHDEQRIA
SPEFAGNALKGKPAMVVSTTISTAPTMVYFGQEFGEDGSENAGFGTPSRTSIFDYIGVPT
LQRWVNNKQFDGGQSTKEELALRDFYKRLLNFTIQSDALMGEYEDIHHHNRYNTEWYNDK
VVSFVRYKGGEKLIIVANFNAENTYGFELGLPQNIIEKWNLKEGEYQLEDQLYQTYTSTL
KVKNNKATVRVDVKPLHSFILKLKNN
>FCMOIPGL_01870 Oligosaccharide 4-alpha-D-glucosyltransferase
MKNFKIIFFLLFITQISFAQNSNRIFKDVKQTENGLEINVNDGKYLLKFYSDKIVETSFI
PKGEEFLNSSHAVVLEAEKVEMISVISKKESVFSTNGISVHITHKPFQITYQFKGEIVTS
EKQGYYKSKHIPLDLVKGNIEYDKTEKIEFNLTNDEVLYGTGARALGMNRRGYRLPLYNR
AHYGYETKSELMNFTIPLVISSKKYMIHFDNAPIGYLDLDSKKDNSLTYETISGRKTYQV
IVGDSWQDLIENYTNLTGKQPLPPRWTLGNFSSRFGYHSQQETEATIDKFQEENIPVDAI
ILDLYWFGKTVQGTMGNLEVDKDSFPDMKGMISRLKDKGVKTILITEPFILSNSKKWKEA
AEKQVLATDSVNNPAKYDFYFGNTGIVNIYKKEGKNWFWNIYKEILNFGAKGLWGDLGEP
EVLPSWVNFSDKKADEIHNLYGHDWARLIFEGYQKEYPTERPFILMRAGAAGSQRFGMIP
WSGDVNRTWGGLQSQPEIALQMGMQGLGYMHSDLGGFAGANLDDNLYVRWLQYGVFQPIF
RPHAQEDVASEPVFRSDYAKKYAKKAIELRYKMLPYNYNLAFENNQKGMPLMRPIFFEED
DANLMTNSTTYLWGKDFLITPILKEAVKTKEIYFPKNANWFNFYYNEEKIEGGQIKTVKV
KEKAIPTYVRGGSFILMSELVESTDNYKADQLELHYYLDKKENSERTYYNDDGVTANAFE
KDKFEILEFEAEFEKRYLEIDFEAEFGKNWKVSEKEIKLIIHNIKYNPKKIKVDGKRVRI
SSKENTLTIPLKWNPKKELKIKISLK
>FCMOIPGL_01871 Endo-1,4-beta-xylanase Z
MKYLSILFSIVLLFSCKQAKQEKVKEEIQKPKITAVVLDSVNLFAGKLIRIDSFPTKYIT
PRPVDVWLPEGYSSEKKYAVLYMHDGQMLFDETTTWNKQEWKIDEVASKLMKDGVTKDFI
VVGIHNIPAIRWLDLYPEKAMNFLTKEEVERVKSFSNNDVTSEDLTGDEYLKFLVEDLKP
YIDKTYSVYTNKENTFVAGSSMGGLMSMYAISQYPDVFEGAACISTHWVGAQPVENNPLP
KSIFTYLEQNVPDAKTHKIYFDYGNKTLDQYYPEYAPKVDSIFLNNDYSEANFKNLFFEG
TDHSEISWQNRIDIPLTFLLKK
>FCMOIPGL_01872 Neopullulanase
MKHFRNIFLVLSVIIFISCNNTETKKDVSEVSVSNTFLERVEPLHWWVNMKNTSLQLLVK
EENIGQSKPSISYPGVTIKKVNQAKSNNYLFLDLDIDATTKSGKFDITFTFDDQTTKKHT
YELKQRQKTADEYEGFNSTDAIYLITPDRFTNADDSNDINQNLNETTIDRTNGYKRHGGD
LQGIIKGIDYISDLGFTTVWPTPVLENNMYQGSYHGYAITDYYKVDPRFGNLSDYKNLAD
KLREKGMKLIMDQVANHCGLEHWWMKDLPFEDWVNHQKNYEENIKNWNNETNINSNHRRT
TNQDLYASESDRKGNNEGWFVSTMPDLNQRNPFMANYIIQNSIWWIETLGLGGIRQDTYP
YPDKDFMANWAGAIMEEYPNFSIVGEEWSYNPLLVGYWQKGAKNKDGYQSNLKSTMDFPM
QKAIIEGINEEESWDKGLVKLYEGLANDFHYATPEDIMIFLDNHDENRMFTALEEDVVKA
KMALGYMLMLPRIPQIYYGTEILMNDTANPGDHGLIRTDFPGGFKGDKINAFTGLGLTDD
QKSMQNFVSKVLNYRKNSKAIQEGKTIHFAPFMNTYFLFRTKNDETVVHIINKNEKPITI
DLKRYKEVGLEGKTLKNIITGEAFLWKDAIQLSEKGSVILTTKF
>FCMOIPGL_01873 Maltose phosphorylase
MNQVYIQPNEWSILEEGFDAEMVKSSESLFSIGNGAMGQRANFEEEYTGPTFQGSYIDGV
YYPDKTRVGWWKNGYPEYFAKVLNAPNWIGINVLVNDEKLDLHTCKEVLNFKRELNMQEG
WLSRSFEAVLQNDIKIKVDTKRFLSLEFDEIGAINYSITPLSNDVSITYIPYLDAGITNE
DTNWDDQFWDVLGVSQDNHQSFIEARTMKTHFYTCTFMESKLFIDNNEVTTNCVNEQSSN
FTANKYQQEIKKDQTYTIHKFGGYVVDRNHDKDELVAAAKTALDKAVGLGFDALLVIQKE
AWAKIWSMSDITIEGDVEAQQGIRFNIFQLNQTYLGTDASLNIGPKGFTGEKYGGSTYWD
TEAYCIPFYMATKDQSVARTLLEYRYNHLEKAIENAEKLGFKNGAALYPMVTMNGEECHN
EWEITFEEIHRNGAIAFAIYNYHRFTEDYSYIPEKGLEVLIGIARFWHQRVNFSTDKDKF
VMLGVTGPNEYENNINNNFYTNYIAKWCIEYALENIDIVKNDHISDFIRIKEKVNITDEE
LASWKNVADNMYFPFSEKHNVYLQQDGFLDKELITVADLDQSQRPINQKWSWDRILRSPY
IKQADTLQGFYMFEDHFSTEELERHFDFYEPFTVHESSLSPCVHSIQAAKLDRMEQAYTF
YLRTSRLDLDDYNHEVEEGLHITSMAGTWMSIVEGFGGMRVVDNSLSFSPKIPKGWDSYS
FKVNFRQQVITVNVSQNGTQFELEGTKEINILVNGEQVTVSPK
>FCMOIPGL_01874 Beta-phosphoglucomutase
MKKGFIFDLDGVIVDTAKYHYLAWKKLANQLGFEFTEEQNELFKGVSRKRCLEILLEIGK
REATQEEFDKWMIDKNVDYLEFIKNMDASEILPDVPKVLQFLKENNIPIALGSASKNAKP
ILEKVGLLPYFDAIVDGNHVTKAKPDPEVFLLAAKQLGVHADDCVVFEDAVAGVQAANAA
KMISIGIGDKNVLTEAQFNFNDFTEISTNFIKDLIEK
>FCMOIPGL_01875 hypothetical protein
MSFGFLGIQMGFALQNANASRILQIFGADVHELSWFWIIAPLMGLIVQPIIGHYSDKTWG
KFGRRKPYFLVGAILASIGLILMPQADMFIAFLPALWVGAGMLMIMDASFNIAMEPFRAL
VGDNLRTDQRTLGFSVQTALIGFGAVVGSWLPYALTNWFGVSNETSSGVVPQNLIWSFVI
GAVILIISILVTIFTTKEYSPEELASFDKDSDTISTNEEENSSLMDIFDDFKKMPTTMRQ
LSWVQFFSWFGLFGMWVFATPAIAQHIYGLPFTDSSSKTYQNAGDWVGILFGIYNLVSAL
YAFALPYIAKKIGRKRTHSVSLIIGGLGLLSIYIMPNENWLILSMIGVGIAWASILAMPY
AILAGSISAKKMGVYMGIFNFFIVIPQIINALIGGPLVKYAYNNQAIFALLISGISFLIA
AALVYKVKDVDDVIKTN
>FCMOIPGL_01876 HTH-type transcriptional regulator DegA
MKQKITIKTIAKELGVSTSTVSKALKDSHEISKETKEKIQAYADLFNYKPNNLALQLRTQ
KTKVIGVILPKIVHHFFSTVIMGIEEGAVEKGYHIMVCFSNESYKKEVETLKVLSNGSVD
GLIVSIANETLQNKDFKHFLDLVGEEIPLVLFDRVVDEILCDKVVVDDVGAGYKATTHLL
ENGRKKIALITTPNHVNVGALRRQGYEKALIENYIKTDENLIIEVDEQKDILKQIEEVFK
QDIDGVFGVNEIYAAKAMRIAKRKGLKVPEDLSVIGFTDGQISRYSSPSISTVAQHGFTM
GKQAVGLLIERIENESDAYSPKKIVISSDLKIRESTKPSS
>FCMOIPGL_01877 TonB-dependent receptor SusC
MLTRNRFRDFLYSILSGLYSIFTKWNVSLLLRKSNLQLLFNKLYMKKIKLLLIGLLLSTS
FTMFAQQTVKGVVKEKSTGTALPGVSVVVKGTVRGSQTDFDGMFIIEKVKTGDILVFKYL
GYSDKEIVIGSNFNLTVELEESLEQLDEIVVVGYGSVRKEDLTGTTDLLTSKDFNKGPIV
SAQSLISGKVAGVSVIAGSGAPGEGQSINIRGTGSLSLTSQPLYVIDGIPLDNGGVAGSR
NPLNFINPNDIETFVVLKDASSTAIYGSRAANGVVLITTKKGKDKEFKFNISSQTTVYTL
RDKVDVLSANQFTSLINDIGSTSQIALLGNSDTDWQDEIYTTAIGQDHNFSAIGNLYGMP
MRASLGYSEHEGILKGDNLARTTGSINLSPTLFDKHLKIELNAKGMYTENKFANRGAIGS
AVSFDPTQNVYDATSKYGGYFAWLDINGNQNSLAPTNPVALLNLIDDTAEIRRFVGNAKF
DYKIHGFEDFTATVNLGYDTSNSHGRTVTSSLIPKTETGFNGSLTSYIQNSDNKVFDAYL
TYQKTFNEAHNLTVVGGHAYQSFEYDNYSYDSEAQEDGNTYEFIDKSKNVLLSYFGRANY
DYNGKYYLTATLRADASSKLNPDDRWGLFPSFAAAWSIHKEDFMQDSFFNELKLRVGYGE
TGNINGLEDYLFLTRYTGSTDTASYQFGNQYYQTYRPEEINENLRWEVGRTLNIGVDFAF
LDRKISGSVNAYVKETNDLIASSIVDPFTNFGNRIRANIGDMENRGLEFMINATPIRTEN
FEWSLNYNISLNDNEITKLSTDQPQGGISTGVGGQVQVHREGETANSFLVYQQVYDANGK
PLEGVFVDRNSDNIINDDDKYIDNDPFADVLMGFNTNLNYKNWDLSIQTRASFGNYMYND
IAASKGILQNATNNNILSNLHADYYNSGFTVISNDTALSDHFVQDASFFKIDNISIGYTL
DQLENTTFRFYGSLQNVLIITDYDGLDPEISLGIDNNFYPRPRSFVLGVNVNF
>FCMOIPGL_01878 Starch-binding protein SusD
MQQKFKYLIVIMLFSLGVISCHEDLNQSPIDPDSFTEEDVFANATDAQSALAKLYASLAL
TGQQGPSGNPDLDPEDIDEGFSQYSRMLFNLNELTTDHAVVGWGDAGLPDLHGLYWSGNN
DFSEAMYYRLAQEVSFCNSFIDNASALTDTEVASYIAEARFLRAFTYYNLMDLYGSVPLV
TSVTTDLPTQATRKELFNFIETELLEIQDQLKASGANEYGRVDKVAAWALLSKLYLNAEV
YTGTARYNDAVTFSNNVMTSSYSINMIDANGNGSAYDELFLADNNTNGAQSEFIFALNFD
GLRSQTYGGSTFLVHAAIGGNMNPTDFGVNGGWAGLRTTKNLVNKFNVDVTALNNSLGTV
SDWGLVGDATVNGWNGPDMEMYQTGTNTYALYADLNGSEIKFRFNEDWGNNYGDDNSDGT
LEAGGSNIAVPSNGTYFITLDLNTFTYTMSPYTGDKRGMFHKDGQTLEIEEIPTFENGYA
VTKFKNIDSSGNQGSDTAGDFVDTDLPLIRLAEIYLNYAEASLRGGGGDLGLAVTKINEL
RERSYGSTAGNITSGDLTLEFILNERSRELYWEGQRRTDLIRYNYFTSDTYLWPFKGDSK
DGVGVQSYRNLFPLPNNIITTNPNLIQNPGY
>FCMOIPGL_01879 hypothetical protein
MKKIINSLFALIIVAIGFTSCEDISDRVIVNSDVEATTELIILETTPIVLLEENQDEIAL
NTNWAEPDFGFDAAPTYKLLIDLATGDFSNAVTIDVGDNLEKSFKTLQLNSIALGLGAEA
DMPSDLMIKLQGIVGGKLLINSSSKTVNITPYSSILDLSTTWGVVGSAANDWGATPDLPF
FTTSTAGILVAYVTLTDGEIKFRENNEWTNDFGDNGADGTLDTGGSNIAVSAGSYKITMN
LNTNTYKIEEFTLGIVGSAYNDWGVTPDFALTYDSYSDQFRGIVKLLDGEMKLRMNNDWG
TAYGAGADGFLDTAGGNIATTAGRYIITVNLNDLSYSLEPIDHIWGLVGSAYNDWGATPD
ALFTRDWSQPNDDIWVLNNVTLLDGEYKFRSNEAWTLSYGDDGVDGTLEDGGANIPATAG
TYSFVLDFSNPDNPTYTIN
>FCMOIPGL_01880 Malto-oligosyltrehalose trehalohydrolase
MKKITFLFILFITSIGFSQVTITPNPFDISASITISLDANSTATDCNGLSNPTKVYMHSG
VGSDTNAFDISVVGNWGLDDGVGEMTLNTSNNRWEITFVPKTYFSLTDAEATSVTKMGIV
FRNATGTQEMKDNGCSDFIFNVGSFQLTLNSPSSAITVLNSGESLSINATASLTSSFVLK
ANGAIVNQNSGLTYSYSPTVTENTTYLLEATNNGETKSSTFQAVVKPTVTEAAVPSGMKD
GINLNSSDPTKATLVFYAPTKEFVHLIGNFNNWELDDSYLLKKDSSNDRFWIELTGLTAQ
TDYTYQYMIDADLRVADPYSTIILNEYNDQYIDATTYPNLPSYPSGKTNHAVTLLRTGDT
EYTWQTTNFQKPAKTDLVIYEILIRDFDALHSYDAVKARLDYLQDLGINAIEFMPVMEFD
GNESWGYNPSFHMALDKYYGNATSFKQFIDECHRRGMAVIIDVAFNHASGQNPYYRMWNT
DNGGYGGQASTDSPFFNPIARHSYSVFNDFNHSKQATKDYVKRVSQYWIDEYKIDGFRWD
LTKGFTQNCTGSDACTNAYQQDRVDVLKGYADDQWEIDPNFYIIFEHLGTNDEETQWVNY
RLDEGKGIMVWGNHNSTYNQATMGFGASSDFSWISYLNRGWTVPANVSYMESHDEERLMY
KNLQFGNSSGSYNIKTLTTALDREELAGAFYFTVPGPKMIWQFGELGYDISIDENGRTGN
KPIKWEYFDIQARKDLYNTWAKLIKLKLKYDIFQTSDFTLDVANTNGLKKIHLTNPSATD
IQNIVIIGNFGVTTQSISPFFQQTGTWYSLLEDNATINVTSTTANISLAPGEFKMYANSP
ATLSSDDITLENNTLQMYPNPTSTAFYLSKEALDVKVFDITGKQVKQFAKSVIKNNTFSV
TDLNTGIYFVRIKENDNKISTKKLIIN
>FCMOIPGL_01881 hypothetical protein
MKKMKKNYFLMLICFLSFTGISLSQTTYYWRGEAISGNWEESTNWWNGSASTPSGADILR
FNNNHETTMTNDLVATNRYQIFFEATATTSRTIGGTTENTFYDYGGNVPKIENNSVAIHT
LNFPIKLGNNPTELNPVNGDLTFGGNIELTANYIDVYGDNSKTLTFNGVLSGTGGLSLKG
NSKVIFNGENTFTGATNVNSGDLEINADMAGNIQVNNNATLQVNTDLTIPQLVLYNNATV
TVKAGKSLTISGNLENNSSNAIILENGATLIVNGTSTGDISYNVNVTDDNWHLISSPVVG
QVYGDTWANDNIVADGNGTNRGISTYQNGTPDGTTGPWVYMQDGASSTFDSGVGYSLKRT
SSGTYAFTGTFPNGTITPAISTNTNDWNLIGNPYPSNLNIATFITENSTTNDFIADGFDA
IYVWNPTEGGTGAYNELTTGFIQPGQAFFIKSKVDGAANITEAMQSHTTGTFYKNTDTSI
NLLLSNGKSTKRTKINYLGGKSTSLDAGFDIGMFDGVDSDLRIYTHLIENNKGIAFARQA
LPNTDLESLVIPVGVKAALNTEITFSAEALNLPTGIKVFLEDRNANTFTRLDEANSEYKV
TLEEALNGIGRFYLHTSSKSTLNVTNIAIENISIYTADASTLKIVGLQEGNANVKIFNML
GKQMMNSSFKTNGAKEISLPQLATGVYFVQLTTETGKLNKKIVLE
>FCMOIPGL_01882 hypothetical protein
MKKNIENTQDKNQDITRKDAIKKIGNYSKYAALTALGTYMILSPQKAQASSVAPEAPGTG
F
>FCMOIPGL_01883 Cysteine desulfurase IscS
MKAIYLDNAATTKIDAEVLNLMYISMQENFGNPSSTHQFGRKAKSAVETARKNIAKHFNV
TAPEIIFTAGGTEADNLILNNAVLNLGVQRIITSKIEHHAVLHTCKFLEKSKNITLDYVN
VDEFGSIDLLHLEVLLADSEAKTLVSLMYINNEIGNILPLDEIAVLCKKYNALFHSDTVQ
AIGHYNLDLQENSIDFIAASAHKFHGPKGVGFAFFKKGFGVLPMFYGGDQERGARSSTEN
VHSILGMDKALTIAIDNLYADKEYIEKLKLYFITELQKISKSIQFNGLSSDFKKSSYTIL
NVRFPVKNDMLLFSLDMAGIAVSGGSACQSGSNKGSHVLAEILKDEEADKTSVRFSFSKY
TTKEEIDTTIIKIKELL
>FCMOIPGL_01884 Endonuclease MutS2
MRLEIGNKVAVLDDVLKGIVTNINGNIISVETTDGMIFNFSESELVKIGKEQHELTKFSD
INNELLKEKMASNKPKKSFFIKEKNEVILEVDLHINQLVKSVKGLDNYDMLNLQLDTAKR
KVEFAINKRISKIVFIHGVGEGVLKSELHYLLNKYPVKYYDASYKKYGLGATEVYVYQNV
IE
>FCMOIPGL_01885 Protein ArsC
MLKTSTFSLENFFENAYNKAIISDERKTLLLKISKAIAKEYTENKEVNLNFICTHNSRRS
QLGQVWSFYAANYFELNINAFSGGTEVTAFYRNTVKTLQKAGFDFQLENFSHQNPTYQIS
FNGTKKYILGFSKFYSNPINKEPYMAITTCNNADVNCPFIPSASHRFHLPFVDPKYADGT
TAQEKIYLETSKQIAGEIYFIFFEVKKLL
>FCMOIPGL_01886 hypothetical protein
MIRTKNQIIFKIKNSKKYWLKASTALLIGFLSLQMNAQQLPNYTQYLYNMQIINPAYVGA
RADLSMSLLSREQWVGLKGAPITRTFSINGRTSNGLGFGTTVVNDKIGLSESTNVNIDAS
YTIITSQFGRVSFGLKGGMTFFNNNLANGITPDNDVYASTSGNYPNVGFGAFFFNKKFYV
GLSVPYILESPQFYIEENVDKTSLTSNANYFFSTGALFKLTENVMFKPSTMVRYASNLPV
SIDINSNFLYKEIIEAGLSYRHENSMSALFALIIKKKYRIGYAYDHKFSILGGNLSSHEI
IFHLDLDLRRNYRWLLHNKCYF
>FCMOIPGL_01887 hypothetical protein
MVAQTPPIAKVDYDTAEINTTLSVDAPGVLANDTDIDVDDILTVITFNVNGSSFLAGETA
SFSQGSIVINADGSYTFIPTLNYTGDNVPTISYTISDGTFTSVASLFLTVEQIDNLLEIS
GFGSCNQGFTVSGEYKVKYSLTFKNISTSRNSHPTSSIKNIDFINDLEAVFGNTCVTAVS
ELNIATNNNSRVYDYVNSTYYPLEFGNTAINSSFLDRTSNSVFNNSAINDLTLHPGQSVN
VSFCVNIKPDCNGRPNPTPSGSGIDFNNVVNITSDRGSDTESLLLTDFHTTEAVVTAGLY
IPEFYTPRFLNDVPPGVINSDGTYDYSNTVIITNEGTTTANNVNFNMGLGAFFANGISFK
EIKITKVSGGSSVTINNLYDGNTESSLLMAGSSLAAGEKVILSIFYIIKPIYSGNYSYFY
QLQNSQTQGSLDGLDETISSIKNRHSYVTWSDGLGNHLDRYYEASSPTESVSSELQCACT
TSSMRFIFTSSSSTDKIITSVNKAPNDILEHEEVTFQIKIENTSESVQLEKLQLEDDLNS
ICGGNIVSVSKPFIQNSTATTNPTLNLNFDGTSDANIFDGTSGLLKINETITVEFTVLYA
ESCIGLNSAVFTSRDPLNNSTVSSKSVNVNASTDTDNDGIVNTDDLDDDNDTILDIDEYN
GLNPLADDDLDFIPNYRDTDYDADANGDGIVDVFDFDSDGIPNHFDLDSDNDGILDIVEA
NNASKDSNNNGKTNNAVGANGFDNTLETNDSVNASSTYSIPNTDLTGNPNFTDIDADGDG
IVDNIEAQLTDSYKTLNGIFSSEGIDTAFPNGINPIDTDNDTIFDYVDINSDNDIRDDII
EGWDIDSDGIAEKVASNLDADNDGLDDAFDTNRSIVNPTNGQVPTDFPNADNTDNPERDW
REILAIIVLIDDITATEGEDFVFTIKLVTKNDNSILIESASPIVINFSTINGSDTTNVYD
VATSPFDYNGFTNSFFTVPPLTNTIQFTVNSLDDNIYELVELFSLNGSITSNNTINNSIK
GIGTLLDNDVAPSITMNNSREEEGIDLVHTITISHPCSTPILIEVNSGDILAISPEDYTS
FLENLEIEGTIDPNNANTQVSFNISTNIDNLNELDEETLNVTGIVTSTNIGAQDLNKSGV
ILDIDPDPLVDIENVTVVEGETLVFTIRLLNENLKPMQNYRAINFILETIDDTTFANDDY
KSISIFTNIPALTSSITQTVETINDVLNEDTETLFLQATTNLSNVSNTFIPTGTGFIKDD
DYPNLFSPNSDGKSDFFKISGIEEYPNFKLIIVDRWGNEVYNYSNNGKVNPIWWNGYRNG
KPVPAGVYFYTLDFNDGVTKPIRNFIELIR
>FCMOIPGL_01888 hypothetical protein
MDIKLTQSDIKKLNSKKGYMALLSKEPFNIVKALRYIDYQKKLEKLQTELIRMQTWAINN
NERIIVVFQGRDAAGKGGAIRRVTERINPRHMRIIALPKPSEDEQSQWYFQRYVEQFPKA
GEMVFFDRSWYNRAVVEPVNGFCTPEEYDIFMNQVNDFERMILESGIHLVKIYMSISKKE
QAKRFEDIKNDPLKQWKMTKLDEKAQLLWDQYTEYKNAMFAKTNTKISPWKIIRANRKTE
ARVNVINHILKSIPYDKKLEI
>FCMOIPGL_01889 hypothetical protein
MEHLNPRSSRLVALNKPTDVEKGQWYFQRYIKELPNPGEIVFFDRSWYNRAVVEPVMGFC
TANQYKQFLVQVPEFEHMMYEDGVVIIKFWLSITKEEQQTRFEARKENPLKRWKFSPVDK
QGQILWDKYTHYKSEMFSKTHTAYSPWMIIKTNDKKVARLEAMRHVLSHFDYEGKEDAGT
VLNPDPNVAMRYYRSNTLQID
>FCMOIPGL_01890 hypothetical protein
MNTKKSLSIEEFESIKNNDDLLYLLNEKNISYTKIVNTLSYNSELRLLQIELVKLQNYIA
KKRKELPLFLKVEMLQGKVVIFVDLWSI
>FCMOIPGL_01891 hypothetical protein
MKYLLSFCFIIFSFCIFSQEKLSKEFSFITENDLYVSTRKDRYYTNGIFLSYRYLSKTKK
ENQEKRILEWQIGHEMFSPYKAIVQSINDHDRPFASYLFGSFGVNRVYKNAKIFNTSLQI
GIIGPNAFGKELQDFIHNLYGFRKATGWQYQIKNAFGLNFNTEYSQFLVKDASNYYDVSW
INSAKLGTVYTNISSGFFARIGFKPLAKMINSIAFKTNLNNENTNFKREIESFFYIKPMV
RYAFYDATLQGSFLNKSSLVTKEVVPFVFNLEAGFKFTANKFNFCYAFHYSTNKSKELRY
NNGNIYGTISVNYLMH
>FCMOIPGL_01892 ATP-dependent RecD-like DNA helicase
MHKIPTDFYKELLKKFPYTPTLKQGQLLNLLSIFIFNEEKDALFLLKGYAGTGKTTIIST
FVNTLSSVGKKAVLLAPTGRAAKVISLYSKRPAFTIHKKIYFPKKQSNGSVDFVLQPNKH
KNTVFIVDEASMIPDGRQNQKLFESSSLLDDLISYVYAGTNCKIIFIGDTAQLPPVKLNV
SPALEPYTLTYDYHKSVTEIELDEVMRQHENSGILANATHLRLLLQNEGNNFQFDIDFPD
IKRLIDGYDIEDALVTAYDSDGVEDTAFIVRSNKRANEYNQQIRMKIRGQENEISAGDFV
MIVKNNYYWLEEKSAADFIANGDICQVLKIFSIKELYGFNFAEVELKMIDYPEMQPFETV
LLLDTLTSESPSLTYEESNKLYQAVKEDYAHEKSKYKQFLAIKKNKYFNSLQVKFSYAMT
CHKSQGGQWKTVFIEQPYLPDGVSKEYFRWLYTAITRAQEKLYLIGFKDDFFIN
>FCMOIPGL_01893 hypothetical protein
MNLLLMIIGALVAAVAVAFIVVKYLPLKLRWIPSILLMILAVYLGIKIYDGIMEPINFNE
DKVEKFSVVVDNLKIIRDAEVKYYEVNAKYTKDKAGLIKFIDTAQLALTETKTIVEKINK
GGGIIIDEERRVTDTIGYEPVLKYFKGRNYKNMFKVPGVEGTEFEIEIGSVEKVPGLVVP
TFRARTPKEGILAGLNESLVKQELEAVENDQIKGEFVSVGSLDEVTTGGNWPPSYDKKDG
DKEE
>FCMOIPGL_01894 hypothetical protein
MIKKNSKISLKKTKDIELSIQFSLDGFSFCVIDTNTKEKIYFTAYQFEESLNSPEELLEK
IESIFKENSILQLEYSSVTVIHQNNLATLVPSKYFDENNLASYLNFNIKTLKTDFIAFDE
ITAIDVKNVYIPYININNYLFQNFGEFEYKHHLTILIEKLLKIENSSDKTMFINVYKNSF
DIIVLENKKILFSNSFLYSSKEDFIYYILFTAEQLQLNTEEFKLYFMGEIETTSEIYKIV
YKYIKNIFFLESKNSIFEDLEASNHSNFILLN
>FCMOIPGL_01895 Ribosomal RNA small subunit methyltransferase D
MRIISGKLKARRLKAPKNLPVRPTTDMAKEALFNIINNQYYFDSITVIDLFSGTGNISYE
FASRGTKTIYAVDANFNCIKYINSTSKELELDIIAYKSDVYKFLEKTPLQADIIFADPPY
DFDTEKFLEIVETVFAKNMLNDDGVLIVEHSKHTDLSTHEKHSYDKRYGGNVFSFFENAT
EEETED
>FCMOIPGL_01896 ATPase RavA
MSDLKAVDELVVHYNSLKSEIGKVIIGQQEAVKFTLLSIFCGGHSLLIGVPGLAKTLLVN
TISNALGLDFKRIQFTPDLMPSDILGSEILDENRHFKFIKGPIFSNIILADEINRTPPKT
QAALLEAMQERSVTVSGNHYKLELPFFVLATQNPIEQEGTYPLPEAQLDRFMFSINLEYP
TFKEEVAVVKSTTSNIEYNVKALFSSNDIIAIQKLIRKIPVTDNVIEYAVSLVGKTRPKS
KEATEMVKSYLDWGAGPRASQNLILAAKAHAVINGKYSPDIEDVRAVAIPILSHRIVKNY
KADAEGISIADIINSLL
>FCMOIPGL_01897 Chaperone SurA
MQQKTTILKYTKLPILIFIFGLISTSTFAQKLKIDGVAVVIGKNIVLDSDIEKFKQEVEV
RSEGKITISDCEMLEELMQQKLLAHHAIIDSVLVSDAEINSRVERSVQYFTQQYGSEDKV
IAAYGFNDLDDLKKELFTVQKENLLIEKEQEKITEKIDVTPEEVRLYFNGLKTSNELPEF
PAEIELAQIVLYAAPTKEEEDRIVAQLEEIKKEIEEGASFKMKAIINSDDPGVTQNGGRY
EVTKESQFIKEFKEMAFSLDVGQVSKPFKSDFGYHLMQLHEVRGNMRVASHILIQPDIPE
SRLKDTKERAEKLATDIKEGKLSFEEAVKKYSEDKETKNNGGTIVNPYTGETKFDLTRMD
PDLYARVAELKKGELSDVFFDQNRNGEKMFKFIIMKDRTNTHVADLVEDYVKIQDLALRK
KKEETITKWSKEKIKDTYIKMSDTHRKCTFEKNWKKEIAK
>FCMOIPGL_01898 hypothetical protein
MKRFIIAFLTILILNSCNYFKMQEKEEITPEVVAIVNTVKLYKKDLNSILPEDISKEDSI
ILVRSFINNWALKQILLQKAESNNSLEEENEIAALVKDYRESLLINNYKEILIKQQLDTV
IKDIEIAEFYSKSKENFKLNEELVKIKFLHFDKKVINKKELIKLFKSEKIEDLEALEKQQ
LSFKHFQFNDSVWTQLDKVLLKLPFSKDNMLKKSKLLQKQDSLGLYLVAIKDVLVRNDTA
PLSYIKPTIKQMILHQRKIELIRDIEKILVQDATKNNNFKVY
>FCMOIPGL_01899 Chaperone SurA
MRKLVLLVVLSCSSIVFSQKKNKVLVTIDGEKTTISDFKRIYEKNLDAIDNEEAKDVTKN
LDLFINYKLKVKEAYDIKLDTLPSYVKEMETYRNQLSVPYMQDSSFINQLVKDAYYRTKY
EIKAKHILIKTPKVPSPKDTLEAYQKILKIRNRIVKGEDFETVAVEVSDDPSTRDDKKSG
RPGNKGNLGYFSAFRMVYPFEDAAYNTKVGKVSEPFRTRFGYHILKVDSLRESRGEVEVA
HILINDTSAKGEEIANEVYKKLEADEQFPALARQYSSDTGTKSKGGKLRQFGTGAMVKPF
EDAAFNLQKEGEYSKPFKTRFGWHIVQLIKKYPIASFSELESELKNKVRSGDRAQLSQKA
VIDKLKNKYEIVENEQAKAIFNRTDIKSISKDSLQSIILSINDKEFTQAQFVDFLKNKRN
TPVFQIFEDFKDAEILSYYKDHLEKSEPEFAYTLQEYKDGLLLFELMQQKIWEKSSKDTL
GLKSFFDANLSKYEPKELNEIKGEVMNDYQNFLEKNWIADLRRKSVIEVNKRQLKKLIKF
YKNN
>FCMOIPGL_01900 hypothetical protein
MSKNEEFYSKLKIQLEDTTSFPAEYMYKFIVPSNENQSEEVQELFNNTGAVIKTKKSKTG
KYHSLSIVLKVESANKVIEYYRKVEKIKGIISL
>FCMOIPGL_01901 hypothetical protein
MQKNQQKIVLIGGPGTGKSTVLNKLKEKGFFCFDEVSREVILKAQEKGIEQLFLTEPLLF
SEMLLEGREEQYLSAEKRKENIIFLDRGIPDVHAYMNYFKTDYPSIFLEKSKHYKYDLIF
HFSPWEEIHTTDNERYETFEDSINIDTFLIDAYSELDYKIINVPFGSVDERTNFIINSLA
CEL
>FCMOIPGL_01902 ATP-dependent DNA helicase RecQ
MISAKTILQEYWNFSTFREPQEEIVNAVLQQKDVIALLPTGGGKSICFQVPALVNDGVCI
VISPLIALMQDQVENLQKRNIKATTIKSGSSQDEIIILFDNIKFGNFKFLYISPERLQST
FIQQKIQELNVSFVAIDEAHCISEWGQDFRPSYRNIKILKELIPDVNFIALTATANTIVL
NDIAENLELDNPQIFRKSFERENLAYQVFTVEDKLLKLEQIFTKTKKPAIIYVTSRKRTE
EISNFLNAKNYKSSFYHGGLSAKEKQISFDNWMTEKTPIMVSTNAFGMGIDKPNVGIVVH
FDLPFSIENYIQEAGRAGRNGNKSFAVLFKNENDISIYKKQLKKALPSIAEVKEVHRQLY
QYFRIAKGEIIDKFYSFNLLEFARMYNFTAVKTDAILKILSNNGIIELTNTYNQKSTIIF
NSSSKNIILHTIRNIYIKDFVNSILRTYSGLFEQEVKVDEFLLAKKNNITSRQVIANLEQ
LEKENILTYKSVKTDTEIRFLVPREDDLTINRFSRVINQFLKQKEKKSEDFLAYIDNNNT
CRNTQILDYFDEKSTKDCGICDVCLSKKRTKKVDISSEILAVLNQKNGLTSQEINQHLKA
NEKDILIHLRQLLSEDKIQINHQNKYQLK
>FCMOIPGL_01903 Methionyl-tRNA formyltransferase
MKDVRIVFMGTPDFAVTILKHLVDNNYNVVGVITAPDKPAGRGRKLNESDVKKYALSKNL
NILQPKNLKNEDFLQELKALNAHLQIVVAFRMLPEAVWKMPKLGTFNLHASLLPQYRGAA
PIHWAIINGETKTGVTTFFIDDKIDTGEIILQEEIDISENETVGTLHDKLMFLGADLVAK
TIDLISDGNVTTKKQPELEEKSAPKLNPENTKVDWTESLENIYNKIRGLNPFPTAWTIIK
NEDEEISAKIYTIKKETYDHQYKVGKIITTKKEMKVAVKNGFLIIDEIKLSGKKKMDTKS
LLNGFTFSKEAKML
>FCMOIPGL_01904 DNA-binding protein HU-beta
MNKSDLIDAMAADAGISKVAAKAALESFTDNVTAALKGGDKVALVGFGTFSVSNRAARSG
RNPQTGKTIQIAAKNVAKFKAGAGLSDAVN
>FCMOIPGL_01905 hypothetical protein
MTHLKPLKGRLLIAEPSILNDSSFNRAIILITEHTNKSSVGFILNRPLEYTLNDLLPEID
CNFTIYQGGPVEQDNLYFIHKVPNLIPESIEVDRGIFWGGNFESLKFLLNSGGLEKSDIR
FFLGYSGWEKDQLINELNLNSWFISENDIKNILSKEEESLWRNKILQKGGNYKIWANAPS
DINLN
>FCMOIPGL_01906 Aminodeoxychorismate lyase
MINFNSELLVEEKAKLSLENRGFKYGDAIFETIKVSNNRVVFWEDHYFRLMSSMRMLRMK
IPMEFTLEFLEQEILKTVATQNSANSYRVRLNVYRKDGGLYTPKTNKIDYFIVAKANTYV
TKEVYSVDVFKDFYSYSGLLSTIKTNNRMVNTLASIYAKENELDNCVLINEKKGVVEVTN
ANIFVVKGNVVRTPALSEGCIKGVIRSKVIDIIAKNKEFTLEETTISPFEIQKADEVFIT
NAIIGVQKITNYKKKKFTTIFSDKISKSLNVLEVTSS
>FCMOIPGL_01907 hypothetical protein
MNKIKFELEIPVHASPNMLYQYISSPSNLQEWFADKVNSRGKMFTFTWEGVEEKAELITK
KSDDRIRFKWIESEDDESYFEIKIQVDALTKDVSLIVTDFADDEDEVEESKQLWENQIDE
LKHTIGA
>FCMOIPGL_01909 hypothetical protein
MPSFFLLLQGVHDRVHDLPMKLNYSEPKIFTGGVDIKRWSKLSAKEKKSALSKSWYVYYS
FRNPKTGRLKRQTNIKAGVNLYKDKKSRLYILNQLKESLEYILEKGFNPYEDNTSLAEFI
EQLLSTEKSEIKNKPIQKDTPLPIEENTIEEVSIPYSIQKSFDLALNTKSKVLNGVSYQN
FKSRINRFKKWLDKEGYDLKKDISILNKKLIIQYLNTVLQSTSPRNRNNTRTDISSLFQT
LEDNEIIENNFVKKINVLKSVPERNKTYTTTEQKDIFKYLEKHDAVLYLFVQFISYNFLR
PVEVCRLKIGDIDLIDKKIYVRAKNKPVKIKIIPDILIKQLPDLSNLNKNDFLFTPNEIG
GQWDTKENNKRDYFTKQFKKVKDHFELGKDYGLYSFRHTFITKLYKEMAKTATPFEVKSK
LKLITGHATMDALELYLRDIDAVLPEDYSKLLK
>FCMOIPGL_01910 hypothetical protein
MMNYKYFGILTEDMYNPLDEDQILNFFLEKHLITAYRTLDNKKKEDKLTNEKGQLETTVR
GMLSDIKYKYSEELLDNIFIYLKSFFSGLIEVNIIMYTRSFDIKTYGYTKKKKRKEAFRK
FDKLFFEICKEEQIGLGKNLNNETGAEKRFVTLKKVQCSLIEKLKGEEIILTNYLYGNND
YFTRELIDTHPYLLEIFEFENKLSILIDLNKKFKFEEDDVFTPKPKSELIFKEHSNEFHS
LKQVEFIEHQIITKEKVNRAFIVSLFDFFSNILNITTPSGKIFGEIINHYFNFKFGEVSL
NGSEGNNHDRRIQELKKEWEIFTN
>FCMOIPGL_01911 hypothetical protein
MEKTINFRISEELKVELQFIAEEKEIKVSSLVREIITDFIENYYEDEEEINCKPRVLHEV
FLEVPADYNYNQ
>FCMOIPGL_01912 hypothetical protein
MTENKIDIISKDISIHQKKLKNKSFEFGCLIIKEANIWVEEAKNRPIPNMLFSELWYENE
VCILFSDTNLGKSILAVQIADSISKGRPIPGFKLESSPKKVLYLDFELSDKQFENRCSED
YENHYQFNENFLRAELHTELELPKEFKNIEEYLCATLSNIIIETKASVVIVDNLTFLSSE
NEKAKDALVLMKTLKKTSKTNNVSILVLAHTPKRDDSKLITKNDLAGSKMLMNFCDSCFA
IGSSSQEASFRYIKQIKQRNTEHLYHSENVIVCSLDKETNFLEFHFEDFDSEKTHLKTYD
SSSSEERNEQISFLVSEGLSNVKIADRLGLSEGAIRKRRKKLNI
>FCMOIPGL_01913 hypothetical protein
MVASDIYTIAKALSKEEFIKLSNMLRCDIKKSEIKLKKKYELPDFTKEDGLRYLLENHIR
KIKKT
>FCMOIPGL_01914 hypothetical protein
MNHIYKYSLDSSSRKFICPNCNKKTFVKFINNETNQYLNPTDGRCDRESKCGYFKKPTSN
CITNIENCITEVIQPTYHNTIVLQEFCNTKQPSNFITYLLRHFETQNVLQAINLYHIDTT
NYWHNATIFWQIDAKNVIHGGKIMLYNCDTGKRVKKPFNHVSWMHKQLKLNNFVLQQCLF
GLHNLISITKGDTICIVESEKTAIIMSIVMPNFLWLATGSKTGFKQEMLHPIKDYAIIAY
PDKTEYQKWAETTELLNKKGFKISCSNLLEKIDIENGSDLVDFYFDSL
>FCMOIPGL_01915 hypothetical protein
MLYIKFKIQDASKFEDFKILYNHIVEVRQPGFKFDDKGLVGADL
>FCMOIPGL_01916 hypothetical protein
MLYIKFKIQDASKFEDFKILYNHIVQVRQPGFKFDDKGLVGADL
>FCMOIPGL_01917 hypothetical protein
MKNTILLFTLFTSPLATYTVNAQKHIKKFNFAYIESDYRGTCQGLDVVYFSPVVSYKFDS
YDGIIVKGKQEYLQENEMADKWKSKCINHYQFNYDNCMTPNHWVWDKSFNDVDKKRDNMI
KDYKNRGYKVYVNHSFGFRLQ
>FCMOIPGL_01918 hypothetical protein
MKNTIQILTIVITLAITSLVNAQSPYDPCECSQRMEKSIVYGGSNIVSHQGVKYVFYAYY
KPEKYSCAKININESSNITEEAFEKVLEKNSTYQMLLRAGKVWNKGLVGKIYFEATSVSE
IEEKVKKEAMQYATPNTTLKAIKLDVDYQSYFKKFPTCKN
>FCMOIPGL_01919 hypothetical protein
MKTTIKTILLSLCLTTTFFCNAQDASNDATWEETVEFIESTKKNYLNFYVYKESRSMDIK
QLSFSSLDLTIEGEGSYNLESSVKESIKLVNIDLSKLKRADVWYRTLNLEFTSEKAVAYS
QISYSVFYIRDWQPLRKRDDFNKDFIKIKLTKDDEMLPRIEKAFQHLAYLATKKREEERN
ASGSKF
>FCMOIPGL_01920 hypothetical protein
MIKKTILTTALLLMVFGLHAQVKDTQGTTTYELDLSKPAIINTKGLKIKTKKQLVFKLTN
ANPFKYRYVIKHEFVNIFKDESFVNIEELLKKQETTGEQNDDKNKVVKLVEIQKNIKTII
SSYNAEELTNAKTVLSFASSDALTTKDSLKIAIELVENSQKILLSTVDNYLQSLKDLPTI
NQDEFIEQRTSFKEKYNKNLTQQQLLKISFEFFTKDDDLKTFITTYQQSIKKYNDDLVTA
INKMFAANFTSYTLPIDVHGKNIDYVNITLERYTLESNSEPEVFNYRFWVTGGVKIDVSA
GMFITSLFDAEFSTIDSTTDPGKKTIMENDNGAYDFGFGTMINLKYRRYGNIAPMLSFGI
LLTANQKFQILAGPGIAIGKDERIIINAGIAMGRVSRLSNTLSLDTPIELGTNEIPTNQK
FEIGHFIGITYNLAKPKNNK
>FCMOIPGL_01921 hypothetical protein
MTTIKLKKLKLNKTFCCFIFLCFCQYQFYAQSAHYYVLINNSKLANWCSVDTGFKTFVIY
AKINTEKRNKIIEVYRKRLNPSKDSNIKTVDLYVSKSDYVVVYEYIIKSDNCPSKTFKYI
KAFKASSKEKAMELLQKRIATAYTKDRYISHKILLETQPFLDDKTDLLQDVEQFIRENTK
KDTIKKTRNSTVSGVRG
>FCMOIPGL_01922 Serine/threonine-protein kinase pkn1
MNLINKHMKTTITLIATLFLIIATAQAQTPEFIKVTGGTFTMGDEHGLGGDDEQPTHQVT
LTDYYIGKTEVTVAQYRNYCNATGVNMPEEPNWGWNSNDPIVNVSWNDAINYCDWLSEKL
DKNITLPTEAQWEFAARGGNQSKGYKYAAGRSMATAGWYEDNSGDKAHAVAQKKANELGL
YDMSGNVWEWCLDWYKSDYYSTSPSKNPKNTARANGKVIRGGSWNYEASYCRVAYRSNRR
PDNRFSPYGFRVVSF
>FCMOIPGL_01923 hypothetical protein
MKIGKKFNQLNKSEYFQFIDHYKKYSDFNTLGMYRSICENENLKLDDKIEIRDYANSIFG
KTFNFYQLKDPQTYFDLTTLGLELTVADEKQIWNDIIANQQKILSEKKIKHRNFGAYSKH
NCGYKDCPYNGLMIKQGSFLAEGGLHFKSDKNAYSAKLKSKRIKKQRKNKDQIIKDEFNK
>FCMOIPGL_01924 hypothetical protein
MKNLFFISTIATLFNSCNKDDSEIIIEERKYVINSLTQIKGILIPIDVVFQKFNKCENEN
>FCMOIPGL_01925 DNA polymerase III subunit alpha
MYLNCHSYYSLRYGTFSEVELLKLAVENNIDTIALTDINNTSACLNFIQQAKKFNIKPVV
GVDFRNGNSQQFVAIAKSNLGFENINRYLSTFLESKTAIPDQPEFLEDVFIMYPFEKALE
LNLTSFKENEFVGISIAEINKLRFSYLKKYEDKLVIQQQVTIRNKSDFNAHRLLRAIDNN
TLLSKLSTSEQCLITDKMYAATVLQQYFIEFPFVLENTKTLLQQCILHFGFDKSRENQNL
NLYYNSFEEDCKQLIELCNTKLEKRYQNPTQQVQDRLQKELKVIIELKFVSFFLINYDIV
SYAKSKGYFHVGRGSGANSIVAYIIGITDVDPVELDLYFERFINPFRASPPDFDIDFSWK
DRDDVTNYIFTRFKNTALLATYNTFKYKAVIRELGKVFGLPKEEIDKLSKKSKQQKIVLN
GAETPQNKALQQDSNNTATGLQPKINKSAKTHQQESNKKATVYQQQEIDSIAKLVLKYGK
LIEGFPNYISVHSAGILILEKPIHYYSATHLPPKGYPTVQFDMNIADDVGVFKFDILGQR
GLAKIKEALEIIKKNRPNDPPIDITDVESFKKDEKINHLLKSGGAIGAYYVESPAMRGLM
QKLQTQDYLGLVAASSIIRPGVSGSGMKDEFIKRHRFPEKRKEANPILLEIMPETYGVMV
YQEDVMKVASKFADLTLGEADVLRRGMSGKYRSLSEFKAVEDKFVSNCRKKGHQDALIFE
VWNQIKSFAGYAFAKGHSASYAVESYQSLFLKCYYPIEFMVAVLNNGGGFYSAAHYIHEA
RMKGAIIQLPCINKSNHPNIVMDTSIYLGFGYLKNLEHLTIQRLLTERQLHGDYTSLENF
IDRVMISIEQLTILIRIDAFRFTGKSKTQLLWQAIFKLNATKQKTKQSQLFKIQHTKYEL
PKLESHWIENVYDEMELLGFTIHNYFKLVAEPFLPSIKAKEMIDFENQNVLIYGLLVTTR
YNTTSQNKLMRLSTFIDINGNYFDAVHFTNVVHLYPINGMGVYACYGKITDRFGFCSMNV
IQSKKMGIFRDPRN
>FCMOIPGL_01926 DNA polymerase IV 1
MKKNILHLDLDTFFVSCERLIDSRLQKRPLLVGGTGDRGVVAACSYETRAFGVHSGMSMK
VAKRLCPEAIVIRGNTSIYSKYSHIVTEIVKEKVPLFEKASIDEFYADLTGMDTFFGSYK
YASELRQRIIKESGLPISFGMSCNKIVSKVATGEAKPNNQLLINEGFEKEFMAPLSIRKI
PSVGEKTYQILRNLGVEKVKVIQEMPVEMLMSVLGVNGRTIWKRANGIDNPPLIPFHERK
SISTERTFNKDTIDVRKLTETIFAMAENLAYQLRKGNKIASVIAVKIRYSDFNTYSKQVK
IPYTSADHIIIPTVLELFKKLYQRRLLIRLVGVKITDIVSGNYQINLFDDSEQMLNLYTA
MDTIRNKYGESSITRAASMGAKTIGRFDNPFNGEPPALLAHRKQ
>FCMOIPGL_01927 hypothetical protein
MKIISKNIRHLRGLKQLSQERLADDLKVTRSRIGSYEENRSSPTLEFLIDFSNYFKIPID
ILLKNDLTKTKDISFIEIGSKRVLFPITVDAENENLIEVVSAKTSAGYLLGYDDPEYIEQ
LEKIKLPFLPTGKHRAFPIKGDSMLPMKDGSYVVAEFVEDIRDVKSGTSYIIVTKNDGMT
YKRVYNQLEEKGSLLLKPDNREYLSYQVPMEEVLELWKFTCSINTQEYEEHELKLSSIIQ
MFNGLGVELKQLEKSLKMS
>FCMOIPGL_01928 Putative SOS response-associated peptidase YedK
MCYHISNTKPARKLEDFFDVKFNKDVVYEPNYHLNGFDNRFVYIIPQENESAVIEPAKWG
LLPENLENPVDFKKRFNTLNAKSESLFTSNLWKEPIVNRRCLILADGFFESKHVGKNKYP
HYIRLKNHDPFAFAGIYNDHQNGVFSCSIITKKANPFMAEIHNSKERMPLILDTSFQKEW
INPSLSKNSINEIIEKGFMTKEFEAYTVSKDVTNSRKNSNTIDILKPFYYPELNTLF
>FCMOIPGL_01929 hypothetical protein
MKKLKKKNFVITILFILLFKCSYTQITFNKIPLNKQLVGRDLTTNIGNIIIEGSVSNLAI
YYSSIEVELYRNNKIQTTTTKTLNYSSNSASFNFNIPILAELVNYSIKIYGLSESTRTLE
KEVTDIVAGDVYIIQGQSNAIAFNYGSSNSYVSNFIRVFGKGTDNAIDLQNNSNWFIGIG
DAGTGTNGNTGQWGLKLANNIINTNNIPIAIFNGADGAKSINFFQAPENYQTSLASNYSR
LYYRLKTSGLTDYVRAVLWSQGESDGNSTTITQYKNLFIELKKSWLTDYPNIKQIYIFQT
KNGCGGFLMYIKEAQRQLAYENSDVQIMVTAAMTHHTDNCHFPFIDGYEKFADRIFPLVQ
MDLYGGTTSSEINPPMITNAYLSSEVTLVIETDANQLSIPTIAEDFELSNAGSSVITNIQ
TSKSDIIFTLSEYPGANPEISYFAQNSGSGNFIVNTNNLELVCFYKYPIKTNILSINNLN
LNDKILVYPNPTDAVFFVKLPITKDKIRVKILDLLGKKIFDENYYSNEFRIELPNAEVGM
YLLKLELNNKIYTKKIIIN
>FCMOIPGL_01930 hypothetical protein
MQSIYDYLIFTTKIEHDLEHDSKILAPFSSPKFYTAKGDLSKRWYIYFSFRNPKKGKLER
MENVYDKVFNIVILNIQPLLKKTT
>FCMOIPGL_01931 hypothetical protein
MSKKANTNQHKLKMKRALLLFSLFISISLFSQKFTLEGVLKDQYFDVLNGATVYLQSIKD
SIPIAYGITNKKGEFSLPVNAGTDTKIIFNIAYLGYKPYVKNIDVPKGGELNMGDIILSN
QIEELDVITIISRAPPVLIKKDTVEYNADSFKTLPNDKVEDLLKKLPGVDIDLDGVITVN
GIEVSAINVDGMKFFGEQKGDIALKNLPSNVVNKVQVTDYKTDNQKFTGEESDSGTKEIN
FTIKKGKNRATFGDVKLGYGTDEKYQANANIFKLIDGKQIGLIAGTNNINLSKGFNSLPD
TDTSNGYIESDFIGANYTKGKWNENRINGNYRYSAQSRDFDQVSHKETFLPNLNYITDSK
NSSFTDSEGHTAGADLVFILKPKKNISTKKVRLSNKMDFKNSSKESGAIVDKDSYYNNGD
LVSDFNSKNESTSLSNEFKNDFSVTSVLNNKADYFNINLGTDFSKDESDSKKYSENILTS
SGETIVQNQVTTSDSNNSNISFNAFLSKELFTNFRLMPRYNATINSKKTENYIYDFDKTS
EEYNNFNDLLSSDSKYVTTTLKPALKLRYQYKEFRFDVEGAYTNTYRNYEDELVTARDFK
ADFQYFTYSGRIRYKDINGYKNISLQYDQNVDLPSVSQLQPVEDVSDITHVVVGNPLLEP
GVIHNVRFLYQNNLAYNNINISGNAKAQFVKNKIINSTTTDVDLNRFTTYSNIDGDYSYS
GNFAVSKSYFSRKTNINLNVRFNASYKNSLSIQNEVKFTAKTTVLRPSFSFRYAYDNKID
VSTTYSYSKNKSVYDTDEFNDNSYFVQNLDLETNVFFLKNAFFSNRVSYRYNSRVGDEFD
GDAIFWNAGLGVELWDNQATLSLVAYDMLGKNNGYRRSVTETYIQDVENKILEQYFMLTF
TYKFGTFAGQKINVKGVKKGGRGRSRKKF
>FCMOIPGL_01932 Tyrosine recombinase XerD
MKKNPTIFLEQENYKKVSQLLVKFKYSDTIINLMRKIPDASWNKTLRSWQIKYSKENLDI
ILNTFKNITTIDDSKLPKKVLFKRDLTNNQKKLLNNFYLYLKGKRYSKSTIQTYTFFVAD
FVSYYTKRSLDELTNRDVELFIEKVFIERNYSISSQRQFVSALKIFIAFYPHTKINDLIL
ERPKKSRKLPSVLSQEEVLEIIRCTQNLKHRAILTLIYSCGLRISELINLKLVDFHIERK
QLIVKNGKGRKDRYISLADSFLPLLSNYYHSYKPKKYFVEGQNDGKYSAESVRQFLRKSC
AKARIKKTVTPHTLRHSYATHLLENGVDIRYIQSLLGHAKPETTMIYTHVKRKDLMEIQN
PLDIALQKLNKINKDKENVLLSRNI
>FCMOIPGL_01933 hypothetical protein
MTSESFENHNIFDRLNSLKEILENEENKEKIDLEKLSFFQTVFSYINQRVKLTIPDLVLQ
TELDSLSAELNAGISNINKFIGNNNQGHLTNATNNFNAAITKIKNFPIPVAKADFNFSRK
IAEFEKTVKNKYKSLEKEKDELKTEITKFKTDLTTKESEIQRLLKLIDGKETEILNLNST
FQTSFNNIKSEHNQNFENDKKTYRAEIDKSKEVFRKEIDELKSSIDTDTTGLVEKLETKH
SEAKKLVNLIGNVGVTGNYQNIANSHKESANFWRGFAIVFMSIFSGLLVWTIIDLSSLGF
DWTKSLIRLVAAAALSYPATYAARESSKHRKLETINRNAELELASINPFIEGLSDDKKQI
IKEKLVEKYFGNSKDNDFLDTKESEGLSIPAFEKILSAISKLKG
>FCMOIPGL_01934 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MDCPSEENLIRMKLDGISSIANLDFDIPNRKLTVFHSGESDQIEKSVIELNLGGKKISTE
QTDQTEFKENANQKKLLWSVLAINFVFFIIEMTTGIISKSMGLVADSLDMLADSFVYGIS
LFAVGGTIVKKKRIAKLAGYFQITLAIIGFVEVLRRFFGDEKLPDFSTMIIVSIFALIAN
GICLYILQKSKSKEEAHMKASMIFTSNDVIINLGVIIAGILVNWLSSSKPDLIIGTIVFI
LVIQGAFRILKLSK
>FCMOIPGL_01935 hypothetical protein
MPEINLIKLEGKPFEKLIDVISKGIGTLYKPRAIRKEADSKAYEIGIIEQAKSKALAEGK
VLEAETYLRIQERLLFNETERQKSIDNVVEIAAEQLKNEDNISEEPVDKDWSKRFFNLVQ
DTTDEEMQALWGRILAGETKKPKSYSKRTLEVLKNLSKEEAEIFTKFAELKIKVNEYTVI
INNDKGKFIKEEFGITFNDCLLMVELGLISSENSFVISFEPTNNNDKNIYITYGNKGFKI
KRKQNSPERNIQVLSFTKIGCELSKLIHPKVNMNYIEKICLSFKHENTDIEYGDILEKNE
KKFLINIKEYN
>FCMOIPGL_01936 hypothetical protein
MKYKKIRGLKKKVAKIQNWVEEYLKLDIEQLSEYKYHYSKVYVQPWDNISLTNSQIPEPK
GKAKNEILNGLEKIYDSWKVELDKSEKPYYLKIWIYEPRISKSQVVCAIGDRIEYYENLF
EKVNYKQNNSSFTNSLSSEFKWESKIDEVQYWKSELLWPSEQYENIEECYSDRKLLKKLE
NGNYRKELIDNPNEEKDIIYFLKKGKIWVGEK
>FCMOIPGL_01937 hypothetical protein
MNYTFKNTEINNKKATDFETKSLLYLIGKRKDSKEVEYIAFDCFNDVSGINKKSDKIWDI
QSKNEKNLNPKKIGKYFFTLFDNFTSSFDFKEFIFFCPVLKTEYKIDAKLNTYGIENIAD
KTLTRIKNGLNLEVIRVKGTSINYDKKQEDFLKKVIIVEDTELDNEYIKTVTKFKKTEIK
TDAFYQSIFQDLRDIQSSKKNSYIENEIITNIKDVLKFNRHLFSKDVETLIISRIIGCEV
FEYKSIPFYFYPLINALDVEDVKDTVQECNSNLSRAFFNKNSNREFWKICEVIIEFIESN
NITDVEQIFKTIFNNYKPRISYLTPITIKYLIAITIEGKQ
>FCMOIPGL_01938 hypothetical protein
MIIKKTAFGNSQEAFIEDRFKNTTNIIFSNDNNRGKTLVIQGLMHSIGYDSIFPSGFNYK
SYFFYSNIIINQISYEFLRKGNSIILLENDILNVFNSISEFKYYFDKYIYTLPKIEKDGE
LKPVDLTLFYELFFLGQDKRNSSNLIIKGRNNKQDFKNMIFAMQNVLISSTNKYDIEELK
EQKKSIDLKIKTEKRKITILKKNPEIASFISSTANNIDFKNTSKRLSELHKSIADLQKQR
NREENRKIKLENLIIELNSLNRSLNEGKVKCSDCGSSKIIFANQEFEFEVSNNYVRQNIL
KSIQESISMKKEIVQEFNSEINKEQSQIQKLLKTSTPDVKNYILFQDEIIDSKDIDKIVS
ELQKQLEEVQKKINNNESKIVSNKDLQKLIMESVISEMMRYYKIIDKDGLLDFEDLFTKS
GETYSGSEEQEYYFCKILALNKILNIEFPIIIDSFREGELSSTKENIMIEEYIKLDNQVI
LTSTLKDEEYDSAKYLKLENVNVIDYSSFADSQILQDNYVDSFNEILEKFGIKE
>FCMOIPGL_01939 hypothetical protein
MNQNINITDSEFKTFYEPLLKGYGEEFKDVIKSKNDICKLIFLDSKRISIEKLLSNIEKE
SDIYIKSMIYRLIGVREIIYCRENKQKLDVKSVWELISKSIKIIPKEYTISSIGSQGFLS
IPLYKFDESLESFDFLRLHIWDDSLNEYIDLEKCENFSIHTHTFFAESWVIAGKIINNRF
DYNINSENSNHSFFKVVYNSSLNEVNQHTSKAVNEKIDIELYQTSEELHLENGNYKIEAG
KLHKSGHKNSPLPSATFFSFTGKNGLDKSIVIGPKHISESVINRKMIIDPTELLKKIDKQ
LL
>FCMOIPGL_01940 hypothetical protein
MEKKKTMLLDWMRKVHQLEYAHCYQSEYYRKIEKRIGISAFVLSTMVAFSYKFPEIKNEW
FNTYLFFLDKDYFLPFLLFIVALFTGLQTFLKPNEKSDIHRKLGLEYEKIRHTIEITLTK
EESELNIDRDILKIKKSWDSMNTIYVMERYFVEAKNKVKKFEKYPKELSFLEDVK
>FCMOIPGL_01941 hypothetical protein
MSDKDENNNSSSNDSDSNSSSGNSTPYRDSNTYVERTENQDGSVKK
>FCMOIPGL_01942 hypothetical protein
MKNKLNIKLLDKLSIENLQIIKTEAELNLEDLSSSEDIITNKSNTLFQVLVVIFTTIVGY
LVSQINSFDIKSILIQISIVLCIVFGFVLFLLIKVIYPNKVALKGASPNNLIQDFLFNKK
SDKSQTKQILRNRVYSLNIAIESNKENLKNRVRLFDWANKSILIGLIIVLIYSAIYFFTL
PS
>FCMOIPGL_01943 Adenosine monophosphate-protein transferase SoFic
MKPPYEITSSILKLITSISEKIGEVNANLLNKPSPKLRKQNRIKTIHSSLKIEGNTLTEE
QITALLENKKVIGPKKDVLEVLNAINIYENLDQYNPSNEKSFLKAHKNLMEGLIENSGKY
RKQSVGIVKGSKVEHLAPPFGNVPYLMKDLFEYLQKSDEIELIKSCVFHYEMEFIHPFLD
GNGRMGRLWQTLILMEKYPIFEFLPFETLISKGQEEYYKALAESDNSGKSTKFIEYMLNV
IDVSISELLNFNNRTLNEKDRLEYFVSLNKTEFTRKDYMDIFKDISSATASRDLKKGAEL
NLFKKIGEKNKTIYLLK
>FCMOIPGL_01944 hypothetical protein
MSLITIKKSNNESEIFILKGKLESEGIKCYLRNEFTSQIMPHIALVELQVSEGDLERVKE
ILTEINQTE
>FCMOIPGL_01945 hypothetical protein
MKTQNEHCRKKTYEKVTLELKLLVVDQIQNGQISTNFASKKYDIPRTTIGYWIKKYSTLV
QQNTGMSKINEIKKLKERIEALEFIKDFQQDIIADMEIITGVDLSKKSLPKTLVKEIELK
KKNRLKESGSINVLGLVNKPSTKDVKNKKSNK
>FCMOIPGL_01946 hypothetical protein
MVLDYRKKVGMRTGGIKLYDELKSDFIKQNIKMGRDKFYDFLRLHNLLVPKLKNYVTTTD
SNHQFRKYKNLIKDQVPNRPEQLWVTDITYIKTENGHNYLAIVTDAYSKQIMGYKLDNNM
KTSLCIEALAMAIKNRKYPNEKLIHHSDRGFQYCNPKYTAFAEENGMIMSMTEQYDPYEN
AIAERINRTLKYEYGLRNCIKNTAIAQEITKQAVDIYNNLRKHFSLDLRNPADVHLNPNI
KYKSYRKNKVNLPELKI
>FCMOIPGL_01947 hypothetical protein
MAHLTKSNLGKLCQKLKINNEIDLDIFVNNIYNDKEIYYILNRIEIEYLFKYKMMLDNED
EFFAEYFEKVAEKEDSKTFVFNKGGKMKYHLSSNCKLLKKDYLDFAIPQDIQDLGDKNIE
EYRDWFRDNNFADRFKNKTIGKDLIIKAFNDKYTKEPYNIKKIEDNSNLLIVEIPNSSIR
YIEKEYNKVEFINKITELKKQFQNIFQCKISRKLSKFKYLLKMSDLEIQQKIDEVFVEGF
TKNYGIENLKEKFKASKGIVYEIISLLLEYIRWNYKANEKDFNILTLEKFGLECCISCEK
ESKNVLQHRV
>FCMOIPGL_01948 hypothetical protein
MNFNFLKSKPKHIYSELKPMERITKLFLEFTFPYFEKNEFKYLKSQQEFKKRNDFFLYSV
HWYGRKYNEGNLSVEFDIVLNVTSTKYRKWEKEFYNLGEKRERGIDGTRVDYIENWNKEY
YYSGWYDLVKDDNEKVMKRICENFETSGKDFFDNFKSLDSAINKLKKYPIANFESIIDFY
IIQNKWSEANMFFEENRSWYEKKEKIEGNDPNSEYCLNRKEHFELRREKIKNWLQQHI
>FCMOIPGL_01949 hypothetical protein
MKTQNEHCRKKTYEKVTLELKLLVVDQIQNGQISTNFASKKYDIPRTTIGYWIKKYSTLV
QQNTGMSKINEIKKLKERIEALEFIKDFQQDIIADMEIITGVDLSKKSLPKTLVKEIELK
KKNRLKESGSMNVLGLVNKPSTKDVKSKKSNK
>FCMOIPGL_01950 hypothetical protein
MVLDYRKKVGMRTGGIKLYDELKSDFIKQNIKMGRDKFYDFLRLHNLLVPKLKNYVTTTD
SNHQFRKYKNLIKDQVPNRPEQLWVTDITYIKTENGHNYLAIVTDAYSKQIMGYKLDNNM
KTSLCTEALAMAIKNRKYPNEKLIHHSDRGFQYCNPKYTAFAEENGMIMSMTEQYDPYEN
AIAERINRTLKYEYGLRNCIKNTAIAQEITKQAVDIYNNLRKHFSLDLRNPADVHLNPNI
KYKSYRKNKVNLPELKI
>FCMOIPGL_01951 hypothetical protein
MEKVRQVIQYKNYFEEFLLAQPKKVQDKIFKVIEIIETYQHVPKTYLAPMKTHKGLFEAR
IKLGSNIWRVFCFFDKGKLVILLNGFTKKTQKTPKKEIDKAVRLMKEYYEEKNKSNGN
>FCMOIPGL_01952 hypothetical protein
METKSWKDIKDTVYGKKGTERRDELDRDFESFKIGLLLRNAREEKNLTQEQLGELIDKKR
TYISRVENNGSNLTLKTLFDIVEKGLGGKVNISIEV
>FCMOIPGL_01953 hypothetical protein
MKTQNEHCRKKTYEKVTLELKLLVVDQIQNGQISTNFASKKYDIPRTTIGYWIKKYSTLV
QQNTGMSKINEIKKLKERIEALEFIKDFQQDIIADMEIITGVDLSKKSLPKTLVKEIELK
KKNRLKESGSMNVLGLVNKPSTKDVKSKKSNK
>FCMOIPGL_01954 hypothetical protein
MVLDYRKKVGMRTGGIKLYDELKSDFIKQNIKMGRDKFYDFLRLHNLLVPKLKNYVTTTD
SNHQFRKYKNLIKDQVPNRPEQLWVTDITYIKTENGHNYLAIVTDAYSKQIMGYKLDNNM
KTSLCTEALAMAIKNRKYPNEKLIHHSDRGFQYCNPKYTAFAEENGMIMSMTEQYDPYEN
AIAERINRTLKYEYGLRNCIKNTAIAQEITKQAVDIYNNLRKHFSLDLRNPADVHLNPNI
KYKSYRKNKVNLPELKI
>FCMOIPGL_01955 hypothetical protein
MFSLFKSKSNLSESEFSEKFFAELKRKVKGLVLVSINGLEVTTKLKGSDNYRHFLDNSYA
EYKNEPKDLKKIIKKYTLASKELFLPEEPVKLERIVPIIKDKRYLIESSKLVENFENTHV
YEKYNSELYIFYAEDKDHSISYLTKERIEQLNIGIEKLKEKAIENLNSIVSKMESHGENG
YFMLTAGGDYETSLLLFDIWNKENFPVDGELIIGIPARDILIITGTNEKENIEKLENSIG
EINENGDHLVSDKIFIFKKGKFELWK
>FCMOIPGL_01956 hypothetical protein
MVSCENGIKKGNELSKSDLKYIRDLGLLNENEKIILFSSQGGNRMSGNFLSENRLASYWV
ENRKENNQINSAKFIEIDTLITTDLSEALTYASYIKVIKKNSSEFKVYVDGKPEKIDEFF
EKAISEWKKRKK
>FCMOIPGL_01957 Adenosine monophosphate-protein transferase SoFic
MNNFKLEKLPLTKDIETKNILKKLNEAHRALAELKGLVSSIPNEHILINTLGLQEAKDSS
EIENIITTHDDLYKAELNLDGLKSLDAKEVQNYISALKIGYSLISKRNILTNNNIIEIQA
ELEKNNAGFRKVPGTALKNATTGEVVYTPPQDYETIKELMTNLEQFTNDDSLSEFDPIVK
MAIIHFQFESIHPFYDGNGRTGRIINVLYLVMKDLLDLPILYLSRYIIENKAKYYELLQE
VRETGNWENWLLYIIQAVEQTSKQTISTIKEIQVLMLEYKHLIRDNYKFYSQDLLNNLFQ
HPYTKIEFIEKDLGVSRITAGNYLNKLAKDGILIKQKLGTGNYYINHKLYTILTNKVL
>FCMOIPGL_01958 hypothetical protein
MPKRKLKTKYYILFIVILIIWNSKESIEFYYLKNIKNETGIKVIEIDSSKIKTYSELLKI
PELINKPSFIYFNTQLSEKRLKSDKIVLNEMFEKFKNENINIIFISNGLEGENYKKWFIK
MNNLNLNGIHINFENYNHYKSYLKTEIIDLNERTTFPHYLLANKKGKITDTVFDGKIHLE
KIEKLIE
>FCMOIPGL_01959 hypothetical protein
MEKIVIDLKTEILFDKNDWKVFKEGKLEKTETKNLFKYFSLNEYSLDSLENNYVYLSNPK
DFNDPFDCNRNLIIEKQKEIKDLEYVESLNDISGIGICSFSENGIEPLLWSHYANSYRGF
CLKFKPEFLIKKNLEFAKLKKVIYSKEPRSISLKSNFAKYYQYILKLENWNYESEWRLLF
QNPSQVENKYHFNENCIEEISIGYKFMQPTNDNERKLKIKFDKLRKDKFKNVPLYTVGPH
TTKLELQKLRLLEGTKEDAIEMIRKIFK
>FCMOIPGL_01960 hypothetical protein
MQTSEFPPEIPRSQNRNFPYKTTLGKIMKPKLQILLSILILTFSCVQKNEQNKSENVINI
EEKKEIIYPKKEFKNSFEVDTTLVKKNFFGDLKISNSIKEDSIVSLCQCKKYKKDNRIKI
QLKTAIPTKKELDTLSESFKKRNRFLQIGDLGYLKTISGQFKFLTIVLKDSTVESINLYS
KSTEKEYNGIDFDSLSIEKYKINISKFNYSIASNVYGNFELHLKKEFGFFENDTILKSSF
LCNNWVISEKSEIKNWNIKEYFENRHNDRGFRVIE
>FCMOIPGL_01961 hypothetical protein
MKKTLYTFLLTLISYNIYAQNHIVNENDIPKLNSIIKSLEKEFNGNETPTYKSLPHTSAN
YFKIITNKPNDFLNSLDNAENFEQLIKENPTLQIDRDLLIIKNVGFNYKKEKKIEVKSFE
IGQSQRHLIEIKYSDSLNNSNIKFLYSIHKETWSDYKDASIIQGFYLINKFKSINIPEKY
TNWIHYTDIIVKPETSIFYDNKEKSSGLRSYKKTIIDSLVSYYETKTNKPPYRKEQDFIA
RRKELDKWQSKKQKFSDSLYKTDKHFKKLLIEALSYAEENKVSNGDLEDFTSQLISKNRA
LELMRQNRQVGSCSFDNGPVIQQKRIAALAAQNQNWEVFIQSFLNVMNDNVTRNANSNIA
SNARNTYIEELAKLDLDIDKILLGSNLRIQDTVQKHYFSDGSKIAKAYANLDSENQHYFE
KTISDIISDKSIDAFNKLHFYNTYRSYQYFLKDSLKKNEADKNIEKLIPLLPNEIKSRIE
NPNKQLYDLLYREKNELDEFEIKSSIIANIYSYSYGGDCWQAELIEKGSNGKIIYDLTMA
IGEEITPFQNFLYKKDELTSRVISHSFLQEILNENSENKLYVKFTNDKSFANYRNKVTEE
IPEELTSALDFNNAISLYISFPNRKYVRFILLGNGNLLTLGIPKDFELPGYKFEELMTKE
EKSFLSTSYKSFKLFDNKGKMLN
>FCMOIPGL_01962 hypothetical protein
MEIFQNIIIPLISALVGGLFSVWVFNKGLNKKKQEERKNRIQNNFETEEYFFYNLKSILY
FIDQQVDAISKTSRNTKNWFHKNLTLATFSELKMTELRELNFKTLFQILVIDRQGNNKEK
MQDFINIKNCLHNIEDFVQKHKDENEKPHIDLNKYLDIWNSSLKNLTQLYNHYIFLKPSK
DDSLMPILHKYIVVEQRKLMENGNDQNMEVFYNSIIIPFMNEIVAYKNSDDQRILPVIEN
S
>FCMOIPGL_01963 hypothetical protein
MKTQNEHCRKKTYEKVTLELKLLVVDQIQNGQISTNFASKKYDIPRTTIGYWIKKYSTLV
QQNTGMSKINEIKKLKERIEALEFIKDFQQDIIADMEIITGVDLSKKSLPKTLVKEIELK
KKNRLKESGSMNVLGLVNKPSTKDVKSKKSNK
>FCMOIPGL_01964 hypothetical protein
MVLDYRKKVGMRTGGIKLYDELKSDFIKQNIKMGRDKFYDFLRLHNLLVPKLKNYVTTTD
SNHQFRKYKNLIKDQVPNRPEQLWVTDITYIKTENGHNYLAIVTDAYSKQIMGYKLDNNM
KTSLCTEALAMAIKNRKYPNEKLIHHSDRGFQYCNPKYTAFAEENGMIMSMTEQYDPYEN
AIAERINRTLKYEYGLRNCIKNTAIAQEITKQAVDIYNNLRKHFSLDLRNPADVHLNPNI
KYKSYRKNKVNLPELKI
>FCMOIPGL_01965 hypothetical protein
MKKKFYIIILVFSFLSCVKGELFDAKKSKSYFIKNNNIYYSPNGNWFELGYNKSEADYKT
FEILSEQISKDSKSIYFGYQKQSQIDYSSFKLDSNGIPKDKNNVYEYGINYLKPVTIEGI
DIETFEYLRKNRSSKYSWAKDKNNYYFKGKKLNINYNSLKFINEDFFYDNEHLYSDLKGW
KIITISKIESTPKKVNEKYILSNDTLYYVGENKKNRISLFSEKIEKYEKFGTISKNVVSI
DTIIFSFGTKYEPLDPKTLKKIKIDYNSFETLYESHSKISFNYYKDIRNVYFNNFIIEKA
NPKTFKVLGLSFSKDDKFVFYNTEVLKGIDSKSFRKSKNGYTWKDDFGNEFDFKGNRISE
KKL
>FCMOIPGL_01966 hypothetical protein
MEQNTIEIIKTIGSQWKFLLVVFLIVVFIIKWKTIWSFIGNFTQIRVKRGQTEFEMHRKE
NKEDSETTNQEKVIPKGDSLEDDNEELSELENNGNIFIQYHNALSEKKFKEASELLDKVL
AEIESPNRKKEEVVRSYYLRHQYGDTSAFRELEEFTDKIENDNEKKSHGLFYLSLIYNQA
NNYEKSVQLATQALEITNDNQQKAFCVSRISDYHLENDNTKESLKIIIKSIDNINEKQPK
VILYRALANYYKKTENKLLESIAYQKALELTPNNTYLLFDAAYNFSETEQDLKDLSLLFY
KKLLGFDSKFQSALNNIGVTYRNLGLEVKSTEQYKKAFELKNSLAASNIANQLIHLGFVQ
EAEEYLKKAEEFEDPHENVFEATSLIKTKINKEKEEEEKILKKAKKKFRFFNHFGNAVFT
SKKISFKISNQWYNDDDIPITISQNNNTIEFSWENGEEKHSINGVLTNNSIFATYKKPKK
NTYSYNEQNKYIHRDIEGFGYINSSKEMRFIFEFEKEIIELNFTEK
>FCMOIPGL_01967 hypothetical protein
MNLEKKVTKKNTASKNELTQAKFKKVESKNSLNLEYQLLGENNEQIKFSSLTKMAEFPGG
FDSLTVFIQRNLELPKGDYKEIEGKVKSTFIIDTLGKVVDINIVEKLEKNYDYASYEVIS
KIPDWKPAEIENGKKVRIKILIPFKFILEK
>FCMOIPGL_01968 hypothetical protein
MEQIRNYNLEEFKKLLLNHFKEIYDLELLILKGHIITEFTINCYLENLSNSLDANFFKER
YNHSLKIGMIEHFGKFGGRTLEIVKSLRLLNKIRNGIAHTLTVNEQLIQEYVNSVSQIAS
EDFINPDYEIRLKFSMATGYLCGEIFGEYYEQREKKEE
>FCMOIPGL_01969 hypothetical protein
MPEINLIKLEGKPFEKLIDVISKGIGTLYKPRAIRKEADSKAYEIGIIEQAKSKALAEGK
VLEAETYLRIQERLLFNETERQKSIDNVVEIAAEQLKNEDNISEEPVDKDWSKRFFNLVQ
DTTDEEMQALWGRILAGETKKPKSYSKRTLEVLKNLSKEEAEIFTKFAELKIKVNEYTVI
INNDKGKFIKEEFGITFNDCLLMVELGLISSENSFVISFEPTNNNDKNIYITYGNKGFKI
KRKQNSPERNIQVLSFTKIGCELSKLIHPKVNMNYIEKICLSFKHENTDIEYGDILEKNE
KKFLINIKEYN
>FCMOIPGL_01970 hypothetical protein
MKNFIKSILLLSILLISNFSFAQTVDEKTNEKLNINSDNNDLANKICGASYISWGGANPV
KALEMTIINEIGVEADDPLRSQKISDFFNKNHDRLICGDDTRQKFRKREHFFKRAIAFHA
YVYFDHLAESDDYSINMNTYEIIDGKKETLIDYVDKILNDPEKRKLYNVDGLKNLRITLE
ELGVTKGEEL
>FCMOIPGL_01971 hypothetical protein
MRVERKFTKLDETFKPEYKIERIYFPEKRESLYLKRKTCGITGNHQTTVISKKKKFQFET
ETISDYVFKEFLEIIFKAENNKLIIYSYYKPEIPIKFESEIEIELR
>FCMOIPGL_01972 hypothetical protein
MNENPSNNSTLDFYEKLLLGPLMQLYSARKETELSDWMSFSNLLIDKFAIHSSSFFHLSK
GIIEHRKSGEKKRINGYDLFTVNTTFRALLETYVTFHNLFVEPKSEQETELRFLIWKLDG
LYQKRKYDIDKSDFEKAEEILKKDNELINNTQKQIEQSEFFKKLNSEQSIKIYNPNFKSA
NWKFLIKNDLIKPKKILELVKHVCKQKGFVNLYKYTSIHSHSNFPALAEFKDTRGKIISD
KHTEPTTEYATIMTCLLMSDICIIDKNAKSKFETFPKAIKEYINGITKVIKESE
>FCMOIPGL_01973 hypothetical protein
MEQRISISKAINRGHLIVNLPVCISMFGIPALAFYFSAENLIPNWGIGVSFVIGFTLAWL
TWSFMIMKWRIWAFNKVRNVHELKKKAIEQGLMWNDDSWFNKTEIRTNSDKLQWKVLEKK
FDKKDVFKEDQSVSKKSIIYYSKIKNTYEFLIMLIALGGGIYLLLKSDSYIIGTLLVLSG
TYFGFKEIKKVFNFSPQITIDNKGIKTATTEFKNWSEIKNEEIIIEGYGKNKEFYMIYDY
SNGFEKIKIDDFNISPKKLENLIRTYRIRNNKNYS
>FCMOIPGL_01974 hypothetical protein
MRKIYLLTLMSIILFNCQKKTELRTDLQPIYSDSKNALQGNNLYGKVKKIEYYKTTFQNI
ENEDKPVLNKIEEYTDFGELKKVEYFDNYGELTQTNDIDYNKNQEFIKSVSINKSNESNI
IQISEYDTIKNTSELSVFVNDTIDHKTTFYYGKNDYQIKRISIKGNDTTEVNLEYVFDDN
DKIISSTQKEKGNDKSMTTNLFKYDNNNNLIESSYKTEWMEMISETEWKDGRIFKQTSYT
ISADLKKHTNNITEFDILYNPINSKEFDDSKLNRELKFDYEFDKNGNWIKKNVSLKEHFN
NSKGFVPIYVDTRKISYWK
>FCMOIPGL_01975 hypothetical protein
MIELDEIDRIIRKDLLKVLNTNIVYHYSNFEIGVEKIILNNNLKFSSPNEFNDPFDCNED
LLKLRITKESAIKQIKDSKQKLTRNERTRLIKKITNPNTISSQMKETKKDYKLACFSEKS
DETLMWSHYSDKHRGICIGFSFPHQYPGKFILCPIKYLEKIEKLDGESEATKVILYWLTT
KSERWSYEKEIRAITQSKNTNSYGLIEFERKYVSEIIFGCMVPENDINQTMKKINLNYGE
NNIIFNKMRINSDTFLLEKITISA
>FCMOIPGL_01976 hypothetical protein
MKNIPLLILTLILIASCDSKQTSSELEKLTKKLNEKENRISELQSQIENLEKINKRTENT
QTSDYYRFVETTDSEINVAEKLKIGVQKLIDKKDFKDTLDISDNFFVYKHTSEITQTSES
EFESVLRDFDQVKSEYGNDFFVRVMTFYNGQSLPIETENSKTDIHILIQPTELGYENKTF
VISDFYDVDIKMLEKKENSVELTFEHGKFPRKSELIIIKPELVKFGNK
>FCMOIPGL_01977 hypothetical protein
MKTQNEHCRKKTYEKVTLELKLLVVDQIQNGQISTNFASKKYDIPRTTIGYWIKKYSTLV
QQNTGMSKINEIKKLKERIEALEFIKDFQQDIIADMEIITGVDLSKKSLPKTLVKEIELK
KKNRLKESGSMNVLGLVNKPSTKDVKSKKSNK
>FCMOIPGL_01978 hypothetical protein
MILDYRKKVGMRTGGIKLYDELKSDFIKQNIKMGRDKFYDFLRLHNLLVPKLKNYVTTTD
SNHQFRKYKNLIKDQVPNRPEQLWVTDITYIKTENGHNYLAIVTDAYSKQIMGYKLDNNM
KTSLCTEALAMAIKNRKYPNEKLIHHSDRGFQYCNPKYTAFAEENGMIMSMTEQYDPYEN
AIAERINRTLKYEYGLRNCIKNTAIAQEITKQAVDIYNNLRKHFSLDLRNPADVHLNPNI
KYKSYRKNKVNLPELKI
>FCMOIPGL_01979 hypothetical protein
MFEYTKTVLKKVSFNSDLFCKELEKALNMLLPFEVKELTIWIKEYTANKPELYACMYLIK
>FCMOIPGL_01980 hypothetical protein
MSSIKNLKKDINYVLGDVIEYAIDVAALKNQQKEGNVIIDEAIETFDALIANVNTKKVEN
KKAHFKAINADLEAKAKGLVEKINSL
>FCMOIPGL_01981 hypothetical protein
MNSKIKVIAFDADDTLWVNETYFRDAEKEFAQILSGYETENKIDQELFKTEIKNLSIYGY
GIKGFVLSMVECALELSNYQLEQKSFEKILNIGKEMLEKPIELLDGIEEVLQSLQGKYKL
VVATKGDLLDQERKLEKSNLLNYFHHIEVMSDKKEKDYHKLIKHLDIDPSEFLMIGNSLK
SDVLPLVAIGSSAIHVPFHTTWAHEKVSKEKESKTNYVTVLNIKQVLSYL
>FCMOIPGL_01982 8-amino-3,8-dideoxy-manno-octulosonate cytidylyltransferase
MIPARYSASRFPGKLMKDLGGKPVILRTYEAALNANLFDEVYIVTDSDVIFKTINSVGGK
AIMSKKEHECGSDRIAEAVENIDADIVINVQGDEPFIDEVSLSKLIDVFKKDSKKEIDLA
SLKVQITNKEDIENPNNVKVITDVNNLAIYFSRSVIPFHRDLNVDVKYYKHKGVYAFRKQ
ALIDFYHTPITPLEASEKIEAIRYQEIGKKIKMVETDVEAVGIDTPEDLEKAIKYLNK
>FCMOIPGL_01983 Mannose-6-phosphate isomerase ManA
MKINQLIKFKPILKDKIWGGEKLATLLNKKSTRKDIGESWEISDVEGDTSIVTNGKLKGK
NLKELISEYKSDLVGDKIYTHFGEKFPLLIKFIDAKEALSIQLHPNDKLSQERHNSFGKT
EMWYVMQADEKANLIVGFQKEVTSEEYLKHLENKSLLDILNVDEVQKGDVYFIPTGRVHA
IGAGVLLAEIQQTSDITYRIYDWDRPNPDGTFRDLHTEEAIDAIDYSVIDSYKTVYSEKE
NAASEIVSCQYFTTNVLPIKGEISINHQEKDSFVIYMCVEGSVEFQYENQTEKLQTGETI
LVPACIKNIKISSEGKSELLEVYIK
>FCMOIPGL_01984 hypothetical protein
MGFFWDLIQQSKINEQSDKANNLEERVLILEKELQNTKILLRKTLVTLEKHLGKDIDGDG
KLG
>FCMOIPGL_01985 hypothetical protein
MKKKVFLILFVLFFTKLFSLERTLYVDNFNSILGSPSNEDKLLKFASKNNFNTLILYQLN
KVDKLYSLTDPRKNNILAEFISKAKTKFNIKRIGASGESATFFKNRIDIYNTSRNKSEEK
FDIYNLEYEYWSKNASGIDGYYCVNYLEENKLPCTRKGSFKYFIDNLKDLKLLTKNKKHS
VKVDAYVGYYTQNEILEISKNCDRLVIQAHGKSPELSFSFAKKNLENLYKTNSKIKASII
FSTNMDKLGYWLKFDSLDNGESKFFDKMNSINANLKKKLNFDGFSYHSYSILERSVNYYT
YSKN
>FCMOIPGL_01986 6-carboxy-5,6,7,8-tetrahydropterin synthase
MPKVTVHRKAHFNAAHRLYRKDWSDEKNFEVFSKCSNPNFHGHNYELIVSLTGVIDKETG
YVFDLGILSNLIKEYIENNFDHKNLNLEVEEFKNLNPTAENIAVVIYDKLRKHLPNHLEL
EITLYETPRNFVTYSG
>FCMOIPGL_01987 Isopentenyl-diphosphate Delta-isomerase
MEELVILVDKNDNQIGEMPKMEAHEKAVLHRAFSVFIFNIKGELMLQQRAAHKYHSPLLW
TNTCCSHQRSGESNIEAGERRLQEEMGFTASLNEVFSFIYKAPFDNGLTEHELDHVLIGY
FDDEPNINKDEVEAYKWMQLDDVKSDIEKNPIIYTEWFKIIFKESYDKIKNYKI
>FCMOIPGL_01988 Putative bifunctional phosphatase/peptidyl-prolyl cis-trans isomerase
MKIFFKIVFLVFIISFYHCDNNKVGKENSVEIEKRKTALEKKIIKPWDSLNNENTEAFLT
EYGKQNTETKVIIKTEFGNIKLLLYNDVPIHRANFIFLTKIKYFNTTVIYRVAKNFVIQG
GNSDNMYTQKQRRKYGNYLLKPEFRKNRKHKYGALAAARYWENNPNKLSSPFEFYMVHDR
NGAHHLNNEHTVFGEVISGFDTMDKISKVKVGADEWPIKDIKMTIEILE
>FCMOIPGL_01989 Peptide chain release factor 3
MSFLKEIERRRTFGIISHPDAGKTTLTEKLLLFGGAIQEAGAVKNNKIKKGATSDFMEIE
RQRGISVATSVLAFIYKNKKINILDTPGHKDFAEDTFRTLTAVDSVIVVIDVAKGVEPQT
EKLVEVCRMRNIPMLVFINKLDREGKDAFDLLDEVEQKLGLTVTPMSFPIGMGYDFKGIY
NIWEKKLNLFSGDNKTSISEGVEFDDLSNPELDTIVGDKAAETLREEIELISEVYPDFNQ
QEYLEGKLQPVFFGSALNNFGVKELLDAFIEIAPSPQPKKAEERLVDSKEKNLTGFVFKI
HANMDPKHRDRLAFIKIVSGVFRRNSPYLHVRNGKKVKFSSPNAFFAEKKEIVDESYPGD
IVGIHDTGNFKIGDTLTEGEILNFKGIPSFSPEHFRYVNNADPMKSKQLSKGLDQLMDEG
VAQLFTLDMNGRKVVGTVGALQYEVIQYRLEHEYGAKCTYENLQVHKACWVEPKDIKNDE
FKEFKRVKQRYLAKDKQGQLVFLADSEFTIQMTQSKYPSVKLHFTSEYKS
>FCMOIPGL_01990 hypothetical protein
MKNLLFLFVVLLSFQNYSQTFNLTELKGKELHNSIRLNYILVHQPFEQVNYELAPTLGFI
GLNYNIPLNDWLYTGAGFHTAITGDQGGLFTLGVNLGVNTPIYKNLYFDANVHFGGGGGF
RSLVNGGGMIYPNAGLQYKKNGYSFGVQYGYVNFFTGIQKNDNISFFVEIPSLLRLSSYK
DAQKTFILNDNSIDEFWAKPAVKSVQQITFDYFFPIGMSRADITTNPQYKPLTETLSIIG
FEYQRYLTSNTFIYAHVDTMYSGLVSGFMDLFFGIGKNFIETKNVNFFAKMGIGAAGGRI
YPEGGLTMYPSAGFDVHLNDKLGISAHGGYHRAIGGTFEAYTAGVSLKYYGLTGGLKDPF
SKESASKIKTHGVGVGVQNQTYFKMAKDDNTTIDLEMIALKLFYDLNKRFYLVGETSFAY
EGKSGGYAHGIFGLGVRSNPFLSGKISTFIELMGGVAGGAGVDTGEGVLVRPTIGVNYHL
SDSFSFNIAAGQTRTPYGNVNSTNLNIGFTYNLSILNTKK
>FCMOIPGL_01991 putative peptidyl-prolyl cis-trans isomerase
MDNGIYAKFTTPKGEILVKLEHEKAPGTVGNFVALAEGNLENSAKNQGTPYYDGLKFHRV
IPDFMIQGGCPQGTGTGNPGYKFDDEFHPDLKHDAPGKLAMANSGPATNGSQFYITHVPT
PWLDGKHTVFGTVIDSQDVVDAVAQGDDMKVEIIRVGAKAEAFNAVEAFRTFEGSREKRE
AEEKAKQKELLDTVAAGYEETASGLRYQILQKGTGKQATKGANVSVHYKGQLLDGTVFDS
SYKRKEPIDFNVGVGQVIAGWDEGILLLQVGDKARFVIPSNLAYGAAGAGGVIPPNATLI
FDVELMNVK
>FCMOIPGL_01992 Autoinducer 2 sensor kinase/phosphatase LuxQ
MYTISLLIGGFALLSGIASFNLGLHNLGYYHLITVIVYIYCAYLSKKGRIYYSRIIFFIL
LNLGITITASFYGRAASSEYLFLFSLALPFSVFSFKSEKRYVYFFSSLSGILWIALAFTE
FKLFTNTPIDVEIASRYLYPISIVCLFTMVVTQLVYFSILGTKYYSKIHIKRQEALEASM
AKSKFLSTMSHEIRTPLNAVIGLSHILGDNNPREDQINNIEALNYSGKTLLSLLNNVLDF
SKMQFTTIELDNIPTDITVDLKQIIKTHEAACLRKGISLIIKVDDNIPFVYLDIVRFSQV
INNLVSNAIKFTDKGSVTLTIKKIKTTKRNAILQIEVKDTGIGIQKNKQKLIWEAFAQES
NTVNRIYGGTGLGLPIVKSIINVMGSRVKIRSLTGKGSLFYFRLKLKVADKDIIEKKIVK
KVYNFKGQKVLLVDDNLINAMVGKQILEKEKLKVDVANDGLAALNKVKEQDFDIVLMDIQ
MPIMDGYNATKEIRKFNTTLPILALSANVFTEIKDKIDECGMNGFIFKPFTPEDLLSQIE
KFTRN
>FCMOIPGL_01993 Autoinducer 2 sensor kinase/phosphatase LuxQ
MLETNSWPFSKRRIKMIFTTSMVCLTMSVIWFILTNYLEINILSYYLLFAAALFFTTAIL
SKNGYPKIARSLFLMLFNFSIYFISSYLGKEASVEFFLFFAVGMPFIFYSFSREKVYIIL
FCLLPLLLWLLLFFTNFKPFVDVELKNPTRIKNIIYYFSITATLIFTVFQLTYYSYINSF
ANKNAHSTKQQALDASDAKSQFLSTMSHEIRTPLNAVIGLSHILGDNNPRKDQTQNIEAL
NYSGKILLNLLNNVLDFTKIQSKEIELDNIPVDLSSAIKQIKKIHEASCLRKKIIMNLEI
DENIPFVWLDIVRFNQIINNLVSNAIKFTDKGSITLKIKKVNETKDSIDLFTEIIDTGIG
IPEDKQETIWQAFTQASTTTNRLYGGTGLGLPIVKNIVESMGSKIKIDSEINKGSRFYFQ
LNLKRASKEELFKTTYKKAYNFKGKKVLLVEDNMINVMVGQQILEKVNLKVEVARDGLSA
VNMVKNSHFDIILMDIQMPIMDGYTASTEIRKFNKHIPILALSASVFMQVNNKMKDCGIN
GFIFKPFDPEDLLNQIEDAIKIN
>FCMOIPGL_01994 Autoinducer 2 sensor kinase/phosphatase LuxQ
MSDFSPRRTKMILALSLIAIIVSIMCTLLSIKLKINDLIYFHILNTFLFTITAFVAKKGN
LNISRLLYLIILNAGIVTTASYFGQDAGIEFMLMFSMCLPFMVFSFRHEKISIASYSLIS
ILLWTALYITDFNLITTSKIDVKIAANFIYPISIITTIILVAFQLMQYSYSNFNSSYSIH
NSREDALEASKAKSDFLSTMSHEIRTPLNAVIGLSHILGDTKPREDQIENIEALNYSGKI
LLNLLNNVLDFSKMQSTTIQIDAIPTDILNALKQIRKIHEPNCLRKGISMNLKIDNNIPP
VWLDIVRYNQIINNLITNAIKFTDTGSVTLNIHKRYETKNSINILTEIIDTGIGIPKEKL
ASIWDAFTQASSSTNRLYGGTGLGLPIVKSIVEAMGSKVKVDSKFGKGSRFYFILNLKLA
SEKELVKTNQKKERNFQGKKLLLVEDNLINVMVGKQIIEKSGLTIDVVNDGLAAVNKVKE
NKYDVVLMDIQMPIMDGYTATKEIRKFNTTLPILALSASIFMEVKDKINEAGMNGFIYKP
FDPENLLDKIEEAINN
>FCMOIPGL_01995 Autoinducer 2 sensor kinase/phosphatase LuxQ
MSKYSQRRINLVFNIALVNIGFAILVSFFSHKLDLIWLRNYNALNILAYVLVAYLAKKEE
LNIARILYLLTSNFGIAIISSYAGKNGSIEFIYMFSIGLPFIFFSFRRERILVILFSILP
LILWTLLYKTDYNLFTTTKLDPIIAREFVYPIAVASAISLVLFLLIYFVILNSNYFNKIH
KRELEALEASNSKSQFLSTMSHEIRTPLNAVIGLSHILGENKPRKDQIENIEALNYSGKI
LLNLLNNVLDFSKMQSTNIELDNIPVDLSAAVKQIKKIHEASCLKKGITMNLEIDPDIQN
VWLDIVRFNQVINNLVTNAIKFTDKGSVTLRIRKIKQHPDSLDLLTEIIDTGIGIPEEKQ
ETIWEAFTQASSTTNRLYGGTGLGLPIVKSIVNSMGAEVKIDSVIGKGSRFYFQINLKLA
SDQDFQNTTSKKEHDFKQKTVLLVEDNLINIMVAQQILEKENLKVIIAYDGLMAVNMVKE
NDYDVILMDIQMPIMDGYTASKEIRKFNKHTPILALSASVFMEVKDRMEESGMNGFIFKP
FDPEDLLNHIEEAIKL
>FCMOIPGL_01996 hypothetical protein
MKQILNLLSIFSIILFQNCNLNDCGQACFTPPNSFQFEFVDATTNENLFINNTFNKNEIQ
VINLTDNKNIDFTFIDENDYNILSINSISWQTETVEYSLKIADKDILTLYVDADAKRVNE
NCCSFTHFEEIRIENSNYTFDNTNGIYTILID
>FCMOIPGL_01997 3-isopropylmalate dehydrogenase
MKLKIAVLAGDGIGPEVIDQAVKVSDAIAKKFNHEITWRPALTGAAAIDAVGEPYPDETH
EICASSDAVLFGAIGHPRFDNDPSAKVRPEQGLLKMRKKLGLFANVRPTFTFPSLLGKSP
LKRERIEGTDLVFLRELTGGIYFGEKGRRDEGETAFDNCVYTRDEVKRLAVKGFELAMTR
GKKLCCVDKANVLETSRLWRETVQAMEKDYPEVEVSYEFVDAVAMRLVQWPNSYDVLITE
NLFGDILTDEASVISGSMGLMPSASLGSEIGLFEPIHGSYPQATGLNIANPMATVLSAAM
MFENFGLQAEGKAIRDAVNNALDKGIVTEDLADGGKAYGTIEVGNWIAENI
>FCMOIPGL_01998 2-isopropylmalate synthase
MASRKIEIMDTTLRDGEQTSGVSFSVSEKLTIAKLLLEELKVDRLEIASARVSEGELEAV
KKITSWATEQNFLDKIEVLTFVDGGKSIDWMLDAGAKVQNLLTKGSLNHLTHQLKKTPAE
HFADIKATIDLAAKHDIKTNVYLEDWSNGMRNSKEYVFEYLDFLDTQNVERVLLPDTLGI
LTPDETFNFITEVRQKYPNSHIDFHGHNDYDLGVANVMEAVKAGANGLHLTINGMGERAG
NAPMASVIAVINDFLKEVKVSVNETALNKVSKLVETFSGFRIPVNKPVVGANVFTQTAGI
HADGDNKNNLYFNDLMPERFGRKRKYALGKTSGKANIQKNLQDLGISLNDEELKKVTQRI
IELGDKKEVVSQEDLPYIISDVLDSDTIEKRVIVENYVLGHAKGMKPSTTLQLRVEGVLY
EAHAQGDGQFDAFMNALRKLYKRHSKKDLPALIDYAVRIPPGSNSDALCETIITWRREKN
EFITRGLDSDQTVSAIKATEKMLNII
>FCMOIPGL_01999 3-isopropylmalate dehydratase small subunit 1
MAYDKFDVLTSTAYPLPTENVDTDQIIPARFLKATERKDFDINFFRDWRFEQDGTPKADF
PLNKEIYAGSKILVGGRNFGSGSSREHAAWSVYDFGLRCVISSAFADIFKGNCLNVGVLP
VQVSPKFADTLFAAIMADPKTEIEVDLPNQKVTLVATGESESFVINTYKKDNMLNGFDDI
DYLKNIENEISAFAETRPF
>FCMOIPGL_02000 3-isopropylmalate dehydratase large subunit
MAKTLFDKVWDSHVVRSVKDGPDVFFIDRHFIHEVTSPVAFLGLESRGNSVVYPARTFAT
ADHNTPTINQHLPVEDPLSANQLDALEKNAAKHGISHWGLGDLNNGIVHVVGPENGITLP
GATIVCGDSHTSTHGAFGAIAFGIGTSEVEMVLSTQCIMQPKPMKMRINVNGKLGLGVTP
KDVALYIISKQTTSGATGYFVEYAGDVFEDMTMEGRMTVCNLSIEMGARGGMIAPDAKTF
EYIKGRSQTPKGADWDKAMKYWETLSTDEGAEFDVEFNYEASDIEPMITYGTNPGMGMGV
TKSIPLAENVEGGVDTYKKSLGYMSFSEGDAMIGKEIDFVFLGSCTNGRIEDFRAFCSIV
KGRQKADNVTAWLVPGSHKVVDQIQAEGLDKIITDAGFVLREPGCSACLAMNDDKIPAGK
LSVSTSNRNFEGRQGPGSRTLLASPLVAAASAVEGVVTDPRTLLV
>FCMOIPGL_02001 Putative monooxygenase YcnE
MKKTIIAHFNVKEAKTTAFLKITKALVKDSNTEIGCITYRFFKEIDRENNYVIYEKYDNE
SAIEIHNNSKHFQRFIEAVPALLTKEPIIEIF
>FCMOIPGL_02002 Phosphoglycolate phosphatase
MNFTKKNLIIFDLDGTLINSIPDLTLAINKMLLHYHLSPLTIAELTPFVGNGAKPLVQRA
LNYTMKKQEVAETLVDEAFKIYLSAYKEVTCKNTFLYPEVLETLKYLDNKGYKMAICTNK
PLNLIAPVLNGLKIKQFFKIWVGEDSLAEKKPSALPLLHIIKELNTSLEKSIMVGDSKND
ILASQNANIESIGVSYGYNYNENIANYNPTIVVDDFAELQKLF
>FCMOIPGL_02003 Ribonuclease BN
MRPYFILILLWLSLPILAQQNTNHLTATIIGSGSPKFNRERSGPSVLISYKNTQILVDMG
NGTQANLDKNNTKIRRIDGLLFTHHHLDHNEEFTPIFIQSLLGGNKTFIYGPEPTSKMVN
NILDTYKADINYRLSKSGRNLESATKNSIYKDLKGNESFSIGDIKITCTPVNHTIATLAY
RFDVGNESIVISGDLTYSKSLPILAKNADYLIIDSGGAIQMGSKPRTNNNQNNKKNTQKA
HVNLDESSRMAKEANVKNLVLTHFNFTDIDEAATTSEIRKNYNGNIFFAKDLMEIPIDKS
TIIESKTTQKSSYPIVDTNVKNYYSDVENISKPLENDPFYGQDAHYIGNSPSYTDNNDNT
ITDNITGLMWQKDMGEKMTFDEAFTKANSSTLGGYSDWRIPTIKELYSLILFTGEVKGEH
AIKMFIDTAYFNQPLGNVNANEREIDAQTWSATEYVGKTMNADATVFGVNFVDGRIKGYP
KYNPRTKSENKMYFRMVRGNTAYGNNNFVDNNDGTISDLATGLMWQKADDGIGKDWEISL
SYAENLELASHSDWRLPNAKELQSIVDYTRSLQTMNSAAINPVFETTEIKDPNGNKQYPY
FWTSTTHLDGRNPNASAVYIAFGEAQGKMRNKVMDVHGAGAQRSDPKSGVKENYPEYFGP
QGDVRYVYNYVRAVRDIKPTTKIDTKTATIKTTQAKKQNKQKPARNNNTPPKFSELLEKM
DSNNDQKLSKNEVKGRLKENFDKRDKNGDGFITEDEISKRGN
>FCMOIPGL_02004 ATP-dependent 6-phosphofructokinase isozyme 2
MKVVTLTINPALDKSAKVAEMIPFDKLDCLDITYHPGGGGINISRVLHRLAIESHCVFPY
GGKTGEHLIELLQEERVFVYSTPISVWTRENFAVFENKTNLQYRFGMPTESFKEDEMENV
ERLINEQVATDDIFVISGSLPKGLPTDYYSKIIKNLKAKGVKVIVDTSGPVFSEVLKNEL
FLIKPNQKELARLAGKESLSKEEREAFAMKLVTSNVSKYVVVSLGKDGAFMAHKDGIEYV
AAPEISVKSTIGAGDSMVAGLIYAIVKNETPKNMLRWGVACGVSATLSEGSYLAHKVHID
QVLKKI
>FCMOIPGL_02005 hypothetical protein
MTREKVLAEIIEGYRNTISHRYQYQHIKNTYGIPESIDKNTVNQLREYFLTYMYPTYEQR
ETLNAAFDSLDDYIKHPQKLLSLLLEAVKLIFKYGRHLPKILQAGLNAMKTFKAATNFEN
NLVNEAIKNNIKAPYDLAKIDGLIKLLSREEIDKFIESSITLFEILNDKKLIKKIKEVIK
HLIVAMQKNSANYSQSQIKGLEIGLEMIIEGDALFNKLSKEDQLNFVKLITDIERDNLNH
IF
>FCMOIPGL_02006 tRNA (cmo5U34)-methyltransferase
MTDSEKSIKKKKKPWPTKDAMEQIYELKLWGDNKTKFYSGSGSHQPEILNPYLDVVIAFL
ISFKNPITVCDLGCGDFNVGKKLVKHAKKLIAVDIVSELIDYNKEKFKEEKLDFLCLDIA
KDDLPKADCVILRQVLQHLSNKEIKNIVHKLTDFKYVIITEHIPLGDFMPNKDIISGQGI
RIKKQSGVNLLQPPFNLKIKREKELLVTKLKDNKGVIVTALYQNF
>FCMOIPGL_02007 hypothetical protein
MKKILYLLITLLLLTNCTSQKNSEDFIKNASGRYLFNADEVIEIYFKEHILYAKWRGNEN
IKPLKVTDNSFYMKALNEKMIFVEKPEMHIELAPKTEHDGIIYHFRKMKIDEKTPSEYFK
DKDYKKALTAFLEIKKQDSLSPIIKENKINSLGYNYLRKNNIEAALEVFKINVALHPEKS
NVYDSLGEAYLRNKDTLNAAINFKKALSINPENRSAKRFLTKVTK
>FCMOIPGL_02008 Putative metal-dependent hydrolase YfiT
MDLETLKYPIGKATIPTHISKKHIADWLIVLETFPQNLEFLTRELSENQLDTPYRENGWN
IRQVIHHCFDSHLNSYIRFKWTLTEDKPIIKAYFEDRWADLQDSKTAPIFLSIDGLKALH
AKWIYLLKELNNDDLERYFIHPESNEKVTLKENIGMYAWHCNHHFAHIEQLMIRKGWKE
>FCMOIPGL_02009 putative chaperone CsaA
MNEEISFENFLKVDIRIATIIEVNDFKKARKPAYQLKLDFGALGIKKSSAQITDLYTKEE
LLNKKVAAIINFKPRQIANFMSECLILGVYNIDENVVLLQASKSVKNGEKVS
>FCMOIPGL_02010 hypothetical protein
MCMLSDVRFMNYNTSNWKLKGDNLMITWKKENQRISEKWKIIHLSEKELEIKILSYIISE
>FCMOIPGL_02011 hypothetical protein
MSFFRVLFAIIFPPLSVIDKGCGSFFIIFLLTLCGWIPGVIGALVILNNPKN
>FCMOIPGL_02012 hypothetical protein
MKKLLLFFFLFTISLSAQEVDLSYYLPKNTTYNQNIPTPKSVIGHEVGEWHITHDKLVEY
MKVLASSSDRISIENRGTTYENRPLLLLTITSPENHKNLENIRQKHLDATDDAAVDISKN
PIVVYQGFSIHGNEPSGSNAALAVAYYLAAAENIDELLNNTVILFDPSFNPDGLQRFAYW
ANTNKNKNINPDPNDREYAEVWPGGRTNHYQFDMNRDWLPVQLPESKARIASFHKWLPNI
LTDHHEMGSNSSFFFQPGIPSRTNPLTPQMNQDLTKEIATYHAKALDKIGSLYYSEESFD
DFYYGKGSTFPDINGSIGILFEQASSRGHAQETENGILTFPFTIRNQFTAALSTLEAAKN
MRVKVLQYQQDFYKESKNSGEKKAIVFGDEKDAAKSFLLAEVLKRHQIKIHEVASDFTEN
GKKFKKGYSYVVPMNQKNQRLVKAMFDVRTKFKDSLFYDVSAWTFNHAFGVDYVENIPLS
KAGNEITDLKMKVGKVSSKSDYGYLMPWNEYYTPKALNAILQKELRAKVAMKNFKNRGND
YDYGTIFIPVQNQKLNADELHRFLEEVAIESNVKITGVTTGLNDGIDLGSGNFKVITKPK
VAMLVGDGIAGNDSGEIWHLFDQRFDMTLTRLDMSYFRRIDISKYTHIVIPSSNISSSAI
DKLKTWVQNGGVLIGYKNTAKWLASNKMISLNFESSKIDEIKNVSFEDRSLQSGAQYIGG
AIFEATVDRSHPINFGYKNEKLALFRNSTMFITADKKSYNNPIQYTSNPLLSGYISKENS
KLIKNTVPFKAQRLGKGRVIVFTDNTNFRAFWFGTNKLLMNTIFFGDMM
>FCMOIPGL_02013 hypothetical protein
MILIEHSWRVLIFWNNGGAFSKPKVLTKGDLHGVTIADYDFDGLINLIVVQGGGGGSKPR
NPLLYQINKDRTIVRGSQIEGLEKMRGRASKLIDNDSNGILDLLITGFPTPEQLKNGANN
FHSNDGKGNFTFLNKLPKGDRLSYKTLLTDFNNDTISDFIFYGGKNIIAVKGEKGMTFSE
ADKNVLGDAAKTIEASSISEIDFDNDGDFDLFITSAAHAFNNIDFYDKENKRFAFFERFK
PYTIEKLKIDGNFKIENVQMSYPNFDVFIGKNKQKLDIKNMSKDYKNFSLTQKEAKGFPS
ETKKNGLYIGYVGNGYWKVHADTKAAPTAGVIHNVIEAPELISTEKMHAKLLENRNGIFV
DVTTKMGISIPEQTTGATVGDFNNDGFSDLFVVRFGNPASENKQILLMNQKGKSFKNIKN
HNIISKELGAVGSQAQTIDYDADGDQDIIYANERGNWHLYTNNSINNNNFITIKVGNSPN
KDTSPQGAILTIKTCNNIYKRVVGATSSPYSQGLNTALHIGLGKCNKIEEAKILWTNGEE
LAFDINEINTSIFVGKN
>FCMOIPGL_02014 Anaerobic glycerol-3-phosphate dehydrogenase subunit C
MIDNATLETLNNSLSGDVLFDNLHKTLYATDASVYRKIPLAVAFPKDEKDIKTLIAFATK
NNITLIPRTAGTSLAGQCVGDGIVVDVSKHFTEIISFDEKAKTITLQPGVVRDSLNVFLK
PFGLFFGPNTSTSNRCMMGGMVGNNSSGSTSIKYGVTRDKVLEIDAILSDGSTAIFKEVS
SADFIKKTKENTQEGLIYKNLFDELSLTENQQEIKNEFPKETIHRRCTGYAIDELLSSDL
FGGNSKTINVAKLLAGSEGTLAFSTKITLQLDALPPKESIMVCTHFKTINESLKATVIAM
NHNLYNCELMDKTILDCTKNNRELAKNRFFLQGDPGAVLMLEVSANSLEETEILANKLIT
DLEKNNFGYYHPKVYGKDIAKVHYLRKAGLGALANIVGDKKAVACIEDTAVALEDLPNYI
EEFTQIMAKYQQNAVYYAHAGAGELHLRPILNIKKKEDVVLFRKITTETAELVKKYKGSF
SGEHGDGIVRAEFIPLIIGDKNYQLLRRIKKAFDPNNVFNQGKITDAFAMDESLRYEIDR
VEPEIKTIQDFSDNEGILKLAEKCNGTGDCRKPVDAGGTMCPSYRATKDEKDTTRARANT
LREFLTNSDQANKFNHKELKQVFDLCLSCKACASECPSNVDIATMKAEFLYQYQEVNGYS
FRNKLFANNAKYNKLGSAFPSITNFFTNSIIAKKVLGVAVERSVPKLANQTLESWLKKHH
PKTSKKAVYLFNDEFTNFYDAEIGQDAVILLEKLGYEVKTMKHDESGRSHISKGFLKEAK
QICNNNVNTFKDIITDKTPLVGIEPSAILGFRDEYIRLADDKTSAKKIAKNAFTFEEFLA
KELEKGNIDTSLFTSDAKTLKIHGHCHQKALSGTHASFQILNIPENYSVTIINSGCCGMA
GSFGYEKEHYKVSMQVGEDTLFPKIRNTPKDTQIVAAGTSCRHQIFDGTNRIAKHPITIL
KEALI
>FCMOIPGL_02015 L-glyceraldehyde 3-phosphate reductase
MAKYIADSERYNNMNYRRTGNSGLLLPELSLGLWHNFGKNDDFDNARNLLKCAFDNGITH
FDLANNYGPPYGSAEKTFGKILKKDFKKYRDELVISSKAGYDMWEGPYGNFGSKKYLVSS
LDQSLQRMKLDYVDIFYHHRPDYDTPLEETMGALDLIVRQGKALYVGISNYQPKEAEKAF
KILKDLGTPCLIHQPRYSLFDRWVENGLLDLLGNSGVGAICFSPLAQGMLTNKYIKGLPK
DSRAVKDGRYLKTDQVLEMLPKINALNEVAKSRNQNLAQMAISWILKDDRITSVLIGASK
TDQILDSVKAIKNTTFSEEELSRINNLII
>FCMOIPGL_02016 hypothetical protein
MKTHKKLSVLAATAISGNDISSSVLYVSALAIAFAGQYAWITLLIVSAVLFLFRKIYGEV
VGALPLNGGAYNALLNTTSKSIASFAATLTLLSYMATAVISANEAIHYLHHLIPSIPIII
ATIILLFFFAILTIGGVSESAKVAIGIFIFHLSSFLILSIFITYFLISHGLGTFIENWNL
PVTGGSITKAIFLGFAASMLGVSGFESSANFVEEQQKGVFPKTLKNMWVVVSVINPLAAV
FALALFAMPLLQSDSYQNTLLIEMASHVGGNWLAILIGIDAFLVLSGAVLTSFVGVSGLL
ERMALDRVLPQYFLKKNKKGSSYRIIIVFLILTISVLLITNGNVKLLAGVYTISFLSVMA
LFAIGNVLLKVKRNSLPRPEKARWMGILIAFTAVCFALFGNLIMKPKEGVPSNLSVFLEY
FVPSIIFISIMLNRTLLLKFLLKLIHTVFDPIRRFVILTDKKLLAVIHRINSQEFVFFTK
GDNIANLNQVMLYISKNEHTKKLKLVFVTNESNPIPKNLALEIDFLDREYPEIDIEFIIE
EGVFSPELITSLSKRWKIPINFMFIGSPGDRFPYKIEELGGVRLII
>FCMOIPGL_02017 hypothetical protein
MKQFLLFFSVTIFAIFIGSQITEGVLLVPYWQSLSASDFYTFYNNFGSSISQFYTVLTIV
AALIPVIFSVYCLSINYNALKFSLISAFFSLLFVASFYIYFKGTNELFYQATFNEVELKK
ELIIWSYWHWGRVFIESLSLLFLILACVKIQKTNRDYTFK
>FCMOIPGL_02018 Lon protease 2
MTDIQHMSKSKIIKLDSLSFQNMMNEDSELIPLMTAEDEEIINKESVPKTLPILPLRNTV
LFPGVVIPITAGRDKSIQLIKDANKGNKIIGVVAQRNEEEEEPTLKDIHATGVVAQILRV
LKMPDGNTTVIIQGKKRFEIEEIIQDEPYLKATVKEAIDDKEVTDKKEFDAIIDAIKEQA
LEVIKENPMLPSEASFAIKNIHSDAFLVNFIASNMDLTVMQKQVILEKDNLKERALLTLK
NLNKELQKLKLRNDIQSKTREDLDQQQREYYLNQQLKTIQDELGGVSNDEELEEMRKKAK
TKKWSKEVAETFEKEINRLKRMNPQAAEYGVQRSYLELLLELPWGIYSEDKFDLKLATKV
LNRDHFGLEDVKDRIIEHLAVLKLRGDMKSPIICLYGPPGVGKTSLGKSIAEALGRKYVR
MSLGGLRDEAEIRGHRKTYIGAMPGRLIQNLKKAGTSNPVFVLDEIDKLSNSHQGDPSSA
MLEVLDPEQNTSFYDNYLEVGYDLSKVLFIATANNLGQIPWALRDRMEIINVTGYTIEEK
IEIAKRHLLPKQLKEHGLTTKDLKLGKKQLEQIVEGYTRESGVRGLEKKIAKVVRFAAKS
IALEEEYDIHISSEKVEEILGTPRNRDKFENNDVAGVVTGLAWTSVGGDILFIESILSKG
KGTLSITGNLGNVMKESATIALQYIKSNAEEFGIKPAILEKYNVHIHVPEGATPKDGPSA
GITMLTSLVSSYTQRKVKNKLAMTGEITLRGKVLPVGGIKEKILAAKRANIKEIILCKEN
EKDILEIKESYLKGMTFHYVTDMKQVIELALTKQKVANAKKLV
>FCMOIPGL_02019 hypothetical protein
MIKVKNITYKNWQKAIEISNLEIKLIVTPETGRIIFFGFLDGENVFYENEDFEGINFKIG
NYFSINSIKQAPNVGGNRVLPCSEDYFHLITGSRHIPDPYINASSYSVTLLKNGVVLKSP
VSDLLGIQINRTITISEKGTQVHINQELIKKKLAKNIDLEKIPLTIWSLSKIKTPNICYT
PISDNSKFKDGFTISKWPDSKNNAEENVAVKNGVLSLKSSKDLPQKIGLDAKNWVAGYLN
DTLFIEKFNFDDRATYPDNGTSVTIFGNHLFTELECLSPEKQLKIDEKITYNLSWEFHQI
EDKSNLESILNNL
>FCMOIPGL_02020 ECF RNA polymerase sigma factor SigE
MYNTAHRILKDNYEAEDIMQEAFLTVFTKINTYKGEVTFGAWLKRIVINKSLTQLKKNNR
YQEVKMEVIPNNEIEEEVIDYRGLNPKSVLNTLQNLKENYRVVLTLNLIEGYDYEEIAQI
LNYTNENVRTTISRAKKKLKQVLLAENTQRQAYGK
>FCMOIPGL_02021 hypothetical protein
MENKLNDFFSENNFDFQEPHSGHLERFERKLNQPQKKNKTSWKWLSVAASVVLVLGFWLG
SNHKQQQMDLADVSPKMEEVQNYFVSTIHQELKDLEKNRSLETETIIEEALEQLEELEDN
YKTFVKELNTDGNTRKIINAMIRNYQQRLEVLENVLLQIEEIKNPNLKNNEIYI
>FCMOIPGL_02022 hypothetical protein
MKSIYKITLLFLLFPLITSATTDEKKHEKKKIIKKKYTVNADAKVSINNRYGNLNITTWD
KNSVEIEVTITVKGDDLDSVEDKLAAIDVAFDASSNFVSAKTNFEKEQKSWSFWKKSSNI
NYQINYKIRMPKSNSVDLDNDYGSIFLDYLSGKATIDCDYGKISVGELTANYNNIILDYC
NSSTIGYIKSGNINVDYSKITIDKAGDLKINGDYSTLKFGTVEDINFNADYGSLSIDEAT
SINGNSDYVSMSFGTIKKNLIIDTDYGSISVKKLTKNFKNVEIDAQYAGVKIGVESNAVF
DFEVDLQYAGFKIENDKVAFYKKISKSAKKYYEGKFGKGNSNSKLKIRSQYGGVSIREY
>FCMOIPGL_02023 hypothetical protein
MFKKIILTAIIFTVTIAVNAQKNERIRGNGKVITVNRTTSNYDGVAVGGSFDVILVKGKE
GKIIIEGEENIIPYIVTEIEKDLLQIKFKKNTNINTTKRLTVTVYFESIEKISLAGSGNI
TSNETIKNHDFTVALGGSGNITLNVEANEISSNIAGSGNIELTGKSNELTCSIAGSGSLK
SYDLTTDILNTNIAGSGSVKITVDTKIKAKVVGSGSVYYKGNPTDIDIKSVGSGSVIDRN
>FCMOIPGL_02024 hypothetical protein
MKQIIVLLVILYGFNFFGQNIKIEKPAYVIIVNNEIITKDKLEEYGKNGLIKSMDKGATQ
KERDKLAQKFGNKIIASEVKKLLN
>FCMOIPGL_02025 hypothetical protein
MDIQEILTSNIVDLTSLKEYFSSDKDSLIQLIGVYLTDTTPRVDTLEESLTTMDYESVRS
ICHFLKSSFGLMGVKCLAEITELEKQAQANDPEDVIKEKLNFVIPICRASIIEYKLILDR
LEAL
>FCMOIPGL_02026 Ferredoxin--NADP reductase
MIKDLQLRVNLIEERKENILLYKASKQLSIDVSEISAVKVLRKSIDARKKDIIFNYKVAV
YINEQIPEKSDYIFEYKDVSKAKEVHIIGFGPAGMYAALRCIELGFKPIVLERGKNVQDR
RRDLKAINQDHFVNEDSNYCFGEGGAGTYSDGKLYTRSLKRGDVRRIFENLVFHGATEQI
LVDAHPHIGTNKLPKIIENIRENILKFGGEIHFETRVTDFKIKNNKLEAIQLLNGTEMSV
NSVILATGHSARDIYELLHKKEIALKAKSFAMGVRVEHPQTIIDQIQYHCSGERDELLPA
AAYSLVHQVNNRGVYSFCMCPGGFIVPAATANGEVVVNGMSPSRRNNKFANSGIVVELDI
DRDFKKYEKFGPLKGLEFQKDLEKIAFFAGGRTQAAPAQRLVDFVDGKLSSDLNDCSYQP
GLKSAPLHSLLPKIIGSRLRKGFAAFGQKMHGYYTNEANIIGVESRTSSPVNIPRKENLE
HPEIEGLFPCGEGGGYAGGIVSAAMDGERCAEAAIAAF
>FCMOIPGL_02027 hypothetical protein
MKTTIGRIDKADFPELHLQDIDLKVDSGAYTSSIHCSNIEEIEVEGDNFIRFTLLDPEHE
FYNNKEFSTKNYASKMVKSSNGISEKRFLIETKIIIFNKSFPIHLTLSERKDMTFPILLG
RKFLNKKFVIDTAKKNLSYKLKNIE
>FCMOIPGL_02028 Ribosomal protein S6--L-glutamate ligase
MRIVILSRNPKLYSTRRLVEAATKRKHEVLVVDHLKCNIEIEKRSPKIFYKGEYITDIDA
IIPRIGASVTFYGTAVIRQFEMMKVFSAVSSQALVKSRDKLSSLQILARAGVGLPKTVFT
NYTKDVEHVVESVGGAPLILKLLEGTQGLGVVLAETKNAATSVLEAFNGLGARVIAQEFI
KEAGGADIRAFVVDGKVVGAMKRQGKEGEFRSNLHRGGNATVIELTDEEEKTALKATKAL
GLGVAGVDMLQSSKGPLVLEVNSSPGLEGIEIATGKNIAKEIIRYLEIHVE
>FCMOIPGL_02029 N-alpha-acetyl-L-2,4-diaminobutyric acid deacetylase
MSNKPLVLLGKNIPEGKRTVLDIEVAKLHTRTTVKVPVIIERSKVEGPVILLLAGVHGDE
INGVSIIREIINQKLNVPKKGTIICIPVFNIFGYLIQTREFPDGRDLNRMFPGSLNGSLA
SQFAYQFTKEIAPFVDYVIDYHTGGGERDNVSQIRLESSEKETLELANIFNPPFVVHSGY
IAKSLRESLKKMGKTVLLFEGGKSKNLDNTVINQGIRGTKNVLIHLGFIDGEISLTEKTI
FINKSKWLRSSYSGMFKLLAKNGSHVKKKELLGVIQDPFGEFKKRIYAPFDCYIFCINKT
PIVNKGEALFHVSVNN
>FCMOIPGL_02030 hypothetical protein
MKNYLLLFSLFSFLMSFSQSNESFDYETLSDPNPKNELSLYFKKEIPRKLLRKVRYLKDK
NNILLSFNINKEDKPYNIKVSSYGSVDLDNEVKKAFKKYPLEKLNIENLDRKNSYLFQII
SKKGSKNIFNCSSIIIIKTPPVCKACEDLDYFEDIENCLEIEFKKHFYNTFNFSIVTENE
TNIFFECTLNKNGSLSLKKTKKTIKYSDEIKRTIASFPLIETPGMLNNKLSKTSYRISIP
YKKGEENIYKEPNLYPDSFSKPSTDNEFSKYLVQKLPEGITEKVNLNRLNNKLNLFFELD
NKDKPFNIRTSARSNYIESAIIAAFKEYPIQKLNFTDKSPINSYILQIFSFDGSQSIINT
NTVINYQKIPIFPGCENSESFQAAKKCFSKGVQMHFAKKFNADLPKQLGLSKGRKRVFIA
FKIDKNGDVIDIKVRAPHIKIEEEVKRVMLQMPQIKPGFQSGKAVNIKYSIPFTLIVD
>FCMOIPGL_02031 tRNA (guanine-N(1)-)-methyltransferase
MRIDIISVAPNLLESPFNHSIIKRAQDKGLAEIVIHDLRQYGLGNYKQIDDTQFGGGAGM
VMMIEPIASCIKKLQSERNYDEVIYMTPDAKTLNQSTANTLSLKENILILTGHYKGVDQR
IRDKYITKEISIGDYVLTGGELAAAVLVDAVVRLIPGVIGDEQSALTDSFQDNLLSPPVY
TRPAEFEGMKVPAVLLSGNFPKIDDWRSDQAYKRTQQIRPDLLEDE
>FCMOIPGL_02032 hypothetical protein
MKMNKFLSYIKNNKAISWVLGFQIFRLILLPFMGLMPQDAYYYLYGQNLSLSYFDHPGMI
GYILRIFTDVFGQSIFTIKFADFVITSLTILSFHKLASYFLSKKKLQRAFVLLASTIFIS
ILSFNSTPDVPLLLFWTLSLICLYKAIFEGKKLFWILGGIAMGLAFDSKYTALLLQIGLI
AFLFFSNKYRKLLISPWLWFSLLISAAVTFPVWYWNYQNEFASFAFQSSDRTSSISEFKF
STSYFFGAIGHQMFLLLPVLFLIFITFTYKYIKRALLKFKIPQAKTLFLLAFFIPTFVGF
FSLTPIYWVKLNWMMPSYITGIILAGMFINKKLLKIQVIFSIVFHVLFSLQIIFYLVPIK
SDDTWVGWKELAIETTKLQEKYPNTFVFSEDNYKTSACLNFFMDDKVYAQNIIGLPALHF
DFLGDDLSTLKNKNAIFIDSDKRFKDHKLKGEINPLLSEYFENVTELAPIIIKINNKESR
KFWVFYCTNYQHKK
>FCMOIPGL_02033 50S ribosomal protein L19
MLFYENYKHKEMEALIKFVQDEFVTKKEFAEFAAGDTITVFYEIKEGEKVRTQFFRGVVI
QKKGTGLSETFTIRKMSGTVGVERIFPVNLPSIQKIEVNKRGKVRRARIFYFRGLTGKKA
RITEKRR
>FCMOIPGL_02034 Isocitrate dehydrogenase [NADP]
MSKIAKIIYTKTDEAPALATRSFLPIVKAFTKSSNIEIEVKDISLASRILANFSNYLTDD
QKVEDALAVLGELTNQPDANIIKLPNISASVPQLKDAIEELQALGYAIPNYPEEVITDED
KAVSALYNKVKGSAVNPVLREGNSDRRAPKAVKNFARKNPHSMGKWSKDSKTHVATMTEG
DFAHNEKSVTLKKGTTIKIVHTSTTNKVTVLKDKLALLDGEIIDATIMSKKALLEFLEEQ
IEDALDKNVLFSLHMKATMMKVSDPIIFGHVVRVYFKDLFEKYGKTFKKIGVDVNNGFGN
LLGKLNELPKNTRDEIRQDIRFALDHSAELAMVNSDRGVTNLHVPSDVIVDASMPAMIRT
SGQMYNAEGKLQDTKAVIPDSAYAGIYSATIDFCKKHGAFDPTTMGTVPNVGLMAQKAEE
YGSHDKTFEIPSDGKVQVIDAAGKVLMEHTVEAGDIWRMCQTKDLPIQDWIKLAVTRARA
SNTPAVFWLDKNRAHDAEIIKKVNKYLPNHDTTGLDIRILSPIKATEFTLERIIKGEDTI
SVSGNVLRDYLTDLFPILEVGTSAKMLSIVPLMSGGGLFETGAGGSAPKHVQQFLEENHL
RWDSLGEFFALAVSLEHLGTTTNNSKALVLAETLDDATDKFLENDKSPSRKVGEIDNRGS
HFYLALYWAEALANQDKNAELKAEFTSIAETLTKNELKIISELNSIQGNSVDIGGYYLPN
EDLTDAAMRPNSTLNSILK
>FCMOIPGL_02035 hypothetical protein
MNKKKFAIISIIIIVGTYLIYNYFSSSSDADAYLTAKVTKGTFVNEVYISGEAQSTSSKQ
INGPSNAQRFGLYNIKIQDLVPEGTVVKKGDYIGKLDMSELNGKILDAQLNLEKAESKYT
QQQLDTTLTLKQERNSIKDLLFDIEENKLEFKQSQFEAPGVIRQLEIKIEKYERDLKEKK
EDYSIKKNQANAKMIEVGTEVSKIRKKISDLMDLQKKFTIFSEDDGMVTYVKEWNGTKKK
VGSTISPWEPAIASLPDLNKMESKTYSNEVDIRKIKKGLITKIGFDAFPDIEIEGVVTEV
ANVGETRAGSDIKLFQVLIKLNETNENIRPGMTTANKILTKKIEDVLMIPLEAIFAKDSI
SYTYVKTGLSIEKKQVELGLSNNEVIIINKGLNVDDIVYLNKPEDLENKSITPLQK
>FCMOIPGL_02036 Macrolide export ATP-binding/permease protein MacB
MIISKILLEKLISNFTEAFWFIKTNKVRTFLTALGIIFGVASVITMLAIGNGAEKEILSQ
LELVGVNNIVVTPIPDEKKENENDNEDESSKTENKRFSKGLDILDAESIQKNIPSVKIVS
PEIILNTYVINNGRQLPVKLVGITPNFLESTNIELEKGKSFSKYQIKNALPVCIVGKKVE
KKLFTGESALGKHIKVKDVWLQIIGVIEEKLISDKAQENLGIRDLNEDIYIPTNTFLVRY
KDRKIIVDDVNVRNTNQNGPKKKNLRGNYHQIDKLTIQVTNSNELKATAEVLSKMLKRRH
NDVLDFEITIPIQLLKQQQKTKQIFNIVLSIIAGISLLIGGIGIMNIMLASVLERTKEIG
IIRALGATEEDVVLQFLSESVLISVGGGIVGIILGIIGAYVIEAFSGIETVLSLTSIFAS
FFIAVMVGLTFGIFPAKAAAKKRPIEALRSE
>FCMOIPGL_02037 hypothetical protein
MKKLLIPFCLFLSFTIFSQRQITLEEAITIAQKNSPDYKTLLNQNEASYWRFVNYKASFL
PQLRLDATLPQYSNAVNRMTNDNGQDIFVRSNQSRIDGSLSLNQNIPLTGGTISFSTQVE
RVSVFGDNASTGYAVVPFSINYRQNSLFYNQYKWNKKIEPLIYEEAKRDFIENMEQISYN
TSLKYFALLKAQVQTLIAKSNLSNQDTLFQISKGRFKMGKIAENDLLQIELSVLNSKNDV
TTNEINFKRTSQNLSRYLSLDTESILLNIPEELSTFTVTVEKALEEAKENRKAVIEFRRK
RLEAEQDVAEVKGSNRLQLSLNANFGISQQGAVFNDLFQDYNQQQNVSLSLGIPILDWGV
SKSKRKLVEANKDLVNTNIEQDEQEFEQEIYLHVLNWQNQRNFLETAKKAQEIAVRRYEI
TKKRFVLGKITITDLNIALQEKDSSVLQYLNSLEKFWIDYFTLRRLTLYDFIKNKKIEVE
DIVYN
>FCMOIPGL_02038 hypothetical protein
MIQLKKIFFILFLFSLSTFSQEKTTISGSVYDANNNETLFGVSIYFPELNSGTTTNEYGF
YSITIPKGTYKIQVSYLGFRSISETINLSEKITKNFKLSEETESLNEIIIEGNIEKLNVK
TPQMSVNKLTAATIKKIPVVLGEADIIKSLLLLPGVTSAGEGASGFNVRGGAADQNLILL
DEAIVFNSSHLLGFFSVFNPDVIKDVKLYKGGIPSRFGGRLSSVLDIYQKEGNSKNFNLT
GGIGLVSSRLLAEGPIVKEKSSFVIGGRASYAHLFLPLFDNDNTAYFYDLNTKINYRFND
NNNVFLSTYFGKDIFGISDNFVNKYGNNVVNLRWNHLFSDKIFSNLSAIYSDYFYGLILD
FVGFEWDSGITNFNLKYDFKHYLNENLKLSYGINNIYIKFNPGEIVPNREDSGIQSEKLI
DKYANEFAAYLEAEHSINNKLTLQYGARFSNFTRLGQDELNVYANDNPVIYNSQFKKYES
AEATSTESYKRSDVLATFNNFEPRLSMSYLLNDETSFKLSYNRMAQYLHLLSNTASPTPL
DVWAPSGKYIKPQLLDQFAAGYFKSIKNGDYSLETEVFYKDIQNRIDYINGANLVANNEI
ETVILNGQARAYGLEVLFKKNEGNFKGWLSYTLSKSEQKTPGRTASEPGINQGEWYNTAY
DKTHDISLNASYELSKKWMFNANFLFQTGQPTNYPVGQYEFQGLNVPIYDDNRRNADRLP
AYHRLDISATLTPESNKNRKWQGEWVFGIYNLYGRQNAASISFSQNRETYRNEAIQTSIF
GLVPSVTYNFKF
>FCMOIPGL_02039 hypothetical protein
MKKLYILPILFILFFTSCEKVIDVDVPSIEPKLIIDASFEVYFNRSPVTAKTIVKLSSSA
DYFDETIPAVTSATVFLTDVSTNTIINFSNTNSDGNYEPINSFIPADDTSYELTVIYNNE
TYKGFATKVKSTPFTDVYQGDETLFSGEETELKVSFFDEPIVENYYLFDFSENLFLSIDD
RFFDGNDYNFSFFYQEDEIELPNRVTVKMSGITKDFYTFFEILNSQSGQNSGGPFQSVPS
SLLGNMINTTNEDNFPLGYFHISETDTFTLDLVEKN
>FCMOIPGL_02040 hypothetical protein
MHKYFIIIFIFFISCKKQNKETISEKTSSKTIKTTEYELVKSDKQNGLLILFPCFPCDLE
NTKSEFNIAEISSKNGISVLYMNFNLHLYLTETEKQDLANLLTETIRKEKISEKNIFIGG
FSGGGNVSLLITDYLMKSENQIKPKGVFIVDAPIDLLALYRVSAKNLKQNVSKPAIQEST
WVIHQFDSIFGNPSDGIKPYEKNAPYTFESENIENLTGLKNLKIRFYTEPDLVWWKKRAN
NKYEDLNAFYIKKLSEKLKSEFGESNIELIETQNKGYRANGERHPHSWSIIDKEDFITWI
LE
>FCMOIPGL_02041 N-acetylmuramic acid 6-phosphate etherase
MKFIKTTEQDSKYNHLEMMSVSSILRNINSEDKTVPLAVEKSLPQITKLTEQIVNKLKIG
GRLFYIGAGTSGRLGVLDASECPPTFGVPHELVVGLIAGGDYAIRKAVEFAEDSTNQGWL
DLQEHSISNKDVVVGIAASGTTPYVIAALEKCNEHNIITGCISCNANSPLSNTAKFPIDV
VVGSEFVTGSSRMKAGTAQKMVLNMLSTATMIQLGKIKGNKMVDMQLSNNKLVDRGEKML
VKELNIDQKEASELLQKFGSVRNAIQNYKK
>FCMOIPGL_02042 hypothetical protein
MSTDLNLLSKGLIRLGILIFLFIITPIIITFGFKALDKFTEAPKLYVAYAIIFIGVALLF
FTMYFAFKTFGIIKNAIFDNN
>FCMOIPGL_02043 hypothetical protein
MEKSELENAIIVILSYPDTVVRPAYWESSSKFWPKIGIGSEHAVQAGHAALLLIKKNESE
IKYFDFGRYITSYGNGRVRSVATDPELHIPLKATFKNNKISNLDNILLWLEKHPEKTHGE
GRLIASINDEINYDNALQFIHNLITEKEYPYGAFMKKASNCARFVTDTLIYSCTNKRITL
KLKSSYLLTPSPIGNTLKGKTVKEVYNVKNQKIEIYKNRSILKEYNAAFFKKFDNQLNLI
GTELPDIETFNLPKGTWLSGIGSGAWFHIDEKLEDKKYKISRHAKCGKKDFEGCFTVDNS
FFDITKNYTFLHPSNCREMYIKQGDKKFIFKQLRTNF
>FCMOIPGL_02044 hypothetical protein
MTEAIEKSLKRGVKLLNNISDDEYSNIILELLKIVNLSCFLFLSVFIELINIYHL
>FCMOIPGL_02045 hypothetical protein
MKKGILILVGMFIMTTTVKAKTNYELPNKIEANYTYNNAVNFIEHGIEFFIFTNGDFDFN
ALENDTYYDYNGSRIKNNSRLRIDRDYRGRITRIENIFINYDYRGNVSRVGSIFMRYYRD
RLTKVGDLNIRYDRFGNPAFYGNVRDYYYNNGIRFSINFGDIFDYNNAYFYRSDFSRNYN
RFREDANFYYYKANPNAKIGKRSTIIKRRKPASTIGRNRDIKRNSNNSYRKPTNDKRTVV
VKDTRRNTTPTIDRNIDKRNSNNSYRKPTNDKRTVIIKDTRRNTTSTIDRNTDKRNSNNS
YRKPTNDKRTEVIKDTRRSTTQKLDKKTDNNSRKTETTRKRRN
>FCMOIPGL_02046 Lipoprotein-releasing system transmembrane protein LolE
MNYELFIAKRIIAGKKYKNSISSPIIKIAITAIALGIIIMLIAVATGAGLQYKIRDKMAG
FKGHIQIVNYDANNSDVSITPIKKEQEFYPKFKNIDGIKNIQVFANKVGILRTETDFEGI
IFKGVSTDYDWSFFKEYLVAGKVPNFNQDRTREVLLSETVVNRLQLKLNDTILSTFVKTA
NSKLPSNKKYIISGIYNTGFLQFDKNMMIGDIREVQKLNKWTENEVGGFEVLIDDFNEVD
KKREEIYLELPATLTSKSIVNAYPNVFEWIELFDNNVWFIIAIMILIAGINMITALLVLI
LERVQMIGILKALGSNNTSIRKIFLYNASYLILKGLFWGNVIGLSIISIQYYFGIITLNP
ETYYVTTMPVYISFSAVLLLNIGTLLLCFLMLIIPSYIITKILPSKSIKFA
>FCMOIPGL_02047 hypothetical protein
MINFKPFKSTYLCWFLAMNFTLISCAQKPNTTIEKNIVSASILKTGGERTNLYLNLLKGK
NVAIVGNQTSIIQTTSKNKVQRHLVDSLLSLDIKVKKVFAPEHGFRGKADAGEIVKNGID
TKTGLPIISLYGKNKKPSAEQLKNIDVVVFDIQDVGARFYTYISSLHYVMEACAELKIPV
IILDRPNPNGHYIDGPVLELAHKSFVGMHKVPVVYGMTIGEYGKMINGEKWLENEIKCDL
TVIPLENYTHKTEYSLPVKPSPNLPNDKSINLYPSLCFFEGTTVSAGRGTEMQFQIAGSP
YLKLKRFYFEFKPKPNNGAKYPKHKGEICYGYDLRNEEKLTKIELKWLIDFYKGHKNYAK
EKDFFNTFFTKLAGTEKLQKQIEQGVSEKEIRKTWTKDLNEFKLIRNKYLIYK
>FCMOIPGL_02048 hypothetical protein
MEKRLQELPKLAEQAKKESKKYFTNLKKRTPKNLDYIMQELHDKEFEKTDCLACGNCCKT
SSPIFIDKDIERISKHLKMKVVDFVSQYLQRDEDDFMVLKSAPCTFFDETDNTCFIYDVR
PKACAEYPHTNRVKFIQITDLTIANTAICPATYNIVEALKKRIPLESNEKRKRK
>FCMOIPGL_02049 Arginine--tRNA ligase
MNIQNTIETKVKEGFLALYNIEIPSVEFQATRKEFEGDITVVVFPMLRFKKGNPVQIGED
LGKYLVENVTEITNYNVVKGFLNLVIDDAFYTNFFNTIYLDASFGLVLPKADEKAIMVEY
SSPNTNKPLHLGHVRNNLLGYSVAEIIKAAGKKVYKTQIINDRGIHICKSMLAWQKFGNE
ETPESSGLKGDKLVGNYYVKFDQEYKKEISQLIAEGKTEEEAKKEAPLLIEAQQMLLKWE
AGDAEIVALWKEMNSWVYKGFEATYKNMGVDFDTLYYESNTYLLGKDVVNQGLEKGVFYK
KEDGSVWCDLTDDGLDEKIVLRSDGTAVYMTQDIGTAIQRVKDFPDVGGMVYTVGNEQDY
HFQVLFLILKKLGFDWAKQLHHLSYGMVDLPSGKMKSREGTVVDADDLMIEMTDTAKEIS
EELGKLEGYSEEEKGDLYKTIGLGALKYFILKVDPKKRILFDPKSSVDFQGNTGPFIQYT
YARIQSIIRKADFDFSKSVSIDLHEKEKELLKQLELFPETIQLAAANYSPAIIANYTYDL
VKEFNSFYQNVSILGEEIQDKKIFRVQLANKVAETIKSAFSLLGIKVPERM
>FCMOIPGL_02050 Dihydrolipoyl dehydrogenase
MKYDIIIIGSGPGGYVTGIRASQLGFKVAIIEKESLGGICLNWGCIPTKALLKSAQVYDY
LKHVDDYGLKAEAIDKDFEAVIKRSRGVAEGMSKGVAFLMKKNKIDIINGFGKIKTGKKV
DVTAEDGTVTEYSADNIIIATGARSRELPNLPQDGKKVIGYRQAMSLPNQPKSMIIVGSG
AIGVEFAHFYNSMGTDVTIVEFMPNVVPVEDIDVSKQFERSIKKSGIKVMTNSSVESVDT
SGEGVVATVKTKKGEETLTADILLSAVGIKSNIENIGLEDVGIIVDRDKILVNDYYQTNI
PGYYAIGDVVPGQALAHVASAEGITCVEKLAGLHTEPIDYGNVPGCTYATPEIASVGLTE
AKALEAGYELKVGKFPFSASGKAKAAGTPDGFVKVIFDAKYGEWLGCHMIGAGVTDMIAE
AVLGRKLETTGHEVLKTIHPHPTMSEAVMEAVADAYDEVIHL
>FCMOIPGL_02051 hypothetical protein
MSFVEWFLSFVYKIKTFPLIIQITVVLTVFFIIATLALVITIYTIRRRYNKLQKKLKDSV
PDIIALFEQILFTDKKFSEQEVFDSFEDIVGNVNRESLDIGVDVLVQFKNDDKESEKYPL
IISALGIVRHLEEKFDSRSNSEKMDAFQEAFVLDLNRFDSKILQYAYSKNKRIRSEARNS
YLALSSNDPYRFFDDFEGNLTKWDEIELMQYLKQQNIRGNLEGLGKWINYSKNDSLVIFL
IKMVGFFKQKGIDEILLEKLEDDNANIRAESILSLGELDIKETEDTLIERYYTEPEVCQV
AIVKTIKKLNTGKSLSFLQEIFGETNNIDTKKIIAEAILNYSYEGQIAFQTLKNSLKGFD
LLILKHIETPLIKYK
>FCMOIPGL_02052 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MFDIFVKVYEYFIFFYATALILSYLILSVFSFIAINKYKSYNTDIDDEELLNSNLAPGIS
VIAPAYNEEKTIIINVKSLLTLNYPLFEVIIVNDGSKDKTLDLLIEEFELVEAPFAYVEK
IKSKPYKRTFKSENPKYEILTVIDKENGGTKADAFNAGLNASVFPYYLNTDVDCILARNT
LTKMIKPILNSKVRVIAVGATLRMSNNCEIDEGVITRVRPPKALIPRFQELEYIRSYLLG
KMGWEFINSVPNVSGGLGMFDKEIAVKAGGYGADSHAEDMDMLTRMAAHMMNNRMDYKIG
YIPLSCCWTEGPPNIQILGRQRTRWASGLFQMFSDHRKILFNPSYKRLGLITFPYIFIFE
FLAPIIEAFGILFSIFLVLYGYVNWSFAPLILLYSYTFAIMISSIVIIWDQMTFKYYNTT
REVVTLFITAIIEPILYHPMILFFSLKGYFSYITSRELAWGTMTRQGFDNEDKKKDNNDK
PNTNEKKQSLFDRLKKKKNSADSDIIKT
>FCMOIPGL_02053 Beta-barrel assembly-enhancing protease
MKVNKFIYIFIVIVLSQIKVYAQVYESSDLYFQEAKKDIAEQNFTKAAKMSWRGLQISPT
DQDLKTILGAANLQLGRYDTARYVLRQVYDKNRKNTTVLKYLVNIEQTTRRYSDAICFVN
ELLEITPYSKTWWLRKIAIYKEMGNFEEAERALKRIYQIYPEDTEIKESYNYIMIGDGNK
ALEEKKYDDANEIYKIVIDNNPESKQAYLGIIRNELLKGNPESALQFTDRALLVMEHDRQ
LIEKKIGLLEQLGRHAQAIAFINDSKQVPKDKFPDIHSITLPYLMQQTAGFNEFNDPYET
HKKLVELNGNSESQDYVIKNALGKGYDVDAEYFLTKAIKKSPNSKKLLIQEMELYKPIKT
DENYEKKVLALHEKFPNDDDITSAYNNIMYNRAKEYVGDKQYDIALPMFVELVSFPDFQE
VAEQQIFGILLSLERYDEATDQIDKLIGLDPENPDYLLRKSTLYQKMELYDDALDITRSL
EQKYPLNLRYPAVYVQQVEEYASFLLKEQRNSQALEVIDDGLTRENNNKRLLDMAINASS
AIPDFERGINYSKSALSFYPQNKNFKLKLSGLLAQNKEYDEAIVVLDSLKTIYKYDRTIK
NSLAEVLWFRAKNQEEEGLIDEALENYNMSDSLNPAENYSLQRMINLYIVQKPNDEALEI
INEKIEKYPNDTFLKYKKGLVFELMKQYDSAYYYQKFRVVDDPFERSEWNSSLSILKAAE
LKNKLAASFTKATSDSLPFSTSLASLAYSHKYDNKNTFGADLNYAARRSGVGVQGGLNYS
RIINPTLYADVGILLGSKFFPKFILYGNAYKELKNGYEAQAGLRYSYLQNNSSFITLNLG
ASKNWEDIWLNAKLQLMSSSGYSTSVTNAITGFTDVENYPANMYFNFATQTKININPKQD
YISFIVSFGSAPFNDQLPEGETALLDFSNVLVGAGYGHNISAKTLLLLNGSWINFKSPIT
DSTALAYINQYNLSVSIITKF
>FCMOIPGL_02054 hypothetical protein
MFNKSIYIIMIFLSITSCAQKKNAPLYSKEHKIYPKINIPLAADKFVEQAANEFRNNFKK
ITGHSIDIERSNSLNSNYNYIVLRVNPTQKENYCFYKKDNNITIQAFDTQNLVFGINAFF
QKYTPLKFKDKTKEVIENTITNEIEIPNKFSHCSYPDFEYREPYFSTNFDPNFRGWNKTN
YLELEWGLWGHNISKILKKHNLPETVYAQFGNRRVKNQYCFTSDSLFKYVNEHVKNTYES
DHALNKYMILPNDNNIVCTCNTCKAVGNTTKDAAPAIFTFLNKLAENYKNLSFFTTAYVT
VKEIPKFKAEPNVGLFYSTINIQKGVPIEFSKYYKKFENDIKKWRSYVNNVYIWDYTVNF
DNYFDIYPSIRVTQLNLQLYKKLGVNGVFLHGSEYDYSAFQDLKATLFAKLLWNTNINID
NEIDTFFHEKYPKKLAGALANYYSFVNNSFFINKKELGIYSGIHQSIEKYLDPKLFFSFY
EEFDANTEKNKYDKEFLKIATALTFLKLEIMRDYGLGTYGFATLNKQDQIIVKNEAALLL
DRLTAFSKSSKLKTYNELKFTLDDYIKSWRQNIFRYHKRKHYFYKKPFKVLSKLDEDYRD
ISKLNDAAFGLKDYNTNWLICSIDDLILKIDKEQIKESKKITFSFLQDTKHAIFYPSVIE
ILDTNYKVVKKLKLTVDNTDLATKEISIDLPTKFDDEQLPNTFIVKITKSITKGKKALAC
DEIIFN
>FCMOIPGL_02055 hypothetical protein
MKNIYFILLIALITVSCDLRKPDIDKVEKTKMEIEDPERHYYPILRGSEISTTYKIYNRG
NAPLIIYDVQASCGCIALDFPSNSIGKDDFGFITLDYDSAKNIGYVEFYIMIRANTEKET
FTTIKFDLNVVTSAHYTQDYEEIYLQRRKEKLGGEVDGDLTQQGYYVDDVKTIR
>FCMOIPGL_02056 hypothetical protein
MKAKYQSVLDLGQELNIQNGDVKEENGKLIVKGTAATQYEKNLIWDKIKEIGGDNPTDIM
ADIKVADTTIFANHTVKSGETLGKIAKQYYGSAGKYTVIFNANTNILKNPDVIHPGQELV
IPNL
>FCMOIPGL_02057 hypothetical protein
MNSKKYYEKKNENFINYWNDKRKNKHKYSFFQACIFIIPFSIFLGILNYGLKNLISLKFI
LLFSISFFIYYLFTYFIDFRIHEKRYQKLKKEKQHFDH
>FCMOIPGL_02058 hypothetical protein
MITNKKQFYKEILKSLAKLIIAGIFIGVLKEYDAIIAFILLLKIFHNIYTEIIKPKTNKN
WLLLIGMLLTGFGGIVGETWGVSNGYWEYNKVTRELPLWLPFAWMLAFHYLYKLERNLIP
LLSNQSQKNKIVLAIILALILPAFGEVITIYLGVWTYYWPYQLLGVPLYAFICLLFVHML
VYSILHYVCKKYKINDIVFN
>FCMOIPGL_02059 Ribosomal RNA large subunit methyltransferase F
MKEKSLHPQNKFNKGYNFDDLIIKNPQLKEFVLENKFGAISINFSDPKAVKELNKALLFT
FDKIKVWHFSDENLCPPIPGRLDYILHLSDLLSLEKEIKILDIGTGATCIYPLLGVAQFN
WNFVATDIDLDSLDAAQDIIDDNNLESKIELRQQLNEQQILKGVLKDDDLFSAVMCNPPF
YKSAEEAQGANRRKTKNLGNNAVRNFSGNNNELWFPGGEKAFLHNYLYESSLFSKQSIWF
TSLVSKKENVESLQTSSKKLGAKEFKVIDMNQGNKVTRVVCWRF
>FCMOIPGL_02060 hypothetical protein
MNFRPLTLIIIILTFSFCSNKTDSLEININNLEEKIDQAFLDSELHDNTQPLIPVLFFID
NHKVNFTDPCILSKINHLRALKKYTLSKSEDFLGNLKKGVDEAEFCNDYAVKTALNNLLG
IFYHGKNKNSLSVEYYNKAVYFGELNKDKTFVVDTYFSLCRLYTEENDWKRVLINAEKGI
IAIGKSKSKLPRLKYFHIFLAEANINLSKFKLAEANLLIASKLTNKLADTLTTIKEEEDF
LKSSRQISLTNAKLNRKQKNFDLAYKYLKASDSLLILNNLSQNELNRAFLSTESELEDKL
LKSNKAVIFNQKLILVGSILFLLICFYLIFKSNQFSNKLKFALKEKDKLNEKLHNNYDKL
EEVHSGLIAKNAEINTLLKYNEQTLFTKTLKISNYKDAVNNVVKNIDKLIENKETIESVK
MHSVNRSLQQVISEEEIWEDFKIEFEKNRPDFFEKLITKCESLSITEQKHCAYVAVNLKS
KEVASILNLSPRSVETTRYRIKKKLELEESLQGFLNGL
>FCMOIPGL_02061 Putative cysteine ligase BshC
MKVTQIPFQKTGFFSKTMHDYLEKNENIKPFYNNFPDISGFHNQIEEKQKSYRLQSRLTL
VNALKTQYKSFVTSEKTSENIELLKQQNTFTITTGHQLNLFTGPLYFLYKIISTINLSEE
LSEKFPEQNFIPIYWMATEDHDFDEINYFNFNGKKVQWNREDGGAVGRFSTEGLQDVFDV
FSNHLGNSKNAQFLKDLFSEAYLKHTNLADATRFIANELFKEHGLVIIDGDDAGLKQLFN
PYIKEELEKQISFLEVSKTIVELEKNYKIQVNPREINLFYLGNDFRERIIFEDNIYKVNN
TSITFTKAEILEEVDKNPKAFSPNVIMRPLYQEVILPNLCYIGGGGEMAYWFELKAYFEK
VNIPFPVLLLRNSVQIVSEKQATKLEKLNISFEELFLNQNELLSKKVIENSEIKTDFKEK
IQFLQNQFSDLKEVAKKTDVSFINAVNAQERKQIKGLENLEKRLLIAEKRRQKDLVTRIT
ILQNELLPNQSLEERQRNFSEYYLEYGTFFTSVLKSSLKPLLLDFTIITL
>FCMOIPGL_02062 hypothetical protein
MKFKSLLLLSLLTFSNLFSQEIKSPSEFLGYEIGARFTRHHKVVDYFLYVSNKLSNVKLE
KYGETNEQRPLYLATISSEENSSNLEKIRKSNLSQAGILDENQENKTAIVWLSYNVHGNE
ASSTEAAMLTLYELVTSKKTWLKNTVVIIDPCVNPDGRDRYVNWYNQVKSTPFNIAQDAK
EHHEPWPGGRPNHYLFDLNRDWVWATQVETQQRISVYNKWMPHVHVDFHEQGINSPYYFA
PAAEPFHEIISDWQRNFQTQIGKNHAKYFDKEGWLYFTKESFDLLYPSYGDTYPTFMGAI
GMTYEQAGHSRAGLGIKTDEGEVLTLKDRASHHLTTGLSTVEIAAKNAEKLNSEFKKFFD
NRNFEYKSYVLKNDNQDKTNRLKRLLDIHEIKYEYATNGTVKGYNYNTQKEEKATINDGD
LVIHTNQPKGKMVKVLFEPKAKLVDSLTYDITAWSIPYAHGFDAIASKNKVSSTTNTTIK
NNINTIDKNAYAYISKWNSIEDAAFLSALLQQNIIPRFAGKPFSLEGKNYDRGSLIILRN
DNRTADFDKKLIKIANNHQRKVQAVATGFVDAGLDFGSYTVKPINKQKVALLSGKGTSSL
NFGEVWHFFETELKYPITNLNSDYFGGINLSKYDVLIIPEGYYGSFLSKNNLEKLSSFIS
SGGTLITMGNAVNAFADKKGFAVKSKEVKKDTNKFNLTPYADLERKGVKNRITGAIFKSK
VDVTHPLAFGYKSDYFSLKLSSNSYKYLIDGFNVAYFDKDAKNVSGYAGSQAVKNIPESL
LFGEQQKGRGSIVYLVDNILLRSFWNNGKLFLANAVFLLNSDSLK
>FCMOIPGL_02063 hypothetical protein
MIKITKSIAKNESLSEDKIIQILNLYFTNKYKTDWISKVKCRLKKIYSFESNGWETIQKK
LTPIDSGIITINENSIKFELILMKQFLISVLGGILLTLILWKGYNINFSISVLIITIIEI
IIWAAIIRIGNEFLKKSLIKIEKTINE
>FCMOIPGL_02064 30S ribosomal protein S1
MSEETKNTEEQVVATEVQEKATPAVDPQQFLADFDWHKYEQGIEAVDEEKLKEFETALVG
TVGFVNERDVIEGTVIRITDRDAIIDINSKSEGVISLNEFRYNQNLAVGDVVEVLVDKRE
DSSGQLVLSHRKARVIKAWERVNNAHETGEVVNGFVKCRTRGGMIVDVFGIEAFLPGSQI
DVKPIRDYDQYVEKTMEFKVVKINHEFKNVVVSHKALIEADIELQKKEIIGQLEKGQVLE
GVVKNITSYGVFVDLGGVDGLVHITDLSWSRINHPNEVVELDQKLNVVILDFDDNKSRIQ
LGLKQLTAHPWEALNSDLKIGDKVTGEVVVLADYGAFVEVEQGVEGLIHVSEMSWSTHLR
SAQDFVKVGDKVEAQILTLDREDRKMSLGIKQLHPDPWTDITTKFPVGSTHTGTVRNYTN
FGVFVELEEGIDGLVYISDLSWTKKIKHPSDFVTVGDKLEVQVLELDVENRKLNLGHKQT
KDNPWDVHEDTYAIGSTHEGVVKEKNDKGAVVTFADKVEGFAPSRFLEKEDGTTLEKGDK
VNFIVLEFSKEYRRVVVSHTSLFKEQEKRNVKAAVKKAAEAEKTTLGDIGGLADLKAQME
AKAKKKK
>FCMOIPGL_02065 7-carboxy-7-deazaguanine synthase
MDKKTKDLVNRGTMLPLMEEFYTIQGEGAHTGTAAYFIRVGGCDVGCHWCDVKESWNADL
HPPTLADTIVENVKKHAKTVVITGGEPLMWSMDYITEKLQKNNIKTHIETSGAYSFSGKW
DWFCLSPKKTKLPLAECYPEADELKMIIHNLSDFDFAEEQAAKVGEKCELYLQPEWSKKE
KMTEKIVDYVMKNPKWKISLQTHKYLNIP
>FCMOIPGL_02066 Cytidylate kinase
MKRKITIAIDGFSSTGKSTIAKLLAKKYNYIYVDTGAMYRAVTYFAMKNKLVSKKVLNEE
VLISKLKDIKLTFKFNKILGFAEMFLNNVNVEKEIRSLAVSQLVSKVAAISEVRRKLVAE
QQLMGVNGGIVMDGRDIGTVVFPDAELKLFMSASADKRASRRYKELIDRGDDVSFEDILF
NVEERDRIDSTREDSPLIKAEDAIEFDNSDMGIEDQFNKICTLVEKKLL
>FCMOIPGL_02067 hypothetical protein
MKFYYWFLLIFLFPLSIQSQVGGENVYQFLNLSSSARQIALGGEVLTLIDDVNQPIWNPS
VINDDMDNFISANYSSYLSGINIGSLSFARLISRRFGTIHGSIKYLDYGTLIGADEHGNE
TGNFNANDLALSFGYATNLPWTNFYFGTNIKLINSNISNYTSFGFAVDFAILYYSPYKPY
SFTIVARNIGTQLKTFNGTSERLPFKVAVGGSYQLEHVPLKWYFTLDNLQKWDISVENPS
EQTTDLEGNITTEEIGFVSNTFRHFVLGAELFPESAINLRMGYNFRRAAELKLQDIRTFG
GVSVGFGIKMNNLKFNYAYSKFHSATNASTFSLQLDLNNR
>FCMOIPGL_02073 Carbamoyl-phosphate synthase large chain
MPKRKDLNSVLIIGSGPIVIGQACEFDYAGSQSLRSLREDGIETILINSNPATIMTDPSM
ADHVYLLPLTTKSIIQILKEHPQIDAVLPTMGGQTALNLCIEADTKGIWKDFDVKLIGVD
IDAINITEDREQFRELMLKIGVPMAPQATATSFLKGKEIAQEFGFPLVIRSSYTLGGAGA
SIVYESNDFDELLSRGLEASPIHEVMIDKAMMGWKEYELELLRDKNDNVVIICSIENMDP
MGIHTGDSITVAPAMTLSDTTFQKMRDMAILMMRSIGDFEGGCNVQFAVSPDEKEEIIAI
EINPRVSRSSALASKATGYPIAKIATKLAIGYTLDELENQITKSTSALFEPTLDYVIVKI
PRWNFDKFEGSDRTLGLQMKSVGEVMGIGRSFQEALHKATQSLEIKRNGLGADGKGYTDY
NQIIEKLTFASWDRVFAIYDAIAIGIPLSKIHNITKIDMWYLKQYEELFQLQKEISTYKI
ETIERDLLLEAKQKGYGDRQIAHMLGCLESQVYNKREEFKIQRVYKLVDTCAAEFKAKTP
YYYSTFENEIETAGGEIIIANESIVTPKKKIIVLGSGPNRIGQGIEFDYCCVHGVLAAAE
CGYETIMINCNPETVSTDFDTADKLYFEPVFWEHIYDIIRHEKPEGVIVQLGGQTALKLA
EKLTKYGIKIIGTSFEALDLAEDRGSFSSLLKDNNIPYPEFGIAETADEALALADQLDFP
ILVRPSYVLGGQGMKIVINKEELVEHVVDLLGRMPGNKLLLDHYLDGAIEAEADAICDAD
GNVYIIGIMEHIEPCGIHSGDSNAMLPVFNLGDLVMQQIKDHTHAIARALKTVGLINIQF
AIKHDIVYIIEANPRASRTVPFIAKAYQEPYVNYATKVMLGHNKVTDFNFNPQLSGYAIK
QPVFSFNKFHNVNKKLGPEMKSTGESILFIDSLKDDEFYNLYARRKMYLNK
>FCMOIPGL_02074 50S ribosomal protein L34
MPKRTYQPSKRKRRNKHGFMERMASANGRKVLARRRAKGRKKISVSSETRHKK
>FCMOIPGL_02075 CTP synthase
MHNTKYVFVTGGVTSSLGKGIIAASLAKLLQERGFTVTIQKLDPYINIDPGTLNPYEHGE
CYVTDDGAETDLDLGHYERFLNIPTSQANNVTTGRIYQSVINKERKGEFLGKTVQVIPHI
TDEIKNRIQILGETGDYDIVITEIGGTVGDIESLPYVESVRQLLWEKGHENAIVIHLTLI
PFLAAAGELKTKPTQHSVKMLMQSGVSPDILVCRTEHQISNDIKRKLALFCNVKQEDVIQ
SIDAETIYDVPNLMLKEGLDTVVLKKFNLTSKQEPKLTTWNSFLQKHKNPKYEVEIALIG
KYIELQDSYKSITEAFIHAGSSHETKVNVRWIHSESLTPENTEEHLKGVNGILVAPGFGD
RGIDGKIKAVQYARENNIPFFGICLGMQMAVIEFAKNVLGLVDAFSTEMKSDCRNPVINL
MQSQEDVTEKGGTMRLGAWDCKLEKGSLAFEAYQTENISERHRHRYEFNNEYLQQIELKG
MKATGMNPKTGLVEVVEIPSHPWFVGVQYHPEYKSTVLKPHPLFVAFIKAALKQSKA
>FCMOIPGL_02076 Membrane protein insertase YidC
MEQKKFDFNSFIGMILLGGIMLWYFNTNQPEIDPEDITTEQVTDTVKNDTQQTITKLPVI
KNDSLQQVAYQNKLGAFALSAINGAEGTSVIENNLVKLTIDNKGGQIIEALIKNYKTHDS
LPLYMIKDNNSSFNINFGTTDNRILNTQDLFFEPSLTKNGDSQILSMKLKVSDSQFLEYR
YEMKPKKYMVDFSIRSQGLNNVINSSNPINLDWSLNGYRHEKSIKTENTMYSHFYYKAED
DVDYINAGKSEILNDVDWVSYKQHFFASNLLTDTPFNNATIISTDLVKNEEIDTIYTKKY
ELKTPLALTAGELNYNMKWFYGPSDYNLLKKYEGTSLDETADLGWGIFGFLNRTVFYPVF
NFLKGFLSNYGLIIILMTIVVRIIMSPLVYKSYLSSAKMKVIRPELTALNEKFPGKENAM
KRQQETMAIQRKAGVSMLSGCIPALLQMPVFFALFKFFPTNLALRQQSFLWAPDLSSYDI
VFKLPVYIPLYGDHVSLFPILASVAIFFYMKMNQSQQANMQAPTQEGMPDMGKMMKYMIY
FSPIMMLFFFNNYASSLSLYYFISNLLTIAIMLVIKHYVIDEDKIHAQIEENKKKPEKAK
SKFRQRIDDAMKQAQEQQAKQQKKK
>FCMOIPGL_02077 hypothetical protein
MNKIHILFLAIGLFYSINCNSQISYVEGYYINNSNQKINCLIKDIDWKNNPQKFKYKTTE
QAEDKTLTIKTVKEFGINNVSKYIRAVVNIDMSSRKLDQLSNEKDPIFKQEQLFLKVLIE
GDASLFLYNYKSLRRYFYQTPNKDINQLVFKEYKSANNKIETNNKFRNQLYTNLKCNDIT
INDVNDVDYKKEELLNFFTKYNTCKNSEFINFEEKRKSDSFNFTIRPGINSSSLSIRNGA
ANSRNEDYDNEFNFRLGLELEFIMGFNNNKWALLIEPTYQYYKTNNEVLNYSLNNADYQS
IELPIGIRHYVFLNKTSKFFINGSYIYDLAINSKVRGLDAKSNSGNFAFGVGYKYNNKYS
VEFRYHTSRDILTDYVTWTSDYKTASIIFGYSIF
>FCMOIPGL_02078 L-fucose-proton symporter
MSSVTTTKSYKSAFIFLTTLFFLWGFITVLVDSLVPRLKDVFEMSYAKTVLVQFAFFVAF
FVFSLPSGFILSKIGYKKGIVLGLLTMALGCLLFYPAAAYRLFPVFLIGYFTLAGGITIL
QVAANPYVALLGSENGASSRLNLSQAFNSLGTTIAPVVGALFLLSNSVKTSEEIAVLSEI
EKTNYYINEAATVQTPFLLIAFLIAVLATIFAFIKLPEVMQESPKRGYFTLLKNKIMLMG
ALGIFVYVGAEVAIGSFLVNYFSDMNLATVVLQNETMMNIANTIASTFNKTFSGSDSKSL
LGIFVIFYWGGAMIGRFVGAYLTKIMAPGKVLAIFASLAIAMILISINTTGLLSMWSILA
VGLFNSIMFPTIFTLSLEGLGDLKAQASGLLCMAIVGGAIIPFIFGGLIDDFGFKTAFVL
TIICYGYILFYGRFKAKKNLN
>FCMOIPGL_02079 N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase
MKRRNFIKKASATSLGIVAVSSTLMSFDEKSEDKKAVILSTLKPIRPLVIATWNTPLAVE
TAAKILQNGGSALDAVEQGCIIEEANEKNQTVGKGGLPDRDGDVTLDACIMDNKGDYGSV
LGVKNITHVISLARKVMEDTPHVMLVGEGAEKFAYEKGFKKENLLTESSKKAWENWKIKS
EYKPIINIENHDTIGMLAIDKKGSISGACTTSGLAFKMAGRIGDSPIIGGGLFVDNEIGG
ASATGLGEEVLKTVGSFLIVELMRQGKSPQEACEEAIGRIVNKPGKDFKNFQVGYIAVNK
QGETGAYSIHEWFSYNLFKDGENKNIKSDYFNKA
>FCMOIPGL_02080 hypothetical protein
MPTNKQVFNNGADGKEGYRSNFSHENEVAEPGFYKVHLDDTNIEVELTVSKRSGMHKYKF
PSKENQFVILDLVHRDKVLDAKIEKISDTELSGYRFSEAWATDQRLFFNIKTSHPFTDVL
QSPEKEGMTGAQKIALNFINPNNEPVIIKIGISAVDVEGAKKNLKGEIGNQTFDEIKKTA
QDFWEKQLEKIVVEDSNQDNKVNFYSALYHTMIAPNLYQDVDGRYRGMDLEIHETKDFDY
YTVFSLWDTYRAAHPLYTIIEQEKTNDFINTFLAKYDEGGIMPIWDLAANYTGCMIGYHA
VPVIADAYLKGIKNYDVEKAFTAMKHSATRDKLGLDSYKYFGFIPVEKESESVSKTLEYA
YDDWTIAQMAKSLRKEEDYKNYAERAQYYKNVFDPSSRFMRGRFRNTWFAPFDPYEVNFN
YTEANSWQYSFYVPQDISGFMKLLGGKEKLENQLDKLFLADDKTSGSHQVDITGLIGQYA
HGNEPSHHMAYLYNFVNKPSKTQEKVRQILTELYTNTPDGISGNEDCGQMSAWYIFSSLG
FYPVTPGLNQYIIGSPLFNKATINLENGKTFTVEAKNQSAENKYIKSVKLNGDNYEYSYI
NHQDIINGGNLIFEMINVPSNWGTKDAFIPSTEIKEHVIVASPFIAKGEIAFKGSTEVTL
ENVDKEAIIYYRLGYKGGFKKYEKPFIIDTFINLSVYAEKNEVKSPVITTDFYKIDPNIK
IDLKTDYANQYNAGGKNALIDGIIGAEDFRTGTWQGYFDKDLIAVVDLGKEKLIYNVKIS
FLKDQKSWIFLPKEVEIYTSLDGQNFQKVVNRNFKKPENSDEVKIESVAVSKLGKARYIK
IIAKKLGKLPEWHLGYAHDGRSWLFVDEIQIK
>FCMOIPGL_02081 hypothetical protein
MKRYFLPFFIVLFAMFSCVLNTDKSAVKKDKSLISYVNPFIGTGGHGHTYPGATMPFGMM
>FCMOIPGL_02082 hypothetical protein
MKIHQYFLQVFILIFFGCKNDIKKPIEPNIIPKPLSQTIKKGVFILNKNVKIISPSE
>FCMOIPGL_02083 Exo-beta-D-glucosaminidase
MRKILLILSLIVIWNSKSKKDIPLHISIDTNWQFKGTDTLDWKSATVPGNIFTDLLDHKI
IENPFVKNNEEKVQWVSKKNWIYKTNFTLSDETFNRKNIEINFDGLDTYASIFLNDSLVG
KTNNAFQKFSFDIKKIAKKENKLTIIFTNTDTIEIELENKNPYKLPEGKRVYTRKAQFQY
GWDWGPKLNTSGIWKEVSINAWNDFKIDDIFIRQEKLTDQKVKLVAEIDIERDLILETDE
TVTSEIKIIFDGIEITKEIDIKKGMHTYKIPLEIKNPKLWWTHNLGNPYLYSFNFQLISD
GKIKDEKEIKKGIRTIKLINKKDKIGESFYFELNGKPVYAKGANYIPQNSFQNKVTNKHY
EKLLSDVVNSNMNMLRVWGGGIYENDIFYDICDEKGILVWQDFMFACAMYPGDKDFLENI
KEEAEQQVKRLRNHSSITLWCGNNENSEGWKRWGWQTNRTEKEKQEIWNDYLVVFDSILP
NTVSKFSETDYWETSPKYGRGDPLYEFEGDAHDWWVWHDEYHFKYLEKRVPRFMSEFGFQ
SLPSYEALKYINQNDTINLNTDAVKAHQKHNKGFRLIDEYMIRDYKKPTNDEDYVYVSQL
LQAKGIVMGIEAHRRSKPKNMGTLYWQLNDCWPSISWSSIDYFGNWKALQYKAKKAFENV
LISSKKEKNKVKTYIINDSFDTIRGNLKIKVIDFYGNEIKSDSIEIKALENSSKEFYRFS
IKNIDKKTTVLVTEFNNQKSNFYFVKPKELLLPKGEINKEIIKTENGFLITLKSSVLQKD
VFLFTNKKGHFSDNYFDLLPNETKTIYFETSTNSLNDLKLKSLNEI
>FCMOIPGL_02084 Tyrosine-protein kinase ptk
MKEFQKNNQEIIFEDNDKINLKEEFDKYVYYWRWFVLALCISFCCAYYYIKKTPPLYNAS
AYIMIKDNLKSGISDELKAVSDLGIVGNNSTNNPENEIFIIKSRKIVSRVVDSLELNISY
FDEQGRNAIEAYKNSAIKVDFLNDNTINSIIDTSFVVSFTEKNRFSIKDSEGEILKSAYF
DEIITSDNLGSFKITKNLLDKDIDTDQKDILVVVRPKKNVVSSYASRIIVSAVSEFSSIL
KLEIKDANKSKAEDILNELIKQYNLDALIDKNEISKKTKEFIEERLQNMSVELGVIQDKL
KDFKTDFGISGFSKQAEIAFESISSYDEVIVRLKTQLTLVEWAENDLKKHTKSYEILPEN
LGFSDEITSKAINEYNQLVLEQQRLRIKAGDKNPSLVLLQNRIQVLRENVYRNLENLKSS
INIQLNKSLKESKVAQTKVAQIPLIERGMIDIQRQKAIYSELYSYLLRKKEETAISLAVT
VSNAKIIDVAYSSDGSISPKKKIIYLIALVVGLIIPFLLIYLKFILDTKIHNRKDIESNL
NIPYLGDIPNSVSLEKIIVKKETRTSTAEAFRLLRANLSFMLPKTGANSKGKTIFITSTI
SGEGKSFVSLNLAATMALTNKKVLLLGLDLRAPKITDYLELPDRKGVTNYILDDKLTLKE
LIFNVSDIDNLDIISSGLIPPNPSELLLNDRVKNLLEIAKNEYDFIIVDTAPVSLVSDTL
LIGDLADMFLYVTRANYLDKRMLIVPETLYKEKKLPNMAIVLNSTDSSRGYGYGYGYIEK
EKKSFYKRILGK
>FCMOIPGL_02085 Chondroitin synthase
MKLLFSIIIPVYNRPNEIDELLESITKQDFSNDFEVLIIEDGSTQKSNLIVEAYKNQLNL
KYYFKKNSGAGASRNFGMQKASGNYFIILDSDVIVPNQYLSEVEKALANNFTDAFGGPDA
AHKSFTALQKAINYSMTSVLTTGGIRGKKQAVGKFQPRSFNFGLSEKAFAKTNGFSDLKI
GEDIDLTFRLWQNGLETQLIEKAFVYHKRRSSVQQFFNQTFAFGAGRPKLNKRFPGSAKP
TYWFPSLFILGIIFSLFLAFIGYHEFLYFYGFYFLLIFLDSLNQNKNLNVAFLSILTSFV
QFLGYGLGFLKSQIFIKILKQ
>FCMOIPGL_02086 hypothetical protein
MGFFKKIDKVFRSSENFNLMERSEVDIQIEDNIKSVGINKFAESDYGDLYVRVNELGGFL
ILETIIVSATNLKSKKGSKLTFKNQNETLKLESDENKIESDFSNAVKKSVTKIDYNISVE
EAENFKEEKYNEVHFEINGKKILFSVLRS
>FCMOIPGL_02087 hypothetical protein
MKKITLLLLFLSITFSVRAQFPESFVDGVIPTGWTTFIGANGLGTTENWSASTGGYMLCF
DENAGDFTEDWLVSPSVNITSINSLLSFYEQTLYTDVYEPSNMSVRVSTTSQTDISTFTS
LSSLTATEVFNGSNSRSIDLSAYEGKTIYIAWVLEQNYGDGWLIDDISLNNQNATAPSCA
ENLLPANGNTDVYLTDGEVSLSWDAPSTGDAPTEYEIFWGTTSGSLTSLGSLVGTSVNII
NVDYSTTYYWSIVPKNAGGSATGCAELSFTTQADPTLGIKENKIEGLSLFPTIINQNLSI
TSLKSLDAINVFNLLGQQVYSSKPNTTNLSVDLSSLKAGIYLVKVKVGDSKGTYKIIKE
>FCMOIPGL_02088 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MYNLLKGKRGIIFGALNEHSIAWKVAERAHEEGATFVLTNAPIALRMGELNELAAKTGSQ
IIGADATSIDDLNNLVEKSMEILGGKIDFVLHSIGMSINVRKGKHYTDSNYDFTTKGWDI
SAVSFHKVMNVLYNKKAMSEWGSIVALTYMAAQRVFPDYNDMADNKAYLESIARSFGYFF
GRDHKVRVNTISQSPTPTTAGSGVKGFDGFIEYAEKMSPLGNATALECADYTITMFSDLT
KKVTLQNLFHDGGFSNMGVSDPVMEKFTKE
>FCMOIPGL_02089 DNA repair protein RecN
MLTQLSIHNYALINHLSIDFSSGLSIITGETGAGKSILLGALGLVLGNRADLSSLKDTSR
KCIVEAKIAVSNYDLKDFFEEVELDYEDITILRREILPSGKSRAFVNDTPVTLTVLNELK
SKLIDVHSQHQTMQLSDVNFQFTVLDALAKNNAKVGSYKRGVLKLNKLNKELEKLEKTQK
EINLQYEYNLHLFNELEVAKLKVDEQETLEESLERLNNIEDIKLNLSEALEISSNEEIGV
QDLLHTLENRLSKIASFSKEYQEISERVTSVKIEIDDIVAELENANENVEFNSNEAEEIN
DRLQLIYNLQKKHAVNTNQELLQILEALSEKVNEVESADATISKKKKEIAEVSEKLDAIA
LKISNARKNVIPKLKKELEELLSDLGMENARFSIKIIPTKNYFYNGKDELEFLFSANKGG
NFGELKKVASGGELSRIMLSVKKVLSENIQLPTIIFDEIDTGVSGEVSNKIAAIMQQMGM
HMQVIAITHLPQIAAKGINHYKVYKEEINNVTTTNLKQLTTEERVVEIAEMLSGKDISES
AITHAKELLN
>FCMOIPGL_02090 hypothetical protein
MCKHVFLFALFLITFNINSQELNCLITVNDQQVDGSNKQVFTTLQKSLTEFINQTKWTNR
VVKSEERIDCAMTIIITNRQNNTFTATLQVQSTRPVFGSSYATPVLNIKDNDFTFKYNEF
DPLIYNKNSFDSNLISTIVFYVYTIIGIDADTFTQFGGETELKEAQNVMLQAQQSGLSSW
QNVVGKQNRFLMIDNLLSPKLKSYRSTLYDYHIKGLDNFASNKDFGKQAVEDAVLSVGNI
YNKTVGNYLIRMFFDAKADEIVSIYSDGPRTKNAERLTTSLKNISPNNNSKWKNIE
>FCMOIPGL_02091 Coenzyme A biosynthesis bifunctional protein CoaBC
MSVLSGKKILLGITAGIAAYKTASLVRLFIKLGADVKVVMTPASKDFITPLTLSTLSKNP
VHSTFFDVEDENEIWNSHVDIGLWADYFLIAPATANTMSKMANGTCDNLLLATYLSAKCP
IYFAPAMDLDMYIHPSTKESLDKLQDFGNIIIPATSGELASGLVGEGRMAEPEDILSFIE
NDILSKLPLRGKKVLITAGPTYEAIDPVRFIGNHSSGKMGFAIAKEAANLGAEVILITGP
THQQINHSFVNRIDVISADQMYTEVHNYFNDVDIAISAAAVADYKPKNVANQKIKKKDSS
LTIELAPTKDILASLGAIKKHQFLVGFALETNNEIENAKSKIKRKNLDAIVLNSLQDKGA
GFAANTNKITIIDKNLNEKPFELKSKTAVAKDIINEIVNSIR
>FCMOIPGL_02092 hypothetical protein
MDYKDTQAAISTVTYNKNKIEAPTNNIYEAISIIAKRANQINSDLKTELVDKLDEFATYN
DSLEEVFENKEQIEVSKFYERLPKPTALAVEEWLNDKVYFRTPETT
>FCMOIPGL_02093 Cell division coordinator CpoB
MQKIKNLACLLVLSLLLFSCGEYQKVLNKGTVEDQYKMAVKMYEGKKYGKALRLFEKVTP
AYRGKPQMERIQFMVAQSNFNEKNYIESGYYFDRFVNNYPKSSKKEDAAFLSAYSYKLAS
PVFSKDPTETNKALNAFQSFITTYPNSDKIEEANKHYKDIRYKLQKKYFEIAKTYYTTAD
YDVRNYKASIQAFDNLLSDYLGSEFKEEALYYRFKAAHDFVLRSTDRRKLERIKDAVEAF
EKLERNYPESTYMVESKEMLSTLQKEQVRVEALIEKLKAKQELLEREKENSKEK
>FCMOIPGL_02094 4-hydroxy-tetrahydrodipicolinate synthase
MQKFIGTGVALVTPFKEDLTVDFDALIKLVNFNIENGTDYLVINGTTGESATISREEKEQ
IIDVIVKTNNKRLPLVLGIGGNNTLAVVKEVSTRDLSQIDGILSVAPYYSKPTQEGFYQH
YKAIAEATEKPIILYNVPGRTARNMEPATTLRLAKDFSNIVAVKEAGNNQQQYNTLLKDK
PADFLIISGDDDLALGVALAGGSGVISVIGQAFPKEFSKMIKLGLEGKNVEAYKIHFKMM
DIIDYIFEENNPAGIKVVLKELGICAGTVRLPLVKASAELQAKIAKYVSNF
>FCMOIPGL_02095 hypothetical protein
MIPFRRYFLKKQFKKKLIENEIHRVVSDEQIKTVGIITTDEISKWVNVKEEVENILNLKN
AQIYSFGSHKDDRSFKSFTEKDFNWKGNIYKSNFKIFIDEPFDLLIGYFNKNNLYIESAV
LNSKAKFKVGISGVNQELYDIEIAETPSKTDRFFLELKKYLVVLKKLEN
>FCMOIPGL_02096 hypothetical protein
MMKNFYFLAAFSLLIFSCTKKTETKLTFLDEYDLADSIQFKNTIIGGLSGVDFVNNQYYF
VVDDERNPRVLSANISISDDKIKSVKFNDVILLADTTNNFYQKNALDLESVFVDETTNEI
YLTSEGSIKNNKLPSVFKSDINGRFLEEIQLPENLLNIKSIKHNAAFEASSKSIDNKGFW
VAMEAPLNVDGEEPTFTKTSSPIRITYFDKSTKKATKQFAYQLEHITKPAKGNINLNGVT
AMLEYKENQFLVVERTYQSGYGSHGNIVRIFDVIVDETATDILEIDALKTSEFTPLKKRL
VFNFEDVEGELTDKIIDNIEGIAFGPELLNGNKSLLLISDDNFQFYGKQLNQFILLELQA
N
>FCMOIPGL_02097 putative membrane protein
MTKQIKITTASIAFLAVVILHILGLLFHDKTAFLSKPFIITSLVIVYLVAVKKPNFWYVS
ALFFSFWGDVLLLFKDQFFVFGLASFLVAHILYIKIAAGFIKKESVRKLILASIPFVVFL
IFLFYLILDNLGEMKIPVIVYGTVISTFGVVSLLNYMQKKSTENLWLFLGTIIFILSDTL
IALHKFYEAKEIYSVSIMVTYIVAQYLICKAIIAKDSLKE
>FCMOIPGL_02098 hypothetical protein
MFSTIFKQELKYWFQKPIFYIYISIFFLISLLLSATAAGIWDGITGTTGSSRIVNSPIGV
TGLLNGLTILIFFLFPSIIGVSIYRDFKSEMHTILYSYPFTKANYLFAKFFSGIVVVSAI
VLVIAFGMSIGFRFPGTNSDIVGDFNIMTYLQTYLVYILPNVLFFGAVVFAIVTFSRNIA
AGFITVIILFFAQGALSSIFSDPEQASLLAILDPFGSAAADYYTKYWTIFEQNELQIPIK
ELIIYNRLLWLAISSLIFGLVYKFFKFNQNAISISFRKVKSERVTKNNFSGITRITLPKV
THDYSFSQNLKTMWRLSNLDFKYIFTSLPFICILVVGILLLVGTLFTVGEIFGTKTLPVT
WQMLGGGNIFSALIINLCTFLYAGILVQRANTAKISHLVDSTPIPNWTLLFSKLIALLKM
QLVLLAVIMVSGMLFQAYQGYYDFEIGHYLKELYGLKFLNYVIWALLAIFIQTLVKNQYL
GFFILLILAIGIPFLSLIGIELSIFKYNEGPGYSYSDMNGYGSALSRYLWYKLYWILGGT
LLLIVSMLMWVRGLPNSFAERFYVAKQRFKTPIKISFMVVLVAFLTLGVTIYQKTKSDNK
NSSSKQAELDAVKWEKTYKKYENYKQPRITAVNAEMHIYPKKKTYKASAIYTMINKTNQA
IDSVFLNHNSLESTFEFNKPNNLVLEDTVFNFDIYKFDKKIQPGDTLQLTIHVKSNENSM
FQLKSPILENGTFISNSSLFPSLGYNSRGELTDDKTREKYKLPKNNLRPAPTDSTALGNT
YISKDSDWIDFEATVSTSKDQIAIAPGYLQKEWTEGDRKFFHYKMDSKMLNFYAFNSARY
EVKKEMWKGISLEIYYHKLHDYNLDRMMKGMKASLTYNAKNFSPYQHKQLRIIEFPRIKG
TFAQSFANTIPFSEGFGFIADVDEKDENGVDYPFAVTVHEVSHQWWAHQVIGADVLGATM
LSESLSEYVSLKVLEHQHGKPKMRTFLKEALDSYLMQRTFEAKREKPLMYNDGQGYIHYQ
KGSLVFYALSDYIGEENLNGALKKYVEKVKFQDSPYTTSTEMVNYIRKVTPDSLQYVIKD
MFETITLYKNRIVGAKTTELENGKYQVDIEFEVSKYRNDEKGKKFYGEKVGDTLSYKSEK
MSKSILSVPLQDYIDIGVFTEEEVDGKKKEKELYLQKHKITQINNKITIIVDKKPREVGV
DPYNKLIDTQSNDNRRKL
>FCMOIPGL_02099 putative ABC transporter ATP-binding protein YxlF
MKLVIKNLTKTYKNGVKAIDDLSIEIGTGMFGLLGPNGAGKSSLMRTIATLQSPDSGSIM
FGDINVLEDNMSLRKVLGYLPQSFGVYPKMSAEDLLDYFATLKGVSNKSERKAIVKEVLE
ITNLYDVRHKYVAGYSGGMKQRFGIAQLLLNNPKLIIVDEPTAGLDPAERHRFLNVLREV
GTNCTVIFSTHIVEDVKELCNEMAILNGGKILNHTTPQEATKQIEGAIWKKIINREDLEE
NEKMYNILSSNYNQDNTLNIRVHAIEKPSDDFVAATPQLDDVYFIALKQDKPVLTN
>FCMOIPGL_02100 Putative aminopeptidase YsdC
MAKKSILNKKSLTFLEKYLNNAAPTGYEWEGQKIWMEYLKPYVDTFITDTYGTAVGVINP
DAKYKVVIEGHADEISWYVNYISDNGLIYVIRNGGSDHQIAPSKIVNIHTKNGIVKGVFG
WPAIHTRNKANEEAPKPDNIFIDTGCATKEEVEKLGIHVGCVITYPDEFHILNGDKFVCR
ALDNRMGGFMIAEVARLLKENDKTLPFGLYITNSVQEEIGLRGAEMITQTIKPNVAIVTD
VTHDTTTPMIDKKTAGLMELGKGPVIAYAPAVQQKLRDLITETAEANKIPFQRSALSRAT
GTDTDAFAYSNGGVASALISLPLRYMHTTVEMVHREDVESVIKMIYETLLNIKNGETFSY
FE
>FCMOIPGL_02101 Isopentenyl-diphosphate Delta-isomerase
MDELIDILTPEGKLTGKTALKSEAHKNGWFHATVHIWLFTSDEKILLQKRAMTKKVFPGL
WDISVAGHIAAGEEILTSAKREIFEEIGLQLEEKDLIKIGTRIHQVSHKNGIQDNEHHHV
FIAELKKPLSELTIQKEEVDAVQLFDLEILKNTEKHQNVLLSRFHGYYCSVYNEIIKITS
K
>FCMOIPGL_02102 hypothetical protein
MKKNKVVNLFGDKNNLQNTALNYSTLLDKFVEQFINKLKEFESQEDAYEFAQNAWNLGNM
RSIIDTAEFKNIISLAKDNGEDYRLLEKMTSYKVKHLKEFTEFIVDFDFFEVKGSQKLKV
TTQTEDDYLSEMLEINFPKESTEDDFEENFINRSAISLKPLQPFIDWHNTIYTDSKIDET
DLKDVNIYLISNATYYEDVEAHLKKKFDNYFQRELEGWHTNKKEWPQRRNYKMFKNWFQI
NISTAILDLEKTPVSKSE
>FCMOIPGL_02103 Inosine-5'-monophosphate dehydrogenase
MKNTISERVFDFLKNYPPFNLLTAKKIAEIASEVKIIYLEKGKILFNQNDTNHEHFYIVR
NGGISMYKNSENDKTLIDICDAGDIFGLRPLISKENYLLDAIANEESIVYGIPIAIFQAL
SEKSLKINKYLLTSFASTSFDPYTSEQNNNIFTDYIAKENLAESNLQSINYTKKPLKCTI
KSTIKEAAIKMSAQKIGCIVVVDDACVPIGIITNSDIKNKIATGLFSIETSVKDIMSFPV
ITQSKNLTVLDAQLQMIKHKVGHVCITADGTSNSKLIGILTNHDVLASLGNNPTVILKEI
KRAKRTREIREIRSKANLLLKSYLEQNIPLSHISKIISEINDGVTIRTIELSLKKMDSPP
PVKFSWLALGSQGRKEQLLYTDQDNALIFEDVAPEKYLETKNYFLKLSGHITKSLHKIGY
EYCPAEMMASNPEWCLSLSEWKNQFKDWIMNIDEKAILLSSIFFDFNAIYGDPNLPKELT
NSIFENLNNKNLLCTFLAKEAVASPSPLGFFKQFLVENNGDHKDSFNIKKRALMPLINAA
RLLVLSNNISEINNTAQRFEKLAEIEPQNKELYQSCSYAFKAVLKFKTKQGILHNNSGRI
IQLESLTKEEKLKLKRCFKPIREIQEVLSVRYNLANFR
>FCMOIPGL_02104 DNA polymerase III subunit epsilon
MKLNWFQKKEKKPLPGYFLAYQESFLNAKKLPIKETRFVIYDTETTGFLRKDRVLSIGAV
SVIDNTINVNDTFEVYVKQKVFKAETVPIHGILKGGEIEKITELAALKLFLKYIGNAVLV
GHHVKFDVEMINEILRRNKLPLLLNKTIDTGYLYKKSKHTIYQNGKQHYTLDNLCDELNI
SKSDRHTATGDAYITAIAFLKILSRLNKNGNLKFRDLLNY
>FCMOIPGL_02105 hypothetical protein
MKKVLLLLIIVISVSCKNETKKGVKQETIVEVKKENFPVELAKVFEKHGGIDTWRKAQIL
SFNKGEEVHTVDLKSRKTVINSPKYSLGFNGKDVWLSEVEKGSYKGDPAFYHNLYFYFYA
MPFVLADDGITYEKTADLVFEGKNYPGYKMSFKANVGSSPDDNYKIYYNPETYQMQWLGY
TVTYRSKKASDKFKMIKYGNWNNVNGLILPSEITWYKTDENGVPTEPARPTTVFTLPLIS
EGKLADSFFEKPKN
>FCMOIPGL_02106 Putative multidrug export ATP-binding/permease protein
MQHYKESSKDKKKPKVTLKQAFKTIIWPRRNLVFLGLILIIIRSLSGFVLPLQSKVLLDE
VVPNKDYNQLYTLIAIVIGAISVQAITSFLLTKVLSIQAQYLISELRAEVQKKVLTLPIS
FFDNTKSGALVSRIMSDVEGVRNLIGTGLVQLIGGSFTAILTLVILLKMNVWMTLFTFVP
LSVFGLIALKSFKYIRPIFRARGKINAEVKGRLTETLGGIRVIKAFNAEEQESKIFEKGV
ADIFINVKKSMTATAIMTSSSTFLIGLATTGVLGIGGYYMVQGTMTSGDLFKFTTLLAFM
VAPIVQMSNIGSQLTEALAGLDRTEELMNMPAEEDDEERTITLNKIKGEIIFDDVSFEYE
EGKEVLNNINFDVPAGSVTALVGSSGSGKSTIAGLSATFLNPKSGTITIDNKDVSKVKLS
SYRKNLGVVLQDEFLFEGTIRENILFPRPNATEEELQNAVNAAYVNEFTDRFDDGLDTLI
GERGVKLSGGQRQRLAIARAILADPKIIILDEATSSLDTESESLIQKSLSELVKDRTTIV
IAHRLSTIKQADQILVIEAGSIAERGTHDELIAKKGRYFDLYTYQSKI
>FCMOIPGL_02107 Acetyl-coenzyme A synthetase
MSNYHIKHLEEYFKVYRKSIREPEVFWEEIAEEHFLWRKQWDKVLDWDFSKPEIKWFQGA
KLNITENCIDRHLATRADKTAILFEPNNPEEPAEHITYNQLHERVNQFANVLKDYGVKKG
DRVCIYVPMIPELAISLLACARIGAIHSVVFAGFSSTALATRINDSDCKIVITADGSYRG
KKTIDLKGIVDEALEKCEGVNTVLVAKRINSDIKMKAGRDKWLQPLLDEASKECKAEIMD
AEDPLFILYTSGSTGRPKGMVHTTAGYMVYTAYTFKNAFQYRENDVYWCTADIGWITGHS
YIVYGPLANGATTVLFEGVPSYPDFGRFWDIIDKHKVSQFYTAPTAIRALAKHGTELIEN
HDLSSLKVLGSVGEPINEEAWHWYNDNVGKGKSPIIDSWWQTETGGIMITPIPYVTPTKP
TYATLPFIGIQPAIMDEKGAELKGNQVEGRLCIKYPWPSIARTIWGNHQRYKETYFSAFD
NMYFTGDGALRDEVGYYRITGRVDDVIIVSGHNLGTAPIEDAINEHPAIAESAIVGFPHD
IKGSALYGYITLKDAGEYRDHANLQKEINQLITDRIGPIAKLDKIQFTEGLPKTRSGKIM
RRILRKIACNEMDNLGDTSTLLNPEIVQKIIDHRL
>FCMOIPGL_02108 hypothetical protein
MGIQIIFESILQNWNIILFFFIVAILYSSVGFGGGSSYLAILALTGIVFTQIRATALLCN
IVVVFGNMFLFHQQKKIEWKKIISIVIFSVPMAYIGGYLKINKEFFFILLGFTLLFAAIT
MWISKNIISSDEKQIKINTKKNAAFGGIIGFISGMVGIGGGIFLSPLLHLTNWDTPKKIA
ATASFFILVNSIAGLVGQYSNPDFYIDWSLTSILLITVFIGGQIGSRMSNNYFTPIQLKK
ATAILIAFVGIRILIKYFF
>FCMOIPGL_02109 Penicillin-binding protein 4*
MKNLLFFKSTLLTVICVFFFNVSQAQSLASKIDKILTNQFKNNETGVSALVAKDGKVLYR
KAFGKANLELDVDMTSDNVFEIGSITKQFTSVSILMLLEEGKLSLDDEITKFIPDYPTNG
NKITIHHLLTHTSGIKSYTSMQSFGEIATIDKTPLEFINFFKNEPMDFDPGEKYLYNNSA
YFILGYIIEKVSGISYEKFLQERIFDKINMKSSYYGSHTKLIKNRASGYEKGADFVNAQY
ISLTLPYAAGSIMSTVDDMLKWQTAITNNVFVKKETIAKAFTNYTLNNGDKINYGYGWSL
DELNDVPTIEHGGAIPGYLSMGVFVPSENVYVILFSNCGCQSPTNTALEIAALAINKPKF
EAGKEVKLSIEQLNNWVGTYEFDAKVLRFITLKDGQLYSQREGSPKSFKIFPTSPTSFTF
EEGFISYDFSIKDGKKVALFKNRINKVEGIFTDKVATKEKEIITVSADVLKTYEGVYEIQ
PGFDLTITAKENQLFAQATGQAQFELFATTETNFFLKVVKAEIEFHKNEKDEIIALTLYQ
GGNAMKAMKK
>FCMOIPGL_02110 hypothetical protein
MLENLFTLFMLVMLQAVLGFDNLLYISLESKKAPETDQKKVRKTGILIAIVLRIVLLFVL
VSIIDFFQEPFSFLSGGIENIIKFAFNGHSIIVLVGGGFIIFTAIKEIWHMISTKGLEVS
EMASDRSTKSSKAVVFSIVLMNLVFSFDSILAAIGLTSEIESSTTAFIIMAIAIVISGLL
MLIMADKISVFLSKNRMYEVLGLFILFIVGIMLVTEGGHLAHLKLFGNEIVPMSKTTFYF
VLAILIIVDVVQGKYQKKLAKEKK
>FCMOIPGL_02111 hypothetical protein
MNKKERPILSDLVNEGTSELEKFQNEIIRPVIKMQHDLLIASFKQYLQKRKIDFSVLSDQ
KKRSRISSIFKTDNNYKNMTLGFIVGHFSTDEFTFYTANVSEVNKRILQIITQRIKDSIT
ELL
>FCMOIPGL_02112 hypothetical protein
MKAVTIKQLKDELTHKSANELKELCLHLSRFKKENKELLTYLLFESHNEEGYIQSIKDQM
DDQFLEINTKSFFYIRKSVRKILSLTKKYIRYSKNKETETELLLYFCKKLKAMKPSIKNS
QRLQNVFDSQIKMIKKAIEKLHEDLQYDYQLELDELLDE
>FCMOIPGL_02113 Enoyl-[acyl-carrier-protein] reductase [NADH]
MIIEPRTRGFICLTAHPTGCEKNITDQIAYVKSKGKINGAKKVLVLGSSTGFGLASRISS
AFGSEAATIGVFFDKPSAPGKTGSAGYYNTAAFEKHAHEAGLYAKSINGDAFSNEIKRQT
LDLIKKDLGQVDLVIYSLASPVRTHPDTGKRFKSVLKPIGGVFSNKTVDFHTGNVSEISI
NPAEGDDVANTVAVMGGEDWKMWMDALKAENLLSEGATTIAYSYIGPKLTEAVYRKGTIG
AAKDHLEATAFTITDDLKSIGGKAFVSVNKALVTQASSAIPVIPLYISLLYKVMKAKGIH
EGCIEQIQRLYSERVFGGDLDLDEKGRIRIDDWEMREDVQAEVDKLWPTATTENLSEIGD
LEGYSNDFFNLFGFKVDGVDYDADVNEMVAIPSEK
>FCMOIPGL_02114 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MNTINETNFQFPGQKSIYKGKVREVYNINDQLLVMIATDRLSAFDVILPRQIPFKGQILN
QIATKMMNETVDVVPNWLLANPDENVAVGHLCEPFKVEMVIRGYMSGHAAREYKLGKRVL
CGVTLAEGLKENDKFPIPIITPSTKAANGEHDEDISREAILSKGIVSEKDYVVLEDYTRK
LFERGTEIAAKRGLILVDTKYEFGKTKEGKIVLIDEIHTPDSSRYFYADGYQERQNKGEA
QKQLSKEFVRQWLIENGFQGQEGQQIPEMSDEKIIEISNRYIELFEQITGEKFVKASTEN
VMERIEKNVNAFLAN
>FCMOIPGL_02115 hypothetical protein
MEHKNDFIEREIQKISFFLRKMFSSISSTDEVFSLQAFNEDLKEKLDFGFYELLALNEEE
LKNKIHGVDILILEDLLKVFYEIDKEEIVTLESYNLSRVSLILINEIENKSKVFSFERQQ
IKNYFNSEKKEIESLFLRKQQHKK
>FCMOIPGL_02116 hypothetical protein
MIKIEKDKLGIQDYFYIGYLYLIILGIVSDAIFYGIFGISYLSYTTILDALISPLSLLAN
NWKISIFLVFMFWLMRMYFTKWMFNLYKYFKVKKWYKKIYNIEKLDKKYAELEKKKNNVE
GMMFIFFLLFISMRTGMGIGMKQRFTKEEIIPNYTLIFKDNTRLDVKKVGQNSAYFFYFI
PGEEIITVTPIADNLKQIKVLKNKK
>FCMOIPGL_02117 PhoH-like protein
MNERILELTEISPKEFFGTQNNTIEQLKKYFPKIKIVARGSKLKIYGESSVLDEFEIRFD
RLIKYFNRYNKLDDNSIERILTSNGNEEKSVASKFAKDILVHGVNGKLIKPQTENQRKMV
ASMAKNDMLFAVGPAGTGKTYTAVALAVKALKEKEVRRIILTRPAVESGENLGFLPGDLK
EKLDPYMQPLYDALRDMIPHEKLEAFIEKGVIQIAPLAFMRGRTLDNAFVILDEAQNTTH
NQMKMFLTRMGKSAKFIITGDPGQIDLPRKQVSGLKESLLALKDIKGIAHVYLDDKDIVR
HKLVKEIIAAYKSIETE
>FCMOIPGL_02118 5'-fluoro-5'-deoxy-adenosine synthase
MSFITLTTDFGTRDHFVGAVKGAIYSELADAKIVDITHHISPFNITETAYILKNSYKSFP
EGTIHIVGVDSELSDENKHIAIELDNHFFVCPDNGIISMIASEIQPTRIVEINIHTRVES
SFPVLDVFVQVACFIARGGNLTVIGKEIREFKKLVEIQPKVNQNQTQIIGGVVYIDNYGN
VISNISKKMFNEIGKGRNYKITASRYLFTKIFTKYNEITGDNSQNIKQFDGNKLAIFNSA
GFLEIAIYRSNLKTVGGACSLLGLEYRDPIIIDFFTESKPEYTSLS
>FCMOIPGL_02119 hypothetical protein
MFVRIVKMSFHLKHINEFLILFEEKKKLIRNSEGCNLLELYQDKTNPEIFFTYSYWENES
NLENYKNSKLFKNVWAKTKTFFNDKPQAWSVDKKVSLQ
>FCMOIPGL_02120 hypothetical protein
MNFNFTPFPVLETERLTLRELNLTDAKAIFGLRTNKEVNEFIDRKRPNNLSEARAFIDRI
STLTLNNEGIFWVIESKSNHQLMGSIGLRNFEDEDDYAEIGYELDPIYQQKGFMSEAFEE
VLKFGFNQMELKTIEAFTHKNNMDSIMLLEKQKFVFHPEIKDEGFENNISYRLTK
>FCMOIPGL_02121 hypothetical protein
MTLFSFKSFPNLKSERLFLRKATLKDTQDVLFLRSNNEINKFVFTERIKNIEETKSFIAL
CDTLFKQKNRIFWLIEYQQKIIGSIILHQISLNESYAEIGYKLKPEFHQKGIMSEALNIV
LEFSFNKMNLKTVEAFTHKNNSASIALLKKQHFNFQPERKDTNFENNRIYKIENIR
>FCMOIPGL_02122 hypothetical protein
MKAILKKEFNSFFASPIAYLVIGVFLLINGLYLFIFNDDFNILNAGFADVTPFFYLAPWV
FLFLIPAITMKSFADEFNTGTIELLKTKPISDWQIVLGKFSASFLLVIIAIIPTFIYVFT
VYKLGNPVGNIDFGSTIGSYIGLLFLAGTYTAIGLFTSTLSKNQIVAFIIGVLITFFLFF
GFDAIATSFANDSLTIKNLGINEHFKSISRGVIDTRDIIYFLSVTFFFLFITKTRLENE
>FCMOIPGL_02123 hypothetical protein
MNKKLRNIAFLIVGLIALNFISQSVYKRLDLTQDQRYTLSETTKTIISKVDKSLFITVYL
EGDFPSEFKRLQIETRQYLEELAAKNSNIIIHFANPDNQREDLIKKGMMPSQLTVEENGK
LSEAIIFPWAEINFNSQTKIVSLLPTAIVASQEEQLQKAIENLEYSFSNAINSITQKEQK
RVILLKGNGELEDLYQYSFLSEVAKKYKLAKFTLDSVAKNPQKTLQDLNSFDLAIITKPT
QKFTEKEKFTLDQFITNGGKTLWMIDNIQADQDSLLSTGKMLAYPRELELTNLLFSYGIR
INTTLIKDLYAAKIALATGTIGNQTQFQNLNWFYHPLVTGNPNNAITKNIAPVRLQFTNQ
IDTLKNNIQKTPLLLSSPLTQKVGTPTIIELQSIADEPLEKEYVSGHQLFAVLLEGNFNS
AYKNRVKPFETSLFKANAINNKMIVIADGDIGKNQILKGKPTDLSRDKWTNEEFGNKDFL
LNSVDYLLDDTGLIKLRNKTLKINILDKQKAFKERTFWQFINVALPLVLLFVFGFAFNYF
RKRRYS
>FCMOIPGL_02124 hypothetical protein
MKNVSVLGCGWLGKSLAISLLDEGYSVKGSTTSEEKLELLELNNIEAYLVNISDFEEFDD
FLNSDILIIAITSKDIDGFENLISQIENSSIQKVIFISSTSVYGRLNKVMTEEDEVLKTL
LSEIENLFRENTFFETTIIRFAGLFGDTRQPSNWFKNGRKIPQPKGFVNMIHKEDCIEII
HEIIAQNCWNETFNACSNHHPTRREFYTIAKLSNDFEVPEFENNEVYEWKIISSKKVQEV
LDYTFIHDDLLSI
>FCMOIPGL_02125 hypothetical protein
MKKLLLSLLVVALSYTTTAQKKIPASPSQKIEQTVGLSTISVEYSRPGVKDRTIFGDLVP
FGKVWRTGANQNTKITFSSDITVGDTTLKAGTYALYTIPNEESWDVIFYTDATNWGNPKK
WDETKVAAKVSAEVQPVPDTIENFTILFDNLKDTSTVLGFLWESTYVGVQINVTN
>FCMOIPGL_02126 hypothetical protein
MKKRTRLFNFLIDSTTFFIIVILLSILLKNYIERENLKYFMILLYYLYYFIFEFTTGQTI
GKIITKSKVVSKKNGGKPNFSETLIRTLSRLIPIDFISYLFTSNGIHDILSKTELKPVKL
>FCMOIPGL_02127 hypothetical protein
MKSIKKGIALVMVALMMSSCATVFGGKVTEYQKRKPLPGEQQREVRVGALIADVILFWPG
LIVDFATGAIYKPKK
>FCMOIPGL_02128 Glucose--fructose oxidoreductase
MEKRKIRWGIIGLGKIANKFATDLATLENTELVAVASRNLQNANEFAEKHNAKKAYNSYE
ALAKDADVDAVYIATPHSFHKEHSILCLQHKKAVLCEKPFAMNLQEVIEMIAVAKEHNIL
LMEALWTFFLPHFKYVLEIVKSEKFGKIKSLEADFGFHPIYDENSRVFKKEVGGGSLLDI
GIYPIFAALSTLGKPNSIDAEATFFESGADADCTMIFNYKEAKATLKSTLLENTPTHAIF
TFDKAIVKINTQFHAPSTVTILENGKEETIDFGYKTIGYNFETAHFNQLLRDGKKESDIM
TFEFSKNLIKTLDKVRGIIGLEYS
>FCMOIPGL_02129 Sodium/glucose cotransporter
MEIASKLHYVDWVILSVTLLFIVVYGTYVTRKNSNVTDYIKGGSDSKWWTIGLSVMATQA
SAITFLSTPGQAFHSGMGFVQFYFGLPIAMIIICVVFIPIYHKLKVYTAYEFLEGRFDLK
TRSLAAILFLIQRGLAAGITIFAPAIILSAVLGWDLLTLNIIIGFLVIIYTVSGGTKAVN
VTQKQQMIIIFLGMLIAFFMIMSQLPENITFTKALEIAGASNKMKVLDFSFDLSNRYTVW
TGILGGTFLMLSYFGTDQSQVQRYLSGKSVRESQLGLIFNGLLKVPMQFFILLIGVMVFV
FYQFNPSPLNFNPGANEEVLNSKYAKEYQQLELKHINIENTKKAIFADGFQIAEKQQIQE
LNTEDLKIKEAAKKIINKIDEENDLKKIESNDKDYVFIHFILNNLPRGLIGLLLAVILSA
AMSSTASELNALASTTAIDLYKRNVKEEKSEEHYVKASKWFTLGWGIIAISVACIANLFD
NLIQLVNIIGSIFYGNVLGIFLLAFFVKFVKGNAVFVAALITQILIILVWYLDWLPYLWL
NLLGCALVMGIAIVLQFFIPSNNNTSDNLETIEIE
>FCMOIPGL_02130 Mycothiol S-conjugate amidase
MKKIFFFSLAFLLISITVFAQKPKKLTSNEIYQKVQKLNFLGTALYIAAHPDDENTRLIA
YLANTIKARTGYLSITRGDGGQNLIGSEIRELLGVIRTQELLAARNIDGGEQFFTRANDF
GYSKHPDETLEIWDKDKVLSDVVWAIRTFKPDVIINRFNDKTPGTTHGHHTTSAILSVEA
FDLAKDTTQFVSQLKYTNVWAPKRLFFNTSSWFYKTQEEFDAATKGKLTSFDVGAYYPLK
GVSNNELASIASSQHLSQGFGRLTSRGEQKEYVAFLKGEPLKDKNDIFSGINTTWNRIDN
GGEIGDILYDVEKDFDFVNPSKHLPKLMEAYKLIQKLEDAHWRAIKEKQIKEIIEACAGL
YLEASAISSSGTPNSSIEVDFEILNRSNIPMQLTSITSTIDKNIIYKGFELSENKKFNFK
EHILLKTNEFSDPYWLKNEPSLGMYTVENQQLIGKPETPRIVKVDFNLIINYMTITITKD
VIVRYAERDKGEIYEPFEILPKITTRIKNKVLIFSDSIPKKISVEVRAGASYINGKVSLE
VPENWSVSPKEINFGIAQKNDIKTVSFVVSPPNNKSEGKLKVIATSEGKTYDKELVEINY
THIPKQTVLLNSEAKIVRLNIEKAGNYIGYINGAGDAVPESLRQIGYTVDEINPLEINEN
NLLKFDAIVLGIRAYNVVDELKFKQKFLLDYVKKGGNMIVQYNTNRGVDIKAPYPLKLSR
DRVTDELAEVGTFDDTQEVLNYPNKITSEDFKGWVQERGLYFPNSWSQEYTPIFYMNDKG
ETPKYGSLLIAKYGKGNYIYTGLSFFRELPAGVSGAYKLFANMLSVKKREIEIKAEVKK
>FCMOIPGL_02131 DNA polymerase III subunit beta
MKFIVSSSQLLKQLQVLGGVINSNNTLPILDNFLFEISTNQLKVSASDLETTMSSVIDVE
SDSTGSIAVSARLLLDTLKTFPDQPLTFKTEGDNTIEISSDQGKYDMAYFGGDEFPKAVT
LPSPSKTIIPGHILGTAISKTIFAAGNDDLRPVMSGVFFQFSSQSLTFVATDAHKLVKYS
RTDVTAEQTAEFIMPKKPLNLLKGILGGSESEVTIEYNDANAKFTFDNIVLVCRLIDGKY
PNYEAVIPKENPNKLTVDRASFLNSVRRVSIFSSKTTHQIRLKMAGTELNISAEDIDFSN
KADERLSCDYQGDDMQIGFNSRFLSEMLNNLNSNEVLIEMSLPNRAGILTPIDGTDEGEQ
VTMLVMPVMLNS
>FCMOIPGL_02132 hypothetical protein
MKKVILLLLLYPINSFCQTSEKDALVWFDSIIGKKNLDINIGIRYIEKFRTLKDNSQFLI
DDKFYASTINYNGQTYYNIPLKYDIYKDDLIFKIKSYHENYSTILDKTKIKSFITDGKLF
INIADNGFNEKLFSENNFVIYKKNSKRVIKSIKSDFYYDEFILNNSYSLLVDDKFVPANE
KSDWKKVFPSKKSEINKFFKKNRKKLKTSPDIFMKELLTVLTSNSLT
>FCMOIPGL_02133 hypothetical protein
MKKSLLLITLFFTVHFVYSQEEKISIEFNNLSQLKAIELLEQNTNYQFYFIDNWFVDKKT
ITKKFTNVNIQDILDVIFKNSDLNYFVFEKNKIILTKNSRIHSSIYKDNKVNETLNENIV
ERNGPILLDENNTQNDNTKTIVIGREKVDKNQKFYTLSGYVKKINTNEAIDGLILLERDK
NIYTTTNNKGYFSIKLPFGINYIETVLSGIENSKYKIIMYDNGTYNFKLNETLEQLGEII
IQADVKNNIKSVSSGLVQIKIENIKTVPQVLGERDILKVATTLPGIKSSGEGSDGVNVRG
GKTDQNLFLLDNSVLYNPTHFLGLFSAVNPFVTKNLNVYKGSIPAEYGGRISSVFEITTK
NSTTKKFSGEASIGPVTSNIALDIPIVKDKSGLIVGARGTYSDWILNAIDNESLNNSSAS
FVDAFAKYSHQINEKNSVNGMVYYSKDKYSISSDTTNTYGNKILTIDWDHKFNDKNFGNL
SLSNSDYSFDIDYDSNSNNNFNLKYNINETTLKLKMNYLHSKKHNFNYGFSSKLYNVSPG
SISPKGNSITEPFSVQEDKALENALYFSDDFSITKKLSLDVGLRYSLFSALGESTQRVYD
ENSPKNEATVTEVKEYKNNEIYKSYNGLSLRLSSRYFFNDDLSVKASYSNTYQYIHRLSN
NTTASPTDTWKLSDLNIKPQEAKQASLGVYKNLDGNKYELSLEGYYKTYNNILDYKVGST
FLLNEHIETEVLQGKGKSYGAELLLRKNEGNLNGWISYSYSRSYLKFDSEFAEETINNGN
YFSANFDKPHDLSIIANYKFTKRYSFSANFLYQTGRPVTYPIGKYVYQGNEYPLYSDRNE
FRIPDYFRLDIGINIEGNHKIKKFTHSFWNISIYNLLGRNNPNSVFFVTDEGKVKAYQSS
IFSKPIPTITYNFKF
>FCMOIPGL_02134 hypothetical protein
MKSLKIFLILFCASFILTSCLEEIPLTNSESKSFLVIESTITNEYKFQTVKLSRTIELDS
LNSIKETNAIVVIKDDSNNSFNFTETDDGIYVSNNEFEAELNKNYTLEITTKDGKRYTSK
QQKIAGVNEMDSLEAKLGTKTNGEEGINIVVNSNTTDENAQYYRYEYEETYKIIAPLWSN
QKLEIIIDEFPFSEVALVTDPVDNKICYNTINSSDIIQTETTLLSGNDVNFNVHFLGKND
FKVSHRYSVLVKQYVENLEAYTYFNTLKKLSESQGIFTQNQPGLVVGNISSVSDIDENVI
GFFEVVSVSEKRIFFNYEEYYPDGEVDYISDCVITAPPLLAVAAFPGQKPPQTSPLVNAL
KQNSIFYLLNSEPTEQLIGNYLLVPRECGDCTVLGSNVKPTFWID
>FCMOIPGL_02135 hypothetical protein
MKNKIILFILLVTASFNFFGQTKINDNEYEYETFKSLPQESIYIHSNTNFILTGEKLLYK
VYTVNSLTKTNSSLSKIAYVELINERKESVLKQKIRLTNGIGKGDIFITSEIETGNYKLI
GYTEWMKNNNLFFQESVTIINPFSGKIISIKNKTEEEKVSNNKEGKTTENNALLDLNLKS
DTYGKRQKVVLKLSLKNKEKISGDFSVSVRQVNTIKKNKKQNTTLFTESLSKLKPTASNS
TNTIYLPEFRGELISGKIEATNASIENIRIGLSLIQKNGIFKITNTDKNGLFYFNISEKY
DSEKAYFQVLEDNKEAYSIKITENKGLNLNNLVFNPIEIDTKTNDLILERTAHIQIENAF
HELKQDPIVAHKSIENVYENKFTTINLDDYTRFKTIRETMVEIIPNSWVTKNGDNYAFHV
RDYNKTINYNSAPLLLIDGYIITNPNELIKFSSKKVSKISISQEIFKFNSKIYEGVIRFE
TYKGDYTPIVTKGVIETNITKPIASKEYYTQVYENNSDTFKRIPDYRTQLLWQPNLDLNQ
QEISFFTSDVSGDFEVSIEGFTSKGTPLSVKKMIYVK
>FCMOIPGL_02136 hypothetical protein
MYYLDNSPTELRPGKYQLVPKKCGDCTVLGSNIKPTFWVD
>FCMOIPGL_02137 Acyl carrier protein phosphodiesterase
MIGNFIADHIRGNNYEEYSKEIQQGILLHREIDTFTDAHKIVRKSKRRLHERYRHYDGVI
IDIFFDYFLAKNWADYSAIPLDVYTNAINLFFDEISSELPLKSQQFIKYMIEYNILFNYQ
FQDGIEKVLNGMNNRTKGKSQMNLAIEDLQILHKEFEDDFTVFFKDLQYFTNQKLTELTK
IK
>FCMOIPGL_02138 Gamma-glutamyltranspeptidase
MKKNILLFTLSLLLVNCKSEIKKEKTTGLITQKAMVVTAREEASKIGVVILKKGGNAFDA
MVATEMALAVAYPFAGNLGGGGFMVYRKNDGEIGGLDYREKAPLAATKNMYLDNEGNIID
GKSTEGATAIGIPGTVAGVFAVHEKFGTLTIKEILEPVIQLAKRGVIVTDKQAKRIKNYK
DLFLKVNKDAILFTKNWQENDSIKYPALAETLTLIQKNGKDEFYKGETAKRLVKFIQANG
GIITLEDLAKYEAKWRTPVTFTYDDLKIISMSPPSSGGICLAQIMNALEPFDLDKFGHNS
TKSIQLITEAERRAYADRSYFLGDPDFVTIPQQELISKAYSNKRMAGFSFEKATKSSDVS
HGNIEIIESDETTHYSIVDQFGNAVSVTTTLNGAYGSKLYCSELGFFLNNEMDDFSSKPG
VPNMFGLIGAKANEIQPEKRMLSSMTPTIVEKNNKLFMVVGTPGGSTIITSVLQTILNVH
EYKMGMQEAVNAARFHHQWLPDVVKMEPNSFDKKTITELEKLGYNIDETTSRIIGKVSAI
LVLPNDNLEGGADKRGDDTAVGF
>FCMOIPGL_02139 hypothetical protein
MIQPFHLAIPVQNLEKCRTFYRDILNCEEGRSTENWVDFNFFGHQLVIHQKDDFKPERIS
NPVDGHDVPVPHFGVVLTWEDWHVLSERLKAANTKFEIEPCIRFKGKVGEQATMFFKDPE
NNALEFKAFQDMSQLFAK
>FCMOIPGL_02140 tRNA pseudouridine synthase C
MQLVETHIVEKLEIPIRFQEYGVGIFNTIPTKSGIKKAIKKELIFIDGILATTSKYISGG
EKIELFESENSSPFERLQLDLEVLFEDDYLAIIYKPAGILVSGNKFVTIANGLTQNLKKS
NLSDAVKPQPIHRLDYPTSGLLLIGKTSASIIELGKLFKNKEIQKTYFAISIGKMNSEGF
INSFVDKKEAYTNYTVLQSVISKRFEFLNLIKLLPKTGRKHQLRKHLFSIGNPILGDKEY
FLDDKILNGKGLYLHAATLEFIHPFTKEKISISKELPKKFTKIFPKY
>FCMOIPGL_02141 HTH-type transcriptional regulatory protein GabR
MFPYKTSFQLNRKSKQALYLQLSNQFIALIKERKLIPETKLPGSRTLSEMLQVHRKTVVA
CYEELLLQGWVESISKKGTFINAKLPELHQQEFISKKEILPISNIGFQFYKDKSLERISP
EIKEGFMYLNDGVSDARLTPTEDLARTYRRICSRKDIYKEMSYGSLFGNEKLRITLADYL
NKTRGLNIHKDNVLITRGSQMGIFLSAKLLLQENDNIIVGQTNYTSADTNFLQRKTNLVR
VSVDENGLVTDEIEQICKQKSINAVYVTSHHHHPTTVTLSAERRIHLLNLAKKFNFAIIE
DDYDYDFNYNHSPILPLASHDINGNVIYIGSVCKTVAPVFRVGYVIAPKEFVNEAANQRR
FIDRQGDALLELTFEDFIKSGDLDRHIKKVMKVYKTRRDLFCKLLKEEFSTIFNFEKPKG
GMAVWITLDKKYSWKTISEIAKKHKLEIGEWQRYDNANSGHNSIRMGFAAYNEQEMIELI
NRLSKTMKEVIQI
>FCMOIPGL_02142 hypothetical protein
MNKKDLQPKEYHEYYARYIDKVDENIELNIGFEVDKKMVVDFFNTIPKEKQEFRYQPEKW
TIKEVLQHIIDTERVFIYRLFCIARNDKTAFPGYEQDDYIAPSEANKKSMEDLIEEFSIT
RLSSLNLIKSISKENLKNLGTASDSTISARACAFILLGHSVWHIEIIKERYL
>FCMOIPGL_02143 Spermidine/spermine N(1)-acetyltransferase
MLEIRRANSNDATHIALLGRITYTESHGNFIEDKQNLLDFYKKYYAVAQIKSEINDENNL
FWIVFIDELPIGFAKLSLNVNYADSKDTNFCKLQRLYILNDFINLKIGSQLQDLILQKAI
DLQFKTIWLTAYYKNIKGIKFYQKYGFKEVGSIDFFVGETNYENLIFAKEL
>FCMOIPGL_02144 hypothetical protein
MEEYQKSKLNRVKRGANRATYDVDKINTILDAGFLCYVGYIYEGKPITIPMAYARQDDKI
YIHGSTANRMLLSILESGETSITVMHLDGLVLARSGFHHSVNYRSVTLFGSLQKVEEEAD
KTEILKWIVNQMVPNQWDSLRPMNQKELDRTLVVEFTIETASAKVRETGVADEPEDYNED
VWAGIVPVKQVAEYPIADKGKPQQMEIPKHILDYYEANK
>FCMOIPGL_02145 hypothetical protein
MKKLFKFIGIILLLIIAAITIYYFVNNEALPKGKKGKEAEALATKMFDALNHEAYENTEV
LKWSFRNEHHYTWYKKENIVHISWAQYKVTLHTKEIEKSEVYIDGKLTDNKEIVKKAQDF
FNNDSFWLIAPYKIFDGGTERSIVKHEDQDALLITYTSGGSTPGDSYLWILDENYLPTSF
KMWTSIIPIGGVSATWSDLKNTKSGIKLPTKHTLSLFGLEIPMGNVKAYNEKADVLANIV
LKAIKHKNYENTRFIEWSFAGKRSFKWDKEKHIVDVSWDTIRVNLHPQEKEKSTVFYNEK
KQEIADTKIVKRAWDIFNNDSFWLVAPHKLFDYGTIRNIVSINNKNALKVTYTTGGSTPG
DSYIWILDENNIPKSYKMNVPSMKMNGVNATWQDWITTESGTLLPTNHTFDSGKKLSMGD
VKAYN
>FCMOIPGL_02146 hypothetical protein
MTSKHISNGILRALAIVVGILLLLYFLVKIQSVIIYIIIAAVLSLIGRPIILFLRNKLKF
PNTIAVISTMILMLSLLTGLVVLFIPLVLEQGKSLSLLEVDVLQAKIQDIFNQITAYFSS
KGIDVLQKFENFDFVSQFKTIPNILNSIIGALGSLSVGLLSVLFISFFLMKDSQLLKKGL
LTLMPSNNSEGRFSKSLETINNLLSRYFIGLIFQITILFVIYTIILLIFGISNAVVIAFL
CALLNLIPYVGPLIGGILMFFLSMTSNIGLDFQSEILPTSLWILFCYGLAQLLDNFVSQP
VIFSRTTKSHPLEIFLIIVICGILFGVVGMITAVPLYTALKVILKEFLSENKIVKSLTKD
I
>FCMOIPGL_02147 hypothetical protein
MKLAILQPEVQQFIVDNLKSDITKLILKGSPFDKISTQELANQIVAKQKSEHKLATWFAT
ENIYYPPKISIEQTSSEITANYKSNLVKGDSIIDITGGFGVDCFYFSKQFKSVFHCEINK
ELSTIVKHNYQQLKVENIDTFSGDGIDFLKKSAQTFDCIYIDPSRRNDIKGKVFLLKDCL
PNVPEIIDFLFSKSNQILIKNSPILDISSAISELKFVKEIHVIAIKNEVKEVLFLLEKNY
DKSIKIKTINSINNNAQQFEFNLNEVITSNYAEPLTYLYEPNAAILKSGAFHQIATQLNI
FKIHQHSHLYTSEKLIDFPGRCFKIIAILNYDKKKIKRLIPTNKANITTRNFPKTVAQIR
KETNLKDGGNSYLFFTTNIQNKLICILCSKS
>FCMOIPGL_02148 Sulfurtransferase FdhD
MQTTSYQGLKLSFSNQLKTEDFLVVEAPLQININNEAYTVVMRTPNDDFELIRGLLFAED
IYKKIIPLSYKIIKEDAKTPTIINVTISKEDLGKGYLNKRTLLSVSSCGICGKKELKDLK
VDGEKLESTFFSSEKVYKMFAKMSAFQETFKKTGGSHAAAIFDKNQDLLSIKEDIGRHNA
VDKTVGDLLQKEILKKANYLLVSGRVSYEIVSKAFIAKIPIIVAVSACSSLAVDFAKEFG
ICLIGFSRDNKMTIYANPNYLKKLENV
>FCMOIPGL_02149 putative oxidoreductase
MSKKTAAQPPEKLTGIELTDVPKSSVGVKAIKSALTHVKDEVGIIKGLSLLSKLNQKNGF
DCPGCAWPDPDEKRAFLAEYCENGAKAIAEEATKNKVSPLFFTTHSVEELAKLSDYEIGK
SGRITHPMYLPEGKTHYEEISWGKAFKLIADELNGLDSPDEAIFYTSGRTSNEAAFLYQL
FVREFGTNNLPDCSNMCHESSGVALSQTLGIGKGSVTLDDFNHADLVIVIGQNPGTNHPR
MLSALSETKKKGGKIITINPLPEVGLMNYKEPQNPLKWLGKGQDLTDLFLQVKINGDVAL
LKIILKLMKEQEDLKPNSVFNHQFINEKTAGIEDLLKDLDTYSIDELVPQTGLSLNEIKN
ATELIINNEKIIICWAMGLTQHKNGVDNIREVVNILLLKGSIGKKGAGTCPVRGHSNVQG
DRTMGIWERPPSSFLDNLEKEFKFKAPRRFGFDVVEAIEAMHQKKAKVFFGMGGNFVSAT
PDTEFTADALRNCKLTVQVSTKLNRSHLITGKKALILPCLGRSEKDYQVTGEQFVSVENS
MGVVQQSRGHLEPCFDKLLSETAIVANLANFTLKRSNTDWIELMSNYDLIRRKIEATIPG
FENYNKRVRIKGGFYLPNNARDNNFETTKTNKANFSINKPSEIELENNQFIMMTIRTHDQ
FNTTIYGLNDRYRGVLNERRVVFMNPDDMKTLGLQKLDLVDLTSHFNNEKREAKGFLAIP
YSIPKQCTATYFPEANVLVPLKSKADISNTPASKTVIITIKKREI
>FCMOIPGL_02150 hypothetical protein
MKKHIFLFAIVCITQFIYSQNDNIPEKKTQKGFGKIDFLSIKMPETTIPNESNMGFTGIH
YNLMMNDWSYAGLGIYGAVTGERGGFFTLGINAGIKKYFTNNFYLDTGFHFGGGGGKSAP
DGGGAFILPHFNLGYNFKDLSINSGWSYVNFFDGGEIKGHQLNVGLEIPLDFSYADYDVA
ENDYSFDGLQKSNWNVNSKKSSLMLHLNNLEIKGDDTNKNVQNFGRATIRLAGFEIASYL
SKNWFTFVKFDGAYDGIKAGYMDVFLGGGYHLPFNKNRTNILAKFGVGAGGGGGVDSQGG
FLIYPDISIEQKIFDAFFISVNKGYVMSPNSHFYTSSYGLGLKYYVERNGIISDENSFSE
GIFKGIEVITKQDLYFNAKRDGEPTEDMHQISVQINFDLNKNLYIAGQTSFANFGNAGAY
AEGIVGLGMQTNPFINDKTSFFAQVLGGAAGGGDISTGEGFIVKPSAGFNYQLNNTLSLR
TAAGYVKAKGGDLSSPFINLGIKYNLSFLKMN
>FCMOIPGL_02151 Beta-hexosaminidase
MKNKSFLLFISLLFIHILTINSQDINIIPKPQEFSFDKGNVVINENTIIIHTSESNASAK
TLQNYFKDVYELDIKSTEFQSLKKNSIHFKMDESIVNEGYELSISDGEITICALNDKGWF
YAVQSLIQYCSSNSYFSKYEKSIKLKEVTIKDAPRFKWRAFMLDEARHFKGMQQVKMLLD
EMALLKMNVFHWHLVDDQGWRIEIKKYPKLTQIGSKRKSTQIGPLQWESPIQSAEPHEGF
YTQDQIKEIIKYASDRHITIVPEIEMPGHSTAAIASYSWLGTSKEEIEVPIKFGVGKDVY
DVSNPKVIQFLTDVLDEVMALFPSEVIHIGGDEVKYNHWKNSAAVKTYMKEKNLKTPADL
QVYFTNNISNYLQGKGKRMMGWNEIMGHNLHFYQDKKDTETTQKLAKETIVHFWKGDNEL
LTTAASNGYEIVNSLHSYTYLDYTYNVLPLSKAYSFDPVPEKLDVKYHDKIIGLGAQMWG
EWIPTNGEMHFKVFPRIAAYAEIGWTRKENKDFAAFTSALKHLQKRWTAKGIYFATDEFV
EKKK
>FCMOIPGL_02152 Galactokinase
MTEIISIAPGRTCLFGDHQDYLGLPIIACAINRHITLKAIKNNSDTFTIDLPDINQKRTI
AVFDEHLILEKEDFIIAALRVLKRNNCVPTCGYDIVITGTIPINAGTSSSSALTISWIQF
LLKAYGPKELLTPEIISKLAHEAEVLEFNAPGGKMDHYSIGLGNIIYLETGNHFSYQVLQ
KPLSGLIMAESGVPKETLGLLKRLKENSWKAIDVVAKNVKNFELEKAKLKDLEMYLSFLS
DDLKPYFEAAIGNFDVTKKALLEFKKEELNLVEIGNLMNQHHHYLKNLLKITVPKIDAMI
DAALEAGAYGAKIVGSGGGGSIAALAPKNKEQKIIDAILKAGAKDAYAVSVDKGARIL
>FCMOIPGL_02153 Glucose-1-phosphate adenylyltransferase
MNDNLLILAGGMSSRMKSPSTSNLINKEVENQANVRSKSLISVGNQGRPLMDYLLYNAKK
AGYKNIYIVINEKGGLFKEFYGKKTANNNFNGLNISFATQYIPTDRVKPFGTADAVFQAI
EQFKDLQSKQFTVCNSDNLYSEKALRMLRETSSSNAFISYNRDGLEFSLEKILKFAVVQL
DRKNYLQNIIEKPSLETANSYKDTLGKIRVSMNIFKLDGKMMYPYLKNCPVHPVRDEKEL
PSAILNMVKEHSNAVLGIPLSEHVPDLTAKDDIIIIKEYLKKHYPTLLNWAN
>FCMOIPGL_02154 hypothetical protein
MRPSYKVFTSLIIIKCLPEKNKIIDVIKIIDTIFMVLVSITWGVWGLVISKFSKIKGTRT
KKNYLFL
>FCMOIPGL_02155 hypothetical protein
MYKDTLQQIIFFIISSVVFFKTGKALITLNGINSFLDFGIIMLFFVSFVFFINFLLRLFH
KLINAFSF
>FCMOIPGL_02156 hypothetical protein
MVKIIPISKSNPQDRGAENKYYAQAVATGKTDLERLAYLVANQSTVREGDCYAVILSLIH
NIVDELNQGRIVKLDKLGTFNISVSSNASDTPEAVSANLIKDVRIRFRPDQRIKNSLNIN
TMNFTTSQSM
>FCMOIPGL_02157 hypothetical protein
MKILKTISAVALLLIGVFSFSKAEKTTPKSSLNLEEVNITQILSSEEKGCRPSSEVFFYV
DTKLVKKSRGCTTINASIYVLDRVSGQSNLLANENIVVPSYKDAVLHYDTIPSTCNKIEL
TNGDKIVGSEIQTPYCFNELIQYKTIYKSYNNATNKLLHIDRTL
>FCMOIPGL_02158 putative type I restriction enzymeP M protein
MAKKTKNTFEQDLFKAADKLRKNIDAAEYKHVVLGLIFLKYISESFIELHNKLEADEWSD
AEDRDEYIAENTFFVPKLARWSHIHAQAKLPSIGQTIDEAMEAVEKENKELKNVLPQVYG
KANLDKTSLGELIDLISNTELQAENENSKDLFGRVYEYFLGEFANAEGKKGGQFYTPKAI
VKLMVEMIEPYKGRVYDPACGSGGMFVMSEKFVTEHAGNIKDITVYGQESNQTTWKLSRM
NLAIRNINSKFVAWNTEGTFLKDAHPDLKADYILANPPFNQKEWGIDILQDDARWQYGTP
PNGNANFGWMQHMLYHLAPTGVMATVLANGSLSSNTSGEGDIRKTLVENNLVECIVALPK
QLFFNTGIPACIWFLRRGRTKTNEVLFIDASEMGYLKDRVHRDFSDADDENKKGDFHDNG
LGDIQKITRTYHNWKTVTVNEPSLRGTKQSVYEDIKGYCKSATLAQIQKHNHVLTPGRYV
GIPDEIDDGIPFETKMADLTTTLQQQMQQEEALNQEIKTQLANIGFQL
>FCMOIPGL_02159 Putative type-1 restriction enzyme specificity protein MG438
MSSVDEKMPEGWVKDTLGEVIDIKHGFAFKGEFITLQSNNKILITPGNFKVGGGFKSNKF
KYYTGDYPENYVLKPNDVIVTMTDLSKEGDTLGFSAKVPNDEKEYLHNQRIGLIQFKNSD
FDKEYVYWLLRTKHYQKSIVNSATGSTVRHTSPSRIQEYQFKYPEDKKEQKAIANVLTAF
DDKIENLRAQNQTLEQTAQTIFKEWFGLYQIDDVLPEGWRVGKLGEIGTIVCGKTPSKSK
SDYYGDDIPFIKIPDMHNQVFILGANDNLTLMGANSQRKKMIPKNSIIVSCIATVGLVSL
STQDCQTNQQINSVIPINEFMREYLYLKLTSLRKYLNDLGSGGTATLNVNTSTFSNIELV
IPAKDFLMKFNKIQSPLFEKILSNLKQIQTLTQTRDTLLPKLMRGELRVNGLKKE
>FCMOIPGL_02160 hypothetical protein
MKHYNLKKHNRKSIRLKGYDYAQNGLYFITICIQKRVCLLGNIINETLETNNAGKMIDKW
YWELENKFPNIKCHAHIVMPNHFHCIIEIVHNVGADLCVRPNTNTDLRVRPNTDLHVRPN
TANKNKPIPTKNDLETNDNAFVSNVNVPVSNKNVPVSNKNVPVSNVNVPFSNANVPIMGE
HIGSPLHVVVQWFKTMTTNEYIRNVKTNNWQRFNGKLWQRNYWEHIIRNEKSYQNISEYI
MNNPTKWIADKLNPNNISN
>FCMOIPGL_02161 Type-1 restriction enzyme R protein
MHKLSEDSIEQSFIDQLIGQGYTYHYGPDIAPYSDNPQREGFESVLLEQQLKNALRHLNP
NVPESARVEAYHKIINLGTQDLMENNERFHTLLTNGVTVEYHKEGRTKGINVRLLDVENP
ENNQFWVVNQLVVKENNNEKRFDVVIYINGLPLVFVELKNATDEKATIKKAYTQIQNYKT
AVPSIFYYNSICVISDGIDAKTSSVSAPLSRFLSWKSPTPKVKDPRTELQILTEYMLNKK
TVVELIRYCTVFEQEEKKDDKTGLIFQIKIKKVAAYHQYYAVQKAVAQTIRATGNMPSSN
FSQRENKNINYRGNYMFSGLLKTAREFRKKGTPVEKTLWEVLRNRQVLDLKFRRQHQIGD
YIVDFYCNELKLIIELDGDYHFTETQQLKDKKREAYLTKIGNTVIRFKNETVDNNIEEIL
LKIKEIKDVKSGFSPAGRDGSEGYGNRKIGVVWHTQGSGKSLSMVFYSGQIVTHPQMENP
TIVILTDRNDLDDQLFATFGNCKELLRQTPVQAESRNHIKELLHVSGGGVIFTTIQKFSP
EEGNVFETISERTNIVVVADEAHRSQYGFTGRLVETDEGSEIRYGNAKYLRDALPNASYI
GFTGTPIEKEDKSTPAVFGEYIDVYDTKQAVDDGATVPISYESRLVKIKLNEEVTKSIDA
KIDDIEDTTEAQIEKAKKKSAAIEKIIGKEDRLKDIATDLVSHFEARQKVFEGKAMIVGM
SRTICAKLYNQIIALRPDWHHDDLDKGAIKVIMTSTSDDDAILQPHHTTKTQRKALAASI
KDPNDPLQMVIVRDMWLTGFDAPNLHTMYIDKKMQGANLMQAIARVNRVYKDKPGGLIVD
YIGIGQDLRNAMATYLQSGGEGTPIVDIKEAIAGMLEKFEVVEQQFHGYDYKAYFASETN
IKLQILLGAQNFILQTEDLKNRFLKEVTLLSKLFAMSIPSPQADNIKDEVAFFQAVKARI
NKFTGTSTKSDYEVETAIKQIVDDALSSEGVIDVFEAAGIKAPSVGILSDEFLLEVKNMQ
QKNVAFELLKKLLADEVSVRKTKNIAQGKRFSEILESVVKRYHNNQIDSAQVLAELSAIA
KDMRLEDQKSTDLNLTPEEYAFYSVLKENSSTSFLKDDKMKELIHTIVDVIRKNATVDWS
KRDDVRAKLRLTVKKILMRYGYPPDVAKMEADKVLAQGESLAEMFSKE
>FCMOIPGL_02162 Mannose-6-phosphate isomerase
MTDKIWRLKGKIQNYAWGGTAYISELLGEQVSEEPRAEYWLGAHVNAPSMLESSEGSTPL
DAYLNANLTKVLGTKIADKFGRLPFLFKVLDVNDMLSIQVHPSKKEAEKGFKFENEQGIP
LTAKNRNYKDDNHKPEIMVALSEFWLLHGFLPKEKLIQVLKTIPEFNPLVTVFEEKGYFG
LYKQVMEQTTEETNNILQPLVDRLLPLYKAGKLDRTNPGYWAAKAVDAAEDTTILDKGIY
SIYFFNIVKANKGEAVFQDAGIPHAYLEGQNMELMANSDNVLRGGLTPKHVDVPELLKHV
VFEETHPNIMLGELQEDGIERIYKSPAPDFELSQIVLKPEVKYQSIAQTAQVLIVIEGEA
EVSEGAVSLVLKKGQAAFLSAESNYSISSPSFATMYKATAP
>FCMOIPGL_02163 hypothetical protein
MNQLIFKQQIKNNIIEINISNYQELSLSYSFEELNKRILSYILESKADYIKLSFKNISNT
DLSISKIIKIRESLAFLELTVISIEISFML
>FCMOIPGL_02164 DEAD-box ATP-dependent RNA helicase CshA
MKNTLLFKDLNFPPTYKYSSDSNHIPLEFYEDTFPIAKTIDLLLGYFSSNAIKVLSKSFA
EFIYNGGKMRLITNHFLSENDFDNLLDNTEINNEDKIIDIFKNLEDLEKNLSKEGQHFFD
CLKFLLKKKRLELIPVKFNGFDLAHCKKMILFDGKDYISTDGSINFTLSALIKNSESFQL
DAPWVSNVSKERIEEEKVNFEKIYSNQHPNYKQIDKKEIEKVISNIGNDKNIRDLLDDSI
KLGSDSYSKKVNFILTKKKERFNTLIEKIDNTPKFPFPQGPRKYQKDAYNEWVKKDYSGV
FAMATGTGKTITSLNCLLNLYKESGNYRAIILVPSIALLNQWEEEVKSFNFKKILKVGGG
NNWEKDLANYSSNYSWGLKNDLIIISTYGSFVLDRFQKLFQKIQEDFLLIADEAHNMGAN
NIQKKLKDVKVNKKIGLSATPKRIYDPEGTLAIDSFFKDTPPYTYSFGMAKALEFGFLTG
YKYYPLIVELSECEFEEYTEISKKLLKFFDFDKGKFRDDPIVEILLLKRKSIIHKATNKL
DLFSSIIKELIKNKKNKFVFAYIPEGNTTNNDGDTVKILNEYLKRIHNNYPKLKMNSYTS
EDQNLEEVLRGFEDGKIEVLFAMKMLDEGVDVPRAEVGIFASSTGNPRQFIQRRGRLLRK
HKDKAFATIYDMVVIPRLESNLGELFNIEKNLVKNELNRVAYFASLAMNFYDSKEALNDV
CQKYDLDLDTIINEL
>FCMOIPGL_02165 hypothetical protein
MERDQILKEILSDSELMKKYSINKQELDTLTTTPSGPYSKKIIEVLSVIINENDNHLNTT
MIYKKLKNVHNI
>FCMOIPGL_02166 hypothetical protein
MASIINSISFKNFFNYYGDYDTTRYEFEDGVNIVVADNGAGKSKFFNAFLWLFYDQVLDS
DDKKKKNVKDFAVKIISDKAKNETSIGEQVQTGIKIEYSTGRYKYQITKSFTATRISEKL
TDFDSWQITIDDIEVDKTDHVLPKYKPVYDAEEKQKVISQLILPTLRQYSFFQGEEVDKM
IDFSKKSSIEDAVRTLTNISKYEDIANIVKDIALKAEKDLNKQTNATSEHNDRLNKAIVV
KKELQEKLIQESEKLTEFNTLYEAAEQEKNELEQNFANAEKRKELDDKISDKNRVLKRVK
DDYDTFLDGINNRFFDGNFSWITLGFEDSINDFKNNIKEFRQKRYEKRALQNAAENPNDY
FTMLPVNSPDAVTLDQMIEDKKCYVCDRDAEVGSDAYNYLLKLKNRPNENNTKKEFVKND
LEDFFGNLQLNAAPFLNKFDSIPSSVLRTREKELELKQRLDKLSSELKALKSQRKDILIA
GTEGEGVDNATTIINQYKGSIRRMEQASSRIERLQDTIKSLKTQIINTEKEITNLRPKDI
PEGFTVNYEISKDLVEATLQAKERVFDKMVSLLEDHANKHFQSLIKYNDIKGGVLRFQKS
PSGGISLDYIDELGNDVSGASEGFQRMKKFAVVMSIISANTSQYNYPLLADAPLSAFGKA
FNKGFFEAIPDVFPQSIILVKDLYDKDSEDKLTDLGQQLIKSDVIKTFYLNEVDEESSQI
ERTTKIERRK
>FCMOIPGL_02167 hypothetical protein
MNSQEFKSNLVSKRPRYANSRIPLLEALANKGSRSSEYSQFGPIYELYIYAMMTGIKKKR
RLPLPPRNLTSDFLEIGKWKRDSSLVDFLLMVIFTQTDDLNINWNELEDMEEDQLNKVIS
DVVTLIEEYANGGLEYLENLYEKGELENSHYMFIDIYKNNF
>FCMOIPGL_02168 hypothetical protein
MSKIKKIKVTQSDTSKEYYSVHSIQKLNSEFDTNVFAATVPIIELFNNRDIILVEDLRGD
ARWGMNKVIQRNISKKRVKEIKNEYLNSSNRLIKFFPAITVVLLPKSEGEPRQSFSMNDK
GFNQIDFINIDKQYEGEDYIMNLPVSISWDKNKISALVIDGQHRVSAIREYYKGKNENTY
KNVSIPVSFVIFKNDPKIDLIQATRALFIDVNNTPRLVSEEKLIFIDDRNIQRRITAKIL
GANDPGNQEEDVYQKMLGDENFFLNNTNFINRYFLEESGKDDEEHRGFLSNHNSLFPWEV
SNIMTIHKNILANIFLKHVEADKTRDIRSIAKQLSSSILDEIESTESVEELSESKTQKLL
NRLRSNGLSVSELEIFNNLIILRKRHLEELQQAQRDFMTGSVADEDETTDLEEFKRVLSN
IYNQDCSKDTAFEISSNEISNLLNETCAIYVNFIVEVYNGLWFTKQIKNSIIEHEKEDRT
LIFNFILSTHEKLKIDNNIRQRKDKVDRLISNFFSEYDEVPNDKKDVIQNWSNKLSDDLD
SILLKKIVGQEMLFIYLTELNPKLSSINLTDSIEFINSLGVNGFFNSNSGIEVTFFNMEE
FKIENFNPWSEIIMKNKSMKPGLINAKKGADLILFIQNRWTNRKNTSGGNLRKLDKIQKS
YGIEILSSIAKDDQGTLFKMYTQTKDFKEFDKYLTPNEIETIKEKFDSQELLSPRAIAVL
GKFYGGLALEQIINHISKILENETL
>FCMOIPGL_02169 hypothetical protein
MKLYKYRGFKKDSEEKHWTKRIISEQELFFSSIKAFNDPFDGKVKLKFDGKLNEIIAAQA
RVQYTNKLVKKEKHQGITMNDAFTLVSSRITSEVIENSEFKDNLEKRVQSIHDSKGVLAL
SAIPDNILMWSHYADNHYGICFGFEWSKETEVFGNYKKVKYQTHYDEVWSWLHTDNEIVE
GIIFNKSIDWNYEKEFRIVIDNIEAVKFDKLNLTEIIFGCKTNSTDIDEVIELVKQYELN
VKFKQAKIDVNTYTLNIEDYNIE
>FCMOIPGL_02170 hypothetical protein
MFTHIRTSKENKEVVSKLTRRLNLGTENIISRIALAHSLSQDRVLKLEDIQNSGGKDYSK
AVLFGDYLDYYLGMVALHYGIHITDKDLPKYIKMHIDDGLQLLNEELNQRSNIDGFDFLV
EKIQEGLLVLDN
>FCMOIPGL_02171 hypothetical protein
MKISKIKLNNFRIYKGQNELNLAAKGDKNISIIAGKNGFGKTTFLTSLIWCFYGKLMTQV
EDKYKKDIKNIGGYDNYLLSLVNKDSKDESSETTFSVEVELQDLLIPAIPCRTVNIIRTY
SLKTQQETLQILIDGDENELTKDVGFEVFINDFILPREIAKFFFFDAEKIVSLAEAKSKA
ELRSLSKAYSEVLGIKKYEELKNNLESLLTKLRRRGVSDLEEYKLKELLSEEEELEKLIN
HNQDKQDEIDKHLVILKSESDSLQEKLIREGNSITLEELKELKSKRDNLKEESVSIKQEL
RKLLDLTPLVIAGKNLGKLYNQLVLENDDLYGALTEKLLKKELESFSTSILANQDLLSLD
PSIKDKIEKAISNSIKSKFKKKDSKSKVGKVYLEFSEESFREFEAIYNNIKTTFLSQFNA
IVKEEKITRALLSRTNKKIKQGEARKDNHLARQFRDEKTNADTKIEDFLNEKNNLLEEVG
GLRLKLTSHKKVRSEYEKNFNLVETDKKKYDVTQKLLVKINELIKRIKEDKKYSLQKSVS
LGLRKLMHKKDFISNVRVNIIDDVMDIDLLDKKGQVIDKDSLSKGEQQLYATALLKALVD
ESGIKFPVFIDSPLQKFDKYHSKNIIKEFYPSISEQVVLFPLLEKELSEAEYELLKPNLN
KVFLIHNTENGSEIISTRVNNLFKEFKKEKDVYTY
>FCMOIPGL_02172 hypothetical protein
MIKIKSRKVETIISEIIDQYTYADKSDRPWIIGFSGGKDSTVLLTLVWIALQRIKETLPF
PYQLKRPVYVVCNDTMVENPIISSYIDDVLVKVEEGARDQGIPIIVKKTVPKLEESFWIN
VIGKGYPVPNNTFRWCTDKLKIKPTSNFLLEQIDEKGEAIVLLGTRYEESATRERSMRKH
EVEGRRLSKHNTNANTYVYAPIKELLLEEIWYIINTVKSPWGFDNSILFQIYSDASADDY
ECPTVVTNKTHSSCGQSRFGCWTCTVVKQDKSMTALIENGQHWMQPLLEFRNNLVENRNI
SENRMPIRINGQKAVTEDGHNQGYYKAEYRSRLLRELLTIQKELQKERPHITLITNQELI
AIQVMWNRKLEFDFTVGEIYKKIYNKDISTNNIKSLDDTERRILKEVCKEDASYYHLIDN
LITLQETKTLMISKYGLHNDVENRIESFVNENQL
>FCMOIPGL_02173 hypothetical protein
MSQNLKWLSSKDAQKIAKIKSCDLMHYRVQGKLEFEKRGNAYFYTKESIKKIKPKSK
>FCMOIPGL_02174 hypothetical protein
MKETMENQNNSFIIYKAENTQNGYVYVGATKKSVECRQKDHFKKSKKGKSYTFQNAIATY
GADAFKWEEIDTAITTNELAKKEKEYILEYNSKEQGYNSDSGGGIQKTVYQYDILRGVLV
NKYSNLTDASATIGLNKQNLSKVCLSVNKASKGFYWTYDYVERFIPLEDKRKKKVHQYNI
QGEFINEFESVSEASKQTRINKSCIAKVCRGERKSSGGYLWKFN
>FCMOIPGL_02175 hypothetical protein
MKKDLMEKEKRKIKIEKGFDQIQDLKNEPEVKVLWEGISEGTFGLMCGVAKTGKTTFAEN
LAISISVGRTEYFGKKMNGVPRKVLFVNMEESWKIRGRRNTKQLNELSVAELDLYKENYM
TVPKDFPEFLNNENDWEYLHDYIAEANPDVIFIDSLTHMFSGEIEKSANCVNFIKNFKKY
VTCFDKTVIVIHHNVKGNDKPIDQNNVAGSRVILQSFQFAFGFANIPMGGKYMCPLNNKE
FAIDTTLATLYEVKENGWIEETGVKCNKFKLYKDFYKNDGRKDSTNTNLLYNYIIKGTSQ
GSQGSYSVTANEMMKQFVENSTKTMSKDTLYKSLGKLEKEGKITKESKGVYALNIKNENE
RDNGESK
>FCMOIPGL_02176 hypothetical protein
MNDKELAEFLKYISPFEIYVVNRENELECLKCPFEVVLKEDISFLRKHQVVFVELVKVTR
DLKTVFIIRGKAFFAFHFYIPDINKR
>FCMOIPGL_02177 hypothetical protein
MELVANYNPIEMIQEVSQVVQKSESNFIGANTIEVSFEHIQNKCIVPVFAKDNEVTISHY
GFINSVKEVVESVYSDINVITPSIRASHQIKGRIPSAIGKPVKELLAHEKTIYYERMAFM
MEIPNKQVVVNDQILNLTIGGVRAYNQENLFSKKSIEKFKVFIGFKNTVCTNLCIATDGL
QSEIRVSSITELKEGVLNLIQGYNQEAHLGVMERMSKFQLSEQEFAHLLGKMRMYHFLSK
EERKTKFPLQLTDSQIGIITKNYFTDKNFKRASNKMINLWQVYNLFTEANKSSYIDTNLE
RNVSVYEFIQMLGFYRDNGQNNFFNHIII
>FCMOIPGL_02178 hypothetical protein
MQLQKAQRHQVKLRLGLSGASGFGKSYSALLLAYGITEDWTKIAVVDTENNSASLYSHLG
DFNVVSLNQPYSPERYIEAIKLCEENQMDVIIIDSITHEWNGKGGCLQIHEQLGGRFQDW
AKLTPRHQAFIDAILQSNCHVITTVRKKMDYSMDRDSSGKTRVVKHGLKDITREGFSYEL
TVDFEIINENHMAKATKDRTGLFMDKPEILITKGVGRMLIDWCNQGVSIADAKKEIAECT
TVKGLRHLYQKYLPLKKELHDTILNRKQEIESVKSMVVERKEIIHNNKISENGTRS
>FCMOIPGL_02179 hypothetical protein
MVKIVGFKTFERKDGSEFCALIVQGGIEAVKSKETGKTYFTARKVNVSCTFEEEMCESLL
GSDFPGSIQKVEVEAYEYAIPETGEMVTLTHSYEYVSEEDNVVKSNVVEKELVL
>FCMOIPGL_02180 hypothetical protein
MIFFGALNGVGEVLSSIPWYLNIVLTIGGVYVIAKIIG
>FCMOIPGL_02181 hypothetical protein
MIKITRIEKEGQLVWEKNNRFTAVIVTTEFVMNLETLNEYQESNTLWFKAGTEARLEKMV
ATQIKLIEAGALVPYRVFSETPMYEGQEQDRKINADGSLGEEIGRYSQSKLGLPEKAMVM
NRTFITPAFAKVNADAIRSTVATSSLKDDAPIILEETEVYKETIHKNNNVDHYNQYFEEE
KKERQRKVEDEKSYSWVKSIFFYLDYSLF
>FCMOIPGL_02182 hypothetical protein
MKKHLLSIVILITTISNAQLKPLKDADLLTKEVTKNTTFKVDKFEYKIEWTDKLSYSPNL
GYLGGIKSLKIYLKGILINDFKSIEDEVGLQEFIIDFYDFNLDGTIDFRIRRECGGSCYY
SYYLSNIKLNKFENPKEWDYIRVRALDFKNKLLADQLAGINEVADIFKVKGNRLIKQLEK
K
>FCMOIPGL_02183 Internalin-A
MKFTIIFITLIIIYFWVKEQIKEKKITNSINENAVKKKKIHKKEVASRITTKEMYSYFYS
FVFSKSLNMAVVQAFKDVDILKTIYSYDSFPVVSSGLFSPYLYKERRIESTMTSRGDGMV
EIQYSGGVIDLEEKLYTINSDLKMIELKIYDGNKDLNSIYSILFFVEGIGEKIHHYVITN
EIDVNKKKVLSIDSEGYSLLIKSINNDEFNIKKVIDEIASTFSVKKDVNIPIASNEGVLN
IDWWNDLEDDLKKRLNFFINIPSHNFDEFEMRGLHLEKNIINFIDVNGVVEVPCRGKIDE
LVKVESLNLSNLNIENLKFLNCFTHLEWLNLDNNKIVDISPLVSLKNLKTLLLKNNENIN
FELLKKIQCLGHLSLSENNIQNIDFLSELINLEYLSLSENNIEDITPLKKLINLEYLLLD
DNKIQDIFILRNLTNLITLHISRNQLKNIDAFSELTNLESLSFMDNQVENVMPLENLKQL
ESLALYGNPISLNDKKKLSNLLPKWEYEIDITDILTPFIKD
>FCMOIPGL_02184 hypothetical protein
MKLEERFPNYKNAFFSVMGEYNPAKGYSDTNQISFVLRQSKINGNRAVDFFELNRLNDGS
VYYKIETMIGLKLILTNESHKIEDDLSYLEWIDLIQNVNIKHFFNPEYQALKEGFVKQKG
GCTTVFLFFTVLALFFIL
>FCMOIPGL_02185 HTH-type transcriptional regulator DdrOC
MRAFGLNLKRLRNNCNLSQEDLANDCDISISQIGRIERGEINTTISTLFVLAKALNIEVK
DLFDFK
>FCMOIPGL_02186 Tyrosine recombinase XerD
MNNFKLNILFVLQKIKINKKGQCPIKCRITFLKSRKEFSTGIFINPDYWDSGKQKALPQN
KENIILNNKLSLIHQQIDKAFLMLQILPNDFDVDDIYRKYKGEDSKEEITILGAYDLHND
KTKKLIGIDFNKLSWSRYVESRRKVALFITKFYKRKDVKLKDLDLKFIQDLEYFFKTELN
LKQATVYRSIQRVKKIIQFAISENYLKKDPFHLYKNKKHKTVIIYLTDVELKKLEKHNFS
QVRLQQVKDMFIFCCYTGLAYTEMSTLTTKNIEIGFDGKEWIQMIRKKTNRKISIPILPK
AREILDMYDNKLPTLSNQKFNSYLKEISELVGIHKKLTHHTARKTFATTVLLFNNVPMEI
VSELLGHSNMNVTQSHYGKIVQKKVSDEINRLY
>FCMOIPGL_02190 Cyclic-di-AMP phosphodiesterase PgpH
MSEIINRIYRNNTFIYKVFLFLITTVAIVYLFPKGGQFKYDFNNGQLWKYENLYAPFDFA
IQKTAEEISQEKKDIETNAKKYFTYDTSIFSDVKKTFSSRVNLIKPTDSISRVEINELKK
IGEKVIQDVYSIGFLEVVSEVRVLKKDEIVAIIKDNEVKDVLFKNLLTSKNVLEIIHIRL
GKEPYSFGQKQMLNILASIIKPNVSYNNQYTSKIIENDISHISYTRGKVSADELIILKGD
IVEGRKLAILNSLKSEFNSKVWSDSNYHWIVFGYTILVSLALLMLLLFLHKNRIEIFENN
TKVTFIFFNVFAMIFIQTLVIKYNPEYLYVVPLSVLPIILKAFFDARLGLFAHVLTVLLL
GYIVPNSFEFIYLHIIAGIVTILTVSELYKRANLFISVAQITVIYMITYFAFSIIKEGNA
SQINWDYFMLFAANGLLSFLSLILIYIFEKVFGLVSDVTLLELSNTNTKLLRELNEKAPG
TFQHSMQVANLAEAAANEIGANSMLVRTGALYHDIGKMLNPMYFVENQSTGVNPHNDLSP
RDSSKIITDHVIKGVELAKKYNLPDRIIDFIRTHHGTSSTYYFYKKEQELNPDTKVDIKE
FQYQGPIPFSKETAILMMCDSAEAASKSIKVPTAQTISDLIDKIIDKQMADNQFLNSDIT
FREIKVIKKVIKKKLMNIYHLRVEYPE
>FCMOIPGL_02191 putative acetyl-CoA acyltransferase
MKEVVIVSVARTPIGSFMGSLSSIPAPILGATAIKGALSKINLQANLIDEVFMGNVVSAG
LGQAPARQAAINAGIPNTVPCTTVNKVCASGMKAIMLAAQTIALGDADVVVAGGMENMSS
IPHYQHARKGSKFGPITMEDGMQKDGLVDAYDNVAMGVCADECATEYGFSREEQDAFAIE
SYNRSAKAWSEGKFSDEIVPVSIPQRRGEPIIFSEDEEYKNVKIDKIPALRAAFTKNGTV
TAANASTINDGGAALILMSADKAKELNINPIAKIVSYADAAHEPNWFTTAPAQALPKALA
KANMSLADVDYFELNEAFSIVGLANMKILNITNDKVNVNGGAVSLGHPLGVSGARIVIAL
TSILKQNNAKIGAAAICNGGGGASAMIIEKI
>FCMOIPGL_02192 hypothetical protein
MIFGICNLSIVPLRTEASDKSEMTSQMLFGEQFTILEKGKYFSKVKMFFDDYEGYVDNKQ
YEEITEDFFYKLSEQKNFIQEKLSISYLVLPTI
>FCMOIPGL_02193 hypothetical protein
MVYKLCGYKLFRDAKQQAKQGEVLSFIEESEPGDLAFFDNEEGEIIHVGIILNDYHIIHT
HGKVRIDTLDHSGIFNADLHKHTHKLRVIKKLI
>FCMOIPGL_02194 Beta-barrel assembly-enhancing protease
MKKQIIALSLGLMTIGAFAQKNELKAAEKALKKSDFKTAKEIVLSLEGTEASMDAKYKAK
YYYLKGQAFGKSNVKKAAEAYNQLFDYEKETGKQKYTKQAQPKLNDLIQFVSTKAVKFYN
EDKDFKNAAKNFYLTYKLSPADTSFLYNAAISASLAKEYDAALGYYKELQEVGYTGITTQ
YLATNKATSEVENLGSKANRDAMIKFGKYSNPTDKTSESKRGEIIKNISYIYINQGKTDE
AIVAIKEARKSNPKDLDLLLNEAQLYIKLEQMDKFGALMQEAIELDPTNPTLFFNLGVVN
ANEKHTEEAIGYYKKAIELKPDYADAYMNLAVAILSGEQEIVAEMNKNLSNIKKYDELEL
KQKALFRRALPYLEKADELNRSEETVRSILNIYDILRMNDKADALRPIYKKMRGQ
>FCMOIPGL_02195 DNA gyrase subunit A
MAEGEKLIPINIEDQMKAAYIDYSMSVIVSRALPDVRDGLKPVHRRVLFGMHELGIKATG
SYKKSARVVGEVLGKFHPHGDTSVYDSMVRMAQPWSVRYLMVDGQGNFGSIDGDSPAAMR
YTEVRMQKISEDMLADIEKDTVDHRLNFDDTLQEPTVLPTRIPNLLVNGASGIAVGMATN
MAPHNLTEVINGTIAYIENRDIEVDELMQHVTAPDFPTGGIIYGYDGVREAFHTGRGRIV
MRAKAVIEEVKGRECIIVTEIPYQVNKAEMIKKTAELVNDKKLEGIANIRDESDRNGMRI
VYVLKRDAIPNIVLNKLFKYTQLQSSFSVNNIALVNGRPEQLNLKQLIHYFVEHRHEVIV
RRTEFELKKAEARAHILEGLIIASDNIDEVIKIIRASSNADEAREALIERFELTEIQAKA
IVEMRLRQLTGLEQDKLRAEFEEIMLTIADLKDILANEPRRYQIIKDELQLIKDKYGDER
RSVIEYAGGDMRIEDMIPDTKVVVTISNAGYLKRTNLEEYKVQNRGGRGQKGATTRNEDF
LEHLFVGTNHQYMMFFTQKGKVFWMRVYEIPEGGKNTKGRAMQNLINIEQDDKVKAFLVT
QDLKDEDYINSHYVIMATKKGQVKKTSLEQYSRPRTNGINAITIKEGDELLEAKLTTGDS
QVMLALKSGKSIRFEEAKTRPMGRTASGVRGITLQHENDEVIGMVAVNDMESNILVVSEK
GYGKRSKLEDYRVTNRGGKGVKTLNISDKTGGLVAIKNVDDSNDLMIINKSGLTIRMAVE
DLRVMGRATQGVRLIKIKADDSIAAVAKVVHEEEVEDEDVAAENENGTEIENDTNENQE
>FCMOIPGL_02196 Negative regulator of genetic competence ClpC/MecB
MDDNFSPKVRDVITFSKEEALRLGHEFIGTEHLLLGLIRKGEGKAIEILAAFDVDLSLLR
KKLELLNPSNPSFINTDKPNLSLTRQAEKALKTTFLEAKLYQSESIDTAHLLLCILRNEN
DPTTKLIQKYHVNYDEAKALYKQLHVDNSEADLPSNPIAETPSDDGDYASEKSNPFDQPQ
KGKNVKKSKTPVLDNFGRDLTDLAERGKLDPVVGRQKEIERVSQILSRRKKNNPMLIGEP
GVGKSAIAEGLALRIIERKVSRILFDKRIVSLDLASLVAGTKYRGQFEERMKALMNELEK
NDDIILFIDEIHTIVGAGGATGSLDASNMLKPALARGEIQCIGATTLDEFRTNIEKDGAL
ERRFQKVIVDPTSVEETIQILQNIKSKYEEHHHVNYTDDAIEACVKLTNRYMTDRYLPDK
AIDALDEAGSRIHITNIVVPKQVLELETQLETIRDNKTKAVNGQKYEEAAKLRDDEKNIE
AALNSAQKQWEDDSKLNREIVTEDNVAEVVSMMTGIPVNRVAEAETHRLHELPSLIKGKV
IGQDEAVTKVVKAIQRNRVGLKDPNKPIGSFIFLGQTGVGKTQLAKVLARELFDSDDSLI
RIDMSEYMEKFAISRLIGAPPGYVGYEEGGQLTEKVRRKPYSVILLDEIEKAHPDVFNML
LQILDDGHITDSLGRKIDFRNTIIIMTSNIGARQLKDFGGGVGFGTSSKQEQADAHAKSV
IEGALKKSFAPEFLNRIDDVIVFNALERENIHSIIDIELDKLLKRIADLGYTLELSEKAK
DYIADKGFDKKYGARPLKRAIQKYIEDALAEEIVNSKLSEGDTISMDLDDEKNELTIKIK
KGKKKPETKTETETETES
>FCMOIPGL_02197 hypothetical protein
MIFLEITLSYKALMIIGTFSTLSSLVLIFFSVKHLINKKKRKTSNL
>FCMOIPGL_02198 Histidine ammonia-lyase
MNIFHYIDTKPLDLTKIQEIISSDKKLALSEIAVHKIEKCRAYLDEKTKSISKPIYGINT
GFGALYNVKIDDNNLQKLQENLVMSHACGTGDEVPKEIVKLMILFKIQALSFGHSGVQLA
TVNRLIDFYNNDIIPVIFTQGSLGASGDLSPLAHLSLPLIGLGKVYYKNELISSEEVLKI
FSWDKIKLQSKEGLALLNGTQFMSAYGIYCLLKAHKLSYLADVIGAISLEGFDGRIEPFN
ELIHFARPHNGQIKTAKRIKDLLEDSELIEQEKQHVQDPYSFRCMPQVHGATKDTIKFVT
KTFLTEINSVTDNPNIFVDEDEIISGGNFHGQPLALGLDFLAIALSELGNISERRTYQLV
SGHRHLPPFLISNPGLNSGFMIPQYTAASIVSQNKQYATPASVDSIESSNGQEDHVSMGA
NAATKCKKVVDNLQTILAIELFTASQALSFANGKSSPFLESIVSMFRQEVTIVDEDRVLH
CDIAIASDFITSLEIDSLELFE
>FCMOIPGL_02199 Thiol-disulfide oxidoreductase ResA
MKKISLILLGLVLLSACGNKHPKDYLSLSGKLENNKDSIVSIANQLGIVKKIKINTDGAF
KDTLKIETGAIYTIQTNNNRAPIYLKNGYDITVNGDIEDFMKSLKFSGEGSSNSNFILAQ
IEKSQTLGNPQLILDLEEDAFKKKVDQIKFEYDSILNSYSNLDSTLYTTMLAQNKQIVTY
FNNAYNSSKNMGKGMPSPTFENYADIKGGVKSLSSFKGKYVYIDVWATWCGPCIQQIPYL
QTLEKEYHGKNIEFVSISTDESQRSGGSWEAAEKKWRDFVKDRNMSGVQLWSGQDFSFQQ
AYQINAIPRFILINPEGNIVNANAPRPSDPALKTLFTSLGI
>FCMOIPGL_02200 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLDFEMPIKELEDQLQKCEIIGTESDVDVTATCKKIEKKLAEARKDIYKNLTPWQRVQ
LSRHPNRPYTLDYIRAICGDTFMELHGDRNVKDDKAMIGGLGKIGDQSFMFIGQQKGFNT
KTRQFRNFGMANPEGYRKALRLMKMAEKFGIPVVTLLDTPGAYPGLEAEERGQGEAIARN
ILEMTRLKTPIITVVIGEGASGGAVGIGVGDRVYMMENTWYTVISPESCSSILWRSWEFK
EQAAAALKLTGTDMKKLKLIDGIIKEPVGGAHTNREGAFKAVEKQIVLAFEELKGLSDAD
LVAQRMDKYCNMGVYKE
>FCMOIPGL_02201 hypothetical protein
MLENKLKNYLLLHLIVFIWGFTAILGALISIDAIPLVFFRMGLAVLFIAIYFLVKKKSFY
LNKTGVIKFLFTGIVIATHWIFFFKAIKVSNVSVALVTMSTGAFFTSLIEPLFFKRRIKL
LEIIFGFIVILGLYIIFNFESQYKLGIIYALISSFLGSLFAVLNGLFIKRYDANRISFYQ
LLFGVLFVTVYLFFNNSFSASFFDLSKSDWMYLVVLSSICTAYAFIASVKVMEFLSPYTV
MLTVNLEPIYAIILALFIFGDKEKMNPEFYLGAGIVLGVVLLNGVISNKSKIKEKFLQKT
KLKK
>FCMOIPGL_02202 hypothetical protein
MVTFLFTLLILIPIAVAIDISEKIDNFLEHADLGFYQIVNEYYVNFIIYYTNTFMPLALF
IAVILFTSKLSNNTEIIAITNAKVSFTRFMYPYFIGATLVTILSLLMNHFVVPNSSKVRK
KFEKQYINSRKQKNELKYVNDFSLQLTDSTYIFIRRFDTDRNSGYDFSSELYDGLKLKSK
LAADNIKFNPKDSVFTIHNWRKRQIYKDRDSIFSGNKIDTVFNFTPKDLIYKSALSQEMP
SDELIKFIRVSEKRGVKNLNAYFVEFHKRTSLPIATYILTVIAVALAFRKKRGGTGINLA
IGVGIMFMYVFLMKISEVLGAVAGVNSLLYVWMPNLFFGLIAAYLYYNARK
>FCMOIPGL_02203 Queuine tRNA-ribosyltransferase
MKFDLKITDPKSKARAGSITTDHGVIETPIFMPVGTVGTVKGVHQTELKNEINPDIILGN
TYHLYLRPGLDILEKAGGLHKFMNWDRNILTDSGGYQVYSLSGRRKINEEGVKFKSHIDG
SMHHFTPENVMETQRTIGADIIMAFDECTPYPCDYNYAKRSMHMTHRWLKRCINHLDKVP
YKYGFEQTFMPIVQGSTYKDLRQQSAEYIANSGQQANAIGGLSVGEPAEEMYAMTEVVTA
ILPEDKPRYLMGVGTPINILENIELGIDMFDCVMPTRNARNGMLFTAHGTINIKNKKWED
DFSPIDELGTTWVDTFYTKAYLRHLFAAKEMLGKQIASIHNLGFYVWLTREARKHIIAGD
FREWKDRMVIQMDKRL
>FCMOIPGL_02204 23S rRNA pseudouridine(2604) synthase
MDTNNQKSINLNKYISSSGICSRREAEKFINEGRVTINGKPTQLGNRVAKKDVVKLDGRL
VEPKNVTLYIALNKPVGIVSTTDEREPNNIVEYVNYPERLFPIGRLDKPSEGLIFLTNDG
DIVNKILRAGNNHEKEYFVSVNKSITADFIEKMANGIPILGTVTKRCFVEKVSDKIFKII
LTQGLNRQIRRMCEYLDYEVTKLKRTRIMNVELGYLQTGDWRELTEDEMKEINKMISTSS
KTQEASVVKEKPKKQVSKKKAAPTKNDFNKKSASFRKSSSKNKKKNSGFSAKKKRW
>FCMOIPGL_02205 hypothetical protein
MKKKIILIVLVASVNVLCGQNNSNTPYSLFGLGVENKTATGGLTGLGNTGVAQSNPYEIN
IFNPASLGNILQKSFLYEFGLNATYSTLQTNSITQTSNNGNISHVAIAFPVKKDWGVGIG
LLPYTKTGYNVDLERPIEGSADSYITRITGEGGLNKFYLSTGFKALKNLSFGVDLSFLFG
SIEQESLLYTDSFVSINDQNHYGGVKLKTGFQYKLPNVKKIETTFGGTLELPTSLGGTQT
RTSYKTTLGGTALSIEDEVENDLEDFELPLSYGFGLTSVINKEFTTSLDYRKILWNDTNQ
QQNNERYLDQSIYAFGLEYMSSKDKFNYSSNIKYRFGLNYNTGFLKISNQQIDSYFISFG
VGLPMRKYSNSNFNVSYSYGKEGTLENNLIQEDFHKLTLNLNFVGKWFEKRKVD
>FCMOIPGL_02206 hypothetical protein
MRYLIIGFISFVFLASCDTDETTTYEVGSDFIENDVRVRVIDTFAIKAGTFKLDSLLTSS
TNRILLGSVKDDNLGNLTAKSYMQLITSTYSVSTDAVYDSIGMILNYDSYYYGDTTKVQT
YKLHRITETFEPIEGDYFYNTSFLDYDDETLGEISFTPKPNRETDSLFIKMDNVLGKEIF
DKIVDNDINNSDDFLQYFKGLAIIPETTQNTHVLGFNVSATSSLSGNSCMRLYYSINDDD
SEDNSYYIDFVISGAANQFNQIETDLSSSVLGNLEDEEEIKLSEDTNDLIFAQSGSGIAA
RIEMPSIKKLLELSENATTLSATLSFNPLLGSYDENNPLPESLLVYIVDHKNRIIKTLSD
LDGNVTSAILYKDDSEFNDNIYYSIDLSGFVEEILFSDIDLNYALMIQYQDYSNNVNNLV
IENNLSTNNNVKLSVKYLNY
>FCMOIPGL_02207 N-acetylneuraminate epimerase
MNKFNIMRKTNFIQKSSVLFIATVLSLFFIGCSSDDDDDEYGNWVESSTFDGNSRANSVS
FTIGTKGYLVTGYDGDDYLSDTWEYDSEGDFWKEKAPFPGTARSGAVGFSINGKGYLGTG
YDGTNKLNDFWEYDPTTDSWTQKADFAGTERYGAIGFAIGNDGYIGTGYDGSEQKDFWKY
NVASDTWEQSVGFGGQKRQNASVFIIDDIAYIGLGIHNGSYEEDFYSFNGSTWTRLTDLD
DDDDDDDDYEILLSSGVGFSLNGLGYITTGISGAITTESWSYDPTTDTWDELPVFEGSAR
QNASAFTFPNKAYVLMGRSGSYYFDDVWEFRPDELENEDD
>FCMOIPGL_02208 Sensor histidine kinase YpdA
MSKLNSILKKSNTTIIVHIIIWLFFIAITAIQSYSRFSTIPNEFYFLNFIFISVFYLNYT
VLIPNFLLNKKIITYIIISISLIFLLFLIFEPLIKNQIKPPFINEELKNRFQGPREGRIN
LKPPILLLLFFALSTCVKLVSEWYKSEKERTIAATQKVNSELSFLKAQLNPHFLFNTLNS
IYSLANKKSDDTTVAIVTLSELMRYMIYEANEEFISLEKEIDYIKNYISLQLLRLKDSSG
VHINVHGDLNYKIEPLLLISFIENAFKYGTDYKGKTDIKIKITIQNNELCLEVVNISSLQ
NTINKNSGIGLENIKNRLQLLYPNAHTLEITNHKKSFEVNLKIKLKK
>FCMOIPGL_02209 Transcriptional regulatory protein YehT
MKCIIIDDEPLALELLEDFISKVPFLELIASCSNAFEAANVLQEQKIDLIFTDIEMPDFS
GIDFIKSLDTKPMFIFTTAYSHYAVEGFNLNAIDYLVKPIPFHRFLKAATRAQNLLKLKV
EEEITVPSNQETAPKFIFVKSEYENLKINLADIKYIESLKDYIKIHTNKEKPILTLSSLK
SFEEKLGKLNFIRVHKSYIVSLKHIYSVQRNRIIIDDNWIPIGQNYRDDFIKKIEN
>FCMOIPGL_02210 hypothetical protein
MDLFSSDKIRNILPFDGITNYHGIVLTKKQCDFYYQQLLENINWKNDEAIIFGKKIITKR
KVAWYGDSEYSYTYSKVTKTANLWIKELLELKEIVEKESNETYNSCLLNLYHSGEEGMAY
HADGEKMLRKNGAIASLSLGAERKFSFKHKENKQRIDIILQRGSLLVMKKGTQTNWLHRL
PPTKKVNSPRINLTFRTIELED
>FCMOIPGL_02211 hypothetical protein
MKNLNKILTEITQLTNTIETKYPELYRDLDENPMTIPSNNHPQMDKKIMEEYLDSLKQLL
EHYLQEEKIRKNTL
>FCMOIPGL_02212 hypothetical protein
MGEIATSNRQISLFYNSKSATGKQTLAYAMTEGLPVLEIDILKTKLTGTQIVELAHRLHL
EVGDLIDKNHAAYKTDLNSDEFSTDDWIKMIQHKPEIMKQPIAIRGDITILIKTPTDILK
I
>FCMOIPGL_02213 Miniconductance mechanosensitive channel MscM
MVLNFLKISFSKETWITFCVILFGAILLGFALSWVLFWILKLSNRRKSTVLKSLLLKHLK
QPTLFFLSLLFLYSSFSFIELNTIWYKIIQSLIIINFSWILIASLNIVEELVKQKFIKED
NHKSKDRKVLTQLRFLKSISLVIIITIAVAAILWNIPDVKKIGTTILTSAGVIGIIAGVA
AQKSIANLITGFQIAFTQPIKIDDEVEIKGEFGTVEDITLTYVVIKTWDWRRLVLPLNFF
SDNSFVNWTFSTTDLIGSVYIYVDYTFPVQELRKKLNSLLKENPLWDKKVGELLVTKSDQ
YVIELRATFSARNASDTWTLRCTIREELIKFIQENYPNSLPKLRRMEVIEDK
>FCMOIPGL_02214 putative NTE family protein
MKTGLVLSGGGARGAAHIGAIKALEENGIYPTHIAGTSAGAIVGALYAQGVGWAEILNFF
KTIPIFNTNRFAYNKPGFIDSVKFYDDLKTFFPVDDFNTLKKPLFITATNVIDGTLKIFS
KGQLIKPIIASASFPGVFTPTKINDSFYIDGGTLNNFPVEPLKKDCDQIIGVYVNPLKKI
SIKDLKHSYSVVERAFKIKSSSESILKFSDCNLVIYPEDLINYGTFDMNSIDAIFNLGYN
ATIEILRNYKNLTVR
>FCMOIPGL_02215 putative cardiolipin synthase YwiE
MVLALIIYSLIAFFLVGKLLLNGVRPTKTLAWLLAIFTIPVGGMLFYFILGRNRKKNKFY
KLKQTKEISEYYEQVDHYYNHLNENEDTNIPTAIKKHVKLAKLIIKGSKFIPSIENELTP
LINGPATFEAIFSAMETAKKFIHIQYYIFEEGDLADKFKSILMRKQKEGVEIRFLYDALG
SRTLSNKYLHKLKETGIEVYSFLPMKFGKFLSSINYRNHRKIIIVDGVFGFTGGINVSDK
YIKGDPDLGNWYDMHLQLKGDVVNSLEAVFAMDWYFASGKDDLLNVKYFFKNLVSGNSIA
QVVASGPDSDFSSIHQLYYAIINSAKKYVYITNPYIIPGEAIKEALQVAAMSGVDVRLLL
SANSDSFIVKWNVRSYFETLLESGVKIYLNPDGFLHSKVIISDDELTSIGTANLDIRSFE
QNYEVNILIYEREITTKLKLDFLNGCEKSNQIDYQQYIKRPKIERLKEGLAKVFSPIL
>FCMOIPGL_02216 Spore protein SP21
MSLVKFKSRPLENLISTDFFDNDEFFGSKLWNKKLDEPALNIKETDDAFEVELAAPGFEK
KDFDVTINEGCLNISAESSKSKEEKEDNYTRKEFSYNSFEKRLKLPDSVKEEDVMAKYKD
GVLSFNLLKKEDSKKLKPKKVEIV
>FCMOIPGL_02217 hypothetical protein
MSKLKGSFYLKNDKQKNELAIFYAKIKLGSSTSTLATRKYICPIRWKKTNMLLQAEIINT
EVSLKNYIYDIPMKIAGIYHNLNSNKPKRL
>FCMOIPGL_02218 Tyrosine recombinase XerC
MSFLKNHRISLDFTKIGCKFGCNFLIGMIQIKRNLIFSLEKRKKAGQLITENVPIRLRIN
YEGSRLDIQTGFRIDIAKWNQDKEQVKNGSYNKLEQSSASINSRILELKVAIQDFFQECE
SQDKIPTKDQIRIIAKSLKKKGKVEVEKTTESSFFDVFDLFVKENSHLNNWSDATLTKFA
TVKKHITSFNPISKFEDFDESGLTDYLTHLRKEKKMRNSTIKKQLGFIKWFLRWSFEKRH
HNNNAYQGFRPKIKDAQKTVIFLTEEEKTKLLKYEIPSTKKYLERVLDVLIFCSYSGLRY
SDVYNLKNSDIKSDFFQIITVKTDDALIIEFNKHSRAILEKYSHIPYKKDKALPVISNQK
MNEYLKELGELAEIDSPVRLTHYIGNKRIDEVFPKYELMTTHIGRRTFICSALSIGIPVQ
VVMKWTGHSDYKAMKPYIDVADKTKKNAMEKFNEL
>FCMOIPGL_02219 hypothetical protein
MIYFTTITDCILAIKDNLKVLQINTIRITDLESYQKFCDTFSIDEFRSSIREYRDINGRE
NLKQELRLILSTIKDYSKFYNENQISLNSMDPSCLLRNLIKPIELKETLAYRKQIPTNKS
ITVLKGNYEQMSLRFSDEHPEMITILKKINLLEKEKEKLLNLYNEWVLERKILEKKYNNL
LSFKFYYVLQKLETIKEIIEEDYIENIEILNLNFNNDLLEIINEYFTRSLTAVSAKDFFN
NFELSGLKVEKKKMSDTKLYFLIDSLANTIKDKLQKEKWINTSLDYFEKKRHIYDKKKTY
EKEFYEKIITNEVKENHFVNRLSKAIQMI
>FCMOIPGL_02220 hypothetical protein
MNLESIKEKPLFQMTGEEFIFLQNNLNNELPSKTLEPEKGKKYVYGIRGIAKLIDGSTSK
ANRLKKSGIIDKAIIQNGRKIIVDAELALQLMNQSK
>FCMOIPGL_02221 hypothetical protein
MENKKANSKNSQGNDMPNKRNILTDKTANEWLEIGSRIIDPKPLFGNIWHQGEVGILFSN
TGKGKSILAVQLADAISKGNPILGENTDKYIVLYFDFELSTKAFQKRYSKSNTELYSFSP
NFVRIEIDRGENSEDEKLSFEQLIINSITIQALKNNAEVLIIDNITYLAASNEKSHEALE
LMKIILKLSREYSISILLIAHTPKRDIYSPIQLEDLAGSKALSNFVDICFCIGESVKGDN
IRYIKQLKNRNYPIEYGQENVINCEIEKENSFLKFNMMGFGGEKEHLQASKTNEDKRILE
AQSLKDAGKTNTEIAKTFGVSPRTIGRWLKLT
>FCMOIPGL_02222 DNA primase
MNCKKAKQIDLVPYLKKQGFRVSKTTKKDIWFFSPFKNEKTPSFKVNISKNVFFDHSSGI
GGTIIDFVMKYNNCSIKEALVILSEDTFSIHQQTKRIKSETKPTYSIKKVTELTNPQLLN
YLSNRKINLKFATRFCFQVHYSFSNGKELYGIGFMNDVGGLEIVNIFNKKFRKICLGKKE
ITTINNNSDVVSIFESWSDFLSYLTLKKEIPKENFIILNSTSLVKKTISLLEDYMVIKLF
FDNDEAGNKATDFIVENANGKIIDNRIHYKNFNDLNDYLMNKN
>FCMOIPGL_02223 hypothetical protein
MKSDSNNKVKVVFYLNAEDKEVIKIQCESLQIKPSFFYRNAVLEKLGKPIFTKKVHDLDT
KKYLTSLIRIGNNLNQIAKKLNSNEQFLIKDQQVVLNEIKHINNHIIEINSKL
>FCMOIPGL_02224 hypothetical protein
MEENTNNAIFTLMQKVVDKLDAISKDVSNIDQTELSHVFSEENEKLKNLIETTISNQHVL
DQKILSKKEIDDSIKENAVTPNVNNYTEFSLLGSKSHFKPKTLIIMLFSLLIIWSSIKYL
PSYFMEKNSISKAKEDYQIFYNYFYFKEFEKNKNAAANEILKKIIQKDPIFMEEYQTLLS
TYQREIKKQELKEQLNALDNNDR
>FCMOIPGL_02225 hypothetical protein
MIAKLESIAYLQNALDYCERGGELIASNKCIGNSTEINSQIERNNALNDRCVKNTFHIKI
RIAPEDKGKLNTQDWIDISNDYAKMIGFKENLYAVYMHEEGTNKEHIHIVASRIQSNNLA
VEDSFTHYKNMDFCREIEKKYKLRQVKRVLETVKKQEIFIKNDNRIAPLEEKIKSAINQS
DSFEDFEFHLKNMGVKTKKGRGIGFIDEKGVYIKGSAINRKYSLKGIEKLLSYEQQEKRM
NKKNKGFKM
>FCMOIPGL_02226 hypothetical protein
MIKINQIAEVQFGLYKKKSKKGDTKYLTTGHFDNFLNPTLFDDSFINITGKDTKFLLQPN
DVILTGKGQRIFAWSYDESFGKVVPSSLFYIIRADAALIDSRYLAAVLNSGRKRYELELL
GVGSSIISIAKNDVLDFEIPLPSIEEQQKVINVLALLEEEISLTNQLLEKKKALKKGVLN
ELITNKIEL
>FCMOIPGL_02227 hypothetical protein
MSNTRHVVPNPDGGWDSKKGGAERASKHFDNKQDAVDYSRELSKKQKTELVIHKKDGKIQ
RKDSHGNDKFPPKG
>FCMOIPGL_02228 Type I restriction enzyme EcoKI M protein
MSKLTQSDINNKVWKACDTFRGTVDAGQYKDYILTMLFIKYISDVNKEKKAEYKKKYNGD
KARIERALKHERFSLPEKSSFDYLYEKRNESNLGDIINIGLEVLEEANRSKLEKVFRNID
YNSEANLGETTDRNRRLQHLLNDFRELDLRPSNLDNNDVIGDAYEYLIGNFAAGAGKKAG
EFYTAAQVSQLLAKLVEPKAGDRICDPTCGSGSLLLKVAKEVGSTNVSLNGQEVNGSTYA
LARMNMFLHEMDNANIEWGDTLNSPKLVENDALMKFDIVVANPPFSLDKWGAEDASSDRY
SRFHRGVPPKSKGDYAFITHMIETLNEHGKAGVILPHGVLFRGSSEGKIRKQLIDENLLK
AVVGLPANLFYGTGIPASILIFDKNKGDNTEILFIDASNEFENGKNQNRLRDEDVDKIYN
TFSEWKTVDKYSHIATLEEIQENDYNLNIPRYVDTFVEEEPVDIVETQKEIVALKAKLND
VESQMEVYLKEMGY
>FCMOIPGL_02229 Type-1 restriction enzyme EcoKI specificity protein
MGNNDNNMTYRQDVQSNKRIQTNTGSRKWKKIGFQKLFTFSTGKNIKQNQASPYFSIPCV
RYGELYHMYNEVITDVINYTNLKKEDLIFSEGNEILLPSAGEDPLDIGSASALMVKGVAI
GRTINVLKPLKDGVYNQSYVAHYISHILRNNIARLAKGTSISNVYNSDLKQLKISLPPLK
EQQKIAEILSQWDEAIETTQTLIDQLQLRKKGLMQALLSGKKRLTGFSEEWKEDKLGSYF
TERKETGLDNLQLLSVGKEGVYPQDDSNKKDTSNSNKSKYKRICKGDIGYNTMRMWQGRS
ALSQLEGIVSPVYTILKPKENCDSVFFSHLFKLDDMIHKFYRNSQGMVSDTWMCKFKDLK
IVKFNAPSSLEEQKAISKIIGLADVEIEEKKTYLLKLKEQKKGLMQQLLTGKKRVKLN
>FCMOIPGL_02230 hypothetical protein
MAEIYQHNIYIDESCHLENDIHPLMCIGYTKIAAKDYELYKNELKKIKLTHKTPTELKWN
KLSNNRLPFYKAIIDFFFDSNIEFRAILVKNKAQLDHTKFNRGDHNSFYYTLVFLLLRNP
WVNYLENPHKVILDIKDTRGKERLTKLDTRLNEEYRQKYNRDSPFNFFQHIRSDESEFLQ
LADFFIGAITYKARGLHLLEKSSQVKKEVVAYLEQKSGYQLDDGTAPFEEKFNIFDFQIQ
TQNKQ
>FCMOIPGL_02231 hypothetical protein
MNYFEEEHELDIVDDLFEYLDLDGPDKEQMYQLYGVFKKDMIDEPIFINNVQVVYDKKKS
RHYLFKGKPVGFEHICTRESKHSKKRYFDPERTNKIHWIKPVVHFKEDARVRYFEREHHN
GKNQQYYWLHEKDYVVIIREVTEKLQLVTAFKVDNLEKPRFNNWYNDYQK
>FCMOIPGL_02232 Type-1 restriction enzyme R protein
MSTPSYLEDNVSQIPALQLLINMGYTYVSPKKAEQWRGGKSQVLFTEILRTQLAKINTIH
RRGKEYAFSDANINSAVIAAKDLPIQDGFINANKAFYDLITLGKAFEQSIDGDKKSHTIN
YIDWQHPENNIFHVTEEFPVLRTARTDTYRPDLVLFINGIPSVIIECKSPSLGGTKSPVT
LAIEQHTRNFSKDGIRSLYVYSNLLLSIATNESSYATTGTSKEFWAKWTEQFTSSETEKK
YWTALKKLKNKTLEEDQKNMVFEERAEYVRKTFDGIDTEDRLLTEQDKLLFNLCRPERLL
DLILNFTLYDDGIKKIARYQQYFAVNNTINRVTKFDKTGKRQGGVIWHTQGSGKSLTMVM
LAQMLASNPHISNPKIVLVTDRVDLDDQISDTFKKCKKEVRQAKTGAHLTELLEDNSDAI
ITTIINKFEAAVKNNKKPFTSSDIFVLIDEGHRTQYGTINVSMQRVFPNACFLAFTGTPL
MKKEKSTASKFGGYIGKAYTVKDAVEDGAVVPLLYEGRHNQITLNEAPINTYFEKLAERN
NLSERGRAKLKQKFNTVNELNKTDQVIYARAWDISEHYTEFFQTHSDNYKPKAQLVAPTI
KSALLYKKYLDEIGLVDSEVVVTQSDQREGTEDGYFNENEDKRREDEYLNAMIDKYGDLK
KYEKSIINQFKKRDKPEILIVVAKLLTGFDAPNNTVLYLCRSLKEHTLLQAIARVNRVYP
GKDYGYIVDYYGNLENLDTALSTYSNLEGFEEEDLEGTLTNISDEIGKLSQAHSELWDIF
KTLKGRNLEATAYEEHLSPEDVRNKFYTKVSQFARLLKLALSSVDFVTNTDEKKIDTYKR
DAKFFLKLRVDVTRRYNDDIAYKEFEPQIQKLINKHITTDGEIMKITELVDIFNKEERDA
QVENIKGKAAQADHIASRTVKAINLKMQEDPIYYRKLADLIKETIAAYHQKRIDEAEYLK
RAKENEDKFFNGRSKDAPDELADNTVALAFYNFSRSVFENVELLNTPFHIEVSLAIDKTV
KEHIYLNEKKIIDWHKNEDITGKINIELGDVIYDLHQKFDIDTDWDKIDYLISECLKIAI
LKYK
>FCMOIPGL_02233 hypothetical protein
MELKSIPYGNSRIDFCLKRNKRKTLGIKVYPNGSTVVTAPIETPYDKIAVKVKSKAQWIN
KQKDFFMLFEPRTKEKLYESGESHLYLGKNYRLKITESNTNSVKLKGGYILIDIKDKHNK
NAIEKELKKWYKSKAMIHFENLYHNRLDLAKELSNKEVSLKYKWLNNRWGSCFIDGTIYL
NLELIKAPKECIDYVLVHEICHLDHHNHSTSFYKLLTKKLPKWKMSKDKLEKLLS
>FCMOIPGL_02234 hypothetical protein
MENVKRQIREAFILVGIIEPSIKGLLSKFVYHLKQLIFLIIKLKSKKTPNSNRIGCNIGC
QTHN
>FCMOIPGL_02236 Chorismate synthase
MSFNSFGNLLKVTTYGESHGTAIGGVIDGFPAGLKVDFDAIQAELDRRKPGQSKIVTQRK
EPDTVIFHSGIFEGITTGTSIGFVINNTNQKSKDYNHNTNIYRPSHADYTYDKKYGIRDY
RGGGRSSARETANWVVAGALAKQLIAHISINAFTSSVGEIFIDKPYQDLDFSKTENNIVR
CPDELSAEKMITKIQEIRKSGDTIGGTVTCVAKNVPVGLGEPIFNKLHAELGKAMLSINA
VKGFEFGSGFCGAKMKGSEHNDIFNADGSTQSNLSGGIQGGISNGMDIYFRVAFKPVATI
MTNQQTINSEGELTEITGKGRHDPCVVPRAVPIVEALTALVLADFWLINRTRKI
>FCMOIPGL_02237 hypothetical protein
MHKKRLYFIDIIRAFAILMMLQGHFIDTLLATEYRDLTSIPFSIWSYFRGITAPTFFTIS
GLIFTYLLLKAKERGETNLRMRKGLIRGFFLIFVGYLLRIPFLRWITGDFNTYFLVIDVL
QCIGLSLILIVTLYFLCAKNTLIFSVTNFFLGIIIFLTERMYYDLNYENIPIVFSNYISK
NNGSIFTIIPWFGYVAFGAFIATLFHGYLKKPKFKTNIIFSFFVTGCVLIFYSSHILVSI
YKLTHIEIFLKSASYNYLFTRLGNVLIYFAFFYALEKYLKFPLVLKIGQKTLSIYVIHFI
IIYGSFTGLGLNTIIGRNLTPIQAILGAIVFLITVCFLSFFYVRTNTFLYANLRRIFEKT
KSLF
>FCMOIPGL_02238 hypothetical protein
MEENQNKDGQLNIELDQEVAEGTYSNLAIINHSMSEFIVDFINIMPGVPKAKVKSRIILT
PQHAKRLTKALADNVRKFEQAHGEIKDYEQPPIPMNFGPTGQA
>FCMOIPGL_02239 DNA-directed RNA polymerase subunit beta'
MARNQEKYTVKKFDKISIGLSSPEAILEISKGEVLKPETINYRTHKPERDGLFCERIFGP
VKDYECACGKYKRIRYKGIVCDRCGVEVTEKKVRRDRVGHINLVVPVAHIWYFRSLPNKM
GYLLGLPSKKLDMIIYYERYVVIQPGIAKNPEGEPLQKMDFLTEEEYLDIADELPQDNQY
LDDSDPNKFIAKMGAECLIDLLARIDLDGLSFELRHKANTETSKQRKTEALKRLNVVEAF
RDSQKNRENHPEWMIMKAIPVIPPELRPLVPLDGGRFATSDLNDLYRRVIIRNNRLKRLV
EIKAPEVILRNEKRMLQESVDSLFDNTRKSSAVKTESNRPLKSLSDSLKGKQGRFRQNLL
GKRVDYSARSVIVVGPELKLSECGIPKDMAAELYKPFVIRKLIERGIVKTVKSAKKIIDR
KEPVVWDILENVIKGHPVLLNRAPTLHRLGIQAFQPKLIEGKAIQLHPLACSAFNADFDG
DQMAVHLPLGPEAILEAQILMLGSHNILNPANGAPVTVPSQDMVLGLYYMTKERISTPEV
PIKGEGLTFYSPEEVTIAFNEESVDLNAGIKVRTQDVDENGEQVTRIIKTTVGRVLFNEK
VPAAAGYINEVLTKKNLRGIIGGILKATDIPTTGDFLDDIKNMGYKFAFQGGLSFSLGDI
IIPNEKQSMIDEANKEVDLIVGNYNMGMLTQKERYNQVIDVWGSTNNRLTELSMKRLRED
QQGFNSVYMMLDSGARGSKEQIRQLTGMRGLMAKPKKSTAGGGEIIENPILSNFKEGLSI
LEYFISTHGARKGLADTALKTADAGYLTRRLVDVSQDVIINEEDCGTLRGLEVSALKKND
EIVESLSDRIEGRVSLNDVFDPVTDELLLEANQSITSKLADRVEASGIDAVEVRSALTCE
SSRGICSKCYGQSLSTRNKVQIGESVGVIAAQSIGEPGTQLTLRTFHVGGVAGNISEDNK
LIAKHEGRVVIDDLRTVVGKDSDGKEIDIVISRTAEIKIIDKKTDITLSTNILPYGSIIF
DKERKSIKKGDVVVQWDPFNGVIVSEFGGKVKFDNLEQGVNYSVEIDEQTGFQEKVMIDS
KNKKLIASLIIEDNDGNALRSYSLPLGAHLMVSDGDKVVAGHTLVKIPRKSGKAGDITGG
LPRVTELFEARNPSNPSVVSEIDGVVSFGKIKRGNREIIVESKTGDVSKYLVKLSNQILV
QENDFIKAGMPLSDGATTPSDILRIQGPSAVQEYLVNEIQEVYRLQGVKINDKHFEVVVR
QMMRKVKIIDSGDTLFLENQLIHKNDFIEENDAIYGMKVVEDEGDSENLKAGQIISARQL
RDENSLLRRNDKNLVTARDAKPATAEQVLQGITRASLQTKSFISAASFQETTKVLNEAAV
SGKIDTLEGLKENVIVGKRIPAGTGMRAYENILVGPKDEIEKSF
>FCMOIPGL_02240 DNA-directed RNA polymerase subunit beta
MATKNTTERINFATSQMIKEYPDFLDIQVKSFQDFFQLQTKAEERGEEGLYKTFMDNFPI
TDTRNQFVLEFLDYFVDPPRYSIQECIERGLTHSVPLKARLKLYCTDPEHEDFETIVQDV
YLGTIPYMTNSGTFVINGAERVVVSQLHRSPGVFFGQSFHANGTKLYSARVIPFKGSWIE
FATDINQVMYAYIDRKKKLPVTTLFRAIGFERDKDILEIFDLAEEVKVSKAGLKKVLGRK
LAARVLKTWHEDFVDEDTGEVVSIERNEIIFDRDTILDKEHIDEIIDAGAKTVLLHKEDN
HMADYAIIHNTLQKDPTNSEKEAVEHIYRQLRNAEPPDEETARGIIDKLFFSEQRYNLGE
VGRFRMNTKLQLNEPIDQKVLTKLDIITIIKYLIELINSKAEVDDIDHLSNRRVRTVGEQ
LAGQFGVGLARMARTIRERMNVRDNEVFTPIDLINAKTLSSVINSFFGTNQLSQFMDQTN
PLAEITHKRRLSALGPGGLSRERAGFEVRDVHYTHYGRLCPIETPEGPNIGLISSLSVFA
KVNNLGFIETPYRKVNDGVVETVEPTYLSAEEEEGMKFAQSNLELNEDGSFVTDRVIARE
GGDFPVVSPDAINYMDVAPNQIASISASLIPFLEHDDANRALMGSNMMRQAVPLLRPESP
IVGTGLERRVAKDSRILINAEGAGEVTYVDANKITIKYDRTDEERLVSFDSDEVSYNLIK
FRKTNQGTNINLKPIVQKGDRVEEGQVLCEGYATQKGELALGRNMKVAFMPWKGYNFEDA
IVISEKVVREDIFTSIHIDEYSLDVRDTKLGTEELTNDIPNVSEEATKDLDENGMIRIGA
EVNPGDILIGKITPKGESDPTPEEKLLRAIFGDKAGDVKDASLKASPSLRGVVIDKKLFK
RALKDKTKRLRDKEAVATLEASFVSKFETLKDELIDKLFTLISGKTSQGVFNDLGEEVLP
KGKKYTLKMLNSVDDYIHLTGSWTTDKELNDLVGELVHNYKIKVNDLQGNLRRQKFTISV
GDELPAGILKLAKIYIAKKRKLKVGDKMAGRHGNKGIVARIVRAEDMPFLEDGTPVDIVL
NPLGVPSRMNIGQIYETVLGWAGQKLGTKYATPIFDGASLDQINGITDEAGVPRFGHTHL
YDGGTGKRFDQPATVGIIYMIKLGHMIEDKMHARSIGPYSLITQQPLGGKAQFGGQRFGE
MEVWALEAYGASSILREILTVKSDDVMGRAKTYEAIVKGETMPEPGLPESFNVLMHELKG
LGLDVRLEE
>FCMOIPGL_02241 50S ribosomal protein L7/L12
MADLKDFAEQLVNLTVKEVNELATILKDEYGIEPAAAAVVAGPAAAGGESEAEEQTEFDV
ILKAAGGSKLAVVKLVKELTGLGLKEAKGVVDSAPAPVKEGISKAEAEGLKAALEEAGAE
VELK
>FCMOIPGL_02242 50S ribosomal protein L10
MTREEKSQVIQDLTAVLAGTNTVYLADISGLNAQNTSNLRRACFKAGVQLSVVKNTLLAK
AMEASDKDFGTLPSVLKGNTSMMIAEASNAPAKLIKEFRKKSKKPLLKGAFAEESIYIGD
EQLDALVDIKSREELIGEIIGLLQSPAKNVVSALQSGGQKLSGIIKTLSEK
>FCMOIPGL_02243 50S ribosomal protein L1
MAKLTKKQKEAHAKLDRSQSYDLATASALVKDITNVKFDASVDLAIRLGVDPRKANQMVR
GVVTLPHGTGKDVKVLALVTPDKEAEATEAGADYVGLDEYLQKIKGGWTDVDVIITMPSV
MGKLGPLGRILGPRGLMPNPKTGTVTMDVAKAVQDVKAGKIDFKVDKTGIVHAAIGKVSF
DAKKIEENANELIQTIIKLKPTTAKGTYVKSVFISSTMSPSIAVEVKTV
>FCMOIPGL_02244 50S ribosomal protein L11
MAKEVSKVVKLQVRGGAANPSPPVGPALGAAGVNIMEFCKQFNARTQDQQGKVLPVVITV
FKDKSFDFVVKTPPAAVQLLEAAKIKKGSGEPNRKKVASVTWDQIKVIAEDKMVDLNAFE
VTSAMKMIAGTARSMGLTVKGNAPA
>FCMOIPGL_02245 Transcription termination/antitermination protein NusG
MADTVMKWYVVRAIGGQENKVKAYIETEISRVGLSDYVSQVIVPTEKVVQIRNGKKINRE
RVYFPGYIMVEANLSGEVPHVIKSITGVIGFLGETKGGEPVPMRKSEVNRMLGKVDELSV
QDENIAIPFNLGETVKVVDGPFNGFDGTIEKVNEEKRKLEVMVKIFGRKTPLELSYMQVE
KI
>FCMOIPGL_02246 hypothetical protein
MTWISKEEAQKSTVTVAVFTIVFALAVAGIDYVFQTGLDNFFKLF
>FCMOIPGL_02248 Elongation factor Tu
MAKGTFDRSKPHLNIGTIGHVDHGKTTLTAAITKVLADAGFSEARSFDQIDNAPEEKERG
ITINTSHVEYQTSKRHYAHVDCPGHADYVKNMVTGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGIPRMVVFLNKVDMVDDEELLELVDMEVRELLSFYEYDGDNGPVVSGSALGALN
GEKKWVDTVLELMEQVDAWIEEPLREVDKDFLMPIEDVFSITGRGTVATGRIETGIANTG
DVVDIIGMGAEKMTSTITGIEMFRQILDRGEAGDNAGILLRGIAKEDIKRGMVICKPGSV
TPHAKFKAEVYVLKKEEGGRHTPFHNNYRPQFYVRTTDVTGTINLPAGVEMVMPGDNLTI
TVDLIQPIALNVGLRFAIREGGRTVGAGQVTELLD
>FCMOIPGL_02253 Ribosome hibernation promotion factor
MKVFTQSVNFNADNELIKFVEKKVQTLEKFHDKIVDAEVFLKVQNTSDKENKITEIKINI
PGSELIVKRETKTFEEGVNAAVDNLKRQLKRSKEKLRDSLIS
>FCMOIPGL_02254 Tyrosine recombinase XerC
MITHFLDYLSLEKKYSIHTVTAYKNDLISFRDFLITEYNQEELVSVSYPQIRNWIVSLVD
SDISNRTINRKVSSLKSFYKFLQKSEQITINPLSKHKALKVAKKVQVPFTSKEINSVINI
INEENDFISVRNKLIVELFYSTGIRRIELINIKEKNISFSNKTIKVLGKRNKERFVPLLQ
SVVCTLKNYLELKKEFSIGLEEVFITEKGNKIYETLVYRVINSYFSKVSSKVKKSPHILR
HSFATHLLNEGADLNSVKELLGHSSLASTQVYTHNSLEVIKKVYNQAHPRGQHKKE
>FCMOIPGL_02255 30S ribosomal protein S21
MLIIPVKEGENIDRALKRYKRKFDRTKTMKNLRNRKNFTKPSVAKRAQRIKASYVQKLRT
QEEVG
>FCMOIPGL_02256 Acyl-CoA dehydrogenase
MNSMYFTEEHEAFRSSFKEFLQKEVVPHIEKWEKQGFVDRFIWKKFGEMGYFGLSTPEEY
GGLDLDLFYTVIFLEELQKINSGGFAAAMWAHEYLAMTHLNKEASEATKQKYLLPSVEGD
MIGCLCITEPFGGSDVAGMRTTAIKKGDTYIINGSKTFITNGVYSDYLIVAAKTDPSDKY
KGISLFIVDRESKGLSATMLDKLGWKASDTGEIAFDNVEIPAENLLGEEGKGFPYIMQHF
ALERLVMGINAHARAEFALDYAVNYMQEREAFGKSLNKFQALRHKIAEMASKVDICREYN
YSITKRLNDGQYVVKEASMSKLLSTKMADEVIYDALQLLGGYGYMEEYPMARLLRDSRLG
PIGGGTSEILKEIIAKIVIDKKEYKPAT
>FCMOIPGL_02257 hypothetical protein
MKIFKSHFWYNKSQRNGIFLLVTLILILQVFIFSDVFSSDEIIDTNTSEIIAFQNQIDSL
KAIEIENRKPKIYPFNPNYITDYKGEQLGMSLAEIDRLLAFRKTNKFVNSKKEFQQVTKV
SDSLLIKISPYFKFPDWVVKQNQPYKSSLRETKQSFNEKVKHKLSTTDINKATAADFKTI
NGIGVAFSERIIQYRLKLQGFSFDNQLYDVWGLEKGVADKVLTTFKIVEKPIIKKQNVNT
VTFKELLKNPYIDYDLCKKIFNYRDEVAELQDISELKNIKDFPLEKYDRIVLYLLAK
>FCMOIPGL_02258 hypothetical protein
MQSWGNLFAKGKVADITYKILFLLFVVIGAEATLVVVIKFSDVMILALVFPNMIGLLFLF
LKVRHEIKCYVGAISIKNKQFKTVQ
>FCMOIPGL_02259 Amino-acid carrier protein AlsT
MKKRILSMFLLAIPMLTFAQEKGLDQQIDEAFGNATGWFVDIIFYQIPFTDTISIYWVLF
PLILGAMYFTFYFNFINFKGFFTSINIVRGKYDDLEERLNHKVEISKSKFSDEEDNPDTI
RIEGHEGEVSHFQALTAALSATVGLGNIAGVAIAVSIGGAGATFWMIIAGFLGMASKFVE
CTLGVKYRDIEEDGTVYGGPMYYLTKGLKNKTLGKILAGLFAIFVIGGSFGGGNMFQVNQ
AFQLVQNITGGSESVLAGKGWLFGLVMAILVGIVIIGGIKKIAKVTDKIVPFMVAIYVGA
ALFVIFANYNMIGDAFSQIFNGAFSPEGIAGGAVGVLVQGFRRAAFSNEAGIGSASIAHS
AVKTKYAASEGMVALLEPFIDTVVVCTMTALVLIITGNVTAENASLNDAQAILLTSGAFE
SAISWFPYVLTIAVVLFAFSSMISWSYYGFQGWVFLFGRSKKMEYTYKVIFCIFVVIGAA
ASLGSVIGFSDAMVFAMMVPNMIGLIILAPKVKEELSKYMTAIKSR
>FCMOIPGL_02260 dTDP-4-dehydrorhamnose reductase
MIKVVITGSNGLLGQTLVKLLLLEKEKYQVIGFSKGKNRSGREDFNYISINLTDEQKLKK
TLSEIQPDFIINTAAMTQVDDCENNKEACDLLNITVVKWLSEISEELGTHLIHLSTDFVF
DGLKGNYKETDAPNPVSYYGLSKQKSEEVLGNSKINYTILRTILVYGKVFDMSRSNIVLW
VKDMLEKGKEITIVDDQYRAPTYVEDLALACEISMDKKTKGIYHISSKELFSVYEIAQQI
AETFNLDKNLIKPISSFALNQTAKRPPKTGFDLSKTNKVLEFYPKSFIEDLQRFKEVVI
>FCMOIPGL_02261 Voltage-gated potassium channel Kch
MRINVLESKINKTLFLVVTIISIGTIGYMLLSHYSFVDALYMTVITVTTVGFGELRPFSP
EEKIFTIFLILTSITVFGYAVSAFSEYLVSGRLFKHFKHRKVEKKIANLKGHTIVCGYGR
NGKQAILKLTNYNKEFVVVEKNKERTETLDTLGVLNINGDATLDETLQAAGIEKAAYLIT
ALPSDANNLFVVLTVSQLNKDCKVISRASNESSYSKLKIAGASNVIMPDKLGGDHMASLV
TTPDVIEFVDRLTIEGETTANLEEVAVNDLPGKYLNQTLLDLDLRRQTGCTVIGFIGPNK
EYIINPESDCKLIEDSHLIVLGRRSQILKLRELF
>FCMOIPGL_02262 hypothetical protein
MNLIHAVRHFFERHGFGVFSRFADKLGMRAKNVRIFFIYISFVTVGLSFGLYLTLAFLLR
LKDMVYTKRSSVFDL
>FCMOIPGL_02263 UvrABC system protein A
MKDQQYIEVYGARVHNLKNIDVKIPREKLVVITGLSGSGKSSLAFDTIYAEGQRRYIETF
SAYARQFLGGLERPDVDKIDGLSPVISIEQKTTNKSPRSTVGTITEIYDFLRLLFARAAD
AYSYNTGEKMVSYSDEQIKELILTDFADKKIAVLAPLIKSRKGHYRELFEQISKQGFVKV
RVDGEIKEIEKGMRLDRYKTHDIEVVIDRLLINESAENRLEETIKTALYSGNNIMMVIDI
DDNNPRYFSRELMCPTSGIAYPNPEPNNFSFNSPKGACNTCNGLGIINEINLKKVIPDDS
ISIKNGGIVPLGEQKNSWIFKQIQNIAERYQFKLTDAIKDIPKEALDIILNGGNESFAIE
SKTVGVTRNYKIDFEGILAFINNQYINAESTTIKRWAKAFMDEVSCTTCEGKRLKKEALH
FKIIDKNISDLAQLDITELAEWFATIEKDLSEKQLIIASEIIKEIRTRIQFLLDVGLDYL
TLDRTSKSLSGGEAQRIRLATQIGSQLVGVLYILDEPSIGLHQRDNQKLIDSLLKLRDIG
NSVLVVEHDKDMMEHADFVFDIGPGAGRHGGQIVSEGTFEDLKKQDTLTADYITGRKEIA
VPKTRREGNGKFIKLKGASGNNLKNVSVAFPLGKMICVTGVSGSGKSTLINETLYPILNA
HIYRGVKKPMPYKKIEGLEHVDKVIDIDQSPIGRTPRSNPATYTGTFSEVRSLFAKTAEA
AIRGYKPGRFSFNVKGGRCETCQGGGVRVIEMNFLPDVQVECETCQGKRFNRETLEIRYK
GKSISDVLNMTIEDATDFFENIPKIHRKLKTIKDVGLGYITLGQQSTTLSGGEAQRIKLA
SELSKRDTGNTFYILDEPTTGLHFEDIRVLMDVLNKLADKGNTVLIIEHNLDVVKLADYV
IDVGLEGGKKGGTILCTGTPEEVAKHKKSYTAQFLKKELI
>FCMOIPGL_02264 Beta-barrel assembly-enhancing protease
MNIKNLLIVIAFLFFVVLGVKAQNSSKDYWSIMLENNNKEAYEVFLKSEKEYEKSIELLI
SNEILRNENGLINGASDGFLNKLMKFKDFEYYVYALWNDPFMFEDYLKTGFHEKNVKSIK
TIEASKVENKTIFYALKYLKGVVERDHKDIVKYDEAVKQVDAIKDWQYCGVFENLNKSGY
DTSYEPELYAKNDKLFDANSNGTINWYTPNKEYQKEPYQFFSNHIEYGYGVNYAQTFITT
DKEQRVQLRMGNSSAFKVWLNDVLVYENDKDVDTDLDAYTVNVNLSKGTNRLLIKNAENN
GMSYFMARLSDFEGNKLDGITYSSKYASYNKATISAVNPEKKSNTIEDFFVEKLKENPTN
FFYKYCLIKTYFRNQKYEEANVIINDLLKTHTKSSLLRVLKTYTSSFEGDFNAINELNKN
IFLEDPNYYYSLVKKASDFQELERMSIAELEVYIDKLRNATDSPILKFIAQFVLDIRNED
IKALKATMNDLNNVASDRVFVLQRFIPLYDNIFQDQERSITEYEKILKKRFSPALLGGLA
RLYDKTDRKDDVLQLYKEYVKDFPAENEFLFSLIERLHQYEKYQESLPFIKQALENYPYS
FKAMEFMGNALTQLNQKDKAVDFYQQSLIYNNGNNQLLKKIETIKRAPNFLEKFTENDVY
SYVEKERNKYLKNNYGTNILLDSKVYQIYETGALKAKSVYLYEITSKNGIENYKEYDLGL
SGSYSILKSEIIKKDKSVIPAERTGSSFVFNGLEVGDVIYVDYETTSVSSGRFFKDFVDD
YQFDSESFCLKTSYTLITPKNLEFTHKVTNGKLDYTKKSEANYDVHQWQLLNAAELPKGE
DYMPTASDYARFLHISTIKSWNEIANWYSDLVRSQSVFNAEVEQKYNEIFPEKDVLSLSE
EERAKRIYYYIMNNFTYSFVDFKQSGFIPQKPSKTISSKLGDCKDFSTLFATFARRAGLD
VNLVLVLTSDYGMKSLILPSQNFNHCIVKIKLNGKDQFLELTDKNMPFKSIPNSLLNATA
LEIPYMVDESKESTLFHLSNMDGNPSNLISEVFIKVDENKTQNITINSKVTGSLASIYFN
ILNQDNFELVKEDILADFNQRIGEGLVLDTIKDIAAQKGTDFLTYTTKVHLDDKMNEMGS
MTFFKLPLVAHSYNGGIVSLEERKYAIDYQSYENSNFYNSVYNLEIPAGKKFIEIPENQK
FNYKQHSFEVLYKAVSENQLQITIAAATDLSDIAANEYLDFKSYVEKVLKAKDILIGYK
>FCMOIPGL_02265 Cytokinin riboside 5'-monophosphate phosphoribohydrolase
MTNDDRKIKEKLKPKTWNEIKTKDAWGIFKIMAEFVEGYETLSKIGPCVSIFGSARTKPD
HPYYKLAEEVAFKLTQNGFGVITGGGPGIMEAGNKGANRGKGLSVGLNIELPFEQHDNPW
IDQGKSLDFDYFFVRKVMFVKYSQGFVVMPGGFGTMDELFEAITLIQTKKIGRFPIVLMG
TKFWGGLLDWIKNTLIEEGNISEEDLNLFRIVDTADEAVEHFNKFYSKYKLKPNF
>FCMOIPGL_02266 hypothetical protein
MKTSLNIIICCFFISAFSFAQENKIAIKSTFNPDKDELLIQQEIVFYNTSDSILINIYLH
NWANSFRDRKTPLSKRLIKDFRKNLYFADEEDLGKTTIKNLSVNYENTRFLEVKDQADII
DIPLTNSLKPKDSAKIAITYIVKIPSAEFTSYGKTKEGYHLRFWYITPAVYNNGWQLMSN
LNIDDLYESATDFTVDIDIPKEYVLESNLYQYKTDNENFTNYYLLGKSKTDIILSINKTK
QLKTFKTKKATVYTDIFPDEIDTYAATNILNRELLFIEKFLGKYPHVEIYVDKITQSKDP
VYGLNQLPNFLRPFSDTFKWDVTMFKALSRKYIENTLLLNKRNDYWILDGLQNYLMLEYI
EEFYPDVKLLGELSNKWFIKNFHISKQKFNDKYPFVHQFVSRKFLDQALTTSADSLSNFN
RKIASKYKAGLGFRYLKGYLGDSILNSSIKEFYQHHNTKTISTIDFQNILSSKTNKEIDW
FFNDFVKTNKKIDYTIDKVKVKGDSLKVTIKNKRNITAPVLLYGLKDKEIKYKKWYTNIE
SSQTVTIPKEDFNKVSLNYENLYPELNTLDNWKSLDNKIFNKPLKFTLIKDAQDPYYTQI
FHQPYINYNFYNGLILGTKIHNKPLIKRNLEFRLAPSYATKSNTITGQFSALYNQYLEET
KIYKVMYGLSAATLDYAPELSYTSFVPFVNIVFKRKSLRDATSESISAKLVHIDKEISPI
DIKTDQDNYSIFSLSYNYVNPDIIKEFRYNFSLEAGEKFSKLAVDLRFRSLSTTDTQLDF
RFFAGAFLNNKTEGDYFSFGLDRANDYLFQLNYLGRSESTGFFSQQFIITDGGFKSVLPT
RFANQYMFAFNSSFGLWRWMEFYNDVAFLKNKNNPIYFGYNNGIRFNFVHNIFEIYFPLY
SNNGWEISQGSYPEKIRFTLTGNINSIYNFFRRGFL
>FCMOIPGL_02267 hypothetical protein
MKMKNYLLYIFFLTLSLKGHSQDVSSASEKKNALAVSFGSPGLGLEYARKLSPKLNAKLV
WHSFNLKDFEQEDVEIKDDVVDILANLEVAIIDAGIEYLPFTNSSFKLTAGVGFLSNVNA
NGVITYTEEVVFGDVTVSKNDIGEINADTSWSGVAPYLGVGFGRAIPKKRLGFGIEFGSY
FTSSPDVKLTATKLLAPTAEQEENLKEALTTFKFIPRIQLRLAYSF
>FCMOIPGL_02268 hypothetical protein
MKKFKLLITMSFLTLFALSCDIDGVTDSVDITISNNILKQEALISVLDITNPENLEGNNK
LKVELIGADADKFVTNSGEKTSNLKVIDGNIALAVNPNHASTEPLKVLLKISGDDYLTTT
IPLVMFPEDTLVTRSINIVNKLNTVEGIDFIENNKSLANNTLSTDYSVETPATKASTKTE
IKIESGTVFQDADGNTITGGTLKSEVAHFSLDTPESIASFPGGLTPLSVIDENGEENEDI
SFITAGFTSIDMFIDGKEVKNFSKPISVGIEIPSDYINPETGNTINVGDQIPIWSYDEDG
QWGYHKIGTVSMNASNKLNITFTTTHLSWYNLDYHYWGVCRYGRYTEVSAPKAPSLSDNF
YELSFELVYAANNQVIATNSIQISKTRNNSSGFYNTPNQSLKIKVYYGRYSEKVLLYTSE
AFDGCSSNVITLDGAAITSALPPKPVIKNIFIEYTARCGDKILRPFLYIYRLETYTYNGR
QYSYWQWVGFTYSGRGYIYNARIGESQKYRVYFGGTAYDYDYTFNSDNIVIDDFEVPGDL
CSRLF
>FCMOIPGL_02269 Pyruvate dehydrogenase E1 component subunit beta
MLQETVTSNNQEITFNDFKNEVLNDYRIAKISRECSLLGRREVLTGKAKFGIFGDGKEIP
QLAMAKAFKKGDFRSGYYRDQTFMMALGELNAQQFFAGLYAHADIKEDPMSAGRQMGGHF
ATHSLHQDGSWKNLTEQYNSSSDISPTAGQMPRLLGLAQASKIYRDEKSVQHKTNFSNNG
NEIAWGTIGNASTSEGVFFETINAAGVLQVPMIMSIWDDEYGISVHAKYQTTKESISEIL
NGFQRDKEKDGYEIFVINGWDYVQLVDIYQKAAKIAREEHVPVLIHVKELTQPQGHSTSG
SHERYKGKERLQWEQDHDCISKMRSWILDFELETETGDILRFVESEEELIILEKEVKKEV
TAAKRNAWNAYLNEIKAELLVAVEILEKVANKSINGTFINKYKNDLLRITEPTRKDVLAA
TRKCLRYIKDEHFAAKIELQNFIKAAINNGYQKYSTHLINDSDISVLNILEKKPIYSPEK
NLVDARIIMRDNFDAILKKHDDILIFGEDAGFIGDVNQGLEGLQDKYGKIRVSDTGIREA
TIIGQGIGLAMRGFRPIAEVQYLDYLLYALQIMSDDLATLRYRTFGKQKAPLIIRTRGHR
LEGIWHAGSPMGGIINNVRGIHVLVPRNMTKAAGFYNTLLEGDDPALVIECLNGYRLKEE
LPTNLGDFKTPIGVVENIKEGSDITVVSYGSTLRLVQEAAKDLSQNGIEIEIIDAQSLLP
FDLNHDCVKSLAKTNKLIIIDEDVPGGASAYLLQEILENQNGYQYLDSKPATLTSKAHRP
AYGTDGDYFSKPSAEDIFEKIYDIMNEANPQKFKSLY
>FCMOIPGL_02270 hypothetical protein
MKKIVFLSLLIAFTIPSQINAQRKKSKKDIKTETTVTSKKSKTPKYTDFVTSKTKTDDGV
FKVHETNDKFMYEIPKSYFGKEMLLVTRIKELPAGLGGGYVNAGSKINTQVIVWQQFKNK
ILLKVKSYNAIANDSLPIYKSVTANNLEPVIYAFDIKIQNTDSTAVLIDVSNFFSSDVKA
ITGLPDSFRKRYKVKRLDASRSFINSIKSYPKNIEVIQDFTFDADEPPSNSSTKTISLRI
NQSMILLPEDKMMPRVYDKRVGYFSLGNVDYSSEALKADDKRYIKRWRLEPKDLAAYNRG
ELVEPIKPIVYYLDPATPDKLKKYIKQGVDDWQKVFETAGFKNAIMAKYAPTKEEDPEFS
MEDIRYSAIRYVASTTRNATGPSVADPRTGEIIESDIIWYHNHLRSYRNRYLLETGAANP
SARTLDTPAEEIGEMMRMVISHEVGHALGLPHNMAASFAYPVDSLRSGSFTQKMGVAATI
MDYARYNYVAQPGDKNIRFIRQLGPYDHYSINWGYRKIPNIKNPEQEIITLDSWIEEKID
NPIYRFGGARFDPSSQTEGIGNDQVKASTYGIKNLKIVAENLPNWTSDKTNNYEDLSELY
GELLSVWSRYAGHVSGNIGGVYEFNKKPNQTGNIYVPVTKEKQKESIAWLHKNVFKTQDW
LLDKKILSNYKEDGYTDLISNLQKRQLNSILRISTLKRMIDTEIIEDNYYAASDMIRDLR
TGIFIEANYTRNVDLFRRNLQKYFIDKLGSLLTSEEAKNTDITSIIRGELEMMNFQLTIA
KNRSINRMTKYHYRDCLTIIKQLLNPKN
>FCMOIPGL_02271 hypothetical protein
MTEEFLYYVWQYNLFSKTALFTSDNQEIIILKSGIQNKNSGPDFLNAQLKIDNQLWVGNV
EVHVKSSDWYLHNHEEDTNFDAVILHVVWENDAVVFMKNNKPLPTFEIKSFVDEKLLSNY
NGLIYSKQNWIPCENQIKNVDDFLVNNWLERLYFERLEQKSVFIKEVLKQANNDFEAVLF
QLLAKNFGLKVNGDSFLQLAKSIDFSVVRKERFDEQKLTALFFGQAGFFEADVQNDYFSL
LKTEYEYLKHKYNLHSISNKNFQFFRMRPQNFPTIRIAQLASLFFIHQNLFSKLMSIHKK
EDFYTLFSFDIQEFWKTHYTFESESKKSAKKLSKSFIDLLLINTIVPLKFVYLQSRGAVD
EEEILQLVRQISSEKNSIIDQFSKLEIKSKNALESQALLELKNHYCTMKRCLQCAIGNDL
LKRK
>FCMOIPGL_02272 Putative NAD(P)H nitroreductase
MNTIESLQWRYAVKKFDEHKILSEKQITTLKEAFNLTATSYGLQPLKLVVIQNKNIQKEL
IEHSWNQPQVHEASHLLVICIPKNYTSEDVRNYFTLVKEIRNTPDAILNPFKKFLTDEIE
KKTQEELLIWNKNQAYLALGNLLTVCATEKIDSCPMEGFIPEKYDEILKLDTQNLTSILV
LPVGFRADDDYMKDLKKVRKNIDDIIIEIN
>FCMOIPGL_02273 Cytosol non-specific dipeptidase
MNQDIRNLQPKSVWNHFADLNAVPRPSKKEERVIQFMVDFGKKLNLETFVDKVGNVIIKK
PATSGMENRKTVVMQGHLDMVHQKNADTIFDFDKEGIKMFVDGDWVKAKGTTLGADNGLG
VAAIMAILSSTEIDHPTIEALFTIDEETGMTGAMGLEGGVLEGEILLNLDTEEDDEIGMG
CAGGVDITATRTYLEEETPENTTAFSITVKGLNGGHSGMDIIKGLGNANKIMNRILFDGF
ANFGLRISEINGGSLRNAIPRESVATVVVDNISKEPFLFETNELINTIKAEFSTLEKNLS
VEIKEIESPKKVMELGVQEGFTKSIYAALNGVYRMSPDVVGLVETSNNIARIILKDGRIK
VGCLTRSSSESNKWDLANSLRSAFELAGLEVDFSGTYPGWLPNVKSEILTIVTNIYTDLF
KEKPIVAACHAGLECGILGQNYPEMDMVSFGPTIRGAHSPDERAQISSTQKFWKLLIEIL
KNTPLKSN
>FCMOIPGL_02274 Sporulation initiation inhibitor protein Soj
MGKIIAIANQKGGVGKTTTSINLAASLGVLEKKVLLIDADPQANASSGLGIDVEGLEIGT
YQVLEHTVSAKDVIVKTTSPNVDLIPAHIDLVAIEIELVDKQDREFMLRRALAEIKDDYD
YILIDCAPSLGLITLNSLVAADSVIIPIQCEYFALEGLGKLLNTIKSIQRIHNTDLDIEG
LLLTMFDSRLRLSNQVVDEVRKHFSSMVFDTIIRRNTRLGEAPSYGESIIAYDATSKGAV
NYLNLAQEIIKKHK
>FCMOIPGL_02275 putative chromosome-partitioning protein ParB
MAKATKKQALGRGLSALLQESSNINSASDKNADKVVGNIIEIELSSIEVNPFQPRTYFDE
ESLQELAGSIRELGVIQPITVRKLEGNKFQLVSGERRFRASKLLGNATVPAYIRLANDQE
MLEMALVENIQRKNLDPIEVALSYQRLIDEIQLTQEDLSIRVGKKRSTVTNYLRLLKLDP
ILQTGMRDGFISMGHGRAMINVDNTEDQLAIYEKILREKLSVRQTEDLVKNLKSGAIAKP
KKKIIPPYIKESIKDIGDYFGNKIDISVGNNGKGKISIPFNSEEDFNRIKNLLK
>FCMOIPGL_02276 hypothetical protein
MFFKKTILFFTLALFTATLFAQKDSTEVKIKDVKIEGNINTTKEGIYDPLAPSKAAFYSA
IFPGMGQLYNKKYWKVPIVWAALAIPTYYYQINNRDYKRYRTAYKLRKNGLQDEFTDDDG
VSSVSLTTLETAQEQLSENRDMSLLSGVIIYILQIVEASVNAHLLQFNTDDNLSFKPAMI
MDPIRIQTPSVGLTIKYSF
>FCMOIPGL_02277 4-hydroxy-tetrahydrodipicolinate reductase
MKIALLGYGRMGKEIEKIAISRGHEIVIRKDVDDIIDITLADVAIDFSVPTSAFNNITNC
LNNNVPVISGTTGWLDKYKEAVALCTEKKGAFIYASNYSLGVNIFFELNKQLAKMMKTVE
GYNISMEEIHHTKKLDAPSGTAITLAEGIIENSSKINWELGEKASEENIPIVAKRIPDVP
GTHTVWYESEVDTIEIKHTAHSRKGFALGAVIAAEWIANKTGVFSMKDVLNIR
>FCMOIPGL_02278 Signal peptidase I
MTYTQWFIFFLAVQVLHFLGTWKLYVKAGRKAWEAAIPIYNGIVLMQIINRPKWWIILLF
IPIVNLLMFPVIWIETIRTFGFYKKLDSFLVIVTLGFYIFYINYATDTAYNKGRSSKPRS
ELGEWVSSITFAIIAATLVHTYFMQPFTIPTSSLEKSLLVGDYLFVSKFHYGARVPSTVI
AAPMVHDSLPFTGTASYLKKPQLPYTRLPGLQKIKNNDIVCFNWPADSLATMWGDHSGKF
TYKPVDKKTNYVKRAVGIAGDSLELKDGYVYINGKKNELPYRAKIQFYYTFECKEPISQS
TYPKFLLDKERTGVYKILSEYWNNDRVQDSIKVNGNLSKIGEDSLYTEVVGGINQNFARK
LKMINVENKININLTEEEVSRLEKYPLTVSVKKVNHAPDIAVFPHVEKLKWSQDNFGPIY
IPKKGATVKLDSESIPFYEQIIKNYENNDLVINGNNIFINGQKADSYTFKQDYYWLMGDN
RHNSLDARYWGFVPFDHVLGKPVMIWFSWDANAPSFTAKIKSIRWDRMFTTVHGDGEPVS
YRYFVLALIGLYIGYSFYKGKKKSKK
>FCMOIPGL_02279 hypothetical protein
MSLFIPTYFSPISQYSEIVKADEIVFEMEDNFQKQGYRNRCYIYNSNGKQLLSIPVKHLT
KDKRKKTKDTLVENNFPWQDQHFKSLQIAYRTSPFFEFYEDDLVPIFEKKYKYLQDINID
TFLFLKDALQLETDFSLTKEYQVETTEKDFRLLAEIKHQPEKLVEKYIQMFDDKHGFIPN
LSILDLLFMEGPNTISYL
>FCMOIPGL_02280 hypothetical protein
MYYSMNNLKEFTANFKNIPQKKIDLFLSLASKEKFKKNDLIAKIGEKTHYFYIIESGIIR
SFYTDEKGKEFTRTIFTKQKTTGPLATLITGEPSKLTYECLSDCTVYKINYNEFVALAKK
DISMANLYSKMLEFIFLVMESKIYDLSALNATERYYKLKKEIPDIDNLIPQYHIASYLNV
SPVQLSRIRKEMYSK
>FCMOIPGL_02281 hypothetical protein
MIKFTIHYFLHFLAPLLISYFFFRDNWKKVYLIFLLSMLVDLDHLLANPIFEKNRCSINF
HPLHSYIAIAIYFLGLFFKKTRILAIALLLHMLTDFIDCYL
>FCMOIPGL_02282 hypothetical protein
MGIVIKQSFKNTLFIYLGFAVGGINTLVLYTRFLEDEYYGLVTFLLATSNILMPLIALGI
HHTIVKFFSSYFTKIDKDKFLSSVLFLPLLIAIPIGFFGDLFYEQISNHLSVKNPIIKEY
TFVIYLVAFACAYFEVFYAWAKVNFQTVFGNILKELYNRVAVMILLFAVYFQWITKSEFI
YYLTGAYFIRMLLMMFYAFRLYLPKFTFQRPDNFKEVLSFSFYIILAGSAGAIILDIDKF
MIPGKESLETAAYYTVAVFIGSFIEAPSRAMLNILQPLTSKTLNEKNHLEVASLYKKSSI
NLLIISGFFFVLINANINELFRLLPVQYAGGALVVFMISLLKLYNGFLGNNGAIINNSKY
YKITLPYSLIMAISVYFLNKLFYYELDMGTDGLALATLIVIFSANTSKIFFVKRKFSMTP
FTDKSFIMVLVIAVLYLLFNFWDFPIHNINVFNFPIDPIINIILKSAIIAVIYLFLIIKL
NISTEISGLFKRFISNNL
>FCMOIPGL_02283 hypothetical protein
MKVLIITYYWPPAGGSGVQRWLKFVKYLQNFDIEPIVYTVDNANYPKEDNSLINEIPKNV
TVLKQPIWEPTDLLFWKKKNQQKSDVSNAVNNGLLSFIRGNFFIPDPKVFWVKSSVKYLN
KYLKDNKVDVIISTGPPHSMHLIAQKLKQKNKIKWIADFRDPWTDLYYNNEFKQLSFAKK
RNLKLEASVFKNADCILTVSNSLKKDFAKKATRVEVITNGFDDEVLRNNSVRLNKKFSFS
YIGLLPKQSNPKLLFRVLKNLCVENTDFKNDLELNFIGDISEDVRQEIEANNLLENTNFS
GYVSHIDAIKFQKKAQVLLLLIPDVEKSEGILTGKLFEYLTAKRPILAMGSENGDLSEIL
ENTNAGVVVGFRNEIKLTSEITKLYQQYKLGNLQVDSINIEQYHRKELTKNLSEIIKNL
>FCMOIPGL_02284 D-inositol-3-phosphate glycosyltransferase
MKIGMILDASFPPDPRVENEAVSLVNAGHQVFLFCLKYADEKSSEIINGIEVRRYKSNKL
EYKLSALAYTVPFYTFLMQSKIYQFIKDTKIEALHIHDIKIAQAVFNANKKYNLPIVLDL
HDNMPEVMKLYPHLQIFPGKYIISPKKWKQKEEEFILKADKVISVSPEFLETLKTRIPSA
KNKLVLVPNTIRKSFFEDYTIDTSIIERYKNKFVILYLGDTHIRRGLQTAISSVEKLKDI
IPNLKLVIVGKNTTDIILKQQVQDLKIQEFVDFEGWQNVSLFQSYIFSSDVCISPLHRNL
QHDVAYANKIFQYMSLAKSLLVSDAIAQKKLVERTNSGLIHQEKNVEDFTDKVLKLYADE
KLRNELGENGKNFVRNEFSWEQTSKKLLHLYDNLLN
>FCMOIPGL_02285 hypothetical protein
MVKKKSLLLLLLFLFSGLVFSQTIKEDNFNIKKIIDFKDINNDSLIYYANKLKSSKNLCN
YYHALNTEATAFYQKGNLKKAEVNVLRILDSLENKEEICFIKNKNTALNRLFWIYKNQNK
FQEAFNVIIKRRKVLNSLPIKDNYFNVNNISLDKSLATIKKILGLHEEARTILKEMLPKL
PSIYKGFNENDYTLKLNISSTLNTIGESYLESNKENTKNYLDSASVYFKKAFEVAKTFNP
PHKNSEVLYQLRIAEILIAKEDFKEALKIIQKNDIIHKEFRVNQLINSLKAICFYQLKDN
DSTLYYSKQFLKEHSKKSIVKKSVISIYDILANQYYKNKQIDSAYKYSELTIAELKVLNE
NKNEANKSHYLYDYKNAQELNKLILKKGKKTNNYYIIILLIIILLGIFTVYFLLKRNKKT
SKDLTEIKTEINEKPLPQKKEYNIDEKLEKTLLNGINELEKNKDFLDPNFSINGLAKKLN
TNTSYLSYIINKESNQSFKQYITELRIEYLIKRLIEEKKFRNYTIKSLAEEIGYTNASAF
TRAFKKYKGITPSDFIKSLKEN
>FCMOIPGL_02286 hypothetical protein
MKAKKFLPYIVAVVIFIIASLVYFYPVLKGQKIAQSDITQFQGMVKEINDFRADNNTEPY
WTGASFSGMPAYQISAYYPYDFVRSIDKLLRFLPRPADYTFLYFLSFFVLMLALKVKWRL
AILGALSFGFSTYLIIIFIPGHNAKAHAIAYMPLVLAGVLWVFQKKYVLGFLVTGVAMAL
EIYTNHIQMTYYLSFCLIILGIVELINAIKEKKLTTFLKQAAVIIAAVCLGIGANSPRLM
AMKEYADFSTRGKSELTINVDGTKKEATKGLDKEYITQFSYAKLETFNLFIPRFMGGGTV
EKLNKNSNFYKLIEKQAGKKVADDYSEQVLTYWGDQTIVEAPAYIGAVIFFLFFLGIFLV
KGKLKQWLVAATVFSILLSWGRNFEGLTNFFIDYIPLYNKFRAVSSIQVIAELCVPILGI
LALKEFFSSNVSRKKKRRALKKAVVVFAGLIVFGFILAHVFSTFEGLRDSNYKDLSGLID
AVIADRKAMLLKDTLRSLALVLIAAIILKFSLKNKIKQKFTILALAVFLLLDLISVDKKY
VNATDFISSRKVEKPFTASNADKLILQDKSHFRVANFTTDPMQDGSTSYFHQSIGGYHAA
KMGRYQELFDYQIAKNNMQVLNMLNTKYFIIADNNNEKQAQQNPDINGNVWFVENVKVVN
SANEEMQLLDSLNTKFTAVLDKSNLSENISFNFEKDSTAIISLVKYDVTDLIYQSKTAKE
QFAVFSEIYYKDGWNAYVDGKLTPHFRVNYVLRGMKIPAGEHKIEFKFEPKVIQQGGLIS
LSSYAILILVSVGWFFYDKKKKK
>FCMOIPGL_02287 hypothetical protein
MGLLKTILYILVFYYAFKFLARLLAPFLMKKAAETIQKKAEQQFGNQQPNGSVKEGETII
DKTPRKDQQGKSSVGEYVDFEEID
>FCMOIPGL_02288 hypothetical protein
MKNRKLKLFSLLFLLGFCSIYGQYTEVINSNKPGFSESPYSVGKGVYQFESNLFLRNNNI
EPTFSVPNSFGFDMLFRTSLFFEKLELNTHVSYQKDKIVPNDISIPDYSTSGFREFTIGA
KYLIFQQEYKDKSKEIRSWKRKHAFDINRLTPSIAIYVGINTDFINDIYKMGSISSKIGL
LFQQDLSTDFNLVSNFYYDKIGTEFFDYSFIITATYTFGNRWSTFFENQTEFQEHQNTTN
FGTGLAFLYNKNLQINSSARYYLDGREQGFYAAFGVSYRIDKHKDSFKEKNNSRTKVGNT
PISSYNKKEKGFFSRIFGIFAKKKTTRKRPKRKRNN
>FCMOIPGL_02289 hypothetical protein
MITLKQVTNNLEMKRFVLFPFNLYRKNKFWVPPIIKEEVDNFNPKKNPVFKNADAQFFLA
YKNKKIVGRVAAIINWSEVNNQNIKKIRFGWFDMIDDLEVSKTLLDKVREIGRHNNLEFM
EGPVGFNNLDKTGVLVEGFDQLGTMITWYNHPYYKDHLEQLGFVKEKEYLENKFKFQNVD
AAYYNRVSKILKSRFKLKALDFKKTKDILPLVDEMFDVFDKTYSKLSTYVPISQEQITYF
KKKYITFINPEYIKFVMDENDKLIAFAIVMPSFSTALQKARGKLFPLGVLRMLKAKRQAK
DVTFYLIGVHPDYQNKGVTAIIFDQYTKTFTKKGIVNCIRTPELEDNEAIKKIWADFNPV
THKRRRTYRKNIS
>FCMOIPGL_02290 Ribosomal RNA small subunit methyltransferase E
MQLFYNADITKNTTQLTFDKIESKHIVRVLRKKESDILHITNGLGFLFEAKITVASDKKC
IAEIISVEEKPKPWQYYLHIAIAPTKLNDRMEWFLEKATEIGIDEITPIICNNSERRIVK
LERFEKIIQSAMKQSLKFTLPQINKPVKFNDFINQDFEGTLCIAHCEDQEKNLLKSVVNP
SEKTTILIGPEGDFSIQEITKALEKNWIPISLGESRLRTETAGLVAVQNVSFINQ
>FCMOIPGL_02291 hypothetical protein
MKQFLFLLVFSIFLTTNAQDVAILKYNGGGDWYANPTAIPNLVAFANANIKTNISKNPQT
VSAESEDIFSFPIVFMTGHGNVLFSDEEATNLKNYLISGGFLHISDNYGLDKYIRPELKK
IFPALELQEIPSNHPIYNQTFKFPEGIPKIHEHDKKPAQGFGLFYEGRLLIFYDYETDLS
DGWEDEIIHNNPKEVREKALKMGSNIIEYAFKN
>FCMOIPGL_02292 Pantothenate precursors transporter PanS
MQNEIDIDSIKINFDSSGLWVLNIAIAIIMFGVALGITIDDFKRLLKNPKILMVGVLSQF
ILLPAFTFLAILIIKPHPSFALGMMMIAACPGGNVSNFFSKMAGGNAALSVSLTAFATLI
CIFMTPFNLQFWGSLYEPTNEILKTVSLNPFDLFKLVSLILGIPLILGMLIKHYHAEMAD
KIEKVLKPLSMLVFIILIFVAFSQNLDVFMNHIHHVLFLVIFHNIFAFILGYFTAKSFGL
NKQDCKTISMETGIQNGGLGLLLIFGFFGGLGGMALLAAFWGIWDVFSGMILATYWGRKA
KL
>FCMOIPGL_02293 hypothetical protein
MLQKIWYHFFRLLVKTGVFFYSKKIRVSGAKNIPKKGAVLFCANHPDGLLDPLMITTNCP
RVSHYLVRAAAFNNPLIKKFLESLNLMPIYRIRDGISEVGKNKEIFENCFELFKKGETLL
IYPEASHNRKRTIRPLSKGFTRIVFGALDKYPDLKITIIPVGLTYQNASFYPSKVAINYG
KPIAVDEFYTINELNVSINSLKNEVSNQLKKLSVHITDDENYDSTLTQLNNLNVDFTNVD
FVNKMIAKNSFTDKNKRRTNFLKPLYYIILLNSIFPVLIWKKIVKKIDEAEFIDTFRFAI
NLVLFPVFYGLQTWIIWLFFNWKIAISYLLISLLLILVYSKFSPTNTENEEYLTKLAKRL
SPD
>FCMOIPGL_02294 Beta-hexosaminidase
MKKEFILIFLVSLVFNLSAQTVDPLRTKDFEAQEIWVDSIINNMTIDEKIGQLFMVQAYS
NLDKKHEDFITEMITKYHVGNLIFMQGTPEKQAALNNKYQAVSKLPLMIGFDGEWGLDMR
LQNTYRFPWNMTLGAIQDDSLIKEFGEHLGKHCKRLGIHINFAPVVDINTNPDNPIIGNR
SFGESKENVTQKAIAFTQGMQKYGVMANAKHFPGHGDTATDSHHTLPVLNFDKARLDSIE
LYPYRKIFDAGIGSVMTAHLSIPSLEPNAALPTSLSKNVVTNLLKQELGFNGLIITDGLN
MKGAANYATSAEIDLAAIQAGNDLLLIPQNVPATTDLIKKAIALKTLSLERLDFSVRKIL
KAKYWMGLNKYKPVVLENLQEDLNTVEDELLHRKLVKNSLTILKDSKQNIPFSNLEDKKI
AYVNLGDDSGEYFLEMLKNYTKIDEISDKNLDALMLKLKPYSHVIVGFHKSNLHPWKSYK
FTQKELVWLQEIAREKNVILDVFTSPYSLLQIKTFKNIRSVIVSYQNSKIAQELSAQLIF
GAFEAKGKLPVSIGDEFKLGAGLQTYSLGRFEYTIPEEANLSSKKLALIDKFADTILKDK
MAPGFQVLVARNGKVVFQKSYGHHTDEKSLKVKNSDVYDLASLTKILASLPLIMKAEEED
VIPLSASVKDILPSFKNSNKSAVSVMEILSHYGNLKAWIPFYKETQDSSTHKNLPIFYRN
VKSTNYDVKVADHLFINKFYKDSIYKYIKDADQRTKKGYKYSDLGYYIFKEALETAYHKP
LNKLVDEGFYKSLGADRMTYLPLEKFNKSEIIPTEIDDYYRNQLVHGYVHDMGAAMMGGV
GGHAGLFANANDVAKIMQMYLQKGFYGGRRYLKEETVDKFNHRYYSDEKVRRGLGFDKPE
LDPKVKATCGCVSDESFGHSGFTGTYTWADPKSGIVYVFLSNRVYPHANNRGLIRSNIRT
KIQQTIQDAILD
>FCMOIPGL_02295 hypothetical protein
MFTEYKNLPNNSRVWIYQSEREFNQKEIEIISAKAEEFINSWTRHGDDLKGSFTIKYNQF
LVLAVDESFNNVSGCSIDSSVRFVQQLENEFQLDLMNKMNVTYKDGDNINLLKLTDFQKF
AKEQKITSETIVFNNMVNTKEDFENNWEIPANQSWHKRFLV
>FCMOIPGL_02296 DNA polymerase III PolC-type
MNLNLTKPIVFFDLETTGINIATDKIVEISILKVFPNGNKESKTWLVNPEMEIPKESSEI
HGITNEKVASEPTFKELANKVNELIGDADLAGFNSNRFDIPLLAEELMRAGIDFDMKNRK
AIDVQVIFHKKEQRTLSAGYQFYCGKELEGAHGAEADTNATYEILLAQVDKYGDIGNSVD
TLSEYSTHGERADFAGFILMNDDKQEIFSFGKYKGRTVEEVFKENPGYNNWIQNADFPLY
TKKVLREIKVRMSAPKDTMSDAEKLQALQQKFNLR
>FCMOIPGL_02297 hypothetical protein
MSLDKYKVIEAISLKDSSTKVVVKDAKKDLKKSRKKLSKLQDAMYAEGKYSALICLQGMD
TSGKDSLIREVFKDVNARGVVVHSFKVPTELELKHDFLWRHYIALPAKGKMGVFNRTHYE
NVLVTRVHPAYVFGENIPTVNSLDDLNDEFYHNRMDRINDFENHLAKNGTIILKFFLNLS
KEEQKNRLLRRLELPDKNWKFSADDLKERKLWDKYQFCYEDLLNRTSKENAPWFVIPADD
KDSARIILAKILVKELEKYNFKEPTLSDKLVAQLDDFKAQLNKE
>FCMOIPGL_02298 hypothetical protein
MPKKGKAKNTLNKAKHTKLMNQKINKVKLEKQRTKDRLKALIKKVNEQKNEQKSDEL
>FCMOIPGL_02299 hypothetical protein
MNFKYYLGVIISIPLLPFMYFQGKNIRKKVPKLPEAKEPKGFVNGGFNKTINILSIGEST
IAGVGIDFHKTGFTGTLANTLSTELKSNINWRVYARSGYTVKQVCEKIIPKIKETSTDII
VVGMGGNDAFTLNSPKKWISDINNLIDLLQHKYPNTPIFFTNMPPIKEFPAFTKTIKFVI
GNLVEILGKELKNSIQHKENVFYYDEIITLKDWSKKHSLSNSDSTIYFSDGVHPSKLTYQ
IWGKEIGEFILKKYPKSF
>FCMOIPGL_02300 hypothetical protein
MKLPVIKHLTSFIEENDQDYLLETIETLEALTEVPSLKDEELDVIGELISNMYGALEVDK
MIKEGTPKKEALNAFMKRVLGSIDK
>FCMOIPGL_02301 Putative thioredoxin 2
MLQELSQDNLSEIISDNNKVVVQYSATWCGNCRIMKPKFKKLASENEEVSFVIADAEKFP
ESRKLADVSNLPTFATFVDGKLVNQTQTNKFDVLLDLVKEVI
>FCMOIPGL_02302 putative peroxiredoxin
MATAVGKKFPDLNVNAMNEMGDTFKLNVLEEAVNNKKKVLLFWYPKDFTFVCPTELHAFQ
AALGEFEKRNTVVIGASCDTAEVHFAWLSTSKDNGGIEGVTYPILADSNRNLSSILGILD
ITDETFDEASQTIQVEGDNVTYRATYLIDEEGTVFHEGINHMPVGRNVNEFLRLIDAYAH
VQSHGEVCPANWEEGKDAMSPDAKGTAAYLASH
>FCMOIPGL_02303 Catalase-peroxidase
MENLKHTSEDISKCPFHGGSTTNETSNNWWPNSLNLDILHQHDTKVNPLGEEFNYHEALK
KLDIDTLKEDVKKLMTDSQDWWPADWGHYGGLMIRLAWHSAGSYRLSDGRGGGGTGNQRF
APLNSWPDNASLDKARRLLWPIKKKYGNKLSWADLIILAGTIAYETMGLKTYGFAFGRND
IWQPEKDVYWGAEKEWLAPSDERYTDIENVNTMENPLAAVQMGLIYVNPEGVNGKPNPAK
TALHVRETFARMAMNDEETAALTAGGHTVGKAHGNGDASKLGPEPEAAPIENQGLGWSNP
NRSGVGRDTVTSGIEGAWTTEPTKWDNGYFDLLFGYEWELTKSPAGAWQWKPINIKEEDK
PVDVEDPSIRLDPMMTDADMAMKVDPIYREICEKFKNDHAYFSETFARAWFKLTHRDMGP
KARYFGPETPTEDLIWQDPIPVGNSNYDVNLVKEKIANTDLSISEMVSTAWDSARTYRGS
DMRGGANGARIRLAPQKDWKGNEPERLQKVLSILEPIATEFNISIADTIVLAGNIGVEKA
AKNAGFDITVPFSVGRGDATDEMTDVDSFDVLEPLADGFRNWLKQEYIVSAEEMMLDKTQ
LLGLTAPEMTVLIGGMRVMGTNYEGSKHGVFTDNIGALTNDFFVNLTDMTYSWKPLENGL
YEIRDRKTNAIKWSATSVDLVFGSNSILRSYAEVYAQDDNKEKFVKDFVKTWAKVMNADR
FDIK
>FCMOIPGL_02304 hypothetical protein
MNILNTFFGAIQNVNINLIETLLKKFPSLANSKDQRGFSPLVFATYFDKKEIAETLIKHN
ANVNHRDSKGNTALLGVAFKGNVEIAELLLNNNAEINAQNKLGYSALIFATLYNQPKMVE
FLIKQNADLSLKDIENKTALDYAKAKDFKEIITLLETQETTYLQTT
>FCMOIPGL_02305 Transcriptional regulatory protein ZraR
MSKILVIEDEASIRRVLKKIISEENEAYNVEEAEDGLMGLEMIKNNDYDLVLCDIKMPKM
DGVEVLEKAKKIKSEIPIVMISGHGDLDTAVNTMRLGAFDYISKPPDLNRLLNTVRNALE
NKVLVVENKRLKKKVSKNYEMIGESAAISHIKDIIEKVAATDARVLITGPNGTGKELVAH
WLHEKSDRSKAPMIEVNCAAIPSELIESELFGHVKGSFTGANKDRAGKFEAANSGTIFLD
EIGDMSLSAQAKVLRALQESRISRVGSDKDIKVNVRVVAATNKDLKTEIAEGRFREDLYH
RLAVILINVPALNDRREDIPLLVDFFTAKISQEQGTPKKAFSSEAINLLQKYDWTGNIRE
LRNVVERLIILGEKEVSANDIKLFASK
>FCMOIPGL_02306 Mechanosensitive channel MscK
MQDNIEKVANDIVDQATSILDYSFTFSKEISISVKGLIFVVFALIVANFLLKLIRSLVTK
RMPKNDQLKFVSVFGYLKWFLYLIIFLIAMHTSGVNVTAVFAASAALLIGVGLALQTLFQ
DIISGIFILVDQSVHVGDIIELEGKVGRVLDIRLRTTRAVTVDNKVLVIPNHLYLTNILF
NWTENGTETRESVDVGVAYGSDVELVKTILLNIAKSQPTVLKNPAPMVLFRDFADSSLSF
RIAFTLKDSFDVRFTQSNIRFEIDKAFKKNNISIPFPQRDVHVYQNK
>FCMOIPGL_02307 hypothetical protein
MSKLTLIIHREFIAKVRNKSFIMMTFLSPLLMVGMGALVFFLMKKNDEKVKEIVYVDNSG
LFSKDDFSDSETIHYQDYTSFGIDQTKKKVEEGDYYGALIIPKQDSLEVLAKSIEFYSKD
SPGMSIMDALESKVETKIRNEKLNNFGIDINQINASKIQSDIKMYNFSGEESSKLINGLK
IGVGALAGYMLMMFVMIYGTSVMRSVIEEKTSRIIEVIVSSVKPFQLMLGKILGNASAGL
LQFFIWGILLFIIATVASSIFGVDMVEMQTAKLPAEQLEAAKQAAGSDKMQMVVQEILRL
PLLKMFCLFIFYFLGGYMLYSSLFAAIGAAVDNETDTQQFMLPIMLPLILGVYVGFATVI
NDPHGSIAVLFSYIPFTSPIVMLMRVPFGVSWYELAISMILLLATFIFMVWLAAKIYRVG
ILMYGKKPTYKDLYKWLKYKG
>FCMOIPGL_02308 ABC transporter ATP-binding protein NatA
MKNLLEINNVTKNYGDFRALNDVSIHIPKGSVYGLLGPNGAGKTSLIRIINQITMPDAGS
ILLDGEPLSPKHTAVIGYLPEERGLYKSMKVGEQALYLAQLKGLSKSEAKKRLKYWFDKF
DISAWWGKKIEELSKGMAQKVQFIVTVMHNPKLLIFDEPFSGFDPINAQLIAKEILQLRD
EGATIIFSTHRMESVEEMCDEIALIHKSNKILDGKLSDIKRQYRTNTFQVGLHTDNPKEV
EAKLKENFEVFPADFKLLGNELTLNVKLGQNNSANELLSFLTNSGQVQHFVELIPSANDI
FIQAVNKNN
>FCMOIPGL_02309 Transcriptional regulator SlyA
MDKNKSIDHQLRATWQAVAKMYNEQAANYGSTMAIAFVLLTIDKVNGTPSTALGPLMGME
PTSLSRILKSMEEKGAISREKNPDDGRSVIIKLTEYGFEMRKFSKNHVYQFNNVVREYVT
EKELDSFFKVTSTINKLIADKKIYESINQENKK
>FCMOIPGL_02310 putative 3-hydroxyacyl-CoA dehydrogenase
MTRRIKKVAIIGSGIMGSGIACHFANIGVEVLLLDIVPRELNDKEKAKGLTLKDKVVRNR
LVNDALTTSLKSKPSPIYSQKFAERITTGNLEDDIAKVADVDWIMEVVVERLDIKKIVFE
KLEKYRTPGTLITSNTSGIPIKFMNEGRSEDFQKHFAVTHFFNPPRYLKLFEVVPGPNCK
QEVTDFLMMYGDKFLGKTSVLAKDTPAFIGNRIGIFGIMSLFHVVKEMGLTIEEVDKLTG
PVIGRPKSATFRTIDVVGLDTLVHTANGVKDNCPNDEAKDQFVIPDFVNHMMENKMLGSK
TGQGFYKMTKDAKGNKNILSLDLNTLEYREKKSAKFATLELTKSIDNVVDRFKVLVSGKD
KAGEFYRKSFAAMFAYVQNRIPEISDELYRIDDGLRAGFGWEHGPFQIWDAIGVEKGVEM
MKAEGHEIAPWITEMLANGQTSFYSIKEGATYYYDIPAKAQAKKPGQDSFIILDNIRKSN
EVWKNSGAVIEDLGDGILNLEFQSKMNTIGGDVLAAVNKAIDLAEKNYQGLVVGNQAANF
SVGANIGMIFMMAAEQEYDELNMAIKYFQDTMMRMRYSAIPTISAPHGMALGGGCEISLH
ADKVVAAAETYMGLVEFGVGVIPGGGGSKEMALRASDLFHKGDVQLNVLQENFLTIGMAK
VATSAYEAFDLGLLQKGKDVVVVNKDRQIAQAKKHAVLMAEAGYTQPVKRDDVLVLGKQA
LGMFLVGTDSMEDSKYISAHDQKIANKLAYVMAGGDLSEPTKVTEQYLLDLEREAFLSLC
TERKTLERIQHMLKTGKPLRN
>FCMOIPGL_02311 3-ketoacyl-CoA thiolase
MKTAYIVKGYRTAVAKAPKGLFRFKRADELAAETIQYMMKELPEFDKKRIDDVIVGNAMP
EGAQGLNMARLISLMGLDIVDVPGVTVNRFCSSGLETIAMAVAKIQSGMAECIIAGGAES
MSSVPMTGFKPELNYDLISAGHEDYYWGMGNTAEAVANEFKVSRKDQDEFALNSHLKALK
AQAEDRFQSQIVPIKVEQTFVDANGKKATKSYTVNKDEGPRLGSNIEGLARLRPVFAANG
SVTAGNSSQMSDGAAFVMVMSEDMVKELNLEPIARMASYAAAGVPPRIMGIGPVAAIPKA
LKQAGLLQNNVGLIELNEAFASQSLAVIRELGLDPNIINVNGGAIALGHPLGCTGAKLSV
QLFDEMRKRDMKNKYGMVTMCVGTGQGAAGIFEFLN
>FCMOIPGL_02312 putative acyl-CoA dehydrogenase
METTNKEILRGGQFLVVETKCEDIFTPEDFSEEQIMMKEAVKEFTEREIIANRDRFEAKD
YKLTEEVMKKAGELGFLGVAVPEEYGGMGMGFVSTMITCEYISSGNGSLSTAFGAHTGIG
TMPITLYGTEEQKQKYVSKLATGEWMGAYCLTEPGAGSDANSGKTTAELTADGKSYKING
QKMWISNAGFCNLMIVFARIENDKNITGFIVEYDAANPNGITLGEEEHKLGIRASSTRQV
FYNDTIVPVENMLSIRGGGFKIAVNALNIGRIKLAAACLDSQRRVLDTALQYATERKQFK
TPIADFGAIKSKLAEMAANTYAGESASYRAAKNIEDRIAMRIADGNTHQEAELKGVEEYA
IECSILKVTVSEDVQACADEGIQIFGGMGFSEETPMEAAWRDARIARIYEGTNEINRMLT
VGMLVKKAMKGHVDLLGPATAVADELMGIPSFDTPDYSELFAEEKEMIAKLKKVFLMVAG
SAIQKYGPDLEAHQQLLMNAANILNEVYMAESAILRAEKNAKRFGETSQEGQIAMARLYL
YNAVEIIAKNGKEGIISFAEGDEQRMLLMGLKRFTKYTNYPNVIELRNFIAEKLKAENKY
CF
>FCMOIPGL_02313 Aminopeptidase YwaD
MKINYNFIAALLLIICSCSRPKEIDIDNNKLLENIKILSNDTLEGRYFSTPGNYKAQKFI
IRKFKEIGLKTFSQNNYLQTFSYTFKGQKRQDVFPVKKDLTNVPDTTAIGGNILGMLKGQ
TNKSIVITAHFDHLGIKDGKIFNGADDNASGTAALFTIAEYFKNKPIYHNLIFAAVDAEE
IGSLGAEYFLKNFNDKKNIALNINLDMIAHSDYDPELFACGLYHYPDLRKPLKRIKSDKV
ILLFGHDAPEDKDQSDWTFSSDHRVFHREKIPFIYFGVPDHKDYHRSTDTFATINTDFYI
ESVKIIIQAIENFDEYLKD
>FCMOIPGL_02314 hypothetical protein
MKNLQTILTQITQLTTNIETNFPELYRSLDENPMTIPSINHPHIDAKVMQEYLENLIQLL
IHHIETHKATKEINQESAGL
>FCMOIPGL_02315 Lipoprotein E
MKKISFITLCVFTLLIGCKSQITKIKQENIKTIPNKEHTIQALLWQQNAAEYKALTYQAY
NLAQFQLDKILAENDFLKPLAIVTDIDETVLDNSPYSGKQVELDENYSSSRWAEWVKKIK
AKEIPGALSFFNYAKSKGVEVFYISNRSATQTKETIENLKLYDFPFADETHVMLKTSSSE
KETRRNNVRKTHEIVLFLGDNLSDFSSVFENHSTAQRNKSVDSLKAFFGKKYIVFPNPIY
GDWETKGILEGKYNWTNSQKDSIRRKKITSY
>FCMOIPGL_02316 hypothetical protein
MKTNISYYQNKNEFRLFVTKSFSNLINLKKEENKTSFNKLVLKILPEIRSYINERLNIAI
EKGHFSKMKYKADDFIDQLFITVYDNIEEVENENDFYVWLFKKTDELLEDIVVEEEFNEL
FFKNIEDYSKLEWDEMQEEFSTDGGGDLLLIEELDDMSYNHNDYTLNHVFIENNEKKMAE
KLDKELTDDKINEHIELVLHNMPVDMRIVFYLFTNQKLKVEEIAEIQKKTISEVEKLLND
AKKVLQVSLFNRYSN
>FCMOIPGL_02317 Co-chaperone protein HscB
MKRIKEYKKLFKIEGTIDLKELKKSYRNLVKEWHPDKFQEKAEKEEADIVSTQIIDGYHF
LVSIAPETKEANLEEYKKTITEFQVADWHHKSMLLEVTFTDGNKYEYFGVSKILFGKFVN
AKSMNNFGKRNIFNSFTYRKSMKASVAV
>FCMOIPGL_02318 Thioredoxin reductase
MSDIVEKIKCLIIGSGPAGYTAAIYAARADMKPVMYTGMQMGGQLTTTTEVDNFPGYPAG
TDGTAMMGDLQKQAERFGTEVRFGLVTKVDLSDKIGGIHKIIVDETKHIEAETIIICTGA
TAKYLGLESEQRLIGGGVSACATCDGFFYKGQDVVVVGAGDTAAEEATYLANICNKVTLL
VRKDYMRASKAMQHRVNKTKNIEVLYNTEIDEVLGSNVVEGVRAINNKTKETTEISVTGV
FIAIGHKPNSDLFKGVLDMDKTGYLLTQGKTTKTNLPGVFAAGDIQDKDYRQAVTAAGTG
CMAALDAERYLGALE
>FCMOIPGL_02320 Sensor histidine kinase TmoS
MHRVLFFIGLVITLFTQQINSQNFERISNNEGFNQNTVNAIEQDKYGFLWYATPNGLIRY
DGYEFKTFTTQSKGKGAISSNNITYLFNDKDGILWIGTNVGINIYVPWLERFFTVPLKYK
IDVNKIDSENDGFVWISSSKELIKCKLTDINEGKFSVSDNILDKKTENIKISTFSFGLNS
SIILGTNKGLKKVSYQSGFSIVNKDSFNLDEFPFFNDKEITEIIKADNIFWIGTKKGLYS
SNLDSNSKYLVKKIKILNEDSEFFVNSLFKDSQNTIWIGTTGDGLYKYNPILNSFGHFKY
DLNDKNSISSSQINAVYQDSFNVIWVGTAQGGINKLDLFQKPFYSYTNNPSNKLSIGDNL
ITSILEDNNGKIWVSSYNKKLFRSIDIVNENTIDNIKFEDLQAQLPINKNDVIRSIYQDQ
RNYIWFGTDKKVFVYNPIKKDFKEVQFLSENDKSPLVLVREIAQINETDIVLSGNKIVVI
ENPWKEIKEKRNPKIHVKSTLKIAANRVQCFLQDSNNQLWFGTDYGLLQCKYEEGEVKVI
RQYQENKTGSSKISYNSVFSLLEDDQKNIWIGTFGGGLNKLTLDNDHNPIKIDYFRKNDV
LPDDAIYGILPQENSNKLWISTDMGLVRFDKETNQANVFNVNDGLIQNNFRQSAYAQGKS
GFMYFGGLNGLTIFNPNKIFLNKQPPKVLVTSLSINNKPIEIGEKLNDIIILKNAISETE
TVTVCKSQRIISFNLVAEHTSAPTKNKLAYKLDGFNKDWVEINKGKSTITYTNLAAGTYH
LKVKSANGDGIWSASTKTLTLVILPLWYQTWWSYTIMIILFLAVGVWIVFYFVSNEKLKQ
KLIYEQLDKDKMEVINQGKFKYFTNLSHEFRTPLTLISGPLDRVIENNINPENTRFLTII
KRNTHRLLSLIDQLITFRQAEQGFLNLNYTKSTLGDFLYPTTEAFENYALEKNINFYYKI
SSPNEEIVIDVEKVERILFNLLSNSFKNTPAQGTISIDASIVFEENNKSIKIDVVDTGKG
IPKENLDNIFERFYQLGNQEGNVSGGGVGLSFCKSLIDLFEGSISVKSIPKKETRFTVVI
PSSKTEEVQIEESSVKKSFIKNWVPLQSENLEENTSKKQSKKKHSVLVVENELDIQNFLE
SALSNTYNITIANNGVEALEEIKKTEFSTVISDVMMPEMDGFELCKRIKENTKTCQLPVL
LLTALGDNADLIKGLEFGADEYISKPFSLKHLELRLKKLIENNLKIKDYFSKNSLPPKDK
KELNLSKRDLEFLEKIAEVIEKNLSNSTFGVEELSKEAGLSSAHFYRKLKQLTGQVPNVY
LRNFRLQRAAELLASNSGFNVAEVMYQIGIESNSYFSTSFKKLHGVSPSEYSKRAK
>FCMOIPGL_02321 hypothetical protein
MIMKKHLLKIFKKKKTAFLLLAFIGLCSFQANAQKTTNYLDTTSDGLWATVGNWSNGLPI
AGDGDVANLTESVDLGGVNREIGQLLGANNTNTKTYSNGTLTLNGTTVSNTDQIIRIRSN
KTITVTCDVVVGVDGKDINIRNNATSQLVFDGGFAIGTNTVHVDNNSTATTAPIPVQFNG
AVTGSGTINIEDQNISTGAAADFTGFTGSITFDGTNALLTVNGANTIEGSIGVLAGADGN
SKIEFMASQSGLDNLTVDTQNLAIDFDAAATSVVFSGYTTSTTEGVVDLQNYVSGSLKIG
TTATSVPAAVLSTWTLDGAAATLTQDATGAIVFAGCSTPDVITTLAATAGAEYVTLSWDA
PTCFDEVLVVAKEGSAVTVAPTGDGSAYTADADFGSGTDLGTSEYAVFKGTSNAADITGL
TKGGTTYHFEVFTRKGTTWSAGVTTSATTNNMYTSTSGGNSTGLNWEDASSWIAGVIPSS
TSDDVTINTGIIINSDVDINNIIINNRVTINAGFSLNVNDLQQNSQFILQSTSEAFASVI
ATTLSGTGTLIYNRWLNDSPNNDLISSPVSGVPFSSVAAASNNEDKFFINPSVAGNYFFG
PFNNTTGLYETYTTPDDDAVVIGTGKGYRAATIAGEASTVRFVGDIEIGDLNIDITDGGA
GGGTLAEWNLIGNPYPSYLDFGAFFTANSGEFHLDNVAVYGWNGTDYTVWNGTNSSDKLT
PGQGFFVRTKDATTGNVDFTTAMRTIGNSDDFVAGKSANSNRALAKINLSRSTKTYATNV
YFIENKTKGLDFGFDAGAYSGSATGIYTNLVEDNKGLALAIQSLPYEDYNNIVVPVTINS
DAGEQLTISIDKKSSTLPENTYVFLKDNVLNTTTLLNDSDYLFTPDTALSGSGRFFLEFS
ASSVLSTDEFAVNEMLIYTNQATKSIIIKGLLKTDASAKVFDIQGRMVLEQKIESTNITN
VINANSLNTGIYLIQLEGRTQKVIIN
>FCMOIPGL_02322 hypothetical protein
MGKYAALTALGTFMILHPQKAQAQSVPPDASGGF
>FCMOIPGL_02323 hypothetical protein
MKKVILFLVFSLVLSGSLFAQKNIEKKVNTYVETVASKITLSSKEKETLKTLKVAQMQSA
FEINKKYEKGTPELKEQRKASNKDFSKALIKAFGKERAQEIKKASKKNKKKKE
>FCMOIPGL_02324 hypothetical protein
MIKKVYLIVIFSCICICSLQAQHLWYENETDTENIIFSNSGNGTFSINETNPDTSGINTN
ALTSKFVREANVTKGFSYFELSKNLLEDVTYTISLKAYVDIPTENLTSINRIRFYIKNTT
TGDLKAIQLKFSKGQEWEEFSFVFNEGDLPSKGFLEDGYNQVYIGYGNGQGSTSEVTYYI
DQIYGSVLQEIVVPDPLEEDPLVNVLKGSWGGRFYVRGGEDLDEYVDNRGYDYIAGAQEI
ADSYPTMGHVITNGTNNANSHLWTLRTNPNVDAVMGATGSVVDEEFVPSLANEQIIIDVI
DIFKKSGKKVILYINSLSPGDRASDEGAASWNNYVDTYFDGNNHEAWMNYCEGYIKRFTE
LGVDGYWFDTFGQYARNNSLGSAGVDTTDEEKNEFVEMIRNTAPNAIIANNKDKHQFLDE
DGELILVDTDGVNETVGIDYNDLAEGEDDDDIPFEEDERDYAIIKMQATNPWSDFTAGHI
TPLGQGAPPNSWAYEEFTVPDIEENHITIYEENSKQTLKHLFLPIRATWSSERSNLMFDK
EQAYRFAKRITDAGGSVTFSNTTSTDGTTSDDEVEILTYIDQQFAINADATVYQRPAGAF
LVGEDHTLNTWSGFSDSNWLTASNWSKATVPVLTDNIRIPVDAPNYPTITTTVSVNSVSI
ENSASLLYNGGSLTATEGVNYSISVTDTNWHLVTSPVSGENYNDDWVTDNSIASGTTNSE
NRGIATYQNGTATGNWLYMQGGTSATFGDGVGYSLLCSTGTGNFTFTGTANSSSMAPAIS
QNGTNFWNLIGNSYTSYLDVAAFITANSTNFGGAYQAIYVWDGSSYLAKTTGYVYPGQAF
FISASTTGTNASFTTAMQSHQNDITFLKSSNTETSIEISITDGTNNKATTINYLDEKTLG
LDPGFDIGMFDGVSSELSLYTQLVENNEGTAFARQTVPNSEIETTVIPLGIKATVSKEIT
FTAEALNLPSGINVYLEDRQEKTYTRLDEANAKYKVTLSESLNGSGRFYIHTSTNSVLSI
DSAILESIGIYKTNNSKLKITGLSQGKSTVKLFNILGKQMMETSFESSGSDTIPLPDLAT
GIYIIQLKTTSGVLNKKIILE
>FCMOIPGL_02325 hypothetical protein
MINLQTNPSYNTAKEEPTDNDELIAYAKENIYFPLAVFF
>FCMOIPGL_02326 hypothetical protein
MKKQLLTSLLFLLASITTVAQTWYDVDNGVTDLTFTSTCDGCSVSTVANPDATDTEATNV
LLWKIAADTTLDTAGLTDDEIAALKIGNKDLSFSFPNGYVLTPADFASLSVNVRLYMPDI
TNYSNFDSLTRIRFYLGTQQVQVKLSDLEGTDVNGWYTLTFDFSGKTYTENVTSGYIRIL
GQSNRFTNLNNDIDFHFDTFTSSVALSLDQGAVLDAEAVLDAGNAWYHNYSPDTFGVTVN
EVQGGVFLEQGDAVTTPTTTGNSSPLVAKFTKGEDPHSQIKFQLPGVIDTDYQSGAIFKI
RAYVPSTNVDGTSGRRLRMYLRNGTDNAGQKNITIDVTVFDAWQEYTFDFTEVNLTEGVS
YSTANLLIDQPDADLLATGNVYYFDAFQGPAAAILSVDNFELSNASIVAYPNPATNSFQI
DSSLDIENVKLYNINGRLVKTFKANTNYDVSNLAKGIYIVDIKTLKGLKTLKIVKE
>FCMOIPGL_02327 Arylsulfatase
MKTQYKNFLPLVLTSVLLYSCNTQKAPNNKTQSNDRPEPNVVLLLTDDLGWQDLKVYDID
NPSPYETPNIDAFAKEGVQFWQAYSPAPTCAPSRCAIMSGTHPARAQKTHVVGGAPPTVY
ASKETQRIMDPWYSGRMPENETTLARVLQQKGYTTGHAGKWHMAINHLAYPQPEDQGFDV
TTHDRGATIPQKPHRLTDFATNKASDPYRLDEKGFPFHQNNENALKFLKENKQDPFFLYY
ATFLVHAPIHTRSKALLEKYCKKLGLDYPTDPHGWDVKGQNNPYYAAMVEMLDYYVGQVF
DYLQTTDDPRWPGHKLSENTYIIFTSDNGGMEGHPGEVFTDNYPLDKGKINAKEGGTRVP
LIIAGPGIKKGIQSDVVVNGLDFYPTILSLLNVEKPKNKHLDGDDLSTLLLKDPTDSKLV
LDKEGNERNTMMWHFPHSSYQSTLRVGDYKIIRNYDYKNNPKIPEFELYRLYDTSNGTAE
RVDIEEANNLAKVEVKRTKEMNDKLTSILTEMNASYPSYNPFYLKKMEHKETVPTVISES
IKKGKVTFKYKKNGAKVVKANLIYTTNGGNEYEEWFKAEANIEGVSTITAVLPKGTTHYL
INLIDEYNFLVSYPEMPTIKSLKTEKKQYSNYALSSK
>FCMOIPGL_02328 Arylsulfatase
MKNSILYFFLLISIFSLNGQELVKPNIVFIYADDLGWQDTQLNDVGTVVPWETPNMLALA
ESGANFSQAYASAPSCSPSRGGTMSGRMPLKNKMTHVAGGQIPEGKATNKTIISYFPGRL
QVDEVTIAEALKPSGYVSGHIGKWHMAANHNIYPEAVDQGFDYQDTDRGITRSMGDRSVD
FATDAEDDPYRLDEDGRPYDAVTELALDFMEDNKEEPFFLYMAHWLVHSPIQTRDLALLQ
YYCDKLGIPLPTTDADITTPGQTNPYYGAMIASLDWSLGRVVDYLKETDDPRNPGKKLFE
TTYIIFASDNGGAEIHGKEIITDNYPLDLGKTNTKEGGLRTPLVITGPGIVENKLYDNMV
SHLDFYPTIMEMTGADAILDESVLNNLDGVSLFPFLRGAETEIKNNDDEVRTDLFWHFPH
GQDEKATSAIRSGNYKLYKIYDKGDYYQAFKLYNDDGSDNDIEEMFDVIDTMDASLKNEM
ILKLETLLAENNARVPLFNPDYNGDPLEHQDIVPSVVSTVFDQDTGVATATLTTNAGDAI
IETAYLLYRVLEADSKEIEWFEISATVNGNVITAEVPEEATGVIFTLEDENNFLVKSEEI
SIFNPHKITLATSIGEQPFKVVDEYAELIGNTTVGGTAYLQARTVEGGDGAKFYVKAPAD
VASITCDKITLGIISQAGDTVNVDIIIDGETQNFTYTSTNNNTPELFEFDTPVTFTQSSK
EVQVITTSLSNSEGLAPRVRFVNLFFNVLGATEPLHEITLNSSDLEQTFTAVDNYSELIG
GTAAGSDIYLQMRTEIDPADNLEGDGAKFLVKSTEGYQSILNKVTFAVKSQKNDIVDVAI
TINGETQQQATYTSGGNNEGNNFEFVFNTPLTLADDEATEIKFVTTGLSNSGEDVVGRLR
LQDVILHVSEFTLGIDDVNKESNERLSLYPNPVKNTFSLTKEVASGILYNVYGAIAYKFE
NANKDIDISNLKSGIYLLKVICKDGNRKHIKLLKE
>FCMOIPGL_02329 hypothetical protein
MIKKITFLIVFLFSVQISNAQFLWLEDETNTRKIEFTAEEDVPTNLTGNFPNPHTSGINT
HTIVSKYNRPEGTNDFLSFNLFNYVTDLTDYTVTLKAYIDIPTDELTTNNSKLRVFFQSS
DAGGRVYEQLKFTVGQEWETFTFHFQDVAIPQNVLDVGGYDLMIIGLANGSIEEPAMSYY
FDEIYGSTDQTATTVNHPAAWLAGSWGGTFPVFGGERLDEEIATGHDPIGGVNELVTELP
ALGHVITNLSYFAHSHYFTIRDNTNVDVATEIHESLIPSAENQEIMFEVLQTLKNSGKKI
ILYISTNYLDRASDETQAAWVNYYTTKFDGNEYLAYKNLVQGFIPAVAEYADGYWFDTTT
SLRDDGYLEDFVQMFKDADPGAAMSVSEFGHLHYIEGEPVVVDSDGVDDEDDRDYNVSNF
RGNNSYSDFTRGHVSALGGGAPPNSWGYEEFTIPAMVGNPWSVYEKKQVLKHAWFPIRDK
WHVSSANLIFGIEDAYRFSKILIDAKAGVTFANTISNNNNNGVDAGHIKDDEMVIMKTIN
DRLLSNPVPDYEPYVRPEGAYLVGEIDKTLSSTDDYINSKSNLPQINLYPNPVVDALTIT
KTATGISNIIVVSVTGTKVLEKLWDDGALITQLDLSTLKSGMYFVKLTNSNNQSLTRKII
ITK
>FCMOIPGL_02330 Arylsulfatase
MKKVFLLVMACLVTSSSFAQERPKKPNVLVILTDDLGWQDVKCYDIDEPSPFETPNIDKL
ATEGVLFWQAYSAATVCSPSRGAILSGKHPVRLERTSVRGGHPPLPFNYGSLLISPWMRG
ALDTSEVTIAESLKTNGYKTGHSGKWHVGIAVTDYPEPKDQGFDFSKHGFGSHKRMKDRT
KGFSTADKSDPFYLDEAGFPFDDITQDGIDFMDGNKKDPFFLFYASRLVHTPIHTRSEAL
LKKYYQKLGIDYPKEKDLWEEKGQRNAYYAAMVETIDHYTGLLIKYLEQTEDPRWPGHML
IENTYVVFTSDNGGMEQHTGEIITDNYPLDKGKINAKEGGTRVPFIVKGPTISSNIESNV
MVNGLDLYPTILSWTGTQKEDNQILDGADLSTLLDKDPTDSKLVLDPETGKARNTMMWHF
PNSSMQSTLRIDGYKLVREYVATEEKTELALYELYKNESERVDIEEAKNLAKKMPEKAKE
MNRLLEERLEKLNARYPYLNPTSKAQLPNKAKIPTVVKNGVDGKEVWLEYKNNGAKVVKA
ELIYTKNGGVKGEIWFPVTMNLTNNKVSVTLPKGTTHYVFNLVDENNYLISYPDAGYQKT
TKIFATKAIQVK
>FCMOIPGL_02331 Arylsulfatase
MKTILYHLFIISSILSCTGVTQIVQAQEKKPNVIFIFSDDQRFNSLSMTGDPIIQTPNID
ELAKEGVFFNNAYITSPICGPSRANIFTGQWERRNKIGFTNVSKNLISETTYKNSWLAQL
KKAGYSTAFIGKHHTKIGDRNDTPLRKDVDFCYYGNGHLGFYPAKKHKQFANLKNETQVE
GMLEATKAFLTQGDAYDYFYKNADASIKNQIKKRDPNEPFSAWINLNLPHASSIGGMGSH
ETDPEYYKTGYDDVKDKIELPEGYPQNISLPEDVYATKDLMKYYITSKKGKLLNEKLKMT
RAIHAIDIMIGNLRSFLKEIGEADNTVIVFCSDNGLFLGEHGLGGKTILYDESVHVPMIV
YSPFFTDKTQGKVIDDLVVGQDIPATLLEMCGVNIPTSYQGASVLPLIEKKNVKWRDDIF
LENLFTDQGYPRQEGVRSKQYKYIRSFSKLNDRNKYVPNQSSNNNEQPIYEELFDIIKDP
KEQNNLVGNKDYIKVLNEYRERCKTLVSELN
>FCMOIPGL_02332 hypothetical protein
MFPMKLKVLFLCIFILFSIPFSSQEKQVDFKVDFESFLSKHDMLWDIVPDKWQTAPYSGN
GNIGFLFYQAQESEKNVISLHIGRHDYYDHREAKTKADEMLWIKRSRLPLGHFQLTSKGK
ITGVDMRLDLWNAELTGTIKTSKGTYSIKGFTHSTNDNIYFETDTTDENVEITWHAEEPI
PPVYEVLKSGGGPKGGTWDKMRAVTLEMAPKPTFSEKNGYSFCYQPLFNHRGETTTGYKI
TGNSSGKQQLITSVHHSYPERNSLEIVTENLEVGEKLIKENSFISSHKKWWHDYYPLSFL
TINDAEKESFYWIQMYKLGSASRGNGPILDLMGPWYNRTFWPMVWGDLNVQLIYWTHLTA
NRMSIGESLPNNIDKYVKNLENNVPASWKNSAAVAALMPQDLIAFNGAKVPDMLAWILND
YWLHCQFAGDDIRMRDKLFPILKKTVNSYLNYIKDNPVDAKDGKIHIKYSWSPEYKPGRG
QDINFTLALIRWSCQTLIDIDEKHQINDPLKKEWEHLLTNLVDFQVDENGLMVGKDRPFA
NPHRHYSHLLAFYPLMVITPEKEADKKLLRTSLDHWLDVTFNSGKKIKAMPVTGYTATGA
SSMYANLGDAEKAYYYLDFLIKHKNISSTTMYSEGKINPVIESPLSFATSVHDVMLQSWG
GKIRVFPASPKKWKDVAFHNLRAQGAFLVSAKKIEGTTEFVSIKSLKGNACNVQVDFENP
QFYIDGKSVTINKSEDGSYKVDLKKNESVIITSKEINKTDLSIKELPKSKEEQNLFGYGS
KTKRLPGHTYYSSY
>FCMOIPGL_02333 Arylsulfatase
MYKSIIAVVFLILSQNILTQKKADTSRPNIIFIYADDMGIGDVSHTTGKAATPNIDRLAA
EGIRFTDAHTSSSVCTPSRYSLLTGRYNWRTTLSKGVIHKPTAKPLLKKGETTVANLLKQ
ADYHTAMVGKWHLGIGWELLPNYKKEKWQIGGGWDIDYTKPAITPTSNGFDYFYGIAASL
DMPPYVYIENEKVTELPSVMNDPKIRSRKGPSAPSFKSGECLQVFAEKSVDYINERAGEN
EPFFLYLPLTSPHTPIVPSEKWRGKSELGPYGDFLMETDWVVGEVLKALDKHHLTENTIV
LFSTDNGCSPAAKIPALKKKGHSPSGNLRGNKADIYEGGHRVPFIIRWPEVIEAGTQTDR
LTCMTDFIATCSDITGIELDETSGVDAISFLSTLKKPTITNREDIISHSINGSFSIRKGN
WKLALCPGSGGWSAPRAGKTPEGSPSLQLFDLSNDIAETTNLYDKYPEKVEELTKLLQSY
VDKGRSTPGKLQQNDREVNIYAEDVAK
>FCMOIPGL_02334 hypothetical protein
MKKIITLLLVLCIVPLYALDIHVATNGSDANDGTASKPLLTIKAAQAKLRASGLLGKEAC
NIVIHEGVYRLITPLQITTADSGSEQFPVVYSAAKNENVVITGAQLITSKWEEFKDGIYR
THVGDLNAIDQLFVDQKRQHMARYPNFNAGFIPTDGDPSVRGKKAGTVPFSGAAPDAWDA
KKAAEWKDPTGAILNGMHRGLWGSQHYFVTGKNNKGELVYEGGWQNNRSAPPHKGYRMIE
NVFEELDVPGEWYHNTKDGWLYYMPEANTNLNNTKIEAVLQIKHLIEVYGDHKLPVAEMV
IRKSGNAQKETIVKNYETTNPVKHIQISGIHFTGTKRTLRETIEPLLRSDWCVYRGGAIH
MRGTENIVIDHCSFKELGGNAVFVDSYSRNVQIKENIFQNNGSTDVNFVGSFAAVRDPSF
SFQHLPPPLDEIDTTIGPKAEDYPADCIVENNLMMLCGRFEKQASGINISMSSRITLRHN
TISHTPRAAINICDGTWGGHIIEWNDCFETVLETHDHGAFNSWGRDRYWFRAGPSGPDFR
DENGKAMISYYIEKYPNAPLWDAYQTTIIRNNRMQCDHGWDIDLDDGSTNYEIYNNISLS
GGIKTREGYHRTVTNNVILGRGYTCNVPYPKPTNDIFERNILWGGTVYKSSNPTLWGGTR
NFNFVHNPDSKNVVPAYGAQEQTQDDAESLYGNVLFAGKPQHGDFTVSNKSAALSLGFKN
FPMSGFGVTSDKLKNLAMKPKILAPKEIASNVFVKSKLKGFMGAKFKTLETEAELSATGM
FDTYGVLLVSVPKNSKLAKMGFKVDDVVIELNSEKIADEKSFVRTMSRLNAKEHNVKVWR
HQKPVAFSFTK
>FCMOIPGL_02335 hypothetical protein
MKNRTQINKAFLLLTFALFTVNGALQAQNTWTLESQEDWQANIATKTNLEISKGKVIPTE
KEAVFKSSMKKFAKKRAAKSITFSQSPEWLNWEQIPTAAPANLGDAPVALQLGDGNYWMF
GKYDTRKNNKRPNDFKSKDTILKGYDVVLKTTHLKNQFDAPSGLKKPLKGYHAWHSIDMK
NWVHYGPISDMSSRWVTSAEYIDGKFYFYYDFPNDQDPHLLIDENLTDGIVGKKMGMAFK
DPSDGSDCAVIRDLEGNFHIIAEDWSPIDASTHAWDSPLATHAVSKDGFNDFKILNPPVD
ERTKPTGKFAEYAHPHWFKEDPDNYPGKASPVDIPRQRIKKGDVVSFGKYEIHEPEQNSF
GDWASISIGGQYYLFADYDPAGKTGGKHMSVAWFTSDNINKKFEFCGNIGQGHPDPDIMF
AEGKYYLLTQTRNDYVSTGPWVETVEVRMGVDTTNDGLVNEWSDWQVVKEQYDYIKGFSK
QIEKTPAQMNFSDLPKGYGFQFEVKMTDTTENESKPILDKVVVSFEK
>FCMOIPGL_02336 hypothetical protein
MIINRNLLTILLVLFMLSNSFAKDIYVSPKGNDANSGTKNSPYLSFKRAFQEVKKYAGKE
TVTVWFSAGEYYIDETLTLDSEFSGTTKKPVVFSAIPGEKVVIKGSRQLASLKWKKHKGG
IYKTQVPSGLSMDQLFVDDVRQVRARFPNYDYENPLRDGKGYLQVTGGTDKRYDKWFSYD
PETFSDKTWSNTETGIVHSFQSHNWGNMQYRLKSINKEESRIYLNEGGWQLQRTHGIGGK
KNHASYYFVENIFEELDVPGEWFLDNKTSTLYYYPMQDVKLSDVKIEVPVIADIIQLKGT
KEAPVKNIQFKGFHFTQTNYTFMEAYEPVARGDWAVHRGGTIFMEGTENLLIEDCNFEYV
GGNGVFMSAYNRNNKVSGCRFVHTGESAVCFVGSPKAVRFYQTWDDRLLHGKNWNAMREN
MDLEAGPKTPDYPKECVVENSIMHDFGDVGKQVAGVYISMSHKITASHNTIYNCPRAGIC
INDGTWGGHLIEFNDIWETVRETGEHGPFNSWGRERQWKGGRGTNEHFIKELTRLDAIDN
TILRNNKIANYRKSISAGNWTIDLDDGSSYYEIYNNLNLGSTIKLRDGMGRKVYNNITVS
AVPSGWHVWPEHSEDEIYKNIFVIAGTLPGKNTPTKNFIRGVGLSKKVKWSENYDNNTYW
NVNYPDNFEMSPNQNMEAWNKEGYDLNAVSANPNFVDPINGNYQVEENSPALKTGFKNFP
MDQFGHTMTRILPFGGDFENETIVSLRADIRAGKKSNVYYTTDGSEPTMSSLKYSKPFKI
NQSTLLSARTFDSNGIPVGFTNEVEFTKVEKVTYPSWLATLLAGKYAEETVVEGKTTKIK
KALQKEVNGALLINIADDPDLIDATGGYNFGCYIESLDNKKAKMWLDAGLNKDWVIQKLN
KHKISNIAHLQKFLKEYSGQTVKITAVRDYGSKVFEVTIP
>FCMOIPGL_02337 hypothetical protein
MSKLKILLLLLFFLLLGNRTLAQHLWYENETGTENITFSRTVDGTFTTAETNPDVSGVNT
NTKSSKFVRDADVNRGFTYFQLFTPLTTASKYTVTLKAYIDVATSDLSSEPNRLRIYLRN
TTTGDFKQITKTFTVGKAWEKFSFVFDKADFTTEGLGSGGYNQLDIGFGNGQESTSAINY
FIDQIHGSIPQVPLKDVLKGSWGGRFYVRAGEDLDDYVDNKGYNYIAGAQEIADSYPTMG
HVITNATNNANSQLWTLRTNPNVDEVMGAENSIVDEEFVPSLANEQIIIDVIDIFKNSGK
KVILYVNTQSPANRATAAGAVAWNNYVDTYFAGDGHAAWMNYCEGYIKRFTEIGVDGYWF
DSFGSYNINNSLGNADVASTTEQRAEFVAMIRNAAPNAIITTNIDKDSFVDENGDLILVD
TDGIDESVGVDGTGDDPNRDYTIIKMTATNSWSDFTAGHITPLGQGAPPNSWAYEEFTIS
DIEESSISIYEGTKQTLKHFFLPLRATWSSERSDLMFDNEQAYRFAKRITDAGGSVTFSN
TTATDGTTSEDEVEILTFMDQQFAINADATVYERPEGAFLVGEDQSLSIASNLSDDISLK
VFPNPVKDVFKLSKEFNSLTIYAITGEKILQFSGNKESFDVSSLNPGFYIIKAYVNNNFE
VIRFLKR
>FCMOIPGL_02338 Arylsulfatase
MNKFSFFNVKLVFLVMLVSVLSSCAQNKSAIAQNKSIKPNIVFILCDDLGYGDVQSLAPE
TSKIKTPHIDKLNQEGMTFTDAHSGASVCTPTRYGIMTGRYSWRTKLQSGVVSGFAPNLI
KEDRPTVGNFLGTEGYHTAIIGKWHMNFQYIDPISKEVIRKKGRNLPPVGATIPDGPINR
GFDYYHGFHHAGSMKAVLENDKVILHEDEINMLPRLTTKSVEYINNQAKNKDGKPFFLYV
PLGSPHTPILPSKEWQGKSGLGAYADFVMQTDATVGAITKALKDNGFSENTLVIFSSDNG
ASKAANIKGLAKQGHIVSAGYRGSKSDLWDGGHRVPFIVRWPGKVEAGSVNNDLICLTDI
FATFSDIINVAVPSKSGEDSVSFLPALNGEAINSTRAGVIHHSISGHFGYRQGKWKLLLS
RGSGGWSSPQEDDTTLDNMPIAQLYDMENDAAETTNLYLERPEIAEKLLQLLENDIKNGR
STTGEFSQNDIDNIILWKKRTVSRSKKAKNKKKKSKK
>FCMOIPGL_02339 Carboxylesterase NlhH
MTQSRKFNFSLVILCITFPFLKGIAQSDDQSNGAYREVYIKKTWERLDENKDGEFTEEDN
KRIWKHLNKLLDSNGDALISFEEFSTKKQVPYLKTEGKRKLNVLYKVTKEEDLYLDIYYP
KTLKEGEKLPVVIYTHGGGWAAGSRHGAANASFKTVHTALLEKGFCVVSVSYRLWKNGGN
TTMRDCVIDSKDAMRYLSKHNKELGIDANRFFSFGDSAGGQIAQMLLLSPPESLKGEKSL
EKYTYKMIAGVSWYGPCDFEDISLFNHDDSPNFKDRFGARITKPDTKPKDKLLLYKEMSP
INYLHKNSAPLLMIQGDKDTTIPVKHAYYMAEKANEFGAPVTTLIVKNAGHNWRKVGADI
NPNRGNIEQSTIDYFVSHL
>FCMOIPGL_02340 Arylsulfatase
MKIFKFLFILVLAISCKSHATIKKQDTIVKNTAPNIVYILADDMGYGDLSSLNSESGIQT
PHMDKILKEGVHFTDAHTNSSVCTPTRYGIITGRYAWRSSLKKGVLNGYKPALIEESRPT
VASYLKSNGYTTACVGKWHIGLDMQPKDGDRSIKAKDGLSNVDFSKRIKDPSYLGFDYSY
IIPASLDIPPYLYIENGKAVELPTEYTTEKRKGRGLSWRPGEKAPSFVFDQVLDNFTKKS
VSFIDDQKKTDSPFFLYFALTAPHTPWLPVGDAVGKSKAGDYGDYVTMVDDAVGAVVTAL
EKSGQLENTLIIVTSDNGSNWTERDKQKFAHRANYIYKGQKADIYEGGHRVPYIAKWPGV
IPAGLESNQLMCTTDLFATLSGILNLPKVEKGADDSYNMWPAYTSNIKTPIREAVVHHSM
YGMFSIRKGKWKYTPELGSGGFTKPKNVEAKPNEATGTLYDIINDPEEKNNLYKENPEVV
AELSSLLEKYKKQGYSNK
>FCMOIPGL_02341 Arylsulfatase
MKSILTQIFQIRFLLLTVLLITTNCASSQTSKKEDQKKPNIIYILADDLGIGDVSLYNEK
SKIQTPNLDKMGKEGMQFTDAHTSSAVCTPTRYGILTGRYNWRTPLKEFVTWGNSPSLIQ
KNRLTVAQLLKDNGYKTASIGKWHLGLNWTMKNDSPEFDHFSDKSERLNFKNIDYSKPLK
FGPNDMGFDYSYMISASLNMPPFVYIENNKATMIPTKITERSRKKYPFSSWIKGDVADDF
KHEEVLPNVVKKSISFIKENANKEKPFFMYIPLPSPHNPVLPIVPWKGQSEIGSPYADFV
IMIDDLMGTIFKTLKEQGIDENTIVIFTSDNGYATTNDLKTLKQHKHSPSYIYSGYKGSF
LEGGHRVPFLVKWPGKIKPNSVSDVTLCTTDFMATCADIINYDFKDNEAEDSYSMLPLLT
NKGTFLRDATIHHDKYGVFAIRKGDWKLIVSPNSGISASGETKKHKDISADEILYNLKKD
IKERNNVADQFPEKVKELKELLSQQIINGRSTPGKAQNNDAITGEWPQANFAFKK
>FCMOIPGL_02342 hypothetical protein
MNTIKNILRMKLTSYTFLIALFLISVSCKTNVDSTALNHQVFDQTNNWIVLNKVDAKKEG
NTYSWNFNVKHPSEYVLQMVSSGEISEDNNSAKVKIDKQEFEESLLENYVINSNEIVSEF
KSKIQFKNTGEQKISITTDTNFKTVRIIPHYKKPIGSGNYHQEWLSMHNSDEKQKALKRF
KEAKLGMFIHWGLYSEIGGIWKGTKINNSPYPGPKVAEWLMYAFQIPRGEYKELAKTFNP
DKSFAQNVAKLAKDVGMKYIVITSKHHDGFALFDSKSSEFDIVDATPYKADIVKELYDAC
LKEGIDFGVYYSHGNDWMDGADGNYTNVKKVNDSLGIYTHPTGKNLWDPSKNTHKEYLQN
KAYPQVKELLNVLPELRLIWFDGTGFITEEQAFQFYKLVYDINPNVVVNRRVGYAFGDYL
DAGDNKIPSASEKLEKYWETCGTTNNSWGYKSYDKDWKSPKELLYYFVDILSKGGNYLLN
IGPDGKGNVPETSAQNLREMGKWIHQNADAVYGTSRWKTPNEGQEETLLDGTGHRAAKGF
ERKFTSKDFWFTTKENKVYAISLTNTEGDVLIRSLRKGEGDIEQVKLLGSDKTLKWDQNK
NGLKTTVIGLPKNALGYVIEVTLKNN
>FCMOIPGL_02343 Arylsulfatase
MKNIVTTCFLCFLFLSKIAYLQENIKKLKNSKPNIIFVMTDDQGMGDFSCMGNQVVKTPN
IDAFYQKSTRFTEYHVSPTCAPTRAALMSGNHEFRAGVTHTILERERMALDVYTLPQVMQ
SAGYKTGLFGKWHLGDGDEYLPQNRGFDEVLMHGAGGIGQVSLGDFPANKENLYFDNVLL
HNKTIVKTKGFCTDVFFDAGLAWTKQQIDANKPYFTYLSLNAPHAPLIAPESYKKRFLEL
GYDEGTAGRYGMIENIDDNFGRLIKKLKEWDVLDNTLIIFTTDNGATHLGGTLNGKKVKH
FNANLKGGKNSPNEGGNHVPLFFYWKGVLSEGKDINQLTAHIDLYKTFTELAGAKLPETM
QSLKGLSLIPLLENTATTWEDRLLFTHCGRWKTGKVEEAKYTKMAIRSQQWRFVNNKELY
DVINDPGERNNVAAENPEVITKFEEPYNKWWSSSIPFMINENRKRVKKQPLHTKYYKQLE
EKGILEWNPKFD
>FCMOIPGL_02344 Arylsulfatase
MKNKTNLLGLLFLSLFVSNTMYSQRNSKLIKPNVIIFYADDLGWQDVQLNDLDEPCAWDT
PNIAKLAKDAINFTNAYSPAPTCAPSRSALLSGLHPAKTGITNVSGGGIPKAQRSEKYMS
PYFPEGLMPENFTIAEALKMNGYKTGHVGKWHAGAMDIQSSKNQGFDFAHESRGAHTGPK
KPDTRLTVFATNDANDPYRLSKEKYFPFTKENPKGISYPTDAVTENALKFITESKEQPFF
LYLAHWMVHYPIHSKNRALLDYYCDKLGVELPEVDAEWTKEGQNNPYFGAMVTTLDWSLG
RVVDLLKKTDDPRNPGKKLYETTYIFFSSDNGGAETRKAEVMSDNAPLDKGKKYSEEGGI
RVPMLISGPSIPKEKTKDVLINQLDFYPTILNLTNSEIPSKYSDDLDGLDISKVLLNNEK
DVKDSNGNPREDLWWHYPYGDDVKNQSAIRSGDYKLYKNFNSGKYVLHRLYKDGKRYDLE
EQHDIAAESPEIVKKLAAKLEKYLKDYDAKLPYKDPSKFKNEEDAAAIPVIVNDVFDANS
RTVTIQLEKGKSNVIESYALIKISDKPSATGKKKLHTTYIKVPLESSKDKLEYTVNVPKE
AHECGVIFIDENRFMVKSKFHELIKAPKKGKKKNKKKTKKKN
>FCMOIPGL_02345 Arylsulfatase
MKSILTSLAILLFFSNHVISQEKKDLIKPNVIIFYADDLGWQDTEINNLDEPSPWETPNI
SKLAEDAVNFTNGYSPAPTCAPSRCAVLSGLHPTKTGVTHVAGGQMPNAEQSPNYISPFF
EGGLFPKHFTIAEALKMNGYTTGHIGKWHAGHDDSQKSKNQGFDFVHESRGAHQGPKKPD
NRLNTFATRAKNDPYRLSDEKYPPFTKDSPEGISYPYDEITENALKFIGESKNEPFFLYL
AHWMVHSPIHTKNRELLQYYCDKLGIDFPTKDVPVTTEGQTNPYFGSMVTTLDWSLGRVV
DLLKKTDDPRNPGKKLYETTYIFFSSDNGAVEHVGKEIVTDNFPLDEGKKYAQEGGIRVP
MLISGPSIPKGKVYDGLVNQLDFYPTILDLTNSKIPAKYSSDLDGLDISGVLLNNETVIK
NNNGEPRKDLWWHFPHNREFQMQSAIRAGDYKLYKNHVKGNYELYRLYKNGERADLEEKF
DIAEQSPKIVKDLSTRLEKYLKEYDAKFPYKNPSKIKGEPENVATIPKIKTDSFDASSRE
ITVTLEKGNSKVIEFYGLISYKDLHAVSKNGKQRKVHEPFTKLEGEFNKNTSEYTLTLPV
GVTEAGIIFIDENRFMVKSKFHVLKAPKKSKKVKKNRKNKN
>FCMOIPGL_02346 hypothetical protein
MDSKFSFLLIVLTLTLGSCKAQNVDTSTINLVKNKLPEFSWDKMPLYMHLRKSTSFSNKE
IQYLSKFPLITFEKTTGSKTFGSTEKGTIKAAKAVKKLNPNAKIVYYKNVVINWGGYSED
ENFLYEHPEALLINAKGQKAVMPNGKTGFFDISEEYVRKYWLQHVKKVTENPFIDGVFLD
ANIKVLVPGFFNSRVGEEKQEAIKSGYLSMMTDLESQLGDDNLLIANILRVRPEFEDSGR
AYLKFFDGSYIEGFEHESFGMAYEDYLAQGIEAVQKSAREGKVIAMSLGIGKGLKNAEAG
IDDVRKKVSKHEDFSKRLEYLLAIFLVCAEKYSYVYPHDGYGTEKSAVWLKTFPQYEKPL
GKPLGFAKREGYIYTRKFEHVDVWLDIKNKTSKLNYK
>FCMOIPGL_02347 hypothetical protein
MKKFTTILFLTLSATFVFCQNNQFQKTIAPNWESMAKNYQVPEWFQDGKIGVWMHWGIPS
SIDENRIEDGSHYGRRMYGDTDYDARNEPDRMRTVKLTKWHTERYGKPSEFGYEKFIKDF
KAENFNANEIVKFVKECGARFIMPVATHHDNFDMYDSFFPWNSVKMGPKKDILREWKNAA
TKYDLKFGVSTHLYWSPRFFRTARKFQKEGTPEWEFFNMDYDSFEFASQDSWNEHWYKRS
WDLIEKYDPDMFNNDSPYPTIKTGKGLGVKLFSDYLNRDLKENNGKQTTVLSFKDIKKNK
AAFTYNLERGMFGEQQKYPWIWATDLSGSWFYRKNSFTKMSLDVLIGNAIDAISKNGVVM
INIALKGDGTIPDNQIKMLSDFGAFVKINQDGIYNTRPWKIYGEGPLKIVTKRAGENLKK
FSEKDIRITTKDGNLFAFVLAAPTEDVLIKTLHKGGVLQKKIKEIKLLGSDEKVTWQQEK
EGLIIKNNFKKLPNQPAICFKIFLN
>FCMOIPGL_02348 TonB-dependent receptor SusC
MKKLLTIIAALLMSSFAFSQEKVITGVVTDENNVTLPGVSIIVKGTTTGAVSDMDGEYRI
KVKKEGAVLMFSYLGYKTVESVIAGKKIINVQMKADTQSLTEIVITGIRASNISEVRAKR
DAATVIEAITPEDIGNFSDTNAADALQRVAGVQIERDVDGVSGDRVSIRGIGPQFVGVTM
NGRTPISAGNEGKSDFRKFNLNVIPTEIISGARIHKTTQAKEVSTNLGGTVDFQTIRPLD
AKYRKKNYFASINVRGASNSTIEDLDFGHRFSGVYGTKINEKLGVALSVIYADEDNIKDE
ASLRGITQGINLTDENGTEYSDVIVGRTINNSLLRTNQVRFATSAAIQWRPIKEIDMVLD
YTRTTVEANSDRQQFQIGLGSTGSTQLLGGNHIFNEGDLDFNGNILTYISPSSEDNVRTT
ITNANQFYDNHSTNNIVGLNTTYKPTRKLKIISDISYSDLDYFQNLTQITHRVQGRNGGY
DQTSLDIDLRGNTPDYGLPVEAFDPASFDLNRVSRRLIRTKGYNYAAKVDFEYKLDKKSI
ISFGARYAETDFEARQTTSSHTDSDQLSGLYGGIVADLNSSGAYTDLLGEITGVGFNEGN
VAGLENGWVKVPGQAVLDLMPGYSDVDGGSIFDFDVDLKDVKAEENNLGFDARRSYGANE
ASTDFYTQMDIKTALLKLPVSFNFGVRAVRTQNKSRGFSGVAFEDADTGDDLDEFSIENF
YYEVETSRWDVLPSFNANFTLQKRTKLRFSAYQGVSRPKFVDLIPNNEITFLTNIAPADA
ADLANSELRGTIVSGNPDLKPYTAWMYDTTLEFYTNNGGAFIFSAFYKNLKNYIVKAVTP
DQAYPGEELLGIALPDGTGGTDDLTGLLFDITKPINITDGQIYGFEVGLNQHLSFLPGFA
KDFGVKANYSYVESEFDGDLGEQADGFPGTAKHNANGTLYYERSGFSVRFTAAYRGDYLS
NLGAIGGNTRADEPHYTEGNTTLGITVRKNLLNKKLQLSAGVSNLTGEDIRRFQGGDTRN
FSAYYARNPIWKLTMRYKF
>FCMOIPGL_02349 hypothetical protein
MLKKGYLFFSILVLFIGVSDINSQEPKEKGMEEMWGETKVSGDALKSGKAKLFDEGNYGM
FIHWGLFSNLAGVWENKTYYGIGEWIMNPRMAGIPVEDYKKVANDFNPTGFDAKAIAQLA
KDAGMKYIIITSKHHEGFAMFDSKASDFNIVKATPFGRDPMHELSDACHELGLGFGFYYS
HNQDWTAPGGTRGPKVDENGKEATFEDYFYNKCKPQVKEICSNYGQIDFVWFDTPGDMEE
KYVVELADMVRELQPKAMMCSRVGYGLGDYASVGDMEVPTKKIKGLWETADTNNDSWSYA
WYDNNFKSPKVILGRVIETVARGGTYLFNVGPNQMGVIPEIGAKFLRESGDWLKKYSQVV
YNANPSPWSYKLPWGDVTTKDNSMFLAVSEWPTDGKLYLPGLKTKIKSAYIVNPKGKNKK
VKFNQSDDTDWVSFDVPYKAPDDLISVIEVKFNEDDTILVEDNSLGVYPNTDTVLITEFG
EAKNATQSNKRWMEKFGEWKHADQVSDWKENGTITWNIDVKEAGYYYLDLSYAGKKRLVW
KTVTDEGITVQNQQAATEKYVFYSMGILEFKTPGLHTITTSLVEGDKKTSSLKSLKLRPI
K
>FCMOIPGL_02350 hypothetical protein
MKTPFSHISLLLICLFLVQTAFSQNDSYYPAFSWDKVPVAFHFGKKGDLLTKKEAKFIAS
HSNFVVLEKAHGFPKYKYSEESIAADAKVLKKLNKDVKVVFYWNAFLDYSMYKAHDEYQT
KEDWWLKTATGEFDLKDNKMKRYDLSNPDFRNWWSDVAKENLENKNIDGVFFDALNQVTS
PGNKRLWGVEKYNAIQQGLKDLIKETRAKIGDDKIIVYNGIRSTPLRNAGNDFPENTDAI
MIEHFGYFNSKTKESMLKDIQEMEAAGKTGKIVVFKSWPENAWLNKGFMAKSEKEKEQIS
KEHLNFALASFLAGAQKHSYLIYNWGYRLEMGSLLWYPEFDKPLGKPLDDMQTNGWILTR
NYEHASVWVDLENKKSRIDWKK
>FCMOIPGL_02351 Arylsulfatase
MKLTSYFYLLILIVLSSCQKKTKLPNEISKPNIIIFYADDMGYGDLEIQNPESKIPTPNL
DQLAREGMLMSDAHSSSGICTPSRYALLTGRYHWRDFNDIVHSMGPTVFKENQVTLPKIL
KENGYHTAAIGKWHLGWDWEAIRKKDFTQKEKIIRRKKELEIWPAQAYDWNKKIPGGPLS
IGFDSYFGDGTINFPPYTWIKNDKVTEVPTLTLQHPKEEFALEGNWELRPGPAVKDWDFY
KVLPTVTSSAVTFIKNQENAQKPFFLYMAFPSPHAPIIPNEEFRGKSKAGPYGDWMYQTD
DAVGQILEALKLIKADENTIVIFTSDNGSERYAYERIKNYNHNSSNPFRGVKRDVYEGGH
HVPFIVKWPNRIKSGTKNTQLFSQIDILNTLATITNSDLPKGFQHDSYNFSDVWLTDTSK
PVREVLVQNTFTSKYAIRKGDWLYINNKDGYHSRIPKWFEEGQRFEKAKDTVQLFNLKDD
IGQSTNLASQFPEKVKELAADFINQQKTETFKN
>FCMOIPGL_02352 Arylsulfatase
MKMSLLKSISLVIVLVTMLSCNKTKKETTIEKESIAANEERPNIIFIFADDWGFGDLGVY
GNKEVVTPNIDKMASEGTRYTQFHVTSGVCSPSRTSVITGHFPARHRVHGHLAGHALNVK
RNMPDYLDDSLPVYLPKTMQKAGYKTAHFGKWHLGGGGLPNGDPNAPEPKTYGYDEARVW
NGNGPTWKGDKKWPTTRYMDNDTLWVQSSSKVAVDETLNFIKKNKGKQPMFINLWLKDPH
TPLWPSEEQRKDFKGLSPSKETYYAVLKDADFHVGRLLKSLLEMGMDENTLVIFSSDNGP
AAYGASLKAGSTAGLKGRKVDIYEGGVVVPFIVKWKNRVAANKVDSTSVLSTVDLLPTFA
NLAQIELPKDYGIDGENIATILDNKSFERTKPLFWEWRFPKVKTNHWAEGAVRKGDWKLL
FNDKINKVELYNIPKDPFEKNNLAENNEEIVNELKTLWKDWKKSLPN
>FCMOIPGL_02353 Arylsulfatase
MNKKLVLLITLVGIAFSCTSQSKKITDSKVTKKPNVIIVITDDQGYGDIGAHGNTLVKTP
ALNKFHDESVRLTDFHVGPTCAPSRSGLMTGRYADRVGVWHTIGGVSILRKDEVTMADVF
NENGYETAMFGKWHLGDTYPSRPQDKGFKYTISHGGGGVGQTPDYWDNDYFDDTYFKNGV
PTKYEGYCTDVWFDEAIKYIEEKKDQPFFAYISTNAPHLPYNVPEDYYNKYKDLDIPEFQ
KVFYGMITNVDDNFAKLQKKLEDLKIADNTIVIFMTDNGTASGYKTVGGKLYGFNGGMKG
TKNSEYEGGHRVPFFISYPGKNINGGKDVTDLTAHLDILPTLATLCDLDFPERQKKIDGS
DISSLLLGTAKTIGREYLITDSQRVQSPIKWRKSAVMSDKMRLVNGTELYDIAKDPGQEN
DIAKQFPEKVEKMRGFYNEWWSSVSSEFNLFPIIILGSDNQNPIELTCHDTHIHDSKIPW
NQNYIREAKKNPLGGEFTVEFEQSGTYQIELSRWPFESGIAINDAVKGREATISTESISD
GRSMNFKSGGVKIGAWEQSLKIENGAKTLSFKGNFTKGKTNMSAWFTNDKNVDWGAFYIR
VYRL
>FCMOIPGL_02354 hypothetical protein
MKIKPKKMKENKNHITLVVQYFVQQKEHELKK
>FCMOIPGL_02355 hypothetical protein
MQFFNITDILNLNKIYKINLINSCSGFKSANLLGSISDNGIYNVAVFSSVTHLGSNPPTL
GFILRPTTVPRDTYKNIKETGIFTINHIWEDSIEDAHHTSAKYPKEISEFNMTNLEPEFK
GKFKAPFVKNSPVQMSMKFIEEIYVSSNDVILIVAQIQELYINDELLEEDGLINLSKGNI
ATINGLDTYAIPKFKKRLSYQRPKDLNKIS
>FCMOIPGL_02356 hypothetical protein
MKILVTGATGYIGKRLIPLLLNDGHTIVCPVRDKKRAQNYYKEQKNITLVEADFLNKETL
DSISKDIDAAYYLIHSMSNSAKEFHVLEEKCAFNFKQFAEKTSIKQVIYLSGITNDTKLS
KHLLSRKNVEEALASKKYALTTFKAGIIVGSGSSSFEIIRDIVEKLPFMITPKWLNTKTQ
PLSIRDVLSFLHKALNKEELYNTSYDIFGPEIMTYKTMLLQFAEVRKLKRWIITIPVMTP
GLSSYWLYFVTSTSYKLARTLVNSMGVEVIGNKSDINKILDINPISYKEAVELAFKKIEQ
NSIISSWKDSYISSGKLKNYVHEFINVPEYGCFKDFKKRKVKNKKTVLNKIWAIGGETGW
YYGTFLWKIRGFVDQLFGGAGLRRGRRHPSELNAGDALDFWRVIYADKEKGKLLLYAEMI
LPGEAWLEFRIENGILYQTATFRPHGLAGRLYWYSVMPFHWFVFNGMINNINK
>FCMOIPGL_02357 Non-motile and phage-resistance protein
MNENIENIALLQKIFNASHQGILVINNADFIINANAKCQKMFGYNADEILEKKIETLIPE
KIKKTIKKQREKFEQKPKLDGINLNLNSIGVKKNGSAFPIEINLSLTTLNNKPIVIVFLI
DNTKQQSDKQKLAISEFRKAEAQRLAHVANWSWNLKTDERNWSDEFYRIYGLTPGDERLN
NKTVLSFTHPDDRKKTLKEIDNAIKSYKPYKYQKRIIRPNGEIRYIIAKGKILFDEDSNP
KEMYGTIQDITKHKKIEYKLKSSQEKNQAILEALPDLMVLYDKNGNYLEIHSSEGDELAI
AYNENIGQNIDKILPKDVCEKIRKSFDNCEKTKKTQIIEYSLSIKDKLKHIEARIVQTDE
GNFLSIIRNITKSKNVEKFILEKEQRLRLTLEAGEFGSWDWNLITNKIERDRYQNSLFGI
KNNENTATYESFLNKIHPEDKERVKRTILEAIKKTKNYTLEYRVIHADSSIHWLHEKGKI
FKNNHGKPIRIIGVTNNITKQKKAEEKLIESEEKLRNYTIKLEEKVTERTKELTTTVQKL
VESNLNLEDQILITDEAERSALTSKLLLTNISKNFPRGLIMVVNENYCIDYIEGEELDKM
EMRGVVVDGTKIDKIQVFSEERKTRLKENIKKTLSGKHLSFEIEFKGIPYLVNTTPLFNN
EKIIKRALLVYNNIFEQKQVEIDILNTLKKERELSELKSRFISMASHEFRTPLSAILSSA
ILIEKQNGVGKEDKRINYVSKIRSNVKDLVVILNDFLSLGKLQEGKVVAQPTTFNLIDFL
KLLIEEINNIKKNGQIITLQYENSIIKVVLDPKLLKHIIHNLLSNAIKYSEENQEIIIKV
TPNNKLVNIKIIDQGIGIPQEDQANMFQRFYRADNAANIQGTGLGLNIVKQYTDLMDGTI
NFKSELNKGSTFYLEFPLKEKKDEKNIIN
>FCMOIPGL_02358 Transcriptional regulatory protein WalR
MKKILLIEDNKDVRENTADILELENYSVITAENGKIGVEKALEFNPDIIICDIMMPVLDG
YGVFENLSKKPKTASIPFIFLTAKSEKIDVRKGMNLGADDYLTKPFEENELIDAIECRIK
KNNFLIKKFSKNVEGINEFLNEATAYLNLEELSKDQSAEKYIKKDCIFTEGTAAHQLFLI
KSGNVKTFRTTESGKEFVTGLYSAGDFIGQLSLLSEKGLYIETASILEDAEIFSIPKADF
IRLLYENKEVSNKFIDIMSNNLIDLQEHLVDMAYATVRQRTAKALLELDHKGMIKDNNHK
GISMPREDFAGLIGTATETAIRMLTEFKNEGLIGIETNRKIVLLDKQTLKQIVEFG
>FCMOIPGL_02359 hypothetical protein
MSNSYNSFEEINNQLKILSLKKQINKQHIKLNFQNSKTIFNVTNLKNEFKRAFQEQLLSY
VINNLLKRFR
>FCMOIPGL_02360 hypothetical protein
MAFKELKENVLEADINIQEYFKNSEAYIKLKSFKVLMLCITYMSKMLIIGVLVAMSLLII
SFAVAFRLAQVLENTFYGFLIVGLFYVLVVLVFYFFRDKLNRPLLRKFSNYYFINDDVK
>FCMOIPGL_02361 hypothetical protein
MSNNNENTLLALLAGAAIGAGIGVLYAPDKGKNTRGKIKHKAEDIKHDISERVNHAKADL
TKSVNEKKQEIKEKLDETISHMNGKAEDIIASLERKLEELKKMEPQQK
>FCMOIPGL_02362 hypothetical protein
MKTPEAQHKEVILKSYPEFQQIEKAVNILKKLKNNNLQVTIIGKLDEENLDDKLNEINLE
KSMEKKCLALFEPPLDFGILSNPNIGTIFIAGFLVSMFLQEVEHKKIGVMLTGPFGILRG
LGINKERTSFYLEALHRGNYLFIVRGYDTEINQIKRKLSSFSHK
>FCMOIPGL_02363 hypothetical protein
MEKRILCYTDFSKNALNAIQYTSKLYEQQPCVFYILNAFQAGKDASDIEALIPETDNETY
ILDKKTSEAGLKTIINTLNSTSKSTKHTYKTISSFNSLLFSLKDAIKNNAIDLLVLGSKN
TFKEEEDENVPLVDITEYITECSILIVPSDHKFNGLDKIVLPIDYDEALHETNFSEILTI
AKLHQSEINILHIKKEHQLDEDQLENKNKLASILVGLKYNFHTLKRMNVNKGINLFIEDD
TYSLIVFIKGKVGFISNELPRPLLKELDSHLSLPVLVINDLILVEN
>FCMOIPGL_02364 hypothetical protein
MKKIILGLFLIGLAIQSYSQEVLFQAKIKKEKVPIAVIESVGEEFGYLEEIEFFAVPIVF
IEEDVYINSTINSDEDYETYQVVLKAKNTIITATYDKEGKLYSTVEVGKDIEPAIEVKDA
MLSAFPGWVITKDRYKMTHYSGKQKKERYKFIIAKGKSEKVVYMNGTGEILKVHKKINLE
L
>FCMOIPGL_02365 hypothetical protein
MKTDTQKPKAIKLQTEFKNKFSLGELYSASVYLPRAIIKMMENSKNKLIDNDFVKRLQLA
VTEVNGCVICSYGHTKMALRQGMSGEEISSFLSGENHFIKPEEAKAIMFAQYYADTRGYP
KKYAFDSIVKEYGNKNANIILSVIQIMTVGNIFGIPFSAFQARLKGKPYKDSSLFFELGT
LIIGVFLLPIAIIHGLLRSLIGLPNSRFDKSSSE
>FCMOIPGL_02366 Exodeoxyribonuclease
MKIVSWNVNGIRALVKKDLFKAIEILSPDILCLQETRAQNQEIEEALLPLKNYRKYFNSA
EKKGYSGTAILSKSKSILSDNFVNISAKKQEGRIQCVAFENFYLVNVYVPNSGQKLERLN
FRKQWDIDFLNYIKDLEKTKPVIICGDFNVAHKAIDLKNDKSNYNKTAGYTQIEIDGIDH
LIKAGFIDSFRYFYPDKIAYTFWSYRFKSRERNTGWRIDYFLISKSLIKKVKGVAIYSDI
FGSDHCPISLEIDV
>FCMOIPGL_02367 Osmotically-inducible protein Y
MKTDLEIKNDVLEELTWLPYVYENQIGVIVKDGVVTLNGLVFSYPIKLAVEKAVKNIVGV
KAFAEELKVGYISSLNKNDTEIANSAINAIEWNASVPNNKVIVEVQNGWITLSGTLEHAF
QRDAAKRTVGGLTGVKGVTNLIILEQAEKSNDIEEKIIKAFNRSSIIDAEGIKVETTNHA
VKLSGKVHSLAQKEEAQKTAFNAPGVYEVQNELKVEY
>FCMOIPGL_02368 putative 3-hydroxybutyryl-CoA dehydrogenase
MNYKNITIAGSGVLGYQIAFQTAFHGFHVTVYDINDVVLEKAKNKFNSLSIAYKNDLNAT
QKQLDETYQNLSYTSDLTEAVKNADLLIEAVPENPTLKIDFYKKLAKVAPEKTVFVTNSS
TLLPSHFAEATGRPSKFLALYFANSIWIHNTAEIMGHSTTDPKVFKDIVAFAKSINMLAL
PLKKEQPGYILNSLLVPLLSAATNLLVNEIADSEIIDKTWMKATGAPLGPFGILDVVGIT
TAYNINKMAAENTKDELKIKTAKYLKENFIDKNKLGVSTGEGFYKYPNPVFKKSDFLE
>FCMOIPGL_02369 hypothetical protein
MRTDLSIKEDVLDELEWQPSIDETQIGVIVNDGIVTLTGTVDSYAKKREAEKAAKSVFGV
KAVAEDIVVKYATTSHKSDTEIAEAAVSALKWNISVPENKIDVKVEDGWIYLTGEVMWAF
QKNAAKKAVQNLTSVKYVVNNITLKNNIDTSDIKDKIKKAFERSADIDAKDITVKADGHT
VKLTGKVHSLKEKDEARNTAYYAPGVWTVDNELEVVY
>FCMOIPGL_02370 Anthranilate 1,2-dioxygenase electron transfer component
MLRNIKRLLWGLLVGVTVLWILANVPFPDTITSKIIRHLSIQYSGVIGIGVMSVAMILAL
RPVWLEPILGGLDKSYRLHKWLGIVGLAAAIFHWIATKAPYWLSSLGLIAGGRGRGGGPD
SKSDSLNQIQAFFDGLHNPAKFIGEWAFYGLVFLIVLALIKRFPYRLFAKTHTLIAVVYL
ALVFHTVVLLDFASWTQPLGIIMALLLVAGVLSAILVLTRQVGKRRKVEGTIVEQYYYPK
MKVLETLILLKDGWKGHKSGQFAFVSFDKKEGQHPYTIASDWNPNNPTIMFITKALGDYT
NHLPEKLNIGDKAVIEGPYGCFTFDDEAKRQIWIGGGIGITPFIARMKHLAHNPTSKPID
LFHCVSELEPDALNKLTADAKAANVNLHITIDKIDGHLSGEKLRKIVPDWKSASVWFCGP
VRFGKAMHKDLLKNGLPLKRFHQELFSMR
>FCMOIPGL_02371 DNA protection during starvation protein
MKIANIGISSKNKQNLADQLSKVLADEFVLYSKTLNFHWNIEGPDFHSVHLYLETLYEEQ
QEVVDTVAEKIRMLGHFVPATLEKYLELTHLTEKTKGKNDSQSIFSELLEDHESIIIFLR
EEIKPIVEKWHAEGISDYITGLMEQHEKTAWMLRSHLE
>FCMOIPGL_02372 Inner membrane protein YjdF
MKLQSSVITVIGHKLFWYGLLFCIVWVNSLIGTTDIKNWLIENTLTVIALLFLFFMYKKY
RFSNFSYFLICLFLCLHVYGSKYTYAENLFGFWLQDIFHSSRNHYDRLVHFCFGFLLYYP
LQEIFIQWIKIPKYIALKIPILIIISASALYEIIEWLVADVFFVEEGISYLGTQGDVWDA
QKDMSVAFLGVVFAAVLCHGCKLIYTAKD
>FCMOIPGL_02373 Oleate hydratase
MKRHKNKNPKDAKVYLIGSGIASLASAVYLVKDAGLQGKNIHILEKDNILGGALDGAGNE
EDGYVVRGGRMHEKHYECYWDLLSYIPSLEDPKVSVRDESFEFNERFVSNGKARLLKEGK
KLDVSSYGLSLKQQADFLKLLMTSEKLLENKRIEDWYDHDFFETNFWYIWSTMFAFQKWS
SVAEMRRYMRRLIHLVDGLYRLGGVMRTKYNQYDSVVRPMKKYLEDRGVNFDMECEVIDV
DFDLSSDKKTATVIHLKDKNEIVLGENDYVFITNGSITDSTDNGAWDRPSKLKGVAESGS
WKLWKNIAKKDEAFGNPGVFCDNIDLQKWYSFTATLKDSTFHDYMENFSGNVDGTGGLVT
MTDSNWLMSIVIARQPHFPNQPKDVKVFWGYGLYPDRKGNYVNKTMAECTGEEILEELWY
HLKIQNLMKPIVSAGKVNCIPTAMPFIDSLFMPRAYGDRPEVLVEGASNFAFLGQFAEVP
KDIVFTVEYSVRTAQTAVYGLFETGKKVIPVYPSIHEAKSLIKAAKSISR
>FCMOIPGL_02374 Oleate hydratase
MKVKTKETKAYLVGGGIGSMAAASFMIRDAKIPGENITIYEELPVLGGVLDAAGNAESGY
SMRGGRMLCADIYECMWSLMKTIPSLTDPNKSVYDETVEFNKVVKTDAHARIINKNRAVP
DLSSLGLSMHNRFELLRLLETSEEKLGNDRITDWLSPELLESNFWYMWITSFAFEPWHSA
VEFKRYMHRFLKQFTQIATMGGISRTVYNEYDSIVRPLEAWLVEKGVKILKGHKVTDLNL
DFDDEDGKWAVNKLEYVYKGKTETIPISKNDLVFFQNGSMGDATSIGSMTSPPKHLTKED
SKGWVLWEKLAKGRPEFGNPAVFNSSIPESNWESFIVTLKDPVFFDKMEELTGNKHGTGA
LVTFKDSNWLLSIVLKHQRRYPQQPDGVQVFWGYSLRPDRIGDFVSKSMTDCNGKDILKE
ICGHLRFDMDEVFSKATCIPCKMPYITSMFMPRTNTDRPLPVPKTSRNLAFVSQFVEIPY
DTVFTVEYSVRAAQMAVYELLDIDLEIPPITRHDKNLKVNLEAALRTLKN
>FCMOIPGL_02375 hypothetical protein
MATTIISSAQSVVKNWWISLLLGILYIIAGVWVFQTPIASYVSLSIVFSVFIFVSGISQI
IFSISNKDDIEGWGWYLAGGILDLMVGILLISHPLMTMTILPFYVGFWLLFQGFMVIGLS
FQFKSADVPNWGWLLFLGIMTLLFSFLLLANPIFAGLSIIYMTAFAFISAGISRIFLAIG
LKKVKNTFK
>FCMOIPGL_02376 hypothetical protein
MKTNILSLTIMIFMAGTLLTSCGQASKKDANSVKEDVKELNKDLVKGAKDTNVEIKTAVK
ANWEQFKTSSDLAIENTEKQIEVLRTKIANANKSEKEKLTKALDKLEQKNKELKEKLAKR
GKEFKENMIDFNESAKENEQKFEREFTHDMNELGAALKDLFKNNVQ
>FCMOIPGL_02377 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MGKLILVRHGKSVWNLANRFTGWTDIDIAPEGVEEAKIAGELIRDHHISIDICFSSYLKR
AIKTGEIILETANMMQVDFIKSWKLNERNYGAWQGRNKEDVKNEVGAELFWKIRRGFSTP
PPSLSIDDERHPKFDPKYNHVSINDLPRSESLEQTKERTVQYFFEAIVPELVKGKTVLVS
AHGNSNRALIGHIENIVSSDMPKVEVKTGVLNIYEFNNNMSLKEQYKLEQLSELKI
>FCMOIPGL_02378 hypothetical protein
MSHIIIVSFKEETKAIDALHKIKELDDYGDITLYEDMMIRKKENNQYQVLNDETEGEGWR
TFTGMALGGLIGAIAGPVGLIIGLYSGTLVGAIFDGSHFNFEKNFIQKVSNKMEIGEIVI
IAEVNEDSDIFIDNAMKPFSSEIIRSEAEIEYDIYVDEHIEDLEDKIEDEREKIKKATKE
EKVKINTKIANLKAKRNAKIAELEAKRKSTLEEIKNKTKVRINKLEASLKGYEDSISDSI
TKAKVNRIQKKINKQKSKLSKLNKLLEEVLL
>FCMOIPGL_02379 putative bacterial non-heme ferritin
MKTKSEFLSGEMVDLLNYRVEQEEYSSRLYLSMSTWLDDEGFAGAAKLFKQYSNEELVHA
TKAKKMLLANGIRPITPALKQPKQDYLSLPDVIIAALAHEKEITRQCYDLTKVAHKEGNF
MVVELGLWYCKEQAEELNKVQYLIGRLEAFGEELSMLRELDEEMGELAD
>FCMOIPGL_02380 hypothetical protein
MDAFQGVIKFVDPYILGVLISLGIGLIIGLEREYDKLKEEKGIAGIRTFPIVTILGFSLG
ILTKTFTVWLLIIGLGAFILFLASNHFSQKQEEYGHGLTTNLALIATFVLGTMVSSQFYR
DAVATAVIIVTLLSLKTRFRSVISNITSEELFAFIKFSIIALLILPFLPNKTYGADKLIN
PFEIGSIVVIVSFLNFIGYFLVKFVGSKRGIILTAILGGLISSTAVAWNYASRSKEFPEL
SKKYSAGIIIASAIMFPRLALLAYIFNTDILKYLAIPFGILTIVCVIATLILMRRDDNKP
DTKIKLGNPLNILNAIGFGFIYVIILFAVFYSNQFFGESGLYYSALIAGLADTDAITISM
SKFSLDGENLQLASSVIIAATISNMLVKLIITLFKGSTSAKKIIGCAFGSVILIGIIYIL
LN
>FCMOIPGL_02381 putative protein kinase UbiB
MASIKLLNKKQIIRYHKLFGILTKYGFEDIMAHNKLKKLVPKSYLTNHPDAQKLLSFTKF
ERIRMVLEELGPTYVKLGQIFSNRDDMLPPDLIKELAKLQDHVPELKNFNVNEVVEKELG
ISISEHFISINPKPIAAASLAQVHKAKLLTGENVVLKIQRPDIQEVIESDILVMKQVAKT
LQKYSSQAKAFQPMLIVTSFEKSIREELQFLKEVGNMERFTKNFEGNEAIYVPKAYRNLC
TDKLICMEFITGVKVSEIATLNSLNINPVKVAKVGVDLYLQQVIEYGFFHADPHPGNIFV
LTENQQICFIDFGMMGSIMPNDKEALSNLLIYFLKKDVQKIITVLERVAVKVEVSDYKKL
KYDLYELVEGFSDTSLQDIKLSTILTQFKTILYENKITLPHYLYMLIRALIIIEGVGLKL
DPAFSITDNLQPYTSKITKKRFSIKRLFKKNLNRLQDISDLIEVLPNDINTILKKIKEGK
LVIVHEHKGLNEFQETINKSVNRLVFAVIIAALSIGSSILVIAKMPPLVNGIPLLGAIGF
LLSAILGFYILISIFRNNQFKN
>FCMOIPGL_02382 hypothetical protein
METKILYNSNMHFEHVLWKRELDFWIDELKTFNNRLSELVTRWTDKNVLARLEHYQNEFI
LHGGVIEDLQEAIEEHEMRIAGQSESGFNAIDTKLARKHVEFRNRIETEREIYADLKKKF
FRFLEEYM
>FCMOIPGL_02383 hypothetical protein
MQLDSIAIDRIIEMAWEDRTTFEAIQFQFGLKEQDVIDLMRRELKLKSFKNWRQRVQERK
TKHDKLRVFKKGRFKCSRQRTITNNSISKR
>FCMOIPGL_02384 GTP cyclohydrolase 1
MITEVTLKEKELEQKLNGFSFEEIGDDHLYTGLETPMKPNAFAISDEEKKEKIASLFSEI
MNVMGLDLTDDSLQGTPKRVAKMYIDEIFSGLNPANKPKVALFDNKYQYNQMLVEKNISF
YSNCEHHFVPIIGKAHVAYISSGKIIGLSKLNRIVQYFAKRPQVQERLTNQIAEELKTIL
QTENVAVIIDAKHLCVSSRGIKDDTSSTVTSYFGGDFNSSEKIAELQNTLKY
>FCMOIPGL_02385 hypothetical protein
MDIIKKALEFENRKMRFPTTSDRILAAREAKSLILSLNELYKENKDKKIMDIMKRLTAIK
QRIEKRLKGKPLTAA
>FCMOIPGL_02386 hypothetical protein
MNLIERAIEFENRKFSFKTTSDRILASREVKALILELNEVYKSEKDPEMMDLMKRLTAVK
QKIEKRLKGRP
>FCMOIPGL_02387 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase
MKKIVVIGGSKGIGKAIIKSLVDKNQVINISRSVPLLSHNNLTHFSCNILTDELPKTDQI
DTLIFCPGSINLKPISRLKLEDFRTDFEINVVAAVKAIQHFLPALKKGTNPSILLFSTVA
AKLGMPFHASVAAAKSAVEGLTKSLGAELAPTIRVNAIAPTVTDTDLAAKLLRNDRMIES
IKERHPLKKFLNPEEVADMATFLISDKAKSISGQIFELDCGIVSFKI
>FCMOIPGL_02388 Hydroperoxy fatty acid reductase gpx1
MNLYDIKIDSLQGKPIKLLDFKNKYILFVNVASKCGFTPQYKDLETLSKTYKDNLIVIGV
PCNQFGKQEPGKADEITEFCQVNYGVSFLMTEKIDVRGENQHPLYTWLTSKKMNGKKSSS
VKWNFQKYLVDKEGKLIDYYFSITKPLSKKITKHLK
>FCMOIPGL_02389 hypothetical protein
MFNLFKKKSEVEKLQDSYKKLMEEGFKLQSINRSDSDQKYFEADAILKKIEKIQAK
>FCMOIPGL_02390 Tryptophan-rich protein TspO
MKQFKLTILFLFINFGGLAIGSWLMNNGPLTEWYTNLNQAPWTPPGWVFGVAWTLIMICF
SIYLGKLFIEDNSQKLKLVFLFQFILNVSWNYIFFNQHLVLFGLITIVLLTSLLFYYFFK
LSNKTNNYKFLLVPYMIWLCIATSLNLYVLIHN
>FCMOIPGL_02391 hypothetical protein
MKIYTFHRKQKLPITLEKAWKFLSSPKNLKTITPDYMSFDILSGAEKPMFAGQIIQYIVT
PIFGIKTKWVTEITHVKDLNYFVDEQRFGPYALWHHKHFIKEIDGGVEMEDIIDYKVPMG
FLGQLIHPFLVKPKLEEIFAYRQKKLIELFGEHK
>FCMOIPGL_02392 Deoxyribodipyrimidine photo-lyase
MKTTINIFWFRRDLRLDDNCGLFHALSSDKKVLPIFIFDEDILKKLPKEDARVSFIHQEL
KNINQQLLEINSGLSVFHGKPMDIFKDLSEKYIINTVFTNHDYEPYALKRDLEIKDFLAS
KNIIFKTFKDQVIFERNEIVKKDGTPYKVYTPYSKKWLEAFHSKGIQFFPSDEKLENFIK
SETHQFLSLKDIGFTKSSIKVESYKINDSLIDSYEETRNFPAKNSTSKLGTHLRFGTVSI
RKMVEKASKSNNITFLKELIWREFFMQILWHFPHTVKDSFKPQYDRILWRNNEDEFNAWC
KGETGYPLVDAGMRELNQTGFMHNRVRMLVGSFLCKHLLIDWRWGEAYFAEKLHDYEQSS
NIGNWQWVAGTGVDASPYFRIFNPTTQILKFDKNLEYIKKWVPEFQELTYSTQIVEHKMA
RERCLKTYKTALQKF
>FCMOIPGL_02394 Putative diacyglycerol O-acyltransferase
MAKKVIKDLLQEVLDSSMQQISGQDATFLYAESPTSTMHVATLTIVEGSIEFNDFKEIVA
SKLHLIPKFRKRLLNVPMNLDYPYWVDDPNFDIDLHINRLKLPNPANWKTLREMTSSFLA
AL
>FCMOIPGL_02395 Putative diacyglycerol O-acyltransferase
MWSIDFIEGLDEVAQVPKGSIAILSKIHHVMIDGSSGVGLMSILFDKNKEEKEKKPSSPK
PFEPEPLPDEISLLIKSSYSFFKNPFKVPKLIGETAFSFLKVKMNNQLRVKRTSFKSSYS
TPKTIFNECVSPKRTWGTAILAFDRINKLRKIIDVSVNDLILAICAGAIRRYLEEKEKLP
VQPLVANVPISIRTKGEEQKMNNQISNMFIKIGTHIKNPLDRLDFIQEQTSLGKSKHKAV
GAKTLSKMADAMPFGLANLAASLYSKYNIKEFHRPPFNVTITNVPGPQNPLYLKGHKVVG
IFGLAPVLDGFGLIIAAFSYNGLVSITTTSDAKTMPDADKFSRYIRESANELEALILTKE
KQKTVEKVKKIKSSVFFTAFKKYLIADKNLREQIIGLYDFHLNLGESEINYQLAVLKETV
SVKKKKTAKPSVKIIIDDNYLINLHKKNLLLEEAIIQERLFFTGTKKNIDKFSQILSEFL
EKN
>FCMOIPGL_02396 Monoacylglycerol lipase
MSFSTNTYRTIDDKTIFYYKWPSKKNSTLKGIVQISHGVGEHAGRYQHFATTLQNEGYEV
YANDHRIHGKSVKNHDYLGYYDGDDYFLDALNDMRQLTEIIKKEHPNKKIILFGHSMGSL
LSRNYVTKYGDDLDALILSGTASFMKGIGSFGLISAKFLGKLNGKHRSNELLKNLFFTQF
NKKFKPNRTNVDWISSDEHQVDLFEADPLRIEDFSLSVFRDILKGTKKVNETKTFKNTPK
DLPILIFSGDKDPVGEMGKGVIKVVNAYKKADIKDLTLNLYEGGRHEMLNEINKDEVEHD
VINWLKERMKAKI
>FCMOIPGL_02397 hypothetical protein
MENNKILYTSFTKLALKVAMSKGMTLKKAKEIVILKFELHPFEKMIVGLIDESKLIKKEV
NTLLNECISVCEDFGPDRDYVTLNIVLERISKIEATKKGTNDIANQVLKTFKEKVDEINK
RIESPPLFNVLLETRSVVEWVSMFGVYPFIPKHKASKNKPVLLMPPYLGNDNSTAFVRKY
LRSVGFKTYKWDLGVNMINSKSLPKLIEKLDEIYEKHQEKVSLVGWSGGGIFAKIIANRH
PEKVEQLITIGSPVWGVKNMKTPLVRSLEFLRGRKLRERNDKFIKELEEIPDVPVTCIYT
KTDGLLPWKHCMEAETLRKDINNIEVFGSHCGMGANASVLLTVANSLNTNITGKKPKGIT
TKIESLFFPEFWEQKGISKFTNLFFS
>FCMOIPGL_02398 Putative acyltransferase plsB1
MEHHIKNIIEHPKFQENLKTIAKEQKVLFSEIQKKGAECITELYSQQHPIANMLSVKGFQ
FMMSKAYNNKIDIDPKEIKSLMKLMRQNSVAFILTHKTYLDTVVLVSTLARYGMPIPYTF
GGINLAVPGFKQLGKNSGLIFIRRSFKEDQIYKAALRHYISCLIENGDHLTWNIEGTRSR
TGKIVYPQMGILKYIMEGEKESTRNIKYVPVSIVYDLIPDVKEMTEEGKGVAKKSENIGS
FINYFKKLGNQYGKAAIRFGEPVDAAAHQNAIIPDIEEDSYSDTNSLPRFAFELIHKANM
ITPVTTVSLVCNVLLNNFSLTKSEIEFSVIKLMNYIEQRKKDVLIERGKSIAASVQKALN
LLQSSGIIQKNKAGYKTQYSLAPTEFLSATYYANMASVHLYHRAFIEMALVKIKDEESSD
RILSFWTEIMRLRNLFKFEFFYTNKPKFSSEIEAELLLFDKNWRAIISDPKGDINSLLSR
QELFVSKGLLLIYLEAKKVVCHTLHSWDLEDDFSEDEFIELCLFKGKELHWQNRISRLDS
ISKPFLISALRLAKNSKLTPVDKKIDTKELDIWMDLLDNLTERLHFLQKLEILNTKKLIN
KKNGETATVPGADLDSVSKDVLEDEEGAHIAAFFDLDKTLINDFSAKQFLKTRLLSGKST
AKELLSQFATVLVYAAGNRDFEMLTKISALGVKGIKEKQFIDLGEEVYHDYLANTIYPEA
INLIATHIEKGHKVVIISAATRYQITPIANELGIKDIFCTEMEVRKGKFTGVISEMCWQE
GKARAGRKFAKANNIDLSKSFFYTDSIDDYPLLEIVGKPIATNADHKLSQLAFENDWKIL
RFKETKKIPLVNGLRTGLAASSLYPSALKGIIKGTLSMSHKEGINTTISSIGDLGTRLAG
LDIVVKNKHNLEDHRPAVFCFNHQSSADFFIILKLLRKDVTGIAKKELEITPFGPIFKAM
GAIFIDRSNKRKALESMKNASEILKKGTSVAIAPEGTRSGSKTLGEFKKGAFHLAMKGGV
PIVPIVIKNAYMAMPKGSKMFNPTHIEVVILDPIDTSEWKPKNINIYLNDVRNLFLKELE
N
>FCMOIPGL_02399 putative glycerol-3-phosphate dehydrogenase 2 [NAD(P)+]
MKLKVGLLGGGSWGTTVASLTAKNSPTIIWARNQEIVNEINEHHTNKKYLPNAKLTDTLR
ASTSIKETVENADVIVMGVPSQSLREVLIEAKPYIRPWVPIINLAKGLEMSTKMRMTEVI
EELMPGHPIGVLTGPNLAKEIHFGKAAAAVIAMVDHSIAKSLQPVFNSGLFRVYTNDDVI
GCELGGALKNIYAIATGMGDGSNAGDNTRAAIITRGLAELTRLGIAMGGKKSTFAGLAGM
GDLVATCSSSKSRNHHVGFQLGRGKSLEQIIDEMDEIAEGVKTAKVVMELAKRYKIDMPI
AKEIYKVLYEGNNVNDAFKGLLKYETGSEKEPG
>FCMOIPGL_02400 hypothetical protein
MTKKQDQTASFMVRFNQQIFEENGESKLQWRGKISHIQDGDEKRFSDFNDALLFMQQKLS
ELTEEATKHKTTEEQENIIQKSLSMWKTIKDFGPKVIRDTLKDPKKQFTHLQDEIQDKIS
LIGDEISEKVQIDQWRNASRSDFNKIQNQIENLSSEITKLTTKIDAIKKK
>FCMOIPGL_02401 hypothetical protein
MSNSLLQLQELQTFKKDAKIRIETLGHFCVWRNHQKVDNKEWARDKTIQLLQYLVSNRQR
NALHKEKIMDGLWEDWNDRDFKVALHGINKVLEPKRLSRTESEYIIRQGVSYQIDLKKVW
IDVEALEKYIIIGNESLIIDKTVSKIAYKAAIDLYKGSYLPNRIFEDWTSEEREKTQLLI
LGTYITLAEILLQENPLESIRLAQKALAIDATWEDAYRIQMQAYIIRGNRPQAIKTYLKC
EVILEEEYGISPLPETKKLLNEIENIH
>FCMOIPGL_02402 hypothetical protein
MEIISTKSIKENTLKLNDFALKTTEKIVSKSIDSVENLQKITSKTIKHGLKFSAKQQDNL
FNNLEKEKGMIWRNLNKTLDFFSKN
>FCMOIPGL_02403 hypothetical protein
MATKKSKKEIKKEDTLGKAKAIVKKINSDLIDASFNAIETTVKTGEKWQKLTAKLIKKTE
PLTKQQINMVVDTAESIKGQLENSTERLKTLVGYDPKMVENAKKMISENPLIEKAEAMKD
KIEKEVSSNKLVKKAEKMSSKLKKNISETIENVKDKIEDYTEDILDDVDEKIDEITKPKK
ASTKKTTTQKATPKKTTPKKKVVVKKEVVVEKVIVEKTDVTNDLKVIKGIGPVLEKNLND
LNITAYNQISKMTVKDLTNLLIGAGINAKIYDLEGWKAQATLALKGEL
>FCMOIPGL_02404 hypothetical protein
MSTKKTNNVKFTDTVNKVLDTAKTSVKKANDFALNTTEEVVTDSITIASEWQQVLDKALK
GGVHLLDNQQNLVFDTLESYKKQLVSGKKRLGKIFA
>FCMOIPGL_02405 hypothetical protein
MAKKKKNISKIDVLTLYMDFVIENKQKPTDVDDFCENVDLDVALFYSHFKSLKNVEKTVF
KELFKNSIEVLNESEEFLSFDKKNKLISLYFTFFENLNLNREYVLIALKGCKNQLKSFSA
LSGLKKHFIAFVNNLDLSESILPIDGLEKIQRKFVNESAWIQLYLTIQFWLEDSSESFEK
TDIFIEKSINTSFELIENKFLKNAFDLGKFVYKEKIQKKAN
>FCMOIPGL_02406 putative protein kinase UbiB
MKKASKIPISKIQRASKLVQTGAKVGVNYLKYFGDKIVNSEEDARDKLNKSNAEDIYDSL
KDLKGSPLKVAQMLSMDKSILPRAYVEKFSLAQFSVPPLSEALVLKTFKKSFGKFPSEIY
DQFDVKAFNAASIGQVHKAEKDGQELAVKIQYPGVADSIKSDLAMLKPFVIRMFNMKGKM
SDDYFFEVQDKLLEETDYVLEVEQSIEIVNACKNIPNLTFPNYYKDLSSKQIITMDWMHG
IHLSEFTDINKNQERGNALGQALWDFYMFQIHNLKKVHADPHPGNFLISKDYKLIALDFG
CMKSIPIDFYNPYFVLARKETLADKALFEEKMYELEILLETDSKEELTFFSAMFHEMLTI
FTQPFHVETFDFSDEEFFGQITEFGERFSKSTELRSYNASRGSKHFIYMNRTFFGLYNLM
FDLKAKDIKINNFNTF
>FCMOIPGL_02407 Uridine kinase
MLIIGIAGGTGSGKTTVVNQIIKQLPTDEVCVISQDSYYNETFNLSYEERSKINFDHPRA
IDFELIVKHLKKLRLGKTIEQPVYSFVTHNRTTDTIKTHPRKVVIVEGILILNNEALRKL
FDIKIFVHADTDERLIRRIRRDITERGRDIDEVLNRYQDTLKPMHQQFIEPTKNFADIII
PNNKHNTVAIDVVRTVINDRL
>FCMOIPGL_02408 hypothetical protein
MSFFSNLKKNPIFKILTNTFVIIFIPFIIWMLFFDENSYLTHREFNKEIEDLESTITFYE
EKLDSDKEMIKNLQDSLKLERFAREKYLMKKENEDIYIIEFDTIKK
>FCMOIPGL_02409 Methylmalonyl-CoA mutase
MSTFLFDDFEPVTAAAWKQKIQVDLNGADYNETLLYKTDEGILVKPFYTKEDRTNSKINL
PKKKFNICQTIFIHDEKIANFLAIDALKRGANSIQFKADKKFDYHKVLHKIEVKSTIIYF
QFSFLDDHFQIELSKYCNSENTFFQTDSIGNLAESGNWFVNLKEDQKKLENIVLATKNCI
SVSADLYQNSGANIVQQLAYTLAHANEYLHDFGKDVATKINFNFAVGSNYFFEIAKLRAF
RILWETLLNEYDLKNIEAHIFTKPSLRNKTLYNYNVNMLRTTSECMSAIIGGSNTISNVS
YDAMFHKSNELGERISRNQLLILQQESDFSDAQNFANGTYYIEAITNQLAENALTIFKQI
EKVGGFLHQLKAGIIQKKIQENALTEEENFINKNIVLLGTNIHTNSADKMKGELELYPFV
KQRNIKTLITPINRKRLSESIEKERLAQENA
>FCMOIPGL_02410 Methylmalonyl-CoA mutase large subunit
MPRKSFEHIKLKSSNLEPQQNFKHEDFVAGIAPNLRGIYATMYIKKPWEIRQCISFSSAK
EGNIFYKKNPETHLKELSITFNVETQNTYDSDDEILKNLVSKTSVNIDSVEDMKMLFYQV
PLDKISVSITSNDAILPLLAFYIVAAEEQEVPLDQLSGIIQYDVLKDLMVKETDIVSPNL
SMKIFTDIFKYTSNKMPKFNSFSISGFHMQEANTTAEIELAYTFSKGLEFIKKSIEAGID
IDTIASKLSFFWAIGMDHFTEIAKLRAARMLWAKIVKQFNPKNQNSFALRTHCKTNNSSL
KAQDPFNKIARTTIEAMAAAFGGTESLYTNTLNESNAFLKDYSNILTKDTQLFLQQETHI
TKTVDPWAGSFRIEKLTEEIANRAWSLLKEVNDLGGLTKAIEKGIPKKRIEETATKKQTK
IIMSKEVLIDVNKHQLKQEDSLRVSKIDSDAVRKSQIEKLQLLKANRNPEKVKNSLANLT
KAAKSGKENLLDLTVKAARNSATLSEISNALEIGFNSYKTSTKL
>FCMOIPGL_02411 Cytochrome c biogenesis protein CcsA
MKNIFNFLYSTRLMAVLFILFATSMGVATFIENDFGTQTSKALVYNTWWFETIMVFFVIN
FFGNIFRYRLYKKEKWAVLMFHLAFLFIIIGAGVTRYVGYEGIMLINEGETTNQFLSETN
YVNVIVDDNKDQKTIHKPILLSAWGSNSWGFSDDFREKEYKVDLVDYIPWAEKKLVEDKN
GVEHLFLVESSSGSRHEHYIKSGTVQNIHNILVGYNSTDNNASINIFKRNDSLKIVAKSD
GNYQIMATQATGSLKKDSIQDFKLRALYNVAGLPFVAPNEPSKGTMQTISGPKDDKKLDV
IILDVTSNNETKRVELSGGKYNNDNFEQVSVNDLNFRMWYGSKILETPFSVKLNDFQLEK
YPGSESAASYASEVTVIDAKESFDFRIFMNHILDHKGYKFFQSSYDLSGEKEQTHLSVNH
DFWGTFITYFGYSLLYTGLICILFAKHTRFDDLKNTLKKIRKKKLTLSVMFAVFLSSFSY
SQQADTHQQKRVTDQQIDSILKANEVSLKHAEKFNKLVIQDAGGRMKPAHTFASELVRKV
SQSEVLHGMQPSQVLLSILESPRLWFEVPAIYLEKGNTKIREIIGVEKDAKYARLSDFYD
ERGQSKIDSYITEAQKKNIQNKFEKDVIKIGRRLWLFTSALSGNVLKIYPIPGDENNKWI
SHPEVANSKIIQTSDSLYIPKLLPLYMQLLQTSKRTGDYTKADQILDGIKNYQKKYGAAV
YPSESKIDLEITYNKLGIFKLSAFFYLFLGLLLIFIEILKIFYYKSKVLTYIIKGLITLI
LLSFIFHTFGLASRWYISGNAPWSNAYESIIYVAWATMLFGLYLGRKSALTIGATTFLAA
IILLFAHQNWLDPEIANLQPVLNSWWLLVHVSIIVASYGPFSLGMILGIVSLILIAFTTE
KNKKRMDVNIKELTIINEMAVTVGLVMLTIGNFLGGMWANESWGRYWGWDPKETWALISI
MIYAFVLHMRLIPGLRGRLSFNFASAFAYLSIMMTYFGVNFYLSGLHSYASGDKAVTPKE
AFIYIGFIIALLIFASIKYKKYYKK
>FCMOIPGL_02412 hypothetical protein
MFHKNIKLVLAGLISAWAIYQFSLGNIMNGISILLLAGIFVLFYFKNEFILLAFLQLRKQ
NFPAAQKWLSYIKNPEAALITKQQGYYNYLHGIMLSQTNITQAEKYLRKAVKLGLSMDHD
LAMAKLQLAGIAMTKRRKREATNLMSEAKKLDKHGMLKEQIQMMKQQMKKI
>FCMOIPGL_02413 hypothetical protein
MGIEHMKHLKFFIFLCILTFTVSCGQQNRYIQYKVKKGETIYTIAKNLNMKEKDLIRLNP
DVNGGLRADSFIVVPEKSLNYYNSKKLNEDTDIVDAESISVEEEIIDEKTKLINELKERF
VIHEIQKGETFYSLSKAFNVSRGELLLLNPELVEGLKVGQILKIREIPVSAITDVTFYED
YIQPNTSLKVALLLPFKADQYNIDTLAPKEIFSKNATLVNIATDFYLGAEIAVDSLRNRG
VAIELNVFDTGDRNTTEIRSILANRDFNNNDVVIGPLYSEEVQMVANNVNIPVVFPVYSN
KQSEFSSSNIVKTSPDKSIFRLELERYIKENFDHGNIIIVSDDKAASLETSRILKSSLQT
KIDASSIHLLTPDKGYIAKSRFSQILKPNAKNWVILASDSNLIIADVINSLISLPEETTA
KVFTFDKSSVYENVDNRKLAKIGFTYVSDEFVDENSMETSAFNTQYYKKNNTLPSFYATK
GFDITYDILVRLASGNDLKSTFKEGATSRIETRFDYRNNNTENQGLFIVQYNKDLTLTKL
K
>FCMOIPGL_02414 GMP synthase [glutamine-hydrolyzing]
MEQDQVLILDFGSQYTQLIARRVRELNIYCEIHPFNHPPKELENFKAVILSGSPNSVRGE
NVLHPELSEIKGKKPLLAVCYGAQYLAHFSGGKVAESNTREYGRANLSYIKNDEIFFQNI
SDGSQVWMSHSDTIKELPTGGILLASTKDVENAAYKIDGEDTFAIQFHPEVYHSKDGKQL
LANFLVDIAKVAQTWTPDSFVESTVADIRAKVGNDKVVLGLSGGVDSTVAAVLLHKAIGK
NLYCIFVNNGLLRKNEFESVLTQYEGMGLNVKGVDASQRFLDKLAGISDPEGKRKAIGST
FIDVFDDEAHHIKDVKWLAQGTIYPDVIESVSVNGGPSATIKSHHNVGGLPDYMKLKIVE
PLKMIFKDEVRRVGASMGIDPELLGRHPFPGPGLGIRILGDITAEKVRILQEVDAIFING
LKEDGLYDKVWQAGAMLLPVNSVGVMGDERTYEKVVALRAVESTDGMTADWVDLPYKFLQ
KTSNKIINQVKGVNRVVYDISSKPPATIEWE
>FCMOIPGL_02415 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1
MISSKITGTGTFIPTLKKENTDFLKDKFLDTDGTLLASENEVIIEKFKAITGIEERRYAR
KEYTSSDLAFFAAQKAIEDADIDKEELDYIIFAHNFGDVKVGSIQSDMLPTLATRVKNKL
KIKNPNCVAYDLLFGCPGWIQGVIQAQAYIKAGIANKCLVIGSETLSRVIDKYDRDSMIY
SDGAGACIVEKTTEPDAGILSHATQTFANEEAFYLHYGSSYNKNEDKNVRYIKMFGRKIY
EFAITNVPAAMKFALDKSGVEIDDVKKIFIHQANEKMDEAIIKRFYRLFKKPVPEGIMPM
SIHKLGNSSVATVPTLLDLVLKGKIENQSVQKGDVFILASVGAGMNINTIVYRY
>FCMOIPGL_02416 Group 3 truncated hemoglobin ctb
MKPDISSRKDIKLIITKFYDKLLVDEKMIPFFTDIVAKNQLEHHLEIITDFWNDIIFDTT
TYSNNVMKKHLDINVFVTFKKEHFALWVSYFFNTIDTYFLGDNSERMKARAQSIATVMQL
KLNLYTT
>FCMOIPGL_02417 hypothetical protein
MVFKPILTIDPAAQIEIDKAIEWYEKVRKGLGLEFYNYLDGYFKTLQQGKVNFQIKRKPV
FRELALKRFPYIIIYEFTNEEIYIYSVFNTYQDPIKKKK
>FCMOIPGL_02418 hypothetical protein
MELRDKIINQFQLFIEDDTKLDVLNGVFDSMSAVNSVSIVSEEHYKIIEERRQKRLKGKT
VGKSWEEVKLNLRQKYGF
>FCMOIPGL_02419 Cytidine deaminase
MRKIEIATSAVLFKDVSELSSEDKMLMDKAVEARKKAYAPYSKFNVGAALLLENNEIVLG
NNQENAAYPSGMCAERVAIWKAGSEFPGVKILKLAITASSTIKEVSKPVGPCGACRQSLS
EYEIKQKQSFEVLFMGEVGEIVKTDSLLSLLPFSFDSSYL
>FCMOIPGL_02420 hypothetical protein
MKKIGFCIALCALVSLKTSAQTTINTDDIGGITTAVPFLLIVPDARAAGMGDMGVATTAD
AFSLFHNPAKIVFSDRQIKTGLTYSPWLRNLTDDIFVGSGSYINRFSENSAWGADFKYFS
LGEINLTNNDGSDNGSINPNELVATGSYALKLSETFSMGVSLKYIRSNLTFNGTNSNLQP
INSFGVDVSGYYQSFEENYGNFNGRYRIGFNIANIGPKVSYTPGEEDFIPTNLKLGGGFD
FILDDYNIISTTVEFTKLLVPYSGDDTADEDQGWIEGMFSSFGDAPGGFSEEMKEFTYAL
GAEYLYNNAFALRAGYFHESEDKGNRQYFTLGAGFKTNALNVDLSYLINGSDVNNPLENS
LRFSLSFDLGEIYDNY
>FCMOIPGL_02421 hypothetical protein
MRYLNTYMKKQLFLIFCLFLVQFSVAQRSNSVLSSGDWYKFSVDTTGVFKIDRNLLQRIG
VSTSGLNPKKIHIYGNGGQLLPELNSDFRYDGLQENAIYIEGESDGSFDNSDYILFYAKG
PHDWEVNVSANSIKHRQNIYSDKAYYFITVNDTDGKRITPKTPITTSATSQISVFDDFNF
YEKEEKSLFAVGTQWFFTEDFNIVNTQSFKIPFKNAAPNTDLNVRVRGVSNSVASSTMDV
KVNAKDVFTISYPMVNASSLTKAYDVERNGTITNSAESIEVAITFNNNGNPSANAFLDYI
EIVGKKKLSFSDYQFSFRSLAQANATGVVEYQITNGSNAFQVWDVTTAINPQLIINESIT
NDFTFKDNAASLKEYIILDDSDYYLPETVDNSKVINQNLHALNDINYIVITNSELSAQAQ
RLADYHQNNSNLTTKVVLLDEIYNEYSSGSKDITGIRDFIKHVYDTNSSEDKKLKYVCFF
GDASYDYKDRIQANNNIVPVKLSTISFNLASSWVTDDFYVMMDDNEGTMSSSHTVDIASS
RIPVSTISEATIVVDKILNYYNKNTIGDWRNTITLVADDIDATGEEVLEQGVESIADEIK
ANQPIFNINKIYSDAYVQENSSGGERYPDVNLAITNAIEKGTLVFDYFGHGGEDGFATER
ILDVPQIQGFNNPNTLPLLITVTCDFSRFDNPSRITAGELTLKNETGGAASMITTTREVY
ITVGQNFNEALIRVLLAFNDEDFTIAEALMTTKNNFSSTQKFFIYSFGDPAMKLAIPKPN
IRITKMNDVDITTSLDTIRALSKVKFEGVVTDNLNAVLTDFNGTLSTTVFDKLIDKTTLD
NDGYGIKMTFDTQDSKLFRGKSTVENGAFSFDFIVPKDIKIAYGKGKLSFYAENGEIDKA
GYNFDVVVGGIDENAPDDALGPEIKLFMNDESFIDGGNTNASPNLIAVLFDASGINTSIT
AVDHDIVGILDGDTTNPIILNDFYQTELNDFSKGKVTYTLSDLEVGPHTLKLKAWDTYNN
SSETTLNFVVVSDAILNLENVLNYPNPFVNYTEFWFNHNKPNEPLEVQVQIFTVSGKLVK
TINQNVQTTGNLSRSITWNGLDDFGNKIGKGVYIYKLRVKSTTNNLVSEKYEKLVILQ
>FCMOIPGL_02422 Hercynine oxygenase
MKNIFKITLVVLTTVLLTNCNRSNANKSRLTGLSFNDPKNGNFIKGNEDAGQKPPLGMVA
VEGGTFTMGQVQDDVMFDWNTTPRKLHVRSFYMDEAEVTNSEYFLYVQYMKNVFPPSEEN
YKHIYNAILPDTLVWRKSLGNTDILSENYFRHPAYSDYPVVGVSWLQANEYCKWRTNAVN
LKNLIDKGHIKNIFEQDSISNFFDTDVFLTDATQLFNGDSTVYKKGVGRTLRKKGDPKRT
RGSFQGRKITQADGILTQRFRLPTEAEWEFAAKANIENREYNNIRGRKKYAWNGKYTREK
GKRDRGDQLANFKQGNGQYSGLPGWSSDGADIPNKIKSYPPNGFGLYDMSGNVAEWVADV
YRPIIDNEANDFNYFRGNIFTKKMIDENGNVVIAANDESAEVEFDTLPNGKIIPKQLPGT
IKYIPITKDDATLRRNFSVSNNANIDDGDLNSSRFYEDDEDEFKSKPNMYNSPKSPTIVT
DANGKTTFTNDDKMRTTLISDNSRVYKGGAWSDREYWLDPAQRRYLPEYMATSFIGFRCV
SDKVGPMSTGKRKARNPSR
>FCMOIPGL_02423 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MKIANLYNIYRQHFLVDTDTRNIRKNTIFFALKGENFNGNTFAEQALKLGASYAVVDEPA
YKTCENIILVTDVLKTLQELANFHRKQLHIPVIGLTGSNGKTTTKELINVVLSKKLNVTA
TKGNLNNHIGVPLTLLSMTDKTELGIVEMGANHQKEIEFLCTICEPDFGYITNFGKAHLE
GFGSLEGVINGKSELYTYLQKNNKTAFVNTEDAIQVEKTKEIKAVLINTDELQFLEVNPF
VKLRYKSIQIQSNLIGKYNYTNIAAAITIGDYFKVSENAIKEAIAYYTPTNNRSQIIKSK
TNTIILDAYNANPSSMKVAIENFEAIKTTSKAIILGDMFELGKESLQEHQAIVNLVTSLN
FKETYFVGENFYQTKTDKTQFKTYQDLEAFIKKNPLENQSILIKGSRGMRLERILDLL
>FCMOIPGL_02424 hypothetical protein
MILIADGGSTKADWIAINKDKNEAFRVRTLGLNPEVISEVELKNRIINMFQLIKIKKEVT
EIFFYGAGCGTPVATKILKDVLESIFINAKVVVAEDMLAAVYAVAGNKPAIVCILGTGSN
SCYFDGENIHMKTPSLGYVIMDEASGNYFGKRLLRAYYYDRMPKKIAEKFESQFNMEADF
VKKNLYREQNPNMYLANFAQFMFEFKEDKYIKKIIKKGFQEFFKYRVLPFEKGDETPLYF
IGSIAFYFRDILEEVAEKYDLKITDVIQRPIDNLLEYHKNLIE
>FCMOIPGL_02425 Tyrosine-protein phosphatase YwqE
MFFFKKKEIPLSDFFPNGFVDIHSHLLPGIDDGAKDLEDSIALIQKMASYGIKNFITTPH
ILGEMYPNTPEIIKGKLQEVREELVKRNITDITIDAAAEYMMDEQFSILLEKDEILTLKD
NLVLVEMSYFSPPLNLFDILFQLQLKGYKPVLAHPERYISYHNDFKVYQKLKTAGCLFQL
NLLSLTEQYGKGVQKTAEKLLKENLYDFVGTDTHHQMHLELLRKIGTPKNLKQLAHIMKS
TVQRFGKQTK
>FCMOIPGL_02426 hypothetical protein
MTYKETLFFIGQSLTINHSKENKDAIEKQLKENPVDWDAIVKVSTGHFVFPALYCNLKRA
HFLHYLPEDLVNYMVHITDLNRARNQKIIDQAKEINELLLANNITPIFLKGTGNLLEGLY
EDIGERMVGDIDFIVSRDEYLKTISTLDKNNYKIIKESDNYRTFHWHYPALVNPEKIGAV
EVHNKILKKPYDYLLDNNILKKDLIKKQETHFLSTKNKLLNAILPKIINDHLYYSQNISL
RTMYDVFLISKIEESQIDIKNKAIFKKFNSVLGCIQMVLNCSETIKIEKTKGLENYKRNY
ISRLGNSKKVKIKSDIIDYLIKYREKMFILKMAFYDPEYKNFVLKELAKINFYKKLLGFK
STI
>FCMOIPGL_02427 hypothetical protein
MFKKYIVYIITNKNKTVLYVGVTNDIQRRLSQHYFDSRNAKKSFAGKYNCYYLLYYEVFE
DVNAAILREKELKGWRREKKRILITNFNPDWEFLNHDVF
>FCMOIPGL_02428 Tyrosine-protein kinase ptk
MQENNEKEFSNRLETSETLNIREELEKYLTHWKWFLIGSILALSLAFIYLRYTTPQYNAT
TSIMIKDNNKSGVSAELAAFEDLGIIGGGSANNTDNEIEILKSRKIIGNVVDSLKLTISY
FKEGRVKLSELYDQTPIEINIIKKNKDFRDKDTIFKLIFKDSKDIELQDLEGNLILTTKL
DELINSEIGQFKLMPSELFDKYSKEDLRELNLLIKLSNRNNVIDTYRGKISISSVDKNSS
VLIMSLQGALKPKIEDILDELVIQYNIDAIKDKNIVSTKTKVFIEDRLLSVGNDLALIQD
NVKSYKTKFGITGLSAEGELALEAVSMNNQQIVTLKSELSLADWIQKKLIKQSEEYDVLP
TNLGFTDASISTAIMSYNELVMQRNKLLVTAGEKNPQLIEIQSQISTLNKNLLASLDNLK
KSLEIQLQQLNTEASKVGAKTASIPLIERGMIDIERQKQIYAELYSYLLKKKEETAISLA
VTVPNAKIIDYAYSNGVPVSPKKKIVYLAALVIGLLIPFLFVYVKNVLDTKIHSRKDIEQ
LTSIPFIGDVPHSETDAKVVIGNDSRTSTAESFRLIRTNLDFMLSSKTDGLGQTVFVTST
TSGEGKSFISINLAAALSLSNKKVLLVGLDLRAPKVTEYLGIAERKGITNYITNDKISID
EIKFSIPEIKGLDILSSGVIPPNPAELLLSDRVKDLFEQVKKDYDYIIIDTAPVNLVTDT
LLVAKYADMFLYVTRANYLDKRMLNIAQTLYREQKLPNMAIVLNDTDMTRGYGYGYGYGY
GYGYGNAYVERVKKPWYKRILS
>FCMOIPGL_02429 hypothetical protein
MIGYFTVKKCSRYNFDKKSKLIELRFDILTLKVDKISKYFKIYVILAKKISMSKKSNNIL
FVFAIVLISSCVSKKDIVYFQNDAIDQSKVSNSYKTIIKPDDVLQITITALDTEAVRPFN
LAAVNYATTSNTATGTPQLQTYLVDTKGEIDFPVLGKLKIGGLTRDELIAFLKHKLAPDY
ILNPNINVRITNYKVTVLGAVRNPGSYTIPNERITILEALGLAGDLNISALRNNILVQRE
ENGKKTQYRVDLLSKNIFTSPVYYLQQNDVVYVEQNYASIQSASSNSNTSLIISVTSLLI
GIITLIIR
>FCMOIPGL_02430 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MIKVKSKFIPVLFSFVDVLLLFGSFLLAKYMVFHGEIPNVLFYNSLVLGWSVLWVAICLK
FDLYEIPRILFTYKILAKNVYAIFTFIFLSAGFIFFVTDYKFSRLFFGYSMLFFSLFLLL
WRFISFSKVKSFRKKGYNSRSILLVGMNKNIISLLHQIYLNPKYGFKIVGLYTDAEVSTE
IKNYYKGKLSEINSFLEANTVDEIIISLPYHQSKLINDLFRYADNHMMRVRVIPEFSEYL
SQTFSIDYIQNIPIMKLRSEPLNSFTNRILKRMFDVVFSSVIVIVLFSWLFPIIALIIKL
TSKGPVFFVQERTGKDGKAFNCFKFRSMTVNATSDVQQATKNDTRVTSFGAFMRKTSIDE
LPQIFNVLLNNMSLVGPRPHMLKHTEEYRVLVDKFMVRHFAKPGVTGWAQINGFRGETKY
IRDMENRAIADIWYIENWSFFLDIKIVVNTAWSMFFKKDENAF
>FCMOIPGL_02431 PGL/p-HBAD biosynthesis glycosyltransferase
MKVSIITIVYNNAAFIESCIKSVLSQSYTNIEHIVIDGGSTDGTLDIIKPFIPQLGYFLS
EKDKGLYNALNKGIKAATGDVIGILHSDDLFYETTTVEKIANSFKTSNTDLLYANGMYVE
RENIKKVKRIYKSKPFKKKYLNFGWIPLHTTIYVKKEVFSTYGLYDESYHIASDYEISLR
WFQEESIKKYFLKDWLVKMRLGGKSTTLKLQKKKSSEDLDIIKKKQLLGVFTLFFKILRK
VKQYLITKIKNY
>FCMOIPGL_02432 SPBc2 prophage-derived glycosyltransferase SunS
MKSSNTISAIILTYNEEQHISRCIASLKNTVDEIFIIDSYSKDNTVAIAENLGAKVYQNA
WVNYATQFNWALEHCDIQSEWVWRIDADEYYESKKKIYLKESLANLENDVTGVYIKRKII
FMGKELLYGGWYPVWHLKIWRNGKGFCENRWMDEHIKLTEGTTKQIDLVQVDENLNDLSW
WTDKHNGYASREMVDLLDTQYQIFSTSSVTPKLFGTGEQRKRYLKLKYLKLPLFVRPFMY
FFYVYVIKLGFLDGKSGFVWYILQAFWYRFLVDAKIYELKKEFNNDEKKIIAHIKEKYQT
K
>FCMOIPGL_02433 Putative acetyltransferase
MSKKVDLSQYNHSFSVKNKIGRLLWSICYIFLFKPFISRFFRSWRNFVLRVFGAKLHNKA
NIYASVKIWAPWNLEMGAYATLGPNVDCYNQGMITIGANTTISQKAYLCASTHDFTDVNN
NLVLKPIVVEEESWVAAGAFVGPGVTIKQGAVVGARAGVFKDVDAWTVVGGNPAKFIKKR
NLQ
>FCMOIPGL_02434 Alpha-maltose-1-phosphate synthase
MDNKKIKKVLHIVGSLDESAGGPSRSVPQTCEQVSKLGLKIELISRPSDKPVKINTSKLF
QVNFYSTINIFAYCMKLSKKEISLIHLQHVWDPYIHIVAFFARLKGIPYIITPRGMLEPW
IMKQRSWKKKLGLFLYQKKDLKKAAVIHATCKLEETNVRNLGFTNPITIIPNGVDISKFP
TEEPIKTDQPRKILFLSRIHPKKGIELLIEAWSQLTSDIRKDWVLEIVGNGDANYIKSLQ
EKIAKQQLEQQLFIKEPVFGEKKMTLFRESTLFVLPTYSENFGIVVAEALASFTPVITTT
GTPWEELNTHKCGWWIDLSVENLRVTLQAAMQKSPEEMLLMGLNGRKLVEENYDVKVVAQ
NMLKLYHNILDK
>FCMOIPGL_02435 hypothetical protein
MNKPDILIVTATLGNRSTLKRTINSVSNIGKDRTYHVIIAPPVHCFRLRNEFPNVNVIEE
PETCKGIYSALNYGLKKYAKDFKYLTYINDDDYWLDNFVKLFEIMDSNPNVDVAYGKTCY
VDENNEVIGEQTSSSRYKAFKPLLLNRIVLFTQQATIMKSDLFLRIGGYDESYKLIADTN
FWIKSIESKAVFYYVNSICAAYTIQSGQLSSDGTLQNEEHVRLGLAYNYRYSLIPFFEKL
IFRITNFRIYVRRILKYKKISRMGGFFHNS
>FCMOIPGL_02436 hypothetical protein
MSFAIIFIVLSTVFHFGEPFIYLIGKEDFISVKNIELARYSIEIYNQANFFALFIQSCVV
TGFLLSSNKISCSYNEFVLYDREKKELKFLIGLGKILLILGLFSYYYYYSIQIQSILNGG
VYSGIRDQNYGPEIVFKPFYHPGLFMLIIGYKKNLRIVKSLIVFGIVIELLTMLSGNRSS
QILTIIVLFFIYYRIISNLSKKKVFIFAAILFVFSNVLYLISSIRNYGIVKESENISIST
LLNIDGFISLLAQLGSNLNVVILSIRDVPLYTSFNYGWTYIVSLVSFVPNVGGILGEMPN
QYAFLNYLNTDYPLGGSYIAELFFNFGWFSFPFAILIGFVLGKFNNLIEYTIINRLWISF
SLYISVLSSLLWWIRDYFSSWILVYVWISIAIYSYKKLKVINKNI
>FCMOIPGL_02437 hypothetical protein
MDKKYQNTVLYLIINLLIALPILSFTDLNYNYISVVSIINLMLSIFF
>FCMOIPGL_02438 General stress protein A
MNIVLATDDNFVQHCSVTIVSVAKNNPNVTFYILTEGLNSENQILLNNLGVILNIIKINR
NVLNKFPMPDDDKLSHISLATYYRLLISSLLPIDVHKIIYLDCDIVVRKNIYELWNEDIS
KFAMAAVFQIARENIESISRLGYSIENGYFNAGVLLINLDYWRNNNVESQLIDFISNYHS
RIVFHDQDTLNAVLHSKVKELSCRWNMLSSYFKLDVHKIINMKVNGNMKNISYNYSKEIL
SEILDPTIIHFVSRPKPWSRKCYHPYMYEYYVYLSKIKNKLCFPNSFDYFISRFIYIAIK
SRVFVLLVKKNNG
>FCMOIPGL_02439 Putative acetyltransferase
MFLKKIPFYQFIIALNKFIFMRFYLLFNLFKIRSFGPCMRVGKHPRLNNKLYLRIARNSS
VQIGDNFVLSSGDNLNPLSRNLRSSIATSNNAKIIIGNNVKASSPSIWSHKEIVIGNNVQ
LGADCIILDSDCHSLDFMDRRNSSIDNLNKLSKPIIIMDDVLIGAKTIILKGVKIGARSV
IGAGSVVVKDIPMDCIAAGNPCKVIKNIKKD
>FCMOIPGL_02440 Putative acetyltransferase
MVTLYNLARLLKRYKFSLLRLSKLNRVRFLYPNVNISSNCIISLQDLDQISIGSGSSIHD
YTYIVVCNDPNNTIRNSKLVIGENTYIGEFNNIRAAGGTIEIGDNCSISQHITMVASNHG
HDKGKLIRTQKWILKENYIIIGDDVWIGANVVILPGVTIGEGAIIAASSVVTKDVKKNSI
VAGNPAKLIKFRK
>FCMOIPGL_02441 Putative glycosyltransferase EpsH
MNDPIISVIVPVYNAKKYLECCLISIIRQSIHNIQIIIINDGSTDGSDVLCDKFKSIDSR
IEVIHKKNEGVGIARKIGVENATGKYVAFVDSDDFLVDNAFSILLQNNNNFTDVIIGDYN
LIDEKLSIKKISRSIDSKEEYIKKLLEWGSIETVLWAKLIKRDLFEKSTISFSNGLDFGE
DYAIMPRLFYFADNIVKIDKAVYNYRKGVEGSYTSSLDNKKIEDLIKANLLVSSFYEKVS
NYKFYYKSIGIGKLNIRKYLCLRDKKNFQFKGLQEFYQYYPKGDRVFFKLLDYGLINLAV
LYKKIYSRIK
>FCMOIPGL_02442 hypothetical protein
MKIGILTLPIHINYGGILQAYALMQVLKNMGHDPILIDEYKSFYLPIKKRPKEYSKRFIK
KYLLQNKDVNVFQERNRRRELLITGRNIKYFNDIYLQPKIPVKKLKELKDKDFDAFVVGS
DQIWRSKYYPRIEDAFFNFAKNWNVKRLSYAPSFGAGSWEYSDEQTKKCKKLLGKFDAIS
VREDIGVELVSKFLDNTATHVLDPTMLLSKSNYIEILKQRKSEVKAKDIFVYVLDPNEIT
DKVIDKLSDKYGYKPFFTSTDNQKVSIENRKASSVEDWLRSFYEAKYVVTDSFHATAFSI
IFNKPFVSYCNKERGAARFKSLLKEFNLEHRMVVDKKDLDNSELLNKEVDWDSVNNILEK
RIFQCKKFIEEGLNDE
>FCMOIPGL_02443 hypothetical protein
MEVCKSEVNELFEKVVDNGFCIGCGACALVNNSPIEIKFDEFSKLQATIKDDDNLNTESA
VLSVCPFSDESSNEDELGENLFRNVENIKHDEKIGYYKQSYAGYALDEGFRENGSSGGMG
TWIISELFKNNIVDGVIHVHEVDSNKTNEDNSKLFKYKISRTINEIQKGSKSRYYPIELS
EVLTLVKDTPGKYAVVGLPCFIKSIRLLMKQDEILKNRIKICVGLVCGHLKSANFAKMWG
WQVGIHPDNLKSVNFRHKLNGEGANNYAISATQNVNGIDKEYISKPLKEMYGSNWGWGLF
KYKACDFCDDVVAETADVTIGDAWLPQYINDDKGTNIVIVRNELIYKIIENGIKNNNLKL
DFLSSGDVIKSQSSGFNHRREGLSYRLALVDKTKQWRPIKRSFTKLKSISNKSKKIQKLR
IKIYEKSHVSFEKAIRKNSFLFFKDELDLLITRYNELYKPSFIEKLIKFVKIPFRPIIKI
IKKNRI
>FCMOIPGL_02444 hypothetical protein
MNSVKRVVKNTLFLYIKMLVTICIALFSTRLVLEALGVVDYGVYNLVGGVIALLAFLNSA
MTVSTQRYLSVNIGTGNSSKISQVFKTSIRLHLIIGIFIVILLELVGLFIFDGFLNIPSD
RLETAKIIYHLMVVSTFFTINAVPYDASINANEHLVFDSILGIIESFVKLVIAVYLITYE
KDRLLLYVILLTLLIILVRVIKSIYCFMKFEECSFRARGTGVSRVLFKEMFSFARWNMFG
SLAAIGRNQGIAVILNIFFGAAINASFAIANQVSAQLSSFSAMMLKAVNPQIMKKEGANA
RSSMLNLAMTSSKISFFLLAFFAIPLLFLMPDVLKLWLKDVPDGTVIFCNLILISTMINQ
LTIGLQSAFQAVGKIKLYQFTVGSLLILNLPISYLLLNYGLPAYSVFFSFISIDILAGCF
RVILSIKISGLLISEYLHKVLIPSLVSIVPTIALSSLVFCFIEKSFIFYILIFLSIIIFI
VSIIIFGLNKYEKYKIISLYSSIINKK
>FCMOIPGL_02445 UDP-glucose 6-dehydrogenase
MKITNICCIGAGYVGGPTMAVLAQKCPHIKVTVVDLNKQRIADWNDADLNKLPIYEPGLA
DVVAEARNRNLFFSTEVDTAIDEAQMIFISVNTPTKTFGIGKGMAADLKYIELCARQIAK
VSKDDKIIVEKSTLPVRTAEALKTILNFTGNGVKFQVLSNPEFLAEGTAVTDLHAPDRVL
IGGGEDAEGQEAIAALVEVYNNWVPLENILTTRVWSSELSKLTANAFLAQRVSSINAISA
LCEQTGADVDEVAKAIGMDSRIGSKFLKASVGFGGSCFQKDILNLVYICQHYNLQEAAEY
WLQVVKMNDYQEHRFANNIMKSLFNTVSSKKIAFLGWAFKKDTNDTRESAAIYVADELLQ
DRAEIHVYDPKVSAAQVYADLEYLQSNRIGEFVEKGAFLSSEEIRKLVTVHTEPYAALEN
AHAIAVLTEWDEFKTYDWQKIYDAMLKPAFVFDGRNVLDVSELEAIGFQVKSIGKG
>FCMOIPGL_02446 GDP-mannose 4,6-dehydratase
MKVALITGITGQDGSYLAELLLEKGYEVHGVKRRSSLFNTNRIDHLYQDPHDPNQRLKLH
YGDLTDSMNLTRIIQECQPDEIYNLGAMSHVAVSFDTPEYVGNVDGLGTLRILEAVRILG
LEKKTRIYQASTSELFGGMPENKNERGFYDENSPLYPRSPYGVAKIYGFWITKNYREAYN
MFACNGLLFNHESPRRGETFVTRKITRAVAKIALGLQEKVFLGNLEAKRDWGHAKDYVRM
MWMILQADVAEDWVIATGVTTTVRDFVRMAFSEVGIEVEFKGEGVDEKAYIKSINHEIYT
AATNIDQRTSNIDLVIGKEVLSVDPTYFRPTEVDLLIGDPTKAKEKLGWVPEHDLASLVK
DMMQGDVAIMKKDVDLLKAGHEILKQAE
>FCMOIPGL_02447 hypothetical protein
MSYKIYSFEKLDVYQAARKFKIDIKKMSSLFPKEERFDLISQMNRASASISANLAEGSGR
SSNFDQAHFTNISYASGLEIIDHLNTALDLHYIQKDEYEQTRIKLDGILSKLNALYKYQL
RNTNTLKKKLN
>FCMOIPGL_02448 GDP-L-fucose synthase
MDTNTKIYIAGHRGMVGSAVWRVLEKKGYTNLVGKTSKELDLKDQVAVVAFLEKEKPAVV
IDAAARVGGILANNDFPYQFLMENMQIQNNLIDSSLKAGIEKFIFLGSSCIYPKFAPQPL
KEEYLLTDSLEPTNEWYALAKITGVKACQAIRKQFNKDYVSLMPTNLYGHFDNFDLQTSH
VLPAMIRKFHEAKENNNSDVVLWGSGTPMREFLFVDDMAEAVVYALENELPEYLYNVGSG
KDITIKELAETIQKVTGHQGQIVWDAEKPDGTPRKLMDVSKMKDIGWQYSTELKEGIEQT
YAWFLENIENFKEVKM
>FCMOIPGL_02449 Glycerol-3-phosphate cytidylyltransferase
MKVGITFSAFDLFHAGHVKMLEDAKAECDYLICGLQTDPTLDRPEKNRPIQSVVERYIQL
KGCKYVDEIVPYATEQDLEDVLRSFKIDVRIVGDEYAHKPFTGREYCEQSGIELFYNKRE
HRFSSSGLRKEVQEKENANSKKSK
>FCMOIPGL_02450 D-beta-D-heptose 1-phosphate adenylyltransferase
MKRKAIIVSGYFNPIHKGHLEYFNNAKALADELFVIVNNDLQRGLKGSKEFQKEEERLFI
VQNIKAVDKAIISVDKDRTVRESIRTIFETYGEEFDLGFANGGDQDNNSIPEAPICKELN
IELIDGLGDKIQSSSWLLNKQ
>FCMOIPGL_02451 UDP-N-acetyl-2-amino-2-deoxy-D-glucuronate oxidase
MKNFALIGAAGYIAPRHLKAIKDTNNTLIAALDKFDSVGIMDSYFPKADFFVEFERFDRH
IEKLRRNGTQLDYVSICTPNYLHDAHIRMALRSGADAICEKPLVLNPWNVDALMDIEKES
GKKIHTILQLRLHPSIIALKKKIEADTSHTKYDVDLTYITSRGKWYDISWKGDLSKSGGI
ATNIGIHFFDMLAWLFGDIQENKVHLREKDKSAGYLEFEKARVRWFLSIDENSLPVRIQE
LGQRTFRSITINGEELEFSTGFTELHTKSYLQILKGEGFGLVDAKESIKIAQNIRNNTII
TKGEKHPFCS
>FCMOIPGL_02452 hypothetical protein
MECKLEVWKLAHQLTLEVYVVSKKFPSSELYGLTSQVRRSSSSVPTNIIEGQGRQYKKEF
IQFLYIAKGSLEEANYQLFLARDLSYISNEEYNELNTLCTRIKMMLYKLIKSLK
>FCMOIPGL_02453 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MSTVKIAIIGLGYVGLPLARLFATKYAVVGFDINIHRVADLKKGIDATQEVANELLQEVI
SDTYSKEKGLFITADPTYLKDCNYYIVTVPTSVDKNNQPVLKPLLSASKTIATYLKKEDI
VIYESTVYPGATEEDCIPVLEKESGLVFNKDFFVGYSPERISPGDKIRTVENILKVTSGS
TDETAKKVDALYQSVIKAGTHLAPSIKVAEASKIIENCQRDINIAFVNELAKIFSLMNIN
TNEVLEAAATKWNFLPFKPGLVGGHCIGVDPFYLAQKAQQFGYYPEIILSGRRLNDSMGA
HIASEVVKLMIDKEVKVKGANVLILGITFKENCPDIRNTKVIDLYRSLKSYGVQVDIYDS
WAKKEEVKAEYEIDLIEDMYAKKYEAVVLAVAHKDFKDIDVVRLKKEAAVVYDIKNFLAI
KDKSL
>FCMOIPGL_02454 hypothetical protein
MVKVKTTERPNPQDRLADNKFYAQAIATGTTDLERLAYLVSHQSTVREADCYAVLISLMH
NVIDELEQGKIVKLDKLGAFQIGVRSEGVATPEEVTVNLVKKSHINFRPDKLLRKMLQNV
EFTHSSL
>FCMOIPGL_02455 hypothetical protein
MKLFLISILLCISVAVFSQNQQNTKNHFQTAGYVIKTSFNTIPSDFAFLGKEFSDDWKKT
GYYAAGILGLFATDKITTKAYHKHIEPNIDYSLPTITPNFLRSSKNVWINGENSYLTYPI
IGIYVGSLFANQEKGQFAAINSLKAIAYSTIITQFTLKTIFGRNRPNRPLGTEPANKPFT
NNNWDFFNGRDEYLYGSARGTSLPSMHATGYFAIAKVIQMEFDNYWIPYSIMGITFLSDI
KSHEHWVSDMVVGGLLGTLIGRSIVRSSWKARGIIDRSKQGRISFNYTPRFSSEFTGIQI
VGTF
>FCMOIPGL_02456 Glutamate synthase [NADPH] small chain
MGKVTGFKEFERQDETYTSVKDRVKDYKEFTVPLSEKEITKQGSRCMDCGIPFCHSGCPL
GNLIPDFNHMVHQGEWQKASWLLHSTNNFPEFTGRLCPAPCEKSCVLGIIEDPVSIENIE
KNIVERAFKEGWIKPQPPKNRTGKTIAVVGSGPAGLAAAQQLNRAGHTVTVFERDDEVGG
LLRYGIPNFKMEKGIIDRRVAILKAEGIVFKTNINVGVNYDVKELKAFDSIVLCGGATER
RSLPTPGIDADGVVQAMDFLTQQTKVVFGKEVKDQVLATDKDVIVIGGGDTGSDCIGTSN
RHGAKSVVNFEIMPKPPGHRSPTTPWPFWPLQLKTSSSHKEGVERNWLINTKEFVKDENG
KLTALKTVNVEWKMVPGERPQLIEIAGTEKTWPCNLALLALGFTGPESNLADKLGIKTDA
RSNYKADYGKYQTNVKNIFTAGDMRRGQSLIVWAISEGREAARQVDLYLMGKSELPTKDV
TGDLVAM
>FCMOIPGL_02457 Ferredoxin-dependent glutamate synthase 1
MEKQGLYLPEFEHENCGAGFICNLNGEKTNQIIHDALEILVKLEHRGGVSADGKTGDGAG
ILIDIPHDYFKRVCDFPIPEQREYAVGMVFLPKVSNQYDYCKKTFENEIKEQGLAVLGWR
EVPVDSYQLGEIALASEPNIEQLFIGKTSEISEATFKAKLYAARKIAEHTIRKSKISESM
YFYVPSLSITTIIYKGIIMPEDIGPYYKDLQEIDLVTRLALVHQRFSTNTMPTWELAQPF
RHMCQNGEINTLRGNVSRMRVREEIMKSDVFGPQIDKLFPIILPGKSDSASMDMVVELLT
HTGRSLPEIMMMMIPEAWEKHKTMSASRKAFYEYNGCIMEPWDGPASVPFTDGDYIGALL
DRNGLRPSRYTVTKSGKLIMSSEIGVVDIDPADIKEHGRLEPGKMFLVDMNKGRIIEDEE
IKSKIVSERPYQEWLSKSRLHLKDVPYTGETCPIETIDVKTRQRLFNYTFEDIQEVITPM
AIVGKEALGSMGIDTPLAVLSDRPQLISNYFKQLFAQVTNPPLDGIREEIVTDISLNLGK
DRNIFSITDRQCRKLRIQNPVISNADLEKIRSIDIESFKAETIQILYPKAKGLNGLEDAL
DAIVLQVEKALEQKNNIIILSDRGVNQELAPIPALLACSFVNHQLNRLRKRSHFDIIIES
AEPREPHHFATLFGYGASAVNPYMVNEIIRMQVKEGFITGMDEQGAVDNFNKAIGKGILK
VMNKIGISTLHSYRGSQIFEIVGFNSQFVEKYFPYTASRIEGIGLYEIEKEIDQRYKQAY
PDKHIDQNLALNIGGDYRWRRNAERHLFNPTTVAKLQQAVRLSDQASYDVYSKAINEQSE
SLMTIRGLFQFDNLDPIPIEEVEPWTDIVKRFKTGAMSYGSISREAHENLAIAMNRIGGK
SNSGEGGEDRKRFQKDINGDSRNSAIKQVASGRFGVTSHYLTNAQEIQIKMAQGAKPGEG
GQLPGAKVLPWIASARNSTPFVGLISPPPHHDIYSIEDLAQLIFDLKNANREARINVKLV
SEVGVGTIAAGVAKAKADVVLIAGYDGGTGASPLTSLKHAGLPWELGLAEAQQTLVLNNL
RSRIVVECDGQLKTGRDVAIAALLGAEEFGFATAPLVASGCIMMRKCHLNTCPVGIATQD
KELRKNFKGTPEHVINFFYYIAEELRQIMAQLGFRTLAEMVGQTHKINANHAIKHYKAKG
LDLSSILHRPTAYKSMTVKNTEKQDHNLENVIDFTILKDSHRALYRKEKMNLVYPIKNTN
RTVGAIVSNEISKIYGHLGLPEDTLNINFTGSAGQSFGAFGAHGLTFTLEGNTNDYLGKG
LSGAKLIIKKPAKADFLAENNIIVGNVCMFGAVAGQAYINGIAGERFAVRNSGATAVVEG
VGDHCCEYMTGGKVVVLGKTGRNFAAGMSGGIAYVYDPDNKFVNGLCNTETIEFEPISDE
VAAELKSTIQKHVLYTDSKKGAALLADWDASLKNFVKVMPTEYKKALKRLETEEPMFEEL
TIA
>FCMOIPGL_02458 Ammonia channel
MELLTINNVWMMICTALVFFMHLGFAFLEIGLTRQKNTLNILFKNIFIITIGLLLYCLVG
FNLMYPGFGEGSSGFFGFAGFGLSSPLTDTGALDLAYNEGYTYWTDFLFQGMFAATAATI
VSGAVAERMKILPFMIFAIVYVGFVYPIAGSWKWGGGFLDQLSTPFYDFAGSTLVHSVGG
WAAVVAVCLLGARIGKFKDGKPQAIPGHNIPLATAGVLILWLGWFGFNGGSVLSADPTLT
SLTLVTTCLAAAAGGVLAALVSTIMYKNLDLTMFLNGILGGLVGITAGADQMSPTDAILI
GGIAGTLIVFAISLVDKLKLDDPVGAIAVHLICGIWGTLAVGIFGNLASVDQFISQLIGV
GSYAIFCVTTSFIIIFTLKKTMGIRVDEKEELEGLDAHEHGMDAYPDFRLNEH
>FCMOIPGL_02459 Nitrogen regulatory protein P-II
MKKIEAIIRKSKFRAVKDALHSIGVNFFSYWDVTGIGNEKEGHVYRGVSYSTSDIQRRHL
AIVVNDDYEEITVKTIIDAASTGEVGDGKIFVSDVNEAYRIRTGEKGGATLN
>FCMOIPGL_02460 Ammonium transporter NrgA
MSLFLTLLQDTPTEEVAKAVEQINADMGMLWMLIAGILVFLMQAGFTLVESGMTRSKNAV
NIAMKNLLDICVGSLTFWLVGYSLMYGDTSNGWFFWSGLFQGEGADLFFQTMFAATTATI
VSGAIAGRTKYSTYIIFSIVMTAVIYPISGGWQWQGSGWLTEMGFIDFAGSSIVHSVGGW
AALVAAFMVGPRIGKFVDGKVLPIAGHNQILATLGVFILWFGWFGFNGGSQLAWGGADST
AASNVVLITNLSAAAGGLGALITTWIWYGKPNLSQTLNGCLAGLVSITAGCGNMTAGGAV
LAGLIGGILVVFAIEFIEKKLKIDDAIGAASVHGVAGAWGTLVIGLWGVDGDTAIGLFNG
GGASQLGVQATGVLAYAAWAVGLSFIVLGILKATMGLRVTKEVEIEGLDISEHGSIAYPG
VRQRELEDK
>FCMOIPGL_02461 hypothetical protein
MKKIILTLLVASSLVINAQEKEDAGTFTLSGTVDVYGTTNFTKDAGTPGILIAAPENANA
FGLGFANTVFAYEKGKAGVVADIAFGPRADDANMAGAINQLYAYYNVSDKLTLTAGQFNT
FLGYEVINPSANFNYTVSYLFNAGPFSHTGIKADYAVSDDLSFMLALTNAHGIASDDGNF
TDDTQFGAQIGYKGQYLNFITGAVSAGGATDWMFLDYTGGFDLSDTFFLGINAAYADSSD
EDAGYSGVALYLQNTFSDKFALGLRPELFTSTTAGVDSSVTAFTLTSNMNLTSNLKLITD
LRFDSSDDYIIEAFPAEKSTSTLTIAAVYSF
>FCMOIPGL_02462 tRNA pseudouridine synthase A
MKYAHSYLVKIQFLGFRFSGWQKQKNAKTLHQMVDKTLSFVFEDVNYKTIGIGRTDAKVS
ANSYYVQLFTDSLINEPFFMNSINSNFSADFKAISITKVATNFNIIKASKLKEYHYYFSF
GDKNHPFAAPFITNIDKNLHIDTMTKGAKLFEGEHYFHKYCTKPSDTTIFKRCIDSCEIV
ENDILTANFFPKKSYILKVKGKGFLRYQIRLMMATLFELGKGNLDLDFITSSLKEDNDRK
SLRNIAPASSLQLYDIELEF
>FCMOIPGL_02463 Acyl-CoA dehydrogenase
MDFNLTEEHIMIRDAARDFAQTELLPGVIERDNKQEFPQELVKKMGDLGFMGIMVDPKYG
GSGMDAISYILIMEELSKIDASASVMVSVNNSLVCYGLEAYANEEQKQKYLTKLATGEFM
GAFCLSEPEAGSDATSQATTAIDKGDYYLMNGTKNWITNGGRSDVYLVIAQTDREKGHRG
INAFIVEKGTPGFHIGPKEDKLGIRGSDTHTLQFNDVKVPKENRIGEDGFGFKFAMKTLS
GGRIGIAAQALGIAAGAYELALKYAKERKAFGTEICNHQAIAFKLADMHTEIEAARMMVM
KAAWDKDQGNNYDMSSAMAKLYASKVAMEHTVEAVQIHGGNGFVKEYHVERLMRDAKITQ
IYEGTSEIQKIVISRGIIKG
>FCMOIPGL_02464 Anhydro-N-acetylmuramic acid kinase
MNKKEVFSIGLMSGTSLDGIDLVYVKFDANNYKDFEIIYAETISYTDVWKNTLQKAIHFS
SDELAILNNDYGKLLGNVVHRFIDKFQIQKIDFIASHGHTILHQPAKGITLQIGDGQTIA
AITNQKVVCDFRTQDVKLGGQGAPLVPIGDELLFSDFDFCLNLGGFSNISFKKEDKRIAF
DICPVNIVLNFYANKLGLEYDTSGKIASEGKLNETLLKQLNALTFYQQKPPKSLGLEWVQ
ENIFPLIDELETDVSSILRTFVEHVAIQISNIIIGNNSVLITGGGVFNSFLIERIADHSN
IKIKLPNTKLINFKEALIFAFLGLLKTDNQVNCLSSVTGASIDHSSGEFFYPILVNK
>FCMOIPGL_02465 NAD-specific glutamate dehydrogenase
MKELLKIYENKQPEIVFNWKDPETEAEGWTVINSLRGGAAGGGTRMREGLDMNEVLSLAK
TMEVKFTVSGPAIGGAKSGINFNPQDPRKKGVLERWYKAVAPLLKSYYGTGGDLNVDEIH
EVIPITEESGVWHPQEGVFNGHFKPTEADKINRIGQLRHGVIKVIESKYYSPDISAKLTI
ADMITGFGVAEAAHHYYDIYGGTVVGKRAIVQGFGNVGSAAAYYLAQMGAKIVGIIDREG
GVINENGFSFDEIKELFLNKKGNTLVAQDMISFKEINEQIWNLPCEIFAPCAASRLIKQE
QINEMINSGLEVISCGANVPFADKEIFFGSIMEDTDKKVSLIPDFISNCGMARVFAYFME
RKVEITDKAIFEDTSNTIKKALQTTFAKSASKTKISETAFEIALKQLI
>FCMOIPGL_02466 Na(+)/H(+) antiporter NhaD
MESVIIIVFVMGYLAITLEHNLKLDKLIPALIMMAVCWALVALGIDNFTQWFDSSKHSLI
EGFGSLVHEDKLHLVEETLLHHLGKTAEILVFLLGAMTIVEIIDYFDGFSTIKSFVKTKK
KKSILWIFAILAFVLSAIIDNLTATIVLISILQKIVKNRDERIWFAGLIIIAANAGGAWS
PIGDVTTTMLWIGKKVTTLKLIEYLLLPSLLCMAVPTLIASFLPAFKGEIDAEEEKETSK
SPHSARMLYLGLGAIVFVPIFKTITHLPPYVGMMLSLAVVATFAEIYSKSKFSISSVDGE
EADEHTAGAHHSPVHASLSKIEMPSILFFLGILMAVAALESLGILFNFASTLQESIPMMG
TELHHEGVSDLVIMLLGVGSAIIDNVPLVAASLGMFSQGLDNELWHFVAFSAGTGGSMLI
IGSAAGVVAMGMEKIDFFWYLKKISWLALIGFIVGSATFMITRTMF
>FCMOIPGL_02467 hypothetical protein
MISFYQENTGLLEEVVSEEKTLSIYNLIVDGGLGGQIIIAILFVLLAVAFYIYFERFFAI
KSASKVDKNFMNQIKDFVSNGKLDAAKALCKNTNTPTARLIEKGISRIGKPLDDINTAIE
TAGKLEVYQLEKNVSVLATIAGAAPMIGFLGTVIGMIVAIHEIANAGGQIDIKMLSDGLY
TAMTTTVAGLIVGIIAYVTYNHLVVKTNKIVYQMEAKSVEFLDLLNEPV
>FCMOIPGL_02468 hypothetical protein
MNLRGRNKVDPTFNMSSMTDIVFLLLIFFMLTSTLVTVSAIDVFLPKAGGKTENSASVAV
TITSESVFYIDKTAVSASNLESEILKSVGADKKKTIVIRGDKEVPYKKVMEVIDIANKNK
LKMILAVKGK
>FCMOIPGL_02469 hypothetical protein
MAILDTNPKRKSTAITASILLLLLFVIFNYGLKYLDPPEEYGLAINFGDSDFGSGEPVEN
TKKALTPEVVEKEEVIEEVIEVPKEVVKEEIIADETSEEITVIEKKEVEKEPVKEVVKKE
EPKEKPKPKPSKEATEALNSLLNGNSSDGNPKGEGDDKKEGVKGNENGDPNSNKYYGNEG
TGSGGNYNLAGRKALSKPIEQPDCQEEGIVVVRITVDKNGKVISAVPGVKGSTNTAACLL
KPAKEAALKTTWNADEKAPANQVGTIIYKFTLTK
>FCMOIPGL_02470 Dihydrofolate synthase/folylpolyglutamate synthase
MTYQQTLDWMFAQLPMFQREGKTAFKKDLTNILAFSKQLDFPEKKFKSIHIAGTNGKGST
SHMLASILQEAGYKVGLYTSPHLKNFTERIRINGIEIPKNKVTSFIAKHKVFLENQKLSF
FEMTVGLAFDYFANEKVDIAIIEVGLGGRLDSTNIITPVVSVITNIGLDHTQFLGETLPE
IAFEKAGIIKNNIPVIIGEEQSEVKSVFLEKAKKCNAAISFASDDLQEYTSDLLGDYQKS
NTKTVVAALKQLKGFSISQKNITDGLLHVVKNTSLKGRWQILQENPKVICDTAHNTEGLK
IVLNQLKKESYKRLHFVLGVVSDKKLEDVLPIFPQDAIYYFSKPAIPRGLSEAILQEKSA
KFNLFGKKYLSVRKAYKEALLNANQGDIIYVGGSTFVVAEII
>FCMOIPGL_02472 hypothetical protein
MSTLIDIAKLLLPEVLVENFKLTKHAVKQGELHFYFTELNIIPEEFKDLKLSSKGFFPEA
TIQDFPIRGKNVFLHVIRRRWIEETSKKLTTRDWQLVAKGTRITSEFADFFKRH
>FCMOIPGL_02473 hypothetical protein
MLFPENIGEYLSIDETAFSNGDLYTIVTNKKAKGKKGALIT
>FCMOIPGL_02474 hypothetical protein
MISNSKIIEIFCSLDDFMKEFNSILLKNSISDGSPTKKRNRKFKMSDSKVMTILVMFHLK
SYRNLKHFYLNHICKYRQDIFPDCVSYNRFVELQKKITQPLAVFMKMYCLGDCTGVSFID
STPLKVCHYKREKQHQVFKRYC
>FCMOIPGL_02475 hypothetical protein
MGWYFGFKLHLVCNDKGEIIDFMFTPANVDNRFPLKEKKFHDKLFGKIFGDKGYIGKDLF
ERLFVDGIHLITKVRKNMKKKAMDFMDKVILRKRAIIESVNDALKNTCQIEHSRHRSFDN
YITNMISGLIAYSF
>FCMOIPGL_02476 hypothetical protein
MLLLSSNSRLIAMIRGTKADTVVKTLLKILIKYRKKVEEEVTLDMAGNMGLIVKKSFPQA
VQVIDRFHVQKLASEALQEIRIKHRWQAIDAENDAIENARNKNLKYSPELLSNGDTLKQL
LARSRYLLYKKSSKWTENQQQRAIILFEKYPDRQKAYKLCQNLSWIFNNTKDKTSALIRL
AKWNEKVRQADFKSFRTIARTMSIHYQNILNYFDNRSTNASAESFNAKIKAFRAQFREVK
NIEFFLFILSNIYA
>FCMOIPGL_02482 Threonine--tRNA ligase
MIKITLPDGSIKEFAVNSTPMDVAKSISEGFARNVISANFNDITVETTTPLTTDGSLILY
TFNDNGGKKAFWHSSAHVLAEAILSFYPKAKLTIGPAIENGFYYDIDLGEDVISDKDFPA
IEKKFLEIARGKHEFSLRSVSKEDALSFYKGENNEYKVELIENLTDGEITFCDHSNFTDL
CRGGHIPNTGIIKAVKIMNVAGAYWRGDENNNQLTRVYGITFPKQKMLTEYLELLEEAKK
RDHRKLGKELELFTFSSKVGAGLPLWLPKGAALRERLENFLKKAQKKAGYEMVITPHIGQ
KELYVTSGHYAKYGEDSFQPIKTPKMDEEFLLKPMNCPHHCEVYNFKPHSYKDLPKRFAE
FGTVYRYEQSGELHGLTRVRGFTQDDAHIFCTPEQLDQEFKDVIDLVLYVFGSLGFEDFT
AQVSVRDKSNPDKYIGDADTWEIAENAIISAATDKGLDFVIEEGEAAFYGPKLDFMVKDA
LGRSWQLGTIQVDYNLPKRFDLTYKGADNQLHRPVMIHRAPFGSMERFIAVLLEHTGGNF
PLWLIPDQVILLPISDKYQKYSEKVLESLENSEIRALVDDRNEKTGRKIRDAEISKIPYM
LIVGEKEEEDGTVSVRKHGEGDLGTFTIEEFVSLVKKEIESTLVKF
>FCMOIPGL_02483 Translation initiation factor IF-3
MGDNVEVGVYPLAKAKDLAKEQELDLVEISPKAKPPVCKIIDYKKFLYEQKKREKVLKSK
ATKVTIKEIRFGPQTDEHDYEFKKKHALKFLQEGAKLKAFVFFKGRSIIFKEQGQILLLK
LAQELEEYGKVEQLPKLEGKRMIMFIAPKKLK
>FCMOIPGL_02484 50S ribosomal protein L35
MPKMKTKSSAKKRFKVTGSGKIKRKHAFKSHILTKKSKKRKLKLTHDTLVHKSDVANIKQ
QLTL
>FCMOIPGL_02485 50S ribosomal protein L20
MPRSVNSVASRKRRKKILKAAKGYFGRRKNVYTVAKNAVEKGMLYAYRDRKNNKRNFRSL
WIVRINAAARLHGMSYSQFMGKVKANQIELNRKVLADLAVNNPDAFKAVVEKIK
>FCMOIPGL_02486 hypothetical protein
MRSKLLLFLFLTISFIAFAQETTEEDNSIKGQFDKIYRISTTYQTYKVIDRDKYQNLKSN
VLDSLKSSKELISEKENLLKTERDNVEQLNASLKKTKLELDNALQKENSVSLFGMHLNKI
TYNLILWTIIILLALGLGFFVFKFSKSNILTNEAQNNLQDVEQEFDSHRKKSLEREQKLR
RQLQDEINKHRNV
>FCMOIPGL_02487 Alpha-maltose-1-phosphate synthase
MKTLFYTREFPPYVYGGAGVHVEYLAEELSKLMNVEVRCFGDQDSKDRTLTVKGFPYDNP
VFENADDKLKAVLQTLSTGLHMNADVIDADIVHCHTWYAHFAGIIAKLCYGVPLVITTHS
LEPLRPWKREQLGRGYDASSWIEKTAIEMADALIAVSEETKEDVLKYFNVDEKKVKVIYN
GINLQEYITTTETDTLQTYNVDKTKPYVLFVGRITRQKGIIHLVNAIKYIDPETQIVLCA
GAPDTKEIGKEMEDAVNEVKKTRKDVIWIDKMVTKKEIIQLYSHADVFCCPSIYEPFGII
NIEAMACDTAVVASAVGGIKEVVVHGETGLLIPVEQQISAPFEPVDPDKFARDLADGVNK
LIKNPELRKSMATKGRKRVEDYFDWISIAKQVEELYKTLKK
>FCMOIPGL_02488 Glucose-1-phosphate adenylyltransferase
MINNKVLGIILGGGQGSRLYPLTKDRSKPAVPIAGKYRLVDIPISNCINSDIKRMYVLTQ
FNSASLNAHIKNTYHFSFFSSAFVDVLAAEQTINSDKWFQGTADAVRQSMHHFLENDFEY
ALILSGDQLYQMDFNDMIKKHEESGAEISIATYPVDAKDATEFGLLKTNDENIITSFIEK
PAPELLPDWTSDVGDQMKSQGRNYLASMGIYIFNRKLLVDLMSNPDTNDFGKEIIPQAIN
THKTLSYQYEGYWTDIGNIDSFFEANLGLTDDVPQFNLYDNDKHVYTRPRILPTSKIAGS
ILNKAVIGDGCIIHAEKIERSVIGIRSRIGKNSLISNTYMMGNDSYESLDEVAKNHIDIM
MGIGDRCYIHNCIVDKNCRIGDDVRINGGQHIENTETDTYFVKDGIVVIKKDATILKGTN
IG
>FCMOIPGL_02489 Alpha-1,4-glucan:maltose-1-phosphate maltosyltransferase 1
MQNQSRIVIENIAPQLNQGTVFIKRVVNEIVNVTADVLVDGHDVLQANLLYKHESEKKWT
DTRMQATSNDQYIAHFITEKQGFYSYKVEGWVDYALNWQHGIERKIDDYQHVNSELLEGA
ELLFAIIDDVNANDKEYLLYLIFIFKNSDTYAEAIKEAVSKRLTIILKNNPKKTLIQTSP
EYKVYVDRIKARFSTWYEFFPRSASEQEGKHGTFNDCHRLLPRVAQMGFDTLYFPPIHPI
GEVNRKGKNNTTVAQDGDVGSTWGIGSKYGGHKDIHPELGSLDDFKHLVAKAKELGIEVA
MDYALQAAPDHPWVTEHPDWFKWRPDGTVQYAENPPKKYQDILPIYWESKDYKNLWKECL
DTLFYWIDCGINVFRVDNPHTKPYYFWGWIITEVKKKHPDVLFLAEAFTRPKIMHQLAKQ
GYTQSYTYFTWRDSKHELIEYMNELTQTDQKEYMRPNFWPNTPDINPYHLQGAPEAKYLQ
RYALAATLSSNIGIYGPVFEQMIDTPIAGKEEYYMSEKFQLCHYDWFKENKVTTLISVIN
NIRKENESYQQTNNIKFLETGNDQLIAFYKWNQDRTNETLTVISLDAYNAQTGSVQLPLQ
DLGIPHGHKVEVVDLVTRNSYNWYNERNYVQLHATLPFHIFKINK
>FCMOIPGL_02490 Maltokinase
MIQETITISESTIFSSSNNWEEIIADKDFVAVFLSDVLEEYIQKQRWFGGKSSQLKYIEL
SEYFKIQQDGEIYFGLILEVNFVEAFYHHYFLPIAFVADESISKENRILPIKLKNTTGYI
VDAMHIEGFRKVAYERISSALPVDKTPVQYHKTEGFNFPTYKSSRLMGVEQSNTSIIYND
AFILKFFRRIYTDKNPDYEMSRFLSNTKEFKHTPLYLGSINIIDSDNINVTIGLMQKLVP
NNGDAWEYFLKEIHKIYQTIDSKNISYKNLPDVEMFKRVKISEVPPQIIDWIGLNLLSKV
KKLAQRTAEMHIALGSEFADTSFTPTRFNGDYTVWLKNRLTYQFQNRLHLAENNLHKLEG
DSLQLAKEFLERKNEIRKRLVNFDWTKLKGERIRIHGDYHLGQVLVQDDDFCILDFEGEP
ESTIRDRKVKQPPLKDVAGLFRSFHYAIYSTIFNHQNEYKKTQEELFKYGELLYKYMVSI
FLDTYIETTKNANLHIGYRNERIFLLKYCLLEKAIYELGYELNSRPKWTIIPLKGIANIL
NS
>FCMOIPGL_02491 1,4-alpha-glucan branching enzyme GlgB
MTKTKVHSLFTEFDINLFKAGKHYRLYEKFGSHLITLDGEEGTYFAVWAPSAKSVSVTGD
FNFWLEGEHHLNVRWDGSGIWEGFIPGVKKGSIYKYKIQNSNNDVITEKADPFARRCEHP
PKTASVVWEDDYAWKDKKWMKERKKNNALDAPFSVYEVHLGSWKKQIEENRFLSYVELAD
ELVNYVADMNFTHVEFMPIMEYPYDPSWGYQLTGYFAPTSRFGYPDEFKFLVDKFHEKGI
GVLLDWVPSHFPSDDHGLGYFDGSHLYEHPDRRKGYHQDWKSLIFNYGRNEIKAFLISNA
IFWLDQYHADGLRVDAVASMLFLDYSREEGEWEPNMFGGREYLEAIDFIKEMNTAVYEAF
PDVQTIAEESTSFPKVSRPIYDGGLGFGMKWMMGWMHDTLDYFAKEPIYRKHHQNDLTFS
LNYAFTENFMLPLSHDEVVYGKKSILEKMPGDEWQKFANLRLMYSLMYTHPGTKLLFQGG
EFGQTSEWNFNGSLDWHLLQYDVHKGAQALVRDLNRLYKKEPALHQKQFTHEGFEWIDHG
DHQNSVLSYLRKGNNENDNVIIILNLTPVPRENYRIGLPKAGTLKEVFNSDNSKYNGTGS
FNNKNLNSEVKEWNNRKNSLELNLPPLGMLAFKFK
>FCMOIPGL_02492 Oligosaccharide 4-alpha-D-glucosyltransferase
MIVNTELEQKGNLFPSKIINYKKDVDTLSFTTENNVVLQVTVVRDSVIRFRYSTTGKFEK
DFSYGVTIHASRGYNFLTVTEDTTHYIITTSKLICKIEKLSLQVSLFDAIDLKLINEDEI
GFHWEESYEYGGDIVKMSKICQKSESYYGLGDKPVNVNLKGKRFENWATDSYAFGKNTDP
IYKAIPFYTSIQDNKSYGIFFDNTFKSHFDFANERRNVTSFWAQGGEMNYYFIYGPQMEE
VVKNYTDLTGKPHALPPLWALGFHQCKWSYYPEANVKEVTKTFRDLKIPCDAIYLDIDYM
DGFRCFTWDKNYFPDPKRMVKELEEDGFKTVVIIDPGIKIDLEYDVFKEALDKDYFCKRA
DGPYMKGKVWPGECYFPDYTKPEVREWWSGLFQELIEDIGVKGVWNDMNEPAVMDVPNKS
FPDDVRHDYDGNPCSHRKAHNIYGTQMARATYHGLKKYSYPKRPFVITRSAYSGAQRYTS
TWMGDNVATWEHLAIANYQAQRMAMSGFSFAGSDIGGFAEQPQGELFARWIQLGVFHAFC
RVHSSGDHGDQEPWVFGEEVTDIVRKFVELRYQLLPYLYTAFWKYINEGTPILKSLVLYD
QEDTATHYRSDEFVYGEQILVCPIQEPNAKGRRMYIPRGKWYNFWTNEVVDGGREMWVDA
DIDSMPIYIKEGAVIPKYPVQQYVGEKKFNEITLDVYYKEGKEVSKLYDDAHDGYDYKKG
RYSLRTFKVTGKKNEFILQQHKQGKFDADYKNFNIVLHNLPFTIASVQIDNVVVEVNKSN
TGEFQSITVDKEFTELHLLGK
>FCMOIPGL_02493 Peptide chain release factor 1
MLDKLRIVKQRYDEVSDLIIQPEIIMDQKRYAQLSKEYKDLGSVVKKGEEYQSLLSNIEE
AKEIIADGSDAEMTEMAKMEIEEANIRIPQLEEEIKFLLIPKDPEDSKNAVVELRAGTGG
DEASIFAGDLFRMYTKYCESKGWKVSTVDYSEGTNGGFKEIQFEVNGADVYGTLKFEAGV
HRVQRVPQTETQGRVHTSAATCMVFPEAEEFDVEINPKDVRIDFFCSSGPGGQSVNTTYS
AVRLTHIPTGLVAQCQDQKSQHKNKEKAFKVLRSRLYDMELAKKNAEDALKRGSMVSSGD
RSAKIRTYNYAQGRVTDHRIGLSLYDLPNILNGDIQKIIDELMLAENTEKLKTLSDGF
>FCMOIPGL_02494 hypothetical protein
MRLLLFSFCFFLMVSCNNKTEKLDKPLFLIGNWVRLNDKEGNQTYETWNTNLTGIGYTKQ
EQKTTFQEILSIVTIKDTLYLKVEDVNKTPTLFKFTEQTDTSFVCENPENEFPKKIKYYI
EDKQLKAIISADDFRIDFVFEKAK
>FCMOIPGL_02495 Phytochrome-like protein cph1
MKKNEFIEKEKKDFEQLEKDKIIERQLRFQDLLISISTKYINSDLSNTDSLVGKSLKQIG
EFVEADRSYIFSYDFMSNTTSNTYEWCAEGVEAEINNLQNLPLNFITHWLDAHKKGDPFY
VEDVSLLPKDGEFGLRAVLEPQGIKSLITIPMIKNKELIGFIGFDSVKKINKYSENEKDI
LFVFANMLVNVIQRKEHEELIKNQEEKKEELLYNLSIQNEELNEYAHAVSHDLKAPLVNI
HTLIDWFLEDNKEALDQNFSNLLQEILFDVEKMDFLIKGILDYSSIDKIESEDRLVDFNL
IVDEVLKDVLVPYNIKIKIQENLPSLYGNVWRFKQVFLNLIENAIKYNDKEIGTIEVGVT
EKNNHFEFYVKDNGVGINSDYFDQIFKVFTKLESSSSSSGIGLSIVKKIIKYYKGTIWIE
SKEGIGTTFYFTILKQ
>FCMOIPGL_02496 Vitamin B12-dependent ribonucleoside-diphosphate reductase
MKSHTVLTPKKIYSRDKALEAALKYFKGDELAASVWLNKYALKDSADNIYESTPDQMHQR
IASEIARIEKKYANPLTEEEIFEVIKNFKYIVPQGSPMAGIGNPFQIASLSNCFVIGNNG
ESDSYGGIMKIDQEQVQLMKRRGGVGHDLSHIRPKGSPVKNSALTSTGIVPFMERYSNST
REVAQDGRRGALMLSVSINHPDAEDFIDAKLEQGKVTGANVSVRIDDAFMKAVKDNLKYT
QKYPTFSKNPVYTKEVEATKIWNKIVHNAWKSAEPGILFWDTVINESVPDCYADLGYKTV
STNPCGEIPLCPYDSCRLLAINLFSYVENPFTKKAEFNFELFKKHIVIAQRMMDDIIDLE
LEKIDGILAKIDADPEEDDVKATERNLWLNIRQKAYEGRRTGIGITAEGDMLAALNIRYG
SEEGNTFSTKVHKVLGIETYRASVGLAKERGAFSIFDANREKDNPFILRIKEADSKLYYQ
MLEHGRRNIALLTIAPTGTTSLMTQTSSGIEPVFMPVYKRRKKVNPNDKGIRVDFVDEVG
DSWEEYVVFHHRFKQWMDVNGIDSTKNFSQEEIDDLVKKSPYYKATSNDIDWNSKVEMQG
AIQKWVDHSISVTVNLPNDATEELVGELYLKAWQVGCKGVTVYRDGSRSGVLISADEKKD
NKPTTSNFSKKRPQILEADVVRFQNQKEKWIAFVGLVDDRPYEIFTGLTDDEDGILIPRW
VEKGLIIKNRNEDGSSRYDFQYQNKRGYKTTIEGLSHKFNPEFWNYAKLISGTIRHGMPI
DKIVELIQSLQFDSESISTWKNGVQRALKRYVEDGTAVKGHTCGNCNSVNLIYQEGCLTC
KDCGSSKCG
>FCMOIPGL_02497 Phosphoribosylformylglycinamidine cyclo-ligase
MSQEVSKRYAQRGVSASKEDVHNAIKNIDKGLFPKAFCKIVPDYLTNDDDYCLIMHADGA
GTKSSLAYMYWKETGDISVWKGIAQDALIMNIDDLLCVGATDNIMLSSTIGRNKSKIPGE
VLSAIINGTEELIEDLKGFGVTIHSTGGETADVGDLVRTIIVDSTVTARMKRSEVIDNAN
IKVGDVIVGLESFGQASYETEYNGGMGSNGLTSARHDVFHKYLATKYPESFDAAVPEDLV
YSGNVKLTDKVENSPIDAGKLVLSPTRTYAPIIKKILSEFNSDKVHGMIHCSGGAQTKIL
HFVDNLHIVKDNMFPIPPLFKLIQEQSKTDWKEMYQVFNCGHRMEVYVSPEIAEDIIKIS
KSFNVDAKIVGRVESLAPDAHQSKKLTIKSEFGIFEY
>FCMOIPGL_02498 Glutamine synthetase
MSTVRFAALQETLNRDALKIVENEKRSALFGNNVFNKYAMQQYLTRAAYESVMNAIEKGT
KIDRKIADQVAVSMKDWAISKGATHYTHWFQPLTGATAEKHDAFFESINGGLAMEKFDGE
QLVQQEPDASSFPNGGIRNTFEARGYTAWDPTSPAFIYETTLCIPTIFVAYTGEALDNKT
PLLRALQAVDIHAAAVCKYFDKNASKVYATLGWEQEYFLIDDALALSRPDILLTGRTLLG
HSPAKGQQLDDHYFGSIPARAMSFMQDLEQECMLLGIPLKTRHNEVAPNQFELATIYEEV
NLAVDHNSLLMDVMQKLARRHRFKVLFHEKPFAGINGSAKHNNWSLSTADGINLLSPGKT
PMKNLQFLTFFINTIKAVYEYEELLRASIASESNDRRLGSSEAPSAIMSVFIGSQLSNVL
DELENVTKGKLSPQEKTDLKLNIIGKIPEILLDNTDRNRTSPFAFTGNKFEFRAVGSWVN
CAKPMTVLNTIVAKQLKEFKIEVDHLIDTKNLKKDEAVFNVLREYIKESKKIRFEGDSYG
EPWEKEAKKRGLSNNKTTPEALKVKISKKAIDLFEEMDVMNKVELEARFEIAIEEYTKRL
QIESRVLGDIARNHVVPTAIIYQNTLLENTKNLKEIFGEAYKNIAQEQIELIMTISNHIT
EINALSIKMVDERRKANKFTGIKSAEMYCNDVKPFFEQIRYNCDKLETMVDDNLWPLTKY
RELLFTI
>FCMOIPGL_02499 Glutamine synthetase 2
MLTSHIQLFTMAKIKLEYIWLDGYFPTQNMRSKTKVEEHDNFQGTIEELGMWSFDGSSTR
QASGGASDCLLKPVAIYPDPARINGYLVMTEVLNADGTPHVSNGRATIDDDDNDFWFGFE
QEYFIMDTKTQLPLGFPIGGYPAPQGMYYCSVGGKNTHGRLLVEKHADLCIDAGLNFEGI
NQEVASGQWEFQLFAKGAKKAGDEIWIARYLLDRLTEQYGYYIDYHPKPLGKDMDWNGSG
MHANFSNEVLRTCGSEEIYGKICEAFRPVVKEHIAVYGEFNDQRLTGLHETAAITDFSWG
VSDRGASIRIPIIAVEKGWKGWLEDRRPASNGDPYKIAGRIIKTVKSAKI
>FCMOIPGL_02500 hypothetical protein
MKKSFFLLLSIVVLYSCNTVKVVTDYDSKVDFVSYKTFAFYKPGIDKAEISDLDKKRVLR
AVESELLAKGFTKSESPDFLVSFFTKSRQKVNVNQNNNFGYGFGWGWSPWMYSGMNNNIN
VSQYTEGTLFIDFIDKEKKELVWQGVGTGALKIENREKKEARINEFVKEIISRFPPEENK
>FCMOIPGL_02501 Urocanate hydratase
MTFQEQIKQGIPAILPPKKAYDVAINHAPKRKDILSADEKKLALRNALRYFDERHHPELI
TEFLEELEKYGRIYMYRFRPTYKMYARDIAEYPGKSEQAKAIMLMIQNNLDYAVAQHPHE
LITYGGNGAVFQNWAQYLLTMQYLSEMTNKQTLTMYSGHPMGLFPSNKNAPRVVVTNGMV
IPNYSKPDDLEKMNALGVSQYGQMTAGSYMYIGPQGIVHGTTITVLNGFRKIKKQPKGSL
FVTSGLGGMSGAQPKAGTIAGCVTVCAEVNPKIAQVRLDQGWIDEKITDLDKLVAKVKSA
KENKETVSIAYLGNIVDVWEKFDVENIHIDLGSDQTSLHNPWAGGYYPVDISFEDANKMM
AENSKLFKEKVQETLRRHVKAINKHTAKGTYFFDYGNAFLLEASRAGAAIMAENNIDFKY
PSYVQDIMGPMCFDYGFGPFRWVCTSGKPEDLAKTDVIACKVLEKIKKNSPEEIQQQMTD
NIQWIKGAQENKLVVGSQARILYADAEGRIKIAKAFNKAIKKGKIGSIVLGRDHHDVSGT
DSPYRETSNIYDGSKFTADMAIHNVIGDSFRGATWVSIHNGGGVGWGEVINGGFGMLLDG
SKSASKRLESMLFWDVNNGISRRSWARSKQAVFAIKRAMKVKKDLQVTLPNVVDDALIDS
LT
>FCMOIPGL_02502 Fused isobutyryl-CoA mutase
MKQITPYKPQHKVRIVTAASLFDGHDASINIMRRIIQSTGVEVIHLGHDRSVEEVVNCAI
QEDVNAIAMTSYQGGHNEYFKYMYDLLQEKGTGHIKIFAGGGGVILPEEIKNLMGYGITR
IYSPDDGRELGLQGMINDLVKASLNPPHSAEKVCNEDGDWLLELGSEKVLENLKNKNVNT
IARLISLAENNHTDFNKIFNKDWNSSPSERLGGTPVLGITGTGGAGKSSLVDELVRRFLI
DFPEKTIGLISVDPSKRKTGGALLGDRIRMNSINDSRVYMRSLATRQSNLALSKHVNEAI
EVLKAAEFDLIILETSGIGQSDTEIIEHSDTSLYVMTPEFGAATQLEKIDMLDFADLVAI
NKFDKRGALDAVRDVKKQYMRNNNLWHINQDDLPVFGTIASQFNDPGMNTLYKSIMDKLV
EKTGTDLKSNMKITKEMSEKIFVIPPKRVRYLSEIADDNRDYNKKVEEQVKVAQKLYGIY
QTILSLGDNVWSSAVETSSLTKTGLDNDEILSLDCAREDKEFVKLLLAQFEKVKMNLNPY
NWEIILNWQEKVNKYKNPIYTFKVRDKEINIETHSESLSNIQIPKVALPKYKAWGDLLRW
NLQENVPGKFPYTAGLYPFKRTGEDPTRMFAGEGGPERTNRRFHYVSLGMDAKRLSTAFD
SVTLYGNDPGKRPDIYGKIGNAGVSICCLDDAKKLYSGFDLSHHMTSVSMTINGPAPMLL
GFFMNAAIDQNCEKYIKEHQLEGQVEATFTEVYDLKGLKRPKYQGELPEGNNGLGLLLLG
LTGDLVLPSDVYQQIKTDTLAQVRGTVQADILKEDQAQNTCIFSTEFALRLMGDVQEYFI
EKQVRNFYSVSISGYHIAEAGANPITQLALTLSNGFTYVEYYLSRGMDINKFGPNLSFFF
SNGIDPEYSVIGRVARKIWAKAMKNKYGANSRAQMLKYHIQTSGRSLHAQEIDFNDIRTT
LQALYAINDNCNSLHTNAYDEAITTPTEESVRRAMAIQLIINKELGLTKNENPIQGAFII
EELTDLVEAAVLEEFDRITERGGVLGAMETMYQRSKIQEESLYYETLKHNGDFPIIGVNT
FLSSKGSPTVQPAEIIRATDEEKLHQIKTKELLNKINPKKVEQQITILQEAAIQNENLFD
KLMEATKVCSLGQITDALFKVGGQYRRNM
>FCMOIPGL_02503 hypothetical protein
MNILGIGSRINHSEFGLGVVTNVTSKHYWVTFIKDGLETIDIDSDFEVIEAVEDEVDTIS
FYEVEKSLKTILQKWSDVTQISPIADRWKKGTLILRPADSNLADKEIPIDTFFHKIVMVR
DRIRVMEQKINASKTLVDQDKIDLQQYITRIYGSLTTFNVLFKVKSDHFVGERSK
>FCMOIPGL_02504 hypothetical protein
MDNQLLKKTFYRHLKLGKSALKKNNFKNAFYHFENTHILGQKHVVRHTVSHYWMLLFAIK
SKNRKEIIGQLFRIIASILFTLVWVPKGNTGGTNVSPIKKMPIRKELKKYF
>FCMOIPGL_02505 ECF RNA polymerase sigma factor SigM
MTTNQVWTTYSEDLKRFIISKVKDVTIADDILQDTFIKIHTKLHTLKDITKLKSWCFTVA
RNSILDYWKSTNKTFEIANFEAETEIIENSHTEKDCLRGILKHLPKLYRDPLFLSDIKGL
KQQEVADQLHQTLSTTKSQIQRARKLIAQGFMDCCGFTVNEEGNLVGEIQEKEDCKVCNY
N
>FCMOIPGL_02506 Carboxymethylenebutenolidase
MKTLKKEDISQEVFDLYDDYAHNKIDRKTFLKKLSLYAVGAITLPALLSFISPNYKDSIV
VKSNDPRLKSETISYDSPKGGLKMKGLLSILKNTTEKVPGIIVVHENRGLNPYIEDVNRR
VALEGFISLAPDALSPMGGYPGNDDDGRAMQKKRSQSEMLEDFIAGYNYLKSHKNCNGKV
AVVGFCFGGWISNMMAVRLPDLAGAVPYYGRQPEKEDAAKIKAPLLLQYADLDKRVNAGW
PEFEKVLKENNIEHEAYFYADVNHGFHNNTTPRYDETAADLSWERTLAFFNKHLKE
>FCMOIPGL_02507 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MKKKTLISKELDDFYNKASEETRLEKGMGIFEFERIKELIEPHISNPNSTIIDVGGGTGK
YSEWLAKKGHVVHLIEPVLKHIKLAEKRANKLKNPFSVAIGEAKTLPFKNETADLIILHG
PLYHLQKREDRVATILEAKRVLKKGGIILGFAINATASTVVGLMNGMIHANSFFDMCKAE
LTSGIHNAPKDFPFLLADAFYHKPAGLKAEFLEQNLHFINLFAVEGMIWLDNEYFANMLD
KRKSKTLKALQTLTQNDEYLLPFSPHMMIAVKK
>FCMOIPGL_02508 FAD-dependent urate hydroxylase
MENVTNKEKYWNVCSTCKGIGKKRKSVRKNIRLAYQKEFEFFEKSNGKIAAPIKPKGVLQ
ACANCKGTGLIQSNYKPIVNNEKYPHVAIIGGGIGGVALAVACLHRGIPFTLYERDINFD
ARSQGYGLTLQQASKAMASLGILSLDKGITSTRHVVHTTDGTIIGEWGIRKWGRSGKKAA
AKHTNIHIARQSLRLALLEQLGEHKSLKWGHQLLSFEESEEKNVSLKFQVKDKILNEKAD
IVIGADGIRSTVRKLLIGDEKNPLRYLDCIVILGICPLKNLTNIESPLLDSETVFQTANG
NERIYMMPYDADSIMWQLSFPLSEKEAKALNTLGAKALKAAACKRTQWHNPIPQIVAATK
ESQISGYPVYDRELLKPELLEKGTKVTLIGDAAHPMSPFKGQGANQALLDALSLARTITK
NYNSSSLFKDVGLIKKVLSDFESEMIKRSASKVKGSAEAAKLLHSEMVLKEGNGPRGKHR
K
>FCMOIPGL_02509 hypothetical protein
MKKQVAIIGGGPSAFLLAAFLDAKKFKITIYEKNKTCGRKFLVAGKGGFNLTHSESVEKL
IKRYTSDGFLDESLLNFTNTDFRNWLDLIGIPTFTGSSKRVYPKEGIKPIEVQNAILKHL
KEKGVIINYEQTFSDWDDATNPIINNTSIQTDYTVFSLGGGSWKITGSDGSWLDIFSEKG
IKTKPFQASNCGYQIDWKPEFIKQHEGTPLKNIAIYCNKVIQKGEAVITKFGLEGNAIYG
LSPQIREQLNTNGTATIFIDFKPSLTLENIHSKIKNTIYKNTTQILKKELKLSEAQINLL
KTYLSKESYLNTESLVKNIKKFPLEIINTAPIDEAISTVGGIDLTAISENFELKKIPNQF
CIGEMLNWDAPTGGYLLQACASMGVHLANHLNKTN
>FCMOIPGL_02510 hypothetical protein
MEGTKKHQLTDWLPTTNKEVKIRGWEELDVILFSGDAYVDHPSFGPAVIGRILESYGLKV
AIVPQPSVNDNLQDFEKLGKPRLFFGVTGGCMDPMVSNYTASKKRRDKDAYTPNGDKGFR
PDYATSVYSKILKEKFPDIPVLIGGIEASLRRVTHYDYWSDKLLPSILETSKADMLVYGM
GEQPLREIVELLQKGVPFSSLKNIKQTAVLIDEKKEKLPVVNDWEDVTINSHKACLADKK
TFASNFKVIEQESNKLKARRILQDINGKTLVINPPCPTMTETEIDASFDLPFTRLPHPKY
NKRGPIPAFEMIKFSINIHRGCFGGCSFCTISAHQGKFIASRSQESVLKEIDKVANMPDF
KGYLSDIGGPSANMYQMKGKVQSICDKCVAPSCISPVICSNLDTSHKPLTELYQAVDKHP
KIKKSFIGSGIRHDMLVPEFNKNADPKELDAYTEEVMTKHISGRLKVAPEHTSDPVLKLM
RKPSFKYFHMFKERFDRINIKKKLNLQLIPYFISSHPASEVEDMANLAAETKDMGFQLEQ
VQGFTPTPMTVATVIYYSGYHPYTLKPTKTPKTKKEREDQHKFFFWYKKENKDWIRNTLN
KVGRQDLLNVLLPENNSWKKNKQAKGTKNTFDDAVPFNRRKKKVSRAKSKKRR
>FCMOIPGL_02511 hypothetical protein
MLVCTFLCLSLNSQDLFKKGYIIDKSNKKTECLIKDLDWKNNPSEIEYKISGSENIFIGN
YDNINEFKVYNSSKYVFFEGDIEKSSLSLNLIGKERNPNFVTEKIFLKVLVDGKAMLYSY
TGSNLYKYFYQKENSGISQLIYKKFLIGNSQTDVGINNKYKQTLLNKLTCNTISEKDFLR
LDYTAKSLTNLFIKYNTCVNPSFINTISKKRKGKFNFYVKGGLTYSNLIANNKPNSNLNS
DYGYKLGYSLGSEFEYIFPFNNNKWSFLFEPTYNSYESDIILESSTFSGGTLDVKADYTS
IDLTFGPRYYFSLKNKESKLFANIFIVFSKPISSSLKATNRNDNLYNLEVKGLTPNAALG
FGYLLNDEYSFELRYRIDRNIMSDFLSWQANYGGLSLLFAYKIF
>FCMOIPGL_02512 Chondroitinase-B
MKKHYSKLKAFSFLILLLASSSLIAQTYNDADDLADAVNDATNGGTFIVANGSYNDFEVS
FEKVATEENPIIVKAETVGGVTLTGESAFRLKKSAFITIEGFVIDANGDNTLVKLEGCNN
IRISRNVFELATTESIKWVYIGGVWDDKTYPFTYPSHHNRIDHNIFQNKNTPGHYITVDG
STDESTDVAYQSQYDRIDHNYFKNNSPRAVNEQESIRVGWSEMSASSGFTTVEFNLFEEC
DGDPEIVSIKSSDNIIRHNTFLKSYGTLSLRHGNRNRVEGNYFFGGDKAIGTSPDGATLY
TGGIRIYGKDHVIINNYMQGLNGTKWDAPITLTLGDAEEGNSNLTKHFRADNVLIAYNTL
VDNSHGIEIGFDNNGSYSKDLKDVTIANNLITGSENSLVAIIDGNDQGNNITWESNLFNP
TGTATTIADATTTSFTASMVKEENPYIVSESYNDYTIWKTTDSSPTYLSGVNSENIDFDI
EGQSRPILSNPGADHFSTESKRYMPLKPTNVGPNAYETDENLESLYLSTISNFDAIEGTQ
TITVTANVDWSTSTDSSWITISPVSGSNNGSFDVTVSANTEYTERTGKVTITGGDLTRFL
NITQSAADPKSNLTLINDASENDHVVVNYVFAEEIDADKDKNNIAEHSLDKDFDTQWSGE
GVPGEIIYDLGGTFDLQLVDFAATNGKTYEFQIWVSKTGTDAADFINAYATNDNLVSNSD
GTFKGFMFPTVATDTKYVKIVGYGQPARPSNWNTITEIEFYKTKTLAVNNTDLADEITLY
PNPTNSQLNIKISKRNISQVQIFSVNGKKVFETKIDTQKSEINMDVSKLAKGAYFVLISD
NNNSKTSKTVIIK
>FCMOIPGL_02513 Cocaine esterase
MKKQIFRILIVAFSFTFFIGCNQKSKKEEKKDTYVIDNYTKKEVDITMRDGVKLHTTIYT
PKDKSTTYPILMQRTPYSSAPYGEGKMKSKIGPNVHLMKEGNIVVYQDVRGRWMSEGVYD
NMRAYIPNKKENQSDEVSDTYDTIDWLVKNVENNNGNVGTWGISYPGHYATISAIDAHPA
LKAASPQACIGDFFFDDFHHNGAFLLSYFRAISLFGTYKDTPTDTSWYSFPKMVSQDQYQ
FFLDKGPLKNLNEFFQYDKLDVNSTASKDKIDDFFWKEIVEHPNYDSVWQSKGIIQHMDK
VPSTVATMIVGGEFDAEDLYGPLETYKGIEKNGKDNYNTLVFGPWDHGKWASSRVKNDVG
NYYFGDSISLKFQKEIETKFFNHFLKGNGDKNSGLPEAYVYDSGKKEWKSFNSWPPKNVM
KQDWFLSEDQELTATKKSISEIKFISDIKHPVPYSEDIKTVFTPRKYMTDDQRFAARRPD
VLVFETEILSEDFTLAGDILAKLKVATTGTAADWIVKVIDVHPLDTKENNDKLQDHLKMS
NYHLMVRSEVLRGRFRNSFENPEPFTPNKKTAVNIKLQDVFHTFKKGHKVQIQVQSTWFP
LIDLNPQTYVNNIYKADEKDFKTQTHTVFTDSSIEFSVLK
>FCMOIPGL_02514 Xaa-Pro dipeptidyl-peptidase
MTSKIKFQFLILFLIAFSINAQEKAVPVFKDGEAQIVEAFNDPEKWIRTDLWVETTFDSD
GDGKLDRMHVDVTRPAQTETEGLKLPVVYESSPYYAGVAGNAPGLFWEVKHEIGAKEKPR
THVEVQRRGVRPIISNSQVKTWVPRGYIVVHSSSPGTGLSDGAPTVGGDNESLAPKTVID
WLNGRAKGFTSREGNETITAFWATGKVGMTGTSYNGTIPLAAATTGVKGLEAIIPVAPNT
SYYHYYRSNGLVRSPGGYLGEDIDVLYDFIHSGKEENRARNNKIIRDTEMANGMDRMTGD
YNDFWAGRDYLNDMKPMKAALLMSHGFNDWNVMPEHSYRIYKKASEMGLPTQIYYHQNGH
GGPPPITMMNRWFTHFLHGIDNGVENDAKAWIVREDDKTNAPTAYKNYPNPDAKPVTLYL
EAGAPKAGNLSTDKSKSKGEETLVDNYSFSSEMLAQADYTNHRLLYVTPVLKEDLHISGL
ASITLKAASSKAAVNLSVYLVSLPWTEGRRAKITDNIITRGWADLQNNTSLSKSTPLKPG
KFYEMTFDLQPDDQIIKKGQQIGLMIFSSDNNYTLLPKPGTELTIDLEGTKITIPVVGGE
DAFKKSVNNVQKIFD
>FCMOIPGL_02515 hypothetical protein
MFNTRIPLEKDDYYLNEQGYKVFTEKYHLKRGYCCKSGCKHCPFGYDKKTDSFK
>FCMOIPGL_02516 hypothetical protein
MIKRILVLVIAIQFVGCAELQNVIKQLPNGGGLTQEQIGNGLKEALDKGIENQVSKLTSQ
DGFYKNDLVKILLPEELQAVDNGLRKLGLGNLADEGIKVLNRAAEDAVKTATPIFVNAVK
EMTFDDAKNILLGEQNAATSYLQTKTSESLYSSFSPVINDSFSKVGADKVWANLITKYNS
IPFVNKVDPDLTGYVTNQALKGVFTMIEIEEKGIREQAGLRTSALLKQVFALQD
>FCMOIPGL_02517 Beta-glucanase
MRNLFTLLAITFLTSIFSQQNVVDDFEGDGTISTWFGDDCGLNTNFSNPFKTGINTSNTV
LKYIDKGGQYANVRFDVPVNFDLSTNHTFSVKIYVPSSSITGSEKNQISLKLQDGKISAP
WSTQSEIIKTIVLNQWQTITFDFANDTYINLNETSAKPIDRKDFNRVLIQINDENNNSNV
TAYIDDFLYDGTLNDNNNDNSGPDPVFNHLVWSDEFDGNGNLNTENWFKQIIPIINGQSW
ANGEIQHYTDRIDNSYVSNGTLKILAKKETYSKNGVTKNYTSARLNSKFAFTYGKIEIKA
KMPFGAGTFPALWMLGQNITETGGYWAENFGTTGWPDCGEVDIIEHWGENQNFVQSALHN
RSSFGGTVNKGGQVIQNASSEFHVYSLEWNANKMIFSVDNIVHYTYNPENKNIENWPYDA
PQYLLFNVAILPNIASNFTESAMEIDYVRVYQEATASVFDIDNLTDVRVYPNPVNDKLTI
KMPNLEGVSNVNLYNITGKKLYTFNQNSATQTHDFSFLKKGVYLLKIETKSKSKFIKIVK
N
>FCMOIPGL_02518 hypothetical protein
MELIEKSNNYRFVDEAISDLAAFKAMKLNEKLNQISYLD
>FCMOIPGL_02519 Vitamin B12-binding protein
MQVQDQIGRILEFEKTPKRIVCLVPSLTELLVDLGLEDSIVGLTKFCIHPMDLKQTKTIV
GGTKSIHAEKIKALEPDIILCNKEENSKEIVEICSKIAPTHVSDIFTIDDNLELIKQYGK
LFSVEKKALDICIEINLKLTDFNQFIKNKGTKKVVYFIWKDPWMAAGNTTFINHLLQLNK
FDNIYQNKERYPEVNLEEMKLNNQLDFILLSSEPFPFGKDHILEIEKFTSKAKAILVDGE
MFSWTGSRLLKAFDYFKSLH
>FCMOIPGL_02520 Orotidine 5'-phosphate decarboxylase
MTTEELVSQINQKKSFLCIGLDVDLNKIPVHLLTLEDPIFEFNKAIIDATHHLCVAYKPN
TAFYEAYGLKGWQALEKTISYINKKYPEIFTIADAKRGDIGNTSTMYAKAFFDDLAFDSV
TVAPYMGKDSIEPFLAFKNKHTIMLALTSNEGAFDFQTKKMGEKELYKQVLETSKNWKNA
ENLMYVVGATKAEYFKEIRKIVPTSFLLVPGVGAQGGNLQDVCKYGLSENIGLLINSSRG
IIYASNTSDFAQVAAIKAQELQQEMAAILNL
>FCMOIPGL_02521 Thiol-disulfide oxidoreductase ResA
MKKIIFILLIVFVSCNSEKPTQFSEEANLEMLVGLDNSKITLREVLEAHKGKKILIDVWA
SWCKDCIVGVPKAKELQKEFPEVVYLFLSVDRSNPSWKRAIKKYNLVGEHYNLPEGMNDG
DFVNFINLNWIPRYMVIDETGKIILFKATNASDEKIKEALKINT
>FCMOIPGL_02522 Triosephosphate isomerase
MRQKIVAGNWKMNNDKDETKQLIKDIKKSIKKLSLKSTRVIVAPTFVNLALAVKRADDTK
IEVVAQNMHQAKSGAYTGEISADMLKSIGIKTVILGHSERRSYFGETDAILAEKVNAILE
NKLETIFCFGELLEDRKSDNHFKVVESQLTNGLFHLDGAAWKSIVLAYEPVWAIGTGETA
SPEQAQEMHAFIRSILEKKYGKEIADNVSILYGGSVKPGNAEEIFSKPDVDGGLIGGAAL
NADDFTAIIKAI
>FCMOIPGL_02523 Ribosomal protein L11 methyltransferase
MRQDLNLDAFLIMDNIYIEYNFTITPKEPATEILIAELGDVGFESFVENENGVTAYIQKS
EWNSSILEDIFVLNSDEFSIEYNQTEVKQTNWNSEWEKNFTPIQVEDLVSIRAPFHENPN
LKYDIVIEPKMSFGTGHHETTHMMVQHLLNLDLENKKTLDMGSGTGILAIFAEMKGANPI
DAIDIDNWCYENSIENIERNNCKNISVFEGDASLLINKKYDVIIANINRNILLMDMQVYT
NCLNEKGVLLLSGFYEEDIPIINAEVSKYNLKLENFIQRNNWVALKYNKE
>FCMOIPGL_02524 ATP-dependent Clp protease adapter protein ClpS
MSTKEKIQEEVDVLEQETFQHEIVLHNDDVNTFDFVIDSLVSVCEHTFEQAEQCATLVHY
KGKCTVKSGEFKDLEPRCSKLLQLGLSAELI
>FCMOIPGL_02525 hypothetical protein
MENVLKYYEFSLFKKDESNTFSSNDIAYTELNETHFLIFEKKETTYNLYVSKYANKREIG
VKPPEILELLVENYDKSIPEHRIAIKQYLN
>FCMOIPGL_02526 hypothetical protein
MNKFALKSRKLLLTVSDLEKKHKIITYVSLLFLTVSTYFLRSENQNVKIEFATLQERNLN
LQKNMVLFNRSYEEFPLPLWQKVKRGNQFVMNYVNPEYIKKFGHHFNNDKFSVLGKNNFE
IFKDQPNIAQSYYEHDITVSVTGKELESIEYSIDKEGRRMKLLVIKWRDIKGS
>FCMOIPGL_02527 hypothetical protein
MDKIKTKIKVSLNKLIKKHYINVVQFCEKEHLLNLLNTNRTISIRYRIHLVLERFKKYFG
INFHAILISVLYSNEAFLFNLKNEKV
>FCMOIPGL_02529 hypothetical protein
MKTEHTKLFTGSNIIVNGLKNLLDTEDISYIIKDKFESARLGGFGEQMDSVEVHVLDSDV
EKAKMIIESYKGKINE
>FCMOIPGL_02530 hypothetical protein
MKIKIFKILAKINKAILPSFTKQKLDITKATKIQLAIIGWRAFVTKNSIN
>FCMOIPGL_02531 Inner membrane protein YrbG
MNFLLIIGGLVLLILGGNWLLKSAVALSLKLDIPKIVIGMTVVSFATSAPELIVSINAAL
IGKSDLALGNVIGSNIANLGLVLGITLLLGTMEVQKSFYKTDWPVMMIASGLLYFFLIGD
NVIEQYEGVILFSFLIIFLIFLLRFQKTAVIDELPEDDEPLPLYKIVLFFILGGLGLWGG
SELLIKGATTLATEFGVTDRVIAVTVVSIGTSIPELAASIIAVVKKEKAISLGNLIGSNI
FNILAVLGITSIITPITLVDDRLLTSDIFWMLGISFIILPLVFIPKGYRLNWKDGIILLA
AYCIFIYLTI
>FCMOIPGL_02532 Multidrug resistance protein MdtG
MKKLFRNYINTFKGLSKEVWWLSLITLINRAGTMVIPFLSLYLTKDLNFSLSDVGWIMSF
FGLGSVIGTWLGGKLTDKIGYYKVMFVSLILTGILFVLLQYLTTFKEFCAGIFLVMLVAD
SFRPAMFVALSAYSKLENKTRSVTLIRLAINLGFSAGPAIGGLIIVGIGYQGLFWVDGIT
CALAAVLLLQVLHPKKAKVQDDVKVQNPVSAYKDKAFWVFFVAMFIFGFVFLQYFSTIPL
YYKDVRFLSELEIGLLMGFNGFFIFLFEMPLIKWLENPKNSKIKLVLIGLFLVAISFVVL
NSTSWMGILIVGMFLMTVGEMIAFPFSNAFAVQRAKKGNQGEYMALYAIAFSLSHIFSHN
SGMHLVAKFGFEVTFNFLTIFGLIGVAILFWLMILLKKEKTV
>FCMOIPGL_02533 hypothetical protein
MYFYRKNFIMKKINLVYLTHLLLIIFAFNFQSCASKKSKIIVNEKVVTKKYDNHNLDKNI
LYLIDGKEVSANDIKKLKPENIASLNVIKNKKEVAKYTNKKINGVIIIKLKK
>FCMOIPGL_02534 hypothetical protein
MSCNSQDKRPLMGETEYQKELNASYKDASKSPLKKKDLKNFKGLDFFPIDSTFIVTAKLT
KTENAPTFEMATTTDRKPIYKEYGILNFTLKGKECQLTIYQSQDNLRDEKYKDYLFLPFT
DDTSGEDSYGGGRYMDVMTTDENPDGTIRLNFNNTYNPYCAYNDKYSCPLTPRKNHLDLE
IKAGVKVFKKH
>FCMOIPGL_02535 putative enoyl-CoA hydratase
MNEFVTYQSEEKYAIITIINGKANAISNEVIAGLNISLDKAAQDGKIVILTGTSGIFSGG
FDLKVMSKSVESAKELVTKGSKLSLRMLSFPKPIIIACNGHAIAKGAFLLLSADYRIGVE
GDFKIGLNEVMIGMTMHNAGIAIAKSRLSEVYVNRSVNNAEIFNSKDAVKAGFLDVIVPE
NQLLPTAIKVAEMFTKLNKKAHAATKLKVRKPHLEALENAIELDLKSDIFINV
>FCMOIPGL_02536 Chloride/fluoride channel protein
MDKIKKFFLSFEQSFSLLFLLKWSFICLLIGALTGSTSAVFLWCLEWATNYREANFWIIS
LLPIAGLVIGLSYHYYGESVVKGNNLLLEEYHSPKKVIPFKMAPLVFIGTVLTHLFGGSA
GREGTAVQVGGAIADQFTKVFKLSDSDRKIVLIAGVSAGFASVFGTPLAGAIFALEVMVI
GRIKFDAILPSFLAAIFANYFCDVWEISHHTHYTISTIADLTPATILWSLLAGIIFGLAS
LLFSKSTHFWGNLFKKNIKYPPLRPVIGGIILAVTWYFMGTTKYIGLGVPTIVDAFNIDL
NSYDFFLKILFTSFTLGAGFKGGEVTPLFFIGATLGNVLIWFIPLPMPLLAGMGFVAVFA
GATNTPIACTIMGIELFGIESGVFIALACTTAYLFSGHSGIYAAQIIGSPKHIFFNKEKG
LTLTDVDKLRNKK
>FCMOIPGL_02537 hypothetical protein
MIQKLITQISRILVGALFIFSGFVKLVDPIGSQYKFQEYFSESVLNMEFLIPYALIFSIV
LIVAEILLGVMILIGYKPKLTVWSLFFLTLIFLFLTWYSAHYNKVTDCGCFGDAVKLSPW
ETFYKNVILIALIIILVIKVKLIKPIFGGKIPKVITLVSLAGFMFIVQHVLTHLPIIDFR
PYAIGKNITEGMQYKDDGEIPPVHDFMLEDTQNDLAPEILQMEKVMLIITSSLEKSNSDG
FPQIKIVAEKAIEKGYKVYGVSASFTDIILETKDTYNLPFEFLFCDETTLKTMIRANPGI
IILNKGTVTQKKNWIDADEIEL
>FCMOIPGL_02538 hypothetical protein
MKKLVYLIAVLFFVSCAVEKSSTYKEMKSDVSMSEFFTDSELQDLAKIVDFFDSEIHLDK
SKPKDEAYFEFNKNIIEECINEIKGFKIPLNYKLQEEVYSKIDTAFFKEIWVHKTFYKGS
GMEKPILEKAYDLNLFGKYMLFLKSLKNEDVLFRDFYKRFSLSNEISFGVQSAAFYQFEM
KEFKGIKRRMFFAVYYLTVNDKMHNYINRKS
>FCMOIPGL_02539 hypothetical protein
MQDTSKQYDAVIEECRSLFIKKMSDYGSAWRILRLPSLTDQIFIKAQRIRQLQENEVRKV
DEGEKSEFIGIINYSIMALIQLENGVVENPDLNTEEATILYDKHSKITKELMMNKNHDYG
EAWRDMRVSSLTDLILQKLLRVKQIEDNKGKTIVSEGIDANYQDMINYAVFAMIHLAE
>FCMOIPGL_02540 LOG family protein YvdD
MKRIVVFCGSSLGFNPIYKEAAIELGNYFAANKIGLVYGGGKLGMMGILADTILDHNGEV
IGVIPKLLEKEEVVHAGVEEMIVCKKMSERKVIMSKLIDGYITLPGGFGTLDELFEALTL
GQLQIEQKPIGLLNVNGFFDAILLQLDKMVEEGYLKQINRNMLIVGTSVNDLMQKMNAYK
APKISPIINKVVR
>FCMOIPGL_02541 Dihydropteroate synthase
MTINCKGTLVDLASPKVMGILNITPDSFFDGGKYKNEADILNQTEKMLSDGATFIDVGAY
SSRPGAKHISEEEELKRIVPVINLLIKNFPEIIISVDTFRSKVAKETINAGAAIVNDISG
GKMDDKMFETVANLQVPYILMHMLGTPQNMQLNPVYKDVTQEIISFFAEQIFKLHQLKLN
DIIIDVGFGFGKTNTHNFEILKNLSLFKSLDAPILAGISRKSMLYKTLDISAQEALNATT
SANTIALLNGANILRVHDVKEAIEAVKIVNQIL
>FCMOIPGL_02542 hypothetical protein
MSRKESPEINAGSMADIAFLLLIFFLVTTTMNIDSGIMRKIAEKPIDNRVIDIKEKNILE
VNINFNNELLVDEKIVQLTDLKQIAIDFIDNGAGLDANQKPCDWCNGKQIDTSSDHPSKA
LISINADRNTNYETYITVLDNLNSAYTHLRNKLSVALYNKNYVSLEEDFKKSNNNDKLIE
SKINLIREKYPLLLSDVEIKN
>FCMOIPGL_02543 Diadenylate cyclase
MLDFIEFSFLDILDIVLVAILLYYVYKLLKGTVAINIVIGIALIFVIWQITQALKMEMLS
GILGYLLSGGVIALIIVFQQEIRKFLLMIGTTNFTNKKSFLKQLKFLNSEIGPEIDTDKI
LKACSNMSKTKTGALIVIERTNSLDFLINNGDSMNALINEVILESIFFKNSPLHDGATII
RDNYIVATRVILPISDSTKIPSRFGLRHRAAIGVSEKTDAVCLLVSEETGEISYIKDGEF
VLFKNLEELNEKLKKDLM
>FCMOIPGL_02544 hypothetical protein
MKKIVLTIMVAASIVFTACKESTKKEVNNEMTEIGNDLEEGVDDLGNDIKEGYNDAKDGI
NSAFDNIEIPKLDDEKAEAYLENYANYVKTQMDKGAENIKNSEFTMKTKEFANDSEQYMK
NLGEEAKESFKATMAKIDAKVEEMEKDM
>FCMOIPGL_02545 putative ABC transporter ATP-binding protein
MAEKTGNAFDIQIFSRLMSFAKRYRLYFFIAASSTILLALFSVLSPYILINTVDDYILSK
DKAGLLDYTLLMLAVLLIEVLLQFSFIYFANWVGQHIIRDIRSKIFRHILQFKMSYFDKN
SVGKLVTRVVSDIETIAAFFSNGVFTILSDILKMLAVTVVMLFLNWKLALITLAILPILV
YATKLFQVAIKATFQEVRNQVANLNGFVQERVTGMKIVQLFNRENIEYQNFKEINEKHKK
AHVKTIWYYSVFFPIAEILSSIGIGLIVWFGGGQAIQNSGISVGMIMGFIQYAQMLFRPL
RQIADKFNQLQMGIVAGERVFKVIDTNSSVAKSGTIKAENLKGNISFKDVTFSYIQDEEV
LKGISFDVKSGQTVAIVGATGAGKSTIINLINRFYEIDKGTIAVDGVSIDDYTLESLRNQ
VAIVLQDVFLFSDSILNNITLKDENITLKDVENAAKQIGIHDFIMTLPGGYDYNVKERGA
MLSSGQRQLIAFLRAYVSKPSILILDEATSSVDAQAEQMIQYATETITKERTSIVIAHRL
ATIKQADKIIVMDKGLIVEEGIHSELLEKENGYYKNLYDKQFSLDVAS
>FCMOIPGL_02546 tRNA pseudouridine synthase A
MRYFIELSYNGKNYHGWQIQPDAISVQEKLNNAISTIFQEKIQVVGAGRTDTGVHASQMF
AHFDIEKELKKNIVFKLNSILPNDISVHQVFLVDAEKHVRFDATSRSYEYKIWLGRNPFL
LDFSWQIHSQKPDIHLMNEAAKLLLEYTDFQTFSKVKTDVYTFNCDVTEAFWELKGSELT
FHISANRFLRNMVRAIVGTLVDVGLGKISIDGFRAIIESKNRGNAGLSVPAKGLFLTNIK
Y
>FCMOIPGL_02547 hypothetical protein
MKKILLLSDTHSFIDDQILKFVKQADEIWHAGDIGNLEVTDKIKKLKPLRAVFGNIDGTD
ARAEFPLDAKFSVENVAVWMTHIGGYPNRYNIRIREEIAKNAPKIFISGHSHILKVQFDK
KLNLLHLNPGAAGNHGFHSIRTMLRFEIEKGEIKNLEIIELAKRG
>FCMOIPGL_02548 Oxygen sensor histidine kinase NreB
MKEKIVILFICFNFYPVKAFKFIKKETLFNKVSFLYTQKNDSLYQKKYLGIQKLFNNARY
PEALEKALPLLKSDLDPEISFKLNFLVAEIYSINNNHNISIIHYKNALNILELENNSIYD
LNYDEYYEVEKIRTYLKLGNEYLRNSQIDSARYFYHKTLEIESLETKSLSYQASASTNLS
GIHRKDSLYDLAKQYAIRAVSIHQKRNNKISEAAAKGNLASIFLDQNNYKEAKKTYKEAL
DLIKNESSDRALRVKENLYYNLAYNLYKMKDYEAYSFQELSYEIKDTLRGKEIRRIIEKL
GFEYDFNTQKELLEKKQDIKLLEEKDRANTIVVISSLILIFLLVIITYYSLRQKNLQIKL
SKTELLQSQKLDKLKSDSQVRILNATIDGKESERKEIAETLHDSVSALLSSANLHLQASV
RQFEGDVPIEIDKTQKIINEASAKIRDLSHSLMSSVLLKFGLNFAIKDIAEKYSNSELSI
DTQIGSLRRYDQNFEIKTYNIIQEFINNILKHSKADSAFIQLKEEEGSLILEISDDGIGF
DKKKTFSKKGIGINQIYARIKMMKGKFKIITSKNNGTIIKVELPIQEREYV
>FCMOIPGL_02549 hypothetical protein
MKKRNFLAVAVVFSLVFSSCSSEEEALMPEQSKELFKTFELKRDATGAYSIDLDLDSNVK
VAKVKNTAENINELYLSVSDDDLEQKSNLQSDLFFDDENFKVDFITENSNKVPSISIFDD
NIKYVKKSDDSFLEEYSVIKNENGTYELDFKVSNNVSVDFVYNDEISVYEVHLEESGKSQ
QNDSYSRTLEKEENELLQIHFVNHTGDNAKGDATSADRKPVIIIDDGEDW
>FCMOIPGL_02550 Oxygen regulatory protein NreC
MKKKIYVHVADDHKILIEGIIAVINTDKDIEIKDYSLTGKEVTDWFDKKGNIADVLILDI
TMPILDGFEVLRHFNKKGIAQKVIILSSYDDIKIVQEMLSLGCKGYITKNNAGEHIVNAI
KAVARGEQYFSDDIQKILLKSFSGHHVPAGEAPVKKIIEALTEREIDVLKLITKEYSSPE
IAEKLNLALSTVETYRKNLLRKLKVKNAVGLAMYAVKNKIV
>FCMOIPGL_02551 hypothetical protein
MLQRIQSIYLFLASIISGGLIFVFYLWNTLKEQIFVLDLFSNEEIILKVIPFMFFASAIL
SLVTIFLFKDRKLQFVLGRIIILINLFLLGLLIYLSLTLPGENAVSEKGIGMFLPILVIL
LIVLANRAIKKDEDLVKSVDRLR
>FCMOIPGL_02552 Transcription termination factor Rho
MFEISELKEKTLADLQVIAKSIGLTKTSQLKKLDLVYQILDTQAANPTKVSNTEGSETPK
TDKPKRRRVVKKIQPKKTVVETTTPEITTENTKTKENSKPIEKATPAAKKEEVKKVIEKR
TPARPRVKQEKKEEVDSSSKSTEETTDIKTKKEQKPVNNNPNRNPPRKNNSQKSKEQNNS
KNNSNRGNKSGNRYKDPDFEFDGIIESEGVLEMMPDGYGFLRSSDYNYLSSPDDIYVSQS
QIKLFGLKTGDTVRGNVRPPKEGEKYFPLIRVSKINGLNPNIVRDRVSFEHLTPLFPEEK
FNLAEKGSSLSTRIIDLFSPIGKGQRGMIVAQPKTGKTMLLKDIANAIAMNHPEVYQIVL
LIDERPEEVTDMQRSVRGEVVASTFDEPADKHVRVANIVLEKAKRLVECGHDVVILLDSI
TRLARAYNTVAPASGKILSGGIDANALHKPKRFFGAARNIEGGGSLTIIATALTETGSKM
DEVIFEEFKGTGNMELQLDRNISNRRIYPAIDLIKSSTRRDDLLLDAKTVQRMWVLRKYL
ADMNPIEAMEFINERIKFSKNNDEFLISMNG
>FCMOIPGL_02553 Chaperone SurA
MAVLSKIRERSMFLIIIIGLALFAFVLDPSTLGDFFNSSKVNEIGEINGESISREEFVQE
LENYKQQTGGQVSEMQAAKTVWDNILRKKIYENQLTQAGITIGEADIWKEIVSAPFVQSN
PQYQTESGLFDESKFKQFLATEKENKTELWAQWSGYMNQIRDNEETNTYNNLVTAGLGAS
LKEGELEYLLDNTKLNAQFVYIPFTSIADSIVKIKKSEVESYIKNHKNDFKVEASRDVSY
VQFNIVATPADEKVIKDDVATLIEDLKNTKDESIFLSDNNSDTGLNENFQFKNLVNQEAA
TQIFEANKGDVVGPYKDKDYYKISKITEVSKMPDSVRASHILIPFIGAQRVGADVTRTEE
EAKVLADSLLSVVKRNVRKFGDLAKTFSSDLGSGAKEGDLDWFTYSRMTPFFRDFCFEGK
KGDIGVVKTPFGFHVIKIDNQKNSQKVVKLATYSRKIEASEATENDVFKNAEEFALAISK
NNKFYDLATEKKYTPKIAVGLKVLDENVPGLGNQRQIVSWAFGKETNVNDFKRFDLEGSH
VVAFITSAEEKGVMSAEKATNTVRPILLNEKKAALLKDKLQGASLADIATANNTNVRTSN
GLTLKTPTLSGVGVEPKVVGAMYNASLNKVVNSVIGDRGVYAFMVTKKELPTALPNYDAN
RKRISESRKRLTNKMYEAIKNASDIEDNRAMMYTAN
>FCMOIPGL_02554 Hemolysin C
MEFELIVIIISILLSAFFSGMEIAFFSANKMHIELEKKRDGFIPKVLTKITQKSSKFITT
MLVGNNISLVIYSYYMGKLLVRVFSLDTNFNDFTNLLIQTIISTIVILITAEFLPKAIFR
IYANEVLKIFSVPAYIFYKLFHYFSEFITLISDFFLRVFFKTNADEMQTEFSKEELGNYI
NEQLETGNTDDEVDSEIQIFQNALGFHNVKAREVMVPRTEIVSVEIHETVVNLKKIFIET
GLSKVLVYKTSLDDVVGYVNAFELFKKPKTIKSILLPLEIVPESMMINDILNTLIKKRKS
VAVVVDEYGGTSGMITIEDIVEELFGEIEDEHDSQEFLEEKISESKFNFSARLEIDYLNE
EYDLNIPKSEAYETLGGFIIEHTENIPSEKELIDIEDFEFRILKMSGAKIDEVSLKILNE
GA
>FCMOIPGL_02555 hypothetical protein
MNNIWKFFQYGYLLVALICLIEGVVRFNTDKEKALFFIGFSIFITLVFFLKRHFRKKVVK
RNNQNK
>FCMOIPGL_02556 Lipopolysaccharide export system protein LptC
MSTYKNILSKSIAVLYVTAMLFSCDNNTQKVRDLLADKNLPVGTAKDAYHVYKDSGRITS
KLITPILLDFSNRKEHPYSEFPVGIKIINFEKNGIDSITITGNYAISYQKTSLSEIKGNV
VVVNHTDKTRLETEQLFWDQKTKYFVSEKAFKLMTEKDTIYGIGFESKEDLSKHLAKKTT
GKLETSEE
>FCMOIPGL_02557 hypothetical protein
MKKFTFLLAVTLLLATAKTNAQDDAKRECTIKYNLFKGDYQSKKYDEAYANWIYLMDNCP
DLSVSIYQYGSTLAEDIRKDPVLAKRVYEQRLKYYPDAKPAKVHSDYATYLADNNLASKE
EVFVYLEKAYEISPQDMGVKNIYKYFHGITDKYKDENPQKVFDTYDDVVESVGEKLDDYA
KKINVLSDSTRVLDAKEKRRLNAYQINSRALGQIEGGLDNIITEIATCERLIPLYQRNFE
ENKGNAVWLRRAVNRLFNKECQDDPMYEKLAKAYAEATPSPDSYSFYAGVLEKNGDASGA
AAMRQKAFDLETDPIKKSRYKLKFAEAARSRGQLSTARRLAREALKYNPSSGRAYLLIGR
LYQSSVNACGEDEFEKRMVYAAALRQAETAARVDPSMSSVARRYINSYRANLPSKTVIFT
SGVEPGSSYTIKCWIGETVTVPK
>FCMOIPGL_02558 hypothetical protein
MIRKILVAFLLLTSVTFLAQRTNSSPYSYFGIGDEFSQTTVEQSSMGGIGVAFNHYKYLN
FTNPAAYSDLRYTTYSFGILNNDLTIRSGDTKQNVNSTSLSYFALAFPIGKKAGLSFGLQ
PVSSVGYSLSNSITGDDGDISEISLFSGNGGVNRIYSSFGIKVVKGLSVGLEADYSFGNI
ENSIINQRADVILATKYNETTFIEGFSLKLGAQYQKELKNKLVVNAGATFKLDNDLKVSG
DDYLYSLSIGSSGYEIPRDTISTTIIDGEFNLPYKAILGVGVGKIDKWHAGIEYENQDAI
STTTLLASSNGVYRYGSSNRISLGGFYLPKINSISSYWDRVVYRAGVRFEKTGLLVDGSG
NNTNFTAIDDFGISFGLGLPLQRLSTLNMGFEFGKRGTATNNLIQENYFNFRLSLSLTDT
WFIKRKID
>FCMOIPGL_02559 Type III pantothenate kinase
MKLIIDAGNTRIKVAVFEQSTLVEVVLIDKKRFLSEIKKIVKKYKIHIGILSSVSFISEK
KIEKLKFLLKLVVLSSSTKVPFINLYETPKTLGVDRIALVSCAVKKFPNKNILIIDAGTC
ITFDFVNDKSEYLGGAISLGVEMRYKALHYFTSKLPVLEKNYPKNFIGNNTDESINSGVV
NGVIQEIEGIISQYKKKYMDLTVVLTGGDTNFLSKQLKSSIFAHQNFLLEGLNEILIFNE
NK
>FCMOIPGL_02561 putative epimerase/dehydratase
MSKEVILIVGANGQLGTVLSQKLQQIYGNSHVITSDLFKKNDSEPNFITLDATDFKAVED
VVLKNKITQIYHLAAILSAKGEQNPLATWSLNMKTLFNVLEVSRLHKIQKVFFPSSIAVF
GHNIDKENTLQYSNLTPTTVYGMSKVAGENWIHYYYQKYGLDVRSLRYPGVIGYQSLPGG
GTTDYAVDIYHKAIINEVFECFLAPKTTLPMMYMDDVIRATIELMEAPKENISVRTSYNI
AGISFSPEEIAQSIKEFYPDFKIKYNPDFRQAIADSWPKIINDSEARKDWNWKPAFDLKL
MTKTMIKNLK
>FCMOIPGL_02562 DNA-binding transcriptional activator DecR
MLPTIKIDETDLKILRILQKDAKKTTKEIAEILNLTSSPVYERIKRLEKQKIIKKYVALI
DKKKLDIPITAICMVSLRYHNEGFIDKFEKQIKELKEVQECYHMAGKVDFFLKINMESLD
DYHEFVRSKLSRIENIGVLESYFVLKEIVSSTEYCI
>FCMOIPGL_02563 hypothetical protein
MLEREFSFIKANIQHLEDENLKISKAKVGWHLDHSLKVINSVVANIKDSKSKEYQHKFNG
LRLVVFTLGFFPRGKAKSPKRVLPPEIISKNDIEYQLKIAEKNVEIIDKLDKNQFFTHPL
FEQLNKKQTIKFLRLHTNHHLKIVKDILK
>FCMOIPGL_02564 Ribosomal large subunit pseudouridine synthase B
MESNKNSSRGRQEGGKSRPQKDTKRSTSQRGSGKSSSSRDAKKATFKRVANKPTFKRDAR
KSTPLNRQNVKKEYKKINPDKKSDDSLGIRLNKYIANSGVCSRREADTYIEHGSVEVNGK
LVTEMGYKVQPDDIVRFDGTSISPEEKRYILLNKPKNYITTMDDDRGRKTVMELIANASK
ERIYPVGRLDRNTTGLLLFTNDGDLAKKLTHPKHNVRKLYHASLDRKLELNDLEKLRGEV
IIEGKKVFIDAISYVNNEPKTEVGIEIHSGRNRIVRKIFEHVGYKVNKLDRVIFAELTKK
NLPRGRYRELTKLEVTNLQMMK
>FCMOIPGL_02565 hypothetical protein
MFTGSKLELINSSKVKAFLKKIFSLLSVVRGYNILILVIAQYLAAIFIFSSEKSIRHVIF
DLDLLYIVLASVCVVASGYIINNFYDVKVDQINRPLKTSLDNYVKQETKLSLYFFLNFLG
FVFGLFVSVKAALFFAIYIFGIWFYSHKLKKHAFTGLISATILTILPFFAVFVYFKNFSK
IIFVHAIFLFLVIMVRELIKDLENIKGALVNNYKTFSVVYGEAKTKQLSIFLLLLTIFPV
IVLLSYPAISYMKYYFYLSFLTLFYVGFYLCKSNKQRQYAFLHNILKILLLIGVFSLVFI
DTSLLIEKVIDRLN
>FCMOIPGL_02566 hypothetical protein
MKIDKEKKMKGPLFYAKILLFGEYGIIKNSKGLAIPFNTYRGALKTTEVLEGKAKVSNEN
LYKLYNHLSTLETELVSFNLKKFKTDLEKGMYFDSSIPQGYGVGSSGALVASIYDKYASD
KITVLENLTREKLLRLKEVFSLMESFFHGKSSGLDPLNSYLSLPILINSKEHIEPAGIPS
QKQGKGAVFLLDSEQIGETEPMVSIFMNKMKNEGFRKMLNEQFVTYTDACIEDFLHGNVS
SLFSNVKSLSKIVLKNFKPMIPDAFHKVWANGIKTNDYYLKLCGSGGGGYILGFTEDYEK
AQKSLKGYKTELVYRF
>FCMOIPGL_02567 hypothetical protein
MKVSSLFILIIISFLSISIQSQETIWLDENLEKTTEHKANYYKVGTKLEGEVSYFYKNQN
IYRKVFFVNGKAEGNYSEFYISGELKETGRLENGLRDGVWKTYYKNGKIESRGKYKDGEK
VGIWKTFYKNI
>FCMOIPGL_02568 hypothetical protein
MNTDQFLVKSELKHIDTASFTWQTPSNIALVKYWGKSNPQISKNASISFTLNNCHTITTI
DFSKKQNSELVSEFNRTVDFDLFFEGKQKEEFKPKIAEFFRRVEEYCPYIFDYKMTINSE
NSFPHSSGIASSASGLSAIAMCLMSLEKEINADLSADFINKKASFLARLGSGSASRSIEG
PLVVWGKHPAIEGSSDLFGIQFPYKVHSVFENYQDAILLVDEGEKQVSSTIGHNLMHNHP
FAESRFLQANENLAKMAKILQEGDIKSFVNLVESEALTLHAMMLTSNPYFILMKPNTLEI
INKIWEYRQENNSNICFTLDAGANVHVLFPESEKLNVLQFIDSQLSKFCQKNHYICDTVG
FGAKKL
>FCMOIPGL_02569 hypothetical protein
MNFKINTDTWFIFCLLFIGILALFIVLYIVIPYRTRIKNTKRRHLRFHRKLDNFERLKNK
QKEEKIRNLELENSKLQVSLNNDLAKIINNNNQENLDSFFSNFEKLHPNFNENLFKIAPK
LTSNELKLAAFLRLNLSSKEISKLLNINPDSVNKARYRLRKKLNLSINNDLTTFILNI
>FCMOIPGL_02570 hypothetical protein
MRIFEIILLILSIASIFYFSIRKTTTNKKIELPIILGLLAIHLIFEGYRWQMITIYFLLL
IVAIYSYKELSLLKGKWFLKTIKIIGLLLLLIIGFLLPNVLPIFNLPKTTGNYKVGSQYI
LLKTDREEIITENPDDKRELMIKVWYPAIIKNEEKEPYLNNGDRFSFAAKYGLPNSTFNY
LNSVETNTYASPKVANEKFPILIFSHGSYSKASGYYAIIEEIVSHGYIVLNINHTYESTG
TLFPDGSIKLYNQEYDQKYISTQKMAELAWNGTQNYNNAKTEEEKLAVSKEVLKNYIAAE
ITRNWSKDFVSVIDALKTWNRNSFLENHLNLSKIGVFGHSQGGSSAGQAILDDERISAGV
NLDGVQWGEMIDTSLTKPFLNISSEWISPHPNFNIFAYRNSSKNIFYDAKIKNSGHASFM
DIPLMFNIPTLNESGTIEPKEAYKIINKTVISFFDNHLKNKENDLLKLQKEFSSLEISIK
>FCMOIPGL_02571 Thiamine pyrophosphokinase
MKQKKVFLLLNGEPPKTLPEFSDYAIICATDGAYQFLKEQQIIPDFISGDFDSLENLPKD
IEVIHTPNQDFTDFDKILQILFDKGFTTIDIFGASGKEQDHFLGNLHTTIQWKEKLQLTF
FDNHSRYFLADKSTELTISKDKIVSLVPFPKATNIITDGLQYPLRKEDLIFGERIGTRNK
SIKNKLKITFESGELFIFINH
>FCMOIPGL_02572 hypothetical protein
MSRKIKLLWDFRGPDAQETAKHHTIHLKEFATIENLAFHEIDIQEKNSMLFSAFITVNEA
DMKTYRDALKPHRGEVG
>FCMOIPGL_02573 hypothetical protein
MKHFIVSFLLLSIINITKAQNKPAYQLFQNNGELANYDEMVKDLAQSDMVFFGEYHTNPI
SHWLQLEISKSFFEIKGKNLFFGAEMFESGNQLVLNEYLAGLYPENKMIPEITQLWSNYK
TDYKPLVEFAKDNELRFIASNIPRRYAAMINKKGINALDELSTEALALIGPDLKKYFDPT
VKAYAEMADNMGGHVPPNMLNIQTAQAAKDATMAHFSLKNFKPGNLLLHFEGSYHSNYEQ
GIIWWIHKIQPGLKLKSITTVTQSEWDEMNDEKKNTIANYIIVVANNMTQTNQ
>FCMOIPGL_02574 L-lactate dehydrogenase
MVTNNKTNSKVVIIGTGMVGMSFAYSLLNQGTAKELVLIDINKERAIGEAMDLNHGMSFA
PRKMKIYAGEYSDCEGADIVVITAGVPQKDGETRINLLNRNAAIMKIVVGQVMKNNFDGI
ILVASNPVDILTYVAWKASGLPPSKVIGSGTSLDTARLRFEIAQKINISVKNIHAYIMGE
HGDSEFVCWSQAYVGAKPLIEIIETMKEIEFKDLEEIHNSVKNAAYEIIKRKKATYYGIG
MTLVSITSAILNDENRIIPISVYNDGIYDTEKDLYIGLPAVLNASGVNHIMKLKLNNKEL
EQLDESATILKNILNQMDI
>FCMOIPGL_02575 hypothetical protein
MMKNKHQIIKVLLLISIYCFGIYLSANSSAYFSEQNVVKDNKQKEYVSTTSKVLFIHTQQ
YESLQSNLTEYSLPTFESPDNLFWLISNSNELLFNSKFKQYNNYLKNILIRHRKSDLIFP
FHNFW
>FCMOIPGL_02576 hypothetical protein
MNLGTTIIGLVCVALCAMPFILTSRSKKKKEKELINSLKNLAKQNGSEITQYEICGNYAI
GIDESKNSVSFIIKTYEVFKIQFVNLSLIKNCKINKISSSSSNNDQIIDKLNLNLSAVDN
NKPDVILEFYNSEISYQPYRELESIEKWNKLINNLLNTKKQNKVA
>FCMOIPGL_02577 Metallothiol transferase FosB
MHTFSFNHIALSVRDVDISIKFYQKVFHFKEIKNTASNSKTRWLSIGEDKQLHLIPRPNF
EIKVNKAVHFALSTADIDSFVVDLKELQIDYSDWKNTQKKDYVRNDGILQIYFQDPNGYW
IEVNNDV
>FCMOIPGL_02578 Thiol-disulfide oxidoreductase ResA
MALTESNEFRIGTKAQDFNLINTVDDNFLSLENAKGEKGTVIMFICNHCPFVIHVNSELV
KMANDYQKKGIHFIAISSNDVENYPQDSPELMKQLAIDENYPFPYLFDETQEVAKAYDAA
CTPDFYVFDADLKSVYHGQLDNSRPGNGKPVTGIDLRNALDNLLANKSAIENQKPSMGCG
IKWK
>FCMOIPGL_02579 hypothetical protein
MQEKHTDKENSGFSPLGNKKGLQIIIVGGGAAGYFTAINAKENNPDLDITILEKGKDVLQ
KVKISGGGRCNVTHACFEPKELVKFYPRGEKELLGPFHKFMTGDTFEWFENKGVPLKIED
DNRVFPEANTSQAIIDCFQNAVDKLNINVLTNCGVNSVYQQENKWIINTKEEVFEADKVV
IAAGSSKKVWELCETLNHTVVEPVPSLFTFNINDKRLVDLLGISVQNATVSISGTKLEAS
GPLLITHWGMSGPAVLKLSAFGARVLADKKYQYNVEVNWLSRPTEKVLNVLLNLKKKEPR
KTVILKSPFTEISKRLWERFVLAAGIRIDQNWADLNNNQLENLANQLTKGVFNANGRTTF
KDEFVTAGGVDLKEIDFKRFESRKHKNLFFVGEVLNIDAVTGGFNFQNAWTGGFICANAL
AE
>FCMOIPGL_02580 hypothetical protein
MNFYSNGKLLLTGEYLVLDGAKSLAVPTKFGQDLIVDKIAAPQLIWGSFTYSGECWFEAV
FDLPKLRLVSCTFNSDKEGNGEIIAETLLDILKEAKCLNPDFLNSEHGFLVKTNLTFPRN
WGLGTSSTLINSIASWSNVDAFKLLWNSFKGSGYDIACAQNNTSIFYQIEDEKPIVEKVA
FNPSFKENLFFVHLNQKQDSKEGIAKFRESSINFDKEIKRISEISDEFLSAKSIVDFDKL
IVEHEQIISSIIKLKPVKEKLFQDYFGAIKSLGAWGGDFVLVTGNEKTPTYFKNKGFETV
LTYNQMVKPTLILPKRGN
>FCMOIPGL_02581 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MSKIIAGFSKFTKEEKIDWLTKNYFHNQTETVNIIKQYWNIDTDLQELHDDFIENTISNF
YMPYGVAPNFIINDREYVIPMVVEESSVVAAASLVAKFWSTRGGFKTKVIGTKKIGQVHF
MFAGDKQDLESYFNQNKTELFAATASITKNMEKRGGGILSINLVDKTAKLANYYQLHVTF
ETKDSMGANFINSCLEAIAKKFENEDIEIVMSILSNYVPECLVRAEVSCKIEELGGENPQ
KFAEKFQQAVKIAEIEPYRAVTHNKGIMNGIDAVVLATGNDFRAIEAGAHAYASRSGQYS
SLSHCSIDDGVFKFWIEIPLALGTVGGLTALHPMAKLSLEMLQKPSARTLMQIIAAAGLA
QNFAALRALTTKGIQHGHMKMHLQNILNQFEANEEEKEIITVYFEKRTVSHSAVVEKLNS
LRKPKINWINFLDENSVRAHLSKLTLNSKPNFGLMNAQQMIEHLSAVTQIANGNWVVNTF
VSDEKTARRKPFLNTENELQTGFKASFLAEEPNDLKFNSIAEAIDDLIKQVAIFVKVFSD
DKNRTVVHPFFGELDFEYWQKFQVKHFTHHFKQFGLL
>FCMOIPGL_02582 Prolyl tripeptidyl peptidase
MKKLFILVSISLLISCKEHTKTTSNLTSGTKEITLEEIWDDTFKPQSMIALNSMNGDFYS
LINVDKTTKETTVDAYSYKTLEKVETIVNSKNLEGLDSFSSYSFNAEESSLILGTNFKKI
YRHSFTGTFYYYNIGSKKLMLIGEDIQEPTFSPDSKKIAYVKNNNIYILNLTNDHKLTQV
TKDGKFNSIINGITDWVYEEEFGFVKAFEWSKNSDYLAFLRFDETDVPTFSMDIVGSELY
PKQQVFKYPKAGEKNADVTLHMYTLSSKNSKNIALGDYEYIPRIKWTNDANILVATTLNR
HQNNLKLHKIYALRSSSILLLEETDKAYIDITDNLTFLNDNSFIWTSEKDGFNHIYHYDF
GGKLINQITKGNWEVTRYYGFNEAKNTIYYQSVENGSTNRGVYSIGLDGDNKKLLSNNEG
ENTAAFSKNLNYFINTFSSAETPPIYSLYAAEGEKIKVIKDNAELKTKLSTYKMSQKEFS
TININGNDLNMWMLKPVDFDENKKYPMLMFQYSGPGSQQVGNKWNIDKDYWHNMLAQKGM
IVVCVDGRGTGFKGAEFKKITQKELGKYEVEDQIAAAKQLAELSYIDKNNIGIWGWSYGG
FMSTNCILKGSDIFSTAIAIAPVTSWRFYDSVYTERYMQTPQENASGYDDNSPINYAEKL
QGNYLLIHGTGDDNVHVQNSYRMINSLIEANKQFDMFMYPDRTHAIVEGKNTRLNLYTKM
TNFIDENLNKQ
>FCMOIPGL_02583 Di-/tripeptide transporter
MSKSIISTEEQQLFGHPKGLFYLFFAELWERFSFYGMRALLTLYMVEKIFKAIAERDTAT
AVVYASYGSLVYASTVIGGQISDKILGMRASIFLGGILMALGHFVLAIENDIAFFLALAL
IVVGNGFFKPNISTFVGSLYKEGDVRKDSGFTIFYMGINIGGMVAPFLCGLLALKYGYHY
GFGLAGIGMLTGLFAFWRGIKTNVFGDKGMPPSKEVYEKKLVGIPQKTLIPIVAFLAAPG
IAWLLAAWRDNYVSFIFKFIGVAVLVYLGYIIFNLKTNEARKKLIMAVLITFFMTLFWGF
HELSGSVITLFASRNVDLDGIMSASQTNGLNSMFIIILAIPISLLWGYLSKRNMNPRTPY
KFGLGLLLAGASFYILSISGASADENGMVPFYYLFAMYFIISVGELFMSPVGLSKITDLS
PKNIVAFMMGVWFLSSAFAFQIVGFISEQLAIESTDANVGGLETLTIYTDGFHLIALYAI
GAGAIVLVFSPLMKKLLGNVH
>FCMOIPGL_02584 Di-/tripeptide transporter
MSTVTTNKEFSLLNHKPALFVLFFTEMWERFSYYGMRAIFVLFLTASFSDGGWEWTRERA
LGLLGIYTSSVYLTPLIGGIIADKLLGYQKAVALGALAMTLGHAAMSLETETTLYIGIAL
LIIGNGLFKPNVTSIVSGLYDKYPERKDGAFTIFYMGVNAGGFLGVLLCGFLANNLSYSW
GFGLAGIFMFLGTLQFWFGREIFENIGTSPSKKVDLSDAVANVETPEETVANHIQRDRYI
VVAILAFFTVFFWWAFEQASGSMNIFAKDYTQRALTGNAALTFKIVDVLVSTVPLIIISW
VLLKLFGQTFKKITLSNTVLGISFLSIWGIVIWKLSVIIPQQNAEIEASWFLILNSLFII
FLAPLFSKWWESKFNPSAAVKFGIGMILLGVGFGALAYGSSSIPQGAKTASVSLVWLFLA
YLFHTMGELCVSPVGLSYVSKLVPAKKIGMMFGIWYLVNALGNYLAAKTGSYIDPIVEQY
SMSFFFLIFTIIPAAVGLIFLVLNPIIKKLMHGIR
>FCMOIPGL_02585 Thiol:disulfide interchange protein DsbD
MKKIIVLITILAFNFNLKAQEINWMSLNKALELQKENPKKIMMDVYANWCGPCKLLDKET
FHNKDVVAYVNEHFYAVKFNGEGNETINYKEHTFGNPNYDETRANSRNSAHEFADFMGIS
AYPTIAFLNEKGEFVIPLKGFYNPQQLEFYLKMLAEDKHIELTNQEKYNEYQQAFIPEFK
S
>FCMOIPGL_02586 ComE operon protein 3
MKRLLNYLPFHFVGLLILGIYLQFYHQIWQFGFLKLFASILVTSLFLLILKNKKIVTVVS
FILFFFIGVSAIYFTNDVNYNSYYQHSLKDNSSVVLKVDKVLKSSTYYDKYEVEVTQVDG
IKSNGKVLLNVIKDSLNTALKVDELLVVKSSFQEINSSLNPHQFNYKNYLERQGIHQQLF
LENKQLKRIGFQGFSLLGISAKFRNIIEESLQKYNFKTDELAVINALILGQRQDISKELI
SDYQKAGAIHILAVSGLHVGIILLILSWIFKPLERLKNGKIIKTILVVLFLWMFAFVAGL
SASVVRAVTMFTFLSVSLTFKRKNVIEFSLISSMFLLLVVKPMFLFDVGFQLSYLAVFGI
IWVQPKLYKMYKPRFKIVDKFWQLITVSFAAQMGILPLSLFYFHQFPSLFLLSNLVIIPF
LGAILIGGIVIISLSLLGFLPQILATIYGFVISLMNNFVGWISMQEQFLWKEISMSFLWM
ITFYFLVIFGTRFLIDTSAKKLIYFLISIVLIQSVFVFENHQKKTKKEFIVFHKSRNSVI
GIRVGEQLLIHHDLDTLAIEKSNFITSYSIGENINKVFKNTIPAVFQFKKEQILIIDSLG
VYQLKGLINPIVVLQYSPKINLERLIKTISPKQIIADGNNYKTYVNNWKAICEKQKTPFY
YTGKNGAFVYEKK
>FCMOIPGL_02587 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MKKISFICLFFLFILNSCGTVSPLVLKANKGVSVTDKVVYNALQFEGVRYRRGGVTANGF
DCSGLIYTSFNLENIQLPRQSMYMANEGVEISLSQVKKGDLLFFITGRKSKNINHVGLIV
SKDDNEISFIHATTARGVIVSSLSERYWKNAFLKATKVL
>FCMOIPGL_02588 Lipid-A-disaccharide synthase
MKYYIIAGEASGDLHGSNLMKELYKEDAQADIRFWGGDLMQNVGGTLVSHYKERAFMGFF
EVLKNLSKVLGFMKFCKNDIVDFKPDVLIFIDNSGFNLRIAKWAKLQGFKTNYYISPQVW
ASRAGRVKDIKRDIDKMFVILPFEKEFYKKHDYEVSFVGHPLIDAIADRNQVGIQKFREE
HNLGAKPIIALLPGSRKQEITKMLSVMLSLVDDFSEYQFVIAGAPSQDFSFYQQIIGDRE
VRFINNKTYDLLSISYAALVASGTATLETALFKVPQVVCYKGGTISYQIAKRIITLKFIS
LVNLIMDKEVVTELIQNDFTKEKLVVELRKILDAKNREKLFLEYFELEKILGGKGASKKV
AKSIYKNLKN
>FCMOIPGL_02589 hypothetical protein
MGTVKKDILIGILISFFATAAGIFLYLEYFSKYSFDDTLKMIQEGNLYGKILSLAAIPNL
FVFFVFIKKKQDNRAKGVLFATILIALTTLILKFF
>FCMOIPGL_02590 5'-nucleotidase SurE
MQERPLILITNDDGITAPGIRALIKIMNKIGEVVVVAPDSPQSGMGHAITVDNVLTCNPI
TIDDGPQLEYTCSGTPADCVKMAISEILNKKPDLCVSGINHGANSSINVIYSGTMSAAIE
AGIEGVPAIGFSLLDFKWHADFKPAEEFVKKITLNTLLNGLPEGIVLNVNIPNLKAEEIK
GVKICRQANGFWKEIFDKRKSPFGKEYYWLSGEFVNKDKGQDTDVFALENGYISIVPVQF
DLTAHHMIQKINSWEL
>FCMOIPGL_02591 Tail-specific protease
MKTKFKFNTILLVITLLINSFVINASEKNNFSDPDPDKDKVLIYVLKNILTRGHFVAKEL
NDDFSELVYNSFIDGLDPSKRYFTQEDLKEFSQYKYEIDNQLLRDDLTFYNLVYNRFLDE
MKKAKSYYAALLSQPFDFDEDETIEIDYEKIPFAKNNNELIDYWRKQLKLQTLGRIEEQT
ELQENKVKKDSSFKVKSFATLEKEAREEVLKNMDELYVRIEELENDDWFSTFLNSVVGAF
DPHTTYMSPNIKEKFDQDISGKLEGIGARLQKKGIYTHVFELVPGGPASKQGDLEPEDII
LKVAQGDEEPIDIVRMRLDDAIKFIKGKKGTEVRLTVKKKLDNSIKVISIIRDVVELDET
YVKSSIVEKNGKKFAIIDLPSFYIDFSDDAYRDSAKDMEQEIERLKGEGVTGLIVDLRNN
GGGSLKTAIEISGLFIDQGPIVQVKYRGDNPVVKEDIDPKTQWEGSVVVLVNEFSASASE
IFAAAMQDYKRAVILGGNQTYGKGTVQNVLPINQFYPKYETDLGYLKMTIQKFYRVNGGS
TQIEGVYSDIAMPSRYSYMKFGERDLEGALAWDKVPQAKYTQSNSYSNFADVVYNSKQRI
ASSENFQLVNEYAKWLKKNQDETSYSLNYKKFYEESEVKEVEAKKFKSVFDYKSDFTFSS
PKYEQDLLKIDNSLADKRVAWHKNLSKDMYVSEALNVLSELKLRDKSTIIKN
>FCMOIPGL_02592 hypothetical protein
MSYQVTFATKWSDFDPNRHMRHTAYNEYAAEVRVRYFKEQNFSIDEFTKLNIGPILFTEE
TSFRKEIHIGENISVNIKISGLSKNNERWKIVHEVFNEAGKLSAVIKVYGAWIDLNTRKL
TTPPKEAQDIFLNVDKTDDFEVIQLKK
>FCMOIPGL_02593 hypothetical protein
MNKKVISAILLVIVLSYYLYQEKKELISSDKTVITDVKIEGFNYLPTSTTGAIINHNGYV
LSYSEKHEQAEWVALIL
>FCMOIPGL_02594 Nuclease
MGCAYSLDKKDIVYSDRKRPFFIEDPKVKTKSANWRNYKKSGYDRGHLCPAADRRISKES
YNETFYTSNISPQKHDFNAGIWNKLEQKTRYWAKKYNHLYVISGGVLERNLKTIGSEKVS
VPNHFYKILLDYTKPEIKAIAFLFPHKESKKPLYNFVVSIDEIEQKTGIDFFPNLPDNLE
NKLESSSNYKNWSFR
>FCMOIPGL_02595 hypothetical protein
MKKIIIILVIGFLFSSCESESDSDCDGPLLTFKNGTNFSITLIINGKVEKTISAGQTHLV
RYPSNSITYSAAAGNHRWGKTITLDDCDAKSITLTV
>FCMOIPGL_02597 Succinyl-diaminopimelate desuccinylase
MNTIQSYIKDNKKRFLNELIELLKIPSISADSAYKKDVLITADFVLESLKKAGCDNVELC
ETPGYPIIYGEKIIDKNLPTVLVYGHYDVQPADPIDLWTSPPFEPVIKKTDIHPEGAIFA
RGACDDKGQMFMHVKALEYMTSTGNLPCNVKFMIEGEEEVGSESLAWFVPRNKEKLTNDV
ILISDTGMIANDIPSITTGLRGLSYVEVEVTGPNRDLHSGLYGGAVANPINILTKMIASL
HDENNHITIPGFYDKVEELSSEERAEMAKAPFNLEKYKDALKVDAVYGEKGYSTNERNSI
RPTLDINGIWGGYTGQGAKTVIASKAFAKISMRLVPNQDWREITELFKNHFENIAPKSVK
IIVKPHHGGQGYVTPINTIAYQAASKAYETSFGKTPIPQRSGGSIPIVALFEQELKSKTI
LMGFGLDSDAIHSPNEHFGVWNYLKGIETIPYFYKYFTELSK
>FCMOIPGL_02598 hypothetical protein
MKNGFYILISFVIFSSINTFSQGLLSEKNNFTKQDTLRGSITPERVWWDLTYYHLDITVD
PDKKFISGKNTIKYKVLNENKTMQIDLQAPLKITKVTQDGKVLTVIHDGNAHFVKLVKNQ
NIGKIESIVVYYEGNPKEAKNAPWDGGFSWKKDKKGNHFVATSCQGLGASVWWPCKDHMY
DEVDSMRISVTVPSNLMDVSNGRLESIEDHGTTKTYNWFVDNPINNYGVNVNIGNYTHFS
EVFYGENGNLDMDYYVLKGRLEKAKNHFKDAPKMMKAFEHWFGPYPFYKDGYKLVEVPYL
GMEHQSSVTYGNQYKKGYLGRDLSGTGWGLKFDFIIIHESGHEWFANNITNKDIADMWIH
ESFTNYSESLFVEYYYGKKASSEYIIGLRKSIANKKPIIGKYNVNNEGSGDMYNKGGNML
HTLRQLVDNDEKWRSILRKMNKTFYHQTVTTVQIENFLSTETGIDLSAFFNQYLRDIRIP
ILEYKIENKTLKYRWTNTVSNFKMPLKVTIDSKETWIYPRENWESLDLKTINNNFKIDDN
FYIFTKNKL
>FCMOIPGL_02599 Prolyl tripeptidyl peptidase
MKTNYLKFIAFLCFYLFITSCSKTKEQKEFTIAEYEAAAAQMDRSLYNLVYNEVTGTNFI
NNSSFIYATKTKKGKKFILVDATSKTKKEAFNHEKLAEILSKELEKEIKANDLPIYSLSF
SDDLKTLHFSAYRQKFSYNLKKNSLSKEALSLKRTSRNEHISPNGKLAAYIDNYNLWVRD
LETNKKTQLTFDGIQDYGYATNNAGWTKSDGAVLKWSPNSDKIATFQQDARGVGMMYLTS
TNVGHQKLEAWKHPLPGDKIIFTIERVIIHVGNKPKTVRLKMDKDYQRGTTTDHIADWNN
ELLDAQWNNEGTKFAFVSGSRDHKIAHLQIADANSGVVESIHKEKVDTFYESGVNAENWK
VLFDSNEFIWYSEKSNWGHIYLYDLTTKELKNQITTGNWIVKEIINIDKNNRQIYFKAGG
KEEGNPYHNYYYKVNFDGSNLTNLTPSKGTHTATFSDDYTTLVDTYSTTKTPPISVLRNG
NGEKIIDLESADISELKAKNWQEPVEFSVKARDKKTDLYGLLFLPSNYDESNKYPVLNYI
YPGPQSGSVGNYGFRAVWRDFQAVAELGFVVVAVDAMGTPMRSKSFHDAYYGNMGDNGLP
DNITAIKQLSEKYKGMDIERVGIWGHSGGGFASTRAVFEYPDFYDVAVSGSGNHDNRNYE
ADWGEKWQGLLVDGSLEGNGDGTTNYDNQANQLIAKNLKGKLLITHGSVDDNVPPSNTML
VVEALIKANKDFDMILFPNKRHGYGDMTNYMTRKRWDYFVTHLLNAKPPKEFQIK
>FCMOIPGL_02600 putative lipoprotein YiaD
MKKIILGAFLFCSTIIVNAQEQEYNKWSIDLGGGVTRIINPLSDGYRSNSFDPGQANFGV
RYMFNEKFGLRLGVGYNEFKEGSGSLPYKANYYRTNLEGVVNAGNLFKFSSWTKKFNFLF
HAGFGLSNLNTITPIDNSESIFNIMIGFTPQYKLSNRVSLFLDFSTIMHDNQDITFDGAA
NTRNADNITASIFNTSIGVSVSLGKKKENADFLPDEEVYVNNELSEIKERLDKAETEISD
LKVRKADINKEELIYELDTRYLLKGESNSKYASKVTSSNVDFIRELLNSGYINVYFNTNK
TTIQEGSLNSVNYLKQFMIDNPTVSAQLIGFADETGNADQNLQLSENRAKSVFEILVAAG
INANRLSFSGGGVDASVKEKARQFARKVTFKIK
>FCMOIPGL_02601 hypothetical protein
MKKIVLLASIVLLSSCATVKFKDKWLKEKAPNTFTARFETTQGNFDIVARRLWSPKGVDR
LYQMIKKDYYTDVAIFRVVPNFVAQFGIHNDSLINKSWQKGIEDEPVLAKNDSMSISFAR
GGVNTRSNQIFINLKNNNRLDTLTYSGVTGFPVIAKVISGKENVLKFYNGYGDKLGYKQD
SIAKFGNKYLREKFPKVDYIIKAYILK
>FCMOIPGL_02602 Methicillin resistance regulatory protein MecI
MQLSKTEEQLMQYLWKRKKAFLKDLLEDFPEPKPATTTVATLLKRITDKGFINYKLFGKS
REYYPIVKKTDYFSKHVNGLIKNFFNDSASQFASFFTKETNLSTEELEELKKVIDSQIKK
QQL
>FCMOIPGL_02603 hypothetical protein
MITYFLKSATCLALLLAFYHFILEKEKMHTFNRFYLLGSVFFSFLAPLYIIYIDATPIII
ETTLPVSNVNYSEFTATEANIEKQINYTQILIGIYLTISSILLLRFGRNLLKIINKIRTN
TKVKYQKAKLVLVSDKILPHTFWNYIFINKNDYENQKIEQELFTHELTHVTQRHTLDVLI
LELIQIIFWINPFFILLKKAVQLNHEFLADETVIKQHKNTFQYQHLLLNTAAWKNEYYLA
SNLNYSLTKKRLLMMTTQSSQTKILLKKLAVIPLLTGFIFLFAERVEAQETIEIVEEIQE
IEVVEEIEEISDEKEIYKEYYYKKLTFIRKDENGNKISKKYNELNDEEKARLIPPPSLKF
KKIVPTKQQIEDLKDNSKYAIWIDGKVVKNEVLNNFKNTDFARYSNSHVYKNARSKRFPQ
ENQAHLETTKYFENKNKKRIQAFKEYLEKEHKVETINEQRDTEFRKIINEIGEKYDTNPY
SELNKSYEIERNKKPHFTESSAERQKVLTDLYSKLGSMYFKLSKENKKRNKRPIHPHHPY
LRLMKNNKVFYKLKDELTREDELLIPPPPPVPNASKEQILKAKKAYEEWKMRTGNTISTP
PPPISALDHVIKMAKKDATFYFEGTKITADKAIELLKNNKKLNIDTRNKDSEKPIVKISQ
KPITIERK
>FCMOIPGL_02604 hypothetical protein
MLKKFFLTCSGVDKNIIENCGNGEQNKFVGIGATVFFTAIMATIAGSYALYTVFDNLYAA
IFFGLVWGLLIFNLDRFIVSTIKKKDSKLKEFLQASPRIILAVIIAIVISKPLELKLFEK
EINQVLLTEKNQMTLDNKTQIAQQFTPEIEKINLEIEFLKQEIISKEKVTNALYETYITE
AEGTKGTKKLGKGPVYQEKREKHDVSLAALNQLRKDNLEKIERKESSIAALIENQKLAET
KSQPIISNFDGLMARVTALDQLPWLPSFFIFLLFLAIETSPIIAKLLSPKGEYDYKLEDY
ETAIKTLVKQQVHQREQMLQADISIDNKVYKDIAEEDELHTYKQKLARDLMKLQADSFYK
KQQKML
>FCMOIPGL_02605 Lysine--tRNA ligase
MQLSDQEVVRREKLVKLRALGINPYPADLFPIDSNSTEIKQNYIEGKKVVIAGRLMAKNL
QGKASFGQLQDAEGRIQVYFNRDEICAGEDKTQYNTVFKNLIDLGDFLGIEGELFTTKVG
EKTVKVKSFTLLSKALKPLPFPKEKDGKIFDAFTDPEMRYRQRYVDLVVNPRVKEVFIKR
TKLFNAMRSFFNDAGYFEVETPVLQPIPGGAAARPFITHHNSLDIPLYMRIANELYLKRL
IVGGFDGVYEFSKNFRNEGMDRTHNPEFTAMEIYVSYKDYNWMMDFAEQLLEHCAIAVNG
TSEATFGEHKINFKAPYARVTMADSIKHFTGFDITGKTEDEIREAAKGMNIPVDETMGKG
KLIDEIFGEKCEGNYIQPTFITDYPKEMSPLCKEHRDNPELTERFELMVCGKEIANAYSE
LNDPIDQRERFEHQLKLAQKGDDEATEFIDHDFLRALEYGMPPTSGMGIGMDRLIMFLTN
NQSIQEVLFFPQMRPEQRIVTVELNDGEKELLATIKKAEKIELNTLKEQSGLSNKKWDKS
LKHLTKNKFAKVSKTDEGLFVEIV
>FCMOIPGL_02606 hypothetical protein
MKNLNIFTKTLFTFCILTVSFILISFNVKETADEKKISELSIEIIKINKELQNLKAINKN
ETYSMDPFIGEVGLFAGNFAPRGWAFCEGQLLDLSENTALFSILGNTYGGNGRTTFRLPD
LSENKPNGVNYIIALKGIFPSR
>FCMOIPGL_02607 hypothetical protein
MASLLGAILYYMYTFGEIYKLSIVRSILKLFRFLIGLISPFIFSLILVALTGVIIGFWGL
VNF
>FCMOIPGL_02608 Thermolabile glutaminase
MENYKKIIEDIYLEIKNVEDIGKVPNYIPELSKINPDNFGINITTIDRQNFGIGDFNKKF
SIQSVSKIFSLALAYKFEGVNLWERVDVEPSGNPFNSLLQLEADKGKPRNPFINAGAIVV
CDVLVGHLKNPKEEFLDFCREISNNESLNYSEKIAHSEKISGFRNIALCNFIKSFGNIKN
DVDEVLDFYFHICSLEMSCKELSEIALFLADDNFTTHKGNKVLTMSKAKRMNAILLTCGF
YDESGEFAFRVGLPGKSGVGGGIVAIHPDKYCIAVWSPKLNIKGNSFKGMLFLEKFTSKT
ASSIF
>FCMOIPGL_02609 HTH-type transcriptional activator RhaS
MKNIPNITFQSNEHKRNFELLNLTSLFERLDSIEDHEPRQPHRIAFFALLVVTKGTGTHQ
IDLKDYEVKEGTVLKIAKGQVHSFQRNATYQGFLILFTEEFLMNYFSKSSINLISNLYNY
HLSSPFSMNKIDNEILIHQLQSEIALEINFAHHNIVAAFLDLYLLKLERKSPDNYIPKNK
SKLFRTFDQFKSLVETNFTKTRNVKDYANLLYISTKTLNASVKEFTLNTAKNFIDDYVIL
EIKREMMSTNKSLKEIAFDIGFDEVTNFTKFFKKKMNLSPKEFKSNQLY
>FCMOIPGL_02610 hypothetical protein
MKAKLITLLCIALFTVELGFSQNETKAENNFLFGQAEHFLDGYSFNFQYQNGTGLHMEFK
DGKAKYQWVAGPNKGNGNEDIPYKSTKLGNDMYLVNWHETGLKDYLTIVFDFDKMVMHSS
IIVGYQNKPERTLKTVFTSGIIDHLKRPE
>FCMOIPGL_02611 hypothetical protein
MVIEQSNKIDLILNQLFNDSKNDHYKIMKGLAKSAFRPIQPIDFKDVYLSISKEQGKELV
ALIKENNLKNIVEFGTSFGISTLFLAQGILETKGKIITTELIESKAKTAIENLTKASVKD
LVDVRIGNAMNTLKDHDEPIDLLFLDGWKDLYLPLFNMLASNFHKHTIIYVDNANMAASK
LFLKEIAETEKHQLESKFGGKVVLISMKK
>FCMOIPGL_02612 hypothetical protein
MSQVEICPTCGSKSKIKEKEGNTIYTAVHDDEAFKKIGQMKKAMEKFKLKAETLEKELAA
LKANL
>FCMOIPGL_02613 hypothetical protein
MNIDQNKKNAIAFYKMAYEGNPTKAVELYVGEKYIQHNPMVGDGPQAFIDYFDRMQKEYP
VKTIEFVRAVSEGDLVALHTYQEWPDNDKYVTMDFFRFDNNGKIIEHWDSIQQVPKEALN
NNTMYK
>FCMOIPGL_02614 Sulfoxide reductase heme-binding subunit YedZ
MKAIKKNYGWIIVAILALLPMLVIINMFNVDLSNGFSLSLIEGKGADGKTTLEMLYHISG
EFAIRWMTAVLTLTPVFILFGVMNLFVRQAMGIATAVWSFLHFIIFIWAEGFLETFTQIN
YVAGFVAILILIPLFFTSNRKSMKYLKSNWKKLQRYAYAAIFLSLLHVAILNKTWLIYAI
VVGVGFIIRIPFIKNKLIERRKKLKS
>FCMOIPGL_02615 hypothetical protein
MGLLEHILKKVVLETGVIEKKEKISASVYKIRLKSESIKKVDFKPGYFLRLGIGIGNDNL
SMKDKVRSYSVWDINQTEGYLDLAIATDSKGIGSKWVINCTIGETVYFKWKKGNFLLDET
AESYLMIGDLSALSHLYMLNRNLPNNKQVESLLYSENQSAFFDDIDHSTPFDSYCLEQNS
INEILEKVKEITPKLKGNTIVYIAGDSRVCVALNHYFRNELNWNTKQIKTKPFWNPDKKG
LE
>FCMOIPGL_02616 Hercynine oxygenase
MKLADKYKQVRLQTTTFCNHLNIEDYAIQVVLFASPPKWHLAHTTWFFETFILKKYVADY
TEFNSDFNFLFNSYYNNVGNRILQANRGNMSRPSTNEIFEYRAYVDAKMIAFLKNLSDEK
IIDLVTLGLNHEEQHQELLVTDVKYMFGHNPIFPVFNTDYNLVKDKNTDTKNIQIPAGIY
EIGHQGKDFCYDNELGVHKVYLNDFEIDNHLVTNGDFIEFMESGAYSNFNLWLDEGWTWV
NKNNIKTPLYWHKIDGEWHSYTLAGLKKVDEDAILSHINYYEANAFAEWKRMRLPTEFEW
EIAASQLDWGKRWEWTNSAYLPYPKFKKENGAVGEYNGKFMSNKMVLRGASVATSQKHSR
STYRNFFNPTERWQFTGIRLAK
>FCMOIPGL_02617 Histidine N-alpha-methyltransferase
MIEIVKNKDKKGLTNSLNINETFRNDVKKGLLSNPKTLSSKYFYDKKGDALFVEIMNLPE
YYLTRSELDIFKNKTKKLIDSFTIKADSYFELIELGAGDGLKTKELLKSLTAQNYNFEYF
PIDISSNALGQLKQDLNTEIPNLSVKTQQGDYFEVLDSLKKSKHPKIILFLGSNIGNMTD
EQAAQFIYKLGVNLNPDDKLLLGVDLIKSKEIILPAYDDSKGITAAFNLNLLDRINHELG
GDFNLNQFKHQPEYVEKEGIAKSYIVSKINQTVTIKAIDTSFNFIKGEKIHTEISRKYND
ELIEQIIANTDFSIDTKIMDSKAYFADYILTRN
>FCMOIPGL_02618 hypothetical protein
MSKTQFAILGLGSRSTLYYLEQLNKLYNAKNGGYSTCPFFLLNTNFDNINQLLPNTSVQL
DAILQNYLDQIESLEVAEILIPNITLHETIDRLELQKNIIHPLPLSVVKMRETDTKKVML
FGSLHSMQSRYIRSYLEFNSIEVLLPSLKDMIFIDEVRTHIYNSTETKEIINIYHELIKK
YSENNPVILGCTELSILKPKDQKNVIDMAQLQIEAALKIKL
>FCMOIPGL_02619 Quinone oxidoreductase 2
MKIAVTSASGKLGASIVKHLIKAIGKENVIAIARTPERAVYLDVEIRKGDYNNREDFEKA
LQGIDAVLLVSGMDDPQKRILQHRNVIEAAKSNGVKKIVYTSIVGAEENNAFSPIVQTNR
QTEKDVINSGLDWVIGRNGIYIEPDLEYIDTYIKEGEIRNCAGDGKCTYTSREELGFAYS
KMLLEEKHNGNTYNLVGEAITQSELASLINQVYYTNLTYNSVSVDAYAAERKAALGDFIG
TVIAGIYEGIKEGANEVPSDFEKATGRLHQSPLKMIKAFKGE
>FCMOIPGL_02620 hypothetical protein
MINTSHSDAQIYCVTNFEELLSTPFQGEINAMCWNRKLVGDFSEIVKKLTLNENIQIVHP
KDLLELKLSEQGQLAREILLNDFNVLKAHGASPTINIIKNYESDDAFPFFPTDVYSFHVD
RSPIATDTFLCTYFGASSDILPNSQGTQKILIPEIRSELKKLYGESDEEGFESFLSEFFF
DLHYQPKPNTNPISLGNGHIWKLAIDHPESKVLPCLHRAPKENTGENRLLLIC
>FCMOIPGL_02621 Ribosomal RNA small subunit methyltransferase G
MEIIHKYFKNLSEIQIAQFSKLQELYQDWNLKINVVSRKDIDELYLRHVLHSLAIAKLVQ
FKPGSKVMDVGTGGGFPGIPLAILFPETQFHLVDSIGKKIKVVNEVVEGLGLENVKTTNG
RVEEIKDTYDFIVSRAVAQMETFVGWTKGRIAKKQNHKLKNGILYLKGGDLTEELKLYTS
ATIYELTDYFDEEFFETKKLVHLGMKFKN
>FCMOIPGL_02622 NADPH-dependent stearoyl-CoA 9-desaturase
MKTINFSRVDKAKFFRTLNKRVNTYFKENNLKRTGNWKLYSKAIIMFSLFLVPFILILTV
AMPQWVMALLMVVTGIGMAGVGMNVMHDANHDSFSKRKWVNKLMGSSIYILAGNVYNWKV
QHNVLHHTFTNVEGHDEDIDAGRIIRFSMHSKWLKIHKIQKYYSIFLYGLLTINWAITTD
IKQMHRYLKRKLSYGEFPNPATEWTKLIISKIVYYALWIVLPLLILDVSWWKVLLGFFVM
HYTAGMILSLVFQLAHIVPNTEMPIPDKEGNLEHTWAVHQLYTTSNFAPSNSLVNFYTGG
LNHQVEHHIFPHISHVHYDKLAKIVKETAQEFNLPYNEYETMRKAIVEHFRHLGVLGQKP
ELA
>FCMOIPGL_02623 Aspartate aminotransferase
MTHPLSDRINSLPVSQTLAMAAKARELRAEGKDIIGLSLGEPDFNTPEFIKDAAIEAINQ
NYNSYSPVDGYADLKEAVCTKFKRDNNLTYKPSQIVVSTGAKQSIANIAQVLLNPGDEVL
LPAPYWVSYSAIAILCGAKYVEIPSSIDTDFKITPEQLEAAITPKTKMIFFNSPNNPSGT
IYSEAEYRALAAVLEKHPQIFILSDEIYEHINYNSRPFSFAAIESMYDRTITVNGLAKAF
AMTGWRIGYIGAPEWIAKACTKMQGQITSGTNCIAQRAAITALLAPVSKIQYMVDEFKTR
RDIIIGLLREIDGFKVNVPEGAFYVFPDVSAFFGKTIDGVKIETASDFSLFILEKANVAT
VTGDAFGTPNCIRISYAASELQIREAIKRIKEALS
>FCMOIPGL_02624 hypothetical protein
MKYLNTEVVEERGILTSAYKQEIKRNMRLEKSKSISKIKSMILNHEGKIESQTGVVLQVS
LFAFAIILIAF
>FCMOIPGL_02625 Cell division protein FtsZ
MSAEFDNILFDMPKTQSNTIKVIGVGGGGSNAVNHMFTQSITGVDFVICNTDSQALENSP
IPNKIQLGANLTSGLGAGANPEIGAQAAKESLQEIQKMLNTQTKMVFITAGMGGGTGTGA
APIIAKIAKDMDILTVGIVTMPFAFEGKRRTSQAQLGIDQLRKNVDSLIVINNNKLREVY
GNLGFKAGFSKADEVLSTASKGIAEVITHHYKQNIDLHDAKTVLSNSGTAIMGSAKEEGS
SRAKNAIVKALDSPLLNDNKITGAKNVLLLIVSGKTEVTLDEIGEINDYIQDEAGYDANI
IMGIGEDDNLGDAIAVTIVATGFAADQQSTITNTEVKKVVHILEDEQKATYNFDEKTISK
SPTLDTPVVNTTPQKIVHDLGDEIEDTKPNMDLVATNPIIASMPVTFEEVSYQTVSDDDF
IITDVAKAEEKIEEEPKQIQADLLFDLPLAAKKEVKPEEEINVEKELNVNEIQVFEAKEI
KAEPKSVEKRYVLEDFDAQPTIGKSSGFAEKKKVEEQEVQFELKTRKPQAEINKIETLSE
EVSPMDLTISELQQRAEERRRKMKGFNYKFTDQLSKNIDEIERQPAYKRMGVNLDKNASI
SNSETALKKDDNGIDFKSNNSFLHDNVD
>FCMOIPGL_02626 Cell division protein FtsA
MENNKIAVGLDIGTTKIVAMIGRKNEYGKIEVVGIGKAKSLGVKRGVVSNITQTIQSIQQ
AVEEAESVSGLKIEDVVVGIAGQHIRSLHHSDYITRVNADEVIENVDIQDLENQVHKLVM
LPGEEIIHVLPQEFKVDSQADIKEPIGMYGGRLEANFHVVVGQVSSIRNIGRCVKSAGLG
LSDITLEPLASAAAVLSQEEKEAGVALIDIGGGTTDLAIFKDGIIRHTAVIPFGGNVITD
DIKEGCSIIEKQAELLKIKFGSAWPGENKETEIVSIPGLRGREPKEITLKNLSKIIHARV
QEIIEHVYLEIKNYGHETSKGKLIAGIVLTGGGSQLKHLRQLVEYITGMDARIGFPNEHL
AGDSDEVLSSPAYATAVGLLMVGLDKTIKEEEKKEEVVPEVKIEPEPVLEIEPEPIVEKK
LKPKKKSFFEKFTEGLKDFLDNAE
>FCMOIPGL_02627 hypothetical protein
MKFKQFLKYMLFVVLIVGLGVLYGFSSARNSQIKIGEPVIEIDEGGNNFLTHLMVHKLLI
QNSETISNNTKSMINLYGLENTVLKNPYVENAAVFLTVDGQLKTVIKQRTPVARIVSKND
SYYVDKQGVKIPLSNNYSARVLLVSGIENDGEIIEVLPLISFILKDDFLQKEIVGIEKSD
VNEYQFSVRSGDYKIDFGNLSQIDIKFKKLKAFYNKTFKDKTIKSYSVINVKYHNQVVCT
K
>FCMOIPGL_02628 UDP-N-acetylmuramate--L-alanine ligase
MNLENIHNIYFIGIGGIGMSAIARYFATNGKLVAGYDKTPSQITASLEELGVEIHFEDTV
KNIPSSFFNKEETLVVFTPAVPKNHLEFNYFLDNNFTVLKRAEILGKITASTFCLAVAGT
HGKTTTSSILGHIMHQEKATSFLGGISENYNSNLILGDDKISVVEADEFDRSFMQLSPNI
ACITSMDADHLDIYGDAKELEKTFLDFSKKVSDTLIVAKGLPLKGLTYAINEDADFKAFN
VKIESGKYIFDVQTPSEIVKNIEFHLPGKHNVMNALAALAMADVYGVSLENIKQSLSTFK
GVKRRFSYKIKTEDFVLIDDYAHHPTEINAVENSIREMYPDEKVLVVFQPHLFSRTRDFI
DDFAKVLSKFDEILLLDIYPARELPIAGIDSDWLLSKINNEHKKLTQKNNLIKDIKNSSA
KVVVMLGAGDIGVMIHEVMNHFLNADKYEV
>FCMOIPGL_02629 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKPYNILISGGGTGGHIYPALAIANEIKVRYPDANFLFVGAKDRMEMEKVPQAGYEIKGL
WISGIQRKLTVDNLSFPFKLISSLWKANKIIKQFKPDIAIGTGGYASGPTLIMANRKNIP
TLIQEQNSFPGITNKMLSKKANKICVAYDNLERFFPSDKIIKTGNPVRQDLLTIHSKTDE
GKDFFSLDKKKKTILVLGGSLGARKINQLVESNLEFFKNQNVQVLWQCGKLYFDEYKKYD
GLENVQVHQFVNRMDFAYAASDIIISRAGASSVSELCIVGKPVVFIPSPNVSEDHQTKNA
KSIADKHGAILLRESELETFPIVFETLLKDRGKQEGLSENIKELALPGATTSIVNEIEKL
LRK
>FCMOIPGL_02630 putative peptidoglycan glycosyltransferase FtsW
MKTIFKHIKGDKTIWAIFAVLAIFSFMPVYSASTNLVYVVGSGSTLGYLVKHMVLLIMGF
GIIYGVHKIPYRYFSGGSVIMLPVVIVLLIFTLTQGTTIGGANASRWINIPFVGIGFQTS
TLAGLVLMVYVARYLARNKEKEIKFKESLIQLWLPVAAVLVLILPANFSTTAIIFVMILM
VTFIGGYPIKYIGLILGIGFVFLMFFVLVAKAFPDAMPNRVQTWQNRIENFSNPDEKEAY
QVEKAKIAIAMGGPIGVGPGKSVQKNFLPQSSSDFIYAIIIEEYGLAGGLLVISIYFLLF
FRMFVVIRKTTTIFGTLLVVGVGCPIIFQATINMAVATNLFPVTGQTLPLISSGGTSIWM
TCFALGMILSVSASKEETEEDILDDNPLDILHETI
>FCMOIPGL_02631 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MKNQDKHTIPVLHPSGERGFLVILGGGESGVGTAILGKQKGYDVFVSDKGSISKKYKEVL
LNNEIDFEENQHTESKIVNADVVMKSPGIPDKVALIQKLKQNSIPVISEIEFAAQFTDAN
IIGITGSNGKTTTTLLVHHILKKAGLSVGVAGNIGDSFAQQVAEESFENYVLELSSFQLD
GIENFNSHIAILTNITPDHLDRYEYDFNKYIASKFKITKNQKETDYLIYDADDEAINNWL
KVNKTSAKLVPFSLEKELEYGAYIKDNNIIINITKDNINMPISALSIKGKHNTKNAMAAT
MAAQLLKVRKQSIMESLEDFEGAEHRLENVAKIRDVEYINDSKATNVNATFYALECMEKP
TVWIVGGVDKGNDYNDLLALVREKVKAIVCLGLDNDKIKNTFGNVVDIIVETAGAEEAVK
VSQKLSERGDAVLLSPACASFDLFDNYEDRGRQFKDAVRNL
>FCMOIPGL_02632 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYYIFEYLNSQFNLPGAGVFQYITFRAASAFILSLLISAIYGRRIINFLHRQQVGETVR
DLGLEGQKQKTGTPTMGGIIIILATLIPVFLLAKLDNIYIVILIITTVWMGLIGFLDDYI
KVFKKDKDGLSGKFKVLGQVGLGVIVGSMLYFNDGVTIKEQLPVKDQLVQENGRKTVYGK
AHKSTKTTVPFFKDNELEYSKAFNFLGDGYEKYGWIVFILVTVFIVTGVSNGANLTDGID
GLAAGSSAIIVVTLAVFAWVSGNIIFADYLDVMYIPNSGEMTVFILAFAGALIGFLWYNT
YPAQVFMGDTGSLTIGGIIAVIAISIRKELLLPILAGVFVVENLSVIMQVFWFKYTRKKF
GEGRRIFRMAPLHHHFQKKSYHESKIVVRFWIIGILLAVFTIVTLKLR
>FCMOIPGL_02633 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MYIDKAISLGATVIICEDFPSDKKQGITYIQVEDSNVALAIMASNFYENPSSRFPLIGVT
GTNGKTTIASLLYQLFYKAGYKVGLLSTVKILVDEAEFKATHTTPDSVTINRYLDMMLEA
GVEYCFMEVSSHGIHQKRTEGLTFAGGIFTNLSHDHLDYHDTFAEYRDVKKSFFDSLPKS
AFALTNIDDKNGDFMLQNTKAKKKTYALKTIADYKSKILEKQISGTLISVDGTEVWTKLI
GVFNIYNLTAIIATAELLGLEKLEVLTIVSQLESISGRFQYVMSDDGITAIIDYAHTPDA
LKNVLETINDIRTGNEKVITVVGCGGDRDKTKRPKMAHIASQLSSQAIFTSDNPRTENAQ
TILDEMETGVFAENYRKTLTVLDRRQAIKTACKLSEIGDIILIAGKGHENYQEINGIRSH
FDDLEEVTNCFNQLKKN
>FCMOIPGL_02634 Stage V sporulation protein D
MTLFLLAVIFRVINIQYVQGEKYKKLSTELTIKQDTIRANKGNVYAADGNLLATSMSKFT
IRMDVVAVDGNVFEKNFVDLSKELSKLLGKSVAHYQSRLRTAKKRKNRYLLIARNVGYTD
YLKMKEFPIFNLGVYRGGFIAEHKTVRAHPIGKIAERTIGYDDFRGEAGIEGAFADFMQG
ENGLRWKQKIAKNQWKPISDVNEKEPIDGHDIITTIDVNIQDITHHALLSQLQYYEADHG
CAVVMETATGEIKAISNLGKGSKGGYFEKRNYAVWESHEPGSTFKLASLMVALDDKVIDT
STVVDTEKGIFYVNNRKVEDSHRGGYGKISAARVFEVSSNVGVVKIIKEHYDNNPQKFYK
KIEEYGFTKPIGFQIKGEGIPYVPNPKDKSWSKISLEWMSWGYGISVTPMQTLMFYNAVA
NNGIMVKPRFVKELRRHDKAEKIFETEIVNPKIASDETIKKLRKVMENVVIKGTARNIYS
PNFSMAGKTGTAKKYMPRIKNDKGEWEGGYYSTKNYVASFVGFFPADVPKYSCIVVVHNP
NKNTGYYGASVAAPIFKEIAQKIYTTTPIDNQTVEDKVEFTSINNQYKEYNKNINKEYAS
VPNVKGMSGMDAVSLLENIGLKVKFSGIGKVNYQSIKKGEKLVKGSTIILKLS
>FCMOIPGL_02635 hypothetical protein
MSKVKQGVYDFLRGSFLTDESAFKNWRIIIFVVILLLVMISSAHSADKKVIKISELNKRT
RELRAEYVDTGTILMRMKMESSIREKAKARGLKPSETPPKKIKVTYKD
>FCMOIPGL_02636 Ribosomal RNA small subunit methyltransferase H
MKYHNPVLLQESVDALAIKEDGVYVDVTFGGGGHSREILKRLGSKGKLFAFDQDPDALEN
IIDDERFVLIPENFRYISRFLRFHGVRKVDGVLADLGVSSHQFDEAERGFSTRFDGDLDM
RMNQKSKTSAKEIINTYTEEKLAEILFLYGELRNSRNLAKTIVEERAKERIDTSFQLKSV
LKKYLPNAKEHKILAQIFQAIRIEVNEELEVLKEFLTQIPNLLTDEGRLSVISYHSLEDR
LVKRFISSGLFSGELEKDVFGNTDEPLKKVGKLIIPSSEEIKINNRSRSAKLRIATLKSN
KQKLKS
>FCMOIPGL_02637 Transcriptional regulator MraZ
MINLIGTYECKADAKGRVMISSAFKKQLSSVLQDGFVVKRAVFQPCLELYPIQEWNLMME
KINKLNKFKKKNNDFIRRFTAGVQLVDLDSTGRILIPKNLMDFAGIEKQVVMSSSVNIIE
IWDKDKYEKAIDDAAVDFADLAEEVMGNTDEDEIS
>FCMOIPGL_02638 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase
MWLVKIKQKSMTDKLKTEGKFTYAEAGEGPAIIVLHGLMGALSNFESTFNHFSKNGYTVL
IPELPLYSLPLLKTNVKNLAKYLKEFLEYKKIDKAILLGNSLGGHIGLYFTKHYQEKVSA
LVLTGSSGLYEKAMGDTFPKRGNYQYIEEKTRAVFYNPEIGTKEMVDDVYKIVNDRHSVI
RTLAIAKSAIRHNMAGDLPKMKQPTCLIWGKQDTVTPPEVAEDFHKLLPNSDLFWVDECG
HAAMMEQPEEFNKILQDWLTSRNI
>FCMOIPGL_02639 putative GTP-binding protein EngB
MKIRSAEFVMSNSNVINAPKDRIPEYAFIGRSNVGKSSLINMLMERKDLAKISGKPGKTQ
LINHFKINDEWFLVDLPGYGYAQISKKKRTIFQFFIENYFKEREQLVCTFVLIDSRHDPQ
KIDLEFMQFLGENQIPFCLVFTKADKLGSSKLNKQITAYKKKLLNTWESLPMTFLTSSSS
GLGRKEFLDFIGGVNEDVAKDFK
>FCMOIPGL_02640 Ribosomal large subunit pseudouridine synthase C
MHSNKDNLQILFEDNHIIIVNKRSGDITQGDRTGDKPLSDVVKEYIKEKYNKPGDVFLGV
VHRLDRPTSGVIIFARTSKSLERLNKMLRDKNISKTYWAVVKDHPKKEKDTLINYLKKNP
KNNKSSVYPKEITDSKKAILHYKIIKKLDNYSLLEIDLETGRHHQIRAQLSSIGFPIKGD
LKYGFNRSNKDGSIHLHARKIQFTHPVSKEQISVIAPTPKEVIWDACC
>FCMOIPGL_02641 HTH-type transcriptional activator RhaS
MNRNPLTTLIIFQLLCLFTLNTLSQEFKIETSKISVLNESIITDVEQDIDGFIWIASNQS
IYKYNNKDFINFSQKELLLKPHHSTINLVSDANGNIWYFPQNEFSLKILNTKNNKASSIK
DFFPNLPFSESEIINIIYRDHLYNIYISVKNKGLYKFDGKKIEVVKSIKEKNKLPIYFVS
TITHNWFGYDKKIIKQNKETLLEDTFSANSEILGANIFNNEAIFFTQKDIRSDNIFAEHI
KDNKAVNIFQTFKLNSAYHFKKDRIFQNINNDKYWINEKEYLKQIDKDKKIIFQIKKADL
PFGDRYRAFFVDRNNIIWIITQTSLYKIIMHENNFKKYLDGYSLKSIFKRDSTFYISAFS
SSLKELDSKNTIHQSKHLTKQYSFFGTFYHKDTLWAARYSRILRYNFKTKTTTDYKRGSK
VDNEEVGYGAIARHPKTKTFFIGSLTYLAKIDEAKKTAIAVNSLDKYLDKKDRDKLNVRC
FKVYGDSLWIGTAKGVFLMDHKEQISKAFTAKNGFPKNLTIQYIFIENDATFWLATQGQG
LVKWNRLTNTFKTFTTKDGLSNNNIYAIYKDKFGFLWLPTDNGLNRFAPKTLKNHIFLPN
TISHKEFNHLSHFQDKNGDLYLGGLNGLNVFNPEDFLTIDNTKYNVVLNHIKTTLSNNSV
IEKHQINNNTITLNSEVKNTALEFLLLDFKNNLPLQYQYKITPFQKDYVVCENNIVVLPK
LKKGKYLLHVKAQSSDGTWAELKTPIQINNNISGDYLNILIILLCATSAIVLFFIIKRKK
TKKKELNNKEKSVQKEKTEITESDSLSKIKQEEWLNQLKQTILKNMNSINFGMEFLSQEM
ELSERQLQRRIKNLTDLTPNKYITEIKLNEAFRLIEEKEVETVKELSIKVGYTTPDYFSK
LFKNKFGKKPSDYF
>FCMOIPGL_02642 Acyl-homoserine lactone acylase QuiP
MKFLKKLLKIVVVILVLVVIGAWLYSKTYHPKYDGEIKLKNLSEKVTVYFDDIGVPHINA
QNQQDAYTALGYVHAQDRLWQMELIRRIAGGRLSEIFGEKLIRTDKLFSGLGIEEASEKT
IKNLDKNSPKYKMTMAYLDGINQYIEEGKTPIEFTLVGVEKEKYTIKDVYNVFGYMAFSF
AIAHKTDPLLTEVKEKLGTAYFNELIGAESENLTLIKNEKNTELTGGFAKAMNDLYDILP
LSPFIGSNSWVIGADKTKNGKVIFANDPHIGFSQPSVWYQAHLKTPDFEMYGFHLALVPF
PLLGHNRDYAYGLTMFENDDVDFYVEEENPNNKNQYKLENGFVDYKLIEKHIKIKGRKDS
IYTIKVSRHGPVMNGIIDHLDDKRSIAMQWIYTKLDNQILDVAYEISHAKNLSEFKKGAS
KLHAPGLNMMYGDAKNNIAWFASGKLYKYRDSLYTKTYLNGASGKDEIVEYLDFEENPQA
INPNRDYVYSANNQPDSIDGKLYPGYYLNEDRAKRIVELLEPKNDWTKEDVAKMTYDVTS
PNAPIIASDFVKSINKKDLSVSEKQAISFLKDWKGNFEKQEVGPVIYNRMVYEFQKNTFA
DEMGKAYNQFTNTPFIEKVLPVQAKREKSIWWDNVTTKDKIENKEEIVTKSFKNAFAFLQ
NQLGENVKNWTWDRVITVEYKHAVGEVAVLRKFFNVGPFVTTGGDQVINNQIYDIDSTGV
YKVKAGPSTRRIIDFSDVENSLAIIPTGQSGNVFSAHYKDQAKKYLNGEFVKMKLDNKEI
LKIKNQLILIKEKD
>FCMOIPGL_02643 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MVDLQSQYQKIKETVDNSIQEVLNSSTYINGPLVKEFQEDLEKYLNVKHVIPCANGTDAL
QIAMMGLGLEQGDEVITADFTFAATVEVIALLKLTPVLVDVDAKTFNIDIEALKKAITPK
TKAIVPVHLFGQVANMDAILEIAKEHNLFVIEDNAQAIGANYTFKNGKQQKAGTIGNVGT
TSFFPSKNLGCYGDGGAIFTNDDALAHTIRGIVNHGMYERYYHDVVGVNSRLDSIQAGVL
KAKLPLLDGYCDARRDAARFYNNAFANNPNIITPTAKSNKTRNCDTICDVCDCHVFHQYT
LQITNGKRDELHKHLLANGIPNAIYYPVALHSQKAYTDARYNEEDFPVTNNLIKTVISLP
MHTELDKEQLTFITKTITDFLK
>FCMOIPGL_02644 UDP-glucose 4-epimerase
MKKILVTGGLGFIGSHTVVELQNEGFEVVIIDNLSNTTIDVLDKITEITGKKPAFHKVDV
RIKSEVKSVFDAHEIDGIIHFAAYKAVGESMGKPLEYYENNLSSLVYILQEMRDRKLDNF
IFSSSCTVYGQADELPVTEKAPVKPAESVYGNTKQIGEEIIRDTSNAHGIKCIALRYFNP
VGGHPSIKIGELPLGVPQNLIPFITQTAAGIRKELSVFGDDYDTVDGTAVRDYIHVVDLA
KAHIAALSRLINNNHKADFEYFNIGTGKGSSVLEIIKTFEKVNNLKLNYKIVGRREGDVV
AAYADTTTANKELNWKTEMTLEDSLESAWKWQQKQSV
>FCMOIPGL_02645 hypothetical protein
MKKAFLSIAIFTIVLMSSAEVTAQKFAKVDVSPMDAASFPNNWKESNKLVKIIYSRPQLK
GRTLDKLAPIDKVWRTGANEAAEITFYKDVTFGGKEVKAGTYTLFTIPTEGDWTVILSNQ
KNIWGAYFYDMKEDVVRVNGKMSKSEDSIESFSIVFEGEEESAMMYLGWANTIISVPVKG
>FCMOIPGL_02646 hypothetical protein
MQEIITYTLVVLAVVFLMKKFIFPSKKEKGCSTDCGCH
>FCMOIPGL_02647 Fe(2+) transporter FeoB
MSKNDIKVALIGNPNTGKTSLFNQLTGLNQKVGNYPGVTVDKKEGISKLSATQNAIITDL
PGTYSINPTSLDESIVLKTLLKKDIKESPDVILVVADVENLKRNLLLFSQIKDLEIPTVL
AINMVDQMHRKGISIDLSLLKKELNTEVVLISARKNEGIKEVKEAIIRCHVAAKASPLCG
INHKIDPDYFHKLKEISPNYTLYELWLMVTQSNFPETITKEEREKLLAFKQDVSKLKKYQ
HKETIYRYQEINKILKKTYIVDKTKATDLRGRLDRIFTHKIFGYVLFSLILLVIFQSIFD
LASVPMDLIDGVFAQIADFAKSNLPTGVFTDLLAEGIIPGIGGVIIFIPQIAILFLFIAI
LEETGYMSRVVFLMDKIMRRFGMNGKSVIPLISGTACAIPAIMATRTIASWKERLITILV
VPFTTCSARLPVYAILIALIIPDKKIFGFLNLQGLVLLSLYALGFASAIIAAYILHKTLK
VESKSFFVVEMPNYKLPSVKNLFFEVVEKTKAFVFGAGKIILALSIILWFLASNGGSSYE
NAEKSVVENVDNQNLNDDEIQQKIASLKLENSYIGILGKTIEPVIKPLGYDWKIGIALIT
SFAAREVFVGTLATIYSVESDDENTSTIKQKMASEINPDTGEKRFNFPVGMSLMVFYAFA
MQCMATLAIVKRETKSWKWPLIQLFGLAFLAYVSSFLTYQILS
>FCMOIPGL_02648 hypothetical protein
MSTIADLHIGEIGYISEDSLDFIPLKLLEMGCLPGAEVQLIQFAPLKDPLYICVNGSHLA
IRKETADQIKILKNE
>FCMOIPGL_02649 SCO1 protein 
MDFNFFKKSKLTIIFILVFSAISIPVFYHLVKVDKKLKVYNPADVNPSLVDVSLKHITKD
HTISDFELINQNGEIITNNNYKNKIYVADFFFTRCQTICIAMAYNMSELQEYYKNDKDIM
FLSHSVTPVIDSVSVLKEYADRKGVIDGKWNVTTGSKKHIYELARKSYFAVLESGDGGED
DFIHTEQFVLVDKERRIRGYYDGTEKKDMDKLKNDIALLKEEYTNK
>FCMOIPGL_02650 Putative zinc metalloprotease
MEILIKASQFILSLSLLIVLHELGHFIPAKLFKTRVEKFYLFFDYKVSLFKKKIGDTVYG
IGWIPLGGYVKISGMIDESMDTEQMALPPQPWEFRSKPAWQRLIIMLGGVFVNFILGIFI
YIMLMWSYGEQYLPNDNVKDGVWVQDSLAVNLGLQTGDKILTVDGDKIRNFSSLTLEFVN
GNNFQIERNGEVIDKVIPTDFISQLMDRGKDAGAFIYPRYPFAIGKISEDSPNLNSELKP
KDIVTSINGAPLKYYDEAEALLANHKGQKIKATVLRGKETKEISLKVTDEGKLGVAFSGI
AFKDLEKLGYYDLADIEYSFAEAIPAGWNKSWKTLTDYVKQLKKIFNPSTGAYKGLGGFI
SIGSIFPDEWSAESFWNITAFLSIMLGFMNLLPIPALDGGHVVFTLWEIITGKKPGDKFL
EYAQVVGFVLLIILLLFANGNDIFRLFK
>FCMOIPGL_02651 Inner membrane protein YqiK
MLNLIVLESSPFAGLVGIGIAILFIFIVLMTLIKRYKRCPSDRILVVYGKVGGGESAKCI
HGGAAFIFPVIQDYEFLDLTPISIEVNLVNALSKQNIRVNVPSRFTIGVSTEPGIMQNAA
ERLLGLNQDNIQELAQEIIFGQLRLVVASMDIEEINNDRDKFLTNISQSVETELKKVGLK
LINVNITDIVDESGYIQALGKEAAAHAINAARKSVAEKNRDGSIGEADAVQDERIKVSEL
QAKAKIGEAKAAQNERTQVAASMAEAKIGEANANQNERVQTANAIALAKIGEAEALKSER
IKTSEANAQAITGENTAKISIAESDALRREREAEAEKRAVATEKIQAAKALEESYSAEKD
AENARASRDKATKYADIVVPAEIAKAKVEIDAEAEAENIRRIAKGEADSIFLKAEAEAKG
LYEVLTKQAEGLDQIVKAAGNNSKDAVLLLVADKLPELVRIQAEAIKNIKIDKITVWENG
GGKDGKSSTSNFISGMYKSVPPLQEMFNMAGMELPEYLKGKEIPAALVEEKKETTEE
>FCMOIPGL_02652 hypothetical protein
MMEWFAELPSFLKTYWIITIISTFLFLIVLISTVMGTDSDDIGDVDAEIDADTGASFQFF
TVKNLIAFFTIFGWSGIASSDAGYSNPVIIAISIFCGLAMMTVMASLFYYISKLNSSGTL
KMQNALNAIGEVYLTVGANRSKIGKVQIKVQGALRELEALTDFDKDLKQGNVIKVIEVTN
NGILIIEPQK
>FCMOIPGL_02653 Vitamin B12 transporter BtuB
MKIKITVIIALLFYAVQAKAQVEPVKRDTLKEVIITSTRIDLPFKKNSRTINVISSEEIK
NSAATNVADLLQQVAGVDIRRRGTAGSQADLYIRGGGFDQTLLLIDGIKMDDSQTGHHTL
NAVLPVEVIERIEVIKGPAARVFGQNAFTGAINIVTKNKLNNLVSVNVEAGSFGQLNGSV
TIGKEFENSSVMAHVGILTSDGYRHNSDYNNKNYFIKGIFNKKEQPIEVIATFFDKKFGA
NGFYASATATEQYEETQSSLLGASTTFKTENFKITPRVYWKRGQDDYVYIRDNPSVYRNL
HITNKIGVETNASYTSNLGITGFGIDISRVFISSNNLGNRNRTMVNLFLEHRFKLADDKI
DITPGVAVTYFSDFKFHAFPGIDVGFKLSDNLKAYGNLGITYRIPTYTDLFYNDRTTIGN
ENLKSEEAFSQEIGLKYDTEILTTSVAFFNRDADNLIDFIRSDLTSKYAATNIPKFNTKG
FEFNADYRFKINEFNQTLSFGYNFLDDNFTEEKKEFSRYSLSTLKHQFITRFASKLFKNV
RQNIIYKYAERTVGTSYNVWDASVIVDFNQLSFTVTASNIFDADYIETGYVPMPPSNVLF
GFRYSF
>FCMOIPGL_02654 HTH-type transcriptional regulatory protein GabR
MIDSPVNTLFKQLINFDKSISQPVYIQVSQQIINAIQRNYLTKGTILPGTRIFAKLLKIH
RNTAVAIYEELASQGWVEIIPNKGTFVLEPELKTAKIKATSQKINQAYNYAKTTGFPFQK
SFHLASTAELTNAKYSINDGKPDLRLHPINEFTRWYSASMKRKTLVKKWNKLNESSNSLF
QTQLCNFLNATRGFHINPKNLISTRSTEMSLYIVSQLLIKQNDVVLVGNLSNYVANMIFQ
QTGATIKTIPVDADGLDIDYIKKHFIKNSIRCIYICAHRDYPTGVKLSVERRLALLDLAK
KYGFAIIEDDYDYDFQFDGSAMLPMASADSNGMIIYLGKLGQSLFPSFQTGFVIAPENLI
SEAKNYLQLLDKQGDLIQEQMLSELIHEGEIYRLMKKNIVIYKQRRDCLCQLLTQHFSEI
AHWKIPAGGLAIWLQFQPKISLVKLAEEAKKNDLFLPKTVLYQDKNTCAIRFGFGHLETE
EIAIIIKKLKNAYNKLSVS
>FCMOIPGL_02655 DNA polymerase IV 1
MFALIDCNNFYTSCERVFNPNLQGKPVAILSNNDGCVISMSDEAKKLELPFGAPIFKWEQ
FCKEKNITVLSSNYPLYGDMSARVMNILADFSPDVEVYSIDESFLQLKGFENYDLEEYAT
KIRNRILKWTGIPTCVGIAPTKALSKVANKIARSNLKQSKGICIIDCEENRIKALKWTEI
GNVWGIGRRLKKRLQEKGCRTAYDFTQLSSDWVLKEFSVVEWRLQKDLQGISKIPLEEVS
SKKMIATTRSFEYTYSDIDNIKERISTFAASCAEKLRNQASSCHMVIVQLSSDRHQKNAP
QHRESKTVVFSYPTDSTLTISKAAVEAVKMIFKSGIKYKRAGVIVTGLVPNDNFQLNLFS
HENPKHKPLMSAIDKLNRKFKADKIKLGNQDLKRTWKMRQERLSPRFTTNINDILIVKAT
K
>FCMOIPGL_02656 hypothetical protein
MDEKTIDTDPLVSNAIGGVKLLVHKNDFEKAATIYNEIRTYQKDKNGNDIFCPNCNSTKI
LIAPLKRKNIFFMLFPFFEKTKHICNNCKTVF
>FCMOIPGL_02657 LexA repressor
MIGTKNLTFFTPKASSGDGAVLVDVGISAGFPSPADDFRETRISLDDELIQNKDATFFAK
VKGQSMINAGLDDNDLLVIDRSLEPTNNKIAVCFLDGEFTVKRLRVEKNEVWLQPENPNY
PIINITEENDFMIWGIVTSVIKKV
>FCMOIPGL_02658 hypothetical protein
MKKNKLLSIAVVLCKIIQVFYVFIFIVLTTLFIHVLFSPDSYKGVDYTYKNSNLVNITKS
SRWKIRLPGKQQLEDKEVYALNKITKTSLFINYMKLSAVLFLLFLSIKEFQKIMKSVKNL
NTFQKNNVDSFRKIGKYLFIIFLLSSYFKIRFQQGGMTNFSMNFTPLIFMLIAFILAEIF
KEGNLLQKENDLTI
>FCMOIPGL_02659 hypothetical protein
MRKINILKAIVDLLWILSMPIILVILGFSIAIFFVDLGELNITINSVNFDKNTLLSKILL
VVSGLNHLLIIAALYFFRKTLNYFVRIKIFEEIVISSFKKIGHLLSISGVISLTISMISK
VYFEQKVSLEFGLNQHLVIICLGLFFLVLSEVFKIAKHQKQENDLTI
>FCMOIPGL_02660 hypothetical protein
MKTVKTLKISSYFLKFLMSISFLIAFSLAFIYFHSMFYPKKYSNLIVNKERNIQYIFDIE
KAPKTYKEWESSNKLFYYVKLDNYSKFSIIWTKVATFTIFFIVLFLFDKIIRNTKNFDLF
FQKNIRLINNILKLIILLFLFNFVVKGYSDPISMVFEDSGKPHFITSGRITFDFLIYYPL
AIIFFYTLREVFKRGQELKQENDLTI
>FCMOIPGL_02661 hypothetical protein
MAIIVNLDVMLAKRKMRSKELAEIIGITTANLSVLKSGKAKAIRFSTLEAICKALECQPA
DILEYQQD
>FCMOIPGL_02662 Prolyl tripeptidyl peptidase
MKKTILFFVLLFTVSVISAQETPTPNYRQAAKYSPKNLAKMVHSTSVNPHWLKKGNRFWY
AYKTSEGSNYYLVDADKKTKKELFDNVKMAKWLTEITKDPYDAKHLPFFRFKFNDAENAI
RFRVTSTEEVDVVDEKEEVKKDSISAKKEKSKKAKKPKKEKKTYYLEYRLGSNGLTIINN
KKEDKKPWKKWANVAPDSSIVLYGKNHNLYWMDKINFKKFIKDEKDSTVVENQWTKDGEE
NYGYTWDGRDDNVDKEKNKDKRKGVWGTWSHDSKKFVFQKSDSRHIKDLWVINSTGKKRP
TLETYKYHMPGEQEYYKSELLIFDIPTKTHVKVPLDTIKQQSISVFRAPRKQSERDDDFT
PSLLLSKKGKIYFSVISRDRKKYDINVADINTGEYKTLIEERFNTYIESRPLILLNNEKE
MLHWAERDGWAHFYLYDTEGNLKNQVTEGDYHVAGFEGLDEKSRTLYFTANGVNKEQDPY
YTHSYKINLNGSGMKTLNPGDFTATSSMSDSNQYFVSNYSRVNTVPKSEVRDVNGRKVMD
LETADLSQLFASGYKFPEPFKVKADDGITDIYGVMYKPFDMDSTKVYPLLEYVYPGPQTE
AVNKSFSYRMDRVDRMAQVGFVVITLGNRGGHPDRSKWYHNYGYGNLRDYGLADKKYVAQ
QLANKHKFIDIEKVGIYGHSGGGFMSTAAMLVYPDFFKAAVSSAGNHDNNVYNSWWSETH
HGVKEEIDEKGKSSYKYKIDVNQSLAKNLKGHLMLIHGDMDNNVNPAGTIRMANELIKAN
KRFKYMIMPGQRHGFGNMTEYSFWLRADHFSKYLLGKEATDVDFMYMNLDKPMNR
>FCMOIPGL_02663 tRNA-specific adenosine deaminase
MIQPFDDIYFMKKALQEAETAFDKGEVPVGAIIVFKDKIIARAHNLTETLNDVTAHAEMQ
AFTAAADFLGGKYLKDCVLYVTLEPCQMCAGASYWAQIGKIVFGASEPDRGFINLKTTLH
PKTKVVSGVLENECSQLLKRFFVEKRNLN
>FCMOIPGL_02664 1-deoxy-D-xylulose-5-phosphate synthase
MKNLLDNISNPSDLRKLNQDQLPQLAKELRAFIIDIVSTKEGHLGASLGVVELTIALHYL
FDTPNDLLVWDVGHQAYGHKILTGRKNVFHTNRQFGGIAGFPSRKESKFDAFGVGHSSTS
ISATLGMAIASNLKGETEKQHIAVIGDASIASGMAFEALNHAGVSKANLLIILNDNAIGI
DPSVGALKEYLTKVKTDKRLAAQNNIIKALNFDYSGPIDGHDLPKILSELERLKTIKGPK
FLHVITTKGKGLQQAEDDQVTYHAPGKFDKISGERIKKEESLYTKYQDVFGKTIVELAQQ
NENIVGITPAMLTGSSLKFMLQEFPKRTFDVGIAEQHAVTLAAGMATQGLIPFCNIYSTF
LQRAYDQIIHDVALQNLPVIFCLDRAGLVGEDGATHHGVFDLAYLRYIPNLIIFAPRNEI
ELRNILYTAQLGLKNPIAIRYPRGKGKIIDWQKPFEKTKIGKGICLKEGKSIAILSVGTI
ADNVSEAIILSKKSDEIAHFDMRFIKPLDEKLLHGIFEKDQTIITIEDGTIKGGFGSSIL
EFAAKNNYKNNIKVLGIPDEFIEHGSVEILQQKIGLDVKSLTCYIEKQ
>FCMOIPGL_02665 hypothetical protein
MTKIKFLNFLLLFILIGCANSYKLEKKSILSFNESYYSPWSSGVKGGGSGYHVYLLIDEN
INLIDKNIKIEGVYFKGKFANLKLQELNKYQAFIRENSNSDMLEFENNLKNKTEETKTEK
IPFVLKDNEAVISYVTKGKNKYVKIKLNKKQTKGFPM
>FCMOIPGL_02666 hypothetical protein
MNKKLLLPFIAIIVICVFYVKKQNENNESFIITPEGKLKLKSKPENARQLYSIEREKFEF
DMQKNPLTGLVPKDEKTKEYETSLKLKQQKSYQKSASMSFTSRGPSNLGGRTRAFAVDIS
DPTSNTMLSGGVSSGLFRTTDGGASWVKVTSEGEINNVTAIAQDPRVGFQNIWYYATGEF
SGNSAALGSFYFGHGIYKSIDSGLTWTKLSGTDSDQTIYDSYFDLTNKLAVSPITGDLFI
AVLNRVYRYDGASFTLEIEDTSDGNDWTDVVVTNSGKVYVAIDGSSTGENGVWESPTGNG
SWTQIAQNGIPNGWAATGRMVLAKAPSNDAIIYALFMNDDAAVITAGLWQYNSTANTWTN
YTSKLPDEAGGDLAGNDPFDAQGGYDLVVSVKPDNENFVAIGGTNAYKIEDITTDTMFVR
IGGYADNFSYAQYSVGGVTHHSDIHVLEFDPNNNSVLFSGTDGGIHKTIDVTADIIPWIS
LNNNYITYQYYHVALDPLTGSNIVIGGAQDNGTTLGGTDSGLSNNTIMNSIAGGDGVAVG
IARRSTKQQANVYTQLYFGTQQGSIYSNYQGSTSEITPTDAPSGNDAQFVTYFYLDPDNN
DNLYYAANDELYRTSNATSVTSETWISANTLATNENIRTMATTRGAYNAATSFLLIGGSS
GGVFKVDNPKSVTNISLAKNITPSGASTSSGTIVSDIAIHPTNSDIVLVVYSNYGVSNIF
LTTNATDPLPTWTLVERNLSAHSIRSTEITQVGSEIIYFVGTARGLYSSTDPTTKDWELE
GANTIGLSLISGLVYRPSDNKLLIGTHGNGMFETTVEGTLSTNDFNKDKIDVSFYPNPAQ
NELNIQSSTIDLSNNVSYYISDITGKRVKKGVVTDKKINVQNLNSGVYLINLNIEGKKQG
FKFIKN
>FCMOIPGL_02667 Deoxyguanosinetriphosphate triphosphohydrolase
MNWEQLLSLKRFGDTQKRPRIAQDETRLGFEVDFDRIIFSSAFRSLQDKTQVIPLSETDF
VHTRLTHSLEVSVVGRTLGRRVGKVLLERHPELIELGYTFNDFGAIVAAASVTHDIGNPP
FGHSGEKAIGEYFKSGKGAKYKDQLSAKEYQDLIDFEGNANGFKILTESREGVFGGLRLS
YATLGAFLKYPKESLPKKPTKHIVDKKYGVFQSEKTEFLDVAQELGLLQKSTENISFYRH
PLAYLVEAADDICYTIIDFEDGINLGLIEEEFALEYMIKLVKDTIDIKKYHSLQHKKDRV
SYLRALAIGVLINEAVAIFLANETQILEGTFEKSLLDKCKYEAQINDIIKISVDKIYKSK
EVVEKEVAGYRIIGDLLDVFVTALNNKFDENTSNYDRLVLNLLPEEYQIESNSVYNRIML
VCSYVAGMSDSYAIRMHKKIMGNIV
>FCMOIPGL_02668 hypothetical protein
MIKKIVFISFLAILAVILFFNPNLKTIAAGVAVLLFGMGMLEEGFKVFTKGPLQNILKKS
TDKLYKSITAGAVVTALIQSSSLVSVITISFISAGLLSLSGGLGLMFGANIGSTATAWLV
AGFGLKIDISALAMPMIIFGLIFTFQKKESLKGTGNVLAGLGFFFLGIYFMKAGFDVFST
QINLTEYAVSGFKGVLIYTGIGVVLTVVLQSSAASLVLVLTALAAGQIEYENALALAIGA
NIGTTITAVLGALNSNIAGKRLAAAHLIFNVLTGVVALSLIYPLAKLVNNIADFVHIKQT
DYTLKLALFHTIFNVLGVVIMVPFIKKLEIFLLKLFKENIDKDVDKPKYLNEAILKFPGT
LISSLLKESKDLYKNTIFEIVAHSLNIHRNAITSDEKIKKIVQNSNEQMNVDIDQLYYNK
VKNIYGQIISFAAKGQQNLKFTNAQNKQLTQIKVANRTMVQIVKDTKELSKNVAIFSNSD
NEHIKKEYDKFRKKVIKVLRVIYLFRTNDKKEEHYQELLKLKKSAKKAVNSDNKSIDKLI
RKNLITIDMASSLVNDNVNVNDLVGNLIQVAELLYSEKDAILDNDNK
>FCMOIPGL_02669 Ribonucleoside-diphosphate reductase 1 subunit alpha
MYVVKRDGKKEPVMFDKITARVKKMCYGLNKIVDPVKVAMRVIEGLYDGVTTSELDNLAA
ETAATMTTAHPDYAKLAARIAVSNLHKNTKKSFSETMDDLYYYVNPRTEKKAPLLADDVY
KIIKDNAAKLDSTIIYNRDFNYDYFGFKTLERSYLLKLNGQIAERPQHMLMRVSIGIHKN
DIDEAIATYELMSKKYFTHATPTLFNAGTPKPQMSSCFLLQMQDDSIEGIYDTLKQTAKI
SQSAGGIGLSLHNIRATGSYIAGTNGTSNGIVPMLKVFNDTARYVDQGGGKRKGSFAMYL
EPWHADIFAFLDLKKNHGKEEMRARDLFYAMWISDLFMKRVEEDANWTLMCPHECPHLYD
TYGEEFERLYTSYEVAGKGRKTIKARELWEKILESQIETGTPYMLYKDAANRKSNQKNLG
TIRSSNLCTEIMEYTAKDEVAVCNLASIALPMFVSEKENGEKFFNHKKLYDVTKKVTRNL
DTVIDANFYPVIEAENSNFRHRPVGLGIQGLADTFINLRLPFTSDEAKKLNQEIFETMYF
AAVTSSMEIAKAKEPYSTFKGSPMAQGEFQFNMWGIKDDELSGNWDWAKLRKQVMKHGVR
NSLLMAPMPTASTSQILGNNEAFEPYTSNIYTRRVLSGEFIVVNKHLLEDLVELDLWDND
MKENIMRANGSIQHIPEIPADLRELYKTVWEMSMKDIIDMARHRGYFIDQSQSLNLFMKD
PDFGKLTSMHFYGWKSGLKTGMYYLRTKSAVNATQFTVSKEKKVEEIVEDKPMSPAEFKA
MVDASKNGAPDDDCLMCGS
>FCMOIPGL_02670 Ribonucleoside-diphosphate reductase subunit beta
MSFIEPILQPNDNRFVIFPIQHDDLWEWYKKQQACFWTAEEIDLHADIVDWTSKLTDDER
YFIKHILAFFAASDGIVNENLAENFVNEVQYSEAKFFYGFQIMMENVHSETYSLLIDTYV
KDEVEKDRLFRAIEVFPAIKKKADWALKWIESDSFAERLIAFAAVEGIFFSGAFCSIFWL
KKRGLLPGLTFSNELISRDEGMHADFAVHLHNNHIVNRVSPDRIREIIIDALNIEREFIT
ESLPVSLIGMNSKLMTQYLEFVTDRLLLEFGCEKEYDATNPFDFMEMISLEGKTNFFEKR
VSEYQKAGVKSGGTGSISFDSDF
>FCMOIPGL_02671 Cold shock protein ScoF
MKKGTIKFFNESKGFGFVIEDGSKTEYFLHVSGLIDEVREGDVVEFDLKEGRKGLNAVDV
RVI
>FCMOIPGL_02672 Heme A synthase
MKNKFPQIVQIALISVYIIFLAGSVVRMTGSGMGCPDWPKCFGYYIPPTSEEQITWKPNS
DFKKGMIIIKDEALFVAEHDLKTEANFNKKNWAKYTKHDYNKFNKYHSWTEYINRLSSVL
SGFVFLFLIIAAFKFRKEDKRIPLLAFTAFFLMLVEAVLGKIVVDTNLKPSIITIHMVIG
LVIIALLLQLKFIVSDNKKKHNYNSLFSKLLIVSVIFSLIQIAMGTQVRQFIDEQIKLFG
FENKDYSLMNPSFKFYFHRSFTIAIVLVNFGLFYINQIKNLGYKLVNWIVFLIFIETITG
ILMYYAEFPLGTQAIHLLSGAILFGLQFYLWIQSRKTVAVSS
>FCMOIPGL_02673 Molybdopterin synthase catalytic subunit 1
MQRTSIKITAEKLDLQECYNFVEDASCGGISAFIGTVRNDTQGKEVTQLDFSTYKPMAIK
EMQKIANETLSKFDIKKIAIHHAEGMLQIGDIPVIITVSSKHRKAAFLACEFAIDTLKET
VPIWKKEHFSDGEIWVNAHP
>FCMOIPGL_02674 hypothetical protein
MKNIFRVVSLLEGISFLLLMSLGLYYKYVLNDPSFVKMFGMPHGILFMLYIVLAIMLKKE
MNWNNKDLGIVLLCSMLPFGTFYMDYKYLQK
>FCMOIPGL_02675 Homoserine kinase
MTVFPVTASTISAKELGEFAKEKYDLNNNYDCKLFRTGINHTYFLSDNETKYALRVYSHN
WRSKSEIIEEIKLLNLLSDNNLGVSFPIKDTKGEFIQEINAPEGLRYVVLFSFAEGEKMR
FMNNDTCFEIGLCMAKIHNITANKTIKRTKYNSELLLKKSYNQLTQFFAEDLSEMKYLKE
LGSEISKTFEEINESKIQKGIVHLDIWYDNLAVNSNNEITIFDFDNCGNGLLIFDIGYFC
KQLFFIESDKKQYESKVKSFLNGYQKIRKLTAEEIKLIPESGASIFAFYLGVQAQRFDWS
NIFLTENYLKMFVGRIKSWMNYYKAKEITTTNT
>FCMOIPGL_02676 Molybdopterin synthase sulfur carrier subunit
MNIKTLFFGITTDLVGASELQIDVTENTSVKDFKLVLKKAYSQLENINSYAIAVNEEYAT
DNLILKNGDVVAVIPPVSGG
>FCMOIPGL_02677 hypothetical protein
MKKTTFLFFLFISSVFIAQVKGKITDINNNPLSFVSVYLDKTVTGTTSNDNGDYILELKK
KGKHTVVFQFLGYKTLKKEVDIASFPFELNVILNEENVELTGILISTKDNPANGIIRNVI
ANKDKNTDKFAQYTANFYSRGLYRIKDAPEKFLGQSLGDFGGGLDSTRSGIIYLSETVSD
IKFRKKPKDFKENIIASKVSGRDNGISFNRAEDANINFYENSVEFGNDLISPISTNAFSY
YNYRLEGTFYDKNGKLINKINIIPKRKNDRVFSGSLYIVENDWALYGADVAVTGAQINIP
MVDVLKLKQNYNYSDENDAWVLISQSIDFKFNAFGFKLDGRFSSAFSNYNFTPNFTEKTF
TNEVLTFEKEATEKDTTYWNNLRPVPLTSEEVNDYSIKDSLKIVRKSKVYLDSINKKENK
FSFLSPIMGYTYRNSYEKWSLSFDGIISDFNFNTVQGLNSSVGIRYFKSLNETGKWWSIG
AKVNYGLSEEIARPTFFFAKKWNNLSRPRLTISGGVTTSQFNDRKPISKLDNMIRSLIYR
ENYLKIYEKEFSKIQYSEEIKNGIYLSTSLEYANRKPLFNTSNYSFARQRLNEPYTSNNP
LDATDFVNAGFTEHKIATLNVGATFVFGQKYLSYPDRKFNIGNEKYPTLSVNYRKTFGAP
NADFNSDLFVANLRHNINAGNYGKLAYNIRAGVFLEKKNIAFMDNLQVNGNQLKYNLSDQ
LNNFGLLEYYKFYTNDKYAEAHISHNFKGALLGKIPLINKLNFHLIGGAKSLIMADKNPY
TEYSVGLDNIGFGKWRFLRVDYVKSFNAGIKNDGFLFSLNMSN
>FCMOIPGL_02678 NADP-dependent malic enzyme
MSDSRKRHEALLYHAKPKPGKIEIVPTKKYATQHDLGLAYSPGVAEPCLEIEKNKNNAYK
YTSKGNLVAVISNGTAVLGLGNIGPDASKPVMEGKALLFKIFADIDVFDIEVDATDVDKF
VETVKAIAPTFGGINLEDIKAPEAFEIERRLKEELDIPVMHDDQHGTAIISAAALKNAIE
ITKKDISKTKIVVNGAGAAAISCTRLYVKLGARLENIVMCDSKGVIRKDRDNLTSQKAEF
ATDLDLHTLDDAMQNADVFIGLSKGNVVSPTMLLSMAKDPIVFAMANPVAEIEYDLAIAT
RKDIIMATGRSDHPNQVNNVLGFPFIFRGALDVRATKINEEMKMAAVHALADLAKRSVPE
KVNIVYDEVNLSFGREYIIPKPFDPRLIYEIPPAIAKAAMDSGVALEPITDWENYREELM
ERSGSGSKEIRMIHNRAKSNIKRIVFAEADHLDVLKAAQRVHEEKLGKVILLGRKKLILE
LKEEIGFTADVPIFDPKTDEEEERRQSFGEVYWKNRQRKGRTLSEAIKLMRERNYFGAML
VNENEADALITGYSRPYPSVLRPILELIDKDKGVSKIAACNLMLTKQGPLFLADTTININ
PSAKDMIKTTQMTSNLVKMFGMKPNVAMLSFSNFGSSDTDTSKKIREAVAFMHKHFPDAI
VDGELQADFALNPELLAKEFPFSKLNGKKVNVLIFPNLESANITYKLLKQVESAQSIGPM
ILGLSKAVHVLQLGSSVDEMVNMAALACVDAQQKQKSK
>FCMOIPGL_02679 Holliday junction ATP-dependent DNA helicase RuvA
MITQVRGRLVEKSPTEVVVDCNGVGYLLHISLNTFSGLPADENVVLYTHLSIREDAHTLF
GFINKTEREVFKLLISVSGVGPSIARTMCSSMTSEEIQNAIASENVALIQSVKGIGAKTA
QRVIVDLKDKILKTFDIDEVSVKTSNTNKDEALSALEVLGFQRKQSEKIITAVLKENPDA
SVEKIIKLALKNL
>FCMOIPGL_02680 hypothetical protein
MITSLKKILLLVLFTFAVNASSYAQTTQNKDSTKVKKDTLKLKYDFNHTQKGNLFLDNLA
EKEVIFDKELNRYVIIEKIGNYYTKTPVFLTQKEYKQYRLKRDMLQYFKDKVSATNSKKK
GSLDAQKDLLPSYYVNSKFFESIFGGNTVKFTPTGNLNLKLGVIYQNTENPQISEENRSS
FTFDFDQQINASLRAKVGERLEFTANYDTQSSFDFQNQVKIDFTPTEDDILQGLEAGNIE
MPIKNSLINGAQSLFGVKTKLKFGNTNVTAVFSQQNSESKTVVAEAGASIQEFELQTTDY
DNDRHFFLSQFFIDNYANSLKNYPLISSQINITRIEVWVTNTSATTEDFRSIVALADIGE
SNNTNATYKNLVDDNGTVQNTNPVSITANGQSLNLPQNNSNNIYTTNILDGIRDISTVES
TLNGNFQMEQGTDYSMLENARKLSTSEYTLNSQLGYISLNRRLNDSEVLAVAYEYTVAGT
VNGSTEKSFKVGEFSNDGISSPDNLAVKLLRSEILTTTRSDGFGGKEAFPTWRLMMKNVY
ALGAYPLTQDGFLFEIQYRDDKTGVSSNVLQNAQTADITNTPLIQVLKLDQLDQSQYKTP
DGYFDFVEGITVNADNGYIIFPDPEPFGNGLAEKLTNTSDEAYLFKELYLNTKTNIKNNY
QDKDKYYLKGYFTSENSGGISIGAYNVPQGSVTVTAGGKQLIEGVDFVVDYLAGKVQIID
PSLEASGTPINISTENNAVFNQQRKTFMGVDVEHQFSKDFIVGATILNVNERPLTSKVNY
GSEPINNTMFGFNIDYSTEVPYFTKLANKLPFVDTDVPSNLSVRADMAYLIPGTPSGIDV
TGAATSYIDDFEASQIPISLLSPLDWHEASTPKYFDGFFGNQSDLSYNYKRGKLAWYSID
QIFYGYGDTPANIDADELSRAETRQINYNELFPNVELDITQNSLINTLNLAYFPQERGSY
NYNPTANIENDNVTLTNPESNWGGVMRALTTTNFDQANVEYIQFWVMDPYQNYSITNEEG
LPTNINPKDISNQVGDLYINLGNISEDIVKDNRKMFENGLPEDGLKLNGSNVDRTTWGDV
PKTTSIIYAFSENDEDRLNQDIGLDGLNDIEEKSLANIGAYSSLSDPAGDNFQFFRGSEL
DNIDASILRRYKNYNNTQGNSPTLNQSTETYTTSSSTYPDVEDINKDQTMNTVESYYEYK
ISLNQADLVNGRNYIVDEKTTSVSLENGNTQQTKWYQFRVPINNGTAINGITDFNSIRFI
RMFLTNFKMPVVVRFGELDLVRGDWRRYTKTIDINSDTETDLTQTELSNFEVGVVSIEQN
NGSYIEPPGIDRESLQGSTTVQLQNEQSVTLTVNDLEPNQTRAIYKNISIDLRRFKNLKM
FMHLEENEGRESVSDDDFSAIIRLGTDLTDNFYQIEVPLKVSTSSTTDFDIWPEANNLDA
LLEELGLLKVERDGLGLLVNDIYPAEIIGEAPEYRVRVKGNPTLAQIKTITLGVKNNSSI
NKSGEIWFNELRSANFDNEGGWAAVVSADANFADVANVSVSGSIETIGFGSVDDRVSQRS
LDETKQYNVSTTINLGKVFTPAKWGIQLPMSYSVGEEFIDPKYDPQYQDVTLKDALEQND
NSEFSRDYTKRTSISFINVKKNRNPNSTKKPKFYDVENLAVSYSHNKEYHRDYNIEKYIN
ENVTASAGYNFNFESKSIELFKNSESFKSKYWKFIKDLNFNPIPQTLAINSRINRSYNEQ
QSRNLVEGLSAQPELKQRRFLFDWDYAIGFDLTKSLQLNFNATNSYMYDTFGDGEDLQVF
DDFFNTGRPNHYHQKLNTTYNIPLNKFPFLSFMKADYAYTADFDWQVSSQDETIVEQIGN
VIQNANTHNINTTLTFDKLYKQIGFEKLLLTKTQRKNAKGKNTARIKPNKNLPLGKKILK
TTWDIVTSVKQGKISYTENNGQYLQGYIEDIGFLGGAPTSFAFGSQVNIRNKALENGWLV
TRTDGGEYFSKTFSRTKYDKLDYTFTLKPINDLNIDVIGNKINTSDISQQIDLIEGKSAF
EDTPVFETGNFSTSYSMLSTAFTNGDELFQTMKDYRSIISNRLATETGEPAAGFGENSQQ
VLLPSFMAAYSGKNPNKVNTGLFRNIPIPNWTLRYNGLMKLNWFKKTFSTFVLSHGYRSS
YTISSFTNNLQYSDDTAYSKTNAAGNYESKRLVAAATLVDEFSPLIKVDMKMKNSFSLRG
EIKKDRTLTLNFNNSTLTDIAGTEYVFGFGYVFKDVKMNTRFTGKKTTLKGDINLRADVS
LRDNLTQIRYVDEDNDQISGGQTLFSIKFTADYTLNSNLTASFYYNHQTSKYAISTTFPR
QAINGGINLVYNLGGN
>FCMOIPGL_02681 Glycine cleavage system H protein
MNIPAELKYTKDHEWIQIEGNIATVGITDFAQGELGDIVYVDVDTLDDTVVEGEVFGSVE
AVKTVSDLFMPLTGEVVEFNETLEDEPELVNTDPYGKGWMIKIEIKDSSEIEKLLNAEAY
KKLIEG
>FCMOIPGL_02682 hypothetical protein
MLKLIKNLLKDKLYIVAIIITFTIVFLSLIKMPSSDVKIANIDKAYHSIAYFTLGITWLF
SYYKKPEKKYLIVICCIIFGIIIEVMQGKLTSYRSGDYLDAIANSCGILLALLIFNVFSK
KKYIN
>FCMOIPGL_02683 hypothetical protein
MEIKKSPKSNLENFSKIFMQIGLVLALFVTYKSIEYKTFDKTYGDLGVVNMSAEMEEEIP
ITVKPERIEPKSPPPPAPEKIEIVKDEEEIVETVIETTETDETVAVVVAEIVEVEEVEEV
IEDVSFMIIEDVPVFPGCSGNKDELKDCFSKMVQKHFSRKFDAELPNELGLSSGRKRVFI
GFKIDKNGNIVNVQARGPHPKIEDEVIKVMKQLPKMKPGKQRGKPVGVKYSIPFTLLVE
>FCMOIPGL_02684 hypothetical protein
MFLVCFLTIIGATVIFGYVINATILGLNYIGKNSNSKKIEYNIKKIVKYKTRGRKKIRRN
NLKVTLEKDGKIVKRTLSEHYNLNKKYSEYNTIKFIINKGLFGFEVIENNEFKK
>FCMOIPGL_02685 hypothetical protein
MKNIITICMLSLATIGFTQDKEPTFKAEGDLVKATYYFEDGSVKTQGFFKDKKLAGEWTR
FDKKGNKTQIAFYNKGKKVGKWFIWSKNSLKEINYEDNVIASVNEWKPESKVAFINE
>FCMOIPGL_02686 Calcium dodecin
MAIMKVIEVLANSEKSWEDATRKAVKQASKSVKNIKSVFVQSQSAVVDRDEVIEFRVNLK
ISFEIN
>FCMOIPGL_02687 hypothetical protein
MNIIQNIIIGFVALIHIYIVYLEMALWTTKKGIKTFGLKNKEFAEETKVMAANQGLYNGF
LAAGLIWSIIINKTDVAIFFLTCVFIAGIYGAYSTKKKSILYIQTIPATIGILFILLN
>FCMOIPGL_02688 Small-conductance mechanosensitive channel
MEKYIESAKEILFFYAPKVIAALLILIVGLYMIKIIIKSAKKIMAKGGIDITLQKFLGNL
GGWVLKILLFIVVISMLGVETTSFAAILAAAGLAVGLALQGSLANFAGGVLIMIFKPFKI
GDLIEAQGQIGVVKEIEIFTTKLIGLSNKEIIIPNGEMSNGTILNYSTEGTRRVDLVIGV
SYDADIKKTKEVLMDVLTSHPKVLKDPAPGVTVLELADSSVNFAVRPWCNTADYWNVYFE
VTENVKIALDKAEIEIPYPHRVNVNK
>FCMOIPGL_02689 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MSIILNIETTTKNCSVSIANNGTILAIKELNNGNYSHAEVLHPFIVDVLKEANISSDKID
AVAISKGPGSYTGLRIGVSAAKGLCFAFDKPLISIDTLTSLSYSISIDTGFLVPMLDARR
MEVYAAVFNEKHEKVREIKAEIIDENSFSEYLKSKKVYFLGDGAQKCKGIITHKNAVFVD
AKFPSAKEMAQLSYDKYKKSDIENVAYFEPFYLKDFVVIPEKKKKPIY
>FCMOIPGL_02690 Outer membrane protein TolC
MKIKFIVLIAFLTSLSIFSQKQWSLKECVDEALAKNISIQQNKLSLELAKKDVEISKGNF
LPNLSASTSGGFNSGLSSDENGILKNTNNFSSNVGLSASGIIFNGFRNTNTYKQAQLGVE
TSILNLKNIENDISLLVVNGYLNILFAKENLNAANVQYEISKKQIEAAESRFKAGVIPKG
DLLNAQSTAASDQQSVITQENSLDLALLNLAQLIQVPVAGFDVASINVGSPSAMLLYNNS
NLVYQKSLVEMPEIKRAQLAIENADLNIEISKGAFLPTLSYSLSSGTSFYHQFNNLLPNQ
TNSSFFGQVEDRLQHGLSLSLSIPIFNRFQTKNSVAKSYINKEISETQLESEKLSLKQTI
EQAFLDVKSALKSYEVAKISLAAQKEAFKNGQERYNFGAMTQFDFDQVRTRLVNAQATLI
SSKYDYVFKTKVLQFYAGDLVLE
>FCMOIPGL_02691 hypothetical protein
MLKKIIVSYFLLMFFTVKVSYSQCAMCKAVVENGNDSMAEGVNNGITYLMVFPYLLIGVL
FYTIYRYKKRSKN
>FCMOIPGL_02692 hypothetical protein
MNNNLALEKKYRKIITALSIIIPIAVAALFGVNLRDLGFNVEPLTFLPPIYASINGVTAV
ILIAAVIAIKKGNKKLHEQLNTFAIICSLAFLLMYIAYHMTSDSTKFGGEGAIKYVYFFI
LFTHIVLSIIVIPFVLLTFMRAKLGNFAQHKKIAKITFPIWLYVAVTGVIVYLMISPYYA
>FCMOIPGL_02693 SCO1 protein 
MKKKYSYVGVTFIILLFGIYTVPKVVDHFKEVGLHKFNKVPDFEFINQEGKIITNESYKG
KVYVVEFFFSTCPSICPIMNQKMLTIQDEFFGNPEFGIASISITPEIDTPEILKEYAKKT
GITHKNWNLLTGKSEEIVYTLSNQGFKLYAGKGDEDHAGFEHSGLFALVDKEGYIRSRKD
EFGNPIMYYRALQEQSFPDQIVELKEDIKLLLNE
>FCMOIPGL_02694 hypothetical protein
MKFLTKKKVVLFLLFIFPLICFLILSTGKNNFIKLPIITKNIIDVSQINTTKHLQFKDNV
SIVCFLGNDVNTNKSRLFNLNEKVYKKFIDYKQFQIVAIYPEGKEVEIQRLKQEIGAFTD
MQKWKFVASSKDEIEVFYASFSFDEPLVDLASANAFLIDKDVNLRGRLKDADSKNSKLYG
YNMNSVSVLNGKLKDDVKVLYYEYYAAFKDKNKNKADRKEVGL
>FCMOIPGL_02695 hypothetical protein
MAHAHESNVKRIWMVFGLLSVVTIIEVFLGIVKPESLHLTSILGTSPLNWIFIILTLFKA
YYITWTFMHMEGEKKWFRRSVVWTAVFLICYIVTLLLIEGGYLHSTLAPLVKW
>FCMOIPGL_02696 Cytochrome c oxidase subunit 3
MEANIAIPSDSKETWSGGNVKPFGASYGKMMMWFFIVSDALTFSGFLAAYGLTRFKFIDS
WPIADEVFTHIPFIHGNYPMYYVAFMTFILIFSSVTMVLAVDAGHKMQKSKVAWYMFATI
IGGLVFVGSQAWEWNTFINGSYGAVKTTNGKVLQFVKDGHQIALSDFVVGERMDERVSSV
KQNGLWFESGDAVPQYSLAQITASYNADPSVQIRIEKMDLDTKQKVILSREKGLTELAKG
KMVIEGANLKANEYGNTIFADFFFFITGFHGFHVLSGIILNIIIFFNVVLGTYEKRGHYE
MVEKVGLYWHFVDLVWVFVFTFFYLV
>FCMOIPGL_02697 Cytochrome c oxidase subunit 3
MIGEQALKQEYTVAKKKSAKPMLWISMISMVMFFAGLTSAYVISMKRDDWVSFDLPEAFY
ISTLLIVLSSITLFLSQRFLKQDKRQLSLIMILVTLILGIGFIWQQYVGFNQLKSVGLFF
TGPESTVSTSFIIGITFMHVLHLFAGVIVLLVVIYNHFKYKYKSDDMLGFELGAIFWHFV
DLLWIYLFFFFYFIR
>FCMOIPGL_02698 Protoheme IX farnesyltransferase 1
MIFIKYICNRFVVFIMNSIVISETKISMNTLFTDLKQLTKVGLSLSVVFSSVAGYLLAVD
IINYATLLLLALGGFFMVGASNAFNQIIEKETDAIMLRTQNRPLPTNRMTVNVALTIAVL
FTILGISILYSINPKTALFGAVSIFIYTSVYTPLKSVTPLSVFVGAIPGAIPFMLGWVAA
TDHFGIEAGMLFMIQFFWQFPHFWAIGWLQFEEYKKAGFNMLPMNTKDKGAVKQIIFYTC
IMILVSIAPVLKLSGKFYIYPITAIIVALLGIVMLYYALQLHKSEKNADARKLMLSSVLY
ITAVQIIYVVDKFLH
>FCMOIPGL_02699 hypothetical protein
MKFKKIHFTLIFFAILPFLNFIHFDDYCFGIADLLIIGGLTIMFFISFLVITFYDLYNLS
IRKLRFNFLPLLIVLIFSVSLFIGVKYQGKHFLKNITKSYKNEVGEEATSKILLFTDKTF
EFQQVDENEVCYKKGTYYFKNDSLFLEKNDKSVKDVVFDSIYYFSYKENLLIPINKTLPN
FKTNK
>FCMOIPGL_02700 hypothetical protein
MKIVSTNIGERKEVIYKKLRVTTGIFKFPVDKPVFLDIEEVKGDAICDRENHGGIDQAIY
GYSLKHYEYWKPLYPKLVWSLGMFGENLTIDDLDETKIHVGDTFKVGETILEATLQRSPC
YKLGIRFNNMKIVKQFWNTTFCGVYFKVLQTGFVKAGDEFEQIKSCPKKPTIADLLIKRK
KEEEI
>FCMOIPGL_02701 Short-chain-enoyl-CoA hydratase
MKTTRQNGSLYTSIQKNIAIIEFGHPASNSFPSELLERLTKELNSIAKNDAISVIVLKSE
GEKAFCAGASFDELVAISSLKEGKQFFAGFANVINAMRTCGKLIVGRVQGKAVGGGVGLV
AACDYVLATENASIKLSEFTIGIGPFVIAPAVKRKVGVAGLSELTLDATNWKNSYWAKDK
GLYAKVFETIKELDEEVELLASKLASYNPDALSEMKKVLWENTQNWDELLVERAAISGEL
VLSEITKKALTKFSKK
>FCMOIPGL_02702 Sugar transporter SemiSWEET
MINLHEIIGLVAAVLTTASFLPQVFKTHKTKNTSGLSLTIYIVFFIGVVLWSIYGFYINS
LSVILANSITAILALYLIFMKLKYK
>FCMOIPGL_02703 Leucine--tRNA ligase
MQYNHQDIEKKWQKFWAENQTFKASNESEKPKYYVLDMFPYPSGAGLHVGHPLGYIASDI
YARYKRHKGFNVLHPQGYDSFGLPAEQYAIQTGQHPAKTTEENVATYRRQLDNIGFSFDW
SREVRTSNPEYYKWTQWIFIQLFNSWYNKDSDKAEDISELEKTFKKEGNATVNAVSDEEI
TIFSADEWKAFSKAEQEEILLQYRLTFLSDTEVNWCPALGTVLANDEIVNGVSERGSHPV
VRKKMKQWSMRISAYAQRLLDGLEKIDWPQPLKDSQTNWIGRSQGAMVTFKVEENTTKSN
SEVKLSYKELEALKELRQNLSKAETTLWDELKNKKGASKFRKKYTIGTFMVDYVCVAKNL
IVEFVGKEDEEERTAFFHKEGFNVIRFTNEEVLQNVVKVVSEINFAIQFPKVIDKSAEKE
TEVKVENQYKIDVFTTRPDTIYGVSFMTLAPEHELVSKITTDAQKAEVEAYVTATAKRSE
RDRMADVKTISGAFTGAYAIHPFSGEKVQIWIGDYVLASYGTGAVMAVPCGDQRDYDFAK
HFNIPIPNIFEGVDISEAAHADKDGTVITNSDFLSGLKYKKALKLAIYEMEKRGFGYGKI
NYRLRDAVFSRQRYWGEPFPVYYKDGMPQMIDEKHLPIVLPEVEKYLPTEDGKPPLGNAT
EWAWDSRGKKVVSNEKLKNKTVYPLELNTMPGWAGSSWYFNRYMDATNSTEFASKESLEY
WKEVDLYIGGSEHATGHLLYARFWQKFLFDKGIVPVDEFAKKLINQGMILGTSAFVYRST
AFVKNGCGCADEKSLDDVLEKIPTVIVSKNLFNSDDEFETVVKNYLLDNKFLDPNFADLV
MITKTAIHSDVSLVNASDELDVDGFKNHPLNADYKNAEFVLEEGVYKVGREVEKMSKSKY
NVVNPDAICEQYGADSLRLFEMFLGPLEQAKPWKTSGISGVSSFLKKLWKLYFNGEILEV
SDAEPTKAELKTLHKTIKKVEDDIENFSFNTSVSTFMIAVNELTALKCNKRTILEPLTVL
VSPYAPHIAEELWSLLGKDESISTADFPVFEPKHLVESAKNYPISFNGKMRFTLELPLDM
SKDEIEKTVMAHEKTIAQLDGRTPKKVIIVPGKIVNIVG
>FCMOIPGL_02704 hypothetical protein
MIKKLWIACFAIVFASTINAQDVKIGFKLGMNVASVNGNDANNLDSRTGFVFGATAEVPL
SEKFSIQPELLYSAQGAQQRDNFKYDLNYVLLPIMAKYYIANGFTVEAGPQFAFLVKDQL
VPIDQNNGGSKENTNSENFDLAANLGLGYQFQSGIFFQTRYNLGLIAITENPDIKNGVFQ
MTLGYQF
>FCMOIPGL_02705 putative zinc protease
MKKILFTFLLAAAFISCKNSSEEKTEDKIPELSINYNKIKLDNGLEVVFHVDKSDPVVAV
ELMVHVGSAREIEGRTGFAHLFEHLLFLESENLGKGGLDKMSARIGGSGANGSTSRDRTN
YLQTVPKDGLEKMIWAEADKLGWFINTVTDPVLAKEKQVVKNEKRQSIDNRPYGHNQYVI
GKNLYPKDHPYNWQVIGSLEDLQNATLEDVKTFFKKWYVPNNATLVLSGDIDVDQATKWV
HKYFDEIPKGTDEIPALVKRPGKVDKIKSLYYEDNFARVPQLTMVWPSVAQYDADSYALD
VLTQYLTDGKSAPLNQVLVDDLKLTSNTTMYNYASEIAGETQLIVRAFDGIHLDDVKAGI
EKGFTKFEAEGISEKDLNRIKAGQETRFYSSLSSVLGKGTSLASYNTYTGNPGFVTEDLK
NTIAVTTDDVMRVYNKYIKNKNYVATSFVPKNAAKLALKGAVLADIVEEQIVTGAEEKFD
PKIAATYEKTPSSFDRSIEPPYGETPSLAVPEVYESSLENGLKIFGIESNEVPLVRFNIT
IDGGQLLESFDKLGVANLTADLLNKGTKTKTVKELEEAIQELGASIYVYSNTENITLSGT
TLAKNYNKTLALAQEMLLEPRFDETEFDLLKKATIANLRQDEADPNAVARNTYNELIYGK
DNIRSKNTLGSVASVEKITIDDLKIFYKNYISPSVAKILVVGDISKEKVVASLTSLNKNW
IAKEVTIPEYKTPEAPTKPTVYFYDIPNAKQSVLQFGAPALAATDKDFYAASVMNYILGG
GGFASRLTQELREGKGYTYGIRSGFSGTKAKGAFTISSGVRSNVTLESAQLVKKILEDYP
ITFSDKDLETTKSFLIKSNARAFETDRAKLNMLANISNYDLKPDYVKDRENTVNNMTKEQ
ITTLANKYVNPNKMIWLVVGDAETQLQRMKELGYGEPVLLNERQKQIKN
>FCMOIPGL_02706 Oxygen-independent coproporphyrinogen-III oxidase-like protein HemZ
MKFTGKRYLDYSSFIKLNFGERVQKISLDIGFSCPNRDGSKGFGGCTYCNNNTFNPDYCE
PQKGIKQQLEEGISRFSTKYKSQKYLAYFQAYTNTYSDFESLKRMYDEALSVPNVIGLVI
GTRPDCISDEIIDYLELLSKKHFISLEFGVESTLNKTLEKVNRCHSYDETIATYEKCKNR
GFHLGAHLIIGLPGETKKDLLNHAIEVSKLPIDTLKLHHLQIVKQSIMASQYKKNPENFD
LFTSESYIKFISEFVTLVRPNLVIERFISQAPFDLLIAPNWNGLKNFEIVSKIDKQMELE
NTWQGKNYINNEI
>FCMOIPGL_02707 Aminoalkylphosphonate N-acetyltransferase
MKFRKATEKDIYTIVEMMADDILGKKRENLQDPLPTSYINAFKKIDTDENQELIVLENEN
LEIIGTLQLSFIQYISYCGGIRAQIENVFIRKEQRGLGIGKKMFEWAINRAKEKNAHMVQ
LTSDKKRPRAIKFYENLGFKATHEGMKLHF
>FCMOIPGL_02708 Malonyl CoA-acyl carrier protein transacylase
MKAYIFPGQGAQFTGMGLDLYEKSSLAQEYFEKANKILGFSITDIMFEGTAEQLKETKVT
QPAIFLHSVILAKVLGDSFQPEMVAGHSLGELSALVANGVLSFEDGLKLVSQRALAMQKA
CEVQKSTMAAIIGLEDALVEEVCAAIDGVVVAANYNCPGQLVISGEIEAVEKACEILKEK
GAKMAVMLPVGGAFHSPMMEPAREELAAAIEATVFSNPTCPVYQNVPASAVTNPDEIKKN
LMLQLTAPVKWTQSIQAMIADGATEFIEVGPGKVLQGLMRKIDRRMAASGATLPE
>FCMOIPGL_02709 hypothetical protein
MTIKDKQLADSIYLILAALFIASLVASNLIFQKFFYWEPFGIYRFEISVGILPYPITFLI
TDILSEIYGKKKANQVVIAGIFASFFSMFIILIADFTPAITNSPINDKIFHQVFGLSPLA
VFASMMAYLFAQFVDIKIFHFWKKLTNGKHLWLRNNFSTFASQFIDTFTVVFLLCSFNVL
PWNIFTSLLISGFLFKIIIAALDTPVLYGVVFLFRKRFNLKVGEEILE
>FCMOIPGL_02710 hypothetical protein
MKKIGLLLVAFLLVSQVNAQTAVFNDLLRKHVSKNGIVDYKSFKNDEAKLDNYISYLEKT
SPAESWSENKQKAFWINAYNAYTIKIILENYPLKSILDIKQEGKTAWKIPFAKVGHKTYT
LDFIEHEILRKNFSDPKIHVGVNCASGSCPKLGNKAFTEENVEAELTRLMKDFINDSSRN
KISEKKVQISSIFDWFKEDFTKNGSIIDFFNKYSETKISPKAKISYLKYDWTLNGK
>FCMOIPGL_02711 Alkyl hydroperoxide reductase AhpD
MSKSYYDAADLRKFGKITEWNEELGNKFFDYYGKVFEEGALTAREKSLIALAVAHTEQCP
YCIDAYTKDGLQRGITKEQMMEAIHVGAAIKSGATLVHGVQMMNKVNKLEM
>FCMOIPGL_02712 hypothetical protein
MATKSLKARNNDIANTSRQMEILSEGIFANGELPTFANKIKETNQFPLRPKTLEILQINL
GYMCNQVCSHCHVDAGPDRKEIMTIDTMNQCLEVIKKTNAHTLDLTGGAPEMNPNFRWFV
EEAAKAGIKDFIVRSNLTIIRANKKYYDLPEFFKKHNVHIVSSMPHWTRGKTDKQRGSGV
FDKSIKALQELNAVGYGMPDSDLKLDLVYNPSGAFLPGDQMALENDFKKALKADFNIDFH
SLFAITNLPISRFLDYLIASENYEDYMFALVDAYNPAAVENVMCTNTLSISWDGWLYDCD
FNQMLNLKVNAKVKHISEYNEELLQNRNIIINQHCYGCTAGAGSSCQGVVA
>FCMOIPGL_02713 TonB-dependent receptor SusC
MKHLYLWMFLLFTSISISQTKITGTITDKKTKEKLPYVSITSSPKNGTVSDINGFYSITV
LKENKFLTFSYLGYKTQKIPINNLTNINIQLEEDETGLDEIVVTALGLNRKTKELGYVVQ
EIKAKDVANVKTVNFLDNLSGKLAGVTISQGATGVGSSSKITIRGEASFSNNNPLFVVDG
TPINNNSVFNFTNEAAAGFQEIDFGNGAMDVNPDDIESITVLKGPSAAALYGTRASNGVI
VINTKDGSKKKGLGVSINSSITFDSAFRLPDFQNEYGQGNSGNFEYVDGLGSGVNDVITY
SWGPKLDAGNLIPQFDSPVTLADGTVVRGGDTSLYNGLSITPTLFESNPDNLKDFYQTGV
TTINNIAINDSFERGSYRLSITDLDSESIIPGVNLERKTAALKLNFNPSEKTKITSSINY
VNSSSDNRPANGYGSENANYSLVAWGPRSLNIDNLRNYWQPGLEGVQQYSFNYTYFDNPF
FILHENTNSFNRDRVFGNIALQHYFTDNLSVSLRSGMDFSSENREFKRNFSSNRFKNGAY
AEHDVFYREINTDFLINYNNNFGDVSFDVSFGGNRLDQNASTKQTQTTNLAQPGIFSLNN
AASPIEVFEFESKKRINSLYGIAKLGYKDYLFLDITGRNDWSSALATPFSVDGTSFFYPS
VSTSFILSNYTDLPESISFAKLRASVAQVGNDTDPYQTSGAFVSQTTFNGQATFSNQDFI
PNSDLKPEITTSYELGADLRFFKDRLNIDFTYYNATTKDQIISLPIPISSGYNQQVINGG
KVNTSGVEIILGGTPIRNENFKWNTTFNFASNKSVIKDLPQNDGRLTLAYSRIYDSANQT
VWFQVEEGGQIGDMYGTGYEKNADGEFLLDDDGRYIANNELIKIGNYNPDFTLGWNNSFT
YKNWNASFLFDWRQGGEIVSRTRALGNVGGQLAETAYRPDAGIIAQGVNVNTGLPNTVAV
TAESYYRQFYDRNHEENNVYDASFLKLRQFSIGYVLELNEGFLGLKNPSTMNFSFIGNNL
FVITENPHFDPEQVAVQGNGFVSGVEDMSYATSRSLGFKVGFNF
>FCMOIPGL_02714 hypothetical protein
MKKIIYIFAILAFITTSCTKDFEEINTNPNAPVAVQPSLLLRQVIYDFGEQMSYEGFVAG
DLLAQHRTALDFNLFDRHDLKSPQLGGNPWSIFYVNLRDNEIILNKSRETAAYAVYEGPA
LILKAYMAAGLTDLFGDVPYFDAFNGVDGSVTPQYDLQEDIYQNENGILDNLDKGIAAIN
AYTSSIALEGDILFNGDFQSWIQFANSLKIKYLIRISDKVDVSAELQTLFNNGNYISTNT
ENAVFDFTNSEPNSFRLAQLRVGDFNNFVMSETMEEILFDLSDNRMSTFFRTFANSTANE
FNGLINGINSSTTSIAIADYSLAGTIFREDTSTLDANFMTAWETSFLLAEAALKGYISTD
AETLYNLGIAQAFEYWNTELPTNYLNGNANYNAGTSPLSQIITQKWIAAVINGYEGWVEY
RRTGFPALKDVAASLNNGLIPARMPYPAEAATLNQENYSVAEAATNGNSLDVKVWWNE
>FCMOIPGL_02715 hypothetical protein
MNNMDVINWQWLLVICSSLIMFFLSPLAKTTDEFFKAVHKKKAPNTLVLTGSLIISWIFA
KSITNAANLGLDYGLVGGVAYAGYYLSFAVAGVVIYQLRTKGNYKSIHEFLTTKFGKKAV
AIFSILIAFRLFNEVWSNTMVIGNYFGAQGSTPYYWSIVVFTLLTLSYALKGGLSSSIFT
DVIQMVLFSVLLIVILGTIFATDDFSSKEIINSGTWSFELGLNLFFAALLQSFSYPFHDP
VLTDRGFISSPKVTRRSFLWAGLLGAFCIIFFSFIGIYAQSQGLKGQAAVEVGKAFGVVI
LLVINFIMITSAASTLDSTFSSFSKLLAVDLNLGKSVSFGRIAMVAVAVLGTIPVFLNAE
ILSATTISGTMVIGLTPMFIFWKYKVPKISFYLSIGCGLVFGILLVFNAFPQALIFTEGK
YASLLWVNLWGILSCIILYFIPKWIK
>FCMOIPGL_02716 hypothetical protein
MDQITHCLGKLSGKMLVFGGVYSNLQALEALKQISEKENIAPENCICTGDIVGYCAQPEE
AVQLFKIWGAKSILGNVEIQLRENAEDCGCDFREGSRCDSFSQLWYPYAQSKLSENSLKF
IKTLPNYINFTYANKKVSVVHGSFFNVSEFIYKSTDWSVKNPNFKATNSNVIIAGHCGLP
FSHQQENKIWLNPGVIGMPANDGNSSVWYAILDDANDQFSFTHKTLDYNYKLTSKLMRNG
LLPEEYSRTIVTGIWDNTEILPAIESGLQGFGIQL
>FCMOIPGL_02717 putative adenylyltransferase/sulfurtransferase MoeZ
MKKIVLLFLVISSATFGQKKLDKLLKKWNTRNVPYMSVKTLALPKTDAILLDAREEKEYK
VSHLENAICVGFDNFKLEETIAKLPEDKKAKIVVYCSLGIRSEIVADKLIKAGYTNVYNL
YGGIFEWKNADFKVIDTLGNNTEKVHAFNKNWSKWLKKGKKVYE
>FCMOIPGL_02718 hypothetical protein
MSKNLLLIFTRNPELGKAKTRLAKTVGDKIALEIYKFLLLKTRDISLKVNADKAVYYSVK
IRENDIWDASIYQKQQQFGEDLGIRMLNAFKNGFDSGYEKVMIIGSDLYDLTTEIIDDAF
YQLNNNDVVIGPAEDGGYYLLGMNFLEEKVFKNKDWGTASVRAKTMLDLKDKKVHLLEEL
NDVDVFEDIEFHPAFQKFLK
>FCMOIPGL_02719 Purine nucleoside phosphorylase 1
MSKQEQLAQTIDFLASAGITNPEIGIVLGTGLGKLVNEISIEKQVAYTDIPNFPVATVEF
HSGKLIYGEISGKKVLVMSGRFHLYEGYTPWEVTYGIRTMHGLGIKNLLISNAAGAINLS
YKKGDLMLIEDHINLQGQSPLAFKGANTFGNIFADMLAPYSKEINSKIIEVAKTENILLH
QGTYASVLGPQLETRAEYRMLQILEADAVGMSTVPEVIVAKQLNLPCAAISVLTDECDPK
NLQPVDIAEIIAIAGEAEPKMITLFKEVIKVL
>FCMOIPGL_02720 hypothetical protein
MKTKFFTLIFSFALLLSCTNELPKGETEIVEYITDDITTLVVPEGHDLRPIALQNTNINL
SEDSRADIVKVRIYKIENDENKLIYSGAIDRNTSINSIVKVPNHVSLLSVQADLAAGTRE
WIVTPAELESLIIEDEEVVDVDEDETEAKAKSATAAKTSVTYAQKDAPTWSCDDYKDFSG
NDNGDFKISNNSTQGINVDKKTEIYICSGGSWKPGYLNDNGGKLTIYVASGATLTLSGSI
NSTIYNIGTFNGTNLEVKEDSKFENWGTANITGAFNVSSNDVENYEGVFNVSGSLSVRDK
GDFDNEGGTINVGGHVTVSGNLHNKENSTLNVAGHFTVNSKGDFENECRTIISGNFINNQ
KVNFDNASYTVVTGSFTNNSNGEVSIKEGSIFKCASIMSNAKIKGSKAYSIIETGAITFN
GNSRFEGELDICSDSFKDDMGNNKVLSTCTTFISSGGCSPGYNNLIDEDKDGVIAGVDVD
DNNPNVSSYNYPQGQNSFFTTIYEDLYPCMGDYDLNDLVHNYSYSEGVNTSGSVTEIAFD
YKFPAMGGAFNNSFVLRVMDEDDNATLSLENSTYYSATGIQRLHDSENKTTLFIFNNIKS
IYTSNTGAIVNTAREDYTVIPVISGKVLNINGAYDEFLLQDGKLGHEIHPLYNKLHANYA
ALNNPSMYNDSSNFLRCDDSSSVITSLFVNSNGFPWVLNDLPMDLPWPKEGVSILEAYPN
FDDFVISNSSLDWYSNINGNRILSNLN
>FCMOIPGL_02721 putative HTH-type transcriptional regulator YtcD
MNLIDTKWKPLILFHLLEDGLRSGVLQKQIEGISNKMFTQTVRELEKDGLISRKVYQLVP
PKVVYKLSQRGESLENILRSLDKWVLEDVKS
>FCMOIPGL_02722 hypothetical protein
MKLKTSIIILILSSLVIYLLFSNSNVRNINNFNLLLNISAILIVIGIIGFIIYLIAKESR
KIKNITIGLVFISLAINSYVGFYKYQMNKRNKILSEYYELKSCKEMETRFASDLKKEEIK
YFFYGIGYDTELAKILDNKYKIETFGMGCLIQSEFECYNNLVYKYLKESHNETINDIYRK
IDNE
>FCMOIPGL_02723 hypothetical protein
MKLIALLVLGVIYTSSSTNEEEKTDTTALTVLIQSPNLNQTYVGYWGGAWPEADKVSLKA
LGVDDTKIASMKLTVINDSGTVVFAKTVNSSKSTQTELVISESFTPPEIGTYSVIFNAID
QN
>FCMOIPGL_02724 hypothetical protein
MDTYLDIIKNSYNGYWNYLQKSVLMELNWENYFYGLILISLVVWSLEMLFPWRKNQAVFR
KDFWLDTFYMFFNFFLLNLIILIALSNSAAQLFNDVLSIFNISISDFQLFEINDFPFWAR
ILVFFIVVDFVQWCTHRLLHQFEFLWNFHKVHHSVKEMGFAAHLRYHWMEPVVYSSLKYI
PLAIIGGFNAQDVALVHFFNITIGHLNHANINWDYGFLKYILNNPRMHIWHHAKELPKER
RNGVNFGITLSIWDYIFKTNYIPYNGRDIELGFDDDENFPKDFMHQEMYPLVKK
>FCMOIPGL_02725 Asp/Glu-specific dipeptidyl-peptidase
MKYIKIVLFFFVVQISAQQGGMWIPSLLEGMNEQEMTSLGSKLTAKDIYNVNNSSLKDAI
GHFNGGCTSEIISPKGLILTNHHCGFGQIQAHSTLENDYLKDGFWAMNLNEELPNPGLYV
EFIVRIEDVTDSVLLGVNDSLTEREKQSIITKNGNALQKTTEKEAWQQTKIKSFFQGNQF
FLFVTERFEDIRLVGAPPTNIGKFGSDTDNWVFPRHTGDFSMFRIYADKNNHPAKYSKDN
VPYKPKHFLPVSLDGVEEGDFTLVFGFPGTTDEYLPAVAIKHITQEYNPTNIAIREAALK
VIDAKMKESDAIRIKYASKQARIANYWKKWIGENLGIQKSNAIEKRQEFEATFTKALQEN
NLTEKYGNILPEFDKLYTDFAAINIKRRNFIEVFLVTNELMSMTFRAYQFEQAVTKNPKD
LDKARASIENTLKSIHKNYDVTVDKGVFENVMPFYTKNIDATIYDKTAFTNLNTALGLFN
GKAKKVLKKLNNDAAYQYAKPMIEAFYTSINKEYSEKNAPIVALQKEYMKALMEALPNAR
YFPDANSTLRVTYGQVRGYAPRDAVYYNPVSYLDGVIEKYIPGDYEFDVPEKLRELYKTK
NYGEYADKNGKVPVCFLGTNHTTGGNSGSPAIDAEGNLIGLNFDRVWEGTMSDMNYDPEI
CRNIMVDLRYVLFIVDKYAGATHLIDEMTLVHPKKK
>FCMOIPGL_02726 Bis(5'-nucleosyl)-tetraphosphatase PrpE [asymmetrical]
MSTFAIGDIHGGLKALLQVLNQLEVKEDDTIIFMGDYVDGWSESAQVVDFLIGLSEKINC
IFIKGNHDVWCQNWLKDSNDVNPSWFLHGGKETMESYEGFSDEKKQQHLHFFENLPLYHL
DNQKRLFLHAGFTSLHGVEKEKFQELFYLDRSLWEMLLVMDKSIEKDSMFYPKRLQHYKE
IYIGHTPTTNYNETSPINIANVWNVDTGAAFKGKITGLNIETKEFFQSDNLPGLYPNEKG
RNK
>FCMOIPGL_02727 hypothetical protein
MWYKNIFLFLFILFSSLLFSQENIIADVKIKGEKKIKASFLHKLLVTKKGIVLDSLTIEK
DIVLLKRLPAISNVYYQVSHSHDNFYTVLLNIEENYTIIPKLNLWSTTNKPISYKLGLYD
YNFLGRNMTFGGFYQNNGFHSYGINFSAPNLFSKKWGLELNHKNWKSEEPLYFEDETANY
LYNNISFEVLGSYQVDLKNQLIFSVNFFNEKYQYLSGVTDDSIPLSLDLNKVQLKFVYTY
DNLDYNYQYINGFKSVLYTQFVTSKNPFQKDFFIAWNDFFYYKIIGDKGNWANRLRFGLS
TNEKTPFAPFALDNNVNLRGTGILVDRGTGSFVWNTEYRQTVYDKKWLAIQTNIFTDFGS
WRNPGGKINDFFESKNLRVYSGLGLRFISKKIYNATFRVDYGFRISNNPGQSKGGLVFGI
GQYF
>FCMOIPGL_02728 hypothetical protein
MKKICFLLLLAFSMFFFSCSEDSDITTPRNLEAYVASISNKELGEVTAFAASTGESNSYI
YYYPEEGATDIRYYEADSLNIDETDFSKYRRKELTITDVFGGKLESFSRSDSEDNWCLVT
YMLDGKLHKSDPIHLKNETSLTGWTDVATIKYPETLTPNFTWSDFGISGNTIYFEAISRT
EDDEFISGTFTYDKVFNYFDSSNIVKNINVPETPDDLEEDTEYLFTMMAISDDNWVNLVI
QKTFMLKNLQEYLDDNSEKTIETGTAFAASSSSSESLSYIYYYPLLGFSEMRYYETESLT
VDENDFSNYRRKDLTDAAAFGGKLRRFSRTDDEESWGIVTFVVDEVLYKSNPIKIKNVTK
PTEWFTDVTIEYPESLNPKFTWLDGTYLDSSTYFQVITDSESSFLSGTFTTEKTFQYNNN
SNVTSTINLETPETLILDDEYKFTLMGISDDNWVNLVIQESFIVE
>FCMOIPGL_02729 Putative universal stress protein
MKKIIVPIDFSEHSENALKAAALFSKKVKTEVYALHMLDIQEINLSQSEDFSQEKSVFFL
KLAEERFKKFLQKSYLKGVKIIPIIKHYKVFSEINEIAKEINADLIIMGSNGATGLKEFF
TGSNTEIVIRYAETPVLVIKNELNDVDFSDVVYATDFSEESIPAFKKMLTSLAFLNAEIH
LLYVNLPNDKFLTTPEMDALANNFLMTAEGHIDRFINVNFVCAKTIEKGILSFSNAVGAD
LISVATHGRKGLSHIVAGSISEDISNHSTLPIMTFQI
>FCMOIPGL_02730 hypothetical protein
MRNMKATKFLFLLLIFLQVSCKSQTKKINGLSFVASRDKIDTTHINPALKVHSNYVALMP
FGSIKDLSSPSIRYNSGREWFGESKRGLLQYAEEFQKKQVKIMVKPQLWVWRGEFTGLIE
MQSEEQWKILEDSYSSFILTYAKVAQEINANILCIGTELEKFVLNRPQYWLNLIVKIREI
YKGKLTYAANWDEFKRVPFLNEIDLIGIDAYFPLSDKKTPTVKELEIGWKPHKEEIIRIQ
KKFKKPVLFTEFGYRSVDYNAKQPWFVDRFEGNVNLQAQVNGLQAIHNQFWKEEWFAGGF
AWKWFHKHKNVGGKKDNRFTPQNKPAEATIRKLYQQ
>FCMOIPGL_02731 hypothetical protein
MKKQQLKILITILSFFSIHSYAQEDVDASKSNIQTYTPSKLLNKGQWDIKFFNNLYTETE
GNYNGVKSDKVRETYFTSTLDIFTGISDNNRLNIGLLLEYRSNTKNGENATSVFGFNDDV
NSRNGLSSFAPALKWQPIESIGNFSIQSAFHIPVISDESDENGVYLDQTAYTFQNRFFYD
YTLPSGDWQLFTELNTEYNFGDKESFANKTFVLAPGVFMSYFPTDKSTILGFVQHYQRFG
DFTQNFSSVGFGGKYQLSNALNLEALYSKFVRGNDTGLGQSFNIGLRILF
>FCMOIPGL_02732 hypothetical protein
MRSFKIRNIKITSIHLSLLMVLLFLIIACDKEDIINDETNTNPDVEVTNNITDGFVLYSF
IGDTTTHLIDSLGADVKTWSSSNTSAGGCYLSVNKNLLRLGKLSEVNNGSFSTGGLVAGV
IEELDDNNKVVWSIERFSDASTFHHDFKEIDANTIIALSWELREYNNSDYWNELIVMIDK
TDNSVIWNWSAMDDGGIVPENKDKVDYLHFNSIDYKNGEILISSKNKNTLYIINKESKKI
TKSLTADETLVGQHDATFLENGNILVFNNNAETNKSAILEITKLDVVVWEYSNSFYSDHI
SGVQRLDSGNTLICSGVEGQFIEVTEKGEEVWSYIPENVTLSKSSNIFKARKYADY
>FCMOIPGL_02733 hypothetical protein
MNFKFLKTAISLLTILTIFSCEKDSEASIVEEQEEGDEIVTTNFSYTVVDTNVSDFYSND
AIISVPIKGDDFYGQDATYNGNQPSYTDNGDGTVTDNVTGLMWQQDMGDKMSYADAVALV
ETFNLGEYTDWRIPTIKELYSLAQFTGRCFGDDAVDMFIDVNYFNQPIGNESIGEREIDG
QTWSVTQYVGEIMTGKEAVFGYNFVDGRLKGYPKYKPATGAANTMYFRMVRGNTSYGKND
FVDNEDGTITDNATGLMWQQADNGENYDWENGLKYAESLILADYSDWRMPNAKELQTIVD
YTRSPQTTNSPAIDPLFSCTEITDYNGNSGQYGYYWTSSPLQDGPTPYTDAVYFCFGEAE
GEMNGVLLDVHGAGAQRNDPKSGSTADYPDTFGPQGDIRKVYNFVRCVRNVN
>FCMOIPGL_02734 hypothetical protein
MGYIMDFVGTFFITEIHYRSVKHVKTKNINYEF
>FCMOIPGL_02735 hypothetical protein
MKDFINEELILLVICFTVFYTVTGQTTYPIVDTNVSEFYSNNDVISEPNIGDVFYGQDAT
YKGNQSSYTDNGDGTITDNVTGLIWEKDMGDKMTYEASFSKAQKSNLGGYSDWRVPTIKE
LYSLILFTGKVKGAKSFKLFIDTNYFNQPLGNTNIGEREIDAQTWSSTKYVGKTMNGDET
VFGVNFIDGRIKGYPTFKKRTHSENIMYFRMVRGNTDYGKNNFIDNGDGTVSDYATGLMW
QKADDGKGRDWQASLAYSEDLELADYTDWRLPNAKELQSIVDYSRSPQTTNSPAIDPIFS
TTEIKDPEGKSGQYPFFWTSTTHLDGVNPSASAVYIAFGEGQGKMRNQLMDVHGAGCQRS
DPKSGNENQYPTFFGPQGDVRYVYNYVRSVRTIKM
>FCMOIPGL_02736 Transcriptional regulatory protein YpdB
MITCIAIDDEPLALRQIVSYIDKTPFLQLKGKFTNALDIGDFLKENPVDLLFLDIHMADL
NGLELAKTLENSPKIIFTTAYSEYAVEGYKVNAIDYLLKPIEYVDFLSAANKAADTIKKE
RQLSEVKKKDDFLFIKSGQQHIRINFNDIKYLEAQKEYVSLNLVNGEPVRTLLRLKNIEE
VLPKENFMRIHRSFIVNLNHIVTVERNRIIYSRKESIVVSDTYQEEFKNFLNKNFFS
>FCMOIPGL_02737 Sensor histidine kinase YehU
MSKNLLNKQSSSFFESIFIFLFWILLFLLPLFYQWVNSGFIRWSVIFNVWIDYLPLLIVF
CVNRFLLTPFLLFKRKQFFYLVAVVVVISFTVFGSINIRKNVIFQEIVPLHKQGGLQFPD
SNKTGIKKGLQNRQAPVGTYPPYVNLILLSILLVGFDTGMKLSVKWAETQQQKAEVEKES
VKNELAFLRNQVSPHFLMNTLNNIHALIDFDTVEAKRSVVKLSTLMRYLLYESNDKPIAL
SKEIKFIESYVELMKLRFCEEVIIELNLPKNPPNISIPTLLFTNIIENAFKYGISYEQNS
FVNIRLFVHENELEFTIQNSVHKKLETVESLGIGIENTKKRLKLLYNNDYIFTSIENENV
FSSTIKIPI
>FCMOIPGL_02738 Benzene 1,2-dioxygenase system ferredoxin--NAD(+) reductase subunit
MKHIVIIGNGISGVTAARHIRKNSDHKITIISAETKYFFSRTALMYVYMGHMKFEHTQPY
ENWFWKKNRIELKEALVSNVNTEKKKLEFKDSSTLSYDQLIIATGSKPNKFGWPGQDLEG
TLGMYHKQDLEKLEKYAPNKEVCKRAVIVGGGLIGIELAEMLRSRKIPVTFLVRETSFWN
GVLPAQESAMINNHIKDHHIDLRLSTNLKEIKSDENGRVKSIVIQETGEEIPCNVVGLTA
GVTPNIDFLKESGIELGRGVKVNRFLETNVKDVFAIGDCAEQHEAIGQRRNIEAVWYTGR
MMGETLAQTICGNKTAYKPGHWFNSAKFLDIEYQTYGWVFSERSKQENEAYFQWQHPTDN
KCITISFDKNTNKFLGINTFGIRMRHEIFDKWLTEKKSIKHVLEFLADANFDPEFYKLHE
AEILAKFNKENNTNITLKKKSWKRIFSH
>FCMOIPGL_02739 Putative electron transport protein YccM
MKLIKQSGLIIFLAGLTFFIGILFTGSFNLTQPELDTFIQEKGYKSEVLKEELTKAIVTE
ENLNIFQFSSKVIGAFEASNNHYDALIAKYNAEKNWTKKGAQFKYKISGKPHSISFELAK
KSGKGLAADNTGLAWFLTFGLGILGALMFIIPDVVLLGKPGIKNDGIFLSAATNRGWIGW
FTFIFLVTFYILLYFYPDFIVNWVYLVDPISKSLSGNPAGQWFLYGFLYCVVMTVMAIRM
YIKYRHNKYQILRTTSVLFFQIVFAFLIPEILVRFNQPWYDFKNAFPLDYDFFFKWNLEE
LIASGGLGLFILVWGILLTIVVVPVMVYFFGKRWYCSWVCGCGGLAETLGDPYRQNSSKT
LLSWRTERIVIHSVLVFVLVMTAFALYTFFSGEYQVLGIKTQTIQDIYGFLIGSIFAGVI
GTGFYPIFGNRVWCRFGCPLAAYLGFVQRFKSRFRITTNGGQCISCGNCSTYCEQGIDVR
AYAQKGENIVRSSCVGCGVCSAVCPRGVLKLENGPEDGRINPTEILLGNDVDLMDLINKK
>FCMOIPGL_02740 hypothetical protein
MKHFIIIYIICTSFIFSNQKKYQKEYYKNGQPKQEGWVLNNNKIDYWKFYYRNGNLKKEG
SYKDNLETKYWYFYNENSIKEKEGHFKEGLQNDWWLFYDKKGKVSHKCQLQNNQKNGYCL
IYKKGNLIKASKFKNGKKINEWKDFSSFKKENSLSDLR
>FCMOIPGL_02741 putative glycosyltransferase
MIYDKKPIIKVIIPAYNEQASIAKVINDIPKIVNETIVISNNSTDNTEINAKNAGATVLK
ETRKGYGFACLKGMDYIANQKVKPEIIVFLDGDYSDYPEQLTELIAPIINDNIDFVIGSR
VKELRENGSMTPQQVFGNWLATFLMKLLFRAKFTDLGPFRAIKYDKLLALNMQDKTYGWT
VEMQLKALKQKLTYTEILMKYRNRIGVSKVSGTIKGTIFAGIKILGWIFKYSFK
>FCMOIPGL_02742 Beta-monoglucosyldiacylglycerol synthase
MFLEYFIIVVYSVSLLLIFMYAIAQLNLLINYLKYKNKEDKSPKFDFNNPDEIPYVTIQL
PVYNELYVMKRLLKNIAKIKYPKNKLEIQVLDDSTDESVEMTAKLIKKVQDLGIDIQHIR
RTNRQGFKAGALKEGLKTAKGEFIAIFDADFLPKPNWLYETVPYFKNPEIGVVQTRWSHI
NRNYSTLTKIQAFMLDAHFTLEQVGRNSNGHFINFNGTAGVWRKECIYDAGNWEGDTLTE
DIDLSYRAQLKNWKFKYLEKVETPAELPVVISAARTQQFRWNKGGAENFQKMAKRIFTNK
NISAKTKIHGLLHLLNSSMFICIFLVAILSIPMLYIKNEYAHLKNYFYIMSFFVVSSLIF
FVCYWYMYKNIYGSGIKNFFRYIFAFLTFFSVAMGFSLHNTIAVLEGHFGKKSEFVRTPK
FNIITLKDGWKNNKYIKKKPSIHVILEGLLALYFVFGMYSAFIVGNQGGDFGLFPFHLML
FIGFSYVFFKSIFSKA
>FCMOIPGL_02743 Alpha-(1->6)-mannopyranosyltransferase A
MSFFLKNKVALVTLISTILYFIFAYFLERIEFYKLTFLWVFLFGCFYILIKKSAISFTNL
VGISILFRLIFLFAMPNLSQDFYRFIWDGRMIFEGFNPYLSLPETFIQQGIYPISDASEL
YSGMGELNGSHYTNYPPLNQLCFFIAALFSSKSIFGSVIVLRLLIILADIGILYFGKKLL
QNLNLPIKNIFWYVLNPFIIIEMTGNLHFEPVMIFFLIWGLYKLHQQKWVFSAFLIACSI
SVKLIPLLFLPLFYQWFVKKSIQQSKSNIITTFLAQLKSREFYKLISFYAIILSTTILFF
LPFYSSELITNYTKTVGLWFRNFEYNASFYYLFREIGYLFRGWNEIGIIGKITPILTILF
LLIITFFRKNKSEIQLITALLFGLCFYYFTASTVHPWYLATPIILSVFTKYKFPIVWSLV
VVLSYQAYSNLPWKENLWFVTIEYITVFSFLIYEMKKVKVKNMIN
>FCMOIPGL_02744 HTH-type transcriptional repressor CytR
MKKLTIKDIAKEFNVSISTVSKALNDSYEISEATKSKIQKYAKEHNYKPNFNALSLKNRS
TKTIGIIIPTMLKYFFAQVFKGIEKAAIERGYKVIACISNESYNKEVEIIEMLSNGSIDG
FILSMSKETELKKEFSHFKETIENGTPIVMFDRVAEPIACDKIITDDFNGVLNTVEYLYK
TGHKKIAFVSTISNLHMGEQRLLGYKKGLENVGLPYNEDLVVNILDKGYKEYESILTPFY
KKNKIDSIITTGESAAVAAMKAGLKSGLEIPKDLAVVAFSNGILARHSSPKMTTISQHGE
QMGEMAAKILIDKLEKKHKEIVTRVIKTDLVIRDSTK
>FCMOIPGL_02745 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YbjI
MIDFSKVKLVVSDMDGTLLNSEGKVSSQFFTLFKELQKHNINFCAASGRQYNSIVHKLSA
IKNEIHVIAENGAIAKKGNKTLLTNSLASEKITKIIPALRNIKKANIVLCSQNAAFIEST
DQHFISMFQEYYSSFQIVDDLLEIAKTIPVLKIAIYHFDSSEEFIYPAIKHLKNDYLLKI
SGQNWLDISDEKANKGNALREVQKLLKVTKEETMVFGDYHNDIEMMQEANFSFAMKNAHK
DIKELANYETESNDNFGVEKILEKLIKSK
>FCMOIPGL_02746 hypothetical protein
MKYQGVLKKMSTENLEEIQYYLDMKSDFLNMNQLLNKEITIKFVTYECLNCHLEKKIYRQ
GFCKSCFFEIPNAADWIMKPELSKAHLDIEDRDLAYEKSVQLKPHIVYLANSSNVKVGVT
RKQQVPTRWIDQGAHEAIEIVEVPNRYLAGITEVALKDYVGDKTNWRKMLKNDIEDENLV
EWREKLKQYIPDEAKQYFIENNSETHLNFPVLKYPKKPKSLNLIKTPIFTGKLVGIKGQY
LIFDDETVFNVRSNEGLVVSIDV
>FCMOIPGL_02747 hypothetical protein
MALPIVNSIISWFLKKRVHQIELFLKYPIDVQEELLLKLISTAKRTEFGKEYDFSTIRNY
KDFTNKVPIQKYESIEPLIERCRKGEQNLFWPTPIKWFAKSSGTTNAKSKFIPVSDEALE
YCHMKAGKDMLCLYINNNEETQLFTGKGLKLGGSSEIYKDNNSYFGDLSAIITENLPFWA
DYSSAPSQEVALMAEWETKMEAIIDETINEDITSLVGVPSWMLVLLNRVLERTGKDNILE
VWPNLEVYFHGGVNFNPYREQYKKLIPKEDFQYYETYNASEGFFAIQDINGSKELLLMLD
YGIFYEFIPMTKYKGENSKTIPLSKVKTGIDYALIITTNGGLWRYLIGDTIRFTSLDPFR
IMITGRTKHYINVFGEELNIENVEDALKLACEKTEALITDYTVGPIFMKDKKSGGHEWII
EFNKAPENMNYFTEILDNALKSINSDYEAKRYNSLTLAMPKIHVAKDGLFYDWLKHKDKL
GGQHKIPRLSNSREFVEELLRL
>FCMOIPGL_02748 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MNQVELIKLPILSEMELFEKKFKDAMLSKVPLLNRITYYIVRRKGKQMRPMFVFLVAKMV
SDGGFDERTYRGAAVVELIHTATLVHDDVVDDSNRRRGFFSINALWKNKIAVLVGDFLLS
KGLLLSIDNEDFDLLKLISIAVREMSEGELLQIEKARKLDITEDVYFDIIRQKTATLIAA
CCGIGAASVGANQDTVQQMRKFGEYIGIAFQIKDDLFDYTDDKIGKPTGIDIKEQKMTLP
LINTLNTCSKKEKSWLINSIKKHNKDKKRVKEVIAFVKENGGIEYTTNKMYDYKNRALAI
LENYPKSPYKDSLLTMINYVVERKI
>FCMOIPGL_02749 hypothetical protein
MKNIFLLFFTFLVFFSGFSQKASTEFPESAIGIYKGILLIDSPKGKQEIPMEFHLKKTDS
VHKFNYVLMYNNNPRNYTLIIKDREKGIYEIDENNGIILPSRFANNTLYSFFEVQGNFLS
SRFSFSENELDFEILFSATKNKTTTGGTSKEIPEVFGFPISVVQKAILIKEKN
>FCMOIPGL_02750 putative dual-specificity RNA methyltransferase RlmN
MDKKKDIRALTKEQLRDFFVENGDKAFRGNQVYEWLWSKSLHTFEDMTNISKQTREMLEN
NFVINHIKVDSMQKSADGTIKNGIKLHDGFVVESVLIPAKKRTTACVSSQVGCSLDCKFC
ATARLKRMRNLNPDEIYDQVVIIDKQSRLYHNRKLTNIVFMGMGEPLMNYKNVMKSIEKI
TSPEGLGMSSKRITVSTSGVPKMIKMMADEEAKFNLAVSLHSAIDEVRTTIMPFNTNFPL
KDLKESLEYWYAKTKREITYEYIVWDGINDKREDITALVEFCKAVPCKVNLIEYNPIDDG
EFQQASSSAINNYISNLEMNDITVNVRKSRGKDIDAACGQLANKS
>FCMOIPGL_02751 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MKLSQFDFELPEELYAVYPAEHRDESRLMVLNRKEQTIEHKMFKDIIDYFDEGDVMMLNN
TKVFPARMYGNKEKTGARIEVFLLRELNAENRLWDVLVDPARKIRIGNKLFFGDDDSLVA
EVIDNTTSRGRTLRFLFDGSYEAFREKLLELGQTPLPKSINREVEPLDDERYQTIYAKNE
GAVAAPTAGLHFSKHLLKRLEIKGVDFAEMTLHVGLGTFSPVEVEDLSKHKVDSEQIAIP
AASVARINQAKIDKKRICAVGTTVMRTVESSVSSKQELNAYEGWTNKFVFPPYDFSIANS
MITNFHPPKSTLMMMAAAFAGYDFLMEAYKEAIKEGYKFSTYGDAMLII
>FCMOIPGL_02752 3-phosphoshikimate 1-carboxyvinyltransferase
MDILLNVLQNKKINENITISGSKSESNRLLILQKLFPEITIENLSDSDDSIHMQHALSTS
DELVNIGHAGTAMRFLTSYFAVKEGRETVLTGSDRMQNRPIEILVNALKDIGANITYEAK
EGYPPIRIKGTKITKNKVQINGNVSSQYISSLLLIASKLVNGLEIELIGEITSVPYIEMT
LSLLNQLGIETSFKENILKVFPKKSIKKQTVVVESDWSSASYFYSIIALADVNSEINLSA
YKQESLQGDSCLAEIYKHFGIQTTFGENAINLKKVKKSSKETLEIDLKNAPDIAQTIAVT
CFAEGIACNLTGLHTLKIKETDRLVALHDELSKLGATISVTDVSLHLEKSLVINKNVAIK
TYNDHRMAMAFAPLAFKVPIQILNAEVVTKSYQKFWDDMQQIGIKIDKL
>FCMOIPGL_02753 hypothetical protein
MSFLEKIKNPEFWSNFLKVAMPFFVVVILVSLFINSGRDIFNGDFTKVGEANFGNGKWKN
FFAFKIIFSVFYGLYITNKKME
>FCMOIPGL_02754 hypothetical protein
MKSKIIFAFISFMLLFGINNSLLYNDLEKQVSTAKVINLAGRQRMYSQKITKLALYLNEE
KEDNYSTLRLEGLKEIITNFSEAHQFLEESHLKQYKSLLLNQYFKDIEHSYLKIINSSRE
YLNSPNDSQVKANFIKNIKFNESEFLRIMDDIVNEYEKIAETRAIKIKGREFTFNAIMVL
LTIFSIFSIIIPLLKNKNLNLK
>FCMOIPGL_02755 hypothetical protein
MKKIIFILILISSIGKNFSQNSTVSLNLNKDKNLWQEFTYDLGNMAGGMGYAYSRPLYWK
GNQFSNLAYVAAGTSALYLVDNHVDNWSDNWRGNVPRWLADYGNEYGSPNNNFMVTGAVY
LTGLFTRNPKLRRTGVLLISSASASGLLQQVSKRIIGRARPKANVGKGTFDPLHFDRVYN
YDSFPSGHVMLGFTNAYILAKHFDNPWVKAGLYTVGSIPGFARIVDRFHWLSDVVFSTAL
SIFIVEAIDKYLDTKYDQKYNDKRKTKKVAWDLHFTPQSFGVVMNF
>FCMOIPGL_02756 hypothetical protein
MSLKKINDQLNKNVNEETQLINSLSIGKYFLIYIPILFLMFAVSQLVAGLFFEFEFDWRM
VLVQAIGFAIFFRVFHKVRKYTQQNWKNKHN
>FCMOIPGL_02757 hypothetical protein
MSFIKNFTEGAKIVFSRFQTRFFWIKFAQFAIPFFVIVTLISLLMNSSREIFAGDFTAVI
KENFSDGKWQNFFGFKIFFSIIYALYVTNKNLK
>FCMOIPGL_02758 hypothetical protein
MNIENAQKQVDDWIKTHGVRYFNELTNMAQLTEEVGEVARIIARRYGEQSEKESDKNKDL
GEELADVMFVVLCLANQTGIDLQDAFEKKLDIKTKRDHDRHHNNQKLK
>FCMOIPGL_02759 Sensor protein FixL
MLTFFCLKIEILFLNNRYKLSLNPTPKKLEKNKYKILLIFFILIIIANQIIISNSISKQS
SDAETINIAGKQRMYSQLITKMALYTKNANLQDDNISNLKKVIDSFKKADTYLKQKNKLQ
YNIESLDILFNKNTPYFNKIISSSNKLIEDPNNEVVFNQFFETIKNNEQPFLNSMDAIVN
EYQKLSENRLSFLKKMEYFFITFTSISLFAIIFFMFLPMFRKNKALTNLNKELEKFKKEI
EQKEKDKKSVEEILHRTNSVARIGTWEVDLINKEVSWSKVTKEIHNTKNDYIPSLEKGID
FYKEGYSRDRITKVIDNSIKNNSSWDEELQIVTAQGKNIWVRAIGQPEFINNECVRLYGT
FQDINTVKLAQIELKKANEELNAILDSGTISIIRTDTNGIITYFNEGAEKLLGYKSEELI
NKKTTAIFHDKEEVLKRGKKLSTKYKKEITGFDLLTRLARNNKVDSTKWTYIKKDGTSID
VQLSVSAIRDKKGNIVAFLGVGTDITKLTEQNKQLASFAQIASHNLRAPVSNLSSLLDLY
DICETSEEKEFTFGKFRTVIAHLSETLNTLIEAIKIREKRESNIEIKTLSFSKVFKKTEE
IISEKISRLNAVIISDFSSIDTIKYNESYLESIFINLISNSLRYSSPERAPRIEVTTTIN
AGKIELKITDNGLGIDLEKHGHKLFGLNQVFHRHKDSKGVGLYIVKNQIESLKGTISCTS
EIDKGTTFTITF
>FCMOIPGL_02760 Transcriptional regulatory protein AfsQ1
MPQNPNICIVDDDEVYKFFVKKILKIKNLAKDALTFPDGEEAYKFIKENRENLEKLPDII
FLDINMPIMDGFQFMDEYTKIHNEINKKITIYMITSSIDPVDLERSKKYDQISDFITKPI
SAEVLQRIINPIN
>FCMOIPGL_02761 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKSKKAIITGGGKGLGKATAIAFAKEGIDVAITGRNEATLKATVSEIEKLGVKAIYAVFD
VGNYEEVKTGIKSIIEKFKTVDILVNNAGIAAFGTFNDMKVEQWSQIIQTNVMGMYYVTK
EVLPYLIAKNEGDIINVSSTAGLNGNASTSAYSASKFAVIGMSESLMKEVRKNNIRVCTL
TPSTIASDMSINLGIANKDSEDSVLQPEDFAELIVAGLKLPRRAMLKSAALWSTNP
>FCMOIPGL_02762 Esterase YbfF
MKENNILHSIIQGEGNPLLILHGYFGSSDNWKTLGNKFAEDFQVHIIDQRNHGRSFHEDE
FNYEVLVADLYNYIQFHQLEKIYLIGHSMGGKTAMLFAVTYPDLVDKLIVVDISPKEYQP
HHNAILAGLNSIDFLIQNSRKLVDEQLSKFIPEFGVRQFLMKNVYWREKGVLDFRFNLKS
LTENNVEVGKALPVGSVFRKPTLFLKGEKSGYILLSEQIIIDTYFPNNKVVEIANAGHWL
HAENPKQFYDEVCNFLK
>FCMOIPGL_02763 Pyridoxine 5'-phosphate synthase
MTKLSVNINKIATLRNSRGGNVPNLLKVAADIEEFGAQGITIHPRPDERHIRYQDARDLK
NIVTTEYNIEGNPVKSFMDLVLELKPTQVTLVPDAVNAITSNAGWDTIKHQSFLQEVIAE
FKNNGIRTSIFIDTDAKLIEAAAKTGADRIELYTEDFATQFDLGNKNVIKSYTEAAILAH
KLGLGINAGHDLSLDNIQFFKENIPNLDEVSIGHALIAESLYLGLENVVNMYLHRLK
>FCMOIPGL_02764 hypothetical protein
MNTNDYILKDISAFRLNDSVKSAQNLFKNFPITHFPVVDNDKLLGSFAEEDAQTIENKED
TLEEYTYLLNPFFADEKATVIELIKIFADNNATIIPVLNADKNYIGYYDLNDILEVFAAS
PFMLEESKILIVEKLENDYSMSEIAQITETNGGKILGSYISERKNGFVQLTLKIVADEIN
EIMHTFRRYDYKIISTHENDIYLEDLKNRSEYLQKYLEM
>FCMOIPGL_02765 NAD kinase
MKKVAIYGQSYSISAEKEIQILLDVLQENNISCLIEQQFYKLLVEENVLEKKYNTFSHFS
DLNNSFDAFFTLGGDGTILRAVTYIRDLGIPILGINTGRLGFLATINKNSIKESVELILK
GEFKIQERTLLSIKTIPELEQFNELNFALNEVTIARKNTTSMIGVRTCLNKEYLTNYWAD
GLIIATPTGSTGYSLSCNGPVISPGSKNLVITPIAPHNLSARSMVISDETSIQLTIDSRE
KDFLISLDSRISSVPKNTKVYIEKANFTIKSITPNNQSFLKTLRSKLLWGEDTRNETNL
>FCMOIPGL_02766 hypothetical protein
MYEAGITIGGSNYVGDIGRTDYIYPNKIAGAAFFKYNWNPRIALRATYSYLPIEANDIDA
DTDFKRDRNLDFKNTINELAVGLEYNFYEYDLSTPGKTWTPYILLELAAFNYNYVVSEPQ
PNQYEFDSKNSISVPFGIGFKSKISGSFAFALEAKFRYTFEDDLDYTTDKIAKLDFEGTG
NDWYMFTGFSLIYTFGRPACYTNGL
>FCMOIPGL_02767 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MDKKLRIDLQRVPKHVAIIMDGNGRWAKGKGMNRIFGHKNALTAVRESIESAAEIGVEAI
TLYAFSTENWNRPKMEVDALMQLLIKSLKKELPTFQKNEVKVNAIGNIESLPENAQKTLT
EVRELTKNNSRIILTLALSYGSREEIVKAIKNISKKVVNKELDLENIDENTINNHLYTFN
LPNVDLMIRTSGEQRISNFLLWQMAYAELYFTNILWPDFRQEHFYDAIIEYQNRERRFGK
TSEQLTE
>FCMOIPGL_02768 Putative outer membrane protein assembly factor
MEKLANNLQNKVSKKLFSAVLVPFALLFTFNSTAQTVKDTIINNNISFEKGKEYILGGIT
VTGLKKFSEETVKVFTGLRDGQTIKLPGDKLTSSIKKLYESKQFSNVDVYLAKLDGETVY
LQFDVQELPQLNKVKITGVKKSKAKELIKDAELKLGAMLTDNLIVTTKNYITKKYTDKGF
LKTKVNLDVQKDSSDINSVNINVFVDKGSKIKIKDIVFTGNKELSDKKLRKVMSNTKRKF
IGRFWKGSKYIEEDYQEDLESILDKYSRLGFRDARILSDNISWNDDNTININIDLEEGKQ
YRFADILFVGNKEYSDNQLRAILRIEKGDVYNGAVLKERVKGDGSPTSEDLSTMYQDSGF
LFSQVNAVETKVQNDSITVEIRIREDDKARIKKVTVSGNDKTNDHVIFRELRVKPGDLFS
RSAIIRSIREIGQLGFFDQNVTPDVVPDYQNKTADIDFTVAEKGGSQIELQGGYGGGSFI
GTLGLSFNNFSIRNLFNKDAYKPLPMGDGQSLSLRLQTSRTFNTYSFSFTEPWLGGRKPK
SLSFSIYSSNQYQYDYTTGDVNKDQSLGIIGASIGLGQRLNWPDDFFQLSQTISYQSFKL
NNYGFQVGTDILNEGTLNNLSYNAAISRNSAGPSLIFPTYGSEFSLAVKATLPYSLFTNK
DYDNLDPQEKYKWLEYYKFTAKGKWYTAFTDKLVLMTNAEMGYLGYYNSELGQNPFERYY
VGGDGISQFQLDGRETVGLRGYENNRLSSSEGGTIFNKFQLELRYSITDSPAASIYTLGF
LEGGNSYDNFDTFNPFEIKRSAGLGVRIFMPAFGLLGIDFAHGFDPLPGETEKSGWQTHF
IIGRQF
>FCMOIPGL_02769 hypothetical protein
MKKIFLLVVLLFTATNFWSQRNQIIAYIDMEYILENVPEYIQAQNTLDAKVAKWKNNLDK
QARHIEVLKSDLANEKAILTKDLIEEKEEEIEIKQVELRRLESLYFGPNGDMFLVRKQLV
KPIQDQVYNAIQSIAARKKYDFVFDKSSELVMLYSNKKYDISELVLSTIDRTRLSKEKKE
LMNKKSNTPNEDLTDRQKELLEQKENAKNKKEEALAKKAAENKAKKDAIAEKRAALIKKR
EEQRKILREKKEALRKKKEEEKKEQEENENN
>FCMOIPGL_02770 hypothetical protein
MKNLKTLLLIAVFTLGLGGVANAQKIGHINYQRVIVNMPEARALQVTLEKLGKTYQDEIE
TMGKKIEAKRTKYTAEQNSQTPQINESRAQEVQQEIARYQQLRQTAAADIQQREQDGLKP
ISEKAQKAINEIAASKGILYVLEENSLIVKKGEDLYDAVKAKLGLLKDLPRPTAENK
>FCMOIPGL_02771 Glutamate racemase
MKSNNFPIGIFDSGIGGTSIWREIKTLLPNENTIYLSDSRNAPYGEKSKQEIINLSIKNT
EFLIKQNCKLIVVACNTATTNAIKILRKKYSIPFIGIEPAIKPAALKTKTNIIGILATKG
TLNSKLFEKTSSTISRKITVKEKIGTGLVELIENGDIDTSKMKELLTSYLEPMLKKQVDC
LVLGCTHYPYLIPVIREIVGDKIQIIDSGEAVARQTKTILEKKQLLNNTSKDGNHQFYIN
KDKKVLEMLISKYGKKIKINQLDF
>FCMOIPGL_02772 hypothetical protein
MKLLYINFCLLTLFFFSVKSYTQETLPIYQDYLSDNVYLVHPSAAGIGNSSKLRFTARQQ
WSGIPNAPALQTMSFHTRLSEDSNAGYGFVLFNDKNGYHSQKGLQGTYSYHLPMSNGTYF
NQLSFGLAFTFVQNQSDQRTFTGDQAVSAIIESTSYYNADFSVAYHLGGFSSYFTVKNLL
LTAKNNLNIQEPLDLRNYIFSTGYYFGEDLVVQFEPSVMLQFRESTGERIADLNIKAYKN
ISKTQLWAALSYRKSFDTNAIENSQFISPIIGLNFENFMFSYTYTNQMNETVLTTSGFHQ
ISLGLNLWTRKQRASACPNINSAFGSF
>FCMOIPGL_02773 hypothetical protein
MSKFRKKKKGIPAVNTAALPDIVFMLLFFFMVTTTMRETDLRIENPRLPSASEVKKLEHK
SLVCTIYVGKSKDPSRDGVGYNKIQLNDKIASAEQVPAFIINARSKVSEAEVPFMTTSIK
ADKESNVGTITDIRLKLRDVNALKISYSASKGGGN
>FCMOIPGL_02774 hypothetical protein
MARRENPEINAGSMADIAFLLLIFFLVTTTMNVDSGVSKKLSEKPPADYVPPIIKEKNIF
VVLINRNNELLVEEQRMDIKDLKKAAVEFIDNGGGVGKPGEDGSPGKPCDYCEGARSESS
SDHPNKAIISVQSDRGTEYGTYIKVQNELLRAYTDLRNRLCRKRYGMSFDELEEAFKGDK
TNEALKKKVEDIKTSYPQIISDAEPTS
>FCMOIPGL_02775 hypothetical protein
MKSNKILNILIAAIALIGGVLFIRVLMEDSVAIEESVDLQNSLVSPLISFSYWLCIAAVV
ITIGLAFWSLIRNPENLKKTLGGLAVLAVLLFVAYFLSDSNVVYDAAGKIQPGGEEGSAT
NHWVGAGIWYSVILGGIAGVFFVWDLIKGLIK
>FCMOIPGL_02776 Biopolymer transport protein ExbB
MKKVVNVLSVTGFMFFGAIQSTFAQEAAATEAKTFHQILKQNFIDGGPGFMGIVLVALIL
GLAIAIERIIYLNMATTNTKKLLANVDDALSSGGVEAAKEVCRNTKGPVASIFYQGLDRL
DEGVEEAEKAVVSYGGVQMGQLEKNVSWISLFIALAPMLGFMGTVIGMIGAFNDIAVAND
ISPAVVAGGIKVALLTTVFGLIVAIILQIFYNYIVAKIDSIVNSMEDASISLIDLLVKYK
K
>FCMOIPGL_02777 L-asparaginase 1
MSKKPNILLVYTGGTIGMIKDYKTNALKAFDFSQILEKIPELEQLNCVIKSISFDVPIDS
SNMNTLYYKDIVSIIEDNYHDFDGFVILTGSDTMSYTSSAISFMIENLQKPIIFTGSQLP
IGDLRTDAKENLITSIEIASARKEGKPIISEVCLYFEYKLYRANRTTKINAEQFEAFASM
NYPNLAESGVYLNFRDHYIYKPSEERKELIIRKNLVTDILILKLFPGITEKVVKSILNTV
DLKGVILESYGAGNAPDEVWFLNLLKEAISKDIRIINVTQCSGGNVIQGHYETSIELKQI
GVVSGKDITTESAVAKLMYLLSENLTLDKFTYYFEKPLRGEISDK
>FCMOIPGL_02778 hypothetical protein
MIGFYILIGAISLISWLVSNKLKSKFKKYSQIQLRNGMSGAEIAEKMLADNGIFDVKVIS
TPGRLTDHYNPVDKTVNLSEAVFNQRNAASAAVAAHECGHAVQHAQAYSYLKMRSQLVPI
VSVTSKFSQWLVIGGIILGATYDSATGSAGIGFYIAITGLIFMGFATLFSFITLPVEYDA
SNRALAWLKSKNMVSQQELAGATDALKWAARTYLVAALGSLAMLLYWGMQVLGGRD
>FCMOIPGL_02779 hypothetical protein
MKFFTTSIFILFFGILATFSQHTISGKIIDQQNVALPFANIILYEIGSKENPKGTVSDDK
GTYKLENISSGKYKVEISMLGFETQNITEFELNSNKTINITLKEESQLLNEVVVKSKRPV
IKQTAEKLIVDLENSEMINTNLQDVMRKIPGVLVTNNGITIAGNSGVRILINGKTTEYMD
VETLLRDFPADNISKIELVEQPGAEYEASGSGAIINIILKKNVHLGTHGSTNLWVGEDEG
FEYGTGFSIASYKNKLNWQASTTFSQPTWREDLYLNRTVGDENYNQLTKEPYDPTNFRVS
GNIDYYINDKNSFGIGGSLSTRNSNRIASSTTIISDVNNTNTLLSENSFDRERKNFNINP
YYEYKTDTDKLVIDFNYVDYANDNTNILSEAFGNTVSFDERKYIQDGKYSIKTYKADYSK
TFSDNLKLSAGTRFANVNTDNDLQTFSDNTAGDFEFDENASSQFLIDENIFALYTKVNAT
AGKWSFSGGLRYENSNTDGTSIYMEDGEQKTAIKKRPIKKVFPSASISRKLTEVLGTSLS
YSYRIQRPSYNSLNSFETYLDPYSAGVGNPNLTPSYTNNYQFNLTYEGQPFFTVGYSKTE
DIIFQLIKQDNETKQIRQQDVNIENSENWNFRLFAPLSFTKGLEGYTGIIVTNKDYKSSA
FDVDVDVDLNKWNLIWFVQASYQLPWDVNLELSGNYGTGALEGQIEVDWLAELDFSFGKK
FLDDQLKVNLGFNKMLNRGFVGNIDYGNGIAAVESNGSRQNIQLRLVYSFGSKFGKKKSS
RNSNNDEENRIQDNN
>FCMOIPGL_02780 hypothetical protein
MNKNQIIGLLLAIIGVTLGLLWKKPEYADVLDFLFGVLAAIGLSMVLKFLPIKRKKKSDS
>FCMOIPGL_02781 Elongation factor 4
MKNIRNFCIIAHIDHGKSTLADRLLDFTGTVTSREKKEQLLDSMDLERERGITIKSHAIQ
MDYIYKGEEYTLNLIDTPGHVDFSYEVSRSIAACEGALLIVDAAQSIQAQTISNLYLALE
NDLEIIPVLNKVDLPSANPEEVTDDIVDLLGCNPEEVIHASGKTGFGVDNILAAIIDRVP
APKGDPDAPLQALIFDSVYNSYRGIETYFRVLNGEIKKGQEIKFMATGKNYFADEVGTLK
LTQVVKKSVKTGDVGYLITGIKTAKEVKVGDTITDALNPTIERIDGFEDVKPMVFAGIYP
VDTEDYEELRYSMEKLQLNDASLVFVPESSAALGFGFRCGFLGMLHMEIIQERLEREFNM
TVITTVPNVSYHAYSKKNPEEVIILNNPTDLPDPSRLDRVEEPFIKASIITKSDFIGQVM
SLCIEKRGQIINQTYLTTERVELIFEMPLAEIVFDFYDRLKTVSKGYASFDYHPIGMKES
KLVRVDILLNAQPVDALSALLHADNAYTIGKKIVEKLKELIPRQQFDIPIQAAIGAKIIA
RETTKALRKDVTAKCYGGDISRKRKLLEKQKKGKKRMRQVGNVEIPQEAFMAVLKLND
>FCMOIPGL_02782 hypothetical protein
MGAKENILKKIHSLISTKYKSPTEAFHFYDEDKDGKLNKDEVKKLLKSADISGLLRGVVA
GELIKGYDKSGDECINLDEFKIAIAELERDI
>FCMOIPGL_02783 Dipeptidyl-peptidase 5
MKFKLHYLLLIAAVLTTACKKSKKEDVDAKSGETKKWEGGLIYPEEVHFKSMKQITFGGD
NAEAYWSFDDKQLIFQSNNKDWGVDCDQMFLMNADETFKDSKPPMISTGFGRTTCAYFLP
GNKEYVYGSTHLSGKECPEAPLRREGKYVWPIYESYDIFVSDLKGNITKQLTTEPGYDAE
ATVSPKGDKIVFTSMRTGDLELFTMNIDGSDVKQITDQLGYDGGAFFSPDGTKLIFRSSR
PKTPEAIKEYQDLLKEGLVQPTEMELYICNADGSELRQLTDLGNANWSPFFHPSGNKILF
SSNFEAERGFPFNLYLIDLDGKNLERVTHGETFDAFPVFSNDGKKLIFSSNRNNGGGHDT
NLFIAEWQD
>FCMOIPGL_02784 Aminopeptidase S
MRNILFLIFLCFLISCKPSINQETRIKEDVTFLASDKLEGRQTGTKGEKEAANYIVKRFK
ELGLTKKGTEGYLQPFTFRPKTNPHEQVKFDVNGDGTITGNNVIGFIDNKAENTVIIGAH
FDHLGFGGEGSLYRDSIKAIHNGADDNASGVAILLNLASKLKGKNTSNNYLFMAFSGEEM
GLLGSNYFVKNPTIDTKKVSYMINMDMVGRLKKDSALAVYGTGTSPIFKQTLKSHNDNFK
LIQKESGVGPSDHTSFYLNNMPVLHFFTGQHEDYHKPGDDSEKLNYEGMYLISDYIFNII
TDLDNNGKLAFRKTKNESEETPRFKVGLGVIPDYMFDGKGMRIDGISEDKPAQKAGLQKG
DIVIQLGDSTVVDMMSYMRALSVFKAGDKSKVLVKRGEKEVESEINF
>FCMOIPGL_02785 putative tRNA-dihydrouridine synthase
MVKIGNIELPDFPLLLAPMEDVSDPPFRALCKENGADVVYTEFISSEGLIRDAAKSIMKL
DIYEKERPVGIQIFGANLESMLQTIEIVEKSNPDIIDINFGCPVKKVVSKGAGAGILKDI
DLMVSLTEAMVKHTNLPVTVKTRLGWDHDSIRIVEVAERLQDVGCAAISIHGRTRAQMYK
GNADWKPIADVKNNQRMHIPVFGNGDITTPEKAMEMRDKFGLDGAMIGRAAIGYPWFFNE
VKHYFKTGEYLAKPTIAQRTEMARRHLQMAIDWKGEHLGVVETRRHYTNYFKGIPHFKEY
RMKMVTSDDAKDVFAAFDEVEETFGNMIIPEYK
>FCMOIPGL_02786 hypothetical protein
MKRLSLFFSFFIFISVGCSSTKNTPKIEKFTELDATTVKTLMKEYSIDVPNNWYSYLEGH
NHLSHSPKELLLNKYVPQTNLYIFKKKAKKYTNINDLTIYFVKKLEKKYQNFNYDLVKGS
LPLYGRYNFIIYKTNYFNKDYTTLNAIILKDNYYYTITYRALSNDYQKYADDVVKMIHSF
RIKE
>FCMOIPGL_02787 Lipoprotein-releasing system transmembrane protein LolE
MSFPLYIAKRYLFTKTSSNAINIVTIIASFGVIVGSLALFIILSGFSGLRTFSYSMLNAS
DPDIKITSVKGKSFFITDEVKQVLKNNQLIAATSKVIEERVFLEYKDKSEIAYIKGVEDN
YSQITQIDSVLSQGVWLDTTYVNTAVIGRTIAIKLSLGVRSYGEQLQIMVPKPGTGFINP
TNAFYKTEVQIVGLYTGTEEFESKYVFVALPQAKRLLNFKENQITALELKLIDDNFADAV
ANELQEKLGNSYKVQTKEQLNEVFYKVINTENFVSYLIFTLIVIIALFNVIGTIIMMIID
KKDNLKTLFSLGANVKEIKKIFVLQGFLLTFFGMIIGLTLGIILVFIQQRFELFMITDNL
AYPVEFRISNLLIVILTITILGFIAAKIASSRISKEFIEN
>FCMOIPGL_02788 30S ribosome-binding factor
MEETNRQRKIAGVLQKDLVDVLQKAAQDGMKGVIISVSKVHVTSDLGVAKVYLSIFPSVK
RDEIIKGVVSNTVLIRHEMAKRTKNQLRRMPELLFFGDDTLDYIEEIDKSLSGKDEDPIK
NPEVLPKRKKI
>FCMOIPGL_02789 Transcriptional regulatory protein DegU
MKQFTVVIVDDHTLLSQAIQTMVNTFQKFKVLYTCKNGKELLEKFSDQKNIPNIVLMDIN
MPIMNGVETTEWITKHHPKVNVMALSVEDEEFTILKMLKAGAAGYLLKDTEKSVLEKALI
EIAENGFYHTKSVTTILMNSLSGNEVKEIDINDKERQFLKLSCTELTYKEIADQMNLSPK
TIDNYRNSLFSKLNVKNRVGMVTYAIKNKIYTL
>FCMOIPGL_02790 Oxygen sensor histidine kinase NreB
MQESEGIVLIVSTLLVLFIVIALIVLFTVFQKKKNSLVEERKEALEKFEREITETQIEIR
EETLRNISWELHDNIGQLLTLAKIQLQNATEENIKDVSETITKGLTEVRALSKLINPEAI
NNIELKDAIQLEIDRFNRLNFIDSSIIVLGDKKNIDKKHSIIIFRILQEFFSNTIKHSRA
SNLKVVLDYKEDFLNIIAQDNGVGFSSDVKKDGIGLINIKKRAQLIGAEIDFESEKNIGT
SLEIHYKL
>FCMOIPGL_02791 hypothetical protein
MLGDFYSYFEYASLIFALIYYTKYKEYSFYKYFILYLLFIVIFEKLSSLDTPKDNWYECF
NNGVKILNIFTFFEFNLVALIYHSLLKEKISKNILLYLVLFFNIIYLFSFYFIKLQNYTV
VLEGIVNTVLVILYFRELLNSDRILNYKKLLPFWVSVGFLLFYLTSIPFFTLVYSSYFNS
RIMFPILYSIIIVFHLCFIYGLISCKKVKG
>FCMOIPGL_02792 hypothetical protein
MKTKLIRLLTFFVLSILFFSCKSELKHEEHIQNSERPVQAISYTEMASMFKEYDNGQRIV
LNEYITKKSKGKDSVATISQFFSLSEIKQYIAYIERLSKEKDIDLTGIRIFTSAYPSDYK
IKEYQNRMCFILAPTTNIGDQKNIAYEPLKSGKSKPVAMKSILDKYADETTRNVNRASLF
SLKLALRDSSSALNRGEVNPPN
>FCMOIPGL_02793 ATP synthase epsilon chain
MFLEIVTPEAILFSSKIDSFSVPGIDGEFQMLNNHAPVVSVLKEGRVKIHMHTQQHLEID
IISGLIEPHIDDDKILTLAIKSGTLELKDNKAIILAD
>FCMOIPGL_02794 ATP synthase subunit beta
MSTAKGKVSQIIGPVIDVEFNTENELPRIYDSLEIKKEDGSILVLEVQQHIGEDTVRTIS
MDATDGLSRGTEVTATGNPIQMPIGNDIYGRLFNVTGDAIDGLGNLPKEGNDGLPIHRSA
PKFEDLSVSTEVLFTGIKVIDLIEPYAKGGKIGLFGGAGVGKTVLIQELINNIAKGHGGL
SVFAGVGERTREGNDLLREMLESGIIKYGDDFMHSMEAGGWDLSKVDKPGMKDSKATFVF
GQMNEPPGARARVALSGLTIAEYFRDGAGEAQGKDVLFFVDNIFRFTQAGSEVSALLGRM
PSAVGYQPTLATEMGAMQERITSTKKGSITSVQAVYVPADDLTDPAPATTFAHLDATTVL
SRKIAELGIYPAVDPLDSTSRILSAEILGEEHYNTATAVKEILQRYKELQDIIAILGMEE
LSEEDKLVVHRARRVQRFLSQPFHVAEQFTGIPGVLVDIKDTIKGFNMIMDGELDKYPEA
AFNLRGSIQDAIDAGEKMLAEA
>FCMOIPGL_02795 Outer membrane porin F
MKQLKMAVMALFTLVAFSNVNAQDANNPWAVGFGVNVVDFYNGSDFGDQVDDLLGNKDWN
FLPSISRITAEKYLDKGFSLQLAGSLNKITWYEAEDDVDALYYSLGANVKYDVNNLIGDT
SQWFDPYVYLGGSYVSYDSNGEGMLNVGVGFNTWFNDNLGLSFQHGSIVGFADNVKAHYQ
SSLGLVVKFGGTDTDGDGVYDKEDACPEVVGLKEFNGCPDADGDGIKDSDDACPNVAGLA
AMNGCPDSDGDGVADKDDKCPNAKGTKANKGCPDSDGDGVADKDDKCANVAGPAANNGCP
WPDTDGDGVLDKDDNCKDEAGPASNNGCPEAAMTEAQIATLAEYSKGLEFAFDRAEVNKK
TAEKLDKIFDLISPIKDVIFVIEGYTDSIGDAGYNQYLSERRAVSAKAYLVKKGFDANRL
ETLGFGEKNPIANNNTSAGRKDNRRVDVKLTE
>FCMOIPGL_02796 2-amino-3-ketobutyrate coenzyme A ligase
MYGKIKDTLKKEIQEIKEAGLYKSERIITSSQDAVIKISTGEEVINFCANNYLGLSNHPE
VIQAAKDTMDTHGFGMSSVRFICGTQDIHKQLEAKIAEFYTTEDTILYAAAFDANGGVFE
PLLTKEDAIISDGLNHASIIDGVRLCKAARYRYNNNDMASLEEQLIEANKQNHRFKIIVT
DGVFSMDGIVAKLDEICDLADKYDALVMVDECHATGFIGKTGRGTVELKNVMDRVDIITG
TLGKALGGAMGGYTTGKKEIIEILRQRSRPYLFSNSLAPAIVGAILKVFDLIFDDTTLRD
KLEWNTNYFRTEMEKAGFDLVGADAAIVPVMLYDAKLSQEMANLLLTEGIYVIGFFFPVV
PKEKARIRVQLSAAHEKVHLDKAIDAFTKVGKALEII
>FCMOIPGL_02797 ATP-dependent helicase/nuclease subunit A
MQELSTFHVYNASAGSGKTFTLVKEYLKVLLDSEDIFKFQKVLAITFTNKAAGEMKERVL
SNLEDFADGKENDLFKIIINEIAVDKPTIQIRSKKILEVILQNYSAFSITTIDSFTHKII
KSFAYDLGLPLNFEVEMDAVSLLNEAVDILISKIGTDRKLTKLLIDYSLDKTDDDKSWDI
SRDLNEFAKVLLNEDDIKHFRALSVKNLEDFTSLKSKLFTHQKELKEAIKKVGEDCLELI
ENNDLVHKDFMRATIPKFFTDLSVKSVNIDFLKRSETIERAIDNHQYYAKSTKDDIAAII
ENIVPEIVSFYQKSKEIYSQFLMNKLALKNIIPLAVLNNINQELEQIKEDNNIRLNSEFN
QLISDNIKEQPAPFIYEKIGQRFQHYFIDEMQDTSVLQWQNLIPLIDNALAQESSNLLLV
GDGKQAIYRWRGGKAEQFIELGSDVENPFHIGKEIRSLETNFRSYSEVINFNNSFFQHTA
NFLQNESYKNLFIEGNKQIENAKKGGFVSLTFLEDEKDKEEKKLRYPKKVLEKIKHLKND
FSLNEICILTRTKKDGVAVANYLSENGIDIISSETLLLQNSAKVNFIIDVLKVLENPNDE
ETRFEMLYFLHQHLQIGSPKHIFLKEFAKADNQTIFESIKSYGISFEIATFHQLPFYEKI
EDIIRGFNLVNSSDAYVQFFLDVVLEQQRKSTDVAEFLEFWEIKKDKLSIVAPESKNAVQ
IMTIHKSKGLEFPVVIFPCDVDIYRQINPKVWLDELPENYDNFSELLVDYNKSLSYVNNT
GLEIYNQQREELELDNFNLLYVVLTRAVEQLYVITEKKISSKGEENTDFYSGVFINYLMQ
NNLWNDELLEYTFGDENRVSKKEEESSLAEIHEKFISTPWQEHNVVLLTSASKLWNTTQG
EAINFGNLFHEMLSKIITKKDVDKVVEQYQQQGFIDENQSKEMISKINAVVNHPELINYF
SEAVIIYNEREIVDFDNQIMIPDRLIFTDKNEVVIIDYKTGNQSKEHHQQVLKYERVLKS
MNFKVGKKLLIYINDKIDIIEI
>FCMOIPGL_02798 Fe(2+) transporter FeoB
METNNIDKIIELSNELRWQIGDDFHDDLTEAIYADASKIVEKTVVKDGNKGASYLNAKID
KIVTSKIWGFPIMLLLLGLVLWLTIIGANYPSSMLASLLLDTVHPLLKEGAAFLNFPWWL
SGFLIDGVYLAVAWVIAVMLPPMAIFFPLFTLLEDFGYLPRVAFNMDALFKKSGAHGKQA
LTMTMGFGCNAAGVVATRIIDSKRERLIAIITNNFSLCNGRWPTQILLATIFVGAVVPSA
YSSLISLVAVVGIAVLGIFFMFFFSWALSKTVLKGEVSTFNLELPPYRTPMFWKTIYTSL
IDRTLIVLWRAIVFAAPAGAVIWLVSNIFIGDESIAVHLIHFFDGFGFLIGLNGVILLAY
IVAIPANEIVIPSILMLTVMVTGAVGGAGAGVMFELDSVTATGDILRAGGWTLLTAINVM
LFSLLHNPCSTTIYTIYKETKSVKWTVVASVLPLIAGFIVIFLVTQIWRIIA
>FCMOIPGL_02799 Fe(2+) transporter FeoB
MTATKSACDTCAHHSLEGVKKLGVDTSNVDFVIALAGNPNTGKSTVFNALTGLRQHTGNW
PGKTVTRAEGAFEYQQKKYKLIDLPGTYSLMSRSEDEEVARNFILFGKPTLTVIVVDASR
LERNLNLVLQILEITSNAILCLNLIDEAEKNNISIDYRSLSKELGIPVVPTSARSKEGIP
ELIATIGDLANGKIVCKPHKIKSIPKHVEEAVKKMSDAIKKEYPNVANSRWLAFRVLEGD
THILEALKTGAFI
>FCMOIPGL_02800 Iron-dependent repressor IdeR
MNTYNPTVALLVFFGVILVLFFIFNPKNGLFFKYLKARKESEKTAIEDVLKLLYHDSNIS
KNTIFNELDFSHGLLMESIETMIETGLVKKENELFSLTKDGHEYALRIIRAHRLWEKYLS
EKTGFHKEEWHKRAERKEHELSSEEVEDLSTLLGNPRYDPHGDPIPTKTGKIHEKKGILL
SDLPVFNFGKIIHIEDEPIAIYKEILAKNIHLDSQVYVKEKSKNRLVFESEGEQFALTPI
VAKNITVISLDKVDVIEKDTMRLSNLESNQKAIIIGISKECRGENRRRLLDLGFVKGATV
SIDLLNPLGDPKAFLIKGTAIALRNDQAVKILITKT
>FCMOIPGL_02801 Iron-dependent repressor IdeR
MYLCILIYEMFSQSEENYLKAIYHLSLISNKGISTNSIAKKLETKASSVTDMIKKLSDKE
VVVYKKYQGVALTDFGRKEAASIVRKHRLWEVFLVENLNFSWDEVHDVAEQLEHIKSPKL
VKQLDAFLGFPTHDPHGDPIPDEEGNLKIVKKSLLSTLLKNEAGVCVGVNDSSSDFLQFL
DKKGITLGKQITVLEKEDFDDSLSIMIEDKKLSISHKIANNLYIQKI
>FCMOIPGL_02802 Colicin I receptor
MKLKIFILSIALFGLNSLFSQENSISGKISNNAEALPYVNIYLKKTKIGVASDENGYYEL
KNIPKGNYTLIISSIGYKTKSVKISVLNNQKIIRNFSLSEDNSLDEIVISGTLKPVSKTN
SPVPVEVYSKTFFKKNPTPSIFESLQNVNGVRPQLNCNVCNTGDIHINGLEGPYTFVLID
GMPIVSGLSTVYGLTGIPQALIERVEVVKGPASTLYGSEAVGGIINIITKKPSNSPKLTT
DTFASSWGEINTDIGLRYKLSEKTQGLLGINYFNYQNRIDNNNDGFTDLTLQNRISLFNK
INIERESNKVFTIAGRYVYEDRWGGEMDWEREFRGSDIKYGESIYTNRWETFGTYQLPTS
ENINFQFSANGHYQDSFYGTDAYDAEQLIAFGQFVYNKQIKEKHDLLVGIAYRYTFYDDN
TFATIDKNGAINQPSKTHLPGVFLQDEISLNKRKKLLLGARWDYNSAHGNIFSPRINYKW
NSRDNSNIFRASIGNGFRVANIFTEDHAALTGAREVEFNGELDPETSWNANLNYVKKINT
ENSFITLDASAFYTYFDNRILPDYETDSNKIIYANLNGHSVSQGISLNADILFTSGLAIN
AGATLMDVSVTENNIKTKQLLTESFSGVWSVSYKFNNDFTVDYTGNLYGPMRLPLLGEND
TRAEYSPWYSVQNIQLIKKFTNSWEIYGGVKNLLNFTPAANSINSANNPFDVGVDTEANP
ELAFDPSYVYASNQGIRAFIGLRYTLF
>FCMOIPGL_02803 Thiol:disulfide interchange protein DsbD
MKKFLLLFLLFGYFSTNAQSEKKTLNTYTFSEVEKLHQQKPKPIVVFTYTDWCKICLGMK
KKTFKNKEIINLLNDKFYFVKFNAEQKEDITFLGKTFVYKPSGNNTGIHELAIALASIDG
KISYPTTTILNPKLEIDLQIDSFINSKKMKSILNKYLKINKN
>FCMOIPGL_02804 hypothetical protein
MKKKLKNKYFFILFIFFTIVIQSQDINNKWVIGIGAGGVLYSEADGPSIGYRYSEQFPRL
SIARYMFKNVTFAGAISTHIDVNRKYTTFDGEARYDFGTSENRLSPYVLVGGSFIDQKYL
LPVINFGIGGTLWISDRFGLNGQLMYKVNHLGFQSQGSHIYGSGNLVYRFDFGSGTSRKR
GNRRRLWERKH
>FCMOIPGL_02805 Transcription-repair-coupling factor
MSKQQIVNQYQKSANVAQLNKALQQDKNHFQISNLIGSSLSFVISETFKKSEKPYLLIFN
DKEEAAYYLNDLEQLLGEKNVLFYPGSYRRPYQIEETDNANVLLRSEVLNRINSRKKPAV
IVTYPTALFEKVVTKKELDKSTLKVAVGENLSLDFVNEVLFEYKFKRVDFVTEPGDFSVR
GGIIDVFSFSNDEPYRIEFFGDEIDSIRTFDVETQLSKEKLNKVSIMPNVENKTLEENRE
SFLKYISSKTVIFYKNIDLIVGNLDKFFNKAEEAFLDLSKEIKHAKPSELFCDGAFIKNQ
LQDFTLVNFGNQKSENTKIEFNTIAQPSFNKQFNLLIDNLEEYHKAKFTNYIFCANEQQA
KRFHDIFDDAEQEVHYETVVFPLYKGFVDVDNKLVCYTDHEIFERYHKFRLKNGYAKKQA
ITLQEINKLEIGDYVTHMDHGIGKFGGLQKIDVQGKKQEAIKLVYGERDILYVSIHSLHK
ISKFNGKDGKAPKIYKLGSGAWKKVKQKTKARVKHIAYNLIQLYAKRKLQKGFAYGPDTH
IQHELEGSFMYEDTPDQFTATQDVKLDMEKEQPMDRLVCGDVGFGKTEVAVRAAFKAVDN
GKQVAILVPTTILAFQHYQTFSERLKDFPVRIDYLNRFRTAKQKTAAIDGVNDGSVDIII
GTHQLTNKRLQFKNLGLLIIDEEQKFGVAVKDKLKTLKENVDTLTLTATPIPRTLQFSLM
AARDLSVIKTPPPNRHPIESNVIRFSEETIRDAVSYEVSRGGQVFFIHNRIENIKEVAGL
IQRLVPSAKVGIGHGQMEGKKLEELMFGFMNGDFDVLVSTTIIESGLDVPNANTIFINNA
NNFGLSDLHQMRGRVGRSNKKAFCYFITPPYHMMTDDARKRIEALVLFSDLGSGINIAMK
DLEIRGAGDLLGGEQSGFINDIGFDTYQKILQEAIEELKENEFKELYPNDNSKPKEFVKE
VQIDTDFEILFPDDYINSITERLALYSKLGDLNNENELQIFETEIIDRFGEIPTQVEDLL
DSVRIKWLAKDLGLEKIILKQKRMIGYFVSNQQSDFYQTEAFSRMLKYVQQNPKSCVMKE
KETKNGLRLLITFIRIDSVKTALSILNKI
>FCMOIPGL_02806 Inner membrane protein YbcI
MASLIGHAFTSIALGKSFSRNRRNWKLILIAIVCAIIQDIDVIGFQFGIPYNSFWGHRGF
THSLFFALLLAILVTAIFYKKLFFSKKGIILILFFFLCGAFHSILDAFTDGGNGVAFFTP
FNNTRYFFPWRPIKASPLGITRFFSERGMLVIRSEVTWIVLPGFIYMVIAFLIRKKRNKI
>FCMOIPGL_02807 Threonine/homoserine exporter RhtA
MENSHNKNLSILLLGTLFVSTSGVLGKYIALPAEAIIFSRAILASIFMYTFCRIKKVDLK
IKSRKDFYSFVISGFFMAAHWVTYFIALKLSNVALGMLTLFTFPVITALLEPFFTKQKLN
PIHIFLAILVLIGVYILVPDLSIENDQLKGVLFGIFSAFCYALRNLTIKKHVKDYNGSML
MLHQMIVVAVLLIPVLFFSDFTNLQSQIPLLILVALLTTAIGHTMMVNSLKHFSVATASI
ISSVQPIFGIIIAYIFVNEIPSFNTFIGGGLILSTVIIESIRSKK
>FCMOIPGL_02808 hypothetical protein
MLIFETMKSERKLMSKKKPTFPINGMLNEYLKKYKRNVKIPIFYDDLLRFQGSVTVYDKN
DEDTLWVRTYYSEWDRVEIDNSLKKIYMMLLSDGSDETLPFLNVDAIDYCTFGNSKPFRV
KVRNILNDNYTYFYVKKADASRVYGLELEHILSPHNINFLVYKDTLIEEHIVGIPGDDFI
KNFLPKCTESEKSQIAKEFVKFKERCLVRLLGDMRSYNYVVTPTHDFYHIVYKIRAIDFD
QQSFEGNLKVYNLQFMKENFKMVEMVSKKLQNSSINQYKIEERSFMAKRMITAPRRTEWL
LNCMKNDTISYPENVALLKNQLIKYVGDVKFKECTNMGEILEVILSFVKRNYLDIRNKDL
F
>FCMOIPGL_02809 hypothetical protein
MYFPFSIGISVVHYFGLGDDLLIFSTLFLSIILVNIQGLRVFNPNNKKLKFILFSLLPLV
LYLLFLIIYKENYFILYKVLIVIPCLFSLFQIFKNFKFGNN
>FCMOIPGL_02810 DNA processing protein DprA
MKEEKLLAILRLQKSKAIGDILAKKLIANVGDVENIFKEKSTSLLKINGIGNHAINHLFD
KKNIELAEQELFYIQKNKIAYSYFLEDDYPKNLHNCIDSPILLFKDGNINLNNDKIISIV
GTRNMSSYGRDFCNKLIEEIAEFNPIIVSGFAYGVDICAHKAAVKNKLQTIAVLAHGFEQ
IYPKVHKKYINQVNENGGFFTEFWHEEDPLRENFLKRNRIVAGISKATIVIESAAKGGSL
VTADIANSYNRDVFALPGRATDIYSKGCNNLIKYNQANLLTSSKDIIKMMNWDLSEKPKK
AIQKQLFVELNTTEQIIYDYLLKEGKQLLDVIAIDCNIPLFKLSSILLQMELKGIINPLP
GKMFEIV
>FCMOIPGL_02811 hypothetical protein
MNLANYINDLLYRYNCIIVPNFGGFVTNKIGATIDEATHTFYPPKKQITFNSHLKKNDGL
LANYIATSENISFEKASNAIDLAVSDWKNKIQTESLQIGSIGVLSLNEEGQIIFEPNAKV
NYLSTSFGLSSLESTSVKRYQEQVKPLIPITNTESKKGIPTFIKYAATAAILLTLSFVGN
NVYQQNKQKTILANQEKALEKKIQSATFVIANPLPTIELNVVKEVEIVKPYHVVAGAFQF
TENAEKKVNQLKELGYNAKIIGINKWGLTEVSFNSFADKNDAINSLYKIQKTISADAWLL
VKK
>FCMOIPGL_02812 putative acyl-CoA thioester hydrolase
MEAKTPKDSLTILTDLVLPGETNYLDNLFGGELLARMDRACSIAARRHSRRIVVTASVNH
VAFNKAIPVGSVVNIEAKISRAFKSSMEIYVDVWTEDRQSGHRTKVNEGIYTFVAVDETG
KPVVVPQIIPETALEKKRFEGALRRKQLSLVLAGKLNPHDATALKSLFN
>FCMOIPGL_02813 Low conductance mechanosensitive channel YnaI
MEFLNHFKIIETFIVIIAAFTLRFLITKSLGKIQLKFGFQQARIMLTNKIITILIYVLII
VIVSFIWGVDEKQLLIYISSFLTILGIAFFAQWSILSNITAGLILFVNYPVKIGDTITIL
EKDNEVSGEIRDIGAFFITLKTAENELITVPNSIILQKNIKYYPQDTNS
>FCMOIPGL_02814 hypothetical protein
MKNRSFYIFLFSVFLINSAVFSQTRKELEFQRIKYKTVIAQLNTLLFNEKEKEKNALDDL
RDLQLKIDARNKLIETINLETKLLSREIVANQKEINKLDKKLTDLKTDYGDMIFKSYKSK
SQQSRMMFILSSQNFYQAYKRLEYMKQYTAFRKKQGEEIIVQTTIIKGLKDSLLGQKKIK
DALLLSEINEKKEIEKDKSRQEGLINEIKRKEGKYKRELQNNIKEDKKIAAKIDKIIKDE
IDKANRLALAKAKKNNVAAPVTTKKNEFILTPEAKALAAEFEQNKGKLPWPVRQGLVVRR
FGEQPHPTFPGISINGTGLHIVTSKASSAEAIFNGEVLNILLGSGGTKNVLIRHGNYITS
YNNLENTFVKKGDRVVTGQEIGKIFTDKVTGKTTLIFVLFKNTTRLNPASWMLRR
>FCMOIPGL_02815 hypothetical protein
MKFLKYMLFLTIVLTSCKAKKNMIDANAIAKDFSAKKVAKKHVAANFDKKTIDSKLKVNY
NNGKTNQSLTVNLQIDKDKVIYLKGTKFITVFKAKITPTSISYYSPFAKNYFEGDFSMIK
KLLGVEINFEQLQNLFLGQSLLNVREEDQTVEIVNNRYILSPEEQAELFDIFFVINPSHF
KLDEQSIVNVSKNLRLDVKYPSYNLIDKTVFPSEINLKAKKPGSFTDIDIIYKSVEFNKN
LRINFDIPSGYKRLEI
>FCMOIPGL_02816 hypothetical protein
MIIREKNKDKRIRRIFVSKRSFLFSLFFMLLSTNFFSQDSIPEKEDLTEETELKFQQFFF
RALSEKSIGNYKKAIENLESCNQILSNDVAVFFEFSKNYLFLKNTLLAKEYIERSLAKEP
NNIWMLTHLVQIYIKDRNFEEAINTQHKIVAINPKKREFLVRLYVYNSQIREAFSLMDSL
EKENVLSSSLKRLRNRLEVRKEYLTKKNLVQKDVKEEGSSIGLNELINQFKTDKSYKILE
DILNKSTGNYKNLLKFSEEGIALFPAQPFLYLINGKVLNDTKNHKNALPVLQSGIDFVID
NEMEVDFYLEIAKAFKGLGNDKEKIKYLQKAKNLKNK
>FCMOIPGL_02817 Glucose-1-phosphate thymidylyltransferase
MKIIVPMAGIGSRLRPHTLTVPKPLTVIAGKPIVQRLVEDIASVIDEKIDEIAFVIGTAA
KGFPSDTEEKLLKIAQKLGAKGSVYVQHEALGTAHAIYMAKESLSGPCVVAYADTLFKAD
FTLDVNADGAIWVSKVKNPSAFGVVKLEDGIITDFIEKPKDFVSDLAIIGIYYFKSGDKL
LEEIQYLIDNDLKENNEYQLTNVLESLKQQGAKFIPGTVSAWMDCGKKDPTVDTNKQTLG
FEYAAGNNLVSADVVLNNSEIIQPCYVGKNVVLNNTKIGPYVSIGENSVVDNSIIVNSLI
QTNVAISNADLNNAMIGNYAKYNAQYTSVSIGDYTELT
>FCMOIPGL_02818 Energy-dependent translational throttle protein EttA
MNYLSVENISKSYGERILFQDISFGINKDQKVAFVAKNGTGKTSILNIIAGLDVPDTGQV
VKRKDISIAYLAQNDELNPDLTIEETIFATDNIILSVINKYEKALKNLDDTEAYQKAFEL
MEQYNAWDFETQYTQILSKLKLDDLSLKISTLSGGQKKRLSLAIVLISKPDFLILDEPTN
HLDLEMIEWLESFFASEKITLFMVTHDRYFLERVCNEILELDEGKIYKYKGNYSYYLEKR
EERIQLEQVTTDKAKNLFKKELAWMRKQPKARTTKSKSRIDDFYQIKEKAHQRRNDHKVQ
LEINMERLGSKILELHKLYKSYGDKKILDGFDYVFKRGERIGIIGKNGTGKSSFLNIITQ
KNEVDAGKVVVGETVKFGYYTQSGINIKEGQKVIEVIKEFGEFIPLTKGRKISASQLLER
FLFDKKKQYDFVEKLSGGEQKRLYLCAVLIQNPNFLILDEPTNDLDVVTLNVLENFLLDY
PGNLIVVSHDRYFMDKIVDALFVFRGEGVVENFPGNYSDFRAYDSSDSDETIEEKPVEIA
LKETEKKATKNTLSFNEKREFGALEIEIERLQKRKATIENQFLNVEIAPDDIAKKSEELQ
EIINEIDAKEERWFELSMKMEE
>FCMOIPGL_02819 hypothetical protein
MNLTYNINDILFLDIETVPEEESWNSLSKTTQELFEKKTQYQRKEEFTAAQFYERAGIWA
EFGKIICISVGYFVDVKEVKQFRITSFFGDDEHQLLTDFKVLLDKHFTKKANILCAHNGK
EFDFPFIARRMIVHQIELPKKLNLFGKKPWEIPHLDTLELWKFGDYKHYTSLKLLTSILG
IPSPKDDIDGSEVASVYYKEKNIDRIVTYCEKDTIAVAQILLRFNNEVLLKEENIVSV
>FCMOIPGL_02820 hypothetical protein
MKKNYIFTLLITLCLTAVSFGQEMILNGGLENWDDDTTPTSWTKAEVLTKSTDAHSGSFS
AVRDGGSGTKDLSQTISGVIPGNSYTISFWYKVTAGDEEDVRIWSNWKSGDTFVYHVGDV
NDRSNDPLRGPEDGYLDDGDGVWTKHEVTVTAPADVDSFYFEVRSYSNSTTYWDDLSFVN
NGTASVKDNSIEGFATYPNPVTNNKFTVTSSSSNRKEIAIFNVLGGKVFSSTVSGVKSTV
DVSSISSGIYILKVTEDGKTATKKLVLK
>FCMOIPGL_02821 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MNKSDIKILLVDDEPDILEIVGYNLKNEGYQVFTAENGLQAIKAAKKNTPHLILLDIMMP
EMDGIEACEKIRKIKSLENVIISFLTARGEDYSQVAGFEAGADDYITKPIKPKVLVSKVK
SLLRRLKNEEESDETFKVGDIVIDRDEYVVYKAGTKISLPRKEFELFSLLTSKPGKVFKR
EVILDTVWGNEVVVGGRTIDVHIRKLREKIGDDHFKTVKGVGYKFVLEGAE
>FCMOIPGL_02822 Alkaline phosphatase synthesis sensor protein PhoR
MKTKKTYSYALWSAVYLTLLSVIITAICYFFISSHSNVFTIIISILSLFFISFLIIQYRT
EHFIYRRLKKIYEDISFLNVKDLKKESATTDIEILSRKMEKFVEGKRLEIKNLTEIDSFR
RDFLGNVAHELKTPLFTVQGYILTLIEGAVNDKQIRMKYLDRANKGVERLVAVIKDLDMI
TKLENDGMKINFEVFNILELIQNVFDLFEMKAKKRNITLQFDKIYEFPVFVKADSEKIEQ
VLINLVVNSIKYGKPNGTTIVGVESYNNKKFIVKVIDDGEGVKKIHLPRLFERFYRVDQS
RSREQGGSGLGLSIVKHIIEAHNENIFLKSTYGKGSEFSFTIEKAR
>FCMOIPGL_02823 Phosphoribosylamine--glycine ligase
MNVLILGSGGREHAFTLKLLKSNKINQIFVAPGNAGTHKIATNINISVSDFIAIKKTVLE
NDIKMVVVGPEVPLVEGVHDFFLEDNELKNIPVIGPKKDGALLEGSKDFSKQFMQKHGVP
TARYQSFTKDNLTQGFAFLETLDPPFVLKADGLAAGKGVLIINSLDEAKTELEEMVSNQK
FGEASTTVVIEEFLKGIELSVFVLTDGKNYKILPSAKDYKRIGEGDTGLNTGGMGAISPV
PFADKAFLDKVEELVVKPTIDGLQKDGIDYRGFIFIGLMNDNGNPSVVEYNVRMGDPETE
VVLPRIESDLFELFEGVANQTLDKKSFSVTDKTATTIMLVSGGYPEAYEKNKEITGFDTV
DESIVFHAGTTIKDDKVVTSGGRVMAITSFGNTIEEALEKSYNSIDKIHFDKMNFRKDIG
FDLV
>FCMOIPGL_02824 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MLVLNVVVYSVSDEKYLNFSFLLYISISWLIISYYTKFYKVYRYTQTSKLFSLLLSQFFV
FSLAYLSYFTVFEEGELVGNQILIFSLTIILITFFKVLIFFLRRNYRSKGNNYRNVVHFG
EIYSSKKLENLFHFKNDFGYRYIGFFSSKEYESKYYLGHIKTGFKYIEENDIDEIYCDPA
EISTSMLIKISKYAEENDLELRLMPENNAIYSKELVLEYFGTVPILKPKPLPFEKIETHI
VKRVLDIFCSAFVCIFVLTWMLPLLWLVIRLDSKGPLFFKQKREGIDGTQFLCYKLRSMK
VNNDADKVSATKNDKRITKVGAFLRKTSLDEFPQFFNVLLGDMSIVGPRPHMNLHSKKFI
NEVDNYLLRNSVKPGITGLAQISGYRGEVVKKSDIKNRVRLDIFYIENWSFFLDIKIIAQ
TFFKVFIKEEKAY
>FCMOIPGL_02825 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MKEILDLSASIVLYNENLEELTSTINAFLNVPLKKKLYLIDNTNKKRFQNIFNQKDVEYI
AVGKNIGFGAGHNIVIDRIKNNSNYHLVLNPDVNFEKTVIPNLILELSKDESLSMIAPKV
LFPSGEHQYSCRRYPHFLELVARRFPFVKPLFKPAVFKGQYKDKDLTNSFFAEYLAGCFQ
LYRTDDFVKIKGFDERYFLYMEDVDICRKIDQLDKKKLYYPEEVIFHVLKQGSAKDLKLF
LRHSSSVIKYFVKWGF
>FCMOIPGL_02826 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MKKRYSYLIKPFQLIIDLIIINLVFYFIYDAEYLNLFFLVYISFFWIISSYLLGFYKVFR
FTRLLRVLSLLVKQFFVFILGYFAFFGIFREGQVVDYQFLVLVSIIISISVIKILWLFLL
KKYRSFGNNLRTTIVLGFDQSAKNIIKLFKSKSNLGYNYLGFFSNKEYKNKEYLGDLEDV
FIYAKKNEVDEIYCSLPVLTKEQIKKINKFATEQNITLKLIPDSIELYSKNQSVEYYDDA
LMVLNVNRLPFEFSENFYIKRIFDIIFSLLVSILILSWLIPILWVLVKLESKGPLIFKQD
REGLNGDHFICYKFRSMRINDLSHKVHATKNDERVTKIGAFLRKTSMDELPQFFNVLLGN
MSVVGPRPHIESLSLEYQKEVEDYLKRHIVKPGITGLAQISGYRGEVQKRSDIKNRVRLD
IFYIENWSFLLDIKIIIKTILNAFKGDEKAY
>FCMOIPGL_02827 O-antigen biosynthesis glycosyltransferase WbnH
MVKILHIARPIAGIGVYVSLLSKYLDSSKFSNTIICNTNEDIIDIVNDNGVKIDHFHCEL
KREIRFIYDIKCLIGIFKIVKKLKPDIIHCHSSKSGILGRIIGFITNTKTLYTPNAYSYL
SADAKSKRFLLKSIERFFGLLPVKTLACSTSELNRAIVDLSIKKDNVTLWNNSIENEIIT
KNSEYLSKLPKDFICSIGRPSYQKHTELLIKAVLKIKETQKNIHLVILGVGFYSPTLNKI
KKSILSNNLSENITLVPWLERSEGLGILDKSLIFVSSSRYEGLPYAVLEALSLSKPCVLT
NVDGNKDLVKNNYNGFLVDENADELAQKIDKILSDTVLRKDMEKNARKEFESFYDIKKNI
KTLEKIYLSFIK
>FCMOIPGL_02828 hypothetical protein
MKKELILKLSSYFYFLMMFFLPISLLLDNIFLGLLFLSVILNSKKTIKNNILYYLFAFFT
FTVLNGVLNSFFVVEKENYLRLLPLLLIPFSLGNIDNTTKLKGLFFLSLGIVIIQLNSVY
GIINYYYFTEGKKYALRNYYKVNEILNYERPYLGFFSAINIIICLHYFVTYKRKILSIVV
ALFSLILIIVISARLAIIVVALTGLITVFKIFKTKNIIKPLLILFGILFLVLLSKSSLKY
RFLQITKDARLVTWTGASDIFFKNSYYIFGSGSEQQTRDNLLEHYKDYDGFDSEAEQNRF
ITKNYNTHNQYINELLRGGFVGLFLLVIPQVILLYSNFKKNNDIALMFLFAIISFSFVEN
ILDRQVGVYLYALLLCLTGINYKVKE
>FCMOIPGL_02829 hypothetical protein
MIIAFNILITLIAIIIMLYLLEKDLGLFLLSIMIFVQYIWMFFSLTVIESGIHVVEQGRN
GYFVFSTLVLLLFFITTIISLVFFKKIFTQLFKKINITKIKYGKIKEHQITRVIIGFVLF
LAFLNLFLSPIPVFSDSVTKFNFWEYAKFPFLKSIVGNVMAFVAFGSAILYRYYKKTSIF
FFFLYIVYLLLIGQKFTGFFIGISGALIAFYFSSEDKIKFKLKWIFNKYLWIFIGVIFFL
ALYKYSIDNPFRNLKMTALEAVFYRFFGLQGHVFWGVTDQYIYQGKANTWNVLELWKGMH
HLMLEFWPWRYQDFISVTTRGVSWTNAYPSILIRIFPLPLALFANFILMSFVALMQTLLT
VFIKRKSLFVSLILFQLLIWTSYAYTMAYFSKLTIPVFFILAFFTYKYLVMRTKNEQQ
>FCMOIPGL_02830 hypothetical protein
MINIYIGLSKNQISSYESIIREKKKTNCQNILISNKTLNNDVECWDKVVYAKESFNNQSS
GKLSAFTNITLKIKQYKEIIKELTIYKTEQNITLYFTYIEDILTNFLLFSFNKNMRGIVV
EDGTLNYYPHTIKSLSQKKVILKWMLSNLYNVRFKFYKGHSSGIEYENVVKQYVRVPELS
QFPEKSVKLIYPTRKLNVTDTILIIGQEGYINQLGESRYINNLKDLGKLIQSKKYYSQIE
KIYYKPHRNGKRIDLEQLKSLFLTKQVIYLESDEPLEDLYFNKLGSKYIYSFDSSALINI
YLESEDVIKKELNFNVLLRYNNLLKPIFQKFNFNIYK
>FCMOIPGL_02831 hypothetical protein
MFKTSLFFKLLNVFLRIGGIGTKFLIITLMSKYFDVDVFGNYGLITSIITLLIFILGLDF
YNFSVRDILKTNDKQEIVNKVILTFILYIVVYLLFIILGYFILGNLSYIKPYLFLVLFLA
ITEHLSQEIYRLLIGFKKVLLANIILFFRTVSWSAIITFYYYNNSLITIEKIFNLWLIAN
VLTIVYVLVFSIGKNYDSILKLNLDFFWLKKGLKISSVFFIATISLKSMEYANRFIVDFF
MGEKLAGIFLFYSNISILITVYVNTIVISFELPELIKSIRLPNIDLLLKKFKKSLIIHVF
ISSLFILLIIKPLLLWQNKVEFENYLPLIYFLIIGAGLMNYSLLYHFKLYIYHKDKALLK
SMVISAVLSLLLTISLTYFYGIYGTATAFVISSIILFYMRYYEAKKMKYD
>FCMOIPGL_02832 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MLPKLILTDIDGVWTDCGMYYDEKGNELKKFNTYDSAGVLFCKLLDIPFGIITGENVKSV
ERRAKKLKVDYLFLGANNKLEIVKKLTKELNIQLSDVAYIGDDINDYLLLKSVGISAVPK
SAPVYMKEIVNWQLEKKGGEGVFREFVEKILAENNINVIDLLKESNFINEFNQ
>FCMOIPGL_02833 N,N'-diacetyllegionaminic acid synthase
MTYIIGEIGQNHNGSVDLCKLLVDVAARPVKDDLFGNDLKQMDAVKLTKRDLSQELSSTQ
MKSLYNSPHSFGETYGEHRAFLELNDEEHFEVYKYTKEKGLDFVETLCAIGCLSLLKLFT
PDRLKVASRDLTNLPLLSALAETKIPIIVSTGMSGVKELDLALQTINKYHNNISILHCVS
EYPTRYENVNLKTITYLKKQYPQYSIGYSDHTIGISTPIAAVAMGAEIIEKHITLDRNLK
GTDQKGSLAIEGIYRMVRDIRNLDASMGEEKMEIVNSVESARNKLERSIATNKNLKKGSI
ITEEDIHLLSPGNGVKWVDKNHVLGKELISDIQKDEIIYLKNIK
>FCMOIPGL_02834 3-deoxy-manno-octulosonate cytidylyltransferase
MLERTGIIIQARISSTRLPKKIILEIDEQITFLDILLGKLKKLKTNFPIILATSNLSVDD
VLVEFASKHKIQFYRGSEENVLKRFIDCAEENNLNTIVRVCSDNPFIDLNYIQKIITNYK
GEDYLSYKINNSPSILTHFGFFTEIVSLNALKKIASKKDNQCIEHVTNCIYKNPNHFNVR
FLEENILNNDIRCTLDTKGDFEILKDIYFNFIKENPNAGYLEIIKYIETRNDLLVAMKKI
IKENTK
>FCMOIPGL_02835 dTDP-4-dehydrorhamnose 3,5-epimerase
MTVKESPLRGCFILEPNIFADDRGSFFESFNQKIFEEKIGMKINFVQDNQSISNKGTLRG
LHFQKGKFAQTKLVRVIQGKVLDVVVDVRKESETFGQTFSCILTGDNNKQLFIPKGFLHG
FSVLEDQTIFAYKCDAYYNKASEDGVIYNDTDLNIDWMLKDKEVVLSKKDCKLKTFKEYL
CLKEQEL
>FCMOIPGL_02836 Glucose-1-phosphate thymidylyltransferase
MKGIVLAGGSGTRLHPLTLSVSKQLMPVYDKPMIYYPLSTLISAGIKDILIISTPQDLPL
FKKLLGNGNQIGCDFQYEVQEDPNGLAEAFLIGEDFIGDDNVALILGDNIFYGSGLSKLL
KENNNPDGGIVYAYHVNDPERYGVVEFDEHQNAISIEEKPLRPKSSFAVPGIYFYDNSVV
EKAKKLQPSKRGELEITDINKAYLKENKLSVRILDRGTAWLDTGTFKSLMQASNFVEVIE
ERQGLKVGSIEEAAFSSGFITQKELKELAKPFLKSGYGKNLLDIK
>FCMOIPGL_02837 dTDP-glucose 4,6-dehydratase
MQTVLITGGAGFIGSNFIPFFLEKNQELKIVNLDLLTYAGNLSNLKEVENTGRYTFVKGD
VCDRVLVEQLFIEHNFSSVIHFAAESHVDNSIKNPDTFVRTNVFGTFNLIDIAKNYWMKE
PFKFKKGFETSLFHHISTDEVYGSLAETGLFTEQTSYAPNSPYSASKASSDFFVRSYFHT
YGLNVVTTNCSNNYGPKQHDEKLIPTIIRKAISNENIPIYGDGKNIRDWLYVLDHCKGIE
LVFKNGKKGETYNIGGKNERNNLYIANVICEILDEIKPKEKSYKEQINFVKDRPGHDFRY
AIDASKIEKRLGWKAEEDFESGIRKTIKWYLKKYKK
>FCMOIPGL_02838 hypothetical protein
MSTNHKNNEEEVDLGSLFVIIGKGFSKFFNFIGTIIKRIFDFIISTLIFLKQNIIKISIA
GIIGLVAGVFLEVKTPTRFGSDLLLEPNFKSARQLYNNINYYNDLVKQKDTLTLQKTFNI
DKASAASIKKFEIVPLKVDGDLIDAYNNLILSVDTLTIKSYEYADFKEAFTDYDYKVHKV
TVIAEKNNVFDKLDSVIISSVVNNKYFNRIKVLTNENLNRTDSLYRENLTQIDSLRRVYM
QVMVEEAKKSVTGTSIDLGSQKKTTKELELFDTNRKINYDLGVIANEKSQKYDVINVISN
FQPIGYKIKGITKNYAFLLAILAAGFMILFLLLIKLNTFLENYKK
>FCMOIPGL_02839 hypothetical protein
MLETKNIERTRAQESTNAIEKLYISMRHLFSRGFYKPMGVSGETLRKSLLQLRPEIYGSI
AEDRTELNGLAYVIERLPEGIEECQFINLTADEGYKNSHFEAIIPPKRRRNCYRIDKDQM
NIEITRGRSEIYDILTHLTFLFIESHKIQARVSLNEGEDFIREWKYLEEIVLNKKPISEK
DKEVLIVHLGNILGRTFDEVARIYNAFSTGTNPHKFFNLIYWLGNLAIKEVFEDKKRTVT
FSTVLIEEIGHHIYGEIWANEIKSTLKKHNLLKRPIHIISANMHSVLNSIYAKGALPKEA
KNLKGFELFQLLSNADSKPLQKKVKNYASDNGLIYIEDTSGTNINVQIIDTDKINFDASS
FKKEHSLKEHAVIVVMDYAFGEQAYETMDELLKPYDAEDEKVFLDVKSVSVMGKAGILEG
GKGDIMIPDAHIFEGTADNYPFKNELSKEDLEGFGVKAFDGSMISVLGTSLQNKDLLKFF
HDSTWHVIGLEMEGAHYQKAIQSASRIRGNISENVKVRYAYYASDNPLETGATLASGGLG
MTGVTPTYAITQRILEQIF
>FCMOIPGL_02840 putative CtpA-like serine protease
MKKFKTKKTLFVILLVGTIFLSFSFQSKFFEVAKQIEIYNTLFKELNMYYVDEINPAELT
TKAIKNTLKDLDPYTNFYNEQDVENAKIRREGEYAGIGVGVYYTKNGIEISEVYRGFSAD
KVGLKAGDIIVSAEGQSLKNMERDQLSMFLKGTPGTKIAVEIERQGKILKKEIARENVEI
NPVPFYEMIDEETGYITLTQFNEKASSEVKKAFRELKKKGMTKLVFDLRSNPGGSLQEAI
NISNFFIPKGKVIVTTKAKIKKWSNTYKTANEPLDLEIPVVVLVNGRSASASEIVSGSLQ
DYDRAVIMGQRSFGKGLVQRYRTLTYGTQLKLTISKYYTPSGRCIQELDYTNRDDKTGVI
PKFSDKGVNAFKTENGRTVFDGGGVLPDVEIKTSEKTEATDNLLKSKAIFNFAIDYFYKN
LEIDKVEDYQFSNADFKSFTNYLKIDTTFVTKQERLFDAAFLSAENKDISKEYQKIKEKL
FEAKISEVSKNQDIISVFLEDEILEKYYYKEGVYQHHLKNDLIIKEAVKLLENQDKYKQV
LSGK
>FCMOIPGL_02841 Ribonuclease P protein component
MKHTLGKEERLKSRKLIGRLYAEGNSVKAFPLRMMYLQTAHTSNFPAQVGVSVAKRNFKK
APDRNRLKRLMRETYRLQKEIVYDNLENPYVFMISYIGREERPYEELFTKMNKLLHTFIK
EVKNKSDEKI
>FCMOIPGL_02842 Acyl-CoA dehydrogenase
MKPDLFQAPDYYNLDDLLTEEHKLIREAARDWVKRDVSPIIEEYAQKAEFPKQIIGGLAE
IGAFGPYIPEEYGGAGLDQISYGLIMQEIERGDSGVRSTASVQSSLVMYPIFKYGNEEQR
KKYLPKLASGEWMGCFGLTEPNHGSNPAGMETKFKDMGDHYLLNGAKMWISNAPFAQIAV
VWAKNEEGRIHGLIVERGMEGFSTPTTHNKWSLRASATGELIFDNVKVPKENLLPNKSGL
GAPLGCLDSARFGIAWGAIGAAMDCYDTALRYCKEREQFGKPIGQFQLQQKKLAEMITEI
TKAQLLAWRLGNLRNEDKATSAQISMAKRNNVDMAIHIAREARQMLGGMGITGEYSIMRH
MMNLESVITYEGTHDIHLLITGFDVTGLSAFK
>FCMOIPGL_02843 PPi-type phosphoenolpyruvate carboxykinase
MQETRNDIIQFINLQLASLGQPTFKDKPENSEKFLNPKFEELTNGLIKSLQEKSRLLANH
HSPVDARIQAFIDDYLKDISINKSIVLPNNTLILSKKGQAREVSLPPDGNSFKSDLVTTN
RVKQGILNNPLNDKRTTKGTFHIVEGDLPVPLDKFEVPKVTFAHFLNAAFNPSEDLKILP
FTSSQEEQAKVMASMLLRPKVCPEVKGVVTEKSLEVRFFVPGNLVSNLDFVESIFGNAGD
PNLAHNDAALDTEHWTGHTGCIILAPQLKELKKKDVGLPHFDDATERQKADGMCWTDENE
LYNNGGAFKITCRDDRGVVITLIADNYYGYSKKEIKTQISYSANLFGLVEEEHAGGAIAF
ARRVMGDTVDGKDYSEFHNFMHTFEGVKELLGDTIDVKPENYAVDKKYPNIIYIPESSYI
NTNTNSITWMHNGKEQKLTISPYKTYVHPTGSKLKLEKHKSIDLWRIIETFAEGVFCHKP
CTVSGGGKSEISKSMQNAITYSSFNIHNIDEDFKKADEIIEFVYSNRWKIKDPNRPISRS
FLSEERTLSSAVRLLTPSDQNSDEFNEMLNNIPVHIRSLVLFVKRLFRQAHGNLNWKDYM
SVEIINGKKGTGLLYNNTPVVGSYVRIGFNEKGNWMLNKLRSDFSPSEKIQTEDDITASI
TLPRTELSNLNPEFTNKSLKLLTNCEAHLFQRPDEAVVRGYDKNAELDLVTEGRFLTNYE
LLKKADAIALYEDTINFDKYTKPVKDFIESIVKSDKEEEFFVVPSHTRIVDGEPTKNPRY
LEPSLNVNETEATYLADIGVRLVRRIKLDEPVHHVVNAVLPGRRNNPVDKAAGIRPLAVY
NPIHYQEAPELFMDFICSLTGKSPSTTGAGTEGALTKAPFNMLTPTTDLNNALLSHILTE
SNGFSTAAGYVGAENKIDHDVSLLIPEIWARLEPADRNPANLIANGSLEKIEDFEYEGET
ILASRLGYRITKTFSYRCLNRIFDEPTAVFSERMLKPELQGLEDYVDGIKNIVEAQQKVA
LNYFKDGSIEAAIPPLKILLHIMAYGNYEGKHISDPELRKYFNRDYVINSDWYKERLKIK
QQIDVAFYGNQIKYLENFIANSNNKFLVSEMQINDRLEKVKELFADVNSDTYLETLIGTI
GADPLCRKTA
>FCMOIPGL_02844 hypothetical protein
MKKILFLSCLFISTIAFSQTKKFTISGIIKSEDDKELLESATVHLERLKDSSIVSYTISN
EKGAFNLEGETSDSKIKLVVSFIGFKPYSKIIDVKNQNVGSLLLTGSNVLDGVVIKSSAP
ITIKKDTLEFNVKSFKTKADANVEDLLKKLPGVEVDDEGAITVNGKSVNKILVNGKPFFG
NDPTITTRNLTKDIIEKIQISDTKTNAQAFSGEDSDGENKTINLTIKKENNKGYFGKVAA
GAGTDDRNEYAGMITRFKQSERIGLLAGGNNINSPGFSFGNQRLQFGGNNRSFGGGQGIV
TSNNYGANYINSFGKIFEFSGDYFYKNSSSDNKSTSDRETFLSDGTSFYRNSENTSLNDS
DSHDASIDFEVEIDSTFRIDIESDFNKNLNTNRYNSISETLDNSKILTNDSQIGSIADSD
KETFNNEINLTKRFGSKGAFLRVELTANLSKTLTDDFVKSETNIYGSDSEQIIRDQYSDG
SSNVKELASEITYRFPIIANNLFLDAAYTIGNTKTTNKRSTFDFDDNTNDYSDFSELLST
DFKYSDKISRPSLELEFRNEKWSASTEIALNNRTLENTDYLRPETNLEREFNNLEYGLNV
RFRKSRANSYRLRYNFRNSTPSLSQLQPFRDESNPLNIVTGNPALSPSKTHSLRFGAANF
NWQNRTGFWSYANISFTNDRVVAKTTINTSTLIRETTYANVDGFISARAGGSYSSTKKWE
DFGSLKTEFRVFADYSKNINFNNDVQYSSKIVSISPNIGFDFSWDDILQIRPSYTISFSK
NTYDIDSFSNKDFTNHDVTIATSTNFLKKFEWLNDVNYNYNPNIADGFQKSAWFWNTTLR
YSILKDNGAISLKIYDILDQNTNARRVATEDYIQDSSSTVLNQYAMLSFTWKFNSLGNSG
KKFEPQRRSRYRG
>FCMOIPGL_02845 Internalin-J
MKKTLLFLLNYFCLGLLLVSAQNVTIPDAAFKSHLLANTAINTDNDTEISVAEAQAFSGE
LLINGLSISDLTGIEAFINITRLDCYSNNLTALDVSSNLALTRLHCSNNQIETLDISANT
QITDIQCHNNGVLYQLNIANGNNSNFSYMKAYGNSLSCIQIDAGFTPPAEAGIYSQGWTK
GNSAIYGVDCVALNQEVNIPDANFKNFLVSDNTINLNGDSEITLAEAQATTELIMDGIGI
ADLTGIEAFTNLTRLDVPNNSLTTIDVSNNLSLTRLHAGFNKLTSLDIRLNTNINELFCH
ENSGLETLLISNGNNSNFIYMKAYSNASLTCIQVDAGFSPPANSGQYVVGWTKDTQASYS
ENCIPAVYYVDANATGVNDGSSWTDAFTNVTDALASTNLNDAVWVAKGTYTLADKNTPIA
VSTNEVDIIGGFTGTETTLADRDLTAIHTTNATIFTGDINGDDVDGDFTSNKTDNAERLF
ELRTSNVTFDGIIFENIYDTSQSGGVEENGVIFIPNSLNSNNLKIKNSVFRNNYSNGYLL
KIRKFNQGLLIENTKFINNTIVNMGLVYIQSDSTNRYIFTRWANVLVADNDINLSALDIY
RDDFNNGNTLDVVINNSTFINNNYNNTFGNSISASGDGSVNLNINNSIFWKNTINGSVAT
RDISNGMNSTYDVFIKNTIAAVPSNAGTSGTFSTTNVTTLNSTTDNLNLDANYKPTSASN
YIKDQGDNTLYNVNLFGSLDLSGNDRIFNTTIDLGVYEYNSTLGMEDETFMSELKLYPNP
VSDRLFVSTIDPVESIVIYNINGQLVKQVNVIKNGVDVSELPVGVYLVKIQTNTSNINQK
LFKK
>FCMOIPGL_02846 Transcriptional regulatory protein YehT
MKAIIIDDEKRARHLLSNLITQNCASITSIQEAQDLASGVDLIKKTKPNLVFLDIEMPNQ
SGLDILEYFPNQIDFKIIFVTAYNQYAVEAFKLSAVDYLLKPVDIIELKAAVTKAEKAIK
SNNLNDQLNKLRDSLKQLSIDKIALEIPKGIMFASHSDILYFEADGMYTNVQLISGKHKT
ICKPLKHFVEQLENNVMFFKCHRSYLINIKYVDELVKDDGNYLLMNNKKKIPISKSKHDH
FLEIIKETFM
>FCMOIPGL_02847 Sensor histidine kinase YpdA
MLKIYKNIVFVVLLSFSALYSQNPVVENMSSISNLPDIEFYDVLEDQDHFIWLAADKGLY
RYDGKSYKHFSNPIQKSNSLFQLKLDKEGRLWCNNINGQIFYVEKDRLKLFYDANLFVKA
QLSLYVILENKIRLFTTQGVFDIYKKDKKVSKILDGMALSMGEYQNESFCFAVDKEKNRK
LNRVYKITENSVKIIFEVEGNKHIQSPKVFAFKEEVLFTFKKEDFNQIYHINKENETSKL
LITPSILKHLTIYNIVKIEEHYWFLTTSGVFVFKLEAKKLKFVEQLFETESITDVEVDFN
KNYWFTTLDNGVFVSPSLSIRRVALTTLKDKITAACTLNKNNFLLGTNTGKLLLYNHSKL
VKTIELPGSKIIGNLFYDANKEKLIVSINASESYIVNLKNNAVKDVKNKFSVAKSFAKVD
HQNLFYGNYKEGIVYKNPYLTSEKKSIRSSRVKTSMVTNNSLFVSYIDGLFIYDLNTFSS
KELKFNNKSVLVNSIVKTNNTIWLATQHNGLLQLKNNKLQHAPFVVSDKIQINEMKSDGI
VLWISTDDGLHYYSLLTHQIKRLSAQDGLNVLINKFLVLEDYLIVLLSNSFYILPKNERF
FKTYKTAAINIEAVAINDKDTLVTSNYNLAYYNNKIRLDFNSNGFQSNKHVSYRYRVKQL
DTVWSKVPLNNHFVTFNSLPSGTYTFELEAKNISSEKAVLSDPITFVIHKPFWETYWFFT
IVLLLFFGLIWFYFKWKLKQKEKQRILEIDKILIDKKIAHLRLENLRSQMNPHFIFNALN
SIQDYIVSNKKELASSYLVKFSRLIRMYLDYSQQNEITLQEELSALQLYLELEKVRFEDE
LSYKIKIDKRLQIHQIKVPSLFIQPYVENALKHGLLHKLNNRKLMVEAKLISQNKVQILV
EDNGIGRQQSAKIKRQNQKHKPFATKANQERVHLYKNKLKRDINIQIKDLKDKNKLSLGT
KVIINISIQ
>FCMOIPGL_02848 hypothetical protein
MLNKYFRIIVGFMVLLMVALTYYVNINWLWFGVFIGVNLIQSAFTKWCLLETILMKLGIK
KEGAGCSVK
>FCMOIPGL_02849 hypothetical protein
MKLVLVTAVEEYQKDVLNIFKKANIENFSSSDIDGYKNVSSLLMASSWFSSEKSGNESTM
FFSFTEKEKIDGLFILIDEFNKNLKTNNPLKAIVLPIERFI
>FCMOIPGL_02850 Swarming motility protein SwrC
MKEGLAGKIAKVFIGSKLTVLLMIVFMVVGVYSSFLIPREEEPQIDVPMADIFVGYPGAS
PTEVENRVVKPLEKLISNIKGVEYVYATAMNEKAMVIVQFYVGEDIERSFVKLYNEINKH
MDQMPQGVTFPLVKTRAIDDVPMLGLTLWSENYSDYQISQMAQELETEIKKVNDVSITHK
IGGRNRQLRVVLDKDKLAASGLDFLSVSEMIKANNTQLSSGSFDKNDTEFLVNTGKFLAS
VTDVENLVVGVQQNLPIYLKQIATIVDGPEIPQNYVSLGFGQASDKAQTYKSEYPAVTIS
VAKRKGADAMKIAEVVLDKVAHLRTTLIPDDVHVEVTRNYGETASHKVSELLLHLIGSII
AVTLVVMLAMGWRGGLVVFLSVPITFALTLLSYYMLDYTLNRITLFALVFVTGIVVDDSI
IIAENMHRHFKMKRLPFKQAALYAINEVGNPTILATFTVIASVLPMAFVSGLMGPYMAPM
PIGASIAMILSLFVALTITPYLGYIFLREKDKKGGEEKVEKPLEETFIYRVYNKFERPLL
ENATKRWLFLGGTFFVLIATMGLFVTNSVAVKMLPFDNKNEFQVVIDMPEGTTLERTGVV
TQEIAQYLSTRPEVVNYQNYIGTSAPITFNGLVRHYDLRGGSNMADIQVNLVDKGEREIQ
SHGIAKLLRPEIQKIAKKYNANVKLVEVPPGPPVLSTIVAEVYGPDYKEQIEIANQVQNI
LNNTDDVVDVDWMVEADQKEYQFEINKEKAMLYGVAPQQIAYTMNMALSNRAITNLYDEN
AVNQIGLVLTLDEKEKSTISDISQLKVKSKMGNMVPIADLVEIKETIAQKSIYRKNQKRV
VYVMADMAGELESPAYAILGMEKELNKIELPEGYKLNEIYLGQPDFEDDYTVKWDGEWQI
TLEVFRDLGIAFLGAIILIYILIVGWFQNFKAPVVMMVAIPLSLIGIIIGHWIMGAFFTA
TSFIGMIALAGIMVRNSVLLIDFINLRLEEGVPLKQAAIEAGAVRTTPILLTAGTVVIGA
FVILFDPIFQGLAISLMGGTIVSTVLTLLVVPLVYYMIEKKNYK
>FCMOIPGL_02851 Efflux pump periplasmic linker BepF
MKKHINIITLIALSIFITSCGSEDKKAIVDNSPAIKVVVNKITTNNNNQFLSVSGKIQAT
NSADLSTRMMGFVNKVHVNVGDKVKKGQLLVSINNTDLQAKKAQVDAGIVQAQTAFTNAE
KNYNRFKNLMASNSISQKEMDDMTANYQMAKAGLESAKQMKNEINAQFTYSNITAPFSGI
ITSKNIETGDMANPGMPLISLETPNNFEVIAMVPETEISQIKKGAAVNVLVKSIDKMIKG
KVTEVSSSAKNTGGQYLVKVALEKTDVHILSGMFSTVQFPVERKVKSELVLIPTKAVVKN
GQLSGVYTVSESNTALLRWLRLGRTYGNEVEVLSGLNADESYIVSAEGKLFNGAKITIQ
>FCMOIPGL_02852 hypothetical protein
MKNTLYITIISLFASTLFLQAQEIIPISKADVFAKVKEHNTSIKISEEEFNAAKADYSQT
NAVFLPNITASHTGISTTNPLMAFGSKLNQEILTANDFSPALLNDPTTTRNFATKIEIQQ
PLINLDGFYQRKAARSKMEAMSLKTERTQDYMVFEVDKAYMQLQLAYKAVEVLEKALEAA
NANKKMADNSYKEGFLQRADVLNVEIRVTEVKNQLQTAKSNVQNASNYLSFLMNDKSDFI
YKPTENLSVVSLNVADKKISENRSDIKAMELALKGYEQMNKADKMAFLPRLNAFGSYEMY
DNKVFSGDANGYIIGAQLSWDIFQGSKRFGKTQKSKAELEKSKLEYNQYVSKSNLELNKV
KRQLIDAKNRLELTSLAVQQSEESLRIRKNRFKEGLEKTSDLLMAETQFSQKQLEYYQTI
FEYNFTQTYLEFLTKQ
>FCMOIPGL_02853 hypothetical protein
MTQRISKYQRFKMMNPIIQFFKFIYLSIKIMIVVAGGHGGTRKVS
>FCMOIPGL_02854 Sulfide-quinone reductase
MSKIVILGAGISGHVAASHLRRKLSAKHEVVVVSPNSNYQWIPSNIWVGIGRMKSEKILF
PLAPLYKKKGIGYKQAKAISFFPEGDKNEAKPYVLAEYVVGENKGTQEKVTYDYLINATG
PKLNFEATEGLIPGKNKTYSVCTYTHADHAWQGLETLIQEMKKGKKAKILIGTGHSKSTC
QGAAFEYILNVEQELHKHNVRDMAEITWISNEYQLGDFGMDGMLLSYGSLTMKSHEMIEM
IFEDRGIKWILEAGVNKIEDGVAYYENLDGEHKTETFDFAMLIPSFSGHGFKAYDKNEKD
ITEKLFKGFMLVDADYTLKPYEEWSVKDWPETYQNPNYKNIFAPGIAFAPPHAISKPRKS
KNGTAISPAPPRTGMPSGITAKIVADNIIDSIKKGKESLNHKGSMGNMGAACIASAGYGL
TSGSGVSITTFPIVPDYEKYPNTQGRKLGKTFGEIGLAGHWLKLALHYAFIYKAKMRPFW
WLIPE
>FCMOIPGL_02855 Inner membrane transport permease YbhR
MKTILFIIQKEFKQIFRNKGMLPIIFVMPLIQLIILSNAATFDVKNIKFGYVDHDHTSTS
RALVEKFNASTYFNVLTDFPSEKLASQAMLNGEVDVILEVPLSFERDFQKEKKAALGVTI
NAIDGAAAGVENVYVTQIIQRFNKDLKVNVSQFDKQQNQPIQITTIPSFWYNNTLNYKTY
MVPGILVLLVTMITLFLSGMNIVREKEIGTLEQINVTPIKKSQFIIGKLFPFWVIGLAIL
SVGLIIAKVIFNVPMVGSLLLMYFYTTIYILVVLGIGLFISNFTDTQQQAMFIAWFFMVI
FILMSGLFTPIESMPKWAQTLTDFNPIKYFVQVMRMVMLKGSGFMDILPQLLKTLFYAFV
MNGLAVWSYKKTS
>FCMOIPGL_02856 Inner membrane transport permease YbhS
MKRFIGFIKKEFYHIFRDKRSLFILFGMPIAQILLFGFAITNEINNVDIAILDHSKDATT
KEIINKIAASKYFSINQFIEKESDIEVVFKKGKVKAVLNFEKDFSKNIIKENNANIQVIT
DATDPNTANTISNYVNAILQSYLKEQNKSIAQVYQIVPQTHMVYNPELKSVYMFVPGVMT
IILMLVSAMMTSISITKEKELGTMEILLVSPLKPFQVIIGKVFPYIFLSIINAIVIIVLS
IFIFKMPVQGSLFLLGMESVLFIITALALGILISTVSATQQTAMMISLMGLMLPVILLSG
FIFPITSMPLPLQVISNIIPAKWFIIIIKGIMLKGVGLQYIWKETLVLLGMAVFFIALSV
KKYKIRLE
>FCMOIPGL_02857 putative ABC transporter ATP-binding protein YbhF
MKKTNKVIQVENLTKIFGDFTAVNAISFDVEKGEIFGFLGANGAGKTTAMKMLIGISTPS
FGKANVASFDVHTQAEDIKKNIGYMSQKFALYDDLTVKENITFFGGIYGLSRKKIREKAA
LLIEELGLEKVANSLVGSLPLGWKQKLSFSVALIHNPKIVFLDEPTGGVDPITRRQFWEL
IYKAAHNGTTVFVTTHYMDEAEYCDRVSIMVNGKIEALDTPKKLKEQFNAADMNDVFLKL
ARSPSPTLPKGKGAE
>FCMOIPGL_02858 putative ABC transporter ATP-binding protein YbhF
MSIKITNISKSYKKVKALENISFEVKPGELFGLIGPDGAGKTTLFRILTTLLIANEGEAS
VAGFDVITDYKSIRKNVGYMPGKFSLYQDLTVEENLDFFATIFGTTIEENYDLIKDIYIQ
IEPFKDRRAGKLSGGMKQKLALCCALIHKPKVLFLDEPTTGVDPVSRKEFWEMLKRLQQK
DITILVSTPYMDEAALCDRIALIQDGKILEIDTPKAIVKHYPKPIYNVSANNMYQLINCL
NDFESNHSVYPFGEFVHYTDCKLDFNPNKLKEYLESKNLTDIQIEETEATIEDTFMELAK
>FCMOIPGL_02859 Macrolide export protein MacA
MKNYILAVSIITTTLFSCGKDNGKADGYGNFEATEITISAENNGKLIQFTIDEGDKLKKD
QFVGFIDTVQLALKREQLVVSKSVVSSKSKGVLSQISVLKSKLKTAKINKVRIENLLKEN
AGTQKQLDDVSGEIDIIKSQIRSVEIQNAPVVNELKNIDVQLKQIDDQIKKSKIINPVNG
TVLTKYAEPNEITAFGKPLYKIADLSTMELRVYVSETQLSDIKIGQEVSVKIDGEDIMKT
YKGVVSWIASEAEFTPKIIQTKEERVALVYAAKINVVNDGSLKIGMPAEMWITTAE
>FCMOIPGL_02860 hypothetical protein
MKKIVFILMLTILSFGAFSQESLTLNECYNLVETNYPLIKQHQLLENQHQIDKEIISNSK
LPQFNLDAQATYQSDVIEFPAAMSGVEPLNKDQYRATFSINQLIYNGGLTDANLKIKQGQ
LKTKQKQIDANMYQLKTQINQLYFSILLAQESFKLLEAKELQLQSKLKEVKSGIKYGTLL
PASDSVLEAELLKIKQQFIEVENRKSSLIETLSSLIGKPFNSLTKFEKPLIRTQLQNEIN
RPELELFQLKKEEVNNYESLISKKNLPKLNGFATGGYGNPGLNMLDNSFQTFYTVGVKLH
WNVFDWNTNKKQKEVVAINKDFIENETEVFKLNTNIELNKQQKEIEKISAFINSDLEIIK
LRKKVLKTLESQLKNGVITSSVFVTEFTNLFEAENTLLKHRIQIELAKANYNTIKGD
>FCMOIPGL_02861 HTH-type transcriptional repressor NicS
MMKSKKNENTEGLILEAAKSIFQTKGMDGARMQEIANEAGINKAMLHYYYRSKQLLFEAV
FKNAFSLLAPQLNTILNDDSSIEEKVRNFSSNYISFIVEHPYLPNFIIQELNRNPDFILK
MKENSAFPNLEKFKKQVDFEVEKGVIKKIKAAQLFINILALNVFPFIAKPLIQNLINADD
TAFQQIIEERKTEVADFIINSIKK
>FCMOIPGL_02862 hypothetical protein
MTDTLISIISIFVGMIGANLLAVFLKKYSLQFIGNTITGIFGSIFFIKMFSRLGFDPMTI
MKTGNVNIALFTVNMIVSLFGGVIGLLSAKWIIAKMNK
>FCMOIPGL_02863 Cytochrome bd-II ubiquinol oxidase subunit 2
MELFWYIVLMTMLAVYVILDGYDFGAGIIHLFFAKKEKDKKAITNAIGPFWDANEVWLIA
AGGVLFFAFPTLYASSFSGFYLPLIMILWLLIFRAIGLELRGQVHNKMWESIWDKAFGIS
SLLLALFFGVALGNVVRGVNLGNVVNGVSTHEAHYFFLPLWNPTFSPQTEQLGILDWFTV
LLGVIGVVALTIHGANWIIFKTNSDINEKLKKVIFNLNFVLLGLVIISLFVWHIIEPKPF
HNFLDKPWLFIFPMITFTGLFGLFKVKSFKKHGLGFLFSSLFLLGGLTSTVASIFPKVLP
STNNINPDLTLYNVAAEEYGLSVGLYWFPIAVVLVAIYMVIQYRVFKGKMDNVGYGEH
>FCMOIPGL_02864 Cytochrome bd-I ubiquinol oxidase subunit 1
MEDMLFYDRMQFAFTITFHYLFPQLTMGLSLLIVYFKWKFLRTKIDKYNNAAKFWMKIFA
LNFAMGVVTGIPMEFQFGTNWAKFSELTGGIIGQTLAMEGMFSFFLESSFLGLFLFGEKL
LGHKLHFLTGFLVFLGSWASGYLIIATHSWMQYPVGYEILENGKFVLNNFGALFSNPWLL
PSYLHNQAASLVTSSFVVAAIGAFYLLNNKHHDFGKLFVKTGIIFGLVSSLLVAFPTGDL
AAKNVAKHQPAAFAAMEGIFETEEGGSEIVLIGQPNILEKKLDNKIAVPNILSFLTYQDW
NAEVKGLNEFDESVHPTNIPGLYYSYHIMVGLGTIFIGLMLLATVQLFRRKLYKTKWILW
ALMFMLPFPYIANTTGWYTAELGRQPWLVYNLLRTSAGASPTVSSGNTLFTLLGFIGLYL
LLGMLFLMLAGKIINKGPELEKH
>FCMOIPGL_02865 hypothetical protein
MAKEHYYQVKVNWLENRKGALSSDVLDEKITIATPPEFPKGEANIWTPEHYFVAAINGCL
MTTFLAVAENFKLNFVDFESDAEGKLEMIDGKFMMSEVILKPIVTIFNEDDVELAKKVVA
KSEKACLISNSVNSKIKLEITIKVKKG
>FCMOIPGL_02866 Alkyl hydroperoxide reductase subunit C
MNTQETNQEQETFAMPRIGDKAPQFTAVTTQGEINYPSDYKGKWSILFSHPADFTPVCTS
EFMTFAHLEEKFEKANCSLIGLSIDGLYSHIAWLRTIKDKIEFNGMKNIEVKFPLIEDIS
MNVAKKYGMIQPGESKTQAVRAVFFVDPNETVRAIIYYPLSLGRNFDELYRALIAMQTSD
KFNVATPADWNPGDDVIVSPAGSCGVAEERMTSTEDLDCKDWFFCTKKLDKDLVLDSILK
K
>FCMOIPGL_02867 putative metallo-hydrolase
MLITEVEKVSRNFNRLKNKDMNVIQFEDKPLAHYSYAIISGNEMALVDPSRDPKPYYELA
EKHQVKIKAIFETHPHADFVSSHLQLHKETGAKIYVSKLVGANYKHESFDDGTSITLGDV
TFSAINSPGHSPDSITIIAVDKEKNHAMFSGDTLFIGDVGRPDLREKAGNMKAKREELAK
NMYHTMQHKFTQLPDATIVYPAHGAGSLCGKNMSTDSQSTLGKERKENWAFQDMTELQFV
NHILKDQPFIPSYFGFDVDINKNGADNFNANFGDIPVQFGITDFPSDDTLIIDVRNADDF
KNNHLKGSINIIAETEDDKIETWLGSIVEPNEKFHLVLNSIDDLDTLLSRIAKIGYEKQI
QSIITLGAHNFETNKSLDLQDFKKNTDQYTIIDIRNKSEVDEGKIFENAISIPLNQLRAS
KNKIPTDKPIVVHCAGGYRSAAGSSVINNLLQSDNVYDLSDNVNDFK
>FCMOIPGL_02868 Thiol-disulfide oxidoreductase ResA
MKKNKNTKKTWIQNGVFILIIITLYATGLHTEVIGFVQRGVLATGLMNPDIEEITYTKTP
KTISNTIKADLNLKLMDSNGKITSLSDLKDKVIFLNYWATWCPPCIAEMPSISKLHKEMG
NDVAFILLSFDKDFEKAKNFNKRKGYNLPIYTLIGNLPTMLQSSALPTTYIIDTEENIVL
THKGMANYNTDEFKSFLENIK
>FCMOIPGL_02869 hypothetical protein
MKNWKVILSIIFSTLILYNSLRVSITYLYYNLDTKGFIEAYCENKDKPELQCNGKCHLKK
VTKTTDEEKNQPIQLIDFKDILLYNQNISSHEIDTNIFQTKSNFFYLNLYNFRLLDSYFH
PPNV
>FCMOIPGL_02870 Heme/hemopexin utilization protein C
MKIFYSVLLCALISATSYSQAKENTKNDSIKKAVKLDEIIITGKLKKDPVFSSSSNNYAK
KIVQPKNVADLFNNINGFSVIKRGNYAIDPSFRGAQYEQLNIQYDGGTKAMHACPNRMDP
ITTHIIPEEISKIEIIKGPYTVRYGATFGGIINLVTQKPNYEDYGFHGKVSSGFESNGNS
LVNLAELQYINEKFDIVANAGYRDFGNYKDGFGTEIPSSFKSSDYGIKLGYNFTKNQRLK
LDWRQSFGRDVLHAALPMDTEYDNSSILSVDYKIENIADVVKSISVKGYHSYVDHLMSNN
NRPTFMMMEAESAVEATTIGGKFEMNWQPNKDLDVFSGIDLMNIARDGGRTRIVKMMNGN
TLATPVTFNDKVWQDSQITDLGFFTEARYNLSPKSILTAGIRYDNVTSDIKDPEADFAAM
YDLEKRTEHTFSGTVSFKKVLSENYTLEAAYGRGTRTANMIERFINHFTVGQDPYEYVGN
PNLKAEVNNQFEVGIKGLEILKNGFDSFQFETSVYYSAFENYIVGIVDPTITRKFNPTTD
PTNVKVFQNLDKAYKTGFEAMTQLNFLENYNFKTEFSYVHTKNKDLDESLPLTPPFTTKF
VFGFEKENIWANAQYNLVSKQDNISESFGETETDGYQTLDLRFGGKPFKNVTLGLAVLNV
FDQGYNSHLNFSFTNQANFGRTPVTEPGRNFSAFLQYKF
>FCMOIPGL_02871 Thiopurine S-methyltransferase
MLNLSEDFWENKYKTNKIGWDLGDVSPPLKAYFDQLTNKELKILIPGGGNSYEAEYLFKE
GFKNVFVVDISNIPLEHLKERVPDFLESQLIHANFFDLEGDFDVIIEQTFFCAIDPDLRV
KYASKMKDLLNEEGKLVGLLFDAKLNEDHPPFGGNKEEYVSYFKPYFYVDILDLCYNSYH
NRQEMELFVKLIKK
>FCMOIPGL_02872 Quinolinate synthase A
MEILDVAKKNLTEKGFLDIETPNIDYVEEILKLKKEKNAVILAHYYQIDEIQEIADFVGD
SLALAQQAAKTDADVIVFAGVHFMAETAKILNPDKKVLLPDLLAGCSLADSCPPEDFSAF
KKQHPDHVVVTYINCSAEIKALSDYVCTSSNALKIINSIPKEQPIIFAPDRNLGDYLNKE
TGREMLLWDGACMVHEAFSMEKLIDLYKEHPDAELIAHPESEAHMLKVAKYIGSTSGLLN
YVKNSDKKKFIVATEVGILYEMLQENPDKIIIPAPAKEDNTCACSECAYMKMNTMKKLYL
CLKHELPNIEVEAELAKQAIIPINRMLELSK
>FCMOIPGL_02873 L-aspartate oxidase
MLPDKNIISTDFLVIGSGISGLTFALKTALKFPEAKITIVTKDEQSESNTKYAQGGIATV
YNKTVDTFEQHINDTLIAGDGLCDEKVVRMVVKNAPDRLQELINWGTEFDENKNGDYDLG
REGGHSQNRILHHTDITGAEIERALLAQVNAQTNIDFLTHHYAIDLITEHQTKKRKTKRN
GKISCDGAYILDEKNAKVKTFVSKFTILASGGNGQVYETTTNPSVATGDGIGIAYRAKAE
ISEMEFIQFHPTALYNPGEYPAFLISEAVRGFGAKLRDFNGNFFMHNYDEREELASRDIV
ARAIDNELKKSGKPHVYLDCTKLDMKKFKEHFPNITEKCASLNIDIEKDYIPVVPASHYI
CGGVNVNKKAKTSIKKLYACGEVTRTGLHGGNRLASNSLLEGLIYAHNAFLNVSKKFKKA
KLPKDVPVWNDSGVVKNMEKILIAHDRNEVKTIMTNYVGIVRSNERLRRAEKKLRVLYED
NKRLYDHSELSVDLCELRNLITTAYLITQFSKKRTENCGGFYSLDCITK
>FCMOIPGL_02874 Thioredoxin-like protein
MSNFTEIINKDKPVLIDFFADWCGPCKIMSPILKDVKDTLGEKVSIIKIDVDKNKPLAAK
YQVRGVPTLILFKSGKQVWRQSGVVQKKELVSIINNN
>FCMOIPGL_02875 Cytochrome c-550
MKIFVLLVAFVFLFSCKDSQKPSYATKKVTSITSDEITTSSQDHLGKKLMQTNCYVCHSV
TATEENRIAPPMIAIKKRYLMGNTTKQEFINSLQNFIKNPTEENAKMYGAVKRFGLMPKQ
AFPKETIKQIADYMFDYDIEKPEWFEDHYNEEHGNSRGMQNGNGKQNGKRKKQQGNVIKN
QSYSERGLNYALSTKAELGKNLMSKIQKEGTLAALKFCNVKAYPLTDSMSVVHNAIIKRV
SDKPRNPKNIANSKEKAYINIFKDDAALNKESNPIVVESAENVKFYYPIKTNSMCLQCHG
KPSSDIKPVTLAEIKKLYPTDLAVGYEENQVRGIWSISFNK
>FCMOIPGL_02876 Global nitrogen regulator
MNQLSINFGYLFEDALIEEINQIGTYKKFVSDTTIIEIGDYIKSMPLLLNGAIKILREDE
NGDELVLYYLEKGDTCAMTLSCCLGQTKSKIRAVAETDVELLMLPKEKMAEWLSTYKTWQ
SYILQSYHHRMDELLEAIDTIAFLKMDERLFKYLKDKAMVTHNDVLHVTHKEISEDLHTS
RVVISRLLKKIENEGKIILFRNSIKVLEL
>FCMOIPGL_02877 hypothetical protein
MNYLNLPLVSWINGTIMIGIFALVVVGLVAAIFLLMNSDKPKKTKE
>FCMOIPGL_02878 Outer membrane protein TolC
MKIIKNTILVVGFLSTLQGFSQEILTKKEALEITLENNFGIKIANNNLEVAKNNTSIYNT
GFLPTASISSGANYSNNNQTNTPQQGDATSTTGAVTKSYNASIGLNYTLFDGLGRKYNYQ
QLKETYNLTELQARETIENTYLQLFTSYFQIARLSENKTNLNEALSISKQRLLRAKYQYE
YGQSTKLELLNAEVDVNNDSITLVNANQELSNAKRSLNIILGVEKEVAFIVETEVSFNKM
MNFQDLKQKTISNNSTLKQNEKNIAISEFNIKINKANYLPTLDFNTSYGWNQNDNENLAN
AFQPKSTSSNGLNAGLSLSWNLFDGGSTKTSVANSKILLENQQILLEQQKITIDNNLKNT
WENYQNQLFILSAQEKNVLTTQNNFERTQERYNLGQITSIEFRQAQINLLNSKTALNNAK
FDAKLIELQLLQLSGDILNVKL
>FCMOIPGL_02879 Swarming motility protein SwrC
MKKIITYFIKYPVAVNVFIIAFLVFGSIGILSMKSSFFPLVDSELINISLTYPGASPQEM
EEGVVLKIEDNLKGILGVERVTSVSRENSATVSIEIERGKNIDIVLTDVKNAVDRVPSFP
SGMEPAVIAKVENIRPTISFTVSGDGIPLKAIKQYARGVENDIRGIEGISQVSLSGFPDE
EIEIAVRESDLRAYNMSFAEVGTAIQNSNLLITGGNIKTAQEDYLIRASNRSYYGIELQN
LIVRTETNGNIIRLKDIAEVRDTWSETPDRLYYNGNLAIDVTVSNTNNEDLLTTADKIKE
YIHKYNQENQNVQLNITSDSSISLNGRTRLLVENGIVGILLVLFFLALFLNLRLAIWVAF
GLPVAFFGMFIFAAQFDVTINILSLFGMIIVIGILVDDGIVIGENIYHHYYDLGKSKIQA
AIDGTMEVIPPIVSAILTTIIAFSTFFFVDGRMGNFFSQVSTIVLLTLSVSLIEALVILP
AHIAHSKALDRKRLEKGEEKKKNVIDTFFNKINKFADGLLMKLRDKLYIPFLKFGLKYKI
LAFSIPIALMIFTKFAMDAGVVKQSFFPRVASDRVQIVLTMPQGTNDQITDSIISSIEEK
VWLINKEYSAKQSGDLQVIENVIKRVGPGSANATLTVNLLPGEARDFSSPEITNSISDKV
GKVQGVESLVFGSGGNFGGSPVAVSLLGNNIDELKAAKQELKQELESNILLKDIADNDPA
GIKEVSITLKDNAYLLGLSLQSVMAQVRNGFFGMQAQRFQRGQDEIKVWVRYNRNDRSSI
KNLDDMRIVTPTGVRIPFSEIGNYTIKRGDIAINHLNGKREIQITADLRDLETSAADVLD
DIKVRIMPKIMSKYHSISALYEGQNREANKTKDSLNIVLPIILLLIYIVIAFTFRSYSQP
ILLIIMIPFSMIGVALGHYFHNFPIGILSFLGIIALIGIMVNDGLVLIGKFNNYLKEGIK
FDDALIKAGQSRFRAIFLTSLTTIAGLAPLLLEKSRQAQFLKPMAISISYGIAIATVLTL
IMLPLLLSVSNSIKVGIKWLKTGEKVSKEEVERAIIESKFDENEDH
>FCMOIPGL_02880 Efflux pump periplasmic linker BepD
MRKIILASLGILTIIGAIFLGKYLVDKNQKPKPTFKRQIKTVFVENVINKEIPIILTASG
NLTAKNKIEIYSEVSGVLKTSIKLFKAGTNYNRGETLLSINSDEFYASLQSQKSNLNNLI
TAILPDLRLDYPSDFKKWENYVNEFDMNKSTPKLPNFSSDKEKYFINGRGIVTAYYNVKN
LEVRLSKHQIRAPFTGILTEALVSPGTLVRVGQKLGEFIDPKVYEMEVSVNSEFADLLKV
GNSVALSNLEKTKKYTGKVVRVNGKVDQVTQTIKAYVDVSHKDLKEGMFLEADLVANSET
DAIEIPRKLLVENSAVYTVKNDSILTLVKINPVYFGAETVVVKGLKNNDKILSQNLPGAF
DGMIVTINKK
>FCMOIPGL_02881 Catecholate siderophore receptor Fiu
MKYQLLTTLLLLTTFITFSQNSTITGIIKDNSKNALSEVTISAKGTTKGTQTNEKGEFKL
ENIENGNYTLSISYLGYKTKEIKISILKKETKNLGTIILFEGNEILSEVIIEGKRTNKFS
RKKTAYVAKLPLKDIENTQVYSTITSELIESQLVTNFDDALKNTAGVEQLWTSTGRGGDG
AGYYSLRGFSVQPQLVNGLPGLTNGTINPANIERIEVLKGPSATLFGNTVSSYGGLINVV
TKKPFVGTGGQISFTSGSFGLNQIIGDFNTALSEEDNIYFRLNTAYTSQQSWQDAGFMKS
FFVAPSISYKVNNKLSFSFYAEITQAEQTNPTFLFLNRAAPQKNTNLEDLGYNNSLSFTS
NDLTLENPNQNYRVEMDYKLSENWKSQTLLSKSTTSTKGYYSYVYDFGTFATDTFSRYIN
KQNANTQTTDIQQNFIGDFKIASLRNRMVIGLDYFSATQTDNGTGYAFYGNVNPDGTTNG
DHPFTAAVETTAYPLSTSGVDAALASQGVNNSKSRNEIYSLYASDVIDLTNNFSAMVGLR
LDRFVNEGDVTTDDDNYNQTTLSPKVGLLFQPIKEKLSLFTNYQNGFTNVAPQLVGDPSA
GAQTLKTFTPEKANQFEFGIKTNLFKNKLNATISYYNIKVIDRVITDPSSPFNKIQGGEV
ESKGFEIELNANPVDGLNIRAGFSNNDSETTKSDNTEILNKRPLEAGPETLYNLWANYEF
QEGNLEGFGIGFGFNGASERFAINYVSTGDFMLPSYTIANSTIFYQAEKYRLSLKVNNLF
DKEYYKGWTTINPQPPRAVLANFTYTF
>FCMOIPGL_02882 hypothetical protein
MKTKKIIFQLHKILGLTTGIVVFIVAITGCCWTFREEIESLYDDYKTVAQQEGTIITVTK
AKKIAQKIFPENTVHGTVFKKQNDAVEVIFYDAEPEFYQSVFLNPYSGEIIQIDNHLTGF
FAFILKGHMRVWLPKKIGENVVGASILIFILIIISGFILWIPKKRKNLKQRIKFDWKKTT
KWKRKNFDLHTVTGFYICSLAFIIAFTGSFMSYDWLKYVVYKSTGGQRTVVFKVPENRDS
IAIASTTKPIDLLIPRLQKESPNADGFELHYPKTKEESIYVEVSKSKGLFYDSDFRFFDQ
NSLKEIETEAIYGKYENATIPDKILRMNYDIHIGAIGGITGKIIAFFVSLLTATLPVTGV
LLWFGRKYKKNKTPTIK
>FCMOIPGL_02883 hypothetical protein
MSSNFRISRAFKNAKRICFNTDSKFVFFSDSHRGNNGFADDFAHNRNMFKHALEHYYNND
FTYIELGDGDELWENRNFTNIFKANKHIYMWLKKFHENDRLHFIWGNHDMKYKYPKTIRK
NLHYYYDSISDTKKELLVGASFSEAIILEDENSGKKIFLLHGHQADWFNYVFWKFSSFLV
KVLWKPLQILGFSDPTSPAQNFKERIKVEYKLEKWIQENNNQMMITGHTHRPRFPAKNEI
PFFNDGSCVHPRSITGIEIENNEICLIKWHIITLENGTLQIKRTVLEGPENLKHYMN
>FCMOIPGL_02884 hypothetical protein
MICCTNTNTALFFSSIDEIPSQIWETLGCTKNIYFHPDFLKSLEKNHPEISFSYIVLVDN
ENQPTAFASLKLIDFHINSIKNDFEFLKDIGRKLHVFPDKKPLKLLICGNTFVSGEHGVF
IKENQDKKAIVKELAESMNHFVNSDKKLKKQIDAFLVKDFAKESLFITDALKDFSYHPFS
VEPNMKLQIHENWQNFDDYLASMKTKFRVKAKKAFKQSSSIIIKEITLENLDEILPKMTA
LYTKVALNAGFNLGVFNLETYRNLKENFGDNYILKSYCLDDKVVGFISGIINKNSLDAHF
VGIDYQLNREHAIYQRMLYDYIEIAISKKLKIINFGRTASEIKSSVGAVPQDLTMYLRHK
KTIKNKILKLFLQRVQPTPFQQKFPFKNLEISHEKH
>FCMOIPGL_02885 Acyl-CoA thioesterase 2
MKNTKELIALLDLDDLGNHNFSGKSVTIGSPHVFGGQVLAQAINAAYKTIPENRFLHSLH
SYFLEAGDLTIPINYNVQEVRNGGSFSTRRVTASQNEKTIFILAASFHRKEDGFEHQTTF
DPNIKQPEKLLSWDDMLAQFGDFLPKPMKYFLSIERPIEFKPVRIPNPLQPENLPPNEQV
WFRLKGEKQAMDFRTKQEILTYISDYNILNPAFNPNASEYNFGNTQTASLDHSMWFFRDF
DFDDWMLYVVESPNAFGARGLSKGNIFTRDGKLVASVAQEGLLRPIKK
>FCMOIPGL_02886 hypothetical protein
MNPITYVLTTNGLLFLLSVIFWKFPPKKINNIYGYRTFKAMQNDDIWKFANSTFNKNFLI
YAGISFLAALILATISVQELTWQPMVLVMLSLLVSIIKTERSLSDNFTEEGKRK
>FCMOIPGL_02887 Colicin I receptor
MKYIFLVFIVFFSSTTFAQEIKVLDKKTGKKINNVTIFNKDKTISLTTNYLGLADVSSFK
KDDVILFSHLSYANFSLKKSILKQQNFIVYLTKHSEQLDEIVISVFKKEEKSKRIAEQIA
VLSSKDIQKISAQTSADLLAEIPGIKVQKSQFGGGSPVIRGMESNRVLLVVDGVRMNNAI
YRKGHLQSSITIAPNLLDKTEVVFGPSSVIYGSDALGGVIHYYTKTPKLSEENKVSSQLF
SRYSTVNQEITTNVSSELSFKNWASFTSISYSDFGELTAGKNRNHGFSDWGKVFYYSENV
NGNYNENPTKNANPNTLRNTNYNQTDVLQKFFVPLSKNTDLKINLQYSTSSDIQRFDRLT
ELTDLNDVSSLKFAEWYYGPQKRLLISSRLDIKPSENWLESGSITAAYQNLQESRIQRKF
GSLDRSYREENVDVFSVNGDFSVPLTEDKTRTLSYGFEVAYNEVSSNSYGKTLNILNGEI
NGFSDDFKVQSRYPDGGSDYLSSALYVDYRQDINPKSTLNSGIRFTNTNLHAIWIDQTFI
QLPEIEISSNNSAVTATLGYVYKPSKNWQLNSVLSSGFRSPNIDDVGRVREKSGDVTVPN
IDVKPEFAYNAEIGIQKYFNNRKFRLGANVFYTLLDNYIIRDSFTINGSDQVLFDGEYGN
AVANQNRGNAFITGYTISYLGKLSNTFNTSGFITYTKGRTYDTEEPMSSIPPLFGQFEIN
YKKEKIEVGAALRFNSKKDISDFNFTEGIDNHDLTPIVDANATDDVDIYFGTPSWVTFGV
NSRYAVSENFSVQARLSNLFDEHYIEFASGVSSPGRNLSVSFVANF
>FCMOIPGL_02888 DNA repair protein RecO
MAIVTTKAIVLSALKFGDTSLIVKCYTQEEGVKSYLVRGILKPKKSGLKAAYFQPLTQLR
IVANHNNKNTLNSIKEVQVIHPYKTFHTDIVKQSVVLFLSEVLSSSIQEEEQNSALYKYL
ETAFIWLDMHDKVANFHLLFLLNLTGFLGFYPDTSEINKKGFDLLDGVFSDNIYEKNVIS
KNDFNQFKKLLGIIFDTLENVTYSKVERQLVLQVIIQYFKLHLGNFRTPKSLQVLETVFS
>FCMOIPGL_02889 hypothetical protein
MKKLIFLFLFLSSISVSAQVDYSDSWEDFYSYNNVKDFVKVDNIIYALVDNAIFTFNETT
LETKKLSSIQGLSGETTSSIHYNATFNRLVIGYQNGLIEVIDEDDSVTISSDIINFNQTG
EKSINHISEFGNTLYLSTPFAIVEYDIEKLEFGDTFFIGNSSTSLLINKTIISDGKIYAV
TEDGIFIATVSSNLLIDFKNWDQQFNGRNFSNISVFNTKIYVTEGSRLFWLNNGVLTQIR
DFSETIIGLKSSSTNLTIALNKKAIVLDVTENQIAEFISNVDFDFTLLNAFFENNNIYLA
TKEFGVLKTSISQINSFQEIHPEGPLSNDVFSIAVKDDNLWVVYGGYDVTYTPIQNKQGF
SHFNGENWINTKFNPDFPLMDLNYITIDPNAENKVYISSFGDTGAINSVSTGGLLVVEND
EIETFYNHLNSPLEDIRLSDPGSVTIRISGTAFDSQGNLWVTNIGVTNELKKLSPSGQWS
SYDMSSVKTSTAFGLSEMVVDNSNSIWFGSRRSGVFVFNENGSRKKALIATENLGNLPDT
DVLTVAVDKSNRVWLGTRSGMVVYRNASGVFDADVLNAEPIVIEENGVGERLLGDQRINS
INVDGADNKWFGTDSGGVLYTNPSGQTTLANFSKVNSPLPSNQILKIRTDTSNGKVYFAT
EKGIVAYNSKVATFGEVLGDVYAYPNPALKNHETITIDGRNGTHLPNGTNVKILDVAGNL
VYETNVVEGQELQGGKVVWNKKNLAGKKVASGIYIVLLVNDDGSETSTTKIAIVN
>FCMOIPGL_02890 Inorganic triphosphatase
MSLEIERKFLVENEDFKKECYQKKLVKQGYLNSDKNRTVRIRIADDKGFITIKGKSNETG
TTRFEWEKEIDILEAEQLLLLCEPSIIDKTRFYVKSDNHMYEVDEFYGDNKGLIVAEIEL
TSENEEFKKPSWLGKEVTGNIKYYNSSLSKNPFKNW
>FCMOIPGL_02891 hypothetical protein
MSESLNHRYSNTEEKLNVISHGFGLVLSVIAFPFIIFKSIEFTGFWKPVSFIIYGLSLII
LYAASTFYHAAKNPKKRRKLNIFDHSAIYVLIAGSYSPFCLVGLDSNLGWYMFLFVWLFA
LTGVILKLFFTGRFDKISTAMYLLMGWQVVFFIKPLMQSLTPEGLQFLIGGGVFYSIGAI
LYSIKKIPYNHFIFHVFVLLGSISHFIAIYNL
>FCMOIPGL_02892 1-acyl-sn-glycerol-3-phosphate acyltransferase
MFKKINKQKNITTFAHYFNYYLILSVKFIKIPFLLIWRIWFYILMIVTILILSPFLLIFT
FKEEQYHNFWKVARILSKILIYGMGFRLKVQNDQITESDKSYMFCPNHASLMDAFVLIAL
SKNPIVFVGKHELGKIPVFGYFYKKVVIVVDRNNPESRKRVYKMAKKRLHDGTSMAIFPE
GLVPTEDVVLAPFKNGAFSLAIEFETPIVPQVYYDCKRLFSWDFFKGSPGVFRIHQHRFI
ETKGLKMEDMENLKQKVFKIIEDDLLSDKKFMNDTNRPNNEREFKSPL
>FCMOIPGL_02893 Tryptophan--tRNA ligase
MSRILTGVQSTGTPHLGNLLGAILPAIKMANSPGNESFIFIADMHSLTQIKDGDLLRENT
YSVAATWLACGLDISKTIFYRQSDIPQTTELTWYLSCFFPYQRLTLAHGFKDKADRLGDV
NAGLFTYPMLMAADILLYDAEIVPVGKDQLQHLEMTRDVANRFNNIVGETLVPPQAEIQK
GTKLVPGTDGEKMSKSRNNIINIFLSDKKLRKQVMSIKTDSKGLEEPKNPDTDNVFGLYK
LLASDEQIAEMRANYEGGNYGYGHAKQALYELILEQFSTIRERYNHFMENKNEIDEALEI
GAEKATIVANGVLKRVRAKIGY
>FCMOIPGL_02894 hypothetical protein
MEINFYIFFLAALVPLVTGFIWYGPLFGNTWMKEMGFTKESLADKNMALTFILSYVFSFL
VAFFLQFIVIHQGGVFSTLLESGSTELQGETLAYFEDFMAKYGTNYRTFKHGALHGTMSG
VLFVLPILSIIAMFERKTVKYVAINAGYWIITLAIMGGILCEWA
>FCMOIPGL_02895 hypothetical protein
MKKILSILLITFLLSSCVGHDKVILKESIGKINKVMVVAKVSDWTGDVGKEVRNSFGELM
VGLPQPEPILDVSQVAPNGFSSMMKASRNILIITESTNEGFTVKNNIYAQPQTIVYVQAK
DDEGIIKLLQKHKKQIRSIFLEADIKFTQGIFEKDKQDNSNYKTLQNLGISLTIPKKFNT
VDDTGEFLWLRNHLTSGIAKTGSNNILVYSIPLGDESKVADNIVAVRDSIGEKYIPGTDA
ETQHMITEEAYTPFTFDATIDGKKAYETRGKWEVKNDFMAGPFLNYSVIDKKNNRLIVFE
GFTYAPSVNKRAFLFELEAIAKSMKIQ
>FCMOIPGL_02896 Membrane-bound lytic murein transglycosylase D
MNKFLFLLLFSLSVFSQKPKGVVLEPIRDTLWPDDNVKRTIKVANIIEKDTFSNQDLIII
DSLLVDEKFNSSLIDSLEFVLNDIDITGNTSTVLTTDLLKLRLSLLNEKTPFNLAYNTTL
EKVINSYLSSRKKYFPQLFARAKYYFPMFEQYLDEYDIPLEMKFLAIVESALLPQIKSRA
GATGLWQFMYGTGKQFDLKVSSYVDERQDPVKSTIAACKYLSQLYRIFGDWDLALAAYNS
GPGNVSKAIKRSGGNKNYWNIRPYLPRETASYVPAFYATMYIFEYAEEHNIYSELPQFFN
FETDTIRVKRTIGFDHITEILKVEEDVISFLNPVYKLDIVPFIKDHNYAIRLPKDKIIEF
LEKEKEIYALAEADEASREKPLPKYFEMDNSIRYKVKNGDFLGKIAQKFGVRVSDIKRWN
SLKTSHLKIGQRLTVFSGKLSVNRTSSTIKKVSTSIAKGDYEVYTVQKGDSLWTISKKFK
NVSIEEIKKWNNIWSAKSLKTGTKLKIYKS
>FCMOIPGL_02897 Exodeoxyribonuclease
MKIISYNVNGIRAALKKGFLDWLQAANPDVICIQETKAHKEQLDLSEFENAGYPYHYWFS
AQKKGYSSVAVFCKEKPNHIEYGTGIESMDFEGRNLRVDFDEVSIMSLYLPSGTNSERLD
FKFTYMDEFHEYINNLTQEIPNLVICGDYNICHEEIDIHNPKMKGVSGFLPEERTWLGNF
INSGFVDSFRFVNPDAQEYSWWSYRANSRANNKGWRLDYAMVSNPLKEKISRAYILSEAK
HSDHCPIALELDI
>FCMOIPGL_02898 hypothetical protein
MKLFKKTYWLIYPILIIVFMSIFDLVYITDNFILKIGVCSVLAFIVSPRKKLILTETGKT
KQITWLFLKKPISLD
>FCMOIPGL_02899 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit B
MLDKNGIAKRIAQEVQNGFYVNLGIGIPTLVANYVREDIEVEFQSENGVLGMGPFPFDGE
EDADIINAGKQTITTMPGASFFDSSMSFAMIRGKHVDLTILGAMEVSENGDIANWKIPGK
MVKGMGGAMDLVASAENIIVAMMHTNKAGESKILKRCSLPLTGVGCVTKVVTNLAVLEVK
NNAFHLLERAPGVSIQEIKNATEGTLVVSGEILEMNI
>FCMOIPGL_02900 Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A
MINKKVNNVQEALVGVENGMTFMLGGFGLCGIPENAISELVKLDVREVTCISNNAGVDDF
GLGLLLQNKQIKKMISSYVGENEEFERQMLSGELEVELTPQGTLAEKCRAAQAGFPAFYT
PAGYGTEVAEGKETREFDGKMYVLEPAFKADFAFVKAWKGDAAGNLVFKGTSRNFNPNMC
GAATITVAEVEEMVEVGELNPNNIHIPGIFVQRIFEGKNYEKRIEQRTVRKHN
>FCMOIPGL_02901 Penicillin-binding protein 1A
MATKKTTNFKKYLIWFWGIVLGGFTIIIFTFLFASWGYLGELPTFKDLENPESNLATEVI
SSDGVTIGKYAKENRTPVKFNELPDNLVNALIATEDERFYEHSGIDFRGTTRAVLKPGSG
GASTITQQLARMLFTGEKSRNKFKRVLEKVKEWVVAIKLETQYTKHEIIAMYLNKYDFLN
QAVGIRSAARIYFGKEPKDLVVEESAMLIGMLKNSSYYNPLRREALVKQRRNVVLLQMAK
NEFITESEKINLQQLPLNVNYTPESHSDGYATYFRAHLQKMMRTWVRENPKPNGEQYNIF
SDGLKIYVTIDSRMQKYAEEAVSEHMANLQEYFFNEQKRNKTAPFYDLDAGEIARSYERA
KRSSERYRRLKAVGKSAKEIDKIFKTKTEMSVFTWKGDKDTIMSPMDSIKYYKYFLRSGL
LSIEPQTGHIKAWVGGIDNKHFKYDAVAQQKRQVGSTFKPFVYATAINQLRMSPCDELPN
TPYTIPKGKYGIPKDWMPENSDGKYGGMITLKDALAGSVNVISANLMDKVTPENVVRLAK
AAGIETDIPANPSLALGAVELSLYEMVSAYSTFANKGLRVRPMIITRIEDKNGTVLKDFT
PQTQEVLSEESAYVILDLLKGVTESGSGIRLRSTYSSAGKAATGFPYLFTNPIAGKTGTT
QNQSDGWFMGIVPNLATGVWAGGEDRATHFAGISKGQGATMALPTWALFMKKCYEDKTLN
ISKEDFEKPEDLTINIDCIDKSDEEINTNTGGDIDF
>FCMOIPGL_02902 Gliding motility lipoprotein GldH
MEIILRRNRSFIYLLVLLFFVSCNDKIEFTKYKSLPDASWQANKNISFEFTVVDTILPKD
LFINIRNNNNYPFSNLYVITELNFPNGNKIVDTLQYEMADETGKFLGKGFTEIKENKLFY
KEQKVFPISGKYKLNIRHAMRKNGEVEVIPFLEGVQDVGFSIEKTK
>FCMOIPGL_02903 hypothetical protein
MACGSCGTTENGVPKGCKSNGNCGTGTCGSGSEKLAVFDWLSNMTLPSGEERFNIYEIRF
KNGRKHFFKNTENLTISMGDIVAVESSPGHDVGIVSLSGELVKVQMKKRKISVDHEDVKK
IYRKASQKDIDIWQASRDKEEETQRRGREILGRLGLQMKLSDVEYQGDGNKATFYYTAET
RVDFRQLIRDLASAFSIRVEMKQVGARQEAARLGGIGSCGRELCCSTWLTDFRKVSTSAA
RYQQLSLNPLKLAGQCGKLKCCLNFELDTYLDALKSFPKQDVVLKTEKGDAVFVKMDIFK
KHLWYTYKEERFKWFRLSLDQVQEIIEQNKKNEKSISLEEYESEIEIPEKVNFEDAVGQD
SLTRFDVPKSSKRRKNNRKKKAVAVANSSSENTRKPQQNRKPNQNRKPRPASNDATSTQN
VARRKPQRRKSRPVVNDANITNEVAKKKPQKRKPRPNAANAKISDNVTKQKPQQRKPRPV
AKPKGETKTKPEVNPKVKGQQNQPKAEGTRANKPRRNNRNRKNNKPKNGDNSQEK
>FCMOIPGL_02904 Internalin-J
MEELSVQMNFITSLSVANNPVLKVLNCETNEISSLDVTTNLFLEEMSIGANNIPNIDISN
NTELTTLNLKNANNAILDKLDVTGNSNLSCIEVDNVADALAKADWKKDVTATYNVSCKAL
SKEDFLKENVAAYPNPASSFVEILLSNGLELKKVEIFNATGKKITTAKNTLLNVEELSAG
IYFIKITTDKGAINKRIIKD
>FCMOIPGL_02905 Internalin-J
MSGGRGTSFYYFENTGDDDAPAYAAVQNNPFGLINIPNNPSGSSDSDSFPTFVDSDGDGD
MDIISGDTYGDFHYYENTGSSSVPQFANPVKDPFGLTDEITFSSYPTFGDIDNDGDLDLL
SGAARSSSGNPVFYYFENTGSSTAPQFSAPISNPFGLTLSTPYIRIQLGDLDSDGDLDIM
IGGSGGNFRYFQNGPSPSYTQIPDAKFEQALIDRNIDTDGIINGRALTSDLEIVTGLVTV
GLEIEDFTGIEAFRDLEVLNIYNNFNTSIDLSGNGKLRELYASNETKDSETLLNSLDVSN
NPLLEKLEVLNNNISTLDLSNNPLLTEINVGGNNLTSLDVSNQTAILELNFVSNAISTID
VSQNTALTFLQGNDNGLSTLDVSLNTNLTSLAVNQNPELGSFSTAANLSLVYLNVADTGI
SSIDVSANTALTELFVGSNSLTSIDVSNNLLLKRLGVAFNQITNIDVSANNKLISFRAEN
NALVSLNIKNSANNLIPSTFIAFDIRNNPALECVLVDNATAATANWGVKDAGTTFSDTIC
YSASNYT
>FCMOIPGL_02906 hypothetical protein
MKLKLLFILSIIIGLNGFVQTSSAQVSAESFKFTRLTNSSTQGVFASGSTVYIGTTSGLL
ISTDGGTTFTTKTITNGLGANNVKNVFVDGSTIYAATSGGVSVSTNGGNNFINYAPASFT
YGNDMNDVFADGDAIYALASNRLWISNDAGATFIEKTESDGIGSTIFREIVANGSDVYVA
TDGGLSISSDGGATFINKTNTDGLANEGANGVSFSNGVLYVASEGFDPVGGLSISTDKGN
TFTVVQQADGLAANSVNTVYS
>FCMOIPGL_02907 putative transcriptional regulatory protein pdtaR
MIDEDIKSVLIVEDELLIAGQLKIALLNHGYLCAGIAINYNSAKAILETTKVDLVLLDIK
ISGRKTGLDVALLLNTIYGIPFLFITSYNDANSLHKIKELSPKGYINKPINEITVLTTID
IILNAKRYETKKFVSIHIGATTYNINLSELIYIEAEHVYVRLCYKTKKSLVRTSLTNIVE
LLPNESILRISRGIAINPKFIESVTSTSIKVNREVFKLSKKYGKDVENFLNI
>FCMOIPGL_02908 putative sensor histidine kinase pdtaS
MLKELNHRVKNNLSLIISLIKFQSQEIKEQFYKEKFKHLENRINTIAIAHEQFIYSDTKT
AGEFYNLEEYLQKIAGLVNVSSRNVKYVQNIVAIQLNIDTALPIGILINELISNSIEHAV
SKNPLIINVQIKKKRNLIYITYVDSGTIFSKDSKKDTLGLFIIESMVAQLNGKIEREKST
FKIVLEHKN
>FCMOIPGL_02909 hypothetical protein
MLNKTLIKHKSIFLVLLFFIKSTTIFAQNYELLYKKLEGDLLLGNFGVVIRLVDSINADK
NLTKIISNDFTTLKVVALSKNNNLTSSLKLINQTLLNPQEINERSLVRLYLAKALILEIY
NKREASELEFKKVENIYKTRPKDRLYGQYLYRKASYFRVMKAIKNNDSLSLIYVNKGIKF
GEENKFYEVSATSKMILAFLAEKESQDQRTFLLKNSLKDFLLSKNQLNISNMYKNIGFHL
LYNNKLDEADKYLDSSLFIIKKRKDLQVLSWLYEAKSKLNQKLKRIDSALFYYKKFHENE
MLKNDKKQEREISLINYKNQIEGEKQKSIVSKNLLEETEKKNKILFFL
>FCMOIPGL_02910 hypothetical protein
MVVITLQRNKCIGCNYCVEVAPEQFQMSKKDGKTVLLHSKEKKGFFTIKSFDESIYDCSV
EAKKACPVKIIEVKQV
>FCMOIPGL_02911 putative protease YdcP
MQKIELMAPAGNFESMQAALDNGCDSIYFGVEQLNMRARASINFTLDDLEEIAKRCSEKN
VRTYLTLNTIVYDHDLSIVKTLIKRAKEANITAVIAMDQAVISMAREQQMEVHISTQINI
TNIETVKFYSLFADTIVLSRELSLRQVKKITEDIEKEQIKGPSGRLIEVEIFGHGALCMA
VSGKCYMSLHSANSSANRGACKQNCRKKYTVIDQETGFEMELDNEYIMSPKDLCTIDFLD
QVADAGIKVLKIEGRGRAPEYVAKVIKCYRDAIDSLAAGTYDKEKVISWMQELEKVYNRG
FWNGYYLGQKLGEWSKESGSHATQKKVFLGRGEHYFDKAKIGQFKIDAYDVNIGDTILIT
GPTTGAQEMELKQMFVNDKPSEKATKGDEVTMKLDFKIRRSDKLYKIVKTEFAEN
>FCMOIPGL_02912 putative adenylyltransferase/sulfurtransferase MoeZ
MQLYNKLSAIERAALIDEAGKDRLTISFYQYYKIENPQLFRDKLFLEWNELDVLGRIYVS
YEGINAQLSVPSENFYALKDQLDSISFLKDIRLNVAVEQDNKSFLKLKVKVRNKIVADGL
NDDTFDVTNKGVHLNAKEFNEMLANPDTVCVDMRNHYESEIGHFDGAVTPDVDTFRDSLD
IIEEDLKDNKEDKNLLMYCTGGIRCEKASAYYKHKGFKNVFQLEGGIIEYTRQVKSEGIE
NKFIGKNFVFDHRRAERITDDVVSNCHQCGKPCDTHTNCANEACHLLFIQCDECSEKMEN
TCSTDCQEIIKLSYEEQKELRKGKGNSNKIFKKGRSEVLKFKK
>FCMOIPGL_02913 Formate acetyltransferase
MEVQELTLEKPKRVTFNEGVWNKSINVRDFVIQNIVSYYGDDRFLVGPSEKTQKLWNVCK
IGTEIERKNGGVHSVDTETISGVSNFKAGYIDKENEVIVGLQTDSLLKRAMKPFGGYKVV
QKALEEQGLKPSEDINTLFTKYVKTHNDGVFSAYNAEIKKFRSLGFLTGLPDNYARGRVI
GDYRRIALYGIDRLIEAKKNDLANIGGPMTDAVIRLREEVAEQIKALKDMIVMGNHYNLE
LNRPAKNAQEAVQWTYMAYLAAVKEQDGAAMSLGNVSTFLDIFIERDLQSGAITEVEAQE
YIDQFVMKLRMVRHLRMAAYDEIFAGDPTWVTEAIGGMLNDGRSKVTKTAFRFLHTLYNL
GPSPEPNITVLWSPLLPENFRKFCSKVAIDTSSIQFENDDLMRTSRGSDDYGIACCVSYQ
EIGKQIQFFGARTNLAKTLLLAINGGKCEITGTKMVDGIEADNSEYLDFDKVMANFKIAM
KEVARVYNDAMNIIHYMHDKYYYEKAQMALIDTNPQINIAYGIAGLSIVADSLSAIKYAK
VKPIRNEEGLTVDFKIEGEFPKYGNDDDRVDIFAHDAVEDFNNDLKKLKVYKDAEPTMSV
LTITSNVVYGKKTGATPDGRAMGVAFAPGANPMHGRDNNGAIASLNSVAKIDYKDSLDGI
SNTFSIVPKSLGATEEERIDNLAATLTGYFDHGAQHLNVNVLDKETLLDAMEHPENHPQL
TIRVSGYAVNFIRLTREQQMEVISRSFHESM
>FCMOIPGL_02914 Pyruvate formate-lyase 1-activating enzyme
MYCHNPDTIDTHGGEEHHIEDLVQRAIKMKSYFGDKGGVTVSGGEPLLQAQNLIPFFKRL
KEEGINTNLDTNGRLLNHPTIELLDEYADLVMLDIKHMTEDGFQYLTGKRNKETTFNFAK
HREESGKKMWLRYVLIPGITNSPELLHQLGNHFKDYKTIEQIELQPYHKLGIHKWEALGW
EYELKDARENTKEELQEASDILSNYFKKVKIN
>FCMOIPGL_02915 putative formate transporter 1
MNTPKEVIHLVNQLALNKGKYKTKKTLILAILAGAYVAFGGLLAIIVAGGSPEMAANNPG
LVKFIFGATFPIGLILVVVVGAELFTGNNAYFIPNLLRKKQPISDMFKNWGLVYTGNFIG
ALFLAYVITHLTHIVHSEPYINSVYNIAEGKTSHTFLVTFIKGIGANWLVCLAIWQGMAA
KDTIGKIFAIWLPVMAFVAIGFEHSIANMYFIPLAIFEGADITWTTFIFKNLIPATLGNI
VGGALFVGLPYGYLFGKEK
>FCMOIPGL_02916 Aspartate-semialdehyde dehydrogenase
MKIAVVGATGMVGTVMLKVLEERNLPITEFIPVASERSAGKKLSYKGKEYTIVTLADAVK
MKPDVALFSAGGDTSLEWAPKFAEVGTTVIDNSSAWRMDPTKKLVVPEINGDVLTADDKI
IANPNCSTIQLVMALSPLHLKYKMKRVVISTYQSVSGTGVKAVQQLDNEEAGIEGEMAYP
HKIGRNALPHCDVFLENGYTKEEMKLVKEPKKILRDDSFSVTATAVRIPTAGGHSEAVNI
QFENDFDLADVRKLLSETPGIIVEDDLANNIYPMPINAHDKDEVFVGRIRRDESQENTLN
LWIVADNLRKGAATNTIQIAEYLIANNLV
>FCMOIPGL_02917 1,2-phenylacetyl-CoA epoxidase, subunit E
MSTFHKVTIQEVKQETANAVSVLFKIPPHLKSEFNFTAGQYITLQKEIKGEEIRRAYSIC
STPKSDEIRVAIKAVEDGIFSIYATTHLKAGDEIEISVPEGRFLLNPEANKNYIAFAAGS
GITPILSMVKTVLETEPTSNFTLVYGNKSVADTIFYTELNALKESFSSRFKLHYIFSREN
VKNDLRGRIDGNVTNYFVKNMYKETTFDAAFLCGPEEMILDVSKTLKSNKIAEENIHFEL
FSTSVDEEAISEIKEGTTQVKVLLDDEETTFIMQQTDNILAASLRNDLDAPYSCQGGVCS
SCLAKVTEGKAVMVKNSILTDSEVEEGLVLTCQAYPTTSKITIDFDDV
>FCMOIPGL_02918 hypothetical protein
MDIYDFKNAILIGFFMAFMIGPVFFMLIQTSILKGARAAIVFDLGVILGDISFILIAYYG
SRSLLEKIKDDPRLFFIGGLVLIIYGVITYLDKENKKENLKSTKSIEIPIVKNNYLKLFL
KGYFLNFINIGVLAFWLGTVLVIGPTLNMDQNAIFTYFAVIILAYFVTDLGKIFLAKQLK
DKMTPTLTYRIKRIMGVILIICGVFLILKGFIPNDKIDEFIH
>FCMOIPGL_02919 Aminopeptidase N
MVNNQPKRRSIMRKFLSIIFASLLFASCSETKNVINKQNASNVTSAYWQQHVDYTMDIDM
DVNNYQYKGKQQLVYTNNSPDELDKVFYHLYFNAFQPGSQMDVRSLNIKDPDGRVGDRIS
KLKPDEIGYIKVNELKQNGAAVSFETVGTILEVTLNKPIKSGESVTFDMNFDAQVPVQVR
RSGRNNKEGVALSMAQWYPKMAEYDFQGWQTPPYIAREFQGVWGDFDVTIHIDKSFTIGG
TGYLQNPQEIGHGYEDKSAALSLPEGDKLTWHFKAPRVHDFVWAADPAYIHDILKIKNGI
DLHFFYKKTLDEKYLKDWKDLQPKTAELMDYYSKHVGQYPYKQYSVIQGGDGGMEYAMAT
LITGQRGFGSLFGVTAHEMAHTWFQFLLASNESLHPWMDEGFTTYISNKASNEILESGKE
NPHSGSYRGYNYVVNNNLEEPLTTHADRYNTNTAYSIASYSKGNIFLSQLEYVIGKENVA
KGLKQYFTNFSFKHPTPNDIKRTMEKVSGIDLGWYLNEWTETTHTIDYGVKSVEGNEITL
ERIGQMPMPIDIEVIYTDGTKQSYNIPLEMMRGNKPTTATILKDWGWAYPTYTFKAAKKV
KSVEIDASKLMADINDENNVFEVK
>FCMOIPGL_02920 Cell wall-associated protease
MKTNKLFLYSALAVLSFTGCKSIAKISVPTGSTDAISATAKKMPLTEAESQNWQHLDLVK
DSIPGMSVDKAYEFLTGKKGTTVVVGVIDSGTDLTHEDLSGNAWVNSKEIAGNGIDDDKN
GFIDDINGWNFLGSIYKENTELTRIIANPSIADTETAERAKIAYDKTVEEAKMNKQRYGQ
MLAGVQNADETIKKELNKTEYTKEDVLAITSTAPEVVQSVTVAKQMFGFGLNSLQQAIDE
LSKLVETADDLLSGDGLKKNYRTAIGDDENTMEVTIYGDNKVGNTIKSEAHGSHVSGIIA
AVRNNEIGMNGVANNVKIMAVRAVPDGDEYDKDVALAIRYAVDNGAKVLNTSFGKGYSPK
KEWVWDAIKYAASKDVLIVNAAGNDGKNIDEELTYPNDSKDLKTEISDNVLTIGAMSSNY
NENLPASFSNYGKVNVDVFAPGVQIYSTTPGNEYQKFSGTSMAAPSTAGVAALVRSYYPK
LSASQVKHILMNSGTLITIDVVKPGSQSRANPIGEKVPFTDLSVSGRVVNAYNALLMADK
MVNGK
>FCMOIPGL_02921 putative quorum-quenching lactonase YtnP
MKIYPIETGNFKLDGGAMFGVVPKSIWQKTNPADSNNLIDMSMRSLLIEDGNRLILVDTG
LGDKQSEKFFSYYYLFGGFSLDASLAKHGFHRDDITDIFLTHLHFDHCGGVIQRDKNGLL
IPAFKNAKVWSNDKHWKWATEPNPREKASFFKENINPIKESGQLNFIHRNAKDQVGFDVL
FMDGHTEKQMLPKIEYQGKTLIFMADLLPTVGHIPLPYVMGYDTRPLLTLKEKAAFLNEA
ADNNYYLFLEHDASNEICTVKHTEKGVRLNEIHKFTNIFN
>FCMOIPGL_02922 Penicillin-binding protein 1C
MKIINYLRQHKKKTIFVVILLIFYAFCLPKKLFTKPTSTVITSASDELLGALIANDGQWR
FPHNDSVPEKFKTCLIQFEDEYFYKHFGFNPVSILKAVKQNLQANGVKRGGSTITQQVIR
LSRDDKPRTYFEKIKELILATRLEFRFSKEKILSFWSSNAPFGGNVVGLDAASWRYFNRK
AANLSWAESATLAVLPNAPRLIYPGKNQQKLLEKRNRLLEKLLDKKIIDSLTFDLAVLEE
LPQKPYSLPQEAPHLLQKINKLKKGEYVKTTIDRKLQEQVNSIVENRYNILKNNEIHNVA
VLVLDVKSRQVLSYVGNSKTTQKHQKDVDIIDKPRSTGSILKPFLYAAMLDNGALLPNTL
VADVPTNFGSYKPENYDKKYAGAVSAKLALSKSLNVPTVRMLQEFGLEKFYNYLQKLHLK
DINKNASYYGLTLALGGAESNLWDLCKSYASMASTINHFSENSSRYFKNEFSEPTFFKDN
KIDFGKKTSEKIIFDAASIYLTFESLKDVNRPNAEENWEFFDSSKEIAWKTGTSFGFRDA
WAIGVTKDFVVGVWVGNADGEGRPGLVGVQTAAPILFDVFDKLPNSVWFEKPFDEMTQVE
ICTKSGYRATEICEDIKFEFIQNSGLKTAPCPFHVLVNVDKTASYQVNTSCESFESIQQK
SWFVLPPLMEYYYKDNNPFYKSLPKYRMDCLGNSNNSMKFLYPTEKSTIFLPKNFDGTKN
ELILKVAHSNKDVTLFWSVNNTFLGTTKEVHDFAIKPTIGTYLLTVTDNFGNEIHQEIEI
KE
>FCMOIPGL_02923 putative lipoprotein YfhM
MKTQNLLSAFLILFLFFSCKNEDVKTDNIYKFKEYISYTTSGIVSKTEKITVNLTKEVEN
WETDQDISSDIISIKPFVNGKIKTLNKHAFVFIPDEDLDADTEYTVTLKLGKLYKNIPQE
FEDYTFQFKTITPNFTIKTGALQSYSKEYQYLEGVVNSADVISLENAKKLLNASQKGTSK
KIVWNESYKNNRVFEFKIDSIQRFEEESKLAISWNGNSINADSKGENEISIPSKNNFKVL
SVKIYNENEQYISINFSDALKKQQNFDGLITVENVKTPRFIVDGNEIKIFSEARFQGAIL
VSVFQGIQNSDEYKLKNTYTETISFEQKKPEIRAISNGTILPNSKDLKFNFEAVNVKEVD
VRVIKIYHKNILQFLQEEDINSNSNYAIKRVGRRVAKQTITLIDKKENNTQKWKAFSVDI
SKMVATEPGAIYRIELSFNKNQALYDCSENTSSTENNDNFEDRDFNFNEFDDEEKREELY
WDDKLYSYKNYSYNWSQRNNPCYDAYYNEGRIISQNLLASNLGVIAKKGTDNTYFFAVTN
ILNTNPEAEATVRLFNFQQQEIASKNTNIDGFVSIKSKKNAAFAIVSKGKNKAYLRLLDG
NSLSLSKFDVSGSKTQKGLKGYIYGERGVWRPGDSLHLTFVLNDADNKLPKNHPVKMEVT
DPSGKLIYKKVASENLHNFYTFKVTTLPESKTGTYSVKVSVGGAKFYKYLKIETVKPNRL
KIKIDFDDEILTSKKPINGTLDVKWLHGTPAKNLKAEVKAKVSSTNYSFKNYEKYVFSDP
SRTFESEELTVFEGKLDENGFAKIKSNLTIDKNAPGMLNVQFLVRAFENGGDFSMDAFSK
KYAPFNSFVGLKSPEGNRYGSFFTDENQTFSVISVDEKGNPVQRDELEVEIYKIEWRWWW
SSSEDNLSRYTSSTYHKPYLTSTISTNSKGEGSFKLHIPERDRGRYLIRVIDKKSGHSTG
RTAYFYKNWWQNSSSGDKEAAKMLVFSADKEKYNVGETAKITFPSGSEGRALISIENGTK
VLETKWVKTTKGTTSVEIPINKNMAPNVFVNISLLQPHQVSENDLPIRLYGTIPIFVEDA
ATKLEPQIVMPKEVAPEKEFVVKISEKNNKEMTYTLAIVEEGLLDLTRFKTPNAFDVFYQ
REALGVKTWDIFDDVIGAYSGSVDQVFAIGGDGSLSKGKNQKANRFKPVVTYLGPFFLEK
GKTKSHKITLPNYIGAVRTMVVAGDINNEAFGNAEKSVPVLKPLMVLASLPRKLSPKEKV
TLPVAVFAMHKKVKNVKIEVKTSNGIKIIGNKTQTINFDKPDEKMVYFELDVLKANGINS
VEIIATGNGEKSTHKIELDVVNPNLITSKLIDKTVEGNQTQTINFDTFGVEDSNAAILEL
STIPSINFSSRLAYLIQYPHGCVEQTTSSVFPQLFLNDIFDLTSDKKKEIQKNIENGIQR
LGNFQKANGGLSYWMGENDVDDWGTSYAGHFLLEAEKKGFVLPLTFKSNFIEYQKKAARN
WRQGYNTYSSDLEQAYRLYTLALAANPDLSAMNRLREFKQISNEAKWRLAATYALVGQKE
AGEEIMNSANLNFSGYNYYNYGSETRNRAMALETMLLTNNKNAKDVAKSITKELSSNNYM
STQTTAFSLLSIGKMVVKNGGKSIDIKFTNDGKSETVKTSSAFVQRSLKVRNGTNSITLK
NNENNIVFARIINAGKLPLGDEISESRGLSVSLKYIDLTGKIININQLKQGQDFVAKITV
SNPKNETVKNIALTQVFPSGWEIVNTRFTDFGTTTKSDARYTDIRDDRVNFYFDLNQQSK
KSETKTFTVLLNAAYLGTYYLPGIQVEAMYDNDYLVRTKGSWVEVVK
>FCMOIPGL_02924 hypothetical protein
MEIQESRILNETTTIVRFKEGVLHLIHQEGIFKTHFFEEVPIYFFEGDNIPDMR
>FCMOIPGL_02926 Dihydroneopterin aldolase
MGIIKVNNIKLYANHGCLEEEAKIGSEYRIDVEVKASLRKSSKTDDLVDTVDYVHLNYIV
KEEMAIRSKLLEEVAQRILNRFFRELRMIKKATVSVAKLNPPIGGNVEEVAIILTKKR
>FCMOIPGL_02927 hypothetical protein
MSNQIRNYSCPKCNNKTYKIGELRATGGTLSKIFDIQNQKYTSVTCERCTYTEFYKTKTS
AISNVFDFFTS
>FCMOIPGL_02928 Glutamine--tRNA ligase
MSEEKKSLNFLEQIIEEDLANGMPKEDLRFRFPPEPNGYLHIGHTKAIGISFGLGLKYNA
PVNLRFDDTNPAKEEQEYVDAIKEDISWLGYSWANECYSSDYFQQLFDWAVLLIKDGKAY
VDSQSSEEMRVQKGTPTEVGTNSPFRTRSVAENLELFLGMKDGKFKEGEHTLRAKIDMES
PNMLMRDPLMYRIMYKSHHRTGDDWCIYPMYDWTHGESDYIEQISHSLCSLEFKPHRELY
NWFRDHIFDFSKSEYPNPPKQREFSRLNLSYTIMSKRKLLKLVEENIVAGWDDPRMPTIS
GLRRRGYTPAAIRSFVETVGVSKRENIIDVALLEFKIREDLNNTAKRVMGVLDPVKVIID
NYPEGKEEMLDASYNDYEEGFGSREVPFSREIYIEREDFREEANKKFFRLKLGKEVRLKN
AYFITATSCEKDENGEITVIHCTYDPLTKSGMDTEESKRKVKGTLHWVSVKHAIKAEVRA
YDRLFLDEAPDSHKDKDYMEFVNPNSLEIIEAYLEPSLQNATIGERFQFQRLGYFNVDDD
STTDNLVFNKTVGLRDSWAKK
>FCMOIPGL_02929 hypothetical protein
MSLITIKKSNNESEIFILKGRLESEGVKCYLRNQFSTQIMPQISSVELQISEVDSEKVKE
ILSQINQT
>FCMOIPGL_02930 50S ribosomal protein L13
MNTLSYKTVSANSATVNKEWVLVDADGQTLGRLASKIAKLIRGKYKPNFTPHVDCGDNVV
IINAEKINLTGKKWTEKSYIRHTGYPGGQRSLTATEMFDKDPTRLIEKAVKGMLPKNTLG
SALFRNLYVYAGTEHKHAGQEPKAINLNDYK
>FCMOIPGL_02931 30S ribosomal protein S9
MDIVHKIGRRKTAVARIYLSEGTGTIVVNKKDYKSYFTTSTLQYKVQQPLMLTENLTSYD
IKVNVYGGGVTGQAEAIRLAITRALVAIEPEHRLILKPEGLLTRDPRMVERKKFGQKKAR
KKFQFSKR
>FCMOIPGL_02932 30S ribosomal protein S2
MANVNIQELLESGVHFGHLTRKWNPNMAPYIYTERNGVHIIDLYKTAAKIEETAEALKKI
ANSGRKILFVATKKQAKDIVAERAKAVNMPYITERWPGGMLTNFVTIRKAVKKMAHIDRM
KQDGSFDALSKREKLQINRQREKLEKNLGSIADMTRLPGALFIIDIKKEHIAVAEARNLN
IPIFAMVDTNSDPRLVDFVIPANDDASKSVNKVLSYVSDAIAEGLSERKSDKEKGKEGKA
EKSAPKKVKAKAEATESVEKDSE
>FCMOIPGL_02933 Elongation factor Ts
METVKVSAADVKNLREATGAGMMDCKKALVEAGNDFDKAIDILRKKGQKIAAKRADRDST
EGVAVTKINDEKTAGVAIVLACETDFVGKNDAFVALGSQFADIALNHDTKESFLAADFGG
MSVADKLVEQTGVIGEKLEITAFEKIEAAYVGAYTHIGKIAALVGLSAVVDNAETLSKDV
AMQVASMGATSLSYKDFDPAYVAAETEARIAVIEKDNIELGRLGKTLKNVPQFISMSQLS
EEVLAKAEEAAKAELAAEGKPEKIWDRILPGKMERFISDNTTLDTEQCLLDQAFIKDEKK
NVAQYVKTYGDVEVSSFKRVTLG
>FCMOIPGL_02934 Leucyl/phenylalanyl-tRNA--protein transferase
MIWLTDKIIFPDYQFTTKDGIIALGGDLSVKRLEYAYKNGIFPWFSDDEPIVWYCPFKRM
VLFPDELKVSKSMRKIINKKEFVITENIAFEEVIYNCKNIDRNDGFGTWITDDMQQAYIN
LHKKGIAKSIEVWLNNELVGGLYGLEINGIFCGESMFSKVSNASKIAFIHLVNNHDYKLI
DCQVYNNHLASLGAREVERDLFLKMLKE
>FCMOIPGL_02935 hypothetical protein
MRKLKRKKRIKTKKEKATLIHNYYARTGFYQFVGNNLKKAILPIIGIVVAIFLFNKYVYN
INDGLHHFTETFSRLGVLITFFISETLLGLIPPEIFIAWSKKTDDPILNLAILATLSYSG
GLISYFIGKTALKIQSVKKYLEVKMAKNLENTRKWGGILILVGALLPLPFSIACVAAGMI
KYPFKNVVLFGLFRFGRFAIYAWAIFSVVS
>FCMOIPGL_02936 hypothetical protein
MGLTNNDILKKLRVAHKLRDTDIVKICALVDFKVTKGELGALFRNEEHEKYVECGDQILR
NFLNGLIIHLRGPMPPKKQKPTS
>FCMOIPGL_02937 hypothetical protein
MEVIGKVKIIGDVQTFGTGGFRKRDLVVTTDDQYPQMISIEFHQDKTDLLNNYKVGQDVK
VSINLRGREWINPEGQARYFNSIVGWRIENLSQGTSSQSVPPVDKFESASSVSDEEPDDL
PF
>FCMOIPGL_02938 hypothetical protein
MLTIDPKEISTGKLHGYLLGAIAPRPIAFASTIDINGNPNLSPFSFFNVFGSNPPILIFS
PARRVRDNTTKDTLDNVLETKEVVINVVNYAIVQQMSLSSTEYPKGVNEFDKAGFTMLPS
DKIKPFRVAESPVQFECKVKDVIFTGDEGGAGNLIVCEVVKIHISEAVLADDGSIDQHKI
DLVARAGGNYYTRAKDGFFEISKPVSTLGIGVDVIPIEIRNSAVLTGNNLGMLGNVEQLP
TLETVNNFGKDHPEFIGIEVTKKHTFAKRYLSKNDVESAWKVLLLK
>FCMOIPGL_02939 Sporulation kinase D
MSYILEIFIFVLMKVYSKTLFFKRFTIAASFIIVSLILWNTYTFFQKFKKAERAKMEIHG
EAIKELRTVSIEELDQNISELPLKIISRTKDIPFILVDVDGNIKGSNNLDTIKEKDPEYL
KEQLAIMKSQNQPILVEYLGKTDYIYYRDSDLLDKLTYYPLAFLLILVLFLAVIYLFYSS
NKAAETNKLWTGMAKETAHQIGTPLSSLLGWIAILKMEKVNDTYITEIEKDVHRLNAIAN
RFSKIGSIPELKEENIVDISKQAFDYLESRSSKQISFSFFTTDEDIQIKLNSELFGWVIE
NLIKNAIDAMLRKGELTLRIESFGKKVKISVSDTGKGMPKKMFKQIFKPGFTTKKRGWGL
GLSLSKRIVEDYHNGKIFVKKSEIDKGTTFEILLNRV
>FCMOIPGL_02940 hypothetical protein
MKGWVKVGLGWGVWMFLAMAFIWPLIDGEGITLKTVIIKLIFWIIAGLVFGYLSAKYKIA
KTKFRK
>FCMOIPGL_02941 putative HIT-like protein
MSIFTKIITGEIPSYKVAEDANFIAFLDINPNAKGHTLVVPKKEVNKLFDLSKDEYLQLM
DFSYRVAKALEKTVACNRIGMSVIGLEVPHVHVHLIPLNAMSDIQFSQKVKLTNEEFVSL
AESISDNFE
>FCMOIPGL_02942 Transcription elongation factor GreA
MSNISYYSPEGLKKLKDELLQLEQVERPRVTQEIADARDKGDLSENAEYHAAKEEQSHLE
FKIAKLKNVVSNARILDESQLDTSKILIHSIVKIKNTTNGMEFSYTLVADSETDVRNGKL
SVNSPIGKGLLGKKVGDIAEIQVPNGVMKFEIMEISRK
>FCMOIPGL_02943 hypothetical protein
MKKLIIPFCFLLLSGCVDNTTIINNCFLNVYISGTINLNNPQFLNLQVPLGYASATIDGR
DLLIIKSTSSYKAYDLECPEADCSDKMTFDGLKLICPCSKKEYNSLNGSPIDGEGCFALE
YNVMQTNNSTLQITR
>FCMOIPGL_02944 N5-carboxyaminoimidazole ribonucleotide synthase
MKNYFSSDFKLGILGGGQLGRMLLTETQKFDIYTSILDSNPNAPCAQICNHFEVGDLLDF
DAVYNFGKTVDILTIEIENVNIDALDKLQAEGLTIYPKPKDLRIIQSKARQKHFYFDHQI
PTAPFSHFAYLEELHHCLENDIINFPFVWKAARFGYDGNGVKIVRNFSDLESLPNVECIT
EQLIPFKNELAVIVARNADGETKTYPVVEMEFHPEANQVEYVICPARIEESVAKKAQELA
LKVVNDLDFVGLLAVEMFQTETNDILVNEVAPRPHNSGHYSIEASYTNQFEQHLRSILNL
PLGNTDSKVAGIMVNLVGEEGFSGNVIYQNIEEILKIDGVTPHIYGKKETRPFRKMGHVT
IVNTDIDKARKIAQQVKETIRVISKNN
>FCMOIPGL_02945 N5-carboxyaminoimidazole ribonucleotide mutase
MVGIIMGSDSDLPIMQEAIDILESFDIQIEVDIVSAHRTPEKLFDYSKNAHLRGIKVIIS
GAGGAAHLPGMVASMSPLPIIGVPVKSRNSIDGWDSVLSILQMPGGVPVATVALDGAKNA
GILAAQIIGASDKYVLDKIIAYKEGLKLKVEQASERVRK
>FCMOIPGL_02946 Oligopeptidase A
MNPLLQDFNTPPFSKISNEDYKPAIKKGIEIAKSEIDEIIHNTDAPTFENTTVALDFSGE
KLNKITSIFFNLNSAETNDEIQKIAQEVSPWLSEFSNDITLNEDLFKRVKAVYDTRENLD
LTPEQEMLLDKQYKSFARNGANLNEEAKIKLREIDAQLSKLSLQFGENVLAETHAFEMHL
TDENDVSGLPESVKESAKEVAKSKEKEGYIFTLDYPSYIPFLTYADNRELRKKMAIAAGK
KAFQDNEFNNENVVLNIVNLRQQRANLLGYKTHAHFVLEERMAETPEKVIEFSNNLLEKA
KPAALKEFENLENFAKKLDGIDQLQKWDGSYYSEKLKKELFDLDQEILKPYFKLENVIDG
VFEIANRLYDLKFEEVFNIDKYHEDVKTYNVTDTEGNFVAVFYADFHPRKGKRNGAWMTS
YKSQQIKNGINERPQVSIVCNFTKPTATKPSLLTFTEVTTLFHEFGHALHGMLANTTYNS
LSGTSVSWDFVELPSQILENWCFEKEALELFAKHYETGEVIPMKYVEKIKESASFHEGMQ
TLRQLSFGLLDMQWHGQNPSGITSIKEFENDAFSNTKLYPDVAENCMSTAFSHIFQGGYS
AGYYSYKWAEVLDADAFEYFLEEGIFNKEVATKFKENVLSKGGTEKPMDLYKRFRGKEPK
PDALLKRAGLV
>FCMOIPGL_02947 hypothetical protein
MKNRFLFLLFFTSFFSIAQVTITGTVYEKNNPLEGVAVYFNNTTIGTTTDLNGDFSIKIK
EGKHDLIISYLGFKKINYTLNTSTYKKPLIFNLEEENNKLNEIIIRKTVYDEDWKYNVSR
FKKEFIGTTKLAQDCKILNPEVLHFDYDAKNNVLTAIARKPLIIKNKGLGYEITYELEDF
TINKNRVTYLGYSRYKNLDGSKRKHRKWRKKRVKAYNGSSMHFYQSLVKNTTYKDGFLVH
QFKRVPNPERPSEEEIKKAREFVQLNKEIINSFKIIDTSNTALTNAISTLNKVKLPKFID
YLYKSKIPVNEIISQKNGVFYLDFENNISVVYTKELEETGFITRNAFSKIRNPLPQSSAI
IPLKFPSILDKDGALVNPLDVFYEGYWSYEKFADSLPLDYIPIE
>FCMOIPGL_02948 hypothetical protein
MSKQQVLIIGYVWVEPNSSAAGSRMLQLIKLFLKQGYNMTFASPAQKSEKASSLKSLGID
EVSIDLNNASFDDFIKELQPTIVLFDRFMMEEQFGWRVAENSPNAIRILDTEDLHFLRKT
RHQQLKKGEEFATEVLLKSDGAKREIASILRCDMSLIISSFEMDLLKTVFKIDEKILYYL
PFLLDKIDEYQIKKWKSFEEREHFIFIGNFFHKPNVDAVLTLKKDIWNKIREQLSKAEIH
IYGAYLNQQIQELHNKKEGFIIKGFAENAQEVVENARVVLAPLRFGAGIKGKLTEAMICG
TPSVTTSIGAEGMCNNLSWNGFIEDDFSNFSEKAIQLYTDKKLWKTSQENGIETINQIYD
KELLGSSFINQIKEIQQNLEQHRTQNFLGSLLQHQTLQATKYMSKWIEAKNK
>FCMOIPGL_02949 hypothetical protein
MKIIKKIAIILLVAFVIAQFFGPEKNEGDIASVPVFLAETNPPENVKKILTESCYDCHSN
STRYPWYNTITPVNFWLADHVKGGKKHLNFSDWSTYSLKKKEHKMDELYEEVEKGEMPLD
SYTWTHSEANLSQEQINEIVTWGKKVQTNYQQQLNSK
>FCMOIPGL_02950 Dihydrolipoyl dehydrogenase
MKYDIIVIGSGPGGYIAAVRASQLGKKVAIIEKYSTLGGTCLNVGCIPSKALLDSSHHYY
DAVHHFEEHGITVEKPSFDFAKMVERKAKVVETTTGGIKYLMDKNKVDVYEGLGSFEDAT
HVKITKNDGSSEIIEGINIIIATGSKPSTLPFISIDKERIITSTEALELKEVPKHLLVIG
GGVIGLELGSVYKRLGADVTVVEYAPKITPTMDADVSKELQKVLKKQGMKFNVSTGVTSV
ERNGDEVIVKANNKKGEEVTFTGDYCLVAVGRKPYTEGLGLEKAGVKVSERGQIDVNDHL
QTNIANIYAIGDVVKGAMLAHKAEEEGVVVAEFLAGEKPHIDYNLIPGIVYTWPEVAAVG
KTEQELKDAKIDYKSGKFSMRALGRSRASGDIDGFVKVLADKNTDEILGVHMVGARVADL
IMEAAVAMEYRASAEDLARICHGHPTYSEAVKEAAKAAWDGKPLNA
>FCMOIPGL_02951 Aminodeoxychorismate synthase component 1
MRSFLFRKLSSIFAAIMQRTIQTFSVDDIDKFKQNLLAWSQQFDTVLWLDSNNYKQQYSS
FDCALAADEFTAIKTDYYNAFEKLKEYQTITNDYIFGYISYDVKNDVEQLSSKNFDGLDF
ADLYFFQPQKLFLIKGNDIEFNYLKMVDDEIESDFEEIQKSKNPKIQKSENDIKIKLRIH
KDEYHQKVTKLLQDIKRGDLYEANFCQEFYAENSTINPLEVYNHLNKISEPPFATFFKNE
HQYILSASPERYIKKEGTKIISQPIKGTAKRLLSEIDDAKIASDLSRDIKERAENVMIVD
LVRNDLSKSAKKGSVKVEELCKVYTFKQVHQMISTVVSTVEENTHPVDIIKSTFPMGSMT
GAPKFSAMKIIEELEETKRGLYSGSVGYFTPNGDFDFNVIIRSILYNEEKKYISYSVGGA
ITAKSIVEKEYEECLLKAKAMKYVLLNSK
>FCMOIPGL_02952 hypothetical protein
MIIDQEEKFKLIFDKIQEKQTEQNMFNTFLEVYPAEWKQLKITFSKFNRSKQFGKSIPLP
KPEVSLRKEIRVWLKKQ
>FCMOIPGL_02953 hypothetical protein
MNIKLSEKDYKKLVIEIALKISPALIEKTDDISTASEQISLYAKDIANSIQSVLEKPD
>FCMOIPGL_02954 Monoacylglycerol lipase
MHKEFNLNIYKTTFYGQVWEAKRTKAVVVLVHGMGEHSGRYKHVAKKLNENDFSVVAFDH
FGHGKTSGKRGHNPNFEAVLESVSKTIEKAKELYPNKPVFLYGHSMGGNVVINYSIRKKH
NLKGIIATSPFLKLAFQPPKIKLIVGKLLQKIAPSITMGNELNANDVSRDKIEVNKYVHD
PLVHNKISPNFSLTFIETGQWAIKNASKLQTPMLLLHGTDDKIIDYKGTQEFANNSDKTT
LKLYEGGYHELQNDLCKEEMLQDVVNWLNSQL
>FCMOIPGL_02955 tRNA(Ile)-lysidine synthase
MLQKFKEHINLNFPFLKDKKLLIAISGGIDSVVLTHLFSDLNFDISLAHCNFKLREKESD
LDEEFVKSLAQKTSNQIFTIKFNTQEFAQKNKLSTQIAARELRYNWFQKIIKKNNFDYVL
TAHHADDNLETFLINLTRGSGLDGFTGIPKINGNIVRPLLAFSREEILAFAKANNIDWRE
DKSNASTKYIRNKIRHKVLPVLKEINPNLLKTFAKTVENLQESKQIIEDKIADISQKVIE
TDVSTALEVTKINIDKLNQLSSPKAYLYQLLKEYNFTEWNDVYNLVSAQSGKQVFSKTHR
LLKDRAFLLLSKTDEDKNHQDEHYFIYQDEKEIINPIHLILEDVQQKSTENKQTIYLDKD
LLKYPLIVRKWQNGDYLYPLGMQGKKKLSKYFKDEKLSLLEKENTWLLCNNENEIIWVIN
YRQDRRFVNENNLKISLKEN
>FCMOIPGL_02956 Thiol:disulfide interchange protein TlpA
MKKLALFFIALTIFSCKQEVKVDYAILSGKIENAASEKITLYNSYERSDKKELTLENGQF
TDTVKINNGNQFYLIQGKNNVSLFLTEGDKLNFSYDANKVDSTLTFTGNNSAISTYLVEK
KINNKDIKLNTEDLYSLNEDDFITSVLKVKKAQEDFLYNATSLPESFIKNETSNINYEYL
ATISNYESYHTYFAKIKGGFKASDKITSKLKDLTYENENDFQFSSNFRSLVTKNYQNETA
DLVKADSIERDIAYLKTLATIKSDKIRNKLLFDDAKYGITFTKNLEDYYSLYSKASTNQY
NNDKITEIYRNLKTLTKGNASPKFTDYENNAGGTTSLDDLKGKYVYMDIWATWCGPCIGE
IPFLKKIEKLYHGKNIEFVSISIDKEADHEKWKKMIVDKELGGIQLFADNNWESQFIEDY
SIKGIPRFILLDPQGNIVSANAPRPSNEKLIALFDELKI
>FCMOIPGL_02957 Thiol:disulfide interchange protein DsbD
MKQFFLIFVLFLSFSTFSQTADEPIKIETSVKKISETEYDIVFSATLFKGWYLYSQYNPD
EASLPLEITIQQGETGYKLVGKADEKDTFKKYSDIWEKVEIVFKEKALITQRIELTNKDI
TQIKLNFFGQVCETACINIDEDFSFSLSGNTIKEKVSIDDKSKNLTNKLQLNLKNTSLLK
NSTEKESESSNGLFSIFFLGFVGGLLALLTPCVFPMIPLTVSFFTKQSKNKKKGVFNAIL
YGVFIVLIYILLSLPFHFLDNLDPEILNTISTNVWLNMFFFVVLVFFAFSFFGFYEITLP
SSWGNKMDSASSVGGIIGIFFMALTLAIVSFSCTGPILGSLLAGSLTSDGGATQLTAGMT
GFGLALALPFALFALFPSWLNSLPKSGGWLNTTKVVLGFLELALAFKFLSNADLVAHWDL
LKREVFIGIWVVIFIGLALYLFAKIKFPHDSPIKKLSFSRISFGVLIISFIIYISPGVLK
NPTWNLSLLSGFPPPQFYSIYEQESNCPLGLNCYKDFDEGLAAAKETNKPILLDFTGWAC
VNCRKMEENVWSEPDIYQTLKDDYILISLYIDDNEKELPKEEQFDFLKKNGKVKKIETVG
DKWSTFQVINFKNASQPFYVLLSPDLEVLNNTQQYTDRDTFYNWLQEGLQAFNKK
>FCMOIPGL_02958 hypothetical protein
MRNIHFFIAFFFLFSISINAQKSDKNLLKKPASIYTFSALSNDKNSFSAINKKLKLANFS
FVFVDAINLDLNQFSIDFKDIGKTPSAFIYDDYQRYQDRNLLKGFLLKNDPTRWNLQNQQ
HNLQP
>FCMOIPGL_02959 Phosphoenolpyruvate carboxylase
MSGFPKITRFNDNVLSKYQIYNSIFITLPFDTINNTGVLLPLFHKICNKGFKKGLNPSEI
VEKFFKKYLENPAEDDQNPTENDKIDLLFQLIQYIERQVVLFDAVEDAAFPIVNNMDGFG
TLRNSRETAILNGKKEDLKKHLEDFKVRIVLTAHPTQFYPGSVLGIITDLDKAIQNNDLL
LIKKLLAQLGKTPFYKKSKPTPFDEAVSLIWYLENVFYHSVSKIYNYIQQNIYDGGTMNN
EIIDLGFWPGGDRDGNPFVTTQITLDVAERLRQTILRNYYRDIRRLKRRFTFDGVHEILA
GLEKRLYKHVVRSYAKVNFSQKILLEELYAAREIVINKHQSLFVEELNDFINKVRIFGFH
FATLDIRQDSRVHHKAFTQIVTDLIATGDTTFPENYHRLSEDEQIAILSLVKGNIDPKIL
TDEMSVKTIESIYALKTIQQRNGERGANRYIISNNQSALNVMQTFAMLHLCGFENELPVD
VIPLFETVEDLENSSDVMRTLYTNNAYRYHLTKRKNKQTIMLGFSDGTKDGGYLMANWGI
FKAKEALTKVSREFDIDVIFFDGRGGPPARGGGKTHKFYASLGPTIEDKEIQLTIQGQTI
SSNFGTLDSSQYNLEQLLSSGIKNDMFTKDQLNDKDRKIIEDLASLSYKTYVDFKNHPQF
LPYLEKMSTLKYYAKTNIGSRPSKRSTSDTLDFSALRAIPFVGSWSQLKQNVPGFYGVGT
ALKKYEDEGRFDEIVDFYNESDFFKTLLENSMMSLTKSFFGLTSYMADDPVFGEFWQLIH
EEYKTTKRLLLKLAGHTELMENHPVGKASIAIREDIVLPLLTIQQFALKKIQELQKTEGN
EKEIEIYEKMVMRSLFGNINASRNSA
>FCMOIPGL_02960 Competence protein ComM
MLVKVYGSAVFGIEATTITVEVNIDKGIGYHLVGLPDKAVSESSYRISAALNNNNYKLPG
KKIIINMAPADIRKEGAAYDLTLAMGILTASNQIKSTNIHEYIIMGELSLDGSLQPIKGA
LPIAIKAREEGYKYFILPKENAKEAAIVDNLEVLGVENIMEVINHFNDDKKIEPTIVDTR
AEFYKNIDFPEFDFYDVKGQESIKRCMEIAAAGGHNIILIGPPGSGKTMLAKRLPSILPP
MTLHEALETTKIHSVVGKTKNNGLLFQRPFRSPHHTISDVALVGGGQYPQPGEISLSHNG
VLFLDELPEFKRTVLEVMRQPLEDRDVTISRAKFTVTYPCSFMLVASMNPSPSGYFNDPS
SPMTSSPQEMQRYLSKISGPLLDRIDIHIEVTPVPFEKLTEKRKGESSVAIRKRVTEARE
IQSVRFKGFENVHYNAQMNVKQIREFCKLSPESLSLLKTAMEKLNLSARAYDRILKVSRT
IADLGNSNDISPDHISEAIQYRSLDRDGWLG
>FCMOIPGL_02961 Putative phenylalanine aminotransferase
MKTTNLSRREWLKKGTLTLGALALVPHEIWSSNVEISQKENSTFLYNSNNYFNEFTPPLI
KEADSLTILRANENPYGPPPKSAEAFQKEVFGGNRYSWKTLTDLKAKIAKNEGINPNQIL
MGPGSSDLLEKVAMVLFQNGGNVVSADPSYMSLIVVAKSVGGNWKSYKLLDDAQHDLDAM
EAGIDEDTKLVYICNPNNPTGSITDAKKLKEFCSRVSEKVPVFVDEAYIELSKNGIKDSM
NSLVAEGKNVIVARTFSKIHGMAGLRIGYAIGKKETLDSISKITRGGMGITGPSIAAATT
SLENTDFLDMCKTKIANARNYTMSYLKENKYSYLPSETNFIIFEIPMEGKEFLKEIYSKN
VAVRAFKFWDKNWCRVSIGTMDEMKTFTNAITEIFA
>FCMOIPGL_02962 hypothetical protein
MDGALEKSISFLLFIFIGVLLKKKISVGDETNGIKSLILTIALPATIFIALLKVKIDGNL
ILFPILALGLNVILFAITPVLLSLIGINRNSDKGRSARLLLPSLAPGLSCFPFILEFLGD
NSLAKAAMADLGNKFFVLFLLYLVALKWHYKNADFEANSLKTKLKSLTKTLLYEPVNIFI
IVALILVSFGITLDKIPNFLSSTLTRLSYIMTPLVLLFIGLAVKFKKQQFFQLFSLLLLR
AGFTLLLIAGIVFFADISIKKDILVMIAFSLSSASFWPFAHISAVNFREQKENNCEKTFD
PNFALSILALSLPISVILILGILTAGNTFTSINNILILGVCLSFIGIIYPIILKIKSRFS
VSKIDGKTSKKRSVEFLADK
>FCMOIPGL_02963 Adenosylhomocysteinase
MSTKTATYIPFKVKDISLADWGRKEINLAEAEMPGLMSLREEFKDSQPLKGARIAGCLHM
TIQTAVLIETLQALGAEVTWSSCNIFSTQDQAAAAIAATGTQVYAWKGLSEEEFDWCIEQ
TLFFGEDKKPLNLILDDGGDLTNMVLDKYPELAAGINGLSEETTTGVHRLYDRVKAGTLP
MPAINVNDSVTKSKFDNKYGCRESAVDAIRRATDIMLAGKRVTVCGYGDVGKGTAASFKG
AGSIVTVTEIDPICALQAAMDGFEVKKLETVIANSDIIITTTGNKDIIQGRHFEAMKDKV
IVCNIGHFDNEIDMAWLNENHGKTKDTIKPQVDRYNINGNDIIVLAEGRLVNLGCATGHP
SFVMSNSFTNQTLAQIELWTNKDAYENDVYMLPKHLDEKVAKLHLAKIGVELTELRPDQA
SYIGVTVEGPFKPEHYRY
>FCMOIPGL_02964 hypothetical protein
MALYKTLTINKTTKVLIWKIEETINELKTGITLSENSKIRLDAMKSNLHQKGFLSIRHLL
KELNLTDADVYYDEFGKPNLTNGSYISITHSFNFTAIIFSDERPVGIDVEKQREKILKIA
HKFTPIEEYKTIANVDALISKLTIVWGAKESLYKIFGKKKIRFLHHIYVDDFNFADNKTI
GEIRFDGKTDSYTIEFLEFEGFTCVYAY
>FCMOIPGL_02965 hypothetical protein
MKKLFIFLFTVAIITGCQKDEKHIFIPENHFKKFQTEKIQIFDLDTLSFKQIIGKNGTKI
SFNRNDFIISKNKKISLELIELYDFNEIIYKNINTITTDNELLETNGVLYISFKSDEKEI
DLKLNKKIVVYPAEGKLLDNDVFKTNTDSLQNIKWELLKQVDTIFPIYKGGGVWVSTIVK
KDSVDYFKKQNEKLSKFKNYNSFIKSKYPAYFLLANDDLGYINIDKLINIKDKITFSLLD
KKVKFPGFNIYFTYDKLKSFIYNSRLKDDLKFDNIPLSGKTWITIIGEQKGILYYDKIEL
EKGLNNSEIILNMKEISIKNLVSIINN
>FCMOIPGL_02966 Nicotinamide riboside transporter PnuC
MSEIFNSLFGQYKTYETIDIVLEIIAVIFGFLSVWYSKQNKIWVFPTGMISTLIFVYLLL
KWELLGDMLINGYYFIMSVYGWYIWTYKSDGEHETPISTTTTKEKKLSVFIFIATLIFVY
AVYSYFEKWTSWTAYVDTVTTAIFFVGMWLMAKRKIENWIYWIIGDIISAPLYFYKGFTF
TSFQYLIFTFIAISGYLAWKKSLNKNPSTL
>FCMOIPGL_02967 Trifunctional NAD biosynthesis/regulator protein NadR
MEKKLKQKPINLVKVVLFGPESSGKTTLSRQLARYYHTVWAPEYAREYLQNKWNNERKTC
EAEDLIPIAIGQMKLENKLAKRADKILICDTDLLETKVYSEEFYGGFVDELLNKAANENK
YDLYLLTYIDTPWEEDDLRDRPEQRLEMFNAFETALKTHNRPYILLKGDRETRLKNATEA
IDKIISEKENLHSFSDSLLDIDMHFLHQNNDFGTNLDY
>FCMOIPGL_02968 Peptidyl-tRNA hydrolase ArfB
MNSETIIKELSFKAIRSSGAGGQHVNKTSSKIELTFDLESSNSLSEDEIILLKTKLSSRL
TNESLLILFCDESRSQHRNKDIVIKRFLELIKTNLIRPKKRRPTKPSKSSILKNAEKNKR
NSLKKNLRKKPKFE
>FCMOIPGL_02969 TonB-dependent receptor SusC
MFASILANAQTFTLKGKVVDENNESLPGATILVKENNQGTSTDFNGKFQLNLIKGEYTIK
VSFIGYKTITKEISLVKNDEIEIVLLPNSTVLEEVLVSAVRVKADAPVTHSNLSKKEIAK
RNLGQDIPVLLNYMPSVISSSDAGAGVGYTYIRVRGSDASRVNVTVNGIPYNDAESQGTF
WVNMGDFASSTQSLQLQRGVGTSTNGSGAFGASLNILTDAISEEAGGEISNSFGSYGTRK
HTVKFTTGKVNDHFEFAGRLSNIYSDGYVDRAFADLKSYFLQGSYSDENTLIKALAFGGS
EKTYQAWYGLEADQLEENRRQNPYTYDNETDNYWQDHYQLHWNEKLNDNWSTNIGLNYTS
GKGYFEQFKGESAVSKYNNIVSPTTVTWDEKPATDVIVRRWLDNHFYVFNGNTTYKKEQL
EIVSGFSYSNYKGDHFGEVIWAKEFAPTANIRDQYYFSDASKKDFSVFSKATFNISDEFK
AFVDLQGRFVNYKTDGLTSDRNTLNVEEKFNFFNPKIGLTHTINKNNSLYISYAKANKEP
NRNDYKNGEDVKYESLNDYELGWRLKNNTIQLNTNLYYMSYNNQLIQTGGLNDVGDYLRE
NVKDSYRLGLEIDANVKVSGQFSINQNLTLSSNKINNFMLDRDGTITNIGTTNIAFSPDV
IASNALVYYPTENFQVSLLSKFVGEQYLSNTDTEASKLDSYFTSDLNFVYEIKTSSIFKS
ITFTGVVNNIFNKEYEDRGYTYLDYWSGPTSFEVQGYFPQATRNFLVGVTMKF
>FCMOIPGL_02970 RNA polymerase sigma factor SigA
MRQLKIVKQVTNRDAKSLEKYFQEISKIGLITADEEVELALKIKKGDDKALDKLVKANLR
FVVSVAKQYQGQGLKLSDLINEGNLGLVKAAKRFDETRGFKFISYAVWWIRQSIMQALAE
QSRIVRLPLNKIGSINKIKKIYARLEQNEQRMPTNKEIAKQLDMTETEVAQSLKNSGRHL
SMDAPFKEGEESNLYNVLQSDESPRPDKNLMQQSLSIEIDRALETLSNKEAKVIKMFYGI
NLPSASSLAEIGEVIDLSRERVRQVKQKAIKTLQSKSRAHLLKSYLG
>FCMOIPGL_02971 hypothetical protein
MKLIFLTTLLVIFGINTNAQNSNLKGITVHANKILYIENDEPKSRDTDQVFAVSFSDKIF
THLIFSDGSINNSQVYQIENDKTLINDGNTIYKFEALSGISGNKYFYEIKIDSDGSLLAL
KITQPDNIDFSIYKGYSTDLKTFKQ
>FCMOIPGL_02972 hypothetical protein
MTTDIQIENLKCGGCAATIKKGLLSLENIEDITVDVEKSIVSVTSNKDVLESVKEKLSKL
GYPEVGDKNTVLHKAKSFVSCAVGRMDS
>FCMOIPGL_02973 Thiosulfate sulfurtransferase GlpE
MKNVFCLLLMSFFFINCNSQDEIKSISTSELKVLLDKGEIQLLDVRTPQEIKQGFIETAK
FANFFDTDFNTKATSKLDKNKPVYLYCRSGNRSDKSAKRLQKEGYEVYNILGGYNKWKQE
N
>FCMOIPGL_02974 Beta-lactamase hydrolase-like protein
MIIEQIYTGCLAQGAYYIESKGEVAIIDPLREVQDYIDSAAKNNAKIKYIFETHFHADFV
SGHVTLAEKTGAKIVYGPTAKTNFDAIIAKDNQVFKVGDISITVLHTPGHTMESSCYLLK
DEKGKDYALFSGDTLFLGDVGRPDLAQKGDITEKDLAGFLFDSLRNKVMTLADDVMVYPA
HGAGSACGKNLSKETVGTIGNQKETNYALRADMTKEEFIKEVTDGLLPPPAYFPLNVKLN
KEGYQDIDEVIENSVKPFSVEAFEIHANETDALILDVRHQSEFIKGFIPNSIFIGLGGTF
APWVGALIKDIRQPILLVTPEGEEEGTIIRLSRVGFDNVLGYLEGSFDSWQKAGKEIDTI
TSITADTLAKKMDENPLIFDVRKPGEYASEHIKIAENTPLDFLNNYISEFPKKGNFYVHC
AGGYRSVIAASILKARGFHNVIDVDGGYDAIKNTTIERTAAVCPSTLK
>FCMOIPGL_02975 putative sulfate transporter
MNIKKIIPILDWLPNYNRSLFKGDLVAGLTVGIILIPQGIAYALIAGLPPIYGLYCALVP
QVMYAIFGSSRQVAIGPVAMDSLIVATGVSTLALAGSESYISIAILLALMVGAIQFLLGV
FSLGFIVNFLSKPVITGFTSAVALIIGFNQFRNLLGADFIQSDQIQYILEDVWLKIATFN
KHTTIIGIISVAIILIFRKINKKLPNALIVVVLGIIIMKYFGKSFNDVSIVKDIPSGLPG
FGIPEFDLDQIKELLPIAFTLVMVGYLETISIGKSLEAKQDEYRIRANQELIALGLSNMV
GSFFKAYPVASSFSRSAINQESGAKTGMAALISVIMVVITLLFLTPLFYHLPKTVLAAII
IVAVFGLINFKEAAFLWRANNLDFWLMLSTFLATLLLGIEYGIMVGVGLSLIVLIYRTSR
PYVTELGKVPGSNFYRNKNRFEEVIIDDDILIFRFDAQIFYANSNYFRDNLDKMAAKKGK
ALKLIVIDAESINRVDSTGVEMLKERIKFYQKKGIMFYFAGVKGPVRDDLFRSGVLQIIG
INHFFMRANEAVKFYKTGDRQHQEKYAKYIHQAYK
>FCMOIPGL_02976 Holliday junction ATP-dependent DNA helicase RuvB
MNENLNPDNSNLSNEDLDVEKKLRPLTFDDFTGQDQALDNLKIFVEAANQRGEALDHTLF
HGPPGLGKTTLAHILANELQVGIKVTSGPVLDKPGDLAGLLTNLDERDVLFIDEIHRLSP
IVEEYLYSAMEDYKIDIMIESGPNARTVQINLEPFTLIGATTRSGLLTAPMRARFGISSR
LQYYSTELLTTIIQRSSHILGVPISMEAAIEIAGRSRGTPRIANALLRRVRDFAQIKGDG
TITIQIAKYALKALNVDAHGLDEMDNKILETIIDKFKGGPVGLSTIATAVSENTETIEEV
YEPFLIQQGFIMRTPRGREVTDLAYKHLGRVKGRNQGELF
>FCMOIPGL_02977 Alternative cytochrome c oxidase subunit 1
MSEHHHKETFVTKYIFSQDHKMISKQFLVTGMFMGIIGVFMSMLFRLQIAWPEKSFSIIE
AFLGPHQTDGVMNPDIYLAIVTIHGTIMVFFVLTAGLSGTFSNLLIPLQIGARDMASGFL
NMVSYWLFFLSSIIMVISLFVEAGPASAGWTVYPPLSALPQAIPGSGTGMTLWLVSMAIF
IASSLIGSLNYIVTVFNLRTKGMKMTRLPLTIWAFFITAIIGVVSFPVLLSAALLLVFDR
SFGTSFYLSDIFISGEVLHYQGGSPVLYEHLFWFLGHPEVYIVLLPALGITSEIISTNSR
KPIFGYRAMVMSIMAIAFLSTIVWGHHMFVSGMNPFLGSVFTFTTLLIAIPSAVKAFNYI
TTLWKGNLQLNPAMLFSIGLVSTFVTGGLTGLVLGDSALDIAIHDTYFVVAHFHLVMGVS
AIFGMFAGVYHWFPKMYGRMMNKTMGYWHFWLSIICAYGVFWPMHFIGLAGLPRRYYSNT
AFPLFDDLADINKVITIFALVGGLAQIIFIANFFISIYRGQKATQNPWNSNTLEWTTPVE
HVHGNWPGKLPEVHRWAYDYSKRVDANDDDSDYLHGQDFVLQTTPLLDGEEPS
>FCMOIPGL_02978 Alternative cytochrome c oxidase subunit 2
MLALFYIFIGVAIGVSLWQITRIMNFRSVLATDEDNTRQGRNALLFLVFFYAIMIYCLIF
MNVIMLPESASIEGEHDDNLFNITFWLIGIVQFAMQFLIFYFTFKYKGSKDRKAKFYADS
HQLELIWTVTPAIVLVVLIGYGLWQWNNIMDLSDAEDPVVIEVYSQQFRWDARYAGEDNA
LGLGNVNYIKGLNTMGVDMSDKNSLDDKQVTELYLPKGRKVHFKFRSQDVLHSAYMPHFR
AQMNCVPGMVTQFGFTPKFTTEEMRQQSEVVEKTANINKIRKAKGEDPYEFDYLLLCNKI
CGASHYSMQMKITVVEQDEYDKWIAEQPTLATVIQ
>FCMOIPGL_02979 hypothetical protein
MYQFSGKLKTFSIALIIIGALGIGLSFMNVPSSLDEAKEIIANQASHDGGYATSHEEVKK
DIHQMDVKEEAFSHSDEAHHEVTKENHEVADTHGDNHDDAHAEHVYHQLKNKPWSALYVS
LFFFLGITLLVLAFYASQRVAQSAWSVVLFRVMEAITANLVPTSIVMLGVIIAAVLHINH
MFPWMAEGVFDPTSPNYDAIIDGKSWWMNLPGWAIRSVLYLAIWNTYRWFIRKNSIKEDT
ANDGYKTFKLNYNVSVGFIFLFMISESMMSWDWIMGLDPHWFSTLFGWYVLASLLVSALT
VIAFVTIYLRSKGALPAVNDSHIHDLAKFMFGFSVFWTYLWFAQFMLIWYADIPEETTYF
ALRFNEYKLPFLAMLGMNFVFPILLLLNSDFKSIPWFVVIGGVVILAGHYVDVFVMIMPA
TVGAQWSFGIPEFSALLFFLGVFIYTVFSAFAKANPIPKGNPFLEESKHFHYYNIEHRGE
GSADHH
>FCMOIPGL_02980 hypothetical protein
MKKLKLIIALVTLTSIVSCNDKRTPQVQYMPDMYVSVPYDPNGVDGIKGEPVNLEPVAGT
IPRGGHPAYDIPNTNEGYEKAKNELRNPYEASEENLENGKAMYTIYCISCHGSKGDGNGY
LSQADKFAGIPNYKDRDINAGSIYHVIMHGKNLMGSHASQLTYKERWQIVHYVEKLRTDL
IQ
>FCMOIPGL_02981 hypothetical protein
MESSKVIHAFYNDDEVVLDAVKTVKADGHHIEEVFCPFPVHGLDKAMGLAPTRLAITAFF
YGITGLSFAIWMTNYMMIQDWPQDIGGKPSFSWFDNMPAFVPIMFELTVFFAAHLMVITF
YMRSRIWPFKEAENPDPRTTDDHFLMEIPVHNNVDELKALLSKTGAVEINVVDKH
>FCMOIPGL_02982 hypothetical protein
MSHYEAPIREPLVLGDKSYHDITEDIAKPIEGIANKNWYIAFYISLAAMLWGFGCIFYTV
GTGIGVWGLSKNIGWAWDITNFVWWVGIGHAGTLISAVLLLFRQKWRMAINRSAEAMTIF
AVFQAGLFPIIHMGRPWNGYWVLPMPNQFGSLWVNFNSPLLWDVFAISTYLSVSLVFWWT
GLLPDFAMIRDRAVKPFQKKIYALLSFGWSGRAKDWQRFEEVSLVLAGLATPLVLSVHTI
VSMDFATSINPGWHSTIFPPYFVAGAIFSGFAMVQTLLGIMRKVTNLEDYITRMHVEYMN
IVIILTGGIVAVAYATEFFIAWYTGSPYENYTYLSVGAATGPYAWAFWSLIIFNIITPQL
LWFKKIRRSFIWTFIISIAINIGMWFERFDIIAIVLSKGHLPSTWWRFEPTFVDVGIFVG
TIGFFFVLFLLYARTFPVIAQAEVKTILKSSGEFYKKRSEQGIPTKPVINVAKVAGISDK
SEKE
>FCMOIPGL_02983 Menaquinone reductase, iron-sulfur cluster-binding subunit
MASNKKYWKSVEELKGSSIVETLSKNEFVEEIPSDEFLGDKETLESSSTSRRDFLKYVGF
TTAAASLAACEGPVRKSIPFVVKPNDVTPGIADWYATSMADGYDFANVLVKTREGRPIQI
MPNKDANGTTSARVQAAVLSLYDEKLRLKEPTKGGEVISWADADREILAKLNAFKEANKS
VVLLTGTMASPSTSKIVDEFNVAYPNVKHVVYDAVSESGAADAMLSMYGKRVLPNYHLDK
AKTIVSFGADFLGDFHGGFEKQFIAGRKPETGHMSYHVQIESNMSLTGANSDKRIVVKPS
DQVFALLNLYKAITGDTISSKTTAIDDTVKKLASELKKAGSKGVVLTGLNDENAQLIAFA
INKAIGSEIFDAVNTLNIRQGNDTEVAQLVSDMKAGKIAGLISYNVDPIYSLSNSSDFSQ
GLKKLELSVALSIENNETVNASNYALPTPHFLESWGDTQFNSVTYGLVQPTIQPLFNTRQ
IQDTLLSWSGNTTKYYDYLKAFATANVLNGSSWNTALHNGFYNIETLEDIQSLESTVVIS
DVASQLSNSAKKATGFELNLYTKTGLGDGKQANNPWLQEFPDPITRASWDNYLMMSIADA
RELGFSNPVKDNGAIDGDYAKVSVNGVEVVVPVMVQPGQAKGSVGLALGYGRTFGLKEEM
QVGVNGYPLYTKGNNIQYGVKIDKVSGTHQFACTQVQKTIAGRHDILKVASLKEYNTVAP
KDHHHGWNKPSMVSYDHQEVEANTIDLWDEHNREVGHHFNLSIDLTSCTGCGACVVACHA
ENNVPVVGKNEVRVGRDMHWLRIDRYYSSEVETREEAKELGLSRGEMYEALETEAENPEV
TFQPMMCQHCNHAPCETVCPVAATSHGRQGQNQMAYNRCVGTRYCANNCPYRVRRFNWFN
YADNNEFDFNMNNEYGKMVLNPDVVVRSRGVMEKCSMCIQMTQATILKAKKEGRAVDTDE
FETACSSACTTGAMVFGDLNNKKDNVAALAIDKRAYNVLDYLQTKPNVIYQVKVKNTNEA
>FCMOIPGL_02984 Menaquinone reductase, multiheme cytochrome c subunit
MKSVALHNKLTGVLFKGFAVILFFAFSLSSYSQDVDEARQKEGRSLFKSLCASCHKLDKK
LVGPALAGVEERRENVWLKAWIKNNAELRASGDRDANSIFEEYKGSPMTAFPQLGDQQID
DILYYTTVGDPKPTVVAGEEGVVRNSADAPGWLIYILAAAIIVAFLIIAGLLKTISELKG
APKTKGAVASLKDVWIGYKQNTFLVVLTVIFFMLMGAYVFFGTLFKVGVDEGYSPLQPIA
FSHKIHAGDNKIDCQYCHTSAKHSKTSGIPSVNVCMNCHKNISEVAEDTKVEWDGVTYGK
PELDKEIAKIYEAVGWDNDILEYTGNTKPVKWVRIHNLPDFVYYNHSQHVTVAGLECQKC
HGPVEEMDEMRQFSPLTMGWCIDCHKETKVDLKGNDYYEKIHEELAKKYNVDQVTIAQLG
GKECGKCHY
>FCMOIPGL_02985 hypothetical protein
MKNKLYLGTFILLLLASSNSISAQNTTNSSNQIKNLIAKKRAFNSKFGFGFRVQIFYGNE
TEARSLQNKFKLNFPDVYTKLDYDQPYWKVQVGNYKTRLEADKAMVGFSEKFSGLIVIPL
GK
>FCMOIPGL_02986 Translation initiation factor IF-2
MSEGKTMRLNKVLRELNISLDRAVEYLAKKGHEIDSRPTTKISSDVYRVLQDGFEKDANK
KAASKEVGEEKRKEKEAIRLEIEAKLEKKRAEETKKEEILIKAKAEKLEFKTVGKIDINN
LGKKSVDATEEVAETPKVQEPEKVQEVEVVKKSEIVEEAKEVKEEPKKVVVEPKLEEVVA
EKQTVKKTVSEIEKEASKVDAKNESKKDSSKKEEKPEEVTAENAEAIKTQYKKLDGPNFT
GKKIDLKQFERPKKKKPEVKKDTNADAKKKRKRINKPTTGGNANTRTGGAKRGTSGNTRG
GVGRPGFRGKANQRTPIKKEEPTEADIQKQVRETLEKLQGKSSRGKGAKYRRNKREAHRE
HTEAELEAQALGNKVLKVTEFVTVSEVATMMDVPVTQIISSCMMLGMMVTMNQRLDAETL
VIVAEEFNHKVEFVGAEVEESIEEVEDKPEDLITRAPIITVMGHVDHGKTSLLDYIRKAN
VIEGESGGITQHIGAYSVNVGDQKIAFLDTPGHEAFTAMRARGAQVTDLVIIVAAADDDI
MPQTKEAISHAQAAGVPIIFAINKIDKPNANPDNVKTQLSSMNLLIEEWGGSIQSQDISA
KTGEGIDGLLEKVLLEAEILELKANPNKNAIGTVVEAQLDKGRGYVTTILVQAGTLNIGD
YLLAGKHSGKVKAMFDDKGNKMKKAGPSTPVSILGLDGAPQAGDKFNVFDDEREAKQIAS
KRSQLQREQSVRTQKTLTLAEIGRRIALGDFKELNIILKGDVDGSVEALTDSFQKLSTEE
IQVNILHKGVGAITESDVLLATASDAIIVGFNVRPQGNARMIADREEVDIRTYSIIYDAI
NDLKDAMEGMLSPEMKEEVSGNVEIREVYKISKVGNIAGCMVMSGKIFRDSNIRIIRDGI
VVHDGILSSLKRFKDDVKEVAKGYDCGLQVKNYNDIVEGDIIEAYKEIAVKKKLK
>FCMOIPGL_02987 Transcription termination/antitermination protein NusA
MENIALIDSFSEFKDNKSIDRVTLMSILEEVFRAALKRKFGSDDNFDIIINPDKGDLEIW
RNRIVVADGFSEDDNEEIELAEARLIEPDFEIGEDVSEEVKLIDLGRRAILALRQNLISK
IYEHDSTNIFKHFKDLEGELYSAEVHHIRHNAIILLDDDGNEIVLPKSEQIRSDFFRKGD
SVRGVIKAVELRGNKPAIILSRTSPSFLNKLFEQEIPEVFDGLITVEGVARIPGEKAKVA
VDSYDDRIDPVGACVGVKGSRIHGIVRELGNENIDVINYTKNEQLYISRALSPAKVTSME
IEMYDEVRNGKKGRVKVLLKPEEVSKAIGRGGVNIRLASELTGYEIDVQREGLEEEDVEL
TEFMDEIEDWVITEFKKIGLDTARSVLEASVAELVKRTDLEEETILDVQRILKEEFE
>FCMOIPGL_02988 Ribosome maturation factor RimP
MKGTKKSPLFIFYVKVYMDQKQIKDLVDEALALNESLYLVDLIISTNNKIQIIIDGDNGV
PLSECIRISKSVDSNLDREVEDFSLEVSTPDIAHPLKLNRQYIKNINRILKVKTAEEEIE
GTLLEADDDKIVLAWKAREPKLVGKGKVTVQKTATLEYKDIKEARVKILF
>FCMOIPGL_02989 Stress response protein NhaX
MKTILVPIDFSKSSEYAAKMAAKIALKMDATVYLIHLIELPKGVIDMGFASRFSIPESML
YLRKVREKVLEFKENFFNKDIQVEYFIKLNNPFEGIIKYADKIDADLIVMGTKGHSNFKE
IRIGSNTEKVVRTSTTPVIVVKKDSKKFKLKNLVFASSFKNEDKKEVFRKFLYFANIFNS
KIHLLKVNTASNFESTHDAKEKITEFIKEYQLPKYSINIYNDVSIEKGILNFSRDVNADL
ISLSTHGRSGLSHLINASVTRKLSNKALKPILTIRV
>FCMOIPGL_02990 tRNA pseudouridine synthase B
MTEEDFKNGQVLLIDKPLKWTSFQVVNKLRWEIKQRFKIKNIKVGHAGTLDPLATGLLII
CTGKQTKKIGTYQGQIKEYTGTITLGATTPSYDLETEINETFSIDHISEELLKETTKQFI
GEIQQKPPIFSAIKKDGKRLYELARKGETTEIKSRTVTISEFEITNINLPEVDFKVVCSK
GTYIRSLAFDFGNVLNSGAHLSALRRTKIGNFSVDKSLSVDGFIDTLKLDAI
>FCMOIPGL_02991 Undecaprenyl-diphosphatase
MDLLEAIILGVIQGLTEFLPVSSSGHLELAKAILGDTSVPEESLTFTVVLHFATALSTLV
IFRKEVAEIFKGLFQFKWNDELKFSLKIIISMIPAVVVGLLFEEELESFFGGKILLVGIM
LLVTAGLLLLADKAKSTNKEVSFSNSVLIGVSQAIAMLPGISRSGATISTSVLLGIDRTR
AARFSFLMVVPLIFGKIGKDLLGGDISFESSEIIPISVGFIAAFVSGLVACKWMIALVKK
SKLSYFSIYCAVVGVIAIGYSLLS
>FCMOIPGL_02992 hypothetical protein
MEKENIQEKEFLFGKKNYTIMLIGIVFIVLGFVFMAGGGSDNPEVFNEEIYNWQRIRLAP
TLVIIGLAIEFYAIFAEKK
>FCMOIPGL_02993 Cell division protein FtsX
MSSKFDSYQKRRLQSSYISVVISIALVLFMVGVLGLILLKSTKVANHVKEKVAITLFIKD
KVTQKQIKTFRESLLEEEFTKKAVYTSKEQAAKKYSKEIGEDFLQFLGENPLKNGIDIYL
KADFVTPEKMQELETRFQKNAFVADVSYDKPLINLLTKNIKRVSFWLLVFSGFFALVSMI
LINSSIRLSIYSKRFNIKTMQMVGATKSFIRKPFIWRSIKLGFFGAFLALTGLAFVIYYV
DKYIPSLALLEDYLTLGYLVGGVFLSAFIITWISTFFATQRFLNLQTDELHY
>FCMOIPGL_02994 hypothetical protein
MKRNQTIIMLFAISMSMFFTACVEDNNFKVPENLGVEENLSLNALLDSIQNNQVELKSIK
DLKSLYNSGNDPLKIVSDIVIKGYVVSSDAKGNYFREFYMQDAPENPSAGIKIAINLTNS
YNKFSFGREVYIRLKNLYLGETNSGDGVISIGGKVNLTDIREVESITQNQIENHLFRSIT
TETIVPKIVTLGGLDDISNIGTFVAIENAFFSSDLKGKTFVNPVEDFDTKRKIETCQGPG
FVSSFVETSSFASFANNALPEGGGTIKAVVSRDFGGDFTVLVLNTADDVFMADSRCTPSE
LTDFSTILLQQDFEATSGEIDIPNWTNFIEVGSKKWRSYTDVNSLSIAANIGSYRSGDES
TISWLITEDVNLDATLEEYLSFETSTSFADGSTLEVLISDNWNGNEATITTANWMALPAK
IAANNDDYNSFINSTFIDLSNYSGTIYIAFKYTGNGNDIFDGTYELDNINIIAK
>FCMOIPGL_02995 hypothetical protein
MKRIISSICMLLFLILGVNAQNIVRGIIIDNDSKKPLKDVYILLKKTSKKVVTKEDGSFV
LRNLKNGNFILEIKQLGYETQNFPLDLNGKPIDLGTIYLYKDFTEELDASIITITDDELS
DDTSSADNISGLLQASKDIFLRTAAFEFSSSFFKIKGLDSGNGKVLINGIEMNKIYDGRA
QWSNWGGLNDVLRNQEFSNGLSPSDFTFGGVLGSTNMNTRASLQRQGTRISYSSSNRSYE
HRVMATHATGVSKSGWSMTFSGSRRAGNEGFNDGTSYNAYSVFTSVEKKINEKHSVNFTG
IFTPNRRGKSSPNTQEVFDLKGIEYNEYWGYLNGKKLNSRIKEVVEPILMLSHYFDVSEN
TTVQTNVSYQFGKIGNSRLDFNGGSNPSPTYYQTLPSYFLRYNDLSDAYTAQENFVNSGQ
LDWNRIYDANVTNANNGQNNAYVLYEDRNDDKQITINTIFDSYLNNNISINGKLEYKRLR
SQNFAEVIDLLGGNGYLDINNFADSEAQMQNDVLNPNRVVGVGDKFRYNFNLSSDFMNAF
LQGQFTYNKVDFYAAVNVSQISNQREGLYKNGRFENSSLGTSDKLSFTNYGVKTGVTYKV
NGRNLIDVNVAYLTQAPTIRNSFSNSRENNNIVDNLQSEKVFSADVSYIRRRPIITSRLT
GYYTSIKDATEISFYFADGVGGDNTAFVQEILSGIEKQHLGLEFGLEAQVTSTIKLKSAA
SVGSFIYANNPDLYLTSDVTNEGIFDENGRSGNYISNLKNYKISAGPHNAYSIGFEYRDP
DYWWFGATANFFSNTYVDIAPLTRSSNFYTDADGLTFPNYNINVARELLQQEKFNNYKVI
NIVGGKSWKISRYYVSFFATVNNLLNAEYKSGGFEQGRNANYNELKIDKSIEKPVFGNKY
WYGRGTTYFVNVNISF
>FCMOIPGL_02996 hypothetical protein
MKQKTYLLFILLFSITVAIAQNKEKKYAIRTIAFYNLENLFDTINDVTKNDEASPMMELK
ANRSAVYWDKIDKLSSTIAQIGLDEAKTSPAIIGVSEVENINVLEDLVKSKHLIKKDYGI
IHYDSPDKRGIDVALLYQKKYFKPIFHEVYNPNIFKDNFKVYTRDQLLVSGYLDDELINV
IVNHWPSRRGGEAKSRPLREKAAYQNTKIIAQIREKDPKAKIFIMGDFNDDPINTSFKEV
LKTKSKKSEVGETDIYNPYEDMFRRGFGTLTYRDNINLFDQILISDPLLDKGKKDFSNYK
MFKAMIFNKRFLTIKKGKYKGYPFRSFANGSYTSGYSDHYPVYMYLIKEKK
>FCMOIPGL_02997 Ribonuclease G
MKTELIIRSNSSDIDFALLRDGKLIELNNETTGNKFSVGDIFLAKIGKVLTGLNAAFVNV
GYPKDGFLHYHDLGAQVNSLNSFIKKVGTGKYKEFTLKNFQKEVDINKDGSINNVLKTGQ
NLLVQIVKEPISTKGPRLSSELSIAGRFLVLVPFSNRVSVSQKIEDPAEKERLKRLAKSI
KPKGFGVILRTVAEGKKVAELDKDLQNSLDRWKTMCKRIPNTNTPTKILSELNRASSILR
DVMNETFTNIVTNDETLKVEIKEYLQEIYPEKEKIVKLHRSETPIFEKYGIERQIKTSFG
KTVSMSKGAYLVIEHTEALHVIDVNSGNRSNKAGSQEETALEVNLIAAAEIARQLQLRDM
GGIIVVDFIDMHKVENRNKLFQYLKEQMSFDRTKHKILPPSKFGLVQITRQRVRPELSIK
TTEADPNINGQVEAPIVLLDKIESDLEKFILNSKSNNKKIQLHIHPFIASYLTKGVNSIR
FKWYLKHKKWITIIPRDAYTYLYYKFQASK
>FCMOIPGL_02998 DNA-binding protein HU
MTKADIVSKISDKSGIEKTDVLATVEAFMAEVKGALENGDNVYLRGFGSFIIKTRAEKTG
RNISKNTTIKIPAHNIPAFKPAKTFTEGVKNKVAVK
>FCMOIPGL_02999 Adenine DNA glycosylase
MKFSNTLIYWQLQNNRELPWRKTKNPYFIWLSEIMLQQTRVAQGMAYYLKFTAHFPSVFD
LAKADESTVLKMWQGLGYYSRARNLHFTAKQIANEFNGKFPSTYKEIIKLKGIGDYTASA
IASICFNEPTAVVDGNVYRVLSRYFGIKTPINSSAGIKEFKALAQTLLDTTQPGTHNQAL
MDFGALHCKPQNPLCETCPFSNSCVALKQKLTKELPIKEKKIKVKNRYFNFLVIITDDNK
TILSERKGKGIWQGLYQFPLIESDYNINKDELVSSENFINLFPDETTISLFNKKEIVHKL
SHQHLYTQFWIIETATSSKAKINWKDIKEHPVPVLIANFIEEFLSKSN
>FCMOIPGL_03000 Single-stranded DNA-binding protein
MASTVNKVILIGNLGDDVKMHYFDGGNSIGRFPIATSENYTNKQTGEKITTTDWHNIVVR
NKLAEICEKYLSKGDKVYVEGKLKNRQWEQDGVKRYSTEVHVHEMTFLTTKKSLDSANNS
KQNQQSAAKPTSVASEKNDDLPF
>FCMOIPGL_03001 Magnesium and cobalt efflux protein CorC
MDPDPELFFIFFTSINFLTGINLIAFIALLISSALISGTEVAFFSLSQTDLNVLSNDGKE
DNIIVKLLERPRKLLATILITNNFINILIVLLFASLAENLFGDFDYQLNLHFISVPIRFL
IEVILVTFLILLFGEVLPKVYASRNALPFSKKMSKFIHVINILLTPFSTPLISLTKFVEK
KLGSRNTNFSVETLSQALELTSDGATTKDEQKILEGIVNFGNTETVQIMKPRIDLFALSD
TETYENVLTKILENGYSRNPVYKENIDNIVGVLYAKDLLAHLNKKDFKWQNLVREAFFVP
ENKKLDDLLDNFRARKNHLAIVVDEYGGTSGIVTLEDVIEEIVGDINDEFDDDDLAYSKI
DENNYIFEGKTSIKDFCRVLDDEDEEIFEEEKGESETIAGFILEISGKFPKKGEKINFKN
YTFTIEALDKKRIKQIKATRNA
>FCMOIPGL_03002 hypothetical protein
MRNIFILLFLLIFISCNSDILPKPKAYLSLEYPKKEYSYLTLERPYSFEVLKSTKIIDDE
NNWLKIEYPNLKASIDITYRPVKNNLKELLTESEKLVFKHAVKAEQIIPKDFVNPKKRVF
GSLYEITGNAASQIQFHVTDSTNNFIKGSLYFYVKPNYDSILPAVAYVKEDILHLIETLE
WK
>FCMOIPGL_03003 Endonuclease MutS2
MKKPLDFYVQQKAELESKAAALKKKLINLGIFRFAVFLGVAFLIYLTLGKYPDVFIVAFL
GISLFTFLVLQFIKLKRKKEILDAKIKINKIEIKVLSRDFHHLETGKEFINPLHYYSNDI
DLFGTGSFFQYLNRTATNDGKNLLANTFTENKTIAILEKQNVLKELSKKVIWRQHFSALA
SLVSVKNTSKSIVSWISNYTSVFSKHLSKIQIVFSLISVVLIGLISFGIIPFTIIIIWFF
IGLSVTGSFIKKTSHLYSETDKVRETFKQYHQLLDEIENEEFTSKILKEKQEIIKSEEKK
ASTIFKEFSKTLDGFDQRNNIVISVLGNGLFLSEIFNACKVEKWILKYKHTVQKWFEVVA
FFDAQNSLANFKFNHPKFVFPEILSEKEIIKATNLGHPLLKVDKRIDNDFTIDDEQFFII
TGANMAGKSTFLRTVSLSIVMANCGLPVCAERFKYQPIKLITSMRTTDSLTEDESYFYSE
LKRLKFIVDEIKSEKYFIILDEILKGTNSKDKAIGSKKFVEKLSKSKSTGIIATHDVSLC
ELENEFSGIKNYYFDAEIINNELHFDYTLKNGICKNMNASFLLHKMEIV
>FCMOIPGL_03004 putative adenylyltransferase/sulfurtransferase MoeZ
MKPTKNQLFKRQITLSEIGEVGQQKLQNASVLVVGCGGLGSPVAVYLASSGVGKIHLVDF
DTVDITNLHRQVFYSLEDVNQPKAKVLSEFIKKRAPFTEVSFTNNPITKENVFELIENID
IVVDGTDSLPTKYLLNDACVIKNKPLVYGSLYKFDGYVATFNVLQKDGNYSANLRDAFPE
MATDIPNCEEAGTLNAVVGMIATQQVNEVLKLITGIGKPLINELLIYNSLQNTQLKMKLK
PRFLKDKIAKIFKVQTYFDIVCATQNPDWQISAKELKQILSHRVQSRNIEIIAVLNDLKL
PFDVNKTIHINKFDADKIEVDYDKTYIMVCQRGLNSYKATEKMKKKYPGLKVLNLTGGIS
NYK
>FCMOIPGL_03005 Molybdenum cofactor guanylyltransferase
MAKHKKHTNLEKRNNDNFAPNEIAILGANCGVISDLVHKVSKKFSNYKLAYFDASHAKDV
EQISLSEYFFHHEGNLQITTSENVNKFQQRLDFAKFDFVFINGNHYQGTKQILILDEAKE
ASVLKRLDQLDNIQFVVKLKSETEYFDFLEEKYPQIKNLNCYTIDAVDAISNHINSLIQE
KIASVKGLVLIGGKSTRMGTDKSELNYFGKSQKKYVKILLENQNLETFYSVKNQSDKSFE
IADEFYNLGPFGGICSAFQKDPNSAWFVLATDVPFVNEEVIQLLLKHRNPSKVATAIKGK
NKDFPEPLITIYEPKAYAILLQYLAQGYSCPRKMLINSDVEIVEIDDSFIRNINTPEEFE
VAKSEISSTSLRGRMTK
>FCMOIPGL_03006 Cyclic pyranopterin monophosphate synthase
MNDFSHINKKNNPKMVNVSDKKITKRTAIAKATMFLGKEVIAHFTNDELITKKGPVFQTA
IIAGIQGVKKTSDLIPMCHPLLINGVDIDINIIDSENVEVLCEVTITGKTGVEMEALTGA
NITCLTIYDMCKSISQKMVIKEVKLLEKTGGKSDIKNG
>FCMOIPGL_03007 hypothetical protein
MKTYYVYILKCSDNTYYTGITSNLEKRFFEHQQGKHQESYTYKRRPLELVFYAEFSEVGF
AIDTEKRIKKWSKAKKEALINDEYEKLPNLAKKKFKK
>FCMOIPGL_03008 Molybdopterin molybdenumtransferase
MISVKEAKNIVLNSPQDFGVEEIPFIKSVGRILKEKIVADRDFPPFNRVSMDGIAIDFQS
FKNGQRSFKIEGIQAAGSEQITLNNSANCIEVMTGAVLPNKANTVIRYEDVSTENGIATI
NIETVCDRQNVHQKGKDGKIGDLLIEENTIISAAEIGVLATVGKSLVKVAKQPKVMIVST
GDELVGVDEIPLEHQIRRSNVFTLVSLLERLHISSETAHITDDKPILKSKIEAYLQEYDV
LLFSGAVSKGKYDFLPEVFDELGVEKLFHKVTQRPGKPFFYGKTSGCNIFGFPGNPISTF
VNCLAYFYPWYYKSVGVETKEETAILNADATFKPNLTYFLQVKLESKFGHLVAFPISGNG
SGDLASLVKTDAFIQLPNDKTEFKKGESFPIIRYR
>FCMOIPGL_03009 GTP 3',8-cyclase
MSKLIDNFGRQMEYVRLAVTDRCNLRCQYCMPAHGIDIVPRQELLTFKEMYRLIRVLTEL
GVNKVRLTGGEPFVRKDFVGFLEMLSYNDLLDAINITTNGALISHHISRIEQLEKVKNIN
LSIDSLDREKFAKITRRDVFPEVYKTFELLEKSSLNLKLNVVVQSGFNTDEIVDFVRLTK
DKNVSVRFIEEMPFNGKGQREMQENWTFNKILNEVKTEFDVAEVQSEKSSTSRNYKVDNH
LGTFGIIPAFTRTICNDCNRIRITSTGTFKNCLFDDGVFNLRDFIRKGASNDDLKELFLG
LVKQKPENGFIAEVNRKDGGASESMSTIGG
>FCMOIPGL_03010 hypothetical protein
MKNIKFLILGIFFAIVLSKTEAISWYRFYEMFKFQSFHMFGVIGSAVVISMLFMQLFKNG
KIKDINGNKIIPQPKEKGFIRTILGGTFFGLGWGISGACAAPIFVILGFKLIPALILLIG
ALLGAFIYGILSKKLPN
>FCMOIPGL_03011 hypothetical protein
MDFILQPWAWYVGGPLIAISLLLYFYFGRNFGASTNFDTLCSMAGAGKVSDYFKKDWKDR
DFALMFVVGLIIGGFISAKYLIPDQTIDLNPKTVHELTDLRFSNVGNQYFPDEIFGEDIS
TSLKGFLILLVSGVLVGFGTRYAGGCTSGHAITGLSNLELPSLLAVIGFFIGGVIATWFI
IPILF
>FCMOIPGL_03012 3-deoxy-D-manno-octulosonic acid transferase
MLLSILAFFSKKLKLFVDGRKETFSKISALKNEETIWIHAASLGEFEQARPIIEELKKDY
KQYKILVTFFSPSGYEIRKNYNLADVVCYMPLDSRTNARKFIETVNPKFAIFIKYEFWPN
FLNELKKKEIPTILVSGILRKNQIFFKFYGGFMRKSLQAFNHFFVQNQISKELLNSISFN
NVTIAGDTRFDRVSKILEQDNSLDFINQFKDHKYTVVAGSTWQEGEELLVNYINNNASED
EKFIIAPHNIKQEAILELQKSINKKTVLFSDKSDKNLSEYQVFIIDTIGILTKIYAAADI
AYVGGGLNTGLHNILEPATFGIPVIIGNKYDKFKEALDLVKIGGCISIKNQEEFTNNLIH
LKKDGNFRKLTGVINKRYIKDNLGATKLVMNYLKDKL
>FCMOIPGL_03013 putative transcriptional regulatory protein pdtaR
MDKVKILVVEDEMIIADNICDALEELGYQALEPAISYTEAIGRIEEEKPDIAILDIQLSG
KKTGIDIAKKIRESYHFPFIFLTSNADSLTLNQAKEVMPPAYLIKPFSKEELYTSIEIAL
SNYSIIHKNKEDEADDSHVIKDAFFIKNKGSFLKIYFDDILYLKSDHVYVELHLKNTQQF
LVRRSLNDILSSLDARFVRIQRSFVVNVKYISEVKTASVIINNSEIPIGKTYKEELIKFI
KLI
>FCMOIPGL_03014 putative sensor histidine kinase pdtaS
MRSTLFTLLFYFIFLLSFTAQENQISQKEFIKKVEGYILDKKLDSASIFLRQLENNDYTS
ILTRIKNREELSYSEYDRFLKSVSRRKPLNYFSIHSFINEFIKEPNNYKNINSDYVYIKW
SQISNLRDEVTLEAANVEQEKLEAYVNKFDDADDQVLALKTQITSHPIIMYNIKQDLKGK
ELCLKSIEAARKLKDIKLEIIFLYYLTDFLVQEDKLQEYIDVSEQSLELEKKLPEQTAFH
HAILEHLVDAYIYKGGNHLRIRDLLDEIYDNENSRANSYEFYVKFIAKLDENSTEKRAIL
NKFEVKNVFELTEKFTELGKDLNQHEFTKLIAASADALVAHGFYEESIRYKKHEIFLIKN
IYSKELSETLSNYKTEAAVKEKEVEIESEKERTKIFIVIAALIGVFLLISLFTIRKIRKQ
SKELSEKNKLINKSLKEKELLVKEVHHRVKNNFQIVSSLLELQSKGIEDEKALELANEGK
NRVKSMALIHQKLYQNESGLVDFDEYIQLLVKELSSLFKSDNKIDTSITSKDMSFDIDTA
IPLGLIINEIITNSYKYAFKQGKENTLSISINKEIDNNFKLIIEDNGPGLYSNFDVKKAK
SLGLRLVNRLVKQLHGTLSLTNEKGARFEIIFKDLHARQLVD
>FCMOIPGL_03015 50S ribosomal protein L27
MAHKKGVGSSKNGRESESKRLGVKIFGGQAAIAGNIIVRQRGTTHNPGENVYMGKDHTLH
AKVDGVVEFRKKKDNRSYVSITPFEV
>FCMOIPGL_03016 50S ribosomal protein L21
MYAIVEIAGQQFKVAKDQKVYVHRLQGEAGSKVTFDNVLLLDNAGNVTIGAPAIEGASVT
AQILSHLKGDKVIVFKKKRRKGFKKKNGHRQYLSEIQIESIAATGGAKATPKKETAKAAP
KKAAKADDLKKIEGAGPKAAEALVNAGLDTFAKVAKADPAKLSEILTEASSRLSHLVTTT
WPKQAGLAADGKWDELKELQDRLDGGIEK
>FCMOIPGL_03017 putative zinc protease
MKKSILSLASAMLFVFSANAQKVEFEEYNLDNGMHVILHKDTSAPVVVTSVMYHVGAKDE
QPGRTGMAHFFEHLLFEGTKNIKKGEWFKLVSSNGGRNNANTTDDRTYYYEIFPSNKLEL
GLWMESERLLHPIIGQDGVDTQNEVVKEEKRLRVDNQPYSHFLEYVKENIFKKHPYKGTT
IGKMEDLDAATLEEFLAFNKKFYVPNNATLVVAGDIDIASAKKMIQDYFGPIPKGAEITK
DFPMEDPITEAMYAKGYDPNIQIPAIMAAYRTPSMKTKDSRVLDMISSYLSTGRSSVLYK
KLVDEKKMALQAGAINASQEDYGTYILYGLPQGETKLEDIIKEIDEEIVKIQTELISERD
YQKLQNKFENDFVNSNSSVEGIANSLARYNVLYGDTNLINTEIDIYRSITRDDILAVAKK
YLNPNQRLILEYLPEKK
>FCMOIPGL_03018 putative zinc protease
MKTKILSLIAFLLVSVAVNAQIDRSTMPKPGPDPEIKLGTPKTFTLKNGLKVIMVENNKL
PRASASLTIDNKPYFEGEIAGVSSMMGSLLGRGTTNISKDEFNEKVDFLGANVSFFSSGA
YASSLKKYFPEILGLMADGVKNSQFTQEEFDKEVQITLDGLKSNEKNVTSAARRVENVLT
FGKNHPFGEFTSKESVSKITLDDVKNNYNTYYKPNNAYLVIEGDINTKEIEKLVKSLFSD
WEQGEIPAYTIPATESVATTEINFINMQNAVQSEIAVINNVDLTLGDKDYYAALMASNIL
GGGGTARLFMNLREDKGYTYGSYASLRQNRYAGSFRATASVRNMVTDSSVVEIQKEINKI
RYQKVTPEELENSKEEYIGGFVMDVQKPRTVANFALNIERYNLPKDFYANYIKNIKAVTL
DDVQNAAIKYFRGDKARIIITGKGIDVLKNLEKTDYVIKYFDKYGNPTEKPAMTLPIPEG
MTTANVIDKYITAIGGKDKVMAIKTTMMVANATIQGTPLVMTKKSSAPNKTSQEIAVMGN
VMQKSVFDGTTGYKEARGQRTNLEGDDLEKAKKDASIISDLNYTNGKLDRIEPIDGKNYF
VIIYNDVEAFYDMETGLKAQEIRTTKAPDGSEAKVPTTFSNYKEVKGVKFPFAIGIKSGP
MDLKFEVTDFKVNEGVTDADFK
>FCMOIPGL_03019 putative inner membrane transporter YedA
MYLNKYQTFVKNLIKLMNIQQKKWLYLGLLSLVWGSSFILMKKALIGLTPIQLGALRILI
AGLFLLMIGSKSLKEIKKKHYKYIVSTALLGTFFPVFLFAYAVSGIDSSITSILNSLTPF
NTFIVGALAFGFTFKKQQFIGIVIGLIGTILLILQGADLNPNQNYWFSILVVIASVGYAF
NVNIVKKHLSDISAISIVAGNFLLLVIPAFVVLVFTDFFSTFEYTETKMSALGYITILAV
LGTGIAKIFYNNLVHLASPIFASSVTYLIPIVAISWGILDGEKLDLIQFFAGVIILFGVY
LVNKKK
>FCMOIPGL_03020 hypothetical protein
MKVQKIIFSIAIACFILTGCKNEAPKEVKKENVSLAISGMTCEIGCAKTIQSKLSKKEGV
LDAKVVFTDSIANIEFDANKTSKEDLIAFVSGIAGGELYKASEASNKMNTSKKTHACSDA
CKESCDMKADKPACKEDCKMACCADNKA
>FCMOIPGL_03021 hypothetical protein
MYNRPPFFISILDSISIIEFDANKAFKEDLIAFVSGIAGGELYKASEASNKMNTSKKAHT
CSDARKESCDMKADKPACKEDCKMACCADNKA
>FCMOIPGL_03022 hypothetical protein
MKKSVFKILNIVAFSIATLSFTNCGSDEPGIIITEPESEVIQSLQSGVMSGNLEEDFTLS
SSTIYNLSSSFIVQSGVTLTIPAGTRIQAANGGTNVYIAVLKGGKIDIQGTSSNPVFMTS
ASGNPGDWGGLTICGDATTTAGVDAEAEVGGFIYGGTNDTDNSGSINYLIIKGTGAQINA
DSQYNGVSLYAVGSGTTISNVAVINGSDDGFEFFGGTVSASNLYLENNEDDSIDWTEGWS
GTVDNAYISHTVSGFSTVFEGDKQNNNPKFNNITAVSTVGGTALQFKLQSGGTITGLSLT
GYDVSIDMKDDGPLTNVLIDGVAANPLLSYTNAPSVTASDFTWVNSSVSIPTSILQGTVT
GTVTLDASVSYKLNSSYIVQDGGELVIPAGTKIEARNGGTGVYIAVLKGGKIDIQGTATN
PVVFSSAAGTAGDWGGLTICGDATTTAGEDAEAEVGGFIYGGTNNADSSGSIKYLVIKGT
GAQINADSQYNGISFYAVGSGTTIENISVINGADDGVEFFGGTVSASNIYLENNEDDSVD
WTEGWNGTLTNTYISHTVSGFSTAFEGDKDNLNPKFVNLTAISTVGGTGLQFKKNSGGTI
TNIWLEGYDLDIDMVDGGSLDNVIIDDVSASTTADYKTGTKVDVSTWSWKSAGL
>FCMOIPGL_03023 TonB-dependent receptor SusC
MKKILFITLLVLSQFMNAQDQGTLKGTLKDKEANNESLPFANVLIKGTTIGATTDFDGNY
SIKVPAGNHIVVFSFLGYKAIEKSFAIKVGETVVINEILSAEEGVALDDIIIKTSSNKES
VSALLLEQKKATVIKESIGAQTLSKVGVSDAANATTKISGVTKSESSGDIYIRGLGDRYL
STTMNGLPIPSDDVNNKNINLNLFSTNIIKNVGISKTYTTSSYADQGSGNVDVNSKEYSG
KEFTISLSGGANTNVLNLSDDFRTTIINNDVTLGFHKKQYALQDAITYQGWDTETISTPI
NFSGSFSAGRKFEIFGKDLSIFVAGSHSKSFEYREGVFNSYRLNVLNTSFPGVTRQVNID
RGISADETDVEQYISTTNTTGYINVGFKFNENNKLKYNTLFVNNGIDNLYEQGRKGYGYV
YDQDPQDDGAFVRDQNFKQTTLFINQLLGEHKWNENNTLNWAAGYNFVLAEEPNRIRNEV
NILNIDVSPTIQYAHVGDYQQRKSSQKIEDIEYNALVENKWALGLPDENDDKPFALNYGF
NYRHKERTFKSLFVGVKAKDFTAPSIDQLSTTFTSTGFNNGLTLTTQPTDRYEADLDIMA
GFVNFDFSLDKLSGNLGFRYEKDEIKVLWDVGNYVGRIGSLDKTYESFYPSVNLKFEVNE
NQYLRFASSITQTLPEFKELAPFEYVSPTGRVTKGNPDLEKSEIYNWDLKYEMFPNRGQL
FSATAFYKQINNPINLALTRGSSGYFFYANTGDKATVYGFELEAKTDLIKNSDDEGILNI
TGNITKMWLNQDLFENFQYKDATESSLQGASDFIVNSSLSFSNKKEKEFLATLTGNYSSD
KIFSLGGAEGYANRATEFNDQIIEKGFVTLDLVMSKELTKNLQIKLVGRNLMNPEIKQTQ
DIKDIITGVETNETVLSYKKGSQLTLGFKYDF
>FCMOIPGL_03024 hypothetical protein
MINSSMLQNVVTFACISVFLSINAQETNAPKFGKGLFNLIGEDSTWTMKVGLRFQTLAIS
SWDVENGLSNPSSSMLIRRSRLKFDGFAFSPKLKYKLELGLSNRDQSGASEYTSDAPRYI
MDAVLKWNFSRNFVLWFGQTKLPGNRERVISSGDLQMVDRSLLNSRFNIDRDTGVQLRHK
TKLSEKFLMKEIFSISQGEGRNVTTGNEGGHQFTGRIELLPFGDFESKGDYRGSDLKFEQ
NHKLSFAFGYNLNKNAVRTRGNQGAYMINNNGLYATDISNIFIDAMYKYKGFSFMAEYAN
RDAKDPLAKNSDDTLTGDEVQVGNGLNLQTGYLLSKTVEVSARYTNISLNKNITGEGAEN
QYTLGLSKYIAGHKLKVQTDVSYTDIGFSTNKLLYRLQVDIHF
>FCMOIPGL_03025 hypothetical protein
MGDPYILMLVALAILAIVDLVVGVSNDAVNFLNSAIGSKAIPVKKIMIIASLGVFFGAVT
SSGMMEVARKGIFNPNMFMFQDIMIIFMAVMITDILLLDIFNSLGMPTSTTVSIVFELLG
AAVCISLLKISANDAHSISDIWSYINHEKALDIINGILLSVVVAFSVGALVQFASRLIYS
FNFEKRATYVNALFGGFAITAITYFIIIKGLKGTPFYSDVKHLIEGNTLTIIAGSFIAWS
AISQILIQFLKVNVLKLIIGIGTFSLAMAFSGNDLVNFVGVPIAAWNSYEAWSVSGVAAD
SFSMGILAKKVPSNVWLLLLAGTIMVVTLWTSSKAQNVIKTGIDLSRQGDGHEKFQPNGV
SRIVVRAAMTLNTGISYIIPKSTLAFIDSKFQKPVVKLPKDKKYELPAFDLIRASVNLIV
AGILISIATSMKLPLSTTYVTFMVAMGTSLADRAWGRESAVYRVAGVLNVIGGWFLTAIV
AFFAAALVAYLISWDMVMIPVLLAVVAILMGRNTLLLRKETKEVKKQQYIEREELITING
VIEESADHISEVINRVNKLYTNVVDDLSSHDLNKLRKTDKHVEKLNNEIDNLKDGVFYFI
KSLDDTSVQASRFYIMVLGYLQDVAQSISYISRASFKHVNNNHKNLKKAQIKDLKEIDIE
LSDLLTKEASIFGNRNLDDLNNLLKEKNQLLKSVSVSIEKQVARIRTDETSPKNTTLYFS
ILLETKDLISALINLLQTYEEFYLSTKQMKK
>FCMOIPGL_03026 putative NTE family protein
MKNYTTIFFLLITAVFFSQQKQPKIGLVLSGGGAKGFAHVGVLKEIDKAGIKLDYIGGTS
MGAIIGGLYAAGYSADQIETIIIETDFFALVRDLLPRSSETFFEKEYGENTMITLPVKKG
VIGFPKAISKGQNVLNLLLELFDSLDGNQDFTKLSVPFYCIGTDVETGGEVLIEKGSLPL
ALRASGSFPTLLNPVVLDGKLLVDGGIANNFPVSVMKAKGIDIVIGSDVEGKLYKKDKLN
SAISILNQIMSYQMYSKTEKEKEKIDVYIHPDISKFGVVDFDKKDEILKIGIDEAIKYRK
VFKELAVKQKNKKKRAPLKLNNEKLTISSISIDGIKDYTRAFVLGKLKLKEGDSVTRREI
TKKIYLLSATRNYDRIEYNLIKKVDNTYLLSFYLKETNENASLKLGVHYDLLYKSSVLAN
YSQKHLLLDNDLLSVDMILGDNLRYNLNYFVDNGFYISYGFRSRYNHFTSSTKVNPLVST
FPNIDNINLKYIDFTNQFFVQTTFDRKFAIGLGAEHKYIKATTATITTNNEETILDKSHY
FNTFGYLKLDTYNKNYFPTKGYFADLNFRFNMASSDYNGDFETFGQAKGTLGFAKTFWNK
LTFQFTNEAGFTLKNPESGIFDFYLGGYNQNYINTFISFYGYDFAELSDNSFVKSEFNFR
YAITDKHNAIFIANYGRLGDNVFRDIELFKDVISGYALGYSYGSLVGPLEIKYSWSPETN
QSFWLFNLGFWF
>FCMOIPGL_03027 UvrABC system protein C
MSASLELQVQTLPNEPGVYQYFDKDDVIIYIGKAKNLKKRVSSYFNKNHENGKTRVLVKK
IVNIKHIVVNTETDALLLENNLIKKYRPKYNVLLKDDKSYPWLCIKNERFPRLFMTRRVI
KDGSEYFGPYTSVRTVRVLLDLIKELYPLRTCAFDLSKKNINEGKYKVCLEYHLKNCKGA
CEGLETEANYNDSIREIRNIIKGNFKESLEKFQEMMLDFAEKMEFEEAQKIKEKLSLLGN
YQAKSTIINPSINNVDVFSIISDETHGYANFLKISNGSIIQSNTTEIKKKLDETDKELLE
LFIVEIRQRFNSQSPEIYVPFKVDLGESVKVTIPKLGDKKRIVELSERNAKYYRQEQFKQ
IKIVDPDRHVKRIMAQMKKDLRLSVEPRHIECFDNSNIQGTNPVAACVVFKDGKPSKKDY
RHYNIKTVEGPDDFASMEEVVYRRYKRLLEEEQPLPQLIIIDGGKGQLSSALKSLDVLGL
RGKIAIIGIAKRLEEIYYPDDPIPLYLDKKSETLKITQYLRNEAHRFGITFHRNKRSKSA
IKSELEQIPDIGKQTITTLLRKFKSAKRVKEASLPDLVEVIGNARATKVYQFYHPQKT
>FCMOIPGL_03028 hypothetical protein
MKISRYILVFFIGFFIAKYWYQKDNKHQQKEEIQVVVNSIKNMSKLVVSNANFSEIYNYS
DSKKYFYETISFDKKAIVTVNATVEVGYDLSKLDIQIDSLQKKIYINKMPDEEITISPDV
KYFDLQQSQFNTFSKTDLNKINQKSIDKIKESIKLTNLKTAAKTRFFEEISKIYQLSAIY
GWQVVDNTNAGFLENIAY
>FCMOIPGL_03029 Lipoprotein signal peptidase
MSKRNLAIFTILFTIILDQVIKIYVKTNFVLGEEVVVFDWFKIHFVENNGMAMGFEFGGK
AGKLFLTVFRLVAVTAIMYWLVGNIKTKVHNAVIIAISLIFSGAVGNIVDSVFYGAIFDD
SSHKVATLFADEPYGTFFHGKVVDMFYFPLWTGDLPSWIPFVGGEQYTFFQYIFNPADAY
ITIGVVLLFIFSKQAFPKEEKNSENKVA
>FCMOIPGL_03030 hypothetical protein
MKYIYLVSFLFFSTIVFSQKKVIKKFETNLQEVEISTIGLDNFVLENSPSGFIEIILFAE
NPNEKHILFKEENNVIQLEFIIEELQSEETIFRKFITKRLQRASVVVKIPKGKKVTIFGE
NINIESKNYQGDLAVFIDEGIVKFNEVKANTSVKLYEGNIYATLKNTNINVTSNTGKIQI
DNILHEKRYQKESEKNQKNFTVTSLKANIYLTTQKPQ
>FCMOIPGL_03031 hypothetical protein
MKKKLFLIVFLFCGFLFYKSFGKKNKIEKVQESYAKLIKNHPFNNALNFTKEERVAFGIP
PNKYFEEKYLLEINPYTGKTHPENIYNLQQELKLKRAYEQRAPGDAINNQWQERGPNNVG
GRTRMLLFDPNDVNNKRVFAGGVSGGLWVNNDITDENSSWISVGIDENLSVTCMAVDPNN
SQIMYIGTGELYVPQQALGNGIWKSIDGGATWTNIYKVRGTTSSGYVPGTYYITDIIVRD
ADGDSLTTNDSEVFASIGATFYTTNPINTYVGLNEYGLYKSSDEGENWSKISLDVDGNSV
AGNDFEISLDNKLWLGTVSNLYGKGGGRVYNSSDGNTFTLKHTIANARRTEISVSKKNAN
ALYVLARVRTYDEDNNLIAPFVSLLKTDDAFGTLPTLLTLPNDADTDIPANDFARGQAYY
NLMLEIDPTDDDIAYVGGIDLFRTTNSGTSWDQISKWSENNNLAALNVSYVHADQHAMAF
YPSDANVAIFGNDGGVFYTSSLSTANSSTTAIKSRNKDYNIVQFYSSAIGQSIDSEYILG
GSQDNGTQFFNNPSEGINSSIKISGGDGARCFVDKDNSYLIVTNSYNKISRFNLPYIGNE
FVISSSESSSSFLNAMALDENLDILYSNGADHLSRFSDITTNTPIRTNITNALLNNITAL
KVSPFTTTSSSVFAGTRTGKLVKIENANTATQTITDISSGSFLGSISSIEFGVSENEIMV
TFYNFGVESIWFTDDGGVNWMNKEGDFPDINVRSILMNPLNNDEVIVGTELGVWNTSNFK
DASPVWNQSYNGMSNVAVTSLSLRTVDNTILASTFGRGMFTGKFTGNPLTIWTGIIDSDW
TNAGNWSNGLPAINMDVKIPNTTIKPILNSAVIVDNIAIETGALLTLNAQAALTVNESLT
NNGTLKINSNSTNSGSLIIDENAIGNVTYNRSVTANWHLVSSPVKGQIYNDAWILDNSII
SSSSNANRKGLGVYDNSDGWQYFLAGNSSTFNQGEGFTILRSEAGNLSFTGSLLTINKNV
TISDGSNNAYNLLGNVFTSYIPINADADASNNFLTVNSSSLSEQTLWLWNGTSYITVNHA
SSSQFLSPGQAFFVASKIGNNTVSFTKEMQSHQTTNFLKTKEQKSEITLTVSLEKENRTT
KIFYIDGASTDFDNGYDSSIYNETSNNLEIYTKLINQKDKRNLAIQSLPKEYSNIIPVGV
VLPANSRVEFSISSKNIAEDVNIYLEDKKLGIFTLLENEGGSYIFTSKEKINNSDRFYLH
TLKETLHVIDEDLSRIKIYTSNKKVYFSGLPKGENVVEIYNLIGKKIIQKSIEKSEDYIS
IEKIVKGLYIVDLKTEKGTKSKKIIIQ
>FCMOIPGL_03032 General stress protein 16O
MSGVKVKYSEEDLLEFKEIINKKITRAQEDLEMLEGAYKNNADNGTDDTSPSFKSFDEGS
EVMNKEANVQLAIRQEKFIRDLKNALMRIENGTYGICRVTGKLIQKERLKLVPHATLSIE
AKRAQ
>FCMOIPGL_03033 Isoleucine--tRNA ligase
MKAKFPEYKGLDLPKVAEEILNYWQENNIFEKSVTSRENAKPFVFFEGPPSANGLPGVHH
VLARAIKDIFPRYKTMKGYQVKRKAGWDTHGLPIELGVEKELGITKEDIGNKISVEDYNA
ACRKAVMRYTDIWNDLTNKMGYWVDMEDPYITYEPKYMESVWWLLKQIYNKELIYKGYTI
QPYSPKAGTGLSSHELNQPGTYQDVTDTTVVAQFKAIENTLPDFLQNEGTVYFIAWTTTP
WTLPSNTALTVGPKIEYVLVETFNQYTFEPIKVVLAKNLVSKQFAGKNNVQVETSEELST
YNAGDKKIPYHVIKEFIGKDLVGIKYEQLLDYCLPNDNPQDAFRIIAGDFVTIDDGTGIV
HTAPTFGADDAMVAKQATPEIPPMLVKDKNDNLVPLVDLQGKFRPEMGEFAGKYVKNEYY
ADGEAPERSIDVELAIKLKTENKAFKVEKYKHSYPNCWRTDKPILYYPLDSWFIKVTDVK
DRMHELNKTINWKPESTGTGRFGNWLANANDWNLSRSRYWGIPLPIWRSEDGKEEICIGS
VKELKQEMAKAVEAGVLAEDIFADFEVDNNSEENYAKLDLHKNIVDEIVLVSASGQPMKR
ESDLIDVWFDSGSMPYAQWHYPFENKQKIDGNESFPADFIAEGVDQTRGWFYTLHAIATM
VFDSVAYKNVVSNGLVLDKNGHKMSKRLGNATDPFTTLSTYGADATRWYMISNANPWDNL
KFDLEGIEEVKRKFFGTLYNTYSFFTLYSNLDGFSYKEADIPLEERPEIDRWILSELNTL
INKVDKFYEEYEPTRAARAISDFTQDYLSNWYVRLSRRRFWKGDYQTDKISAYQTLYTCM
ITIAKLSSPIAPFFMDRLYQDLNSVTGKETSESIHLSNFPVYDASFVNKSLERKMENAQI
ISSLVLSLRAKEKIKVRQPLQKIMIPVDNPQQKEEILAVENLIKHEVNIKEIQILDDASD
ILIKQIKPNFKALGPKFGKDMRFIASEVQKFTQEDINKIEKDKNISIEINGKNIILDASD
VEISSKDIEGWLVANEGALTVALDVTITEELRKEGVARELVNRIQNARKDSGLEVTDRIK
LTVLNNQNLQQSIADNKEYIMSETLTTELVFVDELEDGTEIEFDTIISKILIEKA
>FCMOIPGL_03034 Chaperone protein DnaJ
MGSFTKWLGAGLGFSLGGPIGAAIGFALGSFVDGFSEKDLKQEQIDYDRANQSGQRRGSV
DTESGDFEMSLLVLASIVIKSDGKVDKRELDFVRNQFVSMYGKERANSAFKLFKGIIKKE
VSARQVCMQIRAHMSHSSRLQLLHFLFGIAKADGFVIQSEIEEIRKIAGYLYINQNDFDS
IKAMFYDESNASYKILEISKEATDDEVKTAYRKMVKKYHPDKLQGLGEEHLKGANEKFQS
IQAAYEKIKNERGL
>FCMOIPGL_03035 hypothetical protein
MYPEELVKPMRDELINAGFEALYTSEDVENAMSKEGTTLVVVNSVCGCAAGTARPGAVAS
LGAEKTPTNLTTVFAGVEKESTQKAREFMIPFPPSSPAIALFKDGNLVHMLERHHIEGRS
AQMIAQNLAQAYEEFC
>FCMOIPGL_03036 hypothetical protein
MASILSTYTIEELKKKLKKQKTMLIIQSVVLFLMIVFAVFSTIENGLSFQTFLPLFFAPM
LFVMLFEIKNIKKELILRK
>FCMOIPGL_03037 hypothetical protein
MNQEKIIQNTIKFVKTELKYAEGGHDWFHIERVFKNAILISKDEKADIFIVSLGALLHDI
ADPKFYDGDETIGPKMAADFLKNQKVDAKIITHVINIIKYISFKNSLETNREKFNSKELE
VVQDADRLDAIGAIGIARCFNYGGFKNRALYNPDILPNLNMTKEEYKKTDSPTINHFYEK
LLLLKDKMNTATGKKIATERHQFMETFLSQFYNEWNGKL
>FCMOIPGL_03038 hypothetical protein
MEDKIEKAIEYYTFKSKEILNFINSKDNLTVEEIIEKGEELAVLESKITALEVAKEN
>FCMOIPGL_03039 HTH-type transcriptional activator RhaS
MQIKPTLEKITPNFGSSLLVKKHLEFLKTDKPFWHFHPEIELVYVNKGKGKRHIGNHISY
FNNSQLVLIGSNLPHVGYMDRLTTNGSETLIQFKPDFLGSEFFKIPEMIAVEALFERAKK
GIRFNIEIKQRIGAKIEALVELEGVQRIASFLEILNDLATTDDYTLLNANGFAFETIPQD
SNKIEVIYNHINNHFREHISLDEVSELVSMTVPAFCRYFKKSTGKTFTKLVNEYRVVHAT
KLLAESNSSITDVSFECGFNNFSHFNKLFKNFTGKSASKYRSEMKNLIQ
>FCMOIPGL_03040 hypothetical protein
MKTMKKRVLVIMLMLVSLFNYANNENDFNKTVNANKVKVVFNDVTKGQLLTVNDENGIQL
HAETVSTTGELTKFFDLSSLNNGLYTVELNKEFIIVIKSLEVKDNKVSFIKGSDKVFFKP
FIRNEENLVLISKIGFHKELIKVTIFYNSEVILAETIDNETMLKRAYRLDEKLKGNYKVI
VSSNNKSYSNEFKY
>FCMOIPGL_03041 hypothetical protein
MKTIKRKVLVVVFMLGTLLNYANNESDFNKIVNVTKVKVVFENVKKGQQLTVNDQNGIQL
HSETISTEGSLIKFFDLSPLNNGLYTIELHKEFEVIIKSLEVKDKKVVFIKESEKKIFKP
VIRNEENLVLISKINFDKKPLKIDLYFNGKVIYSEIVKNEEYLKRAYRLDNEIKGDYKII
VSSNDNNYTKKFKI
>FCMOIPGL_03042 hypothetical protein
MKTIKRKVLVVVFMLGTLLNYANNENDFNKIVNVTKVKVVFENVKKGQQLTVNDQNGIQL
HSETISTEGSLIKFFDLSPLNNGLYTIELHKEFEVIIKSLEVIDKKVVFIKESEEKIFKP
VIRNEENLVLISKINFNKEPLKITLYFNGKLIYSEVIKNEEYLKRAYRLDNEIKGDYTVI
VYYNDYNYTKDFKI
>FCMOIPGL_03043 hypothetical protein
MKTIKRRILVVVFMLGTLLNYANNDNEINKTINASKVKIVFENVKKGQQLTVNDKNGVQL
HSETIYTKGKLIKFFDLSPLNDGLYTIELHKEFEVIIKSLEVKDKKVVFIKDSEKVIFKP
LIRNEENRIFISKINFDKKPLKIDLYFNGEIVYSETVKNQEFLNRVLRLDDEIAGDYKIT
VNFDDDNNYTKEFKL
>FCMOIPGL_03044 Short-chain-enoyl-CoA hydratase
MKFDNILVEKNNKIAQVTINRPNKLNALNKAIIHELSEAFKALEGDNDIKVIVLTGSGDK
AFVAGADISEFSHFSVDEGGTLAKKGQEILFNLIENLSTPVIAAINGFALGGGLELAMAC
HFRIASNNAKMGLPEVSLGVIPGYGGTQRLPQLVGKGKAMEMIMTATMIPADEAFNCGLV
NHVTTQEELLPLAEKIASKIMRNSSVAISAAIRAVNANFEDGVNGFDVEIEEFGNCFGTN
DFKEGTTAFLEKRKPNFPGE
>FCMOIPGL_03045 Sensor protein ZraS
MFNFKNISLRIRIFLSMILLVLLASILILGVTVYQYDEQTKDYNIQRFERKEATTQETIE
LELTNKTTYLVNTENLPKIFQERIYEISSINKLNISFFDLKGNFLISSKTNAFEETDIKP
LNHLILNELSQNSNHKILKSREEDGVGYQTSYSYINDPKFKRIGILEMQFTQDNSEIESE
LREFIYRLGLVYLLMFIIAIALAYLLSSYITRSIQTISDKMHQTRLHERNEKIILNAASS
EIEVLVEAYNNMIDQLEESAVKLAKSEREQAWREMAKQVAHEIKNPLTPMRLSVQSFERK
FNPADENIREKLAEYSKTLIQQIDVMSSIASAFSDFAKMPTQKREKVEIISVVKLALDIF
GEDFINYYPKEEELFAYLDKTQLIRIVTNLVKNAIQATENKETPIIDVTVLSENNNVKIT
VTDNGRGIQEKVKDLIFEPKFTTKSSGMGLGLAMIKNIIEAYDGTISFTSEEGIGTVFTV
VLPKI
>FCMOIPGL_03046 hypothetical protein
MKVVKFLVIILFGILIVSCKKEKMLQDFMVDSWQTTYLKIEMPTANKTDSLSVYEDEFDN
NPDRIAQSKYNADGTFSAWFINKQGVKDSKSNGTWSVNKDTLHIEYFYLGRNVKVNYIVT
KAEEGFIAKSVYDWDDDGEFDDTLIMKTKRIKSE
>FCMOIPGL_03047 DNA damage-inducible protein F
MKTDISFKRINKLAIPALIAGIAEPLLSITDTAIIGNMDKNATESLAAVGIVGAFISMLV
WVFGQIRSAISSIISQYVGANKLDEINTLPAQAIAIVVVGSLLILAISYPFAAQIFQFYN
ASGSVLEACVIYFKIRIFGFPFSLFVFSIFGIFRGLQNTFYPMIIAICGALLNIFLDIIF
VYGIEGFIPAMHIEGAAYASVIAQITMAIIALVLLMKKTSISLKISLPFHKEIPNLMGMI
GNLFIRTIALNTALYFATAFATGYGKEYIAAYTIGLNLWLLGAFMIDGYSSAGNILAGKL
LGAKDYKTLLKLSNKLTKYGLATGVFIALLSTVFYNFIGQVFTKESLVLEQFYHVFWIVI
LTQPISAITFIFDGMFKGMGEMKYLRNVLILSTGLVFIPTIFFFDWLDYKLVAIWIAFTL
WILARGVPLIIKFRSKFLPLSQL
>FCMOIPGL_03048 hypothetical protein
MKNILVPIGSTESAQNTLQYAIDFASEVNANVLVFRAYSAQTKAGIMKNVNSIIERETNL
YLRAIVNSVDRKNVAVKLISAKGTLVDSVESIDSKLDIDLIIVGAKSNSIKEEVFLGKTA
GKLVKQTDIPLLTVPDGYKYVPIKNILMAFNSGIVKSKTVLIPLQLIAKKFNPEINLLQV
KTADYTDEDLVLDKDLEKLKTSLTITENATAFQGVLEHFQKFNPDMLCVFRRKRGFFKKL
WEKSTVLKEEFHTNIPLLVLKGK
>FCMOIPGL_03049 hypothetical protein
MQSFISETLDDILQTTKSFEDVVFILPSQRAKVFVKQAFKDKIAVGFLPEMLNIEQFIQQ
ISGVQKADNIQLLFHFYTIYKSVEKNPDSFDAFSSWALTVLQDFNEIDQHLINTKEIFTY
LRDIERLRKWSVNGTFKETELIKGHYSFLEKLNNYYNAFYQFLLDKNIGYQGLMYREAAK
KVDTFLDKNTAKKFFFIGFNALNKAEELLFQKVLENGNSEIYWDIDESFFNSNHQAGKFI
RKYKKEWRYYEKNQLKSLGNSFSSPKKIQVIGAAKNNTQIKYIGEILEENAQFKNTALVL
ADETLLPITLNSLPKNINAINITMGYPLKDIPTTSLLFAVFQLFVSQDKFQKNSLNEFYY
KDVIRFFKHQSIYGLISNIDNFTSEIAKDNQTFINEKLLEKFLENQESEVKNVILNLFKN
FDSVSNFMDRILDLINILKEKVDALEKEYLFRFYTVFTQLKTLQNEFEYFTDLKTLSLFF
RQLIGSESLSFQGEPLKGLQLMGMLETRVLDFENIILASANEGVLPASSQQNSFIPFDVK
VEFGLPTYREKDAIFSYHFFRLIQRAKNVFILYNTEHDVFGSGEKSRFVTQLEMMRTDIV
HKIVSPKVVSQKTNLKQITKNEQVFERLKELAKQGFSPSSLTNYLYNPVAFYKQKILRIK
EFDDVEETVAFNTLGTVVHETLDELYKPFIGKFLTVDAILDMEKIAKDLVVKHFKIHFKN
GDLSTGKNRLIFEVANRFVTNFLSQEKTLLKDKNNQLKIIATEENLSAEIEIDGINFPIK
IHGNVDRVDELNGEIRIIDYKSGMVQSAELKVLDFEQLREKQQYKAIQVLLYAYLYSKNK
KHDFSKNLKGGIYSFKNLNNGFLAIKFSSNYRNPDHNISSEKLEEFITELKEYIKEIYNP
AIDFIEPADLKY
>FCMOIPGL_03050 2-oxoglutaramate amidase
MTDELHIVGIQTDLFWENPTKNIASFEEKINSLPKNTDLIVLPEMFTSGFTMKPEIVAEK
MNGNAVSWMVKMATENQFAITGSLVINHDNNYYNRLVFVHPSGKIETYDKRHSFSLAGED
KVYTSGKEKLIVTFKGWKICPLICYDLRFPVWARNTENYDLLIFMANWPVIRIKAWKTLL
KARAIENMSYVIGVNRTGIDANKYEYSGNSLVIDYLGENLSKLSKNEVGIVSAIISKKHQ
QKVREKLGFLNDMDSFEIRF
>FCMOIPGL_03051 Putative acyl-[acyl-carrier-protein] desaturase DesA1
MSIKNIRIEVMQTLEKNIDSFVEKFLIPAEKIWQPTDFLPNSQKDTFISEVEEIRELSKE
LHDDFWVVLVGDTITEEALPTYESWLLDLDGVTQQPDNGWAKWVRTWTAEENRHGDVLNK
YLYLSGRVNMREVEITTQHLISDGFDIGTASDPYKNFVYTSFQELATYISHNNVAKIARQ
KGHKSLAKMSKIIAGDEMRHHIAYSEFVKEIFKIDPSEMMLAFQHMMKHKIVMPAMHLRE
SFGAKGSLFDDFSTVAQRIGVYTGFDYVDILKKLTVNWEIDKISNLTPEAEKARDYLMKL
PDRMYRITERITVPDTNFQFKWMIPA
>FCMOIPGL_03052 hypothetical protein
MKIISYILSSIFAIVFYLFLIIFHPLQWLGLKIFGYKGHKFVVDYMNWFLTKSLLILGTS
VTVRNKQKLPENTTLIFVSNHQGMFDIPPIIWAFRKYHPKFVSKIELGKGIPSISFNLRH
GGAALIDRKDAKQAISTLASFAKKINKNNWSAVIFPEGTRSRNGQPKSFATNGLKVLAKY
NKEGYIVPLTINNSWKVFRYGKFPLGIFSPIKITTHQPIKIDSLPFDELIAQTEKVIKEH
IK
>FCMOIPGL_03053 hypothetical protein
MKDIHSYWAYLVLAILIFAVVNAIIGFTQKKQFTDKDLRIGLFTLIVSHIQLLIGLGWYF
MSPWYKALKENGAEVMGDKAIRLLAVEHPIMMILAIVFITIGWSKHKKKIEDAAKFKTFA
IFYGIGLLLILSRIPWSNWF
>FCMOIPGL_03054 hypothetical protein
MKKILLLLTVFSMVFTSCDPLEDIYEKVEGRDIAGEVTYTLTDDDYESLGFDNRYFSSED
EAKSLLPSFLSEKYPLWGSGSTASVLYKIETLGDYTGAVEYSLAITDYPSNFTDNAVAFY
ENENTSDVLSSILEANFTTAVEGDVVLAKYNQYVGETENGISEFYSRDFASEKSLLDFEA
VSVIGDQTWVATQYGIEMSGYDGGRFENEDWLISTDIDLSSFPNSTLQVNQTFNYGDPSG
FSVLISTDYTDDIATATWDVINLVNVPDGTTWDDIVSDEYSLAAYNGKTINIAFKYTSTG
SNTETGTYQVNYVSLKAAGVEGETEGVSEFYTFDGSAWELSEGVYYISDADFDSMGEASG
QPGRYNNFSSSTAPNDYLPTFLKSKLPYAQEGDVYSLVYRYYDGAAILKGSTYSYSNGVW
GDFNYTIDFSHDGITWAPATKYELIPEDYTLIADTYRTVEGFEAPVANLESYGNISTFNW
EDEQIDAAIGTVLKTRFPDAQEGQNFDVIVFVYNGSSQNMTFNYTLSSGVYIRR
>FCMOIPGL_03055 TonB-dependent receptor SusC
MKNFKNLLFLALFFVTATVLGQTKITGTIVDDTNQPLPGASVVVKGTTNGTSTDFDGKFT
LKADSSSGVIVISFIGFKKREVSFSSSKSNLKLIKLEEDAGALDEIIVTATSFAIDRKTP
VAVSTIKAADIEAKLSNQEFPEILKSTPGVYATKSGGGYGDGEINLRGFRTQNIAVMING
IPVNDMENGAVYWSNWAGLSDVTSAMQVQRGLGASKVAVPSIGGTINIISKSTDAVKGGS
IVMSTGNDGYQKYGMTLSTGMMDNGFAVTASASKVSGEGYVDGLQFEGVNYFLNVSNQIN
DSHKLSFNAIGTIQEHGQRYNRRTIAEYEATEQGGKRFNPDWGYRNGKVENSSFNFYHKP
QISLNHDWTISDKTFLTTSVYASFGSGGGRRTQGTKFTSDSYRLGDFDQPINFDQIVAEN
VASGANGATDIFAASKNSHEWYGVLSTLKTDLSETLTLSGGIDARSYVGSHWYEVTDLLG
GQYFYNDDLEEKTGGQALKVGDKFNKDYDGKVGRYGLFAQLEYSKDDLSVFFSSSVSNSV
YSKVDRMSYGAEDRESESASFMGYSTKGGANYNLDEKQKVFANIGYFSRAPIFDNVFDSD
YSVDLYDGALNEKVFSLELGYGFKTQVFSANVNLYNTSWIDRFMTFSLPGADGEFITSNV
TGLDALHQGIEVDFLFRPIEKLAITGMASLGNWRWKDDASANTFNDTTGELISSETIYAK
DLKVSDAAQTTFAFGIKYDVLDKTSISLDYNYAGDNYATMNVTGRTADSPEEADRTNTWK
LPNYHLFDLGLRHGFEIAGLNSTLSANMNNIFDVEYISDANNGSNSSYDTAQVYYGAGRT
FSLGLKVKF
>FCMOIPGL_03056 Glucose-6-phosphate isomerase
MALKNINPTTTKSWKELTNHFNDIKNIKIKDLLKDQNRKEDFSIEFDDLLVDFSKNRITK
ETIGLLVELAKEVDLKGAIESQFTGEKINVTEDRAVLHTALRSTSDEPVLVDGKNIKPQI
QAALRKIKSFSNKVISGKWKGYTGKSITDIVNIGIGGSDLGPDMIVESLQFYKNQLTTHF
VSNVDGDHVSEVMKKLNPETTLFVIVSKTFTTQETITNAETLKNWFLKSATIFDIPKHFV
AVSTNLEAVDSFGIDKNNVFPMWDWVGGRFSLWSAVGLSISLSVGFDNYKALLEGAEEMD
IHYRNTDFEENIPVVLALISIWYNNFYLAETEAVLPYTQYLKKLPDYLQQATMESNGKGV
DRNGDKVDYQTGTIVWGSTGTNMQHAFMQLVHQGTKLIPADFIGYKESLYGLKDHHKKLM
ANYYGQMEALAFGKTKEEVHLELKFSGDEDKIATLLPFKVFEGNRPSNAILFDKLTPRSL
GKLVAMYEHKIYTQGILWNIYSFDQFGVELGKELAKKLLNNQ
>FCMOIPGL_03057 Murein DD-endopeptidase MepM
MKKIAILLALILCFSSCKKEEKKPEIKIEKPEPKTEIRFGYKLDDYKVIQDTIKKGESFG
AILDRHHVYYPKINQIATSITDIFDVRRVRAGKPYTILASKDSTEQAQIFIYKHDKINAT
VVDFKDSLVTATLFKKPIKILEKEVSGVINSSLSVTMDSLGLKPNLTWSIADIYAWTLDF
YALQKGDSFKFVYEEKFIDDTIFAGYGDVKSAVFKHKGKDLFAFRFIADSINGIPEYYDE
AGNMLRSQFLKSPIKFQYRISSRYNLKRRIAYYGNKIRPHRGTDFAAKIGTPIIATASGT
VIESTRRGGNGKFVKIKHNSTYSTQYLHMSKRKVNKGDYVKQGDVIGWVGMTGNTGGPHV
CYRFWKNGKEVDPLSPKTKLPEAEPLKESIKPKYNKFIQPLKYRLENKKVPITKPQIITE
IIAKK
>FCMOIPGL_03058 hypothetical protein
MKKYILSLFILFFLTTTFSQEKPLAFKSGEWLRYKMSYSGFLRAGTAILEVDEKEFNGKK
VFYSKGKGWTSGMIKWFFEVDDTYESFFDKDSVKPYLFKRKIDEGGYKKHRITSFNYDSK
KAYVQDFTLQKDTLVGFTNVQDMMSSFYFLRNTETSGLKIGDEIKLDMFLDAQIYPFKLR
FLGREVLKTNFGKVNSLIFRPLVQSGRIFKEQESVTLWITDDANKIPIKMMASLAVGSLR
AELEGYKGLANPFHSF
>FCMOIPGL_03059 Tryptophan 2,3-dioxygenase
MNRDEILKAIEEKYDKLGVPVDAMLEGLLHSTPITYWDYIQTDALLGLQIPRTTQPDEMV
FIMYHQVNELLFKMVLWEIDQVAKTIEITADKFSMHLGRISRYFDMLCSSFTVMADGMER
EQYLKFRNTLTPASGFQSAQYRKIEFASTELINLIDVRYRDTIDRNSSFKNAYNHLYWQA
AGKNYTTGQKSTLLNLFEKKYIGDFIDFMEDYNDINLSLKFKQLPKEVQENQDLIKAMRH
YDYTVNVKWVMAHYNAAAKYIGGNDSELKATGGSNWRKYMHPKYQRRIFYPYLWSEEELK
NWGTF
>FCMOIPGL_03060 4-hydroxyphenylpyruvate dioxygenase
MYTLEKIFEGAQDFLPLLGTDYVEFYVGNAKQAAHFYKTAFGFQSYAYKGLETGSKDVVS
YVLTQDKIKLVLTTPLNSKSPINDHIVKHGDGVKVVALWVEDARKAYEETTSRGAKSYME
PRVETDENGEVVRAGIYTYGETVHMFVERKNYRGTFLPGFKKWESSYNPPIAGLKYIDHM
VGNVGWNQMNVWVKWYEDVMGFENFLSFDDKQIHTEYSALMSKVMSNGNGRIKFPINEPA
EGKKRSQIEEYLDFYEGAGVQHIAVATDDIIATVTQLRFSGVEFLSTPPEEYYRAVPGRL
EEYSHELREDIESLKKLGIMIDADEEGYLLQIFTKPVEDRPTLFFEIIQRMGAKGFGAGN
FKALFESIEREQEKRGTL
>FCMOIPGL_03061 Homogentisate 1,2-dioxygenase
MPFYHKLGEIPPKRHTQFRKKDGSLYYEQLFGTIGFDGMSTNSYHEHRPTMVKEIRKQYS
VKPKIAKANNIQSYRFRGFQVPPENDYLESRKIILTNTDCNIILSAPRKSTTDYFYKNTD
ADEVIFIHKGTGKLRTHLGNIDFKYGDYLVIPRGIIYKLDFDDENNRLFIVESYSPVYTP
KRYRNYFGQLLEHSPFCERDLRRPYELETHNELGDFLIKVKKQGEIIEMIYASHPFDVVG
YDGYNFPYAFSIHDFEPITGRIHQPPPVHQTFETNAFVICSFVPRLYDYHPNAIPAPYNH
SNIDSDEVLYYVDGDFMSRNDIDQGHISLHPAGIPHGPHPGTTEKSIGKIKTEELAVMVD
TFKPLMVTEEAMKIADEEYYKSWL
>FCMOIPGL_03062 Fe/S biogenesis protein NfuA
MTEQETLNNVEKALDEIRPFLMSDGGNIKLLSIENSIVKVQLEGACTGCSVNQMTLKNGV
EATIKKYAPKIEKVINVA
>FCMOIPGL_03063 Iron-sulfur cluster carrier protein
MSFTKQDIYKALETITAPGEGKSLIENNNVTNIVTFGNEVIVDVTISNPTLQAKKKIETE
ITKVIQTNVDEKIDVKINLKVVAAAPKENPNQIRGKEIPNIKNIIAIASGKGGVGKSTIT
ANTAISLAKMGFNVGVLDADVYGPSQHIMFDVEKAKPLSVNVEGRSKMKPVENYGVKLLS
LGFFTNPDQAVIWRGPMASKALNQLIFDADWGELDFLLIDLPPGTGDVHLSIVQALPING
AVVVSTPQNIALADAKKGVAMFQQENINVPVLGIVENMAYFTPEELPDNKYYIFGQDGAK
NLAEDIKTKFLGEIPLVQSIRESGDVGHPVALQEGTILEKAFNDITKEMVAELLKRNANL
PPTEVVRITTMSGCSTK
>FCMOIPGL_03064 DNA base-flipping protein
MKESDNFFDKVYQVARLIPFGRVTSYGAIGTYLGAAKSARMVGWAMNKAHNLEDVPAHRV
VNKKGLLTGKHHFDGTNLMQQLLENEGIVVVENQIQNLEKVFWNPTDELS
>FCMOIPGL_03065 tRNA (guanine-N(7)-)-methyltransferase
MGSKNKLKRFEENETFKNVIQPTREEVTTNFSLKGKWHSFFGNNNPIVVELGCGKGEYTI
ALARKNPNKNYIGIDIKGARFWRGAKTALEENLENVAFVRTQIELVDFIFSENEVSEIWI
TFPDPQIKFQRTKHRMTNSSFMKKYHHILNEEGIMNLKTDSEFMHGYTLGLLHGEGHEVL
YANHTVYKNEGAPKEVTETQTFYENQYLEVGKPITYIKFRLNY
>FCMOIPGL_03066 hypothetical protein
MIASNIFKWIGSLFTDFLFVPFKWLRLDVALSDSGWWTSNAINWGFLVVLLVLFAYWMKE
SKKFLNEGTEDRA
>FCMOIPGL_03067 hypothetical protein
MLANFLNKSKPINFIGILVFFIICFIITVSSSFLSNGFSTNKLLQNFNLLLLFLSVFFFY
NFILNKNRLTFDNSYAYFLFTLLIICILPELTTYKILISDTIYFFFLRKLYSLRSSKKVI
QKLFDSGFWLGILFILEPISMLFFILVFSAIILNLKITLHTLLTAIIGFITPLFIYFTYF
FWFDKTEEFTKLFNFNTNFDVHFYTQTKFIWFFVCIVICSLLSIIFKSAETLGVSNTFRR
SWTLLIINFLIVFLYLPFLPAKNGSEIIFILFPVSVIIANGIELINNKIIQNLILYSFLI
GSIFFCFFL
>FCMOIPGL_03068 Uracil phosphoribosyltransferase
MEIHYIGESNSILNTFISEIRDKEIQKDSLRFRRNIERIGEILSYELSKTLSYSTTSINT
PLAKKEVRLPSNNLVLCSILRAGLPLHQGLLNYFDKAENAFISAFRHHPNNDAEFEIVVE
YFASPEIENKTLLLADPMLATGQSLVAVYEAIKKYGTPKELHIIVVIASKEGVELIEQYF
PENTHLWIAALDDELNSKGYIVPGLGDAGDLAFGEKL
>FCMOIPGL_03069 putative cystine transporter YijE
MNKRIVALIAVFIASLIYAINYTIAKEVMPLHIKPFAFIFLRVAGATIFFWTIGLFIKQQ
KIEKEDYKKILLAAFFGTALNMLTFFKGLSLTTPISASVIMVTSPIMVLIFSSILIKKPI
ERQQVLGILIGLIGAILLITYGNSNTGNAINSNLGNFLVFINAASYGLYLVLAKNLIVKY
HPIVFVKWLYLFGLIFVIPFSYNELIEVSWQTIPIKMYWNIGYVVLFTSCITYLFNLYGL
SKLKPTTVSIFIYLQPVLTTIYALIVGSDSLNLVKVSATIVIFFGVYLVTKKAKIRITS
>FCMOIPGL_03070 hypothetical protein
MIQSMTGYGKSVLQLPTKKVTIEIKSLNSKNLDLNVRIPSYYKEKELNVRKKLANALVRG
KIDFSIYVEMTADETSTKVNPGVVKQYMQQLRNVVQTGSSDDVELLKMAITMPDSLSTER
EELDENEWNLINQNIDVAIKEIVQYRIDEAASLEIDFRERITNIKKYLEEVYSFDADRIE
NVKARLQKAIDDLKVETDQNRFEQELIYYLEKLDINEEKVRLANHLEYFLQTLETPDSNG
KKLGFIVQEMGREINTTGSKANFAPMQKAVIQMKNELEQIKEQILNVL
>FCMOIPGL_03071 Guanylate kinase
MKTKKIMSDFKGKLIVFSAPSGSGKTTIVRHLLKQEELNLEFSISATSREARGLEKDGID
YYFISLKEFKNHIKNDEFLEWEEVYRDNFYGTLKTEIERIWALKKHVIFDIDVVGGLRIK
KKYPEETLAVFVKPPSVDELKIRLKKRKTESEAKINMRIAKASVELATAPQFDKIIKNYE
LEVALKEAEDLVSDFLKKQ
>FCMOIPGL_03072 Nicotinate-nucleotide adenylyltransferase
MKIGLYFGTFNPIHVGHLIIANHMVEYSDLDEIWMVVTPHNPFKKKSSLLENYHRFELVY
RATEGYDKIKPTDIEFKLPQPNYTVFTLAHITENYPDKEFCLIMGEDNLKSFHKWKNYET
ILEHHHIYVYPRIAEGIVEHQFKNHPKIHVVAAPIVQISSTMIRNGIKNKKNVKPLLTKE
VWKYIDEMNFYKK
>FCMOIPGL_03073 Murein DD-endopeptidase MepM
MGKQKKKKGKLKQRLTNKYRLVVLNEGTFEERFSLKLSMLNIFVFGGVLSFLLILVTTFF
ITFTPIKQYIPGYSSTELKIKATKLAIQTDSLKRRLTILQDFTKALQPILTGEIEAEQLD
SLQLLDRIHVQDSLLNASKEDSIFREKIDIEDRFPIQNNALSNVKIVFFAPLTGTISQGF
DIKKNHLAVDIVAKKNTAVKAIADGTVIFSGWTTETGYVIILKHAYDYISVYKHNGNLLK
QQGDLVKSGEVIASVGSTGELSTGPHLHFELWSGGYAINPTNLIDF
>FCMOIPGL_03074 hypothetical protein
MSIKSVFAIPFAKIATKRVFKWANNPHKTQEKVFQKLISKAKNTAFGKDHDFKNIVSYDD
FKKRVKVTDYEGLRSYVDRVVAGESDVLWIGKPLYFAKTSGTTSGAKYIPITKESMPTHI
KAARNALLFYIAEKKDASFVNGKMIFLQGSPVLTNKNGVKLGRLSGIVAHYVPKYLLKNR
LPSWETNCIEDWDTKVNAIVEETINEDMSVISGIPSWVQMYFEKLIEKTGKSVSELFPNF
NFFIYGGVNFEPYKNKFESLIGKKIDYIELYPASEGFIAYQDSQTEKGMLLQLNSGMFYE
FIPATEFFDENPTRISLKDVKMGVNYAIILNTTAGLWGYNIGDTVEFTSTKPYRIKVTGR
IKHFISAFGEHVIGKEVEKALNDAISGTNINISEFTVAPQVEPKKGLPYHEWFIEFENEP
ENLEEFASKIDASMQAQNIYYFDLITGKVLRPLIIRKVKKGGFHEYMKSIGKFGGQNKIP
QLSDNRKIADVLKDFLVD
>FCMOIPGL_03075 hypothetical protein
MSTIRITKLFNFETGHALYGYDGKCKNVHGHSYKLSVTVSGKPIKDNTNVKFGMVIDFGD
LKKIVNEEVVDVFDHATVFNKNTPHIELAKELIARDHHVILVDYQPTSEMMVIDFAKKIK
SRLPENIKLYSVKLQETDSSFAEWFASEN
>FCMOIPGL_03078 D-ribitol-5-phosphate phosphatase
MKKIKNIVFDLGGVIMNLDVPRTIKAFKELGITNIVNNTGHNYQHSFFYELEVGKISEDT
FLESLLKLSSKSPSYLEIKKAWNQMILDMPKDRVDFLHDIKKTYNIFLLSNTNGIHQKKY
LDDFKDDYKTSFNKIFKKAYYSHEIGIRKPDVEIFNYILNDSNLKAEETLFMDDSFSNIE
GAQKAGIKTFHVQNYNTIDVLKLLNE
>FCMOIPGL_03079 hypothetical protein
MKSTINNFLKISFSILLLYGCNNFSEPEVIVAVDEDSNVLSIPAGFDFSTYHDVTISITE
NDEYAKYDIYAYSDELYDAGTETFENESGETVTETVYKSDMLENLIFSGVAKNGGLIQTI
NLPKFYTKVYIRRNEQLSFSSSIKDIVDQKVAYNSIEAKNNLQSKSTSDVTDYLYSVNGS
GQLFQVDPLTGTLTDLSTMPIGSWTCAIDQENKTLYSIGRSSPFPLMKYSILNDTWETVA
NLGIGGPRLDFNTADGLLYFSNRDKLYTFNPSTGALLNTWKINGLHDVGGGDLAFADDGT
LFVCTFSGLYKLNLDTNNEYQSTRISSDNLPFKPTSMTFDSNQELWLADSSSSADLIIMD
TQTGGWKYQYGASANNNTDFGRSINDLTTFRVYADVKDETDSDGDGIFDQDDAFPNDAEA
AFESFTPSKYGKGTIAFEDLWPSTGDYDFNDAALSYQAIAVLNSDNLAVRLDFICNIKAN
GAGFTNGIGFEIEGLDPSKIESVTGTVFTQNFISLNANGTEANQENAVIILTDDVDNILN
ETTISIKFVTPISTADLGVAPFNPFIIANKVRSKEIHLPYRKVTSLGVSGIEIDGVNKDA
DGNFISDNGFPWAISIIHDFKVPKEKIDITDAYNFFSTWAESGGTTNVDWYKDNPGNRNE
DLIDN
>FCMOIPGL_03080 PE-PGRS family protein PE_PGRS18
MKRLKYILILFVVLCSVLFLSIIVVRLPSYSIQTSGKLYIVSKVSREVQVFDLFTGKNIA
EIPIDMFSHEAITTLDKNNVVLTNYGSTNGNTVKVVNTKTNILEKTIELKENIRANGIVA
YPEPNKVGVIDYVRNTFFVLNVKTDSIEKRIQTKQEKSHLVVIHPYKLIAYVTNINSGSI
SVIDLKNNRVIKIIYCGVGRKGIDITPDGSEIWVTNTKENSMKIINTNTYEILDTFSTGD
EPLKLKFSIDGKFCLVTNAHEGSIYVYDQQSKKKIKSIMLHGKNTLLERILYHTPRPVNI
LMHPNGLYAFVSNSNANKIEVIDMKTFKVVSTIGTEKVPDALVFVE
>FCMOIPGL_03081 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MIGLKIIFWFLLFVIVYTYVGYGVLLYIIIKIRRAFIIGNKIEIDSSYEPEVTLFIAAYN
EKDYVEAKMENTLALDYPKEKLKIIWITDGSDDGTPNLLKGYPNTTVHHLDARNGKIGAM
NRGMEFVKTPIVIFSDANTNLGKESIRRIVNLFSIPKVGCVSGEKRIIDKESDVASGAGE
GIYWKYESTLKKWDAELYSVVGAAGELFAIRTELYRHVEKDTLLDDFMISLRVAQDGYTI
QYDPEAYAIESASANVKEELKRKIRISAGGIQSVVRLRSLLNIFKYGTLSFQYISHRVLR
WTLTPLSLVLLIPILFVLAFNEGLLDFGIYSILFWLQMLFYAAALLGWFLENKSIKIKLL
FVPYYFFIMNLSVVLGFFRYMKNSQSVNWERSKRAS
>FCMOIPGL_03082 Putative teichuronic acid biosynthesis glycosyltransferase TuaH
MIEGKNIICISQTTWHGEFTKSTVQLLSLLAEKNTVVFVEYPFTLKDVVMSLLGKQRAQV
SRMLGFKKRIVDEKTDNDAIVKHLVMPPVLPVDFISNESVFKKVFSINAFIYKNQLRKTI
KKLKLDDPIIITAYNPMYGLPMIGKLNEFLNVYYCYDGMDTQRHKSRIYNIEQQFCKEVD
GIITTSDYLNSKKKKLNPQSYVVKNGVDFKLFVPHAKKIVSSQSSIKKVGYIGTLDFRFD
IDIMEYAIKELSQVLFEFTGYLLNHNIKERLSVYKNVSFFKSVKPHEVPELLSKYDLGII
PYKMNEVNKNIYPLKINEYLAVGVPVVMTAFANLTDFKSMVQSAENKNMFKSYIENELKN
DNNSLIKKRIEFAKLNSWEGRALEFENVLGKFIKDKYSS
>FCMOIPGL_03083 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIGIEGQRLFRKKKHGMDMVALELIKNLQIIDKENEYFIFVKPDEDSSVLQETSNFKII
ELNGGSYPTWEQIALPKAAKEYGCDILHCTSNTAPFFTDIPLITILHDIIYMESSYLKIL
KSSASSYQKFGNIYRKLVVPRVVKKSKKVITVSHFEKNRIGEFFGIKGDNKLDAIYNGVS
EHFKPVTNKEELKRVKERYNLPDKYFFFLGNTDPKKNTKGTLKAFSDFLKQTGSNHKLVM
LDYDKIELHKLLAEINDTNLINNIVLTGYVINTDLPAIYAQCDVFLYPSLRESFGIPMLE
AMSCNVPVITSNTSSMPEVSGDAAHIIDPFKSEEITQGIIKILNNDAYRKSLCEKGLERS
KQFSWKNMAKDYLKQYELIHLENSKK
>FCMOIPGL_03084 hypothetical protein
MNNKKLQKLEAIRGFSALYVVFFHMLPQKIFFLGINVGFLFRFGSEAVIMFFILSGFVIK
YSWGKSENKRFKHYFFKRFIRIYIPLFFIFILAYCAKSYTEGGLANPDWATLLGNIFMLQ
DVISLKPNVISATYMANSVLWSLSYEWWFYMLFILLVKKISSSKLNTWVNILTISTTVSY
LIYPFFLNRIIMYFAIWWIGVRLADIYLKGETFTFKSIKKYSYVLLSIIALLGINLFMNF
EYTKVYDYPLVAYPFVELRHFVFAFLAMFGGIIWNKLNWFGFDKIFGIFRYLAPFSYVIY
ISHYYLVTKASYLKFIDNKIIEYTLYVFIMLLFSYLIEVVIYGKIKKQIISYFSINY
>FCMOIPGL_03085 hypothetical protein
MLLFNIIQIILLILLGLATLYIFVFSIASLFYKQKTYSDNGNMKTIAVLVPGYKEDQVII
EVAKLALEQDYNSNLFDVVIIADSFKEETLAALKLLPIKLIEVSFDKSTKSKALNKAMET
LDREYDIAVVLDADNVMAPDFLKKINAAFEHDFIAVQGHRTAKNTNNSWAILDAISEEIN
NNIFRKGHRVLGLSSAIIGSGMAFRYNYFKSLMSTVTAIGGFDKEIELKMLKEGRKIVYL
DDALVFDEKIQKSEVFGNQRRRWLSAQFHYFRKDFLNALKDLILKGNVDYFDKAIQFIQP
PRILLLGSVLFFSVGFVLANYFLDGQILYSRYWIIVAIACILSFIFSVPRSFYNLKTLGA
LASLPKGMFMMLLSLLKIKGANKTFIHTQHTSNTEEISSK
>FCMOIPGL_03086 hypothetical protein
MNYRNIKDLNNTILQRLSIIPRDFDLIVGVPRSGMLPANLLSLYLNRPYTDIDSFLNGHI
YKAGARSQFFDSDGAHKKVLVVEDSIASGSAMIEVKESLKHLEDKFDLKYCAIYVVPGKE
KMVDYFFELVPLPRYFQWNILNHTTLEKACFDIDGVLCADPLPEQNDDGEKYIDFILNAP
PLFIPGSKIGTIVTSRLEKYRKETVTWLAANNIKYNDLVMLDLPNMAARQKANNHGDHKA
KAYMSKPYVLFIESELNQAIEINRISKKPVLCTANFEMIFESESFMYNLKSGKHLPFLRE
FGLKVRNKLRSFK
>FCMOIPGL_03087 hypothetical protein
MSEHNNINSFENYSGSMNISKPGYLLLLFALLSILAVVVVKFGVIGIVLVLALMFGSVFI
YYLFCYPILGFYTAVGLNFLLIGLGRYIKGLPLGFGIDAILLLTYLALFMNKFREKIDWS
PANKSITFLCIIWFGYSLFEIINPEARSIQAWISGRGIAFYPLLFVPLTLLFINTNKKLE
WLLYVWGVFSILATLKGILQMVFGVDAAEQEWLNEGSYKTHILFGKLRVFSFYSDAGQFG
ANQGYTGVVFLIYSMSQKKILSKLFFIFVGVLGIYGLVISGTRGALSVPIVGFMTYFILS
KNIKVIITGIAFLAIIFVFFKYTTIAQGNAQVRRMRTAFDPNNASLQVRLDNQKILKNYL
ASRPFGGGIGHGGTKAQRYLPNAFLSNVATDSWYVLIWVEQGIVGLLLHLGILFYVMIKA
SLIVMFKIKDPILKYKISALIAGMAGVMVASYGNAILGQMPTALLIYATMAIVLNTEVFE
KENEMNQNALNKL
>FCMOIPGL_03088 hypothetical protein
MKKLKKIVSEDNFLSLSGNVVIAILGISGFALLARSLSLEVFGEWVLFIAAGSLVEMFRF
GITNTGLIRYLSGADDNSRVKLIGSNALISLCATVLVALVLIFCKLFFPEAIQNSGYNMF
FTWYPLLAFLNLPWNIALVVLQADRKYMQILALKSINSGVFFIIILIHFLILKLTLNQLV
IGLIIVNAATSILSFVLGWDGILLIKKASVETNKVLLHFGKYTTFTLIGTNLLRSVDTLI
ISLSPLGSAAVALYSIPLKLTELQQIPLRSFVATAFPKMSKASLHNKIDEVKSLFYTYSG
ALTYLFVGISLVTFVFAEFFVIVISGHQYLTTDPVTGFNVVDIVRVFSIYGLLLPIDRMT
GVGLDSVNKPKINAIKVFVMLIANVIGDLVAIFIFKSLIVVAIASIFFTILGIWMGMYFL
DKELSLSFKEIFRKGMLFYVSLFNKATHNHYERLVKIENKNK
>FCMOIPGL_03089 hypothetical protein
MKIVDFIRLILRHLGVLIFVPFLLALLVLILTLKPNLEYTSQTVLYTGLATGSSIEMDKT
FNYFATNIAFDNLINIINSRETQEEVAVRLLATHLMLPEANPKYISKKIFDELSLKVPKD
IYNYIEKGENKAGLQIDSLAVYNFLPPEINRYNYEKTVENLLTLMKSSSGNYIYELLNYE
EDLHYSLKALSTIKASRINSSDLVKISYTVDDPGICQQTLEIYNAVCIKNYKKIKENRSD
AVVKYFEEQLSLANKSLKKAEEKLLEFNKTHNIINYYEQSKAVAVVKEDMEVDYNNKKAQ
LAGTIASTKRLEEKLKVQDKIQKETYKILENKKLLGDINYQIAFHEGSLESKANELLLSK
INDLEKQKEVINNELRESVDNIYSYQNSVEGVQLSKVLPDWMNSVVEADNLKAKIGVMDQ
QNRKFLEQYATYAPAGATIKRLEREISVSEQGYLELLHGLNLAKLKLQDNEMSSNIKSID
PPYYPLSANPTKRGLFIIAAAFLGGILTLGIILLMEYFDNTLRNTSRASKKLGLKSLGML
PKMVVDTLGVDIAFIQKRVIGIITQNIVQYLDKNASKKAVKTIIVFSTRKKEGKTVVAGN
IARTLKAEGKKVVLLNYDSEPEPINQQIKYPFLNKILGYPDSRIDRTNPFLSEVSSYLDN
SEYFSYTINNQFIDAKDYSEMLEQNNISLNYNPDFVIIELPALIYNNYPLSLIDNADLGI
LVCRSNRVWSDADKSAMSNLLTTSASKINFILNGVHIDEMESVLGELPKERSKFRARLKT
IFKFQFFSNSQI
>FCMOIPGL_03090 hypothetical protein
MNKFFHLLSICCLIAISLNTIQAQTSQIDDNSLEGSEFGLPPLNVVLDSVLKRSAGLNFR
KHHIGVKESTLKTEKIYWTRNFGFQAETKFGNLNSFSTDSDGAISSSSLVTTQQATYFVG
AYIKFPVFDLLNRKNQVKLAKLEIDEAKSMAQSIEDEIRQTVIKMYQNLILKQKILKIKS
KAFGDGKVNMQMVEKEFRNGVVPVSEYVRITSITSNVEVDYEFAKSEFITAKKLLEDMAG
FTFYQ
>FCMOIPGL_03091 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MSSNINILYIGNLRDYFNLDNKNCTITNLENSIKATKYLQSNQKIDAIICDYYLPGNTGV
FLYDWIRAQSEYNSIPFVLIAKEFNVDVYKRAFKKQIDDFYVSTVTNPEDILKRVEFLCT
HKKPISKKEVPKIKEEGYKMPISKRLFDIFVASSVLLLASPFLLLILLAIRLESKGKVYY
ISKRVGRKTFDFYKLRSMRTGSDELLKKLAAEKNQYKKEEIKSEDSTLEIPCPRCSALPD
GETCSPLMYIDTHQICDYWFNVQKRESAKNNSTFVKIVDDPRITRVGKFIRNTSIDELPQ
LINVLKGDMSIVGNRPLPVYEAEMLTGDDLSKRFLAPPGITGLWQVELRGKGGKMSEEER
MRLDNEYADQFIGDNYSFWYDIKLILRTVPALFQSDTV
>FCMOIPGL_03092 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MKKKILVVDDEISICMLLQNFLSKDYEVVTIYSALEALEWLEDNLPDLIISDIQMSEMDG
YEFLTKVRTRGFTKHTPVVMLSGRAESKERIKCYRLGAQDYLTKPFNPEELEELVKKNLY
PIHYAIEW
>FCMOIPGL_03093 hypothetical protein
MNLPPNSNLSKIKLYDLQLVDQMCRGNQEQVLNMVEVFIGQISQSIKDIKIAYSENDFLK
IKSLAHKIKPLLTYFGTSKLEKEFLLAEDLISKETTSLELDSKIENLDLMINEVISELKI
DFNLIDK
>FCMOIPGL_03094 UDP-glucose 4-epimerase
MCERLLNEGNEVYCLDNYFTGQKQNIIHLLKNPYFELIRHDVTEPFYIEVDQIYNLACPA
SPVHYQYNPIKTMKTSVMGAINMLGLAKRVNAKILQASTSEVYGDPLVHPQTESYWGHVN
PIGERACYDEGKRSAETLFVNYHQQNNVDIKIIRIFNTYGPNMHPHDGRVVSNFIVQALQ
NQDITVYGEGNQTRSFQYVDDLVEGMIRLMNSRDGFTGPVNVGNPNEFTILELAQKVIKL
TGSTSKIIYKPLPSDDPMQRQPDISLAKKELDWSPKVQLDDGLIKTIDFFKTII
>FCMOIPGL_03095 UDP-glucose 6-dehydrogenase TuaD
MKVTIVGSGYVGLVTGACFSEVGIDVTCVDIDQKKIENLKEGIIPIYEPGLEEMITRNMK
KGRLSFTTSIKEALEESEVLFISVGTPPDEDGSADLKYVLAVARDCGKHMNDYMLVVTKS
TVPVGTSKKVKKALQEELDKRNVDIEFDVASNPEFLKEGAAIDDFLKPDRIVVGLDSQRA
EDLMKSLYNPFTLNGHPVIFMDIVSAEMTKYAANSMLATKISFINDIANLCEIVGADINK
VRKGIGSDSRIGPKFIYPGIGYGGSCFPKDVQALIRTASENNYELQVLKAVEAVNKYQKL
VLFNKINAYFKGDLKGKTIGVWGLSFKPQTDDMREAPSLYIIDSLLKAGANVKAYDPVAI
EEAKHHFGDTITYCEEQYEALIDADCMAILTEWPEFKFPSFKIIKKLLNNKVIFDGRNIY
DRDQIKRNGFEYFCIGVDTAESNKSLTVN
>FCMOIPGL_03096 CAI-1 autoinducer sensor kinase/phosphatase CqsS
MNTKENTNTTSFSLKGKKILVVDDNIMNRMVANVILQEFEVTVLEAADGDEAVNYLKDNS
CDLVLMDLQMPVLDGFKASEIIRQELKLETPIIALTASDIQEEKEKCFEVGMNDYLFKPF
NKNQFIKIIIKWINN
>FCMOIPGL_03097 Transcriptional regulatory protein YpdB
MVCIIIDDDATARLIIKQHCLKSQSINVLEEFSSAIDAIKYLNNNKVDLVYLDIHMPTFS
GFDFIETLKNPPKIVLTTSDKNLALEAFEYKSVVDYLVKPISKERFEKSLEKLVAISIVD
KPLLTDEKLSEFIYVNVDKRLVKVDIASIYLIEAKGDYINIKTNDKNYLVHSTLKKIEDK
LPSNMFFKVHRSFIINFSEIIDIEDNTVLIRQVVVPVSRSNKSELMKKLNLL
>FCMOIPGL_03098 hypothetical protein
MEQPNLVFIKEIVGDDAAFQESLLEIIKKEFPEEVKLFIKNFSQKKYEEASNNVHKLKHK
ISLLGLKEGFDMATDFENELKEGKTTLHSSFLEILNKIGLYLHL
>FCMOIPGL_03099 Regulatory protein AsnC
MKIDGIDKIIIKSLVNDARTPILSIAREVGVSGAAIHQRLRKLEKSKLIDGYKMVINPKI
LGYSTTAFIGVFLDSSSLYSSAIKRLKEIPEIIESHYTTGNYAIFIKVLCKNNEDLMHLL
NKDIQNIKGVSRTETFISLDQQIDRQISI
>FCMOIPGL_03100 Biotin carboxylase
MFKKILIANRGEIALRVIRTCKEMGIKTVAVYSTADAESLHVRFADEAVCIGPPSSSESY
LKMSNIIAAAEITNADAIHPGYGFLSENAKFSNLCEEHNIKFIGATGKMIDQMGDKANAK
STMIAAGVPCVPGSEGVIKDFEDCEKIAIETGYPVMLKASAGGGGKGMRAVWKSEDLKDA
WESARQESKAAFGNDDMYMEKLIEEPRHIEIQIVGDSYGKACHLSERDCSVQRRHQKLTE
ETPSPFMTDELREKMGDAAVKAAEYIGYEGAGTVEFLVDKHRNFYFMEMNTRIQVEHPIT
EEVVNYDLIREQILVAAGVPISGRNYYPQLHAIECRINAEDPYNNFRPSPGKIVTLHTPG
GHGVRMDTHVYAGYTIPPNYDSMIAKLIVTAQTREEAINKMKRALDEFVIEGIKTTIPFH
RQLMDHPDYVAGNYTTKFMEDFVMES
>FCMOIPGL_03101 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDIKEIQNLIKFVAKSGASEVKLEMEDIKITIKTGTEKTETTIVQAAPYANVPPVAAAAP
VAGNSVAEIVTAVKADDESKYLVVKSPIIGTFYRKPAPDKPNFVEVGTEVSVGDTVCVIE
AMKLFNEIESEVSGKIVKILVDDSSPVEYDQPLFLVDPS
>FCMOIPGL_03102 3-oxoacyl-[acyl-carrier-protein] synthase 3
MTKITAAITAVGKYVPDYILTNKELEEYVDTNDEWITSRTGIKERRILKGEGLGTSYMAI
KAVEDLLKKSKVNPEEIDLVIVGTATPDLPVASTAAYVASEVGAVNAFAYDLQAACSSFL
YGMSTAASYIESGRYKKVLLIGADKMSSIIDYNDRATCIIFGDGAGAALFEPNNEGLGLQ
DEYLRSDGIGRDFLRIEAGGSIMPTTAQTVNDNKHFVYQEGKTVFKYAVSNMADVAEKML
TRNNLTEPDIQWLVAHQANKRIIEATANRVGVASEKVMMNIHRYGNTTSATLPLLLADYE
NQLKKGDNLIFAAFGGGFTWGAIYLKWAYNS
>FCMOIPGL_03103 50S ribosomal protein L32
MAHPKRKISKTRRDKRRTHYKAADQQIATDPTTGEAHLYHRAHWHEGKLYYRGQVVLESA
AAEA
>FCMOIPGL_03104 hypothetical protein
MKGLKDFTIPFVGLKEGKHLFEYIIDSKFFEAFNFDEFSSSSVKVLLTFVKKSTLFELNF
TAEGTVEVPCDVSNELYHQEINTKLPIVVNFGPEYNDDNEEILILPHEAYEIDVSQYIYE
MIVLAVPNKRVHPKVLDGTMESEALNKLKELQIKEVKTVDNTDPRWDKLKNLITEKKT
>FCMOIPGL_03105 4-hydroxythreonine-4-phosphate dehydrogenase 1
MDKSDKIIVGISIGDLNGIGIEVILKTFEDKRMLDFCTPVLFGATKVISYHKKALRIETP
VHGITSINQINHSKINVLNIWKEEVAIEFGTATKVSGEYAAKSLAAAVEHLKDKKIDVLL
TAPINKENIQSETFNFPGHTEYLEANLEGKSLMILMTNELRIGLITGHIPISKVAESLTP
ELIKSKVETMHMSLMQDFGIDKPKIAVLSLNPHCGDKGVIGTEDDEIIKPTIEKIRETGK
LVFGPYAADGFFGSETYKQFDGVLATYHDQGLAPFKALSFGKGVNFTAGLNAVRTSPDHG
TGYDIAGKNMANPSSFVEALFTGIEVFKTRKEYLELTHNPLIVK
>FCMOIPGL_03106 Riboflavin synthase
MFTGIIETLGLVTNVVKEQENVHLTIESNITNELKVDQSVAHNGVCLTVVAINNNEYTVT
AIKETLDKTNLGKLKKADIINLERAMKLGDRLDGHIVQGHVDETGICKNIKDENGSTVYT
FHYNSDKNNITIEKGSITINGISLTVVNSKKDEFSVAIIPYTKENTTFKTLQIDDVVNLE
FDVIGKYVARLTNL
>FCMOIPGL_03107 DNA polymerase III subunit tau
MLFNQIIGQEHIKKHLQKSAENGRVPHAQLFVGKEGCGTLPMAIAYAQFLLCNFSDDVDS
CNIKCNKLQHPDLHFAFPVTTSDAVKKHPVSDLYLEDWRSFIADQPYGSLFNWLQHIGVE
NKQGLIGVDEAEAVVKKLQLKSYEGGFKVMIIWMAEKMNIAAANKLLKLIEEPPNKTVFL
LITENEEQIINTIRSRCQALHFSALSEQDIENALIVNHQVEDKEAANIAHQAEGNLNKAL
HLMDKDAADLVFEEWFITWIRTAFKAKGNAAVVQQLIAWSDTIAKSGRETQKRFLEYCLQ
FFRQALLLNYKSDQLVFMETKSGFNLSKFAPFVHSGNILDIEKELNDAMYHVERNGNAKI
ILLDLSMKLTRFLHKKEEKI
>FCMOIPGL_03108 Phosphoglycerate kinase
MLKISTKMKTLKDFNFENKKAIIRVDFNVPLNDKFEVTDATRIEAAKSTIIEVLEGGGSC
VLMSHLGRPKGKQDQFSLRHIVDDITNIIGVNVKFVDDCVGPKVEEAAANLENGEILLLE
NLRFYDEEKKGDVAFAEQLSKLGDIYVNDAFGTAHRAHASTTIIAQFFEGNKCFGNLLAR
EIESIDKVLNNSEKPVLAILGGAKVSSKITVIENILDKVNHLIIGGGMSFTFIKAQGGTV
GDSICEDDKMELALDILKQAKEKGVEVHIPVDVIAADDFSNDANTQICDITKIPDGWQGL
DAGPKSREIFDEIVNKCKTILWNGPLGVFEMETFAGGTIALGNSIEKATKNGSFSLVGGG
DSVAAVKQFGFADKVSYVSTGGGAMLEMLEGKTLPGIEAILK
>FCMOIPGL_03109 General stress protein 69
MKYTKLPNTDTKVSKICLGTMTWGNQNTEAEAHEQMDYALEKGVNFFDAAELYPVPANAE
TYGETERIIGNWFQKTGNRDKVVLASKIAGTGDYTKHIRTGGFNKQNITEAIEGSLKRLK
TDYLDLYQLHWPDRGVNCFGSREYPYKTFSKEVEKHLEILETLQDFIKQGKIKHIGLSNE
TPWGTLKYLQTSTENNLPRPVTIQNSYSLIHRPYEIGLSEVSMRENIGLLAYSPLAQGVL
SGKYLDGNLPEGARGTLYPRFISRYKNDGSEKAVLKYLEIAKKHNLSLIQMSLAFINQLP
FVTSNIIGATKISQLKENIASIYVHLSDEIIDEINAVHALIPNPAP
>FCMOIPGL_03110 hypothetical protein
MFRHQGKSRTLKHNLRIASILSFVAGVVNVSGFLAFKQLATNVTGHFALFINDVAHFKFW
KGTIYFLYIFSFLLGSFSSSFLIEIFKENKKLNVFVIPTIIESLVLISIAIISDVVVIQY
PNLIICLLLFSMGMQNSFVTKISDAIVRTTHLTGLFTDLGIELSQLFFPETHPHREEIKS
TIKLRIFIICFFFMGGLIGGFIYSKLDFKLNTLIFGAIILLISLFFDDFRYKVIRTRRKY
KHKKNVKGNIITSLE
>FCMOIPGL_03111 hypothetical protein
MKTKESDFFIDKLIVKYQAFTHKEKTILNLSIALFFVLFIIGSFYNGGEVLGKFLYNISH
>FCMOIPGL_03112 UDP-2-acetamido-3-amino-2,3-dideoxy-D-glucuronate N-acetyltransferase
MDYFAHETAIIDDNCIIGKDTKIWHFSHIMSNCVIGESCNLGQNVVISPDVILGRNVKVQ
NNVSIYTGVICEDDVFLGPSMVFTNVINPRSAVIRKNEYQKTIVKKGASIGANATIVCGK
TIGEFALIGAGTVVTKEVLPYALVVGNPSKQIGWVSEFGHKLEFNELGFAICKESGEEYN
LTNNSVTKI
>FCMOIPGL_03113 Deoxyribose-phosphate aldolase 1
MKINQFLDATYLKTASQANITEEENQQNVVDLINEAILYNYKLVMIRAKYIPLAKEMLLK
ANVDVLIGTVIDFPEGNSSKEIKLEEAQKAIALEADELDFVVNYTAFKEGKINLVKAEVF
AATKLGLENNKVVKWIIEVAALTSEEIITITQLIKEVVLTNFDENAAKKVFVKSSTGFYK
TENNLPNGATFETMKLIAENAKPLQIKAAGGVRDYGTALKMITLGVDRIGTSSAKEICTK
QEGNNAGY
>FCMOIPGL_03114 hypothetical protein
MKNLKKLPTKQLEKFSNIFTQLGLVVVLFVVYLTLEHKTEQKQFAVVDFDPPEIVIFNPD
EIIEFRREVQKAPKIPEVSVVDVFIPDEPIKKGDNNVVETVINLPKDKIVHINPDDIVVI
DETWETPIETVPFINIEFAPVFKGCEGLSKEENKVCFDKKMKKFVQRNFDIELASELGLQ
SGKYKIQTQFIIDNQGNVVDIQIRAPHDKLKNETQQLIEKLPKFTPGKQRDKSVKVKYTM
PISFQVD
>FCMOIPGL_03115 hypothetical protein
MFQLGKTIVSEDIIEKNFVCNLSACKGACCIDGDAGAPLEKEETKILEKIYPKVEPYLSE
KSKAVIEKEGTWVTSEWGELETPLIDGADCAYVIFDKNKTALCAIEEAYNQGEIGWKKPV
SCHLYPIRVKDYSEFSAVNYDKWDICDDACTLGKELQVPVYKFVKQALVRKFGQNWYDEL
EKVAENM
>FCMOIPGL_03116 hypothetical protein
MTFSYKEIITAFMVLFAVIDIIGNIPIIIDLRKKVGHIQSEKASLISGLIMIVFLFLGQS
LLKFIGIDVHSFAVAGSFILFFIALEMILGITLYKDDGNHGVVTATVFPLAFPLIAGPGS
LTTLLSLRAEFAIQNIIIAVILNVIFLYIVLKTSSKIERLIGATGILIIRKVFGVILLAI
SVKLFTQNIKMLFI
>FCMOIPGL_03117 hypothetical protein
MSFDAIIIGGGVSGMQCALVLGSAKNKAFAADKKIAIIMHQKSSHLENALFNNVLGLQPK
TLGKDILTNGKEHLSTLYPHISQIDSEKVLSVKEINGLYTIVTNKKKYQSKIVVLALNYA
KPFLIKGLDLFIIPHKKANPNKDRIQLKNDDYLIKKRLYCCGTIAGCRSQFSIAAGSGAS
VATDILTIWNENIPTKVHDKV
>FCMOIPGL_03118 hypothetical protein
MEIKKNPKQQLENYSKIFMQIGLVLTLYITYACMEYKTYDMDNTSNLGVVNMIDEMQEDI
PIVEIKKVEPPKQNDPPPTIEKIKVVEDDLKVEETIIESTETDEGQAVVVNTQDIVEVEE
VEEVVEDIPFILIEDVPVYPGCKGNNKELKDCFTKKVTEFFGKRFDVNLATELGLQPGKK
KLFVVFTINKNGKITNVRSRGPHPVLEKEVGEIIGALPKMTPGKQRGMPVGVSYSIPITF
EVR
>FCMOIPGL_03119 Transcriptional regulatory protein DegU
MAKEVSSIGDIRLINSLQEAMSILIETNFDLLILDLKLPDGNGIELLKWLKEKKIDTKVF
VFSISKELKKTALRYGAYAFFDKAKDADELIEALKKA
>FCMOIPGL_03120 Transcriptional regulatory protein DegU
MNVIKLILVDDHKLLRDGLRNIIEQRSNMHIIGEASDGREAIKVCTKLMPDVVVMDVAMP
GLNGIEAASQIHKINPKIKIIGLSMHSSKQFIQGMFKAGAFGYLLKDGDSDELIIAITTV
VENKKYLSKDINQEFLTLLKQGENLQKAKLSTREKEVLQLIAEGKSSKEIGEVLFLSSKT
VDVHRNNIMKKLDLHTIPELTKYAIQKGLTSLDV
>FCMOIPGL_03121 Oxygen sensor histidine kinase NreB
MRIRKKFQIAFILTSIIFIAGIITIFYFTLMNDFEEVEGNRLNQRVENSAKAIDNFMLTR
IADFNVLSNNPLFSSSSSEITSEYLTRVENQYPFYNKLLFVNKEGIILSSSDKKFIGENL
LQLEPDLEDEFKKTINGGNDDVFVSNLSITSKDEIKKNQSFNLKLFSDVIDLEGNVVGVL
VGFMNMKPLNELILYIDNISTGYKRTYLLNNEGVVLVSGNKEVKIYQKHPDFLINELQQK
FEKAEKGFYFNENSKGIKFLSGFTTLSKYGTESVNNWYLLRIVPFNEIMKPFYKTVYIVV
FIILFIISLFIIFLIYSNTKRVKNSLLAAESREYSLKEVSKVAKIGYQEYDIATNTFIWS
DYVYEIFGLDPKDGMPSPEEIVSVFDKESQKKIAEADQNIDYNGIHCDIELKLINKREQE
VWVRYVAQPVVNQKNKIVGRRGVLQDITVSKNAQLELQHSKQQIQDSLDLLEKSEFAKDE
ASKVGKIGYWNYDAATGDTVWSDYVYEIFGLKPQKIAPVITETAKFFNKEYQIKIAQVTS
DLATKGIPYDIELKFINKDNKEVWIRTKGQPIYNEQNEIIGRGGITQDITESKIAQLELE
LSKQKIQATLELLEKSEFAKSEGNKMAKIGYLEHDLATNVFVWSDIVYQFFGLEPSDEIP
SRDEIMKLYDKESQEKLAQANLKLITKGISYDVDLRIINFKKEEVWVRNAVQAVYNQDNK
IVGRRGVMQDITASKKVQLELQFSKQKIQESLKLLEKSEYSKNEGSKIAKIGYWDHDLIT
NTIIWSDYLYQIFESNPKNGIPPQNEIMEKFDKESQEKLAQATLDIISKGISYDIELKFI
NKQNEEVWLRNVAQPIYNKENEIVGKRGVMQNITASKKAQLELELSKQKIQISLDQLEES
EYSLKETSKIAKIGFWEYDLSTKVFIWSDYIYHIYAIDPKDEIPSRKELIAFYDLESQKK
IQQSIQDISIKGISYDIELKLINLKKKEIWVRTVVQPIYDKENNIIGRRGVMQDITASKK
VQQELELSKQEIQESLNLLEQSKYSMDEASKVAKIGYFEQDIATDTFKWSDYLFNIHGFD
PVKKIPSKEEFFKNIDKESLEILNEATSNLYAKGVSYDIEMKIFNQIKNKNVWVRSVAQP
IYNEKNEIIGRRGVTQDITASKKAQQELELSKQEIQESLNLLEQSKYSMDEASKVAKIGY
HDYDIATDTFIWSEYLYYIFGIDPKETITRNKAITYFDEASKEKVIQATLDLDSTGTPYD
LELKIINGRNEEVWVRNVAEPIFNEQNEVIGRRGVSQDITIAKKAQLELEVSKQEIETAL
ELLEKSEYSKNEASKVAKIGFMEYDNATDVFKWSEYLYNLYGLDPTKKVPPIKEIIPYFD
EESKQKMKVATTALERDGVPYDLELKLFNQKKKTVWMRLVVQPVYNEQQEVVGRRGVAQD
ITQRKLIQNELDRQNKRLFELNNSLNLAQKLSHVGSWQWDMVTDTAEWSDEMYNIYGVSK
ENFCPTNENVKKTVLPEDLYKLEQGVSSLLINKTFVPFDFRIQRPSGEVRTVFIMALEKA
DNEKVFGVTKDITERVQIEKENLRIKNNFRRLFDNATISIWNEDLSQVFKEIEVLRRLDI
PNIKLYLEAHPDITNSLLDKIKINSVNRATLKLFKAKSHQEFLNNFRDTLGIGSKKVFIR
FIEAIWNNEKAFTSEVTYKTLAGDEFATLLSVGIPKTLTEQQTVPVSVQSIQSIKDAQLE
KKESIRRLKEAQELAHVGSWLFNISSKKTEWSDETFRIWGYDLDKSVPSHAEIINRIHID
DQEMFKNSGDLASTIGEPYDIEFRIYIPNQEQKILRSICQPIFDENGKVVTLRGTNQDIT
AQKLAMQEIEKAEEMYRILTDNSNDLISLQEKDSTFKYVSPSVKTLLGYEPSSFIGKKVF
NLVHKQDVEKLKEDIQNRLSTDKYNEALTFRVRHKEGHYIWLEYLSSPVYEGKEISHFVT
TSRDITMWVKAKKEIEEYQKSLQKMTTEITMIEEKQKKEIASNIHDHLSQSLVISKMRIN
QLKKNPQLQVIDDDLKFIETHISEALENSRKITYELSPPVLYQLGIIDALNWLLDDVEAT
HKITCQFNSNVNNVKLDDVKSILLFRSIQEVIKNTIKYANASLITLNFDRNDFGIYILIY
DDGIGFNTDKLKNINNHSGSGFGLFTVQERIQNIKGKFSIESQKNVGTFVKIFIPLAT
>FCMOIPGL_03122 hypothetical protein
MNYSQIALLLLQGTIVAFLILLLFRLRKKLGIGVLFACLGLFQFVQVFLSSTLYVSIANN
FIVSPGSSVLFTATLFVLLIIYIKEDSFETEKVIYTLLIVNVVMSILLLTFGLNFKEESA
LNPLNISINLFDISAWVLFVGTITLFLDSLLIIIIFEFISKKIKYLFLQICLTMLIVVIF
DSIFFSIIAFWNFNNLSSILVSGIISKGVFAIFYSIIFYIYLRYSNSVNNLSKTFKIKNF
INRNG
>FCMOIPGL_03123 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGISAYIGFREAYPIVINGLKRLEYRGYDSAGVMIYDGDQMQLSKIRGKVSDLEGVTNK
DEARKKGNIGIGHTRWATHGVPNDINSHPHLSQSGDLAIVHNGIIENYDTIKKELISRGY
TFKSDTDTEVLINLIEEVKINEGCKLGKAVQLALTNVVGAYAIAVFDKTKPDEIIVARLG
SPIAIGVGDEFKEFFIASDASPFVEYTKNAIYLEDEEMAIIKLGKKVKVHKINDDSKVEP
TVLKLQMSLDQIEKGGYDHFMLKEIHEQPKAITDTFRGRLLAEENMIRMSSIEDNLDRFL
NANRIIIVACGTSWHAGLVGEYLFEDLARIPVEVEYASEFRYRNPVVTDKDVVIAISQSG
ETADTLAAIKLAKSNGAFVYGICNVVGSSIARETDSGAYTHAGPEIGVASTKAFTTQITV
LTLIALKLGRANKSLSEEIFKNYLDKMQLIPEQVEQLLKIDEHVKSIAAVYKDAKNCLYL
GRGFNFPVALEGALKLKEISYIHAEGYPAAEMKHGPIALIDENMPIFVIATNKGHYEKVV
SNIQEIKARAGKIIAIVTDGDTQVRDIADHVIEIPDTEEALTPLLTTIPFQLLSYHIAVM
LGKNVDQPRNLAKSVTVE
>FCMOIPGL_03124 hypothetical protein
MRKIIIKSVYVGVLLSFISTIISCEEDFTDIRSNVISNTKFDKATASIEITAKNSTIEKV
KSDNITTEPGQYLLGVYKSTDYEKIEASIVSQLAINTSLSLIEADTITKYETSTTSILTT
IDTVFIKLPYQATLTDNTSTGPVYTLDSIIGDQTKAFKLNAYETSTYLNKLNPLDPSKLN
TYFSNDVFDTTGDALNAVPDFEFTPNVKDTVIMIKRWASNKTLVQTDEVKYSTSTTTVVP
LPFATIPLNEEKFKQLFLDKYGSSDFDSQEAFNDYFRGIILEASGDQGSLISFNFNNSVT
ALNPSIEVYYTNTVINTQSNDTIKTFRKNNSFLLSGVRSAIYKMDEKVYPENNEIKLQGT
AGSEATIDLFGAEDLDNNGIADKIDDLRANDWLINDASLTFYINQSADTTAIPYKLYMYK
TADDSTISENLTQIKDSYSEVTFGGVLERDANGKVEKYTFNITDYISDLSSGEEETSPIL
KLKVHNITDDPVSSTVFTNYSWSPKAITLFNEDVMNGDKRAVLKISYSERKN
>FCMOIPGL_03125 Glycogen synthase
MKDKRILFVSSEVVPYLPETELSSTAFISAKNAHSKGVQTRIFMPRYGVINERRHQLHEV
IRLSGMNLVVNDIDMPLIIKVASIPKERMQVYFIDNEEYFKRKAVFTDEDDELFSDNDER
AIFFAKGVVETVKKLNWAPDIIHVHGWMASLLPLYLREFYKEEPLFTESKIVTSLYNSGF
EGELNTNLAEKVKFDLSETNKLETIQTPNHTNILKSAIENSDAIIQGSETVSEELSSFIE
EKELPVLEYESENLKESYLNFYAELLAANK
>FCMOIPGL_03126 Pantothenate synthetase
MQNIKAYKRTIGFVPTMGALHKGHLSLIQKAKKKNDIVIVSIFVNPTQFDKKEDLIKYPK
TLENDSKLLESVDCDVLFYPSVEEIYNKNVVSDAFDFDGLEHQMEGKFREGHFNGVGTIV
KTLFEIVTPNRAYFGQKDFQQLQIIKKMVKKHRINVKIKGCAIYREDDGLAMSSRNTRLT
QEQREAAPFIYKTLKTARKKFGTENADIITKWVENRFKKHPLFKLEYFTIADEKTLETIK
DKEFGKKYRAFIAVFAEDVRLIDNIRLKN
>FCMOIPGL_03127 Aspartate 1-decarboxylase
MLVQVVKSKIHRVKVTGADLNYIGSITIDEDLMDAANIIEGERVQIVNNNNGNRLETYAI
PGPRGSGEITLNGAASRLVAVGDVLILIVYAFMDFEEAKKFKPCLVFPNEKDNTLT
>FCMOIPGL_03128 hypothetical protein
MGGFLVWYSISKISIDVLIGYFKEANYSWIFLGLFFGILSHLSRAYRWKFMLEPLGYKPK
FTNSVLAVLVGYLVNLALPRAGEISRATVMANYEKIPFEKGFGTIVAERIADLIMMLSIV
AITLFVQFDFIYNLLTKNFNPIKISIAIVVLIIGFYIFSSFVKKATSGFLLKIKTFVSGL
IEGVTSIFKMKNKWAFIFHTVFIWVMYVAMFWATVPAIEGLNVPFGGILIGFIAGGFSIA
ATNGGIGLYPIAVAGALALFNIPTEPATAFGWIMWTAQTAMIIVFGGLAFLLLPIYNKNK
>FCMOIPGL_03129 hypothetical protein
MNTEETDTKIVAYTVSREALTKEKYIQKVKEAEKRMEEGHFTTHEDLLKEMQSW
>FCMOIPGL_03130 DNA repair protein RadA
MSKIKTTFFCQNCGTQHAKWVGQCGACKEWNTIVEEVIHKEEKRVWKQSTTAKQSVNKPL
KIADIQLNPEERVVTNNNELDTVLGGGLVKGSVTLLGGEPGIGKSTLLLQVALNISQKVL
YVSGEESQSQIKMRAERLEGKNSNCLILTETNTQNIFKNIEETEPEVLVIDSIQTLHTSS
IEASPGSISQIRETAAELIKFAKETATPVLLIGHINKEGNIAGPKILEHMVDVVLQFEGD
RNHTYRILRSQKNRFGSTSELGIYEMLSNGLREISNPSEILISKKDADLSGTAIASTLEG
IRPLMIEIQALVSTAVYGTPQRSTTGYNLKRLHMILAVLEKRAGFKLGAKDVFLNITGGI
NVDDPAIDLAVVAAILSSNQDIAINPNVCFAAEVGLAGEIRPVSKIDQRILEAEKLGYKT
FVASKYNKITSKKHAIKLILVGKIEEAFATLFA
>FCMOIPGL_03131 Thioredoxin
MTENLTKETFLKKVFNFEENKDWKFEGKRPALIDFYADWCGPCKMIAPILEQLSEEYGDK
LDIYKIDTEAEQELAAAFGIRSIPSMLFCPAEGQPQMANGALPKPELERIIADVLKVTK
>FCMOIPGL_03132 Prolyl endopeptidase
MKYPKTNKKPVIENFFETTVVDNYRWLEDDKSAATKAWVKTENEVTNNYLSKIPYREQLK
DRLSELWNYEKIGTPFIEGDYTYFSKNNGLQNQSVIYRKKGDGEPEVFLDPNTFSEDATT
SLGSLSFSEDSKTAAYSISEGGSDWRKIIIIDTESKMITEDTLVDIKFSGVSWYKNEGFY
YSSYDKPKGSELSAKTDEHKLYYHKLGTPQKEDVVIFGGIPSEKHRYVFGSLTEDYKYLV
ISAQVSTSGNKLFIKDLSNPNSTLITILDHVESDTHVIDNRGSKLYLITNLNAPNKKIIT
VDTTNPTSENWKDFIPETENVLSISTGAGFLFANYMVDAVSKVLQYDLDGNLLREIKLPG
VGSAGGFSGKTTAKDLYFSFTNYNTPVSSFQLNPTNGTYTSYWKPSIAFNLDAFESKQVF
YTSKDGTKIPMIITHKKGLELNGKNPTILYGYGGFNVSLTPAFSIANAVWMEQGGIYAVP
NLRGGGEYGKKWHDAGTQFKKQNVFDDFITAAKFLISKKYTSSKFLAIRGGSNGGLLVGA
VLTQKPTLAKVALPAVGVLDMLRYHTFTAGAGWAYDYGTAEDSKEMFEYLKGYSPVHTVK
KGIEYPAILITTGDHDDRVVPSHSFKFAAELQDKQCGENPTLIRIETNAGHGAGTPVAKT
IEQYADIFGFTLFNMGFKQLPNPTKAKK
>FCMOIPGL_03133 Neutral endopeptidase
MRNIKKAFYTTAVVFIAFMSCKTDKPEEKTPGIALENMDKTVKPTDDFFRHVNGTWLDKT
EIPDDQTSWGGFNQLRKKTDADVLTILNKAIENSNFPKIKDAKGNEIDSDQEKAVNYYQT
IMDTVARNTQGKAPVMPYLAKVDELKTKKDIETYLTNMAPYGGGGFYGFGVFNDLKNSSQ
YAGYMSSGGLGLSRDYYVDAKVKDKLEKYEVFVAKMLQEFGDDATTAKKNAATIVALETS
LATPMMSKEESRDIRKIYNPMTVAELQKLAPSIDWQAHLNGIGVTNLETVIVTDPGYFKA
LGAIFAKTSVADIKLLLRWNTINSSLGSLSTDLETANWEFYSKEMRGAKKQRPRDERALG
SLNGAVGEALGKLYVEKMFPPEAKEKAKEMIDNVMLGFEARIAQLPWMSAVTKEKALEKL
HKLTVKIAYPDVWKDYSELQVKGLKEGGSYFENAINVTKWNYNKNMDKLGKEVDRTEWGM
SPQTVNAYFNPVNNEIVFPAAILQPPFYDYKADEAVNYGGIGAVIGHEISHSFDDSGARF
DGDGNLKNWWTEDDSIKFKEIGGQLIKQYSDIIAIDSMHLNGEYTLGENIGDLGGVQAAY
EGLQIFLNKNGRPENIDGYTPEQRFFLSWGTIWRTKMRDEALKNLIMTNPHSPGMYRAYM
PLKNVDAFYKAFDVKEGDNMYLKPKDRVRIW
>FCMOIPGL_03134 L-fucose-proton symporter
MTQNQQKNTLVPILIIAGLFFIFGFVTWVNSALIPFMKTINELTDAQSYLVASASYISFV
VMALPASYIINKIGYKKGMSLGLITMAIGALIFIPAAEARTYWLFLLAIFIQGAGMTLLQ
TASNPYITILGPMESAAKRIAIMGIANKVAGSLGSVIFGTLLLSGIGSIKEKLLVVDEAE
KANVLNTMADSVVAPYIVMAVVLFLLGILIRKAPLPNVEAQPIKVSEIGKKAKTSIFQFP
HLWLGVLALFLYVGVEVVAGDTIISYGISLNIPVEEAKFFTLFTLMAMVVTYALGVFLIP
KYISQSFALKASAILGIILSFCIVLTTGFTSVLFVAALGIANALVWPAIWPLALTGLGKF
TKTGSALLIMAISGGAIIPPLYGALVDHKKVALITSGILEPSALAEASSFGYWILLPCYL
VILYYAFFGHKVGLKKE
>FCMOIPGL_03135 hypothetical protein
MKKYIYFVLLLLCCMCSNDLKENKTDIFDDEETTVLDNEAKLKQLYNDTIIPLFSDYNAI
DIPIEFQIIKDDMGINAGASFGYVEVSMGLVNLSKKSIQLFALTHEVAHIATLPQARLFH
LEGYVTNGAFVNEYQKSEYLADLIAIHLIKTKAPIYFEALKEDLAYLKLILGGETFTHPS
GANRLKEINKYITLSNTKTSAIAFKELYVEIWF
>FCMOIPGL_03136 hypothetical protein
MKKIFSILSLFVAFAITTVSCSNDDDPISLSTLATITDFTISINDVDADDITYDLGSAIT
IDVPFGTDISAVTPTMVISDGATITPASGEVISFVDGEAMSFVVTAEDGVTTKEYSVTIN
IKGEVGSGSQLLTYQIADLFGENSITTYTYNESNFVSSYSVELDDWGTLITAEYTIIYDD
KNQVIEKKSTEAKESTVYEYNDAGQIVEALYSNDGTLTYTYAYSYDAAGNLSKEVRTDHT
DADATTEVAFTIVDGNVTVETRYGDDYVATYDDKNNPFKGQYPAAYSAIHAAIQLVNTNN
PVSGTLADDAITYEYNTDNYPTKSSYTYFDGLATVEKTFTY
>FCMOIPGL_03137 SusD-like protein
MKKIIYILVFSLSFIACDDYLDIEPTGQIIPKSVNDYRSFLTAAYAITKNSKVLTTYRSD
ELSLSTSSVGIEQYEDLFIWNDLNPSPLTTAYPYATIYNIIFYTNHVINNADTMIGDTLE
KEQLLGEAYALRALQYFDLINLYAKPFNAATASKDAGVPITTVYDSEKEYTRATVQEVYN
LILNDLNEAEILINTDTQESGYKYRFSTLAVKAFKARVYLYQKEWEKAITSSSEALSINS
GLQNLNSDNSIMPSEYNSVEAILALEKVSSFDITSNASISENLLSIYNQAEDLRFASYFY
KDSDGTYHSNKSAETKFKSSFRTAEMYLIQAESYAQLNASTEAKEKLLELAVNRYTSDGM
AAYTLKVNALNAGDLLTEILEERRREFAIEGHRWNDLRRTTQPLLTKTYDGETYQLDKND
ARYTIPFPDDATINNPNL
>FCMOIPGL_03138 TonB-dependent receptor SusC
MKRLIYLLIFIPAILMGQNQKVITGQVVDKTTKTPIIGASVYVSSAIIGSKSNTEGVIDG
RMLGTTTNFDGEFKLTIRQDIKYFLVSYIGYETEKIAVSAEKTNYTIVLKESDEVLDEII
ITGYQKIEKRKITSAYEKIKVAEIEQSGVSSIDHMLTGQIAGVVVQPTSGAPGAPAKIVI
RGSATLNGSSDPLWVLDGIPLDGSDIPEDFRDKDNIDNLESYPIAGLNPEDIESITVLKD
ASATSIYGARAANGVIVITSKSGKKGSMRIQANGNFFVTQKPNFSKLNLMNSSQKVDFEL
YLAGRSDLTYQQDRGSVARILNYYGEYDNFQNNGFESLSLNTQNEINNLKQTNTNWGDQL
YQTAVNQQYSVSISGGDDQNNYYFSTGLFDQKGTTTGTGQQRYNVTLKDKFSINDKLKVG
VSLFGSQTKTSSYITGADAYTNPSYYSRTANPYLSLTDENGDYVYDPDLVERSDLNLNYN
VLEERENTNYELISNSLKAILDVNYKIAKDFEINSQLGLQLDFDKTEKFSDEESYYTRKY
EQRSQYNTSSGSAYYMPKGGIIQNWNSDVFQYNWKTTANYSTIFNNRHELDVMIGTEFRR
NKKTEIHAKGFGFNANTLTTIAITDERALTNSLFDTYSKSYYENAYASFFGTASYTLDKK
YTFFTSLRYDGSNLFGVNPKYRYLPLWSVAGSWNVFREDFISDIDFISDFKIRASYGVQG
NIDKSTSPYVIGEYYTETILPGTSEEIIRATSAPNANLRWEKTVSSNIGFNLGLLDNRIH
ITSDYYTRTSTDLIGLQSVPLESGFSFINTNWASVSNKGFEFLLHTVNIKKDDFKWSSSF
NISHNKSIVEDIEIREEDFKPSLKGYSSTAIFGIKTAGLDSNGLPLFWRDGVKVSAVDFY
NLEEGTDGSQLTREEHRNLYSYIGDATPKFSGGFNNSFTYKQFGLRILTNFNLKQTVKAT
PSYNLTQAQPGNNYSTDILKAGKGNLPALIGFNTPGFDTDLVYNWFNSSDDGRTYDDLDI
WIKDISYLRISSIKFSYSFPKKAVEKLNFSSLNFNIEGRNLFVIGTNYDGFFDPETYGSI
YAQPIPKIISVGFNLTF
>FCMOIPGL_03139 hypothetical protein
MKYTSFKDKALIRYTVFCMLFFICSTNFAQEKEDETKKDSNNISDTKKLNYQKFLKEAKV
KKGVFNLYTLKDEYYFEIPDSLLSRDFLIVNKVSSVPYALNGHGLNKGMTFETKMVRFYK
DTLANKVWVKTINPRVQSPTNDAISLSVKDNFRESIIEEFDIEANNTDSTSVFIKVNKVF
NGKEKSFSDVLTNIGLGGSVKTKLSKIETIKSFPENIVVKSIVTTGVKEAGSAELPLTIG
VTINIVLLPTKIMKPRFDDHRIGFFSIPMEYYSDSQHEVEIRHMITRWNLEPKDKDIAAY
SRGELVEPKKPIVYYIDPATPKQWRSYIEKGVYDWSVAFEAAGFKNAVKVKFPSDNDIDF
DADDVRYSVITYAASEKQNAMGPSVVDPRSGQILEADIIWWHNLMKGLHAWIRVQTGPID
AKARGNKFSDTHMGEAIRFVSSHEVGHTFGLKHNMGASFSYPVDSLRSRTFTSKMGGTAP
SIMDYARFNYVAQPEDNVVDITPKIGVYDTYAINWGYRWIQNKTAHEELPILNQWIRKHE
NDPLYFYGAQQNSIVDPRSQSEDLGDNAIKASEYGLKNLKRIMPNILKWTNEEGQDYYKA
SKLYKSVIDQWELYNNHVMANIGGVYVNNTVSGDGKDTFKPVSGAFQKKALNYLINNAIM
PQKWLFTPQITNKIFAVRDAPDGERYYSPVSMLRIYQTNVIYALVKTDRLMRITENQVLS
NDKEEAFTEEYLFDTLFDAIFKKTKKGLSLDMFDRITQKNYIDVLTVDRNKLLEKTKENT
ISNDTNKFKNIHFSYLPRVADIGTNKRAALEKALRLLEKKKRKGDRATKEHYSDLIARIT
YNLKN
>FCMOIPGL_03140 putative sensor-like histidine kinase
MASNNLFLKFKQHRQYFFISFLFIAIYFIGSALITPKITSVTENLVEDLIQGNLKDKENV
VFFEFNQLNSYLNDAEQIIKYSNKTSTKELKEKLVFTAGLALENQNISNTFIVFSKNDTV
DFYSPNKNALYTKEIHNYLSKKNVSETKNTRDTILTSKNKVLYRKTYAIKLKNDTTVTFG
YDVDLLNFWNYFSEKYKGDGGYTVVTNKDGVCILHPDTTYIGKKLEGYFDTISIEKVLQS
TIKINGYYVPRNKNILTSKAVSEFLDLEVLRYYQTIKISNTSLITVVSFPVQIHLKETTQ
SIQRYFSWISSLAFATFMLILIVYRLQLKKEFVENLRVLEEKEQLIYANEKYQKENAVLQ
LNQLKKKMNPHFLFNSLNSLHVLIDLNPELSQQFVIKLADVYRYLLEERDGNLISVKKEI
TFLQQYVFLQEIRFNNSLNVSIINKSDAKVLQNKIPFLSLETLVENAIKHNNITKQNPLF
IEVIILNDKIKVINNYMPRKQKDENSHQIGLTYLENTYQYYQIKNFNTAILDGKFICTLP
FINVK
>FCMOIPGL_03141 Sensory transduction protein LytR
MDIVIIEDEDLAANSLEKMLLKMEYPITIKKRLESVEQSIEWFKNNTCDLILSDIHLGDG
ESFEIFDSLKIKTPIIFTTAFDQYAIQSFQFFAIDYLLKPYDTVRLENAIKKHINFNKNT
AVDFKQLDKYILELKDSNEKKEEQKRFLVSIGENFRSIESNQIAYFMAENKSLFIFTISG
ESYLYADTISSLEHKLSKDQFFKINRKYIISHLAIKKIAKYSHNRLKIELQPQINARDLI
FVSSNRITAFKDWLNR
>FCMOIPGL_03143 (2E,6E)-farnesyl diphosphate synthase
MNILQYQQEFLQYLESKVWIHEPKNLYEPIDYILQLGGKRIRPVLTLMAADIFSSDYKKA
MPAALAVEVFHNFTLIHDDIMDDAPLRRGKVTVHEKWNINTGILSGDAMLILAYQYFENY
EPIVFQKLAKLFSKTALEVCDGQQLDVDFETRNDVTIDEYINMIRLKTSVLVAAALKMGA
IVAKTDEENANLIYDFGLNLGLAFQLQDDYLDTFGDPETFGKQVGGDIIENKKTFLYLKC
LEVANEKDRNKLKHYYNLKLDDNSIKIEEIRRIFDLNDIPVLIKHQIEHYTQKAFNTLAK
MNITKSNKEGLREFGLWLMNRTV
>FCMOIPGL_03144 Transcriptional repressor Mce3R
MYICTRIMKEKILEKSNELFLNLGFKSVTMDEIANALGVSKKTIYKYFSNKTALIAAVTD
NMFETICCSIDTVCEEKMNPIDELYHIKRIIMSHLKDEKSSPFYQLQKYYPKIYASLTQK
QFHVMQETVQDNLQRGIDSGLFRTEIDIEFISRIYFSGMIGIKDQQLFPVIKYSMNTLLN
NYLEYHIRGISTEKGVQELEQQLKNNNL
>FCMOIPGL_03145 Outer membrane protein OprM
MKKYIYIFSFFAFTISLKAQEKTMELSLKEAISFGIENSYNTKVARNDIKSAKDKVWETT
AIGLPQINGAVDYQQYLKLPITLIDFDGDGTNEEFVFVQKQSLNASVTLTQLLFDGSYLV
GLQASKTYLKISKQAEEKTELTTREAIINAYGNVLITESSIAILESNIKILQKNYDDAKK
IYENGLNEEEDVEQLEITLGNLKNQLNSVIRMKKIAYQMLNLSLGNDINTTLILTDNLDS
LVKTNIELALISEDFDVNNHIDFKISENDRETKRLTVKLEQSKALPTLSAFVNYGSQAYS
DSFSFFKGSQEWFASSLLGISLNVPIFSSFSRKSKTAQAKIALENANLRLEETKQRLNLL
AETAKSEYQLSIENYTTAQKNLGLSERIEKKQRIKFFEGISSSFDLLQAQNQLYTQQQNY
IQSMLDVISKKAALENALNLPIKQ
>FCMOIPGL_03146 Cobalt-zinc-cadmium resistance protein CzcB
MRKIYSLLVITTVLISCGEKKTTSIESLISSGTLTELTAKKKEITTNLEAINADLEAINN
AIAIKDTVKKLPLITTFVAKEEVFKHYLEIQGSVKTKQNILIYPEMAGILKSVYVKEGQK
VTKGQVLATIDDGGLSNQVAQLEATTQLAKTTYERQKRLWEQKIGSEIQFLQTKTNYDAQ
QNTLKQLKTQLGKSTIKAPFSGVIDDVIKESGNVVAPGIGSEIFRIVNLNNMYIEAEVPE
RYITSIQKNKEVKIEFPVLGTNINSSVRQVGSFINPNNRSFKIEVPVANKNGHVKPNLTA
KLQINDYTDDTAILIPQSIISENASGEQFVYVIKNKTSENEAIAERLVIKTGKTQGNFIE
VLENLPVGAEIIKEGARSVNNGQTVKVINK
>FCMOIPGL_03147 Multidrug resistance protein MexB
MTKQKKQVDKEFKLSAWAIHNKTTIYTLMAVLFFYGISAYLSMARENFPEVKETKIYIST
AYPGNTAEDIEKLITDPIEDQVKTVSNVVEVTSTSQEDYSIVVVEFDENISVELAKQKVK
DELATETASEDWPTFNGAKIEPNVFDLSLSEEIAILNVNISGDYPVYKLKEFAEYLQDDI
EDLSEIKQADIRGAQEKEVEVAVDIYKMMAAKVSFNDITSAINNGNVTMSAGNFITSGQR
RTVRIIGEIEEPKALENFVIKSEFDNPIYLKDVATVSFKDKDKTTFARERGQEVVMLDVK
KRAGENMVAASEQIQVIVNEAIKNYFPKDLKVTITNDQSDKTIGQVDDLVNNIIFGVILV
VTVLMFFLGFKNAVFVGFAIPMSMFMSLMILNLLGYTMNTMILFGLIMGLGMLVDNGIVV
VENVYRLMDEEGMNRIDAAKKGISEIAYPIIISTATTVAAFIPLGLWPGIMGDFMVLLPI
TLSTVLGSSLLVAIFFNSVLVSQFMSVEDVDMPIKKIAILTGVMTVIGIIILFIGGSYSA
LGALMIFVAIMLWVYRLFLRGWANTFQNKVLPILEGWYENSLRFALSGKMPYVIVISTTV
LLIISFMAFGWSLGTQRTKVEFFPDNKPNQIIVYIEYPEGTDIQKTNDITKQIEQKVESV
LYSDEYMDGDYNFMVESLVSQVGEGAGNPQTDGGSAAEMPHKGKVTASMREYKYRRGLDS
ELMRQKVQTALVGIYPGVLISVEKDANGPPAGSPINIEIKGNDYAELIHTAQRMRDFINT
KSIAGIDELKIDVNRDKPGMQVLVDRKKAGELGISTGQVGSQLRASIFGNKAGVYKEDGE
DYDIYVRFNKEDRYNTSALFNQNIIFRDMASGKVKEIPVSTVATQKNNSGFSAIKHKDVK
RVVTVYSALTPGETDAAAVVGKIQAEMENFKNLPKGIKIDYTGQIEEQNKQMAFLVGAFF
TGLALIFFILIFQFNSISKPGIIMLAIFLSFIGVFGGIVISGSSFVIMMTMMGIISLAGI
VVNNGVVLLDYAQLLIDRKKDELDLDHEDYLDKKSLYEAIVKAGGARLRPVLLTAITTIL
GLIPLAIGLNINFFTLFTEYNPHIYFGGDNVAFWGPLAWTVIYGLLIATFLTLIVVPILF
YLITQFKMWLKIKFA
>FCMOIPGL_03148 Regulatory protein RecX
MTKKVFTVDEIKRKLENYCVYQDRCHKEVEQKMREFRLIPEARELILLSLMKDNFLNEER
FSKSFARGKFRIKSWGKQRIVRELKFRDISAYNIKTALKEIDEDEYLKTIYRITENRNEV
ISEPNIYKRKKKLIDFLMRKGFENDLIYKTVNDVVS
>FCMOIPGL_03149 hypothetical protein
MKKAVLLFVFLMILVSCKSTLKPISFKNQQEIKKAVNTVLDDWHLAATEANFENYFNKMD
SISIFIGTDATENWTKKQFMSFSKPFFDKGKAWDFKTLERTIYVNASGDFVWFDELLNTW
MGTCRGSGVLEKSNNEWKIKQYVLSVSIPNDDVQAVIAAKKKNDAIFLKKFN
>FCMOIPGL_03150 hypothetical protein
MKNSFLFLVLVVFFSCDKKKDEVVEVQETKSVLSVVKNYGVAQKVDTTFLKDIEDWQELK
AVDLFLSRFKKASPNEILSNALELKELVKSLKDSVKPALFENPSFNTRIDILDNEVLRLS
DMTFIPAIKADEVSKQTEKIINAFSAVNSKVNSILLKERFQDEIELDLDFIGLDSTKIDS
VSRKSINNKLKDKRLNRKKMIEGS
>FCMOIPGL_03151 hypothetical protein
MKNTLEKSLKQSISYQEYRDLVTNLLAENKSTGPNQSEELTNYSLLNATRMKRLDKTIKI
SDETTKEIQQITTPQTWLLITEGWCGDAAQNLPIINKMADLNSNISLKLVLRDENEDLID
LFLTNGGKAIPKLIILDQENNVINTWGPRPTVATKMVADYKAKHGALDAEFKQDLQVWYN
KDKGKSTQEDFINLIKNN
>FCMOIPGL_03152 hypothetical protein
MFVEYNTIAEDAKVWVYPSSRKFYPTEIEEIEEKIKTFTENWKAEDENFKVSYQFLHNRF
IVFIADVSETTISNTDIDASVSFILELQETYKVELLDKMNICFKQGEFIQYKELKDLKKL
IKNKALTGKTIIFDNLINNKEDFENFWQIALEDSWYNRYL
>FCMOIPGL_03153 Fe(3+) ions import ATP-binding protein FbpC 2
MLQVNNITFGYSKKKIVLNNFNFTLYEGEHLCLMGESGCGKSTLLKAIYGLIDLHEGSIF
WKGNKVLGPKHHLVPGMDFFKYVAQDFDLMPYTSVSENIKKFLSRFYPEESEKRTQELLD
VIEMKPFEHTKVKNLSGGQQQRVAIARALAKEPELLLLDEPFGQIDNFKKNSLRRKLFRY
LKEKNIACIVATHDKNDALSFADKLIVIRNNKILVNNSPKEIYKNPKEKYIAALFDDVNE
ITINNKEYLLYPHQLKIIEKSNLKAVVLNSYFKGSFWLIEVEFENQVIFLKHPHFLEKKN
EISLDILKKEIT
>FCMOIPGL_03154 HTH-type transcriptional activator RhaR
MPNNFFKTHNYLKLEQSNFDIVNFQDLVRFEEEEILTINHKVNFYAFIFITKGFGKHSID
FTDFEYSKGTILAIRKNQMHKFYLNKEREGFLLCFKEEFLNSYLNEIEVASAIQMFNELL
VSPKTQLIDADFGGIFQLVKGIEKEVLEINDMYSFKLIRSLLHILITLIYRLKSKEHNHI
TQSKYLKEFIRFQNMLEEDYYKTRKVYDYATNLGFSTKKLNTVVRFIANKPAKEFIDETV
IIKVKRLLLEYDLSIKEIAFKVGYKDPTNLYKYFKKHTKSTPEEFRKQFIN
>FCMOIPGL_03155 hypothetical protein
MNIKEELFKQCEIFVNKRAQTVTEIISSNQKALNSETKSSAGDKHETGRAMLQLEMEKAS
QQLSGIQEMKEILSKINISKKSTIAHLGSIIETDSVNYFLSISAGQLTVNGKVYFAVSVS
SPIGKLLLGKTLGNELVFNKIKKIIRNIN
>FCMOIPGL_03156 L-2-hydroxyglutarate oxidase LhgO
MNYSYWELKEWFTNIDFTIVGSGIVGLNCALELKKIHPKAKILILEKGMLPQGASTKNAG
FACFGSLSEIIDDLNTHSEEEVFNLVDKRWKGLQLLRKNLGDKNIDYQQNKGFELCKDLS
FFEECVSKKTKINQLLKPIFKEDVFLVVPDKFGFKKVVSNHFVNSFEGQINTGKMVVSLI
GKVQKLGVKILYNISVENFVELGNKVEVKTDKITFKTSKLFIATNGFANQLLNINVKPAR
AQVLITKPITNLHIKGTFHLENGYYYFRNIDHRILFGGGRNLDFKSEETTKFGETAIIQN
QLEKILKETILPNTNFEIEHRWSGIMGVGFKNFSGQKKAIVKQVSENVFCGVRLGGMGIA
IGSIVGKDLADLV
>FCMOIPGL_03157 DNA polymerase IV
MELQPPFRKIIHVDMDAFYASVAQLDNPELVGKAIAVGGNEIRGVISAASYEARKFGVKS
AMSGVLAKQKCPHLIFVKTDFARYKEISAKIRAIFFDYTDLVEPLSLDEAYLDVTENKKG
NPSANDIAREIRQRIFDEIGLRASAGISINKFIAKVASDINKPNGQKTVHPNEVLQFLEE
LPVNKFYGVGKVTAAKMYNLGIFIGNDLKKKTLEELVKLFGKSGVHYYNIVRGVHNSKVK
PNRIRKSVAAERTFEENISSEIFMLEKLEKIADELERRMKKSDTKGKTITLKIKYSDFTQ
QTRSKTTAKFMQKKSEFFPVVKELLYQDEIVNSVRLLGLSFGNLNTILKEPVWVQLQFEF
NKI
>FCMOIPGL_03158 hypothetical protein
MGNQKLYKGSLQTIILKLLETNDKMYGYEITQKVKELTKGELQITEGALYPALHKLEADG
LLDVEVAKVGNRLRKYYKLTESGTKETANKLEEMQEFLKTMQHLVNPKFSLE
>FCMOIPGL_03159 hypothetical protein
MEKSYEITEKQLDFLEGFLKRKYPSITDETKIELTDHLISDFEATTENGNLSQYLSNELE
FIRKFVSTRVKLLGVNYNRDVWQEYLSYYTSIKKVPISIFTYFLIYFLSVNLNNKFVWLS
FFFSVFGVYGYSLFAQTSKIPIEIRKLPELQLLGKGITMGIPYLMCMVIFFPDIKTVLLE
NSILFSFYWFFAFSLSIAALIVMHKKKNIITEKYKHLLN
>FCMOIPGL_03160 hypothetical protein
MELTKTQIQQVESYLKNKRFDFIDLKVEVLDHMISDIESLISKNISFENALKMTILKWNT
HFRETSSFFFGLMYSDSKIVVKKAVKIFKPFYFLYLASYILPVIILMNFSFVFSETSINI
INGFLNGFTITFLCYLIFIIVKVITSKVKTTYRFILKTQYLGIIFLIIPLLTGNHFDDDK
KLNPVFTGFLLAGFAVTYICHYFYKKHEEAIKKYKIS
>FCMOIPGL_03161 hypothetical protein
MELSKEQLLQIDNYISACGIKFYDVRAEIVDHFANILEQKLIKNPDLDFKKEIENIHRNF
SDRGFSKLLKEKTKSVQKKFYKQSLKHLITFFKLPKIIISGALFYTLFLIMNLFEDKEFF
FQVLTGFGFLYIFIFFFSLFIKKKKKKELFLVLDMNTNFFNIINNTVIWLNVITSLRTSE
SFFNPIHNIIQLTFFVLFILFLWSASNVFYQNKKQVKEQYPNVIV
>FCMOIPGL_03162 hypothetical protein
MELSKEQIQYIDHRLENDGVKYWEIRIEMLDHIVSDVEKNLQPENTDYQFKELVQNAFVT
LGWKENFNGSSFPNNDKDTFKNVNNEYRKMYLQGFINFFKKPLNFFLFTLFCLILFSLSE
FLNLKTFKRVSIVFFILPLIGSLFELFKTSRNKYGKSIHRDFGVTYLTMSFLIFNFIIQS
VTNDSLFEMPIEYHKTILLFTIPFHLILSFSGYQVYKKSIRELEQMRKELLS
>FCMOIPGL_03163 hypothetical protein
MKLTKAQIEELYIFTRKHYVEYYDVQTELVDHLANDIESIWEEYPNLSFDEARNKSFKKF
GIFGFMDVVNSKESQMTKKYFKLILKFTKQWFQLPKIILTIVLFVGFYQLQNIPNADVIY
NGVFVCTLLSQIILLIINSRKLKKKFKITKKKWLFENVINIQGLGSNALLFFYFFDFPFS
HTQDFLVMGDFRKVFSALLITFLVIIGYITLIVIPKKADKLLQETYPEFKLS
>FCMOIPGL_03164 hypothetical protein
MKLSEIQIDELYKFTRQHYVYHYDVQSELVDHLANDIEEIWVEYSNLSFEQAREKSFKKF
GIFGFMDVIEAKQKQMNKRYRKIYWRFFKEWFTVPKILLTISLFLAFIIILKNTIAIYFI
LGITFIYILYDLFYLARARKRNKKKIEKQEKIFLLEAMIRDTRSNFTGLNLLNILNMSFI
FRYHFNDLAFHWLLLLALFFTIAVISIYINNKVIPQKAEELLQETYPEYKLVKKL
>FCMOIPGL_03165 hypothetical protein
MISHFLKLEWKQYFRSANWQKSIFLNILLVLFALYFMLSFLAIGIGGFFILKEQFPDKDP
LFLVNSFLLFAIVGDLIFRYIMQKLPVMNIKPLLTLNIPRNKIVHFILVKSSFSFFNIMS
LFFYIPFSIVLIKEGYNVTGVLGWLATMILLIQSANFLNFLINKNNIAFGGLITLLVGGY
LVQHFDIFNLAGFVGEGFDFIYQNPITAVAFLIVLIALYLLNYKQLRNEVYLDALISEKT
KEANASDLSFADKLGDLAPFIKNDLRLIWRNKRTKSSTWMILMGLGYGLFFYPQPMYKDM
VFMYVLVGIFSTGTFLINFGQFIPAWDSGYYKMFMSQNFKYHRYLESKFTMMAITVVALF
VLGIPYVYFGWKVLAVHFAAMIYNIGVNAHVILYGGTFNRKKINLDEKAAFNLQGTGAVQ
WLIGLPLMLLPMAIFALVNWLVSFEIATLVLAILGFIGIAFHQKLMAFITKKYITNKYVM
IHAFNQEN
>FCMOIPGL_03166 putative ABC transporter ATP-binding protein YxlF
MIVTKQLSKKYGKTEVLHIDSLEIPTGQSFGLVGNNGAGKTTYFNILLDLVRPTSGSIIN
HNIQVNRSEEWKSFTGSFIDESFLIGYLTPEEYFEFVGDLRGMNKADVAKYLGQFDEFFN
GEIIGKKKYLRDLSKGNQKKAGIVAAMMGKPKLVILDEPFANLDPTTQIRLKTLIKELTE
NKEITVLISSHDLTHVTEVCERIVVLDKGNVVKDIQTSAETLKELESYFSV
>FCMOIPGL_03167 hypothetical protein
MKKYIQKIIVILFIFVAAYSCSTKKDTVISRNFHAITTKYNVLFNGQESFNKGIENINNN
YKDDWFSRLPIEPIVFEEDKIVMASFNSGPGAGFGGAPKEEKELTTFERAEEKAVKAIQK
HGMNINGTEHNRQIDNAYLLLGKSRYYSQRFVPAIDAFNYVIANYPQADLIAETKIWRAK
ANTRIDNEETAIEAMKLLLFVRDTFEANLPDRIKEQAHTTLAMAYVKSDSMQKAKKHLQL
ATRTLKDRDQGARNLFVLGQMFSDENKKDSAFYVFNKLANFKKAPYKYKIHANIELAKNF
SKDSLSTTLLERMQKLIKNRDNRPYLDELYYQTAVLHQNNDSITLALENYNNSLRANNGS
DKQKTFTYENLGDLYFKNSEYQYASAYYDSVLQVSKDSLDIRIRRIKRKHRNLASLIKFE
EIVTINDSIVKIASLSKDEQKQYFENYIKKLKKIDEDAAQLRLNQMAFGNAAIGLQSGKK
GNWYFYNNQSLSFGKTEFKKVWGNRRLEDNWRWSEKATSGKTSVEDAAQTNAVNLRYDLD
TYLSTIPDKKETIDSLKIDRNQALYELGLIYKEQFKNQNLARLRLERLATLNPKEELILP
INWHLYQIYNNLGDTETSEIYKNVILTKYPDTKFAQIILNPNKNVEQEEKTAINEIEKTY
KEMYYLYKEGKFEEAVLNIDAFIITIPNSNLVPKFELLKAYAIGKFKDIKTYKTALEFVA
VSYGNTEEGKKAKEIIIQIGK
>FCMOIPGL_03168 hypothetical protein
MERNVIAKNTVIVGEIKSDGDFRIDGTLEGNLTTKGKIIIGATGIVKGDLTATTANIEGT
SSGNLIIEKTLTVKAIAKISGNVIVGKLSIEPGADFNASCVMKGDINKTESIDGKESKIK
KTFK
>FCMOIPGL_03169 hypothetical protein
MEKNPKSKKPLNKAIQLSGAGLQMGLTIYLGFLLGKWLDKIFETAFLKETVTLLAIFLAM
YSLIKQANRIND
>FCMOIPGL_03170 hypothetical protein
MIKTIFLYTVIFFSLFFISFFLHENYIEKAAIILPFSLRKIYLFHLGFSLLICINFKVFS
SVDKIFPQLGFIYLGTIFLKIVLFSAFFYTSIFTGDNLSQTARISLFIPMIIFLLTEAIF
VSKILNNKQ
>FCMOIPGL_03171 ATP synthase subunit a
MKIAQKTIKFLTIAAIALFTATSFASGTDKKHDKQNDGGRVNTKEKVDAYIKHHVKDSHD
FSLYSYTGDDGERHHKGFPLPVILWTSEGLVTFMSSEFHHNDDGHVIVEKKGLKFVKVHS
KILELDEGAASVSFDETHHPINAHKVLDFSITKSVVGVLLIGLLMFLGFVRLAKQYKTKQ
IPTGFARVLEPLVLYVRDEIARPNIGNKHYRRFTGYLLTVFFFIWASNLLGLMPFGFNIT
GQIAITAALAIFTLVIYSFSGNKGYWMHMLWMPGVPVLIRPVLAIIELAGALLIKPFSLL
VRLFANITAGHIVVMSLIAIMFTLKETMGVAGATFLSVVLSFLIILIEILVAFLQAYIFT
MLSALFIGMAVEEHEEAH
>FCMOIPGL_03172 ATP synthase subunit c
MYNLIGAGLVVIGAGIGLGQIGGKAMEGIARQPEATGKIQTAMIIVAALLEGLAFGALIL
GKG
>FCMOIPGL_03173 ATP synthase subunit b
MEALLNDFSPGLFIVQTILLLILIGLMVKFAWKPIMNSLEERESGIEDALAAAENARKEM
QNLNADNERLLKEAREERDAMMKEARHISDNMIAEAKEDAKEVTATLIEKAQASIQQEKQ
AALAEIKKSVAELSISIAESVIKKELSNKKDQLDLVEGILKDVTLN
>FCMOIPGL_03174 ATP synthase subunit delta
MKDARAAIRYAKAILNLAKDSKEETAVNDDMLFISKTISENDEFEVMLNSPIVKISDKIN
ILNAIFKGKVNNITLGLFHLLQDNKRISMLYSIAKQYAIIYDFDKHMQVAKVTTAVPLTK
EIETKVLAKIVTLTGDKANLENEVNPNILGGFILRVGDMQYDASISNYLNELKKEFDNSH
YIPKI
>FCMOIPGL_03175 ATP synthase subunit alpha
MASIKPAEVSAILKQQLTSFEAKATLNEVGTVLQVGDGIARVYGLSNVQYGELVEFDNGL
EGIVLNLEEDNVGVVLLGASTSIREGSNVKRTDRIASLKAGEGIVGRVVDTLGSPIDGKG
PITGKTYEMPLERRAPGVIYREPVTEPLQTGIKSIDAMIPVGRGQRELIIGDRQTGKSTV
ALDTILNQKEFYDAGNPVYCIYVAIGQKASTVAAIANMLEERGALAYTTIVAANASDPAA
MQVYAPFAGAAIGEYFRDSGRPALIVFDDLSKQAVAYREISLLLRRPPGREAYPGDVFYL
HSRLLERAAKVINDDKIASEMNDLPDSLKGIVKGGGSLTALPIIETQAGDVSAYIPTNVI
SITDGQIFLDGDLFNSGVRPAINVGISVSRVGGNAQIKSMKKVSGTLKLDQAQFRELEAF
AKFGSDLDAATMSVISKGQRNVEILKQAQNDPFTVEDQVAIIYAGSKNLLKDVPVNQVKK
FEKDYIDYLNAKHRDALDILKSGKLTPEVTATLESAAEEISKHFN
>FCMOIPGL_03176 ATP synthase gamma chain
MANLKEIRNRITSIKSTMQITSAMKMVSAAKLKKAQDAITAMRPYSSKLTELLQSLSATL
DSDASGAYSNQKEISKVLIVAITSNRGLCGGFNSSITKEVINTVQEKYSDVNVDILSIGK
KGADILGRKFNIIESRNDVYDNLTFDNISVIAEKLMSLFTNGTYDRIELVYNQFKNAATQ
ITQVEQFLPIKPIDDIETSAVNSDYIFEPSKEEIVLALIPKSLKTQLYKAIRDSFASEHG
ARMTAMHKATDNAQDLRDDLLLTYNKARQAAITNEILEIVGGAEALNN
>FCMOIPGL_03177 hypothetical protein
MKTLKLLFAIIITGTLLNSCTTVYQDSYYEYEPTLEEVVSEYDLWYVDYHRTSGNGDIPY
VSRAFTLSFINGVLYANNNIVDIGKTGNGLGIDVGTYNTFSGLLKTNHDLDGVNNFEVTI
LSNNEIRLYNQRQNVNYYLIGYNINNFDYDKLFYENIEYFLQEYIAWENTDVFGGTPNAF
DNEHFLAFTPENITTFYSSQDNFGTQVDYINWDYIGGYEVYDVTGYEDLKFLTLNYDGGD
IEEFELSVINDSKIRLYHINSDTTYDFSGRGFVQYLKGEKNVKTETPTVRNNNRKRTKVE
RKTKIRRNLK
>FCMOIPGL_03178 putative oxidoreductase
MKKTAFITGATSGIGKATAELFAKNNIRLILCGRRSARLEKLKEELSKLTKVITLQFDVS
KREEVATAINSLPENFKEIDILINNAGNAHGLSSIQDGHLDDWDAMLDINVKGLLYVSKA
IIPKMVSNNNGFIVNIGSIAAKAVYPNGNVYCASKHAVDALNKAMRIDLNKHNIRVSAIH
PGAVETEFSDVRFKGDTEKAKTVYAGYKALQAEDIADIIHFVVTRPYHVNIEDLVVYPTA
QATATILNRN
>FCMOIPGL_03179 Oxidoreductase YdhF
MPTSEIIIGCMSWGKWGKQFSTKEQVELIQFCLENGNSTFDHADIYGDYSTEAEFGKAFV
ESGIAREDIQLISKCGIQLVGEARNNKLKHYNYAKEYIIWSVENSLQNFKTDYLDTLLLH
RPSPLMQPDEIAEAISELKESGKIINFGVSNFTPSQVDLIADKIPVSINQIEFSLTHYAA
MQNGSLDQMLQKQIQPMCWSPLGNVFKNETPQSFRIRKILNILSKKYAVSNDVLLLAWIL
KHPAKIYPVIGTTNKERILNANKALEIDLDLQDWFLLLEASKGEEMP
>FCMOIPGL_03180 hypothetical protein
MINKRLLIKNLLSHNDENSFYDKKQKLSLSTKDGKAKFLKHICALSNSNPENNSYIVIGI
EDEENKIIGVDFYDDSKIQNLVNAYLKNPPKIEYENVPFPRLPRHKVIGLVTIHPNNKIT
SLLKNAWKYRKGTTFYRRGSNSIPANSNFELLNTNKEIVAAIEKNARNNIELTLDGVFDF
INNHKTEYNPKYKVFNEQFVLCWAGEKKVLNGEEFFSRVDIELINEQVKLFFSALDDVQI
SFNNHSFIVTEFIYLGLEKQEKLYPLEKTIINFKNNGKHDIIKEFLFQPPKFDGTIIQHI
FLNNKAIIKKIEKGIPLSVTEHEDVLRLPTNSLICFLYGFLDAADLLKNAKDYIKNLDDK
TTYISYKEALRVIRKVKYG
>FCMOIPGL_03181 hypothetical protein
MKIGTKILILFLTLNFLSCKGSAQEIETKESKTEVESSGTIKSTFPKPIGIINDYGKVFT
ELQRTELSKLLYYYDIETTRQIVIITIDSIKPYQNIQKYAVDIGNEWGIGNAEKNNGLTI
VVCNPCRQIGIATGTGTELILTDEICKNVIEETIIPEFKNGDFYDGIKKGVTELIKKWK
>FCMOIPGL_03182 hypothetical protein
MPRIELQTEIKADRNIVFDLSRSIDLHKISTEQTNEEAIAGKTSGLIGIDESVTWRAKHF
GIYQKLTSKITEFDKPNYFADEMVKGAFAEFKHEHHFAESNGGTLMTDFFDYKSPFGILG
KLADKLFLEKYMTELLTERNRIVKEFAESDKWKEVIK
>FCMOIPGL_03183 hypothetical protein
MKRRDFLKQTTFASGMFFVPQFLKAFENNTMKAFSNKKVVIIQLKGGNDGLNTVVPFNND
IYYQQRNNIALKQNDLFRISDEVGLHKSLKPLQDLYNKGFVSIINNVGYPNPNLSHFRAT
DIWQTASDSNEYLQNGWVGRYLDYTKGNPYNAIEVDESLSLMLKGKTQNGLAITDPNLFY
KSMREPFFNNVIKSYSDAHLNEHNLGYLYNTMIDAKSSAKHIFEKSKTKSSSSDYPKNIF
GRQLKTIAEFINSGLETQVYYAGLSGFDTHANQAGTQERLLKIYAESMEVFVNDLEKNNA
FDDVIILTFSEFGRRVKQNESKGTDHGTANNVFVMGNNLKKQGLYNNLPNLGDLDKNGNL
KYEIDFREIYATILDKWLQVDDVSILNKSFSKLSFV
>FCMOIPGL_03184 hypothetical protein
MKSAHIQHLYNRVGFGITPKELVRLSKKSKKNVINELFISSDKTTLLTVDTSFLKNITPK
DYKDQKQRRELQKISRKKIQEFSINWVERLKNPSEILREKMTLFWANHFVCESKNILFVE
NYNNALRKNALGNFGDFTKIIAKEAAMLGYLNNKQNKKKSPNENFARELMELFTLGQDNY
TEQDIKESARAFTGYNHNFKGEFSFKVRNHDENEKTFFGKSGNFKGDDIIDLILEKKECA
KFISEKIYTYFVNDNLNEDHINEMTAVFYKDYNIENLMRFVLLSDWFYADENIGTKIKSP
IEFLIGINTIVPYTIEKSKQILLLQKLLGQVLMSPPNVAGWKTGRNWIDSNTIVTRLRLP
SVLLNNAEITYSDKGDEESIDTNFDEKKLRRKAFIKTKTDWETFNENYKKSSHQELIKHV
ITTKLNLGTSKMLMNNMQMPKQDFCVQLMSLPEYQLC
>FCMOIPGL_03185 FKBP-type 16 kDa peptidyl-prolyl cis-trans isomerase
MSQVKENNTVKVNYTGKLTDGQIFDTSEGREPIQFTLGQGQIIPGFEKGLIDMEVNEKKT
ITIAKEEAYGEVNKALIQEVNKADLPQDMEPKVGMGLVSKTPDGQEMNLMVVEVKEETIV
IDGNHPLAGKDLVFDIEVLEIS
>FCMOIPGL_03186 NAD/NADP-dependent betaine aldehyde dehydrogenase
MFLFNLQIDKKIVNSFFEFKQQKRNNKMIDFGIKESLKELGIKDLNEGTSTGSNSFSNGE
IIESYSPVDGKLIGKVKSTTKEDYEKVMETATKAFLSFRNMPAPQRGEIVRQFGNKLRDL
KEPLGKLVSYEMGKSLQEGYGEVQEMIDICDFAVGLSRQLNGQTIPSERPGHVMREQWHP
IGVVGIISAFNFPVAVWAWNTALAWICGDVCVWKASEKAPLCSIACQNIIAEILKENNLP
EGISCIINGDYKVGEMMTSDIRIPLISATGSTRMGRIVGATVAQRFGKSLLELGGNNAII
ITPTADLKVVVPGAVFGAIGTCGQRCTSTRRLIIHESVYDKVRDAIVGAYKQLTIGNPLD
EKNHIGPLIDHDSVNTYLAAIEKAKAEGGKVLVEGGVLEGEGYESGCYVKPAIIEAENHF
EIVQHETFAPILYVMKYAGEVENAIEKQNGVAQGLSSAIMTNEMKEAEKFLSFAGSDCGI
ANVNIGTSGAEIGGAFGGEKETGGGRESGSDAWKVYMRRQTNTINYSDELPLAQGIKFDI
>FCMOIPGL_03187 Isoaspartyl peptidase
MKKIITLLSLLIVFLGCKNETKNSSEETQTNIKKNKFAIIIHGGAGTILKKNMSDEKEAA
YKSKLEDAIKIGYTILKNGGTSQEAVMKTIQVMEESPLFNAGKGAVFTHEEKNELDASFM
DGKTLNAGAVAGVTNVKSPIELAIKIMTDSDHVMLSGSGASEFAKEKGLEIVDPSYFYTE
KRFKSLQRIKDKEKTALDHDDKKAVFYDADIKNSKFGTVGCVALDKNGNIAAGTSTGGMT
NKRWGRIGDAPIIGSGTYANNKTCGVSSTGWGEYFIRSQVAYDISAQMEYQQKTLKEATK
DVIQNKLTKLGGTGGVVALDKNGNMSFEFNTAGMYRASMDDKGNLILKIYKE
>FCMOIPGL_03188 hypothetical protein
MKFKLSTYRTFSGTKQVVELIKKKDTQWVIYQDDKPKFFVDFFDLEKESNAMMNSLVLCG
KRSIEEVLELINKRNNINLSIPKITKLGLKKKLKSESIELNLESLPEEWLDYSL
>FCMOIPGL_03189 hypothetical protein
MDHNNLDKLFQEQLKNLEATPNKRVWNNIESKLKKKKRRVVPVWWFASGIAAMLLLGILL
FPFSDDKDVFNKTDSDIIITESPKKEIKLKTIYKTKIDTIIQDEKSEEKILISDKQINRR
PSNQQKINPKNTDIIKKLVSKKNEKEKTFFADNSNKENIDSIHKKEIIIIDNTTFFSDKK
KELTKVEKESITNKVDLNKFVEKKDSLFSPKSSKEKWSIAPVFAVLNSNSFSNTSPIDKS
LSNSTKGQSSYSYGLQIGYKINKKWSIQSGIHLQEMSFSNRQVTAVVTISTSSSSVAFNS
GDSFSFNEISTQSSDFASSSVISRTSLSGELNQQYGYIEIPIEVKYNFLSSKKFNTEIVA
GFSSLFLNKNEINLESQFLSKSGKANNLNTINFSGNLGFDFNYSLNKKWSLNLNPMLKAQ
LHTFSENSNGFAPFNLGIYSGIKYKF
>FCMOIPGL_03190 ECF RNA polymerase sigma factor SigW
MEEFDIDTTIFSVDVLLNYIQQLPDRYRLIFNLYVLDNYTHKEIAEMLNISVGTSKSNLS
RARKILKEQLENHQKKAQKN
>FCMOIPGL_03191 hypothetical protein
MKKFTLLLFGLLVFSACLNTDNDELNYTFEYLPIDEAITPASFTYGQIDTIAVKYSLPNG
CYHFNQIYYEPQDTTRIVAISAFVELDSPCTEAIIQEEKKIPVKASQLEDYVFKFYKGKD
SNGENIFEEVVVPVN
>FCMOIPGL_03192 hypothetical protein
MKTKTAFLSLFLTVFLFSCEINNQSNELIIDPNDSLLFGYWAETSYEDEQITFTRVNSLP
NDSYGISFVEKGVFIERSSGWCGTPPLTFTDYTGTWEFVEDSLVKISTTSFIGDFQWRIL
EVSEEKLVVKRELSEKELEHRSLMDLFNEIQNLSYSISCSDAADWNFVAYGSKACGGPKG
YIAYSSKIDTTAFLQKIETYTQTEKDFNIKWGVISDCSITNPPTSVECQNGFPKLIY
>FCMOIPGL_03193 hypothetical protein
MQETIFNIKSNEQFAKAALEVFKHQFKNNKVYRSFCDLLYIHPSDVTKIDEIPFLPIQFF
KLREILSSTEKVEEIFTSSGTTGSVTSKHFVTDINLYKQSYLSGFSHFYGNIEDFVVLAL
LPNYLERNGSSLVFMVDDLIAKSKNSESGFYLNNLDELAQKLINLDKNGQKVLLIGVSFA
LLDLIEKHQFKLKNTIIMETGGMKGRRKELIRNELHQLLQDGFGVDEIHSEYGMTELLSQ
AYSKGNGIFETPPWMKILTRDTEDALTILPKEKTGGINIIDLANYNSCSFIATQDLGKVH
KNDTFEIIGRFDDSDIRGCNLMVL
>FCMOIPGL_03194 Large-conductance mechanosensitive channel
MRLKLIQDFKEFAVKGNMIDIAIGVIIGAAFNKVVNVLVKEILMPPLSFMTNGSNWESKK
IILREAVIVDNKITLEQIAIGYGKFLETGVDFLIITFSVFVVVKVMNSMKKKAEDPKNEK
VVTPKNIELMNKTNELLEKQNEYLKKLISKDI
>FCMOIPGL_03195 hypothetical protein
MKQYTTLLLLLISITFSAQNYNTKNGFVAEGYDVVSYFNNKAEKGNKEFTTEFDGVKFKF
SSKENLAKFKENPKKYAPQYGGYCAYAIGLKGEKVTINPKTYEIRDGKLYLFYNSWGTNT
LELWQKEGPEKLQKQADKNWKKIIAN
>FCMOIPGL_03196 Tyrosine--tRNA ligase 1
MTNFVEELRWRGLLHDIMPDTEEYLLKNKTAGYIGFDPTADSLHIGSLVQIFILKHFQNA
GHNPIALIGGATGMVGDPSGKSAERNLLDEATLAKNIAGVRENLERFLDFDASVENKAEL
VNNYDWMKDISLIDFVRDTGKHITVNYMMAKDSVKKRLSSESSEGMSFTEFTYQLFQGYD
FYHLYTEKNCKLQMGGSDQWGNITTGTELIRRKAQGKAYAITVPLVTKADGTKFGKTEGG
NVWLNADRTSPYKFYQYWLNSSDEDAENFIKKFTFLDKETIENLITEHSENPHLRLLQKK
LGEEVTILTHGKEAYENALKASSILFGKSTASDLKSLDEQTFLDVFDGVPQATVSIADIE
EGLDMIGALAAKNNFLNSNGEARRALKENAISVNKEKVKDDFTITKEDLIANKYVLLQRG
KKTYYLLVVE
>FCMOIPGL_03197 ADP-L-glycero-D-manno-heptose-6-epimerase
MILVTGGTGLVGSHLLYHLSLQNDAIRAIYRTKSSLEKVKNVFSYYTDDETFFNKIEWFL
ADITDVPAMIPAFINVKHVYHCAAFISFNPKDYRQMRKVNIHGTAIIVNLCIDAKIDKLC
FVSSIAAVGNSLNSNFTTEEDEWNKELDNSGYSITKFGAEMEVWRASQEGIDVVIVNPGV
ILGSGFWNAGSGKLFSQVYNGFQFYTEGITGFVSEQDVVKSMILLMNSAIKNERFILVSE
NKIFKEIFFLIADGFSKKRPSKKIKPWQTNIFWRVAWLLSKITGKEPLLSKYSARSAHSI
SEYSSEKIEKSIAFKFEKTEKSIERICKNYLNDFF
>FCMOIPGL_03198 hypothetical protein
MMKLKENASLLIVKMKNISYLLIFVFLISCTSNTILEKPKDLIPKDTMRLLIQEMMIASS
AKYVKNKNMETKIEYMALVYDEFKIDSTRFQTSNLYYMSKIDDYQEIFEDAKADLEKQKK
VYDDIIAIKDSLRKDSINKLKKVKKRVAIGDSLDINKKELNFKKNR
>FCMOIPGL_03199 Allantoinase
MKKLILIKNATIVNENNTFKGDVLIENEIIKEIASEIKATENTTIIDAKGKYLIPGFIDD
QVHFREPGLTHKANIATESRAAVAGGITTFIEMPNTVPQATTQDLLEDKFTIASKDSYAN
YSFMFGGTNDNLEELLKTDPKKVAGIKLFLGSSTGNMLVDNEEILEKIFSSTKMIISVHC
EDEATIRKNTQEFIDKYGEDIPVKYHPIIRSEEACYLSSSKAIALAKKTGARLHIFHVST
AKETELFRNDIPLEEKQITAEVCVHHLWFSDKDYEEKGTHIKWNPAVKTEKDRLGLWEAL
LDDRIDVLATDHAPHTLEEKTNVYTKAPSGGPLVQHAVTAILEKVKEGVISIEKAVEKMS
HNPAKLFQIEKRGFVKEGFYADLVLIDTNKPQTVSKENILYKCGWSPFEGTTFSSTITHT
FVNGNLIYNNGVFNDEIKGKRITFNR
>FCMOIPGL_03200 dTDP-fucosamine acetyltransferase
MNKSISLRTANLDDLETLLQFEQGVVEAERPLDPFLADRDICYYNIPELITAEHINFVVA
IFNEEIVACGYVRIDNSKIYQKNPQHGYVGFLYVKPNFRGQKISTIILESLKEWATKKGL
KELRLDVYNNNIAAIKPYEKFGFTKILVNMRMDI
>FCMOIPGL_03201 Polyprenol monophosphomannose synthase
MSDALVIIPTYNEKENIETIIRATFNQKKVFHILIVDDNSPDGTSEIVKKLITEFPEQLF
LEKRIGKNGLGTAYIHGFKWALSKKYNYILEMDADFSHNPKDLVRLYNACHKDGADVSVG
SRYSQGVNVVNWPMKRVLLSYFASKYVRFITRIPVFDTTAGFVCWKRNVLETINLDKIKF
VGYAFQIEMKFKAWKHKFNIKEVSVIFTDRTLGASKMSGNIISEALFGVIKMRLKGLPK
>FCMOIPGL_03202 hypothetical protein
MQAIEKITATNSWITAVLMLLFLCIVLLKILDANRLKSNALSLFNIHFVENESDKNSNFF
NPFRFVIFTFTVVVLSLVIYSFKTYYLSTNIVNFSSYLPIFLGLLSYFIIKRVLEYLLFY
LFLIKNEVRFFIISKINYLHTITFLLYIAVVLTEYSSLKKLYLFYFAALLFIVRFVIHVV
SNKKLIFNKLFYFILYICAFEIAPLFILFKLMF
>FCMOIPGL_03203 hypothetical protein
MKVKTILVSQPAPKTETNPYFDLSDKQKVKIDFRSFIHVEGITVKDVRLQKIDFKNFTAI
ILTSRNAVDHFFRVAEEMRFKVPDSMKYFCQSEAVAYYLQKYVVYRKRKIYVGTRTFTDL
TRLIKKHKTEKFLLPSSDKLKPLIPAELDALGINWQRADLYKTVVSDLSDLEDVFYDVLV
FFSPSGIESLFQNFPNFKQNETRIAAFGNSTVKAVTEAGLKCDIEAPTPDTPSMTMALDK
YIKEVNKK
>FCMOIPGL_03204 hypothetical protein
MKLNYLLIAITCFLISCKNSSNLKLKNDYKEELNNLFFSKEDVEKNNSKTKNYINNFALN
KDEFLTIHFTLNKPLVENLQLLAPNLTENQLLEIGSFQFSFLVDGKIIYVENLNKGAGLK
ESKTTQIQHSIRLVAPKQLDYWGWFMWLKFMKLGGGQDALVTGKHLLSIEVRPYIKQDIL
KVGPLLAKGKITVEVAKISVDENLIPVQKIQENSGWEISKDTFDKNKIEALNRKIAENRF
ENINGIVVIKDNKLLLEEYFNDENRNSLHDPRSVGKSIASTMLGIAIDEKFIKNENELLK
DFYDLKKFSNYSNKKEVVTLKSLVTMSSGFLGDDSDFSSPGNEENMYPTENWVKFTLDLP
MDKEKEIGKDFAYFTAGVVVLGDIIDKSVPEGLVSYADKKLFKPLNITNYKWEYTPQKVG
NTAGGIRLRALDFAKYGQLYKNKGLWNGQQILSKQWVEKSLDKHIKQSLDKGYYGYLFWN
KIFKVNNKEYEVSFCSGNGGNKIFIFKDIPFVIVITSSAYNSPNAQADADKIMTDYILPA
ILDK
>FCMOIPGL_03205 hypothetical protein
MNISKNTIIQGKHNKPILVDVFYKETHQPKKVIIFCHGYKGFKDWGAWNMMAESFANAGF
FFIKFNFSHNGGTVENPIDFPDLEAFGNNNYTKELDDLETVIDWISTNSDFKNEADNEEI
ALIGHSRGGGIVLLKANEDAKIKKVITLAGVCEFEKRTAKIGNLEQWKNDGVKYVENGRT
KQQMPHFYQFYEDFIKNKERFNVEKATKNLKISQLILHGNADTSVLIDEAENLHKWNPKA
EYQIIENANHVFNTSHPWNEKQLSKELEITVNFCVDFLK
>FCMOIPGL_03206 hypothetical protein
MKIAVLGWGSLIWQPKELAFDKEFRWKEDGPTLPIEFARISKDGRLTLVITSEGTEVLTL
YTLSTYKVLEEAVLNLAVREGSGRKSIGYYDKTSDDFMPEKFQFKTKIREWIHKTNFDAV
IWTNLGEKWKIEEKVNERLISPEKRIEYLREFKGNKKALAEEYIRKTPIQIRTKYRKLIE
KELNWTPII
>FCMOIPGL_03207 hypothetical protein
MKKEEIKIAGNLTVNDWKDIKEKLETPNNKLWGLAVHFFEERIKTRYLDPIHAIQKLNIN
EGEGFTMLNLQCSLIETFECFINGWLFYLEGRNLVWKDKEGKVASYNNKVNSRQIFISFF
DKFKDEFHDLEGRDFYSNVRCGLLHETQTKGNWIIRVDTEDTKKCYKYDDGNYIIYRNNF
QEKLEQLLEEYRKAIVDGKKFKEIGISTEDLRDNFIAKFNHICEQS
>FCMOIPGL_03208 hypothetical protein
MNNEDFLYDLIKEEKEFFINLISKYYYFNLQNLQKVKEKVNWKFISNNQNILWSLEFVKE
YEDKLYFDLLDWSNHQDSERPGLSSNPKISIEIIEKYKNELNWEMLSSNFNFSNLDIDEV
LEREGFLWNWNDLYYNLTLPSWNETFIEKHRNKLDWKVWKKLSRYFNFSNLDYNRILEKN
FFLWDWYYLSNNETLPWNENFIEKYKSKLNWKELCSNSKVNWTESFIEKHNDKLDWINLS
FNSRLPWSKSFLIKYEKQININNLSRNEGFSWSVELIDKYKDIINWDYLSKNTGVQWSSN
LIERFGYKNIDIFDLTEPQVFYSYELSQNKSLPWQDITFFMKFILFYISDCDYTGLINNQ
GIIWDKIKIGICKMKWKDFSLEKNDHKKTLTNLPFYMKDKEENEDIIWELINPFIEDNNL
EEILK
>FCMOIPGL_03209 hypothetical protein
MKNRLLFYFFFFTVSLNAQLLDLKDKDIVFKTVNKSQIFKVNNFKFNVTWDKKLSYSNNL
GSYGGIKELKIYKGNKLVNVFKNIEDPNALNQIVFRFFDYNLDGYIDFSVQIDSGKSTWE
KYYLYNPTENKYEHIETWDYLRIQKIDKTNKRILTQPDGNVDNRELFKIEGVKLIEIKRK
>FCMOIPGL_03210 hypothetical protein
MILVSHFFFGLIFSFLGSITPSMLNMTALKITLENGKKELNKYVIGVSLVVLPQAYVAVF
LTKQIVENPSIIETLEKVGIVIFFFLSYYFYSESKKSKIKIETTDVKRENAFLAGITLSA
LNMFSIPFYFGIVATLDAFNLFNFDVIPVLFFILGSTIGTFYILYLYGKFANFIQKKTGK
LTKDINIILSILTAFVAVLSVIKLIF
>FCMOIPGL_03211 NAD(P)-specific glutamate dehydrogenase
MAENIDFKITEFMEMVKKRNNHEPEFLQAVQEVAETVIPYIVNNDIYNGKNILLRMVEPE
RLISFRVSWVDDSGEIQVNRGYRIQMNSAIGPYKGGLRFHPTVNASILKFLAFEQVFKNS
LTTLPMGGGKGGSDFDPKGKSDNEIMRFCHSFMTELYRHIGHNTDVPAGDIGVGAREIGF
MFGMYKKLNNTFTGVLTGKGASWGGSLIRPEATGYGNVYFAQNMLTRKGNSFKGKKVVIS
GSGNVAQYAAEKAIELGATVLTLSDSAGYILDETGIDLEKLKHVMFIKNEKRGRISEYLD
KYPSATYVAGQRPWSVKCDIALPCATQNELNGDEAKELIKNGCVCVSEGANMPSTPEAIH
EFQKAKILFAPGKASNAGGVATSGLEMSQNSLRLSWTRKEVDDKLKVIMENIHDSCVEYG
ENEDGSIDYIKGANIAGFVKVADAMLAQGVV
>FCMOIPGL_03212 Phenylalanine--tRNA ligase alpha subunit
MLDKVKELIGDVKSFNATTKEEVENFRIKYLGSKGLLKDLFAEFKNVDVELRKDFGKALN
NLKSSAEGKVAELTDALENSTNEKSFYGDLTRPSEPIELGSRHPISLVRNQIIEVFNRIG
FTVSEGPEIEDDWHNFTALNLPEYHPARDMQDTFFIEQDPDILLRTHTSSVQVRYMEENQ
PPIRTISPGRVFRNEDISARAHCIFHQVEGLYIDTDVSFADLKQTLLYFTKEMFGKSKIR
LRPSYFPFTEPSAEVDIYWGLETETDYRITKGTGWLEIMGCGMVDPNVLKNANIDPTKYS
GYAFGMGIERIAMLLYQIPDIRMFYENDKRFLEQFKSVI
>FCMOIPGL_03213 hypothetical protein
MNYFSQYWDENRDDEYADWGFSTWYFETNNADEVLKQITVYKNGKVTKYNEDNLEDEFGG
LCDGTLTIDECDGEEMTKEEFYKIW
>FCMOIPGL_03214 hypothetical protein
MKQEICKVKMGLVEKLGVHLENREHLAPVAARILSYIILTGKKGATFEDMVTILCASKST
ISTHLNHLQDLKKIMYFTKTGDRKKYFIINKDMILQHIENLINEWKEVSELHLEIKNYKE
LQNNLKIEKEEEKFNLNFHNDYIKFLDGATASIEELRTKLTNNKLDI
>FCMOIPGL_03215 Solvent efflux pump periplasmic linker SrpA
MKHHKLLTLVTLSIFLVAVSCTNNEKQKTAAVQGLAPSFPVVNLQTKTVTGFTDYPATIE
GIVNSDVRAKTSGYIEKVYVDEGAKVRKGQALFKLETQSLSQDADAAKALVNVAQVEVNK
LIPLVEKNIISPVQLETAKANLEQAKANYSSVSANIGYATIKSPIDGYVGAINFREGALI
SPSDATPLTTVSEIDQVYAFFSFNEAQYIDHLQRSEGQNKAERIKNSPDLTLILANGKEY
SEKGRIQTSTGQINQSTGTITIRAAFNNPNEILTNGNSGKIRFPIEYKDAIVVPQTATFE
QQGNIMIFKLSADNKIATSIIKVKGTVGNLYVVESGVDVKDQIVVSGVGKLRNGMAISPQ
VTPFDEAIKPIATLFKN
>FCMOIPGL_03216 Efflux pump membrane transporter BepE
MLKTFIERPVLSTVISIIIVLLGIISITSLPIEEYPDIAPPTIKVTANYTGANAETVLES
VIIPIEEQINGVEGMTYITSTASNTGAAEITVYFDQKIDADIAAVNVQNRVARATPLLPS
EVTQTGIITQKQETSALMFISMYSESDDYDATFIQNYLKINVIPAMQRISGVGDVSVFSQ
QDYAMRIWLNPEKLASYGLIPSDISAALAEQNLEAAAGSLGQNNGESFSYTLTYSGRFKD
EAQYSNIVIKALGNGQFLRLKDVATIELDAQSYASNAMSKGNPAVFMGIFQTKGSNAQEI
IENIKITLEQVKADLPEGLDVFVPYDTSLFLNASIEKVISTLLEAFLLVFLVVFIFLQDF
RSTLIPAIAVPVSIIGTFFFLNVFGYSINLLTLFALVLAIGIVVDDAIVVVEAVHAKLDE
GEKSAKKATLTAMNEISGAIISITLVMAAVFIPVTFVTGPTGVFYEQFGVTLIIAILISA
VNALTLSPALCALLLKPHKEDEEIKGKSPLKRFYTLFNRGFNATIDRYGKSLQFLYKRKF
VSGLLLIIAIIGIFWAAKTTPTGFVPNEDRGIVFANIELPPGASLDRTDAVARKLYDKIE
GIEGIVAVNFIKGRSLISGAGSNFGFGIIKLEDWADRTDPALSAQAITGKLFGVAASIPD
ANIIFFSPPSIRGFGNSSGFEINLLDKFGGEFADLDKANKDFSMALMSHPEIKYAQSSFS
TSYPQYEMEVNVPLAKEKGVSVTSIFSTLQGYIGGVYASDFSRFGKQFRVYIQALPEDRA
DENALNSMYVRTDSGEMTPITQFVTLKRVYGPQSVTRFNLFNSTMISGATNEGFSTGDAI
RVIEEEVAKLPSNYTVAYSGLTREEVNAGNQTTFIFILSILFVYFLLSAQYESYLLPFAV
VLSLPFGVFGAYISTKFLGLENNIYFQIALIMLIGLLAKNAILIVEFALQRRKNGESIVD
AAIHGAKSRLRPILMTSFAFILGLMPLALAKGVGSEGNNSIGSGAAGGMLIGTILGVFVI
PILFILFQWLQEKVSSKPAVISQQNED
>FCMOIPGL_03217 Outer membrane protein OprM
MKSRLKNTSLQKGLVIAIMAFTLQSCFVAKDYTRPEVTETENLYRTDNLPSDSISMANIS
WKNLFTDTYLNQYIEEGLQNNMDVRIAIQQMVAAEAYAKQGKAGYLPSVSVGANATHQEL
SKNGQFGSIFGGGIDQYDVTANLSWEADIWGKIRSNKRASAASYLQSVAAHKAVKTQLIA
SIATTYYQLLALDSQLEITKKTIESRKNGVETIKALKDAGLTNQVAVDQNIAQYNSTRAL
QVDIETAIFKTENTLSILLGKSSQKFERSHLTNQIIETELKLGVPSTLLSNRPDVMAAEY
NLIQSFELSNVARSNFYPSLKLTASGGFQSLNLDNLIDTNSLFATILGGLTQPIFNKRSL
KTQREVALAQQEQSLLQFKKALLVAGNEVSNALFTYTSETKKFEFRKNEVEALRKAEQNS
EELLKNGYATYLDLLTARQSALSAELSVIDSKLQQLVSIVDLYEALGGGWQ
>FCMOIPGL_03218 hypothetical protein
MSTLLVATNFSKASKNAVLYSASIAQLFNTKLVIFNAYKLPVHASNTLLSAVSIDGLIEK
ERNKLKETALDISKKFNIDVEVICKYVNLEQEIDRLMKLYDSPFLVMGMSSKSMEQNLLG
NPTTTLISMKKFPVLAIPVNAKFNGIQKILFACDLMRDIPLKTLARLRRVATKLKAEITV
FYVDQKIDELKLNTQCLENINQELEGVAYLYKNISSNTVIEEIEKEIKKSDSELLVMVPK
KYGFWESIIHKSKTRVMASGMNIPLLSIPIE
>FCMOIPGL_03219 HTH-type transcriptional repressor KstR2
MIDKQQLLECSITNFIKFGSKRFSMNELASELGISKKTIYKHFKTKDELVSKGVRLLIDK
YLHEVDKIKKNSEDPLQKIILIQETSFQYLNYLKPSFLFGIKKYYSNADDVFTNFKDNFI
KSNLQPLLEEAIEKEYLRKNLNSDLFCDLYFTRVQNLIFDPKNLFEIYSEKVVFEHLIVN
SLRGFITPNYKDTNKLFA
>FCMOIPGL_03220 hypothetical protein
MKKDIKIPEVTDVEIAIVYEYNDLYKTDDWNVYIINNKNVDLEMVVIVTQGFSDKKITSL
FRKKINVLPANSYAKIELIQPELFKLNNRFQVTFFEGNTLFEKTFILKENTIKEGALRMI
TELKKRGILAE
>FCMOIPGL_03221 hypothetical protein
MVIVSLRESAYHLFFKEEQGKESNATLFMHRKIERPYHIDFCFISDYFVNRLKKVSIGKY
QNWTKLSDHNPIICEFENEKK
>FCMOIPGL_03222 Malate-2H(+)/Na(+)-lactate antiporter
MEYGFLSVIPPIVAIILALKTKQVYIALLFGIWFSWLIIKGWNPLTGTLAMIEGMVNVFQ
SEGNTRTIMFSALVGALLIFIQYSRGVEGFINILNRQLVKLENKKSGYSRVMVQVLATLT
GLLLFVETSISSLTVGTLYRPIFDKLKIPREKLAYLADSSSAPSSILIPFNAWGAFIMGL
LLTQGIDKPFSVMIASIKYNFYPLIAIAMVFIIIFTKKDFGPMKKAEERTKETGELMNKG
SKPMVSDAVTSFPPKEGIEAKAYNMIVPLLVMVCMMPINLMYTGWDAVKESNSFLNHASQ
AIGEGSGSSSVLYAVITSLLVAMIMYFIQGIMKPKEAVNLTLKGISELMPLALLMLLAFA
IGDACKELETGVYVANATKEWLSPELLPAVVFIISSFIAFSTGTSWGTFAIMLAISVPMA
NIHGADITIVVAATLGGGIFGDHCSPISDTSIISSMASASDHIDHVKTQLPYALVGGAIT
VLMYLVIGFLG
>FCMOIPGL_03223 Glycerol kinase
MAKKYILALDQGTTSSRSVIVDEKGVIIEIEQQEIQQIFPKSGWVEHNALEILETQVSTL
KKVIEKANINVADVIGLGITNQRETTVIWNKNTGKPIYNAIVWQDMRTADVCEKLKKEGL
ENHIKQTTGLVVDAYFSATKIHWILENVPNAKVAAAKGNLLFGTIDSWLLWNLSDRKIHA
TDYSNASRTMLFDIKNLCWDETILAALNIPKSMLPEVKPSSFHFGNYILDGYKIPIAGIA
GDQQAALFGQACFRKGEAKNTYGTGCFLLMNTGTELQFSKNGLLTTIAWGIDNKVYYALE
GSVFVAGAAIQWLRDGLQIIKSAEESEAFALEVEGENPVIVVPAFAGLGAPYWDMYARGA
IFGLTRDTGKNHLIKATLQSLAYQTKDLLVAMQHDAEIPLTSLKVDGGACENNLLMQFQS
DILDVVVERPEITETTIMGAAYLTGICVGLWKQEEILSHRKIDKEFTPEYTVEKRDRLYK
KWLKAVERSKDWID
>FCMOIPGL_03224 hypothetical protein
MKIRNVILGLSLILLTSCVVKSLHPFYTKETISFDQNFIGDWQDSKKGNWKIVSFKSEMI
KDNPVEKMKKEDLKFYEEYKNSYYILREYEGKEAIYIATPFIINNQKFLDFFPIDHQEDV
DNLLESHSIYTHSLVKYDVQKNGEIEVRWLDEDKIRALFKEHKIKIKHETFGVLNDKYLL
TASPKKLQKFIEKYMASNDDEKWKTDIKFTLHKVNESN
>FCMOIPGL_03225 Sensor histidine kinase YpdA
MNQIKPFLTRTNAHNKVIFNAILWSCSFLILLFLFSGSSSPSKIDYIYTASFIFTLIIPV
CINLYWLLPTYLKKEKYGLFGILFIVNLIVFAEINPWVFNILVNNFFNDYFFISYHNTIE
IYFIFSVFFILTALIKLAENWVYLNQLENKTLKIQKQQIENQLYYLKGQINPHFLFNSLN
VLYSLAIDEKKEITNAILQLSDILRYVIYDVNADKISIRKEIELLKNYIEFEKNRHVNDS
TITFDFKVDEDLKIYPMLLLPLLENSFKHGLKSGVKNPYIDVKLIAKSKKIDFVISNNFQ
ETKKYNTKEKKGIGLKNIQENLAIIYPDEHLFSIENTQTIFTVKLTIDLEK
>FCMOIPGL_03226 Sensory transduction protein LytR
MNIRCLIIDDEPSSQNVLKSFIQKIDYLELIHVCNNALEALEFLKSNTVDLFFLDINMPQ
LSGIDFYKSLKNPPKVIFTTAYSEYALEGFEVDATDYLLKPFSFDRFVKAVSKVKDLNDA
KIDYIIVKSDKKLHQIKIEDIYFIEGLGDYIKVHLKNNYLVTYKSLKMMHNLLPKSIFIQ
VHKSFIINKNKLDYIEGNLAIINSQKVPLGQKYKKEFLDHFNA
>FCMOIPGL_03227 hypothetical protein
MSKFYTKITSKLQKFIEAQKIFFVATAPNSGRINLSPKGMDSFRVLNENKVLWLNVTGSG
NETAAHLSENERITIMFCSFENAPNILRLYGKGKEIKPKDTNWNDVISLFPETPGTRQIF
EIIIESAQTSCGMSIPFFEYKGERNELNDWATAQGKEGIENYWENKNQTSIDGLPTHLLE
>FCMOIPGL_03228 Aerobic glycerol-3-phosphate dehydrogenase
MNNFSYFNRENITNELKTTEFDVLIIGGGITGAGIALDAASRGMKVALIEKNDFASGTSS
KSTKLIHGGLRYLKQFDFWLVKEVGTERAIVHKLAPHLVIPEKMILPLIEGGTYGSWLTS
IGLKVYDILASVEGEDKRKMLTKKEALEKEPLLPKKILNGAGYYAEYRTDDARLTIEVLK
TALNYDAKIINYTEATQFIYEENRVVGATVKDEFSDETYDIKAKYVVNACGPWVDELRQL
NNSKTGKRLHLTKGVHLVVPHEKLPVKQSVYFDIPDGRMMFAIPRGKVTYFGTTDTNFQK
DKDHVNTSIVDASYLISAVNNMFPKINLTIEDVQSSWAGLRPLIHEEGKSASELSRKDEI
FVSDTELISIAGGKLTGYRKMAERIVDLVAKKYKRRFDKEFDDIKTEKIVLSGGTFKNFK
EVKSYTDAIYNRIAEVDFSQKDAEYLVYNYGKQTDIILKKFDEYTDENQQEKMIKAEVWF
TINYEMACNPTDFFMRRTGRLFFDTQSVYLYKNYVTQLFENQLKLDKITKEKNINNLDEK
LISILNFN
>FCMOIPGL_03229 hypothetical protein
MKKLFTAALVLLIAVSFSAKKITIQENKLVATFKGVTENDYYKFIDDQKVEHLFYDLDES
VELGLEDDENIGKKFSITWSSKEVDELNEEGDETGLKLTVKTILTIVQVK
>FCMOIPGL_03230 Enterobactin exporter EntS
MAKQDPYAALRIKEFNIFLFVRFLLVFGWSMQFIVIEWEVYSITKDPLSLGIIGLMEIIP
AFSMALFAGHIVDQKEKRNLLAICTAAFSLISLGLFFLTSDAITGHWSTNATLYTIYGLV
FFGGFLRSFFGPTIFSLVALLVPKKIYHNAATWSTSTWKTATVSGALFGGFFISWIGVDK
TLCLVFGLVILSLIFLFQIKKKPILNTKIGEPIMKSLKVGVLFVFQNKAILGALTLDMIA
VLFGGTVAILSVFAQDILKVGPEGFGVLNASISMGSIVTMLLTTYIPINRNTGKKMLISV
FIFGLSMIAFGLSSIFWVSVLALFVSGAADGISMVIRQTILQLKTPDEMRGRVSSVNSMF
VGSSNELGAFESGLAAKLIGPVAAVVFGGTMTLITVVATGALNPTIRNLDLTADIEENEK
E
>FCMOIPGL_03231 hypothetical protein
MKTIQEVVESTIRKTPFIEEALNEKLINVSSLARIILPEVSTVLKKNVKVGAVMMAINRL
SPASELRIRKNIKKLALDLGDVIVRSDLCDFTFKNTPSLLREIAKILTKSSENSDYFLTV
SQGIFETNIVTSKNLRPFVEEIFEPETLINSVLELASITIKLPKENQEQSGIYYFILKQL
AWADIPLQEIISTTNEMTIVVKEEDINQTFAILMDMKLS
>FCMOIPGL_03232 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MSEHQKIAVFGGGSWATAIVKMLTENLETVGWYMRSVQTIKYIKENDHNPKYLSSAELDA
THLDLSSNINYMVANYDVLIFAIPSAFLTSELGKLKKSLKGKTIFSAIKGIVPETGLIVG
EHFNIQYNIPLENIGVITGPCHAEEVAMERLSYLTIACQDEEKAKKMSLALESDYIKTKI
SDDIIGTEYAAMLKNIYAIAAGMAHGLGYGDNFQSVLMSNAIREMKRFIKKVHKMKRNIN
DSAYLGDLLVTGYSVFSRNRQFGNMIGKGYTVKSAQMEMSMIAEGYYATNSAFKIKEENG
AKTPIIDAVYNILYGNKNPKKEFKKLTNKLD
>FCMOIPGL_03233 hypothetical protein
MSTLKRFFKDTIIYGIAAVLPRAINIFLVKLHTSTLDAEKYAVNTDYYVYAAYLNALLTF
GMETTFFRFFSREKDKGKVLSTSFISLLISTLIFLFFALFFNDVIAAFFGFKNPLFFKLL
VYTIALDTLVVVPFAYLRVTNKPLKFTAIKLINIIVFSILNVFFLWFVPYAIQNEIYLPE
SLVNYYNEYPKVIHIFVAGAVASLSTFLLMISAVLKFKFNFDFKLFKRMLVYSFPIMIGS
LAFVTNENLDKLLLGDMLGEKQMGIYAACYKLGVFMTLYIVAFRMGAEPFFFNNADKENA
KETYSKILTWFTIFGAFFMLIVVVFIDLFATILLGKPEYFEALSIVPIILLANLFLGIYN
NLSIWYKLTDKTKYGMYFSIIGAFITIVFNIIMIPKIGFMASAWATLFAFGTMMIVSYFV
GQKHYPVNYKLKKVTYYLISSTILGLVSFHVFRGQYWFSVCTIFLFFGLIYFNEKMEIKQ
LLKR
>FCMOIPGL_03234 Endo-1,4-beta-xylanase Z
MKLKILLFLSLLFLMFSTKIYAQKKESSSVNTDERKSTKATNVSILKKEFIIDGLNDISH
KVWLYLPPNYDKSKEKYPVIYMHDAQNLFDDVTSFVGEWGIDETLNELYKNTGKNFIIVG
VENGGEKRIEEYTPWKHEKHGGGKGDIYINFLTNELKPFIDKNYRTKSEANQTAIIGSSL
GGLISFYGGLKHPEVFGKIGALSTSFWFSDKVQIFAKENGNQKNTKLFLLVGEKEGDSMV
PDTKNMEKLLLETGFPKENIKTKIVTEGKHSESFWKAEFLEVITFLYNL
>FCMOIPGL_03235 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MNVQIINKSKHATPAYETEGAAGMDLRANIDASITLKPLERTIVKTGLFIALPVGFEAQV
RPRSGLAAKKGITVLNSPGTVDADYRGEIGVILVNLSNDDFVINDGERVAQLVIAKHERA
TWQEVTVLSETERGAGGFGSTGV
>FCMOIPGL_03236 hypothetical protein
MDEIDLQPLRITGSWNVEWNLFYEADPTEETMHYLDASSLLHLNNYSLMRAINLDFRPEN
DVNGHFYLRVINLTKIENPRTKKIDYDGDWENLYFELTSKSRIEIVKEIERLVREIPPFK
G
>FCMOIPGL_03237 hypothetical protein
MILGVCEWLSTKTQFSAKNIRILFVLLVLLAGFGVGAYLILWLVKIFSNE
>FCMOIPGL_03238 Protein RecA
MAVDKEKEAKLKALQLTLAKLDKTYGKGSVMKLGDVAVDDIECISSGSLGLDLALGVGGY
PRGRVIEIYGPESSGKTTLTLHAIAEAQKAGGIAAFIDAEHAFDRFYAENLGVDIENLII
SQPDHGEQALEIAENLIRSGAIDIVVIDSVAALTPKSEIEGEMGDSKMGLHARLMSQALR
KLTGTISKTKCTVIFINQLREKIGVMFGNPETTTGGNALKFYASVRLDIRRRTQLKDGDR
VIGNSTKVKVVKNKVAPPFQIAEFDIMYGEGISKVGEILDIGVELGIVKKAGSWFSYGET
KLGQGRDAVKGLIKDNPELADELEKKIKLAIENQE
>FCMOIPGL_03239 hypothetical protein
MNSKIFLKNTNSIVIIEKGELISFQKDNQEYIHQKGNPGWRNSDDEMFPVIGPTAKNNFR
VHTKNGDAIQDQHGLLRELDYSLVSSDENSAKFIKKYKKDTLINNSKFPAKSKEENLSWP
FNFTFEKNFTLENDVLTINFIINSDKGMPFMLGYHPAFLLSDTGTETLEAGEEKITLDDI
YKVGSNAFPVLGTDKIILKNTDKNDLEITTIGFNNFMLWTEVDNMLCIEPITQYTSYTDQ
KFSEENMSLSEGKNYFSVTIKVL
>FCMOIPGL_03240 Ribosomal large subunit pseudouridine synthase E
MIEKHRHFIIHKPWGMISQFVNPAKRKKKLLGDLYNFPAGTMAIGRLDVASEGLLLLTTD
GKISEKIRSSKFEKEYYVQVDGIINEEAVEKLKKGVEIGFDGKKYITKPGKAFLINDPKF
PLRSQKIRDDRHGPTSWVSIIIREGKFRQVRKMTAAVGFPTLRLIRVRIGNIKLENMEVS
GVIETDKLM
>FCMOIPGL_03241 hypothetical protein
MNNSNTTLYIVAAVIILHFVVGFGYLIYKMNKKNDK
>FCMOIPGL_03242 hypothetical protein
MSKPLQYFIIAISIASIFLSIYTIYKTQIFFDGLGGIIVGAGLLGALYFDNYKKKTKQ
>FCMOIPGL_03243 Acetyltransferase
MNFIIKSFKEFTIDELYQILQLRSEVFVVEQDCVYQDIDFKDQKSLHVFGIKKDKIIAYT
RIFKPGDYFDNASIGRVVVAADERTYGYGHDLMKASIKAIKDHFKVDKITISAQKYLKKF
YESHQFIQVGEEYLEDGIPHIKMIKNKL
>FCMOIPGL_03244 Ribose-5-phosphate isomerase B
MTIAIGNDHAGTEYKFEIIKHLEEKGYKVLNFGTDTNDSMDYPDAIHPTADAVESGKAEF
GIILCGSGNGAQMTANKHQGIRAALCWNNELVTLTRQHNDANILAIPARFVSLQQAIGFV
DIFLTTEFEGGRHQNRINKISC
>FCMOIPGL_03245 hypothetical protein
MKNLRKIIALFIFIFIAGIFVTVITINTSLNKDETQIETVKIQKDTLSLLKAEKKTV
>FCMOIPGL_03246 Putative lipid kinase YtlR
MSNSWFIIANPTSGNRNFSKQWKEIQQLLNTKKIDFSFAFTQFSKHEIELVDKAIQKGFR
NIISIGGDGTLHHVVNGIMLQRYTKTSDITIAVIPIGTGNDWVKNYNIPNNIEKALEIIQ
KNKTILQDIGVLKTENKTTFFNNAAGLGYDGYIVNKLKTLKYLGSIAYLLSGLIGLLFYK
KSVFKIIFDDKIFEENCLMTVFGICKFSGGGMQFTENVNPSDGLFDITIAKNLNLLDLVF
NLPKLYSGKIVNHKKVATYKTKKITVIPQTSKPFIQADGELIGTGKVSVKIIEKAIGFVI
S
>FCMOIPGL_03247 Ribonuclease R
MTRKKNKIYKKKGKIVKDLTKNIFRILNEDSEKFYNYKQIAAKLKISDTDGKTQVLKKLA
ELTATKKIKEVDRGKFQINTDRKYSIGTLDITSNGNGYFITDDYENDIFIPNINLGKGLH
QDTVKAYVYKKRSGKKLEADVVEILERAKTEFVGVLQMNKNFGFVVPDSNKMYADIFISQ
NKLNGAQDGDKVQATIVDWPENSKNPFGKITTVLGKPGDHNTEMHSILLEYDLPYEFEPE
VEKEAGNLPIEITKAEIAKRRDMRKDLTFTIDPKDAKDFDDALSFTKLENGNFEIGIHIA
DVSHYLQPKTILDDEAYKRATSVYLVDRVVPMLPEMLSNGVCSLRPNEEKLTFSAVFEIN
KKAQIINQWFGRTVTYSDQRFAYEEAQSIIENCKLSDDIKPYTMPLETSIIDEEYQVDPK
IVEATLKLDELAKILRKKRMKEGAISFDRVEVKFNLDENANPIGVFFKESQDANKLIEEF
MLLANRKVAEFIGFSKGKATNKTFIYRVHDEPDVEKLASLQNIIGKFGYKINTDSKESTS
DSLNKLLNDVHGKAESNMIETLTIRTMSKAVYTTQNIGHYGLAFDYYSHFTSPIRRYPDV
MTHRLLQYYLDGGESPKADIYEEKCKHSSKREELASKAERDSIKYMQVKYMQDHKDEIFD
GVITGVTEWGIYVEISSNKCEGMVRIRDIKSDYYIFDEKQYAIVGQSTKNIYQLGNEVKI
RVKNTDLERKHLDFSLIED
>FCMOIPGL_03248 hypothetical protein
MVNSFTDEYNKLYKQLYDNIPDEESWFFPALKELIEKYDKQTAIIFATQQPWPEYTFELL
VKAGLTDIDKEILIPYLKTKNEDNCYCIAFCLAACGYQEGFVVLKQFAKQTHLLSKHTHP
FVDILPDLIFIKDDRISEISIICKNYNKQHKP
>FCMOIPGL_03249 hypothetical protein
MILTTTNNIENFKIVDYLGIVTGTAYDSSYTSKGKKMSFKDMFSMSKYYEMYSLGLEGIK
EKAFQNLKDNAVKLGANAVVGIQLDVEPLANSSTLLVSITGTAVKVE
>FCMOIPGL_03250 hypothetical protein
MMKKTIFICALLVSFNFLAQSTVTTNLGDFTTLKVYNGIEVELIKSNEQKLEITGKKSEM
VKVKNVDNTLKLSLPFSLKPENNAANGQVLIKLYYNSNIAIIDANEGSTITGKEITQDKL
EVNAQERAFINLVVNTKHLDVRTSSGGIIKLSGKTKNQDVNVDLYGIYNGFALKATANST
VFSGTGAKAEILAGETLNAKVSFGGSIFYKGNPEVVKDKKVIGGIIQKRD
>FCMOIPGL_03251 Sec-independent protein translocase protein TatAy
MYSFNIFLLGMPSGPSMILIIVAVLLLFGGKKIPELMKGIGGGLKEFKKAAKEEPEEKIE
EKK
>FCMOIPGL_03252 hypothetical protein
MYKSILNFLKKPFNIKPYLSNKLALSLLHGVFVFIFLNLFKPFNLDVLKDYLLGYSIVMG
ILTFLIPFFLFFILEKIKFKNWSIYSFIIVTFFFTIIYSYILWYFSGIYKDLYGLIKLNF
ILFYKYSSSLFIISILFMLIVNDKLLKLKKEKINSIKKDEITIFSENKKENLTLNIDKLI
YITIDGNYASFFIKKTKGIKELILRNTLSNILKQIENYPFIFRCHKSYIINSLFFDEITG
NARGYFLKSKNIENKIPVSRSLNKTELEKLLKI
>FCMOIPGL_03253 hypothetical protein
MPSIALIIIVIIGLLLFASFFIVKQQTAAIIETFGRFTSIRQSGFQLKIPGMQKVAGRLS
LKIQQLDVIVETKTLDDVFVKLKVSVQYKVIYEKVYEAFYKLDYPHDQITSYVFDVVRAE
VPKMKLDDVFVKKDDIAIAVKAELNDAMMEYGFDIIRTLVTDIDPDPQVKIAMNRINAAE
REKVAAQYEGDAQRILIVERAKAEAESKRLQGQGIADQRREIARGLEESVDVLNRVGINS
QEASALIVVTQHYDTLQSIGQETNSNLILLPNSPQAGSQMLNDMVASFTASNQIGEAMKN
QKPKKKE
>FCMOIPGL_03254 hypothetical protein
MKKLILLIILFSAFAAEAQYGNGYGSQQRRRQSDMMQTQEKAPEPNFEIEKYLGIVIYNI
EKAAKKTKIKLSSKEGKLFSKALTEYNKDIKDITRINSFLLRSTKETVENFQKVSAKSGD
FSNRTEVIKTMNDNLKPISNTLKKEDIKLDATMKSILSEKQYKKWIKYNRKLYKIFPKEG
EEEE
>FCMOIPGL_03255 Glutamate--tRNA ligase
MTNFYRKTIFAALKQEKMESNVRVRFAPSPTGPLHIGGVRTALYNYLFAKKYNGTFILRI
EDTDQTRYVANAEQYIIDSLEWCNIPFDEGPGKNEKFGPYRQSERKELYKKYATILINSG
WAYYAFDSSESLDAERKGHEAEGKTFIYNWHNREKGRLVNSLVLTADEVQTKINAGENYV
IRFKSPQDETLILQDEIRGTIKIDTNTLDDKILFKSDGMPTYHLANIVDDHLMEISHVIR
GEEWLPSMPLHVLLYKAFGWNAPKFAHLPLILKPVGKGKLSKRDGDKLGFPVFPLAYTNE
ETNEVSRGYKEDGYFADSFINMLAFLGWNPGTEQEIFSLDELVQSFDLKRVSKSGAKFNP
DKTKWFNQQYMQSKSDAELTDLYLPILSEKGISKDKEFVQKVVSSIKERAIFVADFWDLS
NFFFETPTEFDAKASKKNWKEGTAELMTELIAVISSIEDFSSANTEKEIKEWITAKEIGF
GKVMQPLRLALVGKLAGPHLFDIIAMIGKEETIKRLENAIKNL
>FCMOIPGL_03256 hypothetical protein
MKNITKLLFLFISISVFSQGPWTQEKGKFYTQLSFTTIPSYNELFGDPDYTISGEISDNT
MQIYGEYGLSEKTTLLVNIPYKLITFNRTSTINCVTTPCPGIVNNTYKENSLGNIEIGLK
HNFYKKTWLLSAQLSMEANTGSFDENSGIRTGYDAFTFSPLFIAGRSFSKSYLQTFMGTK
IRTNNYSSNFKIGGEYGGKISKNIWLIGFLDIEKSFKNGDIVLPASNLATGLYVNDQEYG
VVGVKAIGEFSDNFGVTASLPAAFFGNNVAKQVALSFGVYKKF
>FCMOIPGL_03257 Chromosome partition protein Smc
MDGYTKITQKLHQFTRKYYTNELIKGTILFLSLGFLYLFFTLFLEYFLWLKPTARTILFW
VFILVELFLLIRFIVIPVFKLIGLRKGISLQDSSKIIGNHFPEVQDKLLNILQLKESSNY
SDLILAGINQKSEEIAPIPFLKAIDFTQNKKYLKYAIVPFLIFIISFFTGNKNALTQSLE
RVVHYRTSYNPPAPFLFSLLNTDLNVIQGKPFSISVKTIGKVVPSEAKIIFNNQQYYLNN
TGNNTFSYTFSDVQEPINFYVEANGIQSQDYQLKVIGTPTINSISLELKYPNYLGRRNET
IQNSGNLIVPEGTNITWNVKTAQTDSVAFISNQKREPFKSLSKNNYELSKRIQNAFSYQI
SSSNKNLKDFENLQFSVDVVKDEHPMISVTSNIDSISRGVAQFAGQISDDYGLKKLQFVY
YDEQNSNNLQKFDLQINKENIQTFFYQFPDGLNLKTGINYEMYFQVFDNDAVNGNKRAKS
TIFKYRQKTEEEVEEDLLQEQKQTINNLENSIQKQKKQQEQLETIQQDLQNKKDINWNDK
KKVDNFIKRQEQYKQMMERQTDQLQENLDEKKEDTESLQEKKEDLKQRIEELKKLDKQQK
LLDEIQKMSEKLNKEDLLKKAKELAQQNKQEQRSLEKILEMVKRFYVEQKTMQIANKIEE
LSKKQDELEKNSDDTLEDQKEIKKEFEEIKKELEELDKDNEKLKKPMELPDVEDEKIDID
KELDKSEENLKENKTQEANKRQKQSSKKMKEMSAKMQQQMMEMEGESIEENMEDLRKILE
NLVIFSFQQEQLMNKFSETSTTHPDFGKDLKKQHEIKKYFEHIDDSLYVLSMRLPKISTK
IQDDLSAVHYNLDQSLENFSENYFPEGISNQRYVMTSSNNLADYLSNMLNSMKENMSMKM
GKGKKGKGQGFSLPDLIKKQKGLSEKMKDGMKNGKKKGEGKDGDKPDKNGKPGKKGENGE
KGEDGKSGKNGNKQGEGEGNSNDDLDGELYEIYKQQSQLRQELQDAIKEGENGKPGGSSG
ARKALKTMEQLENEILEKGFNRGTLQKMQNLNYELLKLDKAALEQGEDKKRKSASNKKEN
QKNNLKQLEFKKQFYNQTEILNRQSLPLQQNYKIKVRDYFSDIKKE
>FCMOIPGL_03258 Endoribonuclease YbeY
MVEFNYVTTFQLDDENRLENWIEKVASNQGFEVGEINYIFCDDEYLHKLNVEFLQHDTLT
DVISFDNTLGKLINGDIYISVERVTENAKEYNDSFDDELHRVMIHGVLHYMGFKDKDEVD
IKQMRNAENTALLLLNN
>FCMOIPGL_03259 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MSLFSTTYDVIVVGGGHAGSEAAAAAANMGAHTLLITMNLQNIAQMSCNPAMGGIAKGQI
VREIDALGGYSGIVTDKTAIQFKMLNKSKGPAMWSPRAQSDRMMFAECWRTMLEQTENLD
FYQDSVNGLLFDGDKIVGVKTALGLEIKAKTVVITAGTFLNGLIHIGDKTFGGGRAGESA
STGITEDLVSKGFESGRMKTGTPPRVDGRSLDYSKMLEQPGDENPEKFSYLPSTKSLVKQ
RSCYLTYTNPKVHELLREGFDRSPMFNGRIKSTGPRYCPSVEDKVNRFATKERHQIFVEP
EGWTTVEMYVNGFSTSLPEDIQDKAIRAIEGFENVKFFRYGYAIEYDYFPPTQLTHSLET
KLVENLFFAGQINGTTGYEEAASQGLMAGVNAALKVHGKAPFILKRNEAYIGVLVDDLIT
KGTEEPYRMFTSRAEYRTLLRQDNADLRLTPLAFELGLASKERMDRVLEKQRKTDLLIKF
LAETSVTEAEINPILEAKNLDLINQSLKLFKVAARPQLDFSDFKDLEKLKIFIADNNIDW
EIIEQVEIHLKYSGYIEKERNNADKLNRLENVTIPSNFNYQKLQSISFEAREKLTKIQPT
SISQASRISGVSPSDISVLLVYMGR
>FCMOIPGL_03260 Ubiquinone biosynthesis O-methyltransferase
MNSKIDFYQNLQPFLNCKDYTVSGEVYQVMIHKEYDMLVTNPVPKNLADYYKSENYISHT
DSKKSLLDKVYQVVKNITLKRKLKLIDSFKTSSKNILDVGAGTGDFLKVCQNNSWKVLGV
EPSLDARNIAAKKGIILQEDLSEIKNIQFDVITLWHVLEHVENLSIYISTLNKLLTENGK
LIIAVPNFKSYDANYYKEFWAAFDVPRHLWHFSQTSISKLFSSENMIVEKTIPMKFDAYY
VSLLSEKYKSGKMNPIKSFYRGFVSNLKATSTKEYSSLIYVLKKS
>FCMOIPGL_03261 hypothetical protein
MKTRIFTILFLVLCVLGFSQNNESNYPNFIGLNIESVKNNLDWEILQNATGDLNKDGFED
YSLIIESKDSVLEKRCSDCFLLKNKARILLVFLNKDGEKKVTIQNNRFIARGDEGGMANY
IEPELSIENQLLTIYYQFTRSNQSYTFGFRNDQMEIVRAESNGVESWSGNFESDKYDFIK
NVITSEIGNISQDKVKTEIIKINSKPKTLSEFGEMYDWEIAENKYL
>FCMOIPGL_03262 hypothetical protein
MKLLSNYPAEILILLFLVITFLISVVEKISDWKGTVTFIKEHFKNSPLKNSVPFLVSILV
FLEFIATIFMIIGVYQIYTSEIKEFALLGLELSAVVLIFMLIGQRLAKDYPGAMSLTVYF
ILTVFGVVLLNS
>FCMOIPGL_03263 hypothetical protein
MSESKKIKDLSETAKEKTTEFVTDTKIVYDVLKNKLNESLTEENVKNSTVKTAKLAKEAS
EQLQVFADEAKDELIEISKKSKVLFQKLFRK
>FCMOIPGL_03264 hypothetical protein
MFNYRVENLVELLVELKKEGVTIVGEMQEFDYGKFGWILDNEGNKIELWEPIDEAFL
>FCMOIPGL_03265 hypothetical protein
MKKRVTGIGGLFFKSDDPKASKDWYKKHLGFNTDDYGSTFWWKDKKGKDCSTQWSPFAEK
TTYFEPSKKTLCLIIESKI
>FCMOIPGL_03266 hypothetical protein
MTYEANTPEEYIAQLPDDRKIVIEKLRKIIKKNLPKGFEEGVNYKMLGYYVPHSKYPEGY
HCNPKLPLPFINIASQKNSVNLYHMGIYADKELLDWFVSEYPKHCKRKLDMGKSCIRFKK
MDEIPFDLIGELASKISVNKWVTIYESAIKKNK
>FCMOIPGL_03267 Hydroxypyruvate reductase
MKILHLDSNHPLLINQLNDLGFTNDVDYTSSKQEIEAKIHLYDGFIIRSRFSIDKAFLDK
ATNLKFIGRVGAGLENIDCGYATSKNIALIAAPEGNRNAVGEHSLAMLLSLFNKLNKADK
EVRNGIWLREENRGIELDGRTVGLIGYGNMGKSFAKKLRGFDVDVICYDIKPGVADENCK
QVSLAEFQQKADVLSLHTPQNELSKNMVNIDFINSFKKNFWLINTARGTAVVTKDLVTSL
KSGKILGAGLDVLEYEKSSFENLFSDDKMPVAFQYLINSENVLLSPHVAGWTFESKEKLA
QTIVDKIKAKFY
>FCMOIPGL_03268 3-methyl-2-oxobutanoate hydroxymethyltransferase
MSVAKKQYKRITVKSLVEMKANGEKISMLTAYDYTMAKILDGAGLDVLLVGDSASNVMAG
HETTLPITLDQMIYHASSVVRGIERCLVVVDLPFGSYQSDPKEALRSAIRIMKESGGHSI
KLEGGREVKESIKRILNAGIPVMGHLGLTPQSIYKFGTYTVRAKEEEEAEKLMDDAFLLE
RLGCFAIVLEKVPAHLAKKVAESISIPVIGIGAGNGVDGQVLVTHDMLGMTHEFNPRFLR
RYSDLYTEMTGAFQQYVTDVKSKDFPSDDEQY
>FCMOIPGL_03269 hypothetical protein
MLKIILAIIAFVLSFTLVAQNKSEEKAIKNVIETFFDGLHNGDSTLIKTTLHNDIKIQTT
YTNDKNQNILKLETKKALLTNIANKKPETIYQEKLLSFDIKIDGNLASVWTPYEFYLNEK
FSHCGANSFQLFNNNGNWEIIYLVDMRRRENCKAVNEEK
>FCMOIPGL_03270 RNA polymerase sigma factor YlaC
MIKEISTLNPNKWIDNYADYLFNYAVVRVNDSDLAKDLVQETFFAGLKSAKNFQGKSTER
TWLVSILKRKVIDYYRKINSKKGKAEVRMNFYEDGENEGNWLEERVPQSWDNASEKDIEN
EELKTQLDRCIDKLPEKYAMVFRMKTIQEFETEEICKELDITASNLWVIIHRARTQLRKC
MEDNWFNN
>FCMOIPGL_03271 hypothetical protein
MFKKFLINCDQATTICDKNQYGEATIADKVKLGIHFLRCKICSVYSKQNVFLSLMYKDHA
KSCKKMKHCLSDEDKAELKKNIESKI
>FCMOIPGL_03272 Putative O-methyltransferase/MSMEI_4947
MHFLPEKIDDYVVNHSQQEPKILQELSKETWQKVLNPRMLSGAFQGRVLSMISKLIKPTS
ILEIGTYTGYSALCLAEGMSSEGQIITIDKNEELETLQNKYFEKSGYRNKIKQKVGNAIE
IIPNIDEKFDLVFIDADKRNYVNYFHLIIDKMNSGGIILSDNVLWSGKIVEELNPKDVDT
KVLLAYNKLLNSDERIETVLLPIRDGLTISRVK
>FCMOIPGL_03273 Sec-independent protein translocase protein TatA
MLIMNITFLFIGAPEVMIILLIVVMVFGADKIPEIARGLGKGIRQVKDATNEIKKDINES
AKSQGLDTDFTKDIKNSISDVKENLDDITGPIKRNR
>FCMOIPGL_03274 D-alanyl-D-alanine carboxypeptidase DacB
MFKKKLYFLCFIIVLVGCKTLKIKHKINKELTLSIFKNQFTGIYIYDVNADKTIYNYNGT
KYFTPASNAKIFTLFTGLELLSDSIPAFKYSIHKDTITILGTGDPTFLHPFFKDSTAFKM
AKKYKKVNLITNNISDKKYAPGWAWEDFDSYFSPERSAFPMYGNVLTIQNENELKVTPNF
FENDLKMTDKNYGRKEFANDFYFDKNRTRETTIPIIISDALLLNLWNDILPNRVNLNQTT
TLKPSKIAYSVPSDSLYKRMMEVSDNFLAEQILILASSTISDTLNTTFAKNFMLENQLKD
LEQKPRWVDGSGLSRYNLFTPNSFVQVLTKMYQKIPEERLFQFFPVGGKSGTLKNWYAGN
PTPYIHAKSGTLGNNYNLSGYLITNSGKVLIFSYMNNHYMHSNADVKKKMQAVFEELRDN
Y
>FCMOIPGL_03275 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MVNNLEQGFFGIGIQNGKTPENLGVLWRSAQNMGASFIFTIGNRYAKQACNTHKAIGAMP
YFHYETFEDFFNNLPKGAMLVGVELDEKAVQLETFKHPRRCVYLLGAEDHRLSKIAIEKS
HHLVKFKSELSLDVSVAGSIIMYDRQAKFSF
>FCMOIPGL_03276 hypothetical protein
MKLSFFQLDDPLLENIKEEILATNIDTLTPIEALMKLNEIKRMLVKK
>FCMOIPGL_03277 hypothetical protein
MKILDTINSSIKKFAKGMFALFTINILIFGGILLVQSCQTEDFQEQLDANANFLSVLEQN
KMDLNQANLILPKFKKKNLFRKGIDSDNEIVSLSFPDNFSENEIDEINNNTESFTDLMGA
IQKYDAVMTYDNSESEIVYDIPVEEVTNMLQPTLIEAKKYLYTKGFNDLEIQNMILEEEG
QELDLIPFVMALTSIEKNQKQANNIKSPNLFANTAYAKVNYKDYIRCAIIGIGADAIWAL
GGSSSSSWGKAAMKRAFGAVAKRLLGPIGVAIAVGTFGICIAEAYLTD
>FCMOIPGL_03278 hypothetical protein
MLYFVILPIIAVSIKTRIDNIILSVKNKNKEKTKAELIFLCFTIIIIFITISAIEYRT
>FCMOIPGL_03279 hypothetical protein
MKTQNEHCRKKTYEKVTLELKLLVVDQIQNGQISTNFASKKYDIPRTTIGYWIKKYSTLV
QQNTGMSKINEIKKLKERIEALEFIKDFQQDIIADMEIITGVDLSKKSLPKTLVKEIELK
KKNRLKESGSMNVLGLVNKPSTKDVKSKKSNK
>FCMOIPGL_03280 hypothetical protein
MILDYRKKVGMRTGGIKLYDELKSDFIKQNIKMGRDKFYDFLRLHNLLVPKLKNYVTTTD
SNHQFRKYKNLIKDQVPNRPEQLWVTDITYIKTENGHNYLAIVTDAYSKQIMGYKLDNNM
KTSLCTEALAMAIKNRKYPDEKLIHHSDRGFQYCNPKYTAFAEENGMIMSMTEQYDPYEN
AIAERINRTLKYEYGLRNCIKNTAIAQEITKQAVDIYNNLRKHFSLDLRNPADVHLNPNI
KYKSYRKNKVNLPELKI
>FCMOIPGL_03281 hypothetical protein
MKIKQVGENHTIALNAVYKDLLRKKNENIKFRTSVVDPRVNVNNILSTVGETIYSGNELI
TYKESITTGESNITQADSLNNYKTFSNTLEISFNDISNSFNSSGLNSETNENYLNEIKNI
MLGSFNATDSNDIVSNLDTKFNIIQYDTSLTLSQKAILLSTIDLYKDSLLYWESNIDDWI
NLNDNVAKRIDGPDINYTVVGAADAIGAVRGGIAGAASGVLLGGIGAVPGAICGALAGGA
QGSALAVGAQLLAWAWDSFW
>FCMOIPGL_03282 DNA mismatch repair protein MutS
MKQYNAIKNKYPDAMLLFRVGDFYETFGEDAKKAAGVLGITLTKRGAGSETETALAGFPH
HSLNTYLPKLVKAGMRVAICDQLEDPKMTKTIVKRGVTELVTPGVSLNDEVLQTKTNNFL
AAVHFDTSTRSATKKQLGISFLDVSTGEYLVAQGNAEYIDKLLQNFSPSEVLVQKQHKQQ
FLELFENRYYTFYLDDWVFQKEYANETLHNHFEVKSLKGFGIQDVKNGIIAAGAVLYYLS
ETQHNQLKHIQHIGRIAEDNYVWMDRFTVRNLELYNPNSINAVTLLDVIDKTISPMGGRL
LKRWLALPLKNIDEIKNRHELVKVFIDSDEFSQTVTYQLKQVSDIERLISKVATGKASPR
EIVLLKDSLKAILPIKASAENSKNKTVQHLGNQLHSCMVLIDKITETLFDDAPVNINKGN
AIATGVHQELDDLRAISSTGKQYLDDMLARETERTGISSLKISFNNVFGYYIEVRNTHKD
KVPQEWIRKQTLVSAERYITEELKEYETKILGAEEKIAKLEQEIFSKLLQYIIQFVQIVQ
ENAQIIAKIDCLLSFSVLAIDNNYVRPIMDESTDLDIKNGRHPVIEKQLPIDQTYIANDV
VLNRNQQQIIMITGPNMSGKSAILRQTALIVLLAQMGSYVPAQNAKIGIVDKIFTRVGAS
DNISMGESTFMVEMNETASILNNLSERSLVLLDEIGRGTSTYDGISIAWAITEFLHEHPS
KAKTLFATHYHELNEMTATFERIKNFNVSVKELEDTIIFLRKLVSGGSNHSFGIHVAKLA
GMPNMVIHRANKILAQLEKNNKNSDVKDVLKQTQHEEMQLSFFQLDDPLLENIKEEILAT
NIDTLTPIEALMKLNEIKRMLVKK
>FCMOIPGL_03283 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MRKLKNNELGRISVDEFKTVKKTPLIVVLDNIRSLNNIGSVFRTSDAFLIEKIYLCGICA
TPPNKDIHKTALGATESVAWEYVEDTLELVEKLKAENVKVLAIEQAENSTKLDVFYPKKG
EKYAIVMGNEVKGVQQKVVTASDLVIEIPQLGTKHSLNISVTTGVVIWDLFTKIIR
>FCMOIPGL_03284 hypothetical protein
MFKKVFLLAVMMICSTFYSENKAERLLDSLNKYFSISVSIPFPEKKLNI
>FCMOIPGL_03285 hypothetical protein
MLIVLIIKVSSSLAGENVISDNIENYEKANNVL
>FCMOIPGL_03286 hypothetical protein
MKNKIRVLLVDDHPLLLKGLVLTFDEIKDFTFDIVYKTSCDSAYEAVLLSEKTNPFDILL
TGLSFSLNDGNIVSGEELINQLKKVAPNLKIGVITGHSETNRIFNVIKNQQPLVYLLKDD
CNATELNFAIHKMLKNQNYYSHLVHQKILKRSIVQISMDSIAIQILEELPKHAKINNLVG
HIKREDGKLLKIRSIEMKLADLRIDLNAKNNTDLVLKAKELGIID
>FCMOIPGL_03287 Magnesium transporter MgtE
MAFDITNDFLDNLTDLIESNNKTAIHDLFEDHHYADIAEVLDEVDFDEAVYIIKLLDSEK
TSEILTELDEDIREKILDNLSAKEIAREIGEMDTDDAADIIGELSEERQRNVISALKDEE
HAADIKELLSYDDNSAGALMGKELVKVYETWTVAGCMRRIRAQAKEVSRVHSIYVVDKQD
KLMGRLSLKDLIVAKNDQKISEIYIDKVDFVNVNEDDEEVAKIMSKYDLEAIPVVDDNNI
LLGRITIDDIVDVLKEEADKDYQLAAGLTQDVEADDTVYQLVKGRLPWLILGLFGSLGAV
IIMQNFQTIMENPEYKALFFFTPLIAAVAGNVGVQSSAIIVQGLANDLIKGSLWSRLLKE
IAISLINGLLLSIIITIFTSILGFHFSFSLAISISLMSVIIIASLIGTFVPIILDKRGID
PALATGPFITTSNDIFGILIYFSIAKFILGI
>FCMOIPGL_03288 Ribosomal RNA small subunit methyltransferase A
MSVKAKKHLGQHFLTDETIAKNIADALTGTGYNNVLEIGPGMGVLTKYLLQKKPKVTVLE
LDRESVSYLKDTFWLEHIKLDTSKDKFTILEGDFLKQNIEELFDKKQVAIIGNFPYNIST
QIVFKAIEYREFVPEFAGMFQKEVAMRIAEKEGSKIYGILSVLTQAFFDVEYLFTVPPTV
FNPPPKVDSGVIRLIRKKDYSLPVDEKLFFRVVKTAFNQRRKMLRSSLKSFNLSESLKED
PIFAKRPEQLSVADFILLTQKLANHGI
>FCMOIPGL_03289 hypothetical protein
MKRIFVLIMFLFAMNLVSFAQTGKLEEGKESLKESSASPNTTSSTTRSTTKKSGRRTRNY
NDNSSFRSFFAGIFIDLFAYTAYGVAIESPFELNGRMHDAELANYPYKNSFHGNFIYTDS
MNYNIARFDITNNFVIENSNLYGNNFGVDFRFLKRFGLEFDYLYLTEKINTNRDQFSMYS
ALINYHRIRTQKLDAWFGLGVMHVGYDVNKTGFGIGLGAEWFVAKPISFKFSHKWTNINS
REVNNTKLLLKYHIKNYHISSGYEHFKIGVSKIDAFSIGVGVSL
>FCMOIPGL_03290 hypothetical protein
MYIYNVTININETVHEEWLTWMETHILDVLNTGKFISAKLTEVLVDEEMGGKTYSVQYAA
NTREDLNDYYEKDADRLRIKSLKKFGDQILAFRTELKLVKEFYPTNVSN
>FCMOIPGL_03291 Lipopolysaccharide assembly protein B
MKHFLILILLTFSSLSFCQETDQNDFFLADTYYRQGEFEKATQIFKKLYDKSPFNTTYLS
KLITCYQETDNFKTVEKLLQKRIQQNNTVAYLYVFLGYNYERQQQEELANANYQKAINSL
DKNPAYGTAIGNLFKYYNLLDNAILVYKKVMEQNPNANYSFQIAQIYGEKGNYQKMFESY
LDLVAKNVSYLSLVQRYASKYITDDAENETNILFKKTLLKKSISNAKNEWNVLLSWLFAQ
QKEYGKALIQEKALYKRNPFNLDEIFSLGKLAFDNEDFESAKSCFDFINEKTSFAEEKID
ANLYLVKIAVATKNPETEKIFESLITEFGINEFTINLQVEYANFSTFNKNNPEKARAILE
KALTFSRSKFDEASIKLKLGDVLVFSGNYNKALIYFSQIQTQLEDHELAQEARFKVAQTS
YFKGDFTWAKAQLKVLKGSTTQLIANDALDLFLKITDNEPVDSIPSGLKQLAKAELLAYQ
NKDAEALAEIETLSKSKKILVNGLVPGEVIYDDVQFFKAKLYIKQKKYDDAIITLAEIIA
ADNQSFLTDDVYFMMAEMYNYNLNNVEKAKEYYQKIIFEQPSSIYLVEARNKFRKLRGDT
I
>FCMOIPGL_03292 hypothetical protein
MNDLNNKYENAKLNSIEFMKTGQISAYFNALLEMNKYKRLLTAVIAN
>FCMOIPGL_03293 Serine--tRNA ligase
MLQVNFIRENKEVVLEGLAKRNFANATTIIEQVLTADENRRATQVELDTTLGESNKLSKE
IGNLFKSGEIEKANILKEKTGLLKESSKNLSDKLTMYADELQTLLYQIPNIPHASVKQGV
SADDNENIFSEGNIPDLGENALPHWELARKYDIIDFELGTKITGAGFPVYKGKGARLQRA
LINYFLDKNTKAGYTEVQVPHLVNADSATATGQLPDKEGQMYHCEVDDLYLIPTAEIPIT
NMFRGNLMQETEFPIKATGYTPCFRREAGSYGAHVRGLNRLHQFDKVEIVRIEHPDNSYA
ALNEMVEHIKNILRELKLPYRILRLCGGDTGFTSALTFDFELFSTAQDRWLEISSASNFE
TFQANRLKLRFKNKDGNSEFAHTLNGSSLALPRVLAGILENYQTANGIKIPDVLVPYCGF
DIIK
>FCMOIPGL_03294 Riboflavin biosynthesis protein RibF
MKIVQDTSNFSDKEKTYVTIGTFDGVHFGHQKIIEKLVNEAKKANKKSVVLTFFPHPRMV
LQKDVALELINTIDERAALLEKTGLDYLIIHPFSKEFSRMTALEFVRDILVNQLNISKLI
IGYDHHFGKNREGNIVQLTEYSHLYDFVVEEIPAQDIDDVSVSSTKIRRALASGNLETAN
DYLGYNFMLNGNVVNGKKLGGKIGFPTANIDVNETYKLIPKTGVYIVKSNIDNKTVFGMM
NIGSRPTVNGKHQTIEVHFFDFNQNLYDKNITVELIYFLRNEEKFDSVNTLVQQLKKDEK
TAKDYIKTNC
>FCMOIPGL_03295 TonB-dependent receptor SusC
MIKKILLVAFIAFSSLAMVGQTTVTGTVKDAKTGDLLPGANIKISRRAVGTSTDFDGNFV
LIVTDKPPFTIEISMIGFHSITAEITKNNQKVEVSLKENETSLDEIVVSASRTPERIMES
PVTIERMDARSIKNTSAPSFYDGLENLKGVDVNTNSLTFKSVNTRGFATFSNTRFMQLVD
GMDNSSPALNFALGNLLGMSELDVKTVELLPGASSALYGANAFNGIMFMTSKSPFEDQGI
SVSLKGGITSQDAGGNNEFTDFNLRMAYAFSDKFAAKATLAVLQGTDWFATDYRNTADGE
YAPGTRESVNDYNGVNVYGDVAATDLGGAIGRVSRTGYNETDLMDYDVESVKFLGALHYR
PFGDDRLEIIWNSKLGTGTTQYLGGQKYAIKNFFMEQHKLELKGKNFFVRGYVTAEDAGD
SYNTLFTALNINREWSGDTNWFTEYAGAYLTTGSHQAARSYADRNRLLPGTAGFKEAFNK
VTSDANLITGSKFRDETKLYHGDANYNFQDVIDFAELQIGGSYRRYSLNSFGNIFTDTDG
PIDYDEYGIYTQVQKNFLDEDRLKVTASLRYDKAQNFDGNFSPRVSFAYAGGENKNQNFR
ASFQTGFRNPTTQDQYIGLDVGNAILVGGVEDNIDRYSTTFTDPGDGQTYTLTGRDAYEN
SYTLASGGTVKADLAFVKPEKVTAYEIGYRGLVNTGDSNRFTVDLSVYYNQYEDFIANTN
VIVPYNLTGGYKVFQLYANSTADISSYGASIGLNTKILDGFDVGFNYTLAKFEFDQASNP
DFEAGFNTPEHKVKLQFGKTDLFKNFGFNINARWQDKYRWESTFLDGTIEARTVLDAQIN
YSVPSLKSVFKLGGANLTGQEYLSAPGVGAIGSQYYLSWTINN
>FCMOIPGL_03296 hypothetical protein
MKNYKYIGLFLLSLSIASCDVNNELDTILEETIQYPAASSGSANFSKFVALGASFSGGVV
DGSVFLAGQQNSFPKMMANQMVAMGGGEFIQPLVSDNIGGLTYGGQVIVEPRLYFNGAGP
VRLDATPTTEVTSKLTGSFNNFGIPSAKSFHMIAPGYGSIPGVIAGTANPYFARMSSSET
TTVLADAMAQAPTFFSISEIGGNDVLSYATSGGIGTVQTTNYDASTYGPNDITSPVVFET
VMNAMVTTLTSAGAKGVIVTVPSIVNLPFFTTVPYNAVPLDAATASAVNTGYAGYNGGIQ
QAFAALAGTGLFTQEELDKRTISFAAGQNAVVIIDEDLTDLGAINPAFAAIPKYRQATAE
DFLLLTSSSFIGTTVGGNAQLINGVTVPLADQWVLTPQEKDAIQSATDSYNESITSIAVD
NGLAIADLNALLNAAAGSGIMFDSYTLTTGFVTGGLVSLDGIHLTTRGYGLMANKILEAI
DAKYGSNFIESNNINKANDLTAVYSPTLR
>FCMOIPGL_03297 Cysteine desulfurase SufS
MFNIDKIREDFPILKRTVHGKSLVYFDNAATSQTPQIVIDAIVDYYSNYNANIHRGVHTL
SQEATDKYEEARIKIQKHFNAKEAFEIILTSGTTHSINLVASGFASLLNNGDEIIVSALE
HHSNIVPWQMLCEKTGAILKVIPMTDEGSLDMKTYHQLLNKNTKLVFCNHVSNALGTINP
IEEIIEAAHKVGAAVLIDGAQATPHIKPDVQKLNVDFYVASAHKLCGPTGVGLLYGKQEW
LEKLPPYQGGGEMIETVTFEKTTYAGLPHKFEAGTPNICGGIAFGTAIDYMNSVGFENIA
TYENELLKYGTEELLKIDGLQIYGTSKEKTAVISFNINEIHPYDIGAILDKLGIAVRTGH
HCAQPIMDYYKIPGTIRASFSFYNTKEEIDVLVAGVKRAKMMLS
>FCMOIPGL_03298 hypothetical protein
MIAAVIYNYPKLNIIAGYSAKSTASSVFVADRTLEFTNKTDTNFSPINLADDTVNTDEKS
VTSSVFGLLTRKAFVREGLGSVLTLEEEDLSKKYLSPKRGIADNITPFPYGNGAQKDTIF
NNVDYSKLEETLNVLFDSVNQTRAAVVIYKNQIIAERYADGFTKDSKILGWSMTKSIVST
LFGVLEHQKKINVFDRAPISAWQNDERKEITIHNLLQMNSGLEWDEDYNSISDVSKMLFL
ERDMTKSQIDKPLIGKPNESWNYSSGTTNLLSGILRNQFKTHQEYLDFWYAELIDKIGMN
SMVLEGDLAGNYVGSSYAWATARDWSKLGLLYLYNGNWNGEEMFSKEWVKYATTATPTSN
GTYGAQIWLNAGKTYKNVPQNMFSFNGYQGQNVFVLPDQDLVVVRMGLTKNADIDTFLSG
IIKSIKQ
>FCMOIPGL_03299 hypothetical protein
MNKTIKTILLIVGVILLAYGIYTMVIPETQVSIGDLDLIESQDNTNSYITIGLGLVAVVL
SLIKGKSS
>FCMOIPGL_03300 FeS cluster assembly protein SufD
MELKEKILSSYVAFENGLDINSDVHEIRTEAFENFEKLGFPTKKLEAWKYTSLNSVLKHD
YSIFTNKGNDVEMADVKQYFIHDIDTYKVVFIDGKYSSFLSETTHDTIDVCLMSAAFSKP
KYKAFVENYYNKVAKQDSLTSLNTAFATEGAYIHIPRNVEVEKPIQIINFTTGSEAATMV
QPRNLIVVEENAHVQIIERHQSLTSNPVLSNIVTEIFADKSSTVDYYKIQNDEENASLVD
NTYVDQKSNSVVSVHTFSFGGNITRNNLNFYQNGEHIDSILKGITIIEGKQHVDHHTLVH
HIEPNCESHQDYKGIFDERSTGVFNGKVIVNKEAQKTNAYQQNNNVLVSDRATINAKPQL
EIFADDVKCSHGCTIGQLDDDALFYMQQRGIPKKEGKALLMYAFANTVLESVKIPEVKKR
INKLIAEKLGVNIGFDL
>FCMOIPGL_03301 putative ATP-dependent transporter SufC
MLKINNLHANIEDKSILKGLNLEVKAGEVHAIMGPNGAGKSTLANIIAGKEEYEVTDGNI
ELNGEDISELAPEERAHNGVFLSFQYPVEIPGVSVTNFIKTAINETRKAKGLEDMPAKDM
LKMIREKSELLEIDRKFLSRSLNEGFSGGEKKRNEIFQMAMLEPKLAILDETDSGLDIDA
LRIVANGVNKLKSKDNAVIVITHYQRLLDYIVPDFVHVLYDGKIVKSGDASLALELEAKG
YDWIKKELV
>FCMOIPGL_03302 N-acyl homoserine lactonase AttM
MKKIIILFLGLAIVSCKKTEKKVEETAKADVKLYQLVGGSIFVKKLEAFSQDTTYTGQTK
QFTDAYYVISHPKGNLMWDAGLPEQLVQPEPFDEPSGVFRIQRPDSLVNQLKTIGFKIED
FNYFAMSHSHFDHTGHANYMKDAKWIVQENEYNANLGDTLKAKNPALAALKNVQKIKGDY
DVFGDGTVVIKYTPGHTIGHQSLYVEVAGLEKPVLLTGDLYHFEENRATKGVPSFNYDAK
ETLESMDKFETFAKEKNAEIIIQHSPIAYKKLEELLNSLEPKA
>FCMOIPGL_03303 FeS cluster assembly protein SufB
MSKYTEEQLEQELKTKEYEYGFYTDIESETFAKGLNEDVVRAISKKKNEPQWMTDWRIEA
FRVWEKMEEPDWANVNYPKPNFQEIAYYSAPKKKPTLNSLDEVDPDLLETFKKLGISIDE
QKKLANVAVDIVMDSVSVATTFKKTLGEKGIIFMPISEAIQEHPELVKKYLGTVVPTTDN
FYAALNSAVFSDGSFCYIPKGVRCPMELSTYFRINEGGTGQFERTLVVADKGSYVSYLEG
CTAPQRDENQLHAAVVELIAMDDAEIKYSTVQNWFPGDENGKGGVFNFVTKRGLCETNAK
ISWTQVETGSAVTWKYPSCILKGNNSVGEFYSIAVTNHYQQADTGTKMIHLGKNTKSTII
SKGISAGKSQNSYRGLVQINSRAENARNFSQCDSLLMGNECGAHTFPYIEAKNKSAQIEH
EATTSKIGEDQLFYCNQRGIDTEKAIALIVNGFSKEVLNKLPMEFAVEAQKLLEISLEGS
VG
>FCMOIPGL_03304 Iron-sulfur cluster insertion protein ErpA
MIKVSDTAKKKVIELMTDDGFDATKDFVRVGVKSGGCSGLSYDLTFDNKQEENDKIFEEN
GIKIIVDKKSFLYLVGTTLEYSGGLNGKGFVFNNPNANRTCGCGESFSL
>FCMOIPGL_03305 Aminopeptidase N
MVRLIAISFFILIGISKISAQEVINISESEAKSASKKVLFKANPNTSNYDITYHKLEFSV
DPAVASISGKVTTTFTALQNMNSVTFDLDDNMTVIAVTENNNSVSFTQNTNDELIINLQN
TLNQGNSTSVSITYSGNPTSNGFGSFEVNTHNGTPVLWTLSEPYGALGWWPCKQDLNDKI
DEIDVYITAPEQYIAVTNGLEQSVTISAGNKTTHFKHQYPIPAYLIAIAVTNYETYSHTV
TNNGNPFPIVNYVYPESLSSAQNSTEITADIMNHFIDLFGNYPFENEKYGHAQFGWGGGM
EHTTVSFMGSFDRNLIAHELAHQWFGNKVTCGSWKDIWLNEGFATYLTGLTVEHLDGDNS
FKSWRNSNISSITSSTNGAVYLSDSDTTSVGRIFNGRLSYNKGAMVLHMLRKKLGDTDFY
KGLKNYITDPNLAYSYAKTPDLIAHLEAASSLDLAEFFNDWIYNQGYPTYNLEWFQQSDN
SINITLNQTQSHNSVSFFEANVPVRLNGTNGEVLDLILDNSKNAQTFTKTVSFTVSSVHI
DPDFHLISKNNTIVLNTEKQNLTLHNIEIFPNPVNDFLTIKTTNNTTFNKLIIYNLLGQK
VFKSTKNQVNLSEIKKGIYIIKVDTDAGIIRKKIIKK
>FCMOIPGL_03306 Thiamine-monophosphate kinase
MLQDKNQQKTSLAELGEFGLINHITKYFKIENASTIKAIGDDAAVLDTSEKQTLVTTDLL
IEGVHFDLSYMPLKHLGYKAVMVNLSDVYAMNGTAEQITISIAVSNRFPLEAIEELYAGI
QLACETYNVDLIGGDTTSSTKGILISVTAIGKVDKGEAVYRNTAKETDLIVVSGDLGAAY
LGLQVLEREKQVFKVDPNNQPDLDNYTYLIERQLKPEARKDIAGLLKELEIKPTSMIDIS
DGLSSELFHICTQSKVGCKIYEDKLPLDPQVISTCEEFELDSTMVALSGGEDYELLFTVP
IADFDKIKGNPNFSIIGHVTAENQGLQLITRAGQEIELKAQGWNALNE
>FCMOIPGL_03307 Inner membrane protein YbjJ
MKSLRLILSNFTFFAPAWVFSSINILIGTWILYIPFIKLKFNLNDGELGFALFFTALGLL
ISIPFIPKINKLIGVGKSTKIGVFLLAIAFNLPLLAPSYLLLCAALLCVGLFSAFTDISL
NALTSNIEKREQQNFMSAAHGFFSLGGFIGAGIGSLFMSMFSNPQLHMLLISVFVILSNL
FLAKNYELIIGEEKENQNDNTSFFKNVKPLLVLAIIAFIILFNEGAVEHWSNLFLFDIVK
VSESKAGLGFIIFSFTMTVGRFLGDGFSHKIGSRKIILFSTIIAFVAYLFIITANLVLSV
LGFGLLGFGLSVIIPEIYRIAGKNKEIETSLAISIVSGIGFIGFLAGPVLLGAISNASNL
VMSYVFLSVLIIIAFCLALFGLKRKV
>FCMOIPGL_03308 hypothetical protein
MKKKRFRIILTITVIILLIPLIAMQFTNEVNWKFLDFIVAGILLLVNGLVWDIAIRKIKK
TKHLILVIIGILVIIALIWTELAVGIFGSPFAGS
>FCMOIPGL_03309 hypothetical protein
MNTKTLNLLFTILCPAILFAQTITGKISDKTNVIPFANVILKDTNNNIISGTTTNNEGSF
EVKMNAGNYKIEISYLGYRTWEKQIKVDANLNLGTIILEENAQALNEIIVKTEKRILERK
IDRLVFNVEKSIAAVGGNGLDVLKITPGIQLQNGNLSILGKGKTQIMINGRISPLKGDEL
MSFLSGFSANDIVKIEVITNPPAKYEASGNGGLINIVLKKGIKDSWKNATTISYNQNRYN
FTTITNNLFYNKNKISFSGSINATKGGFENSEGLLIDYPANNWEIDVNSKTYKNQFSGRF
LIDYALSDKTTFGLQYLGNNTKPDIIGTTVSSIFDNNNTLEYSLVNKGDNIVDTKNHTVN
FHLITQLDSLGKNISFDADYFTFNSENSRDFFTEKFNNKGNSEGINSAALNISNQEIKNF
SSKIDVDFPMKKINLSYGIKASFTNTKSNVLYYNTLSGSTILDSNRSNKFNYKENVLAAY
FSGNTTITNQLKMQFGLRLEDSKTKGVNTEINKETVNKYTKLFPSIYFSYKKNEHNNFGF
SYGRRINRPNFNHLNPFRFYINENSYSVGNPFLKPSFSDNFEISHLYKKNLNTSIYLNIT
TDGFGTVFTSVAENQAQIITKENYFKQYNYGITENFSFNKNSWFKSINSINLLGYYTKFM
KDFGAKPKNGVQLYVTSNNTFSLSKKTKLQVNSWYSSQHNRGLYSLGKMFDISLGLQHQF
KNNIKLSLLFSDVLNTASLNNYTSTVNDIKQIYRQNESSRNFRVSLSYDFGNKKINVKKR
DFGNDDERRRSN
>FCMOIPGL_03310 hypothetical protein
MNYISILSVLSILIVTLFLFFSGFLLTVKTDKKLSNRLLAAFLIITAIDISAFFYHNFIQ
LPLGLEMLRVRISSFKDPLLFLYILSVIYTNFNLKKKHLVHILPWLVHIIVLIPNFFLVD
ENSKLTFFNNYEQTSEGKFLTIFGRFISASYFIAEIYYVLRYRKLLLENYTDKNAFKNYN
WLKQLLILLTIGQIITIVKNNFRSYYSLEATDVLRTITLLFGIFFIFWLVLKALNSPKLF
RGIDVNLLTSKEISKVSVVDQKVNEQLKSLKKYMETEKPYLNPSLTIRNLSEEIKMNSRD
LSVLINQNLNQHFFDFVNEYRIKDAMEILKNPSKKEFTVLEILYEVGFNSKSSFNTAFKK
HTNLTPTQFRKSP
>FCMOIPGL_03311 Haloacetate dehalogenase H-1
MILNFKNANIFYTDEGKGSAVVLIHGFLENATMWDEIKPELIKKNRIITIDLLGHGKSDC
LGYVHTMQMFSESIEAVLKHLKIRKCILVGHSLGGYISLAYTKMNITKIKGLCLLNSTSY
EDSKERKDLRTRANKMVQNNFENMVKLSISNLFHQENLAAFKNEISKIKKEALQTSLQGY
IAANEGMKLRTNTNAVLSENNFKKLIVIGEKDPVLDYKTSLDEAKKTNSEFVVFPDGHMS
HIENKNELITVLKEFVKKC
>FCMOIPGL_03312 D-alanyl-D-alanine carboxypeptidase
MFFKKITLLVLFVFSASINAQIDDKKLDNLIEQTLKTFDVPGISVGILKDNKIVYAKGFG
VRSLTNKKDMNENTLVGVASNSKGFTCFALAMMIDEGKLNWDDKVRKYIPEFQMHDAWIT
ENFTVRDLVTHRSGLGLGAGDLMFLPENKSFTTQDIINNVKYLKPQSIFRTDFKYNNNMF
IIAGEVLKRVSGLTWEEFIETKIMKPVGMTSSKASYNRVTNRTNIIDAHTRADGKVIQIP
HDWSETANAAGGIMSNVNDMLTWANFLMNNAVTKDGKRLLSEQQFHELWQLQTPLKVSKK
DAYNSNFRGYGLGWFLTDVKGGHKQVYHTGGLIGTVTQFTMIPDLDLGIIVLTNQMNGNA
FNTITNTIKDAYLGYEDRNWLKNYGSRNAKYLEYNDSLKATIFDKITLAKADKSLPKPTQ
IIGTYKDDWFGNIIISHNGTTYIIECERSSTLVGELLPYNQTTYVAKWNNRSYDADVFVQ
FRFNEKGNATGATMKFIAPITDFSFDFHDLNLKKVN
>FCMOIPGL_03313 Branched-chain amino acid transport system 2 carrier protein
MNKTKEIWIAGFALFSLFFGAGNLILPTSLGVKAGPDWWIVVLGFILTAIVIPILAIFAH
ARLQGTLYDFGKKVSPLFSTIYCFLIYIIAVAIPSPRTAAVTHEIAIQPFFNSSALLTSV
IYFVLVFVFAVNRSKVISLIGEFLTPIIVTILLVIIGIAFFTSPGSVTPSEFKHPFVDGL
LEGYQTFDAIAGVILGAVIIISLNLRGHTTFDAKKELITKAGVIAGGGLLLIYGGLIFSG
SLFSSTFAENASRIEILSSLSSQTLGNLGSTFLSVLVALACFTTAIGIVTGTADYVRGLC
NNSNIAYTITAAVCAVIGIVVGSNDVGFIIDIAVPALMFVYPITIVLILLNIVPEKYASK
LVFRAVVIVTFIFSIPDFLGFIIPRENLVGIKSMIPFAEHSLGWVLPALVVFVGLNLKKI
>FCMOIPGL_03314 hypothetical protein
MKKKKKKKVIELRTLIIIILFLWIISAFISWFIFKDWKESASFGDTFGGINSLFSGLALA
GIIYTIFLQKTELSLQRKELKYTREELKRTAIAQEDSAKSMTMQIRLTNFPYLEFDSEIN
NDEKCITIKNRTNNVAFDIAISIFCFIPEDEYPFSKYIEKNISESYKKRALGISLLDDHL
WSISDVGYYPSISKNKKIIIPLKFPIDFGVYSMFVQYKDVLGNNYSNLINFNSFQDYETI
DDKPFSGIRIRPEFPVITDRINPNDKKKTGDNVPKFINEFIKIDKSSIGLGLLKNAKFIS
NDFKWKVELHSS
>FCMOIPGL_03315 Transposon Tn10 TetD protein
MAIQNITKHSYKDTFSVSTVQFEKACTIDHSVQQNAYSIYWIQEGSGSYNIDFESYTFND
NVLFFLSPGQVFTVDSEQIKTAYKLTFVRDFYCIQTHDAEVACNGILFNNIYETPFVKPC
EKDTAKLNFILESLIEEFQQDETAQYDMLQSYLKQFIICAVRVKKENHVIKEDVETRLFK
DFSLLVEQNFKTMHSVTDYANRLGLSPKSITKHFQKLGAKTPSDFIKSRILLEAKRQLIY
TDKTVKEIAFELGFNDPAYFTRFFTKAISKSPLQFKKEY
>FCMOIPGL_03316 Thioredoxin C-1
MEIQLEQTDFINVIENNDNVLLDFYAEWCGPCQTLLPTIHKLADELKDDVLIKKVNVDEY
PKLAAKFNVRNIPTLLFFKNGEPADRHTGLITERNLRSKINRLK
>FCMOIPGL_03317 hypothetical protein
MSTFNVPTKNEVSENNQAIFNQLEKGLGFVPNLYAAFAHSETALGNFLAIGQGKTSFSAK
EKEVINLAVSQVNECVYCLSAHTAIGKMNGFTEAQILELRAGEASFDAKLDALAKFARSV
AINRGSATTEAIENLYAAGYTKGNLADSIILIGEITITNYFHKTTDVAVDFPVAQTLEVA
TI
>FCMOIPGL_03318 hypothetical protein
MKKLIAVVVIVLGFAFNTSAQEVKTVSLEQTKGEFTQKQLTLSEGTYIFEVANNNVGHNV
GFVLAPKSDVKAHIKNAYVTAQVKNNTKETSKKVTLKKGEYVYFCPLNPTPQYTLIVE
>FCMOIPGL_03319 hypothetical protein
MKKLLIIILFFCSIFTFGQKSDFNLIQLDSTWGQEVLRFPARNMNYIGVGDIRFPPKGWI
NPEHTFFWSYAYAWSIDVNRKIPASELELDLEKYFNSLNKVDVNDKTNSRKASATIKKVK
SKKNVTFFEGKVHTFDRFATNKRFVLNVKIKSHFCKKAKKTVLLFTFSPKEFTNEVWETL
NNIDLEKGGCKN
>FCMOIPGL_03320 Protein YceI
MFTLIIICFFTLIINAQEKIKLNTKKSTITWEGSKLFGFGSHDGTVYFKEGEVVVKDSKI
INGSFIIDMNSIKSNEKETWVYDLIEHLKSKDFFDVKNNSTSIIVFTNIKYVGDGFVQIT
ADLTINKITKSVFFVAKQNDTKKQLETRLKIDRTDFKITYKSQGETSIKDQIISDAISFK
VLLNF
>FCMOIPGL_03321 Transcriptional regulatory protein SrrA
MKQKKNLFLILLLAITVFVFFNFTDSSDENKDFSERVKVALREVGNQLLLSNGDSISLVL
PVKEHDKNEFEISFENQLKFMPNDLVLIVKKVFKKTTFSKNYRVSVISSFDSEVAYSYEI
NADKEKTIIPCSGRNLPKNRYTIKVTFLEIKSSNFLWIFYIFIPIIFGVFYKRFFKVEKQ
KMVIEKVDNNCTVLGSFIFYPAQNKLVKKASEINLSKKECELLAIFVANPNQVIKREELT
KKVWEDNGVFVGRSLDTYISKLRKKLQEDKNIKLTNVHGVGYKLEIK
>FCMOIPGL_03322 hypothetical protein
MMSVLLNIKIKKSIVFLGFVLLAFQNFANHNFKICSNHEPDSFEFFFCDLCGCSTSSGSF
GLGTLNNASFVGIRYIYQTFESKDGIFSNSPTSTENFHTYQLWGRVPVTDNFYVSAILPY
QDLKRKYTDREENINGFGDATIMGWYKIKFFKKVDKEKAKLYTNVQKEASGHSLEIGLGT
KLPTGKFEQILTDRVNPGFQLGTGSFDGIFALAHSYGADKFGVNTSVTYYLKGENKNDYK
FGNQFSYASNFFYAISKEKYLLLPFIGLSGNIYDKIEQYEEEIPKTDGNVFNGTFGAEIT
TKDFIIGANYTLPISHNLFGGNVTPKQSLSIYINFNLNN
>FCMOIPGL_03323 Cytochrome c551 peroxidase
MRKIIILFLGICTLISCDKEDVYTAIPTYIDLEIPSNFPQLEYNLSKNPLTEEGVALGKK
LFYEGRLASDGIIACGFCHEQASAFTHHGHTVSHGVDGAIGFRNAQPIQNLAFFTEFTWD
GAAIHLDLQPIIPITSEVEMNETIPSILAKLSSYSEYEPLFTKAYGDAEVTSERMLKALS
QFMVTMISGNSKYDKVVRNEDNTAFTSEENKGLEIFTNKCATCHSGALFTDKTYRNNGVP
YNSKFPEEEGRKRVSGYEADFYKFRVPSLRNVALSFPYMHDGRFGTLEDVLNFYTDGMTE
NGGIVDPLLIKEDGSLGIDLTTDEKTALIAFLNTLTDNTFLNDERFAEY
>FCMOIPGL_03324 hypothetical protein
MKITKYIVACFIAMSITACSSNEDEEMITGEGSVSVEFDNSYLTSDLLLSTATYLANDTE
EIKISDVKYIVSNIRLENEEGVIFTYPKEESYFIVSEADTDSQFITLSNIPAANYTKITF
GIGVDQEKYLEGATDQGDFLTLAQDAGMMWSWQAGYKFFVYEGLYTSDATTTETAFAFHM
GSHGSSLDNYKEITLDLTNSARVRTDLTPEIHVVADLSNVLSGTTTFLLDDAAQIHVDAV
KSPQIATNVNSMFTIDHVHN
>FCMOIPGL_03325 Nitric oxide reductase subunit B
MKKIWIAFISVVVLSFAVLIWVGTEVYQKQPPIPEKVVVKDTNEVFYTIEDIQIGQNVWE
SIGGMEVGSIWGHGSYVAPDWSADWIHREAVFMLDLWAKKDFNKKYDDLDVENKAAIKAR
LIKDIKTNTYNSATKTIIISQERVAAINNNIQHFSDIFSKGNERYAIPEGALKDKVKLKQ
LNAFFFWTSWAASTNRLGKDYTYTSNWPHEPLIDNNITDGSIIWSGLSIVLLLVFIGILS
FYYLRNHEKGESLTKPDSDPLLNMKLAKSQKAVLKYFFVISLLIALQVILGIITVHYTVE
GQSFFGFDLAKFLPYSVSRTWHTQLAVFWIAATWLATGLFLAPMISKKEMKYQLFGINFL
FVALIVIVLGSMLGEWLGIHQFLDLTTNFFFGHQGYEYMDLGRFWQIFLGIGLVLWVVMV
SRHILYAIRKNDESKHLLIILLISVMAIGMFFFSGLMYGENSSLPVINYWRWWLVHLWVE
GFFEVFATVVIAFIFSRMEIISAKTAGRVSIASASIFLAGGIIGTLHHLYYSGTPVQAIA
LGATFSALEVVPLTLMGFEIRENWNLLKSKKWIQNYKWPIFYFISVSFWNFLGAGVFGFL
INPPIALYYIQGLNTTAVHAHTALFGVYGMLGMGFIIICLRFYSDRAWSNTKLKRAFWFL
NIGLIAMMVFSMLPIGIIQAYTSITEGYSFARESDLLYSPTIQTLKWMRMIGDILFSIGI
YYFCWFTIDEVIYNYKRKK
>FCMOIPGL_03326 hypothetical protein
METDTTKEIRIVMRKNQEMKEHSAPKPIVVEIFEGEINFGVNKKVLNLKRGDLIALDANV
PHDLVCTEDAIVRLTIAKTDSIKRVNDVVS
>FCMOIPGL_03327 HTH-type transcriptional regulator IscR
MFSKTCEYGLRAVIFIAQESKIDNKLSITAISEAIDSPHAFTAKILQQLTKNKIVQSIKG
PHGGFFIDEKNLKTVTLSNIVEVLDGDTIYTGCGLGLHECNENKPCPLHFKFIEIREELR
KMLENTTLLELSEDKNLRDSFLKN
>FCMOIPGL_03328 hypothetical protein
MKFNYDRELAKLHTELVHMQEWVKSKGLKVVIVFEGRDASGKGGTIKRFTEPLNPRICKV
VALGVPTEREKTQWYFQRYTQYLPAAGEIVLFDRSWYNRAGVEKVMGFCTDNEYDEFLRS
CPEFERMLVRSGIIVLKYWFSVSDEEQERRFKNRISNPLKRWKFSPMDLESRSRWIDYSK
AKDQMFAHTDTKQVPWFVVNSDNKKKARLNCISHVLSKIPYKQMDIKTIELPPLPDNKSY
VRPPMDYQTFIPEKF
>FCMOIPGL_03329 3-oxoadipate enol-lactonase 2
MLNYYSYPHTTSKEWVTFVHGAGGSSSIWYKQIRDFKKQFNVLILDLRGHGDSKPKLKDT
FNSKYTFDAITNDIVEVIEHLKIKKSHFIGISLGTILIRNLAEKRPELVKSMIMGGAIIK
LNFRSQVLMKVGNIFKSVVPYMLLYKLFAFIIMPKKNHKKSRLLFVNEAKKLYQKEFLRW
FKLTSEINPLLRFFRTKDINIPTFYIMGAEDHLFLPSIKNIVSKHLTSSLFVVENCGHVV
NVDKPEVFNNQTIQYISSLP
>FCMOIPGL_03330 2-dehydro-3-deoxygluconokinase
MNQIITFGEVLMRISPLGNKKFIQSNAAEFYFGGTELNVGISLANFGGKVKHISSISDDF
IGDTAFSYLNKFDLDTSSIIRSSRPLGVYFLEVGAVMRPSSISYNRSHSSFSEITPSKVD
WEKALEDGKWFHWTGITPALNKGSQETLLEGLKLARNKGMTVSADPTYRSGLWKYGEDAK
EVLSELINYSTIFIGGINEMNELLGTDYSYSNEDFMEASKELMLKFPSIEKVFDKIRTSI
NSSWHKIKARMWNGKEFKETSELDITHIVDRIGTGDAFAAGIIHGLLNFDDYKAMEFGNA
ACAIKHTYSGDVNYANEKDVIAILGGNTTGRFNR
>FCMOIPGL_03331 Xaa-Pro aminopeptidase
MKYDKIDSKLFIKNRKNFASAMKPNSLAIFNSNDIYPISADSTMPFEQHRDIFYLSGVDQ
EESVLMLFPDCPNPDLREVLFVRETNDHIAVWEGEKLTKDAAFKTSGITSVYWLQDLDKI
LFELSTYCDTFYINTNEHYRANVVTETREDRFTKKLLAKYPAHSVAKSSPIMHRLRSVKD
QIELDLMQHACNITEKGFRRILNFVKPNVWEYEIEAELLHEFIRNRSKGFAYTPIIASGN
NANVLHYIENNQQCKAGDLILFDIAAEYANYKSDLSRTIPVSGRFTDRQKAVYNAVNHVK
KEATNMLLPGTLWKEYHVEVGKVMTSELLKLSLIDKADVQNEDPNWPAYKKYFMHGTSHH
IGLDTHDYGLLHEPIQANMVFTVEPGIYIPKEGFGIRLEDDVVVQEKGTPFNLMQNIPIE
ADEIEDLMN
>FCMOIPGL_03332 hypothetical protein
MKMKKTITYLFAFFMLLLNSQKIIGQTFSQNNNLINVVPLLDDNVFENSEKFSNTLNDYS
IESFVVNDEAIVNLENEKNLITSSVSKVELSAPNAILTPITQANIQTAVDDWIANPTTAT
ATYGHISNWDTSNITSMSSLFLNKTTFNDDISGWDTSNVVSIRAMFNNASSFNQNIAGWD
VSNVTGFDQVFSGATSFNQDISSWNVAASNNFKEMFKDAINFNQPLNNWDVTDTNNMQSM
FRGATSFNQPLNNWNVTNITAMYFMFSGATNFNQDLTNWCATNIASEPIGFADNSALLNT
NKPSWGTCTANTSVDTKVATSITLNSVVLEGYITSNVTVIERGFVFAVTSTNSNPEINGT
GVVKENNDAGSGTFSETITGLTSNTEYSYKAYAITASGIIYGNVLTFTTLGNTPPVFTSV
SSVNFTENTDGIVYTAEATDSDSITYSLGVNADESLFTIVGSTGEVSFVTSPDFETKASY
TINVIATDALGNAANKDVIITIIDLDEVPPTFTSATAVDFTENEAGVAYTITATDNGVIT
YNLGSGNDEASFTIDGAEVSFVASPDFETKVSYTINVIATDDLGNAANQDVIITIIDLDE
VPPTVVITSSLMGPTSTTPIPVTVTFSETITGFDAGDISVSGGTIQSFTGTDADYSFDLV
PSGGGTLTVDIAADVAQDAAGNNNTIANQFSIEYSDLPATALNFDGVDDYVIIGNVLPSN
TSYTKEAWIFTEQNKEAQNIISSLKAPFWLNNLKLEATNLFRYSGSVQSPNTLPLNTWVH
VAVSWDGTTMRLYENGVEVDSRTNVGNYTREAINLGAMVVGNPISMLDGNLDEVRIWNTA
RSSAEIVAYKDVELTGNESGLVAYYNFNQGNVNANNSGVTTLLDRQTNGTVYNGTLTDFT
LTGSTSNWIDGLANDVVSGSLILSTQAATDITTANATLSGLVITVGSKSISEKGIMISDV
NTNPTIPGAATVKYIDTSAGNDISITRTDLNIATQYYFRTYAIDADGKTFYGDVFTFNTS
GHTAPEISTSTATDITLNSATLSGTITVNGTKSIIETGFVIAISSENADPTISGTDTTKL
ESGSISDEFISFATGLSSNVQYSFKAYLIDEDNTEYYGAVKTFTTPNIGLPTVTTTPVYD
VEKNFATFGGNVLTNNGSSITAMGILFSPTASNSNPQLNGTDVQHRSKTPVGVGEFTLRA
GSFSSGVQYSYRMYTTNAAGTAYSQVFTFYPQSSDVSTEDAINFTTTSAMLSGIVNDNYG
SSITEKGVVYSIASINNKPLINGTGVTKEPISDEVGGYFVETINGLDVSTEYSFRTYAIN
AFGTSYGAVKTFTTESTFLDKRIGYWTFEGGSVSDSEGNFGDLVFENADVSIVNGKLDVK
SNGWARTSSYVGSTIEEKTLVSFVEMRDLSVTAGAVIAIDGITNDNFDAIGFAERESGRW
LAGSTSFSRTEDATPGFEETVTNIPVMMAITYVRTPAGIANVKIYRNGEEIGAYYKGVFV
GWPANNTEILFGPRHSPTSTIRRGNIDALIDEAMLFNRALSPTEIRSLYKGSIEKATITS
TPATLIDVTTVTLGGNITSDGKANVTERGIVYARTFANESPEIDGNEVTKVVGGTGIGIF
TENITGLSGGTEYSYRSYAINNQGTAYGDVLTFSTLAPLAPSVTTTDVTNIEAFKATFGS
AVTNNGGADIEDIGVLLIETALNSNPEVTTTDVLKIGVEDAESFISDIKNLKPNTAYSYR
GYANNDSEFGYGVTKTFTTNVVLGIITTTTAYEIRETAAVSGIGVNSNGGSLFTEYGIVL
SDVTLNTDPFVGGSNVNKITIDGIDSPTSGLHRLVLTGLSSCIKYAYKGYAINAAGTTYG
SLKTFTTQCPPPAGVASITTVAPQVITENAAILAGNVSANNGAAVTKRGIVYAKTSVNTL
PTTGGTDLFDVELGNGIGAFNFKAIGLTPSTSYTYRAYAINSVGTVYGDVNEFTTTAIPS
AIPSGLIGHWDFENGSLEDKTGNWAALTLNSSTSIVDGKLDLNPGSLASTSTYAGETIKQ
KTLVSFVELQDLSARAGSVLTIDGKNTTDNFDGIVFSERQVNRWMAGSSWFRRTVNPTPG
FEETTVGEPIMMAITYTEKSNGTVSIRIYRNAVEIASYIKGNIAQWLPNNAEVLFGARHT
LPAMRGNIDALVDEAMIFNRPLSDAEIMTLYKNSVNTTEVVTTPVHSIGTNSAVFGGNVL
NDGGDTITDRGIVVAEKAINANPEIGGTGVTKSQIGEGKGFFGAKVSGFEESTTYAYKTY
AKNSSGTVYGNVEEFSTIEVNADIAPDFSTANQRLKFVQGQYFVAPADGVLLSISLRTHY
ATKGSYLGRINISVYESNSDGSNIELGKIKSFETQAGHMDVNQRSKIDMSSAGISLIRGK
RYYYKFEIEKSAAGNKVIISDYAIYSFVTDRSHYTPGGFISNGTPLTESTTETSIFGIEV
GPLRQSVDGITTFTAGSSNDFSNPANWSKGKPSKNESIAVANGVTLTVDQNDVELDDFFL
NSGAELNIPNDKEVIVNSEFNTDGSLSLESSAESSGVLFLKGITTGTVTYKRGGLLANKW
SIISAPVSGQRVIEFAQNTDNDIRINNSVSPVRYAIGYYDDSMANKWQYYNADTPVADTF
EIGRSYSMSRATDGEVTFTGTLEVGNVNQNVNVGEWQAIGNPYTTYLAANKNESSSFLED
NFDLLDDVFKGLYIWDNTQNKYVAVTQIDTDNRSIPPGQGFFIRTKTSTNVSFNQNKRQL
KPVEGNTTFNKSSNPELVLNISDGISTVKTNIKYFENATRAFDAGYDFGNFGSSQLDIFT
HLLEGNEGVDYTIQSLPLTDVDNISIPIGVSVKAGKEVVFSLSKIDIKDGLNIYLEDKLL
NTFTSLSKKDEDYKISVSEDISGVGRFYLITSSKALNTDEYSFNKNITVYTTDRNALKIS
GIPLGDKATINLFNTLGKQVGVFKINEAEIQNTFNLNNLPKGVYFVRLQSNRTSISKKIV
LK
>FCMOIPGL_03333 hypothetical protein
MKNKKNITRKEAIKKIGNYSKYAALTALSTYIILHPKSAQASSVSLPEAPSDEDFESF
>FCMOIPGL_03334 ATP-dependent RNA helicase RhlE
MSFKDLGLSDALIKAVNEKGYTSPTSIQQKAIPVILEGKDILASAQTGTGKTAGFTLPVL
QYLSDTKHPKYRPLRVLVLTPTRELAAQVHDNVREYSKYVNIKSAVVFGGVKAASQIATL
RRGVDILVATPGRLLDLHDQKAVSFKRIDVLILDEADRMLDMGFARDLNKLISFMPAKRQ
NLMFSATFSNDIKKLAAGILNNPVSVESAPQNSTAKKVTHKVFKVDKGQKTTLLIKLIKD
GAWTQVLVFTRTKHGANKLTEKLIKAGISAAAIHGNKSQGARTKALKNFKDNSIRILVAT
DIAARGLDIPLLPHVINYELPNVPEDYVHRIGRTGRAGAAGEAISLVCSEETEYQNEIEK
LLKEKLKTTILEGFEPTDTAPAKRASTQSKSSFGKKKKKTNSQGSKPKNKPHFKGNKPAG
STSRRGRTGAPKKKRN
>FCMOIPGL_03335 hypothetical protein
MDGLLYTIIIGAICGYIADVLMSDNGYGLIVSIIIGIAGSFVGGWAFGQLGISIGSGWIG
DIIKGASGAILILFILGILKGRRKR
>FCMOIPGL_03336 hypothetical protein
MKKIIQYLLFFFSGIFIAQQNPTNSSLIVKSLKDKKQLESTSLVKNVNFTNIGPTVMSGR
VVDVDVNPNNTTEFYVGYASGGLWYTNNNGTTFTPVLDNSDTQNIGDIAVDWKSETIWVG
TGEKNSSRSSYAGIGILKSTDKGKTWTNVGLLDSHHTSRILINPNNTNEVVIGSIGHLYS
SNKERGVFKTIDGGKTWSKTLFIDENTGIIDVAVAPENFNIMYAASWERERKAWNFDGNG
KHSAIYKSIDAGATWAKISDKSGFPIGDGVGRIGLAVFNANTVYALHDSQFRREKNKEKK
RSDDLTKEDFKTMSSDDFLKLTDKKLNTYLKNNGFQEKYRAENVKQMVRVGSVKPIDLAK
YLEDANSMLFDTEVVGAEVFKTTDGGKSWKKTHNDYLDGVYSSYGYYFGEIRVDLQDENG
IYILGVPILKSKDGGKTFISISKENVHADHQALWVNPKKAGHILNGNDGGLNLSYDDGES
WIKLNNAAVGQFYSVYADNQKNYKIYGGLQDNGVWVASNNARIDKRWKQTGQNPYESIMG
GDGMQVQVDDRNPNIVYTGYQFGNYYRIDRESGNNKYIQPKHILGENPYRFNWQTPILLS
KHNQDILYLGGNKLHRSLNKGDDWTTISEDLTNGGKKGNVAYGTLTTIAESPFQFGLLYT
GSDDGFVHVSKNGGGSWTKISDSFPQDLWVTRVVASAHKKERVYVTLNGYRFDDFTPYVF
MSDDFGQTWENIGNSIPTSAVNVIKEDPASENIVYVGTDNGLYISFDYGASWQVFSKNLP
NVAVHDLVIQPTAKHLIVATHGRSLYKADIESLQLFTDELMAKSTHIFAINSIRKRSSWG
SSWSKWSKPNLPEINIPFYVNTKKKVTINVFSDDIKVNSISIDADRGFNEAIFDVSFSDK
GKKAFKRGNKEIIIKKAKNDVYYLPKGKYTIKIDDATSEFEIK
>FCMOIPGL_03337 hypothetical protein
MKKYIAFLFLVFTISVNSQSNFKKFFKLSGPIKSWVLFHPFKATKALKISEEASKVSDSI
KKTNLLDGDDSGGQVDAFRHAYWMARLHQEIGESAARSLGKAHEKENYLTFKKWQLEEGV
VPDEISSKMDLYNNEQGLKLISRESKVSKKGLIYRVLNAIKEGEMKIIKKDEKGDFLTCD
GNLILKESLKGKWENNKCLISSEKNKKAILIK
>FCMOIPGL_03338 Aspartate/alanine antiporter
MEFFSELLTKDYFVLFLVIGLGIALGNVRVKGINFDTSAVIFVAIFFGYLYNLYGITFSI
PPIIQSVGLVLFIYTIGMQAGPSFFSSFKEQGTKLIALAAITVITGGLTAVSISYIYGVD
MNMMSGLLTGALTSTPGLAASIESSHSPLASIGYGIAYPFGVLGVILFVKLGPSLFRVKI
KEEEQKFEEQSNSNTPMVINKNLIISNQNVHGKTIDELKIRFMTKANISRIMKPNQLPIS
PTKDTVLEIGDIIKAVGTVNALHRIEILLGKVTDIKIPRSGTYEVKWYVVSNDNVVNKTI
QELNLFENYSATITRIRRASIDLAPHPTTKIKYGDKILVSCSTGNVSAVTQLFGNSLKRI
GETSFLPVAFGIAIGILVGSIAIPLGGMHLKLGLTGGVLLSSIFLSWKGKTGPIIWNLPG
PANQILRQLGLLLFLTPVGLNAGQSLVSAVQEHGAILFLYGALITLIPMIIAVFTGRFLL
KINFLSILGALTGGMTSTPGLSATDSMTESDAPQIAYAAVYPFSLVLIIAVAEIMAIL
>FCMOIPGL_03339 hypothetical protein
MSGFFKSSIGRKVAMALSAFFLMIFLIIHIAVNITSLFSEDLFNELSHFMGTNPLIQFAM
QPVLVFGVIFHFVLGFILELKNKKANGVAYARDNGAANSTWMSRNMIYSGLAILAFIILH
FIDFWIPEMNHKYIAVLPEDPTRYFHELQEKFVPIWRVAAYVVAFVFLGLHLAHGFTSAF
QSMGVTAGRKKALQTFGKIYSIIIPLGFIIVAVFHHLNNNH
>FCMOIPGL_03340 Fumarate reductase flavoprotein subunit
MALDSKIPEGPIKDKWTTYKDKIDLVNPANKRNIDIIVVGTGLAGGSAAATLAELGYNVK
AFAYQDSPRRAHSIAAQGGINAAKNYQGDGDSNYRLFYDTVKGGDYRSREANVHRLAEVS
GNIIDQCVAQGVPFARDYGGLLDNRSFGGVLVSRTFYAKGQTGQQLLLGCYSAMNRQIAR
GKIEMFNRHEMLDVVKIDGKARGIIARDLITGEIERHSAHAVVIATGGYGNVYFLSTNAM
GSNATAAWKIHKKGAYFANPCYTQIHPTCIPRSGDYQSKLTLMSESLRNDGRIWVPARIE
DAKAIQAGKLKPTEIAEENRDYYLERRYPAFGNLVPRDVASRAAKERCDAGFGVNATGEA
VYLDFASAFERYGKEQAKIHGIKNASKEKIIELGQGIIEEKYGNLFQMYEKIIAENPYET
PMMIYPATHYTMGGVWVDYNLMTTVEGLYCIGEANFSDHGANRLGASALMQGLADGYFVL
PYTIGDYLSADIRTGKIPTDTKEFDEVEKEVKDRIDFFINNKGTKSVDHFHKRLGKVMWD
KVGMSRNEKDLKAAMAEIKAIREEFWKDVMVPGTANEMNVELEKAGRVADFLELGELFAK
DALTRNESCGGHFREESVELDGPQKGEAKRNDKDFAFVSAWEYKGEPADAVLHKEELEFN
DIELKQRSYK
>FCMOIPGL_03341 Fumarate reductase iron-sulfur subunit
MSGKGMNLTLKIWRQKDSSSNGQMVDYKVTDISEHMSFLEMMDVLNEQLVNSGEEPVAFD
HDCREGICGMCSMYINGEAHGPDRGITTCQLHMRMFNDGDTITIEPFRAAAFPVIKDLIV
DRMAFERIQQAGGYISVNTSGNTQDANSLPISKHAADEAMDAAACIGCGACVATCKNSSA
MLFVGAKVSQYALLPQGQVEAADRVQNMVAQMDLEGFGNCTNTGACEVECPKGITLENIA
RMNRELMKANL
>FCMOIPGL_03342 Peptidyl-tRNA hydrolase
MKKFLIVGLGNIGEKYANTRHNIGFKIVDEVAEEHNVVFETNTLGDVATFRFKGRTFILL
KPSTFMNLSGKAVKFWMQKEKISVENLLIVTDDLNIDFGTLRVKAKGSDGGHNGLKDIQE
KLGTNVYPRFRFGISGNFSKGRQVDYVLGEWNKEETSQLIERLPTSAKIITSFGTAGLAN
TMNTFNGK
>FCMOIPGL_03343 hypothetical protein
MKEKEKEKEKEKEKEKEKVESYYTAVLKKLAKNRAEAGLSQIDLALQLGISESGYFKIEK
GKTRLDIQRLLTILYKLDISPKDFFKDFK
>FCMOIPGL_03344 hypothetical protein
MVFVFATGAMMNANSSNEEVTLNDYFKMSHCDEVYFEVTDAVTSMTGSEYVGISAAIAAE
SACLDEEIDIIEY
>FCMOIPGL_03345 hypothetical protein
MKKQIVRFFFLIIPFITFSQEIISGKIIYKYQIKEKGFDSEGKSENIKSVFNNFNDNLED
NKDKISFELVFNNDASYYKLVKNLESDYNKDLSFTILITGGNEEVFTNKKSDLKIKKIDV
FGDFFLVKSKFKEAWKLTQESKKINHYTCYKAILEKEFIDVNNKKKNLEIEAWYTPEIPV
NFGPKGFGGLPGLILELNQGSFVFYAHKIEIKKNKTIIINPPSKGKTISEEAFSNLFRKF
DEKKEKNRN
>FCMOIPGL_03346 hypothetical protein
MKKIILSLVFVLATGSMMNATSSKEISYQESCFEKANRLTNVIAINTNMDLGYDYVVFSI
LYDECMGGSNGEFVFPE
>FCMOIPGL_03347 hypothetical protein
MKIVIVYFFILFSANQFSQSGEIIYEAELLMKEDSSNDSKKAKQNADFEVIMKNQKKVTY
KLIFNKNESIFKKEEKLIIDEPKLNLVKILVGNGLFYTNTFLKKTLNKTEFSGKEFLIEV
PQFNWKLTQERKKIGNYICYKATTSREIDTRRGKSIRNITAWYTPQIPYNFGPKEYNGLP
GLILELQEDSLLFKATKISLLTDKVIEIEKPVKGKKVTQKEYDSIVKNIILQNKRYKQK
>FCMOIPGL_03348 TonB-dependent receptor SusC
MNLLKNLLFVLILVISTATFSQRITLFGTVKDSLQNPMSYANVIAKPKDVSKNLQFAITD
NEGYYKLLLAQGDTITISISYLGYKPIESQFIALKSVRKDFVLQQSSEQLDEVIIEMPVT
VRGDTTTYKTSKFINGSERKLKNVLKKLPGVEVDKNGGVTVQGKKVTTMLVDGKKFFGGN
SKLAVENIPADAVGNVEVIDNYNEVAFLKGLTDSDEMAMNIKLKEDKKRFVFGDIEAGKG
NKEFYKTSANLFYYSPKTNVNFIGNINNIGEKTFTFSDYMSFSGGINAVFNGNFSFKVGD
FSQFMESNDVVTSKQKFGALNITKVATQKLDVSGYAIFSDTNTSSFVENLNEYISFTEQR
TSKTATDNLLGIGNLNLEYKPNSLERWVARTQVKRTNNTNDNTVVSLINAKTNTIATDRD
LTATYINQNIEWHKRQNDKHTFSSVFNYVFDKSDKTNYWQTQDAILQGLIPVDETQDFLR
INQLKNTKEINIDAVFKHFWEINNSNHIYTTVGNKFLNQDFLTDDSQTLDDGSLNNFANG
GFGNDLNFELNDLFLGMHYKFRTGIFTVKQGVEVHNYNWNLANQTNIENNKWVVLPDFLA
EIEFNKSKKLKLNYNLKTTFSDASKFANRFYLQSYNSIFKGNEILENNLYHAARAYFSRF
SLYRGVMLHVNLNYNKQIKGGRSTVDFNDVNQFLTVKMFDNPSEDWRGDIHLEKTIKDLK
YKFDVGFNNSTYIQEVNNANQTNKNNGYNYEFAIETLFDNFPTIEVGFNTDIGKFIASSN
TSKFVTTEPYLNIDYDFLKGFIFNFDYRKSNYQNKTLGQKNVYEIANATLSYKKENSGWT
YKITAQNMFNAQFKQSNTFSDYLISDSKTFILPRVIMFSIGYNL
>FCMOIPGL_03349 Ribonuclease H
MSKKKFYVVWKGRKTGVFTSWNVCKRQIDGFEGAQYKSFANLDEAEIASKKTYDDYKGKN
TKTATLSSVEKEKFGKPILESISVDAACAGNPGKMEYRGVFTHNKKQIFIKGPFAKGTNN
IGEFLALVHGIALLKSKNKEDVPIYSDSKIAMSWIRQKKCKTNLHFDASNKDLLELIKRA
EKWLKENTFKNPILKWETKAWGEIPADFGRKK
>FCMOIPGL_03350 Phosphoribosylglycinamide formyltransferase
MKRIVVFASGSGTNAENIIKFFNHTKIAKVTQVLCNNEHAKVFERCKKLNVNCLHFRRDQ
FLKEDTILNLLKENADYIILAGFLWKIPAKIIEAFPKKIINIHPALLPKYGGKGMYGMNV
HKAVKENKESETGITIHYVNENYDEGAIIYQAKTALSDDDSPETIAEKIHILEQRYFPRI
IESVILDINE
>FCMOIPGL_03351 Acyl carrier protein AcpP
MSDIASRVKAIIVDKLGVDDNEVTTEASFTNDLGADSLDTVELIMEFEKEFDIQIPDDQA
ENIGTVGQAVSYIEAAKK
>FCMOIPGL_03352 3-oxoacyl-[acyl-carrier-protein] synthase 2
MQLKRAVITGLGALTPIGNNIEEYWKGLINGVSGAAPVTYYDAAKFKTRFACELKNFNVT
DFIDRKEARRMDRFTQYAMVASDEAIADSKLDLDKINKLRVGVIWGAGIGGLETFQNEVL
NFASGDGTPRFNPFFIPKMIADIAPGHISIKNGFMGPNYTTVSACASSANAMIDALNYIR
LGYCDVIVTGGSEAAITIAGMGGFNAMHALSTRNESAETASRPFDAERDGFVLGEGAGAI
VIEEYEHAKARGAKIYAEIIGGGMSSDAYHMTAPHPDGVGVIAVMQNCLENAGIKAEDVD
HINTHGTSTPLGDVAELKAISQVFGEHAKDININSTKSMTGHLLGAAGAIESIAVILAME
NGIVPPTINHTNVDENINPELNLTLNKPQKRDIKIAMSNTFGFGGHNACVAFKKLDE
>FCMOIPGL_03353 Ribonuclease 3
MNFIRKIVTSRSKEDQELNSELKKLLKYSPRNINKYKKAFTHRSVQILDSKGMPINYERL
EFLGDSILGSAIAAYLYKKVPTGTEGYLTQMRSKIVSREHLNELGKDLNLIRFVKSNIDQ
ANVGDNIHGNIFEALIGAIYLDKGYNSCQKFIYENVIVPYVDIEKLEGKITSYKGLIIEW
CQKQKKKYKFDTYEDSGNESIKHFSVRISIDGVQVAKGRATSKKKAEEQAAKRVYFAFQK
QISVN
>FCMOIPGL_03354 hypothetical protein
MQIHSLGLEDLSEDEYTLIGIHTALEDFKLAYLLNKNLSTSFQKAIEDLIIEDLQIKACF
SIFNCSIKKYDFDWFLIANSSKRENKTASNELLLTSETKTYLIQEKKKVDFFIKIAGDLE
YNILSKTVDKIKKIDQVITCYLIDKNTLKSKDFLIF
>FCMOIPGL_03355 Pyruvate kinase
MPNNNRTKIVATLGPAADTKEMLTQLASNGVNVFRINFSHADYEDVRRKVTIIREINKEK
GYNVAVLADLQGPKLRVGVMEEDVILEDGDTFTFTTDKCIGTKEKAFMTYQRFPKDVKAG
ETIMVDDGKLRFEVISTNKENEVVVKVMVGGPLKSKKGVNLPNTAISLPALTKKDKEDAI
FAIGLEVDWIALSFVRTPEDLRLLRDLIAQHSEYRIPIVAKIEKPEAVANIDALIPYCDG
LMVARGDLGVEIPMEDVPLIQKKLVRRAKRARIPVIIATQMMETMIDNPVPTRAEVNDVA
NSIMDGADAVMLSGETSVGKFPLKVIQKMTEIIKAVENSRMIKVPQEPPHIRTNRFVTKS
ICYHAALMANDTDAAAICTLTNSGYTAFQISSWRPRTHVLAFSTDKRILGKLNLLWGVRA
FYYDKNLSTDDTVVDINNLVKEKGFVTSGDIIINLASMPAEARGMVNTLRVSEIE
>FCMOIPGL_03356 hypothetical protein
MLILMKNVTFFFSINNDKKLDITLKEISFGLLTNSNFSKNPKHLL
>FCMOIPGL_03357 Inosine-5'-monophosphate dehydrogenase
MWIQTEFSVNFNQLKNQLIMGIKSFQGKRDESQGKNDEQILVSDYMTTKLITFKAEDSLD
HVINLLIKNKISGGPVVDDKNELIGIISETDCIKHISESKYYNMPTDTNNTVGKYMVTDV
DTIDKDMNIFDAAFKFISSHRRRFPVVENGKLIGQLSQKDVLKAAIKVKGNTWK
>FCMOIPGL_03358 hypothetical protein
MKKRSGIFAIIILIIIIIVSFSLYRKQNNNKIKEEQKELESYQKDKKLEQEQILNQKDIA
ILKRLDSLDSLKRKSMDNKMKKIKQRLQKVNKKKN
>FCMOIPGL_03359 hypothetical protein
MEKRICLECKEPVKGRVDKKFCSDHCRNAYNNKVNKDSKNLIRNINNRLRKNYKILSELN
ISGKTKVTRTNLYDKGFDFQFFTSIYTTKTGNTYFYVYNEGYLALENDIFLLIKKES
>FCMOIPGL_03360 hypothetical protein
MKSFRNESWKAFDLADCNFEKEEILVSNYGRVQKKKKGAEEFKLYKKGIINKFETLSYTN
SKNKVRSFYVHRAVAFLFLEKKEDSKFVIHKNHDLTDNYVQNLKWVNQKELTVHQLTNPE
RKKKLGLKTSAKLSEAKVRVIKKKLLDPNRRTRLRIIASQFGVTTMQLYRIKSGENWGEI
EV
>FCMOIPGL_03361 Single-stranded DNA-binding protein
MSTLRNKVQLIGNLGKNPEIISLESGKKLAKFSLATNESYKNAQGEKVTDTQWHNIVAWN
KTAEIIEKYVVKGNEIVIEGKLTSRSYETKDGEKRYITEVVCSELLMLGNNQ
>FCMOIPGL_03362 Isoquinoline 1-oxidoreductase subunit alpha
MPNYTLHINGKERTVTADADTPLLWVLRDELNLVGTKFGCGIAQCGACTVHIDGVATRSC
QMQVSILDDVKITTIEGLSEDGKHPVQEAWKEIDVPQCGYCQAGQIMTASAFLSENNNPS
EEEIREAMHSNICRCASYNRIEKAVKVAAEKML
>FCMOIPGL_03363 Membrane-bound aldehyde dehydrogenase [pyrroloquinoline-quinone]
MKSQKKDNFSRRSFLKTSLLASGGMLIGFNLLSACKPEAIMPVDIESLNFNDFNAFIKIS
DEGYITIFSPNPEIGQGVKTAMPMIIAEELDVEWNKVNVVQGALDTKNFQRQIAGGSQSI
RFGWDALRQTGATAKQLLVNAAAAKWNVDATTCKASKGIITNANGDQLGYGDVVKEAALL
EVPDNVKLKEIKDFTIIGQEIVNVDIDKIITGKPLFGLDYKTEGMLYASVLRPPAFGQKL
ESFDATEAKKVKGVIDVITIGDKVRKYVESDKRNWTFTMAETDKVVVIAENTWAAIKGKK
ALSAIWKSDSELENTAAHDKFLNEILDGKKFNTRREDGNIEQAFSDADKVIEKTYHSPFL
PHNCMEPMNFYADVSSEKIHLAGPVQTPEYAAQVVADLLGYDLEKVSVEMTRMGGGFGRR
LYGDFVYEAAEISNAIKKPVKLISTREDDMTMGVYRPSIKYRIKASIKDGKVTGYYLKEA
AINGNMYGLIPNFFPAGCIPNFKVDTANYKSNITTGAWRAPYTNFLAFAEQSFFDELASE
LNIDTIQLRLDLLQNVKNTSDKKIEYSGQRMEDTIKLVREKGNWGKTEKGTYQGFSAYYS
HNTHVAEIAEIVLKDGFPIVKKVTVAVDCGVVVNPTGARNQVVGGVLDGIGHAMYADFSF
KEGKPDSQNFDTYRLIRMQETPKVEVHFVENNLSPTGLGEPGLPPAGGAVANAINAALGQ
RIYSQPFIKELKNSAVLG
>FCMOIPGL_03364 putative lipoprotein YiaD
MKKLINKTVIVTLVLTLVFSISSCEAIKNANNKQKGATIGTAGGAILGAIIGNNVGKGGN
GELGAIIGGVVGGGAGVLIGNKMDKQAEKIETEIPGAVVERIDDGIVVTFDENSGVYFDT
NKSNINAKSQETLNKLSDVFLEFPDTNILVVGHTDSSGKDEYNMTLSEKRALSVTDYLIA
KGLVKNRFQTLWYGETQPKYDNATAEGRAKNRRVNVAIVPNDKMVNDAKIESGGN
>FCMOIPGL_03365 hypothetical protein
MKNLIVVALSLILFSCSATKNVRTKEKIIKGNWTLNKIAYSKTGDYKVTMFNDSPKECFE
GSSWKFVPNNNSGTYDINNTNCVNGERDFIFVVQEIDAVSGYYDFLLKPKNNENNVGYRL
QLTELSETTMQWKQYLNVDGTQFIININFTKQ
>FCMOIPGL_03366 hypothetical protein
MLVNSETDKITFFIADAKNVNGYKIDLVLKLQKK
>FCMOIPGL_03367 Methionine--tRNA ligase
MSAPKRYTITAALPYTNGPIHIGHLAGVYVPADIYARYLRLTGNDVAYISGSDEHGAAIP
MKAKKEGVSPQVIIDKYHGIIKKSFEDFGISFDNYSRTSSEIHHETASDFFTKLYNDGEF
VEEVSAQLYDEEANQFLADRFVVGTCPKCGFEESYGDQCENCGTSHNATDLINPKSAITG
NVPTIKETKHWFLPLDKHEAFLREWILEGHKNDWKPNVYGQVKSWVEDGLRPRAVTRDLD
WGIPVPLKDAEGKVLYVWFDAPIGYISSTKEWAAREGKNWEDYWKKDDTKLVHFIGKDNI
VFHCIIFPAMLKAHGNYILPENVPANEFLNLEGNKLSTSKNWAVWLHEYLEEFPNQQDVL
RYTLTANAPESKDNDFTWKDFQAKNNNELVAIFGNFINRVVVLTNKYYQGIIPTPNDFTE
ADEDALAAVKEFPNIIAKSIERYRFREASQELMNLARLGNKYLADEEPWKVIKVDAERVQ
TIMYVAMQISAALAVVSEPFLPFTSDKLKGILNIDNSFTWEDITEKDVLLPANHEVNKAE
LLFSKIEDKTIEAQLEKLIATKKANEEEKRVVEPQKETIDFEDFTKLDIRIGTILEAEKV
AKTKKLLKLKVDVGIDIRTIVSGIAESFSSEEIIGQQVSVLVNLAPRKIKGVESQGMILM
TDTPDGKLAFVEPEKAVKNGQQVS
>FCMOIPGL_03368 hypothetical protein
MNNFSLCIAFFLLIISSTFAQEKRDFIKVQENPIVFSDFILGYSNSGKSAVTAGFNINYQ
KNNNLFTFRTLQTISVDKIDWFLFVPISTVSNTTTEFAVLYGKRYIEDGISYHFSGGISY
NINEDVNGNLKTRDNFAGFPLEIGMSFFKSKKERFRVFYGLIPVGKPTSFGRSIGFKLYA
NIAEKSYVGLGLTFGLGWHKIYKNEK
>FCMOIPGL_03369 putative murein peptide carboxypeptidase
MKNNVIPFLLLMTFSSVFAQKKLTTPPYLKKGDTIAIVAPAGILKNKQEVIEKAKRLVES
WGLKVVLGKNLFNQENHFSGTDDERCQDFQEALDNKNIKAIWAARGGYGSVRILDKLDFT
KFKKNPKWIIGYSDITAFHNHIHNLNVETIHGMMGTSLGDKPEEIIETISSFKKSLFGEE
ITYSISSSNYNKIGVAEGQIIGGNISILASMLGSKSQLNTDGKILFIEEIGEYKYSIDRM
LQSLKRAGYFTKVKAVVVGDMTKIKKNSTNWGSSIEQLVLDVLPNDIPVLFDFPAGHESD
NRALLFGRKVKLVVGRGEEKSTLKFLK
>FCMOIPGL_03370 hypothetical protein
MADHNELGEIGEQIAVDFLIKNEYKILERNYRYLKAEVDIIALKNGVLAVIEVKTRSSDY
YGKPQDFVNPKKIKLLLSAIDYYVIQKDLDVEVRFDIIAIIYQKNNTKIEHLEDAFLYF
>FCMOIPGL_03371 Thiol-disulfide oxidoreductase ResA
MMKNIFYFILFISSFANAQHVIKGTMNPKIETDWVILYKIEGTKQIFVSNTTIKTDSITL
SGKKQAVGRFEFKLKPDAKPGAYRVNYRTEGAGFLDIFYNKENISFIFNPDYPEQTVSFS
KSSENKLYQEYVETISKAQEKLDSIQIAALQNPKLDLKTRYINAFNKVNVVQNKYAELSK
EKYIAPIIKASNQNNSAEILTSVEDYLFKVKNSFFNNLDFNKKTLINSSFLTDRIVSYIF
YINYSDDSRTQQKLYKEAIDVVLYKINNQPYKRDIIEFLIVQFEAYKNLEIIDYLFENHY
NKLPETLQSQKFKSEKIALFASEIGRIAPDFSWKENGKSFKLSTLNDAEKYVLVFWSTSC
SHCMREIPELHSYLKNKKNIKVIAFALEDDAFVWENYSRTNLYGWHNVLGLNKWQNETAK
TYQIFSTPSYFVLDKSKKIIAKPNEIDDVMEYFNQE
>FCMOIPGL_03372 Putative oxidoreductase SadH
MSSFSDKIIWITGASSGIGKALAIELSNQNAKIILSSRKINDLELVKKKCKNPNNVKIVA
LDLEDYTNLQSKVKEAIDTFGKIDILVNNGGISQRSLVKDTLIAVDKQIMDVNYLGTVTL
SKAILPHFIRNKSGHFVVTTSIVGKIGTPLRSSYAASKHALHGFFDSLRAEHFKDNIVVT
LVCPGFVNTNVSKNALTGNGTPQQKMDVATANGIDPDRFAKLMAKAIKNQKEEVYIAGVK
EKLGVYLKRFYPKLLSKMIRKLSVT
>FCMOIPGL_03373 hypothetical protein
MTKVSNLKEKWDFLVNKLTDDFSEGDELNLDGIVYLIGVQELGQGYRAFKKDEKVNLMHI
AICKLLEPYGYYEFDYFDEDGWPHYKTLTELPNLKAGEQTVLMKEAIVSYFDTLSYFKD
>FCMOIPGL_03374 hypothetical protein
MNIFDIIIVALLLFAFVRGIMKGFFAEVASLVAIIAGVFVAIHYAHHMEYYLVNSSAINW
SDETNRIVSFAVTFLFVVILVIFIGKILTKIADITALGMLNKLLGGIFGGLKIALILSVI
FTFFGSVNNTIPFVEKETLDESVMYNPVKKIAPALFPSIIKEGEEGESKIDFSIK
>FCMOIPGL_03375 Carbonic anhydrase 2
MDLEKVFENNEKWIQEKLSIDKNYFEKLGKGQNPELLYIGCSDSRATAEELMGAKPGEVF
VHRNIANMVISIDLNVMSVVNYAVDHLKVKHVIVCGHYGCGGVKAAMQSADLGILNPWLR
NIRDVYRIHSTELNKITNEEKKYEKLVELNVKEQCVNLIKTAAVQKAFRDRGLKVHGWVF
DIHTGKLVDLKIDFEKYLKDIMKIYHLD
>FCMOIPGL_03376 Bicarbonate transporter BicA
MKNLFSNLKGDVFGGITAGIVALPLALAFGVSSGLGPSAGLYGAIFISFFAALFGGTSTQ
ISGPTAPMTAVSMVVIAGIIAANDGDVSKALPAILSVFLLAGFFQIGLGLIGLGKYIRYI
PYPVVSGFMTAIGLIILLTQVLPSIGYYPKEDVEFVSNFKAQAQEVILENILKDEAGEGV
LVLDNFKETIIKAEKITSIEIDKESQTLAAKETSGALGAIKAFPRAIQNINWLELILALG
TIFIIYGFKRITTKIPSTLVALIAMSGIAVAFNLDYRTIQEIPSGIPEMKWEIFTGFSIS
NLTPYIFTALTLALLGAIDSLLTSVVADNMTKTKHKPNKELVGQGIGNSIAALFGGIPGA
GATIRTVVNINAGGKTKLSGMVAGIMLLIIMLGLGPIASKIPAAVLAGILITVGIGVMDY
KGLKAIPSLPRDIKIGPLKLSSEVLIMMVVLLLSTFWNLVYAVGIGLVIASLMFMKKIGD
LTAERSDVKSLKEEEWSDEKGFPANLKEEVFIKHIKGPLFFGSTSDFQALYLQIPDTAKI
VIMRLGRMQYMDQSGLYAMEDMLQDLKTKNVEVLFVNLLQQPRYMMERIDIIPDFIPKEH
IFKNFDECTSWIKKNVKDTI
>FCMOIPGL_03377 Carbonic anhydrase 2
MKAHTRETQATMTPEKSLQYLTEGNQRFQDNLKAHRNLLEQVNDTSTGQFPFATILSCID
SRVSAELIFDQGLGDIFSIRIAGNFVNQDILGSMEFGCKLAGTKLVVVLGHTSCGAVKGA
CDNAKLGNLTAMLNKIKPAVNAISEPKDVSLRNSSNLEFVDNVAEKNVALTIERIRRESE
VLATMEEKGEIMIVGAMYNINDGAVTFLK
>FCMOIPGL_03378 hypothetical protein
MKEEKKYKILVLSDLKKSTQSVLKSTLSFAKIINADIHFFYIKKPTEIIKNDNQLSAKRA
INKESFMIDKKIKNLLTSFSDDNNTSIKYSFSVGNVKNEIDNYLNKNNPDIVVLGKRKSK
SFNILGDNITDFVLQNYKGSVIIASEENILEPHKKLSLGFLNDTKEDTNISLALDLKAKS
KEPVKYFRVVKNSEIEKETHQNLEGKKIEYVFEENDTIAKNISNYLSKSNVNLLCLTKSK
KANDTAFLKKIINDTNVSLLLTT
>FCMOIPGL_03379 Bicarbonate transporter BicA
MFKNIKNDLPSSIVVFFVALPLCLGIALASGAPLFSGVIAGIIGGVIVGSLSGSKLGVSG
PAAGLAAIVLSAIATLGSYENFLVAVVLAGIIQLIFGFLKAGVIGYYFPSSVIKGMLTGI
GIIIILKQIPHFFGYDAEPEGAESFIEASGENTFSSLFNIFDHLILGSLVIGVLGLAVIL
FWDLVLAKKAKFFTIIQGPLIAVVLGIAFFMITGSNESLAISQSHLVSVPIPEDINSFLN
QFSFPNFSAITNPEVWIVAFTIALVASLETLLSVEACDKLDPDKNVTPTNRELLAQGTGN
IVSGLIGGLPITQVIVRSSANVQSGGKSKLSTIIHGFLLLISVILIPTLLNKIPLSVLAA
ILLVVGYKLAKPKLFKQMYQLGWKQFVPFIVTIIGIVFTDLLVGIGLGLAVGIVVILLKS
YQNSHFLHIEDNSNGKHKIKMTLAEEVTFFNKGAILKELDSLPRDTQLEINLIKTRYLDN
DIIEILEDFLFKAKERNIDIKLISKRGIVDKPASFIHFFNERPKSDLSLS
>FCMOIPGL_03380 hypothetical protein
MKIKIVLFFSILFIGVITAPTVISLVNENQDISIFLSLNEEEEENFEIETFKELKVFPNP
YLIIFFKKIQKRKTVRFSSKDYISVFPKITTPPPKLVL
>FCMOIPGL_03381 hypothetical protein
MKKILFLLLIIANTISAQNADELFSSANDLYKNEKFEKAIELYKQIESKGLTSSELYYNL
GNSYYKLNKVGPSIYYLEKALKINPLNEDAKNNLVFAKRLALDKIEELPKTVLQKFNINY
LQQLSYNQWAIVVIVFSILGSLLFLLFYFADAPSIKRFYFVTSSLSFILLIISLLITFNQ
YSLSKNKKEAIVFAEKTEVRNAPTFNSEDVFTLHEGTKVLVLDDVDDWRKIEIADGKQGW
IIAKEIKVLNDF
>FCMOIPGL_03382 hypothetical protein
MKLKLYISIIFSLLTLSFFAQDAELSVNLSKNKLGLNQRLRIEFSINKQGADNFTPPSFR
GFKVIQGPSQSVSQSWINGKVSFSQSYTYIIEPKRKGELIIEAASIKYNGGILNSKMVKV
VVLDPIDVPENPNDPNYIAQQNIHLVAEISKSRPFVGEGIYVEYRLYVSENVSVYDTSVT
EAPQYNGFWNQDIKIDGFPVKMGTYNNEKYRYIVLQKALLIPTKTGNLTIDPMKMDIVIG
VPTGRADFFGNVITKNIKKEFASTKKTISPKSLPLDGKPENFTGAVGQFSFDVSLSKNAL
KANESSQIKVTVSGKGNLKLFELPVIETPAELEKYQPERKESIYVKTDGISGSVTDVYTI
VPQYKGKYKIPNTSFSYFNPEKEKYETIATNDLYVDVLEGKELISNSDNNTNSIQKRDVV
TKGNNFRYILTSSNFEAKENSDFYKSYLFYLLLLLPLITIPIGIIIAKNNEKRNSDVIGR
KQRKAERLAKKYLSEAQKQLGKKEAFYEALERALHNYLKAKLSIEIADISKENITQILQQ
KQVDKSTIHQFIDVLKASDFARYTPVTNTEMKQEFERAKQVIVQLDKQL
>FCMOIPGL_03383 hypothetical protein
MKFYLNILILCLMFLSSTKILAQKDSIASQRKARSLVRQGNQLYAKEQYTDASVAYRKAL
DKSSFYDKASYNLGNALYEDKNFKEAVPQYELSAKTATDKFSKAEAYHNLGNSLMETKNY
QGAVDAYKNSLRNNPNDDETRYNLAVAQKMLEKEKQDQKDDKNKDNKDKKDQDKKDKDDQ
DKKDKDKKEGDDKDKKDDKDKDGEGDKDQDKKQDPKKDDKKDPNEKPKPQKGKMSPEQIK
QLLESLNNEEKKTQKKMNAEKAKGAKVKQEKDW
>FCMOIPGL_03384 (S)-ureidoglycine aminohydrolase
MNKIKLTSISNTVVTRNHALITGDGFVNSLIPGWENCEVNVVINQAMGAEFCQLITTLQN
NSVLKGETIKTQIFFYVLEGFCSIKINKKEILLEKGGYIYIPINESYEIFNSENDTKLLS
FHKEYEVLEGSNLPEIVVNKASNIEKTIFCNDPDLIMQNLLPDQNNTSFDMAINIFTYNP
GANLPFVETHIMEHGLMYLEGQGIYRLDDKWYPVKKGDCIWMAPYCPQWFGALGTEPAIY
IYYKNVNRSPINI
>FCMOIPGL_03385 N-carbamoyl-L-amino acid hydrolase
MKQNGIDINVERIINRLNKLGSISDNDTCLSRYYGTKAHKISSDLLISWMQTAGMEVTKD
TIGNVRGILKSKNENAKHFVIGSHYDTVFNAGKYDGPLGILLGLEVAQKINEEKIELPFH
LNIIAFADEEGSRFNTAYLGSSVLVGKFDKIWLNRKDDAGQTLAEVIEKNNGKTPQIFEE
YIPNNQWLGYFEVHIEQGPVLCTENLPLALVDSISSQTRINIIWEGVCGHAGTYPMDLRA
DALCAASEFILEIEKTGIAHKTNLVATVGKLTVEPNTSNVIPGTVAHSLDIRSPNDLFLS
EIIKTLKKKATNIADKRGITLNWEIMQENPSVLCNEDLKTALSKSILASGVNRVIEIPSG
AGHDAVMISKAAPVAMLFVRCKAGISHNPLEYTSPSDIKEALKVCNHFINEIVILENLKN
N
>FCMOIPGL_03386 putative hydrolase
MNRIHDELKKLATYSSTKVPAITRVLYTDKDLEARDYFIALCEEINLKVTIDAIGNIFSR
WEGSDSTLPAVATGSHIDAIPLSGMYDGTVGVFGGLAAIRTLKNEGYKPTRSIELILFTS
EEPTRFKIGCLGSRMLGGQLKVADVLKLTDDAGESFDEVRKKAGYTSNLSEVLLSKNHYK
AFVELHIEQGPILENEDLDIGIVTKIAAPSSLKITLTGEGGHAGAVLMENRKDAGVAGAE
VMIAVEKVAKESESKDTVATVGIFDIKPRAVNSIPKEVYMEVDLRGTNVTARDFALNKLK
EDVKTICEKRHILYDIKMVNCDSPAICDSDLVNVVESVTKNLGYKSKRMVSRAYHDTLFM
ALIAPTTMIFIPCRGGVSHRPDEYSSPAQIEKGVETLKNTLKILTES
>FCMOIPGL_03387 Purine catabolism protein PucG
MKYTFNPPNRVLMGPGPSDAHPRVLKAMATPLIGHLDPKFVEMMDEVKVMVQDTFLTKNE
LTFVVSAPGSAGMETCLVNLLEPGDECIICVNGVFGGRMVDIAERCGATVHKIVTPWGEV
TSVEQVEEALKTCSKPKLVALVHAETSTGALQPLKEISEVVHNAESLLVVDAVTSWCGMP
LKVDEWGIDAIYSGTQKNLSAPPGLSPVSFSPRAVKVLEERKTKVQSWFLDLNLVKNYWA
GAKRAYHHTAPVSSVYAIHEALSIVLEEGLENRWKRHQDVHQKLKTELESLGFKYLVNEE
HRLPNLNSVFLPEQIKDEAALRNRLLNEFNIEIGGGLGDFAGKIWRIGIMGESCTKNHVN
MLIGALKELMNE
>FCMOIPGL_03388 putative xanthine dehydrogenase subunit A
MFHWIEILNRFQQEKKPVALVTITKCLGSAPCKVGSRMIVDKTKVVYGTIGGGKLEFEVI
DKAINAIKENKIIEASFTLGPEFEQCCGGKVELIIEPMNQSPELFLFGAGHIGVEISNLL
VDTPFKTYLIDSRTDWFENLKLHESVKTCKVSENDFKTFKDVVTWGKNTYVLVMTHDHGI
DLDIIAMAIPEEKKYLGLIGSKTKYVRFNNILKKELQIEEGMENVTCPIGLNLGGSTPKE
IAIDCVAQLLQIHYNQNNNK
>FCMOIPGL_03389 5-hydroxyisourate hydrolase
MITISQLNSLSKKEAFKTLAACCVSTQWISQMVESRPFDSSKELIEKAAFIWYENCVLED
FKEAFTGHPKIGNLESLKAKFADTATWAGNEQAKVEEATQETIEALSEANMLYEAKFGYI
FIVSASKKSADHMLAIVNARLHHNPEDEIYVAMNEQHKITVIRLGKLIEGLLQETDINSH
ITTHALDTSRGFPAKNMVITLKTKHENNWKPVSLGITNSDGRIVDLLPPGKLLESGIYMM
QFHTEKYYKENNMKGFYPEISIQFEVTDDSHYHIPLLINPFGYSTYRGS
>FCMOIPGL_03390 hypothetical protein
MLEIIILIEWLILFTAIVATTYKIHEIIKDLKNEKDYEKADLFQTRQNWFYVLIIITSLC
GIGILYIFLKGTIYESHFFEWLNLTVRLIHITFGIAWIGASFYFVFLENALNRTDGVRDE
LAGNLWAVHGGGFYYLEKYKLAPKKIPKNLHWFKYEAYFTWLSGFSLLAIVYYFNASSYL
IDPEVLDLKPLEAISISIISLIFGWIIYDQICKRLSKNKVIFTISITVLVFFAAWFYAQV
FSGRGSYIHFGAFLGTLMAGNVFFVIIPGQKRMVAAAKKGETPNPADGKAAFLRSYTNNY
FTLPVLFVMISNHFPSTFGNDYQWLILLGITLGTAGIKHYLNMREKEQISIWVMPISVLL
LLGMAFITAPEKTNEENCTTSVTLTDVQTIVNKRCIQCHSSNPTDAVWKVAPNGVKYDTG
EQIYNLRNKIYQRVVVSKNMPFNNNQTEITQEERDLINCWINQGAPK
>FCMOIPGL_03391 Allantoinase
MSEFLIYSKRCFIDNKFIEATLHIKNKKIESILDGYHHLQGLSLFDYNNLIVMPGIIDAH
VHINEPGRTHWEGFHTATRAAASGGITTLIEMPLNASPVTTTVSAFKLKQEASINKLHVN
CGFYGGAIPNNDKDIEGLIEAGVFGIKGFLTHSGIDEFKNITKEHLEAIAPILKKHNVPL
LLHCELEDKNVPTVIDPKNYKEYLNSRPQHWETNAIELALNLQKEFDIKVHIVHLSASNG
VEAIKERKKITDKLTVETCPHYLYFNAENIPNASPIYKCAPPIREKQNNDILWDSLLNDG
FDFIASDHSPAPKDIKNLENGDFFKAWGGISGLQFTLPIMFTETNKRGYSLEKLIPLLTS
NPAKFLGLHDRKGALKIGFDADITIWDDTKNIIISEEIIEHKHKATPYLGHEFKGKIMAV
FVNGYQILKDSKIIKENKGELLLKK
>FCMOIPGL_03392 putative xanthine dehydrogenase subunit D
MDKNISNNKLESKLDALTKDLKSSVKNMDSYTHVRGESIYVDDVNVRQGTFFGVVFDSPK
AHGKIKSIDYTKAIALEGVERIFTHKDVTGENQIGGIIPDEPLFAEDEVHFLGMPIALIV
AESEFIARKARQLIKIDIEELPVITTAKEAKEKKQFINAPRSFSLGNTETAFKNCDFVFE
GETFSNGQEHLYIEAQGAYAEPLENGNIKITSSTQGPTSVQLMVAQVLGLPMHKIEIDVT
RLGGGFGGKEDQATPWAVMAALAAHHLKQSVKLILNRHDDLRMTGKRHPYSSSFKIGLSK
TYKILAYEVEFLQNSGAAADLSPAIAERTLFHATNSYYIPNVSSTVHSCKTNLPPNTAFR
GFGGPQGMFVIESAIAKAASEIGVSSQKIQEANLLDEQDTFSYGQIATQVEVKNTWKSAK
TIFDLNQIEKNINDFNTNNTHFKKGYALMPITFGISFTNTSMNHARALVHIYQDGSIGIS
TGAVEMGQGVNTKMVQIASQIFSLSPKKIKLETTNTTRVANTSPSAASSTADLNGKALLK
ACNALKSRLKNLISEEFDVAINTIEFKNEFVYINNQKSEISWEKLISKAMFNRVALTENA
HYATPIIHFDKTKEKGHPFAYHVYGTAIITTTVDCMRGTYVFDDVKIVHDYGDSMSKGID
LGQVEGAVIQGIGWMTMEEIAYNKDGRLLSNALSTYKIPDIFSVPKNVEIIPVETEGNEM
AILKSKAVGEPPLMYGIGAYFAIQNAIKAFNTNYKMKFHAPMTPEKVLMSLYNK
>FCMOIPGL_03393 4-hydroxybenzoyl-CoA reductase subunit gamma
MIAFILNNKLIHTHANTSMTLLDFVRYEQRLTGTKIGCREGDCGACSVLVGTLKPDNTIE
YHSITSCISPLGNANGKHIVTVEGTNLKNNLTVSQKAMKNNYATQCGFCTPGFVVSLTGF
CLSDTEKKQDNALNAISGNICRCTGYKSIEKAANEVCNQLGDKKENTSTEWLIENNFIPD
YFKDIPKRLSEIKQEKPTQQNETFVSGGTDLYVQKADSLSEKSIHLISDNSKLKGISIKN
NVCTIGAGNVVSDLWNHRELNNYFPNLRKHLKLVSSEQIRNMASLGGNLVNASPIGDMTV
FFLALNSSITIIDKNENERNIPLKNFFKNYKIYDLKEGELLKNINFKLPTETSFFNFEKV
SKRTHLDIASVNSAIHIITDHQKIKEVHISMGGVAAIPKYLHDTVAFLEGKSLNPELIIE
ANEILQKEISPISDVRGSSDYKRLLARQLFFTHFTELFPNIFTLNNVIKNG
>FCMOIPGL_03394 hypothetical protein
MYKIEEPIYFYLLAIIPAMIVVFLLVLWWKKRTQRKFSNAGLLKKLAPNSSVFKSTLKLI
MLLLGIAFLVISLVNPKMGSKLKTIKREGVDIVFALDVSKSMLAEDIAPNRLEKAKQIIS
KIIDKLGSDRVGIIVYAGNAYPLLPITTDHAAANMFLQNANPDMVSSQGTAINEALDLAK
TYYNDDEQTNRFLVIISDGEDHQEETKQMAQDLSNKGIKIYTIGVGSEKGAPIPMRVGNS
MIGYKKDNKGETVITQRKPDVLKGIANAADGNYIDGNVTKNPVKEISDIITSAQKSEFET
KQFSDYKDQFQWFLAIAILFLLLDIFLFDKKTKWLRKVDLFNEEKANK
>FCMOIPGL_03395 hypothetical protein
MYVFSFKKLEVWKEAIQLSKDIYKVTSTFPNEEKFGLISQIRRSKNSIAANLAEVTSRIT
N
>FCMOIPGL_03396 hypothetical protein
MNWNNFEFLNPEFLWLLILIPLLAIWYFFMRKKDAAVLTIPSVKGFKAKASILPKLKPIL
HLLRLFALAAIIVALARPRNVSVSKKTKTNRGIDIVMAIDVSASMLARDLKPNRLEALKK
VAVNFVDRRPNDRIGIVVYAGESFTQTPITSDKSIVKRTISELHWGQLDGGTAIGMGLGS
GVNRLKESKAKSKVIILLTDGVNNSGNIDPRTATELAKELEIKVYTIGIGTNGMADFPWS
KDPRTGLLNFRKQQVEIDEELLKEIATETQGKYFRATDNNSLKEIYDEIDKLEKTKIEEF
KYYNYQELYRELVFLALGFLILEFILRNTLFKSFI
>FCMOIPGL_03397 hypothetical protein
MKKYILHIFLLITTISFAQNPMVKAQIETSRIRIGEQFNLKISVNEIDDVILPKLALKGL
EVVDSAKIDTLNNMLIQKYIITGFDSGAYYIPQQHVFVKNQAYLTDSLLVNVATVAIDTT
KVKKYPIKTIKAEPYTFDDFKIYIYILIAALAIIGFWIYWFVIRKRKIEEDTPTFRVLPP
FEEAVFKLNELDEKLLWQNNKVKEYYSELTEIVRGYIERELSVPALEKTTDEVVEMLKDF
NEAETIRTSKETIKKLKELLQEADLVKFAKSKPLSLEIEEDRKDALDIISNLKPKPVRKN
DELE
>FCMOIPGL_03398 hypothetical protein
METKEILKKVRKIEIKTRRLSDHIFGGEYHSSFKGRGMTFSEVRQYQFGDDVRAIDWNVT
ARYNEPYIKVFEEERELTMMLMVDISGSESFGTSTQFKKDTVTEIAATLAFSATQNNDKV
GLILFSDDIELFIPPKKGKSHVLRIIRELIEFKPKSKKTDISVALKFLSSVMKKKAIVFM
LSDFIDDDYEKTLKIAARKHDLTGIRIFDKHDEEIPNLGMVQMLDAETGAVQLINTSSKS
IRRNYKANALRLTDYYVNTFKRCGAGTINTRVDEGYVKKLLGYFKHKGR
>FCMOIPGL_03399 ATPase RavA
MDVDVRAINEKIERESAFIDILTLEMNKVIIGQKQMIESLLIGLLGNGHILLEGVPGLAK
TLAINTLAKAVQASFSRVQFTPDLLPADVVGTMIYNMKVNDFSIKKGPIFANFVLADEIN
RAPAKVQSALLEAMQERQITIGDTTFKLEEPFLVMATQNPVEQEGTYPLPEAQVDRFMLK
VVIDYPKLQDEQVIMRQNLSGGFATVNPVITVEQILRAREVANEVYMDEKIEKYILDIIF
ATRYPEKYNLPKLKDLISFGASPRGSINLAKAAKCYAFIKRRGYVIPEDVRAVVFDVLRH
RIGITYEAEAENVTSEDIINSIINEVEVP
>FCMOIPGL_03400 Colicin I receptor
MKKNDILKTLMFSFLFLLPLIMAAQTIKGKVTDSSGGALPYMNVVEKGTTNGTVTDDNGE
FSIPVKELPIKLVISSMGFKTKEVTVNKASYLTIVVKEDNALGEVVIIGSRNKSRTMIDT
PVPIDIISMENLSNSGAQTSVTEILNYVAPSFTSTTQTVSDGTDHVDPASLRGLGPDQVL
VLINGKRRHKSALVNVNGTVGTGTVGTDMNSIPTASIERIEVLRDGAAAQYGSDAIAGVI
NIVLKKATNELAININSGANFSEHSNQYNEGGVDGEKFQIDANYGVDLGDNGGYINFTGS
LATRGATNRSDSMGQPIYTMFDIATRNLGYDAAFAMNPSALASYVGGLDPSLQAVYDAGI
ANGDSFLDIISSNGNNGAVSEYELTQRGLTRDDFRMKVGQSKLRSGQFMMNMELPLDDNG
ATFYSFGGLSFRDGLAAGFFRRPAYTDGRGNTDAYANGFLPHIASRVIDKSFAAGIKGKI
GEWDVDFSNTYGVNSFDFTIVNTTNATLGASSPNEFEAGGFSFAQNTTNLDVSKFYEDTF
EGLNVAFGGEYRVENYQLLAGEESSYTAYDVYGEPVNNLTLDSDKVKSYFGGNVPGGAQV
FPGYRPENEVDQNRNSFATYLDLEADLSESFLVSAAIRYENYNDFGDVFNWKIASRFKAS
DNFAIRAAISTGFRAPDLHQIYFNATATQFVGGLPIEQGTFANNSRLADLIGIPTLKEET
SQNFSLGLTAKLPESKIKITVDAYMVNVDDRVGLTRSYSPSGAEQTAIFDAAAAGAAKFF
TNGFDTESSGLDIVIDQNMSIGENGTLNNILSGTFSKTEIKNVKSILGTEILDATLKGYI
QDAMPRTKFNLTNSYKTGKFSAMLRNVYFGSVNDPDFAGAVTYDAKIITDLTFGYEVTEN
LRLTVGSNNLLDVYPDEVPTASNYGGQFIFSRRTSQFGFNGRYVFGKLTFTLK
>FCMOIPGL_03401 hypothetical protein
MKNINKFLGIALLSVSISFLSCDNSEDFDEVVSQIETTDIVNTIFIETDATQQEVAIANV
DESQNITVGVNTAISTDVDFTFNVTKDGSAAVLNTDYTVDNTSLLSGDTNITANVTFLAA
GRYEVFVAGSSSADLTIVENKSIFLVPSPVKYTFEWADDFYDYDVFIFDVLDPNLVDVYD
NFDSSLVTTVYGYSGETVALEEISTALPIGSAYIFVEDYWNDNNASDPVVLTITVAGESP
QVFNLTIDKDKYVLKIETSLNADASGLEYTFTAL
>FCMOIPGL_03402 UDP-2,3-diacylglucosamine hydrolase
MITITTSENKKVYFASDQHLGAPTAAASFPREKKFVAWLNKIKKDAGAIFLVGDLFDFWF
EYDTVVPKGFVRVLGKLAEIKDAGIPIYFFVGNHDLWMNDYFEKELNIPVYHKPQEFLIN
NKKFFIGHGDGLGPDDKGFKRMKKVFTFPLFKWMYKWLHPDLGVKLGQYMSVKNKAISGD
EDAKYLGNEKEWLVLYCKYKLTEKHYDYFVFGHRHLPLEVELQENSKYINLGDWINYFTY
GEFEENFKLLEYKQ
>FCMOIPGL_03403 Carboxy-terminal processing protease CtpB
MNKNNLPIYFSIAIVLGILIGVFFAGNSNDMLSFSKSQSKELKIKKLINFIEQDYVDKID
TDSLLDDAITTILGDLDPHSVYIPKEELQEVTENMQGNFVGIGVQFRMIKDSITVVQTIK
GGPSIKAGIKAGDRILIANNDTLYGKRLRSNNIPQYLKGKPDTKVKLQIYRKSNNSLFNV
DVTRGNVNIKSVDLAYMMNDSIGYIKLDRFARNTYKEFKPALNTLIKKGMKSLVLDLRGN
GGGYIDIANRIIDEFLEDNKLMVFTKNNKEQIEEFFATEIGSFEKGGLYVLIDENSASAS
EIVAGALQDNDKGTIIGRRSFGKGLVQIEMDLGDGSAVRLTTARYYTPTGRSIQKPYTNG
EKTSYYKDYQKRIISGELLTKDSIKVVDSLQYKTPKGKIVYGGGGIIPDVFVAIDTASYM
SNFYFNSINNFAFDYVDNNRKKLSKWTVDSFIADFDKDETVFYNYLTSIENSKNPLLKDL
KNLKITYKDGTAFNSNSNITNGSLDLKKQESLKKYLKAAIANTLFGDIGFYKIIHQDDKM
LQKVLELESKKE
>FCMOIPGL_03404 Riboflavin biosynthesis protein RibD
MTEKKQLKYDKAYLKMALEWGKLSHCKRKQVGALIVKDRMIISDGFNGTPTGFNNCCEDE
EGITKWEVLHAEANAILKVASSTQSAKNATLYITLSPCTQCSKLIHQAGIKRVVYAKAYR
DNAGLEFLEKAGVEIKYLPYE
>FCMOIPGL_03405 hypothetical protein
MDDFLLYFKMGLYHVLDYLAIDHILFLIVLAVVFTFKQWKKVLWLVTLFTLGHSTSLALA
AFKIVEIRVDLIEFLIPLTIFITGVINLFTAKRTSNGKENLNLIFALFFGLIHGLGFSNY
FKMMIGQEEDKILPLAEFALGIEAAQIIIVLAILSFGYLFINLFRVNRRDWILVLSSIVI
GFAIQMMMDRVFW
>FCMOIPGL_03406 6-phosphogluconate dehydrogenase, decarboxylating
MGVSGVGKSTIGSLLSEKLNIPFFDGDDFHPEENILKMSKGEPLNDDDRLGWLQTLNKLA
IEQLVNKGCVIVCSALKEKYRDILNTDIKERAEWVFLNGSFEQIKQRINDRKGHFMSSDL
LKSQFDILEAPKNAIEIDINLSPNNIVEMISKEILKKSEFGLFGLGVMGKSLSRNLANKG
FNISLFNRHVEGVEEDVAKKFKNEFKELSSSLAFDNIESFVNSLQKPRKIMLMVNAGKIV
DYVIEDLLPFLDAGDILIDGGNSNYNKTKERFHYLKSKNIHFVGTGVSGGEEGALKGPSI
MPGCDKDVYKDIQPFLEAIAAKDANNLPCCTHIGTEGSGHFVKMVHNGIEYAEMQLLAEV
YVMLKALGNNPDQIATILESWKASTNSYLLEITIDILRKKEGDDWLVNKIMDKAGNKGTG
NWTTISTAELGVPSTMIASALFARYTSFYKEERITASENFEKNTTSNLNLTTDDILKAYQ
FARIINHYQGFKLIQEASKSYSWNLNLSELARIWTGGCIIKSDLMVEFVDIFKTTDNLLT
NKIIIKKIKLLKPSIKKVVSEGILNELAIPTFSEAINFLNSFAVADSSANLIQAQRDYFG
AHTYQRKDDNSKKFYHTDWINN
>FCMOIPGL_03407 Divalent metal cation transporter MntH
MSTVEKKKSLLKKIIAIVLGFGPGIFAIGYTIGTGSVTSMIVAGSKFNMQLLWVLLLSCV
FSGVLMFAYGNYALLTGETALYGFKKHLKYGKVLAILIIVGITFGQWNSLMGILGISANI
IFEILAINFQGLEAYKYETVLITAIIIIVTFYLLMLVGKYTFFEKILVLFVSLMGFSFLL
SLCFVQPLPLDVVKGLIPTIPDIPGGKMLVAAFVGTTMASATFLSRPLFVKGKGWTIKNL
DQQKKDSITAAVLIFVISGVIMAVAAGALFYQGKEVTQVLDMANTLEPVAGKWAVSIFFF
GALSAGLSSIFPCLLIAPLLIADYQSGVLDTNSRQFRIITAIACLVALIGPAFGANPIEI
QILSQVFNVFVLPVVIFGIILMLSSKKVMKDYKTSLGVYIGMYAALFFSLVISYNGILAL
LEYF
>FCMOIPGL_03408 HTH-type transcriptional regulator LutR
MKISLIDENSNRMFQNDVICKIRDLINAKNLERGDKLPSERVMSEKFDVKRNHIREAIRK
LEFYGVLKSMSQSGTILAIGLTGFNGMIEEIVSLDIPAFNELVETRISLELEIVSLAAQR
RTDFDLKRIKDALNAFKAKITIGDDYLEEDLLFHISIAKASKNNTMVSLMLLLTPPILKT
YDRDTVCEGDKVFSEIKKHEDIYLAIKSKDSQIATKMMHKHFFKLSKHIEINETK
>FCMOIPGL_03409 Alginate lyase
MKKQIIKSVSVCLLFGALLTLNSCKKETKPKAKKEVQKTMYASDIIPFFDHWKLVLGNGV
NAGIANDFENKDFFYTEKDANGEWVVFKAPNAGSTHGTSNNTRTELGQIKKWYPETANDK
LSATLKVMNVSSTGDKTVAASHAVVVGQIHSADKHENEPLKIFYKIYPGHTKGSVFWHYE
INTAGNDNSVRWDYSLPVWGNDFSVVGPDANTPPSEPEEGIELGEEFSYEIEVKDGIMNL
TFTSEGHETKTFTKNLIKSDFSTKADIPEQTQKLFVPIGQDGVERKEAYKGEGCFFKLGC
YNQTNGKSPEVNKNWCSGAETHGGDIQKQYEDGNYAEVWFKKASISVSKAAVSNQGYFNK
NDHK
>FCMOIPGL_03410 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNQNKLNGKNVLITAGAQGIGESISKHFIDAGSNVAIHYFSSADTANELVIYAKSKGVNA
VAISGDLTKEADAITMVEKTVEVFGGLDILINNAGSLVARRLLGEMEAEFWHKVMDINMT
SMMFVTKAAVPYLAKNDTSSIVNLASLAGRKGGHPGSLVYATSKGAILTFTRALSTELGP
QGTKVNAVAPGLILGTSFHNTHTTKESAAETIAGIPIQRAGNAADVARAVLYLASEYDGF
ITGATLDINGGVYNM
>FCMOIPGL_03411 L-fucose mutarotase
MLKTPVIHPTIMEVLARSGHFAQVVIADGNLPVGAMKGLNSTTVHLNFRPGLLDALTVLE
GILEVCPIQGAIVMEKPAEANAEIHDAYKKLLGDVTWDEMERWAFYDKIRDQNTTLIIQT
GEQRRFANLILTVGVVKMAEESNF
>FCMOIPGL_03412 Alginate lyase
MKIRIAKIFIKYFLVVSFGLLLVGCFKSKKKTPIKETNSVTYPSDVIPFMDEWKILLGDG
EHSDDLLKYSKKDFFYVSNDGKTNWVVYKTPNAGITSKTSSNTRTELGQKKHWIPEIGGK
LTGTLKVQHVSTSGDARVAASYSVVVGQIHSDEGHENEPIKIFYKKFPRHKKGSVFWNYE
INTKGDNSKRWDYSTAVWGNDMSVVGENATSYPKEPIDGIELGEEFSYEINVYKGIMYLT
FKSEGHETIKFTKNLLKSDFSTKEDIPQQIWTLYAAIGRDGVERENAYAGEIQYFKQGAY
NQTNGKNPEDNIVWYTGSETYNGDIAKQYANGCYSEVWFKEATVGAGTPPKN
>FCMOIPGL_03413 SusD-like protein
MKKIFLIVFVSMMFITSCDNSLEQVPPNIANADSLTDFTGVLNAAYYYQTAAGTPLAVMG
DFRADNAIFDEAPHNSFQVFNGDLITLEGDFFQPFYANLYKSILSANNVIENSTNATHIA
EAKFLRGLAYFNLVKVFGDIPVNLSASPSTTDTSILAKQPVADVYKIVIDDFTDAINGLD
NSGIITGRASKLAAQGMLGKTYIFMGDFTNAETHLKDVINGAAAAGVSLQDNFADVFGSV
NDLNSEIIFATQTSGAITAGSGTVFAAWFGGNDTKADEYPITSSLVDAFDAEGDVTRKDA
TILISATNRVGVKFDGADQDFIDLRLGDAILLYAEALNENNKTSDAIIQLNKIRNRANLA
NTTATTKATVKVAIANERRLELAFEGHRWFDLVRTNTVSAEMGTTVDSKYYVFPIPTSEI
FASDGIITQNTGY
>FCMOIPGL_03414 TonB-dependent receptor SusC
MSKNNLIKKISTCLFLLASLFAYSQQKVTGKVTDDTSGGVLPGVSVQVKGTTTGTSTDFD
GLFSLKVPNNEAILVFSYIGYAKQEIKVDGKSTINVILKEDASTLDEIIIVGYGTSKKSH
LTGSVSKIGGDDVAAVQATRVDEALAGKLSGVLIQNASGGPGADPKIQIRAASSISSDSN
PLIVVDGFPISGSLATVNPSDIESMEVLKDAASAAIYGSRGANGVILVTTKTGKSGKTTF
NYNTYLSVSNKYRDNILKTGSEWAAFSRKEIAAGNWDLSQIDPAFIEYRLSAYENSPGEV
SVEDWLYQSGTSVNHDFSMSGGTDTSNYFASVGYQDTEGIVRTQGYERFNARLNVNTQFG
EKFKTGLSFNGFMSKRDIVAHDIRDLARSYSFHPIYHTEESIAFVQDLDRQAQALGLNGF
DSGRNSKTDGVTGYVQSIQDLVPGDFVNDWHYGRANNGIGGSGDQGPAAKLDNATNWEKT
YFFNVSSYLEYNIMEGLNLKTVLGADLRDTQLYYYQGILADNQARWENTDLDQTDTKRSS
VLSTTTLSYAKEIGKHDISAVAGIEFQNNYTKATQLLGSYVPFGEVINYGLLEPENITVS
ERNETSTRRSVFGRVSYAYDDKYLASVSLRRDGDSRFGANNRYEVFPAVSLGWNLHKEDF
LADNEKLSKLKLRFSTGSLGTASFLGAYSSLSLLESGTTVYGNGYLIPTDVANPDLTWQT
NTETNFGVDFGFVNNRYTLGVDYYTSDIENILLEQSVSEVLGTNQIKLNSGDVKSTGLEF
ELGADLIRKEDLSWNLSANLSTVKTEITDLGERDELPRLPSGQSGRDIVFRNYVGGQIGE
MWGIETAGQVEMKYLEDPTRSPNNTSGEYYVVDQQGDGIIDITKTVEEGGDLIKVGNNTP
DFYWGLNSSINYKAFDISMQFQGAQGGEVFNVDPYYYGSQWGGRLVDNFKDADGRAVHNG
MFVKDAKSNLDANVQDASYLALRNLTIGYTVEDNIVEKMGLSSIRIYGAATNLLYIFGDD
YTSYNPEGIETTGDYQGPVNSGFQIGASPVVRSFTVGLNVKF
>FCMOIPGL_03415 hypothetical protein
MKKSIFLSFIFILIYQGISSQVILEANGPGNTYELINSILANAGKDVIEVPDCVHTTFGR
HIDEVFDTDLNKNVFRFYAHVSPDNDRCKTFDRQRTEIKSYDSSPENLKATIGETVAYKW
KFKISDTFKPSTSFTHIHQIKSVGGSYESIPMITLTLRKSSPDRLELRYTPTNDQNTLKT
ADLDLFRGNWVEVYEKITFGDVGRYEIEIKNIATSQVIFTYANNSVDMWQDGAEFARPKW
GIYRSLNSPADLQDEIVKFADFSIEEITGSLSVDDLTSNADQIVLFPNPASHEVNFKNVT
SDTYTSVELYDTFGRQIFIKNSLHQNKLNVSELSKGMYFVVFKKDTITTKVLKFVVE
>FCMOIPGL_03416 hypothetical protein
MKNFLFLLSALLLMNCSTTELVDVWKNPAIDSLVISKVLIVGMTSNIEARKEFEQKLKKE
FESRGIEAVMSLELFEPTFTAEKKSKEELRIVEKILATSYFDAILFTKIKGIENKTVYTK
TFKNKEHLDIRFKDDYYKNQEIFYNPDYYKKFDIYHAETSLYCICPVKERELMWKGSIDI
IDPSSTEETVNDYVNLLIFALEEENVLKKIAVE
>FCMOIPGL_03417 hypothetical protein
MKTTPINTNYIEWLSAEEMHNNSKEWLLELEFLNDEYLFFEDLIKWNTLQLIDFQAYSKS
KEIVENFSKSKNTNDTLIKLIKKHENELEILVDGIDQPKEETAYKKEHKALLISFKNHLK
EHRALKSSLFDILKKIKKSEKQNRIIDVE
>FCMOIPGL_03418 hypothetical protein
METKNIFKSFNEKKSIEELKYNMLQFKTKIEEELIEYKFYENLIEASIYKTNAINLFENL
ELFKKEINATENEASDLFIEINLHSNSISNKIECDDLFCDNFFIKRHDELEEKTHNFFIK
CTKFKIQFFQYLESVIIN
>FCMOIPGL_03419 Ribonuclease
MDHFAKIKFLGASGVVTGSKFLIETSEKNILIDCGMFQGLKELRELNWKDLPVAVKKIDV
VLLTHGHLDHVGYLPRLVKQGFTGKIIGTAPTLAIAEIILNDSAKINEEDAEKANREHYS
KHEPALPFYTVEDAEKTINLFKVEVENKWIDLSENIKYRFQYNGHIIGATFIELDIHGKR
FVFSGDIGRSNDYLLENPKTPEWADFLFIECTYGNKLHPKEDVEQKLANIIIDTIYNKGN
LIIPSFAVERMQTLMYILWKLYKENKIPNIPIFVDSPMGEKVLEVFKRFPAWHKLPIEDY
NAMCNHINIVQSFKETWETIDNKRSKIIIAGSGMVTGGRVLTYLQQLIDEPSTTVLLVGY
QAEATRGRQLLEGAHEIRFYGKYYPVKATIKTIESLSAHGDQQDLLNWMKNIKNIPEKVY
LIHGEPTALDAFRVKIKDTYNWQATIPKLDSVEEVVI
>FCMOIPGL_03420 hypothetical protein
MNDKDISIIKYSGEKVKFSANKLYNSLKKTGAEDVVINQIIEKVKDELYEGISTKEIYDR
AFSLLKKQENCLASKYKLKKAIYELGPTGFPFERFVAAILKHSGYNVEVGQILNGKCVTH
EIDVTANKNNETTIIECKFHSEQGFNCNVKVPLYINSRYLDVKSFWDKSSKIQNKLTAGW
VVTNTRFTEDALKFGNCCGLYLLSWDYPKGNGLKDRIDRLGLYPITVSTLLTNREKQFLL
NRNVVLCRELIEDFFFLDHLGISSIRKDKILNEFKQLCNSKNH
>FCMOIPGL_03421 hypothetical protein
MKRKILLPTDFSKNSWNAIEYALKLFKNDECVFYFLNVFTATQNVYDILINFEPGSELYE
LSKAKSEQGLVRILDVLDVEGYKNPKHHFETISTFNYPLEAIKNIVEQKDIEMIVMGTKG
ETNSTQIAYGRTAIYVMEKVRNCPVIVVPEKANHTLPKEIVFPTSYKTHYKRRELIYLIE
IAIKCDAKIAILHVSEEEKLTNNQIENKQLLTEIFEDVSCSFHELKYNSVEAAINIFIES
RDSNMVAFINKKHYFFGSVLTQPLVKEMGFHSNIPILVMHDLRN
>FCMOIPGL_03422 hypothetical protein
MKNILLPTDFSDNSWNAIQYAVELFKDEKCNFFLLNTYTPIIYDVEYMNVGAASFGLIDA
MREASEKGVSKLQKKIEKKYVNSDHKFIQISSFNTLTFEIQELSEAKPMDYIVMGTKGAT
GLDEVLFGSNTVHVIKKAKCPVLAIPSGFSFEAPKEILFPSDYEISFKKKQVKPIVDIAL
SQTSKVHVLNVSYGYDLSEKQEKNKQKLNTLFNTISHVFHSVPDQNVTEAISEFQQKTRV
NLLVMINNKHSFFENLFFKSKIKEIGFHLNVPFLVIPSNTKKD
>FCMOIPGL_03423 TRAP-T-associated universal stress protein TeaD
MKKILIPIDFSKNSINAINYALALFKHEFCKFYILNAYQEDINLSNAPITKEVINEVIRT
AGKDSQLQLKNTLKQIKKLSQNSKHLFKILSANNILVDEADRVVEEKNIDLIVMGTLGKT
NNKKLTFGSHTLQVLKYVRCPVLVIPQGYTYKKPNHILFATDYSMPYQQRELALLNEVAS
DYKSTIDILYISDSGSLSVRQEGYKSFIKENLKNTKIHFKITKDKNISNEINKYIEDYET
DILVMINRRHSFLENILFKDNIDKISLSIKIPFLALQNMRRT
>FCMOIPGL_03424 hypothetical protein
MNVNIQFINMTTSETMEAYTIKKLDSLVKKFEKIISANVVFKKEKNSKDKGTICEIELSA
PGPRLFASSDEKNYELAVKNTISDLEIQLKKRKGIAKPYL
>FCMOIPGL_03425 hypothetical protein
MDSSIFLAKFWGYYLLIFFVILSFNPKRIRQIFNDLEDQKFLIILSFLSIIIGLLNILFH
NIWEPNWKLIITLIGYTSLVIGLSLFIIPKQTINWLKFVNIKFVQVIYTLLFLIGLYLLN
IGYAIILI
>FCMOIPGL_03426 hypothetical protein
MKTILLPTDFSDNSWNAIEYALNFYKDSTCNFYLLHINRLSNVATTDYPYIPTEDVIVDI
YIKPAKTQLKALLKKISENFPKNKKHKFHTLTESNFFIESIRNNVEEKKVDVIVMGTKGA
SGLSKFIIGSNTGDVITKVKCTTLVVPENAKYKKLEEVAFPTDFSLSNNLQVLQPIAEIL
EETSSSLRVLNISKKDSVLNRDQQKSKELLEDYFYNYKHSFHFLTNKKVEDAVQCFVESR
NIDLIAMVAKNLNYFQQILFHTKVEEISYHTDVPFLVLHE
>FCMOIPGL_03427 Transcriptional regulatory protein CseB
MKKILLIEDDLILRENTSELLELANYEVINAPNGKIGVEVAKVALPDIIVCDIMMPELDG
YGVLQALHTNESTHHIPFIFLSAKTERKDVRKGMDLGADDYITKPFNEDELISAIESRLA
KAAILKDLREKKEEKKVVIEEKESIRNLNDLKNYFDDNGEIFHFAKNQIIYQEGNNSNYI
YLIISGLIKCHKLDEQGKQLTTALYKEDDLFGYTSFTQNLSYQESATAIKDSELVGLSKK
ALTNVLNKNHQVTLELIELLTEDLAVVKNQLLQMAYSSVSKKTANTILKFVEKLNSKPEE
QIRISRNDLASVAGIATETLIRTLSNFKKQNIIEIEGRNIRILDLEKLKDIY
>FCMOIPGL_03428 Signal transduction histidine-protein kinase BarA
MLNKEQDVFNVLFEAVSEGVVVVDDQQNIVSVNSSVEKMFGYEKNELLEKKLNVLIPKDY
HAGHGAHFNGFMKHKEKRQMGNGRDLYGARKNGDIFPLEAGLNPFEIYGKTFIMALIIDI
SVRKRQEQEIYKLNEELEKKVSERTKELRKTVNELKAVNLELDEENHKRIEAENQIKDAL
KKEKELNELKTKFLSLVSHEFKTPLSGILTSTILLGKYKLAEQQEKRDKHLGTITNKVHY
LNNILNDFLSVEKLDTGKINYKFHTFRLSKVLDEVIYNANMLLKEGQRIKYPENIDEISL
TQDEKTIELALSNLVNNAIKYSPENTDIDINITQDKQYTTIKIKDNGIGIPEEDQKNIFN
RYFRAENALLTQGTGIGLNIIKSHLENLGGTITFESKENIGSTFTMKIINTAK
>FCMOIPGL_03429 hypothetical protein
MKPSQNTIISFYENLGKLFYAIAAADNVVEDVEFNVLKETVKNKWTKIDHIDDDFHSDAA
YQIETVFDWLNNEGFSDSKTCYNEFIDFKREHPSLFTEETKSLIIQTATKIAASVADLNK
SELMLVAKLSIEFKKTD
>FCMOIPGL_03430 hypothetical protein
MKKAIILFFLIPFLGFSQITDKLDYVSPFNEGYSAVKKGNQWAFINQKGNIVIDFRDDLV
LTETNKEKYPIFVNERCLISEKKDGISYFGFIDTSGKTVVEPLYLNAANFNEEFAIVIHV
YKNLLGKDVLNKQVVSYEITEILINKSGEVKFSLTEPKGIILSKEYIKNPPKINSKFLTK
NLIAVLGKDNKWELKKL
>FCMOIPGL_03431 Putative efflux system component YknX
MKRISVICFLFFCISCAEKEEKTVPESRNMTESVYSSVTIQPDSLYQVYASVAGILEKNL
VEEGDLVFKETPLIKVVNNMPKLNTENAKLMVGLAKENYTGSAAILDGIEEEIIAANLTY
KNDSINFYRQKNLWNQKIGSKVAFETKKLNFELSKNSLQLLESKYNRTKNELKTALKQAQ
NNYESSLINTKDFTVKSIINGKVYALFKEPGEIVSTTEPLAKIGSATNFVIELLVDEVDI
VKISENQEVIINLDAYSGQIFTGKVSKIYPIKDTRNQTFKVEALFDKVPKTLYPGLSGEA
NIIISKKDAVLTIPKDYLIDADKVKTDNGIVKITTGLQNMEFVEVISGISKNTIIYKPE
>FCMOIPGL_03432 Lipoprotein-releasing system transmembrane protein LolE
MVNWKVLLNIAKKHLLTKFKQTAVAALGVTFGITSYITLASFMTGLNNVLDDLILNQTPH
IHVYNEIEPSKQQPISLYDDFKNSFNVVHSIKPKLNQKKIHNALPIIKYLNDNKDVKGAI
SQIKTNIFYISGSIELVGNLTGINPIEEARLFNFKDYVIEGSPKDLKNTENSIIIGSGVA
KKMSLSIGERVQISTVNGTVFPLKIVGIYQSGVSDIDAIQSFTNIKTVQTILGEAKNYIT
DINIKLYDIDKALPLAKKIEQQFNLNAIDINTANAQFETGSSIRNLITYVVSITLLVVAG
FGIYNILNMLIYEKMNDIAILKAIGFSGKDVQIIFMSEALIIGIVGGVLGLLFGLLFTNI
INTIPYETEGLPRIKTYPIDFNLWYYVIGLTFAIISTCFAGFLPSQKAKKIDPVKIIRGQ
>FCMOIPGL_03433 Lipoprotein-releasing system ATP-binding protein LolD
MSTVLEAKYINKYFKKPVSFHVLKDINFKIDKGEFTSIMGKSGCGKSTLLYILSTMDTDY
EGELYLDNQLITGDSKDKLSYIRNKNIGFVFQFHYLLSEFSVLENVMLPAKKLGEKSVKE
IENDAIQKLKILNIEHLAKKKASQISGGEKQRVAIARALINNPSIIMGDEPTGNLDSHNS
ENVFNIFKKLSLEEKLSLLIVTHDEDFAKKTDRIITMEDGKIIT
>FCMOIPGL_03434 Chaperone protein DnaJ
MAFVDYYKILGISKSASEADIKKAYRKLARKYHPDLNPNDKAAEKKFKEINEANEVLSNP
ENRKKYDKYGEHWENGEAYEQQEKQRQQDYQRRSQSSQGSYSQEDFSDIFGDMFGGGASG
RRTSSKFRGQDYNSEIQLHLKDVYKTQKQVITVNGKNIRITIPAGVENGQTIKIKGHGGK
GVNGGPNGDLYIQFSIINNTKFKRDKDNLYIDVDLDLYTALLGGQIMVDTFDGKVKLTIK
PETENGTKVKLKGKGFPKYKKEGQFGDLYITYQLKIPTKLNEKEKELIKELQKQR
>FCMOIPGL_03435 Chaperone modulatory protein CbpM
METENLISIQQFCEHYSIPKTFMNDLKEYELIEIIVAENDDYIKITQITEVEKMIRLHYD
LNINLEGVDVIYNLLNQVDTLKKEVTDLQNKLRFYDNV
>FCMOIPGL_03436 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKSYSLFTILLLCLAILIVDILAFYWLQSITQIIASDGLKTAINIVFWGFTIGLIASIIT
LKITLEDIEPKRKHKLVSALSGLTISSFIPKIIFVVIFSLMYFSNQFFSETESLIVVPLF
GLLSGFLPFFVIMYGFFKAVYKFKVHHVTVKHQKLPASFNGLKIVQISDIHLGSFNYKYH
ILDRAIKVINDAEPDFIFFTGDLVNNYAWELIGWEKVLDKLVAKKGKYAILGNHDYGDYS
EWNSKEEKKENFDKIKTFFKRIDFKLLLNQSEIIEKNNEKIAIIGVENWGKPRFKQYGNL
QKAVKNVTEIPFKILLTHDPTHWSKEVLKKTDIALTLSGHTHGMQLGFQYKKRQWSPSKY
QYKHWAGLYNENEKYLYVNRGLGWVGFPGRLGMRPEITLLELKKK
>FCMOIPGL_03437 hypothetical protein
MITNLKEEECSHLLANNYIGQLAYIYKDRPFVVPITYFFNKNNIIIGYSDEGHKTMAMRK
NNKISLQVSNIIDCDNWISVLAHGVYEEVTGSEAKKYLHEFTSGIKDIILRKEDRCLRSV
GDFSSKKYTNHPPIIFRVTVDEMTGKRRVHHS
>FCMOIPGL_03438 Sodium/glucose cotransporter
MKAGFEMWDYVVFVGYAILILGVGLWVSRDKKGHQKNAEDYFLASKSLPWWAIGTSLIAA
NISAEQFIGMSGSGFALGIAIASYEWMAALTLIIVGKYFLPIFIEKGLYTIPEFVEKRFS
TNLKTILAVFWLSLYVFVNLTSVLFLGGLAIETIMGVDMLYAIIGLALFAAAYSLYGGLS
AVAWTDVIQVVFLVLGGLITTYLALNTVSGGEGMLAGFSKIWEAAPEKFHMILEKSNDNY
INLPGIWVLVGGLWVANLYYWGFNQYIIQRTLAAKSLKESQKGILLAAFLKLIIPLIVVV
PGIAAYVMVNDPSIMANLGEAGMLNVPSTEQADKAYPWLLQFLPTGLKGVAFAALAAAIV
SSLASMLNSTSTIFTMDIYKQYINKNATDKTTVNVGRISGAIALIIAVIIAPMLNGLDQV
FQYIQEFTGMLSPGILAIFLLGLFWKKTTNNAAIWGAILSFPIALALKFIPIAGLEPWMH
QMGITTLLTMLIIMVLSHLQNNGKDDPKGIEITKDLFKTTPLFNIGSIVICILLIVLYCL
FW
>FCMOIPGL_03439 hypothetical protein
MKKHIENTQGTTQDITRKDALKKIGNYGKYAALTALGTYLILSPHKAQASSPIESPGTGF
>FCMOIPGL_03440 hypothetical protein
MKKRILLLIVMLLTIAITNAQQASGTQFTVGDMIYEVNADNTTVSVHDAVTPGTLTGAIV
VPTHISDGSYSYTITVIKSAAYNDEAGITSLVVQGDTEIQLQAFRNTGLTTVDVSAIVTK
KIGNSAFLNCTALTSANFDGVTSIGNQIFSGCTNLTTFSANTLVSSGGGTSMFLNCTSLT
TVNLPVALAVGNKMFRNCTSLTTIDMPKAITGLQYGFQNCNALTTINLPLLETTGTQMFV
DCSSLVSLDLPALTQTGNLSFYKCSSLKYLNLPSLITANTGSFNSTGLESIIFPASFTTF
GSGPSNHFANAASLKHIAFTSATPVGISGRSDMFNGTALSTIIVPEGAASAYDAADVWTD
FSIVEGTLSKTATDITYSRNLSVDDDWFLVSSPVNNEMFNDAYVSANSIDAAGTITTNNA
IATYTTNGNTWDYMQDGEDLQFTPGVGYSVKRANATGAGSISFTGSALNSGDVNNIPVSL
DDDGYNLLGNPYLTNINSGDFLTANTNLSGEIWLYNQATGNYETHVTGDDKILAPAQGFF
VKATSGTDVDFTEAIQNTSTGTFQKAKTLSEIKLLINSEDTQRFAKIYFTEAATTGFDKG
WDGERFNGISNKMDVFTQLLDNNTGKNYQTQSLPSASIESVVVPVGLISEAGKQITFSTE
NINLPENLNIFIEDRAKNIFTNLNESNYKITLSEALNGVGRFYIHTSAKSSLSVDTTSTL
ESVSIYKMNNATLRIAGLSQGKASVKLFNVLGKQMINTSFESNGVKDISLSKLATGLYIV
QLETETGKLNKKIILE
>FCMOIPGL_03441 Sensor histidine kinase TodS
MNNNLINTASLIYKDKIQILKKITLFVLIFFSSSSFSQKNETFFNDLIIQGDPFNKKVNV
LFEDSIGYLWIGSNTGLYRYDGYNLVSYQQDVFDPHSIPNNSINSIIEDKNKNLWIGSES
FLIHFNRKENKFKGFNKNTTTEVLYSDSKGNIFIDLKGSGFAKIDTTKNFNKISDKKKIT
INLKKPILKGQINSFTEDDFGRNWIGTSKGLYILNNDNSFIKSNFNNDIINFKNFGNNRF
IAISSNSLFILNYNKANANLEILESYPNITNTLDTQATLTSLAKNLNNEDLWIGTTNGLF
KAIRKNNCYTFVKFSKEPENGNLKSNYVSSIVFDTYGNLWIGTLKGINKYRIRTSIFEYN
EIIAPNKIENDIANSMVFFSPSNILIGMNSGLYTHNPKTNISTKIHANIRNIKHVSLNYE
KDKLLLASGNKLYESELFDFKKNSFKLSKIKTFNYEITDITVINKNEIWVGLWNGGVDII
NTKNEISKFKKDIIQKLSKSHTSVFLLTEDQKLWIGTRGEGLFKVDLNNETIEDFIPSKE
NGLTSNAILSLHEDNNKNVWIGTRSGGLNKYIKETNSFKSFRKLNGPSSNTVSSIKSDHK
GNIWLSTQDGLARFDIEDEKIIPFKEEDGIKESQFLFNSSTSNKSKNTLYFGCSDGFYTV
HCDNFSQKSILPSTVITSFATLGATENDETDSELNATNLINVNSEKPIVLPYNQNNIVVN
FSSLDLTTPNKNEFAYMLEGLNNYWIYTNASNRNANYNDLSSGKYTFKVKSSNSDGVWNE
IPTELSFKIMPSIWKSNLAILAYIIIALILLFISTILIRRWYRLKQNLVKETISREKDNE
LNQMKMTFFTDISHELRTPLSLILGTIEKVVKEKKFTLSPLTSQRIYNNTLRMHRLINQI
MDIRKFDQGKFKLNISKNDIIKDISIIKNAFNDFARIYGITYELTSNEEVIKAWYDVDIL
EKILFNLLSNAFKYTQEGGEINIITNLVKEDAQELTDLNLPKSKYIKCIVKDNGVGIPPK
DLEHIFDRYYQATKPYSNQIPGTGIGMELVQKLLERHHGLILAESEENKFTEFTFYLPIS
KKMYNKNEILKTSTPLLKNFIKNSEFQIIEEVSTEFDEKVSSTENTKPKVLIVDDNSELR
LMIKEELIDLFNILEASDGKEGYDIMVREKPKLVISDIMMPIEDGISMLKRMKRNSKIKN
IPIFMLTAKNSQETRIECLALGADDYIEKPFSMEFVKWKVKNTLVSRKQLRNEYSKVITA
APSEIEIESNDEKFIKKLVSIVESSMSDHLFSVEYLASEVGMSRANLYRKLKVIVNETPV
NFIKKIRLKRAEQLLKKNSMYISEVAYLTGFNNQKYFSKCFNKEYGISPTEYTKQHKDSI
ENSNNSYMDDK
>FCMOIPGL_03442 Arylsulfatase
MKKSLKMFSLAVLIFTLFSCNHKNTVKESSSQLTKKTNKKPNIIYILADDLGYGDLSSYG
QEKFKTPNIDKLVTQGLMFTQHYAGNTVCAPSRSALLTGMHTGHTPVRGNKEVQPEGQYP
IPDATYTLAESLKKGGYVTGAFGKWGLGYPGSEGDPVYQGFDTFYGYNCQRLGHNYYPNH
LWSNRDSIALTGNDNHQKGQYAPELIQAEAIKFLEKNKDTTFFLYVPTIIPHAELAAPEN
LIEKYRGKYLPEKEFKGTDDGPEYRLGKYESQKDAHAAFVAMIEVMDTQVGEILSKVKEL
GLEDNTIVVFTSDNGPHTEGGADPKYFNSNGKLRGVKRDLYEGGVRVPMTIRWPGKIKPG
TTTDLISAFWDVFPTFSEVAGVDVPDNLDGISFLPTLLDKPEEQKQHDYLYWEFHERGGR
QAIRKGNWKAVKYNVLKKPNAPMQLFDLSTDIGEKNNIADKHPEIVAEMKELFKGARTPS
DVFTFDQVSF
>FCMOIPGL_03443 hypothetical protein
MANAVLCQNLRNININTHKGHAINKGASGFNVRIADKIWSYTHPDFVKSVKELKPGWLRY
FSGTMGDAFSSATGEYDLDYISMLDHTKGYLKGYRYVKVKGPHRIIDLYNLLSEVNAKLI
ITVNAFTESPEMILELARFCKNNNIEVAVWQFCNEPYFYVPNRNRFWWNDGYDYAAKMQP
YAEAIQQIFPDAQLTLNYTWDGVWTFMKEINKYQKENGAYWNVFSKHSYAPHTGKKETVE
QAYKRANTKLLEATSSDAMSEIEAYTWQDVPMVITEFGVWNSPLNGIYSSIYNIEYVMRQ
LAHTNTQYVGAHEISNKYYPGKGNGRVVENAFKNNLKIETDTVLTGVRRDLEGKAYKIYN
EAVNNSEYLYTVDISDNVKVDGLKNSKVNGMFAQGYKGSNGYNYLVVSNRSKIANQYQIN
IDNKAFKDNMLVTYISADSLKTRDTEIKETQIKNGILSVKPFSISVLKWKTDSYKLEQPT
IYRTTVEKEGVLLKWGAISKAKSYKIHYGTDASSLSKTINVAATNTFLVKGLHPKKKYFF
TVEALNDEKISEVSKNVSVTYNLPNKPTIFKVARRDNTVTLFWQSVPDATSYLINYVDEN
NKNIEINTANVFGYRIEELKDNTKYQFTVTAYNGLGKSLSSDKKNVLVSSRVPFSPRNVS
ATKITSNSINVNWKPQDKVLTNTSYNVYRGVKLHEFTKIASGVKDTMYLDNSIKENTQYY
YTVKAETEVGESNFHPNIATAFSIEKNNKIIIQSVENQKEGYLVKVELNQMKLKPEDNFG
VIINNVSYLNVEHIKILGTIDSDKKKSFKVFIPNSKVKIDSKYAIKAFVIKKGKQIESAI
VNQYISKN
>FCMOIPGL_03444 Beta-galactosidase
MKKSLLIIIISLASFASCDKTDTRPIYVAEKWENPEWENPEIFQINREEPTASFYKYVDD
KSALENASWKNSPLYQSLNGTWKFYYADSVQARPTDFYKADFDISNWDDITVPSNWELKG
HGIPIYTNRTYMFPPNPPYIPHNLNNNGSYKKEFEISEDWDGKDIYLHFEGVSGAMYIWL
NGQKVGYNEGSKTAAEFKITDLVKKGKNDLAVQVLRWSDASYMEDQDFWRLSGIERDVYV
YAANKVTLRDFRVTSDLENNFKDGIFKVDLKIDNNTAESTQQEVKVQLLDGDKEVYTATK
NVQLVKGRNVIDFAKKIPNVKTWNAEHPNLYTLLLSVNGEATAIKVGFRNIAIKNNQFLV
NGMPVLIKGANLHDHSDTEGHVISEELTLLDMKVMKENNLNAIRCSHYPKNPHFYRLADK
YGFYVVDETNIETHGMGTTNQGLNNNKKDQAVHPAYLPQWKGMHLDRTIRMFERDKNYPS
IITWSLGNEAGNGENFFATYDWLKANDSTRPTQYEGATKYSNTDIQAPMYWPIEKMIKYA
ENNPNRPLIQCEYAHAMGNSVGNLQDYWDVIEKYDMMQGGFIWDWVDQGILTKNEEGEEF
WAYGGDLGAGHLHNDKNFCLNGIVNPDRTAHPALYEVKKVYQYIKFKATNIKKGEIEIKN
IYDFTNLNELDFSWRLLKNGKEVANGALPTLDVAPYTTKKVKISIPKLDDATAEYHLNVY
AKTKTATDLVPVGHVAAFEQFAVTSPKTKNVLAKNDGSLKAAVDATSIKVTGNGFNLAFS
KENGELTTLDYGNGNVLLKGIKANFWRPTTDNDYGFKMAKKLGVWKEASNNQELKSIESK
KTDTGAVLVTATYHLKGVDGTLVIDYTIDAKGKVLVNTNISGLKAKTPVLPRFGNNFVVK
NEFNNVEWFGRGPFENYKDRKSAALVGVYNASVKDLYFAYIRPQENGYKTDTRWVTFTNE
SGTGIKVTATDLISFSAHHQYNEDFDAGDDKTQRHTTDIKQRDLVNINIDYGQMGIGGDN
SWGRMPHKEYQINAGNLSYSYTIEAIK
>FCMOIPGL_03445 Beta-galactosidase BoGH2A
MHIKKIIFLFVFSFIFSGFSRDKNPKENIKRIRISFDARWKFIQEDVTGAEKVSFNDASW
RTLNLPHDWSIEGEYNENNPMGAGAGYLPAGFGWYRKTITVPKDWKGKHVEIAFDGVFMN
STVWANGQKLGTRPYGWVSFAYDVSEIAKTSETITFAVRVDNDKQPSARWYTGSGIYAHT
WIDVKNNTHVKRDGIFLKTEGNKVFVETELFTKEDCEKVKLITSIVDKNGVVVASTKDKI
KIEKEALAKTELEIKNPNLWSVEDPYLYTLKTEILIGRKVVDIVGTKFGVRDIEWIAESG
MWINGKNVKLQGVCNHQDAGALGAAVPYKILKFRVQQLKNMGVNAIRTSHNPQTPEFYDI
CDEVGMMVMDEIFDGWKKKAKNDYGAHHFDKWWKQDLTDWIKRDRNHPSIVIYSVGNETG
GPVAKDLVATCNLLDPTRPVTSGHSGSDHMNVLGINGGSEKKGFMENLAKNPKDRVFIGT
ENTHTWQVRGYYRTKTWYRDGFPNRNQTYEIPDLTEKEVFTNDWIDESGRKNRKQIFNSS
YDNATVRVSSRLSIAQLRDVPAYAGSFRWTGYDYIGEAGYVHGGWPFKAFMGGAIDLANF
EKDLYYLYQSQWTTKPMVHILPHWTHPKVALETEIPVWVYSNTEEVELFFNDVSLGKQKP
GIAWEEMQCQWMVKWQPGTLKAVGYNNGKVVSEKIIRTANQPSKIKLSVDGEVLQKREDD
IVQVRVTTTDDKGEFYPYGENRTYFNVFGAGKIKALDNGSPVDVEQHVGRDNRIAFYGLT
RAYISSTDATGAINLLASCILGEKKLITSNKVSIDTKIINLRGDKIKPKIEVYYTTNGDT
PTTNSKVYKGSFEINLETTVKALIVVDGKETQFLEENFGKSEGFTWNETMENKGQIGEQA
EEATLVNATISSKGKNFNGKGFVSLAKKGASISWYQENDGSAGKVELTIRYSTNTKNESG
AHIKVSISGKVVREKVLLSNTQHSGNKWKTVKIPIRIGRGANTILIESLENKKVLIDEIM
IK
>FCMOIPGL_03446 TonB-dependent receptor SusC
MKKLNLLLLLISISWGAFSQDVIKGIVKDSGGIPLPGVSVMEKGTQNGTSTDFDGVYQIK
VSSNATLVFSYLGFKGQEIKVTGKSTLNVIMKEDTESLAEIVIVGYGAQKKESVLGAISQ
VKAEAIVQSGAANITNALSGLSAGLNVVQSSGQPGSDAGEIYIRGNSNPLILVDGVEVVG
GFSNIDPRDVESISTLKDGAATAVYGIRGANGVIIITTKRGKIGKPVVSVTSEVSIKLYP
DRYDSLDAYTAESARNVGLYNDAAFDSGFASTTDLNHWKEGDLPYIYPNTDWVGYTTKDF
ATSFNQSISVRGGTESVKYYASAGYLQEGDITNSEQFFNFDPEYKFERYSFRGNLDFTLS
KTTKLKTSVSSRIEDQNSAGGSGSFLGLYTVSPSAGVPYYPAEVMEQYPDPLYPGLAEIR
FPISVTVGNNLAGSTNTLKTIFSIDFQLEQDLDIITKGLKFTGKYNYISNYQTSSSISFD
SSLESRLDRYDLLRDGTWDSFEGADYERPFDFNLGNEGINNTQDITNIRANLNYNRSFGK
HNVSGLALFTRNKRISNTTFPYFEEAWVGRATYNYDAHYFVEFNGSYNGDETFYTGNKFM
FFPSYSLGINLAKEKWVKEAIPALNNFKIRYSNGKTGNKSGLGSNRWQYLSYYDSANPRE
TWRYRFGEGDTGRLSVIRQTQLGNEDLTWSTVTKQNLGVEFGLFKNKITGEVEVFKDKRE
DQISRPSATVPAYFGSSVALPFANIGASESHGLEASLTYKNKTKGGFKYSATAIYGFYEN
RVLISAADGPGTPEYTKVAGKPAGASSLLQTDGYFQNIDELVNYPIYAGEPGLGDYRYID
YNANGTVVGTNLEDQIRFDLPKSPQHSFSLNLKGSYKNWSVSALINGITGHKGLENSSLA
YALPSGDAVGRYEQLDYWTPTNTNASYPALHGDSVDPNLVAGTTARIISLDYIKLRSMNI
GYNFNMDNNESIKTFKLYISGTNLFTFSDMKYADPEGNNPGSYPMLQRINLGLNMSF
>FCMOIPGL_03447 hypothetical protein
MKTIKYTFILILAALFFSCEDYLEKEQDFEGLDQNDVFEDVRLARNFLNGAYTNLITEVT
AKSNNPDILPGMSMSGEGYPARHNNNVPQRYNSYATSDYLTLMNLNGAVGQGQTPNFVSR
YYESWKGVNTVNTFLANSDKIANSDEATVNALKGEAYFLRAYFYHLMTKRHGGLIYLKEN
LNVNNPFNQERETYASNLANMLEDLETAITLLPVNRASEDYGRPTRGAAMALKSRITLFA
ASPLINTTNDNQAWIDAATAASDLINFANNNGLYTLASAPNANNIDVSHNGADLFNPEPE
ELEPYRSIFVGPGKSKILPPEVIFMEVNEFTAGGGGTLVPLPRTYLTVGFDIVKGNNNPM
GIGALANFVEKFETKNGLAIEDDPSYNPQEPFINRDPRFYNNILFDGVPWTVTTSNPTNK
TGFTDLAIINEDGNLGFDFRDPNTPTNREWQVKNKTGLKIRKWLPNGYFLTQGWKGSLDF
YTNNSVFRMAEIYLNYAEAANEAYGPGGTAPGATLSALDAVNKIRNRVGMPNVNGAYSGS
KDGLRDRIRNERAIELCFEGFRYDDIRRWKTAHLEENLKVEFLEMRWQGGTSSTYPTGFS
FENVEQSDLKKTFTDRNYWWPIPSSEIEAVPSFKQTEGW
>FCMOIPGL_03448 TonB-dependent receptor SusC
MKITIKELKGFVFCVLNVLAINIGVAQNTPLNNLAVQDSLKTKGNNELLKTPFGVFNIGQ
TTGAVFRISGDELRKSGGDNLINSLRGRVPGLRIVRTSNTPGNGGYSYTLNGGTPNVLID
GQPRGLQVDLRDVDEVIVLSDATFNALLGNLGDNGLIYVVTKGNKLSKPAIEVNYQVGYS
TPTHLPKLLSASEYATIINEASNNDGLGNVYSPEAIEAYKNGSDPINFPNVDTQETYLSN
LAASNYMSLNLYGASEKVSYSAFLGYSDWEGLEKVGSKIDGRNITFRTKIDTKINDLVKA
HASVYGRFGENERPVIGPDDTFRWITNTPANAFPLMVGDSAYVVNNQFQTNLLSELENGG
TRTDYTSNMIFDIGFDFDLDQFVPGLAYDTYIMMKTYNAHSLLTNNQPALYTLENLEDTN
GLDSLALKVYKNEVLDLSIGRTGGAIQRNFAYGGNLSYVKETAKGILNLNLSHLLFYQPN
ITASQTDQRNFTVNLNGSYALENKYILFANANSSSSSRFLDNHKTKMYPTVGAAWVASNE
NFLKDSKVIDYLKFRTSYGIVGTEYGFTTLLYLDTWSGGRNNGTTYLGTNGNLSQDELGY
RLNTTGNDEIDWVEYNQLFAGVELQMFKKLKLDFNYFNILINNQVIRASQLYASALGNDV
YLPQLNFKESRNKGFNTNITFSDSKDSFKYHISANAGYNKVIGEKIAEVQYPDEYRLQQG
QAQDNIVGYVSDGLYTAENIGSALPQFGDLQVGDVKYVDLNGDNVIDSRDTKTIGNSNPR
VNYGINFGFEYKGINLDVVGMGVTGYDINLNSYAYYQHGGLGNYYGSVNSDLPNGNANPR
LSTLTSINNNKNSDYWLLNGGYFKIANVELGYSLPESIISDSSFADVKLFLRGSNLAVFS
KMKDLDPENINAGFSQYPMMRTFTLGASINF
>FCMOIPGL_03449 hypothetical protein
MKLTKNILIISVLMLSITGCESFLEDTIQYTSEEEVLTSGQRSRGLIDDIYTDYSFRYFT
DFSVEYLTDNGVLNSSATNFANNNWGPAESHPNNYIWQQSYNNIRQIYQYIEEVHNTGLP
YLPSEASASLSDIIVSRYYGEAHFLKAWAEWELLKTYGGPAADGTMLGFPIVNEVLENEE
YALLSRNTYDECVDQIMADLAVAIDHLPLIYSGADKDNPGTSDLETGRASGLAAYALKAK
VALFAASPAFNPTNDVTKWQLAAEYAQEVIQLNGGLKSLQSINNSREDNPDHIWRLRNSR
NNNSLENRLYPPTLYGQGEVNPSQNLVDAFPDANGFPITDASSTYDATAPYASRDSRFYK
FIFYNGDQCFTSENCTDFSPLETYQGGLDNFGGFIANEGTRTGYYLKKYLSNLNFDPSAN
NNPLTTLPKVYVQLGLTEVYLNYVEAVIEGYGEVETAPAGLNYSAKEVLAQIRKRAGLSN
DPYLNTAATDVNVFKDLLKSERRLELSFTGERFHDLRRWKEIDKIEDLKGVKIIKNTDDS
FSYQEITVEQRGYQNKNYYLPLPYAELILNSNLKQNQGWE
>FCMOIPGL_03450 hypothetical protein
MKNNKLRSFTKILVLAVLALSMTSCYDDFVENEFEFTSVYLPKETIDRTFIMGEGMQIGV
GVVLGGRLDNREDVEVSFSLDESLLDPGSALPASYYSLVDADGNPANNKIIIPAGKTQGF
VYVKADSINFLNDPVSLGNNYALGFTLDNVVKADSILVDYKSTKITFTYINQLYGNYVQK
GAYTKDDGTTVETVEYPKDNSNISEAIELTMVSPNTLEYKGLLNLGDDRKLNLVVADDNS
ITIETAPGGVNVVDDGGSSYNPDTREIKLNYSFSYNGVDYKVSDVLEFRNRIVDGVNQYD
I
>FCMOIPGL_03451 Acetyl esterase
MKTSVIVIFLFYFFSSFSQTKTVSLENAKGIIADNLGSVTLWENQIDGYGDASQSDTNLG
AEESQETYPGKTTVLFNKDGSFLELEGSSTYISDNSYSVFYVGKAENEVTGKPASLLGNY
DMSGGFSNCKGIRFVRLQDGKIGFDYGRPNYTRVNIGSNEIPAEDYFFFGFSMDSSGNYQ
YFDSTSPIITTGTITNTMHINSDVDLKFNIFEEVAGAQTYNHTEVVEVTMYDGSLDTAAF
QNEYNRLATEYAELVTAKFSVTEVLPAERTNLSVDSDITVVCDQPIDPTSVFPKIYINKS
ETEAAGNWVLTKSNTLKFTPNTNWPYNGLVTLEINEGLKSTDDVSVNLSKGTKYNFLVET
DKDFGVSENIELTSIATVDFPQAGHTLGLKMNLPTNRTQKTPVHFWVHGGGWSGGTPEAS
AGSYSPHGEYLAENLGIATLGIGYRCSGSSGTFSLAMEDIAAAYQWALDNADTYNFDMTK
VFFSGGSAGTPLAALASQQLPNVIGFIGFNGIYDFVNDAGDFGVGNWYKQNVPSETANSP
IFNLRTPPPATIMMHGDADTTISYTQSTLFADAINANGGQAEAVIYPGEVHAFFNQGKSA
YEDVLIEMVGFINRVLNEQSLSLTDISIDDQITVYPNPVKKGDTLTLQLKSKFSSEKLET
QIINYLGQIVVKKTLYPNKDSNVIKIDTKNLEQGVYILKTFDQQLSKTLKFLIE
>FCMOIPGL_03452 hypothetical protein
MRLKFFYVLAFLFAINNFAQTTSCGNVVNDTFDVAGALPEGWTEYSTSGSVTVVNDYLKF
NLAQNTPSAYRTFTPVSNNSSCSFDVQGSRTTMNFQMDLVSSDGKYIASIALGKATTDIK
YATEMVNTIPGTYIAGVIGTAKFAKNKNYSLSLYVDFDNQTVDFYNDGVLTLENIPFLEA
TTNFAKVDAKLLYMYSNSGTAFLDNLTIVEANESRIALSNAIDSSQNTINAAIVGDKYSQ
YPQSAVDNFQLAIDNANVVLANCDATSSVMDAAISDLQTAQNIFATTSVNDPVLKMYSGY
DFTGDVNEVYCGYYNGGLGAYEDWGVSFTLEKGYMATFAQDVNGLGFSKIYIAQDDDLEI
NLPVDLQSSISFIRVSPWYPVGKKGSLGGDIKWSSADNYNTTWHYSWGLTDQKSEGVQFV
PMSWSKGDNWTSIENMEKVGQNMSFNHLLAFNEPDNKDQSNLTVEQALDAYPKLLASGLR
LGAPGVENVQYSATSDSFNESSWIKEFMDGCVERGYRVDFIPAHDYVRRSKSTFLERFKA
LHDRYDLPVWVTEYNYGNPNMGSAPLTVEQGYNNIKGLTEVLENADFIERYNWYYFFGAD
SGIGGITDGELNITGQFYRDLDSQNPSYIQEEYEQGAQLSVNDALIKSKVLMFPTVITEG
VFNLRYSEEIKDSTIHIYSTVGQLVKKIVGLKSEIDVRTLSSGLYIVKIESHLGNFTKKI
IIQ
>FCMOIPGL_03453 hypothetical protein
MKLKLLYIIASLFAINNFAQTTSCETIVEDTFDTAGVLSEGWTEYSTSGSVTVVNDYLKF
NLAQNTPSAYRTFASVSNNCSLSFDVQGSRNTMNFQMDLVSSDGKYIASIALGKATSDIK
YATEMVDVIPGTYIAGVIGTAKFAKNKNYSLSMYVDFDNQTVDFYNDGELTLENIPFLET
TTDFTKVDTKLLYMYSNSGTVFLDNLTVIEANESRIALSNAVQSSQNLLSSASVGEKYSQ
YPQAAIDAFQLVVDNGNTILSDCDSAASIIDNALAELKEAQDVFSASQVNDPVLKVYNSY
NFGGEEHEIYVGYYNGDLGLYDDWIASFTLDKGYMVTFAENINGTGFSKVYVASEEDLRI
NLTEDLYKKISFIRVGPWRDTLKKGSSGKSSTNDVTLALNTSWFYDWGNGDTDIEGNEYV
VMNWGGTPSLATMEKLGKQMNTTHHLAFNEPDGEKQANMSVDVAVARYATLQASGLRLGA
PAVTDGTKGRAWLDEFMTKAKAAGYRIDFIPVHYYKIMTASNFKAWLKDFYDEYQVPIWV
TEFNYGDIWAANEKTKTEAQVLTNIKAYCEMMDDADFIERYCIFTWQPSETSAQTVMSVR
NPIVLNTVGEFYKNHESPVAYIQETYEQGVALSLDKNVIAPKFSVYPTVITNGVFNWSVS
EEINNIRLSIYNTSGQLVKEIEKPNLEINVSKLSGGLYFVKINSDLGSATKKIIIE
>FCMOIPGL_03454 hypothetical protein
MKTKIFFLLIICCFNFSAFSQKYVNDMDYVLGDTKQAFITNAITTEAQADNLLLGFKNMG
ANGIRIPLFGRGVDGVDLNPNKPMMDYFYEQALAQGFVIFANPAQGGGGKRVANNMLNGN
GANEGEDVAVKNIQAATDELVNRVIEFSNEYPDCKWINPFNEDGRATNSTWSINQINEIY
KRLYEHGLNGAELIGPCTWGLVAGIDMFNKTDIAEYVTVASTHNLGFNHNLWVDFIAEAD
KENLPVWDSEVNHNDKFPDDDVKGGTRLERAIENKVDGLVLYNSWNTVSLTTGAINATGE
KAMALYLIPKVNLALNGTATQSSTNPSYNKGPELAIDNDINGNYGGGSVTVTNNEENPWW
QVDLGSNKTINEIKVFNRTDGCCKANMSNFTVSVINNSGLEVFTQTFTTFPDPSVIVNAG
GIVGQIVKVQLNATGSLTLAEVQVFGSDEVLSTKSYNDIKVNLSPNPFKGNLKVTSPNSS
FNNYTIYNINGQKVLSNKVEANSSEININTSKLSKGIYFVKLNSDTFSKSYKVIKN
>FCMOIPGL_03455 hypothetical protein
MYLNIRIVKRFFILLFIGVNSVAFSQTIYTNDMDYVLGDVKQRFITKDISTQEEADNLLK
GFTTMKVNGIRLPIFPAGWDYNKDIMQYFFTQAKSQGFLIYANPAQDSGARRIASGTLLS
ADLIATNNNAAATATVISTVSQFALDYPGLKWINPFNEDGRPGGAWTAAQINAIYSGVKA
NLESYFTAGQIPNVPELIGPCSWGIPASIDMLNNSNIGEYITVASSHNLGSNDSSWSTFI
AAANNNTTNGVSNPLPVWDSEVNNSVGRDGGTTTRIDAAIANKVDGLVIYNSGNNIFKGS
GELTALNELYMSKYLKDETIEDLGVNVAPNGTATQSSVGYAGATSDKAIDGITDGLLADN
SLSIIRGDDTPPYWEVDLGANKEIGYIRIYNRTDNCCKNRLENFTVYVMDNNRVITFSKT
YTSYPDPSVTMEVNKSGQIVRVESDATDGTALNLAEVEVYESTQLSIENYEDIKVNLSPN
PFLDNLKITSPNADFNSISIYNINGQKILSTKVEADLSDININTSKFSKGIYMIKLNGVN
FSKTYKIVKE
>FCMOIPGL_03456 hypothetical protein
MNKQFISKILSFFMFLILFSCEKVDQKITIESLLNEMVNREKIAQFPDDNFRLKQESSYN
RASVNPKDTLGWFNNKDHNNNNKDYNFIRIEEKNGQKEWVMMDHKGPGAIVRTWMPFRNP
KNSKTNSIIKFYLDGSDTPALEGNMLDLLNGDGLIPFPLAHKSLRSAVSFFPIPYAKSCK
ITVTERPFFYQFTYREYLAETAVKTFTLEDYKLAKPTIDEVAATLLQSEDKKEFDKGTDF
YQLNPNEEKVFELEKGEAALKNLALKLKSYQDSSVTRSVIIKINFDGKETVWSPIGDFFG
TGVGLHPFKGWYRTVAEDGTLSSRWVMPYQKEAKITIVNLGETAVDFKLKTKVASWKWSE
NSMYFHAGYRQQYPVATRPFSDWNYITIKGRGVYVGDALTVMNPEEKWWGEGDEKIYVDG
EKFPSIFGTGTEDYYAYSWGGISTDFYEHPFHAQPRSNVYNKLNRKTTTERNTLGYSTET
RTRALDGMPFSSSLQLDMEVWSWADCDMQYTLGMYWYGDANSTANVKPVPEQVLIFPSW
>FCMOIPGL_03457 Arylsulfatase
MKTKLKLLLITLIASVSFTSCKTIKENKAADKTEVKEVAKKPNIIYILADDLGYADIGPY
GQTKIKTPNLDRMAAEGIIFTNHYSGSTVCMPSRASLLTGYDQGHASVRGNPVWTNSGKP
VNLKRYEKTVGNELKKVGYKTAVIGKWGLSEGNTNGNFPSEHGFDYFLGYKKHGQAHHYY
ADTLYRNNEPYVLKGNKPLLKQGKYTHDVFVNEALSYVEREKDNPFFLYIALTIPHLEIT
VPEESKEQYLNLGWPKRKMNTKGHYKNDPEGNTTYAGMVSRMDRDIGRLLDKLKELGIDD
NTIVFFSSDNGPEFEKRDKFFNSNGDLRGGKRDLYEGGIRVPLIARYPGKIAPSTKSEHI
SAFWDFLPTVCDLAGVTPENKDINGISFAPELMGKTKNQKEHEYLYWEFNERQGPIQAIR
QGDWKLVWLLEKEPELYNLSLDLGEQNNLAKQNPEKLKEMLSILKNVRTENAEFPLETRV
LALKKRK
>FCMOIPGL_03458 Arylsulfatase
MNKYSCHLLVISLLFFSACSSSKVKTKDEKVVSKKPNIIYILADDLGYGDVSSFNPESKI
PTVNLDKMASNGVMFTDAHTSSAVCTPTRYGILTGRYNWRSSLKSGVLGGYSKSLITPDR
TTVADVLKNQGYTTAYIGKWHMGWDWAFNGEPKETINNLHTIQDVDYTKPIQNGPSTHGF
DYSFGFCGSLDMPPYVYVENDMPTMVPTKMTVNKDSKGVWRKGPTSDDFVHQTVLQDLTD
RALNYIGDKANRNDPFFLYLPLPAPHTPILPSDEFLGKSKTNKYGDFVMQVDDVVGQVRK
KLKDLGISENTLLVFTSDNGCSPKANFKELEKFNHDPSYVFRGMKADIYEGGHHVPFIVE
WPNHALKNISTDITIGTTDFFATCADISGYKIKDTEGEDSYSMLPLLTNKKTKEIREYII
YHSIDGSFAIKQGDWKLCLTQGSAGWSYPKPQEIKKKKLDLPAMQLFNIKEDVSETKNLI
ASNPKKAAELKAALKKIILEGRSTEGVVQTNEGMEGWKQIEKIIN
>FCMOIPGL_03459 hypothetical protein
MVPNSGATYKSDSNNDKYEVLEFSTTKGVINLGCFLTFVKFSIEKGPNGGFSPFGEYNSL
ELFKIYSQ
